PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akagi, D; Chen, MA; Toy, R; Chatterjee, A; Conte, MS				Akagi, Daisuke; Chen, Mian; Toy, Robert; Chatterjee, Anuran; Conte, Michael S.			Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice	FASEB JOURNAL			English	Article						neointimal hyperplasia; inflammation; vascular remodeling; fatty acid	PERIPHERAL ARTERIAL-DISEASE; SMOOTH-MUSCLE-CELLS; DOCOSAHEXAENOIC ACID; NEOINTIMAL FORMATION; CAROTID-ARTERY; BLOOD-FLOW; MODEL; ATHEROSCLEROSIS; RESOLUTION; PHENOTYPE	Vascular injury induces a potent inflammatory response that influences vessel remodeling and patency, limiting long-term benefits of cardiovascular interventions such as angioplasty. Specialized proresolving lipid mediators (SPMs) derived from omega-3 polyunsaturated fatty acids [eicosapentaenoic acid and docosahexaenoic acid (DHA)] orchestrate resolution in diverse settings of acute inflammation. We hypothesized that systemic administration of DHA-derived SPMs [resolvin D2 (RvD2) andmaresin1 (MaR1)] would influence vessel remodeling in a mouse model of arterial neointima formation (carotid ligation). In vitro, SPM treatment inhibited mouse aortic smooth muscle cell migration (IC50 congruent to 1 nM) to a PDGF gradient and reduced TNF-alpha-stimulated p65 translocation, superoxide production, and proinflammatory gene expression (MCP-1). In vivo, adult FVB mice underwent unilateral carotid artery ligation with administration of RvD2, MaR1, or vehicle (100 ng by intraperitoneal injection at 0, 1, 3, 5, and 7 d after ligation). In ligated carotid arteries at 4 d, SPM treatment was associated with reduced cell proliferation and neutrophil and macrophage recruitment and increased polarization of M2 macrophages in the arterial wall. Neointimal hyperplasia (at 14 d) was notably attenuated in RvD2 (62%)-and MaR1 (67%)-treatedmice, respectively. Modulation of resolution pathways may offer new opportunities to regulate the vascular injury response and promote vascular homeostasis.	[Conte, Michael S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conte, MS (corresponding author), Univ Calif San Francisco, Dept Surg, 400 Parnassus Ave,Suite A-581, San Francisco, CA 94143 USA.	michael.conte2@ucsf.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL119508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Giorgio Mottola, who provided technical and analytic support for the scratch migration assays. This work was supported in part by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL119508 (to M.S.C.).	Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Godin D, 2000, CIRCULATION, V102, P2861; Gong J, 2014, BRIT J PHARMACOL, V171, P3539, DOI 10.1111/bph.12714; Ho KJ, 2008, AM J PHYSIOL-HEART C, V295, pH1132, DOI 10.1152/ajpheart.00079.2008; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Holt A.W., 2013, ISRN MINIM INVASIVE, V2013, DOI DOI 10.1155/2013/167407; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jones DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000345; Katakura M, 2014, MOLECULES, V19, P3247, DOI 10.3390/molecules19033247; Khatri JJ, 2004, CIRCULATION, V109, P520, DOI 10.1161/01.CIR.0000109698.70638.2B; Klein CP, 2014, NEUROPHARMACOLOGY, V86, P57, DOI 10.1016/j.neuropharm.2014.05.043; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Kumar A, 1997, CIRCULATION, V96, P4333; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; McCauley LK, 2014, J IMMUNOL, V193, P26, DOI 10.4049/jimmunol.1301945; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nosova EV, 2014, J VASC SURG, V60, P1325, DOI 10.1016/j.jvs.2014.05.040; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Petri MH, 2015, INT J CARDIOL, V179, P370, DOI 10.1016/j.ijcard.2014.11.010; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saw J, 2006, J AM COLL CARDIOL, V48, P1567, DOI 10.1016/j.jacc.2006.03.067; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Steffens JP, 2014, HORM METAB RES, V46, P193, DOI 10.1055/s-0034-1367031; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	46	71	73	4	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2504	2513		10.1096/fj.14-265363	http://dx.doi.org/10.1096/fj.14-265363			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25777995	Green Published, Green Submitted			2022-12-26	WOS:000355209500027
J	Edwards-Jones, B; Aw, R; Barton, GR; Tredwell, GD; Bundy, JG; Leak, DJ				Edwards-Jones, Bryn; Aw, Rochelle; Barton, Geraint R.; Tredwell, Gregory D.; Bundy, Jacob G.; Leak, David J.			Translational Arrest Due to Cytoplasmic Redox Stress Delays Adaptation to Growth on Methanol and Heterologous Protein Expression in a Typical Fed-Batch Culture of Pichia pastoris	PLOS ONE			English	Article							UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; ASPERGILLUS-NIGER; ALCOHOL OXIDASE; GENE-EXPRESSION; CARBON-SOURCES; D-ARABITOL; ANNOTATION; INITIATION; YEAST	Results We have followed a typical fed-batch induction regime for heterologous protein production under the control of the AOX1 promoter using bothmicroarray and metabolomic analysis. The genetic constructs involved 1 and 3 copies of the TRY1 gene, encoding human trypsinogen. In small-scale laboratory cultures, expression of the 3 copy-number construct induced the unfolded protein response (UPR) sufficiently that titres of extracellular trypsinogen were lower in the 3-copy construct than with the 1-copy construct. In the fed-batch-culture, a similar pattern was observed, with higher expression from the 1-copy construct, but in this case there was no significant induction of UPR with the 3-copy strain. Analysis of the microarray and metabolomic information indicates that the 3-copy strain was undergoing cytoplasmic redox stress at the point of induction withmethanol. In this Crabtree-negative yeast, this redox stress appeared to delay the adaptation to growth on methanol and supressed heterologous protein production, probably due to a block in translation. Conclusion Although redox imbalance as a result of artificially imposed hypoxia has previously been described, this is the first time that it has been characterised as a result of a transient metabolic imbalance and shown to involve a stress response which can lead to translational arrest. Without detailed analysis of the underlying processes it could easily have been mis-interpreted as secretion stress, transmitted through the UPR.	[Edwards-Jones, Bryn; Aw, Rochelle; Barton, Geraint R.; Leak, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London SW7 2AZ, England; [Tredwell, Gregory D.; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg Canc, Fac Med, London SW7 2AZ, England; [Leak, David J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Imperial College London; Imperial College London; University of Bath	Leak, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London SW7 2AZ, England.	d.j.leak@bath.ac.uk	Tredwell, Greg/L-2294-2015; Bundy, Jacob G/C-2131-2008	Tredwell, Greg/0000-0002-0020-5626; Bundy, Jacob G/0000-0002-1164-8465; Aw, Rochelle/0000-0002-8480-9813	Bioprocessing Research Industry Club [BBF0049071]; Fujifilm Diosynth Biotechnologies; BBSRC [BB/F004907/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004907/1] Funding Source: researchfish	Bioprocessing Research Industry Club; Fujifilm Diosynth Biotechnologies; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the Bioprocessing Research Industry Club (supported by contributions from industrial members and the Biotechnology and Biological Sciences Research Council http://www.bbsrc.ac.uk) for grant (BBF0049071) support to DJL and JRB, and, together with Avecia Biologics Ltd (now Fujifilm Diosynth Biotechnologies) CASE studentship support to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Baumann K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-141; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BELLINGER Y, 1988, CAN J MICROBIOL, V34, P605, DOI 10.1139/m88-100; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brown A D, 1978, Adv Microb Physiol, V17, P181, DOI 10.1016/S0065-2911(08)60058-2; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Diano A, 2006, BIOTECHNOL BIOENG, V94, P899, DOI 10.1002/bit.20915; Diano A, 2009, BIOTECHNOL BIOENG, V103, P956, DOI 10.1002/bit.22329; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dragosits M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-207; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Guarna MM, 1997, BIOTECHNOL BIOENG, V56, P279, DOI 10.1002/(SICI)1097-0290(19971105)56:3<279::AID-BIT5>3.0.CO;2-G; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Hesketh AR, 2013, APPL MICROBIOL BIOT, V97, P9747, DOI 10.1007/s00253-013-5186-1; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hohenblum H, 2004, BIOTECHNOL BIOENG, V85, P367, DOI 10.1002/bit.10904; Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Jungo C, 2007, J BIOTECHNOL, V130, P236, DOI 10.1016/j.jbiotec.2007.04.004; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kayingo G, 2005, MICROBIOL-SGM, V151, P2987, DOI 10.1099/mic.0.28040-0; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Krainer FW, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-22; Kurtzman CP, 2009, J IND MICROBIOL BIOT, V36, P1435, DOI 10.1007/s10295-009-0638-4; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Liang SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-738; Love KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037915; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sreekrishna K, 2009, ENCY IND BIOTECHNOLO; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tredwell GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016286; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; WONG B, 1995, J BACTERIOL, V177, P2971, DOI 10.1128/jb.177.11.2971-2976.1995; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xiao LJ, 2009, CURR GENOMICS, V10, P198, DOI 10.2174/138920209788185261; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	57	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119637	10.1371/journal.pone.0119637	http://dx.doi.org/10.1371/journal.pone.0119637			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785713	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500124
J	Hernandez, JC; Giraldo, DM; Paul, S; Urcuqui-Inchima, S				Hernandez, Juan C.; Giraldo, Diana M.; Paul, Stephane; Urcuqui-Inchima, Silvio			Involvement of Neutrophil Hyporesponse and the Role of Toll-Like Receptors in Human Immunodeficiency Virus 1 Protection	PLOS ONE			English	Article							IMPAIRED OXIDATIVE BURST; INNATE IMMUNE-RESPONSE; INFECTED PATIENTS; TYPE-1 INFECTION; HIV-1 INFECTION; VIRAL LOAD; L-SELECTIN; ACTIVATION; EXPRESSION; CELLS	Objectives Neutrophils contribute to pathogen clearance through pattern recognition receptors (PRRs) activation. However, the role of PRRs in neutrophils in both HIV-1-infected [HIV-1(+)] and HIV-1-exposed seronegative individuals (HESN) is unknown. Here, a study was carried out to evaluate the level of PRR mRNAs and cytokines produced after activation of neutrophils from HIV-1(+), HESN and healthy donors. Methods The neutrophils were stimulated with specific agonists for TLR2, TLR4 and TLR9 in the presence of HIV-1 particles. Pro-inflammatory cytokine production, expression of neutrophil activation markers and reactive oxygen species (ROS) production were analyzed in neutrophils from HESN, HIV-1(+) and healthy donors (controls). Results We found that neutrophils from HESN presented reduced expression of PRR mRNAs (TLR4, TLR9, NOD1, NOD2, NLRC4 and RIG-I) and reduced expression of cytokine mRNAs (IL-1 beta, IL-6, IL-18, TNF-alpha and TGF-beta). Moreover, neutrophils from HESN were less sensitive to stimulation through TLR4. Furthermore, neutrophils from HESN challenged with HIV-1 and stimulated with TLR2 and TLR4 agonists, produced significantly lower levels of reactive oxygen species, versus HIV-1(+). Conclusions A differential pattern of PRR expression and release of innate immune factors in neutrophils from HESN is evident. Our results suggest that lower neutrophil activation can be involved in protection against HIV-1 infection.	[Hernandez, Juan C.] Univ Cooperat Colombia, Fac Med, INFETTARE, Medellin, Colombia; [Giraldo, Diana M.; Urcuqui-Inchima, Silvio] Univ Antioquia, Fac Med, Grupo Inmunovirol, Medellin, Colombia; [Paul, Stephane] Univ Lyon, Fac Med St Etienne, GIMAP EA3064, Lyon, France	Universidad Cooperativa de Colombia; Universidad de Antioquia	Urcuqui-Inchima, S (corresponding author), Univ Antioquia, Fac Med, Grupo Inmunovirol, Medellin, Colombia.	silviourcuqui@gmail.com	Hernandez, Juan C./C-1621-2018	Hernandez, Juan C./0000-0002-9200-5698; Urcuqui-Inchima, Silvio/0000-0002-2865-3041; Giraldo Giraldo, Diana Marcela/0000-0002-3455-6846; paul, stephane/0000-0002-8830-4273	COLCIENCIAS, Colombia [111549326099]; Universidad de Antioquia (Sostenibilidad)	COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia (Sostenibilidad)	This study was supported by COLCIENCIAS, grant number 111549326099, Colombia, and Universidad de Antioquia (Sostenibilidad 2014-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Barquero AA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/989101; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Babadoko A A, 2008, Niger J Med, V17, P57; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; CLERICI M, 1991, J INFECT DIS, V164, P178, DOI 10.1093/infdis/164.1.178; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; Correa RG, 2012, BIOSCIENCE REP, V32, P597, DOI 10.1042/BSR20120055; Cote SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067735; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; ELBIM C, 1994, BLOOD, V84, P2759, DOI 10.1182/blood.V84.8.2759.bloodjournal8482759; Elbim C, 1999, J VIROL, V73, P4561, DOI 10.1128/JVI.73.6.4561-4566.1999; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350; Gabali AM, 2004, J VIROL, V78, P10833, DOI 10.1128/JVI.78.19.10833-10836.2004; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12019; Goh WC, 1999, J INFECT DIS, V179, P548, DOI 10.1086/314632; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hernandez JC, 2014, INTERVIROLOGY, V57, P36, DOI 10.1159/000353902; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Hernandez JC, 2012, AIDS RES HUM RETROV, V28, P1313, DOI 10.1089/aid.2011.0297; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jadhav VS, 2014, J NEUROCHEM; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; KIMURA T, 1993, FEBS LETT, V326, P232, DOI 10.1016/0014-5793(93)81797-4; Kourtis AP, 2000, AIDS, V14, P2429, DOI 10.1097/00002030-200011100-00003; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Marodon G, 1999, AIDS RES HUM RETROV, V15, P161, DOI 10.1089/088922299311583; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Pavot V, 2013, J CONTROL RELEASE, V167, P60, DOI 10.1016/j.jconrel.2013.01.015; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; RANKI A, 1989, AIDS, V3, P63, DOI 10.1097/00002030-198902000-00002; Remer KA, 2003, IMMUNOL LETT, V85, P75, DOI 10.1016/S0165-2478(02)00210-9; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Sawahata R, 2011, MICROBES INFECT, V13, P350, DOI 10.1016/j.micinf.2010.12.003; Schwartz R, 2010, BIOMED PHARMACOTHER, V64, P572, DOI 10.1016/j.biopha.2010.03.005; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Victoria S, 2013, IMMUNOBIOLOGY, V218, P1529, DOI 10.1016/j.imbio.2013.06.006; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463	60	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119844	10.1371/journal.pone.0119844	http://dx.doi.org/10.1371/journal.pone.0119844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785697	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500132
J	Johnson, EO; Hancock, DB; Gaddis, NC; Levy, JL; Page, G; Novak, SP; Glasheen, C; Saccone, NL; Rice, JP; Moreau, MP; Doheny, KF; Romm, JM; Brooks, AI; Aouizerat, BE; Bierut, LJ; Kral, AH				Johnson, Eric O.; Hancock, Dana B.; Gaddis, Nathan C.; Levy, Joshua L.; Page, Grier; Novak, Scott P.; Glasheen, Cristie; Saccone, Nancy L.; Rice, John P.; Moreau, Michael P.; Doheny, Kimberly F.; Romm, Jane M.; Brooks, Andrew I.; Aouizerat, Bradley E.; Bierut, Laura J.; Kral, Alex H.			Novel Genetic Locus Implicated for HIV-1 Acquisition with Putative Regulatory Links to HIV Replication and Infectivity: A Genome-Wide Association Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; SAN-FRANCISCO; METAANALYSIS; TRANSMISSION; INDIVIDUALS; RESISTANCE; RISK; DISEQUILIBRIUM; POLYMORPHISM; POPULATION	Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics. Thus identifying genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development. To date, however, CCR5 remains the only gene conclusively associated with HIV acquisition. To identify novel host genetic determinants of HIV-1 acquisition, we conducted a genome-wide association study among a high-risk sample of 3,136 injection drug users (IDUs) from the Urban Health Study (UHS). In addition to being IDUs, HIV-controls were frequency-matched to cases on environmental exposures to enhance detection of genetic effects. We tested independent replication in the Women's Interagency HIV Study (N=2,533). We also examined publicly available gene expression data to link SNPs associated with HIV acquisition to known mechanisms affecting HIV replication/infectivity. Analysis of the UHS nominated eight genetic regions for replication testing. SNP rs4878712 in FRMPD1 met multiple testing correction for independent replication (P=1.38x10(-4)), although the UHS-WIHS meta-analysis p-value did not reach genome-wide significance (P=4.47x10(-7) vs. P<5.0x10(-8)) Gene expression analyses provided promising biological support for the protective G allele at rs4878712 lowering risk of HIV: (1) the G allele was associated with reduced expression of FBXO10 (r=-0.49, P=6.9x10(-5)); (2) FBXO10 is a component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase complex that targets Bcl-2 protein for degradation; (3) lower FBXO10 expression was associated with higher BCL2 expression (r=-0.49, P=8x10(-5)); (4) higher basal levels of Bcl-2 are known to reduce HIV replication and infectivity in human and animal in vitro studies. These results suggest new potential biological pathways by which host genetics affect susceptibility to HIV upon exposure for follow-up in subsequent studies.	[Johnson, Eric O.; Hancock, Dana B.; Gaddis, Nathan C.; Levy, Joshua L.; Page, Grier; Novak, Scott P.; Glasheen, Cristie; Kral, Alex H.] RTI Int, Res Triangle Pk, NC 27709 USA; [Saccone, Nancy L.; Rice, John P.; Bierut, Laura J.] Washington Univ, Sch Med, St Louis, MO USA; [Moreau, Michael P.; Brooks, Andrew I.] Rutgers Univ Cell & DNA Repository RUCDR, Piscataway, NJ USA; [Doheny, Kimberly F.; Romm, Jane M.] Johns Hopkins Univ, CIDR, Baltimore, MD USA; [Aouizerat, Bradley E.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Aouizerat, Bradley E.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Research Triangle Institute; Washington University (WUSTL); Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, EO (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	ejohnson@rti.org	Bierut, Laura Jean/W-6806-2019; Gaddis, Nathan/GXG-6395-2022; Gaddis, Nathan/GXG-6447-2022	Bierut, Laura Jean/0000-0002-9952-4810; Kral, Alex/0000-0002-9092-3671; Johnson, Eric Otto/0000-0002-8870-1949; Page, Grier/0000-0003-2582-3786; Gaddis, Nathan/0000-0001-5205-7138; Hancock, Dana/0000-0003-2240-3604	National Institute of Drug Abuse (NIDA) [R01 DA026141, X01 HG005275]; NIDA Center [N01DA-09-7770]; NIH [HHSN268201100011I, HHSN268200782096C]; National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131];  [AI034989-S17]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994, U01AI034993, U01AI034989, U01AI031834, U01AI042590, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038632, R01DA026141] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (NIDA) grants R01 DA026141 and X01 HG005275: EOJ. Storage and processing of UHS serum samples for DNA extraction and genotyping was conducted by the Rutgers University Cell and DNA Repository was supported by the NIDA Center for Genetics under contract (N01DA-09-7770). Genotyping was conducted by the Center for Inherited Disease and supported by NIH contracts HHSN268201100011I and HHSN268200782096C. Women's Interagency HIV Study: Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. Genome-wide genotyping of the WIHS samples was supported by supplemental funding AI034989-S17: BEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; [Anonymous], 1992, BMJ, V304, P809; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Goldstein DB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001008; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Joubert BR, 2010, GENOME MED, V2, DOI 10.1186/gm138; Kral AH, 2003, AM J EPIDEMIOL, V157, P915, DOI 10.1093/aje/kwg070; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lane J, 2013, HUM MOL GENET, V22, P1903, DOI 10.1093/hmg/ddt033; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Limou S, 2012, J INFECT DIS, V205, P1155, DOI 10.1093/infdis/jis028; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Luo M, 2012, J VIROL, V86, P11899, DOI 10.1128/JVI.01499-12; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Myers RA, 2012, J ALLERGY CLIN IMMUN, V130, P1294, DOI 10.1016/j.jaci.2012.07.054; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan Z, 2013, J MOL BIOL, V425, P1039, DOI 10.1016/j.jmb.2013.01.003; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Telenti A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007203; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Vassena L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002636; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Xu X, 2012, MOL CARCINOG; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118149	10.1371/journal.pone.0118149	http://dx.doi.org/10.1371/journal.pone.0118149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786224	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500022
J	Ma, PS; Foote, DC; Sinnamon, AJ; Brass, LF				Ma, Peisong; Foote, Darci C.; Sinnamon, Andrew J.; Brass, Lawrence F.			Dissociation of SHP-1 from Spinophilin during Platelet Activation Exposes an Inhibitory Binding Site for Protein Phosphatase-1 (PP1)	PLOS ONE			English	Article							OKADAIC ACID; COUPLED-RECEPTORS; PHOSPHORYLATION; AGGREGATION; SPECIFICITY; ISOFORMS; SUBUNIT; GAMMA-1; COMPLEX; CELLS	We have recently shown that a critical regulatory node in the platelet signaling network lies immediately downstream of platelet receptors for thrombin and TxA2. This node is comprised of a scaffold protein (spinophilin, SPL), a protein tyrosine phosphatase (SHP-1), and either of the two members of the Regulators of G protein Signaling family predominantly expressed in platelets (RGS10 or RGS18). The SPL/RGS/SHP-1 complex is present in resting platelets, dissociating when thrombin or TxA2, but not ADP or collagen, activate SHP-1 and release RGS10 and RGS18 to dampen signaling. Here we demonstrate an additional regulatory role for spinophilin, showing that dissociation of SHP-1 from spinophilin is followed by an increase in the binding of spinophilin to PP1, a serine/threonine phosphatase whose binding site maps to a region close to the SHP-1 binding site. The increase in PP1 binding to spinophilin is limited to platelet agonists that cause dissociation of the complex and is selective for the a and. isoforms of PP1. Studies in cell culture show that SHP-1 and PP1 can compete for binding to spinophilin and that binding inhibits PP1 activity since over-expression of wild type spinophilin, but not spinophilin with a disabled PP1 binding site, causes an increase in the phosphorylation of myosin light chain, a well-characterized PP1 substrate. Collectively, these results indicate that in addition to regulating RGS protein availability in resting platelets, spinophilin can serve as a time-dependent, agonist-and isoform-selective regulator of PP1, inhibiting its activity when decay of the SPL/RGS/SHP-1 complex releases SHP-1 from spinophilin, exposing a binding site for PP1.	[Ma, Peisong; Foote, Darci C.; Sinnamon, Andrew J.; Brass, Lawrence F.] Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ma, PS (corresponding author), Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA.	peisong@mail.med.upenn.edu; brass@mail.med.upenn.edu	Ma, Peisong/AAM-7211-2020	Ma, Peisong/0000-0002-5486-8695	National Institute of Health (NIH) [R01-HL93123]; American heart Association (AHA) [14SDG20380473]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093123] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American heart Association (AHA)(American Heart Association); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institute of Health (NIH) R01-HL93123 (L.F.B.) and American heart Association (AHA) 14SDG20380473 (P.M.). A.S. and D.F. were supported by American Society of Hematology trainee research awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Brass LF, 2012, BLOOD, V119, P3651, DOI 10.1182/blood-2012-02-406629; Brass LF, 2013, PLATELETS, P367, DOI DOI 10.3109/09537104.2013.821602; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Delesque-Touchard N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113215; Ferrer I, 2011, CELL CYCLE, V10, P2751, DOI 10.4161/cc.10.16.16422; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gushiken FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008304; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Johnson GJ, 2007, J THROMB HAEMOST, V5, P1516, DOI 10.1111/j.1538-7836.2007.02611.x; Korrodi-Gregorio L, 2014, TRANSL RES, V164, P366, DOI 10.1016/j.trsl.2014.07.001; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; LEREA KM, 1991, BIOCHEMISTRY-US, V30, P6819, DOI 10.1021/bi00242a003; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Zeiler M, 2014, MOL CELL PROTEOMICS, V13, P3435, DOI 10.1074/mcp.M114.038513; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zsuzsa S, 2010, PLATELETS, V21, P555, DOI 10.3109/09537104.2010.499156	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119496	10.1371/journal.pone.0119496	http://dx.doi.org/10.1371/journal.pone.0119496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785436	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500106
J	Qiu, FF; Sun, R; Deng, N; Guo, TY; Cao, YG; Yu, Y; Wang, XJ; Zou, BC; Zhang, SM; Jing, T; Ling, T; Xie, J; Zhang, Q				Qiu, Feifei; Sun, Rui; Deng, Ning; Guo, Tianyu; Cao, Yange; Yu, Ying; Wang, Xuejun; Zou, Bingcheng; Zhang, Songmei; Jing, Tao; Ling, Tao; Xie, Jun; Zhang, Qing			miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene Expression	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MICRORNA EXPRESSION; GROWTH-FACTOR; PROTEIN; CANCER; PROLIFERATION; SIGNATURE; REVEALS; BINDING; OSTEONECTIN	Nasopharyngeal carcinoma (NPC) is a malignant tumor associated with a genetic predisposition, Epstein-Barr virus infection and chromosomal abnormalities. Recently, several miRNAs have been shown to target specific mRNAs to regulate NPC development and progression. However, the involvement of miRNAs in processes leading to NPC migration and invasion remains to be elucidated. We predicted that miR-29a/b are associated with dysregulated genes controlling NPC through an integrated interaction network of miRNAs and genes. miR-29a/b over-expression in NPC cell lines had no significant effect on proliferation, whereas miR-29b mildly increased the percentage of cells in the G1 phase with a concomitant decrease in the percentage of cells in S phase. Furthermore, we demonstrated that miR-29a/b might be responsible for increasing S18 cell migration and invasion, and only COL3A1 was identified as a direct target of miR-29b despite the fact that both SPARC and COL3A1 were inhibited by miR-29a/b over-expression. Meanwhile, SPARC proteins were increased in metastatic NPC tissue and are involved in NPC progression. Unexpectedly, we identified that miRNA-29b expression was elevated in the serum of NPC patients with a high risk of metastasis. The 5-year actuarial overall survival rates in NPC patients with high serum miR-29b expression was significantly shorter than those with low serum miR-29b expression; therefore, serum miR-29b expression could be a promising prognostic marker.	[Qiu, Feifei; Guo, Tianyu; Cao, Yange; Yu, Ying; Wang, Xuejun; Zou, Bingcheng; Zhang, Songmei; Jing, Tao; Ling, Tao; Zhang, Qing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Rui] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Ning] Jinan Univ, Antibody Engn Ctr, Key Lab Mol Immunol & Antibody Engn Guangdong Pro, Guangzhou, Guangdong, Peoples R China; [Xie, Jun] CAFS, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Jinan University; Chinese Academy of Fishery Sciences; Pearl River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Xie, J (corresponding author), CAFS, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.	xiejunhy@yahoo.com.cn; lsszq@mail.sysu.edu.cn	guo, tianyu/AAO-3591-2021	ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [30770923, 31371163, J1310025]; Sci-Tech Project Foundation of Guangdong Province [2011B090400561, 2013B021800065]; Fundamental Research Funds for the Shenzhen of China [GJHZ201404221516216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Project Foundation of Guangdong Province; Fundamental Research Funds for the Shenzhen of China	This work was supported by National Natural Science Foundation of China Grant (30770923, 31371163 and J1310025), Sci-Tech Project Foundation of Guangdong Province (2011B090400561 and 2013B021800065) and Fundamental Research Funds for the Shenzhen of China (GJHZ201404221516216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Amodio N, 2012, ONCOTARGET, V3, P1246; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gerson KD, 2012, J BIOL CHEM, V287, P9835, DOI 10.1074/jbc.M111.317727; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khanfira A, 2007, CANCER RADIOTHER, V11, P461, DOI 10.1016/j.canrad.2007.06.006; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; [李晓霞 LI Xiaoxia], 2007, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V28, P607; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu Ning-bo, 2013, Journal of Signal Processing, V29, P1; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Luna C, 2009, MOL VIS, V15, P2488; Luo JH, 2007, EUR J EPIDEMIOL, V22, P513, DOI 10.1007/s10654-007-9148-8; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ryschich E, 2009, PANCREAS, V38, P804, DOI 10.1097/MPA.0b013e3181b9dfda; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; SOININEN R, 1987, FEBS LETT, V225, P188; Steele Robert, 2010, Genes Cancer, V1, P381; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang HY, 2011, J CLIN ONCOL, V29, P4516, DOI 10.1200/JCO.2010.33.7741; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wei HY, 2012, ACTA OPHTHALMOL, V90, pe138, DOI 10.1111/j.1755-3768.2011.02283.x; Wong TS, 2011, J CANCER RES CLIN, V137, P415, DOI 10.1007/s00432-010-0898-4; WU CY, 1995, J CELL SCI, V108, P2511; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu XC, 2012, INT J MOL MED, V30, P1321, DOI 10.3892/ijmm.2012.1140	63	57	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120969	10.1371/journal.pone.0120969	http://dx.doi.org/10.1371/journal.pone.0120969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786138	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500199
J	Arrey, AE; Bilsen, J; Lacor, P; Deschepper, R				Arrey, Agnes Ebotabe; Bilsen, Johan; Lacor, Patrick; Deschepper, Reginald			"It's My Secret": Fear of Disclosure among Sub-Saharan African Migrant Women Living with HIV/AIDS in Belgium	PLOS ONE			English	Article							HIV-POSITIVE STATUS; PROBABILITY SAMPLE; CARIBBEAN PEOPLE; CARE SERVICES; STIGMA; HEALTH; EXPERIENCES; SEX; DISCRIMINATION; SEROSTATUS	Patients with HIV not only have to deal with the challenges of living with an incurable disease but also with the dilemma of whether or not to disclose their status to their partners, families and friends. This study explores the extent to which sub-Saharan African (SSA) migrant women in Belgium disclose their HIV positive status, reasons for disclosure/non-disclosure and how they deal with HIV disclosure. A qualitative study consisting of interviews with twenty-eight SSA women with HIV/AIDS was conducted. Thematic content analysis was employed to identify themes as they emerged. Our study reveals that these women usually only disclose their status to healthcare professionals because of the treatment and care they need. This selective disclosure is mainly due to the taboo of HIV disease in SSA culture. Stigma, notably self-stigma, greatly impedes HIV disclosure. Techniques to systematically incorporate HIV disclosure into post-test counseling and primary care services are highly recommended.	[Arrey, Agnes Ebotabe; Bilsen, Johan; Deschepper, Reginald] Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium; [Lacor, Patrick] Univ Ziekenhuis Brussel, AIDS Reference Ctr, Dept Internal Med & Infect Dis, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Arrey, AE (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium.	aarrey@vub.ac.be	Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945; Lacor, Patrick/0000-0002-7252-0924	Fonds Wetenschappelijk Onderzoek (FWO) [1901215N LV]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO)	This study was funded by grant number 1901215N LV from Fonds Wetenschappelijk Onderzoek (FWO). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablon Joan, 2002, Epilepsy Behav, V3, P2, DOI 10.1016/S1525-5050(02)00543-7; Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Andersson N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-274; Andersson N, 2012, AIDS BEHAV, V16, P189, DOI 10.1007/s10461-011-9912-3; Barrett HR, 2010, PSYCHOL HEALTH MED, V15, P357, DOI 10.1080/13548501003653192; Belgian Federal Government, 2013, PROTECTION DE LA VIE; Bharat S, 2011, SAHARA J-J SOC ASP H, V8, P138, DOI 10.1080/17290376.2011.9724996; Bos Arjan E R, 2009, Issues Ment Health Nurs, V30, P509, DOI 10.1080/01612840802601382; Bradley EH, 2011, HEALTH SERV RES, V46, P2019, DOI 10.1111/j.1475-6773.2011.01349.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Canadian HIV/AIDS Legal Network 2, 2014, CRIMINAL LAW AND HIV; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; Castles S, 2010, J ETHN MIGR STUD, V36, P1565, DOI 10.1080/1369183X.2010.489381; Cave J, 2012, BRIT J GEN PRACT, V62, P348, DOI 10.3399/bjgp12X652229; Chaudoir SR, 2013, BASIC APPL SOC PSYCH, V35, P75, DOI 10.1080/01973533.2012.746612; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Ciccarone DH, 2003, AM J PUBLIC HEALTH, V93, P949, DOI 10.2105/AJPH.93.6.949; de Alencar TM, 2008, CIENC SAUDE COLETIVA, V13, P1841, DOI 10.1590/S1413-81232008000600019; Degroote S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18643; Dinos S, 2004, BRIT J PSYCHIAT, V184, P176, DOI 10.1192/bjp.184.2.176; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Drummond PD, 2011, HEALTH CARE WOMEN IN, V32, P206, DOI 10.1080/07399332.2010.529216; Duffy L, 2005, J ASSOC NURSE AIDS C, V16, P13, DOI 10.1016/j.jana.2004.11.002; Duru OK, 2006, AIDS BEHAV, V10, P495, DOI 10.1007/s10461-006-9089-3; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; European Central Bank, 2009, MET MAT TENS TEST 1, P1; European Commission, 2012, PROTECTION OF PERSON; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Freund P. E. S., 1999, HEALTH ILLNESS AND T; GOFFMAN ERVING, 1963, STIGMA NOTES ON THE; GOSTIN L, 1987, AM J PUBLIC HEALTH, V77, P361, DOI 10.2105/AJPH.77.3.361; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Hardon A, 2013, SAHARA J-J SOC ASP H, V10, pS1, DOI 10.1080/02664763.2012.755317; Hardon A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-26; Hasan MT, 2012, J HEALTH POPUL NUTR, V30, P22, DOI 10.3329/jhpn.v30i1.11272; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hong Y, 2008, AIDS PATIENT CARE ST, V22, P823, DOI 10.1089/apc.2008.0001; Kaleeba N, 1997, AIDS CARE, V9, P13, DOI 10.1080/09540129750125307; Korner H, 2007, CULT HEALTH SEX, V9, P137, DOI 10.1080/13691050600975462; Lekas HM, 2006, QUAL HEALTH RES, V16, P1165, DOI 10.1177/1049732306292284; Likatavicius G, 2012, EURO SURVEILL, V17; Lindgren T, 2005, WOMEN HEALTH, V41, P69, DOI 10.1300/J013v41n01_05; Makoae MG, 2008, SAHARA J-J SOC ASP H, V5, P36, DOI 10.1080/17290376.2008.9724900; Mawar N, 2005, INDIAN J MED RES, V122, P471; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; Monteiro SS, 2013, GLOB PUBLIC HEALTH, V8, P519, DOI 10.1080/17441692.2013.779738; Moreno CL, 2007, QUAL HEALTH RES, V17, P340, DOI 10.1177/1049732306297387; Navaza B, 2012, AIDS BEHAV, V16, P30, DOI 10.1007/s10461-010-9871-0; Ncama BP, 2007, INT NURS REV, V54, P391, DOI 10.1111/j.1466-7657.2007.00560.x; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Olalekan Adebimpe Wasiu, 2014, Mater Sociomed, V26, P191, DOI 10.5455/msm.2014.26.191-194; Osinde MO, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-50; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Parsons JT, 2004, AIDS EDUC PREV, V16, P459, DOI 10.1521/aeap.16.5.459.48741; Pettigrew SF, 2000, ADV CONSUM RES, V27, P256; Rosenthal T, 2014, J AM SOC HYPERTENS, V8, P171, DOI 10.1016/j.jash.2013.12.007; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Sasse A, 2013, VERBRUGGE R 2013 EPI; Serovich JM, 2003, AIDS EDUC PREV, V15, P70, DOI 10.1521/aeap.15.1.70.23846; Skinner D, 2004, SAHARA J, V1, P157; Smith RA, 2009, HEALTH COMMUN, V24, P459, DOI 10.1080/10410230903023501; Stutterheim SE, 2012, PSYCHOL HEALTH, V27, P395, DOI 10.1080/08870446.2011.585426; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sullivan K, 2010, WOMEN HEALTH, V50, P506, DOI 10.1080/03630242.2010.516697; Thomas F, 2010, SOC SCI MED, V70, P736, DOI 10.1016/j.socscimed.2009.10.063; Uwe EA, 2007, INT Q COMMUNITY HEAL, V27, P87, DOI 10.2190/IQ.27.1.g; van der Straten A, 1998, AIDS CARE, V10, P533, DOI 10.1080/09540129848406; Van Praag E, 1995, AIDS Asia, V2, P10; Varas-Diaz N, 2003, INCARNATING STIGMA V, V4; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; White K., 2002, AN INTRODUCTION TO T; WHO, 2011, GUIDELINE ON HIV DIS	77	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119653	10.1371/journal.pone.0119653	http://dx.doi.org/10.1371/journal.pone.0119653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781906	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600082
J	Aubry, S; Shin, W; Crary, JF; Lefort, R; Qureshi, YH; Lefebvre, C; Califano, A; Shelanski, ML				Aubry, Soline; Shin, William; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Lefebvre, Celine; Califano, Andrea; Shelanski, Michael L.			Assembly and Interrogation of Alzheimer's Disease Genetic Networks Reveal Novel Regulators of Progression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; LINKED MENTAL-RETARDATION; TUMOR-SUPPRESSOR; ACETYLATION; EXPRESSION; P53; PROTEIN; BRAIN; P300; PHOSPHORYLATION	Alzheimer's disease (AD) is a complex multifactorial disorder with poorly characterized pathogenesis. Our understanding of this disease would thus benefit from an approach that addresses this complexity by elucidating the regulatory networks that are dysregulated in the neural compartment of AD patients, across distinct brain regions. Here, we use a Systems Biology (SB) approach, which has been highly successful in the dissection of cancer related phenotypes, to reverse engineer the transcriptional regulation layer of human neuronal cells and interrogate it to infer candidate Master Regulators (MRs) responsible for disease progression. Analysis of gene expression profiles from laser-captured neurons from AD and controls subjects, using the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe), yielded an interactome consisting of 488,353 transcription-factor/target interactions. Interrogation of this interactome, using the Master Regulator INference algorithm (MARINa), identified an unbiased set of candidate MRs causally responsible for regulating the transcriptional signature of AD progression. Experimental assays in autopsy-derived human brain tissue showed that three of the top candidate MRs (YY1, p300 and ZMYM3) are indeed biochemically and histopathologically dysregulated in AD brains compared to controls. Our results additionally implicate p53 and loss of acetylation homeostasis in the neurodegenerative process. This study suggests that an integrative, SB approach can be applied to AD and other neurodegenerative diseases, and provide significant novel insight on the disease progression.	[Aubry, Soline; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Shelanski, Michael L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Aubry, Soline; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Shelanski, Michael L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Shin, William; Lefebvre, Celine; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Shin, William; Lefebvre, Celine; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shin, William; Califano, Andrea] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lefebvre, Celine] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.	ac2248@columbia.edu; mls7@columbia.edu	Lefebvre, Celine/E-6290-2013	Qureshi, Yasir H/0000-0002-2729-2440; Califano, Andrea/0000-0003-4742-3679; Lefort, Roger/0000-0002-8885-606X	American Recovery and Reinvestment Act (ARRA) funds [P30AG036453]; Alzheimer's Association [NIRG-11-204450]; Louis V. Gerstner, Jr., Foundation; NIH [U54 CA121852, 5 T32 GM008798]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG036453] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA) funds; Alzheimer's Association(Alzheimer's Association); Louis V. Gerstner, Jr., Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded in part by American Recovery and Reinvestment Act (ARRA) funds through Grant number P30AG036453 (MLS), by the Alzheimer's Association (NIRG-11-204450) and the Louis V. Gerstner, Jr., Foundation (JFC) and by the NIH (U54 CA121852; 5 T32 GM008798) (CA and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan HM, 2001, J CELL SCI, V114, P2363; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Korhonen P, 2005, NEUROSCI LETT, V377, P121, DOI 10.1016/j.neulet.2004.11.085; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lefort R, 2012, J NEUROSCI, V32, P10674, DOI 10.1523/JNEUROSCI.6473-11.2012; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Pozueta J, 2012, NEUROSCIENCE; Raz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027039; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scheer MP, 2000, GENOMICS, V63, P123, DOI 10.1006/geno.1999.6027; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; World Health Organisation, 2011, GLOBAL HEALTH AND AG; Wu Z, 2004, J AM STAT ASS, V44; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	64	62	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120352	10.1371/journal.pone.0120352	http://dx.doi.org/10.1371/journal.pone.0120352			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781952	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600153
J	Bergfelder-Druing, S; Grosse-Brinkhaus, C; Lind, B; Erbe, M; Schellander, K; Simianer, H; Tholen, E				Bergfelder-Drueing, Sarah; Grosse-Brinkhaus, Christine; Lind, Bianca; Erbe, Malena; Schellander, Karl; Simianer, Henner; Tholen, Ernst			A Genome-Wide Association Study in Large White and Landrace Pig Populations for Number Piglets Born Alive	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CYTOSOLIC PHOSPHOLIPASE A(2); SINGLE-NUCLEOTIDE POLYMORPHISMS; LITTER SIZE; TYROSINE KINASE; ESTROUS-CYCLE; GENE; EXPRESSION; MODEL; DISRUPTION	The number of piglets born alive (NBA) per litter is one of the most important traits in pig breeding due to its influence on production efficiency. It is difficult to improve NBA because the heritability of the trait is low and it is governed by a high number of loci with low to moderate effects. To clarify the biological and genetic background of NBA, genome-wide association studies (GWAS) were performed using 4,012 Large White and Landrace pigs from herdbook and commercial breeding companies in Germany (3), Austria (1) and Switzerland (1). The animals were genotyped with the Illumina PorcineSNP60 BeadChip. Because of population stratifications within and between breeds, clusters were formed using the genetic distances between the populations. Five clusters for each breed were formed and analysed by GWAS approaches. In total, 17 different significant markers affecting NBA were found in regions with known effects on female reproduction. No overlapping significant chromosome areas or QTL between Large White and Landrace breed were detected.	[Bergfelder-Drueing, Sarah; Grosse-Brinkhaus, Christine; Schellander, Karl; Tholen, Ernst] Univ Bonn, Dept Anim Genet, Inst Anim Sci, Bonn, Germany; [Lind, Bianca] Biotechnol Res FBF, Bonn, Germany; [Erbe, Malena; Simianer, Henner] Univ Goettingen, Anim Breeding & Genet, Gottingen, Germany	University of Bonn; University of Gottingen	Grosse-Brinkhaus, C (corresponding author), Univ Bonn, Dept Anim Genet, Inst Anim Sci, Bonn, Germany.	cgro@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Simianer, Henner/A-6574-2015	Große-Brinkhaus, Christine/0000-0002-6190-4463; Simianer, Henner/0000-0002-7551-3797	project "pigGS" [FKZ 005-NA02-018 C]; European Union; Ministry for Economic Affairs, Energy, Building, Housing and Transport	project "pigGS"; European Union(European Commission); Ministry for Economic Affairs, Energy, Building, Housing and Transport	This study was prepared within the framework of the project "pigGS" (FKZ 005-NA02-018 C). This project was financed by the European Union and Ministry for Economic Affairs, Energy, Building, Housing and Transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Ashworth MD, 2006, BIOL REPROD, V74, P1007, DOI 10.1095/biolreprod.105.046557; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Becker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055951; BENNETT GL, 1989, J ANIM SCI, V67, P1230; Bogacka I, 2011, J PHYSIOL PHARMACOL, V62, P559; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Buske B, 2006, J ANIM BREED GENET, V123, P343, DOI 10.1111/j.1439-0388.2006.00609.x; Buske B, 2006, ARCH TIERZUCHT, V49, P259, DOI 10.5194/aab-49-259-2006; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Davis BJ, 1999, ENDOCRINOLOGY, V140, P2685, DOI 10.1210/en.140.6.2685; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Guo Liang-Yong, 2012, Yichuan, V34, P879, DOI 10.3724/SP.J.1005.2012.00879; Hirashima M, 2003, P NATL ACAD SCI USA, V100, P15637, DOI 10.1073/pnas.2635424100; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Hyenne V, 2005, DEV BIOL, V287, P180, DOI 10.1016/j.ydbio.2005.09.004; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kurusu S, 2012, FASEB J, V26, P3800, DOI 10.1096/fj.12-203968; LANDE R, 1990, GENETICS, V124, P743; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Meszaros G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-13; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Munoz M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-23; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Omelka R, 2005, CZECH J ANIM SCI, V50, P249, DOI 10.17221/4165-CJAS; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Pausch H, 2012, ANIM GENET, V43, P689, DOI 10.1111/j.1365-2052.2012.02340.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rohrer GA, 2001, PHYSIOL GENOMICS, V6, P145, DOI 10.1152/physiolgenomics.2001.6.3.145; Rohrer GA, 1999, J ANIM SCI, V77, P1385; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Serenius T, 2003, LIVEST PROD SCI, V81, P213, DOI 10.1016/S0301-6226(02)00300-7; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stuart A., 2009, KENDALLS ADV THEORY, V1; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tribout T, 2008, GENET SEL EVOL, V40, P61, DOI 10.1051/gse:2007035; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	64	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117468	10.1371/journal.pone.0117468	http://dx.doi.org/10.1371/journal.pone.0117468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781935	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600013
J	Ferrero, S; Carretero-Paulet, L; Mendes, MA; Botton, A; Eccher, G; Masiero, S; Colombo, L				Ferrero, Sergio; Carretero-Paulet, Lorenzo; Mendes, Marta Adelina; Botton, Alessandro; Eccher, Giulia; Masiero, Simona; Colombo, Lucia			Transcriptomic Signatures in Seeds of Apple (Malus domestica L. Borkh) during Fruitlet Abscission	PLOS ONE			English	Article							EXPRESSION; ETHYLENE; DOMINANCE; GROWTH; ACID; GENE; BENZYLADENINE; BIOSYNTHESIS; INVOLVEMENT; RESISTANCE	Abscission is the regulated process of detachment of an organ from a plant. In apple the abscission of fruits occurs during their early development to control the fruit load depending on the nutritional state of the plant. In order to control production and obtain fruits with optimal market qualities, the horticultural procedure of thinning is performed to further reduce the number of fruitlets. In this study we have conducted a transcriptomic profiling of seeds from two different types of fruitlets, according to size and position in the fruit cluster. Transcriptomic profiles of central and lateral fruit seeds were obtained by RNAseq. Comparative analysis was performed by the functional categorization of differentially expressed genes by means of Gene Ontology (GO) annotation of the apple genome. Our results revealed the overexpression of genes involved in responses to stress, hormone biosynthesis and also the response and/or transport of auxin and ethylene. A smaller set of genes, mainly related to ion transport and homeostasis, were found to be down-regulated. The transcriptome characterization described in this manuscript contributes to unravelling the molecular mechanisms and pathways involved in the physiological abscission of apple fruits and suggests a role for seeds in this process.	[Ferrero, Sergio; Mendes, Marta Adelina; Masiero, Simona; Colombo, Lucia] Univ Milan, Dipartimento BioSci, Milan, Italy; [Carretero-Paulet, Lorenzo] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Botton, Alessandro; Eccher, Giulia] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy	University of Milan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Padua	Ferrero, S (corresponding author), Univ Milan, Dipartimento BioSci, Milan, Italy.	sergio.ferrero@unimi.it	Mendes, Marta A. M./AAL-1225-2021; Carretero-Paulet, Lorenzo/Z-2744-2019; Masiero, Simona/J-2898-2013; Botton, Alessandro/C-4164-2008	Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Colombo, Lucia/0000-0001-8415-1399; Mendes, Marta Adelina/0000-0001-9223-4119; Botton, Alessandro/0000-0001-5054-1479; masiero, simona/0000-0002-7563-7634	Progetto Agroalimentare e Ricerca (AGER) [2010-2119]	Progetto Agroalimentare e Ricerca (AGER)	This work was supported by the Progetto Agroalimentare e Ricerca (AGER-Grant no. 2010-2119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; Addicott F.T, 1982, ABSCISSION; Ahn IP, 2007, MOL PLANT PATHOL, V8, P747, DOI 10.1111/J.1364-3703.2007.00428.X; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BANGERTH F, 1989, PHYSIOL PLANTARUM, V76, P608, DOI 10.1111/j.1399-3054.1989.tb05487.x; Bangerth F., 1990, Acta Horticulturae, P461; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Buban T, 2000, PLANT GROWTH REGUL, V32, P381, DOI 10.1023/A:1010785604339; BURG SP, 1967, BIOCHEM BIOPH RES CO, V27, P125, DOI 10.1016/S0006-291X(67)80050-0; Callejas R., 1998, Acta Horticulturae, P271; Serrani JC, 2007, PLANT PHYSIOL, V145, P246, DOI 10.1104/pp.107.098335; Clark JI, 2005, PLANT PHYSIOL, V138, P1268, DOI 10.1104/pp.104.058529; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; Dal Cin V, 2007, ANN BOT-LONDON, V99, P1195, DOI 10.1093/aob/mcm062; Dal Cin V, 2007, MOL BIOTECHNOL, V36, P9, DOI 10.1007/s12033-007-0004-6; Dal Cin V, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-139; Dal Cin V, 2009, GENE, V442, P26, DOI 10.1016/j.gene.2009.04.009; Devoghalaere F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-7; Eccher G, 2014, PLANT BIOSYST, V148, P157, DOI 10.1080/11263504.2013.870254; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Eo J, 2009, SCI HORTIC-AMSTERDAM, V123, P224, DOI 10.1016/j.scienta.2009.08.011; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gapper NE, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt021; Gonzalez-Carranza ZH, 1998, TRENDS PLANT SCI, V3, P10, DOI 10.1016/S1360-1385(97)01132-1; GREENE DW, 1992, J AM SOC HORTIC SCI, V117, P775, DOI 10.21273/JASHS.117.5.775; GRUBER J, 1990, PHYSIOL PLANTARUM, V79, P354; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Ireland HS, 2012, POSTHARVEST BIOL TEC, V72, P42, DOI 10.1016/j.postharvbio.2012.05.003; KATSUMI M, 1991, GIBBERELLINS, P211; Kusaba S, 2001, J EXP BOT, V52, P375, DOI 10.1093/jexbot/52.355.375; Lan TY, 2013, ANAL BIOCHEM, V438, P11, DOI 10.1016/j.ab.2013.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama Y, 2013, PLANT SCI, V213, P79, DOI 10.1016/j.plantsci.2013.08.008; MONSELISE S P, 1972, Hortscience, V7, P514; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Ranocha P, 2001, PLANT J, V25, P575, DOI 10.1046/j.1365-313x.2001.00988.x; RINNE P, 1992, J EXP BOT, V43, P975, DOI 10.1093/jxb/43.7.975; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sexton R., 1985, Ethylene and plant development, P173; Sexton R, 1994, HDB PLANT CROP PHYSL; Sexton R, 1987, MODELS PLANT PHYSL B, V2, P149; STEPHENSON AG, 1988, ANN BOT-LONDON, V62, P653, DOI 10.1093/oxfordjournals.aob.a087705; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Sun Tai-Ping, 2008, Arabidopsis Book, V6, pe0103, DOI 10.1199/tab.0103; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; vanDoorn WG, 1997, J EXP BOT, V48, P821, DOI 10.1093/jxb/48.4.821; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	54	12	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120503	10.1371/journal.pone.0120503	http://dx.doi.org/10.1371/journal.pone.0120503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781174	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600168
J	Sambamurthy, N; Leme, AS; Oury, TD; Shapiro, SD				Sambamurthy, Nisha; Leme, Adriana S.; Oury, Tim D.; Shapiro, Steven D.			The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; NORMAL LUNG; EXPRESSION; GLYCOSYLATION; MARKER; OVEREXPRESSION; PATHOGENESIS; INFLAMMATION; MECHANISM	Several recent clinical studies have implied a role for the receptor for advanced glycation end products (RAGE) and its variants in chronic obstructive pulmonary disease (COPD). In this study we have defined a role for RAGE in the pathogenesis of emphysema in mice. RAGE deficient mice (RAGE-/-) exposed to chronic cigarette smoke were significantly protected from smoke induced emphysema as determined by airspace enlargement and had no significant reduction in lung tissue elastance when compared to their air exposed controls contrary to their wild type littermates. The progression of emphysema has been largely attributed to an increased inflammatory cell-mediated elastolysis. Acute cigarette smoke exposure in RAGE-/- mice revealed an impaired early recruitment of neutrophils, approximately a 6- fold decrease compared to wild type mice. Hence, impaired neutrophil recruitment with continued cigarette smoke exposure reduces elastolysis and consequent emphysema.	[Sambamurthy, Nisha; Leme, Adriana S.; Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Sambamurthy, Nisha; Oury, Tim D.] Univ Pittsburgh, Dept Pathol, Dept Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shapiro, SD (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	shapirosd@upmc.edu						Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Clynes R, 2007, CURR MOL MED, V7, P743; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li Y, 2014, DNA CELL BIOL, V33, P251, DOI 10.1089/dna.2013.2303; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Milutinovic PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088259; Milutinovic PS, 2012, AM J PATHOL, V181, P1215, DOI 10.1016/j.ajpath.2012.06.031; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Park SJ, 2011, J BIOL CHEM, V286, P21384, DOI 10.1074/jbc.M111.241281; Ramasamy R, 2007, MOL NUTR FOOD RES, V51, P1111, DOI 10.1002/mnfr.200700008; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P1195, DOI 10.1165/rcmb.2011-0170OC; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHRAML P, 1994, CANCER RES, V54, P5236; Schraml P, 1997, CANCER RES, V57, P3669; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shapiro SD, 2005, TXB RESP MED; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; SNIDER GL, 1989, ANNU REV MED, V40, P411; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Winden DR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-108; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118979	10.1371/journal.pone.0118979	http://dx.doi.org/10.1371/journal.pone.0118979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781626	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351284600041
J	Yao, M; Cai, M; Yao, DF; Xu, X; Yang, RR; Li, YT; Zhang, YY; Kido, HS; Yao, DB				Yao, Min; Cai, Min; Yao, Dengfu; Xu, Xi; Yang, Rongrong; Li, Yuting; Zhang, Yuanyuan; Kido, Hiroshi; Yao, Dengbing			Abbreviated Half-Lives and Impaired Fuel Utilization in Carnitine Palmitoyltransferase II Variant Fibroblasts	PLOS ONE			English	Article							JAPANESE PATIENTS; MALONYL-COA; DEFICIENCY; INFLUENZA; ENCEPHALOPATHY; MUTATIONS; GENE; INHIBITION; PHENOTYPE; OXIDATION	Carnitine palmitoyltransferase II (CPT II) deficiency is one of the most common causes of fatty acid oxidation metabolism disorders. However, the molecular mechanism between CPT2 gene polymorphisms and metabolic stress has not been fully clarified. We previously reported that a number of patients show a thermal instable phenotype of compound hetero/homozygous variants of CPT II. To understand the mechanism of the metabolic disorder resulting from CPT II deficiency, the present study investigated CPT II variants in patient fibroblasts, [c. 1102 G>A (p.V368I)] (heterozygous), [c. 1102 G>A (p.V368I)] (homozygous), and [c. 1055 T>G (p.F352C)] (heterozygous) + [c. 1102 G>A (p.V368I)] (homozygous) compared with fibroblasts from healthy controls. CPT II variants exerted an effect of dominant negative on the homotetrameric proteins that showed thermal instability, reduced residual enzyme activities and a short half-life. Moreover, CPT II variant fibroblasts showed a significant decrease in fatty acid beta-oxidation and adenosine triphosphate generation, combined with a reduced mitochondrial membrane potential, resulting in cellular apoptosis. Collectively, our data indicate that the CPT II deficiency induces an energy crisis of the fatty acid metabolic pathway. These findings may contribute to the elucidation of the genetic factors involved in metabolic disorder encephalopathy caused by the CPT II deficiency.	[Yao, Min; Cai, Min; Li, Yuting; Yao, Dengbing] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Sch Life Sci, Nantong, Jiangsu, Peoples R China; [Yao, Min; Yao, Dengfu; Xu, Xi; Yang, Rongrong; Zhang, Yuanyuan] Nantong Univ, Affiliated Hosp, Sch Med, Nantong, Jiangsu, Peoples R China; [Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan	Nantong University; Nantong University; Tokushima University	Yao, DB (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Sch Life Sci, Nantong, Jiangsu, Peoples R China.	yaodb@ntu.edu.cn	zhang, yuanyuan/GYA-4428-2022		National Natural Science Foundation of China [81370982, 81200634]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China; Natural Science Foundation of Jiangsu Province [BK2010282]; Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD	This research was supported by grants from: National Natural Science Foundation of China (Grant No. 81370982, 81200634); Scientific Research Foundation for Returned Scholars, Ministry of Education of China; Natural Science Foundation of Jiangsu Province (Grant No. BK2010282) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2010, CURR OPIN PHARMACOL, V10, P338, DOI 10.1016/j.coph.2010.02.006; Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390; Anwar Z, 1999, BRIT J PHARMACOL, V128, P465, DOI 10.1038/sj.bjp.0702792; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Bonnefont JP, 2009, MOL ASPECTS MED, V25, P495; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; DELORME L, 1979, AM J DIS CHILD, V133, P822, DOI 10.1001/archpedi.1979.02130080062011; DEMAUGRE F, 1991, J CLIN INVEST, V87, P859, DOI 10.1172/JCI115090; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; Fanin M, 2012, CLIN GENET, V82, P232, DOI 10.1111/j.1399-0004.2011.01786.x; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; HUG G, 1991, NEW ENGL J MED, V325, P1862, DOI 10.1056/NEJM199112263252607; Isackson PJ, 2006, MOL GENET METAB, V89, P323, DOI 10.1016/j.ymgme.2006.08.004; Kasai T, 2000, LANCET, V355, P1558, DOI 10.1016/S0140-6736(05)74614-6; Kobayashi Y, 2013, BRAIN DEV-JPN, V35, P449, DOI 10.1016/j.braindev.2012.06.013; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lehmann D, 2014, J NEUROL SCI, V339, P183, DOI 10.1016/j.jns.2014.02.011; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; MCGARRY JD, 1980, NEW ENGL J MED, V303, P1413, DOI 10.1056/NEJM198012113032410; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; MURTHY MSR, 1987, BIOCHEM J, V248, P727, DOI 10.1042/bj2480727; Olpin SE, 2003, J INHERIT METAB DIS, V26, P543, DOI 10.1023/A:1025947930752; Orngreen MC, 2005, ANN NEUROL, V57, P60, DOI 10.1002/ana.20320; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rufer AC, 2006, STRUCTURE, V14, P713, DOI 10.1016/j.str.2006.01.008; SAUDUBRAY JM, 1982, PEDIATR RES, V16, P877, DOI 10.1203/00006450-198210000-00015; Sigauke E, 2003, LAB INVEST, V83, P1543, DOI 10.1097/01.LAB.0000098428.51765.83; Taggart RT, 1999, HUM MUTAT, V13, P210; Tahanian E, 2011, J INFLAMM RES, V4, P1, DOI 10.2147/JIR.S15880; Tamaoki Y, 2002, BRAIN DEV-JPN, V24, P675, DOI 10.1016/S0387-7604(02)00074-8; TARONI F, 1992, P NATL ACAD SCI USA, V89, P8429, DOI 10.1073/pnas.89.18.8429; Thuillier L, 2003, HUM MUTAT, V21, P493, DOI 10.1002/humu.10201; VERDERIO E, 1995, HUM MOL GENET, V4, P19, DOI 10.1093/hmg/4.1.19; Wataya K, 1998, HUM MUTAT, V11, P377; Weiser M, 1997, J CLIN PHARMACOL, V37, P453, DOI 10.1002/j.1552-4604.1997.tb04323.x; Wieser T., 2011, GENE REV; Yahyaoui R, 2011, MOL GENET METAB, V104, P414, DOI 10.1016/j.ymgme.2011.05.003; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717; Yao DB, 2011, J MED INVESTIG, V58, P210, DOI 10.2152/jmi.58.210; Yao M, 2011, MOL GENET METAB, V104, P265, DOI 10.1016/j.ymgme.2011.07.009; ZIERZ S, 1994, CLIN INVESTIGATOR, V72, P957, DOI 10.1007/BF00577735	43	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119936	10.1371/journal.pone.0119936	http://dx.doi.org/10.1371/journal.pone.0119936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781464	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600110
J	Maria, M; Ajmal, M; Azam, M; Waheed, NK; Siddiqui, SN; Mustafa, B; Ayub, H; Ali, L; Ahmad, S; Micheal, S; Hussain, A; Shah, STA; Ali, SHB; Ahmed, W; Khan, YM; den Hollander, AI; Haer-Wigman, L; Collin, RWJ; Khan, MI; Qamar, R; Cremers, FPM				Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Waheed, Nadia Khalida; Siddiqui, Sorath Noorani; Mustafa, Bilal; Ayub, Humaira; Ali, Liaqat; Ahmad, Shakeel; Micheal, Shazia; Hussain, Alamdar; Shah, Syed Tahir Abbas; Ali, Syeda Hafiza Benish; Ahmed, Waqas; Khan, Yar Muhammad; den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Khan, Muhammad Imran; Qamar, Raheel; Cremers, Frans P. M.			Homozygosity Mapping and Targeted Sanger Sequencing Reveal Genetic Defects Underlying Inherited Retinal Disease in Families from Pakistan	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; RESTORES VISION; CANINE MODEL; MUTATIONS; THERAPY; DYSTROPHY; ROD; CONSANGUINITY; TULP1	Background Homozygosity mapping has facilitated the identification of the genetic causes underlying inherited diseases, particularly in consanguineous families with multiple affected individuals. This knowledge has also resulted in a mutation dataset that can be used in a cost and time effective manner to screen frequent population-specific genetic variations associated with diseases such as inherited retinal disease (IRD). Methods We genetically screened 13 families from a cohort of 81 Pakistani IRD families diagnosed with Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), congenital stationary night blindness (CSNB), or cone dystrophy (CD). We employed genome-wide single nucleotide polymorphism (SNP) array analysis to identify homozygous regions shared by affected individuals and performed Sanger sequencing of IRD-associated genes located in the sizeable homozygous regions. In addition, based on population specific mutation data we performed targeted Sanger sequencing (TSS) of frequent variants in AIPL1, CEP290, CRB1, GUCY2D, LCA5, RPGRIP1 and TULP1, in probands from 28 LCA families. Results Homozygosity mapping and Sanger sequencing of IRD-associated genes revealed the underlying mutations in 10 families. TSS revealed causative variants in three families. In these 13 families four novel mutations were identified in CNGA1, CNGB1, GUCY2D, and RPGRIP1. Conclusions Homozygosity mapping and TSS revealed the underlying genetic cause in 13 IRD families, which is useful for genetic counseling as well as therapeutic interventions that are likely to become available in the near future.	[Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Mustafa, Bilal; Ayub, Humaira; Ali, Liaqat; Ahmad, Shakeel; Hussain, Alamdar; Shah, Syed Tahir Abbas; Ali, Syeda Hafiza Benish; Ahmed, Waqas; Khan, Muhammad Imran; Qamar, Raheel; Cremers, Frans P. M.] Commiss Sci & Technol Sustainable Dev South, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Micheal, Shazia; den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Khan, Muhammad Imran; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Waheed, Nadia Khalida] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Siddiqui, Sorath Noorani] Al Shifa Eye Trust Hosp, Rawalpindi, Pakistan; [Micheal, Shazia; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Ali, Syeda Hafiza Benish] Bahauddin Zakariya Univ, Inst Pure & Appl Biol, Multan, Pakistan; [Ahmed, Waqas] Univ Haripur, Haripur, Pakistan; [Khan, Yar Muhammad] Univ Sci & Technol, Dept Chem, Bannu, Pakistan; [den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; Tufts University; Radboud University Nijmegen; Bahauddin Zakariya University; University of Science & Technology Bannu; Radboud University Nijmegen	Cremers, FPM (corresponding author), Commiss Sci & Technol Sustainable Dev South, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.	Frans.Cremers@radboudumc.nl	Siddiqui, Sorath Noorani/AAT-9861-2020; ahmed, waqas/AAD-9962-2020; Cremers, Frans/A-5625-2014; Haer-Wigman, Lonneke/P-8170-2015; Azam, Maleeha/AAD-9924-2022; Ajmal, Muhammad/G-8163-2012; Hollander, Anneke den/N-4911-2014; Collin, Rob/N-3575-2014; Shah, Syed Tahir Abbas/K-4637-2015; Azam, Maleeha/L-1721-2017	Cremers, Frans/0000-0002-4954-5592; Ajmal, Muhammad/0000-0001-5207-2469; Shah, Syed Tahir Abbas/0000-0001-9151-9374; Azam, Maleeha/0000-0003-0170-3325; Haer-Wigman, Lonneke/0000-0003-3595-0797; Mustafa, Bilal/0000-0003-0865-7974; Khan, Muhammad Imran/0000-0003-0276-5480; Maria, Maleeha/0000-0001-6526-3010	COMSATS Institute of Information Technology (CIIT); CIIT [16-64/CRGP/CIIT/IBD/12/919, 16-83/CRGP/CIIT/IBD/13/144, 16-82-CRGP-CIIT-IBD-13/145]; Stichting Nederlands Oogheelkundig Onderzoek; Nelly Reef Foundation; Stichting ter Verbetering van het Lot der Blinden; Gelderse Blinden Stichting; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund; Foundation Fighting Blindness USA [C-GE-0811-0545-RAD01]; Pakistan Academy of Sciences;  [PAS/I-9/Project]	COMSATS Institute of Information Technology (CIIT); CIIT; Stichting Nederlands Oogheelkundig Onderzoek; Nelly Reef Foundation; Stichting ter Verbetering van het Lot der Blinden; Gelderse Blinden Stichting; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund; Foundation Fighting Blindness USA; Pakistan Academy of Sciences; 	This work was supported by grant no. PAS/I-9/Project awarded to R.Q. and M.Az., by the Pakistan Academy of Sciences, and a core grant from the COMSATS Institute of Information Technology (CIIT) to R.Q. This work was also supported by CIIT grant No. 16-64/CRGP/CIIT/IBD/12/919 awarded to M.M., grant No. 16-83/CRGP/CIIT/IBD/13/144 awarded to M.Aj. and grant No. 16-82-CRGP-CIIT-IBD-13/145 awarded to M.Az. This work was also financially supported by the Stichting Nederlands Oogheelkundig Onderzoek, the Nelly Reef Foundation, the Stichting ter Verbetering van het Lot der Blinden (to F.P.M.C., R.W.J.C., and A.I.d.H.), the Gelderse Blinden Stichting (to F.P.M.C.), the Rotterdamse Stichting Blindenbelangen, the Stichting Blindenhulp, the Stichting A.F. Deutman Researchfonds Oogheelkunde, and the Stichting voor Ooglijders (to F.P.M.C. and M.I.K.). F.P.M.C. and M.I.K. were also supported by the following foundations: the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Landelijke Stichting voor Blinden en Slechtzienden, the Stichting Retina Nederland Fonds, and the Novartis fund, contributed through UitZicht. The work of L.H-W. was supported by the Foundation Fighting Blindness USA C-GE-0811-0545-RAD01 (to F.P.M.C.). The funding organizations provided unrestricted grants and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adhi M.I., 2002, PAK J OPHTHALMOL, V18, P106; Ajmal M, 2012, MOL VIS, V18, P1558; Ajmal M, 2012, MOL VIS, V18, P1226; Annear MJ, 2013, HUM GENE THER, V24, P883, DOI 10.1089/hum.2013.146; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; Azam M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1377, DOI 10.1001/archophthalmol.2011.290; Azam M, 2010, MOL VIS, V16, P774; Azam M, 2009, MOL VIS, V15, P2526; Azam M, 2009, MOL VIS, V15, P1788; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Coppieters F, 2011, Bull Soc Belge Ophtalmol, P59; Damji KF, 2001, CAN J OPHTHALMOL, V36, P252, DOI 10.1016/S0008-4182(01)80018-1; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Gu SM, 1998, LANCET, V351, P1103, DOI 10.1016/S0140-6736(05)79384-3; Guyon R, 2007, MOL VIS, V13, P1094; Hamamy HA, 2007, SAUDI MED J, V28, P1015; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Iqbal M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1351, DOI 10.1001/archophthalmol.2011.267; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4; Khan MI, 2013, CLIN GENET, V84, P290, DOI 10.1111/cge.12039; Khan MI, 2014, GENES-BASEL, V5, P176, DOI 10.3390/genes5010176; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Khan MI, 2010, MOL VIS, V16, P2753; Koenekoop RK, 2014, LANCET, V6736, P60153; Ku CA, 2011, HUM MOL GENET, V20, P4569, DOI 10.1093/hmg/ddr391; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Lheriteau E, 2014, MOL THER, V22, P265, DOI 10.1038/mt.2013.232; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Littink KW, 2012, ADV EXP MED BIOL, V723, P345, DOI 10.1007/978-1-4614-0631-0_45; Mackay DS, 2013, HUM MUTAT, V34, P1537, DOI 10.1002/humu.22398; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Mendoza-Londono R, 1999, Ophthalmic Genet, V20, P37, DOI 10.1076/opge.20.1.37.2299; Nentwich Martin M, 2013, Oman J Ophthalmol, V6, pS18, DOI 10.4103/0974-620X.122290; Nirmalan PK, 2006, OPHTHAL EPIDEMIOL, V13, P7, DOI 10.1080/09286580500473795; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Robson AG, 2008, DOC OPHTHALMOL, V116, P79, DOI 10.1007/s10633-007-9087-4; Roosing S, 2014, PROG RETIN EYE RES, V42, P1, DOI 10.1016/j.preteyeres.2014.05.001; Roosing S, 2013, OPHTHALMOLOGY, V120, P1239, DOI 10.1016/j.ophtha.2012.12.005; Sambrook J, 2001, MOL CLONING LAB MANU, P44; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Simovich M J, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1168; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Wert KJ, 2013, HUM MOL GENET, V22, P558, DOI 10.1093/hmg/dds466	65	23	23	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119806	10.1371/journal.pone.0119806	http://dx.doi.org/10.1371/journal.pone.0119806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775262	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500126
J	Handali, M; Neupane, DP; Roychowdhury, H; Yukl, ET				Handali, Melody; Neupane, Durga P.; Roychowdhury, Hridindu; Yukl, Erik T.			Transcriptional Regulation, Metal Binding Properties and Structure of Pden1597, an Unusual Zinc Transport Protein from Paracoccus denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Manganese; Metal Homeostasis; Metalloprotein; Transcription Regulation; Zinc	TREPONEMA-PALLIDUM TROA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SALMONELLA-ENTERICA; ABC TRANSPORTER; FULL VIRULENCE; UPTAKE SYSTEM; ION-BINDING; MANGANESE	Background: Bacterial cluster 9 ATP binding cassette (ABC) transporters are responsible for import of Zn2+ and Mn2+. Results: A solute-binding protein of the cluster 9 family is shown to preferentially bind Zn2+ in an unusual coordination sphere. Conclusion: A subclass of Zn2+ transporter has been identified with distinct structural properties. Significance: Cluster 9 ABC transporters are important virulence factors. ATP-binding cassette (ABC) transporters of the cluster 9 family are ubiquitous among bacteria and essential for acquiring Zn2+ and Mn2+ from the environment or, in the case of pathogens, from the host. These rely on a substrate-binding protein (SBP) to coordinate the relevant metal with high affinity and specificity and subsequently release it to a membrane permease for translocation into the cytoplasm. Although a number of cluster 9 SBP structures have been determined, the structural attributes conferring Zn2+ or Mn2+ specificity remain ambiguous. Here we describe the gene expression profile, in vitro metal binding properties, and crystal structure of a new cluster 9 SBP from Paracoccus denitrificans we have called AztC. Although all of our results strongly indicate Zn2+ over Mn2+ specificity, the Zn2+ ion is coordinated by a conserved Asp residue only observed to date as a metal ligand in Mn2+-specific SBPs. The unusual sequence properties of this protein are shared among close homologues, including members from the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and would seem to suggest a subclass of Zn2+-specific transporters among the cluster 9 family. In any case, the unusual coordination environment of AztC expands the already considerable range of those available to Zn2+-specific SBPs and highlights the presence of a His-rich loop as the most reliable indicator of Zn2+ specificity.	[Handali, Melody; Neupane, Durga P.; Roychowdhury, Hridindu; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Yukl, ET (corresponding author), 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Yukl, Erik/0000-0001-6519-6938	National Institutes of Health, NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences of the United States Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences of the United States Dept. of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We recognize Tanner Schaub at the Center for Animal Health, Food Safety and Bio-Security, New Mexico State University, for assistance with mass spectrometry and Tanis Hogg at Texas Tech University Health Sciences Center, El Paso, TX, for assistance in screening crystals. We further acknowledge the staff at the Berkeley Center for Structural Biology at Lawrence Berkeley National Laboratory for assistance at the beam line. Finally, we thank Dr. Carrie Wilmot, University of Minnesota, and Dr. Victor Davidson for critical reading of our manuscript. Final x-ray diffraction data was collected at the Berkeley Center for Structural Biology, which is supported in part by the National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Dept. of Energy under Contract DE-AC02-05CH11231.	Abate F, 2014, BIOSCIENCE REP, V34, P743, DOI 10.1042/BSR20140088; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dow BA, 2015, PROTEIN EXPRES PURIF, V108, P9, DOI 10.1016/j.pep.2014.12.017; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Kanteev M, 2013, ACTA CRYSTALLOGR F, V69, P237, DOI 10.1107/S174430911300153X; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	57	16	16	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11878	11889		10.1074/jbc.M115.645853	http://dx.doi.org/10.1074/jbc.M115.645853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25787075	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000354388600007
J	Paladino, LC; Muntaabski, I; Lanzavecchia, S; Le Bagousse-Pinguet, Y; Viscarret, M; Juri, M; Fueyo-Sanchez, L; Papeschi, A; Cladera, J; Bressa, MJ				Carabajal Paladino, Leonela; Muntaabski, Irina; Lanzavecchia, Silvia; Le Bagousse-Pinguet, Yoann; Viscarret, Mariana; Juri, Marianela; Fueyo-Sanchez, Luciana; Papeschi, Alba; Cladera, Jorge; Jose Bressa, Maria			Complementary Sex Determination in the Parasitic Wasp Diachasmimorpha longicaudata	PLOS ONE			English	Article							DIPLOID MALES; HEBETOR HYMENOPTERA; COTESIA-GLOMERATA; MATING SYSTEM; BRACONIDAE; HABROBRACON; POPULATION; EVOLUTION; FEMALES; TEPHRITIDAE	We studied the sex determination in Diachasmimorpha longicaudata, a parasitoid braconid wasp widely used as biological control agent of fruit pest tephritid flies. We tested the complementary sex determination hypothesis (CSD) known in at least 60 species of Hymenoptera. According to CSD, male or female development depends on the allelic composition of one sex locus (single-locus CSD) or multiple sex loci (multiple-locus CSD). Hemizygote individuals are normal haploid males, and heterozygotes for at least one sex locus are normal diploid females, but homozygotes for all the sex loci are diploid males. In order to force the occurrence of diploid males in D. longicaudata, we established highly inbred lines and examined their offspring using chromosome counting, flow cytometry, and sex ratio analysis. We found that when mother-son crosses were studied, this wasp produced about 20% of diploid males out of the total male progeny. Our results suggest that this parasitoid may represent the second genus with multiple-locus CSD in Hymenoptera. Knowledge about the sex determination system in D. longicaudata is relevant for the improvement of mass rearing protocols of this species. This information also provides the necessary background for further investigations on the underlying molecular mechanisms of sex determination in this species, and a better insight into the evolution of this pathway in Hymenoptera in particular and insects in general.	[Carabajal Paladino, Leonela] Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic; [Carabajal Paladino, Leonela; Muntaabski, Irina; Lanzavecchia, Silvia; Juri, Marianela; Cladera, Jorge] Inst Nacl Tecnol Agr, Inst Genet Ewald A Favret, Hurlingham, Argentina; [Le Bagousse-Pinguet, Yoann] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic; [Viscarret, Mariana] Inst Nacl Tecnol Agr, Inst Microbiol & Zool Agr, Hurlingham, Argentina; [Juri, Marianela; Papeschi, Alba; Jose Bressa, Maria] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Fueyo-Sanchez, Luciana] Univ Nacl Lujan, Inst Ecol & Desarrollo Sustentable, Lujan, Argentina; [Papeschi, Alba; Jose Bressa, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet Evoluc, RA-1053 Buenos Aires, DF, Argentina; [Jose Bressa, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Ecol Genet Evoluc Buenos Aires, RA-1053 Buenos Aires, DF, Argentina	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of South Bohemia Ceske Budejovice; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; University of Buenos Aires; University of Buenos Aires	Paladino, LC (corresponding author), Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic.	carabajal@entu.cas.cz	Carabajal Paladino, Leonela Z/I-1361-2014; Carabajal Paladino, Leonela Zusel/AAD-9546-2022; Le Bagousse-Pinguet, Yoann/I-2413-2016	Carabajal Paladino, Leonela Z/0000-0001-9312-0260; Carabajal Paladino, Leonela Zusel/0000-0001-9312-0260; Le Bagousse-Pinguet, Yoann/0000-0002-5615-5541; Lanzavecchia, Silvia/0000-0001-5965-4082; Muntaabski, Irina/0000-0002-0631-791X	University of Buenos Aires [UBACyTX164]; CONICET [PIP 0281]; ANPCyT [PICT 2007-00635, PICT 2008-0502]; European Social Fund; Czech State Budget [Postdok_BIOGLOBE CZ.1.07/2.3.00/30.0032]	University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); European Social Fund(European Social Fund (ESF)); Czech State Budget	The work was supported by University of Buenos Aires (UBACyT X164); CONICET (PIP 0281); ANPCyT (PICT 2007-00635 and PICT 2008-0502); and European Social Fund and Czech State Budget (Postdok_BIOGLOBE CZ.1.07/2.3.00/30.0032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOLIN MF, 1992, ECOL ENTOMOL, V17, P1, DOI 10.1111/j.1365-2311.1992.tb01032.x; Asplen MK, 2009, J EVOLUTION BIOL, V22, P1762, DOI 10.1111/j.1420-9101.2009.01774.x; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; BEUKEBOOM LW, 1995, BIOESSAYS, V17, P813, DOI 10.1002/bies.950170911; Beukeboom LW, 2000, HEREDITY, V84, P29, DOI 10.1046/j.1365-2540.2000.00628.x; Beye M, 1999, GENETICS, V153, P1701; Bostian CH, 1934, GENETICS, V180, P280; Bressa MJ, 2009, CYTOGENET GENOME RES, V125, P292, DOI 10.1159/000235936; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Cancino JL, 1998, PROCEDIMIENTOS FUNDA; Carabajal Paladino L, 2013, EUR J ENTOMOL, V110, P401, DOI 10.14411/eje.2013.054; Paladino LZC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5601; Carabajal Paladino LZ, 2011, 40 C ARG GEN 3 SIMP; Charlesworth B, 2009, COLD SH Q B, V74, P177, DOI 10.1101/sqb.2009.74.015; CLARK AM, 1963, AM NAT, V97, P203, DOI 10.1086/282271; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; CROZIER RH, 1971, AM NAT, V105, P399, DOI 10.1086/282733; DACUNHA AB, 1957, FORMA FUNCTIO, V1, P33; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; de Boer JG, 2012, EVOL APPL, V5, P444, DOI 10.1111/j.1752-4571.2012.00270.x; Dobson SL, 1998, HEREDITY, V81, P261, DOI 10.1046/j.1365-2540.1998.00372.x; Dowton M, 2002, J MOL EVOL, V54, P210, DOI 10.1007/s00239-001-0003-3; Elias J, 2010, MOL ECOL, V19, P2336, DOI 10.1111/j.1365-294X.2010.04645.x; Elias J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-366; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Gokhman V. E., 2009, KARYOTYPES PARASITIC; Gu HN, 2003, ANIM BEHAV, V66, P259, DOI 10.1006/anbe.2003.2185; Harpur BA, 2013, ENTOMOL EXP APPL, V146, P156, DOI 10.1111/j.1570-7458.2012.01306.x; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hein S, 2009, ECOL MODEL, V220, P1663, DOI 10.1016/j.ecolmodel.2009.04.001; Holloway AK, 1999, ANN ENTOMOL SOC AM, V92, P110, DOI 10.1093/aesa/92.1.110; JMicroVision, 2012, IM AN TOOLB MEAS QUA; Kitthawee Sangvorn, 1999, Cytologia (Tokyo), V64, P111, DOI 10.1508/cytologia.64.111; Leather SR., 1995, INSECT REPROD; LI Y, 1992, J HERED, V83, P448, DOI 10.1093/oxfordjournals.jhered.a111250; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Ma WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060459; Montoya P, 2000, ANN ENTOMOL SOC AM, V93, P47, DOI 10.1603/0013-8746(2000)093[0047:FRASBD]2.0.CO;2; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Otto F, 1990, Methods Cell Biol, V33, P105; Paxton RJ, 2000, BIOL J LINN SOC, V69, P483, DOI 10.1111/j.1095-8312.2000.tb01220.x; R Core Team, 2012, R LANG ENV STAT COMP; Rueppell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047220; Ruf D, 2013, BIOL J LINN SOC, V108, P79, DOI 10.1111/j.1095-8312.2012.01976.x; Salin C, 2004, BELG J ZOOL, V134, P15; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sirvio A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-95; Sivinski JM, 1996, FRUIT FLY PESTS, P369; Snell GD, 1935, P NATL ACAD SCI USA, V21, P446, DOI 10.1073/pnas.21.7.446; Speicher BR, 1940, AM NAT, V74, P379, DOI 10.1086/280904; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; TRAUT W, 1976, CHROMOSOMA, V58, P275, DOI 10.1007/BF00292094; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Viscarret MM, 2006, BIOL CONTROL, V36, P147, DOI 10.1016/j.biocontrol.2005.08.009; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050; Whiting PW, 1925, SCIENCE, V62, P437, DOI 10.1126/science.62.1611.437; Whiting PW, 1943, GENETICS, V28, P365; Wu Z, 2005, HEREDITY, V95, P228, DOI 10.1038/sj.hdy.6800720; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	70	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119619	10.1371/journal.pone.0119619	http://dx.doi.org/10.1371/journal.pone.0119619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789748	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400092
J	Ha, NT; Gross, JJ; van Dorland, A; Tetens, J; Thaller, G; Schlather, M; Bruckmaier, R; Simianer, H				Ha, Ngoc-Thuy; Gross, Josef Johann; van Dorland, Annette; Tetens, Jens; Thaller, Georg; Schlather, Martin; Bruckmaier, Rupert; Simianer, Henner			Gene-Based Mapping and Pathway Analysis of Metabolic Traits in Dairy Cows	PLOS ONE			English	Article							NEGATIVE-ENERGY BALANCE; EARLY LACTATION; ASSOCIATION ANALYSIS; HEPATIC REGULATION; LIPID-METABOLISM; MILK-PRODUCTION; TRANSITION; LIVER; EXPRESSION; PERFORMANCE	The metabolic adaptation of dairy cows during the transition period has been studied intensively in the last decades. However, until now, only few studies have paid attention to the genetic aspects of this process. Here, we present the results of a gene-based mapping and pathway analysis with the measurements of three key metabolites, (1) non-esterified fatty acids (NEFA), (2) beta-hydroxybutyrate (BHBA) and (3) glucose, characterizing the metabolic adaptability of dairy cows before and after calving. In contrast to the conventional single-marker approach, we identify 99 significant and biologically sensible genes associated with at least one of the considered phenotypes and thus giving evidence for a genetic basis of the metabolic adaptability. Moreover, our results strongly suggest three pathways involved in the metabolism of steroids and lipids are potential candidates for the adaptive regulation of dairy cows in their early lactation. From our perspective, a closer investigation of our findings will lead to a step forward in understanding the variability in the metabolic adaptability of dairy cows in their early lactation.	[Ha, Ngoc-Thuy; Gross, Josef Johann; van Dorland, Annette; Bruckmaier, Rupert] Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland; [Ha, Ngoc-Thuy; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Schlather, Martin] Univ Mannheim, Chair Math Stat, D-68131 Mannheim, Germany	University of Bern; University of Gottingen; University of Kiel; University of Mannheim	Ha, NT (corresponding author), Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland.	ngoc-thuy.ha@vetsuisse.unibe.ch	Gross, Josef J./C-3833-2016; Simianer, Henner/A-6574-2015	Gross, Josef J./0000-0002-2578-6076; Simianer, Henner/0000-0002-7551-3797; Tetens, Jens/0000-0001-5352-464X	Swiss Commission for Technology and Innovation CTI [13948.2 PFLS-LS]	Swiss Commission for Technology and Innovation CTI	NH and JJG were supported by Swiss Commission for Technology and Innovation CTI (grant number: 13948.2 PFLS-LS, website: http://www.kti.admin.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Contreras GA, 2011, COMP IMMUNOL MICROB, V34, P281, DOI 10.1016/j.cimid.2011.01.004; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Freytag S, 2014, STAT MED, V33, P1828, DOI 10.1002/sim.6063; Graber M, 2012, J ANIM PHYSIOL AN N, V96, P75, DOI 10.1111/j.1439-0396.2010.01124.x; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Gross J, 2011, J DAIRY SCI, V94, P3484, DOI 10.3168/jds.2011-4251; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang GL, 2013, CURR GENOMICS, V14, P250, DOI 10.2174/13892029113149990001; Kessel S, 2008, J ANIM SCI, V86, P2903, DOI 10.2527/jas.2008-1016; Kessler EC, 2014, J DAIRY SCI, V97, P5481, DOI 10.3168/jds.2014-7926; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; LeBlanc SJ, 2004, J DAIRY SCI, V87, P609, DOI 10.3168/jds.S0022-0302(04)73203-8; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; MARKS PA, 1960, P NATL ACAD SCI USA, V46, P447, DOI 10.1073/pnas.46.4.447; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tetens J, 2013, ANIM GENET, V44, P1, DOI 10.1111/j.1365-2052.2012.02357.x; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Vanhatalo A, 1999, J DAIRY SCI, V82, P2674, DOI 10.3168/jds.S0022-0302(99)75524-4; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277; Wellnitz O, 1999, MILK SCI INT, P54; Zarrin M, 2013, J DAIRY SCI, V96, P2960, DOI 10.3168/jds.2012-6224; Zhang JT, 2005, J AM STAT ASSOC, V100, P273, DOI 10.1198/016214504000000575	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122325	10.1371/journal.pone.0122325	http://dx.doi.org/10.1371/journal.pone.0122325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789767	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400212
J	Ross, AW; Russell, L; Helfer, G; Thomson, LM; Dalby, MJ; Morgan, PJ				Ross, Alexander W.; Russell, Laura; Helfer, Gisela; Thomson, Lynn M.; Dalby, Matthew J.; Morgan, Peter J.			Photoperiod Regulates Lean Mass Accretion, but Not Adiposity, in Growing F344 Rats Fed a High Fat Diet	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; HYPOTHALAMIC NEUROPEPTIDE-Y; GH-RELEASING FACTOR; OBESE ZUCKER RATS; ENERGY-BALANCE; SIBERIAN HAMSTER; MESSENGER-RNA; BODY-WEIGHT; FOOD-INTAKE; GENE-EXPRESSION	In this study the effects of photoperiod and diet, and their interaction, were examined for their effects on growth and body composition in juvenile F344 rats over a 4-week period. On long (16L:8D), relative to short (8L:16D), photoperiod food intake and growth rate were increased, but percentage adiposity remained constant (ca 3-4%). On a high fat diet (HFD), containing 22.8% fat (45% energy as fat), food intake was reduced, but energy intake increased on both photoperiods. This led to a small increase in adiposity (up to 10%) without overt change in body weight. These changes were also reflected in plasma leptin and lipid levels. Importantly while both lean and adipose tissue were strongly regulated by photoperiod on a chow diet, this regulation was lost for adipose, but not lean tissue, on HFD. This implies that a primary effect of photoperiod is the regulation of growth and lean mass accretion. Consistent with this both hypothalamic GHRH gene expression and serum IGF-1 levels were photoperiod dependent. As for other animals and humans, there was evidence of central hyposomatotropism in response to obesity, as GHRH gene expression was suppressed by the HFD. Gene expression of hypothalamic AgRP and CRH, but not NPY nor POMC, accorded with the energy balance status on long and short photoperiod. However, there was a general dissociation between plasma leptin levels and expression of these hypothalamic energy balance genes. Similarly there was no interaction between the HFD and photoperiod at the level of the genes involved in thyroid hormone metabolism (Dio2, Dio3, TSH beta or NMU), which are important mediators of the photoperiodic response. These data suggest that photoperiod and HFD influence body weight and body composition through independent mechanisms but in each case the role of the hypothalamic energy balance genes not predictable based on their known function.	[Ross, Alexander W.; Russell, Laura; Helfer, Gisela; Thomson, Lynn M.; Dalby, Matthew J.; Morgan, Peter J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen	Morgan, PJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	p.morgan@abdn.ac.uk	Helfer, Gisela/S-9189-2019	Helfer, Gisela/0000-0003-0634-4683; Morgan, Peter/0000-0002-5071-6512; Dalby, Matthew/0000-0002-0528-3359; Dalby, Matthew John/0000-0002-1137-4337; Ross, Alexander/0000-0002-1799-1432	Scottish Government (Rural and Environment Science and Analytical Services Division); BBSRC [BB/K001043/1]; Biotechnology and Biological Sciences Research Council [BB/K001043/1, 1279840] Funding Source: researchfish	Scottish Government (Rural and Environment Science and Analytical Services Division); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge the Scottish Government (Rural and Environment Science and Analytical Services Division, http://www.scotland. gov. uk/), AWR LR LMT PJM and the BBSRC, (http://www.bbsrc.ac.uk/home/home.aspx, grant BB/K001043/1), AWR GH PJM for their financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; AHMAD I, 1993, NEUROENDOCRINOLOGY, V58, P332, DOI 10.1159/000126558; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Baskin DG, 1999, HORM METAB RES, V31, P345, DOI 10.1055/s-2007-978751; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; CASANUEVA FF, 1987, J CLIN ENDOCR METAB, V65, P634, DOI 10.1210/jcem-65-4-634; Cattaneo L, 1996, J ENDOCRINOL, V148, P347, DOI 10.1677/joe.0.1480347; Cattaneo L, 1997, PHARMACOL RES, V36, P49, DOI 10.1006/phrs.1997.0203; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; El-Bakry HA, 1999, PHYSIOL BEHAV, V68, P87, DOI 10.1016/S0031-9384(99)00151-1; Ellis C, 2008, AM J PHYSIOL-REG I, V294, pR1148, DOI 10.1152/ajpregu.00825.2007; Graham ES, 2003, J NEUROCHEM, V87, P1165, DOI 10.1046/j.1471-4159.2003.02079.x; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; Helfer G, 2013, J NEUROENDOCRINOL, V25, P1264, DOI 10.1111/jne.12116; Helfer G, 2012, ENDOCRINOLOGY, V153, P815, DOI 10.1210/en.2011-1792; Huang L, 2012, ENDOCRINOLOGY, V153, P4380, DOI 10.1210/en.2012-1178; IMAKI T, 1986, ENDOCRINOLOGY, V118, P2390, DOI 10.1210/endo-118-6-2390; Iwakura H, 2007, AM J PHYSIOL-ENDOC M, V293, pE819, DOI 10.1152/ajpendo.00681.2006; KAMEGAI J, 1994, ENDOCRINOLOGY, V135, P2765, DOI 10.1210/en.135.6.2765; Lobley GE, 2007, BRIT J NUTR, V97, P1099, DOI 10.1017/S0007114507691934; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Marcovecchio ML, 2013, WORLD REV NUTR DIET, V106, P135, DOI 10.1159/000342545; MCELROY JF, 1986, AM J PHYSIOL, V250, pR383, DOI 10.1152/ajpregu.1986.250.3.R383; Melhorn SJ, 2010, PHYSIOL BEHAV, V99, P33, DOI 10.1016/j.physbeh.2009.10.004; Mercer JG, 1997, AM J PHYSIOL-REG I, V273, pR768, DOI 10.1152/ajpregu.1997.273.2.R768; Mercer JG, 2000, AM J PHYSIOL-REG I, V278, pR271, DOI 10.1152/ajpregu.2000.278.1.R271; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 2006, PROG BRAIN RES, V153, P325, DOI 10.1016/S0079-6123(06)53019-5; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; OLCHOVSKY D, 1990, ENDOCRINOLOGY, V126, P53, DOI 10.1210/endo-126-1-53; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peacock WL, 2001, PHYSIOL BEHAV, V74, P65, DOI 10.1016/S0031-9384(01)00533-9; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; RENIER G, 1990, NEUROENDOCRINOLOGY, V52, P284; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Ross AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021351; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; SAGHER FA, 1991, BRIT J NUTR, V65, P21, DOI 10.1079/BJN19910062; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; TANNENBAUM GS, 1990, ENDOCRINOLOGY, V127, P3087, DOI 10.1210/endo-127-6-3087; THOMSON ABR, 1986, J CLIN INVEST, V77, P279, DOI 10.1172/JCI112288; Togo Y, 2012, AM J PHYSIOL-ENDOC M, V303, pE777, DOI 10.1152/ajpendo.00209.2012; Tuominen JA, 1997, EUR J CLIN INVEST, V27, P206, DOI 10.1046/j.1365-2362.1997.940642.x; Tuominen JA, 1997, ACTA PHYSIOL SCAND, V160, P83, DOI 10.1046/j.1365-201X.1997.00102.x; WADE GN, 1983, PHYSIOL BEHAV, V30, P131, DOI 10.1016/0031-9384(83)90048-3; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119763	10.1371/journal.pone.0119763	http://dx.doi.org/10.1371/journal.pone.0119763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789758	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400102
J	Doorenweerd, C; van Nieukerken, EJ; Menken, SBJ				Doorenweerd, Camiel; van Nieukerken, Erik J.; Menken, Steph B. J.			A Global Phylogeny of Leafmining Ectoedemia Moths (Lepidoptera: Nepticulidae): Exploring Host Plant Family Shifts and Allopatry as Drivers of Speciation	PLOS ONE			English	Article							ENEMY-FREE-SPACE; ECOLOGICAL SPECIATION; SAWFLIES HYMENOPTERA; DIVERSITY; INSECT; SPECIALIZATION; ASSOCIATIONS; EVOLUTION; INFERENCE; ACCURACY	Background Host association patterns in Ectoedemia (Lepidoptera: Nepticulidae) are also encountered in other insect groups with intimate plant relationships, including a high degree of monophagy, a preference for ecologically dominant plant families (e.g. Fagaceae, Rosaceae, Salicaceae, and Betulaceae) and a tendency for related insect species to feed on related host plant species. The evolutionary processes underlying these patterns are only partly understood, we therefore assessed the role of allopatry and host plant family shifts in speciation within Ectoedemia. Methodology Six nuclear and mitochondrial DNA markers with a total aligned length of 3692 base pairs were used to infer phylogenetic relationships among 92 species belonging to the subgenus Ectoedemia of the genus Ectoedemia, representing a thorough taxon sampling with a global coverage. The results support monophyletic species groups that are congruent with published findings based on morphology. We used the obtained phylogeny to explore host plant family association and geographical distribution to investigate if host shifts and allopatry have been instrumental in the speciation of these leafmining insects. Significance We found that, even though most species within species groups commonly feed on plants from one family, shifts to a distantly related host family have occasionally occurred throughout the phylogeny and such shifts are most commonly observed towards Betulaceae. The largest radiations have occurred within species groups that feed on Fagaceae, Rosaceae, and Salicaceae. Most species are restricted to one of the seven global biogeographic regions, but within species groups representatives are commonly found in different biogeographic regions. Although we find general patterns with regard to host use and biogeography, there are differences between clades that suggest that different drivers of speciation, and perhaps drivers that we did not examine, have shaped diversity patterns in different clades.	[Doorenweerd, Camiel; van Nieukerken, Erik J.] Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands; [Doorenweerd, Camiel; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Naturalis Biodiversity Center; University of Amsterdam	Doorenweerd, C (corresponding author), Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands.	camiel.doorenweerd@naturalis.nl	Doorenweerd, Camiel/AAO-4314-2020; van Nieukerken, Erik/B-4512-2012	Doorenweerd, Camiel/0000-0002-0418-4439; van Nieukerken, Erik/0000-0002-5721-1840	Uyttenboogaart Eliasen Stichting [SUB.2010.05.12, SUB.2011.12.14]; EU	Uyttenboogaart Eliasen Stichting; EU(European Commission)	Field collecting by the authors was partly funded by the following grants from the Uyttenboogaart Eliasen Stichting (http://www.ue-stichting.nl/): SUB.2010.05.12 to CD for the USA and SUB.2011.12.14 to EJvN for Korea and Taiwan. Field work was further funded by the EU-funded EDIT WP 7 project 'All Taxa Biodiversity Inventories (http://www.atbi.eu/wp7/) in the Mercantour/Alpi Marittime natural parks'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Becerra JX, 2009, P NATL ACAD SCI USA, V106, P18062, DOI 10.1073/pnas.0904456106; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; De Prins J, 2011, GLOBAL TAXONOMIC DAT; De Prins J, 2012, ZOOTAXA, P1; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Diskus A., 2003, P318; Emmet AM, 1988, FIELD GUIDE SMALLER; Farrell BD, 2004, EVOLUTION, V58, P1984; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Knolke S, 2005, INSECT SYST EVOL, V35, P401, DOI 10.1163/187631204788912463; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leppanen SA, 2012, MOL PHYLOGENET EVOL, V64, P331, DOI 10.1016/j.ympev.2012.04.005; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Matzkin LM, 2006, MOL ECOL, V15, P4635, DOI 10.1111/j.1365-294X.2006.03102.x; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Mayr E., 1963, ANIMAL SPECIES EVOLU; McBride CS, 2007, P NATL ACAD SCI USA, V104, P4996, DOI 10.1073/pnas.0608424104; McLeish MJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-188; MENKEN SBJ, 1988, ENTOMOL EXP APPL, V49, P141, DOI 10.1007/BF00188247; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Mey Wolfram, 2004, Esperiana Memoir, V1, P27; Miller M.A., 2010, P GAT COMP ENV WORKS; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Nyman T, 2012, ECOL LETT, V15, P889, DOI 10.1111/j.1461-0248.2012.01782.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Ogden TH, 2005, CLADISTICS, V21, P295, DOI 10.1111/j.1096-0031.2005.00061.x; Ohshima I, 2014, J NAT HIST, P1; Ohshima I, 2008, BIOL J LINN SOC, V93, P135, DOI 10.1111/j.1095-8312.2007.00949.x; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Posada D, 2012, FINDMODEL; Puplesis R, 1994, NEPTICULIDAE E EUROP; Puplesis Rimantas, 2000, Bulletin of the Natural History Museum Entomology Series, V69, P3; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rota J, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000045; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SCOBLE M J, 1979, Annals of the Transvaal Museum, V32, P35; SCOBLE MJ, 1978, J ENTOMOL SOC S AFR, V41, P81; Suzuki H, 2011, ENTOMOL EXP APPL, V138, P212, DOI 10.1111/j.1570-7458.2010.01092.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson JN, 2013, RELENTLESS EVOLUTION, P211; Tilmon KJ, 2008, EVOLUTIONARY BIOL HE; van Nieukerken E.J., 1985, Tijdschrift voor Entomologie, V128, P1; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; van Nieukerken EJ, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.32.282; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; WILKINSON C, 1981, Tijdschrift voor Entomologie, V124, P93; WILKINSON C, 1981, Tijdschrift voor Entomologie, V124, P27; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	71	27	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119586	10.1371/journal.pone.0119586	http://dx.doi.org/10.1371/journal.pone.0119586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785630	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500115
J	Gai, QY; Jiao, J; Luo, M; Wei, ZF; Zu, YG; Ma, W; Fu, YJ				Gai, Qing-Yan; Jiao, Jiao; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Ma, Wei; Fu, Yu-Jie			Establishment of Hairy Root Cultures by Agrobacterium Rhizogenes Mediated Transformation of Isatis Tinctoria L. for the Efficient Production of Flavonoids and Evaluation of Antioxidant Activities	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; INDIGOTICA; ACCUMULATION; PROSPECTS; EXTRACTS; LEAVES; MS/MS; FOOD; PH	In this work, Isatis tinctoria hairy root cultures (ITHRCs) were established as an alternative source for flavonoids (FL) production. I. tinctoria hairy root line V was found to be the most efficient line and was further confirmed by the PCR amplification of rolB, rolC and aux1 genes. Culture parameters of ITHRCs were optimized by Box-Behnken design (BBD), and eight bioactive FL constituents (rutin, neohesperidin, buddleoside, liquiritigenin, quercetin, isorhamnetin, kaempferol and isoliquiritigenin) were quali-quantitatively determined by LCMS/MS. Under optimal conditions, the total FL accumulation of ITHRCs (24 day-old) achieved was 438.10 mu g/g dry weight (DW), which exhibited significant superiority as against that of 2 year-old field grown roots (341.73 mu g/g DW). Additionally, in vitro antioxidant assays demonstrated that ITHRCs extracts exhibited better antioxidant activities with lower IC50 values (0.41 and 0.39, mg/mL) as compared to those of field grown roots (0.56 and 0.48, mg/mL). To the best of our knowledge, this is the first report describing FL production and antioxidant activities from ITHRCs.	[Gai, Qing-Yan; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Fu, Yu-Jie] Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin 150040, Peoples R China; [Gai, Qing-Yan; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Fu, Yu-Jie] Collaborat Innovat Ctr Dev & Utilizat Forest Reso, Harbin 150040, Peoples R China; [Jiao, Jiao; Ma, Wei] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Ma, Wei] Heilongjiang Univ Chinese Med, Sch Pharmaceut, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China; Heilongjiang University of Chinese Medicine	Fu, YJ (corresponding author), Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin 150040, Peoples R China.	yujie_fu2011@yahoo.com	ma, wei/GVU-3235-2022		Application Technology Research and Development Program of Harbin [2013AA3BS014]; Fundamental Research Funds for the Central Universities [2572015AA14, 2572014AA06]; National Natural Science Foundation of China [31270618]; Agricultural Science and Technology Achievements Transformation and Program [2012GB23600641]	Application Technology Research and Development Program of Harbin; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Achievements Transformation and Program	This study was supported by Application Technology Research and Development Program of Harbin (2013AA3BS014), Fundamental Research Funds for the Central Universities (2572015AA14), Fundamental Research Funds for the Central Universities (2572014AA06), Special Fund of National Natural Science Foundation of China (31270618), and Agricultural Science and Technology Achievements Transformation and Program (2012GB23600641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulgakov VP, 2008, BIOTECHNOL ADV, V26, P318, DOI 10.1016/j.biotechadv.2008.03.001; Chandra S, 2011, PHYTOCHEM REV, V10, P371, DOI 10.1007/s11101-011-9210-8; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Chen MH, 2012, J NAT PROD, V75, P1167, DOI 10.1021/np3002833; Davies KM, 2014, CURR OPIN BIOTECH, V26, P133, DOI 10.1016/j.copbio.2013.12.010; Dehghan E, 2012, PLANT CELL TISS ORG, V110, P35, DOI 10.1007/s11240-012-0127-8; Fattahi M, 2013, IND CROP PROD, V50, P256, DOI 10.1016/j.indcrop.2013.07.029; Guillon S, 2006, CURR OPIN PLANT BIOL, V9, P341, DOI 10.1016/j.pbi.2006.03.008; Hu ZB, 2006, J INTEGR PLANT BIOL, V48, P121, DOI 10.1111/j.1744-7909.2006.00121.x; Jeong CS, 2009, ACTA PHYSIOL PLANT, V31, P219, DOI 10.1007/s11738-008-0206-y; Lee EJ, 2015, PLANT CELL TISS ORG, V120, P1, DOI [10.1007/s11240-014-0567-4, 10.1007/s11240-014-0467-7]; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Lin CW, 2005, ANTIVIR RES, V68, P36, DOI 10.1016/j.antiviral.2005.07.002; Matkowski A, 2008, BIOTECHNOL ADV, V26, P548, DOI 10.1016/j.biotechadv.2008.07.001; Mohn T, 2008, PLANTA MED, V74, P582, DOI 10.1055/s-2008-1074504; Naik PM, 2010, PLANT CELL TISS ORG, V100, P235, DOI 10.1007/s11240-009-9639-2; *NAT COMM CHIN PHA, 2005, CHIN PHARM, P142; Ono NN, 2011, PLANT SCI, V180, P439, DOI 10.1016/j.plantsci.2010.11.012; Praveen N, 2012, IND CROP PROD, V35, P241, DOI 10.1016/j.indcrop.2011.07.009; Shi YH, 2012, INT J MOL SCI, V13, P9035, DOI 10.3390/ijms13079035; Shohael AM, 2006, PLANT CELL TISS ORG, V85, P219, DOI 10.1007/s11240-005-9075-x; Taneja J, 2010, PLANT CELL REP, V29, P1119, DOI 10.1007/s00299-010-0895-8; Terato M, 2011, PLANT BIOTECHNOL-NAR, V28, P317, DOI 10.5511/plantbiotechnology.11.0330a; Theboral J, 2014, PLANT CELL TISS ORG, V117, P477, DOI 10.1007/s11240-014-0450-3; Tsimogiannis D, 2007, MOLECULES, V12, P593, DOI 10.3390/12030593; Wang Y., 2011, J GUANGZHOU U TRADIT, V28, P419, DOI [10.13359/j.cnki.gzxbtcm.2011.04.025, DOI 10.13359/J.CNKI.GZXBTCM.2011.04.025]; Wilson SA, 2014, CURR OPIN BIOTECH, V26, P174, DOI 10.1016/j.copbio.2014.01.006; Wu N, 2010, J AGR FOOD CHEM, V58, P4737, DOI [10.1021/jf904593n, 10.1021/jf103970b]; Wu N, 2009, MOLECULES, V14, P1032, DOI 10.3390/molecules14031032	29	27	29	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119022	10.1371/journal.pone.0119022	http://dx.doi.org/10.1371/journal.pone.0119022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785699	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500067
J	Ramp, C; Delarue, J; Palsboll, PJ; Sears, R; Hammond, PS				Ramp, Christian; Delarue, Julien; Palsboll, Per J.; Sears, Richard; Hammond, Philip S.			Adapting to a Warmer Ocean-Seasonal Shift of Baleen Whale Movements over Three Decades	PLOS ONE			English	Article							CLIMATE-CHANGE; HUMPBACK WHALES; NORTH-ATLANTIC; ST-LAWRENCE; BALAENOPTERA-PHYSALUS; BOWHEAD WHALES; MARINE MAMMALS; FIN WHALES; MIGRATION; GULF	Global warming poses particular challenges to migratory species, which face changes to the multiple environments occupied during migration. For many species, the timing of migration between summer and winter grounds and also within-season movements are crucial to maximise exploitation of temporarily abundant prey resources in feeding areas, themselves adapting to the warming planet. We investigated the temporal variation in the occurrence of fin (Balaenoptera physalus) and humpback whales (Megaptera novaeangliae) in a North Atlantic summer feeding ground, the Gulf of St. Lawrence (Canada), from 1984 to 2010 using a long-term study of individually identifiable animals. These two sympatric species both shifted their date of arrival at a previously undocumented rate of more than 1 day per year earlier over the study period thus maintaining the approximate 2-week difference in arrival of the two species and enabling the maintenance of temporal niche separation. However, the departure date of both species also shifted earlier but at different rates resulting in increasing temporal overlap over the study period indicating that this separation may be starting to erode. Our analysis revealed that the trend in arrival was strongly related to earlier ice break-up and rising sea surface temperature, likely triggering earlier primary production. The observed changes in phenology in response to ocean warming are a remarkable example of phenotypic plasticity and may partly explain how baleen whales were able to survive a number of changes in climate over the last several million years. However, it is questionable whether the observed rate of change in timing can be maintained. Substantial modification to the distribution or annual life cycle of these species might be required to keep up with the ongoing warming of the oceans.	[Ramp, Christian; Delarue, Julien; Sears, Richard] Mingan Isl Cetacean Study, St Lambert, PQ, Canada; [Ramp, Christian; Hammond, Philip S.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Palsboll, Per J.] Univ Groningen, Marine Evolut & Conservat, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of St Andrews; University of Groningen	Ramp, C (corresponding author), Mingan Isl Cetacean Study, St Lambert, PQ, Canada.	car@rorqual.com	Palsbøll, Per J/L-3494-2013; Palsboll, Per J/G-6988-2011	Palsbøll, Per J/0000-0002-4198-7599; Palsboll, Per J/0000-0002-4198-7599; Ramp, Christian/0000-0001-5528-1733; Hammond, Philip/0000-0002-2381-8302	Natural Environment Research Council [smru10001] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agler B.A., 1990, Reports of the International Whaling Commission Special Issue, P349; Akaike H., 1985, CELEBRATION STAT, P1; Barco Susan G., 2002, Journal of Cetacean Research and Management, V4, P135; Bergerud A.T., 2007, RETURN CARIBOU UNGAV; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham Phillip J., 1993, Symposia of the Zoological Society of London, V66, P131; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DFO, 2010, 201O030 DFO; Dingle H, 1996, BIOL LIFE MOVE; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Doniol-Valcroze T., 2008, THESIS MCGILL U MONT; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fiedler W, 2004, ADV ECOL RES, V35, P49, DOI 10.1016/S0065-2504(04)35003-8; Galbraith PS, 2013, 2013 DFO, V026; Gavrilchuk K, 2014, MAR ECOL PROG SER, V497, P285, DOI 10.3354/meps10578; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Ingebrigtsen A., 1929, Rapport Conseil Exploration Mer Copenhague, V56, P1; International Whaling Commission, 2009, J CETACEAN RES MANAG, V11, P114; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacobsen K, 2006, MAR MAMMAL SCI, V20, P161; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Katona S.K., 1981, Polar Record, V20, P439; KATONA S. K., 1990, REPORT INT WHALING C, P295; Kingsley MCS, 1998, CAN J ZOOL, V76, P1529, DOI 10.1139/cjz-76-8-1529; Le Fouest V, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002423; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Melvin GD, 2009, ICES J MAR SCI, V66, P1784, DOI 10.1093/icesjms/fsp173; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moore SE, 2006, ECOL APPL, V16, P932, DOI 10.1890/1051-0761(2006)016[0932:TISICW]2.0.CO;2; MYERS GS, 1949, COPEIA, P89; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Parsons JL, 1981, DISTRIBUTION ABUNDAN; PETRIE B, 1996, CAN TECH REP HYDROGR, V178; R Core Team, 2011, R LANG ENV STAT COMP; Ramp C, 2014, ENDANGER SPECIES RES, V23, P125, DOI 10.3354/esr00571; Ramp C, 2010, MAR ECOL PROG SER, V400, P267, DOI 10.3354/meps08426; Robbins J., 2007, THESIS U ST ANDREWS; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Schmidt M, 2011, NAT ED KNOWL, V3, P1; Sears R, 2002, MAR MAMMAL SCI, V18, P281, DOI 10.1111/j.1748-7692.2002.tb01034.x; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Sigurjonsson J, 1995, DEV MAR BIO, V4, P425; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Stafford KM, 2007, ARCTIC, V60, P167; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Svaas S., 2001, CHANGES WINTERING SI; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Vaisanen R.V., 1997, LINNUT VUOSIKIRJA, P70; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; [No title captured]	73	72	77	3	176	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121374	10.1371/journal.pone.0121374	http://dx.doi.org/10.1371/journal.pone.0121374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785462	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500210
J	Wu, XY; Tao, SM; Zhang, YK; Zhang, SC; Tao, FB				Wu, Xiaoyan; Tao, Shuman; Zhang, Yukun; Zhang, Shichen; Tao, Fangbiao			Low Physical Activity and High Screen Time Can Increase the Risks of Mental Health Problems and Poor Sleep Quality among Chinese College Students	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SEDENTARY BEHAVIOR; ADOLESCENTS; TELEVISION; EXERCISE; ASSOCIATIONS; INSTRUMENT; DEPRESSION; FITNESS; HABITS	Objective To test the independent and interactive associations of physical activity (PA) and screen time (ST) with self-reported mental health and sleep quality among Chinese college students. Method Data were collected in October, 2013. The gender, age, residential background, body mass index (BMI), perceived family economy and perceived study burden were obtained from a total of 4747 college students (41.6% males and 58.4% females). The outcomes were self-reported PA status, ST, anxiety, depression, psychopathological symptoms and sleep quality. Analyses were conducted with logistic regression models. Results Overall, 16.3%, 15.9% and 17.3% of the students had psychological problems, such as anxiety, depression and psychopathological symptoms, respectively. The prevalence of poor sleep quality was 9.8%. High ST was significantly positively associated with anxiety (OR=1.38, 95% CI: 1.15-1.65), depression (OR=1.76, 95% CI: 1.47-2.09), psychopathological symptoms (OR=1.69, 95% CI: 1.43-2.01) and poor sleep quality (OR=1.32, 95% CI: 1.06-1.65). High PA was insignificantly negatively associated with anxiety, depression, psychopathological symptoms and poor sleep. Low PA and high ST were independently and interactively associated with increased risks of mental health problems and poor sleep quality (p<0.05 for all). Conclusion Interventions are needed to reduce ST and increase PA in the lifestyles of young people. Future research should develop and measure the impacts of interventions and their potential consequences on sleep, health, and well being.	[Wu, Xiaoyan; Tao, Shuman; Zhang, Yukun; Zhang, Shichen; Tao, Fangbiao] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Peoples R China; [Wu, Xiaoyan; Zhang, Shichen; Tao, Fangbiao] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China	Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Peoples R China.	fbtao@ahmu.edu.cn	张, 诗晨/HGD-5158-2022		National Natural Science Foundation of China [81302448]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (grant number 81302448) URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TB, 2007, WOMEN HEALTH, V45, P69, DOI 10.1300/J013v45n01_05; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buysse D J, 1989, Psychiatry Res, V28, P193; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Castillo LG, 2013, J CLIN PSYCHOL, V69, P291, DOI 10.1002/jclp.21972; Chao X., 2008, CHIN J PUBLIC HLTH, V24, P1031, DOI [10.11847/zgggws2008-24-09-68, DOI 10.11847/ZGGGWS2008-24-09-68]; Chennaoui M, 2014, SLEEP MED REV; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Goldbacher EM, 2007, ANN BEHAV MED, V34, P240, DOI 10.1007/BF02874549; Hale L, 2014, SLEEP MED REV; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hamer M, 2009, PEDIATRICS, V123, P1263, DOI 10.1542/peds.2008-1523; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Iannotti RJ, 2009, J ADOLESCENT HEALTH, V44, P493, DOI 10.1016/j.jadohealth.2008.10.142; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Kamijo K, 2009, CLIN NEUROPHYSIOL, V120, P511, DOI 10.1016/j.clinph.2008.11.022; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kim YS, 2012, PREV MED, V55, P458, DOI 10.1016/j.ypmed.2012.08.021; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; [凌宇 LING Yu], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P265; Liu XC, 1996, J MOL RECOGNIT, V9, P462, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<462::AID-JMR283>3.0.CO;2-G; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Matamura M, 2014, J SLEEP RES, V23, P290, DOI 10.1111/jsr.12127; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nuutinen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-684; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Rocha SD, 2014, MED PROBL PERFORM AR, V29, P111, DOI 10.21091/mppa.2014.2022; Rothon C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-32; Soric M, 2015, ANN HUM BIOL, V42, P31, DOI 10.3109/03014460.2014.928367; Tao F., 2008, CHIN J DIS CONTROL P, V12, P309, DOI [10.3969/j.issn.1674-3679.2008.04.003, DOI 10.3969/J.ISSN.1674-3679.2008.04.003]; Themanson JR, 2008, NEUROSCIENCE, V157, P319, DOI 10.1016/j.neuroscience.2008.09.014; Tibber MS, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00088, 10.3389/fpsyt.2013.00027]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372; Tyson P, 2010, J MENT HEALTH, V19, P492, DOI 10.3109/09638230902968308; VanKim NA, 2013, AM J HEALTH PROMOT, V28, P7, DOI 10.4278/ajhp.111101-QUAN-395; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Wang H, 2014, J SPORT MED PHYS FIT, V54, P518; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Yu Qian-chun, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P542; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	49	119	123	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119607	10.1371/journal.pone.0119607	http://dx.doi.org/10.1371/journal.pone.0119607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786030	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500118
J	Ingr, M; Lange, R; Halabalova, V; Yehya, A; Hrncirik, J; Chevalier-Lucia, D; Palmade, L; Blayo, C; Konvalinka, J; Dumay, E				Ingr, Marek; Lange, Reinhard; Halabalova, Vera; Yehya, Alaa; Hrncirik, Josef; Chevalier-Lucia, Dominique; Palmade, Laetitia; Blayo, Claire; Konvalinka, Jan; Dumay, Eliane			Inhibitor and Substrate Binding Induced Stability of HIV-1 Protease against Sequential Dissociation and Unfolding Revealed by High Pressure Spectroscopy and Kinetics	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; RIBONUCLEASE-A; RETROVIRAL PROTEASES; FIREMANS GRIP; PROTEINASE; DIMERIZATION; ASSOCIATION; MUTANTS; MONOMER; SITE	High-pressure methods have become an interesting tool of investigation of structural stability of proteins. They are used to study protein unfolding, but dissociation of oligomeric proteins can be addressed this way, too. HIV-1 protease, although an interesting object of biophysical experiments, has not been studied at high pressure yet. In this study HIV-1 protease is investigated by high pressure (up to 600 MPa) fluorescence spectroscopy of either the inherent tryptophan residues or external 8-anilino-1-naphtalenesulfonic acid at 25 degrees C. A fast concentration-dependent structural transition is detected that corresponds to the dimermonomer equilibrium. This transition is followed by a slow concentration independent transition that can be assigned to the monomer unfolding. In the presence of a tight-binding inhibitor none of these transitions are observed, which confirms the stabilizing effect of inhibitor. High-pressure enzyme kinetics (up to 350 MPa) also reveals the stabilizing effect of substrate. Unfolding of the protease can thus proceed only from the monomeric state after dimer dissociation and is unfavourable at atmospheric pressure. Dimer-destabilizing effect of high pressure is caused by negative volume change of dimer dissociation of -32.5 mL/mol. It helps us to determine the atmospheric pressure dimerization constant of 0.92 mu M. High-pressure methods thus enable the investigation of structural phenomena that are difficult or impossible to measure at atmospheric pressure.	[Ingr, Marek; Halabalova, Vera; Hrncirik, Josef] Tomas Bata Univ Zlin, Fac Technol, Dept Phys & Mat Engn, Zlin 76001, Czech Republic; [Ingr, Marek; Konvalinka, Jan] Charles Univ Prague, Dept Biochem, Prague 12843 2, Czech Republic; [Lange, Reinhard] Univ Montpellier 2, INRA UMR IATE, Biochim & Technol Alimentaires, F-34095 Montpellier 05, France; [Yehya, Alaa] Univ Montpellier 2, INSERM U710, F-34095 Montpellier 05, France; [Chevalier-Lucia, Dominique; Palmade, Laetitia; Blayo, Claire; Dumay, Eliane] Univ Montpellier 2, UMR IATE, Biochim & Technol Alimentaires, F-34095 Montpellier 05, France	Tomas Bata University Zlin; Charles University Prague; INRAE; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Ingr, M (corresponding author), Tomas Bata Univ Zlin, Fac Technol, Dept Phys & Mat Engn, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.	ingr@ft.utb.cz	Ingr, Marek/E-2478-2015; Halabalová, Věra/H-6442-2012; PICART-PALMADE, Laetitia/B-8551-2017	Ingr, Marek/0000-0001-6741-9955; PICART-PALMADE, Laetitia/0000-0003-4229-1056; Hrncirik, Josef/0000-0002-5363-1581; Konvalinka, Jan/0000-0003-0695-9266; CHEVALIER-LUCIA, Dominique/0000-0001-6478-2994	INSERM; Grant Agency of the Czech Republic [P208-12-G016]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	RL is grateful to INSERM for supporting his emeritus status. MI and JK have been supported by Grant Agency of the Czech Republic, Grant No. P208-12-G016 (Center of Excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YS, 1999, P NATL ACAD SCI USA, V87, P9660; Cioni P, 2014, PROTEINS, V82, P1787, DOI 10.1002/prot.24532; DARKE PL, 1994, BIOCHEMISTRY-US, V33, P98, DOI 10.1021/bi00167a013; Neto DFD, 2014, VIRAL IMMUNOL, V27, P60, DOI 10.1089/vim.2013.0088; DEVILLEBONNE D, 1991, EUR J BIOCHEM, V200, P747, DOI 10.1111/j.1432-1033.1991.tb16240.x; El Moustaine D, 2008, FEBS J, V275, P2021, DOI 10.1111/j.1742-4658.2008.06356.x; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Font J, 2006, PROTEIN SCI, V15, P1000, DOI 10.1110/ps.052050306; Fowler Carol B, 2014, J Proteomics Bioinform, V7, P151; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Girard E, 2010, BIOPHYS J, V98, P2365, DOI 10.1016/j.bpj.2010.01.058; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; HOLZMAN TF, 1991, J BIOL CHEM, V266, P19217; Ingr M, 2003, PROTEIN SCI, V12, P2173, DOI 10.1110/ps.03171903; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JORDAN SP, 1992, J BIOL CHEM, V267, P20028; Kornblatt MJ, 2004, EUR J BIOCHEM, V271, P3897, DOI 10.1111/j.1432-1033.2004.04326.x; Kozisek M, 2008, J VIROL, V82, P5869, DOI 10.1128/JVI.02325-07; Kozisek M, 2007, J MOL BIOL, V374, P1005, DOI 10.1016/j.jmb.2007.09.083; KUZMIC P, 1993, BIOCHEM BIOPH RES CO, V191, P998, DOI 10.1006/bbrc.1993.1316; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Marchal S, 2005, BRAZ J MED BIOL RES, V38, P1175, DOI 10.1590/S0100-879X2005000800004; Marchal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050489; Meher BR, 2008, ICIT 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY, P118, DOI 10.1109/ICIT.2008.39; PARGELLIS CA, 1994, BIOCHEMISTRY-US, V33, P12527, DOI 10.1021/bi00207a021; Pokorna J, 2009, VIRUSES-BASEL, V1, P1209, DOI 10.3390/v1031209; Prehoda KE, 1998, NATO ADV SCI I A-LIF, V301, P59; RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026; Ruan KC, 2000, BIOCHEM BIOPH RES CO, V269, P681, DOI 10.1006/bbrc.2000.2345; Schramm HJ, 1996, ANTIVIR RES, V30, P155, DOI 10.1016/0166-3542(96)00940-0; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Strisovsky K, 2000, PROTEIN SCI, V9, P1631, DOI 10.1110/ps.9.9.1631; Torrent J, 1999, BIOCHEMISTRY-US, V38, P15952, DOI 10.1021/bi991460b; Towler EM, 1998, BIOCHEMISTRY-US, V37, P17137, DOI 10.1021/bi9818927; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Uhlikova T, 1996, BIOCHEM BIOPH RES CO, V222, P38, DOI 10.1006/bbrc.1996.0694; Veverka V, 2003, J MOL BIOL, V333, P771, DOI 10.1016/j.jmb.2003.08.049; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Xie D, 1999, PROTEIN SCI, V8, P1702, DOI 10.1110/ps.8.8.1702; ZHANG ZY, 1991, J BIOL CHEM, V266, P15591	41	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119099	10.1371/journal.pone.0119099	http://dx.doi.org/10.1371/journal.pone.0119099			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781460	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600050
J	Kang, ZZ; Li, Z				Kang, Zhizhong; Li, Zhen			Primitive Fitting Based on the Efficient multiBaySAC Algorithm	PLOS ONE			English	Article							RANDOM SAMPLE CONSENSUS; RANDOMIZED RANSAC; 3D; SEGMENTATION; SURFACES; MODELS; PLANES; EM	Although RANSAC is proven to be robust, the original RANSAC algorithm selects hypothesis sets at random, generating numerous iterations and high computational costs because many hypothesis sets are contaminated with outliers. This paper presents a conditional sampling method, multiBaySAC (Bayes SAmple Consensus), that fuses the BaySAC algorithm with candidate model parameters statistical testing for unorganized 3D point clouds to fit multiple primitives. This paper first presents a statistical testing algorithm for a candidate model parameter histogram to detect potential primitives. As the detected initial primitives were optimized using a parallel strategy rather than a sequential one, every data point in the multiBaySAC algorithm was assigned to multiple prior inlier probabilities for initial multiple primitives. Each prior inlier probability determined the probability that a point belongs to the corresponding primitive. We then implemented in parallel a conditional sampling method: BaySAC. With each iteration of the hypothesis testing process, hypothesis sets with the highest inlier probabilities were selected and verified for the existence of multiple primitives, revealing the fitting for multiple primitives. Moreover, the updated version of the initial probability was implemented based on a memorable form of Bayes' Theorem, which describes the relationship between prior and posterior probabilities of a data point by determining whether the hypothesis set to which a data point belongs is correct. The proposed approach was tested using real and synthetic point clouds. The results show that the proposed multiBaySAC algorithm can achieve a high computational efficiency (averaging 34% higher than the efficiency of the sequential RANSAC method) and fitting accuracy (exhibiting good performance in the intersection of two primitives), whereas the sequential RANSAC framework clearly suffers from over-and under-segmentation problems. Future work will aim at further optimizing this strategy through its application to other problems such as multiple point cloud co-registration and multiple image matching.	[Kang, Zhizhong; Li, Zhen] China Univ Geosci, Sch Land Sci & Technol, Beijing 100083, Peoples R China	China University of Geosciences	Kang, ZZ (corresponding author), China Univ Geosci, Sch Land Sci & Technol, 29 Xueyuan Rd, Beijing 100083, Peoples R China.	zzkang@cugb.edu.cn			Natural Science Foundation of China [41171358]; Fundamental Research Funds for the Central Universities [2652012103]; National High Technology Research and Development Program of China (863 Program) [2012AA12A204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Natural Science Foundation of China under Grant No. 41171358, the Fundamental Research Funds for the Central Universities under Grant No. 2652012103 and the National High Technology Research and Development Program of China (863 Program) with the serial number 2012AA12A204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BAYESIAN STAT INTRO; Awwad TM, 2010, PHOTOGRAMM REC, V25, P5, DOI 10.1111/j.1477-9730.2009.00564.x; Bartoli A, 2007, COMPUT VIS IMAGE UND, V105, P42, DOI 10.1016/j.cviu.2006.07.011; Botterill T, 2009, P BRIT MED VIS C; Cheng CM, 2009, PATTERN RECOGN, V42, P1318, DOI 10.1016/j.patcog.2009.01.007; Chum O, 2008, IEEE T PATTERN ANAL, V30, P1472, DOI 10.1109/TPAMI.2007.70787; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gallo O, 2011, PATTERN RECOGN LETT, V32, P403, DOI 10.1016/j.patrec.2010.10.009; Hahnel D, 2003, ROBOT AUTON SYST, V44, P15, DOI 10.1016/S0921-8890(03)00007-1; Lakaemper R, 2006, INT C PATT RECOG, P1077; Liu Y., 2001, P 18 INT C MACH LEAR, P329; Matas J, 2004, IMAGE VISION COMPUT, V22, P837, DOI 10.1016/j.imavis.2004.02.009; Mufti F, 2012, ROBOT AUTON SYST, V60, P16, DOI 10.1016/j.robot.2011.08.009; Overby J, 2004, INT ARCH PHOTOGRAMME, VXXXIV, P296; Papalazarou C, 2013, PATTERN RECOGN, V46, P925, DOI 10.1016/j.patcog.2012.09.013; Rottensteiner F., 2006, INT ARCH PHOTOGRAM 3, V36, P93; Schnabel R, 2007, COMPUT GRAPH FORUM, V26, P214, DOI 10.1111/j.1467-8659.2007.01016.x; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torr PHS, 2003, IEEE T PATTERN ANAL, V25, P354, DOI 10.1109/TPAMI.2003.1182098; Triebel R, 2005, IEEE INT CONF ROBOT, P4437; van den Heuvel F. A., 1999, P SOC PHOTO-OPT INS, V3641, P60; Vidal R, 2005, IEEE T PATTERN ANAL, V27, P1945, DOI 10.1109/TPAMI.2005.244; Yoon M, 2007, COMPUT AIDED DESIGN, V39, P408, DOI 10.1016/j.cad.2007.02.008	23	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117341	10.1371/journal.pone.0117341	http://dx.doi.org/10.1371/journal.pone.0117341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781620	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600011
J	Lu, N; Di, Y; Feng, XY; Qiang, JW; Zhang, JW; Wang, YG; Liu, Y				Lu, Na; Di, Yue; Feng, Xiao-Yuan; Qiang, Jin-Wei; Zhang, Jia-wen; Wang, Yong-gang; Liu, Ying			CT Perfusion with Acetazolamide Challenge in C6 Gliomas and Angiogenesis	PLOS ONE			English	Article							CEREBROVASCULAR RESERVE; CLINICAL-APPLICATIONS; MALIGNANT GLIOMAS; BRAIN-TUMORS; SPECT; EXPRESSION; CD105; PREDICTION; REACTIVITY; PROTEINS	Background This study was performed to investigate the correlation between CT perfusion with acetazolamide challenge and angiogenesis in C6 gliomas. Methods Thirty-two male Sprague-Dawley rats were evaluated. The rats were divided randomly to four groups: eight rats with orthotopically implanted C6 gliomas at 10-days old (Group A), eight rats with gliomas at 14-days old (Group B), eight rats with gliomas at 18-days old (Group C), eight rats with orthotopically injected normal saline served as controls. CT perfusion was performed before and after administration of acetazolamide. Changes in perfusion parameters due to acetazolamide administration were calculated and analyzed. Results Elevated carbon dioxide partial pressure and decreased pH were found in all 32 rats post acetazolamide challenge (P< 0.01). Cerebral blood flowpre-challenge was increased in group C (95.0 +/- 2.5 ml/100g/min), as compared to group B (80.1 +/- 11.3 ml/100g/min) and group A (63.1 +/- 2.1 ml/100g/min). Cerebral blood flow percentage changes were detected with a reduction in group C (54.2 +/- 4.8%) as compared to controls (111.3 +/- 22.2%). Cerebral blood volume(pre-challenge) was increased in group C (50.8 +/- 1.7ml/100g), as compared to group B (45.7 +/- 1.9 ml/100g) and group A (38.2 +/- 0.8 ml/100g). Cerebral blood volume percentage changes were decreased in group C (23.5 +/- 4.6%) as compared to controls (113.5 +/- 30.4%). Angiogenesis ratio = [(CD105-MVD) / (FVIII-MVD)] x100%. Positive correlations were observed between CD105-microvessel density, angiogenesis ratio, vascular endothelial growth factor, proliferation marker and cerebral blood flow(pre-challenge), cerebral blood volume (pre-challenge). Negative correlations were observed between CD105-microvessel density and cerebral blood flow percentage changes (P< 0.01, correlation coefficient r=-0.788), cerebral bloodvolume percentage changes (P< 0.01, r=-0.703). Negative correlations were observed between angiogenesis ratio, vascular endothelial growth factor, proliferation marker and cerebral blood flow percentage changes, cerebral blood volume percentage changes. Conclusion Our findings suggest that CT perfusion with challenge can provide new insight into non-invasive assessment of rat C6 glioma angiogenesis.	[Lu, Na; Qiang, Jin-Wei] Fudan Univ, Jinshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Di, Yue] Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Feng, Xiao-Yuan; Zhang, Jia-wen] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Wang, Yong-gang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China; [Liu, Ying] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University	Feng, XY (corresponding author), Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	xyfeng@shmu.edu.cn; dr.jinweiqiang@163.com		Di, Yue/0000-0001-6905-7476	National Natural Science Foundations of China [30970805, 81400428]; Science and Technology Commission of Shanghai Municipality [09JC1403100]; Shanghai Municipality Commission of Health and Family Planning Projects [2011-187]; Shanghai Jinshan Municipality Health Bureau Youth Foundation [JWKJ-KTYQ-201202, JWKJ-RCYQ-201202]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipality Commission of Health and Family Planning Projects; Shanghai Jinshan Municipality Health Bureau Youth Foundation	This work was supported by National Natural Science Foundations of China (Grant No. 30970805, 81400428), a grant from Science and Technology Commission of Shanghai Municipality (Grant No. 09JC1403100), Shanghai Municipality Commission of Health and Family Planning Projects (Grant No. 2011-187), a grant from Shanghai Jinshan Municipality Health Bureau Youth Foundation (Grant No. JWKJ-KTYQ-201202, JWKJ-RCYQ-201202.) The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aamand R, 2011, NEUROPHARMACOLOGY, V61, P900, DOI 10.1016/j.neuropharm.2011.06.010; Andaluz N, 2010, NEUROSURG REV, V33, P225, DOI 10.1007/s10143-010-0237-x; Asdaghi N, 2011, STROKE, V42, P2191, DOI 10.1161/STROKEAHA.110.611376; Bernsen MR, 2014, EUR J NUCL MED MOL I, V41, pS36, DOI 10.1007/s00259-013-2685-3; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chamberlain MC, 2010, CANCER-AM CANCER SOC, V116, P3988, DOI 10.1002/cncr.25256; Chen A, 2006, AM J NEURORADIOL, V27, P1876; Cianfoni A, 2006, J NEURORADIOLOGY, V33, P164, DOI 10.1016/S0150-9861(06)77254-6; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Eicker S, 2011, EUR J MED RES, V16, P484, DOI 10.1186/2047-783X-16-11-484; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Farid K, 2012, NUCL MED COMMUN, V33, P571, DOI 10.1097/MNM.0b013e328351d583; Folkman J, 2007, J PEDIATR SURG, V42, P1, DOI 10.1016/j.jpedsurg.2006.09.048; Fulesdi B, 2012, J CRIT CARE, V27, P337, DOI 10.1016/j.jcrc.2011.11.002; Guan LM, 2011, J NEUROSURG, V114, P1672, DOI 10.3171/2011.1.JNS101513; Hashemi M, 2014, J CANCER RES THER, V10, P107, DOI 10.4103/0973-1482.131413; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Lu N, 2012, ACAD RADIOL, V19, P159, DOI 10.1016/j.acra.2011.09.017; Lu N, 2011, ACAD RADIOL, V18, P81, DOI 10.1016/j.acra.2010.07.012; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; Park SA, 2012, NEUROREHABILITATION, V30, P359, DOI 10.3233/NRE-2012-0767; Pillai JJ, 2012, TECHNOL CANCER RES T, V11, P361, DOI 10.7785/tcrt.2012.500284; Qu DW, 2014, EUR REV MED PHARMACO, V18, P516; Sasaki M, 2009, AM J NEURORADIOL, V30, P188, DOI 10.3174/ajnr.A1274; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Smith LM, 2008, J NEURORADIOLOGY, V35, P157, DOI 10.1016/j.neurad.2007.11.002; Soffietti R, 2012, CURR CANCER DRUG TAR, V12, P279, DOI 10.2174/156800912799277584; Tachezy M, 2010, HISTOL HISTOPATHOL, V25, P1239, DOI 10.14670/HH-25.1239; Uwano I, 2012, NEURORADIOLOGY, V54, P467, DOI 10.1007/s00234-011-0905-8; Vagal AS, 2009, AM J NEURORADIOL, V30, P876, DOI 10.3174/ajnr.A1538; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; WEIDNER N, 1995, AM J PATHOL, V147, P9; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005; You SH, 2013, J KOREAN NEUROSURG S, V54, P280, DOI 10.3340/jkns.2013.54.4.280; Zhang B, 2014, BIOMATERIALS, V35, P4133, DOI 10.1016/j.biomaterials.2014.01.071	37	6	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121631	10.1371/journal.pone.0121631	http://dx.doi.org/10.1371/journal.pone.0121631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781321	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600209
J	Pitz, S; Kalkum, G; Arash, L; Karabul, N; Sodi, A; Larroque, S; Beck, M; Gal, A				Pitz, Susanne; Kalkum, Gisela; Arash, Laila; Karabul, Nesrin; Sodi, Andrea; Larroque, Sylvain; Beck, Michael; Gal, Andreas			Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CLINICAL MANIFESTATIONS; AGALSIDASE-ALPHA; ITALIAN PATIENTS; SCORE INDEX; COHORT; FEATURES; IMPACT	Ocular signs in Fabry disease have generally been regarded to be primarily of diagnostic value. We explored whether ocular findings, alone or in particular in combination with the alpha-galactosidase A gene mutation, have predictive value for disease severity. Data from the Fabry Outcome Survey (FOS), a large, global database sponsored by Shire, were selected for adult patients who had undergone ophthalmological examination. Three ocular signs were assessed: cornea verticillata, tortuous conjunctival and/or retinal vessels, and cataract. Fabry disease severity was measured using FOS Mainz Severity Score Index and modifications thereof. Ophthalmological data were available for 1203 (699 female, 504 male) adult patients with eye findings characteristic of Fabry disease in 55.1%. Cornea verticillata had a similar distribution in women (51.1%) and men (50.8%), whereas tortuous vessels and Fabry cataract were somewhat more frequent in men than in women. Patients with cornea verticillata, selected as the principal ocular sign for this study, had more severe disease (median score, 20.0) versus those without ocular signs (11.0; P< 0.001). This finding could be confirmed by applying age adjusted severity scores. Moreover, the prevalence of cornea verticillata was significantly higher in patients with null (male, 76.9%; female, 64.5%) and missense (male, 79.2%; female, 67.4%) mutations versus mild missense (male, 17.1%; female, 23.1%) and the p.N215S (male, 15.0%; female, 15.6%) mutations (P< 0.01). Our analyses show a correlation between the prevalence of ocular changes in Fabry disease and disease severity. Consequently, information on ocular findings and a-galactosidase A gene mutation may help assess the risk for more severe Fabry disease. These observed findings are of notable clinical importance, as Fabry disease is characterized by high clinical course variability and only weak genotype-phenotype correlation at the individual patient level. Further confirmatory studies are needed.	[Pitz, Susanne] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Kalkum, Gisela] Childrens Hosp Dr Horst Schmidt Kliniken, Wiesbaden, Germany; [Arash, Laila; Karabul, Nesrin; Beck, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, D-55122 Mainz, Germany; [Sodi, Andrea] Univ Florence, Eye Clin, Dept Surg & Translat Med, Florence, Italy; [Larroque, Sylvain] Shire, Zug, Switzerland; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Florence; Shire Pharmaceuticals Limited; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pitz, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	susanne.pitz@unimedizin-mainz.de			Shire	Shire	Financial support for this work was provided by Shire (http://www.shire.com/shireplc/en/home). The funder provided support in the form of a salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Allen LE, 2010, BRIT J OPHTHALMOL, V94, P1602, DOI 10.1136/bjo.2009.176651; ARBISSER AI, 1976, AM J OPHTHALMOL, V82, P465, DOI 10.1016/0002-9394(76)90496-7; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; Gal A, 2012, ANN S SOC STUD INB E; Hughes DA, 2010, MOL GENET METAB, V101, P219, DOI 10.1016/j.ymgme.2010.06.002; Lidove O, 2007, INT J CLIN PRACT, V61, P293, DOI 10.1111/j.1742-1241.2006.01237.x; Lin HY, 2010, J INHERIT METAB DIS, V33, P619, DOI 10.1007/s10545-010-9166-7; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Morier AM, 2010, OPTOMETRY, V81, P437, DOI 10.1016/j.optm.2010.02.011; Morrone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e103; Motwani M, 2012, MOL GENET METAB, V107, P197, DOI 10.1016/j.ymgme.2012.05.011; Nguyen TT, 2005, CLIN EXP OPHTHALMOL, V33, P164, DOI 10.1111/j.1442-9071.2005.00990.x; Orssaud Christophe, 2003, Ophthalmic Genet, V24, P129, DOI 10.1076/opge.24.3.129.15609; Parini R, 2008, CLIN GENET, V74, P260, DOI 10.1111/j.1399-0004.2008.01012.x; Rudich DS, 2013, JAMA OPHTHALMOL, V131, P1244, DOI 10.1001/jamaophthalmol.2013.2374; Samiy N, 2008, SURV OPHTHALMOL, V53, P416, DOI 10.1016/j.survophthal.2008.04.005; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; SHER NA, 1979, ARCH OPHTHALMOL-CHIC, V97, P671; Shrier EM, 2004, ARCH OPHTHALMOL-CHIC, V122, P1395, DOI 10.1001/archopht.122.9.1395; Sodi A IA, 2006, FABRY DIS PERSPECTIV; Sodi A, 2007, BRIT J OPHTHALMOL, V91, P210, DOI 10.1136/bjo.2006.100602; SPAETH GL, 1965, ARCH OPHTHALMOL-CHIC, V74, P760, DOI 10.1001/archopht.1965.00970040762005; TSUTSUMI A, 1984, ACTA OPHTHALMOL, V62, P923; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Whybra C, 2009, GENET MED, V11, P441, DOI 10.1097/GIM.0b013e3181a23bec	26	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120814	10.1371/journal.pone.0120814	http://dx.doi.org/10.1371/journal.pone.0120814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781336	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600189
J	Wang, WJ; Hu, YL; Ma, Y; Xu, LY; Guan, JT; Kong, J				Wang, Weiji; Hu, Yulong; Ma, Yu; Xu, Liyong; Guan, Jiantao; Kong, Jie			High-Density Genetic Linkage Mapping in Turbot (Scophthalmus maximus L.) Based on SNP Markers and Major Sex- and Growth-Related Regions Detection	PLOS ONE			English	Article							GONADAL DEVELOPMENT; DIFFERENTIATION; RESOLUTION; SEQUENCE; TRAITS; LOCI	This paper describes the development of a high density consensus genetic linkage map of a turbot (Scophthalmus maximus L.) family composed of 149 mapping individuals using Single Nucleotide Polymorphisms (SNP) developed using the restriction-site associated DNA (RAD) sequencing technique with the restriction enzyme, PstI. A total of 6,647 SNPs were assigned to 22 linkage groups, which is equal to the number of chromosome pairs in turbot. For the first time, the average marker interval reached 0.3958 cM, which is equal to approximately 0.1203 Mb of the turbot genome. The observed 99.34% genome coverage indicates that the linkage map was genome-wide. A total of 220 Quantitative Traits Locus (QTLs) associated with two body length traits, two body weight traits in different growth periods and sex determination were detected with an LOD > 5.0 in 12 linkage groups (LGs), which explained the corresponding phenotypic variance (R-2), ranging from 14.4-100%. Among them, 175 overlapped with linked SNPs, and the remaining 45 were located in regions between contiguous SNPs. According to the QTLs related to growth trait distribution and the changing of LGs during different growth periods, the growth traits are likely controlled by multi-SNPs distributed on several LGs; the effect of these SNPs changed during different growth periods. Most sex-related QTLs were detected at LG 21 with a linkage span of 70.882 cM. Additionally, a small number of QTLs with high feasibility and a narrow R-2 distribution were also observed on LG7 and LG14, suggesting that multi LGs or chromosomes might be involved in sex determination. High homology was recorded between LG21 in Cynoglossus semilaevis and turbot. This high-saturated turbot RAD-Seq linkage map is undoubtedly a promising platform for marker assisted selection (MAS) and flatfish genomics research.	[Wang, Weiji; Hu, Yulong; Ma, Yu; Xu, Liyong; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China; [Guan, Jiantao] Ocean Univ China, Qingdao, Shandong, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Ocean University of China	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China.	kongjie@ysfri.ac.cn		guan, jiantao/0000-0003-1607-009X	National High Technology Research and Development Program of China [2012AA10A408-7]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (Grant No. 2012AA10A408-7). Wang is the author who received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUZA C, 1994, MAR BIOL, V120, P609, DOI 10.1007/BF00350082; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Cal RM, 2006, J FISH BIOL, V68, P401, DOI 10.1111/j.0022-1112.2006.00889.x; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Cunado N, 2001, GENOME, V44, P1143, DOI 10.1139/gen-44-6-1143; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; FERNANDO RL, 1989, GENET SEL EVOL, V21, P467, DOI 10.1051/gse:19890407; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Haffray P, 2009, AQUACULTURE, V294, P30, DOI 10.1016/j.aquaculture.2009.05.004; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Howell B., 2006, SCI SERIES TECHNICAL, V32, P1; HUSEBYE H, 1994, COMP BIOCHEM PHYS B, V107, P69, DOI 10.1016/0305-0491(94)90226-7; Imsland AK, 1997, AQUAC RES, V28, P101; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; JANSEN RC, 1994, GENETICS, V136, P1447; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LANDE R, 1990, GENETICS, V124, P743; [雷霁霖 Lei Jilin], 2012, [渔业科学进展, Progress in Fishery Sciences], V33, P123; [栾生 LUAN Sheng], 2008, [海洋水产研究, Marine Fisheries Research], V29, P14; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Palaiokostas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068389; Piferrer F, 2004, AQUACULTURE, V238, P403, DOI 10.1016/j.aquaculture.2004.05.009; Rodriguez-Ramilo ST, 2013, ANIM GENET, V44, P149, DOI 10.1111/j.1365-2052.2012.02385.x; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Ruan XH, 2010, AQUACULTURE, V308, P89, DOI 10.1016/j.aquaculture.2010.08.010; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Shi CY, 2004, AQUACULTURE, V236, P11, DOI 10.1016/j.aquaculture.2003.11.007; Van Ooijen, 2004, MAPQTL SOFTWARE MAPP; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen J.W., 2006, JOINMAP4 SOFTWARE CA; Vinas A, 2012, MAR BIOTECHNOL, V14, P655, DOI 10.1007/s10126-012-9451-6; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang WJ, 2008, I GENETIC MAPPING CH; Zhang QL, 2009, J VIROL METHODS, V158, P18, DOI 10.1016/j.jviromet.2009.01.008; [张庆文 ZHANG Qingwen], 2008, [海洋水产研究, Marine Fisheries Research], V29, P53	39	52	57	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120410	10.1371/journal.pone.0120410	http://dx.doi.org/10.1371/journal.pone.0120410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775256	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500171
J	Yamaguchi, M; Kotani, K; Tsuzaki, K; Takagi, A; Motokubota, N; Komai, N; Sakane, N; Moritani, T; Nagai, N				Yamaguchi, Mitsue; Kotani, Kazuhiko; Tsuzaki, Kokoro; Takagi, Ayaka; Motokubota, Naoko; Komai, Naho; Sakane, Naoki; Moritani, Toshio; Nagai, Narumi			Circadian Rhythm Genes CLOCK and PER3 Polymorphisms and Morning Gastric Motility in Humans	PLOS ONE			English	Article							SLEEP-PHASE SYNDROME; LENGTH POLYMORPHISM; DIURNAL PREFERENCE; ASSOCIATION; METABOLISM; OVERWEIGHT; EXPRESSION; VARIANTS; GENETICS; HEALTH	Background Clock genes regulate circadian rhythm and are involved in various physiological processes, including digestion. We therefore investigated the association between the CLOCK 3111T/C single nucleotide polymorphism and the Period3 (PER3) variable-number tandem-repeat polymorphism (either 4 or 5 repeats 54 nt in length) with morning gastric motility. Methods Lifestyle questionnaires and anthropometric measurements were performed with 173 female volunteers (mean age, 19.4 years). Gastric motility, evaluated by electrogastrography (EGG), blood pressure, and heart rate levels were measured at 8:30 a.m. after an overnight fast. For gastric motility, the spectral powers (% normal power) and dominant frequency (DF, peak of the power spectrum) of the EGG were evaluated. The CLOCK and PER3 polymorphisms were determined by polymerase chain reaction (PCR) restriction fragment length polymorphism analysis. Results Subjects with the CLOCK C allele (T/C or C/C genotypes: n = 59) showed a significantly lower DF (mean, 2.56 cpm) than those with the T/T genotype (n = 114, 2.81 cpm, P < 0.05). Subjects with the longer PER3 allele (PER3(4/5) or PER3(5/5) genotypes: n = 65) also showed a significantly lower DF (2.55 cpm) than those with the shorter PER3(4/4) genotype (n = 108, 2.83 cpm, P < 0.05). Furthermore, subjects with both the T/C or C/C and PER3(4/5) or PER3(5/5) genotypes showed a significantly lower DF (2.43 cpm, P < 0.05) than subjects with other combinations of the alleles (T/T and PER3(4/4) genotype, T/C or C/C and PER3(4/4) genotypes, and T/T and PER3(4/5) or PER3(5/5) genotypes). Conclusions These results suggest that minor polymorphisms of the circadian rhythm genes CLOCK and PER3 may be associated with poor morning gastric motility, and may have a combinatorial effect. The present findings may offer a new viewpoint on the role of circadian rhythm genes on the peripheral circadian systems, including the time-keeping function of the gut.	[Yamaguchi, Mitsue; Takagi, Ayaka; Motokubota, Naoko; Komai, Naho; Nagai, Narumi] Univ Hyogo, Grad Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan; [Kotani, Kazuhiko; Tsuzaki, Kokoro; Sakane, Naoki] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto, Japan; [Moritani, Toshio] Kyoto Univ, Grad Sch Human & Environm Studies, Appl Physiol Lab, Kyoto, Japan	University of Hyogo; Jichi Medical University; Kyoto University	Nagai, N (corresponding author), Univ Hyogo, Grad Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan.	nagai@shse.u-hyogo.ac.jp		Nagai, Narumi/0000-0002-2574-9371	Ministry of Education and Science of Japan [24500988]	Ministry of Education and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Science Research from the Ministry of Education and Science of Japan (24500988). URL of funder's website: http://www.jsps.go.jp/english/e-grants/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Bandin C, 2013, INT J OBESITY, V37, P1044, DOI 10.1038/ijo.2012.180; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Chellappa SL, 2014, BEHAV BRAIN RES, V271, P23, DOI 10.1016/j.bbr.2014.05.050; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435; Garaulet M, 2010, EUR J HUM GENET, V18, P364, DOI 10.1038/ejhg.2009.176; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V299, pG549, DOI 10.1152/ajpgi.00147.2010; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maire M, 2014, CORTEX, V52, P47, DOI 10.1016/j.cortex.2013.11.008; Maire M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00059; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Osland TM, 2011, CHRONOBIOL INT, V28, P764, DOI 10.3109/07420528.2011.607375; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Parkman HP, 2003, NEUROGASTROENT MOTIL, V15, P89, DOI 10.1046/j.1365-2982.2003.00396.x; Parsons MJ, 2014, J SLEEP RES, V23, P595, DOI 10.1111/jsr.12144; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pereira DS, 2005, SLEEP, V28, P29; Ramsey KM, 2013, METHODS MOL BIOL, V1077, P285, DOI 10.1007/978-1-62703-637-5_19; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Steptoe A, 2006, ARCH INTERN MED, V166, P1689, DOI 10.1001/archinte.166.16.1689; Suzuki A, 2005, CLIN AUTON RES, V15, P368, DOI 10.1007/s10286-005-0294-3; Viola AU, 2008, AM J PHYSIOL-HEART C, V295, pH2156, DOI 10.1152/ajpheart.00662.2008; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wakisaka S, 2012, J NUTR SCI VITAMINOL, V58, P333, DOI 10.3177/jnsv.58.333; Yamaguchi M, 2012, PHYSIOL BEHAV, V107, P87, DOI 10.1016/j.physbeh.2012.06.006; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	42	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120009	10.1371/journal.pone.0120009	http://dx.doi.org/10.1371/journal.pone.0120009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775462	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500146
J	Freire, JEC; Vasconcelos, IM; Moreno, FBMB; Batista, AB; Lobo, MDP; Pereira, ML; Lima, JPMS; Almeida, RVM; Sousa, AJS; Monteiro-Moreira, ACO; Oliveira, JTA; Grangeiro, TB				Freire, Jose E. C.; Vasconcelos, Ilka M.; Moreno, Frederico B. M. B.; Batista, Adelina B.; Lobo, Marina D. P.; Pereira, Mirella L.; Lima, Joao P. M. S.; Almeida, Ricardo V. M.; Sousa, Antonio J. S.; Monteiro-Moreira, Ana C. O.; Oliveira, Jose T. A.; Grangeiro, Thalles B.			Mo-CBP3, an Antifungal Chitin-Binding Protein from Moringa oleifera Seeds, Is a Member of the 2S Albumin Family	PLOS ONE			English	Article							STABLE SWEET PROTEIN; FLOCCULANT-ACTIVE PROTEINS; VIGNA-UNGUICULATA VICILINS; SODIUM DODECYL-SULFATE; 7S STORAGE GLOBULINS; STRUCTURAL-CHARACTERIZATION; HOMOLOGOUS PROTEIN; SEQUENCE ALIGNMENT; IDENTIFICATION; PURIFICATION	Mo-CBP3 is a chitin-binding protein from M. oleifera seeds that inhibits the germination and mycelial growth of phytopathogenic fungi. This protein is highly thermostable and resistant to pH changes, and therefore may be useful in the development of new antifungal drugs. However, the relationship of MoCBP3 with the known families of carbohydrate-binding domains has not been established. In the present study, full-length cDNAs encoding 4 isoforms of Mo-CBP3 (Mo-CBP3-1, Mo-CBP3-2, Mo-CBP3-3 and Mo-CBP3-4) were cloned from developing seeds. The polypeptides encoded by the Mo-CBP3 cDNAs were predicted to contain 160 (Mo-CBP3-3) and 163 amino acid residues (Mo-CBP3-1, Mo-CBP3-2 and Mo-CBP3-4) with a signal peptide of 20-residues at the N-terminal region. A comparative analysis of the deduced amino acid sequences revealed that Mo-CBP3 is a typical member of the 2S albumin family, as shown by the presence of an eight-cysteine motif, which is a characteristic feature of the prolamin superfamily. Furthermore, mass spectrometry analysis demonstrated that Mo-CBP3 is a mixture of isoforms that correspond to different mRNA products. The identification of Mo-CBP3 as a genuine member of the 2S albumin family reinforces the hypothesis that these seed storage proteins are involved in plant defense. Moreover, the chitin-binding ability of Mo-CBP3 reveals a novel functionality for a typical 2S albumin.	[Freire, Jose E. C.; Vasconcelos, Ilka M.; Batista, Adelina B.; Sousa, Antonio J. S.; Oliveira, Jose T. A.] Univ Fed Ceara, Ctr Ciencias, Dept Bioquim & Biol Mol, Fortaleza, Ceara, Brazil; [Moreno, Frederico B. M. B.; Lobo, Marina D. P.; Monteiro-Moreira, Ana C. O.] Univ Fed Ceara, Nucl Biol Expt, Fortaleza, Ceara, Brazil; [Pereira, Mirella L.; Grangeiro, Thalles B.] Univ Fed Ceara, Ctr Ciencias, Dept Biol, Fortaleza, Ceara, Brazil; [Lima, Joao P. M. S.; Almeida, Ricardo V. M.] Univ Fed Rio Grande do Norte, Inst Med Trop IMT RN, BR-59072970 Natal, RN, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte	Grangeiro, TB (corresponding author), Univ Fed Ceara, Ctr Ciencias, Dept Biol, Fortaleza, Ceara, Brazil.	tbgrangeiro@gmail.com	SOUSA, ANTÔNIO JUSCELINO SUDÁRIO/L-6603-2016; Lima, João Paulo Matos Santos/AAS-7878-2021; Lima, Joao Paulo/G-4023-2014; da Cruz Freire, José Ednésio/D-8645-2016; Monteiro-Moreira, Ana Cristina O/F-3685-2014; Grangeiro, Thalles Barbosa/E-9606-2010	Lima, João Paulo Matos Santos/0000-0002-6113-8834; Lima, Joao Paulo/0000-0002-6113-8834; da Cruz Freire, José Ednésio/0000-0002-0660-0459; Monteiro-Moreira, Ana Cristina O/0000-0002-3606-6808; Grangeiro, Thalles Barbosa/0000-0001-8276-3092; Sudario Sousa, Antonio Juscelino/0000-0002-4511-8796	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	This work was supported by research grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP). TBG, JTAO, JPMSL and IMV are senior investigators of CNPq.	Agizzio AP, 2006, PLANT SCI, V171, P515, DOI 10.1016/j.plantsci.2006.06.001; Agizzio AP, 2003, ARCH BIOCHEM BIOPHYS, V416, P188, DOI 10.1016/S0003-9861(03)00313-8; Ahmed F, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00084; Almira Ernesto C, 2003, J Biomol Tech, V14, P270; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN NH, 1993, BIOCHEMISTRY-US, V32, P1407, DOI 10.1021/bi00057a004; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; ARCHER BL, 1960, BIOCHEM J, V75, P236, DOI 10.1042/bj0750236; ASENSIO JL, 1995, EUR J BIOCHEM, V230, P621; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; Breiteneder H, 2004, J ALLERGY CLIN IMMUN, V113, P821, DOI [10.1016/j.jaci.2004.01.779, 10.1016/j.jaci.2004.01.079]; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dubovskii PV, 2011, BIOCHEM BIOPH RES CO, V411, P14, DOI 10.1016/j.bbrc.2011.06.058; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fang EF, 2010, FEBS LETT, V584, P4089, DOI 10.1016/j.febslet.2010.08.041; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GASSEN HG, 1990, BIOL CHEM H-S, V371, P760; GASSENSCHMIDT U, 1995, BBA-GEN SUBJECTS, V1243, P477, DOI 10.1016/0304-4165(94)00176-X; GASSENSCHMIDT U, 1991, BIOL CHEM H-S, V372, P659; Gehrig PM, 1996, P NATL ACAD SCI USA, V93, P3647, DOI 10.1073/pnas.93.8.3647; Ghebremichael KA, 2005, WATER RES, V39, P2338, DOI 10.1016/j.watres.2005.04.012; Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068; Gomes VM, 1998, PLANT SCI, V138, P81, DOI 10.1016/S0168-9452(98)00148-4; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Gomes VM, 1998, BBA-GEN SUBJECTS, V1379, P207, DOI 10.1016/S0304-4165(97)00100-1; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Huang RH, 2004, BIOCHEMISTRY-US, V43, P6005, DOI 10.1021/bi036263y; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Joshi CP, 1997, PLANT MOL BIOL, V35, P993, DOI 10.1023/A:1005816823636; Kansal SK, 2014, CHEM REV, V114, P4993, DOI 10.1021/cr400093w; Katre UV, 2008, INT J BIOL MACROMOL, V42, P203, DOI 10.1016/j.ijbiomac.2007.10.024; Kim Y, 2014, NUCLEIC ACIDS RES, V42, P485, DOI 10.1093/nar/gkt864; KORTT AA, 1990, PHYTOCHEMISTRY, V29, P2805, DOI 10.1016/0031-9422(90)87080-E; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; KREIS M, 1985, J MOL BIOL, V183, P499, DOI 10.1016/0022-2836(85)90017-8; Li DF, 2008, J STRUCT BIOL, V162, P50, DOI 10.1016/j.jsb.2007.12.007; LIU XZ, 1993, EUR J BIOCHEM, V211, P281, DOI 10.1111/j.1432-1033.1993.tb19896.x; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lukaszewicz M, 2000, PLANT SCI, V154, P89, DOI 10.1016/S0168-9452(00)00195-3; Luz LD, 2013, INT J BIOL MACROMOL, V58, P31, DOI 10.1016/j.ijbiomac.2013.03.044; MACEDO MLR, 1993, COMP BIOCHEM PHYS C, V105, P89, DOI 10.1016/0742-8413(93)90063-Q; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Moreno FJ, 2005, BBA-PROTEINS PROTEOM, V1752, P142, DOI 10.1016/j.bbapap.2005.07.022; Muzzarelli RAA, 1999, EXS, V87, P1; Mylne JS, 2014, FUNCT PLANT BIOL, V41, P671, DOI 10.1071/FP14035; NDABIGENGESERE A, 1995, WATER RES, V29, P703, DOI 10.1016/0043-1354(94)00161-Y; NIRASAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1202, P277, DOI 10.1016/0167-4838(93)90016-K; Nirasawa S, 1996, GENE, V181, P225, DOI 10.1016/S0378-1119(96)00465-9; Okuda T, 2001, WATER RES, V35, P405, DOI 10.1016/S0043-1354(00)00290-6; Paes EV, 2008, ENTOMOL EXP APPL, V129, P11, DOI 10.1111/j.1570-7458.2008.00746.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; PITTRIVE.R, 1968, BIOCHEM J, V109, P825, DOI 10.1042/bj1090825; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rundqvist L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046435; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sales MP, 2001, BRAZ J MED BIOL RES, V34, P27, DOI 10.1590/S0100-879X2001000100003; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; TERRAS FRG, 1993, PLANT PHYSIOL, V103, P1311, DOI 10.1104/pp.103.4.1311; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomar PPS, 2014, APPL BIOCHEM BIOTECH, V174, P471, DOI 10.1007/s12010-014-1078-9; Tomar PPS, 2014, BIOCHEM BIOPH RES CO, V448, P349, DOI 10.1016/j.bbrc.2014.04.158; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Vatcher G, 2002, BIOTECHNIQUES, V33, P532, DOI 10.2144/02333st03_11824a; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; YOULE RJ, 1978, PLANT PHYSIOL, V61, P13, DOI 10.1104/pp.61.1.13; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	93	39	40	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119871	10.1371/journal.pone.0119871	http://dx.doi.org/10.1371/journal.pone.0119871			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789746	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400112
J	Gaire, BP; Kwon, OW; Park, SH; Chun, KH; Kim, SY; Shin, DY; Choi, JW				Gaire, Bhakta Prasad; Kwon, Oh Wook; Park, Sung Hyuk; Chun, Kwang-Hoon; Kim, Sun Yeou; Shin, Dong Yun; Choi, Ji Woong			Neuroprotective Effect of 6-Paradol in Focal Cerebral Ischemia Involves the Attenuation of Neuroinflammatory Responses in Activated Microglia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; ZINGIBER-OFFICINALE; CHAIN LENGTH; MICE LACKING; BRAIN-INJURY; FACTOR-ALPHA; GINGER; 6-SHOGAOL; DEFICITS	Paradols are non-pungent and biotransformed metabolites of shogaols and reduce inflammatory responses as well as oxidative stress as shogaols. Recently, shogaol has been noted to possess therapeutic potential against several central nervous system (CNS) disorders, including cerebral ischemia, by reducing neuroinflammation in microglia. Therefore, paradol could be used to improve neuroinflammation-associated CNS disorders. Here, we synthesized paradol derivatives (2-to 10-paradols). Through the initial screening for antiinflammatory activities using lipopolysaccharide (LPS)-stimulated BV2 microglia, 6-paradol was chosen to be the most effective compound without cytotoxicity. Pretreatment with 6paradol reduced neuroinflammatory responses in LPS-stimulated BV2 microglia by a concentration-dependent manner, which includes reduced NO production by inhibiting iNOS upregulation and lowered secretion of proinflammatory cytokines (IL-6 and TNF-alpha). To pursue whether the beneficial in vitro effects of 6-paradol leads towards in vivo therapeutic effects on transient focal cerebral ischemia characterized by neuroinflammation, we employed middle cerebral artery occlusion (MCAO)/reperfusion (M/R). Administration of 6-paradol immediately after reperfusion significantly reduced brain damage in M/R-challenged mice as assessed by brain infarction, neurological deficit, and neural cell survival and death. Furthermore, as observed in cultured microglia, 6-paradol administration markedly reduced neuroinflammation in M/R-challenged brains by attenuating microglial activation and reducing the number of cells expressing iNOS and TNF-alpha, both of which are known to be produced in microglia following M/R challenge. Collectively, this study provides evidences that 6-paradol effectively protects brain after cerebral ischemia, likely by attenuating neuroinflammation in microglia, suggesting it as a potential therapeutic agent to treat cerebral ischemia.	[Gaire, Bhakta Prasad; Choi, Ji Woong] Gachon Univ, Coll Pharm, Pharmacol Lab, Incheon, South Korea; [Gaire, Bhakta Prasad; Choi, Ji Woong] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Kwon, Oh Wook; Kim, Sun Yeou] Gachon Univ, Coll Pharm, Lab Pharmacognosy, Incheon, South Korea; [Park, Sung Hyuk; Shin, Dong Yun] Gachon Univ, Coll Pharm, Med Chem Lab, Incheon, South Korea; [Chun, Kwang-Hoon] Gachon Univ, Coll Pharm, Biochem Lab, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University; Gachon University	Shin, DY (corresponding author), Gachon Univ, Coll Pharm, Med Chem Lab, Incheon, South Korea.	dyshin@gachon.ac.kr; pharmchoi@gachon.ac.kr	Gaire, Bhakta Prasad/AAA-4211-2020; Gaire, Bhakta Prasad/I-7776-2019		National Research Foundation of Republic of Korea [NRF-2013R1A1A1A05005520, NRF-2012R1A1A1007057]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C18200000]; Research program for Gachon Pharmaceutical Sciences	National Research Foundation of Republic of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Research program for Gachon Pharmaceutical Sciences	This work was supported by the National Research Foundation of Republic of Korea (NRF-2013R1A1A1A05005520, NRF-2012R1A1A1007057); the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C18200000); Research program for Gachon Pharmaceutical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HH, 2013, J MED FOOD, V16, P437, DOI 10.1089/jmf.2012.0165; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Yuh-Fung, 2012, Front Biosci (Elite Ed), V4, P809, DOI 10.2741/E420; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Chung WY, 2001, MUTAT RES-GEN TOX EN, V496, P199, DOI 10.1016/S1383-5718(01)00221-2; Craggs L, 2011, NEUROREPORT, V22, P1, DOI 10.1097/WNR.0b013e328342741c; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Erickson MA, 2012, NEUROIMMUNOMODULAT, V19, P121, DOI 10.1159/000330247; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gu Y, 2014, J NEUROIMMUNE PHARM, V9, P313, DOI 10.1007/s11481-014-9525-5; Ha SK, 2012, NEUROPHARMACOLOGY, V63, P211, DOI 10.1016/j.neuropharm.2012.03.016; Haratake A, 2014, J AGR FOOD CHEM, V62, P6166, DOI 10.1021/jf500873a; Iadecola C, 1997, J NEUROSCI, V17, P9157; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jeon S, 2011, J ETHNOPHARMACOL, V137, P783, DOI 10.1016/j.jep.2011.06.046; Kannappan R, 2011, MOL NEUROBIOL, V44, P142, DOI 10.1007/s12035-011-8168-2; Kim DH, 2015, NEUROSCIENCE, V284, P42, DOI 10.1016/j.neuroscience.2014.09.074; Kim DSHL, 2004, BIOORG MED CHEM LETT, V14, P1287, DOI 10.1016/j.bmcl.2003.12.041; Kim J, 2013, NEUROCHEM INT, V63, P732, DOI 10.1016/j.neuint.2013.09.013; Kim MO, 2014, CARCINOGENESIS, V35, P683, DOI 10.1093/carcin/bgt365; Kubra IR, 2012, CRIT REV FOOD SCI, V52, P651, DOI 10.1080/10408398.2010.505689; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Liu Shimin, 2010, J Exp Stroke Transl Med, V3, P47; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Moon M, 2014, BIOCHEM BIOPH RES CO, V449, P8, DOI 10.1016/j.bbrc.2014.04.121; Mythri RB, 2012, RECENT PATENTS ENDOC, V6, P181, DOI 10.2174/187221412802481793; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Nurtjahja-Tjendraputra E, 2003, THROMB RES, V111, P259, DOI 10.1016/j.thromres.2003.09.009; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Park G, 2013, ACTA PHARMACOL SIN, V34, P1131, DOI 10.1038/aps.2013.57; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Shih HC, 2014, INT J MOL SCI, V15, P3926, DOI 10.3390/ijms15033926; Suresh K, 2010, PHARMACOL REP, V62, P1178, DOI 10.1016/S1734-1140(10)70380-7; Thomson M, 2002, PROSTAG LEUKOTR ESS, V67, P475, DOI 10.1054/plef.2002.0441; Welser-Alves JV, 2013, NEUROCHEM INT, V63, P47, DOI 10.1016/j.neuint.2013.04.007; Wood LD, 2010, DRUG AGING, V27, P295, DOI 10.2165/11318330-000000000-00000; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409; Zeng GF, 2013, REJUV RES, V16, P124, DOI 10.1089/rej.2012.1389; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	48	63	67	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120203	10.1371/journal.pone.0120203	http://dx.doi.org/10.1371/journal.pone.0120203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789481	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400140
J	Zhang, TP; Kho, DH; Wang, Y; Harazono, Y; Nakajima, K; Xie, Y; Raz, A				Zhang, Tianpeng; Kho, Dhong Hyo; Wang, Ying; Harazono, Yosuke; Nakajima, Kosei; Xie, Youming; Raz, Avraham			Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; HMG-COA REDUCTASE; DISEASE; INSIG-1; CELLS; KAI1	Nonalcoholic steatohepatitis (NASH) is related to metabolic dysregulation and the perturbation of endoplasmic reticulum (ER) homeostasis that frequently develops into hepatocellular carcinoma (HCC). Gp78 is E3 ligase, which regulates endoplasmic reticulum-associated degradation (ERAD) by ubiquitinylation of misfolded ER proteins. Here, we report that upon ageing (12 months), gp78(-/-) mice developed obesity, recapitulating age-related human NASH. Liver histology of gp78(-/-) mice revealed typical steatosis, hepatic inflammation and fibrosis, followed by progression to hepatocellular tumors. Acute ER stress revealed that loss of gp78 results in up regulation of unfolded protein response (UPR) pathways and SREBP-1 regulating de novo lipogenesis, responsible for fatty liver. Tissue array of human hepatocellular carcinoma (HCC) demonstrated that the expression of gp78 was inversely correlated with clinical grades of cancer. Here, we have described the generation of the first preclinical experimental model system which spontaneously develops age-related NASH and HCC, linking ERAD to hepatosteatosis, cirrhosis, and cancer. It suggests that gp78 is a regulator of normal liver homeostasis and a tumor suppressor in human liver.	[Raz, Avraham] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute	Raz, A (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.	raza@karmanos.org						Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Basseri S, 2008, DEV CELL, V15, P795, DOI 10.1016/j.devcel.2008.11.013; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chen ZL, 2014, J GENET GENOMICS, V41, P357, DOI 10.1016/j.jgg.2014.05.005; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181; Gougelet A, 2012, J HEPATOL, V2012, DOI [10.1155/2012/816125, DOI 10.1155/2012/816125]; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Joshi B, 2010, J BIOL CHEM, V285, P8830, DOI 10.1074/jbc.M109.074344; Kho DH, 2014, CANCER RES, V74, P2229, DOI 10.1158/0008-5472.CAN-13-2937; Kho DH, 2013, CANCER RES, V73, P1411, DOI 10.1158/0008-5472.CAN-12-2149; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Naik A, 2013, GENOMICS, V102, P84, DOI 10.1016/j.ygeno.2013.03.007; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754	41	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118448	10.1371/journal.pone.0118448	http://dx.doi.org/10.1371/journal.pone.0118448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789613	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400031
J	Ahmad, Z; Jasnos, L; Gil, V; Howell, L; Hallsworth, A; Petrie, K; Sawado, T; Chesler, L				Ahmad, Zai; Jasnos, Lukasz; Gil, Veronica; Howell, Louise; Hallsworth, Albert; Petrie, Kevin; Sawado, Tomoyuki; Chesler, Louis			Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma	PLOS ONE			English	Article							STEM-CELLS; N-MYC; DIVISION SYMMETRY; MOUSE MODEL; EXPRESSION; IDENTIFICATION; HEDGEHOG; LINEAGE; INHIBITION; PROTEIN	Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are deregulated in MB remain to be fully characterized, amplification and/or overexpression of the MYCN gene, which is has a critical role in cerebellar development as a regulator of neural progenitor cell fate, has been identified in several MB subgroups. Phenotypically, aberrant expression of MYCN is associated with the large-cell/anaplastic MB variant, which accounts for 5-15% of cases and is associated with aggressive disease and poor clinical outcome. To better understand the role of MYCN in MB in vitro and in vivo and to aid the development of MYCN-targeted therapeutics we established tumor-derived neurosphere cell lines from the GTML (Glt1-tTA/TRE-MYCN-Luc) genetically engineered mouse model. A fraction of GTML neurospheres were found to be growth factor independent, expressed CD133 (a marker of neural stem cells), failed to differentiate upon MYCN withdrawal and were highly tumorigenic when orthotopically implanted into the cerebellum. Principal component analyzes using single cell RNA assay data suggested that the clinical candidate aurora-A kinase inhibitor MLN8237 converts GTML neurospheres to resemble non-MYCN expressors. Correlating with this, MLN8237 significantly extended the survival of mice bearing GTML MB allografts. In summary, our results demonstrate that MYCN plays a critical role in expansion and survival of aggressive MB-propagating cells, and establish GTML neurospheres as an important resource for the development of novel therapeutic strategies.	[Ahmad, Zai; Gil, Veronica; Hallsworth, Albert; Petrie, Kevin; Chesler, Louis] Inst Canc Res, Div Clin Studies, London SM2 5NG, England; [Jasnos, Lukasz; Howell, Louise; Sawado, Tomoyuki] Inst Canc Res, Div Mol Pathol, London SM2 5NG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Sawado, T (corresponding author), Inst Canc Res, Div Mol Pathol, London SM2 5NG, England.	tomoyuki.sawado@icr.ac.uk	Petrie, Kevin/I-7115-2015	Petrie, Kevin/0000-0002-9805-9152; Chesler, Louis/0000-0001-7842-2068	Institute of Cancer Research, American Institute for Cancer Research [11-0301]; Cancer Research United Kingdom [C34648/A12054]; Brain Tumour Charity [SDBTT 6/88]; Cancer Research UK [18339] Funding Source: researchfish	Institute of Cancer Research, American Institute for Cancer Research; Cancer Research United Kingdom(Cancer Research UK); Brain Tumour Charity; Cancer Research UK(Cancer Research UK)	This work was supported by funds from the Institute of Cancer Research, American Institute for Cancer Research (11-0301), Cancer Research United Kingdom (C34648/A12054), and Brain Tumour Charity (SDBTT 6/88). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Eberhart CG, 2012, CANCER CELL, V21, P137, DOI 10.1016/j.ccr.2012.01.013; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Jasnos L, 2014, NAT PROTOC, V9, P505, DOI 10.1038/nprot.2014.032; Jasnos L, 2013, STEM CELL REP, V1, P360, DOI 10.1016/j.stemcr.2013.08.005; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Manoranjan B, 2013, CANCER LETT, V338, P23, DOI 10.1016/j.canlet.2012.07.010; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Monje M, 2011, J CLIN ONCOL, V29, P1395, DOI 10.1200/JCO.2010.34.0547; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Poschl J, 2014, ACTA NEUROPATHOL, V128, P123, DOI 10.1007/s00401-014-1297-8; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rostomily RC, 1997, CANCER RES, V57, P3526; Roussel MF, 2013, COLD SPRING HARB PER, P3; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Van Brocklyn JR, 2014, CANCER RES, V74, P5364, DOI 10.1158/0008-5472.CAN-14-0386; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	50	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119834	10.1371/journal.pone.0119834	http://dx.doi.org/10.1371/journal.pone.0119834			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785590	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000352138500131
J	Evers, E; de Vries, H; Spruijt, BM; Sterck, EHM				Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.			Emotional Bookkeeping and High Partner Selectivity Are Necessary for the Emergence of Partner-Specific Reciprocal Affiliation in an Agent-Based Model of Primate Groups	PLOS ONE			English	Article							GROOMING SITE PREFERENCES; MACAQUES MACACA-MULATTA; SOCIAL RELATIONSHIPS; GROUP-SIZE; DOMINANCE RELATIONS; LONG-TERM; JAPANESE MACAQUES; BARBARY MACAQUES; STABILITY; ANIMALS	Primate affiliative relationships are differentiated, individual-specific and often reciprocal. However, the required cognitive abilities are still under debate. Recently, we introduced the EMO-model, in which two emotional dimensions regulate social behaviour: anxiety-FEAR and satisfaction-LIKE. Emotional bookkeeping is modelled by providing each individual with partner-specific LIKE attitudes in which the emotional experiences of earlier affiliations with others are accumulated. Individuals also possess fixed partner-specific FEAR attitudes, reflecting the stable dominance hierarchy. In this paper, we focus on one key parameter of the model, namely the degree of partner selectivity, i.e. the extent to which individuals rely on their LIKE attitudes when choosing affiliation partners. Studying the effect of partner selectivity on the emergent affiliative relationships, we found that at high selectivity, individuals restricted their affiliative behaviours more to similar-ranking individuals and that reciprocity of affiliation was enhanced. We compared the emotional bookkeeping model with a control model, in which individuals had fixed LIKE attitudes simply based on the (fixed) rank-distance, instead of dynamic LIKE attitudes based on earlier events. Results from the control model were very similar to the emotional bookkeeping model: high selectivity resulted in preference of similar-ranking partners and enhanced reciprocity. However, only in the emotional bookkeeping model did high selectivity result in the emergence of reciprocal affiliative relationships that were highly partner-specific. Moreover, in the emotional bookkeeping model, LIKE attitude predicted affiliative behaviour better than rank-distance, especially at high selectivity. Our model suggests that emotional bookkeeping is a likely candidate mechanism to underlie partner-specific reciprocal affiliation.	[Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Anim Ecol, Utrecht, Netherlands; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Ethol Res, Rijswijk, Netherlands	Utrecht University	Sterck, EHM (corresponding author), Univ Utrecht, Anim Ecol, Utrecht, Netherlands.	e.h.m.sterck@uu.nl	de Vries, Han/B-9359-2011; Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027	Netherlands Science Organization (NWO) [864.05.009]	Netherlands Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by a VIDI grant to EHM Sterck by the Netherlands Science Organization (NWO, grant number 864.05.009); URL: http://www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023345; Adiseshan A, 2011, AM J PRIMATOL, V73, P1107, DOI 10.1002/ajp.20987; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli Filippo, 2012, P531; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Barrett L, 2002, BEHAVIOUR, V139, P263, DOI 10.1163/156853902760102672; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; BARTON R, 1985, INT J PRIMATOL, V6, P519, DOI 10.1007/BF02735574; Berghanel A, 2011, BEHAVIOUR, V148, P1257, DOI 10.1163/000579511X600628; Bergstrom ML, 2010, BEHAVIOUR, V147, P899, DOI 10.1163/000579510X497283; BERNSTEIN IS, 1986, ANIM BEHAV, V34, P739, DOI 10.1016/S0003-3472(86)80057-4; BERNSTEIN IS, 1969, ANIM BEHAV, V17, P452, DOI 10.1016/0003-3472(69)90146-8; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bovet D, 2003, J COMP PSYCHOL, V117, P400, DOI 10.1037/0735-7036.117.4.400; BRAMBLETT CA, 1982, AM J PRIMATOL, V2, P43, DOI 10.1002/ajp.1350020107; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; BUZAS MA, 1969, SCIENCE, V163, P72, DOI 10.1126/science.163.3862.72; Campenni M, 2014, J THEOR BIOL, V344, P49, DOI 10.1016/j.jtbi.2013.11.019; Carne C, 2011, AM J PRIMATOL, V73, P1127, DOI 10.1002/ajp.20979; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Chapman CA, 2000, ON THE MOVE HOW AND, p[24, 41]; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Curley JP, 2005, TRENDS ECOL EVOL, V20, P561, DOI 10.1016/j.tree.2005.05.018; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; De Waal FBM, 2000, ANIM BEHAV, V60, P253, DOI 10.1006/anbe.2000.1471; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; DEWAAL FBM, 1991, ANIM BEHAV, V41, P383, DOI 10.1016/S0003-3472(05)80839-5; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Evers E, THE TIMEFRAME OF EMO; Evers E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087955; Evers E, 2012, BEHAV ECOL SOCIOBIOL, V66, P931, DOI 10.1007/s00265-012-1342-3; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; FOODEN J, 1990, J HUM EVOL, V19, P607, DOI 10.1016/0047-2484(90)90002-S; Fooden Jack, 2006, Fieldiana Zoology, P1; Giske J, 2013, AM NAT, V182, P689, DOI 10.1086/673533; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; Henzi SP, 2007, ADV STUD BEHAV, V37, P43, DOI 10.1016/S0065-3454(07)37002-2; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Jaeggi AV, 2013, EVOL HUM BEHAV, V34, P69, DOI 10.1016/j.evolhumbehav.2012.09.005; KUMAR A, 1995, PRIMATES, V36, P1, DOI 10.1007/BF02381911; KUMMER H, 1978, SOC SCI INFORM, V17, P687, DOI 10.1177/053901847801700418; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Leinfelder I, 2001, AM J PRIMATOL, V55, P25, DOI 10.1002/ajp.1036; Leiva D., 2010, P MEAS BEH 2010, P162; Massen JJM, 2013, INT J PRIMATOL, V34, P770, DOI 10.1007/s10764-013-9695-7; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melnick DJ, 1987, CERCOPITHECINES IN M; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noe R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P233, DOI 10.1007/3-540-28277-7_13; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Puga-Gonzalez I, 2015, BEHAV ECOL SOCIOBIOL, V69, P383, DOI 10.1007/s00265-014-1850-4; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; R Core Team, 2012, R LANG ENV STAT COMP; RHINE RJ, 1989, AM J PRIMATOL, V19, P69, DOI 10.1002/ajp.1350190202; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Schaffner CM, 2012, PRIMATES, V53, P49, DOI 10.1007/s10329-011-0271-5; Schell A, 2011, ANIM COGN, V14, P503, DOI 10.1007/s10071-011-0383-8; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2008, BIOL J LINN SOC, V95, P439, DOI 10.1111/j.1095-8312.2008.01067.x; Schino G, 2010, EVOL ANTHROPOL, V19, P130, DOI 10.1002/evan.20270; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schulke O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059789; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; SMUTS BB, 1987, PRIMATE SOCIETIES; Sterck Elisabeth H.M., 2012, P65; TERRY RL, 1970, J PSYCHOL, V76, P129, DOI 10.1080/00223980.1970.9916830; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tiddi B, 2011, BEHAV ECOL, V22, P663, DOI 10.1093/beheco/arr028; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173, DOI 10.1007/BF00299920; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Wilenski U, 2007, NETLOGO 5 0 2; Xia DP, 2013, AM J PRIMATOL, V75, P1009, DOI 10.1002/ajp.22165; Zamma K, 2002, PRIMATES, V43, P41, DOI 10.1007/BF02629575	97	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118921	10.1371/journal.pone.0118921	http://dx.doi.org/10.1371/journal.pone.0118921			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785601	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500058
J	Grossohmichen, M; Salcher, R; Kreipe, HH; Lenarz, T; Maier, H				Grossoehmichen, Martin; Salcher, Rolf; Kreipe, Hans-Heinrich; Lenarz, Thomas; Maier, Hannes			The Codacs (TM) Direct Acoustic Cochlear Implant Actuator: Exploring Alternative Stimulation Sites and Their Stimulation Efficiency	PLOS ONE			English	Article							MIDDLE-EAR IMPLANT; ROUND-WINDOW STIMULATION; BONE-CONDUCTION STIMULATION; OSSICULAR CHAIN; PERFORMANCE; AIR	This work assesses the efficiency of the Codacs system actuator (Cochlear Ltd., Sydney Australia) in different inner ear stimulation modalities. Originally the actuator was intended for direct perilymph stimulation after stapedotomy using a piston prosthesis. A possible alternative application is the stimulation of middle ear structures or the round window (RW). Here the perilymph stimulation with a K-piston through a stapes footplate (SFP) fenestration (N = 10) as well as stimulation of the stapes head (SH) with a Bell prosthesis (N = 9), SFP stimulation with an Omega/Aerial prosthesis (N = 8) and reverse RW stimulation (N = 10) were performed in cadaveric human temporal bones (TBs). Codacs actuator output is expressed as equivalent sound pressure level (eq. SPL) using RW and SFP displacement responses, measured by Laser Doppler velocimetry as reference. The axial actuator coupling force in stimulation of stapes and RW was adjusted to similar to 5 mN. The Bell prosthesis and Omega/Aerial prosthesis stimulation generated similar mean eq. SPLs (Bell: 127.5-141.8 eq. dB SPL; Omega/Aerial: 123.6-143.9 eq. dB SPL), being significantly more efficient than K-piston perilymph stimulation (108.6-131.6 eq. dB SPL) and RW stimulation (108.3-128.2 eq. dB SPL). Our results demonstrate that SH, SFP and RW are adequate alternative stimulation sites for the Codacs actuator using coupling prostheses and an axial coupling force of similar to 5 mN. Based on the eq. SPLs, all investigated methods were adequate for in vivo hearing aid applications, provided that experimental conditions including constant coupling force will be implemented.	[Grossoehmichen, Martin; Salcher, Rolf; Lenarz, Thomas; Maier, Hannes] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Grossoehmichen, Martin; Salcher, Rolf; Lenarz, Thomas; Maier, Hannes] Hannover Med Sch, Inst Audioneurotechnol VIANNA, Hannover, Germany; [Kreipe, Hans-Heinrich] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Maier, H (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Maier.Hannes@MH-Hannover.de	Grossöhmichen, Martin/F-1032-2015; Hannes, Maier/AAE-5070-2020; Hannes, Maier/A-9457-2012	Grossöhmichen, Martin/0000-0002-5720-0981; Hannes, Maier/0000-0001-8457-5327; Hannes, Maier/0000-0001-8457-5327	Cochlear Ltd.	Cochlear Ltd.	This work is part of the doctoral thesis of MG and was supported by Cochlear Ltd. MG and HM received travel support by Cochlear Ltd. to meetings. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM), 2005, F250405 ASTM, DOI [10.1520/F2504-05, DOI 10.1520/F2504-05]; Asai M, 1999, ACTA OTO-LARYNGOL, V119, P356; Bernhard H, 2011, IEEE T BIO-MED ENG, V58, P420, DOI 10.1109/TBME.2010.2087756; Busch S, 2013, OTOL NEUROTOL, V34, P1711, DOI 10.1097/MAO.0000000000000225; Chatzimichalis M, 2012, AUDIOL NEURO-OTOL, V17, P299, DOI 10.1159/000339214; Deveze A, 2013, OTOL NEUROTOL, V34, P158, DOI 10.1097/MAO.0b013e3182785261; Deveze A, 2010, OTOL NEUROTOL, V31, P1027, DOI 10.1097/MAO.0b013e3181edb6d1; Haeusler R, 2008, AUDIOL NEURO-OTOL, V13, P247, DOI 10.1159/000115434; Hutenbrink KB, 2008, OTOL NEUROTOL, V29, P965, DOI 10.1097/MAO.0b013e318185fad8; KRINGLEBOTN M, 1995, J ACOUST SOC AM, V98, P192, DOI 10.1121/1.413746; Lauxmann M, 2014, J ACOUST SOC AM, V136, P1756, DOI 10.1121/1.4895696; Lee J, 2014, HEARING RES, V314, P65, DOI 10.1016/j.heares.2014.04.003; Lenarz T, 2013, OTOL NEUROTOL, V34, P1215, DOI 10.1097/MAO.0b013e318298aa76; Lupo JE, 2011, OTOLARYNG HEAD NECK, V145, P641, DOI 10.1177/0194599811409674; Maier H, 2013, HEARING RES, V301, P115, DOI 10.1016/j.heares.2012.12.010; Rosowski JJ, 2007, AUDIOL NEURO-OTOL, V12, P265, DOI 10.1159/000101474; Schraven SP, 2012, AUDIOL NEURO-OTOL, V17, P133, DOI 10.1159/000333807; Stenfelt S, 2004, HEARING RES, V198, P10, DOI 10.1016/j.heares.2004.07.008; Stenfelt S, 2004, J ACOUST SOC AM, V115, P797, DOI 10.1121/1.1639903; Stieger C, 2013, HEARING RES, V301, P105, DOI 10.1016/j.heares.2012.11.005; Tringali S, 2011, ACTA OTO-LARYNGOL, V131, P27, DOI 10.3109/00016489.2010.507779; Tringali S, 2010, AUDIOL NEURO-OTOL, V15, P291, DOI 10.1159/000283006; vonBekesy G., 1960, EXPT HEARING	23	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119601	10.1371/journal.pone.0119601	http://dx.doi.org/10.1371/journal.pone.0119601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785860	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500117
J	Joe, SG; Yoon, YH; Choi, JA; Koh, JY				Joe, Soo Geun; Yoon, Young Hee; Choi, Jeong A.; Koh, Jae-Young			Anti-Angiogenic Effect of Metformin in Mouse Oxygen-Induced Retinopathy Is Mediated by Reducing Levels of the Vascular Endothelial Growth Factor Receptor Flk-1	PLOS ONE			English	Article							CANCER; RISK; VEGF; BEVACIZUMAB; METASTASIS; ACTIVATION; SIGNALS; CELLS; MODEL	Purpose To evaluate the effect of metformin on vascular changes in oxygen-induced retinopathy (OIR) in mouse, and to elucidate the possible underlying mechanism. Methods OIR mice were treated with metformin by intraperitoneal injection from postnatal day 12 (P12) to P17 or P21. At P17 and P21, vessel formation and avascular areas were assessed using retinal flat mounts. Levels of vascular endothelial growth factor (VEGF) were measured by enzyme-linked immunosorbent assays, and the effects of metformin on VEGF-induced proliferation of human umbilical vein endothelial cells (HUVECs) were assessed. The effects of metformin on the levels of Flk1 (VEGF receptor-2) and phosphorylated Flk1 (pFlk1) were measured by Western blotting (HUVECs) and immunohistochemistry (retinal tissue). Results Retinal morphologic changes were analyzed between two groups (saline-treated OIR; metformin-treated OIR). Metformin treatment did not change the extent of avascular areas at P17. However, at P21, when OIR pathology was markedly improved in the saline-treated group, OIR pathology still remained in the metformin-treated OIR group. VEGF expression levels did not differ between metformin-and saline-treated OIR groups at P17 and P21, but Flk1 levels were significantly reduced in the metformin group compared with saline-treated OIR group. Moreover, metformin inhibited VEGF-induced cell proliferation and decreased levels of Flk1 and pFlk1, consistent with the interpretation that metformin inhibits vascular growth by reducing Flk1 levels. Conclusion Metformin exerts anti-angiogenesis effects and delays the normal vessel formation in the recovery phase of OIR in mice, likely by suppressing the levels of Flk1.	[Joe, Soo Geun; Yoon, Young Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Choi, Jeong A.; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Inst Life Sci, Neural Injury Res Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Koh, JY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea.	jkko@amc.seoul.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X	National Research Foundation of Korea [NRF: 2005-0093836]; Korean Health Technology R&D Project, Ministry of Health Welfare [KHIDI: A092042]; Asan Institute for Life Sciences [2014-193, 2014-624]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health Welfare; Asan Institute for Life Sciences	National Research Foundation of Korea (NRF: 2005-0093836), http://www.nrf.re.kr, JYK; Korean Health Technology R&D Project, Ministry of Health & Welfare (KHIDI: A092042), http://www.khidi.or.kr, JYK; Asan Institute for Life Sciences (2014-193, 2014-624), http://ails.amc.seoul.kr, JYK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dallaglio K, 2014, CARCINOGENESIS, V35, P1055, DOI 10.1093/carcin/bgu001; Ersoy C, 2008, DIABETES RES CLIN PR, V81, P56, DOI 10.1016/j.diabres.2008.02.006; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Giuliari GP, 2012, CURR DIABETES REV, V8, P32, DOI 10.2174/157339912798829188; Hadad SM, 2009, BREAST CANCER RES TR, V114, P391, DOI 10.1007/s10549-008-0016-3; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Higgins RD, 1999, CURR EYE RES, V18, P20, DOI 10.1076/ceyr.18.1.20.5390; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Liao H, 2012, ONCOL REP, V27, P1873, DOI 10.3892/or.2012.1745; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Molavi B, 2007, VASC HEALTH RISK MAN, V3, P967; Munie M, 2014, EFFECT METFORMIN DEV, P1069; Phoenix KN, 2009, BREAST CANCER RES TR, V113, P101, DOI 10.1007/s10549-008-9916-5; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Shibuya M, 2014, BIOMOL THER, V22, P1, DOI 10.4062/biomolther.2013.113; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wu BC, 2012, ONCOL REP, V28, P903, DOI 10.3892/or.2012.1890; Xavier DO, 2010, BIOMED PHARMACOTHER, V64, P220, DOI 10.1016/j.biopha.2009.08.004	38	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119708	10.1371/journal.pone.0119708	http://dx.doi.org/10.1371/journal.pone.0119708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785990	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500126
J	Lee, SW; Hartley, CA; Coppo, MJC; Vaz, PK; Legione, AR; Quinteros, JA; Noormohammadi, AH; Markham, PF; Browning, GF; Devlin, JM				Lee, Sang-Won; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Legione, Alistair R.; Quinteros, Jose A.; Noormohammadi, Amir H.; Markham, Phillip F.; Browning, Glenn F.; Devlin, Joanne M.			Growth Kinetics and Transmission Potential of Existing and Emerging Field Strains of Infectious Laryngotracheitis Virus	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; ATTENUATED VACCINES; BROILER-CHICKENS; GLYCOPROTEIN-G; VIRULENCE; VACCINATION; DEFICIENT; EVOLUTION; POULTRY; GENES	Attenuated live infectious laryngotracheitis virus (ILTV) vaccines are widely used in the poultry industry to control outbreaks of disease. Natural recombination between commercial ILTV vaccines has resulted in virulent recombinant viruses that cause severe disease, and that have now emerged as the dominant field strains in important poultry producing regions in Australia. Genotype analysis using PCR-restriction fragment length polymorphism has shown one recombinant virus (class 9) has largely replaced the previously dominant class 2 field strain. To examine potential reasons for this displacement we compared the growth kinetics and transmission potential of class 2 and class 9 viruses. The class 9 ILTV grew to higher titres in cell culture and embryonated eggs, but no differences were observed in entry kinetics or egress into the allantoic fluid from the chorioallantoic membrane. In vivo studies showed that birds inoculated with class 9 ILTV had more severe tracheal pathology and greater weight loss than those inoculated with the class 2 virus. Consistent with the predominance of class 9 field strains, birds inoculated with 102 or 103 plaque forming units of class 9 ILTV consistently transmitted virus to in-contact birds, whereas this could only be seen in birds inoculated with 104 PFU of the class 2 virus. Taken together, the improved growth kinetics and transmission potential of the class 9 virus is consistent with improved fitness of the recombinant virus over the previously dominant field strain.	[Lee, Sang-Won; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Legione, Alistair R.; Quinteros, Jose A.; Markham, Phillip F.; Browning, Glenn F.; Devlin, Joanne M.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia; [Noormohammadi, Amir H.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic 3030, Australia	University of Melbourne; University of Melbourne	Hartley, CA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia.	carolah@unimelb.edu.au	Legione, Alistair/L-9102-2015; Legione, Alistair/AAX-6064-2020; Browning, Glenn Francis/P-4459-2014; Vaz, Paola K./D-8713-2015; Quinteros, Jose Antonio/Q-2482-2016	Legione, Alistair/0000-0003-2407-4496; Legione, Alistair/0000-0003-2407-4496; Browning, Glenn Francis/0000-0002-0903-2469; Vaz, Paola K./0000-0001-6877-7383; Quinteros, Jose Antonio/0000-0002-3194-9783; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Devlin, Joanne/0000-0003-0400-9670; Hartley, Carol/0000-0001-6174-7341; Coppo, Mauricio/0000-0002-4344-9532	Australian Research Council [DP130103991]; Australian Research Council; RIRDC	Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council); RIRDC	Funding provided by Australian Research Council DP130103991 (http://www.arc.gov.au). The funders (Australian Research Council) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rural Industries Research and Development Corporation PRJ-008792 (http://www.rirdc.gov.au). The funders (RIRDC) had contributed to study design and approved publication of the manuscript but did not have any role in data collection and analysis or the preparation of the manuscript.	Atkins KE, 2013, EVOLUTION, V67, P851, DOI 10.1111/j.1558-5646.2012.01803.x; Baigent SJ, 2013, AVIAN DIS, V57, P440, DOI 10.1637/10356-091012-Reg.1; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2006, ARCH VIROL, V151, P1281, DOI 10.1007/s00705-005-0721-8; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Gandon S, 2008, VACCINE, V26, pC4, DOI 10.1016/j.vaccine.2008.02.007; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; Gimeno IM, 2011, AVIAN PATHOL, V40, P395, DOI 10.1080/03079457.2011.588196; GUY JS, 1990, AVIAN DIS, V34, P106, DOI 10.2307/1591340; Guy JS, 2003, DIS POULTRY, V11th, P121; Haq K, 2013, DEV COMP IMMUNOL, V41, P439, DOI 10.1016/j.dci.2013.04.001; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Morrow C., 2004, MAREKS DIS EVOLVING, P49, DOI DOI 10.1016/B978-012088379-0/50009-8; Mundt A, 2011, J GEN VIROL, V92, P2586, DOI 10.1099/vir.0.031443-0; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Rasband W., 2006, IMAGEJ; Reddy VR, 2014, AVIAN PATHOL, P1, DOI [10.1080/03079457.2014.977223, DOI 10.1080/03079457.2014.977223]; Vagnozzi A, 2012, AVIAN PATHOL, V41, P21, DOI 10.1080/03079457.2011.631983; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Witter RL, 1997, AVIAN DIS, V41, P149, DOI 10.2307/1592455	28	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120282	10.1371/journal.pone.0120282	http://dx.doi.org/10.1371/journal.pone.0120282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785629	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500163
J	Li, ZY; Ding, LL; Li, JM; Xu, BL; Yang, L; Bi, KS; Wang, ZT				Li, Ze-Yun; Ding, Li-Li; Li, Jin-Mei; Xu, Bao-Li; Yang, Li; Bi, Kai-Shun; Wang, Zheng-Tao			H-1-NMR and MS Based Metabolomics Study of the Intervention Effect of Curcumin on Hyperlipidemia Mice Induced by High-Fat Diet	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARNITINE METABOLISM; NMR; MECHANISMS; URINE; LONGA; CHAIN; ACIDS; RATS; METABONOMICS	Curcumin, a principle bioactive component of Curcuma longa L, is well known for its anti-hyperlipidemia effect. However, no holistic metabolic information of curcumin on hyperlipidemia models has been revealed, which may provide us an insight into the underlying mechanism. In the present work, NMR and MS based metabolomics was conducted to investigate the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet (HFD) feeding for 12 weeks. The HFD induced animals were orally administered with curcumin (40, 80 mg/kg) or lovastatin (30 mg/kg, positive control) once a day during the inducing period. Serum biochemistry assay of TC, TG, LDL-c, and HDL-c was conducted and proved that treatment of curcumin or lovastatin can significantly improve the lipid profiles. Subsequently, metabolomics analysis was carried out for urine samples. Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) was employed to investigate the anti-hyperlipidemia effect of curcumin and to detect related potential biomarkers. Totally, 35 biomarkers were identified, including 31 by NMR and nine by MS (five by both). It turned out that curcumin treatment can partially recover the metabolism disorders induced by HFD, with the following metabolic pathways involved: TCA cycle, glycolysis and gluconeogenesis, synthesis of ketone bodies and cholesterol, ketogenesis of branched chain amino acid, choline metabolism, and fatty acid metabolism. Besides, NMR and MS based metabolomics proved to be powerful tools in investigating pharmacodynamics effect of natural products and underlying mechanisms.	[Li, Ze-Yun; Ding, Li-Li; Li, Jin-Mei; Xu, Bao-Li; Yang, Li; Wang, Zheng-Tao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Li, Ze-Yun; Bi, Kai-Shun] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shenyang Pharmaceutical University	Bi, KS (corresponding author), Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China.	kaishunbi.syphu@gmail.com; ztwang@shutcm.edu.cn	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625				Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; BERNSON VSM, 1974, EUR J BIOCHEM, V47, P517, DOI 10.1111/j.1432-1033.1974.tb03720.x; BIEBER LL, 1982, FED PROC, V41, P2858; CASTELAO AM, 1993, TRANSPLANT P, V25, P1043; CHALMERS RA, 1984, PEDIATR RES, V18, P1325, DOI 10.1203/00006450-198412000-00021; Demyen M, 2013, CLIN LIVER DIS, V17, P699, DOI 10.1016/j.cld.2013.07.016; Dieterle F, 2011, METHODS MOL BIOL, V691, P385, DOI 10.1007/978-1-60761-849-2_24; Dou XB, 2008, PLANTA MED, V74, P1374, DOI 10.1055/s-2008-1081316; FRISHMAN WH, 1989, MED CLIN N AM, V73, P437, DOI 10.1016/S0025-7125(16)30681-2; FROHLICH J, 1978, METABOLISM, V27, P555, DOI 10.1016/0026-0495(78)90022-7; GENUTH SM, 1981, METABOLISM, V30, P393, DOI 10.1016/0026-0495(81)90121-9; Goodpaster AM, 2011, ANAL CHEM, V83, P896, DOI 10.1021/ac102572b; Guan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060409; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983; Jacob N, 1999, ATHEROSCLEROSIS, V146, P53, DOI 10.1016/S0021-9150(99)00128-8; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Jiang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066786; JIN SJ, 1989, J LIPID RES, V30, P1611; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Lu JY, 2013, FRONT MED-PRC, V7, P53, DOI 10.1007/s11684-013-0255-5; Manjunatha H, 2007, CAN J PHYSIOL PHARM, V85, P588, DOI 10.1139/Y07-044; Murakami S, 2000, ADV EXP MED BIOL, V483, P177; Mutoh M, 2006, JPN J CLIN ONCOL, V36, P166, DOI 10.1093/jjco/hyi233; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Piloquet H, 2003, AM J PHYSIOL-ENDOC M, V285, pE561, DOI 10.1152/ajpendo.00042.2003; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Sham TT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925302; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Shin SK, 2011, MOL NUTR FOOD RES, V55, P1829, DOI 10.1002/mnfr.201100440; Sim KG, 2002, CLIN CHIM ACTA, V323, P37, DOI 10.1016/S0009-8981(02)00182-1; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Sun J, 2008, J CHROMATOGR B, V871, P328, DOI 10.1016/j.jchromb.2008.04.008; TANAKA K, 1982, J CHROMATOGR, V239, P301, DOI 10.1016/S0021-9673(00)81990-1; TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030; Venkatesan P, 2000, J PHARM PHARMACOL, V52, P1123, DOI 10.1211/0022357001774886; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078731; Wang YL, 2005, J AGR FOOD CHEM, V53, P191, DOI 10.1021/jf0403282; Williams RE, 2002, XENOBIOTICA, V32, P783, DOI 10.1080/00498250210143047; Witkin JM, 2013, CNS NEUROL DISORD-DR, V12, P487, DOI 10.2174/1871527311312040007; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40; Yang Shao-Ji, 2004, Hepatobiliary Pancreat Dis Int, V3, P10; Yu JN, 2000, PRIMARY CARE, V27, P541, DOI 10.1016/S0095-4543(05)70164-0; Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhou YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088281; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	55	8	13	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120950	10.1371/journal.pone.0120950	http://dx.doi.org/10.1371/journal.pone.0120950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786031	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500198
J	Palinkas, A; Bulik, S; Bockmayr, A; Holzhutter, HG				Palinkas, Aljoscha; Bulik, Sascha; Bockmayr, Alexander; Holzhuetter, Hermann-Georg			Sequential Metabolic Phases as a Means to Optimize Cellular Output in a Constant Environment	PLOS ONE			English	Article							AMINO-ACID REGULATION; GENE-EXPRESSION; ESCHERICHIA-COLI; DIVISION; GLUCOSE; MODELS; RED	Temporal changes of gene expression are a well-known regulatory feature of all cells, which is commonly perceived as a strategy to adapt the proteome to varying external conditions. However, temporal (rhythmic and non-rhythmic) changes of gene expression are also observed under virtually constant external conditions. Here we hypothesize that such changes are a means to render the synthesis of the metabolic output more efficient than under conditions of constant gene activities. In order to substantiate this hypothesis, we used a flux-balance model of the cellular metabolism. The total time span spent on the production of a given set of target metabolites was split into a series of shorter time intervals (metabolic phases) during which only selected groups of metabolic genes are active. The related flux distributions were calculated under the constraint that genes can be either active or inactive whereby the amount of protein related to an active gene is only controlled by the number of active genes: the lower the number of active genes the more protein can be allocated to the enzymes carrying non-zero fluxes. This concept of a predominantly protein-limited efficiency of gene expression clearly differs from other concepts resting on the assumption of an optimal gene regulation capable of allocating to all enzymes and transporters just that fraction of protein necessary to prevent rate limitation. Applying this concept to a simplified metabolic network of the central carbon metabolism with glucose or lactate as alternative substrates, we demonstrate that switching between optimally chosen stationary flux modes comprising different sets of active genes allows producing a demanded amount of target metabolites in a significantly shorter time than by a single optimal flux mode at fixed gene activities. Our model-based findings suggest that temporal expression of metabolic genes can be advantageous even under conditions of constant external substrate supply.	[Palinkas, Aljoscha; Bockmayr, Alexander] Free Univ Berlin, FB Math & Informat, D-14195 Berlin, Germany; [Bulik, Sascha; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-10117 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Palinkas, A (corresponding author), Free Univ Berlin, FB Math & Informat, Arnimallee 6, D-14195 Berlin, Germany.	aljoscha.palinkas@fu-berlin.de		Bockmayr, Alexander/0000-0002-5074-1347; Holzhutter, Hermann-Georg/0000-0002-5054-6023	DFG	DFG(German Research Foundation (DFG))	AP was funded by DFG (www.dfg.de) via the Research Training Group 1772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2003, J NUTR, V133, p2040S, DOI 10.1093/jn/133.6.2040S; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartl M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3243; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; COX BG, 1983, P NATL ACAD SCI-BIOL, V80, P4233, DOI 10.1073/pnas.80.14.4233; Dorsaz N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120601; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE556, DOI 10.1152/ajpendo.1991.261.5.E556; Griva I, 2009, OTHER TITL APPL MATH, V108, P1, DOI 10.1137/1.9780898717730; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hoffmann Sabrina, 2006, Genome Inform, V17, P195; Hoffmann S, 2009, ANN NY ACAD SCI, V1158, P57, DOI 10.1111/j.1749-6632.2008.03753.x; Jefferson LS, 2001, J NUTR, V131, p2460S, DOI 10.1093/jn/131.9.2460S; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0; Oyarzun DA, 2009, B MATH BIOL, V71, P1851, DOI 10.1007/s11538-009-9427-5; Price MN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.16; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; ROUSSET M, 1981, CANCER RES, V41, P1165; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; SCHUSTER R, 1995, EUR J BIOCHEM, V229, P403, DOI 10.1111/j.1432-1033.1995.0403k.x; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Slavov N, 2011, P NATL ACAD SCI USA, V108, P19090, DOI 10.1073/pnas.1116998108; Snel B, 2004, NUCLEIC ACIDS RES, V32, P4725, DOI 10.1093/nar/gkh815; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; TOPHAM CM, 1986, EUR J BIOCHEM, V156, P555, DOI 10.1111/j.1432-1033.1986.tb09615.x; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118347	10.1371/journal.pone.0118347	http://dx.doi.org/10.1371/journal.pone.0118347			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786979	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500028
J	Solchenberger, B; Russell, C; Kremmer, E; Haass, C; Schmid, B				Solchenberger, Barbara; Russell, Claire; Kremmer, Elisabeth; Haass, Christian; Schmid, Bettina			Granulin Knock Out Zebrafish Lack Frontotemporal Lobar Degeneration and Neuronal Ceroid Lipofuscinosis Pathology	PLOS ONE			English	Article							PROGRANULIN-DEFICIENT MICE; TRAUMATIC BRAIN-INJURY; IN-VIVO; ACTIVATED MICROGLIA; EARLY MACROPHAGES; GENE-EXPRESSION; HOST-DEFENSE; MUTATIONS; MODEL; DEMENTIA	Loss of function mutations in granulin (GRN) are linked to two distinct neurological disorders, frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL). It is so far unknown how a complete loss of GRN in NCL and partial loss of GRN in FTLD can result in such distinct diseases. In zebrafish, there are two GRN homologues, Granulin A (Grna) and Granulin B (Grnb). We have generated stable Grna and Grnb loss of function zebrafish mutants by zinc finger nuclease mediated genome editing. Surprisingly, the grna and grnb single and double mutants display neither spinal motor neuron axonopathies nor a reduced number of myogenic progenitor cells as previously reported for Grna and Grnb knock down embryos. Additionally, grna(-/-);grnb(-/-) double mutants have no obvious FTLD- and NCL-related biochemical and neuropathological phenotypes. Taken together, the Grna and Grnb single and double knock out zebrafish lack any obvious morphological, pathological and biochemical phenotypes. Loss of zebrafish Grna and Grnb might therefore either be fully compensated or only become symptomatic upon additional challenge.	[Solchenberger, Barbara; Haass, Christian; Schmid, Bettina] Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany; [Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany	University of Munich; University of London; University of London Royal Veterinary College; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmid, B (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany.	Bettina.Schmid@dzne.de	Russell, Claire/A-4879-2012	Russell, Claire/0000-0002-6748-9301	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action [BM0804]; Batten Disease Family Association; European Research Council under the European Union [321366-Amyloid];  [Sonderforschungsbereich 596]	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action; Batten Disease Family Association; European Research Council under the European Union(European Research Council (ERC)); 	This work was supported by the Sonderforschungsbereich 596, International Max Planck Research School for Molecular and Cellular Life Sciences (B. So.), the Elite Network of Bavaria (B. So.), a Short Term Scientific Mission COST Action BM0804 (B. So.), the Batten Disease Family Association (C.R.), the European Research Council under the European Union's Seventh Framework Program FP7/2007-2013)/ ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.), the general legacy of Mrs. Ammer (to the Ludwig-Maximilians University/ C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bonvicini C, 2014, NEUROBIOL AGING, V35, P1206, DOI 10.1016/j.neurobiolaging.2013.10.097; Borst LB, 2013, VET PATHOL, V50, P457, DOI 10.1177/0300985811424731; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; da Rosa CE, 2010, EXP GERONTOL, V45, P449, DOI 10.1016/j.exger.2010.03.012; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2013, NEUROBIOLOGY AGING; Del Bo R, 2011, NEUROBIOL AGING, V32, P1157, DOI 10.1016/j.neurobiolaging.2009.06.006; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Follo C, 2013, INT J BIOCHEM CELL B, V45, P273, DOI 10.1016/j.biocel.2012.10.010; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Ghidoni R, 2012, BRAIN RES, V1476, P172, DOI 10.1016/j.brainres.2012.01.075; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Huang T, 2012, BIOCHEM BIOPH RES CO, V421, P214, DOI 10.1016/j.bbrc.2012.03.139; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Li YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01176; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matthews M, 2012, ILAR J, V53, P192, DOI 10.1093/ilar.53.2.192; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	70	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118956	10.1371/journal.pone.0118956	http://dx.doi.org/10.1371/journal.pone.0118956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785851	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500060
J	Zhang, L; Liu, SR; Sun, PS; Wang, TL; Wang, GY; Zhang, XD; Wang, LL				Zhang, Lei; Liu, Shirong; Sun, Pengsen; Wang, Tongli; Wang, Guangyu; Zhang, Xudong; Wang, Linlin			Consensus Forecasting of Species Distributions: The Effects of Niche Model Performance and Niche Properties	PLOS ONE			English	Article							CLIMATICALLY SUITABLE AREAS; CLIMATE-CHANGE; RANGE SHIFTS; PSEUDO-ABSENCES; PREDICTION; UNCERTAINTY; PROJECTIONS; SCENARIOS; ENSEMBLES; PATTERNS	Ensemble forecasting is advocated as a way of reducing uncertainty in species distribution modeling (SDM). This is because it is expected to balance accuracy and robustness of SDM models. However, there are little available data regarding the spatial similarity of the combined distribution maps generated by different consensus approaches. Here, using eight niche-based models, nine split-sample calibration bouts (or nine random model-training subsets), and nine climate change scenarios, the distributions of 32 forest tree species in China were simulated under current and future climate conditions. The forecasting ensembles were combined to determine final consensual prediction maps for target species using three simple consensus approaches (average, frequency, and median [PCA]). Species' geographic ranges changed (area change and shifting distance) in response to climate change, but the three consensual projections did not differ significantly with respect to how much or in which direction, but they did differ with respect to the spatial similarity of the three consensual predictions. Incongruent areas were observed primarily at the edges of species' ranges. Multiple stepwise regression models showed the three factors (niche marginality and specialization, and niche model accuracy) to be related to the observed variations in consensual prediction maps among consensus approaches. Spatial correspondence among prediction maps was the highest when niche model accuracy was high and marginality and specialization were low. The difference in spatial predictions suggested that more attention should be paid to the range of spatial uncertainty before any decisions regarding specialist species can be made based on map outputs. The niche properties and singlemodel predictive performance provide promising insights that may further understanding of uncertainties in SDM.	[Zhang, Lei; Zhang, Xudong] Chinese Acad Forestry, Res Inst Forestry, Key Lab Forest Silviculture State Forestry Adm, Beijing, Peoples R China; [Liu, Shirong; Sun, Pengsen] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wang, Tongli] Univ British Columbia, Dept Forest Sci, Ctr Forest Conservat Genet, Vancouver, BC V6T 1W5, Canada; [Wang, Guangyu] Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1W5, Canada; [Wang, Linlin] Beijing Agr Univ, Beijing 100094, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; University of British Columbia; University of British Columbia; Beijing University of Agriculture	Liu, SR (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	liusr@caf.ac.cn	Zhang, Lei/N-4381-2017; Wang, Tongli/AAC-8644-2020; Wang, Tongli/AAW-4427-2020	Zhang, Lei/0000-0002-2381-7852; Wang, Tongli/0000-0002-9967-6769	China's National Natural Science Foundation [41301056]; Special Foundation of Chinese Academy of Forestry [CAFYBB2014QB006, RIF2012-04]	China's National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Foundation of Chinese Academy of Forestry	This work was funded by the China's National Natural Science Foundation (41301056) and the Special Foundation of Chinese Academy of Forestry (CAFYBB2014QB006, RIF2012-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bialozyt R, 2012, J BIOGEOGR, V39, P665, DOI 10.1111/j.1365-2699.2011.02665.x; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1709; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; CLEMEN RT, 1989, INT J FORECASTING, V5, P559, DOI 10.1016/0169-2070(89)90012-5; Crimmins SM, 2013, ECOL MODEL, V266, P126, DOI 10.1016/j.ecolmodel.2013.07.006; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Granitto PM, 2005, ARTIF INTELL, V163, P139, DOI 10.1016/j.artint.2004.09.006; Grenouillet G, 2014, GLOBAL CHANGE BIOL, V20, P3080, DOI 10.1111/gcb.12570; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jones CC, 2012, FOREST ECOL MANAG, V284, P69, DOI 10.1016/j.foreco.2012.07.024; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peters J, 2007, ECOL MODEL, V207, P304, DOI 10.1016/j.ecolmodel.2007.05.011; Pinheiro J, 2020, R PACKAGE VERSION 31; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2010, BIOMOD SPECIES CLIMA; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zhang Lei, 2011, Chinese Journal of Plant Ecology, V35, P1091, DOI 10.3724/SP.J.1258.2011.01091	46	67	72	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120056	10.1371/journal.pone.0120056	http://dx.doi.org/10.1371/journal.pone.0120056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786217	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500152
J	Anderson, PG; Kainerstorfer, JM; Sassaroli, A; Krishnamurthy, N; Homer, MJ; Graham, RA; Fantini, S				Anderson, Pamela G.; Kainerstorfer, Jana M.; Sassaroli, Angelo; Krishnamurthy, Nishanth; Homer, Marc J.; Graham, Roger A.; Fantini, Sergio			Broadband Optical Mammography: Chromophore Concentration and Hemoglobin Saturation Contrast in Breast Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY RESPONSE; PHOTON MIGRATION; OXYGEN-SATURATION; HUMAN-TUMORS; BLOOD-FLOW; TISSUE; SPECTROSCOPY; HYPOXIA; MICROENVIRONMENT	This study reports the optical characterization and quantitative oximetry of human breast cancer using spectrally-resolved images collected with a broadband, continuous-wave optical mammography instrument. On twenty-six cancer patients, we collected two-dimensional optical mammograms and created maps of the concentrations of hemoglobin, water, and lipids, as well as the oxygen saturation of hemoglobin. For each cancerous breast, we analyzed the difference between the tumor region (as identified by x-ray and optical mammography) and the remainder of breast tissue. With respect to the surrounding tissue, we found that cancer regions have significantly higher concentrations of total hemoglobin (+2.4 +/- 0.4 mu M) and water (+7 +/- 1% v/v), and significantly lower lipid concentration (8 +/- 2% v/v) and oxygen saturation of hemoglobin (5 +/- 1%). We also found a significant correlation between the tumor optical contrast and the grade of breast cancer as quantified by the Nottingham histologic score; this demonstrates how optical signatures may be representative of metabolic and morphological features, as well as the aggressive potential of the tumor.	[Anderson, Pamela G.; Kainerstorfer, Jana M.; Sassaroli, Angelo; Krishnamurthy, Nishanth; Fantini, Sergio] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Homer, Marc J.] Tufts Med Ctr, Dept Radiol, Boston, MA 02111 USA; [Graham, Roger A.] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA	Tufts University; Tufts Medical Center; Tufts Medical Center	Anderson, PG (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	pamela.anderson@tufts.edu		Anderson, Pamela/0000-0002-6602-9186	National Institutes of Health [R01 CA154774]; National Science Foundation [NSF DGE-0806676]; NATIONAL CANCER INSTITUTE [R01CA154774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health (Grant R01 CA154774). This research was also supported by the National Science Foundation Graduate Research Fellowship (NSF DGE-0806676). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arridge SR, 1998, OPT LETT, V23, P882, DOI 10.1364/OL.23.000882; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Cerussi AE, 2011, PHILOS T R SOC A, V369, P4512, DOI 10.1098/rsta.2011.0279; Choe R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099683; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Enfield LC, 2007, APPL OPTICS, V46, P3628, DOI 10.1364/AO.46.003628; Fantini S, 1996, MED PHYS, V23, P149, DOI 10.1118/1.597696; Fantini S, 2012, ANN BIOMED ENG, V40, P398, DOI 10.1007/s10439-011-0404-4; FENG SC, 1995, APPL OPTICS, V34, P3826, DOI 10.1364/AO.34.003826; Grosenick D, 1999, APPL OPTICS, V38, P2927, DOI 10.1364/AO.38.002927; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Intes X, 2005, ACAD RADIOL, V12, P934, DOI 10.1016/j.acra.2005.05.006; Jiang SD, 2009, RADIOLOGY, V252, P551, DOI 10.1148/radiol.2522081202; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; MUELLERKLIESER W, 1981, INT J RADIAT ONCOL, V7, P1397, DOI 10.1016/0360-3016(81)90036-5; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Rinneberg H, 2008, OPTO-ELECTRON REV, V16, P147, DOI 10.2478/s11772-008-0004-5; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Sassaroli A, 2001, APPL OPTICS, V40, P185, DOI 10.1364/AO.40.000185; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Soliman H, 2010, CLIN CANCER RES, V16, P2605, DOI 10.1158/1078-0432.CCR-09-1510; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Srinivasan S, 2005, TECHNOL CANCER RES T, V4, DOI [10.1016/j.jcis.2014.12.092, DOI 10.1016/J.JCIS.2014.12.092]; Taroni P, 2009, J BIOMED OPT, V14, DOI [10.1117/1.3275480, DOI 10.1117/1.3275480]; Tingleff O., 2008, METHODS NONLINEAR LE, V2nd ed.; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; VAUPEL P, 1991, CANCER RES, V51, P3316; VAUPEL P, 1989, CANCER RES, V49, P6449; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Wang J, 2010, MED PHYS, V37, P3715, DOI 10.1118/1.3455702; Wouters BG, 2002, EUR J CANCER, V38, P240, DOI 10.1016/S0959-8049(01)00361-6; Yu Y, 2010, J INNOV OPT HEAL SCI, V3, P267, DOI 10.1142/S179354581000112X; Zhu QN, 2005, NEOPLASIA, V7, P263, DOI 10.1593/neo.04526	39	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117322	10.1371/journal.pone.0117322	http://dx.doi.org/10.1371/journal.pone.0117322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781469	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600010
J	Friebe, S; Deuquet, J; van der Goot, FG				Friebe, Sarah; Deuquet, Julie; van der Goot, F. Gisou			Differential Dependence on N-Glycosylation of Anthrax Toxin Receptors CMG2 and TEM8	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; LINKED PROTEIN GLYCOSYLATION; ENDOTHELIAL MARKER 8; ENDOPLASMIC-RETICULUM; PROTECTIVE ANTIGEN; GLYCOPROTEIN DEGRADATION; CAPILLARY MORPHOGENESIS; MORPHOLOGICAL EVOLUTION; TUMOR VASCULATURE; GAPO SYNDROME	ANTXR 1 and 2, also known as TEM8 and CMG2, are two type I membrane proteins, which have been extensively studied for their role as anthrax toxin receptors, but with a still elusive physiological function. Here we have analyzed the importance of N-glycosylation on folding, trafficking and ligand binding of these closely related proteins. We find that TEM8 has a stringent dependence on N-glycosylation. The presence of at least one glycan on each of its two extracellular domains, the vWA and Ig-like domains, is indeed necessary for efficient trafficking to the cell surface. In the absence of any N-linked glycans, TEM8 fails to fold correctly and is recognized by the ER quality control machinery. Expression of N-glycosylation mutants reveals that CMG2 is less vulnerable to sugar loss. The absence of N-linked glycans in one of the extracellular domains indeed has little impact on folding, trafficking or receptor function of the wild type protein expressed in tissue culture cells. N-glycans do, however, seem required in primary fibroblasts from human patients. Here, the presence of N-linked sugars increases the tolerance to mutations in cmg2 causing the rare genetic disease Hyaline Fibromatosis Syndrome. It thus appears that CMG2 glycosylation provides a buffer towards genetic variation by promoting folding of the protein in the ER lumen.	[Friebe, Sarah; Deuquet, Julie; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou/B-2279-2012	van der Goot, Gisou/0000-0002-8522-274X	Swiss National Science foundation grant	Swiss National Science foundation grant(Swiss National Science Foundation (SNSF))	GVDG received a Swiss National Science foundation grant (http://www.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2013, CELL REP, V5, P986, DOI 10.1016/j.celrep.2013.10.019; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bayram Y, 2014, AM J MED GENET A, V164, P2328, DOI 10.1002/ajmg.a.36678; Bell SE, 2001, J CELL SCI, V114, P2755; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Buck TM, 2004, AM J PHYSIOL-CELL PH, V287, pC1292, DOI 10.1152/ajpcell.00561.2003; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen D, 2013, ANTXR1 A STEM CELL E; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Deuquet J, 2009, HUM MUTAT, V30, P583, DOI 10.1002/humu.20872; Ding ZP, 2006, PROTEIN EXPRES PURIF, V49, P121, DOI 10.1016/j.pep.2006.04.011; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Keser G, 1999, CLIN RHEUMATOL, V18, P248, DOI 10.1007/s100670050094; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scobie HM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000099; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Tannous A, 2014, N LINKED SUGAR REGUL; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099	60	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119864	10.1371/journal.pone.0119864	http://dx.doi.org/10.1371/journal.pone.0119864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781883	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600102
J	Jiang, Y; Yang, ZQ; Wang, XY; Hou, YX				Jiang, Yuan; Yang, Zhongqi; Wang, Xiaoyi; Hou, Yuxia			Molecular Identification of Sibling Species of Sclerodermus (Hymenoptera: Bethylidae) That Parasitize Buprestid and Cerambycid Beetles by Using Partial Sequences of Mitochondrial DNA Cytochrome Oxidase Subunit 1 and 28S Ribosomal RNA Gene	PLOS ONE			English	Article							AGRILUS-PLANIPENNIS COLEOPTERA; PHYLOGENY	The species belonging to Sclerodermus (Hymenoptera: Bethylidae) are currently the most important insect natural enemies of wood borer pests, mainly buprestid and cerambycid beetles, in China. However, some sibling species of this genus are very difficult to distinguish because of their similar morphological features. To address this issue, we conducted phylogenetic and genetic analyses of cytochrome oxidase subunit I (COI) and 28S RNA gene sequences from eight species of Sclerodermus reared from different wood borer pests. The eight sibling species were as follows: S. guani Xiao et Wu, S. sichuanensis Xiao, S. pupariae Yang et Yao, and Sclerodermus spp. (Nos. 1-5). A 594-bp fragment of COI and 750-bp fragment of 28S were subsequently sequenced. For COI, the G-C content was found to be low in all the species, averaging to about 30.0%. Sequence divergences (Kimura-2-parameter distances) between congeneric species averaged to 4.5%, and intra-specific divergences averaged to about 0.09%. Further, the maximum sequence divergences between congeneric species and Sclerodermus sp. (No. 5) averaged to about 16.5%. All 136 samples analyzed were included in six reciprocally monophyletic clades in the COI neighbor-joining (NJ) tree. The NJ tree inferred from the 28S rRNA sequence yielded almost identical results, but the samples from S. guani, S. sichuanensis, S. pupariae, and Sclerodermus spp. (Nos. 1-4) clustered together and only Sclerodermus sp. (No. 5) clustered separately. Our findings indicate that the standard barcode region of COI can be efficiently used to distinguish morphologically similar Sclerodermus species. Further, we speculate that Sclerodermus sp. (No. 5) might be a new species of Sclerodermus.	[Jiang, Yuan; Yang, Zhongqi; Wang, Xiaoyi] Chinese Acad Forestry, China State Forestry Adm, Res Inst Forest Ecol, Key Lab Forest Protect, Beijing 100091, Peoples R China; [Hou, Yuxia] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; China Agricultural University	Yang, ZQ (corresponding author), Chinese Acad Forestry, China State Forestry Adm, Res Inst Forest Ecol, Key Lab Forest Protect, Beijing 100091, Peoples R China.	yangzhqi@126.com		Wang, Xiaoyi/0000-0001-8136-6642	State Key Program of National Natural Science Foundation of China [31230015]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhongqi Yang received the State Key Program of National Natural Science Foundation of China (No. 31230015). The funder had an important role in study design.	Alencar IDCC, 2013, SYST ENTOMOL, V38, P45, DOI 10.1111/j.1365-3113.2012.00648.x; Banks JC, 2006, MOL PHYLOGENET EVOL, V41, P690, DOI 10.1016/j.ympev.2006.06.001; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Brothers Denis J., 1993, Journal of Hymenoptera Research, V2, P227; Carr M, 2010, INSECT SYST EVOL, V41, P55, DOI 10.1163/187631210X486995; Deng J, 2012, MOL ECOL RESOUR, V12, P791, DOI 10.1111/j.1755-0998.2012.03152.x; EVANS H E, 1978, Memoirs of the American Entomological Institute (Gainesville), P1; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld ID, 1988, HYMENOPTERA, P332; Gordh G., 1990, MEM AM ENTOMOL I, V46, P1, DOI DOI 10.1111/J.1440-6055.1990.TB00341.X; Goulet H, 1993, HYMENOPTERA WORLD ID; Guo XH, 2008, J LIAONING FORESTRY, V5, P5, DOI [10.1002/mrd.22451, DOI 10.1002/MRD.22451]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Kang WenTong, 2008, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V37, P575; Lanes GO, 2008, INSECT SYST EVOL, V39, P55, DOI 10.1163/187631208788784165; Li SQ, 2007, J PEST SCI, V80, P119, DOI 10.1007/s10340-006-0158-1; Mardulyn P, 1999, MOL PHYLOGENET EVOL, V12, P282, DOI 10.1006/mpev.1999.0618; Melo GAR, 1993, P ENTOMOL SOC WASH, V92, P258; Shaw SR, 2005, ZOOTAXA, P49; Shi J, 2009, CULT DIVERS ETHN MIN, V4, P117; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Wang Xiao-jun, 2007, Zhongguo Senlin Bingchong, V26, P28; Wang Xiao-Yi, 2010, Acta Entomologica Sinica, V53, P675; Wei JR, 2009, BIOCONTROL, V54, P733, DOI 10.1007/s10526-009-9224-y; Wu Hui, 2008, Acta Entomologica Sinica, V51, P46; Yang Hong, 2007, Acta Entomologica Sinica, V50, P807; Yang ZQ, 2014, ANN ENTOMOL SOC AM, V107, P407, DOI 10.1603/AN13150; Yang ZQ, 2012, ANN ENTOMOL SOC AM, V105, P619, DOI 10.1603/AN12017; [姚万军 YAO WanJun], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P127; Zhang X, 2007, J SICHUAN FORESTRY S, V28, P16	30	14	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119573	10.1371/journal.pone.0119573	http://dx.doi.org/10.1371/journal.pone.0119573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782000	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600075
J	Siangcham, T; Chansela, P; Hayasaka, T; Masaki, N; Sroyraya, M; Poljaroen, J; Suwansa-ard, S; Engsusophon, A; Hanna, PJ; Sobhon, P; Setou, M				Siangcham, Tanapan; Chansela, Piyachat; Hayasaka, Takahiro; Masaki, Noritaka; Sroyraya, Morakot; Poljaroen, Jaruwan; Suwansa-ard, Saowaros; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert; Setou, Mitsutoshi			Changes of Phosphatidylcholine and Fatty Acids in Germ Cells during Testicular Maturation in Three Developmental Male Morphotypes of Macrobrachium rosenbergii Revealed by Imaging Mass Spectrometry	PLOS ONE			English	Article							FRESH-WATER PRAWN; LIPID-COMPOSITION; BIOCHEMICAL-COMPOSITION; EPIDIDYMAL MATURATION; LITOPENAEUS-VANNAMEI; REPRODUCTIVE-SYSTEM; GONADAL DEVELOPMENT; SPERM QUALITY; MOUSE TESTIS; RAT TESTIS	Testis maturation, germ cell development and function of sperm, are related to lipid composition. Phosphatidylcholines (PCs) play a key role in the structure and function of testes. As well, increases of polyunsaturated fatty acids (PUFA) and highly unsaturated fatty acids (HUFA), especially arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are essential for male fertility. This study is the first report to show the composition and distribution of PCs and total fatty acids (FAs) in three groups of seminiferous tubules (STs) classified by cellular associations [i.e., A (STs with mostly early germ cells), B (STs with mostly spermatids), and C (STs with spermatozoa)], in three morpho-types of Macrobrachium rosenbergii, [i.e., small male (SM), orange claw male (OC), and blue claw male (BC)]. Thin layer chromatography exhibited levels of PCs reaching maxima in STs of group B. Imaging mass spectrometry showed remarkably high signals corresponding to PC (16:0/18:1), PC (18:0/18:2), PC (18:2/20:5), and PC (16:0/22:6) in STs of groups A and B. Moreover, most signals were detected in the early developing cells and the intertubular area, but not at the area containing spermatozoa. Finally, gas chromatography-mass spectrometry indicated that the major FAs present in the testes were composed of 14:0, 16:0, 17:0, 18:0, 16:1, 18:1, 18:2, 20:1, 20:2, 20:4, 20:5, and 22:6. The testes of OC contained the greatest amounts of these FAs while the testes of BC contained the least amounts of these FAs, and there was more EPA (20:5) in the testes of SM and OC than those in the BC. The increasing amounts of FAs in the SM and OC indicate that they are important for spermatogenesis and spermiogenesis. This knowledge will be useful in formulating diets containing PUFA and HUFA for prawn broodstocks in order to improve testis development, and lead to increased male fecundity.	[Siangcham, Tanapan; Suwansa-ard, Saowaros; Engsusophon, Attakorn; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Chansela, Piyachat] Phramongkutklao Coll Med, Dept Anat, Bangkok, Thailand; [Hayasaka, Takahiro] Hokkaido Univ, Fac Hlth Sci, Hlth Innovat & Technol Ctr, Sapporo, Hokkaido 060, Japan; [Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan; [Sroyraya, Morakot; Poljaroen, Jaruwan] Mahidol Univ, Nakhonsawan, Thailand; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3217, Australia	Mahidol University; Phramongkutklao College of Medicine; Hokkaido University; Hamamatsu University School of Medicine; Mahidol University; Deakin University	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan.	setou@hama-med.ac.jp	Suwansa-ard, Saowaros Mai/ABB-2227-2021	Suwansa-ard, Saowaros Mai/0000-0002-9129-2082	JSPS [25116712]; Kiban-B [25293044]; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kiban-B; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI for Scientific Research on Innovative Areas "Machinery of bioactive lipids in homeostasis and diseases" (25116712) and by Kiban-B (25293044) to M.S.; and by MEXT Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA B, 1966, LIPIDS, V1, P197, DOI 10.1007/BF02531872; BECKMAN JK, 1978, BIOCHIM BIOPHYS ACTA, V530, P367, DOI 10.1016/0005-2760(78)90156-X; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; Boucard CGV, 2002, J EXP MAR BIOL ECOL, V281, P63, DOI 10.1016/S0022-0981(02)00409-4; Cavalli RO, 2001, AQUACULTURE, V193, P311, DOI 10.1016/S0044-8486(00)00497-X; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Chimsung Noppawan, 2014, Songklanakarin Journal of Science and Technology, V36, P265; Clarke A, 1984, BR ANTARCT SURV B, V64, P37; CROSS NL, 1994, J ANDROL, V15, P484; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; EVANS RW, 1979, J REPROD FERTIL, V57, P197, DOI 10.1530/jrf.0.0570197; EVANS RW, 1979, J REPROD FERTIL, V57, P189, DOI 10.1530/jrf.0.0570189; EWING LL, 1966, J REPROD FERTIL, V12, P295, DOI 10.1530/jrf.0.0120295; Food and Agriculture Organization of the United Nations, 2009, FISH STAT DAT, P551; Goto-Inoue N, 2012, SURF INTERFACE ANAL, V44, P749, DOI 10.1002/sia.3869; Goto-Inoue N, 2009, GLYCOBIOLOGY, V19, P950, DOI 10.1093/glycob/cwp089; Harlioglu MM, 2013, AQUACULT INT, V21, P273, DOI 10.1007/s10499-012-9549-x; INFANTE JP, 1985, MOL CELL BIOCHEM, V69, P3; JECKEL WH, 1989, COMP BIOCHEM PHYS B, V93, P807, DOI 10.1016/0305-0491(89)90050-3; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Lin DS, 2004, J LIPID RES, V45, P529, DOI 10.1194/jlr.M300374-JLR200; Long JA, 2012, POULTRY SCI, V91, P1990, DOI 10.3382/ps.2011-02028; Martinez P, 1996, FRONT BIOSCI, V1, P103; Meunpol O, 2005, AQUAC RES, V36, P1216, DOI 10.1111/j.1365-2109.2005.01342.x; MILLAMENA O M, 1990, Journal of the World Aquaculture Society, V21, P116, DOI 10.1111/j.1749-7345.1990.tb00531.x; Okumura T, 2004, ZOOL SCI, V21, P621, DOI 10.2108/zsj.21.621; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Pawlina W, 2011, HISTOLOGY TEXT ATLAS, P784; Perez-Velazquez M, 2003, J WORLD AQUACULT SOC, V34, P92, DOI 10.1111/j.1749-7345.2003.tb00043.x; Poljaroen J, 2011, AQUACULTURE, V321, P121, DOI 10.1016/j.aquaculture.2011.08.022; RAANAN Z, 1985, BIOL BULL, V169, P592, DOI 10.2307/1541301; Ranjeet K., 2002, Naga, V25, P13; Ravichandran S., 2009, Middle-East Journal of Scientific Research, V4, P175; Ravid T, 1999, J EXP BIOL, V202, P1819; Rodriguez-Gonzalez H, 2006, AQUACULTURE, V254, P637, DOI 10.1016/j.aquaculture.2005.10.020; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Sadler TW, 2009, LANGMANS MED EMBRYOL, P27; SAGI A, 1988, J CRUSTACEAN BIOL, V8, P43, DOI 10.2307/1548428; SAGI A, 1988, BIOL BULL, V174, P330, DOI 10.2307/1541958; Samuel MJ, 1999, AQUACULTURE, V172, P327, DOI 10.1016/S0044-8486(98)00500-6; Schwantes VS, 2009, AQUACULTURE, V287, P120, DOI 10.1016/j.aquaculture.2008.10.017; Shailender M., 2012, INT J BIOASSAYS, V1, P170; SPRANDO RL, 1987, AM J ANAT, V178, P72, DOI 10.1002/aja.1001780109; Srinivasan P, 2012, J ADV SCI RES, V3, P60; STACEY NE, 1982, CAN J FISH AQUAT SCI, V39, P92, DOI 10.1139/f82-011; Suresh Kumar S., 1998, THESIS COCHIN U SCI; WADE MG, 1994, BIOL REPROD, V51, P131, DOI 10.1095/biolreprod51.1.131; Wang DH, 2010, AQUAC RES, V41, P1140, DOI 10.1111/j.1365-2109.2009.02401.x; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; Wu X, 2010, AQUACULT NUTR, V16, P25, DOI 10.1111/j.1365-2095.2008.00637.x; Zaniboni L, 2006, THERIOGENOLOGY, V65, P1813, DOI 10.1016/j.theriogenology.2005.10.013	52	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120412	10.1371/journal.pone.0120412	http://dx.doi.org/10.1371/journal.pone.0120412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781176	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600158
J	Soler-Membrives, A; Munilla, T				Soler-Membrives, Anna; Munilla, Tomas			PYCNOIB: Biodiversity and Biogeography of Iberian Pycnogonids	PLOS ONE			English	Article							ARTHROPODA PYCNOGONIDA; ABYSSAL PYCNOGONIDA; VIGO NW; ATLANTIC; GIBRALTAR; STRAIT; SEA; AFFINITIES; CRUSTACEA; KNOWLEDGE	Biodiversity and biogeographic studies comparing the distribution patterns of benthic marine organisms across the Iberian Atlantic and Mediterranean waters are scarce. The Pycnogonida (sea spiders) are a clear example of both endemicity and diversity, and are considered a key taxon to study and monitor biogeographic and biodiversity patterns. This is the first review that compiles data about abundance and diversity of Iberian pycnogonids and examines their biogeographic patterns and bathymetric constraints using GIS tools. A total of 17762 pycnogonid records from 343 localities were analyzed and were found to contain 65 species, 21 genera and 12 families. Achelia echinata and Ammothella longipes (family Acheliidae) were the most abundant comprising similar to 80% of the total records. The Acheliidae is also the most speciose in Iberian waters with 15 species. In contrast, the family Nymphonidae has 7 species but is significantly less abundant (<1% of the total records) than Acheliidae. Species accumulation curves indicate that further sampling would increase the number of Iberian species records. Current sampling effort suggests that the pycnogonid fauna of the Mediterranean region may be richer than that of the Atlantic. The Strait of Gibraltar and the Alboran Sea are recognized as species-rich areas that act as buffer zones between the Atlantic and Mediterranean boundaries. The deep waters surrounding the Iberian Peninsula are poorly surveyed, with only 15% of the sampling sites located below 1000 m. Further deep-water sampling is needed mainly on the Iberian Mediterranean side.	[Soler-Membrives, Anna; Munilla, Tomas] Univ Autonoma Barcelona, Unitat Zool BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Soler-Membrives, A (corresponding author), Univ Autonoma Barcelona, Unitat Zool BABVE, E-08193 Barcelona, Spain.	Anna.Soler@uab.cat	Soler-Membrives, Anna/L-3169-2014	Soler-Membrives, Anna/0000-0002-6543-8367	Ministerio de Ciencia e Innovacion [CGD2007-66786]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by the CGD2007-66786 Project: Fauna Iberica, Chelicerata, Pycnogonida (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANADON N, 1981, INVEST PESQ, V45, P105; ANADON R, 1975, INVEST PESQ, V39, P199; Anadon R, 1980, MEM POLICOPIADA FUND; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD F, 1973, Tethys, V5, P147; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Arnaud F, 1988, MESOGEE B MUSEUM HIS, V47, P37; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Bamber R, 2015, PYCNOBASE WORLD PYCN; Bamber R., 2010, SYNOPSES BRIT FAUNA, V5, P1; BAMBER RN, 1995, ZOOL J LINN SOC-LOND, V115, P117, DOI 10.1111/j.1096-3642.1995.tb02325.x; Bouvier E.L., 1923, FAUNE FR, V7, P1; CANDELA J, 1991, DYNAM ATMOS OCEANS, V15, P267, DOI 10.1016/0377-0265(91)90023-9; Carballo JL, 1997, J BIOGEOGR, V24, P223, DOI 10.1046/j.1365-2699.1997.00082.x; Child C. Allan, 1995, Antarctic Research Series, V69, P69; Chimenz Gusso C., 2003, BIOGEOGRAPHIA J INTE, V24, P251, DOI [10.21426/B6110015, DOI 10.21426/B6110015, 10.21426/b6110015]; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; DEHARO A, 1978, ZOOL J LINN SOC-LOND, V63, P181, DOI 10.1111/j.1096-3642.1978.tb02097.x; Esquete P, 2013, THALASSAS, V29, P25; FERNANDEZ E, 1987, Investigacion Pesquera (Barcelona), V51, P167; Ferrer L, 2011, J MARINE SYST, V87, P133, DOI 10.1016/j.jmarsys.2011.03.008; Franganilllo P, 1918, B SOC ENTOMOLOGICA E, V1, P120; Gonzalez-Duarte MM, 2013, MAR ECOL-EVOL PERSP, V34, P33, DOI 10.1111/maec.12022; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths HJ, 2011, ECOGRAPHY, V34, P616, DOI 10.1111/j.1600-0587.2010.06612.x; Guerra-Garcia JM, 2009, J MAR BIOL ASSOC UK, V89, P387, DOI 10.1017/S0025315409002938; Hedgpeth JW, 1969, ANTARCTIC MAP FOLIO, V11, P26; Juan J., 1990, PICNOGONIDOS COSTERO, P187; Kocak C, 2010, ZOOL MIDDLE EAST, V49, P118, DOI 10.1080/09397140.2010.10638403; KRAPP F, 1973, Beaufortia, V21, P55; KRAPP F, 1983, Marine Ecology, V4, P123, DOI 10.1111/j.1439-0485.1983.tb00291.x; Krapp F, 2008, ZOOTAXA, P57; Leon TM, 2000, CAH BIOL MAR, V41, P321; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MALDONADO M, 1995, J BIOGEOGR, V22, P89, DOI 10.2307/2846075; Munilla Leon T., 1981, Butlleti de la Institucio Catalana d'Historia Natural, V47, P77; Munilla Leon Tomas, 1997, ORSIS, V12, P65; Munilla Leon Tomas, 1994, Orsis, V9, P109; MUNILLA T, 1984, Boletin de la Asociacion Espanola de Entomologia, V8, P13; MUNILLA T, 1991, ORSIS, V6, P95; Munilla T, 1999, VIE MILIEU, V49, P155; MUNILLA T, 1987, Miscellania Zoologica (Barcelona), V11, P369; Munilla T., 1988, Butlleti de la Institucio Catalana d'Historia Natural, V55, P59; MUNILLA T, 1993, J MAR BIOL ASSOC UK, V73, P543, DOI 10.1017/S0025315400033099; Munilla T, 1982, ACTAS 2 S IBERICO ES, V3, P221; Munilla T, 1984, ELS SISTEMES NATURAL, V73, P531; Munilla T., 1978, THESIS U AUTONOMA BA; Munilla T.L, 1993, ANN MUS CIV STOR NAT, V89, P445; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; Naranjo S, 1998, BIOL J LINN SOC, V64, P151; NOGUEIRA M, 1967, Arquivos do Museu Bocage, V1, P283; NOGUEIRA MARIA, 1956, ARQ MUS BOCAGE, V27, P65; PEREZ-RUZAFA A, 1992, Scientia Marina, V56, P21; Ros-Santaella J.L, 2004, ACTA GRANATENSE, V3, P3; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Soler-Membrives A., 2010, THESIS U AUTONOMA BA; Soler-Membrives Anna, 2014, P138; STOCK J H, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P135; STOCK JH, 1978, CAH BIOL MAR, V19, P397; STOCK JH, 1987, CAH BIOL MAR, V28, P505; STOCK JH, 1978, CAH BIOL MAR, V19, P189; Stock JH, 1968, VIE MILIEU S, V19, P11; Templado J., 2012, GUIA INTERPRETATIVA; Templado J, 2011, MEM REAL SOC ESP HIS, V9, P343; Troncoso JS, 2011, J OCEANOGR MAR SCI, V2, P23; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325; Woods HA, 2009, P R SOC B, V276, P1069, DOI 10.1098/rspb.2008.1489	71	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120818	10.1371/journal.pone.0120818	http://dx.doi.org/10.1371/journal.pone.0120818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781483	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600190
J	Sumit, AF; Das, A; Sharmin, Z; Ahsan, N; Ohgami, N; Kato, M; Akhand, AA				Sumit, Ahmed Faisal; Das, Anindya; Sharmin, Zinat; Ahsan, Nazmul; Ohgami, Nobutaka; Kato, Masashi; Akhand, Anwarul Azim			Cigarette Smoking Causes Hearing Impairment among Bangladeshi Population	PLOS ONE			English	Article							OCCUPATIONAL NOISE EXPOSURE; AUDITORY-THRESHOLDS; WORKERS; RISK; AGE	Lifestyle including smoking, noise exposure with MP3 player and drinking alcohol are considered as risk factors for affecting hearing synergistically. However, little is known about the association of cigarette smoking with hearing impairment among subjects who carry a lifestyle without using MP3 player and drinking alcohol. We showed here the influence of smoking on hearing among Bangladeshi subjects who maintain a lifestyle devoid of using MP3 player and drinking alcohol. A total of 184 subjects (smokers: 90; non-smokers: 94) were included considering their duration and frequency of smoking for conducting this study. The mean hearing thresholds of non-smoker subjects at 1, 4, 8 and 12 kHz frequencies were 5.63 +/- 2.10, 8.56 +/- 5.75, 21.06 +/- 11.06, 40.79 +/- 20.36 decibel (dB), respectively and that of the smokers were 7 +/- 3.8, 13.27 +/- 8.4, 30.66 +/- 12.50 and 56.88 +/- 21.58 dB, respectively. The hearing thresholds of the smokers at 4, 8 and 12 kHz frequencies were significantly (p<0.05) higher than those of the non-smokers, while no significant differences were observed at 1 kHz frequency. We also observed no significant difference in auditory thresholds among smoker subgroups based on smoking frequency. In contrast, subjects smoked for longer duration (>5 years) showed higher level of auditory threshold (62.16 +/- 19.87 dB) at 12 kHz frequency compared with that (41.52 +/- 19.21 dB) of the subjects smoked for 1-5 years and the difference in auditory thresholds was statistically significant (p<0.0002). In this study, the Brinkman Index (BI) of smokers was from 6 to 440 and the adjusted odds ratio showed a positive correlation between hearing loss and smoking when adjusted for age and body mass index (BMI). In addition, age, but not BMI, also played positive role on hearing impairment at all frequencies. Thus, these findings suggested that cigarette smoking affects hearing level at all the frequencies tested but most significantly at extra higher frequencies.	[Sumit, Ahmed Faisal; Das, Anindya; Sharmin, Zinat; Ahsan, Nazmul; Akhand, Anwarul Azim] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka 1000, Bangladesh; [Ohgami, Nobutaka] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan; [Ohgami, Nobutaka; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi 4648601, Japan	University of Dhaka; Chubu University; Nagoya University	Akhand, AA (corresponding author), Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka 1000, Bangladesh.	akhand66@yahoo.com	Ahsan, Nazmul/AAE-6751-2020; Ohgami, Nobutaka/I-4572-2014; KATO, Masashi/I-7250-2014	Ahsan, Nazmul/0000-0003-1311-1589; Das, Anindya/0000-0003-4142-1517				BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; Baur M, 2009, HNO, V57, P1023, DOI 10.1007/s00106-009-1900-9; Brant L J, 1996, J Am Acad Audiol, V7, P152; BRANT LJ, 1990, J ACOUST SOC AM, V88, P813, DOI 10.1121/1.399731; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Ferrite S, 2005, OCCUP MED-OXFORD, V55, P48, DOI 10.1093/occmed/kqi002; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Karlsmose B, 2000, BRIT J AUDIOL, V34, P47, DOI 10.3109/03005364000000117; Kim KS, 2010, J KOREAN MED SCI, V25, pS62, DOI 10.3346/jkms.2010.25.S.S62; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Lusk S L, 1997, AAOHN J, V45, P397; Mizoue T, 2003, OCCUP ENVIRON MED, V60, P56, DOI 10.1136/oem.60.1.56; Mohammadi S, 2010, NOISE HEALTH, V12, P187, DOI 10.4103/1463-1741.64975; Nakanishi N, 2000, J OCCUP ENVIRON MED, V42, P1045, DOI 10.1097/00043764-200011000-00001; Nasir H M, 2012, Med J Malaysia, V67, P81; Nomura K, 2005, INT ARCH OCC ENV HEA, V78, P178, DOI 10.1007/s00420-005-0604-z; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; Oliveira Daniela Cecílio Capra Marques de, 2009, Braz. j. otorhinolaryngol., V75, P738; Palmer KT, 2004, OCCUP ENVIRON MED, V61, P340, DOI 10.1136/oem.2003.009183; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pouryaghoub G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-137; Sawair FA, 2010, THER CLIN RISK MANAG, V6, P573, DOI 10.2147/TCRM.S15145; Shimada S, 2011, CIRC J, V75, P185, DOI 10.1253/circj.CJ-10-0335; Starck J, 1999, ACTA OTO-LARYNGOL, V119, P302; Szudek J, 2012, J OTOLARYNGOL-HEAD N, V41, pS78, DOI 10.2310/7070.2011.110089; Uy J, 2013, ANN INTERN MED, V158, pITC41, DOI 10.7326/0003-4819-158-7-201304020-01004; Van Tasell DJ, 2013, OTOL NEUROTOL, V34, P9, DOI 10.1097/MAO.0b013e318278c05d; Virokannas H, 1995, SCAND AUDIOL, V24, P211, DOI 10.3109/01050399509047538; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]	32	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118960	10.1371/journal.pone.0118960	http://dx.doi.org/10.1371/journal.pone.0118960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781179	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600038
J	Degen, T; Hovestadt, T; Mitesser, O; Holker, F				Degen, Tobias; Hovestadt, Thomas; Mitesser, Oliver; Hoelker, Franz			High Female Survival Promotes Evolution of Protogyny and Sexual Conflict	PLOS ONE			English	Article							MORTALITY-RATES; ARMYWORM LEPIDOPTERA; BAGWORMS LEPIDOPTERA; SIZE DIMORPHISM; MATING SUCCESS; MALES EMERGE; LIFE-SPAN; PROTANDRY; MOTH; TIME	Existing models explaining the evolution of sexual dimorphism in the timing of emergence (SDT) in Lepidoptera assume equal mortality rates for males and females. The limiting assumption of equal mortality rates has the consequence that these models are only able to explain the evolution of emergence of males before females, i.e. protandry-the more common temporal sequence of emergence in Lepidoptera. The models fail, however, in providing adaptive explanations for the evolution of protogyny, where females emerge before males, but protogyny is not rare in insects. The assumption of equal mortality rates seems too restrictive for many insects, such as butterflies. To investigate the influence of unequal mortality rates on the evolution of SDT, we present a generalised version of a previously published model where we relax this assumption. We find that longer life-expectancy of females compared to males can indeed favour the evolution of protogyny as a fitness enhancing strategy. Moreover, the encounter rate between females and males and the sex-ratio are two important factors that also influence the evolution of optimal SDT. If considered independently for females and males the predicted strategies can be shown to be evolutionarily stable (ESS). Under the assumption of equal mortality rates the difference between the females' and males' ESS remains typically very small. However, female and male ESS may be quite dissimilar if mortality rates are different. This creates the potential for an 'evolutionary conflict' between females and males. Bagworm moths (Lepidoptera: Psychidae) provide an exemplary case where life-history attributes are such that protogyny should indeed be the optimal emergence strategy from the males' and females' perspectives: (i) Female longevity is considerably larger than that of males, (ii) encounter rates between females and males are presumably low, and (iii) females mate only once. Protogyny is indeed the general mating strategy found in the bagworm family.	[Degen, Tobias; Hoelker, Franz] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Degen, Tobias] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hovestadt, Thomas; Mitesser, Oliver] Univ Wurzburg, Biozentrum, Field Stn Fabrikschleichach, Dept Anim Ecol & Trop Biol, Rauhenebrach, Germany; [Hovestadt, Thomas] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; University of Wurzburg; Ghent University	Degen, T (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany.	degen@igb-berlin.de	Hölker, Franz/A-5683-2009; Mitesser, Oliver/B-8500-2008	Hölker, Franz/0000-0001-5932-266X; Degen, Tobias/0000-0001-8001-1604; Mitesser, Oliver/0000-0002-3607-877X; Hovestadt, Thomas/0000-0001-7368-6013	"Verlust der Nacht" (Federal Ministry of Education and Research, Germany) [BMBF-033L038A]; German Research Foundation (DFG, Collaborative Research Center "Insect timing", Project C6) [SFB1047]	"Verlust der Nacht" (Federal Ministry of Education and Research, Germany); German Research Foundation (DFG, Collaborative Research Center "Insect timing", Project C6)	This work was funded by the project "Verlust der Nacht" (Federal Ministry of Education and Research, Germany, BMBF-033L038A, granted to FH) and by the German Research Foundation (DFG, Collaborative Research Center SFB 1047 "Insect timing", Project C6, granted to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2011, ANNU REV ENTOMOL, V56, P445, DOI 10.1146/annurev-ento-120709-144828; [Anonymous], 2014, R LANG ENV STAT COMP; Bento JMS, 2006, FLA ENTOMOL, V89, P199, DOI 10.1653/0015-4040(2006)89[199:BAMBOT]2.0.CO;2; Bonduriansky R, 2002, NATURE, V420, P377, DOI 10.1038/420377a; Boughton AJ, 2007, FLA ENTOMOL, V90, P509, DOI 10.1653/0015-4040(2007)90[509:MBOACL]2.0.CO;2; BULMER MG, 1983, THEOR POPUL BIOL, V23, P314, DOI 10.1016/0040-5809(83)90021-7; Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; FAGERSTROM T, 1982, OECOLOGIA, V52, P164, DOI 10.1007/BF00363830; Fox CW, 2003, FUNCT ECOL, V17, P619, DOI 10.1046/j.1365-2435.2003.00781.x; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gotthard K, 2000, OECOLOGIA, V122, P36, DOI 10.1007/PL00008833; Honek Alois, 1997, Acta Societatis Zoologicae Bohemicae, V61, P113; Kawasaki N, 2008, AM NAT, V172, P346, DOI 10.1086/589519; Kokko H, 2006, J ANIM ECOL, V75, P1293, DOI 10.1111/j.1365-2656.2006.01151.x; Larsen E, 2013, ENTOMOL EXP APPL, V146, P130, DOI 10.1111/eea.12003; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Morbey YE, 2013, J THEOR BIOL, V339, P93, DOI 10.1016/j.jtbi.2013.05.009; Nagoshi RN, 2011, ANN ENTOMOL SOC AM, V104, P88, DOI 10.1603/AN10110; Parker G. A., 1979, SEXUAL SELECTION SEX; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Ramaswamy SB, 1997, ARCH INSECT BIOCHEM, V35, P539, DOI 10.1002/(SICI)1520-6327(1997)35:4<539::AID-ARCH12>3.0.CO;2-B; RHAINDS M, 1995, ENTOMOL EXP APPL, V77, P183, DOI 10.1007/BF02383032; Rhainds M, 1999, ENTOMOL EXP APPL, V91, P375, DOI 10.1023/A:1003619511525; Rhainds M, 2009, ANNU REV ENTOMOL, V54, P209, DOI 10.1146/annurev.ento.54.110807.090448; Rhainds M, 2008, ECOL ENTOMOL, V33, P663, DOI 10.1111/j.1365-2311.2008.01027.x; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Schtickzelle N, 2002, OIKOS, V97, P349, DOI 10.1034/j.1600-0706.2002.970305.x; Scott J.A., 1973, Journal Res Lepid, V12, P225; SIMMONS AM, 1993, FLA ENTOMOL, V76, P333, DOI 10.2307/3495733; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; TAYLOR PS, 1990, ENVIRON ENTOMOL, V19, P1422, DOI 10.1093/ee/19.5.1422; Teder T, 2014, FUNCT ECOL, V28, P479, DOI 10.1111/1365-2435.12172; Uematsu H, 1997, JPN J APPL ENTOMOL Z, V41, P217, DOI 10.1303/jjaez.41.217; WIKLUND C, 1977, OECOLOGIA, V31, P153, DOI 10.1007/BF00346917; Wiklund C, 2003, P ROY SOC B-BIOL SCI, V270, P1823, DOI 10.1098/rspb.2003.2437; Wiklund Christer, 1995, P175; ZONNEVELD C, 1991, THEOR POPUL BIOL, V40, P308, DOI 10.1016/0040-5809(91)90058-N; ZONNEVELD C, 1992, B MATH BIOL, V54, P957	39	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118354	10.1371/journal.pone.0118354	http://dx.doi.org/10.1371/journal.pone.0118354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775473	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500029
J	Shen, XC; Xi, G; Wai, C; Clemmons, DR				Shen, Xinchun; Xi, Gang; Wai, Christine; Clemmons, David R.			The Coordinate Cellular Response to Insulin-like Growth Factor-I (IGF-I) and Insulin-like Growth Factor-binding Protein-2 (IGFBP-2) Is Regulated through Vimentin Binding to Receptor Tyrosine Phosphatase beta (RPTP beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INTEGRIN-LINKED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; P21-ACTIVATED KINASE; C-ZETA; PHOSPHORYLATION; ACTIVATION; ILK; PSEUDOKINASE; DIFFERENTIATION	Insulin-like growth factor-binding protein-2 (IGFBP-2) functions coordinately with IGF-I to stimulate cellular proliferation and differentiation. IGFBP-2 binds to receptor tyrosine phosphatase beta (RPTP beta), and this binding in conjunction with IGF-I receptor stimulation induces RPTP beta polymerization leading to phosphatase and tensin homolog inactivation, AKT stimulation, and enhanced cell proliferation. To determine the mechanism by which RPTP beta polymerization is regulated, we analyzed the protein(s) that associated with RPTP beta in response to IGF-I and IGFBP-2 in vascular smooth muscle cells. Proteomic experiments revealed that IGF-I stimulated the intermediate filament protein vimentin to bind to RPTP beta, and knockdown of vimentin resulted in failure of IGFBP-2 and IGF-I to stimulate RPTP beta polymerization. Knockdown of IGFBP-2 or inhibition of IGF-IR tyrosine kinase disrupted vimentin/RPTP beta association. Vimentin binding to RPTP beta was mediated through vimentin serine phosphorylation. The serine threonine kinase PKC zeta was recruited to vimentin in response to IGF-I and inhibition of PKC zeta activation blocked these signaling events. A cell-permeable peptide that contained the vimentin phosphorylation site disrupted vimentin/RPTP beta association, and IGF-I stimulated RPTP beta polymerization and AKT activation. Integrin-linked kinase recruited PKC zeta to SHPS-1-associated vimentin in response to IGF-I and inhibition of integrin-linked kinase/PKC zeta association reduced vimentin serine phosphorylation. PKC zeta stimulation of vimentin phosphorylation required high glucose and vimentin/RPTP beta-association occurred only during hyperglycemia. Disruption of vimetin/RPTP beta in diabetic mice inhibited RPTP beta polymerization, vimentin serine phosphorylation, and AKT activation in response to IGF-I, whereas nondiabetic mice showed no difference. The induction of vimentin phosphorylation is important for IGFBP-2-mediated enhancement of IGF-I-stimulated proliferation during hyperglycemia, and it coordinates signaling between these two receptor-linked signaling systems.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Key Lab Grains & Oils Qual Control & Proc, Nanjing 210023, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022; Regan, Clinton/E-6250-2012		National Institutes of Health [AG-02331]; National Natural Science Foundation of China [31271983]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-02331. This work was also supported by Grant 31271983 from the National Natural Science Foundation of China (to X. S.).	Brauksiepe Bastienne, 2008, BMC Biochemistry, V9, P25, DOI 10.1186/1471-2091-9-25; Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6; DeMambro V. E., 2007, ENDOCRINOLOGY, V149, P2015; DeMambro VE, 2012, J BONE MINER RES, V27, P390, DOI 10.1002/jbmr.545; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; Deuel TF, 2013, BBA-PROTEINS PROTEOM, V1834, P2219, DOI 10.1016/j.bbapap.2013.06.004; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Galiano RD, 1996, J CLIN INVEST, V98, P2462, DOI 10.1172/JCI119064; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Liu Q, 1998, J IMMUNOL, V160, P1393; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Shen XC, 2012, MOL CELL BIOL, V32, P4116, DOI 10.1128/MCB.01011-12; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Xi G, 2014, J BONE MINER RES, V29, P2427, DOI 10.1002/jbmr.2282; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Zuloaga R, 2013, BIOCHEM BIOPH RES CO, V440, P258, DOI 10.1016/j.bbrc.2013.09.067	41	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11578	11590		10.1074/jbc.M114.620237	http://dx.doi.org/10.1074/jbc.M114.620237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787077	Green Published, hybrid			2022-12-26	WOS:000353719400033
J	Liu, EB; Liu, XL; Zeng, SY; Zhao, KM; Zhu, CF; Liu, Y; Breria, MC; Zhang, BJ; Hong, DL				Liu, Erbao; Liu, Xiaoli; Zeng, Siyuan; Zhao, Kaiming; Zhu, Changfeng; Liu, Yang; Breria, Manamik Caleb; Zhang, Baojuan; Hong, Delin			Time-Course Association Mapping of the Grain-Filling Rate in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; PHOTOPERIOD SENSITIVITY; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; NATURAL VARIATION; MAJOR QTL; YIELD; ENCODES; QUALITY; WIDTH	Detecting quantity trait locus (QTLs) and elite alleles that are associated with grain-filling rate (GFR) in rice is essential for promoting the utilization of hybrid japonica rice and improving rice yield. Ninety-five varieties including 58 landraces and 37 elite varieties from the core germplasm collection were genotyped with 263 simple sequence repeat (SSR) markers. The GFR of the 95 varieties was evaluated at five stages, 7, 14, 21, 28 and 35 days after flowering (DAF) both in 2011 and 2012. We found abundant phenotypic and genetic diversity in the studied population. A population structure analysis identified seven subpopulations. A linkage disequilibrium (LD) analysis indicated that the levels of LD ranged from 60.3 cM to 84.8 cM and artificial selection had enhanced the LD. A time-course association analysis detected 31 marker-GFR associations involving 24 SSR markers located on chromosomes 1, 2, 3, 4, 5, 6, 8, 9, 11 and 12 of rice at five stages. The elite alleles for high GFR at each stage were detected. Fifteen excellent parental combinations were predicted, and the best parental combination 'Nannongjing62401xLaolaihong' could theoretically increase 4.086 mg grain(-1) d(-1) at the five stages. Our results demonstrate that the time-course association mapping for GFR in rice could detect elite alleles at different filling stages and that these elite alleles could be used to improve the GFR via pyramiding breeding.	[Liu, Erbao; Liu, Xiaoli; Zeng, Siyuan; Zhao, Kaiming; Zhu, Changfeng; Liu, Yang; Breria, Manamik Caleb; Zhang, Baojuan; Hong, Delin] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, DL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	delinhong@njau.edu.cn	hong, delin/R-3398-2017; Liu, Xiaoli/HGE-7614-2022	hong, delin/0000-0002-2899-9739; Breria, Caleb Manamik/0000-0002-0976-6956	National High-tech R&D Program of China (863 Program) [2010AA101301]; Research Fund for the Doctoral Program of Higher Education of China [B0201100690, B0201300662]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by following funders: (1) National High-tech R&D Program of China (863 Program) Grant number: 2010AA101301, URL: http://www.most.gov.cn/, the author that received the funding: DH, (2) Research Fund for the Doctoral Program of Higher Education of China Grant numbers: B0201100690 and B0201300662, URL: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm, the author that received the funding: DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cheng BaoShan, 2007, Journal of Nanjing Agricultural University, V30, P1; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Dang XJ, 2014, PLANTA, V239, P1309, DOI 10.1007/s00425-014-2060-z; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flavio B, 2006, GENETICS, V172, P1165, DOI DOI 10.1534/GENETICS.105.044586; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Hong DeLin, 2004, Rice Science, V11, P255; Huang JW, 1996, BIOSCI BIOTECH BIOCH, V60, P233, DOI 10.1271/bbb.60.233; [贾小丽 Jia Xiaoli], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P22; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Jin WeiDong, 2008, Scientia Agricultura Sinica, V41, P3822; Kato T, 1996, CROP SCI, V36, P1135, DOI 10.2135/cropsci1996.0011183X003600050011x; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lapitan VC, 2007, BREEDING SCI, V57, P263, DOI 10.1270/jsbbs.57.263; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Liu Er-bao, 2013, Chinese Journal of Rice Science, V27, P473, DOI 10.3969/j.issn.1001-7216.2013.05.004; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma Lin, 2010, Zhongguo Shuidao Kexue, V24, P237, DOI 10.3969/j.issn.1001-7216.2010.03.005; Mao CX, 2010, ACCELERATING HYBRID, P581; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; OKAGAKI RJ, 1992, PLANT MOL BIOL, V19, P513, DOI 10.1007/BF00023402; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; VIRMANI SS, 1982, THEOR APPL GENET, V63, P373, DOI 10.1007/BF00303911; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoshida S., 1981, Fundamentals of rice crop science.; Yu YQ, 2012, FIELD CROP RES, V136, P65, DOI 10.1016/j.fcr.2012.07.021; Yuan LP., 1994, HYBRID RICE TECHNOLO, P1; Zhang GuoHua, 2013, Acta Agronomica Sinica, V39, P1187, DOI 10.3724/SP.J.1006.2013.01187; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	61	16	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119959	10.1371/journal.pone.0119959	http://dx.doi.org/10.1371/journal.pone.0119959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789629	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400121
J	Byeon, H; Hong, S				Byeon, Haewon; Hong, Saemi			Relationship between Television Viewing and Language Delay in Toddlers: Evidence from a Korea National Cross-Sectional Survey	PLOS ONE			English	Article							CHILDREN; INFANTS; EXPOSURE; SPEECH	Purpose This study investigated the relationship between 2-year-old children's exposure to TV and language delay. Methods The subjects of this study were 1,778 toddlers (906 males and 872 females) who participated in the Panel Study on Korean Children conducted in 2010. The linguistic ability of the toddlers was measured with the K-ASQ (Korean-Ages and Stages Questionnaire). The relationship between the amount of young children's exposure to TV and language delay was analyzed with Poisson regression. Results The average daily TV watching time of 2-year-old Korean toddlers in this study was 1.21 hours. After all confounding variables were adjusted, toddlers with over 2 hours and less than 3 hours of TV watching time had 2.7 times more risk (RR = 2.74, 95% CI: 1.13-6.65) of language delay than those with less than 1 hour of TV watching time. Those with more than 3 hours of TV watching time had approximately 3 times (RR = 3.03, 95% CI: 1.12-8.21) more risk (p<0.05). In addition, the risk of language delay increased proportionately with the increase in toddlers' TV watching time (p = 0.004). Conclusion Two-year-old Korean toddlers' average daily TV watching time of more than 2 hours was related with language delay.	[Byeon, Haewon] Nambu Univ, Dept Speech Language Pathol & Audiol, Gwangju, South Korea; [Byeon, Haewon] Nambu Univ, Speech Language Pathol Ctr, Gwangju, South Korea; [Hong, Saemi] Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea	Nambu University; Nambu University; University of Ulsan; Asan Medical Center	Byeon, H (corresponding author), Nambu Univ, Sch Publ Hlth, Dept Speech Language Pathol & Audiol, Cheomdanro 23, Gwangju, South Korea.	byeon@nambu.ac.kr	Byeon, Haewon/R-2113-2019	Byeon, Haewon/0000-0002-3363-390X				Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Barr R, 2010, MERRILL PALMER QUART, V56, P21; Berk, 2012, CHILD DEV; Brown A, 2011, PEDIATRICS, V128, P1040, DOI 10.1542/peds.2011-1753; Chonchaiya W, 2008, ACTA PAEDIATR, V97, P977, DOI 10.1111/j.1651-2227.2008.00831.x; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P554, DOI 10.1001/archpediatrics.2009.61; Common Sense Media, ZER 8 CHILDR MED US; Garrison M., 2005, TEACHER LIVING ROOM; Heo KH, 2006, KASQ KOREAN AGES STA; Hoff E., 2013, LANGUAGE DEV; International Telecommunication Union, WORLD TEL ICT IND DA; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Kelly DP, 1999, DEV BEHAV PEDIAT; Korea Centers for Disease Control and Prevention, 2007, 2007 CHILDR AS PHYS; Korea Information Society Development Institute, 2013, BROADC MED SURV 2013; Korea Institute of Child Care and Education, 2012, PAN STUD KOR CHILDR; Korean Women's Development Institute, 2014, GENDER REV, V34, P34; Krcmar M, 2007, MEDIA PSYCHOL, V10, P41; Linebarger DL, 2010, DEV REV, V30, P176, DOI 10.1016/j.dr.2010.03.006; Linebarger DL, 2005, AM BEHAV SCI, V48, P624, DOI 10.1177/0002764204271505; Pempek TA, 2014, J CHILD MEDIA, V8, P211, DOI 10.1080/17482798.2014.920715; Schmidt ME, 2009, PEDIATRICS, V123, pe370, DOI 10.1542/peds.2008-3221; Schmitt KL, 2003, J COMMUN, V53, P265, DOI 10.1111/j.1460-2466.2003.tb02590.x; Squires J., 1999, AGES STAGES QUESTION; Strasburger VC, 2010, PEDIATRICS, V126, P1012, DOI 10.1542/peds.2010-1636; Takeuchi H, 2013, CEREB CORTEX; Tanimura M, 2007, ARCH PEDIAT ADOL MED, V161, P618, DOI 10.1001/archpedi.161.6.618-b; Thakkar RR, 2006, PEDIATRICS, V118, P2025, DOI 10.1542/peds.2006-1307; Wartella, 2003, ZERO 6 ELECT MEDIA L; Wartella E, 2007, J CHILD MEDIA, V1, P35, DOI 10.1080/17482790601005207; Werker JF, 2002, INFANCY, V3, P1, DOI 10.1207/S15327078IN0301_1; Zimmerman FJ, 2005, ARCH PEDIAT ADOL MED, V159, P619, DOI 10.1001/archpedi.159.7.619; Zimmerman FJ, 2007, J PEDIATR-US, V151, P364, DOI 10.1016/j.jpeds.2007.04.071; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	35	49	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120663	10.1371/journal.pone.0120663	http://dx.doi.org/10.1371/journal.pone.0120663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785449	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500186
J	Li, WQ; Wang, FQ; Wang, J; Fan, FJ; Zhu, JY; Yang, J; Liu, FQ; Zhong, WG				Li, Wenqi; Wang, Fangquan; Wang, Jun; Fan, Fangjun; Zhu, Jinyan; Yang, Jie; Liu, Fengquan; Zhong, Weigong			Overexpressing CYP71Z2 Enhances Resistance to Bacterial Blight by Suppressing Auxin Biosynthesis in Rice	PLOS ONE			English	Article							GLUCOSINOLATE BIOSYNTHESIS; DISEASE RESISTANCE; CYTOCHROME-P450 MONOOXYGENASE; CONSTITUTIVE EXPRESSION; CAMALEXIN BIOSYNTHESIS; SIGNALING PATHWAY; RESPONSE PATHWAY; ARABIDOPSIS; PATHOGEN; GROWTH	Background The hormone auxin plays an important role not only in the growth and development of rice, but also in its defense responses. We've previously shown that the P450 gene CYP71Z2 enhances disease resistance to pathogens through regulation of phytoalexin biosynthesis in rice, though it remains unclear if auxin is involved in this process or not. Methodology and Principal Findings The expression of CYP71Z2 was induced by Xanthomonas oryzae pv. oryzae (Xoo) inoculation was analyzed by qRT-PCR, with GUS histochemical staining showing that CYP71Z2 expression was limited to roots, blades and nodes. Overexpression of CYP71Z2 in rice durably and stably increased resistance to Xoo, though no significant difference in disease resistance was detected between CYP71Z2-RNA interference (RNAi) rice and wild-type. Moreover, IAA concentration was determined using the HPLC/electrospray ionization/tandem mass spectrometry system. The accumulation of IAA was significantly reduced in CYP71Z2-overexpressing rice regardless of whether plants were inoculated or not, whereas it was unaffected in CYP71Z2-RNAi rice. Furthermore, the expression of genes related to IAA, expansin and SA/JA signaling pathways was suppressed in CYP71Z2-overexpressing rice with or without inoculation. Conclusions and Significance These results suggest that CYP71Z2-mediated resistance to Xoo may be via suppression of IAA signaling in rice. Our studies also provide comprehensive insight into molecular mechanism of resistance to Xoo mediated by IAA in rice. Moreover, an available approach for understanding the P450 gene functions in interaction between rice and pathogens has been provided.	[Li, Wenqi; Wang, Fangquan; Wang, Jun; Fan, Fangjun; Zhu, Jinyan; Yang, Jie; Zhong, Weigong] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing Branch, Chinese Natl Ctr Rice Improvement,Jiangsu High Qu, Nanjing 210014, Peoples R China; [Liu, Fengquan] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences	Yang, J (corresponding author), Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing Branch, Chinese Natl Ctr Rice Improvement,Jiangsu High Qu, Nanjing 210014, Peoples R China.	yangjie168@aliyun.com; fqliu20011@sina.com	fan, fang/GQY-9173-2022; Fan, Fang/GRO-2696-2022		National Natural Science Foundation of China [31301652]; Key Projects in the National Science & Technology Pillar Program [2011BAD16B03]; Natural Science Foundation of Jiangsu Province of China [BK20130723]; Jiangsu Province Independent Innovation Project [CX(14)5003]; Special Fund for Agro-scientific Research in the Public Interest [201303102]; special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements [BAAA2014134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Province Independent Innovation Project; Special Fund for Agro-scientific Research in the Public Interest; special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements	This work was supported by the National Natural Science Foundation of China (31301652), the Key Projects in the National Science & Technology Pillar Program (2011BAD16B03), the Natural Science Foundation of Jiangsu Province of China (BK20130723) and the Jiangsu Province Independent Innovation Project no. CX(14)5003.), the Special Fund for Agro-scientific Research in the Public Interest (201303102), the special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements (BAAA2014134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zaitoon YM, 2012, PHYSIOL PLANTARUM, V146, P487, DOI 10.1111/j.1399-3054.2012.01649.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; FETT WF, 1987, APPL ENVIRON MICROB, V53, P1839, DOI 10.1128/AEM.53.8.1839-1845.1987; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; KESSMANN H, 1994, ANNU REV PHYTOPATHOL, V32, P439, DOI 10.1146/annurev.py.32.090194.002255; Khalid A, 2004, AUST J SOIL RES, V42, P921, DOI 10.1071/SR04019; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li WQ, 2013, PLANT SCI, V207, P98, DOI 10.1016/j.plantsci.2013.02.005; Ljung K, 2013, DEVELOPMENT, V140, P43, DOI [10.1242/dev.085290, DOI 10.1242/DEV.085290]; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; McSteen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001479; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Rupasinghe Sanjeewa, 2006, Phytochemistry Reviews, V5, P473, DOI 10.1007/s11101-006-9028-y; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Song YL, 2009, PLANT MOL BIOL, V70, P297, DOI 10.1007/s11103-009-9474-1; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang MY, 2012, J INTEGR PLANT BIOL, V54, P471, DOI 10.1111/j.1744-7909.2012.01131.x; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	54	21	24	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119867	10.1371/journal.pone.0119867	http://dx.doi.org/10.1371/journal.pone.0119867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786239	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500137
J	Matsuba, Y; Zi, JC; Jones, AD; Peters, RJ; Pichersky, E				Matsuba, Yuki; Zi, Jiachen; Jones, A. Daniel; Peters, Reuben J.; Pichersky, Eran			Biosynthesis of the Diterpenoid Lycosantalonol via Nerylneryl Diphosphate in Solanum lycopersicum	PLOS ONE			English	Article							TERPENE SYNTHASES; GLANDULAR TRICHOMES; EVOLUTION; GENES; TOMATO; VECTORS; CYTOCHROME-P450; METABOLISM; EXPRESSION; DIVERSITY	We recently reported that three genes involved in the biosynthesis of monoterpenes in trichomes, a cis-prenyltransferase named neryl diphosphate synthase 1 (NDPS1) and two terpene synthases (TPS19 and TPS20), are present in close proximity to each other at the tip of chromosome 8 in the genome of the cultivated tomato (Solanum lycopersicum). This terpene gene "cluster" also contains a second cis-prenyltransferase gene (CPT2), three other TPS genes, including TPS21, and the cytochrome P450-oxidoreductase gene CYP71BN1. CPT2 encodes a neryneryl diphosphate synthase. Co-expression in E. coli of CPT2 and TPS21 led to the formation of the diterpene lycosantalene, and co-expression in E. coli of CPT2, TPS21 and CYP71BN1 led to the formation of lycosantalonol, an oxidation product of lycosantalene. Here we show that maximal expression of all three genes occurs in the petiolule part of the leaf, but little expression of these genes occurs in the trichomes present on the petiolules. While lycosantalene or lycosantalonol cannot be detected in the petiolules of wild-type plants (or anywhere else in the plant), lycosantalene and lycosantalonol are detected in petiolules of transgenic tomato plants expressing CPT2 under the control of the 35S CaMV promoter. These results suggest that lycosantalene and lycosantalonol are produced in the petiolules and perhaps in other tissues of wild-type plants, but that low rate of synthesis, controlled by the rate-limiting enzyme CPT2, results in product levels that are too low for detection under our current methodology. It is also possible that these compounds are further modified in the plant. The involvement of CPT2, TPS21 and CYP71BN1 in a diterpenoid biosynthetic pathway outside the trichomes, together with the involvement of other genes in the cluster in the synthesis of monoterpenes in trichomes, indicates that this cluster is further evolving into "sub-clusters" with unique biochemical, and likely physiological, roles.	[Matsuba, Yuki; Pichersky, Eran] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zi, Jiachen; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; Iowa State University; Michigan State University	Pichersky, E (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	lelx@umich.edu	Jones, Arthur D/C-2670-2013; Peters, Reuben J./D-1196-2010	Peters, Reuben J./0000-0003-4691-8477; Jones, A. Daniel/0000-0002-7408-6690	National Science Foundation [IOS-1025636]; National Institutes of Health [GM076324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from National Science Foundation to EP (IOS-1025636, http://www.nsf.gov/) and National Institutes of Health to RJP (GM076324, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Falara V, 2014, PLANT PHYSIOL, V166, P428, DOI 10.1104/pp.114.243246; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Frey M, 2003, PHYTOCHEMISTRY, V62, P371, DOI 10.1016/S0031-9422(02)00556-3; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Gonzales-Vigil E, 2012, PLANT J, V71, P921, DOI 10.1111/j.1365-313X.2012.05040.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Inagaki YS, 2011, NEW PHYTOL, V191, P432, DOI 10.1111/j.1469-8137.2011.03712.x; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; Nomura T, 2002, MOL GENET GENOMICS, V267, P210, DOI 10.1007/s00438-002-0653-x; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Sasaki N, 2015, PLANT CELL PHYSIOL, V56, P28, DOI 10.1093/pcp/pcu097; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Zi JC, 2014, J AM CHEM SOC, V136, P16951, DOI 10.1021/ja508477e	40	33	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119302	10.1371/journal.pone.0119302	http://dx.doi.org/10.1371/journal.pone.0119302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786135	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500095
J	Albuquerque, F; Beier, P				Albuquerque, Fabio; Beier, Paul			Rarity-Weighted Richness: A Simple and Reliable Alternative to Integer Programming and Heuristic Algorithms for Minimum Set and Maximum Coverage Problems in Conservation Planning	PLOS ONE			English	Article							SELECTION	Here we report that prioritizing sites in order of rarity-weighted richness (RWR) is a simple, reliable way to identify sites that represent all species in the fewest number of sites (minimum set problem) or to identify sites that represent the largest number of species within a given number of sites (maximum coverage problem). We compared the number of species represented in sites prioritized by RWR to numbers of species represented in sites prioritized by the Zonation software package for 11 datasets in which the size of individual planning units (sites) ranged from <1 ha to 2,500 km(2). On average, RWR solutions were more efficient than Zonation solutions. Integer programming remains the only guaranteed way find an optimal solution, and heuristic algorithms remain superior for conservation prioritizations that consider compactness and multiple near-optimal solutions in addition to species representation. But because RWR can be implemented easily and quickly in R or a spreadsheet, it is an attractive alternative to integer programming or heuristic algorithms in some conservation prioritization contexts.	[Albuquerque, Fabio; Beier, Paul] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA	Northern Arizona University	Beier, P (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	paul.beier@nau.edu			Northern Arizona University; postdoctoral fellowship from the Arizona Technology Research Initiative Fund	Northern Arizona University; postdoctoral fellowship from the Arizona Technology Research Initiative Fund	This work was funded by Northern Arizona University, and by a postdoctoral fellowship to FA from the Arizona Technology Research Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardron J. A., 2010, MARXAN GOOD PRACTICE; Cayuela Luis, 2012, Biodiversity Ecol, V4, P211, DOI 10.7809/b-e.00078; CDFW (California Department of Fish and Wildlife), 2003, ATL BIOD CAL; Chaplin Stephen J., 2000, P159; CORMAN T.E., 2005, ARIZONA BREEDING BIR; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Delavenne J, 2011, ICES J MARINE SCI; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Haight R., 2009, SPATIAL CONSERVATION, P43; Inventario Nacional de Biodiversidad (INB), 2007, NAT INV TERR SPEC BR; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION, P58; NatureServe, 2013, NATURESERVE HOTSP MA; Preston C, 2002, NEW ATLAS BRIT IRISH; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Sierra Nevada Global Change Observatory, 2013, DAT FLOR DIV SIERR N; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x	20	36	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119905	10.1371/journal.pone.0119905	http://dx.doi.org/10.1371/journal.pone.0119905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780930	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600106
J	Han, ZL; Jiang, Y; Yang, YQ; Li, XH; Yang, ZZ; Cao, KJ; Wang, DW				Han, Zhonglin; Jiang, Yu; Yang, Yuqing; Li, Xuehan; Yang, Zhongzhou; Cao, Kejiang; Wang, Dao W.			Deletion of PDK1 Causes Cardiac Sodium Current Reduction in Mice	PLOS ONE			English	Article							BRUGADA-SYNDROME; NA+ CHANNEL; IN-VITRO; SERUM; INHIBITION; MUTATIONS; SURVIVAL; DEFECTS; DISEASE	Background The AGC protein kinase family regulates multiple cellular functions. 3-phosphoinositide-dependent protein kinase-1 (PDK1) is involved in the pathogenesis of arrhythmia, and its downstream factor, Forkhead box O1 (Foxo1), negatively regulates the expression of the cardiac sodium channel, Nav1.5. Mice are known to die suddenly after PDK1 deletion within 11 weeks, but the underlying electrophysiological bases are unclear. Thus, the aim of this study was to investigate the potential mechanisms between PDK1 signaling pathway and cardiac sodium current. Methods and Results Using patch clamp and western blotting techniques, we investigated the role of the PDK1-Foxo1 pathway in PDK1 knockout mice and cultured cardiomyocytes. We found that PDK1 knockout mice undergo slower heart rate, prolonged QRS and QTc intervals and abnormal conduction within the first few weeks of birth. Furthermore, the peak sodium current is decreased by 33% in cells lacking PDK1. The phosphorylation of Akt (308T) and Foxo1 (24T) and the expression of Nav1.5 in the myocardium of PDK1-knockout mice are decreased, while the nuclear localization of Foxo1 is increased. The role of the PDK1-Foxo1 pathway in regulating Nav1.5 levels and sodium current density was verified using selective PDK1, Akt and Foxo1 inhibitors and isolated neonatal rat cardiomyocytes. Conclusion These results indicate that PDK1 participates in the dysregulation of electrophysiological basis by regulating the PDK1-Foxo1 pathway, which in turn regulates the expression of Nav1.5 and cardiac sodium channel function.				david37212@hotmail.com			National Key Basic Research Program of China (973 Program) [2013CB531105]; National Natural Science Foundation of China [81170159]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following grants: National Key Basic Research Program of China (973 Program), No. 2013CB531105 and National Natural Science Foundation of China, Project No. 81170159 to DWW. (http://www.973.gov.cn/English/Index.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cordes J., 2009, J PHARMACOL TOXICOL, V60, P221, DOI [10.1016/j.vascn.2009.04.059, DOI 10.1016/j.vascn.2009.04.059]; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Di RM, 2010, CHINESE MED J-PEKING, V123, P2358, DOI 10.3760/cma.j.issn.0366-6999.2010.17.014; Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Farr MA, 2004, NEW ENGL J MED, V351, P185, DOI 10.1056/NEJMcibr041466; Frigo G, 2007, EUROPACE, V9, P391, DOI 10.1093/europace/eum053; Harris IS, 2014, ONCOGENE, V33, P1047, DOI 10.1038/onc.2013.24; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Heath BM, 2011, J PHARMACOL TOX MET, V63, P258, DOI 10.1016/j.vascn.2010.12.004; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jiang Q, 2014, BIOCHEM BIOPH RES CO, V449, P278, DOI 10.1016/j.bbrc.2014.05.041; Kaur K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055391; Korkmaz S, 2013, J AM COLL CARDIOL, V62, P340, DOI 10.1016/j.jacc.2013.04.041; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; London B, 1998, J PHYSIOL-LONDON, V509, P171, DOI 10.1111/j.1469-7793.1998.171bo.x; Lu ZJ, 2013, DIABETES, V62, P4257, DOI 10.2337/db13-0420; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; Mao WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032738; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nguyen TP, 2008, CIRC RES, V102, P364, DOI 10.1161/CIRCRESAHA.107.164673; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Remme CA, 2008, EUROPACE, V10, P1253, DOI 10.1093/europace/eun267; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Song WH, 2012, J PHYSIOL-LONDON, V590, P5123, DOI 10.1113/jphysiol.2012.235374; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; Wu XQ, 2013, AM J PATHOL, V182, P2005, DOI 10.1016/j.ajpath.2013.02.012; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173; Zicha S, 2004, J MOL CELL CARDIOL, V37, P91, DOI 10.1016/j.yjmcc.2004.04.003	42	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122436	10.1371/journal.pone.0122436	http://dx.doi.org/10.1371/journal.pone.0122436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781322	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600219
J	Oliveira, TN; Possidonio, AC; Soares, CP; Ayres, R; Costa, ML; Quintas, LEM; Mermelstein, C				Oliveira, Taissa Neustadt; Possidonio, Ana Claudia; Soares, Carolina Pontes; Ayres, Rodrigo; Costa, Manoel Luis; Menezes Quintas, Luis Eduardo; Mermelstein, Claudia			The Role of Na+/K+-ATPase during Chick Skeletal Myogenesis	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; MYOBLAST FUSION; K+-ATPASE; TERMINAL DIFFERENTIATION; CHOLESTEROL DEPLETION; MUSCLE-CELLS; EXPRESSION; OUABAIN; ALPHA-2; P38	The formation of a vertebrate skeletal muscle fiber involves a series of sequential and interdependent events that occurs during embryogenesis. One of these events is myoblast fusion which has been widely studied, yet not completely understood. It was previously shown that during myoblast fusion there is an increase in the expression of Na+/K+-ATPase. This fact prompted us to search for a role of the enzyme during chick in vitro skeletal myogenesis. Chick myogenic cells were treated with the Na+/K+-ATPase inhibitor ouabain in four different concentrations (0.01-10 mu M) and analyzed. Our results show that 0.01, 0.1 and 1 mu M ouabain did not induce changes in cell viability, whereas 10 mu M induced a 45% decrease. We also observed a reduction in the number and thickness of multinucleated myotubes and a decrease in the number of myoblasts after 10 mu M ouabain treatment. We tested the involvement of MEK-ERK and p38 signaling pathways in the ouabain-induced effects during myogenesis, since both pathways have been associated with Na+/K+-ATPase. The MEK-ERK inhibitor U0126 alone did not alter cell viability and did not change ouabain effect. The p38 inhibitor SB202190 alone or together with 10 mu M ouabain did not alter cell viability. Our results show that the 10 mu M ouabain effects in myofiber formation do not involve the MEK-ERK or the p38 signaling pathways, and therefore are probably related to the pump activity function of the Na+/K+-ATPase.	[Oliveira, Taissa Neustadt; Possidonio, Ana Claudia; Soares, Carolina Pontes; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil; [Ayres, Rodrigo; Menezes Quintas, Luis Eduardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Bioquim & Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010; Quintas, Luis Eduardo M/C-3308-2009	Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526; Quintas, Luis Eduardo M/0000-0002-0767-1240	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer/Programa de Oncobiologia	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer/Programa de Oncobiologia	This work was supported by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Fundacao do Cancer/Programa de Oncobiologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; FAMBROUGH DM, 1983, J BIOL CHEM, V258, P3926; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hamlyn JM, 2003, ANN NY ACAD SCI, V986, P685, DOI 10.1111/j.1749-6632.2003.tb07283.x; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; HIGHAM SC, 1993, J MEMBRANE BIOL, V131, P129, DOI 10.1007/BF02791321; HOLTZER H, 1991, INT CONGR SER, P187; HUNDAL HS, 1993, FEBS LETT, V328, P253, DOI 10.1016/0014-5793(93)80938-Q; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; Pauw PG, 2000, IN VITRO CELL DEV-AN, V36, P133; PAUW PG, 1994, IN VITRO CELL DEV-AN, V30A, P9, DOI 10.1007/BF02631408; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; PRIVES J, 1977, NATURE, V268, P761, DOI 10.1038/268761a0; Quintas LEM, 2000, BIOCHEM PHARMACOL, V60, P741, DOI 10.1016/S0006-2952(00)00376-2; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sharabani-Yosef O, 1999, J CELL PHYSIOL, V180, P236, DOI 10.1002/(SICI)1097-4652(199908)180:2<236::AID-JCP11>3.3.CO;2-N; Sharabani-Yosef O, 2001, J CELL PHYSIOL, V187, P365, DOI 10.1002/jcp.1089; SPERELAKIS N, 1972, BIOCHIM BIOPHYS ACTA, V266, P230, DOI 10.1016/0005-2736(72)90137-X; SWEADNER KJ, 1992, J BIOL CHEM, V267, P769; TAORMINO JP, 1990, J BIOL CHEM, V265, P4116; Vaudin P, 2006, DOMEST ANIM ENDOCRIN, V31, P123, DOI 10.1016/j.domaniend.2005.09.009; VIGNE P, 1982, J BIOL CHEM, V257, P5380; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; WOLITZKY BA, 1986, J BIOL CHEM, V261, P9990; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120940	10.1371/journal.pone.0120940	http://dx.doi.org/10.1371/journal.pone.0120940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775465	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500200
J	Tan, YN; Fu, JF; Li, XF; Yang, J; Jiang, MJ; Ding, KF; Xu, JH; Li, J; Yuan, Y				Tan, Yinuo; Fu, Jianfei; Li, Xiaofen; Yang, Jiao; Jiang, Mengjie; Ding, Kefeng; Xu, Jinghong; Li, Jun; Yuan, Ying			A Minor (< 50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China	PLOS ONE			English	Article							MUCINOUS HISTOLOGY PREDICTS; CLINICOPATHOLOGICAL CHARACTERISTICS; MOLECULAR-FEATURES; COLON-CANCER; CARCINOMA; ADENOCARCINOMA; SURVIVAL; OUTCOMES; DIFFERENTIATION	Background We performed a retrospective study to determine the cancer-specific survival of colorectal cancer patients with a component of signet-ring cells or mucin comprising < 50% of the tumor mass. Methods A total of 2454 patients seen in our hospital from 1985 to 2011 were retrospectively studied. The patients were divided into five groups according to type of cancer: signet-ring cell carcinoma (with > 50% signet-ring cell, n = 36), partial signet-ring cell carcinoma (with < 50% signet-ring cell, n = 28), mucinous adenocarcinoma (with > 50% mucin lacking signet-ring cell, n = 267), partial mucinous adenocarcinoma (with < 50% mucin lacking signet-ring cell, n = 145), and classic adenocarcinoma (with absence of either mucin or signet-ring cell, n = 1978). Results Patients with > 50% or < 50% signet-ring cell had the lowest 5-year survival rates (35.5% and 29.7%, respectively), followed by patients with > 50% mucin (48.8%). Patients who had partial mucinous adenocarcinoma with < 50% mucin and classic adenocarcinoma patients had the highest 5-year survival rates (64.8% and 65.3%, respectively). Stratified and multivariate analysis showed that signet-ring cell carcinoma, partial signet-ring cell carcinoma and mucinous adenocarcinoma were independent predictors of decreased survival (hazard ratio 1.699, P = 0.016; hazard ratio 2.182, P = 0.005; hazard ratio 1.532, P < 0.001; respectively), and partial mucinous adenocarcinoma was not (hazard ratio 1.137, P = 0.431). Conclusions Patients with a component of signet-ring cells, regardless of the extent, had poor prognoses. Patients with mucinous adenocarcinoma containing >50% mucin had poor prognoses as well, whereas those with < 50% mucin had survival rates similar to those of classic adenocarcinoma patients. Therefore, in clinical practice, patients with a component of signet-ring cells, regardless of the extent, should be given significant clinical attention.	[Tan, Yinuo; Li, Xiaofen; Yang, Jiao; Jiang, Mengjie; Yuan, Ying] Zhejiang Univ, Sch Med, Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Jianfei] Jinhua Cent Hosp, Dept Oncol, Jinhua, Peoples R China; [Ding, Kefeng; Li, Jun] Zhejiang Univ, Sch Med, Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Kefeng; Yuan, Ying] China Natl Minist Educ, Key Lab Mol Biol Med Sci, Inst Canc, Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China; [Xu, Jinghong] Zhejiang Univ, Sch Med, Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yuan, Y (corresponding author), Zhejiang Univ, Sch Med, Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	yuanying1999@zju.edu.cn	xu, jing/GRR-8698-2022		National Natural Science Foundation of China [81101580]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B07]; National High Technology Research and Development Program of China (863 Program) [2012AA02A506, 2012AA02A204]; Training Program of the Major Research Plan of the National Natural Science Foundation of China [91229104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Training Program of the Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (81101580), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B07), the National High Technology Research and Development Program of China (863 Program) (2012AA02A506), the National High Technology Research and Development Program of China (863 Program) (2012AA02A204), and the Training Program of the Major Research Plan of the National Natural Science Foundation of China (91229104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2012, J CLIN ONCOL, V30; Bittorf B, 2004, LANGENBECK ARCH SURG, V389, P178, DOI 10.1007/s00423-004-0474-y; Bosman F. T., 2010, WHO CLASSIFICATION O; Catalano V, 2009, J CLIN ONCOL, V27; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Catalano V, 2008, J CLIN ONCOL, V26; Chang DT, 2012, MODERN PATHOL, V25, P1128, DOI 10.1038/modpathol.2012.61; Chen JX, 2012, ASIAN PAC J CANCER P, V13, P3427, DOI 10.7314/APJCP.2012.13.7.3427; Consorti F, 2000, J SURG ONCOL, V73, P70, DOI 10.1002/(SICI)1096-9098(200002)73:2<70::AID-JSO3>3.0.CO;2-J; Du WB, 2004, DIS COLON RECTUM, V47, P78, DOI 10.1007/s10350-003-0014-9; Farhat MH, 2008, WORLD J GASTROENTERO, V14, P6981, DOI 10.3748/wjg.14.6981; Fu JF, 2013, WORLD J GASTROENTERO, V19, P8078, DOI 10.3748/wjg.v19.i44.8078; Fu JF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000135; Gao P, 2013, HISTOPATHOLOGY, V63, P603, DOI 10.1111/his.12190; Gopalan V, 2011, INT J COLORECTAL DIS, V26, P127, DOI 10.1007/s00384-010-1037-z; GREEN JB, 1993, DIS COLON RECTUM, V36, P49, DOI 10.1007/BF02050301; HALVORSEN TB, 1988, J CLIN PATHOL, V41, P1068, DOI 10.1136/jcp.41.10.1068; Hyngstrom JR, 2012, ANN SURG ONCOL, V19, P2814, DOI 10.1245/s10434-012-2321-7; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Kim SH, 2013, ANN SURG ONCOL, V20, P3407, DOI 10.1245/s10434-013-3169-1; Langner C, 2012, HISTOPATHOLOGY, V60, P1060, DOI 10.1111/j.1365-2559.2011.04155.x; Lee WS, 2007, AM J SURG, V194, P294, DOI 10.1016/j.amjsurg.2006.12.041; Maisano R, 2012, J CHEMOTHERAPY, V24, P212, DOI 10.1179/1973947812Y.0000000013; Mekenkamp LJM, 2012, EUR J CANCER, V48, P3128, DOI 10.1016/j.ejca.2012.08.014; Mizushima T, 2010, SURG TODAY, V40, P234, DOI 10.1007/s00595-009-4057-y; Negri FV, 2005, ANN ONCOL, V16, P1305, DOI 10.1093/annonc/mdi244; Nozoe T, 2000, J SURG ONCOL, V75, P103, DOI 10.1002/1096-9098(200010)75:2<103::AID-JSO6>3.3.CO;2-3; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ooi BS, 2001, ANZ J SURG, V71, P703, DOI 10.1046/j.1445-1433.2001.02269.x; Pande R, 2008, DIS COLON RECTUM, V51, P50, DOI 10.1007/s10350-007-9073-7; Papadopoulos V N, 2004, Tech Coloproctol, V8 Suppl 1, ps123, DOI 10.1007/s10151-004-0131-z; Psathakis D, 1999, DIS COLON RECTUM, V42, P1618, DOI 10.1007/BF02236218; Sasaki S, 1998, JPN J CLIN ONCOL, V28, P202, DOI 10.1093/jjco/28.3.202; Song W, 2009, CHINESE MED J-PEKING, V122, P1486, DOI 10.3760/cma.j.issn.0366-6999.2009.13.002; SUMA KS, 1992, J SURG ONCOL, V51, P60, DOI 10.1002/jso.2930510115; Sung CO, 2008, MODERN PATHOL, V21, P1533, DOI 10.1038/modpathol.2008.170; Verhulst J, 2012, J CLIN PATHOL, V65, P381, DOI 10.1136/jclinpath-2011-200340; Yamaguchi T, 2012, HISTOPATHOLOGY, V61, P162, DOI 10.1111/j.1365-2559.2012.04235.x	38	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121944	10.1371/journal.pone.0121944	http://dx.doi.org/10.1371/journal.pone.0121944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789685	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400202
J	Boyer, L; Chouaid, C; Bastuji-Garin, S; Marcos, E; Margarit, L; Le Corvoisier, P; Vervoitte, L; Hamidou, L; Frih, L; Audureau, E; Covali-Noroc, A; Andujar, P; Saakashvili, Z; Lino, A; Ghaleh, B; Hue, S; Derumeaux, G; Housset, B; Dubois-Rande, JL; Boczkowski, J; Maitre, B; Adnot, S				Boyer, Laurent; Chouaid, Christos; Bastuji-Garin, Sylvie; Marcos, Elisabeth; Margarit, Laurent; Le Corvoisier, Philippe; Vervoitte, Laetitia; Hamidou, Leila; Frih, Lamia; Audureau, Etienne; Covali-Noroc, Ala; Andujar, Pascal; Saakashvili, Zakaria; Lino, Anne; Ghaleh, Bijan; Hue, Sophie; Derumeaux, Genevieve; Housset, Bruno; Dubois-Rande, Jean-Luc; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge			Aging-Related Systemic Manifestations in COPD Patients and Cigarette Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL STIFFNESS; CELL SENESCENCE; TELOMERE LENGTH; COMORBIDITIES; INFLAMMATION; LUNG; OSTEOPOROSIS; PROGRESSION	Rationale Chronic obstructive pulmonary disease (COPD) is often associated with age-related systemic abnormalities that adversely affect the prognosis. Whether these manifestations are linked to the lung alterations or are independent complications of smoking remains unclear. Objectives To look for aging-related systemic manifestations and telomere shortening in COPD patients and smokers with minor lung destruction responsible for a decline in the diffusing capacity for carbon monoxide (DLCO) corrected for alveolar volume (KCO). Methods Cross-sectional study in 301 individuals (100 with COPD, 100 smokers without COPD, and 101 nonsmokers without COPD). Measurements and Main Results Compared to control smokers, patients with COPD had higher aortic pulse-wave velocity (PWV), lower bone mineral density (BMD) and appendicular skeletal muscle mass index (ASMMI), and shorter telomere length (TL). Insulin resistance (HOMA-IR) and glomerular filtration rate (GFR) were similar between control smokers and COPD patients. Smokers did not differ from nonsmokers for any of these parameters. However, smokers with normal spirometry but low K-CO had lower ASMMI values compared to those with normal K-CO. Moreover, female smokers with low K-CO, had lower BMD and shorter TL compared to those with normal K-CO. Conclusions Aging-related abnormalities in patients with COPD are also found in smokers with minor lung dysfunction manifesting as a K-CO decrease. Decreased K-CO might be useful, particularly among women, for identifying smokers at high risk for aging-related systemic manifestations and telomere shortening.	[Boyer, Laurent; Margarit, Laurent; Hamidou, Leila; Covali-Noroc, Ala; Lino, Anne; Derumeaux, Genevieve; Adnot, Serge] Hop Henri Mondor, AP HP, DHU ATVB, Dept Physiol Explorat Fonct, F-94010 Creteil, France; [Boyer, Laurent; Chouaid, Christos; Derumeaux, Genevieve; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge] INSERM U955, F-94010 Creteil, France; [Boyer, Laurent; Chouaid, Christos; Derumeaux, Genevieve; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge] Univ Paris Est UPEC, UMR U955, Fac Med, F-94010 Creteil, France; [Chouaid, Christos; Marcos, Elisabeth; Andujar, Pascal; Saakashvili, Zakaria; Housset, Bruno; Maitre, Bernard] Ctr Hosp Intercommunal, DHU ATVB, Dept Pneumol & Pathol Profess, F-94000 Creteil, France; [Bastuji-Garin, Sylvie; Audureau, Etienne] Hop Henri Mondor, AP HP, Dept Sante Publ, F-94010 Creteil, France; [Bastuji-Garin, Sylvie; Audureau, Etienne] Univ Paris Est UPEC, Fac Med, LIC, EA4393, F-94010 Creteil, France; [Le Corvoisier, Philippe; Vervoitte, Laetitia] Hop Henri Mondor, AP HP, INSERM, Ctr Invest Clin 1430, F-94010 Creteil, France; [Frih, Lamia] Hop Henri Mondor, AP HP, Dept Addictol, F-94010 Creteil, France; [Ghaleh, Bijan] Hop Henri Mondor, AP HP, Plateforme Ressources Biol, F-94010 Creteil, France; [Hue, Sophie] Hop Henri Mondor, AP HP, Dept Immunol Biol, F-94010 Creteil, France; [Dubois-Rande, Jean-Luc] Hop Henri Mondor, AP HP, DHU ATVB, Dept Cardiol, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Boyer, L (corresponding author), Hop Henri Mondor, AP HP, DHU ATVB, Dept Physiol Explorat Fonct, F-94010 Creteil, France.	laurent.boyer@hmn.aphp.fr	christos, chouaid/R-4477-2018; le corvoisier, philippe/AAO-2862-2020; Boczkowski, Jorge/S-7474-2018; Audureau, Etienne/AHE-2826-2022; Audureau, Etienne/R-4359-2018; Bastuji-Garin, Sylvie/R-3479-2018; DERUMEAUX, Genevieve A/T-2489-2018; Andujar, Pascal/A-2395-2013	christos, chouaid/0000-0002-4290-5524; Boczkowski, Jorge/0000-0001-6619-5785; Audureau, Etienne/0000-0002-6166-149X; Audureau, Etienne/0000-0002-6166-149X; Bastuji-Garin, Sylvie/0000-0001-9855-5183; DERUMEAUX, Genevieve A/0000-0003-1471-1631; Le Corvoisier, Philippe/0000-0003-0402-9591; Boyer, Laurent/0000-0002-2608-6696; Maitre, Bernard/0000-0002-8061-1252; Ghaleh, Bijan/0000-0003-0061-5462; Andujar, Pascal/0000-0002-9408-7033; HUE, Sophie/0000-0002-2530-7346	Institut National de la Sante et de la Recherche Medicale (INSERM) [C09-11]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This research was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) grant C09-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CAUBERGHS M, 1993, AM REV RESPIR DIS, V147, P379, DOI 10.1164/ajrccm/147.2.379; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hoesein FAAM, 2011, EUR RESPIR J, V38, P1012, DOI 10.1183/09031936.00050711; Kirby M, 2013, THORAX, V68, P752, DOI 10.1136/thoraxjnl-2012-203108; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Van Remoortel H, 2014, AM J RESP CRIT CARE, V189, P30, DOI 10.1164/rccm.201307-1240OC; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121539	10.1371/journal.pone.0121539	http://dx.doi.org/10.1371/journal.pone.0121539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785739	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500212
J	Chen, T; Wang, C; Wu, F; Zhang, XB; Yang, H; Deng, X; He, QC; Li, WF; Li, G				Chen, Tian; Wang, Chen; Wu, Fang; Zhang, Xuebang; Yang, Han; Deng, Xia; He, Qiancheng; Li, Wenfeng; Li, Gang			Altered Localization of p120 Catenin in the Cytoplasm Rather than the Membrane Correlates with Poor Prognosis in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; P120(CTN) EXPRESSION; REDUCED EXPRESSION; BETA-CATENIN; ADHESION; CANCER; P120-CATENIN; SURVIVAL; BINDING; REGION	Background P120 catenin (p120ctn), a regulator of cell adhesion, has previously been found in many malignancies, and suggested a role in invasion, metastasis and survival. The aim of this study was to investigate correlations between altered localization of p120ctn and clinical-pathological characteristics in esophageal squamous cell carcinoma (ESCC). Methods Immunohistochemical staining for p120(ctn) was performed on tissue samples from 118 patients with ESCC. The expression of p120(ctn) was scored for intensity and cellular localization by Image-pro Plus 6.0. Correlations between immunohistochemical staining of p120(ctn) and pathological characteristics and clinical prognosis were determined using SPSS 18.0 software. Results Membrane expression of p120(ctn) in ESCCs was lower than that in adjacentnormal esophageal epithelial tissues (P = 0.041), while overall cellular expression of p120(ctn) was not different between the two tissue types (P = 0.787). Furthermore, neither overall cellular expression nor localized membrane expression was associated with histological and clinical variables. The high ratio of membrane expression to overall cellular expression (M/C) of p120(ctn) was inversely associated with lymph node invasion (P = 0.001), tumor differentiation (P = 0.012) and advanced tumor stage (P = 0.005); however, it was poorly associated with T stage (P = 0.274). The high M/C ratio of p120(ctn) was inversely correlated with poor survival; the 5-year OS (overall survival) and the 5-year DFS (disease free survival) for the high M/C ratio group were significantly higher than those of the low M/C ratio group (41.0% vs. 6.7%, P = 0.000; 44.1% vs. 24.9%, P = 0.007). Both the M/C ratio of p120(ctn) and N status were independent variables for the prediction of overall survival (P = 0.007 and P = 0.027). The M/C of p120(ctn) predicted a 0.49-fold risk of ESCC death (p = 0.007, 95% CI 0.29-0.83). Conclusions The reduced M/C ratio of p120(ctn) acted as an independent prognostic factor for ESCC patient survival and for the migration and invasive behavior of the disease.	[Chen, Tian] Ningbo Med Treatment Ctr Lihuili Hosp, Dept Radiotherapy, Ningbo, Zhejiang, Peoples R China; [Wang, Chen] Taizhou Enze Med Ctr Luqiao Hosp, Dept Gastroenterol, Taizhou, Zhejiang, Peoples R China; [Wu, Fang] Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xuebang; Yang, Han; Deng, Xia; Li, Wenfeng; Li, Gang] Wenzhou Med Univ, Dept Chemoradiat Oncol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [He, Qiancheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, F (corresponding author), Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	wufangfyy@163.com; zhangxuebangfyy@163.com; leewf2012@163.com; andrewlee0923@163.com			Wenzhou Bureau of Science and Technology [Y20140366, Y20140281, Y20140354]	Wenzhou Bureau of Science and Technology	This work was supported by the Medicine and Health Grant from Wenzhou Bureau of Science and Technology (Y20140366, Y20140281, Y20140354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; Grosheva I, 2001, J CELL SCI, V114, P695; Ishizaki Y, 2004, J DERMATOL SCI, V34, P99, DOI 10.1016/j.jdermsci.2003.12.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Lo Muzio L, 2002, ORAL ONCOL, V38, P64, DOI 10.1016/S1368-8375(01)00027-6; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; Neto BS, 2008, BJU INT, V101, P746, DOI 10.1111/j.1464-410X.2007.07264.x; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Sato F, 2001, BRIT J SURG, V88, P426, DOI 10.1046/j.1365-2168.2001.01687.x; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Tachibana M, 2004, AM J SURG, V188, P254, DOI 10.1016/j.amjsurg.2004.06.004; Talvinen K, 2010, J CANCER RES CLIN, V136, P1377, DOI 10.1007/s00432-010-0789-8; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Xiao ZF, 2005, INT J RADIAT ONCOL, V62, P82, DOI 10.1016/j.ijrobp.2004.08.046; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhai B, 2008, WORLD J GASTROENTERO, V14, P3739, DOI 10.3748/wjg.14.3739	38	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118645	10.1371/journal.pone.0118645	http://dx.doi.org/10.1371/journal.pone.0118645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785604	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500042
J	Gentile, MT; Ciniglia, C; Reccia, MG; Volpicelli, F; Gatti, M; Thellung, S; Florio, T; Melone, MAB; Colucci-D'Amato, L				Gentile, Maria Teresa; Ciniglia, Claudia; Reccia, Mafalda G.; Volpicelli, Floriana; Gatti, Monica; Thellung, Stefano; Florio, Tullio; Melone, Mariarosa A. B.; Colucci-D'Amato, Luca			Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation	PLOS ONE			English	Article							ESTROGEN-BINDING-SITES; IN-VITRO; NATURAL-PRODUCTS; TERMINAL DIFFERENTIATION; SOMATOSTATIN INHIBITION; DRUG DISCOVERY; RET ONCOGENE; GLIOMA-CELLS; EXPRESSION; PROLIFERATION	Glioblastoma multiforme is a highly aggressive brain tumor whose prognosis is very poor. Due to early invasion of brain parenchyma, its complete surgical removal is nearly impossible, and even after aggressive combined treatment (association of surgery and chemo-and radio-therapy) five-year survival is only about 10%. Natural products are sources of novel compounds endowed with therapeutic properties in many human diseases, including cancer. Here, we report that the water extract of Ruta graveolens L., commonly known as rue, induces death in different glioblastoma cell lines (U87MG, C6 and U138) widely used to test novel drugs in preclinical studies. Ruta graveolens' effect was mediated by ERK1/2 and AKT activation, and the inhibition of these pathways, via PD98058 and wortmannin, reverted its antiproliferative activity. Rue extract also affects survival of neural precursor cells (A1) obtained from embryonic mouse CNS. As in the case of glioma cells, rue stimulates the activation of ERK1/2 and AKT in A1 cells, whereas their blockade by pharmacological inhibitors prevents cell death. Interestingly, upon induction of differentiation and cell cycle exit, A1 cells become resistant to rue's noxious effects but not to those of temozolomide and cisplatin, two alkylating agents widely used in glioblastoma therapy. Finally, rutin, a major component of the Ruta graveolens water extract, failed to cause cell death, suggesting that rutin by itself is not responsible for the observed effects. In conclusion, we report that rue extracts induce glioma cell death, discriminating between proliferating/undifferentiated and non-proliferating/differentiated neurons. Thus, it can be a promising tool to isolate novel drugs and also to discover targets for therapeutic intervention.	[Gentile, Maria Teresa; Ciniglia, Claudia; Reccia, Mafalda G.; Colucci-D'Amato, Luca] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Lab Mol & Cellular Pathol, Caserta, Italy; [Volpicelli, Floriana] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Volpicelli, Floriana] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; [Gatti, Monica; Thellung, Stefano; Florio, Tullio] Univ Genoa, Dept Internal Med, Pharmacol Sect, I-16126 Genoa, Italy; [Gatti, Monica; Thellung, Stefano; Florio, Tullio] Univ Genoa, CEBR, Genoa, Italy; [Melone, Mariarosa A. B.] Univ Naples 2, Dept Clin & Expt Med & Surg, Div Neurol, Naples, Italy; [Melone, Mariarosa A. B.; Colucci-D'Amato, Luca] Univ Naples 2, CIRN, Naples, Italy	Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Genoa; University of Genoa; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Colucci-D'Amato, L (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Lab Mol & Cellular Pathol, Caserta, Italy.	luca.colucci@unina2.it	terracciano, chiara/C-2955-2018; Melone, Mariarosa Anna Beatrice/N-6788-2015; Thellung, Stefano/L-8802-2015; FLORIO, TULLIO/ABG-3182-2020; Florio, Tullio/A-2211-2012; CINIGLIA, CLAUDIA/D-7053-2017	terracciano, chiara/0000-0002-1853-5578; Melone, Mariarosa Anna Beatrice/0000-0002-7213-9277; Thellung, Stefano/0000-0002-2010-331X; Florio, Tullio/0000-0002-2394-996X; GENTILE, Maria Teresa/0000-0003-4239-5330; Reccia, Mafalda Giovanna/0000-0002-5568-0221; CINIGLIA, CLAUDIA/0000-0001-5819-6921; Monica, Gatti/0000-0002-2016-0285; Volpicelli, Floriana/0000-0003-0618-5504	Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA"; Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET"; Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) [20109MXHMR_004]	Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA"; Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET"; Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA" (POR FSE 2007-2013), Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET" (PSR 2007/2013, to CC), and Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN, 20109MXHMR_004, to MABM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0; Auf G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-597; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; BASTIDA E, 1984, BLOOD, V64, P177; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Brower V, 2008, J NATL CANCER I, V100, P838, DOI 10.1093/jnci/djn199; Brzezianska E, 2011, FRONT BIOSCI-LANDMRK, V16, P422, DOI 10.2741/3696; Burrell K, 2014, CANCER RES, V74, P3727, DOI 10.1158/0008-5472.CAN-13-3119; Califano D, 2000, J BIOL CHEM, V275, P19297, DOI 10.1074/jbc.M905866199; Califano D, 1996, P NATL ACAD SCI USA, V93, P7933, DOI 10.1073/pnas.93.15.7933; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen CC, 2001, J NAT PROD, V64, P990, DOI 10.1021/np000582y; Cheng Yen-Po, 2014, Surg Neurol Int, V5, P78, DOI 10.4103/2152-7806.133205; Clara CA, 2014, NEUROPATHOLOGY, V34, P343, DOI 10.1111/neup.12111; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; Colucci-D'Amato GL, 1999, EXP CELL RES, V252, P383, DOI 10.1006/excr.1999.4636; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; CONWAY GA, 1979, J ETHNOPHARMACOL, V1, P241, DOI 10.1016/S0378-8741(79)80014-8; Deschenes-Simard X, 2014, CANCER RES, V74, P412, DOI 10.1158/0008-5472.CAN-13-2381; Fadlalla K, 2011, ANTICANCER RES, V31, P233; Florio T, 1999, MOL ENDOCRINOL, V13, P24, DOI 10.1210/me.13.1.24; Florio T, 2012, DRUG DISCOV TODAY, V17, P1103, DOI 10.1016/j.drudis.2012.06.001; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gentile MT, 2012, J NEUROCHEM, V123, P963, DOI 10.1111/jnc.12004; Gong X, 2011, NEUROLOGY, V76, P1126, DOI 10.1212/WNL.0b013e318212a89f; Gronych J, 2014, CELL, V157, P525, DOI 10.1016/j.cell.2014.04.001; Gutierrez-Pajares JL, 2003, REPROD TOXICOL, V17, P667, DOI 10.1016/j.reprotox.2003.07.002; Haghighitalab A, 2014, Z NATURFORSCH C, V69, P99, DOI 10.5560/ZNC.2013-0006; Hilario A, 2014, AM J NEURORADIOL, V35, P1096, DOI 10.3174/ajnr.A3837; Holand K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094132; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ilkanizadeh S, 2014, ADV CANCER RES, V121, P1, DOI 10.1016/B978-0-12-800249-0.00001-9; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kamson DO, 2014, NEURO-ONCOLOGY, V16, P1373, DOI 10.1093/neuonc/nou042; Kuzovkina I, 2004, PHYTOCHEMISTRY, V65, P1095, DOI 10.1016/j.phytochem.2004.03.003; Lee JS, 2014, NEURO-ONCOLOGY, V16, P191, DOI 10.1093/neuonc/not167; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li L, 2015, ONCOGENE, V34, P129, DOI 10.1038/onc.2013.534; Li L, 2014, INT J BIOCHEM CELL B, V53, P224, DOI 10.1016/j.biocel.2014.05.021; Luo F, 2014, MOL BIOSYST, V10, P1912, DOI 10.1039/c4mb00105b; Mace TA, 2014, CANCER IMMUNOL IMMUN, V63, P889, DOI 10.1007/s00262-014-1564-5; MARKAVERICH BM, 1984, CANCER RES, V44, P1515; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; McNamara Mairead G, 2013, Cancers (Basel), V5, P1103, DOI 10.3390/cancers5031103; Mielcke TR, 2012, EUR J MED CHEM, V48, P255, DOI 10.1016/j.ejmech.2011.12.023; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Oszvald A, 2012, J NEURO-ONCOL, V109, P341, DOI 10.1007/s11060-012-0898-0; Pathak S, 2003, INT J ONCOL, V23, P975; Pollio A, 2008, J ETHNOPHARMACOL, V116, P469, DOI 10.1016/j.jep.2007.12.013; Porcile C, 2014, J CELL PHYSIOL, V229, P1444, DOI 10.1002/jcp.24582; Preethi KC, 2008, ASIAN PAC J CANCER P, V9, P763; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; RANELLETTI FO, 1992, INT J CANCER, V50, P486, DOI 10.1002/ijc.2910500326; Ratheesh M, 2013, INFLAMM RES, V62, P367, DOI 10.1007/s00011-013-0588-1; Ratheesh M, 2011, EXP TOXICOL PATHOL, V63, P285, DOI 10.1016/j.etp.2010.01.007; REHEMTULLA A, 1988, BIOCHEM CELL BIOL, V66, P1270, DOI 10.1139/o88-147; Reme T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066574; Rethy B, 2007, PLANTA MED, V73, P41, DOI 10.1055/s-2006-951747; Rizzo C, 1996, J BIOL CHEM, V271, P29497, DOI 10.1074/jbc.271.46.29497; Ruggiero A, 2013, J NEURO-ONCOL, V113, P513, DOI 10.1007/s11060-013-1145-z; Sallam AA, 2014, ORG BIOMOL CHEM, V12, P5295, DOI 10.1039/c4ob00553h; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Shi ZZ, 2010, MOL CANCER RES, V8, P615, DOI 10.1158/1541-7786.MCR-09-0264; Shibahara I, 2015, NEURO-ONCOLOGY, V17, P136, DOI 10.1093/neuonc/nou112; Skropeta D, 2014, NAT PROD REP, V31, P999, DOI 10.1039/c3np70118b; Spencer D, 2011, NEUROLOGY, V76, pE69, DOI 10.1212/WNL.0b013e318215b914; Sun YY, 2014, P NATL ACAD SCI USA, V111, P3538, DOI 10.1073/pnas.1313814111; Tamura K, 2014, J NEUROSURG, V120, P1010; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Velazquez KT, 2014, J NUTR, V144, P868, DOI 10.3945/jn.113.188367; Vredenburgh JJ, 2009, NEURO-ONCOLOGY, V11, P80, DOI 10.1215/15228517-2008-075; Wang CY, 2014, AM J CHINESE MED, V42, P543, DOI 10.1142/S0192415X14500359; Xie J, 2014, ONCOL LETT, V7, P131, DOI 10.3892/ol.2013.1685; Ye Q, 2014, ONCOGENE, V33, P1828, DOI 10.1038/onc.2013.122; Yi L, 2014, NEUROMOL MED, V16, P578, DOI 10.1007/s12017-014-8310-1; Youland RS, 2013, NEURO-ONCOLOGY, V15, P1102, DOI 10.1093/neuonc/not080; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhuang WZ, 2012, CANCER SCI, V103, P684, DOI 10.1111/j.1349-7006.2011.02198.x; Zustovich F, 2009, ANTICANCER RES, V29, P4275	82	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118864	10.1371/journal.pone.0118864	http://dx.doi.org/10.1371/journal.pone.0118864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785932	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500053
J	Hsu, YHH; Huang, ZY; Ferl, GZ; Ng, CM				Hsu, Yu-Han H.; Huang, Ziyin; Ferl, Gregory Z.; Ng, Chee M.			GPU-Accelerated Compartmental Modeling Analysis of DCE-MRI Data from Glioblastoma Patients Treated with Bevacizumab	PLOS ONE			English	Article							NONPARAMETRIC KINETIC-ANALYSIS; ANTIVASCULAR THERAPIES; CLINICAL-TRIALS; TUMORS	The compartment model analysis using medical imaging data is the well-established but extremely time consuming technique for quantifying the changes in microvascular physiology of targeted organs in clinical patients after antivascular therapies. In this paper, we present a first graphics processing unit-accelerated method for compartmental modeling of medical imaging data. Using this approach, we performed the analysis of dynamic contrast-enhanced magnetic resonance imaging data from bevacizumab-treated glioblastoma patients in less than one minute per slice without losing accuracy. This approach reduced the computation time by more than 120-fold comparing to a central processing unit-based method that performed the analogous analysis steps in serial and more than 17-fold comparing to the algorithm that optimized for central processing unit computation. The method developed in this study could be of significant utility in reducing the computational times required to assess tumor physiology from dynamic contrast-enhanced magnetic resonance imaging data in preclinical and clinical development of antivascular therapies and related fields.	[Hsu, Yu-Han H.; Huang, Ziyin; Ng, Chee M.] Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Ferl, Gregory Z.] Genentech Inc, Early Dev Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Ng, Chee M.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Ng, Chee M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Roche Holding; Genentech; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Ng, CM (corresponding author), Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA.	ngc1@email.chop.edu	Huang, Ziyin/L-2807-2013	Huang, Ziyin/0000-0002-7685-4278; Ferl, Gregory/0000-0002-9943-1569				BENET LZ, 1972, J PHARM SCI, V61, P536, DOI 10.1002/jps.2600610408; Bergamino M, 2014, PHYS MEDICA, V30, P635, DOI 10.1016/j.ejmp.2014.04.005; Eklund A, 2013, MED IMAGE ANAL, V17, P1073, DOI 10.1016/j.media.2013.05.008; Ferl GZ, 2012, CLIN PHARMACOL THER, V92, P118, DOI 10.1038/clpt.2012.63; Ferl GZ, 2011, J STAT SOFTW, V44, P1; Ferl GZ, 2010, MAGN RESON MED, V63, P1366, DOI 10.1002/mrm.22335; Hsu YHH, 2013, MAGN RESON IMAGING, V31, P618, DOI 10.1016/j.mri.2012.09.007; Huang S, 2009, IPDPS RSQUO 09 P 200; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; List, 2014, TOP 500 SUP SIT; McClanahan C, 2012, GPU TECHN C; NAKASHIMA E, 1989, J PHARMACOKINET BIOP, V17, P673, DOI 10.1007/BF01062124; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Oldenhuis R, 2009, MINIMIZE FILE ID 242; Port RE, 1999, JMRI-J MAGN RESON IM, V10, P233; Port RE, 2010, MAGN RESON MED, V64, P408, DOI 10.1002/mrm.22399; Pratx G, 2011, MED PHYS, V38, P2685, DOI 10.1118/1.3578605; Rowland M, 1995, CLIN PHARMACOKINETIC; Sanders J., 2011, CUDA EXAMPLE INTRO G; Shams R, 2010, IEEE SIGNAL PROC MAG, V27, P50, DOI 10.1109/MSP.2009.935387; Shi L, 2012, QUANT IMAGING MED SU, V2, P63, DOI [10.3978/j.issn.2223-4292.2012.01.05, 10.3978/j.issn.2223-4292.2012.08.02]; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang Chun-Hao, 2014, World J Methodol, V4, P46, DOI 10.5662/wjm.v4.i2.46; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Zweifel M, 2010, EUR J NUCL MED MOL I, V37, pS164, DOI 10.1007/s00259-010-1451-z	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118421	10.1371/journal.pone.0118421	http://dx.doi.org/10.1371/journal.pone.0118421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786263	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500032
J	Jacob, MM; Pangeni, G; Gomes, BD; Souza, GS; da Silva, M; Silveira, LCL; Maguire, J; Parry, NRA; McKeefry, DJ; Kremers, J				Jacob, Mellina M.; Pangeni, Gobinda; Gomes, Bruno D.; Souza, Givago S.; da Silva Filho, Manoel; Silveira, Luiz Carlos L.; Maguire, John; Parry, Neil R. A.; McKeefry, Declan J.; Kremers, Jan			The Spatial Properties of L- and M-Cone Inputs to Electroretinograms That Reflect Different Types of Post-Receptoral Processing	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; GANGLION-CELLS; FLICKER ERGS; TOPOGRAPHY; RESPONSES; SIGNALS; RETINA; SQUARE; SINE	We studied the spatial arrangement of L- and M-cone driven electroretinograms (ERGs) reflecting the activity of magno- and parvocellular pathways. L- and M-cone isolating sine wave stimuli were created with a four primary LED stimulator using triple silent substitution paradigms. Temporal frequencies were 8 and 12 Hz, to reflect cone opponent activity, and 30, 36 and 48 Hz to reflect luminance activity. The responses were measured for full-field stimuli and for different circular and annular stimuli. The ERG data confirm the presence of two different mechanisms at intermediate and high temporal frequencies. The responses measured at high temporal frequencies strongly depended upon spatial stimulus configuration. In the full-field conditions, the L-cone driven responses were substantially larger than the full-field M-cone driven responses and also than the L-cone driven responses with smaller stimuli. The M-cone driven responses at full-field and with 70 degrees diameter stimuli displayed similar amplitudes. The L-and M-cone driven responses measured at 8 and 12 Hz were of similar amplitude and approximately in counter-phase. The amplitudes were constant for most stimulus configurations. The results indicate that, when the ERG reflects luminance activity, it is positively correlated with stimulus size. Beyond 35 degrees retinal eccentricity, the retina mainly contains L-cones. Small stimuli are sufficient to obtain maximal ERGs at low temporal frequencies where the ERGs are also sensitive to cone-opponent processing.	[Jacob, Mellina M.; Pangeni, Gobinda; Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Jacob, Mellina M.; Gomes, Bruno D.; Souza, Givago S.; da Silva Filho, Manoel; Silveira, Luiz Carlos L.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Souza, Givago S.; Silveira, Luiz Carlos L.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Parry, Neil R. A.] Univ Manchester, Inst Human Dev, Ctr Hearing & Vis Res, Manchester M13 9PL, Lancs, England; [Maguire, John; Parry, Neil R. A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Vis Sci Ctr, Manchester, Lancs, England; [Maguire, John; Parry, Neil R. A.; McKeefry, Declan J.; Kremers, Jan] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Erlangen Nuremberg; Universidade Federal do Para; Universidade Federal do Para; University of Manchester; Manchester Royal Eye Hospital; University of Manchester; University of Bradford	Kremers, J (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	jan.kremers@uk-erlangen.de	Jacob, Mellina M/D-8507-2016; Souza, Givago/W-6393-2019; Gomes, Bruno Duarte/I-4499-2013; Kremers, Jan/X-3125-2019	Souza, Givago/0000-0002-4525-3971; Kremers, Jan/0000-0002-9293-7380; Monteiro Jacob, Mellina/0000-0002-0268-0332	DFG [KR1317/13-1]; CNPq; Hertie Foundation; CNPq [486545/2012-1]	DFG(German Research Foundation (DFG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Hertie Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the DFG grant KR1317/13-1 to JK. MMJ was supported by a CNPq "Science without Borders" fellowship. MSF and LCLS are CNPq research fellows. JK was supported by the Hertie Foundation. NRAP's and JM's participations were facilitated by the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network. GSS was supported by CNPq grant #486545/2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Challa NK, 2010, OPHTHAL PHYSL OPT, V30, P503, DOI 10.1111/j.1475-1313.2010.00758.x; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; ESTEVEZ O, 1974, VISION RES, V14, P823, DOI 10.1016/0042-6989(74)90147-3; Hagstrom SA, 1997, DOC OPHTH P, V59, P59; Hagstrom SA, 1998, NEUROREPORT, V9, P1963, DOI 10.1097/00001756-199806220-00009; Hagstrom SA, 2000, J OPT SOC AM A, V17, P527, DOI 10.1364/JOSAA.17.000527; Harwerth RS, 2002, PROG RETIN EYE RES, V21, P91, DOI 10.1016/S1350-9462(01)00022-2; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Jacobs GH, 1996, VISION RES, V36, P2587, DOI 10.1016/0042-6989(95)00335-5; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; Jacobs GH, 1993, COLOUR VISION DEFICI, VXI, P107; Kommanapalli D, 2014, J OPT SOC AM A, V31, pA113, DOI 10.1364/JOSAA.31.00A113; Kondo M, 2002, INVEST OPHTH VIS SCI, V43, P2500; Kremers J, 2003, J VISION, V3, P146, DOI 10.1167/3.2.3; Kremers J, 2003, PROG RETIN EYE RES, V22, P579, DOI 10.1016/S1350-9462(03)00049-1; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Kremers J, 2014, J OPT SOC AM A, V31, pA170, DOI 10.1364/JOSAA.31.00A170; Kremers J, 2012, J OPT SOC AM A, V29, pA306, DOI 10.1364/JOSAA.29.00A306; Kremers J, 2008, J VISION, V8, DOI 10.1167/8.15.11; Kremers J, 2010, INVEST OPHTH VIS SCI, V51, P577, DOI 10.1167/iovs.09-3899; Kuchenbecker JA, 2008, VISUAL NEUROSCI, V25, P301, DOI 10.1017/S0952523808080474; Maguire J., 2012, THESIS U MANCHESTER; McKeefry D, 2014, J OPT SOC AM A, V31, pA159, DOI 10.1364/JOSAA.31.00A159; Murray IJ, 2008, VISUAL NEUROSCI, V25, P327, DOI 10.1017/S095252380808036X; Murray IJ, 2004, VISUAL NEUROSCI, V21, P231, DOI 10.1017/S0952523804213268; NEITZ J, 1984, J OPT SOC AM A, V1, P1175, DOI 10.1364/JOSAA.1.001175; ODOM JV, 1992, OPTOMETRY VISION SCI, V69, P106, DOI 10.1097/00006324-199202000-00003; Pangeni G, 2010, VISUAL NEUROSCI, V27, P79, DOI 10.1017/S0952523810000179; Parry NRA, 2012, J PHYSIOL-LONDON, V590, P3141, DOI 10.1113/jphysiol.2011.226951; Shapiro AG, 1996, J OPT SOC AM A, V13, P2319, DOI 10.1364/JOSAA.13.002319; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; Solomon SG, 2002, VISION RES, V42, P2893, DOI 10.1016/S0042-6989(02)00414-5	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121218	10.1371/journal.pone.0121218	http://dx.doi.org/10.1371/journal.pone.0121218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785459	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500202
J	Kono, H; Shirayama, K; Arimura, Y; Tachiwana, H; Kurumizaka, H				Kono, Hidetoshi; Shirayama, Kazuyoshi; Arimura, Yasuhiro; Tachiwana, Hiroaki; Kurumizaka, Hitoshi			Two Arginine Residues Suppress the Flexibility of Nucleosomal DNA in the Canonical Nucleosome Core	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CENP-A; CENTROMERIC NUCLEOSOME; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HISTONE VARIANT; PARTICLE; PARAMETERS; SOFTWARE; H3	The dynamics of nucleosomes containing either canonical H3 or its centromere-specific variant CENP-A were investigated using molecular dynamics simulations. The simulations showed that the histone cores were structurally stable during simulation periods of 100 ns and 50 ns, while DNA was highly flexible at the entry and exit regions and partially dissociated from the histone core. In particular, approximately 20-25 bp of DNA at the entry and exit regions of the CENP-A nucleosome exhibited larger fluctuations than DNA at the entry and exit regions of the H3 nucleosome. Our detailed analysis clarified that this difference in dynamics was attributable to a difference in two basic amino acids in the aN helix; two arginine (Arg) residues in H3 were substituted by lysine (Lys) residues at the corresponding sites in CENP-A. The difference in the ability to form hydrogen bonds with DNA of these two residues regulated the flexibility of nucleosomal DNA at the entry and exit regions. Our exonuclease III assay consistently revealed that replacement of these two Arg residues in the H3 nucleosome by Lys enhanced endonuclease susceptibility, suggesting that the DNA ends of the CENP-A nucleosome are more flexible than those of the H3 nucleosome. This difference in the dynamics between the two types of nucleosomes may be important for forming higher order structures in different phases.	[Kono, Hidetoshi] Japan Atom Energy Agcy, Mol Modeling & Simulat, Kyoto 6190215, Japan; [Shirayama, Kazuyoshi; Arimura, Yasuhiro; Tachiwana, Hiroaki; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan	Japan Atomic Energy Agency; Waseda University	Kono, H (corresponding author), Japan Atom Energy Agcy, Mol Modeling & Simulat, 8-1-7 Kizugawa, Kyoto 6190215, Japan.	kono.hidetoshi@jaea.go.jp	Tachiwana, Hiroaki/AHB-3091-2022; Arimura, Yauhiro/GQH-5158-2022	Tachiwana, Hiroaki/0000-0001-9227-7653; arimura, yasuhiro/0000-0002-1903-6076; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kono, Hidetoshi/0000-0001-5729-8707	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23114723, 25116003]; MEXT [25116003]; Grants-in-Aid for Scientific Research [13J03931] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [Nos. 23114723 and 25116003 to H.K]. Funding for open access charge: MEXT, No. 25116003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop TC, 2005, J BIOMOL STRUCT DYN, V22, P673, DOI 10.1080/07391102.2005.10507034; Biswas M, 2013, WIRES COMPUT MOL SCI, V3, P378, DOI 10.1002/wcms.1139; Biswas M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002279; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408; Dunleavy EM, 2013, NAT STRUCT MOL BIOL, V20, P648, DOI 10.1038/nsmb.2602; Ettig R, 2011, BIOPHYS J, V101, P1999, DOI 10.1016/j.bpj.2011.07.057; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Korolev N, 2014, BIOPOLYMERS, V101, P1051, DOI 10.1002/bip.22499; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Materese CK, 2009, J AM CHEM SOC, V131, P15005, DOI 10.1021/ja905376q; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Panchenko T, 2011, P NATL ACAD SCI USA, V108, P16588, DOI 10.1073/pnas.1113621108; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Ponomarev SY, 2009, PHYS CHEM CHEM PHYS, V11, P10633, DOI 10.1039/b910937b; QUERALT R, 1995, J MOL EVOL, V40, P601, DOI 10.1007/BF00160507; Roccatano D, 2007, BIOPOLYMERS, V85, P407, DOI 10.1002/bip.20690; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ruscio JZ, 2006, BIOPHYS J, V91, P4121, DOI 10.1529/biophysj.106.082099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Voltz K, 2012, BIOPHYS J, V102, P849, DOI 10.1016/j.bpj.2011.11.4028	36	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120635	10.1371/journal.pone.0120635	http://dx.doi.org/10.1371/journal.pone.0120635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786215	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500184
J	Nair, S; Schensul, JJ; Begum, S; Pednekar, MS; Oncken, C; Bilgi, SM; Pasi, AR; Donta, B				Nair, Saritha; Schensul, Jean J.; Begum, Shahina; Pednekar, Mangesh S.; Oncken, Cheryl; Bilgi, Sameena M.; Pasi, Achhelal R.; Donta, Balaiah			Use of Smokeless Tobacco by Indian Women Aged 18-40 Years during Pregnancy and Reproductive Years	PLOS ONE			English	Article							NICOTINE DEPENDENCE; ORAL-CANCER; PAN-MASALA; BETEL QUID; PRODUCTS; HEALTH; PREVALENCE; ABSORPTION; PATTERNS; MUMBAI	Objectives This paper discusses patterns of daily smokeless tobacco (SLT) use and correlates of poly SLT use among married women aged 18-40 years in a Mumbai slum community with implications for tobacco control. Methods Using a mixed methods approach, the study included a structured survey with 409 daily SLT users and in-depth interviews with 42 women. Participants for the survey were selected using a systematic sampling procedure (one woman in every fourth eligible household). Univariate and bivariate analysis, and multiple logistic regressions were conducted to identify demographic and social factors associated with women's use of poly SLT products. To illustrate survey results, in-depth interviews were analyzed using Atlas ti software. Results Sixty-four percent of the women surveyed used only one type of SLT; of these, 30% used mishri, 32% used pan with tobacco and the rest used chewed tobacco (11%), gul (17%) or gutkha (10%). Thirty-six percent used more than one type of SLT. Poly SLT users chewed or rubbed 50% more tobacco as compared to single users (mean consumption of tobacco per day: 9.54 vs. 6.49 grams; p<0.001). Women were more likely to be poly SLT users if they were illiterate as compared to literate (adjusted odds ratio [AOR]= 1.67; 95% confidence interval [CI]= 1.07-2.71), if they had lived in Mumbai for 10 years or more, versus less than ten years (AOR= 1.67, 95% CI= 1.03-2.71); and if their husband was a poly SLT user as compared to a non SLT user (AOR= 2.78, 95% CI= 1.63-4.76). No differences were noted between pregnant and non-pregnant women in SLT consumption patterns. Conclusions Tobacco control policies and programs must focus specifically on both social context and use patterns to address SLT use among women of reproductive age with special attention to poly SLT users, an understudied and vulnerable population.	Natl Inst Med Stat, New Delhi, India; [Schensul, Jean J.] Inst Community Res, Hartford, CT USA; [Begum, Shahina; Bilgi, Sameena M.; Pasi, Achhelal R.; Donta, Balaiah] Natl Inst Res Reprod Hlth, Mumbai, Maharashtra, India; [Pednekar, Mangesh S.] Healis Sekhsaria Inst Publ Hlth, Mumbai, Maharashtra, India; [Oncken, Cheryl] Univ Connecticut, Mansfield, CT USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); University of Connecticut		nairs@icmr.org.in		Nair, Saritha/0000-0002-4560-6124; Pednekar, Mangesh/0000-0001-6266-5356; Begum, Shahina/0000-0001-5590-2210	National Institutes of Health, USA [1R03TW008350-01]; Fogarty Center/National Cancer Institutes; FOGARTY INTERNATIONAL CENTER [R03TW008350] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty Center/National Cancer Institutes; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	1. Grant Number 1R03TW008350-01 entitled: Smokeless Tobacco Use and Reproductive Health among Married Women in a Low-income area of Mumbai, India, National Institutes of Health, USA, Fogarty Center/National Cancer Institutes Drs J. Schensul and S Nair. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; Benowitz N L, 1997, Adv Dent Res, V11, P336; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; Bhisey RA, 2012, INDIAN J CANCER, V49, P364, DOI 10.4103/0019-509X.107735; Bloch M, 2014, LANCET GLOB HEALTH, V2, pE489, DOI 10.1016/S2214-109X(14)70294-3; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Deshmukh J S, 1998, Indian Pediatr, V35, P33; DiFranza JR, 2012, PSYCHOPHARMACOLOGY, V219, P815, DOI 10.1007/s00213-011-2411-4; Digard H, 2013, NICOTINE TOB RES, V15, P255, DOI 10.1093/ntr/nts123; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Government of India, 2013, PRESS NOT POV EST 20; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2012, INDIAN J CANCER, V49, P393, DOI 10.4103/0019-509X.107746; Gupta PC, 2006, EPIDEMIOLOGY, V17, P47, DOI 10.1097/01.ede.0000190545.19168.c4; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Gupta Prakash C, 2011, Indian J Public Health, V55, P199, DOI 10.4103/0019-557X.89948; Hussain HY, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-14; Indian Institute of Population Sciences (IIPS), 2010, GLOB AD TOB SURV IND; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Jacob BJ, 2004, ORAL ONCOL, V40, P697, DOI 10.1016/j.oraloncology.2004.01.005; John RM, 2005, HEALTH POLICY, V71, P213, DOI 10.1016/j.healthpol.2004.08.008; Kostick KM, 2010, CULT MED PSYCHIAT, V34, P529, DOI 10.1007/s11013-010-9185-8; KRISHNA K, 1978, BRIT J OBSTET GYNAEC, V85, P726, DOI 10.1111/j.1471-0528.1978.tb15591.x; McNeill A, 2006, TOB CONTROL, V15, P64, DOI 10.1136/tc.2005.013011; Mehrotra P, 2014, INT J SEXUAL HLTH; Muhr T, 2010, ATLAS TI SCI SOFTWAR; Mukherjea A, 2012, TOB CONTROL, V21, P422, DOI 10.1136/tc.2010.042309; Nair S, 2012, INDIAN J CANCER, V49, P443, DOI 10.4103/0019-509X.107754; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; Narain Jai P, 2011, Indian J Public Health, V55, P151, DOI 10.4103/0019-557X.89940; Nemeth JM, 2012, J COMMUN HEALTH, V37, P1208, DOI 10.1007/s10900-012-9556-x; Nichter M, 2004, SOC SCI MED, V59, P415, DOI 10.1016/j.socscimed.2003.10.032; Norberg M, 2011, GLOB HLTH ACTION, P4; Patten CA, 2008, MATERN CHILD HLTH J, V12, pS30, DOI 10.1007/s10995-008-0331-7; Prasad J, 2003, NATL MED J INDIA, V16, P303; Pratinidhi Asha, 2010, Indian J Community Med, V35, P14, DOI 10.4103/0970-0218.62547; Radhika AG, 2014, OPEN J OBSTET GYNECO, V4, P371, DOI [10.4236/ojog.2014.47055, DOI 10.4236/OJOG.2014.47055]; Rastogi T, 2008, INT J EPIDEMIOL, V37, P147, DOI 10.1093/ije/dym219; Ravishankar T L, 2009, Indian J Dent Res, V20, P346, DOI 10.4103/0970-9290.57382; Reddy K, 2010, IMPLEMENTATION FRAME; Reddy KS, 2004, REPORT TOBACCO CONTR; Sankaranarayanan R, 2006, J MED SCREEN, V13, pS35; Schensul JJ, 2013, TOB CONTROL, V22, P324, DOI 10.1136/tobaccocontrol-2011-050148; Schensul JJ, 2005, ADDICT BEHAV, V30, P571, DOI 10.1016/j.addbeh.2004.05.022; Singh V, 2006, J ASSOC PHYSICIAN I, V54, P609; Thankappan KR, 2007, INDIAN J MED RES, V126, P300; Verma R C, 1983, Indian Pediatr, V20, P105; World Health Organization, 2013, WHO REC PREV MAN TOB	53	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119814	10.1371/journal.pone.0119814	http://dx.doi.org/10.1371/journal.pone.0119814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786247	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500129
J	Pardo, MA; Gerrodette, T; Beier, E; Gendron, D; Forney, KA; Chivers, SJ; Barlow, J; Palacios, DM				Pardo, Mario A.; Gerrodette, Tim; Beier, Emilio; Gendron, Diane; Forney, Karin A.; Chivers, Susan J.; Barlow, Jay; Palacios, Daniel M.			Inferring Cetacean Population Densities from the Absolute Dynamic Topography of the Ocean in a Hierarchical Bayesian Framework	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; SARDINE SARDINOPS-SAGAX; STATE-SPACE MODEL; NORTH PACIFIC; BLUE WHALE; DOLPHIN HABITATS; INTERANNUAL VARIABILITY; BALAENOPTERA-MUSCULUS; SPAWNING HABITAT; ENSO VARIABILITY	We inferred the population densities of blue whales (Balaenoptera musculus) and short-beaked common dolphins (Delphinus delphis) in the Northeast Pacific Ocean as functions of the water-column's physical structure by implementing hierarchical models in a Bayesian framework. This approach allowed us to propagate the uncertainty of the field observations into the inference of species-habitat relationships and to generate spatially explicit population density predictions with reduced effects of sampling heterogeneity. Our hypothesis was that the large-scale spatial distributions of these two cetacean species respond primarily to ecological processes resulting from shoaling and outcropping of the pycnocline in regions of wind-forced upwelling and eddy-like circulation. Physically, these processes affect the thermodynamic balance of the water column, decreasing its volume and thus the height of the absolute dynamic topography (ADT). Biologically, they lead to elevated primary productivity and persistent aggregation of low-trophic-level prey. Unlike other remotely sensed variables, ADT provides information about the structure of the entire water column and it is also routinely measured at high spatial-temporal resolution by satellite altimeters with uniform global coverage. Our models provide spatially explicit population density predictions for both species, even in areas where the pycnocline shoals but does not outcrop (e.g. the Costa Rica Dome and the North Equatorial Countercurrent thermocline ridge). Interannual variations in distribution during El Nino anomalies suggest that the population density of both species decreases dramatically in the Equatorial Cold Tongue and the Costa Rica Dome, and that their distributions retract to particular areas that remain productive, such as the more oceanic waters in the central California Current System, the northern Gulf of California, the North Equatorial Countercurrent thermocline ridge, and the more southern portion of the Humboldt Current System. We posit that such reductions in available foraging habitats during climatic disturbances could incur high energetic costs on these populations, ultimately affecting individual fitness and survival.	[Pardo, Mario A.] Univ Nacl Autonoma Mexico, Posgrado Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Pardo, Mario A.; Beier, Emilio] Ctr Invest Cient & Educ Super Ensenada, Unidad La Paz, La Paz 23050, Baja California, Mexico; [Gerrodette, Tim; Forney, Karin A.; Chivers, Susan J.; Barlow, Jay] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, Baja California, Mexico; [Palacios, Daniel M.] Oregon State Univ, Marine Mammal Inst, Newport, OR 97365 USA	Universidad Nacional Autonoma de Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; National Oceanic Atmospheric Admin (NOAA) - USA; Instituto Politecnico Nacional - Mexico; Oregon State University	Pardo, MA (corresponding author), Univ Nacl Autonoma Mexico, Posgrado Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico.	mpardo@cicese.mx	Palacios, Daniel M./B-9180-2008; Pardo, Mario A./F-9815-2015; Barlow, Jay/D-3565-2019	Palacios, Daniel M./0000-0001-7069-7913; Pardo, Mario A./0000-0003-1248-3399; Barlow, Jay/0000-0001-7862-855X; Beier, Emilio/0000-0001-8478-7709	U.S. National Marine Fisheries Service; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [168034-T-1753]; Posgrado en Ciencias del Mar y Limnologia at Universidad Nacional Autonoma de Mexico; Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional [SIP-20070803]; Cetacean Society International; Ocean Foundation; American Cetacean Society; Sociedad Mexicana de Mastozoologia Marina (SOMEMMA); Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT); Interagency NASA Climate and Biological Response Program [NNX11AP71G]	U.S. National Marine Fisheries Service; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado en Ciencias del Mar y Limnologia at Universidad Nacional Autonoma de Mexico; Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional; Cetacean Society International; Ocean Foundation; American Cetacean Society; Sociedad Mexicana de Mastozoologia Marina (SOMEMMA); Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT); Interagency NASA Climate and Biological Response Program	The survey cruises for cetacean data collection were funded by the U.S. National Marine Fisheries Service as part of its annual budget. This study received funds from Consejo Nacional de Ciencia y Tecnologia (CONACyT; http://www.conacyt.mx/), through the project "Un estudio de la corriente costera Mexicana y el Pacifico adyacente, con SeaGlider, cruceros oceanograficos y datos de satelite" (Grant No. 168034-T-1753; PI: EB), a Ph.D. scholarship and an international internship grant to MAP. The authors also received financial support from Posgrado en Ciencias del Mar y Limnologia (http://www.pcml.unam.mx/) at Universidad Nacional Autonoma de Mexico, and Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional (http://www.cicimar.ipn.mx/oacis/), through the project "Estructura poblacional y movimiento de algunos cetaceos del Golfo de California" (Grant No. SIP-20070803; PI: DG). MAP received grants from Cetacean Society International (http://www.csiwhalesalive.org/index.php), The Ocean Foundation (http://www.oceanfdn.org/), American Cetacean Society (http://acsonline.org/), Sociedad Mexicana de Mastozoologia Marina (SOMEMMA; http://www.somemma.org/somemma/), and Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT; http://www.coscyt.edu.mx/). DMP was funded by the Interagency NASA Climate and Biological Response Program (Grant No. NNX11AP71G; PI: H. Bailey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03125; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Archer FI, 2010, MAR ECOL PROG SER, V410, P245, DOI 10.3354/meps08641; Asch RG, 2013, DEEP-SEA RES PT I, V71, P79, DOI 10.1016/j.dsr.2012.08.006; AU DWK, 1985, FISH B-NOAA, V83, P623; AVISO, 2014, SSALTO DUACS USER HA; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barlow J, 2008, MAR ECOL PROG SER, V371, P285, DOI 10.3354/meps07695; Barlow J, 2009, NOAA TECH MEMO NMFS; Barlow J, 2007, FISH B-NOAA, V105, P509; Barlow Jay, 2001, Journal of Cetacean Research and Management, V3, P201; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Beier E, 1997, J PHYS OCEANOGR, V27, P615, DOI 10.1175/1520-0485(1997)027<0615:ANIOTA>2.0.CO;2; Benson SR, 2002, PROG OCEANOGR, V54, P279, DOI 10.1016/S0079-6611(02)00054-X; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; BRINTON E, 1979, Progress in Oceanography, V8, P125, DOI 10.1016/0079-6611(79)90001-6; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BURNHAM KP, 1976, BIOMETRICS, V32, P325, DOI 10.2307/2529501; Burtenshaw JC, 2004, DEEP-SEA RES PT II, V51, P967, DOI 10.1016/j.dsr2.2004.06.020; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Campbell GS, 2015, DEEP-SEA RES PT II, V112, P143, DOI 10.1016/j.dsr2.2014.10.008; CANE MA, 1983, SCIENCE, V222, P1189, DOI 10.1126/science.222.4629.1189; Carretta J V, 2003, MAR FISH REV, V66, P21; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Clapham PJ, 1999, MAMMAL REV, V29, P35; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Clark J. S, 2007, MODELS ECOLOGICAL DA; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; da Rocha HR, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000640; Danil K, 2006, MAR ECOL PROG SER, V318, P277, DOI 10.3354/meps318277; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Dibarboure G, 2014, J ATMOS OCEAN TECH, V31, P1337, DOI 10.1175/JTECH-D-13-00081.1; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Felix-Uraga R, 2004, CAL COOP OCEAN FISH, V45, P146; Ferguson MC, 2006, ECOL MODEL, V193, P645, DOI 10.1016/j.ecolmodel.2005.10.034; Fiedler PC, 2013, MAR ECOL PROG SER, V484, P1, DOI 10.3354/meps10378; Fiedler PC, 2013, J CLIMATE, V26, P583, DOI 10.1175/JCLI-D-11-00728.1; FIEDLER PC, 1994, FISH B-NOAA, V92, P451; Fiedler PC, 1998, DEEP-SEA RES PT II, V45, P1781, DOI 10.1016/S0967-0645(98)80017-9; FIEDLER PC, 1991, LIMNOL OCEANOGR, V36, P1834, DOI 10.4319/lo.1991.36.8.1834; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Gergis JL, 2009, CLIMATIC CHANGE, V92, P343, DOI 10.1007/s10584-008-9476-z; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gerrodette T, 1996, LJ9610 SW FISH SCI C; Gerrodette T, 2008, NOAATMNMFSSWFSC422 N, V422, P1; Gerrodette Tim, 2011, Endangered Species Research, V15, P159, DOI 10.3354/esr00369; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Gregr EJ, 2000, MAR MAMMAL SCI, V16, P699, DOI 10.1111/j.1748-7692.2000.tb00967.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Havens KE, 2000, ENVIRON MANAGE, V25, P1; Hillborn R., 1997, ECOLOGICAL DETECTIVE; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Irvine LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102959; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Kinzey D, 2000, MARINE MAMMAL DATA C; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kudela RM, 2008, OCEANOGRAPHY, V21, P46, DOI 10.5670/oceanog.2008.04; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Logerwell EA, 2001, PROG OCEANOGR, V49, P391, DOI 10.1016/S0079-6611(01)00032-5; Lunn D., 2012, BUGS BOOK PRACTICAL; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Misund OA, 2003, AFR J MAR SCI, V25, P185, DOI 10.2989/18142320309504009; Moore JE, 2014, ENDANGER SPECIES RES, V25, P141, DOI 10.3354/esr00633; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Olson Donald B., 2002, P187; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Palacios DM, 2013, ENDANGER SPECIES RES, V22, P191, DOI 10.3354/esr00558; Palacios DM, 1998, J CETACEAN RES MANAG, V1, P41; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; R Core Team, 2021, R LANGUAGE ENV STAT; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; REEVES R, 2003, MANAGEMENT TODAY, P35; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; REILLY SB, 1994, FISH B-NOAA, V92, P434; Reiss CS, 2008, FISH OCEANOGR, V17, P126, DOI 10.1111/j.1365-2419.2008.00469.x; Rio MH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002226; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Royle J. A., 2008, HIERARCHICAL MODELIN; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sanino Gian Paolo, 2003, Boletin del Museo Nacional de Historia Natural Chile, V52, P97; Santora JA, 2012, PROG OCEANOGR, V106, P154, DOI 10.1016/j.pocean.2012.08.005; Scott MD, 1998, MAR MAMMAL SCI, V14, P401, DOI 10.1111/j.1748-7692.1998.tb00735.x; Sears R, 2013, ENDANGER SPECIES RES, V22, P23, DOI 10.3354/esr00532; Skaug HJ, 2006, ENVIRON ECOL STAT, V13, P199, DOI 10.1007/s10651-005-0006-0; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafforda KM, 2007, J ACOUST SOC AM, V122, P3378, DOI 10.1121/1.2799905; TERSHY BR, 1992, J MAMMAL, V73, P477, DOI 10.2307/1382013; TERSHY BR, 1991, MAR ECOL PROG SER, V69, P299, DOI 10.3354/meps069299; Torres-Florez JP, 2014, MOL ECOL, V23, P5998, DOI 10.1111/mec.12990; Tsonis AA, 2003, METEOROL ATMOS PHYS, V84, P229, DOI 10.1007/s00703-003-0001-7; TSUCHIYA M, 1972, J GEOPHYS RES, V77, P5981, DOI 10.1029/JC077i030p05981; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; Von ARX WILLIAM S., 1965, LIMNOL OCEANOGR, V10, pR265; WADE LS, 1979, FISH B-NOAA, V76, P915; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wang CZ, 2006, PROG OCEANOGR, V69, P239, DOI 10.1016/j.pocean.2006.03.004; WHITE JR, 1995, DEEP-SEA RES PT II, V42, P715, DOI 10.1016/0967-0645(95)00033-M; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wilson C, 2001, J GEOPHYS RES-OCEANS, V106, P31175, DOI 10.1029/2000JC000724; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Wyrtki K, 1964, FISH B, V63, P355	128	20	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120727	10.1371/journal.pone.0120727	http://dx.doi.org/10.1371/journal.pone.0120727			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785692	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500188
J	Acosta-Reyes, FJ; Alechaga, E; Subirana, JA; Campos, JL				Acosta-Reyes, Francisco J.; Alechaga, Elida; Subirana, Juan A.; Lourdes Campos, J.			Structure of the DNA Duplex d(ATTAAT)(2) with Hoogsteen Hydrogen Bonds	PLOS ONE			English	Article							POLYMERASE-IOTA; BASE-PAIRS; CRYSTAL; COMPLEX; REPLICATION; REFINEMENT; SOFTWARE; REFMAC5	The traditional Watson-Crick base pairs in DNA may occasionally adopt a Hoogsteen conformation, with a different organization of hydrogen bonds. Previous crystal structures have shown that the Hoogsteen conformation is favored in alternating AT sequences of DNA. Here we present new data for a different sequence, d(ATTAAT)(2), which is also found in the Hoogsteen conformation. Thus we demonstrate that other all-AT sequences of DNA with a different sequence may be found in the Hoogsteen conformation. We conclude that any all-AT sequence might acquire this conformation under appropriate conditions. We also compare the detailed features of DNA in either the Hoogsteen or Watson-Crick conformations.	[Acosta-Reyes, Francisco J.; Alechaga, Elida; Subirana, Juan A.; Lourdes Campos, J.] Univ Politecn Cataluna, Dept Engn Quim, E-08028 Barcelona, Spain	Universitat Politecnica de Catalunya	Campos, JL (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Diagonal 647, E-08028 Barcelona, Spain.	lourdes.campos@upc.edu	Campos, J.Lourdes/N-7336-2014; Subirana, juan/L-7192-2014	Campos, J.Lourdes/0000-0002-4136-7082; Acosta-Reyes, Francisco J./0000-0001-8524-1484; Subirana, juan/0000-0002-1706-9341	FEDER; Ministerio de Ciencia e Inovacion [BFU-2009-10380]; Generalitat de Catalunya [SRG2009-1208]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [212993]	FEDER(European Commission); Ministerio de Ciencia e Inovacion(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by FEDER funds and the Ministerio de Ciencia e Inovacion, project BFU-2009-10380 to JLC and Generalitat de Catalunya, project SRG2009-1208 to JLC. FJA acknowledges a fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT-reg: 212993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Campos L, 2006, BIOPHYS J, V91, P892, DOI 10.1529/biophysj.106.084210; Cubero E, 2003, J AM CHEM SOC, V125, P14603, DOI 10.1021/ja035918f; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno T, 2010, ACTA CRYSTALLOGR D, V66, P251, DOI 10.1107/S0907444909055693; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Nikolova EN, 2012, J AM CHEM SOC, V134, P3667, DOI 10.1021/ja2117816; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Pfoh R, 2009, ACTA CRYSTALLOGR F, V65, P660, DOI 10.1107/S1744309109019654; Pous J, 2008, J AM CHEM SOC, V130, P6755, DOI 10.1021/ja078022+; Sehgal N, 2014, CHROMOSOMA, V123, P499, DOI 10.1007/s00412-014-0480-y; Subirana JA, 2011, J THEOR BIOL, V283, P28, DOI 10.1016/j.jtbi.2011.05.025; Valls N, 2005, ACTA CRYSTALLOGR D, V61, P1587, DOI 10.1107/S0907444905029781; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s	25	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120241	10.1371/journal.pone.0120241	http://dx.doi.org/10.1371/journal.pone.0120241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781995	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600145
J	Ding, YH; Gao, H; Zhao, LF; Wang, X; Zheng, M				Ding, Yanhong; Gao, Han; Zhao, Lifang; Wang, Xian; Zheng, Ming			Mitofusin 2-Deficiency Suppresses Cell Proliferation through Disturbance of Autophagy	PLOS ONE			English	Article							RAT KIDNEY MITOCHONDRIA; MARIE-TOOTH-DISEASE; NEURODEGENERATIVE DISEASE; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; SKELETAL-MUSCLE; MYOSIN VI; 2A GENE; MFN2; FUSION	Mitofusin2 (Mfn2), a mitochondrial outer membrane protein serving primarily as a mitochondrial fusion protein, has multiple functions in regulating cell biological processes. Defects of Mfn2 were found in diabetes, obesity, and neurodegenerative diseases. In the present study, we found that knockdown of Mfn2 by shRNA led to impaired autophagic degradation, inhibited mitochondrial oxygen consumption rate and cell glycolysis, reduced ATP production, and suppressed cell proliferation. Inhibition of autophagic degradation mimicked Mfn2-deficiency mediated cell proliferation suppression, while enhancement of autophagosome maturation restored the suppressed cell proliferation by Mfn2-deficiency. Thus, our findings revealed the role of Mfn2 in regulating cell proliferation and mitochondrial metabolism, and shed new light on understanding the mechanisms of Mfn2 deficiency related diseases.	[Ding, Yanhong; Gao, Han; Zhao, Lifang; Wang, Xian; Zheng, Ming] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Peking University	Ding, YH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn			National Key Basic Research Program of China [2013CB512103, 2014CB542206]; National Science Foundation of China [31371350, 30971062]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2013CB512103 & 2014CB542206), and the National Science Foundation of China (31371350 & 30971062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Jin BY, 2011, MED ONCOL, V28, pS373, DOI 10.1007/s12032-010-9662-5; Jin DZ, 2011, MOL CELL BIOCHEM, V351, P165, DOI 10.1007/s11010-011-0724-6; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Limor R, 2005, AM J HYPERTENS, V18, P299, DOI 10.1016/j.amjhyper.2004.09.008; Liu H, 2014, AUTOPHAGY, V10, P372, DOI 10.4161/auto.27163; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenstock TR, 2004, J NEUROCHEM, V88, P1220, DOI 10.1046/j.1471-4159.2003.02250.x; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zheng M, 2010, J MOL MED, V88, P987, DOI 10.1007/s00109-010-0675-5	44	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121328	10.1371/journal.pone.0121328	http://dx.doi.org/10.1371/journal.pone.0121328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781899	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600202
J	Warburton, B; Gormley, AM				Warburton, Bruce; Gormley, Andrew M.			Optimising the Application of Multiple-Capture Traps for Invasive Species Management Using Spatial Simulation	PLOS ONE			English	Article							POSSUM TRICHOSURUS-VULPECULA; STOATS MUSTELA-ERMINEA; RATS RATTUS-RATTUS; NEW-ZEALAND; HOME-RANGE; BRUSHTAIL POSSUMS; SHIP RATS; BEECH FOREST; DENSITY; ISLAND	Internationally, invasive vertebrate species pose a significant threat to biodiversity, agricultural production and human health. To manage these species a wide range of tools, including traps, are used. In New Zealand, brushtail possums (Trichosurus vulpecula), stoats (Mustela ermine), and ship rats (Rattus rattus) are invasive and there is an ongoing demand for cost-effective non-toxic methods for controlling these pests. Recently, traps with multiple-capture capability have been developed which, because they do not require regular operator-checking, are purported to be more cost-effective than traditional single-capture traps. However, when pest populations are being maintained at low densities (as is typical of orchestrated pest management programmes) it remains uncertain if it is more cost-effective to use fewer multiple-capture traps or more single-capture traps. To address this uncertainty, we used an individual-based spatially explicit modelling approach to determine the likely maximum animal-captures per trap, given stated pest densities and defined times traps are left between checks. In the simulation, single-or multiple-capture traps were spaced according to best practice pest-control guidelines. For possums with maintenance densities set at the lowest level (i.e. 0.5/ha), 98% of all simulated possums were captured with only a single capacity trap set at each site. When possum density was increased to moderate levels of 3/ha, having a capacity of three captures per trap caught 97% of all simulated possums. Results were similar for stoats, although only two potential captures per site were sufficient to capture 99% of simulated stoats. For rats, which were simulated at their typically higher densities, even a six-capture capacity per trap site only resulted in 80% kill. Depending on target species, prevailing density and extent of immigration, the most cost-effective strategy for pest control in New Zealand might be to deploy several single-capture traps rather than investing in fewer, but more expense, multiple-capture traps.	[Warburton, Bruce; Gormley, Andrew M.] Landcare Res Manaaki Whenua, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Warburton, B (corresponding author), Landcare Res Manaaki Whenua, POB 40, Lincoln 7640, New Zealand.	warburtonb@landcareresearch.co.nz		Gormley, Andrew/0000-0001-9833-7012	New Zealand's Ministry of Business, Innovation and Employment [C09X1007]	New Zealand's Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was supported by grant funding from New Zealand's Ministry of Business, Innovation and Employment (http://www.msi.govt.nz/get-funded/) awarded to BW (grant no. C09X1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio N, 1998, ECOGRAPHY, V21, P18, DOI 10.1111/j.1600-0587.1998.tb00390.x; Ball SJ, 2005, WILDLIFE RES, V32, P217, DOI 10.1071/WR03125; Choquenot D, 2001, BIOL CONSERV, V99, P29, DOI 10.1016/S0006-3207(00)00186-5; CLAPPERTON BK, 1994, NEW ZEAL J ZOOL, V21, P279, DOI 10.1080/03014223.1994.9517995; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Gillies CA, 2003, NEW ZEAL J ZOOL, V30, P399, DOI 10.1080/03014223.2003.9518349; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; INNES J, 1995, NEW ZEAL J ECOL, V19, P5; King C.M., 1990, P288; King CM., 2005, HDB NZ MAMMALS; Morgan DR, 2006, WILDLIFE RES, V33, P605, DOI 10.1071/WR06055; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pryde M, 2005, NEW ZEAL J ZOOL, V32, P139, DOI 10.1080/03014223.2005.9518406; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Ramsey DSL, 2008, IDENTIFYING OPTIMAL; Ruscoe WA, 2011, ECOL LETT, V14, P1035, DOI 10.1111/j.1461-0248.2011.01673.x; Scofield RP, 2011, NEW ZEAL J ECOL, V35, P312; Smith DHV, 2008, NEW ZEAL J ECOL, V32, P166; Spurr EB, 1999, NZ SCI CONSERVATIO A, V127A, P1; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Theuerkauf J, 2011, ANN ZOOL FENN, V48, P308, DOI 10.5735/086.048.0505; Thomas MD, 2003, N Z PLANT PROTECT-SE, V56, P77, DOI 10.30843/nzpp.2003.56.6089; Tompkins DM, 2007, WILDLIFE RES, V34, P67, DOI 10.1071/WR05109; Warburton B, 2012, ANIM WELFARE, V21, P141, DOI 10.7120/096272812X13345905674123; Warburton B, 1996, NEW ZEAL J ZOOL, V23, P307, DOI 10.1080/03014223.1996.9518089; WARD GD, 1984, NEW ZEAL J ZOOL, V11, P85, DOI 10.1080/03014223.1984.10428231; Whitehead AL, 2008, BIOL CONSERV, V141, P2784, DOI 10.1016/j.biocon.2008.08.013; Wilson DJ, 2007, NEW ZEAL J ECOL, V31, P47	29	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120373	10.1371/journal.pone.0120373	http://dx.doi.org/10.1371/journal.pone.0120373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782018	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600155
J	Zigdon, H; Savidor, A; Levin, Y; Meshcheriakova, A; Schiffmann, R; Futerman, AH				Zigdon, Hila; Savidor, Alon; Levin, Yishai; Meshcheriakova, Anna; Schiffmann, Raphael; Futerman, Anthony H.			Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease	PLOS ONE			English	Article							GENE-EXPRESSION; GLUCOCEREBROSIDASE; BETA	Gaucher disease, a recessive inherited metabolic disorder caused by defects in the gene encoding glucosylceramidase (GlcCerase), can be divided into three subtypes according to the appearance of symptoms associated with central nervous system involvement. We now identify a protein, glycoprotein non-metastatic B (GPNMB), that acts as an authentic marker of brain pathology in neurological forms of Gaucher disease. Using three independent techniques, including quantitative global proteomic analysis of cerebrospinal fluid (CSF) in samples from Gaucher disease patients that display neurological symptoms, we demonstrate a correlation between the severity of symptoms and GPNMB levels. Moreover, GPNMB levels in the CSF correlate with disease severity in a mouse model of Gaucher disease. GPNMB was also elevated in brain samples from patients with type 2 and 3 Gaucher disease. Our data suggest that GPNMB can be used as a marker to quantify neuropathology in Gaucher disease patients and as a marker of treatment efficacy once suitable treatments towards the neurological symptoms of Gaucher disease become available.	[Zigdon, Hila; Meshcheriakova, Anna; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Savidor, Alon; Levin, Yishai] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Botton Inst Prot Profiling, IL-76100 Rehovot, Israel; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	Weizmann Institute of Science; Weizmann Institute of Science; Baylor Scott & White Health; Baylor University Medical Center	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115	Minerva Foundation	Minerva Foundation	This work was supported by the Minerva Foundation.	Benko W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022410; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Burrow TA, 2014, MOL GENET METAB; Cimaz R, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-18; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farfel-Becker T, 2011, HUM MOL GENET, V20, P1375, DOI 10.1093/hmg/ddr019; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Futerman A.H., 2006, GAUCHER DIS; Grabowski GA, 2006, GAUCHER DIS; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mignot C, 2013, HAND CLINIC, V113, P1709, DOI 10.1016/B978-0-444-59565-2.00040-X; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Moran MT, 2000, BLOOD, V96, P1969, DOI 10.1182/blood.V96.5.1969.h8001969_1969_1978; Myerowitz R, 2004, MOL GENET METAB, V83, P288, DOI 10.1016/j.ymgme.2004.06.020; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Parente MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032419; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Schiffmann R, 1997, ANN NEUROL, V42, P613, DOI 10.1002/ana.410420412; Schiffmann R, 2008, ANN NEUROL, V64, P514, DOI 10.1002/ana.21491; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Vitner Einat B, 2013, Handb Exp Pharmacol, P405, DOI 10.1007/978-3-7091-1511-4_20; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839	32	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120194	10.1371/journal.pone.0120194	http://dx.doi.org/10.1371/journal.pone.0120194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775479	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500155
J	Selvan, N; Mariappa, D; van den Toorn, HWP; Heck, AJR; Ferenbach, AT; van Aalten, DMF				Selvan, Nithya; Mariappa, Daniel; van den Toorn, Henk W. P.; Heck, Albert J. R.; Ferenbach, Andrew T.; van Aalten, Daan M. F.			The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Drosophila Genetics; Evolution; O-GlcNAcylation; Post-translational Modification (PTM); Trichoplax adhaerens	LINKED N-ACETYLGLUCOSAMINE; TETRATRICOPEPTIDE REPEATS; TRANSFERASE OGT; CROSS-TALK; CYTOPLASMIC PROTEINS; CYTOSOLIC PROTEINS; KINETIC-ANALYSIS; GLCNACYLATION; GLYCOSYLATION; NUCLEAR	Background: Protein O-GlcNAcylation and orthologues of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) occur separately or together in all kingdoms of life. Results: The basal metazoan Trichoplax adhaerens is the simplest organism to possess functional OGT, OGA, and protein O-GlcNAcylation together. Conclusion: Reversible protein O-GlcNAcylation is conserved throughout the metazoan lineage. Significance:T. adhaerens can be used as a reductionist model to identify evolutionarily conserved O-GlcNAc targets. Protein O-GlcNAcylation is a reversible post-translational signaling modification of nucleocytoplasmic proteins that is essential for embryonic development in bilateria. In a search for a reductionist model to study O-GlcNAc signaling, we discovered the presence of functional O-GlcNAc transferase (OGT), O-GlcNAcase (OGA), and nucleocytoplasmic protein O-GlcNAcylation in the most basal extant animal, the placozoan Trichoplax adhaerens. We show via enzymatic characterization of Trichoplax OGT/OGA and genetic rescue experiments in Drosophila melanogaster that these proteins possess activities/functions similar to their bilaterian counterparts. The acquisition of O-GlcNAc signaling by metazoa may have facilitated the rapid and complex signaling mechanisms required for the evolution of multicellular organisms.	[Selvan, Nithya; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Mariappa, Daniel; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [van den Toorn, Henk W. P.; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [van den Toorn, Henk W. P.; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands	University of Dundee; University of Dundee; Utrecht University; Utrecht University	van Aalten, DMF (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Heck, Albert/D-7098-2011; van den Toorn, Henk W.P./K-8232-2015; Mariappa, Daniel/AAQ-7135-2020	Heck, Albert/0000-0002-2405-4404; van den Toorn, Henk W.P./0000-0002-0270-5763; van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; Mariyappa, Daniel/0000-0003-4775-1656	Wellcome Trust [WT087590MA]; MRC [MR/M004139/1, G0900138] Funding Source: UKRI; Medical Research Council [MR/M004139/1, G0900138] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Senior Research Fellowship WT087590MA (to D. M. F. v. A).	Banerjee S, 2009, GLYCOBIOLOGY, V19, P331, DOI 10.1093/glycob/cwn107; Borodkin VS, 2014, BIOCHEM J, V457, P497, DOI 10.1042/BJ20131272; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Dehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Dorfmueller HC, 2010, FEBS LETT, V584, P694, DOI 10.1016/j.febslet.2009.12.020; Dorfmueller HC, 2009, BIOCHEM J, V420, P221, DOI 10.1042/BJ20090110; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Frederic MY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003804; Fredriksen L, 2012, J BACTERIOL, V194, P325, DOI 10.1128/JB.06314-11; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; He Y, 2014, ACTA CRYSTALLOGR D, V70, P186, DOI 10.1107/S1399004713029155; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee HS, 2011, ANAL BIOCHEM, V418, P85, DOI 10.1016/j.ab.2011.06.016; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2009, CARBOHYD RES, V344, P1079, DOI 10.1016/j.carres.2009.04.017; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MACHIDA M, 1994, BIOSCI BIOTECH BIOCH, V58, P344, DOI 10.1271/bbb.58.344; Martinelli C, 2004, GENE EXPR PATTERNS, V4, P443, DOI 10.1016/j.modgep.2004.01.002; Martinelli C, 2003, DEV GENES EVOL, V213, P492, DOI 10.1007/s00427-003-0353-5; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Perez-Cervera Y, 2011, AMINO ACIDS, V40, P847, DOI 10.1007/s00726-010-0702-4; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Ringrose JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2424; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Sohn KC, 2005, BIOCHEM BIOPH RES CO, V337, P256, DOI 10.1016/j.bbrc.2005.09.049; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STARR CM, 1990, J BIOL CHEM, V265, P6868; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; von der Chevallerie K, 2014, DEV GENES EVOL, V224, P79, DOI 10.1007/s00427-014-0465-0; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	88	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11969	11982		10.1074/jbc.M114.628750	http://dx.doi.org/10.1074/jbc.M114.628750			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778404	hybrid, Green Published			2022-12-26	WOS:000354388600014
J	De Craemer, M; Lateva, M; Iotova, V; De Decker, E; Verloigne, M; De Bourdeaudhuij, I; Androutsos, O; Socha, P; Kulaga, Z; Moreno, L; Koletzko, B; Manios, Y; Cardon, G				De Craemer, Marieke; Lateva, Mina; Iotova, Violeta; De Decker, Ellen; Verloigne, Maite; De Bourdeaudhuij, Ilse; Androutsos, Odysseas; Socha, Piotr; Kulaga, Zbigniew; Moreno, Luis; Koletzko, Berthold; Manios, Yannis; Cardon, Greet		ToyBox-Study Grp	Differences in Energy Balance-Related Behaviours in European Preschool Children: The ToyBox-Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; FOCUS GROUPS; CHILDHOOD; OBESITY; INTERVENTION; ASSOCIATIONS; EXPLORATION; TRACKING; PARENTS	Background The aim of the current study was to compare levels of energy balance-related behaviours (physical activity, sedentary behaviour, and dietary behaviours (more specifically water consumption, sugar-sweetened beverage consumption and unhealthy snacking)) in four-to six-year-old preschoolers from six European countries (Belgium, Bulgaria, Germany, Greece, Poland, and Spain) within the ToyBox cross-sectional study. Methods A sample of 4,045 preschoolers (4.77 +/- 0.43 years; 52.2% boys) had valid physical activity data (steps per day), parents of 8,117 preschoolers (4.78 +/- 0.46 years; 53.0% boys) completed a parental questionnaire with questions on sedentary behaviours (television viewing, computer use, and quiet play), and parents of 7,244 preschoolers (4.77 +/- 0.44 years; 52.0% boys) completed a food frequency questionnaire with questions on water consumption, sugar-sweetened beverage consumption and unhealthy snacking. Results The highest levels of physical activity were found in Spain (12,669 steps/day on weekdays), while the lowest levels were found in Bulgaria and Greece (9,777 and 9,656 steps/day on weekdays, respectively). German preschoolers spent the least amount of time in television viewing (43.3 min/day on weekdays), while Greek preschoolers spent the most time in television viewing (88.5 min/day on weekdays). A considerable amount of time was spent in quiet play in all countries, with the highest levels in Poland (104.9 min/day on weekdays), and the lowest levels in Spain (60.4 min/day on weekdays). Belgian, German, and Polish preschoolers had the lowest intakes of water and the highest intakes of sugar-sweetened beverages. The intake of snacks was the highest in Belgian preschoolers (73.1 g/day) and the lowest in Greek preschoolers (53.3 g/day). Conclusions Across six European countries, differences in preschoolers' energy balance-related behaviours were found. Future interventions should target European preschoolers' energy balance-related behaviours simultaneously, but should apply country-specific adaptations.	[De Craemer, Marieke; De Decker, Ellen; Verloigne, Maite; De Bourdeaudhuij, Ilse; Cardon, Greet] Univ Ghent, B-9000 Ghent, Belgium; [Lateva, Mina; Iotova, Violeta] Med Univ Varna, Varna, Bulgaria; [Verloigne, Maite] Res Fdn Flanders, Brussels, Belgium; [Androutsos, Odysseas; Manios, Yannis] Harokopio Univ, Athens, Greece; [Socha, Piotr; Kulaga, Zbigniew] Childrens Mem Hlth Inst, Warsaw, Poland; [Moreno, Luis] Univ Zaragoza, Zaragoza, Spain; [Koletzko, Berthold] Univ Munich, Med Ctr, Munich, Germany	Ghent University; Medical University Varna; Harokopio University Athens; Children's Memorial Health Institute; University of Zaragoza; University of Munich	De Craemer, M (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.	marieke.decraemer@ugent.be	Radkova, Zhaneta/AAM-1538-2020; Paw, Mai Chin A/N-1665-2019; Moreno, Luis/S-1780-2019; De Craemer, Marieke/P-6072-2016; Gibson, Leigh/B-5010-2010; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Iotova, Violeta/AAO-2387-2021; Androutsos, Odysseas/ABF-8670-2021; De Craemer, Marieke/Z-3050-2019; Manios, Yannis/AAM-8953-2021; De Miguel-Etayo, Pilar/B-5258-2014	Radkova, Zhaneta/0000-0003-2007-8019; Paw, Mai Chin A/0000-0001-6259-2441; Moreno, Luis/0000-0003-0454-653X; Gibson, Leigh/0000-0002-9789-7429; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Manios, Yannis/0000-0001-6486-114X; Gozdz, Magdalena/0000-0002-9753-568X; De Miguel-Etayo, Pilar/0000-0001-6173-5850; Ward, Dianne Stanton/0000-0001-6389-0168; Gurzkowska, Beata/0000-0003-2681-3221; Moore, Helen J/0000-0002-0165-7552; Iotova, Violeta/0000-0003-4160-1200; te Velde, Saskia/0000-0002-4674-8052; Cardon, Greet/0000-0003-4983-6557; Socha, Piotr/0000-0002-1621-464X; Kulaga, Zbigniew/0000-0003-0509-1004	European Commission [245200]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The ToyBox-study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghaeed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071854; Ammerman Alice S, 2007, Prev Chronic Dis, V4, pA67; [Anonymous], 2009, PHYS ACT GUID DOC; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Australian Department of Health and Aging, 2009, GET GROW HLTH EAT PH; Bayer O, 2009, CLIN NUTR, V28, P122, DOI 10.1016/j.clnu.2009.01.001; Belgian Health Council, 2009, VOED BELG HERZ VERS; Biddle SJH, 2011, BRIT J SPORT MED, V45, P937, DOI 10.1136/bjsports-2011-090205; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; CALFAS KJ, 1991, J DEV BEHAV PEDIATR, V12, P185; De Craemer M, 2014, J SPORTS SCI, V18, P1; De Craemer M, 2014, J SCI MED SPORT; De Craemer M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-278; De Decker E, 2012, OBES REV, V13, P75, DOI 10.1111/j.1467-789X.2011.00961.x; De Decker E, 2013, J SCHOOL HEALTH, V83, P654, DOI 10.1111/josh.12078; De Martelaer K., 2007, ONDERWIJSONDERZOEK R, P191; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Department of Health, 2011, START ACT STAY ACT R; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; European Food Information Council, 2009, FOOD BAS DIET GUID E; Flemish Government Department Health and Family, 2012, VLAAMS CONS VERB EV; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Institute of Medicine of the National Academies, 2011, EARL CHILDH OB PREV; Janz KF, 2002, PREV MED, V35, P563, DOI 10.1006/pmed.2002.1113; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Manios Y, 2012, OBES REV, V13, P3, DOI 10.1111/j.1467-789X.2011.00974.x; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Ministerie van Welzijn Volksgezondheid en Gezin, 2012, NAAR EV VOED BEW; National Association for Sports and Physical Education (NASPE), 2009, ACT START STAT PHYS; Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264; Nutrition Information Center, 2006, ACT VOED KLEUT; Puhse U, 2005, CONCEPTS PROBLEMS PR, P588; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; van Stralen MM, 2012, OBES REV, V13, P29, DOI 10.1111/j.1467-789X.2011.00959.x; World Health Organization, 2013, HLTH TOP DIS PREV PH; World Health Organization, 2012, GLOB DAT IMPL NUTR A; World Health Organization, 2013, GLOB NUTR POL REV WH	43	55	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118303	10.1371/journal.pone.0118303	http://dx.doi.org/10.1371/journal.pone.0118303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785738	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500026
J	Hashimoto, Y; Honda, T; Matsumura, K; Nakao, M; Soga, K; Katano, K; Yokota, T; Mizusawa, H; Nagao, S; Ishikawa, K				Hashimoto, Yuji; Honda, Takeru; Matsumura, Ken; Nakao, Makoto; Soga, Kazumasa; Katano, Kazuhiko; Yokota, Takanori; Mizusawa, Hidehiro; Nagao, Soichi; Ishikawa, Kinya			Quantitative Evaluation of Human Cerebellum-Dependent Motor Learning through Prism Adaptation of Hand-Reaching Movement	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; SPINOCEREBELLAR ATAXIA; HUNTINGTONS-DISEASE; NATURAL-HISTORY; INTERNAL-MODELS; FORCE-FIELD; EYEBLINK; LESIONS; INVOLVEMENT; MEMORY	The cerebellum plays important roles in motor coordination and learning. However, motor learning has not been quantitatively evaluated clinically. It thus remains unclear how motor learning is influenced by cerebellar diseases or aging, and is related with incoordination. Here, we present a new application for testing human cerebellum-dependent motor learning using prism adaptation. In our paradigm, the participant wearing prism-equipped goggles touches their index finger to the target presented on a touchscreen in every trial. The whole test consisted of three consecutive sessions: (1) 50 trials with normal vision (BASELINE), (2) 100 trials wearing the prism that shifts the visual field 25 degrees rightward (PRISM), and (3) 50 trials without the prism (REMOVAL). In healthy subjects, the prism-induced finger-touch error, i.e., the distance between touch and target positions, was decreased gradually by motor learning through repetition of trials. We found that such motor learning could be quantified using the "adaptability index (AI)", which was calculated by multiplying each probability of [acquisition in the last 10 trials of PRISM], [retention in the initial five trials of REMOVAL], and [extinction in the last 10 trials of REMOVAL]. The AI of cerebellar patients less than 70 years old (mean, 0.227; n = 62) was lower than that of age-matched healthy subjects (0.867, n = 21; p < 0.0001). While AI did not correlate with the magnitude of dysmetria in ataxic patients, it declined in parallel with disease progression, suggesting a close correlation between the impaired cerebellar motor leaning and the dysmetria. Furthermore, AI decreased with aging in the healthy subjects over 70 years old compared with that in the healthy subjects less than 70 years old. We suggest that our paradigm of prism adaptation may allow us to quantitatively assess cerebellar motor learning in both normal and diseased conditions.	[Hashimoto, Yuji; Honda, Takeru; Matsumura, Ken; Soga, Kazumasa; Yokota, Takanori; Mizusawa, Hidehiro; Nagao, Soichi; Ishikawa, Kinya] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan; [Honda, Takeru; Nakao, Makoto; Nagao, Soichi] RIKEN Brain Sci Inst, Lab Motor Learning Control, Wako, Saitama, Japan; [Honda, Takeru] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Katano, Kazuhiko] KATANO TOOL SOFTWARE, Ichikawa, Chiba, Japan; [Nagao, Soichi] Nozomi Hosp, Nozomi Higher Brain Funct Lab, Ina, Saitama, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Japan Society for the Promotion of Science	Honda, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan.	takeru@brain.riken.jp; nagaos@brain.riken.jp; pico.nuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263	Ministry of Education, Culture Sports, Science and Technology of Japan; RIKEN; KATANO TOOL SOFTWARE	Ministry of Education, Culture Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; KATANO TOOL SOFTWARE	This work was supported by the Strategic Research for the Brain Sciences by the Ministry of Education, Culture Sports, Science and Technology of Japan and research fund from RIKEN. KATANO TOOL SOFTWARE provided support in the form of a salary for author KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alexis B, 2007, SPINOCEREBELLAR DEGE; ANSARI AR, 1960, ANN MATH STAT, V31, P1174, DOI 10.1214/aoms/1177705688; Babinski F, 1899, REV NEUROLOGIQUE, V7, P806; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Baizer JS, 1974, J PHYSIOL-LONDON, V236, p34P; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Block HJ, 2012, NEUROPSYCHOLOGIA, V50, P1766, DOI 10.1016/j.neuropsychologia.2012.03.034; Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x; Burciu RG, 2014, EXP BRAIN RES, V232, P2847, DOI 10.1007/s00221-014-3956-3; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; DURKIN M, 1993, PSYCHOL AGING, V8, P571, DOI 10.1037/0882-7974.8.4.571; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2009, BRAIN RES COGN BRAIN, V9, P223; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Ikeda Y, 2012, NEUROLOGY, V79, P333, DOI 10.1212/WNL.0b013e318260436f; Ilg W, 2012, NEUROLOGY, V79, P2056, DOI 10.1212/WNL.0b013e3182749e67; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2011, THE CEREBELLUM BRAIN; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jacobi H, 2011, NEUROLOGY, V77, P1035, DOI 10.1212/WNL.0b013e31822e7ca0; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kuper M, 2014, HUM BRAIN MAPP, V35, P1574, DOI 10.1002/hbm.22274; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; LEINER HC, 1986, BEHAV NEUROSCI, V100, P443, DOI 10.1037/0735-7044.100.4.443; Lisberger S.G., 2013, PRINCIPLES NEURAL SC, P960; Lowe J, 2004, BASIC NEUROPATHOLOGY, P169; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Gutierrez-Garralda JM, 2013, EUR J NEUROSCI, V38, P2933, DOI 10.1111/ejn.12288; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Nagao S, 2013, NEURAL NETWORKS, V47, P72, DOI 10.1016/j.neunet.2013.01.017; Norris SA, 2011, J NEUROPHYSIOL, V105, P2248, DOI 10.1152/jn.01009.2010; Ohki M, 2009, J NEUROPHYSIOL, V101, P934, DOI [10.1152/jn.90440.2008, 10.1152/jn.90440.2009]; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schmitz-Hubsch T, 2010, NEUROLOGY, V74, P678, DOI 10.1212/WNL.0b013e3181d1a6c9; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; SHELHAMER M, 1994, EXP BRAIN RES, V100, P328; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; SOLOMON PR, 1989, PSYCHOL AGING, V4, P34, DOI 10.1037/0882-7974.4.1.34; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thieme A, 2013, BRAIN, V136, P2063, DOI 10.1093/brain/awt107; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Walker MF, 1999, ANN NY ACAD SCI, V871, P205, DOI 10.1111/j.1749-6632.1999.tb09186.x; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Woodruff-Pak DS, 1998, PSYCHOL AGING, V13, P193, DOI 10.1037/0882-7974.13.2.193; WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443; Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zhang CZ, 2010, CELL TISSUE RES, V341, P341, DOI 10.1007/s00441-010-1016-2	72	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119376	10.1371/journal.pone.0119376	http://dx.doi.org/10.1371/journal.pone.0119376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785588	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500099
J	Li, Z; Wu, TM; Ming, WJ; Chen, X; Xiao, XM				Li Zhe; Wu Tian-mei; Ming Wei-jie; Chen Xin; Xiao Xiao-min			The Influence of Maternal Islet Beta-Cell Autoantibodies in Conjunction with Gestational Hyperglycemia on Neonatal Outcomes	PLOS ONE			English	Article							STIFF-MAN SYNDROME; DIABETES-MELLITUS; GAD ANTIBODIES; T-CELLS; TYPE-1; MOTHERS; PREGNANCY; WOMEN; POSTPARTUM; CHILDREN	Objective To determine the predictive value of the presence of maternal islet beta-cell autoantibodies with respect to neonatal outcomes. Methods A total of 311 pregnant women with abnormal 75 g oral glucose tolerance test (OGTT) results were enrolled in this study. Maternal glutamic acid decarboxylase autoantibodies (GADA), islet cell autoantibodies (ICA) and insulin autoantibodies (IAA) were tested in fasting blood both on the day following the routine OGTT and before delivery. The birth weight, Apgar score, blood glucose and outcomes of each neonate were later evaluated and recorded. Results 1. In this study, 33.9% of the pregnant women with gestational hyperglycemia had detectable levels of one or more types of anti-islet cell antibodies in the third trimester. The proportion of women who produced GADA and/or ICA was significantly higher in the group of women with gestational hyperglycemia than in the control group (P<0.05). The groups similarly differed in the proportion of women who tested positive for any anti-islet cell antibody (P<0.05). 2. Of the patients in our study, those who produced GADA exhibited an increase in uterine and umbilical arterial pulsatility indexes (PIs) during the third trimesters compared with the control group (P 0.05). Additionally, an increased frequency of fetal growth restriction (FGR) was observed in the infants of women who produced IAA during pregnancy compared with those without autoantibodies (P 0.05). 3. The rate of newborn admission to the neonatal intensive care unit (NICU) was significantly associated with the presence of maternal ICA during the third trimester (OR, 6.36; 95% CI, 1.22-33.26). 4. The incidence of neonatal asphyxia was associated with the presence of maternal GADA in both the second (OR, 10.44; 95% CI, 1.46-74.92) and the third (OR, 8.33; 95% CI, 1.45-47.82) trimesters. Conclusion Approximately one-third of the women with gestational hyperglycemia produced anti-islet cell antibodies. The incidence of FGR was higher in women with gestational hyperglycemia who produced IAA than in those without autoantibodies. Maternal ICA production in the third trimester was a risk factor for the subsequent admission of newborns to the NICU. Furthermore, the presence of maternal GADA placed the neonate at increased risk for asphyxia.	[Li Zhe; Wu Tian-mei; Ming Wei-jie; Chen Xin; Xiao Xiao-min] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Jinan University	Li, Z (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	mcal@foxmail.com; xiaoxiaomin55@163.com	Ming, Wai-kit/AAH-5989-2019	Ming, Wai-kit/0000-0002-8846-7515				BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; BUSCHARD K, 1990, DIABETOLOGIA, V33, P31, DOI 10.1007/BF00586458; DIMARIO U, 1987, DIABETOLOGIA, V30, P66, DOI 10.1007/BF00274573; Fuchtenbusch M, 1997, DIABETES, V46, P1459, DOI 10.2337/diabetes.46.9.1459; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Holm BC, 2006, CLIN EXP IMMUNOL, V146, P493, DOI 10.1111/j.1365-2249.2006.03243.x; Jarvela IY, 2006, DIABETES CARE, V29, P607, DOI 10.2337/diacare.29.03.06.dc05-1118; Lapolla A, 1999, DIABETES NUTR METAB, V12, P394; Lapolla A, 2009, NUTR METAB CARDIOVAS, V19, P674, DOI 10.1016/j.numecd.2009.04.004; Li Fang, 2005, CHINESE J PRACTICAL, V21, P425; Lobner K, 2006, DIABETES, V55, P792, DOI 10.2337/diabetes.55.03.06.db05-0746; Nilsson C, 2007, DIABETES CARE, V30, P1968, DOI 10.2337/dc07-0157; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; ROLL U, 1994, DIABETOLOGIA, V37, P1132, DOI 10.1007/BF00418377; Rong Yuan, 2010, HAINAN MED J, V21, P32; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; [吴天梅 Wu Tianmei], 2011, [广东医学, Guangdong Medical Journal], V32, P585; Wucher H, 2011, DIABETES METAB, V37, P47, DOI 10.1016/j.diabet.2010.07.005; Yu SH, 2009, DIABETES-METAB RES, V25, P329, DOI 10.1002/dmrr.963	20	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120414	10.1371/journal.pone.0120414	http://dx.doi.org/10.1371/journal.pone.0120414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785598	Green Published, gold			2022-12-26	WOS:000352138500171
J	Wang, YL; Liou, GG; Lin, CH; Chen, ML; Kuo, TM; Tsai, KN; Huang, CC; Chen, YL; Huang, LR; Chou, YC; Chang, CM				Wang, Yi-Ling; Liou, Gan-Guang; Lin, Chao-Hsiung; Chen, Mong-Liang; Kuo, Tzer-Min; Tsai, Kuen-Nan; Huang, Chien-Choao; Chen, Ya-Ling; Huang, Li-Rung; Chou, Yu-Chi; Chang, Chungming			The Inhibitory Effect of the Hepatitis B Virus Singly-Spliced RNA-Encoded p21.5 Protein on HBV Nucleocapsid Formation	PLOS ONE			English	Article							SURFACE FUSION PROTEIN; IN-VIVO; VIRAL REPLICATION; GENE-EXPRESSION; PRECORE PROTEIN; TRANSGENIC MICE; CAPSID PROTEIN; MESSENGER-RNA; CORE PROTEIN; HEPG2 CELLS	Hepatitis B virus (HBV) is the smallest DNA virus and the major cause of acute and chronic hepatitis. The 3.2 kb HBV viral genome generates four major species of unspliced viral transcript as well as several alternatively spliced RNAs. A 2.2 kb singly-spliced RNA is the most abundant spliced RNA and is widely expressed among all HBV genotypes. The expression of the singly-spliced RNA, as well as that of its encoded protein HBSP, is strongly associated with hepatopathology during HBV infection. Here, we report a novel inhibitory role of a p21.5 protein, which is encoded by a 2.2 kb singly-spliced RNA, in the modulation of HBV replication. We show that overexpression of the singly-spliced RNA is able to efficiently inhibit HBV replication. Furthermore, a mutation in the ATG start codon of the precore region completely abolishes the inhibitory effect of the singly-spliced RNA, indicating that a viral protein (p21.5) derived from the singly-spliced RNA is the mediator of the inhibition. Furthermore, p21.5 is able to form a homodimer that interacts with core dimers forming hybrid viral assembly components. Sucrose gradient fractionation revealed that co-expression of p21.5 resulted in a spread distribution pattern of core proteins ranging from low to high sucrose densities. When compared with p22, p21.5 is almost ten times more efficient at destabilizing HBV nucleocapsid assembly in Huh7 cells overexpressing either p21.5 or p22 protein. Moreover, in vivo expression of p21.5 protein by tail vein injection was found to decrease the amount of nucleocapsid in the livers of HBV-expressing BALB/c mice. In conclusion, our study reveals that the HBV 2.2 kb singly-spliced RNA encodes a 21.5 kDa viral protein that significantly interferes with the assembly of nucleocapsids during HBV nucleocapsid formation. These findings provide a possible strategy for elimination of HBV particles inside cells.	[Wang, Yi-Ling; Chang, Chungming] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Yi-Ling; Liou, Gan-Guang; Kuo, Tzer-Min; Tsai, Kuen-Nan; Huang, Chien-Choao; Chen, Ya-Ling; Huang, Li-Rung; Chang, Chungming] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Mong-Liang] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Chou, Yu-Chi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan	Chou, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	chou0315@imb.sinica.edu.tw; tonychang@nhri.org.tw	Tsai, Kuen-Nan/G-4606-2019; Liou, Gunn‐Guang/AAI-9787-2020		National Science Council [NSC 101-2320-B-400-009]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council grant (NSC 101-2320-B-400-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2009, J GEN VIROL, V90, P1238, DOI 10.1099/vir.0.009159-0; Akter P, 2003, J GEN VIROL, V84, P1117, DOI 10.1099/vir.0.18952-0; Baumert TF, 2007, WORLD J GASTROENTERO, V13, P82, DOI 10.3748/wjg.v13.i1.82; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; CARLIER D, 1995, J GEN VIROL, V76, P1041, DOI 10.1099/0022-1317-76-4-1041; Chen WN, 2010, J GEN VIROL, V91, P2592, DOI 10.1099/vir.0.022517-0; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; El Chaar M, 2012, J CLIN MICROBIOL, V50, P3159, DOI 10.1128/JCM.01251-12; Glenn M, 1999, J VIROL, V73, P6953, DOI 10.1128/JVI.73.8.6953-6963.1999; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Hacker HJ, 2003, BIOCHEM PHARMACOL, V66, P2273, DOI 10.1016/j.bcp.2003.08.001; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Heise T, 1999, J VIROL, V73, P474, DOI 10.1128/JVI.73.1.474-481.1999; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Huang CC, 2013, VIRUS RES, V174, P18, DOI 10.1016/j.virusres.2013.02.004; Huang HL, 2000, VIROLOGY, V275, P398, DOI 10.1006/viro.2000.0478; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lu YW, 2006, BIOCHEM BIOPH RES CO, V351, P64, DOI 10.1016/j.bbrc.2006.10.002; Mancini-Bourgine M, 2007, J VIROL, V81, P4963, DOI 10.1128/JVI.02619-06; NASSAL M, 1992, J MOL BIOL, V225, P1013, DOI 10.1016/0022-2836(92)90101-O; Obert S, 1996, EMBO J, V15, P2565, DOI 10.1002/j.1460-2075.1996.tb00614.x; ORITA S, 1991, FEBS LETT, V295, P127, DOI 10.1016/0014-5793(91)81402-T; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; Puro R, 2007, J VIROL, V81, P7351, DOI 10.1128/JVI.00554-07; Robek MD, 2004, P NATL ACAD SCI USA, V101, P1743, DOI 10.1073/pnas.0308340100; ROSMORDUC O, 1995, HEPATOLOGY, V22, P10, DOI 10.1016/0270-9139(95)90346-1; ROTHNIE HM, 1994, ADV VIRUS RES, V44, P1, DOI 10.1016/S0065-3527(08)60327-9; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; SCHLICHT HJ, 1991, J VIROL, V65, P6817, DOI 10.1128/JVI.65.12.6817-6825.1991; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Soussan P, 2000, J CLIN INVEST, V105, P55, DOI 10.1172/JCI8098; Soussan P, 2003, J HEPATOL, V38, P343, DOI 10.1016/S0168-8278(02)00422-1; Soussan P, 2008, J INFECT DIS, V198, P218, DOI 10.1086/589623; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SU TS, 1989, HEPATOLOGY, V9, P180, DOI 10.1002/hep.1840090203; TERRE S, 1991, J VIROL, V65, P5539; Tsui LV, 1995, P NATL ACAD SCI USA, V92, P12398, DOI 10.1073/pnas.92.26.12398; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; ZHOU SL, 1992, J VIROL, V66, P5393, DOI 10.1128/JVI.66.9.5393-5398.1992	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119625	10.1371/journal.pone.0119625	http://dx.doi.org/10.1371/journal.pone.0119625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785443	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500122
J	Al Laham, N; Mediavilla, JR; Chen, L; Abdelateef, N; Abu Elamreen, F; Ginocchio, CC; Pierard, D; Becker, K; Kreiswirth, BN				Al Laham, Nahed; Mediavilla, Jose R.; Chen, Liang; Abdelateef, Nahed; Abu Elamreen, Farid; Ginocchio, Christine C.; Pierard, Denis; Becker, Karsten; Kreiswirth, Barry N.			MRSA Clonal Complex 22 Strains Harboring Toxic Shock Syndrome Toxin (TSST-1) Are Endemic in the Primary Hospital in Gaza, Palestine	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; PATHOGENICITY ISLAND; SEQUENCE-ANALYSIS; EPIDEMIOLOGY; PREVALENCE; PATTERNS; HEALTHY; ISRAEL	Background Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in both community and healthcare-related settings worldwide. Current knowledge regarding the epidemiology of S. aureus and MRSA in Gaza is based on a single community-based carriage study. Here we describe a cross-sectional analysis of 215 clinical isolates collected from Al-Shifa Hospital in Gaza during 2008 and 2012. Methods All isolates were characterized by spa typing, SCCmec typing, and detection of genes encoding Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin (TSST-1). Representative genotypes were also subjected to multilocus sequence typing (MLST). Antibiotic susceptibility testing was performed using VITEK2 and MicroScan. Results MRSA represented 56.3% of all S. aureus strains, and increased in frequency from 2008 (54.8%) to 2012 (58.4%). Aside from beta-lactams, resistance was observed to tetracycline, erythromycin, clindamycin, gentamicin, and fluoroquinolones. Molecular typing identified 35 spa types representing 17 MLST clonal complexes (CC), with spa 998 (Ridom t223, CC22) and spa 70 (Ridom t044, CC80) being the most prevalent. SCCmec types I, III, IV, V and VI were identified among MRSA isolates, while type II was not detected. PVL genes lukF/S-PV) were detected in 40.0% of all isolates, while the TSST-1 gene (tst) was detected in 27.4% of all isolates, with surprisingly high frequency within CC22 (70.4%). Both PVL and TSST-1 genes were found in several isolates from 2012. Conclusions Molecular typing of clinical isolates from Gaza hospitals revealed unusually high prevalence of TSST-1 genes among CC22 MRSA, which is noteworthy given a recent community study describing widespread carriage of a CC22 MRSA clone known as the 'Gaza strain'. While the latter did not address TSST-1, tst-positive spa 998 (Ridom t223) has been detected in several neighboring countries, and described as endemic in an Italian NICU, suggesting international spread of a 'Middle Eastern variant' of pandemic CC22 strain EMRSA-15.	[Al Laham, Nahed] Al Azhar Univ Gaza, Dept Lab Med, Gaza, Israel; [Al Laham, Nahed; Mediavilla, Jose R.; Chen, Liang; Kreiswirth, Barry N.] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Abdelateef, Nahed; Abu Elamreen, Farid] Minist Hlth, Cent Labs, Gaza, Israel; [Ginocchio, Christine C.] North Shore LIJ Hlth Syst, Dept Pathol & Lab Med, Lake Success, NY USA; [Ginocchio, Christine C.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Pierard, Denis] Univ Hosp Brussels, Inst Med Microbiol, Brussels, Belgium; [Becker, Karsten] Univ Hosp Muenster, Inst Med Microbiol, Munster, Germany	Rutgers State University Newark; Rutgers State University New Brunswick; Northwell Health; Hofstra University; Northwell Health; University Hospital Brussels; University of Munster	Kreiswirth, BN (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA.	kreiswba@njms.rutgers.edu	Chen, Liang/Q-5337-2019; Al Laham, Nahed/HHD-2148-2022; Becker, Karsten/O-2302-2018	Chen, Liang/0000-0001-5845-2235; Becker, Karsten/0000-0002-6391-1341; Pierard, DEnis/0000-0002-7756-3691				Abou Shady HM, 2015, BRAZ J INFECT DIS, V19, P68, DOI 10.1016/j.bjid.2014.09.005; Adler A, 2012, J CLIN MICROBIOL, V50, P134, DOI 10.1128/JCM.05446-11; Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Adwan K, 2005, MICROB DRUG RESIST, V11, P75, DOI 10.1089/mdr.2005.11.75; Adwan K, 2013, AM J INFECT CONTROL, V41, P195, DOI 10.1016/j.ajic.2012.03.040; Al Laham Nahed A, 2012, J Infect Public Health, V5, P43, DOI 10.1016/j.jiph.2011.10.006; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Alon D, 2011, EUR J CLIN MICROBIOL, V30, P1443, DOI 10.1007/s10096-011-1243-9; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Aqel AA, 2012, ACTA MICROBIOL IMM H, V59, P239, DOI 10.1556/AMicr.59.2012.2.8; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Borg MA, 2007, J ANTIMICROB CHEMOTH, V60, P1310, DOI 10.1093/jac/dkm365; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Chmelnitsky I, 2008, EUR J CLIN MICROBIOL, V27, P385, DOI 10.1007/s10096-007-0426-x; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Elmanama AA, 2013, BURNS, V39, P1612, DOI 10.1016/j.burns.2013.04.011; Enany S, 2007, EUROSURVEILLANCE, V12, pE0709272, DOI DOI 10.2807/ESW.12.39.03274-EN; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Geraci DM, 2014, INFECTION, V42, P535, DOI 10.1007/s15010-013-0583-z; Geraci DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087760; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harastani HH, 2014, INT J INFECT DIS, V19, P33, DOI 10.1016/j.ijid.2013.10.007; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kaibni MH, 2009, J MED MICROBIOL, V58, P644, DOI 10.1099/jmm.0.007617-0; Kearns AM, 2008, STAPHYLOCOCCUS AUREU; Khalil W, 2012, DIAGN MICR INFEC DIS, V73, P228, DOI 10.1016/j.diagmicrobio.2012.03.012; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li Z, 2011, PLOS ONE, V6, pe27; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Mathema Barun, 2008, V431, P285; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; Regev-Yochay G, 2006, EUR J CLIN MICROBIOL, V25, P719, DOI 10.1007/s10096-006-0210-3; Sabri I, 2013, EUR J MICROBIOL IMMU, V3, P183, DOI 10.1556/EuJMI.3.2013.3.5; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Song Y, 2013, J MED MICROBIOL, V62, P274, DOI 10.1099/jmm.0.050971-0; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian S, 2014, CLIN MICROBIOL INFEC, V20, P624, DOI 10.1111/1469-0691.12691; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Weber S, 2010, GENETIC FINGERPRINTI; Wikipedia contributors, 2014, DEM PAL TERR; Wolter DJ, 2008, J CLIN MICROBIOL, V46, P3548, DOI 10.1128/JCM.00985-08	64	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120008	10.1371/journal.pone.0120008	http://dx.doi.org/10.1371/journal.pone.0120008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781188	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600118
J	Ansuini, C; Cavallo, A; Koul, A; Jacono, M; Yang, Y; Becchio, C				Ansuini, Caterina; Cavallo, Andrea; Koul, Atesh; Jacono, Marco; Yang, Yuan; Becchio, Cristina			Predicting Object Size from Hand Kinematics: A Temporal Perspective	PLOS ONE			English	Article							PREHENSION MOVEMENTS; PARKINSONS-DISEASE; GRASP; MOTOR; COORDINATION; MODULATION; TRANSPORT; STIMULATION; INFORMATION; COMPONENTS	Research on reach-to-grasp movements generally concentrates on kinematics values that are expression of maxima, in particular the maximum aperture of the hand and the peak of wrist velocity. These parameters provide a snapshot description of movement kinematics at a specific time point during reach, i.e., the maximum within a set of value, but do not allow to investigate how hand kinematics gradually conform to target properties. The present study was designed to extend the characterization of object size effects to the temporal domain. Thus, we computed the wrist velocity and the grip aperture throughout reach-to-grasp movements aimed at large versus small objects. To provide a deeper understanding of how joint movements varied over time, we also considered the time course of finger motion relative to hand motion. Results revealed that movement parameters evolved in parallel but at different rates in relation to object size. Furthermore, a classification analysis performed using a Support Vector Machine (SVM) approach showed that kinematic features taken as a group predicted the correct target size well before contact with the object. Interestingly, some kinematics features exhibited a higher ability to discriminate the target size than others did. These findings reinforce our knowledge about the relationship between kinematics and object properties and shed new light on the quantity and quality of information available in the kinematics of a reach-to-grasp movement over time. This might have important implications for our understanding of the action-perception coupling mechanism.	[Ansuini, Caterina; Koul, Atesh; Jacono, Marco; Becchio, Cristina] Fdn Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Cavallo, Andrea; Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Yang, Yuan] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Turin; Delft University of Technology	Becchio, C (corresponding author), Fdn Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	cristina.becchio@unito.it	Yang, Yuan/I-5936-2019; Koul, Atesh/I-2176-2019; Cavallo, Andrea/AAB-9615-2019	Yang, Yuan/0000-0003-2442-3713; Koul, Atesh/0000-0002-0917-9583; Cavallo, Andrea/0000-0002-3717-3760; Jacono, Marco/0000-0002-5750-4395	European Research Council under the European Union's Seventh Framework Programme/ERC [312919]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC))	This work received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n. 312919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2010, BRAIN COGNITION, V74, P169, DOI 10.1016/j.bandc.2010.07.015; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Carpinella I, 2006, GAIT POSTURE, V23, P445, DOI 10.1016/j.gaitpost.2005.05.001; Carpinella I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-19; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cavallo Andrea, 2013, Tropical Medicine & International Health, V18, P3507, DOI 10.1111/ejn.12343; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; Fukuchi RK, 2011, J BIOMECH, V44, P540, DOI 10.1016/j.jbiomech.2010.09.031; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mason CR, 2004, J NEUROPHYSIOL, V91, P2826, DOI 10.1152/jn.00653.2003; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Schettino LF, 2009, INT J NEUROSCI, V119, P1905, DOI 10.1080/00207450903245296; Schettino LF, 2006, EXP BRAIN RES, V168, P186, DOI 10.1007/s00221-005-0080-4; Schettino LF, 2004, NEUROPSYCHOLOGIA, V42, P82, DOI 10.1016/S0028-3932(03)00150-7; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Theodoridis S., 2003, PATTERN RECOGNITION; Tolambiya A, 2012, NEUROSCIENCE, V210, P179, DOI 10.1016/j.neuroscience.2012.02.050; Tolambiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020732; Vapnik V., 2013, NATURE STAT LAERNING; WING AM, 1986, J MOTOR BEHAV, V18, P245; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Yang Y, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-38	40	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120432	10.1371/journal.pone.0120432	http://dx.doi.org/10.1371/journal.pone.0120432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781473	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600160
J	Ayzenberg, I; Schlevogt, S; Metzdorf, J; Stahlke, S; Pedreitturia, X; Hunfeld, A; Couillard-Despres, S; Kleiter, I				Ayzenberg, Ilya; Schlevogt, Sibylle; Metzdorf, Judith; Stahlke, Sarah; Pedreitturia, Xiomara; Hunfeld, Anika; Couillard-Despres, Sebastien; Kleiter, Ingo			Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; INFLAMMATION ALTERS; SUBVENTRICULAR ZONE; PRECURSOR CELLS; SPINAL-CORD; MICE; PERMEABILITY	Bioluminescence imaging is a sensitive approach for longitudinal neuroimaging. Transgenic mice expressing luciferase under the promoter of doublecortin (DCX-luc), a specific marker of neuronal progenitor cells (NPC), allow monitoring of neurogenesis in living mice. Since the extent and time course of neurogenesis during autoimmune brain inflammation are controversial, we investigated neurogenesis in MOG-peptide induced experimental allergic encephalomyelitis (EAE) using DCX-luc reporter mice. We observed a marked, 2- to 4-fold increase of the bioluminescence signal intensity 10 days after EAE induction and a gradual decline 1-2 weeks thereafter. In contrast, immunostaining for DCX revealed no differences between EAE and control mice 2 and 4 weeks after immunization in zones of adult murine neurogenesis such as the dentate gyrus. Ex vivo bioluminescence imaging showed similar luciferase expression in brain homogenates of EAE and control animals. Apart from complete immunization including MOG-peptide also incomplete immunization with complete Freund's adjuvant and pertussis toxin resulted in a rapid increase of the in vivo bioluminescence signal. Blood-brain barrier (BBB) leakage was demonstrated 10 days after both complete and incomplete immunization and might explain the increased bioluminescence signal in vivo. We conclude, that acute autoimmune inflammation in EAE does not alter neurogenesis, at least at the stage of DCX-expressing NPC. Effects of immunization on the BBB integrity must be considered when luciferase is used as a reporter within the CNS during the active stage of EAE. Models with stable CNS-restricted luciferase expression could serve as technically convenient way to evaluate BBB integrity in a longitudinal manner.	[Ayzenberg, Ilya; Schlevogt, Sibylle; Metzdorf, Judith; Stahlke, Sarah; Pedreitturia, Xiomara; Kleiter, Ingo] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Hunfeld, Anika] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Expt Neuroregenerat, Salzburg, Austria; [Couillard-Despres, Sebastien] Paracelsus Med Univ, SCI TReCS, Salzburg, Austria	Ruhr University Bochum; Ruhr University Bochum; Paracelsus Private Medical University; Paracelsus Private Medical University	Kleiter, I (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.	ingo.kleiter@rub.de	Ayzenberg, Ilya/AAK-5545-2020; Kleiter, Ingo/AAD-1132-2020	Kleiter, Ingo/0000-0002-8249-4408; Pedreiturria, Xiomara/0000-0002-3024-3826; Couillard-Despres, Sebastien/0000-0002-8486-6412; , Ilya/0000-0002-6009-792X	Bayer Healthcare; State Government of Salzburg (Austria); European Union [HEALTH-F2-2011-279288, HEALTH-346F2-2011-278850]	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); State Government of Salzburg (Austria); European Union(European Commission)	Part of the study was supported by a research grant from Bayer Healthcare to IK. This manuscript has been made possible through the financial support from the State Government of Salzburg (Austria) and through funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-279288 (IDEA) and no HEALTH-346F2-2011-278850 (INMiND) to SCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; BERGMAN RK, 1978, INFECT IMMUN, V21, P627, DOI 10.1128/IAI.21.2.627-637.1978; Calza L, 1998, P NATL ACAD SCI USA, V95, P3209, DOI 10.1073/pnas.95.6.3209; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; DeVries HE, 1997, PHARMACOL REV, V49, P143; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Giannakopoulou A, 2013, J NEUROSCI RES, V91, P890, DOI 10.1002/jnr.23226; Guo J, 2010, NEUROSIGNALS, V18, P1, DOI 10.1159/000242424; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; Hochgrafe K, 2013, MOL NEUROBIOL, V47, P868, DOI 10.1007/s12035-012-8379-1; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Huehnchen P, 2011, GLIA, V59, P132, DOI 10.1002/glia.21082; Kim H, 2012, STEM CELLS, V30, P2820, DOI 10.1002/stem.1218; Kim H, 2012, GLIA, V60, P1117, DOI 10.1002/glia.22339; Kleiter I, 2007, J NEUROIMMUNOL, V187, P61, DOI 10.1016/j.jneuroim.2007.04.014; Lee KH, 2003, NUCL MED COMMUN, V24, P1003, DOI 10.1097/00006231-200309000-00009; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Luo J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-6; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nielsen HH, 2011, AM J PATHOL, V179, P2028, DOI 10.1016/j.ajpath.2011.06.006; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Rabchevsky AG, 1999, BRAIN RES, V832, P84, DOI 10.1016/S0006-8993(99)01479-1; REIBER H, 1984, J NEUROL SCI, V63, P55, DOI 10.1016/0022-510X(84)90108-4; Sher F, 2012, CELL TRANSPLANT, V21, P1883, DOI 10.3727/096368911X637443; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Tonra JR, 2001, J COMP NEUROL, V430, P131; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	35	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118550	10.1371/journal.pone.0118550	http://dx.doi.org/10.1371/journal.pone.0118550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780928	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600026
J	Chen, L; Liu, YS; Liu, HD; Kang, LM; Geng, JM; Gai, YZ; Ding, YL; Sun, HY; Li, YD				Chen, Li; Liu, Yushan; Liu, Hongdi; Kang, Limin; Geng, Jinman; Gai, Yuzhuo; Ding, Yunlong; Sun, Haiyue; Li, Yadong			Identification and Expression Analysis of MATE Genes Involved in Flavonoid Transport in Blueberry Plants	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; PROANTHOCYANIDIN BIOSYNTHESIS; ANTHOCYANIN BIOSYNTHESIS; VACUOLAR SEQUESTRATION; SECONDARY METABOLITES; ALUMINUM TOLERANCE; IRON HOMEOSTASIS; SEED COAT; MULTIDRUG	Multidrug and toxic compound extrusion (MATE) proteins are the most recently identified family of multidrug transporters. In plants, this family is remarkably large compared to the human and bacteria counterpart, highlighting the importance of MATE proteins in this kingdom. Here 33 Unigenes annotated as MATE transporters were found in the blueberry fruit transcriptome, of which eight full-length cDNA sequences were identified and cloned. These proteins are composed of 477-517 residues, with molecular masses similar to 54 kDa, and theoretical isoelectric points from 5.35 to 8.41. Bioinformatics analysis predicted 10-12 putative transmembrane segments for VcMATEs, and localization to the plasma membrane without an N-terminal signal peptide. All blueberry MATE proteins shared 32.1-84.4% identity, among which VcMATE2, VcMATE3, VcMATE5, VcMATE7, VcMATE8, and VcMATE9 were more similar to the MATE-type flavonoid transporters. Phylogenetic analysis showed VcMATE2, VcMATE3, VcMATE5, VcMATE7, VcMATE8 and VcMATE9 clustered with MATE-type flavonoid transporters, indicating that they might be involved in flavonoid transport. VcMATE1 and VcMATE4 may be involved in the transport of secondary metabolites, the detoxification of xenobiotics, or the export of toxic cations. Real-time quantitative PCR demonstrated that the expression profile of the eight VcMATE genes varied spatially and temporally. Analysis of expression and anthocyanin accumulation indicated that there were some correlation between the expression profile and the accumulation of anthocyanins. These results showed VcMATEs might be involved in diverse physiological functions, and anthocyanins across the membranes might be mutually maintained by MATE-type flavonoid transporters and other mechanisms. This study will enrich the MATE-based transport mechanisms of secondary metabolite, and provide a new biotechonology strategy to develop better nutritional blueberry cultivars.	[Chen, Li; Liu, Yushan; Liu, Hongdi; Kang, Limin; Geng, Jinman; Gai, Yuzhuo; Ding, Yunlong; Sun, Haiyue; Li, Yadong] Jilin Agr Univ, Coll Hort, Changchun, Jilin, Peoples R China	Jilin Agricultural University	Sun, HY (corresponding author), Jilin Agr Univ, Coll Hort, Changchun, Jilin, Peoples R China.	haiyue-sun@hotmail.com; blueberryli@163.com			National Natural Science Foundation of China [31301755]; Special Fund for Agro-scientific Research in the Public Interest of China [201103037]; Doctoral Program Foundation of Institutions of Higher Education of China [2013223120004]; Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china; Breeding Foundation of Jilin Province Department of Finance [2012004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china; Breeding Foundation of Jilin Province Department of Finance	This work was supported by the National Natural Science Foundation of China (grant no. 31301755), the Special Fund for Agro-scientific Research in the Public Interest of China (grant no. 201103037), the Doctoral Program Foundation of Institutions of Higher Education of China (grant no. 2013223120004), the Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china, and the Breeding Foundation of Jilin Province Department of Finance (2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahams S, 2002, PLANT PHYSIOL, V130, P561, DOI 10.1104/pp.006189; AI P, 2011, THESIS; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Burko Y, 2011, PLANT CELL PHYSIOL, V52, P518, DOI 10.1093/pcp/pcr007; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Chung YJ, 2001, J BACTERIOL, V183, P1012, DOI 10.1128/JB.183.3.1012-1021.2001; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; FRANCIS FJ, 1989, CRIT REV FOOD SCI, V28, P273, DOI 10.1080/10408398909527503; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Gomez C, 2009, PLANT PHYSIOL, V150, P402, DOI 10.1104/pp.109.135624; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; Hadacek F, 2002, CRIT REV PLANT SCI, V21, P273, DOI 10.1080/0735-260291044269; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Kocic B, 2011, J BUON, V16, P602; Lee J, 2005, J AOAC INT, V88, P1269; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Oakenfull RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054119; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Roytrakul Sittiruk, 2007, Phytochemistry Reviews, V6, P383, DOI 10.1007/s11101-006-9022-4; Sanoner P, 1999, J AGR FOOD CHEM, V47, P4847, DOI 10.1021/jf990563y; Seo PJ, 2012, BIOCHEM J, V442, P551, DOI 10.1042/BJ20111311; Shoji T, 2009, PLANT PHYSIOL, V149, P708, DOI 10.1104/pp.108.132811; Solovchenko A, 2003, J EXP BOT, V54, P1977, DOI 10.1093/jxb/erg199; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Tahara S, 2007, BIOSCI BIOTECH BIOCH, V71, P1387, DOI 10.1271/bbb.70028; Tanaka Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1760, DOI 10.1271/bbb.100358; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Thompson EP, 2010, J EXP BOT, V61, P439, DOI 10.1093/jxb/erp312; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8; Zhang W, 2004, BIOMED RES INT, V2004, P239; Zhang XH, 2012, J BIOL CHEM, V287, P27971, DOI 10.1074/jbc.M112.386979; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819	57	42	46	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118578	10.1371/journal.pone.0118578	http://dx.doi.org/10.1371/journal.pone.0118578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781331	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600029
J	Idrovo, JP; Yang, WL; Jacob, A; Ajakaiye, MA; Cheyuo, C; Wang, ZM; Prince, JM; Nicastro, J; Coppa, GF; Wang, P				Idrovo, Juan-Pablo; Yang, Weng-Lang; Jacob, Asha; Ajakaiye, Michael A.; Cheyuo, Cletus; Wang, Zhimin; Prince, Jose M.; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping			Combination of Adrenomedullin with Its Binding Protein Accelerates Cutaneous Wound Healing	PLOS ONE			English	Article							VASOACTIVE HORMONE ADRENOMEDULLIN; GUT ISCHEMIA; INJURY; SEPSIS; METALLOPROTEINASES; MECHANISMS; FLUIDS	Cutaneous wound continues to cause significant morbidity and mortality in the setting of diseases such as diabetes and cardiovascular diseases. Despite advances in wound care management, there is still an unmet medical need exists for efficient therapy for cutaneous wound. Combined treatment of adrenomedullin (AM) and its binding protein-1 (AMBP-1) is protective in various disease conditions. To examine the effect of the combination treatment of AM and AMBP-1 on cutaneous wound healing, full-thickness 2.0-cm diameter circular excision wounds were surgically created on the dorsum of rats, saline (vehicle) or AM/AMBP1 (96/320 mu g kg BW) was topically applied to the wound daily and wound size measured. At days 3, 7, and 14, skin samples were collected from the wound sites. AM/AMBP-1 treated group had significantly smaller wound surface area than the vehicle group over the 14-day time course. At day 3, AM/AMBP-1 promoted neutrophil infiltration (MPO), increased cytokine levels (IL-6 and TNF-alpha), angiogenesis (CD31, VEGF and TGF beta-1) and cell proliferation (Ki67). By day 7 and 14, AM/AMBP-1 treatment decreased MPO, followed by a rapid resolution of inflammation characterized by a decrease in cytokines. At the matured stage, AM/AMBP-1 treatment increased the alpha smooth muscle actin expression (mature blood vessels) and Masson-Trichrome staining (collagen deposition) along the granulation area, and increased MMP-9 and decreased MMP-2 mRNA expressions. TGF beta-1 mRNA levels in AM/AMBP-1 group were 5.3 times lower than those in the vehicle group. AM/AMBP-1 accelerated wound healing by promoting angiogenesis, collagen deposition and remodeling. Treatment also shortened the days to reach plateau for wound closure. Thus, AM/AMBP-1 may be further developed as a therapeutic for cutaneous wound healing.	[Idrovo, Juan-Pablo; Yang, Weng-Lang; Jacob, Asha; Ajakaiye, Michael A.; Cheyuo, Cletus; Wang, Zhimin; Prince, Jose M.; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA; [Yang, Weng-Lang; Jacob, Asha; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Hofstra University; Northwell Health; Northwell Health	Wang, P (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021; Idrovo, Juan-Pablo/AAA-4949-2021; Cheyuo, Cletus/AAM-5785-2021	Cheyuo, Cletus/0000-0002-9717-3738; Wang, Ping/0000-0002-1557-0394	US National Institute of Health [R01 HL07619]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grants from the US National Institute of Health (R01 HL07619) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NA, 1999, CRIT CARE MED, V27, P2459, DOI 10.1097/00003246-199911000-00023; Boo S, 2013, ADV WOUND CARE, V2, P238, DOI 10.1089/wound.2012.0394; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Carrizo GJ, 2007, SURGERY, V141, P245, DOI 10.1016/j.surg.2006.05.017; Chaung WW, 2011, MOL MED, V17, P1075, DOI 10.2119/molmed.2010.00104; CROSS SE, 1995, BRIT J PLAST SURG, V48, P189, DOI 10.1016/0007-1226(95)90001-2; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dorsett-Martin WA, SOURCEBOOK MODELS BI, P631, DOI [10.1007/978-1-59745-285-4_65, DOI 10.1007/978-1-59745-285-4_65]; Elsasser TH, 1999, ENDOCRINOLOGY, V140, P4908, DOI 10.1210/en.140.10.4908; Eming S, 2008, BIOMATERIALS, V29, P2932, DOI 10.1016/j.biomaterials.2008.03.029; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guidolin D, 2008, PEPTIDES, V29, P2013, DOI 10.1016/j.peptides.2008.07.009; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hoffmann U, 2006, SCAND J INFECT DIS, V38, P867, DOI 10.1080/00365540600702058; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Koenen P, 2015, INT WOUND J, V12, P10, DOI 10.1111/iwj.12039; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Lazarus Gerald S., 1994, Wound Repair and Regeneration, V2, P165, DOI 10.1046/j.1524-475X.1994.20305.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medina A, 2005, J BURN CARE REHABIL, V26, P306, DOI 10.1097/01.BCR.0000169887.04973.3A; Mogford JE, 2001, CUTANEOUS WOUND HEAL, P109; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Qiang XL, 2008, MOL MED, V14, P443, DOI 10.2119/2008-00015.Qiang; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Ruckley C V, 1997, J Wound Care, V6, P442; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; Shah KG, 2010, J SURG RES, V163, P110, DOI 10.1016/j.jss.2010.03.064; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Wu RQ, 2008, PEPTIDES, V29, P1223, DOI 10.1016/j.peptides.2008.02.021; Wu RQ, 2009, MOL MED, V15, P28, DOI 10.2119/molmed.2008.00092; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637; Yang JT, 2009, ANN SURG, V249, P310, DOI 10.1097/SLA.0b013e3181961d43; Zhang FM, 2009, REGUL PEPTIDES, V152, P82, DOI 10.1016/j.regpep.2008.09.007; Zhou M, 2002, AM J PHYSIOL-REG I, V283, pR553, DOI 10.1152/ajpregu.00544.2001; Zudaire E, 2003, REGUL PEPTIDES, V112, P121, DOI 10.1016/S0167-0115(03)00030-2	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120225	10.1371/journal.pone.0120225	http://dx.doi.org/10.1371/journal.pone.0120225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781901	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600142
J	Rigalli, JP; Ciriaci, N; Arias, A; Ceballos, MP; Villanueva, SSM; Luquita, MG; Mottino, AD; Ghanem, CI; Catania, VA; Ruiz, ML				Pablo Rigalli, Juan; Ciriaci, Nadia; Arias, Agostina; Paula Ceballos, Maria; Maris Villanueva, Silvina Stella; Gabriel Luquita, Marcelo; Domingo Mottino, Aldo; Ines Ghanem, Carolina; Alicia Catania, Viviana; Laura Ruiz, Maria			Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity	PLOS ONE			English	Article							PREGNANE X RECEPTOR; P-GLYCOPROTEIN; DOWN-REGULATION; HEPG2 CELLS; EFFLUX TRANSPORTERS; DRUG-RESISTANCE; HUMAN CYP3A4; EXPRESSION; INDUCTION; BINDING	Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide. Sorafenib is the only drug available that improves the overall survival of HCC patients. P-glycoprotein (P-gp), Multidrug resistance-associated proteins 2 and 3 (MRP2 and 3) and Breast cancer resistance protein (BCRP) are efflux pumps that play a key role in cancer chemoresistance. Their modulation by dietary compounds may affect the intracellular accumulation and therapeutic efficacy of drugs that are substrates of these transporters. Genistein (GNT) is a phytoestrogen abundant in soybean that exerts its genomic effects through Estrogen-Receptors and Pregnane-X-Receptor (PXR), which are involved in the regulation of the above-mentioned transporters. We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP3 and BCRP in HCC-derived HepG2 cells. GNT (at 1.0 and 10 mu M) increased P-gp and MRP2 protein expression and activity, correlating well with an increased resistance to sorafenib cytotoxicity as detected by the methylthiazole tetrazolium (MTT) assay. GNT induced P-gp and MRP2 mRNA expression at 10 but not at 1.0 mu M concentration suggesting a different pattern of regulation depending on the concentration. Induction of both transporters by 1.0 mu M GNT was prevented by cycloheximide, suggesting translational regulation. Downregulation of expression of the miR-379 by GNT could be associated with translational regulation of MRP2. Silencing of PXR abolished P-gp induction by GNT (at 1.0 and 10 mu M) and MRP2 induction by GNT (only at 10 mu M), suggesting partial mediation of GNT effects by PXR. Taken together, the data suggest the possibility of nutrient-drug interactions leading to enhanced chemoresistance in HCC when GNT is ingested with soy rich diets or dietary supplements.	[Pablo Rigalli, Juan; Ciriaci, Nadia; Arias, Agostina; Paula Ceballos, Maria; Maris Villanueva, Silvina Stella; Gabriel Luquita, Marcelo; Domingo Mottino, Aldo; Alicia Catania, Viviana; Laura Ruiz, Maria] Rosario Natl Univ, Fac Biochem & Pharmaceut Sci, Inst Expt Physiol IFISE CONICET, Rosario, Argentina; [Ines Ghanem, Carolina] Univ Buenos Aires, Fac Pharm & Biochem, Inst Pharmacol Invest ININFA CONICET, Buenos Aires, DF, Argentina	National University of Rosario; University of Buenos Aires	Ruiz, ML (corresponding author), Rosario Natl Univ, Fac Biochem & Pharmaceut Sci, Inst Expt Physiol IFISE CONICET, Rosario, Argentina.	ruiz@ifise-conicet.gov.ar	Rigalli, Juan Pablo/E-2099-2018	Rigalli, Juan Pablo/0000-0003-4168-9396; Ghanem, Carolina Ines/0000-0002-7426-459X; Ciriaci, Nadia/0000-0001-9786-8452	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT0360, PICT1503]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0240]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica [PICT0360 (VAC) and PICT1503 (MLR)] and Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0240 (ADM)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achira M, 1999, AAPS PHARMSCI, V1; Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Anwar SL, 2014, WORLD J GASTROENTERO, V20, P7894, DOI 10.3748/wjg.v20.i24.7894; Arias A, 2014, TOXICOLOGY, V320, P46, DOI 10.1016/j.tox.2014.03.007; BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S; Barone Michele, 2012, J Gastrointest Cancer, V43, P13, DOI 10.1007/s12029-011-9332-7; Borst P, 2006, CANCER LETT, V234, P51, DOI 10.1016/j.canlet.2005.05.051; Cao Y, 2009, J EXPO SCI ENV EPID, V19, P223, DOI 10.1038/jes.2008.44; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cui PH, 2013, BIOCHEM PHARMACOL, V86, P419, DOI 10.1016/j.bcp.2013.05.014; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Floyd KA, 2011, EXP EYE RES, V92, P120, DOI 10.1016/j.exer.2010.12.006; Folmer Y, 2007, CANCER GENE THER, V14, P875, DOI 10.1038/sj.cgt.7701082; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Geick A, 2001, J Biol Chem, V276, P14581; Ghassabian S, 2012, BIOCHEM PHARMACOL, V84, P215, DOI 10.1016/j.bcp.2012.04.001; Haenisch S, 2011, MOL PHARMACOL, V80, P314, DOI 10.1124/mol.110.070714; Herzog M, 2011, N-S ARCH PHARMACOL, V383, P1, DOI 10.1007/s00210-010-0568-8; Hishida M, 2013, INT J ONCOL, V43, P88, DOI 10.3892/ijo.2013.1951; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Keubler A, 2012, DRUG METAB DISPOS, V40, P1178, DOI 10.1124/dmd.111.043844; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kohle C, 2009, BIOCHEM PHARMACOL, V77, P689, DOI 10.1016/j.bcp.2008.05.020; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Korita PV, 2010, ONCOL REP, V23, P965, DOI 10.3892/or_00000721; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Kubitz R, 2005, METHOD ENZYMOL, V400, P542, DOI 10.1016/S0076-6879(05)00030-3; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Ruiz ML, 2013, BIOCHEM PHARMACOL, V86, P401, DOI 10.1016/j.bcp.2013.05.025; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2238, DOI 10.5754/hge11781; Li LH, 2009, PHARM RES-DORDR, V26, P872, DOI 10.1007/s11095-008-9788-8; Li YL, 2009, J NUTR, V139, P898, DOI 10.3945/jn.108.103572; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma J, 2013, CURR DRUG TARGETS, V14, P1150, DOI 10.2174/13894501113149990187; Manov I, 2007, J PHARMACOL EXP THER, V322, P1013, DOI 10.1124/jpet.107.121772; Martins Rute, 2012, PLoS One, V7, pe35461, DOI 10.1371/journal.pone.0035461; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Rigalli JP, 2011, TOXICOLOGY, V285, P18, DOI 10.1016/j.tox.2011.03.015; Peck-Radosavljevic M, 2014, LIVER CANCER, V3, P125, DOI 10.1159/000343868; Rigalli JP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001951; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Salleh N, 2013, INT J MED SCI, V10, P665, DOI 10.7150/ijms.5207; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Shibayama Y, 2011, BIOL PHARM BULL, V34, P433, DOI 10.1248/bpb.34.433; SORMUNEN R, 1993, LAB INVEST, V68, P652; Sun L, 2013, MOL MED REP, V8, P1883, DOI 10.3892/mmr.2013.1742; Tu CC, 2013, J MOL ENDOCRINOL, V51, P203, DOI 10.1530/JME-13-0085; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vore M, 2011, FASEB J, V25; Wang H, 2013, PHYTOMEDICINE, V20, P985, DOI 10.1016/j.phymed.2013.04.014; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yang T, 2013, EXP BIOL MED, V238, P1024, DOI 10.1177/1535370213497321; Ye L, 2013, TOXICOL LETT, V216, P86, DOI 10.1016/j.toxlet.2012.11.011; Zhang T, 2013, BRIT J NUTR, V109, P223, DOI 10.1017/S0007114512001110	56	54	58	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119502	10.1371/journal.pone.0119502	http://dx.doi.org/10.1371/journal.pone.0119502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781341	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600069
J	Seimon, TA; Olson, SH; Lee, KJ; Rosen, G; Ondzie, A; Cameron, K; Reed, P; Anthony, SJ; Joly, DO; McAloose, D; Lipkin, WI				Seimon, Tracie A.; Olson, Sarah H.; Lee, Kerry Jo; Rosen, Gail; Ondzie, Alain; Cameron, Kenneth; Reed, Patricia; Anthony, Simon J.; Joly, Damien O.; McAloose, Denise; Lipkin, W. Ian			Adenovirus and Herpesvirus Diversity in Free-Ranging Great Apes in the Sangha Region of the Republic of Congo	PLOS ONE			English	Article							NATIONAL-PARK; EVOLUTION; CYTOMEGALOVIRUS; CHIMPANZEES; GORILLAS; METAPNEUMOVIRUS; IDENTIFICATION; COINFECTIONS; INFECTION; OUTBREAK	Infectious diseases have caused die-offs in both free-ranging gorillas and chimpanzees. Understanding pathogen diversity and disease ecology is therefore critical for conserving these endangered animals. To determine viral diversity in free-ranging, non-habituated gorillas and chimpanzees in the Republic of Congo, genetic testing was performed on great-ape fecal samples collected near Odzala-Kokoua National Park. Samples were analyzed to determine ape species, identify individuals in the population, and to test for the presence of herpesviruses, adenoviruses, poxviruses, bocaviruses, flaviviruses, paramyxoviruses, coronaviruses, filoviruses, and simian immunodeficiency virus (SIV). We identified 19 DNA viruses representing two viral families, Herpesviridae and Adenoviridae, of which three herpesviruses had not been previously described. Co-detections of multiple herpesviruses and/or adenoviruses were present in both gorillas and chimpanzees. Cytomegalovirus (CMV) and lymphocryptovirus (LCV) were found primarily in the context of co-association with each other and adenoviruses. Using viral discovery curves for herpesviruses and adenoviruses, the total viral richness in the sample population of gorillas and chimpanzees was estimated to be a minimum of 23 viruses, corresponding to a detection rate of 83%. These findings represent the first description of DNA viral diversity in feces from free-ranging gorillas and chimpanzees in or near the Odzala-Kokoua National Park and form a basis for understanding the types of viruses circulating among great apes in this region.	[Seimon, Tracie A.; McAloose, Denise] Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY 10460 USA; [Olson, Sarah H.; Ondzie, Alain; Cameron, Kenneth; Reed, Patricia; Joly, Damien O.] Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, Bronx, NY USA; [Seimon, Tracie A.; Lee, Kerry Jo; Rosen, Gail; Anthony, Simon J.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Olson, Sarah H.] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA	Wildlife Conservation Society; Wildlife Conservation Society; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Seimon, TA (corresponding author), Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY 10460 USA.	tseimon@wcs.org	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386	United States Agency for International Development (USAID) Emerging Pandemic Threats program; National Institute of Health Centers of Excellence for Translational Research (CETR) [1U19AI109761]; United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund; Neu Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109761] Funding Source: NIH RePORTER	United States Agency for International Development (USAID) Emerging Pandemic Threats program(United States Agency for International Development (USAID)); National Institute of Health Centers of Excellence for Translational Research (CETR); United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund; Neu Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats program, PREDICT project to WIL and DJ; from the National Institute of Health Centers of Excellence for Translational Research (CETR) grant No. 1U19AI109761 to WIL, from the United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund, the Neu Foundation, Mr. and Mrs. Bradley L. Goldberg to KC and TR, and donors supporting the Wildlife Conservation Society Zoological and Wildlife Health and Health Policy Programs to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benko M, 2014, FUTURE MICROBIOL, V9, P269, DOI 10.2217/fmb.13.170; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chiu CY, 2013, MBIO, V4, DOI 10.1128/mBio.00084-13; Chmielewicz B, 2001, VIRUS RES, V75, P87, DOI 10.1016/S0168-1702(00)00252-5; Clewley JP, 1998, J VIROL, V72, P10305, DOI 10.1128/JVI.72.12.10305-10309.1998; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Cooper Natalie, 2013, Evolution Medicine and Public Health, P27, DOI 10.1093/emph/eot001; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; King A.M.Q., 2012, NINTH REPORT OF THEI, P125; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Leendertz FH, 2009, J GEN VIROL, V90, P2386, DOI 10.1099/vir.0.011866-0; Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; McVey D, 2013, VIROLOGY, V444, P119, DOI 10.1016/j.virol.2013.05.041; Michaels MG, 1997, J INFECT DIS, V176, P1476, DOI 10.1086/514144; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Muller R, 2009, J VIROL METHODS, V155, P161, DOI 10.1016/j.jviromet.2008.10.014; Noble Rachel T., 2003, Journal of Water and Health, V1, P195; Oates JF, IUCN 2013 IUCN RED L; Olson S, 2012, EMERG HLTH THREATS J, V5; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Prepens S, 2007, VIROL J, V4, P1; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed PE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003143; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; Ruuskanen O, 1997, CLINICAL VIROLOGY, P1355; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vora GJ, 2006, EMERG INFECT DIS, V12, P921, DOI 10.3201/eid1206.050245; Walsh PD, IUCN 2013 IUCN RED L; Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]; Wang X, 2010, VIROL J, V7, DOI [10.1186/1743-1422X-1187-1247, DOI 10.1186/1743-1422X-1187-1247]; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Wertheim JO, 2014, MOL BIOL EVOL, V31, P2356, DOI 10.1093/molbev/msu185; Wevers D, 2010, VIROL J, V7, DOI [10.1186/1743-1422X-1187-1303, DOI 10.1186/1743-1422X-1187-1303]; Wevers D, 2011, J VIROL, V85, P10774, DOI 10.1128/JVI.00810-11; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06	57	27	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118543	10.1371/journal.pone.0118543	http://dx.doi.org/10.1371/journal.pone.0118543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781992	Green Published, gold			2022-12-26	WOS:000351284600025
J	Varnet, L; Knoblauch, K; Serniclaes, W; Meunier, F; Hoen, M				Varnet, Leo; Knoblauch, Kenneth; Serniclaes, Willy; Meunier, Fanny; Hoen, Michel			A Psychophysical Imaging Method Evidencing Auditory Cue Extraction during Speech Perception: A Group Analysis of Auditory Classification Images	PLOS ONE			English	Article							STOP-CONSONANT PERCEPTION; RECEPTIVE-FIELDS; PSYCHOACOUSTIC METHOD; SPECTRAL CONTRAST; PRECEDING LIQUID; COARTICULATION; IDENTIFICATION; COMPENSATION; RECOGNITION; NOISE	Although there is a large consensus regarding the involvement of specific acoustic cues in speech perception, the precise mechanisms underlying the transformation from continuous acoustical properties into discrete perceptual units remains undetermined. This gap in knowledge is partially due to the lack of a turnkey solution for isolating critical speech cues from natural stimuli. In this paper, we describe a psychoacoustic imaging method known as the Auditory Classification Image technique that allows experimenters to estimate the relative importance of time-frequency regions in categorizing natural speech utterances in noise. Importantly, this technique enables the testing of hypotheses on the listening strategies of participants at the group level. We exemplify this approach by identifying the acoustic cues involved in da/ga categorization with two phonetic contexts, Al- or Ar-. The application of Auditory Classification Images to our group of 16 participants revealed significant critical regions on the second and third formant onsets, as predicted by the literature, as well as an unexpected temporal cue on the first formant. Finally, through a cluster-based nonparametric test, we demonstrate that this method is sufficiently sensitive to detect fine modifications of the classification strategies between different utterances of the same phoneme.	[Varnet, Leo; Hoen, Michel] CNRS, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, UMR 5292, Lyon, France; [Knoblauch, Kenneth] INSERM, Stem Cell & Brain Res Inst, Integrat Neurosci Dept, U846, F-69500 Bron, France; [Varnet, Leo; Meunier, Fanny] CNRS, Lab Langage Cerveau & Cognit, Auditory Language Proc ALP Res Grp, UMR 5304, Lyon, France; [Hoen, Michel] INSERM, U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, F-69008 Lyon, France; [Varnet, Leo; Meunier, Fanny; Hoen, Michel] Univ Lyon 1, F-69365 Lyon, France; [Serniclaes, Willy] Univ Libre Bruxelles, UNESCOG, CP191, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Libre de Bruxelles	Varnet, L (corresponding author), CNRS, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, UMR 5292, Lyon, France.	leo.varnet@isc.cnrs.fr	Michel, Hoen/C-7721-2012; Varnet, Léo/GQQ-5522-2022; Knoblauch, Kenneth/H-8156-2014	Michel, Hoen/0000-0003-2099-8130; Varnet, Léo/0000-0002-9702-2649; Knoblauch, Kenneth/0000-0002-4681-4638; SERNICLAES, WILLY/0000-0002-2047-0718	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council [209234]; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program [ANR-10-LABX-0083]	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council(European Research Council (ERC)European Commission); French National Research Agency (ANR) as part of the "Investissements d'Avenir" program(French National Research Agency (ANR))	LV is funded by a PhD grant from the Ecole Doctorale Neurosciences et Cognition (http://nsco.universite-lyon.fr/), Lyon-1 University, France. This research was partially supported by a European Research Council (http://erc.europa.eu/) grant for the SpiN project (No. 209234) attributed to FM and by a public grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (reference: ANR-10-LABX-0083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2006, J VISION, V6, P335, DOI 10.1167/6.4.4; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 2002, J VISION, V2, P121, DOI 10.1167/2.1.8; Ahumada Jr AJ, 1996, ECVP96 ABSTRACTS, DOI [10.1155/2013/627230, DOI 10.1155/2013/627230]; Apoux F, 2009, HEARING RES, V255, P99, DOI 10.1016/j.heares.2009.06.005; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Bouet R, 2004, VISUAL NEUROSCI, V21, P283, DOI 10.1017/S0952523804213141; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; DELATTRE PC, 1955, J ACOUST SOC AM, V27, P769, DOI 10.1121/1.1908024; Fant G, 1971, 2 ACOUSTIC THEORY SP; Fowler CA, 2006, PERCEPT PSYCHOPHYS, V68, P161, DOI 10.3758/BF03193666; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Gold JM, 2004, COGNITIVE SCI, V28, P167, DOI 10.1016/j.cogsci.2003.10.005; Holt LL, 2006, J ACOUST SOC AM, V119, P4016, DOI 10.1121/1.2195119; Holt LL, 2002, HEARING RES, V167, P156, DOI 10.1016/S0378-5955(02)00383-0; Johnson K., 2011, ACOUSTIC AUDITORY PH, V3rd ed.; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Joosten ERM, 2012, BIOL CYBERN, V106, P465, DOI 10.1007/s00422-012-0510-x; Juneja A, 2012, J ACOUST SOC AM, V131, pEL256, DOI 10.1121/1.3684744; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Knoblauch K., 2012, MODELING PSYCHOPHYSI; Knoblauch K, 2008, J VISION, V8, DOI 10.1167/8.16.10; Kurki I, 2014, J VISION, V14, DOI 10.1167/14.11.6; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li FP, 2012, J ACOUST SOC AM, V132, P2663, DOI 10.1121/1.4747008; Li FP, 2010, J ACOUST SOC AM, V127, P2599, DOI 10.1121/1.3295689; Liberman AM, 1954, PSYCHOL MONOGR-GEN A, V68, P1, DOI 10.1037/h0093673; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Lotto AJ, 1998, PERCEPT PSYCHOPHYS, V60, P602, DOI 10.3758/BF03206049; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; MANN VA, 1981, J ACOUST SOC AM, V69, P548, DOI 10.1121/1.385483; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Menoret M, 2014, NEUROPSYCHOLOGIA, V55, P85, DOI 10.1016/j.neuropsychologia.2013.10.001; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mineault PJ, 2009, J VISION, V9, DOI 10.1167/9.10.17; Moore BCJ, 2008, PHILOS T R SOC B, V363, P917, DOI 10.1098/rstb.2007.2195; Nichols TE, 2003, HUMAN BRAIN FUNCTION; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Obleser J, 2009, TRENDS COGN SCI, V13, P14, DOI 10.1016/j.tics.2008.09.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Regnier MS, 2008, J ACOUST SOC AM, V123, P2801, DOI 10.1121/1.2897915; REPP BH, 1981, J ACOUST SOC AM, V69, P1154, DOI 10.1121/1.385695; SEGUI J, 1981, BRIT J PSYCHOL, V72, P471, DOI 10.1111/j.2044-8295.1981.tb01776.x; Slaney M., 1988, LYONS COCHLEAR MODEL, VVolume 13; Sonderegger M., 2010, P 32 ANN M COGN SCI; Stelzer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00462; Thomas JP, 2005, J OPT SOC AM A, V22, P2257, DOI 10.1364/JOSAA.22.002257; Varnet L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00865; Viswanathan N, 2010, J EXP PSYCHOL HUMAN, V36, P1005, DOI 10.1037/a0018391; Viswanathan N, 2009, PSYCHON B REV, V16, P74, DOI 10.3758/PBR.16.1.74; Willmore B, 2003, NETWORK-COMP NEURAL, V14, P553, DOI 10.1088/0954-898X/14/3/309; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118009	10.1371/journal.pone.0118009	http://dx.doi.org/10.1371/journal.pone.0118009			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781470	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600020
J	Marra, A; Mona, S; Sa, RM; D'Onghia, G; Maiorano, P				Marra, Annamaria; Mona, Stefano; Sa, Rui M.; D'Onghia, Gianfranco; Maiorano, Porzia			Population Genetic History of Aristeus antennatus (Crustacea: Decapoda) in the Western and Central Mediterranean Sea	PLOS ONE			English	Article							RED SHRIMP; BATHYMETRIC PATTERNS; MITOCHONDRIAL-DNA; BALEARIC-ISLANDS; RISSO; DYNAMICS; BLUE; DIVERGENCE; ATLANTIC; CLIMATE	Aristeus antennatus is an ecologically and economically important deep-water species in the Mediterranean Sea. In this study we investigated the genetic variability of A. antennatus sampled from 10 sampling stations in the Western and Central Mediterranean. By comparing our new samples with available data from the Western area, we aim to identify potential genetic stocks of A. antennatus and to reconstruct its historical demography in the Mediterranean. We analyzed two regions of mitochondrial DNA in 319 individuals, namely COI and 16S. We found two main results: i) the genetic diversity values consistent with previous data within the Mediterranean and the absence of barriers to gene flow within the Mediterranean Sea; ii) a constant long-term effective population size in almost all demes but a strong signature of population expansion in the pooled sample about 50,000 years B.P./ago. We propose two explanation for our results. The first is based on the ecology of A. antennatus. We suggest the existence of a complex meta-population structured into two layers: a deeper-dwelling stock, not affected by fishing, which preserves the pattern of historical demography; and genetically homogeneous demes inhabiting the fishing grounds. The larval dispersal, adult migration and continuous movements of individuals from "virgin" deeper grounds not affected by fishing to upper fishing areas support an effective 'rescue effect' contributing to the recovery of the exploited stocks and explain their genetic homogeneity throughout the Mediterranean Sea. The second is based on the reproduction model of this shrimp: the high variance in offspring production calls for a careful interpretation of the data observed under classical population genetics and Kingman's coalescent. In both cases, management policies for A. antennatus will therefore require careful evaluation of the meta-population dynamics of all stocks in the Mediterranean. In the future, it will be particularly relevant to sample the deepest ones directly.	[Marra, Annamaria; D'Onghia, Gianfranco; Maiorano, Porzia] Univ Bari, Dept Biol, Bari, Italy; [Mona, Stefano] Ecole Prat Hautes Etud, Lab Biol Integrat Populat, Paris, France; [Sa, Rui M.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Universita degli Studi di Bari Aldo Moro; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Cardiff University	Marra, A (corresponding author), Univ Bari, Dept Biol, Bari, Italy.	annamaria.annina.marra@gmail.com	Mona, Stefano/AAF-5061-2019; Sá, Rui M./AAG-4028-2019	Sá, Rui M./0000-0001-6407-4541; Maiorano, Porzia/0000-0001-5737-3025; Mona, Stefano/0000-0001-9087-0656				[Anonymous], 2008, STATUS DEEP SEA RED, P392; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bertrand Jacques A., 2000, IFREMER Actes de Colloques, V26, P76; Bianchi CN, 2007, HYDROBIOLOGIA; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; Cannas R, 2011, MARINE ECOLOGY, V33, P350; Carbonell A., 2010, Marine Biodiversity Records, V3, pe103; Carbonell A, 1999, FISH RES, V44, P1, DOI 10.1016/S0165-7836(99)00079-X; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; D'Onghia G, 2005, FISH RES, V76, P22, DOI 10.1016/j.fishres.2005.05.007; D'Onghia G, 2009, FISH RES, V95, P236, DOI 10.1016/j.fishres.2008.09.025; Dall W, 1990, ADV MAR BIOL, P283; DANDO PR, 1981, MAR BIOL LETT, V2, P239; de Freitas A. J., 1985, INVEST REP OCEANOGR, V57, P1; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MV, 2013, J SEA RES, V76, P146, DOI 10.1016/j.seares.2012.08.004; Fiorentino F, 1998, DYNAMIQUE POPULATION, V35, P323; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Guijarro B, 2008, J MARINE SYST, V71, P385, DOI 10.1016/j.jmarsys.2007.04.003; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heuer B, 2013, THEOR POPUL BIOL, V87, P90, DOI 10.1016/j.tpb.2012.11.006; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holthuis L.B., 1980, SHRIMPS PRAWNS WORLD; Horwood J.W., 2000, P302; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Larmuseau MHD, 2009, MOL ECOL, V18, P4227, DOI 10.1111/j.1365-294X.2009.04331.x; Liu J, 2011, MOL ECOL, V20; Maggio T, 2009, MAR ECOL-EVOL PERSP, V30, P354, DOI 10.1111/j.1439-0485.2008.00277.x; Mona S, 2014, HEREDITY, V112, P291, DOI 10.1038/hdy.2013.105; Papaconstantinou C, 2001, AQUAT LIVING RESOUR, V14, P303, DOI 10.1016/S0990-7440(01)01128-7; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V 1 5; Ray C, 2003, MOL BIOL EVOL, V20; Relini LO, 2013, MAR ECOL-EVOL PERSP, V34, P90, DOI 10.1111/j.1439-0485.2012.00528.x; Relini M, 2000, SCI MAR, V64, P357, DOI 10.3989/scimar.2000.64n3357; Roasted M, 2012, R J, V4; Roldan MI, 2009, GENETICA, V136, P1, DOI 10.1007/s10709-008-9330-2; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sarda F, 2004, SCI MAR, V68, P117, DOI 10.3989/scimar.2004.68s3117; Sarda F, 2003, J SHELLFISH RES, V22, P569; Sarda F, 2010, SCI MAR, V74, P569, DOI 10.3989/scimar.2010.74n3569; Serejo CS, 2007, SER LIVROS MUS NAC, V24, P133; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tellier A, 2014, MOL ECOL, V23, P2637, DOI 10.1111/mec.12755; Fernandez MV, 2011, MAR ECOL PROG SER, V421, P163, DOI 10.3354/meps08881; Wakeley J, 1999, GENETICS, V153, P1863; Wakeley J, 2013, THEOR POPUL BIOL, V87, P1, DOI 10.1016/j.tpb.2013.06.001; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; WWF/IUCN, 2004, MED DEEP SEA EC OV T	64	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117272	10.1371/journal.pone.0117272	http://dx.doi.org/10.1371/journal.pone.0117272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775363	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500018
J	Freeman, JJ; Feng, YJ; Demehri, FR; Dempsey, PJ; Teitelbaum, DH				Freeman, Jennifer J.; Feng, Yongjia; Demehri, Farokh R.; Dempsey, Peter J.; Teitelbaum, Daniel H.			TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways	FASEB JOURNAL			English	Article						apoptosis; epidermal growth factor; epithelial cell proliferation; mucosal atrophy; total parenteral nutrition	TOTAL PARENTERAL-NUTRITION; NF-KAPPA-B; MOUSE MODEL; BARRIER FUNCTION; INTRAEPITHELIAL LYMPHOCYTES; NECROTIZING ENTEROCOLITIS; INDUCED APOPTOSIS; EGF RECEPTOR; PROLIFERATION; TRANSACTIVATION	Recent studies suggest a close interaction between epidermal growth factor (EGF) and TLR signaling in the modulation of intestinal epithelial cell (IEC) proliferation; however, how these signaling pathways adjust IEC proliferation is poorly understood. We utilized a model of total parenteral nutrition (TPN), or enteral nutrient deprivation, to study this interaction as TPN results in mucosal atrophy due to decreased IEC proliferation and increased apoptosis. We identified the novel finding of decreased mucosal atrophy in TLR4 knockout (TLR4KO) mice receiving TPN. We hypothesized that EGF signaling is preserved in TLR4KO-TPN mice and prevents mucosal atrophy. C57Bl/6 and strain-matched TLR4KO mice were provided either enteral feeding or TPN. IEC proliferation and apoptosis were measured. Cytokine and growth factor abundances were detected in both groups. To examine interdependence of these pathways, ErbB1 pharmacologic blockade was used. The marked decline in IEC proliferation with TPN was nearly prevented in TLR4KO mice, and intestinal length was partially preserved. EGF was significantly increased, and TNF-alpha decreased in TLR4KO-TPN versus wild-type (WT)TPN mice. Apoptotic positive crypt cells were 15-fold higher in WT-TPN versus TLR4KO-TPN mice. Bcl-2 was significantly increased in TLR4KO-TPN mice, while Bax decreased 10-fold. ErbB1 blockade prevented this otherwise protective effect in TLR4KO-sTPN mice. TLR4 blockade significantly prevented TPN-associated atrophy by preserving proliferation and preventing apoptosis. This is driven by a reduction in TNF-alpha abundance and increased EGF. Potential manipulation of this regulatory pathway may have significant clinical potential to prevent TPN-associated atrophy.	[Freeman, Jennifer J.; Feng, Yongjia; Demehri, Farokh R.; Teitelbaum, Daniel H.] Univ Michigan, Dept Surg, Pediat Surg Sect, Ann Arbor, MI 48109 USA; [Freeman, Jennifer J.; Teitelbaum, Daniel H.] Univ Michigan, Ctr Organogenesis, Ann Arbor, MI 48109 USA; [Dempsey, Peter J.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Teitelbaum, DH (corresponding author), Univ Michigan, Mott Childrens Hosp, Pediat Surg Sect, 1540 E Hosp Dr,SPC 4211, Ann Arbor, MI 48109 USA.	dttlbm@umich.edu		Freeman, Jennifer/0000-0001-9144-2645	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [2R01AI-44076-15]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK093697]; Center for Organogenesis [T32-HD7505]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093697] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Organogenesis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (2R01AI-44076-15), the NIH National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK093697), and the Center for Organogenesis (T32-HD7505). The authors declare no conflicts of interest.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bhattacharyya S, 2008, AM J PHYSIOL-GASTR L, V295, pG784, DOI 10.1152/ajpgi.90434.2008; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; McElroy SJ, 2008, AM J PHYSIOL-GASTR L, V295, pG285, DOI 10.1152/ajpgi.00425.2007; Miyasaka EA, 2013, J IMMUNOL, V190, P6607, DOI 10.4049/jimmunol.1201746; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Sun XY, 2006, JPEN-PARENTER ENTER, V30, P474, DOI 10.1177/0148607106030006474; Wildhaber BE, 2002, PEDIATR SURG INT, V18, P570, DOI 10.1007/s00383-002-0869-1; Wildhaber BE, 2003, J SURG RES, V112, P144, DOI 10.1016/S0022-4804(03)00160-4; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yang H, 2003, AM J PHYSIOL-GASTR L, V284, pG629, DOI 10.1152/ajpgi.00290.2002; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/00000658-200208000-00011; Yang H, 2008, ANN SURG, V248, P849, DOI 10.1097/SLA.0b013e31818a1522; Yu XY, 2009, GASTROENTEROLOGY, V137, P221, DOI 10.1053/j.gastro.2009.03.060; Zhang CJ, 2009, J NUTR, V139, P1315, DOI 10.3945/jn.108.096669	35	22	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2943	2958		10.1096/fj.14-269480	http://dx.doi.org/10.1096/fj.14-269480			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782989	Green Submitted, Green Published			2022-12-26	WOS:000356859100023
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)(307)-IRS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN GRB10; ALPHA-GAL EPITOPE; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; EPITHELIAL-CELLS; IMPRINTED GRB10; RESISTANCE; PATHWAY; ASSOCIATION	Inflammation induced by exposure to the common food additive carrageenan leads to insulin resistance by increase in Ser(P)(307)-insulin receptor substrate 1 (IRS1) and subsequent decline in the insulin-stimulated increase in Ser(P)(473)-AKT. Inhibition of carrageenan-induced inflammation reversed the increase in Ser(P)(307)-IRS1 but did not completely reverse the carrageenan-induced decline in Ser(P)(473)-AKT. To identify the additional mechanism responsible for the decrease in Ser(P)(473)-AKT, studies were performed in human HepG2 cells and in C57BL/6J mice. Following carrageenan, expression of GRB10 (growth factor receptor-bound 10 protein), an adaptor protein that binds to the insulin receptor and inhibits insulin signaling, increased significantly. GRB10 silencing blocked the carrageenan-induced reduction of the insulin-stimulated increase in Tyr(P)-IRS1 and partially reversed the decline in Ser(P)(473)-AKT. The combination of GRB10 silencing with BCL10 silencing and the reactive oxygen species inhibitor Tempol completely reversed the decline in Ser(P)(473)-AKT. After carrageenan, GRB10 promoter activity was enhanced because of activation by GATA2. A direct correlation between Ser(P)(473)-AKT and Ser(P)(401)-GATA2 was evident, and inhibition of AKT phosphorylation by the PI3K inhibitor LY294002 blocked Ser(401)-GATA2 phosphorylation and the increase in GRB10 expression. Studies indicated that carrageenan inhibited insulin signaling by two mechanisms: through the inflammation-mediated increase in Ser(P)(307)-IRS1, a negative regulator of insulin signaling, and through a transcriptional mechanism leading to increase in GRB10 expression and GRB10-inhibition of Tyr(P)-IRS1, a positive regulator of insulin signaling. These mechanisms converge to inhibit the insulin-induced increase in Ser(P)(473)-AKT. They provide internal feedback, mediated by Ser(P)(473)-AKT, Ser(P)(401)-GATA2, and nuclear GATA2, which links the opposing effects of serine and tyrosine phosphorylations of IRS1 and can modulate insulin responsiveness.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Lesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, ESN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu						Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2012, DIABETOLOGIA, V55, P194, DOI 10.1007/s00125-011-2333-z; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Di Paola R, 2006, DIABETES CARE, V29, P1181, DOI 10.2337/dc06-2551; Paola R, 2010, J INTERN MED, V267, P132, DOI 10.1111/j.1365-2796.2009.02089.x; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hansen H, 1996, J BIOL CHEM, V271, P8882, DOI 10.1074/jbc.271.15.8882; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huret JL, 2013, NUCLEIC ACIDS RES, V41, pD920, DOI 10.1093/nar/gks1082; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shiura H, 2005, BIOCHEM BIOPH RES CO, V329, P909, DOI 10.1016/j.bbrc.2005.02.047; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; TOWATARI M, 1995, J BIOL CHEM, V270, P4101, DOI 10.1074/jbc.270.8.4101; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yamamoto Y, 2008, EXP ANIM TOKYO, V57, P385, DOI 10.1538/expanim.57.385	43	30	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10764	10774		10.1074/jbc.M114.630053	http://dx.doi.org/10.1074/jbc.M114.630053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25784556	hybrid, Green Published			2022-12-26	WOS:000353404500018
J	Kim, H; Kim, HK; Lee, S; Yun, SH				Kim, Hun; Kim, Hee-Kyoung; Lee, Seunghoon; Yun, Sung-Hwan			The White Collar Complex Is Involved in Sexual Development of Fusarium graminearum	PLOS ONE			English	Article							GIBBERELLA-ZEAE ANAMORPH; BLUE-LIGHT; SECONDARY METABOLISM; GENE; NEUROSPORA; PATHOGENICITY; PHOTORECEPTOR; REPRODUCTION; REGULATOR	Sexual spores (ascospores) of Fusarium graminearum, a homothallic ascomycetous fungus, are believed to be the primary inocula for epidemics of the diseases caused by this species in cereal crops. Based on the light requirement for the formation of fruiting bodies (perithecia) of F. graminearum under laboratory conditions, we explored whether photoreceptors play an important role in sexual development. Here, we evaluated the roles of three genes encoding putative photoreceptors [a phytochrome gene (FgFph) and two white collar genes (FgWc-1 and FgWc-2)] during sexual development in F. graminearum. For functional analyses, we generated transgenic strains lacking one or two genes from the self-fertile Z3643 strain. Unlike the wild-type (WT) and add-back strains, the single deletion strains (Delta FgWc-1 and Delta FgWc-2) produced fertile perithecia under constant light on complete medium (CM, an unfavorable medium for sexual development) as well as on carrot agar (a perithecial induction condition). The expression of mating-type (MAT) genes increased significantly in the gene deletion strains compared to the WT under both conditions. Deletion of FgFph had no significant effect on sexual development or MAT gene expression. In contrast, all of the deletion strains examined did not show significant changes in other traits such as hyphal growth, mycotoxin production, and virulence. A split luciferase assay confirmed the in vivo protein-protein interactions among three photoreceptors along with FgLaeA, a global regulator of secondary metabolism and fungal development. Introduction of an intact copy of the A. nidulans LreA and LreB genes, which are homologs of FgWc-1 and FgWc-2, into the Delta FgWc-1 and Delta FgWc-2 strains, respectively, failed to repress perithecia formation on CM in the gene deletion strains. Taken together, these results demonstrate that FgWc-1 and FgWc-2, two central components of the blue-light sensing system, negatively regulate sexual development in F. graminearum, which differs from the regulation pattern in A. nidulans.	[Kim, Hun] Korea Res Inst Chem Technol, Div Convergence Chem, Res Ctr Biobased Chem, Taejon 305606, South Korea; [Kim, Hee-Kyoung; Lee, Seunghoon; Yun, Sung-Hwan] Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea	Korea Research Institute of Chemical Technology (KRICT); Soonchunhyang University	Yun, SH (corresponding author), Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea.	sy14@sch.ac.kr			Rural Development Administration, Republic of Korea [PJ008210]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This research was supported by grants from the Next-Generation Bio Green21 Program (no. PJ008210), the Rural Development Administration, Republic of Korea, and from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambra R, 2004, FUNGAL GENET BIOL, V41, P688, DOI 10.1016/j.fgb.2004.02.004; [Anonymous], 2006, BLACKWELL PUB PROF; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P417; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Fuller KK, 2013, MBIO, V4, DOI 10.1128/mBio.00142-13; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Kihara J, 2007, FEMS MICROBIOL LETT, V266, P110, DOI 10.1111/j.1574-6968.2006.00514.x; Kim H, 2014, J APPL MICROBIOL, V116, P380, DOI 10.1111/jam.12381; Kim HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068441; Kim HK, 2012, CURR GENET, V58, P179, DOI 10.1007/s00294-012-0375-5; Kim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002113; Kim H, 2011, PLANT PATHOLOGY J, V27, P103, DOI 10.5423/PPJ.2011.27.2.103; Kim S, 2011, FUNGAL GENET BIOL, V48, P400, DOI 10.1016/j.fgb.2011.01.004; Lee J, 2012, MICROBIOL-SGM, V158, P1723, DOI 10.1099/mic.0.059188-0; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Loros JJ, 2006, MYCOTA, V13, P53; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; TSCHANZ AT, 1976, MYCOLOGIA, V68, P327, DOI 10.2307/3759003; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Yang T, 2014, FEMS MICROBIOL LETT, V352, P190, DOI 10.1111/1574-6968.12393; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun SH, 1998, THESIS CORNELL U	40	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120293	10.1371/journal.pone.0120293	http://dx.doi.org/10.1371/journal.pone.0120293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785736	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500164
J	Mesbah-Uddin, M; Elango, R; Banaganapalli, B; Shaik, NA; Al-Abbasi, FA				Mesbah-Uddin, Md.; Elango, Ramu; Banaganapalli, Babajan; Shaik, Noor Ahmad; Al-Abbasi, Fahad A.			In-Silico Analysis of Inflammatory Bowel Disease (IBD) GWAS Loci to Novel Connections	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; IMMUNE CELLS; RISK-FACTORS; VARIANTS; IDENTIFICATION; POLYMORPHISMS; PATHOGENESIS; ANNOTATION; SELECTION	Genome-wide association studies (GWASs) for many complex diseases, including inflammatory bowel disease (IBD), produced hundreds of disease-associated loci-the majority of which are noncoding. The number of GWAS loci is increasing very rapidly, but the process of translating single nucleotide polymorphisms (SNPs) from these loci to genomic medicine is lagging. In this study, we investigated 4,734 variants from 152 IBD associated GWAS loci (IBD associated 152 lead noncoding SNPs identified from pooled GWAS results + 4,582 variants in strong linkage-disequilibrium (LD) (r(2) >= 0.8) for EUR population of 1K Genomes Project) using four publicly available bioinformatics tools, e.g. dbPSHP, CADD, GWAVA, and RegulomeDB, to annotate and prioritize putative regulatory variants. Of the 152 lead noncoding SNPs, around 11% are under strong negative selection (GERP++ RS >= 2); and similar to 30% are under balancing selection (Tajima's D score > 2) in CEU population (1K Genomes Project)-though these regions are positively selected (GERP++ RS < 0) in mammalian evolution. The analysis of 4,734 variants using three integrative annotation tools produced 929 putative functional SNPs, of which 18 SNPs (from 15 GWAS loci) are in concordance with all three classifiers. These prioritized noncoding SNPs may contribute to IBD pathogenesis by dysregulating the expression of nearby genes. This study showed the usefulness of integrative annotation for prioritizing fewer functional variants from a large number of GWAS markers.	[Mesbah-Uddin, Md.; Al-Abbasi, Fahad A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Elango, Ramu; Banaganapalli, Babajan; Shaik, Noor Ahmad] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Shaik, Noor Ahmad] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Mesbah-Uddin, M (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	mdmesbah@gmail.com; alabassif@hotmail.com	Banaganapalli, Babajan/A-6282-2013; Shaik, Noor ahmad/ABE-4084-2020; Elango, Ramu/I-7812-2013; Al-Abbasi, Fahad/H-8940-2012; Elango, Ramu/C-7684-2014; Uddin, Mesbah/J-1276-2014	Banaganapalli, Babajan/0000-0001-8089-2210; Shaik, Noor ahmad/0000-0002-7133-656X; Elango, Ramu/0000-0003-4264-2135; Uddin, Mesbah/0000-0003-1846-0411; Al-Abbasi, Fahad/0000-0001-5609-4913				Amundsen SS, 2014, GENES IMMUN, V15, P355, DOI 10.1038/gene.2014.26; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P2021, DOI 10.1097/MIB.0b013e318281f5c5; [Anonymous], 2014, R LANG ENV STAT COMP; Aujnarain Amiirah, 2013, Curr Gastroenterol Rep, V15, P326, DOI 10.1007/s11894-013-0326-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Biancheri P, 2013, TRENDS IMMUNOL, V34, P564, DOI 10.1016/j.it.2013.08.002; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buckley JP, 2013, INFLAMM BOWEL DIS, V19, P2725, DOI 10.1097/01.MIB.0000435442.07237.a4; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Chen H.B., 2013, VENNDIAGRAM GENERATE; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fowler SA, 2014, J CROHNS COLITIS, V8, P845, DOI 10.1016/j.crohns.2014.01.003; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Hutchinson JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098464; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Li MLJ, 2014, NUCLEIC ACIDS RES, V42, pD910, DOI 10.1093/nar/gkt1052; Lill CM, 2013, J MED GENET, V50, P140, DOI 10.1136/jmedgenet-2012-101411; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mokry M, 2014, GASTROENTEROLOGY, V146, P1040, DOI 10.1053/j.gastro.2013.12.003; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Nguyen GC, 2014, J CROHNS COLITIS, V8, P288, DOI 10.1016/j.crohns.2013.09.001; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Parmar AS, 2012, GENES IMMUN, V13, P474, DOI 10.1038/gene.2012.21; Paul DS, 2014, BIOESSAYS, V36, P191, DOI 10.1002/bies.201300126; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P1266, DOI 10.1111/j.1440-1746.2012.07150.x; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sokolova EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061032; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; TAJIMA F, 1989, GENETICS, V123, P585; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Valk ME, 2014, J CROHNS COLITIS, V8, P590, DOI 10.1016/j.crohns.2013.11.019; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097289; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	66	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119420	10.1371/journal.pone.0119420	http://dx.doi.org/10.1371/journal.pone.0119420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786114	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500103
J	Pannkuk, EL; Risch, TS; Savary, BJ				Pannkuk, Evan L.; Risch, Thomas S.; Savary, Brett J.			Isolation and Identification of an Extracellular Subtilisin-Like Serine Protease Secreted by the Bat Pathogen Pseudogymnoascus destructans	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; DATABASE; DIVERSIFICATION; PURIFICATION; PROTEINS; ENZYMES; BLAST	White nose syndrome (WNS) is a cutaneous fungal disease of bats. WNS is responsible for unprecedented mortalities in North American cave bat populations. There have been few descriptions of enzyme activities that may function in WNS host/pathogen interactions, while no study has isolated and described secreted proteases. To address the hypothesis that Pseudogymnoascus destructans secretes extracellular proteases that function in wing necrosis during WNS infection, the object of this study was to culture P. destructans on various media, then isolate and structurally identify those proteases accumulated stably in the culture medium. We found a single dominant protease activity on minimal nutrient broth enriched with protein substrates, which was strongly inhibited by phenylmethylsulfonyl fluoride. This P. destructans serine protease (PdSP1) was isolated by preparative isoelectric focusing and concanavalin A lectin affinity chromatography. PdSP1 showed a molecular weight 27,900 (estimated by SDS-PAGE), broad pH optimum 6-8, and temperature optimum 60 degrees C. Structural characterization of PdSP1 by MALDI-TOF MS, Orbitrap MS/MS, and Edman amino-terminal peptide sequencing matched it directly to a hypothetical protein accession from the sequenced P. destructans genome that is further identified as a MEROPS family S8A subtilisin-like serine peptidase. Two additional isoforms, PdSP2 and PdSP3, were identified in the P. destructans genome with 90% and 53% homology, respectively. P. destructans S8A serine proteases showed closer sequence conservation to P. pannorum and plant pathogenic fungi than to human pathogenic dermatophytes. Peptide-specific polyclonal antibodies developed from the PdSP1 sequence detected the protein in western blots. These subtilisin-like serine proteases are candidates for further functional studies in WNS host-pathogen interaction.	[Pannkuk, Evan L.] Arkansas State Univ, Grad Program Environm Sci, Jonesboro, AR USA; [Risch, Thomas S.] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR USA; [Savary, Brett J.] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA	Arkansas State University; Arkansas State University; Arkansas State University	Pannkuk, EL (corresponding author), Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA.	elp44@georgetown.edu; bsavary@astate.edu	Pannkuk, Evan/ABF-6170-2021	Pannkuk, Evan/0000-0002-4953-9715	U.S. Fish and Wildlife Service State Wildlife Grant (Arkansas Game and Fish Commission) [AR T-40-R-1]; National Speleological Society; Center for North American Bat Research and Conservation at Indiana State University	U.S. Fish and Wildlife Service State Wildlife Grant (Arkansas Game and Fish Commission); National Speleological Society; Center for North American Bat Research and Conservation at Indiana State University	This study was funded by U.S. Fish and Wildlife Service 2012 State Wildlife Grant (Arkansas Game and Fish Commission, AR T-40-R-1), the National Speleological Society, and The Center for North American Bat Research and Conservation at Indiana State University. The MALDI-TOF MS instrument was provided through the NSF EPSCoR, RII: Arkansas ASSET Initiative P3 Center (EPS-0701890) in the Arkansas Biosciences Institute at Arkansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Heithaus E.R., 1982, P327; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112502; KLUGER MJ, 1970, COMP BIOCHEM PHYSIOL, V32, P219, DOI 10.1016/0010-406X(70)90935-7; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Kwon H, 2013, INSECT BIOCHEM MOLEC, V43, P588, DOI 10.1016/j.ibmb.2013.03.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Madej JP, 2013, ACTA ZOOL-STOCKHOLM, V94, P478, DOI 10.1111/j.1463-6395.2012.00578.x; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Muszewska A, 2011, MOL BIOL EVOL, V28, P3395, DOI 10.1093/molbev/msr176; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Savary BJ, 2002, J AGR FOOD CHEM, V50, P3553, DOI 10.1021/jf020060j; Savary BJ, 2011, RECOMBINANT GENE EXP; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; U.S. Fish Wildlife Service [USFWS], 2012, N AM BAT DEATH TOLL; Vieira DF, 2004, ACTA BIOCH BIOPH SIN, V36, P798, DOI 10.1093/abbs/36.12.798; von Helversen O, 2003, BAT ECOLOGY, P346; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P21, DOI 10.1007/s00253-007-0881-4; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; Yuan HC, 2000, J APPL PHYSIOL, V89, P3, DOI 10.1152/jappl.2000.89.1.3	48	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120508	10.1371/journal.pone.0120508	http://dx.doi.org/10.1371/journal.pone.0120508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785714	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500180
J	Wilkie, IC; Fassini, D; Cullora, E; Barbaglio, A; Tricarico, S; Sugni, M; Del Giacco, L; Carnevali, MDC				Wilkie, Iain C.; Fassini, Dario; Cullora, Emanuele; Barbaglio, Alice; Tricarico, Serena; Sugni, Michela; Del Giacco, Luca; Carnevali, M. Daniela Candia			Mechanical Properties of the Compass Depressors of the Sea-Urchin Paracentrotus lividus (Echinodermata, Echinoidea) and the Effects of Enzymes, Neurotransmitters and Synthetic Tensilin-Like Protein	PLOS ONE			English	Article							CRINOID METACRINUS-ROTUNDUS; CONNECTIVE-TISSUE; STRESS-RELAXATION; VARIABLE TENSILITY; COLLAGEN FIBRILS; CATCH APPARATUS; STIFFEST STATE; FINE-STRUCTURE; SPINE-JOINT; BODY-WALL	The compass depressors (CDs) of the sea-urchin lantern are ligaments consisting mainly of discontinuous collagen fibrils associated with a small population of myocytes. They are mutable collagenous structures, which can change their mechanical properties rapidly and reversibly under nervous control. The aims of this investigation were to characterise the baseline (i.e. unmanipulated) static mechanical properties of the CDs of Paracentrotus lividus by means of creep tests and incremental force-extension tests, and to determine the effects on their mechanical behaviour of a range of agents. Under constant load the CDs exhibited a three-phase creep curve, the mean coefficient of viscosity being 561 +/- 365 MPa. s. The stress-strain curve showed toe, linear and yield regions; the mean strain at the toelinear inflection was 0.86 +/- 0.61; the mean Young's modulus was 18.62 +/- 10.30 MPa; and the mean tensile strength was 8.14 +/- 5.73 MPa. Hyaluronidase from Streptomyces hyalurolyticus had no effect on creep behaviour, whilst chondroitinase ABC prolonged primary creep but had no effect on secondary creep or on any force-extension parameters; it thus appears that neither hyaluronic acid nor sulphated glycosaminoglycans have an interfibrillar load transfer function in the CD. Acetylcholine, the muscarinic agonists arecoline and methacholine, and the nicotinic agonists nicotine and 1-[1-(3,4-dimethyl-phenyl)-ethyl]-piperazine produced an abrupt increase in CD viscosity; the CDs were not differentially sensitive to muscarinic or nicotinic agonists. CDs showed either no, or no consistent, response to adrenaline, L-glutamic acid, 5-hydroxytryptamine and.-aminobutyric acid. Synthetic echinoid tensilin-like protein had a weak and inconsistent stiffening effect, indicating that, in contrast to holothurian tensilins, the echinoid molecule may not be involved in the regulation of collagenous tissue tensility. We compare in detail the mechanical behaviour of the CD with that of mammalian tendon and highlight its potential as a model system for investigating poorly understood aspects of the ontogeny and phylogeny of vertebrate collagenous tissues.	[Wilkie, Iain C.] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Fassini, Dario; Cullora, Emanuele; Barbaglio, Alice; Tricarico, Serena; Sugni, Michela; Del Giacco, Luca; Carnevali, M. Daniela Candia] Univ Milan, Dipartimento Biosci, Milan, Italy	Glasgow Caledonian University; University of Milan	Wilkie, IC (corresponding author), Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland.	i.wilkie@gcu.ac.uk	Candia Carnevali, M. Daniela/I-8048-2015; Del Giacco, Luca P C/A-5812-2014; Barbaglio, Alice/A-4365-2012	Candia Carnevali, M. Daniela/0000-0002-0215-8843; Barbaglio, Alice/0000-0003-0122-0331	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)(Fondazione Cariplo)	This research received financial support from the Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation) Advanced Material Projects 2009 (MIMESIS - Marine Invertebrate Models & Engineered Substrates for Innovative bio-Scaffolds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008; Atkinson TS, 1999, J BIOMECH, V32, P907, DOI 10.1016/S0021-9290(99)00089-5; Bairati A, 2004, J STRUCT BIOL, V147, P159, DOI 10.1016/j.jsb.2004.03.004; Barbaglio A, 2012, MAR ENVIRON RES, V76, P108, DOI 10.1016/j.marenvres.2011.07.006; Barbaglio A, 2015, ZOOLOGY JEN IN PRESS, DOI [10.1016/j.zool.2015.01.001, DOI 10.1016/J.ZOOL.2015.01.001]; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Birenheide R, 1996, BIOL BULL, V190, P231, DOI 10.2307/1542543; Birenheide R, 2000, P ROY SOC B-BIOL SCI, V267, P7, DOI 10.1098/rspb.2000.0959; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307; COBB JLS, 1985, CELL TISSUE RES, V242, P685; COHEN RE, 1976, J BIOMECH, V9, P175, DOI 10.1016/0021-9290(76)90002-6; Dahners LE, 2000, J ORTHOPAED RES, V18, P532, DOI 10.1002/jor.1100180404; Davis FM, 2012, ANN BIOMED ENG, V40, P2541, DOI 10.1007/s10439-012-0596-2; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; DeVente JE, 1997, J ELECTRON MICROSC, V46, P353, DOI 10.1093/oxfordjournals.jmicro.a023530; Di Benedetto C, 2014, MAR DRUGS, V12, P4912, DOI 10.3390/md12094912; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0; Ellers O, 1996, P ROY SOC B-BIOL SCI, V263, P39, DOI 10.1098/rspb.1996.0007; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Eylers JP, 1988, ECHINODERM BIOL; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; GARRONE R, 1975, J ULTRA MOL STRUCT R, V52, P261, DOI 10.1016/S0022-5320(75)80117-1; GREENBERG AR, 1984, J BIOMECH, V17, P161, DOI 10.1016/0021-9290(84)90006-X; Hennebert E, 2010, J EXP BIOL, V213, P1162, DOI 10.1242/jeb.037903; HIDAKA M, 1983, J EXP BIOL, V103, P1; Hilgers H., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V107, P442; Humason G. L., 1979, ANIMAL TISSUE TECHNI; Hyman L. H., 1955, INVERTEBRATES; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; JUNQUEIRA LCU, 1980, REV CAN BIOL EXPTL, V39, P157; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kjaer M., 2008, P249; Koob TJ, 1999, J EXP BIOL, V202, P2291; Lanzavecchia G., 1988, P649; Liao HY, 1999, J BIOMECH, V32, P183, DOI 10.1016/S0021-9290(98)00169-9; Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Matsumura T, 1974, CONNECT TISSUE RES, V275, P451; MCBRIDE DJ, 1988, INT J BIOL MACROMOL, V10, P194, DOI 10.1016/0141-8130(88)90048-7; McKew M., 1999, P103; MORALES M, 1993, COMP BIOCHEM PHYS C, V105, P25, DOI 10.1016/0742-8413(93)90052-M; MOTOKAWA T, 1983, J ZOOL, V201, P223; MOTOKAWA T, 1984, J EXP BIOL, V109, P63; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1987, COMP BIOCHEM PHYS C, V86, P333, DOI 10.1016/0742-8413(87)90089-2; Motokawa T, 2011, BIOL BULL-US, V221, P280, DOI 10.1086/BBLv221n3p280; Ng BH, 2004, P I MECH ENG H, V218, P203, DOI 10.1243/095441104323118923; Nichols D., 1969, ECHINODERMS; ONeill PL, 1995, MAR FRESHW BEHAV PHY, V25, P245, DOI 10.1080/10236249509378921; Park Y, 1997, BBA-PROTEIN STRUCT M, V1337, P217, DOI 10.1016/S0167-4838(96)00167-7; PETERS BH, 1985, CELL TISSUE RES, V239, P219, DOI 10.1007/BF00214922; Pioletti DP, 2000, J BIOMECH, V33, P1729, DOI 10.1016/S0021-9290(00)00128-7; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Ribeiro AR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0038-6; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; SAITA A, 1969, Istituto Lombardo Accademia di Scienze e Lettere Rendiconti Scienze Biologische e Mediche B, V103, P297; Santos R, 2005, J EXP BIOL, V208, P2277, DOI 10.1242/jeb.01641; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Silver FH, 2008, COLLAGEN STRUCTURE B; SMITH DS, 1981, TISSUE CELL, V13, P299, DOI 10.1016/0040-8166(81)90007-0; STAUBER M, 1993, ZOOMORPHOLOGY, V113, P137, DOI 10.1007/BF00403091; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; Takemae N, 2005, BIOL BULL-US, V208, P29, DOI 10.2307/3593098; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Theis N, 2012, J ELECTROMYOGR KINES, V22, P947, DOI 10.1016/j.jelekin.2012.06.004; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Tregear RT., 1966, PHYS FUNCTIONS SKIN; Tricarico S, 2013, THESIS U MILAN; Tricarico S, 2012, ZOOSYMPOSIA, V7, P279, DOI 10.11646/zoosymposia.7.1.26; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Ubukata K, 2001, ECHINODERMS 2000, P555; Vanderby R, 2003, J BIOMECH, V36, P1523, DOI 10.1016/S0021-9290(03)00132-5; Vincent J., 2012, STRUCTURAL BIOMATERI, DOI 10.2307/j.ctt7tbgv.; Vogel S, 2013, COMP BIOMECHANICS, V2nd; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; WANG XT, 1995, J EXP BIOL, V198, P831; Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61; Wilkie IC, 2010, J EXP BIOL, V213, P2104, DOI 10.1242/jeb.039578; Wilkie IC, 1995, ECHINODERM RESEARCH 1995, P147; WILKIE IC, 1990, ECHINODERM RESEARCH, P301; Wilkie IC, 1998, ZOOMORPHOLOGY, V118, P87, DOI 10.1007/s004350050060; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; Wilkie IC, 2005, PROG MOLEC, V39, P221; WILKIE IC, 1993, COMP BIOCHEM PHYS A, V105, P493, DOI 10.1016/0300-9629(93)90425-4; WILKIE IC, 1992, J ZOOL, V228, P5, DOI 10.1111/j.1469-7998.1992.tb04429.x; WILKIE IC, 1984, MAR BEHAV PHYSIOL, V11, P1, DOI 10.1080/10236248409387032; WILKIE IC, 1992, ECHINODERM RESEARCH 1991, P99; Wilkie IC, 1976, THESIS U GLASGOW; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22	107	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120339	10.1371/journal.pone.0120339	http://dx.doi.org/10.1371/journal.pone.0120339			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786033	Green Published, gold			2022-12-26	WOS:000352138500166
J	Yuan, LX; Sun, LG; Fortin, D; Wang, YH; Yin, XB				Yuan, Linxi; Sun, Liguang; Fortin, Danielle; Wang, Yuhong; Yin, Xuebin			Microscale Characterization and Trace Element Distribution in Bacteriogenic Ferromanganese Coatings on Sand Grains from an Intertidal Zone of the East China Sea	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; MANGANESE OXIDE; PINAL-CREEK; IRON-OXYHYDROXIDE; DIAGENETIC IRON; NATURAL-WATERS; HEAVY-METALS; HUMIC-ACID; MN OXIDES; CERIUM	An ancient wood layer dated at about 5600 yr BP by accelerator mass spectrometry (AMS) C-14 was discovered in an intertidal zone of the East China Sea. Extensive and horizontally stratified sediments with black color on the top and yellowish-red at the bottom, and some nodule-cemented concretions with brown surface and black inclusions occurred in this intertidal zone. Microscale analysis methods were employed to study the microscale characterization and trace element distribution in the stratified sediments and concretions. Light microscopy, scanning electron microscopy (SEM) and backscattered electron imaging (BSE) revealed the presence of different coatings on the sand grains. The main mineral compositions of the coatings were ferrihydrite and goethite in the yellowish-red parts, and birnessite in the black parts using X-ray powder diffraction (XRD). SEM observations showed that bacteriogenic products and bacterial remnants extensively occurred in the coatings, indicating that bacteria likely played an important role in the formation of ferromanganese coatings. Post-Archean Australian Shale (PAAS)-normalized middle rare earth element (MREE) enrichment patterns of the coatings indicated that they were caused by two sub-sequential processes: (1) preferentially release of Fe-Mn from the beach rocks by fermentation of ancient woods and colloidal flocculation in the mixing water zone and (2) preferential adsorption of MREE by Fe-Mn oxyhydroxides from the seawater. The chemical results indicated that the coatings were enriched with Sc, V, Cr, Co, Ni, Cu, Zn, Ba, especially with respect to Co, Ni. The findings of the present study provide an insight in the microscale features of ferromanganese coatings and the Fe-Mn biogeochemical cycling during the degradation of buried organic matter in intertidal zones or shallow coasts.	[Yuan, Linxi; Sun, Liguang; Yin, Xuebin] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Jiangsu Bioengn Res Ctr Selenium, Suzhou 215123, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Suzhou Inst Adv Study, Adv Lab Selenium & Human Hlth, Suzhou 215123, Peoples R China; [Fortin, Danielle] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Wang, Yuhong] NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Ottawa; National Institutes of Health (NIH) - USA	Yuan, LX (corresponding author), Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China.	yuanli@ustc.edu.cn; slg@ustc.edu.cn	Yuan, Linxi/Y-9313-2019	Yuan, Linxi/0000-0002-1043-8933	Natural Science Youth Foundation of Jiangsu Province for Youth, China [BK2012202]; National 973 Program [2010CB428902]; Chinese Postdoctoral Science Foundation [2013M540518]; Jiangsu Provincial Postdoctoral Science Foundation [1302080C]	Natural Science Youth Foundation of Jiangsu Province for Youth, China; National 973 Program(National Basic Research Program of China); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Provincial Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Youth Foundation of Jiangsu Province for Youth, China (BK2012202) (http://www.jstd.gov.cn/), National 973 Program (Grant No 2010CB428902) (http://www.most.gov.cn/), Chinese Postdoctoral Science Foundation (2013M540518) (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and Jiangsu Provincial Postdoctoral Science Foundation (1302080C) (http://www.jsbsh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargar JR, 2009, GEOCHIM COSMOCHIM AC, V73, P889, DOI 10.1016/j.gca.2008.10.036; Bargar JR, 2000, GEOCHIM COSMOCHIM AC, V64, P2775, DOI 10.1016/S0016-7037(00)00368-9; Bau M, 1999, GEOCHIM COSMOCHIM AC, V63, P67, DOI 10.1016/S0016-7037(99)00014-9; Bau M, 1996, GEOCHIM COSMOCHIM AC, V60, P1709, DOI 10.1016/0016-7037(96)00063-4; Bau M, 1998, CHEM GEOL, V151, P293, DOI 10.1016/S0009-2541(98)00086-2; Bau M, 1996, CONTRIB MINERAL PETR, V123, P323, DOI 10.1007/s004100050159; Bilinski H, 2002, AM MINERAL, V87, P580; Davranche M, 2005, GEOCHIM COSMOCHIM AC, V69, P4825, DOI 10.1016/j.gca.2005.06.005; Davranche M, 2004, J COLLOID INTERF SCI, V277, P271, DOI 10.1016/j.jcis.2004.04.007; Davranche M, 2008, CHEM GEOL, V247, P154, DOI 10.1016/j.chemgeo.2007.10.010; De Carlo EH, 1997, AQUAT GEOCHEM, V3, P357, DOI 10.1023/A:1009664626181; Duckworth OW, 2009, BIOMETALS, V22, P605, DOI 10.1007/s10534-009-9220-9; Dzombak DA, 1990, SURFACE COMPLEXATION, P89; Feng JL, 2010, CHEM GEOL, V271, P112, DOI 10.1016/j.chemgeo.2010.01.003; Feng XH, 2010, GEOCHIM COSMOCHIM AC, V74, P3232, DOI 10.1016/j.gca.2010.03.005; Fernandez-Caliani JC, 2009, GEODERMA, V149, P393, DOI 10.1016/j.geoderma.2009.01.004; Ferris FG, 2005, GEOMICROBIOL J, V22, P79, DOI 10.1080/01490450590945861; Ferris FG, 2000, APPL GEOCHEM, V15, P1035, DOI 10.1016/S0883-2927(99)00093-1; Fortin D, 2005, EARTH-SCI REV, V72, P1, DOI 10.1016/j.earscirev.2005.03.002; FORTIN D, 1993, GEOCHIM COSMOCHIM AC, V57, P4391, DOI 10.1016/0016-7037(93)90490-N; Fortin D, 2003, RECENT RES DEV MINER, P47; Frierdich AJ, 2011, CHEM GEOL, V284, P82, DOI 10.1016/j.chemgeo.2011.02.009; Fuller CC, 2000, ENVIRON SCI TECHNOL, V34, P1150, DOI 10.1021/es990714d; HALLBECK L, 1991, J GEN MICROBIOL, V137, P2657, DOI 10.1099/00221287-137-11-2657; Johannesson KH, 1996, CHEM GEOL, V133, P125, DOI 10.1016/S0009-2541(96)00072-1; Johannesson KH, 1999, GEOCHIM COSMOCHIM AC, V63, P153, DOI 10.1016/S0016-7037(98)00291-9; Jones B, 2009, J SEDIMENT RES, V79, P689, DOI 10.2110/jsr.2009.071; Kappler A, 2005, REV MINERAL GEOCHEM, V59, P85, DOI 10.2138/rmg.2005.59.5; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Kappler A, 2004, FEMS MICROBIOL ECOL, V47, P85, DOI 10.1016/S0168-6496(03)00245-9; Kay JT, 2001, ENVIRON SCI TECHNOL, V35, P4719, DOI 10.1021/es010514d; KOEPPENKASTROP D, 1992, CHEM GEOL, V95, P251, DOI 10.1016/0009-2541(92)90015-W; Koschinsky A, 2003, MAR GEOL, V198, P331, DOI 10.1016/S0025-3227(03)00122-1; Lack JG, 2002, APPL ENVIRON MICROB, V68, P2704, DOI 10.1128/AEM.68.6.2704-2710.2002; Lawrence MG, 2006, MAR CHEM, V100, P147, DOI 10.1016/j.marchem.2005.11.007; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Leybourne MI, 2008, GEOCHIM COSMOCHIM AC, V72, P5962, DOI 10.1016/j.gca.2008.09.022; Leybourne MI, 2001, CAN MINERAL, V39, P1597, DOI 10.2113/gscanmin.39.6.1597; Manceau A, 2007, GEOCHIM COSMOCHIM AC, V71, P95, DOI 10.1016/j.gca.2006.08.036; Manceau A, 2012, AM MINERAL, V97, P816, DOI 10.2138/am.2012.3903; MCKENZIE RM, 1980, AUST J SOIL RES, V18, P61, DOI 10.1071/SR9800061; McLemnan SM, 1989, REV MINERALOGY, V21, P169; Melim LA, 2008, J CAVE KARST STUD, V70, P135; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; MOFFETT JW, 1994, GEOCHIM COSMOCHIM AC, V58, P695, DOI 10.1016/0016-7037(94)90499-5; Morgan JJ, 2000, MET IONS BIOL SYST, V37, P1; Murray KJ, 2007, APPL ENVIRON MICROB, V73, P6905, DOI 10.1128/AEM.00971-07; Palumbo B, 2001, CHEM GEOL, V173, P257, DOI 10.1016/S0009-2541(00)00284-9; Pattan JN, 2005, CHEM GEOL, V221, P260, DOI 10.1016/j.chemgeo.2005.06.009; Penn RL, 2001, GEOLOGY, V29, P843, DOI 10.1130/0091-7613(2001)029<0843:IOCOSG>2.0.CO;2; Piepenbrock A, 2014, ENVIRON SCI TECHNOL, V48, P1656, DOI 10.1021/es404497h; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Shimizu M, 2013, ENVIRON SCI TECHNOL, V47, P13375, DOI 10.1021/es402812j; Sholkovitz ER, 1995, AQUAT GEOCHEM, V1, P1, DOI 10.1007/BF01025229; SKINNER HCW, 1993, PRECAMBRIAN RES, V61, P209, DOI 10.1016/0301-9268(93)90114-H; Spilde MN, 2005, GEOMICROBIOL J, V22, P99, DOI 10.1080/01490450590945889; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P672; Swartz CH, 1997, GEOCHIM COSMOCHIM AC, V61, P707, DOI 10.1016/S0016-7037(96)00376-6; Takahashi Y, 2000, GEOCHIM COSMOCHIM AC, V64, P2929, DOI 10.1016/S0016-7037(00)00403-8; Takahashi Y, 2007, GEOCHIM COSMOCHIM AC, V71, P984, DOI 10.1016/j.gca.2006.11.016; Tan H, 2010, APPL GEOCHEM, V25, P389, DOI 10.1016/j.apgeochem.2009.12.006; Tani Y, 2003, APPL GEOCHEM, V18, P1541, DOI 10.1016/S0883-2927(03)00075-1; Tazaki K, 2000, CLAY CLAY MINER, V48, P511, DOI 10.1346/CCMN.2000.0480503; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 1997, REV MINERAL, V35, P225; Tessier A, 1996, GEOCHIM COSMOCHIM AC, V60, P387, DOI 10.1016/0016-7037(95)00413-0; Toner B, 2006, GEOCHIM COSMOCHIM AC, V70, P27, DOI 10.1016/j.gca.2005.08.029; Webb SM, 2005, AM MINERAL, V90, P1342, DOI 10.2138/am.2005.1669; Webb SM, 2005, P NATL ACAD SCI USA, V102, P5558, DOI 10.1073/pnas.0409119102; White WB, 2009, J CAVE KARST STUD, V71, P136; Wu CY, 2013, MICROB BIOTECHNOL, V6, P141, DOI 10.1111/1751-7915.12003; Wu ZJ, 2008, CHINESE SCI BULL, V53, P1894, DOI 10.1007/s11434-008-0082-2; Wu ZJ, 2009, GEOCHEM J, V43, P167, DOI 10.2343/geochemj.1.0016; Yuan LX, 2009, CHINESE SCI BULL, V54, P1931, DOI 10.1007/s11434-009-0334-9	75	7	8	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119080	10.1371/journal.pone.0119080	http://dx.doi.org/10.1371/journal.pone.0119080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786213	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500071
J	Abitbol, M; Bosse, P; Thomas, A; Tiret, L				Abitbol, Marie; Bosse, Philippe; Thomas, Anne; Tiret, Laurent			A Deletion in FOXN1 Is Associated with a Syndrome Characterized by Congenital Hypotrichosis and Short Life Expectancy in Birman Cats	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; KERATIN GENE-EXPRESSION; NUDE PHENOTYPE; MOUSE; MICE; DIFFERENTIATION; ALOPECIA; LOCUS; RAT; WHN	An autosomal recessive syndrome characterized by congenital hypotrichosis and short life expectancy has been described in the Birman cat breed (Felis silvestris catus). We hypothesized that a FOXN1 (forkhead box N1) loss-of-function allele, associated with the nude phenotype in humans, mice and rats, may account for the syndrome observed in Birman cats. To the best of our knowledge, spontaneous mutations in FOXN1 have never been described in non-human, non-rodent mammalian species. We identified a recessive c.1030_1033delCTGT deletion in FOXN1 in Birman cats. This 4-bp deletion was associated with the syndrome when present in two copies. Percentage of healthy carriers in our French panel of genotyped Birman cats was estimated to be 3.2%. The deletion led to a frameshift and a premature stop codon at position 547 in the protein. In silico, the truncated FOXN1 protein was predicted to lack the activation domain and critical parts of the forkhead DNA binding domain, both involved in the interaction between FOXN1 and its targets, a mandatory step to promote normal hair and thymic epithelial development. Our results enlarge the panel of recessive FOXN1 loss-of-function alleles described in mammals. A DNA test is available; it will help owners avoid matings at risk and should prevent the dissemination of this morbid mutation in domestic felines.	[Abitbol, Marie; Bosse, Philippe; Tiret, Laurent] Hop Henri Mondor, INSERM, U955, IMRB,Equipe 10, F-94010 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Tiret, Laurent] Ecole Natl Vet Alfort, BNMS Genet Med Comparee Affect Neuromusculaires, Maisons Alfort, France; [Thomas, Anne] Antagene, La Tour De Salvagny, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire d'Alfort (ENVA)	Abitbol, M (corresponding author), Hop Henri Mondor, INSERM, U955, IMRB,Equipe 10, F-94010 Creteil, France.	m.abitbol@vet-alfort.fr	Tiret, Laurent/K-3877-2017	Tiret, Laurent/0000-0001-8573-8335; Bosse, Philippe/0000-0001-5701-6415; Abitbol, Marie/0000-0002-5615-7897				Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Barnay G, 1990, LES SECRETS DU CHAT; Basel MT, 2012, BIORESEARCH OPEN ACC, V1, P63, DOI 10.1089/biores.2012.9902; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BOURDEAU P, 1988, RECL MED VET, V164, P17; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Carpentier C, 1934, REV ZOOTECH, V10, P298; CASAL ML, 1994, J AM ANIM HOSP ASSOC, V30, P600; CASH JM, 1993, MAMM GENOME, V4, P37, DOI 10.1007/BF00364661; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Collet P, 1934, B SOC SCI VET LYON, V37, P175; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; HENDYIBBS PM, 1984, J HERED, V75, P506; Huang J, 2014, J IMMUNOL, V193, P1496, DOI 10.4049/jimmunol.1400915; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; LEROY P, 1983, ANN MED VET, V127, P513; Letard E, 1938, J HERED, V29, P173, DOI 10.1093/oxfordjournals.jhered.a104488; Letard E., 1933, Revue Veterinaire Toulouse, V85, P545; Masui N, 2004, EXP ANIM TOKYO, V53, P399, DOI 10.1538/expanim.53.399; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; MELLEN IDA M., 1939, JOUR HEREDITY, V30, P435, DOI 10.1093/jhered/30.10.435; Naper C, 2011, J INNATE IMMUN, V3, P289, DOI 10.1159/000324143; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Neuber AE, 2006, VET DERMATOL, V17, P63, DOI 10.1111/j.1365-3164.2005.00492.x; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Prowse DM, 1999, DEV BIOL, V212, P54, DOI 10.1006/dbio.1999.9328; REED C, 1979, LAB ANIM SCI, V29, P744; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Romano R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/467101; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Schorpp M, 2000, DEV DYNAM, V218, P537, DOI 10.1002/1097-0177(200007)218:3<537::AID-DVDY1007>3.0.CO;2-P; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zhang ZJ, 2012, INT J BIOL SCI, V8, P1156, DOI 10.7150/ijbs.5033; Zhigachev A. I., 2000, Genetika, V36, P538	49	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120668	10.1371/journal.pone.0120668	http://dx.doi.org/10.1371/journal.pone.0120668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781316	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600179
J	Bailey, EL; Bazigou, E; Sowinski, PSJ; Weinberg, PD				Bailey, Emma L.; Bazigou, Eleni; Sowinski, Piotr S. J.; Weinberg, Peter D.			Mass Transport Properties of the Rabbit Aortic Wall	PLOS ONE			English	Article							TERM ALBUMIN UPTAKE; THORACIC AORTA; BLOOD-FLOW; SHEAR-STRESS; PERMEABILITY; BRANCHES; AGE; PATTERNS; SITES; INTERCOSTAL	Uptake of circulating macromolecules by the arterial wall may be a critical step in atherogenesis. Here we investigate the age-related changes in patterns of uptake that occur in the rabbit. In immature aortas, uptake was elevated in a triangle downstream of branch ostia, a region prone to disease in immature rabbits and children. By 16-22 months, uptake was high lateral to ostia, as is lesion prevalence in mature rabbits and young adults. In older rabbits there was a more upstream pattern, similar to the disease distribution in older people. These variations were predominantly caused by the branches themselves, rather than reflecting larger patterns within which the branches happened to be situated (as may occur with patterns of haemodynamic wall shear stress). The narrow streaks of high uptake reported in some previous studies were shown to be post mortem artefacts. Finally, heparin (which interferes with the NO pathway) had no effect on the difference in uptake between regions upstream and downstream of branches in immature rabbits but reversed the difference in older rabbits, as does inhibiting NO synthesis directly. Nevertheless, examination of uptake all around the branch showed that changes occurred at both ages and that they were quite subtle, potentially explaining why inhibiting NO has only minor effects on lesion patterns in mature rabbits and contradicting the earlier conclusion that mechanotransduction pathways change with age. We suggest that recently-established changes in the patterns of haemodynamic forces themselves are more likely to account for the age-dependence of uptake patterns.	[Bailey, Emma L.; Bazigou, Eleni; Sowinski, Piotr S. J.; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London	Weinberg, PD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	p.weinberg@imperial.ac.uk			British Heart Foundation [RG11/5/28743]; British Heart Foundation [RG/11/5/28743] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The study was funded by Programme Grant RG11/5/28743 from the British Heart Foundation www.bhf.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitschkow N.N., 1933, ARTERIOSCLEROSIS, P271; BALDWIN AL, 1982, ARTERY, V10, P420; BARAKAT AI, 1992, J BIOMECH ENG-T ASME, V114, P283, DOI 10.1115/1.2891385; Barnes SE, 2001, EXP MOL PATHOL, V71, P161, DOI 10.1006/exmp.2001.2395; Bond AR, 2011, ARTERIOSCL THROM VAS, V31, P543, DOI 10.1161/ATVBAHA.110.219683; BRATZLER RL, 1977, CIRC RES, V40, P182, DOI 10.1161/01.RES.40.2.182; Clarke LA, 2012, ATHEROSCLEROSIS, V224, P417, DOI 10.1016/j.atherosclerosis.2012.08.001; Ewins BA, 2002, J BIOMECH ENG-T ASME, V124, P684, DOI 10.1115/1.1517063; Forster BA, 1997, ARTERIOSCL THROM VAS, V17, P1361, DOI 10.1161/01.ATV.17.7.1361; HERRMANN RA, 1994, ARTERIOSCLER THROMB, V14, P313, DOI 10.1161/01.ATV.14.2.313; Mohamied Y, 2014, ANN BIOMED ENG; Otsu N, 1979, IEEE T SYST MAN CYB, V9; Peiffer V, 2013, J BIOMECH, V46, P2651, DOI 10.1016/j.jbiomech.2013.08.003; Peiffer V, 2012, ATHEROSCLEROSIS, V223, P114, DOI 10.1016/j.atherosclerosis.2012.04.020; SCHWENKE DC, 1988, CIRC RES, V62, P699, DOI 10.1161/01.RES.62.4.699; Sebkhi A, 1996, ARTERIOSCL THROM VAS, V16, P317, DOI 10.1161/01.ATV.16.2.317; SEBKHI A, 1994, ATHEROSCLEROSIS, V106, P1, DOI 10.1016/0021-9150(94)90077-9; SINZINGER H, 1980, BLOOD VESSELS, V17, P44; Sloop GD, 1998, ATHEROSCLEROSIS, V141, P153, DOI 10.1016/S0021-9150(98)00167-1; Staughton TJ, 2004, TRENDS IN ATHEROSCLEROSIS RESEARCH, P123; Staughton TJ, 2004, EXP PHYSIOL, V89, P109, DOI 10.1113/expphysiol.2003.002635; Staughton TJ, 2001, AM J PHYSIOL-HEART C, V281, pH53, DOI 10.1152/ajpheart.2001.281.1.H53; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Weinberg PD, 2004, J VASC RES, V41, P1, DOI 10.1159/000076124	25	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120363	10.1371/journal.pone.0120363	http://dx.doi.org/10.1371/journal.pone.0120363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781997	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000351284600154
J	De Spiegeleer, B; Verbeke, F; D'Hondt, M; Hendrix, A; Van De Wiele, C; Burvenich, C; Peremans, K; De Wever, O; Bracke, M; Wynendaele, E				De Spiegeleer, Bart; Verbeke, Frederick; D'Hondt, Matthias; Hendrix, An; Van De Wiele, Christophe; Burvenich, Christian; Peremans, Kathelijne; De Wever, Olivier; Bracke, Marc; Wynendaele, Evelien			The Quorum Sensing Peptides PhrG, CSP and EDF Promote Angiogenesis and Invasion of Breast Cancer Cells In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTESTINAL-ABSORPTION; EXPRESSION; PERMEABILITY; MONOLAYERS; MICROBIOTA; MIGRATION; TRANSPORT; PROTEINS; KINETICS	The role of the human microbiome on cancer progression remains unclear. Therefore, in this study, we investigated the influence of some quorum sensing peptides, produced by diverse commensal or pathogenic bacteria, on breast cancer cell invasion and thus cancer outcome. Based on microscopy, transcriptome and Chick Chorioallantoic Membrane (CAM) analyses, four peptides (PhrG from B. subtilis, CSP from S. mitis and EDF from E. coli, together with its tripeptide analogue) were found to promote tumour cell invasion and angiogenesis, thereby potentially influencing tumour metastasis. Our results offer not only new insights on the possible role of the microbiome, but also further opportunities in cancer prevention and therapy by competing with these endogenous molecules and/or by modifying people's life style.	[De Spiegeleer, Bart; Verbeke, Frederick; D'Hondt, Matthias; Wynendaele, Evelien] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Hendrix, An; De Wever, Olivier; Bracke, Marc] Ghent Univ Hosp, Fac Med & Hlth Sci, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Van De Wiele, Christophe] Ghent Univ Hosp, Fac Med & Hlth Sci, Dept Radiol & Nucl Med, Ghent, Belgium; [Burvenich, Christian] Univ Ghent, Fac Vet Med, Comparat Physiol & Biometr, Merelbeke, Belgium; [Peremans, Kathelijne] Univ Ghent, Fac Vet Med, Dept Med Imaging Med & Clin Biol Small Anim, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	de wever, olivier/J-3094-2013; De Spiegeleer, Bart/A-2001-2008; Hendrix, An/L-5918-2019	de wever, olivier/0000-0002-5453-760X; De Spiegeleer, Bart/0000-0001-6794-3108; 	Special Research Fund of Ghent University [BOF 01J22510]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [131356, 101529]	Special Research Fund of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund of Ghent University [Grant number BOF 01J22510 to BDS and EW, (https://www.ugent. be/en/research/funding/phd/bof/doc)] and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [Grant numbers 131356 to FV and 101529 to MD, (http://www.iwt.be/)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Antunes F, 2013, CURR DRUG METAB, V14, P4, DOI 10.2174/138920013804545160; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Aungst BJ, 1996, J CONTROL RELEASE, V41, P19, DOI 10.1016/0168-3659(96)01353-3; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Burgess DJ, 2013, NAT REV CANCER, V13, P148, DOI 10.1038/nrc3475; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Cattoor K, 2010, J AGR FOOD CHEM, V58, P4132, DOI 10.1021/jf904079h; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Han XY, 2006, J CLIN MICROBIOL, V44, P160, DOI 10.1128/JCM.44.1.160-165.2006; Hickson J, 2009, CLIN EXP METASTAS, V26, P67, DOI 10.1007/s10585-008-9177-z; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jahanfar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005458.pub2; JUNGINGER HE, 1992, DRUG TARGETING DELIV; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kumari A, 2008, ANAL BIOANAL CHEM, V391, P1619, DOI 10.1007/s00216-008-2002-3; LOGAN NA, 1988, J MED MICROBIOL, V25, P157, DOI 10.1099/00222615-25-3-157; Niyaz A, 2009, GUT PATHOG, DOI [10.1186/1757-4749-1-24., DOI 10.1186/1757-4749-1-24]; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Regazzo D, 2010, MOL NUTR FOOD RES, V54, P1428, DOI 10.1002/mnfr.200900443; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwabe RF, 2012, SCIENCE, V338, P52, DOI 10.1126/science.1229905; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Sys G, 2012, CANCER LETT, V326, P69, DOI 10.1016/j.canlet.2012.07.023; Taevernier L, 2014, J PEPT SCI, V20, pS299; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Veuillez F, 2001, EUR J PHARM BIOPHARM, V51, P93, DOI 10.1016/S0939-6411(00)00144-2; World Health Organization, 2014, CANC HLTH TOP; World Health Organization, 2014, CANCER PROGRAM BREAS; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Ziv E, 2000, MICROSC RES TECHNIQ, V49, P346, DOI 10.1002/(SICI)1097-0029(20000515)49:4<346::AID-JEMT3>3.0.CO;2-B; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	47	52	52	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119471	10.1371/journal.pone.0119471	http://dx.doi.org/10.1371/journal.pone.0119471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780927	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600066
J	Guo, J; Roberts, L; Chen, Z; Merta, PJ; Glaser, KB; Glaser, B				Guo, Jun; Roberts, Lisa; Chen, Zhui; Merta, Philip J.; Glaser, Keith B.; Shah, O. Jameel			JAK2(V617F) Drives Mcl-1 Expression and Sensitizes Hematologic Cell Lines to Dual Inhibition of JAK2 and Bcl-xL	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; BH3 MIMETIC ABT-737; CONSTITUTIVE ACTIVATION; FAMILY INHIBITOR; STAT PROTEINS; LEUKEMIA; APOPTOSIS; KINASE; PHOSPHORYLATION; CRITERIA	Constitutive activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) axis is fundamental to the molecular pathogenesis of a host of hematological disorders, including acute leukemias and myeloproliferative neoplasms (MPN). We demonstrate here that the major JAK2 mutation observed in these diseases (JAK2(V617F)) enforces Mcl-1 transcription via STAT3 signaling. Targeting this lesion with JAK inhibitor I (JAKi-I) attenuates STAT3 binding to the Mcl-1 promoter and suppresses Mcl-1 transcript and protein expression. The neutralization of Mcl-1 in JAK2(V617F)-harboring myelodyssplastic syndrome cell lines sensitizes them to apoptosis induced by the BH3-mimetic and Bcl-xL/Bcl-2 inhibitor, ABT-263. Moreover, simultaneously targeting JAK and Bcl-xL/-2 is synergistic in the presence of the JAK2(V617F) mutation. These findings suggest that JAK/Bcl-xL/-2 inhibitor combination therapy may have applicability in a range of hematological disorders characterized by activating JAK2 mutations.	[Guo, Jun; Roberts, Lisa; Chen, Zhui; Merta, Philip J.; Glaser, Keith B.; Shah, O. Jameel] AbbVie Inc, Res & Dev, Div Oncol, N Chicago, IL 60064 USA	AbbVie	Glaser, KB (corresponding author), AbbVie Inc, Res & Dev, Div Oncol, N Chicago, IL 60064 USA.	keith.glaser@abbvie.com			AbbVie	AbbVie(AbbVie)	JG, LR, PJM, OJS, and KG are or were employees of AbbVie. The design, research, and financial support for this research was provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the manuscript.	BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gabler K, 2013, J CELL MOL MED, V17, P265, DOI 10.1111/jcmm.12005; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hayakawa F, 1998, BRIT J HAEMATOL, V101, P521, DOI 10.1046/j.1365-2141.1998.00720.x; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ko TK, 2014, ONCOTERGAT, V1, P1; Lewis RS, 2008, EXPERT REV MOL DIAGN, V8, P73, DOI 10.1586/14737159.8.1.73; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Reynoso D, 2011, MOL ONCOL, V5, P93, DOI 10.1016/j.molonc.2010.10.003; Rubert J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-24; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vannucchi AM, 2011, BLOOD, V118, pA3835; Waibel M, 2013, CELL REP, V5, P1047, DOI 10.1016/j.celrep.2013.10.038; WeberNordt RM, 1996, BLOOD, V88, P809; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0114363	10.1371/journal.pone.0114363	http://dx.doi.org/10.1371/journal.pone.0114363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781882	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600002
J	Lin, CY; Chang, CY; Sun, CH; Li, TY; Chen, LC; Chang, ST; Wu, YT				Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Chang, Shin-Tsu; Wu, Yung-Tsan			Platelet Count and Early Outcome in Patients with Spontaneous Cerebellar Hemorrhage: A Retrospective Study	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ACUTE STROKE; COAGULATION PARAMETERS; INDEPENDENT PREDICTOR; HEMATOMA ENLARGEMENT; RISK-FACTORS; EARLY DEATH; MANAGEMENT; VOLUME; HYPERGLYCEMIA	Introduction The importance of coagulation, hematology, and biochemical variables have been investigated in the stroke population but have not been systemically surveyed in cerebellar hemorrhage (CH) population. The aim of the study was to explore the predictive value of these factors for early outcome in this population. Materials and Methods Eighty patients with acute spontaneous CH were retrospectively analyzed. Clinical and laboratory data were collected on admission for analysis. The patients were divided by Glasgow outcome scale (GOS) score at discharge into the good outcome group (GOS score 4 or 5) and the poor outcome group (GOS score 1, 2, or 3). The association between early outcome and clinical or laboratory variables were investigated by binary logistic regression. Results There were 46 (57.5%) patients in the poor outcome group and 34 (42.5%) in the good outcome group. The platelet count (PC) was significantly lower in the poor outcome group (187.3 +/- 53.0 x 10(9)/l) compared with good outcome group (244.9 +/- 63.9 x 10(9)/l) (p < 0.001). Moreover, PC (OR 0.97; p = 0.004) was the strong predictor with poor early outcome. Conclusions We firstly show that lower PC is the independent predictor for poor early outcome in patients with spontaneous CH.	[Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Wu, Yung-Tsan] Triserv Gen Hosp, Dept Phys Med & Rehabil, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Chang, Shin-Tsu; Wu, Yung-Tsan] Natl Def Med Ctr, Dept Phys Med & Rehabil, Sch Med, Taipei, Taiwan; [Chang, Shin-Tsu] Taichung Vet Gen Hosp, Dept Rehabil, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taichung Veterans General Hospital	Wu, YT (corresponding author), Triserv Gen Hosp, Dept Phys Med & Rehabil, Natl Def Med Ctr, 325,Sec 2,Cheng Kung Rd, Taipei, Taiwan.	crwu98@gmail.com	Li, Tsung-Ying/AAJ-2359-2020; Chang, Shin-Tsu/AAF-8506-2020; chihya, Chang/AAI-6537-2021	Chang, Shin-Tsu/0000-0003-4005-2094				Alexandrova ML, 2011, J CLIN NEUROSCI, V18, P247, DOI 10.1016/j.jocn.2010.07.125; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; DERASMO E, 1990, J INTERN MED, V227, P11, DOI 10.1111/j.1365-2796.1990.tb00111.x; Diedler J, 2010, CRIT CARE, V14, DOI 10.1186/cc8961; Dolderer S, 2004, EUR NEUROL, V52, P112, DOI 10.1159/000080268; DONAUER E, 1994, ACTA NEUROCHIR, V131, P59, DOI 10.1007/BF01401454; Fang HY, 2005, EUR J NEUROL, V12, P226, DOI 10.1111/j.1468-1331.2004.01018.x; Fujii Y, 1998, STROKE, V29, P1160, DOI 10.1161/01.STR.29.6.1160; GAUR SPS, 1994, INDIAN J MED RES, V99, P259; Gonzalez-Duarte Alejandra, 2008, J Stroke Cerebrovasc Dis, V17, P204, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.008; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; JENNETT B, 1975, LANCET, V1, P480; JUVELA S, 1995, ARCH NEUROL-CHICAGO, V52, P1193, DOI 10.1001/archneur.1995.00540360071018; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Matsukawa H, 2011, J STROKE CEREBROVASC, V20, P346, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.005; Mayda-Domac F, 2010, J STROKE CEREBROVASC, V19, P66, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.003; MEZZADRI JJM, 1993, ACTA NEUROCHIR, V122, P39, DOI 10.1007/BF01446984; MULLEY GP, 1983, THROMB HAEMOSTASIS, V50, P524; OMALLEY T, 1995, STROKE, V26, P995, DOI 10.1161/01.STR.26.6.995; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Seo W, 2009, WORLDV EVID-BASED NU, V6, P36, DOI 10.1111/j.1741-6787.2008.00139.x; Smith NM, 1999, VASC MED, V4, P165, DOI 10.1177/1358836X9900400307; St Louis EK, 2000, CAN J NEUROL SCI, V27, P32; TANEDA M, 1987, J NEUROSURG, V67, P545, DOI 10.3171/jns.1987.67.4.0545; TOHGI H, 1991, STROKE, V22, P17, DOI 10.1161/01.STR.22.1.17; VANLOON J, 1993, ACTA NEUROCHIR, V122, P187, DOI 10.1007/BF01405527; Virgós-Señor B., 2006, Med. Intensiva, V30, P01; Weir CJ, 2003, STROKE, V34, P1951, DOI 10.1161/01.STR.0000081983.34771.D2; Wu YT, 2013, CEREBELLUM, V12, P165, DOI 10.1007/s12311-012-0410-6; Wu YT, 2012, CEREBELLUM, V11, P543, DOI 10.1007/s12311-011-0317-7	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119109	10.1371/journal.pone.0119109	http://dx.doi.org/10.1371/journal.pone.0119109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781880	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600052
J	Naniwadekar, R; Shukla, U; Isvaran, K; Datta, A				Naniwadekar, Rohit; Shukla, Ushma; Isvaran, Kavita; Datta, Aparajita			Reduced Hornbill Abundance Associated with Low Seed Arrival and Altered Recruitment in a Hunted and Logged Tropical Forest	PLOS ONE			English	Article							NAMDAPHA-NATIONAL-PARK; LOWLAND RAIN-FOREST; ARUNACHAL-PRADESH; NEOTROPICAL TREE; NORTHEAST INDIA; WEST KALIMANTAN; DISPERSED TREES; EMPTY FOREST; DISTURBANCE; COMMUNITY	Logging and hunting are two key direct threats to the survival of wildlife in the tropics, and also disrupt important ecosystem processes. We investigated the impacts of these two factors on the different stages of the seed dispersal cycle, including abundance of plants and their dispersers and dispersal of seeds and recruitment, in a tropical forest in north-east India. We focused on hornbills, which are important seed dispersers in these forests, and their food tree species. We compared abundances of hornbill food tree species in a site with high logging and hunting pressures (heavily disturbed) with a site that had no logging and relatively low levels of hunting (less disturbed) to understand logging impacts on hornbill food tree abundance. We compared hornbill abundances across these two sites. We, then, compared the scatter-dispersed seed arrival of five large-seeded tree species and the recruitment of four of those species. Abundances of hornbill food trees that are preferentially targeted by logging were two times higher in the less disturbed site as compared to the heavily disturbed site while that of hornbills was 22 times higher. The arrival of scatter-dispersed seeds was seven times higher in the less disturbed site. Abundances of recruits of two tree species were significantly higher in the less disturbed site. For another species, abundances of younger recruits were significantly lower while that of older recruits were higher in the heavily disturbed site. Our findings suggest that logging reduces food plant abundance for an important frugivore-seed disperser group, while hunting diminishes disperser abundances, with an associated reduction in seed arrival and altered recruitment of animal-dispersed tree species in the disturbed site. Based on our results, we present a conceptual model depicting the relationships and pathways between vertebrate-dispersed trees, their dispersers, and the impacts of hunting and logging on these pathways.	[Naniwadekar, Rohit; Shukla, Ushma; Datta, Aparajita] Nat Conservat Fdn, Mysore, Karnataka, India; [Isvaran, Kavita] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Naniwadekar, R (corresponding author), Nat Conservat Fdn, Mysore, Karnataka, India.	rohit@ncf-india.org		Naniwadekar, Rohit/0000-0002-9188-6083; Shukla, Ushma/0000-0001-8775-2800	Rufford Small Grants, United Kingdom [10475-2]; International Foundation for Science, Sweden [D/5136-1]	Rufford Small Grants, United Kingdom; International Foundation for Science, Sweden(International Foundation for Science)	This work was supported by Rufford Small Grants, United Kingdom, Grant no: 10475-2, URL: http://www.rufford.org/rsg/projects/rohit_naniwadekar_0; International Foundation for Science, Sweden, Grant no: D/5136-1, URL: www.ifs.se.	Aiyadurai A, 2010, ORYX, V44, P564, DOI 10.1017/S0030605309990937; [Anonymous], 2007, LME4 LINEAR MIXED EF; Beckman NG, 2007, BIOTROPICA, V39, P328, DOI 10.1111/j.1744-7429.2007.00273.x; Bennett EL, 1997, BIOL CONSERV, V82, P41, DOI 10.1016/S0006-3207(97)00012-8; Bhupathy S, 2013, TROP CONSERV SCI, V6, P241, DOI 10.1177/194008291300600206; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; CANNON CH, 1994, FOREST ECOL MANAG, V67, P49, DOI 10.1016/0378-1127(94)90007-8; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Datta A, 1998, ORYX, V32, P285, DOI 10.1017/S0030605300030088; Datta A, 2003, BIOTROPICA, V35, P208, DOI 10.1111/j.1744-7429.2003.tb00280.x; Datta A., 2009, INDIAN BIRDS, V5, P108; Datta A., 2001, THESIS; Datta A, 2002, STATUS HORNBILLS HUN; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Felton A, 2008, BIOL CONSERV, V141, P545, DOI 10.1016/j.biocon.2007.11.009; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Forget PM, 2007, CONSERV BIOL, V21, P106, DOI 10.1111/j.1523-1739.2006.00590.x; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; Guariguata MR, 2000, CONSERV BIOL, V14, P1046, DOI 10.1046/j.1523-1739.2000.99148.x; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1985, ECOLOGY, V66, P781, DOI 10.2307/1940539; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Kemp A.C., 1995, HORNBILLS BUCEROTIFO, V1; Kinnaird MF, 2007, THE ECOLOGY AND CONS; Kirika JM, 2008, CONSERV BIOL, V22, P318, DOI 10.1111/j.1523-1739.2007.00874.x; Kitamura S, 2011, ACTA OECOL, V37, P531, DOI 10.1016/j.actao.2011.01.015; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Naniwadekar R, 2014, THESIS; Nath PC, 2005, BIODIVERS CONSERV, V14, P2109, DOI 10.1007/s10531-004-4361-1; Nunez-Iturri G, 2008, BIOL CONSERV, V141, P1536, DOI 10.1016/j.biocon.2008.03.020; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Proctor J, 1998, GLOBAL ECOL BIOGEOGR, V7, P141, DOI 10.2307/2997817; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson J., 2000, HUNTING SUSTAINABILI; ROSENCRANZ A., 2007, ENV LAW REPORTER NEW, V37, P10032; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Sethi P, 2009, CONSERV BIOL, V23, P710, DOI 10.1111/j.1523-1739.2008.01155.x; Srinivasan U, 2010, FORKTAIL, P92; Srivastava S, 2002, CURR SCI INDIA, V82, P1479; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thiollay JM, 1997, BIODIVERS CONSERV, V6, P1155, DOI 10.1023/A:1018388202698; THIOLLAY JM, 1992, CONSERV BIOL, V6, P47, DOI 10.1046/j.1523-1739.1992.610047.x; Vanthomme H, 2010, BIOTROPICA, V42, P672, DOI 10.1111/j.1744-7429.2010.00630.x; Velho N, 2012, BIOL CONSERV, V153, P32, DOI 10.1016/j.biocon.2012.04.028; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	57	21	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120062	10.1371/journal.pone.0120062	http://dx.doi.org/10.1371/journal.pone.0120062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781944	Green Accepted, Green Published, gold			2022-12-26	WOS:000351284600123
J	Prato, M; Magnetto, C; Jose, J; Khadjavi, A; Cavallo, F; Quaglino, E; Panariti, A; Rivolta, I; Benintende, E; Varetto, G; Argenziano, M; Troia, A; Cavalli, R; Guiot, C				Prato, Mauro; Magnetto, Chiara; Jose, Jithin; Khadjavi, Amina; Cavallo, Federica; Quaglino, Elena; Panariti, Alice; Rivolta, Ilaria; Benintende, Emilio; Varetto, Gianfranco; Argenziano, Monica; Troia, Adriano; Cavalli, Roberta; Guiot, Caterina			2H,3H-Decafluoropentane-Based Nanodroplets: New Perspectives for Oxygen Delivery to Hypoxic Cutaneous Tissues	PLOS ONE			English	Article							PHOTOACOUSTIC COMPUTED-TOMOGRAPHY; CHRONIC WOUNDS; BLOOD SUBSTITUTES; SURFACE-CHARGE; IN-VITRO; ULTRASOUND; NANOPARTICLES; THERAPY; HYDROGELS; DEXTRAN	Perfluoropentane (PFP)-based oxygen-loaded nanobubbles (OLNBs) were previously proposed as adjuvant therapeutic tools for pathologies of different etiology sharing hypoxia as a common feature, including cancer, infection, and autoimmunity. Here we introduce a new platform of oxygen nanocarriers, based on 2H,3H-decafluoropentane (DFP) as core fluorocarbon. These new nanocarriers have been named oxygen-loaded nanodroplets (OLNDs) since DFP is liquid at body temperature, unlike gaseous PFP. Dextran-shelled OLNDs, available either in liquid or gel formulations, display spherical morphology, similar to 600 nm diameters, anionic charge, good oxygen carrying capacity, and no toxic effects on human keratinocytes after cell internalization. In vitro OLNDs result more effective in releasing oxygen to hypoxic environments than former OLNBs, as demonstrated by analysis through oxymetry. In vivo, OLNDs effectively enhance oxy-hemoglobin levels, as emerged from investigation by photoacoustic imaging. Interestingly, ultrasound (US) treatment further improves transdermal oxygen release from OLNDs. Taken together, these data suggest that US-activated, DFP-based OLNDs might be innovative, suitable and cost-effective devices to topically treat hypoxia-associated pathologies of the cutaneous tissues.	[Prato, Mauro; Khadjavi, Amina; Guiot, Caterina] Univ Turin, Dipartimento Neurosci, Turin, Italy; [Magnetto, Chiara; Troia, Adriano] Ist Nazl Ric Metrol INRIM, Turin, Italy; [Jose, Jithin] FujiFilm VisualSon, Amsterdam, Netherlands; [Cavallo, Federica; Quaglino, Elena] Univ Turin, Ctr Mol Biotechnol, Dipartimento Biotecnol Mol & Sci Salute, Turin, Italy; [Panariti, Alice; Rivolta, Ilaria] Univ Milano Bicocca, Dipartimento Sci Salute, Monza, Italy; [Benintende, Emilio; Varetto, Gianfranco] Univ Turin, Dipartimento Sci Chirurg, Turin, Italy; [Argenziano, Monica; Cavalli, Roberta] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy	University of Turin; Istituto Nazionale di Ricerca Metrologica (INRIM); Fujifilm Corporation; University of Turin; University of Milano-Bicocca; University of Turin; University of Turin	Prato, M (corresponding author), Univ Turin, Dipartimento Neurosci, Turin, Italy.	mauro.prato@unito.it; caterina.guiot@unito.it	Cavallo, Federica/C-5666-2011	Cavallo, Federica/0000-0003-4571-1060; Quaglino, Elena/0000-0002-8151-9124; Varetto, Gianfranco/0000-0003-4262-886X	Compagnia di San Paolo (Ateneo-SanPaolo) [ORTO11CE8R]; University of Torino	Compagnia di San Paolo (Ateneo-SanPaolo); University of Torino	Work funded by Compagnia di San Paolo (Ateneo-SanPaolo 2011 ORTO11CE8R grant to C. G.) and University of Torino (ex-60% grant to R. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mottaleb MMA, 2012, J PHARM SCI-US, V101, P4231, DOI 10.1002/jps.23282; Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093; Bisazza A, 2008, IEEE ENG MED BIO, P2067, DOI 10.1109/IEMBS.2008.4649599; Bos GW, 2005, BIOMATERIALS, V26, P3901, DOI 10.1016/j.biomaterials.2004.10.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brimson CH, 2013, J EUR ACAD DERMATOL, V27, P411, DOI 10.1111/j.1468-3083.2012.04650.x; BROOKS DE, 1973, J COLLOID INTERF SCI, V43, P670, DOI 10.1016/0021-9797(73)90413-X; Cabrales P, 2013, ASAIO J, V59, P337, DOI 10.1097/MAT.0b013e318291fbaa; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Cavalli R, 2013, INT J PHARMACEUT, V456, P437, DOI 10.1016/j.ijpharm.2013.08.041; Cavalli R, 2012, INT J NANOMED, V7, P3309, DOI 10.2147/IJN.S30912; Cavalli R, 2009, INT J PHARMACEUT, V378, P215, DOI 10.1016/j.ijpharm.2009.05.058; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Davis SC, 2007, ARCH DERMATOL, V143, P1252, DOI 10.1001/archderm.143.10.1252; De Backer D, 2012, J CLIN MONIT COMPUT, V26, P361, DOI 10.1007/s10877-012-9383-8; De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0; Dietz I, 2012, MICROBES INFECT, V14, P311, DOI 10.1016/j.micinf.2011.11.003; Dushkin AV, 2013, PHARM CHEM J+, V46, P630, DOI 10.1007/s11094-013-0859-8; Gordillo GM, 2008, CLIN EXP PHARMACOL P, V35, P957, DOI 10.1111/j.1440-1681.2008.04934.x; Gordillo GM, 2009, INT J LOW EXTR WOUND, V8, P105, DOI 10.1177/1534734609335149; Jose J, 2011, OPT EXPRESS, V19, P2093, DOI 10.1364/OE.19.002093; Kagan D, 2012, ANGEW CHEM INT EDIT, V51, P7519, DOI 10.1002/anie.201201902; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; KNIGHTON DR, 1981, SURGERY, V90, P262; Kogan Paul, 2010, Bubble Sci Eng Technol, V2, P3, DOI 10.1179/175889610X12730566149100; Kotopoulis S, 2014, MOL IMAGING BIOL, V16, P53, DOI 10.1007/s11307-013-0672-5; Kotopoulis S, 2013, MED PHYS, V40, DOI 10.1118/1.4808149; Krafft MP, 1998, BIOCHIMIE, V80, P489, DOI 10.1016/S0300-9084(00)80016-4; Laser institute of America, 2007, AMERICAN NATIONAL ST; Laufer J, 2007, PHYS MED BIOL, V52, P141, DOI 10.1088/0031-9155/52/1/010; Lee O, 2013, SKIN RES TECHNOL, V19, pE390, DOI 10.1111/j.1600-0846.2012.00656.x; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Lopez RFV, 2011, BIOMATERIALS, V32, P933, DOI 10.1016/j.biomaterials.2010.09.060; Lundgren CEG, 2004, UNDERSEA HYPERBAR M, V31, P105; Magnetto C, 2014, RSC ADV, V4, P38433, DOI 10.1039/c4ra03524k; Mathieu Daniel, 2007, Int J Low Extrem Wounds, V6, P273, DOI 10.1177/1534734607310299; Modery-Pawlowski CL, 2013, BIOMACROMOLECULES, V14, P939, DOI 10.1021/bm400074t; Moller S, 2007, BIOMOL ENG, V24, P496, DOI 10.1016/j.bioeng.2007.08.014; PINNICK RG, 1990, APPL OPTICS, V29, P918, DOI 10.1364/AO.29.000918; Postema M, 2011, WORLD J GASTROENTERO, V17, P28, DOI 10.3748/wjg.v17.i1.28; Rapoport NY, 2004, ULTRASONICS, V42, P943, DOI 10.1016/j.ultras.2004.01.087; Resink S, 2011, OPT LETT, V36, P2809, DOI 10.1364/OL.36.002809; Riess JG, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400052313; Ryman-Rasmussen JP, 2007, J INVEST DERMATOL, V127, P143, DOI 10.1038/sj.jid.5700508; Said HK, 2005, ARCH SURG-CHICAGO, V140, P998, DOI 10.1001/archsurg.140.10.998; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Sola A, 2014, ACTA PAEDIATR, V103, P1009, DOI 10.1111/apa.12692; Sze A, 2003, J COLLOID INTERF SCI, V261, P402, DOI 10.1016/S0021-9797(03)00142-5; Takahashi M., 2009, MAT INTEGR, V22, P2; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Wu X, 2010, SKIN PHARMACOL PHYS, V23, P117, DOI 10.1159/000270381; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; Young Robert W, 2012, J Extra Corpor Technol, V44, P241; Zbytek B, 2013, DERM-ENDOCRINOL, V5, P239, DOI 10.4161/derm.22678	57	33	34	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119769	10.1371/journal.pone.0119769	http://dx.doi.org/10.1371/journal.pone.0119769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781463	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600090
J	Qi, K; Li, LJ; Li, XD; Zhao, JL; Wang, Y; You, SJ; Hu, FH; Zhang, HT; Cheng, YT; Kang, S; Cui, HH; Duan, L; Jin, C; Zheng, QS; Yang, YJ				Qi, Kang; Li, Lujin; Li, Xiangdong; Zhao, Jinglin; Wang, Yang; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Zheng, Qingshan; Yang, Yuejin			Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							K-ATP CHANNEL; REPERFUSED SWINE HEARTS; NITRIC-OXIDE SYNTHASE; NO-REFLOW PHENOMENON; ANGIOPOIETIN-LIKE 4; VASCULAR-PERMEABILITY; VE-CADHERIN; CARDIOMYOCYTE HYPERTROPHY; ENDOTHELIAL PERMEABILITY; ADHERENS JUNCTIONS	Objective Tongxinluo (TXL) has been shown to decrease myocardial necrosis after ischemia/ reperfusion (I/R) by simulating ischemia preconditioning (IPC). However, the core mechanism of TXL remains unclear. This study was designed to investigate the key targets of TXL against I/R injury (IRI) among the cardiac structure-function network. Materials and Methods To evaluate the severity of lethal IRI, a mathematical model was established according to the relationship between myocardial no-reflow size and necrosis size. A total of 168 miniswine were employed in myocardial I/R experiment. IRI severity among different interventions was compared and IPC and CCB groups were identified as the mildest and severest groups, respectively. Principal component analysis was applied to further determine 9 key targets of IPC in cardioprotection. Then, the key targets of TXL in cardioprotection were confirmed. Results Necrosis size and no-reflow size fit well with the Sigmoid Emaxmodel. Necrosis reduction space (NRS) positively correlates with I/R injury severity and necrosis size (R2= 0.92, R-2= 0.57, P< 0.01, respectively). Functional and structural indices correlate positively with NRS (R-2= 0.64, R-2= 0.62, P< 0.01, respectively). TXL recovers SUR2, iNOS activity, eNOS activity, VE-cadherin, beta-catenin, gamma-catenin and P-selectin with a trend toward the sham group. Moreover, TXL increases PKA activity and eNOS expression with a trend away fromthe sham group. Among the above nine indices, eNOS activity, eNOS, VE-cadherin, beta-catenin and gamma-catenin expression were significantly up-regulated by TXL compared with IPC (P>0.05) or CCB (P<0.05) and these five microvascular barrier-related indices may be the key targets of TXL inminimizing IRI. Conclusions Our study underlines the lethal IRI as one of the causes of myocardial necrosis. Pretreatment with TXL ameliorates myocardial IRI through promoting cardiac microvascular endothelial barrier function by simulating IPC.	[Qi, Kang; Li, Xiangdong; Zhao, Jinglin; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Yang, Yuejin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Qi, Kang; Li, Xiangdong; Zhao, Jinglin; Wang, Yang; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Yang, Yuejin] Peking Union Med Coll, Beijing 100037, Peoples R China; [Li, Lujin; Zheng, Qingshan] Shanghai Univ Chinese Med, Ctr Drug Clin Res, Shanghai 201203, Peoples R China; [Wang, Yang] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Biol Informat & Stat Ctr, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yang, YJ (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	yangyjfw@126.com	Li, Lujin/ABA-6800-2021		National Basic Research Program (973 Program) of China [2012CB518602, 2005CB523303]; National Natural Science Foundation of China [81370223, 30770858, 30572439, 902090038]; Beijing Natural Science Foundation [7042044]; Capital Medical Development Scientific Research Fund [2002-3072]; Postgraduates' Innovative Foundation of Peking Union Medical College, China [2013-1002-39]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital Medical Development Scientific Research Fund; Postgraduates' Innovative Foundation of Peking Union Medical College, China	This study was supported by National Basic Research Program (973 Program) of China (No. 2012CB518602; No. 2005CB523303, http://www.973.gov.cn/AreaAppl.aspx; KQ, XL, JZ, SY, FH, HZ, YC, SK, HC, LD, CJ, YY), National Natural Science Foundation of China (No. 81370223; No. 30770858; No. 30572439; No. 902090038, http://www.nsfc.gov.cn; KQ, XL, JZ, SY, FH, HZ, YC, SK, HC, LD, CJ, YY), Beijing Natural Science Foundation (No. 7042044, http://www.bjnsf.org; JZ, SY, FH, CJ, YY), Capital Medical Development Scientific Research Fund (No. 2002-3072, http://www. bjhbkj. com; JZ, SY, FH, CJ, YY) and Postgraduates' Innovative Foundation of Peking Union Medical College, China (2013-1002-39; http://graduate. pumc. edu. cn/peiyang/view/86. aspx; KQ). All funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkers SCAM, 2010, J AM COLL CARDIOL, V55, P1649, DOI 10.1016/j.jacc.2009.12.037; Bernardo NL, 1999, AM J PHYSIOL-HEART C, V276, pH1323, DOI 10.1152/ajpheart.1999.276.4.H1323; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bouleti C, 2013, EUR HEART J, V34, P3657, DOI 10.1093/eurheartj/eht153; Cheng YT, 2009, CHINESE MED J-PEKING, V122, P1529, DOI 10.3760/cma.j.issn.0366-6999.2009.13.011; Cheng YuTong, 2009, Shandong Medical Journal, V49, P4; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Csonka C, 2010, J PHARMACOL TOX MET, V61, P163, DOI 10.1016/j.vascn.2010.02.014; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Duan L, 2010, SHANDONG YI YAO, V50, P3; [段炼 DUAN Lian], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P430; Facundo HTF, 2005, J BIOENERG BIOMEMBR, V37, P75, DOI 10.1007/s10863-005-4130-1; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Guo JA, 2011, CIRC-HEART FAIL, V4, P79, DOI 10.1161/CIRCHEARTFAILURE.110.957969; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Ikeno F, 2007, CARDIOVASC RES, V73, P699, DOI 10.1016/j.cardiores.2006.12.011; Kang Sheng, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P107; Karalliedde LD, 2009, AM J PHYSIOL-HEART C, V297, pH1967, DOI 10.1152/ajpheart.00944.2009; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Li LJ, 2009, PHARMACOL RES, V60, P277, DOI 10.1016/j.phrs.2009.04.001; Li XD, 2013, INT J CARDIOL, V167, P2657, DOI 10.1016/j.ijcard.2012.06.121; Li XD, 2013, CHINESE MED J-PEKING, V126, P1469, DOI 10.3760/cma.j.issn.0366-6999.20130224; Li Xiang-dong, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P945; Li XD, 2012, ACTA PHARMACOL SIN, V33, P879, DOI 10.1038/aps.2012.27; Li XD, 2012, MICROVASC RES, V84, P44, DOI 10.1016/j.mvr.2012.04.002; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Li Z, 2012, BIOCHEM BIOPH RES CO, V425, P630, DOI 10.1016/j.bbrc.2012.07.130; Maeng YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068659; Milligan PA, 2013, CLIN PHARMACOL THER, V93, P502, DOI 10.1038/clpt.2013.54; Moey M, 2012, CIRC-HEART FAIL, V5, P504, DOI 10.1161/CIRCHEARTFAILURE.112.967489; Muscari C, 2004, LIFE SCI, V74, P1127, DOI 10.1016/j.lfs.2003.10.001; Nicholson JK, 2008, J PROTEOME RES, V7, P3637, DOI 10.1021/pr8005099; O'Rourke B, 2000, CIRC RES, V87, P845, DOI 10.1161/01.RES.87.10.845; OH B, 2013, EUR HEART J, V34, P932, DOI [10.1093/eurheartj/ehs396, DOI 10.1093/EURHEARTJ/EHS396]; Rezkalla SH, 2008, CATHETER CARDIO INTE, V72, P950, DOI 10.1002/ccd.21715; Ruder TD, 2013, FORENSIC SCI MED PAT, V9, P501, DOI 10.1007/s12024-013-9459-x; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu ZQ, 2006, MOL PHARMACOL, V69, P866, DOI 10.1124/mol.106.016501; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yang CJ, 2013, CARDIOVASC RES, V97, P33, DOI 10.1093/cvr/cvs287; Yang YJ, 2006, HEART, V92, P1131, DOI 10.1136/hrt.2005.077164; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013; Zhang HT, 2010, CHINESE MED J-PEKING, V123, P2858, DOI 10.3760/cma.j.issn.0366-6999.2010.20.021; Zhang Hai-tao, 2009, Zhonghua Yi Xue Za Zhi, V89, P1421; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhao JL, 2006, BRIT J PHARMACOL, V149, P243, DOI 10.1038/sj.bjp.0706862; Zhao JL, 2007, MICROVASC RES, V73, P137, DOI 10.1016/j.mvr.2006.09.002; Zhao JL, 2006, CLIN CHIM ACTA, V374, P100, DOI 10.1016/j.cca.2006.05.039; Zhao JL, 2006, CORONARY ARTERY DIS, V17, P463, DOI 10.1097/00019501-200608000-00010; Zhao JL, 2006, CARDIOVASC DRUG THER, V20, P167, DOI 10.1007/s10557-006-8284-9; Zhao Jing-Lin, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P486; Zhao JL, 2007, INT J CARDIOL, V115, P334, DOI 10.1016/j.ijcard.2006.03.017	62	19	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119846	10.1371/journal.pone.0119846	http://dx.doi.org/10.1371/journal.pone.0119846			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781461	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600100
J	Silva, RA; Palladino, MV; Cavalheiro, RP; Machado, D; Cruz, BLG; Paredes-Gamero, EJ; Gomes-Marcondes, MCC; Zambuzzi, WF; Vasques, L; Nader, HB; Souza, ACS; Justo, GZ				Silva, Rodrigo A.; Palladino, Marcelly V.; Cavalheiro, Renan P.; Machado, Daisy; Cruz, Bread L. G.; Paredes-Gamero, Edgar J.; Gomes-Marcondes, Maria C. C.; Zambuzzi, Willian F.; Vasques, Luciana; Nader, Helena B.; Souza, Ana Carolina S.; Justo, Giselle Z.			Activation of the Low Molecular Weight Protein Tyrosine Phosphatase in Keratinocytes Exposed to Hyperosmotic Stress	PLOS ONE			English	Article							REDOX REGULATION; CELL-LINE; OSTEOBLAST ADHESION; SIGNALING PATHWAYS; VITAMIN-D; LMW-PTP; GROWTH; PHOSPHORYLATION; CYTOSKELETON; APOPTOSIS	Herein, we provide new contribution to the mechanisms involved in keratinocytes response to hyperosmotic shock showing, for the first time, the participation of Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP) activity in this event. We reported that sorbitol-induced osmotic stress mediates alterations in the phosphorylation of pivotal cytoskeletal proteins, particularly Src and cofilin. Furthermore, an increase in the expression of the phosphorylated form of LMWPTP, which was followed by an augment in its catalytic activity, was observed. Of particular importance, these responses occurred in an intracellular milieu characterized by elevated levels of reduced glutathione (GSH) and increased expression of the antioxidant enzymes glutathione peroxidase and glutathione reductase. Altogether, our results suggest that hyperosmostic stress provides a favorable cellular environment to the activation of LMWPTP, which is associated with increased expression of antioxidant enzymes, high levels of GSH and inhibition of Src kinase. Finally, the real contribution of LMWPTP in the hyperosmotic stress response of keratinocytes was demonstrated through analysis of the effects of ACP1 gene knockdown in stressed and non-stressed cells. LMWPTP knockdown attenuates the effects of sorbitol induced-stress in HaCaT cells, mainly in the status of Src kinase, Rac and STAT5 phosphorylation and activity. These results describe for the first time the participation of LMWPTP in the dynamics of cytoskeleton rearrangement during exposure of human keratinocytes to hyperosmotic shock, which may contribute to cell death.	[Silva, Rodrigo A.; Machado, Daisy; Cruz, Bread L. G.; Gomes-Marcondes, Maria C. C.; Justo, Giselle Z.] Univ Estadual Campinas, Dept Bioquim, Inst Biol, Sao Paulo, Brazil; [Palladino, Marcelly V.; Cavalheiro, Renan P.; Paredes-Gamero, Edgar J.; Nader, Helena B.; Justo, Giselle Z.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil; [Zambuzzi, Willian F.] Univ Estadual Paulista, Dept Quim & Bioquim, IBB, Sao Paulo, Brazil; [Vasques, Luciana] Univ Sao Paulo, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil; [Souza, Ana Carolina S.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Justo, Giselle Z.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP)	Justo, GZ (corresponding author), Univ Estadual Campinas, Dept Bioquim, Inst Biol, Sao Paulo, Brazil.	giselle.zenker@unifesp.br	Nader, Helena Bonciani/D-9253-2012; Vasques, Luciana/C-7273-2012; Paredes-Gamero, Edgar J/C-4791-2012; Santos, Ana Carolina/GWR-2410-2022; Gomes-Marcondes, Maria Cristina Cintr c/C-3384-2012; Marcondes, Maria Cristina Cintra Gomes/S-9177-2019; Machado, Daisy/ABA-3731-2020; de Souza Galvão, Ana Carolina Santos/B-8114-2014; Machado, Daisy/A-4891-2013; Zambuzzi, Willian/ABD-8339-2020; da Silva, Rodrigo Augusto/G-1222-2012; Silva, Rodrigo/GXM-7197-2022; Zambuzzi, Willian Fernando/F-9519-2012	Vasques, Luciana/0000-0003-2229-6773; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Gomes-Marcondes, Maria Cristina Cintr c/0000-0002-1713-756X; Marcondes, Maria Cristina Cintra Gomes/0000-0002-1713-756X; Machado, Daisy/0000-0002-6435-6159; de Souza Galvão, Ana Carolina Santos/0000-0003-1748-3494; Machado, Daisy/0000-0002-6435-6159; da Silva, Rodrigo Augusto/0000-0002-7754-1855; Zambuzzi, Willian Fernando/0000-0002-4149-5965; NADER, HELENA/0000-0002-7569-2166; Cruz, Bread/0000-0002-2287-6383	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Rede Nanocosmeticos/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP [2006/07315-3]; CNPq [PQ-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rede Nanocosmeticos/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(www.cnpq.br) and Rede Nanocosmeticos/CNPq. The authors also acknowledge support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(www.capes.gov.br). R. A. S. is supported by a PhD scholarship from FAPESP (Grant nr. 2006/07315-3). W. F. Z. is supported by a fellowship from CNPq (PQ-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076307; Berger Angelika, 2014, Oncotarget, V5, P9564; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Buricchi F, 2007, CELL ADHES MIGR, V1, P33, DOI 10.4161/cam.3911; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cirri P, 1998, J BIOL CHEM, V273, P32522, DOI 10.1074/jbc.273.49.32522; Dascalu A, 2000, J INVEST DERMATOL, V115, P714, DOI 10.1046/j.1523-1747.2000.00099.x; den Hertog J, 2008, FEBS J, V275, P831, DOI 10.1111/j.1742-4658.2008.06247.x; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Diker-Cohen T, 2006, APOPTOSIS, V11, P519, DOI 10.1007/s10495-006-5115-1; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Ferreira CV, 2006, BIOCHIMIE, V88, P1859, DOI 10.1016/j.biochi.2006.08.007; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Lannutti F, 2012, J MOL GRAPH MODEL, V32, P9, DOI 10.1016/j.jmgm.2011.09.006; Vu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Maehly AC, 1957, METHODS BIOCH ANAL; Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Quintela-Fandino M, 2010, P NATL ACAD SCI USA, V107, P2622, DOI 10.1073/pnas.0914492107; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Rigacci S, 2008, BIOCHEMISTRY-US, V47, P1482, DOI 10.1021/bi701131e; Rodriguez I, 2002, CELL SIGNAL, V14, P839, DOI 10.1016/S0898-6568(02)00031-1; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Souza AC, 2002, CELL MOL LIFE SCI, V66, P1140; Souza NJA, 2006, INT ENDOD J, V39, P40, DOI 10.1111/j.1365-2591.2005.01045.x; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Torsoni MA, 1998, BIOCHEM MOL BIOL INT, V46, P147; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Zambuzzi WF, 2008, CELL PHYSIOL BIOCHEM, V22, P497, DOI 10.1159/000185506; Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119020	10.1371/journal.pone.0119020	http://dx.doi.org/10.1371/journal.pone.0119020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781955	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600044
J	Zinicola, M; Lima, F; Lima, S; Machado, V; Gomez, M; Dopfer, D; Guard, C; Bicalho, R				Zinicola, Martin; Lima, Fabio; Lima, Svetlana; Machado, Vinicius; Gomez, Marilia; Doepfer, Doerte; Guard, Charles; Bicalho, Rodrigo			Altered Microbiomes in Bovine Digital Dermatitis Lesions, and the Gut as a Pathogen Reservoir	PLOS ONE			English	Article							DAIRY-CATTLE; EXPERIMENTAL-INFECTION; HOLSTEIN COWS; HERD-LEVEL; UK CATTLE; TREPONEMES; PREVALENCE; DIVERSITY; ASSOCIATION; DYNAMICS	Bovine digital dermatitis (DD) is the most important infectious disease associated with lameness in cattle worldwide. Since the disease was first described in 1974, a series of Treponema species concurrent with other microbes have been identified in DD lesions, suggesting a polymicrobial etiology. However, the pathogenesis of DD and the source of the causative microbes remain unclear. Here we characterized the microbiomes of healthy skin and skin lesions in dairy cows affected with different stages of DD and investigated the gut microbiome as a potential reservoir for microbes associated with this disease. Discriminant analysis revealed that the microbiomes of healthy skin, active DD lesions (ulcerative and chronic ulcerative) and inactive DD lesions (healing and chronic proliferative) are completely distinct. Treponema denticola, Treponema maltophilum, Treponema medium, Treponema putidum, Treponema phagedenis and Treponema paraluiscuniculi were all found to be present in greater relative abundance in active DD lesions when compared with healthy skin and inactive DD lesions, and these same Treponema species were nearly ubiquitously present in rumen and fecal microbiomes. The relative abundance of Candidatus Amoebophilus asiaticus, a bacterium not previously reported in DD lesions, was increased in both active and inactive lesions when compared with healthy skin. In conclusion, our data support the concept that DD is a polymicrobial disease, with active DD lesions having a markedly distinct microbiome dominated by T. denticola, T. maltophilum, T. medium, T. putidum, T. phagedenis and T. paraluiscuniculi. Furthermore, these Treponema species are nearly ubiquitously found in rumen and fecal microbiomes, suggesting that the gut is an important reservoir of microbes involved in DD pathogenesis. Additionally, the bacterium Candidatus Amoebophilus asiaticus was highly abundant in active and inactive DD lesions.	[Zinicola, Martin; Lima, Fabio; Lima, Svetlana; Machado, Vinicius; Gomez, Marilia; Guard, Charles; Bicalho, Rodrigo] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Doepfer, Doerte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Bicalho, R (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Lima, Fabio/A-9814-2018	Lima, Fabio/0000-0001-8377-6469	USDA/NIFA Federal Formula Funds project [NYC-478438]	USDA/NIFA Federal Formula Funds project	Funding was provided for research and publication by the USDA/NIFA Federal Formula Funds project NYC-478438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2007, CELL MOL LIFE SCI, V64, P432, DOI 10.1007/s00018-006-6391-1; Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1994, VET REC, V135, P577; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown CC, 2000, AM J VET RES, V61, P928, DOI 10.2460/ajvr.2000.61.928; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Capion N, 2012, J DAIRY SCI, V95, P6457, DOI 10.3168/jds.2012-5335; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; Cheli R, 1974, 8 INT C DIS CATTLE, P208; Demirkan I, 1999, VET J, V157, P69, DOI 10.1053/tvjl.1998.0276; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettema J, 2010, PREV VET MED, V95, P64, DOI 10.1016/j.prevetmed.2010.03.001; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2012, VET MICROBIOL, V156, P102, DOI 10.1016/j.vetmic.2011.09.029; Evans NJ, 2011, APPL ENVIRON MICROB, V77, P138, DOI 10.1128/AEM.00993-10; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Geishauser T, 2012, J DAIRY SCI, V95, P4556, DOI 10.3168/jds.2012-5380; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gomez A, 2012, J DAIRY SCI, V95, P1821, DOI 10.3168/jds.2011-4754; GRAVES S, 1981, BRIT J VENER DIS, V57, P7; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Krull AC, 2014, INFECT IMMUN; Laven RA, 2006, VET J, V171, P79, DOI 10.1016/j.tvjl.2004.08.009; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Losinger WC, 2006, J DAIRY RES, V73, P244, DOI 10.1017/S0022029906001798; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Thomas V, 2007, LETT APPL MICROBIOL, V45, P349, DOI 10.1111/j.1472-765X.2007.02206.x; USDA, 2009, REF DAIL CATTL HLT 4; Vink WD, 2009, PREV VET MED, V92, P235, DOI 10.1016/j.prevetmed.2009.08.018; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; Walker RL, 1997, AM J VET RES, V58, P744; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zuerner RL, 2007, VET MICROBIOL, V125, P256, DOI 10.1016/j.vetmic.2007.06.001	47	69	70	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120504	10.1371/journal.pone.0120504	http://dx.doi.org/10.1371/journal.pone.0120504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781328	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600169
J	Lam, FW; Phillips, J; Landry, P; Magadi, S; Smith, CW; Rumbaut, RE; Burns, AR				Lam, Fong W.; Phillips, Jenny; Landry, Paul; Magadi, Sri; Smith, C. Wayne; Rumbaut, Rolando E.; Burns, Alan R.			Platelet Recruitment Promotes Keratocyte Repopulation following Corneal Epithelial Abrasion in the Mouse	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; DELTA-T-CELLS; GROWTH-FACTORS; PHOTOREFRACTIVE KERATECTOMY; NEUTROPHIL EMIGRATION; MIGRATION; PROLIFERATION; TRANSPARENCY; SURGERY; REPAIR	Corneal abrasion not only damages the epithelium but also induces stromal keratocyte death at the site of injury. While a coordinated cascade of inflammatory cell recruitment facilitates epithelial restoration, it is unclear if this cascade is necessary for keratocyte recovery. Since platelet and neutrophil (PMN) recruitment after corneal abrasion is beneficial to epithelial wound healing, we wanted to determine if these cells play a role in regulating keratocyte repopulation after epithelial abrasion. A 2 mm diameter central epithelial region was removed from the corneas of C57BL/6 wildtype (WT), P-selectin deficient (P-sel(-/-)), and CD18 hypomorphic (CD18(hypo)) mice using the Algerbrush II. Corneas were studied at 6h intervals out to 48h post-injury to evaluate platelet and PMN cell numbers; additional corneas were studied at 1, 4, 14, and 28 days post injury to evaluate keratocyte numbers. In WT mice, epithelial abrasion induced a loss of anterior central keratocytes and keratocyte recovery was rapid and incomplete, reaching similar to 70% of uninjured baseline values by 4 days post-injury but no further improvement at 28 days post-injury. Consistent with a beneficial role for platelets and PMNs in wound healing, keratocyte recovery was significantly depressed at 4 days post-injury (similar to 30% of uninjured baseline) in P-sel(-/-) mice, which are known to have impaired platelet and PMN recruitment after corneal abrasion. Passive transfer of platelets from WT, but not P-sel(-/-), into P-sel(-/-) mice prior to injury restored anterior central keratocyte numbers at 4 days post-injury to P-sel(-/-) uninjured baseline levels. While PMN infiltration in injured CD18(hypo) mice was similar to injured WT mice, platelet recruitment was markedly decreased and anterior central keratocyte recovery was significantly reduced (similar to 50% of baseline) at 4-28 days post-injury. Collectively, the data suggest platelets and platelet P-selectin are critical for efficient keratocyte recovery after corneal epithelial abrasion.	[Lam, Fong W.; Smith, C. Wayne; Rumbaut, Rolando E.; Burns, Alan R.] Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, Houston, TX 77030 USA; [Lam, Fong W.; Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Phillips, Jenny; Landry, Paul; Magadi, Sri; Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Phillips, Jenny] Univ Wisconsin, Dept Pathol, Madison, WI 53706 USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Wisconsin System; University of Wisconsin Madison	Burns, AR (corresponding author), Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, 1100 Bates,CNRC 6058, Houston, TX 77030 USA.	aburns@optometry.uh.edu		Rumbaut, Rolando/0000-0002-8486-1013; Lam, Fong/0000-0003-2034-2625	National Institutes of Health [HL116524, EY017120, EY018239, P30EY007551]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL EYE INSTITUTE [P30EY007551, R01EY017120, R01EY018239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079368, R01HL116524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the following sources: National Institutes of Health HL116524 (RER, CWS, ARB), National Institutes of Health EY017120 (ARB), National Institutes of Health EY018239 (CWS), National Institutes of Health P30EY007551 (core facility), and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (RER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2013, EXP EYE RES, V115, P153, DOI 10.1016/j.exer.2013.07.007; Baldwin HC, 2002, ACTA OPHTHALMOL SCAN, V80, P238, DOI 10.1034/j.1600-0420.2002.800303.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Comaish IF, 2002, J CATARACT REFR SURG, V28, P2206, DOI 10.1016/S0886-3350(02)01698-X; Cooper D, 2004, AM J PHYSIOL-HEART C, V286, pH1895, DOI 10.1152/ajpheart.01000.2003; Erie JC, 2006, AM J OPHTHALMOL, V141, P799, DOI 10.1016/j.ajo.2005.12.014; Erie JC, 2003, ARCH OPHTHALMOL-CHIC, V121, P770, DOI 10.1001/archopht.121.6.770; Etheredge L, 2009, INVEST OPHTH VIS SCI, V50, P3128, DOI 10.1167/iovs.08-3077; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; Geremicca W, 2010, BLOOD TRANSFUS-ITALY, V8, P107, DOI 10.2450/2009.0091-09; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Helena MC, 1998, INVEST OPHTH VIS SCI, V39, P276; Hodge C, 2011, J CATARACT REFR SURG, V37, P603, DOI 10.1016/j.jcrs.2010.12.036; Howard V., 2005, UNBIASED STEREOLOGY; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jester JV, 2008, SEMIN CELL DEV BIOL, V19, P82, DOI 10.1016/j.semcdb.2007.09.015; Jester JV, 1999, J CELL SCI, V112, P613; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; Kamiyama K, 1998, CORNEA, V17, P315, DOI 10.1097/00003226-199805000-00013; Khachikian SS, 2010, J CATARACT REFR SURG, V36, P2015, DOI 10.1016/j.jcrs.2010.08.028; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; Li ZJ, 2004, J APPL PHYSIOL, V97, P641, DOI 10.1152/japplphysiol.00200.2004; Liu HS, 2012, J CELL MOL MED, V16, P1114, DOI 10.1111/j.1582-4934.2011.01418.x; Mitooka K, 2002, AM J OPHTHALMOL, V133, P307, DOI 10.1016/S0002-9394(01)01421-0; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Movahedan A, 2012, INVEST OPHTH VIS SCI, V53, P7476, DOI 10.1167/iovs.12-10735; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Petroll WM, 2012, J FUNCT BIOMATER, V3, P183, DOI 10.3390/jfb3010183; Rozman P, 2007, ACTA DERMATOVEN ALP, V16, P156; Rumbaut RE, 2006, AM J PHYSIOL-HEART C, V290, pH1671, DOI 10.1152/ajpheart.00305.2005; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Servold S A, 1991, Clin Podiatr Med Surg, V8, P937; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Smith TL, 2011, THROMB RES, V127, P391, DOI 10.1016/j.thromres.2010.10.013; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; WEIBEL ER, 1981, J HISTOCHEM CYTOCHEM, V29, P1043, DOI 10.1177/29.9.7026667; WILSON RW, 1993, J IMMUNOL, V151, P1571; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118950	10.1371/journal.pone.0118950	http://dx.doi.org/10.1371/journal.pone.0118950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775402	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500055
J	Nomura, M; Kaneko, M; Okuma, Y; Nomura, J; Kusumi, I; Koyama, T; Nomura, Y				Nomura, Michio; Kaneko, Masayuki; Okuma, Yasunobu; Nomura, Jun; Kusumi, Ichiro; Koyama, Tsukasa; Nomura, Yasuyuki			Involvement of Serotonin Transporter Gene Polymorphisms (5-HTT) in Impulsive Behavior in the Japanese Population	PLOS ONE			English	Article							TRYPTOPHAN DEPLETION; PROMOTER POLYMORPHISM; RESPONSE-INHIBITION; PROLACTIN RESPONSE; PREFRONTAL CORTEX; REGULATORY REGION; AMYGDALA; ASSOCIATION; EMOTION; DEPRESSION	The serotonergic pathway has been implicated in the pathogenesis of impulsivity, and sensitivity to aversive outcomes may be linked to serotonin (5-HT) levels. Polymorphisms in the gene that encodes the serotonin transporter (5-HTT), which have differential effects on the level of serotonin transmission, display alternate responses to aversive stimuli. However, recent studies have shown that 5-HT does not affect motor function, which suggests that the functioning of the serotonin-transporter-linked polymorphic region (5-HTTLPR) does not directly affect the behavioral regulatory process itself, but instead exerts an effect via the evaluation of the potential risk associated with particular behavioral outputs. The aim of the present study was to examine the effect of specific 5-HTTLPR genotypes on the motor regulatory process, as observed during a Go/Nogo punishment feedback task. 5-HTT gene-linked promoter polymorphisms were analyzed by polymerase chain reaction, using lymphocytes from 61 healthy Japanese volunteers. Impulsivity was defined as the number of commission errors (responding when one should not) made during a Go/Nogo task. We found that the s/s genotype group made fewer impulsive responses, specifically under aversive conditions for committing such errors, compared to those in the s/l group, without affecting overall motor inhibition. These results suggest that 5-HTTLPRs do not directly affect the behavioral regulatory process itself, but may instead exert an effect on the evaluation of potential risk. The results also indicate that under such aversive conditions, decreased expression of 5-HTT may promote motor inhibitory control.	[Nomura, Michio] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan; [Kaneko, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan; [Nomura, Jun] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomed Res, Minami Ku, Hiroshima, Japan; [Kusumi, Ichiro; Koyama, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan	Kyoto University; Hiroshima University; Hiroshima University; Hokkaido University; Kurume University	Nomura, M (corresponding author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan.	nomura.michio.8u@kyoto-u.ac.jp	Kaneko, Masayuki/F-9302-2011; Nomura, Jun/C-2411-2011	Kaneko, Masayuki/0000-0002-0477-0171; Nomura, Michio/0000-0003-1043-2811	Japan Society for the Promotion of Science [23500329]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Japan Society for the Promotion of Science (23500329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MEN D; Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Barratt E. S., 1994, VIOLENCE MENTAL DISO, P61; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Daruna J., 1993, IMPULSIVE CLIENT THE; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gelfand M. J., 1998, 25 ANN C INT ASS CRO; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hart S.D., 1997, IMPULSIVITY THEORY A, P212; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jasinska AJ, 2009, J NEUROSCI, V29, P10461, DOI 10.1523/JNEUROSCI.2774-09.2009; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; KINDLON D, 1995, J CHILD PSYCHOL PSYC, V36, P645, DOI 10.1111/j.1469-7610.1995.tb02319.x; Kumakiri C, 1999, NEUROSCI LETT, V263, P205, DOI 10.1016/S0304-3940(99)00098-1; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; LeMarquand DG, 1998, NEUROPSYCHOPHARMACOL, V19, P333; LeMarquand DG, 1999, AM J PSYCHIAT, V156, P1771; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masui K, 2009, PSYCHOLOGIA, V52, P137, DOI 10.2117/psysoc.2009.137; McMurran M, 2002, AGGRESSIVE BEHAV, V28, P439, DOI 10.1002/ab.80017; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Newman JP, 1997, PERS INDIV DIFFER, V23, P583, DOI 10.1016/S0191-8869(97)00078-0; NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Pener-Tessler R, 2013, DEV PSYCHOPATHOL, V25, P151, DOI 10.1017/S095457941200096X; PLUTCHIK R, 1995, IMPULSIVITY AGGRESSI, P7; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reist C, 2001, AM J MED GENET, V105, P363, DOI 10.1002/ajmg.1360; Rodriguez-Fornells A, 2002, PERS INDIV DIFFER, V32, P661, DOI 10.1016/S0191-8869(01)00068-X; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Sebastian A, 2013, NEUROIMAGE, V64, P601, DOI 10.1016/j.neuroimage.2012.09.020; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Triandis HC, 2004, ACAD MANAGE EXEC, V18, P88, DOI 10.5465/AME.2004.12689599; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4; Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1; Zanardi R, 2000, J CLIN PSYCHOPHARM, V20, P105, DOI 10.1097/00004714-200002000-00021	62	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119743	10.1371/journal.pone.0119743	http://dx.doi.org/10.1371/journal.pone.0119743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775400	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500117
J	Kobayashi, Y; Kiguchi, N; Fukazawa, Y; Saika, F; Maeda, T; Kishioka, S				Kobayashi, Yuka; Kiguchi, Norikazu; Fukazawa, Yohji; Saika, Fumihiro; Maeda, Takehiko; Kishioka, Shiroh			Macrophage-T Cell Interactions Mediate Neuropathic Pain through the Glucocorticoid-induced Tumor Necrosis Factor Ligand System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; SCIATIC-NERVE; IMMUNE-SYSTEM; UP-REGULATION; RECEPTOR; INFLAMMATION; FAMILY; GITR; INTERLEUKIN-1-BETA; NEUROINFLAMMATION	Peripheral neuroinflammation caused by activated immune cells can provoke neuropathic pain. Herein, we investigate the actions of macrophages and T cells through glucocorticoid-induced tumor neurosis factor receptor ligand (GITRL) and its receptor (GITR) in neuropathic pain. After partial sciatic nerve ligation (PSL) in enhanced green fluorescent protein (eGFP) chimeric mice generated by the transplantation of eGFP(+) bone marrow cells, eGFP(+) macrophages, and T cells markedly migrated to the injured site after PSL. Administration of agents to deplete macrophages (liposome-clodronate and Clophosome-A (TM)) or T cells (anti-CD4 antibody and FTY720) could suppress PSL-induced thermal hyperalgesia and tactile allodynia. The expression levels of co-stimulatory molecules GITRL and GITR were increased on infiltrating macrophages and T cells, respectively. The perineural injection of a GITRL neutralizing antibody that could inhibit the function of the GITRL-GITR pathway attenuated PSL-induced neuropathic pain. Additionally, the induction of inflammatory cytokines and the accumulation of GITR(+) T cells in the injured SCN were abrogated after macrophage depletion by Clophosome-A (TM). In conclusion, GITRL expressed on macrophages drives cytokine release and T cell activation, resulting in neuropathic pain via GITR-dependent actions. The GITRL-GITR pathway might represent a novel target for the treatment of neuropathic pain.	[Kobayashi, Yuka; Kiguchi, Norikazu; Fukazawa, Yohji; Saika, Fumihiro; Kishioka, Shiroh] Wakayama Med Univ, Dept Pharmacol, Wakayama 6410012, Japan; [Maeda, Takehiko] Niigata Univ Pharm & Appl Life Sci, Dept Pharmacol, Niigata 9568603, Japan	Wakayama Medical University; Niigata University	Kishioka, S (corresponding author), Wakayama Med Univ, Dept Pharmacol, 811-1 Kimiidera, Wakayama 6410012, Japan.	kishioka@wakayama-med.ac.jp		Maeda, Takehiko/0000-0002-3184-0999	Japan Society for the Promotion of Science (Tokyo, Japan) [B:23791724]	Japan Society for the Promotion of Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists Grant B:23791724 from the Japan Society for the Promotion of Science (Tokyo, Japan).	Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Cuzzocrea S, 2006, J IMMUNOL, V177, P631, DOI 10.4049/jimmunol.177.1.631; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Li JJ, 2005, PAIN, V118, P232, DOI 10.1016/j.pain.2005.08.023; Liao GX, 2014, FASEB J, V28, P474, DOI 10.1096/fj.13-236505; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2008, MOL PHARMACOL, V73, P1610, DOI 10.1124/mol.107.044354; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Steward-Tharp SM, 2010, ANN NY ACAD SCI, V1183, P123, DOI 10.1111/j.1749-6632.2009.05124.x; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; You S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007848; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018	33	54	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12603	12613		10.1074/jbc.M115.636506	http://dx.doi.org/10.1074/jbc.M115.636506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25787078	Green Published, hybrid			2022-12-26	WOS:000354569000016
J	Meena, NK; Ahuja, V; Meena, K; Paul, J				Meena, Naresh Kumar; Ahuja, Vineet; Meena, Kusumlata; Paul, Jaishree			Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; EXPRESSION	Background and Aim In health, TLR signaling protects the intestinal epithelial barrier and in disease, aberrant TLR signaling stimulates diverse inflammatory responses. Association of TLR polymorphisms is ethnicity dependent but how they impact the complex pathogenesis of IBD is not clearly defined. So we propose to study the status of polymorphisms in TLR family of genes and their effect on cytokines level in UC patients. Methods The genotypes of the six loci TLR1-R80T, TLR2-R753Q, TLR3-S258G, TLR5-R392X, TLR5-N592S and TLR6-S249P were determined in 350 controls and 328 UC patients by PCR-RFLP and sequencing. Cytokine levels were measured by ELISA in blood plasma samples. Data were analyzed statistically by SPSS software. Results TLR5 variants R392X and N592S showed significant association (p = 0.007, 0.021) with UC patients but TLR 1, 2, 3, 6 variants did not show any association. Unlike other studies carried out in different ethnic groups, TLR 6 (S249P) SNP was universally present in our population irrespective of disease. Genotype-phenotype correlation analysis revealed that the patients having combination of multiple SNPs both in TLR5 and TLR4 gene suffered from severe disease condition and diagnosed at an early age. The level of TNF alpha (p = 0.004), IL-6 (p = 0.0001) and IFN gamma (p = 0.006) significantly increased in patients as compared to controls having wild genotypes for the studied SNPs. However, there was decreased level of TNF alpha (p = 0.014), IL-6 (p = 0.028) and IFN gamma (p = 0.001) in patients carrying TLR5-R392X variant as compared to wild type patients. Patients carrying two simultaneous SNPs D299G in TLR4 gene and N592S in TLR5 gene showed significant decrease in the levels of TNFa (p = 0.011) and IFN. (p = 0.016). Conclusion Polymorphisms in TLR 5 genes were significantly associated with the UC in North Indian population. The cytokine level was significantly modulated in patients with different genotypes of TLR4 and TLR5 SNPs.	[Meena, Naresh Kumar; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Meena, Kusumlata] SMS Med Coll & Hosp, Dept Obstet & Gynaecol, Jaipur, Rajasthan, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; SMS Medical College & Hospital	Paul, J (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	jpaul33@hotmail.com	Meena, Naresh Kumar/GLU-8350-2022; Ahuja, Vineet/N-1705-2019	Ahuja, Vineet/0000-0002-5474-9709; Meena, Naresh Kumar/0000-0001-5450-5184	Department of Science and Technology, Government of India [SR/SO/HS-98/2005]; Council of scientific and industrial research, Government of India in the School of Life Sciences, at the Jawaharlal Nehru University, India [37(1387)/09/EMR-II]; University Grants Commission, New Delhi, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of scientific and industrial research, Government of India in the School of Life Sciences, at the Jawaharlal Nehru University, India; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported in part by the research grant received by JP from the Department of Science and Technology, Government of India (D.O. No. SR/SO/HS-98/2005), and partially by Council of scientific and industrial research, Government of India (Grant No. 37(1387)/09/EMR-II) in the School of Life Sciences, at the Jawaharlal Nehru University, India. NKM is grateful to the University Grants Commission, New Delhi, India for Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen L, 2012, WORLD J GASTROENTERO, V18, P6856, DOI 10.3748/wjg.v18.i46.6856; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Haerynck F, 2013, HUM IMMUNOL, V74, P1649, DOI 10.1016/j.humimm.2013.08.282; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Himmel ME, 2008, IMMUNOLOGY, V125, P145, DOI 10.1111/j.1365-2567.2008.02939.x; Kao YL, 2004, MOL CELL PROBE, V18, P205, DOI 10.1016/j.mcp.2004.01.004; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Klimosch SN, 2013, CANCER RES, V73, P7232, DOI 10.1158/0008-5472.CAN-13-1746; Meena NK, 2013, J CLIN GASTROENTEROL, V47, P773, DOI 10.1097/MCG.0b013e31828a6e93; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Pirie FJ, 2005, TISSUE ANTIGENS, V66, P125, DOI 10.1111/j.1399-0039.2005.00454.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Yang XQ, 2012, MOL BIOL REP, V39, P7003, DOI 10.1007/s11033-012-1530-2; Yang ZH, 2012, CANCER SCI, V103, P653, DOI 10.1111/j.1349-7006.2012.02210.x; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	30	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120697	10.1371/journal.pone.0120697	http://dx.doi.org/10.1371/journal.pone.0120697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789623	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400171
J	Wang, J; Chen, R; Tang, SW; Lv, XZ; Wu, SS; Zhang, Y; Xia, YY; Gao, P; Tu, DH; Chen, DF; Zhan, SY				Wang, Jing; Chen, Ru; Tang, Shaowen; Lv, Xiaozhen; Wu, Shanshan; Zhang, Yuan; Xia, Yinyin; Gao, Pei; Tu, Dehua; Chen, Dafang; Zhan, Siyan			Analysis of IL-6, STAT3 and HSPA1L Gene Polymorphisms in Anti-Tuberculosis DrugInduced Hepatitis in a Nested Case-Control Study	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CELL-MEDIATED HEPATITIS; HEAT-SHOCK PROTEINS; INDUCED HEPATOTOXICITY; INTERLEUKIN-6; SUSCEPTIBILITY; HEPATOCYTES; ASSOCIATION; EXPRESSION; INDUCTION	Objectives To investigate the association of IL-6, STAT3 and HSPA1L polymorphisms with the risk of anti-tuberculosis drug-induced hepatitis (ATDH) in Chinese Han population. Methods The study was designed as a nested case-control study within a prospective cohort. Each case was matched with four controls by sex, age at baseline (+/- 5 years), treatment history, disease severity, drug dosage and place of sample collection. Genetic polymorphisms of IL6, STAT3 and HSPA1L were determined blindly by TaqMan single-nucleotide polymorphism (SNP) genotyping assay. Odds ratio (OR) with 95% confidence intervals (CIs) was estimated by conditional logistic regression model to measure the association between selected SNPs and the risk of ATDH. Results A total of 89 incident ATDH cases and 356 ATDH-free controls were genotyped for IL-6 (rs2066992, rs2069837, rs1524107), STAT3 (rs1053004, rs1053023, rs1053005) and HSPA1L (rs2227956). In genotype analysis, no significant difference was observed in genotypes frequencies of the seven selected SNPs between case and control group after Bonferroni correction. In haplotype analysis, carriers with STAT3 GAT and AGC (rs1053023-rs1053005-rs1053004) haplotypes had a significantly higher risk of ATDH compared with wild-type haplotype (P<0.0001). Conclusion This study suggested that genetic variants of STAT3 might contribute to ATDH susceptibility in Chinese Han population. Studies in larger, varied populations are required to confirm these findings.	[Wang, Jing; Chen, Ru; Tang, Shaowen; Wu, Shanshan; Gao, Pei; Chen, Dafang; Zhan, Siyan] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tang, Shaowen] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Lv, Xiaozhen] Peking Univ, Div Clin Res, Inst Mental Hlth, Beijing 100871, Peoples R China; [Lv, Xiaozhen] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Yuan] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Dept TB Treatment, Beijing, Peoples R China	Peking University; Nanjing Medical University; Peking University; McMaster University; Chinese Center for Disease Control & Prevention	Zhan, SY (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn		Wang, Jing/0000-0001-5701-476X; Tang, Shaowen/0000-0001-5879-8594	National Natural Science Foundation of China [81072387]; Beijing Natural Science Foundation [7111006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is funded by National Natural Science Foundation of China (NO. 81072387) and Beijing Natural Science Foundation (NO. 7111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; Awofeso N., 2008, B WHO, V86; Bajramovic JJ, 2000, J NEUROIMMUNOL, V106, P14, DOI 10.1016/S0165-5728(99)00260-X; BENICHOU C, 1990, J HEPATOL, V11, P272; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619; Carr DF, 2007, PHARMACOGENET GENOM, V17, P961, DOI 10.1097/FPC.0b013e3282f00919; Chen J, 2013, J GASTROEN HEPATOL, V28, P814, DOI 10.1111/jgh.12163; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; Daly AK, 2007, GASTROENTEROLOGY, V132, P272, DOI 10.1053/j.gastro.2006.11.023; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; DiBonaventura MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086070; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; He L, 2014, SCI WORLD J, DOI 10.1155/2014/540309; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Inns T., 2013, EUROSURVEILLANCE, V18, P20654; James LP, 2005, J CLIN PHARMACOL, V45, P1165, DOI 10.1177/0091270005280296; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kim SH, 2012, LIVER INT, V32, P809, DOI 10.1111/j.1478-3231.2011.02697.x; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Liang X, 2013, CLIN TRANSL ONCOL, V15, P331, DOI 10.1007/s12094-012-0936-6; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; National Tuberculosis Association of the USA, 1961, DIAGN STAND CLASS TU; Obayashi Y, 2012, AMINO ACIDS, V43, P2371, DOI 10.1007/s00726-012-1317-8; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Song JY, 2007, EXP TOXICOL PATHOL, V59, P29, DOI 10.1016/j.etp.2007.02.005; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Teuber M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-81; Ucisik-Akkaya E, 2010, CELL STRESS CHAPERON, V15, P475, DOI 10.1007/s12192-009-0161-6; Urban TJ, 2012, PHARMACOGENET GENOM, V22, P784, DOI 10.1097/FPC.0b013e3283589a76; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; World Health Organization, 2005, US WHO UMC SYST STAN; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Xia Yin-Yin, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P419	48	5	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118862	10.1371/journal.pone.0118862	http://dx.doi.org/10.1371/journal.pone.0118862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789467	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400050
J	Avramopoulos, D; Pearce, BD; McGrath, J; Wolyniec, P; Wang, RH; Eckart, N; Hatzimanolis, A; Goes, FS; Nestadt, G; Mulle, J; Coneely, K; Hopkins, M; Ruczinski, I; Yolken, R; Pulver, AE				Avramopoulos, Dimitrios; Pearce, Brad D.; McGrath, John; Wolyniec, Paula; Wang, Ruihua; Eckart, Nicole; Hatzimanolis, Alexandros; Goes, Fernando S.; Nestadt, Gerald; Mulle, Jennifer; Coneely, Karen; Hopkins, Myfanwy; Ruczinski, Ingo; Yolken, Robert; Pulver, Ann E.			Infection and Inflammation in Schizophrenia and Bipolar Disorder: A Genome Wide Study for Interactions with Genetic Variation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TOXOPLASMA-GONDII INFECTION; PSYCHIATRIC-DISORDERS; ONSET SCHIZOPHRENIA; MILITARY PERSONNEL; IMMUNE-RESPONSE; KINASE SGK1; RISK LOCI; ANTIBODIES; AGENTS	Inflammation and maternal or fetal infections have been suggested as risk factors for schizophrenia (SZ) and bipolar disorder (BP). It is likely that such environmental effects are contingent on genetic background. Here, in a genome-wide approach, we test the hypothesis that such exposures increase the risk for SZ and BP and that the increase is dependent on genetic variants. We use genome-wide genotype data, plasma IgG antibody measurements against Toxoplasma gondii, Herpes simplex virus type 1, Cytomegalovirus, Human Herpes Virus 6 and the food antigen gliadin as well as measurements of C-reactive protein (CRP), a peripheral marker of inflammation. The subjects are SZ cases, BP cases, parents of cases and screened controls. We look for higher levels of our immunity/infection variables and interactions between them and common genetic variation genome-wide. We find many of the antibody measurements higher in both disorders. While individual tests do not withstand correction for multiple comparisons, the number of nominally significant tests and the comparisons showing the expected direction are in significant excess (permutation p=0.019 and 0.004 respectively). We also find CRP levels highly elevated in SZ, BP and the mothers of BP cases, in agreement with existing literature, but possibly confounded by our inability to correct for smoking or body mass index. In our genome-wide interaction analysis no signal reached genome-wide significance, yet many plausible candidate genes emerged. In a hypothesis driven test, we found multiple interactions among SZ-associated SNPs in the HLA region on chromosome 6 and replicated an interaction between CMV infection and genotypes near the CTNNA3 gene reported by a recent GWAS. Our results support that inflammatory processes and infection may modify the risk for psychosis and suggest that the genotype at SZ-associated HLA loci modifies the effect of these variables on the risk to develop SZ.	[Avramopoulos, Dimitrios; Eckart, Nicole] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Avramopoulos, Dimitrios; McGrath, John; Wolyniec, Paula; Wang, Ruihua; Hatzimanolis, Alexandros; Goes, Fernando S.; Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Pearce, Brad D.; Mulle, Jennifer; Coneely, Karen; Hopkins, Myfanwy] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Coneely, Karen] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Ruczinski, Ingo] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Heath, Baltimore, MD USA; [Yolken, Robert] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Avramopoulos, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	adimitr1@jhmi.edu	yolken, robert/AAW-2556-2021; Hatzimanolis, Alex/GOG-7992-2022	McGrath, John A./0000-0002-9756-7892	NIMH [MH092515, MH092512, MH094268, MH085018];  [MH057314];  [MH058153];  [MH068406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092515, R01MH068406, R01MH057314, R01MH058153, R01MH085018, R01MH092512, P50MH094268] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The analyses reported in this manuscript were supported by NIMH grant MH092515 to D.A., MH092512 to B.D.P. The collection and storage of the clinical data and biological material was supported by MH057314, MH058153 and MH068406 to A.E.P. The schizophrenia research program of D.A. is also supported by NIMH grants MH094268 and MH085018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Arias I, 2012, SCHIZOPHR RES, V136, P128, DOI 10.1016/j.schres.2011.10.026; Atherton A, 2000, EUR J IMMUNOL, V30, P2540, DOI 10.1002/1521-4141(200009)30:9<2540::AID-IMMU2540>3.3.CO;2-J; Berrettini W, 2004, NEUROMOL MED, V5, P109, DOI 10.1385/NMM:5:1:109; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Cardno AG, 2014, SCHIZOPHRENIA BULL, V40, P504, DOI 10.1093/schbul/sbu016; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; De Berardis D, 2008, INT J IMMUNOPATH PH, V21, P319, DOI 10.1177/039463200802100208; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dickerson F, 2014, BIPOLAR DISORD, V16, P129, DOI 10.1111/bdi.12123; Dickerson F, 2013, SCHIZOPHR RES, V143, P198, DOI 10.1016/j.schres.2012.10.041; Dudbridge F, 2014, AM J HUM GENET, V95, P301, DOI 10.1016/j.ajhg.2014.07.014; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Fawzi MH, 2011, PSYCHIAT RES, V190, P91, DOI 10.1016/j.psychres.2011.05.010; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Hamdani N, 2013, J AFFECT DISORDERS, V148, P444, DOI 10.1016/j.jad.2012.11.034; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Kannan G, 2013, NEUROBIOL DIS, V57, P5, DOI 10.1016/j.nbd.2013.05.012; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Leweke FM, 2004, EUR ARCH PSY CLIN N, V254, P4, DOI 10.1007/s00406-004-0481-6; Li YZ, 2013, SCHIZOPHR RES, V151, P36, DOI 10.1016/j.schres.2013.10.004; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Miller Brian J, 2014, Clin Schizophr Relat Psychoses, V7, P223, DOI 10.3371/CSRP.MICU.020813; Mortensen PB, 2011, BIPOLAR DISORD, V13, P624, DOI 10.1111/j.1399-5618.2011.00962.x; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Niebuhr DW, 2008, SCHIZOPHRENIA BULL, V34, P1182, DOI 10.1093/schbul/sbm139; Okusaga O, 2013, WORLD J BIOL PSYCHIA, V14, P509, DOI 10.3109/15622975.2012.747699; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Pribiag H, 2014, NEUROPHARMACOLOGY, V78, P13, DOI 10.1016/j.neuropharm.2013.06.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rizzo LB, 2013, BIPOLAR DISORD, V15, P832, DOI 10.1111/bdi.12121; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Severance EG, 2014, BIPOLAR DISORD, V16, P230, DOI 10.1111/bdi.12159; Singh B, 2014, PSYCHIAT RES, V216, P277, DOI 10.1016/j.psychres.2014.02.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WEISS JB, 1983, J CLIN INVEST, V72, P96, DOI 10.1172/JCI110988; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Yolken Robert, 2004, Herpes, V11 Suppl 2, p83A; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	51	76	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116696	10.1371/journal.pone.0116696	http://dx.doi.org/10.1371/journal.pone.0116696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781172	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600008
J	Kwiecien, I; Radecka, I; Kowalczuk, M; Adamus, G				Kwiecien, Iwona; Radecka, Iza; Kowalczuk, Marek; Adamus, Grazyna			Transesterification of PHA to Oligomers Covalently Bonded with (Bio) Active Compounds Containing Either Carboxyl or Hydroxyl Functionalities	PLOS ONE			English	Article							MOLECULAR-LEVEL STRUCTURE; STRUCTURAL-CHARACTERIZATION; MASS-SPECTROMETRY; SYNTHETIC ANALOGS; ACID; POLYHYDROXYALKANOATES; BIOPOLYESTERS; BIOSYNTHESIS; COPOLYMERS	This manuscript presents the synthesis and structural characterisation of novel biodegradable polymeric controlled-release systems of pesticides with potentially higher resistance to weather conditions in comparison to conventional forms of pesticides. Two methods for the preparation of pesticide-oligomer conjugates using the transesterification reaction were developed. The first method of obtaining conjugates, which consist of bioactive compounds with the carboxyl group and polyhydroxyalkanoates (PHAs) oligomers, is "one-pot" transesterification. In the second method, conjugates of bioactive compounds with hydroxyl group and polyhydroxyalkanoates oligomers were obtained in two-step method, through cyclic poly(3-hydroxybutyrate) oligomers. The obtained pesticide-PHA conjugates were comprehensively characterised using GPC, 1H NMR and mass spectrometry techniques. The structural characterisation of the obtained products at the molecular level with the aid of mass spectrometry confirmed that both of the synthetic strategies employed led to the formation of conjugates in which selected pesticides were covalently bonded to PHA oligomers via a hydrolysable ester bond.	[Kwiecien, Iwona; Kowalczuk, Marek; Adamus, Grazyna] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland; [Radecka, Iza; Kowalczuk, Marek] Wolverhampton Univ, Fac Sci & Engn, Sch Biol Chem & Forens Sci, Wolverhampton, England	Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences; University of Wolverhampton	Kowalczuk, M (corresponding author), Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.	M.Kowalczuk@wlv.ac.uk; grazyna.adamus@cmpw-pan.edu.pl	Radecka, Iza/AAV-2925-2021; Kwiecień, Iwona/P-4787-2015	Kwiecień, Iwona/0000-0002-6353-5913; Kowalczuk, Marek/0000-0002-2877-7466; Adamus, Grazyna/0000-0001-5439-7400				ABATE R, 1995, MACROMOLECULES, V28, P7911, DOI 10.1021/ma00127a043; Adamus G, 2006, RAPID COMMUN MASS SP, V20, P804, DOI 10.1002/rcm.2365; Adamus G, 2014, ANAL CHIM ACTA, V808, P104, DOI 10.1016/j.aca.2013.09.001; Adamus G, 2009, MACROMOLECULES, V42, P4547, DOI 10.1021/ma900349u; Bowles RG, 1995, CROP PROT, V14, P593, DOI 10.1016/0261-2194(96)81770-4; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Guo-Qiang C., 2001, REACT FUNCT POLYM, V48, P107, DOI [10.1016/S1381-5148(01)00042-6, DOI 10.1016/S1381-5148(01)00042-6]; Impallomeni G, 2002, BIOMACROMOLECULES, V3, P835, DOI 10.1021/bm025525t; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jiang X, 2012, BIOMACROMOLECULES, V13, P2926, DOI 10.1021/bm3009507; Koller M, 2010, FOOD TECHNOL BIOTECH, V48, P255; Kowalski WJ, 2013, AM SOC TEST MATER, V1558, P15, DOI 10.1520/STP155820120064; Kowalski WJ, 2012, ARCH ENVIRON PROT, V38, P119, DOI 10.2478/v10265-012-0034-4; Kwiecien I, 2014, DES MONOMERS POLYM, V17, P311, DOI 10.1080/15685551.2013.840505; Kwiecien I, 2012, RAPID COMMUN MASS SP, V26, P2673, DOI 10.1002/rcm.6391; Kwiecien M, 2013, BIOMACROMOLECULES, V14, P1181, DOI 10.1021/bm400141s; Lobo FA, 2011, POLYM BULL, V67, P479, DOI 10.1007/s00289-011-0447-6; Maksymiak M, 2013, RAPID COMMUN MASS SP, V27, P773, DOI 10.1002/rcm.6509; Muhr A, 2013, REACT FUNCT POLYM, V73, P1391, DOI 10.1016/j.reactfunctpolym.2012.12.009; Numata K, 2009, MATERIALS, V2, P1104, DOI 10.3390/ma2031104; Osanai Y, 2002, MACROMOL BIOSCI, V2, P88, DOI 10.1002/1616-5195(20020201)2:2<88::AID-MABI88>3.0.CO;2-5; Prudnikova SV, 2013, J POLYM ENVIRON, V21, P675, DOI 10.1007/s10924-012-0561-z; Savenkova L, 2002, PROCESS BIOCHEM, V37, P719, DOI 10.1016/S0032-9592(01)00263-1; SEEBACH D, 1992, ANGEW CHEM INT EDIT, V31, P434, DOI 10.1002/anie.199204341; Tappel RC, 2012, BIOMACROMOLECULES, V13, P2964, DOI 10.1021/bm301043t; Tripathi L, 2013, BIOMACROMOLECULES, V14, P862, DOI 10.1021/bm3019517; Vergili I, 2009, DESALINATION, V249, P1107, DOI 10.1016/j.desal.2009.06.043; Verlinden RAJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-11; Voinova ON, 2009, APPL BIOCHEM MICRO+, V45, P384, DOI 10.1134/S0003683809040061; Zawidlak-Wegrzynska B, 2010, EUR J MED CHEM, V45, P1833, DOI 10.1016/j.ejmech.2010.01.020	30	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120149	10.1371/journal.pone.0120149	http://dx.doi.org/10.1371/journal.pone.0120149			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781908	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600132
J	Strick-Marchand, H; Dusseaux, M; Darche, S; Huntington, ND; Legrand, N; Masse-Ranson, G; Corcuff, E; Ahodantin, J; Weijer, K; Spits, H; Kremsdorf, D; Di Santo, JP				Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Legrand, Nicolas; Masse-Ranson, Guillemette; Corcuff, Erwan; Ahodantin, James; Weijer, Kees; Spits, Hergen; Kremsdorf, Dina; Di Santo, James P.			A Novel Mouse Model for Stable Engraftment of a Human Immune System and Human Hepatocytes	PLOS ONE			English	Article							C VIRUS-INFECTION; IN-VIVO; HEPATITIS-C; ANIMAL-MODELS; PLASMINOGEN-ACTIVATOR; ANTIBODY-RESPONSES; CELL MATURATION; T-CELLS; MICE; LIVER	Hepatic infections by hepatitis B virus (HBV), hepatitis C virus (HCV) and Plasmodium parasites leading to acute or chronic diseases constitute a global health challenge. The species tropism of these hepatotropic pathogens is restricted to chimpanzees and humans, thus model systems to study their pathological mechanisms are severely limited. Although these pathogens infect hepatocytes, disease pathology is intimately related to the degree and quality of the immune response. As a first step to decipher the immune response to infected hepatocytes, we developed an animal model harboring both a human immune system ( HIS) and human hepatocytes (HUHEP) in BALB/c Rag2(-/)-IL-2R gamma c(-/)-NOD. sirpa uPA(tg/tg) mice. The extent and kinetics of human hepatocyte engraftment were similar between HUHEP and HIS-HUHEP mice. Transplanted human hepatocytes were polarized and mature in vivo, resulting in 20-50% liver chimerism in these models. Human myeloid and lymphoid cell lineages developed at similar frequencies in HIS and HIS-HUHEP mice, and splenic and hepatic compartments were humanized with mature B cells, NK cells and naive T cells, as well as monocytes and dendritic cells. Taken together, these results demonstrate that HIS-HUHEP mice can be stably (> 5 months) and robustly engrafted with a humanized immune system and chimeric human liver. This novel HIS-HUHEP model provides a platform to investigate human immune responses against hepatotropic pathogens and to test novel drug strategies or vaccine candidates.	[Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Masse-Ranson, Guillemette; Corcuff, Erwan; Di Santo, James P.] Inst Pasteur, Dept Immunol, Innate Immun Unit, F-75724 Paris, France; [Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Masse-Ranson, Guillemette; Corcuff, Erwan; Di Santo, James P.] INSERM, U668, Paris, France; [Legrand, Nicolas; Weijer, Kees; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Ahodantin, James; Kremsdorf, Dina] Fac Med Paris Descartes, INSERM, U845, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Di Santo, JP (corresponding author), Inst Pasteur, Dept Immunol, Innate Immun Unit, F-75724 Paris, France.	james.di-santo@pasteur.fr	Huntington, NICHOLAS/AAV-4704-2020; Ahodantin, James/AAB-7216-2022; Legrand, Nicolas/B-1794-2009; Di Santo, James P/M-4298-2014; Kremsdorf, Dina/O-9797-2017; Ahodantin, James/AAK-3326-2020; Strick-Marchand, Helene/M-6525-2014	Huntington, NICHOLAS/0000-0002-5267-7211; Ahodantin, James/0000-0003-4405-2593; Legrand, Nicolas/0000-0002-0236-7653; Di Santo, James P/0000-0002-7146-1862; Ahodantin, James/0000-0003-4405-2593; Strick-Marchand, Helene/0000-0002-0519-214X	Bill & Melinda Gates foundation [37869]; Agence Nationale de la recherche programme Emergence [ANR-11-EMMA-026]; Agence Nationale de la recherche programme LABEX [ANR-10-LBX-73]; Agence Nationale deRecherches sur le Sida et les hepatites virales [2013-105]; European Commission Seventh Framework Programme PathCO [HEALTH-F3-2012-305578]	Bill & Melinda Gates foundation(Bill & Melinda Gates Foundation); Agence Nationale de la recherche programme Emergence(French National Research Agency (ANR)); Agence Nationale de la recherche programme LABEX(French National Research Agency (ANR)); Agence Nationale deRecherches sur le Sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); European Commission Seventh Framework Programme PathCO	This study was supported by Bill & Melinda Gates foundation global health program grant # 37869. Agence Nationale de la recherche programme Emergence grant #ANR-11-EMMA-026. Agence Nationale de la recherche programme LABEX grant #ANR-10-LBX-73. Agence Nationale deRecherches sur le Sida et les hepatites virales grant #2013-105. European Commission Seventh Framework Programme PathCO grant #HEALTH-F3-2012-305578. AXENIS provided support in the form of salaries for authors Nicolas Legrand and Erwan Corcuff, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Billerbeck E, 2013, J IMMUNOL, V191, P1753, DOI 10.4049/jimmunol.1201518; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brezillon N, 2008, DIS MODEL MECH, V1, P113, DOI 10.1242/dmm.000463; Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Chen QF, 2012, J IMMUNOL, V189, P5223, DOI 10.4049/jimmunol.1201789; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Dandri M, 2013, SEMIN IMMUNOPATHOL, V35, P7, DOI 10.1007/s00281-012-0335-7; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Ding YT, 2014, J IMMUNOL, V192, P1982, DOI 10.4049/jimmunol.1302391; Dusseaux M, 2014, METHODS MOL BIOL, V1213, P81, DOI 10.1007/978-1-4939-1453-1_8; Foster JR, 2014, XENOBIOTICA, V44, P109, DOI 10.3109/00498254.2013.867553; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gutti TL, 2014, AM J PATHOL, V184, P101, DOI 10.1016/j.ajpath.2013.09.008; Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lerat H, 2011, EXPERT REV GASTROENT, V5, P341, DOI [10.1586/egh.11.14, 10.1586/EGH.11.14]; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; STAMATOGLOU SC, 1994, FASEB J, V8, P420, DOI 10.1096/fasebj.8.6.8168692; Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Wilson EM, 2014, STEM CELL RES, V13, P404, DOI 10.1016/j.scr.2014.08.006; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	40	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119820	10.1371/journal.pone.0119820	http://dx.doi.org/10.1371/journal.pone.0119820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782010	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600095
J	Tan, S; Cheng, JW; Zhang, L; Qin, C; Nong, DG; Li, WP; Tang, X; Wu, ZM; Hu, KL				Tan, Shu; Cheng, Jiao-Wen; Zhang, Li; Qin, Cheng; Nong, Ding-Guo; Li, Wei-Peng; Tang, Xin; Wu, Zhi-Ming; Hu, Kai-Lin			Construction of an Interspecific Genetic Map Based on InDel and SSR for Mapping the QTLs Affecting the Initiation of Flower Primordia in Pepper (Capsicum spp.)	PLOS ONE			English	Article							LINKAGE MAP; PLANT ARCHITECTURE; FRUIT TRAITS; ANNUUM; MARKERS; ARABIDOPSIS; SEQUENCE; IDENTIFICATION; SEGREGATION; COLLECTION	Re-sequencing permits the mining of genome-wide variations on a large scale and provides excellent resources for the research community. To accelerate the development and application of molecular markers and identify the QTLs affecting the flowering time-related trait in pepper, a total of 1,038 pairs of InDel and 674 SSR primers from different sources were used for genetic mapping using the F-2 population (n = 154) derived from a cross between BA3 (C. annuum) and YNXML (C. frutescens). Of these, a total of 224 simple PCR-based markers, including 129 InDels and 95 SSRs, were validated and integrated into a map, which was designated as the BY map. The BY map consisted of 13 linkage groups (LGs) and spanned a total genetic distance of 1,249.77 cM with an average marker distance of 5.60 cM. Comparative analysis of the genetic and physical map based on the anchored markers showed that the BY map covered nearly the whole pepper genome. Based on the BY map, one major and five minor QTLs affecting the number of leaves on the primary axis (Nle) were detected on chromosomes P2, P7, P10 and P11 in 2012. The major QTL on P2 was confirmed based on another subset of the same F2 population (n = 147) in 2014 with selective genotyping of markers from the BY map. With the accomplishment of pepper whole genome sequencing and annotations (release 2.0), 153 candidate genes were predicted to embed in the Nle2.2 region, of which 12 important flowering related genes were obtained. The InDel/SSR-based interspecific genetic map, QTLs and candidate genes obtained by the present study will be useful for the downstream isolation of flowering time-related gene and other genetic applications for pepper.	[Tan, Shu; Cheng, Jiao-Wen; Zhang, Li; Qin, Cheng; Li, Wei-Peng; Tang, Xin; Hu, Kai-Lin] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Qin, Cheng] Zunyi Acad Agr Sci, Pepper Inst, Zunyi, Guizhou, Peoples R China; [Qin, Cheng] Sichuan Agr Univ, Maize Res Inst, Key Lab Biol & Genet Improvement Maize Southwest, Chengdu, Peoples R China; [Nong, Ding-Guo] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Wu, Zhi-Ming] Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Sichuan Agricultural University; Guangxi University; Zhongkai University of Agriculture & Engineering	Hu, KL (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	hukailin@scau.edu.cn	cheng, jiaowen/N-3870-2016	cheng, jiaowen/0000-0002-7004-5138; wu, zhi ming/0000-0001-8988-6060; Qin, Cheng/0000-0002-8519-4697	Guangdong Natural Science Foundation of China [S2011030001410]; National High Technology Research and Development Program ("863" Program) of China [2012AA100103]; National Natural Science Foundation of China [31372076]; Zunyi City Natural Science Foundation of China [201201]; Guizhou Province and Zunyi City Science and Technology Cooperation Project of China [201307]	Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zunyi City Natural Science Foundation of China; Guizhou Province and Zunyi City Science and Technology Cooperation Project of China	This work was supported by the Guangdong Natural Science Foundation of China (S2011030001410), the National High Technology Research and Development Program ("863" Program) of China (2012AA100103), the National Natural Science Foundation of China (31372076), the Zunyi City Natural Science Foundation of China (No. 201201) and the Guizhou Province and Zunyi City Science and Technology Cooperation Project of China (No. 201307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YK, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-58; Ahn YK, 2014, GENE, V533, P494, DOI 10.1016/j.gene.2013.09.095; Alimi NA, 2013, EUPHYTICA, V190, P181, DOI 10.1007/s10681-012-0767-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barchi L, 2007, GENOME, V50, P51, DOI 10.1139/G06-140; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Ben-Chaim A, 2000, J AM SOC HORTIC SCI, V125, P66, DOI 10.21273/JASHS.125.1.66; Ben-Chaim A, 2006, THEOR APPL GENET, V113, P1481, DOI 10.1007/s00122-006-0395-y; Chen XueJun, 2006, Acta Horticulturae Sinica, V33, P152; Cohen O, 2014, NEW PHYTOL, V202, P1014, DOI 10.1111/nph.12711; Cohen O, 2012, J EXP BOT, V63, P4947, DOI 10.1093/jxb/ers172; David-Schwartz R, 2013, PLANT SCI, V203, P8, DOI 10.1016/j.plantsci.2012.12.011; Dinh TT, 2012, DEVELOPMENT, V139, P1978, DOI 10.1242/dev.077073; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Duan MM, 2014, CONSTRUCTION INTRASP; Elitzur T, 2009, J EXP BOT, V60, P869, DOI 10.1093/jxb/ern334; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; Jeifetz D, 2011, PLANTA, V234, P1227, DOI 10.1007/s00425-011-1479-8; Kang BC, 2001, THEOR APPL GENET, V102, P531, DOI 10.1007/s001220051678; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lee HR, 2009, MOL CELLS, V27, P21, DOI 10.1007/s10059-009-0002-6; Lee JM, 2004, THEOR APPL GENET, V108, P619, DOI 10.1007/s00122-003-1467-x; Lefebvre V, 2002, GENOME, V45, P839, DOI 10.1139/G02-053; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li WP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0219-3; Liu B, 2013, THEOR APPL GENET, V126, P231, DOI 10.1007/s00122-012-1976-6; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Livingstone KD, 1999, GENETICS, V152, P1183; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Marame F, 2009, HEREDITAS, V146, P131, DOI 10.1111/j.1601-5223.2009.02101.x; Martinez-Lopez LA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-143; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mimura Y, 2010, J JPN SOC HORTIC SCI, V79, P56, DOI 10.2503/jjshs1.79.56; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagy I, 2007, GENOME, V50, P668, DOI 10.1139/G07-047; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Paran I, 2004, MOL BREEDING, V13, P251, DOI 10.1023/B:MOLB.0000022526.30914.31; Park SW, 2014, MOL BREEDING, V34, P963, DOI 10.1007/s11032-014-0089-0; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Schmitz G, 1999, CURR OPIN PLANT BIOL, V2, P51, DOI 10.1016/S1369-5266(99)80010-7; SHIFRISS C, 1977, EUPHYTICA, V26, P491, DOI 10.1007/BF00027015; Sugita T, 2005, BREEDING SCI, V55, P287, DOI 10.1270/jsbbs.55.287; Sugita T, 2013, MOL BREEDING, V31, P909, DOI 10.1007/s11032-013-9844-x; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang XM, 2012, MOL BIOL CELL, V23, P1446, DOI 10.1091/mbc.E11-09-0797; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Wu ZhiMing, 2012, Journal of South China Agricultural University, V33, P171; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yarnes SC, 2013, GENOME, V56, P61, DOI 10.1139/gen-2012-0083; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; Zong HX, 2013, CONSTRUCTION MOL LIN	61	19	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119389	10.1371/journal.pone.0119389	http://dx.doi.org/10.1371/journal.pone.0119389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781878	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600062
J	Varghese, A; Ticktin, T; Mandle, L; Nath, S				Varghese, Anita; Ticktin, Tamara; Mandle, Lisa; Nath, Snehlata			Assessing the Effects of Multiple Stressors on the Recruitment of Fruit Harvested Trees in a Tropical Dry Forest, Western Ghats, India	PLOS ONE			English	Article							SIZE DISTRIBUTIONS; POPULATION-STRUCTURE; SPECIES COMPOSITION; PRODUCTS; SUSTAINABILITY; REGENERATION; DEMOGRAPHY; IMPACT; FIRE	The harvest of non-timber forest products (NTFPs), together with other sources of anthropogenic disturbance, impact plant populations greatly. Despite this, conservation research on NTFPs typically focuses on harvest alone, ignoring possible confounding effects of other anthropogenic and ecological factors. Disentangling anthropogenic disturbances is critical in regions such as India's Western Ghats, a biodiversity hotspot with high human density. Identifying strategies that permit both use and conservation of resources is essential to preserving biodiversity while meeting local needs. We assessed the effects of NTFP harvesting (fruit harvest from canopy and lopping of branches for fruit) in combination with other common anthropogenic disturbances (cattle grazing, fire frequency and distance from village), in order to identify which stressors have greater effects on recruitment of three tropical dry forest fruit tree species. Specifically, we assessed the structure of 54 populations of Phyllanthus emblica, P.indofischeri and Terminalia chebula spread across the Nilgiri Biosphere Reserve, Western Ghats to ask: (1) How are populations recruiting? and (2) What anthropogenic disturbance and environmental factors, specifically forest type and elevation, are the most important predictors of recruitment status? We combined participatory research with an information-theoretic model-averaging approach to determine which factors most affect population structure and recruitment status. Our models illustrate that for T. chebula, high fire frequency and high fruit harvest intensity decreased the proportion of saplings, while lopping branches or stems to obtain fruit increased it. For Phyllanthus spp, recruitment was significantly lower in plots with more frequent fire. Indices of recruitment of both species were significantly higher for plots in more open-canopy environments of savanna woodlands than in dry forests. Our research illustrates an approach for identifying which factors are most important in limiting recruitment of NTFP populations and other plant species that may be in decline, in order to design effective management strategies.	[Varghese, Anita; Nath, Snehlata] Keystone Fdn, Kotagiri 643217, The Nilgiris, India; [Varghese, Anita; Ticktin, Tamara; Mandle, Lisa] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Mandle, Lisa] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA	University of Hawaii System; University of Hawaii Manoa; Stanford University	Varghese, A (corresponding author), Keystone Fdn, PB 35, Kotagiri 643217, The Nilgiris, India.	anita@keystone-foundation.org		Mandle, Lisa/0000-0002-1420-8529	Ford Foundation; NSF [OISE03-52827]	Ford Foundation; NSF(National Science Foundation (NSF))	The field work was funded by the Ford Foundation for work on NTFP in the NBR through a project to Snehlata Nath, Director Programs, Keystone Foundation. The data analysis and writing was supported by NSF grant OISE03-52827 to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anitha K, 2010, ECOL COMPLEX, V7, P217, DOI 10.1016/j.ecocom.2010.02.005; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Asouti E., 2008, Trees and woodlands of South India: archaeological perspectives; Bates D, 2012, LME4 LINEAR MIXED EF; Bawa KS, 2011, CONSERV BIOL, V25, P639, DOI 10.1111/j.1523-1739.2010.01640.x; Berkes F, 2008, SACRED ECOLOGY; Brummitt N, 2010, 1 ROYAL BOT GARD; Champion H. G., 1968, REVISED SURVEY FORES, P404; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Cunningham A. B., 2001, Applied ethnobotany: people, wild plant use and conservation; de Souza IF, 2010, BIODIVERS CONSERV, V19, P1683, DOI 10.1007/s10531-010-9796-y; Feeley KJ, 2007, J TROP ECOL, V23, P191, DOI 10.1017/S0266467406003919; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Ganesan R., 2004, CONSERV SOC, V2, P365; Gaoue OG, 2010, CONSERV BIOL, V24, P605, DOI 10.1111/j.1523-1739.2009.01345.x; GOLDAMMER JG, 1988, AGROFOREST SYST, V6, P235, DOI 10.1007/BF02344761; John R, 2002, J VEG SCI, V13, P45, DOI 10.1658/1100-9233(2002)013[0045:DDICTS]2.0.CO;2; Kathriarachchi HS, 2004, CONSERV SOC, V2, P273; Keystone Foundation, 2007, HON TRAILS BLUE MOUN; Kodandapani N, 2004, FOR ECOL MANAG, V256, P607; Lykke AM, 1998, BIODIVERS CONSERV, V7, P1261, DOI 10.1023/A:1008877819286; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Murali KS, 1996, ECON BOT, V50, P252, DOI 10.1007/BF02907329; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Otterstrom SM, 2006, BIOTROPICA, V38, P592, DOI 10.1111/j.1744-7429.2006.00188.x; Padmini S., 2001, Journal of Tropical Forest Science, V13, P297; Pain A., 2009, P BIOD LIV C COON IN; Prasad S, 2010, ECOL RES, V25, P225, DOI 10.1007/s11284-009-0650-1; Ravikumar K, 2000, ILLUSTRATED FIELD GU; Rist L, 2008, FOREST ECOL MANAG, V255, P1684, DOI 10.1016/j.foreco.2007.11.030; Rist L, 2012, FOREST ECOL MANAG, V268, P57, DOI 10.1016/j.foreco.2011.04.037; Rist L, 2010, ECOL SOC, V15; Saha S, 2003, ECOLOGY, V84, P3118, DOI 10.1890/02-3051; Sandemose P, 2009, THESIS NORWEGIAN I L; Schmidt IB, 2011, J APPL ECOL, V48, P815, DOI 10.1111/j.1365-2664.2011.01999.x; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Setty RS, 2008, ECOL SOC, V13; Setty RS, 2004, THESIS U MYSORE INDI; Shaanker RU, 1997, WRAP UP WORKSH CIFOR; Shaanker RU, 2004, CONSERV SOC, P347; Sinha A, 2005, BIODIVERS CONSERV, V14, P3537, DOI 10.1007/s10531-004-0827-4; Sinha A, 2002, FOREST ECOL MANAG, V168, P289, DOI 10.1016/S0378-1127(01)00747-2; SULLIVAN S, 1995, ECON BOT, V49, P357, DOI 10.1007/BF02863085; Sundaram B, 2011, THESIS MANIPAL U IND; Ticktin T, 2004, BIOL CONSERV, V120, P461, DOI 10.1016/j.biocon.2004.03.019; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Ticktin T, 2012, J APPL ECOL, V49, P774, DOI 10.1111/j.1365-2664.2012.02156.x; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; *WWF, 2002, FOR MAN OUTS PROT AR	54	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119634	10.1371/journal.pone.0119634	http://dx.doi.org/10.1371/journal.pone.0119634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781482	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600080
J	Abubakr, A; Alimon, AR; Yaakub, H; Abdullah, N; Ivan, M				Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun; Abdullah, Norhani; Ivan, Michael			Effect of Feeding Palm Oil By-Products Based Diets on Muscle Fatty Acid Composition in Goats	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; CARCASS CHARACTERISTICS; MEAT; QUALITY; BEEF; CHOLESTEROL; PROFILES; TRAITS; GROWTH; LAMB	The present study aims to evaluate the effects of feeding palm oil by-products based diets on different muscle fatty acid profiles in goats. Thirty-two Cacang x Boer goats were randomly assigned to four dietary treatments: (1) control diet (CD), (2) 80% decanter cake diet (DCD), (3) 80% palm kernel cake diet (PKCD) and (4) CD plus 5% palm oil (PO) supplemented diet (CPOD). After 100 days of feeding, four goats from each group were slaughtered and longissimus dorsi (LD), infraspinatus (IS) and biceps femoris (BF) were sampled for analysis of fatty acids. Goats fed the PKCD had higher (P<0.05) concentration of lauric acid (C12: 0) than those fed the other diets in all the muscles tested. Compared to the other diets, the concentrations of palmitic acid (C16: 0) and stearic acid (C18: 0) were lower (P<0.05) and that of linoleic acid (C18: 2 n-6) was higher (P<0.05) in the muscles from goats fed the CD. It was concluded that palm kernel cake and decanter cake can be included in the diet of goats up to 80% with more beneficial than detrimental effects on the fatty acid profile of their meat.	[Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun] Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia; [Alimon, Abdul Razak; Abdullah, Norhani; Ivan, Michael] Univ Putra Malaysia, Inst Trop Agr, Serdang 43400, Selangor, Malaysia; [Abdullah, Norhani] Univ Putra Malaysia, Dept Biochem, Serdang 43400, Selangor, Malaysia; [Abubakr, Abdelrahim] Univ Bahri, Dept Anim Nutr, Khartoum, Sudan	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Alimon, AR (corresponding author), Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia.	ralimon@agri.upm.edu.my	Abubakr, Abdelrahim/B-1592-2009	Abubakr, Abdelrahim/0000-0003-0858-3952; Yaakub, Halimatun/0000-0003-2691-6984				Abubakr AR, 2013, SMALL RUMINANT RES, V112, P91, DOI 10.1016/j.smallrumres.2012.11.003; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; AOAC, 2000, OFF METH AN, DOI [DOI 10.1007/978-3-642-31241-0, 10.3109/15563657608988149]; BABIKER SA, 1990, MEAT SCI, V28, P273, DOI 10.1016/0309-1740(90)90041-4; Barton L, 2008, J SCI FOOD AGR, V88, P2622, DOI 10.1002/jsfa.3381; Bas P, 2000, LIVEST PROD SCI, V64, P61, DOI 10.1016/S0301-6226(00)00176-7; COLOMERROCHER F, 1992, SMALL RUMINANT RES, V7, P161, DOI 10.1016/0921-4488(92)90205-I; Coltro WKT, 2005, MEAT SCI, V71, P358, DOI 10.1016/j.meatsci.2005.04.016; CORNELIUS J A, 1977, Progress in the Chemistry of Fats and Other Lipids, V15, P5, DOI 10.1016/0079-6832(77)90005-2; Costa P, 2008, MEAT SCI, V78, P502, DOI 10.1016/j.meatsci.2007.07.020; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; de Carvalho GGP, 2004, PESQUI AGROPECU BRAS, V39, P919; De Smet S, 2004, ANIM RES, V53, P81, DOI 10.1051/animres:2004003; Devendra C, 1990, P INT GOAT PROD S 22; Diaz MT, 2002, SMALL RUMINANT RES, V43, P257, DOI 10.1016/S0921-4488(02)00016-0; Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409; Ebrahimi M, 2012, J ANIM PHYSIOL AN N, V96, P962, DOI 10.1111/j.1439-0396.2011.01206.x; Enser M, 1998, MEAT SCI, V49, P329, DOI 10.1016/S0309-1740(97)00144-7; Enser M, 1996, MEAT SCI, V42, P443, DOI 10.1016/0309-1740(95)00037-2; Field R. A., 1992, Sheep Research Journal, V8, P77; FOLCH J, 1957, J BIOL CHEM, V226, P497; HMSO, 1994, NUTR ASPECTS CARDIOV; Hristov AN, 2009, J DAIRY SCI, V92, P5561, DOI 10.3168/jds.2009-2383; Islam M, 2000, ASIAN AUSTRAL J ANIM, V13, P941, DOI 10.5713/ajas.2000.941; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; JOHNSON DD, 1995, J ANIM SCI, V73, P296; Lee JH, 2008, SMALL RUMINANT RES, V75, P177, DOI 10.1016/j.smallrumres.2007.10.003; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Morand-Fehr P, 2005, SMALL RUMINANT RES, V60, P25, DOI 10.1016/j.smallrumres.2005.06.004; Mushi DE, 2010, MEAT SCI, V86, P337, DOI 10.1016/j.meatsci.2010.05.006; Noakes M, 1996, AM J CLIN NUTR, V63, P42, DOI 10.1093/ajcn/63.1.42; NOCEK JE, 1991, J DAIRY SCI, V74, P3598, DOI 10.3168/jds.S0022-0302(91)78552-4; PARK YW, 1993, J FOOD SCI, V58, P245, DOI 10.1111/j.1365-2621.1993.tb04248.x; Partida JA, 2007, MEAT SCI, V76, P444, DOI 10.1016/j.meatsci.2006.12.009; Pena F, 2011, ITAL J ANIM SCI, V10, P212, DOI 10.4081/ijas.2011.e40; Phengvichith V, 2007, TROP ANIM HEALTH PRO, V39, P59, DOI 10.1007/s11250-006-4443-z; Pratiwi NMW, 2007, MEAT SCI, V75, P168, DOI 10.1016/j.meatsci.2006.06.026; RAJION MA, 1985, AUST J BIOL SCI, V38, P33, DOI 10.1071/BI9850033; Rhee KS, 2000, MEAT SCI, V54, P313, DOI 10.1016/S0309-1740(99)00094-7; Ribeiro RDX, 2011, ASIAN AUSTRAL J ANIM, V24, P1399, DOI 10.5713/ajas.2011.11110; Robertson J.B., 1981, ANAL DIETARY FIBER F, P123, DOI DOI 10.1016/S0031-9384(00)00286-9; Sackmann JR, 2003, J ANIM SCI, V81, P3174; SAS, 2003, SAS US GUID STAT; Seephueak W., 2011, Songklanakarin Journal of Science and Technology, V33, P271; Silva HGD, 2005, PESQUI AGROPECU BRAS, V40, P405, DOI 10.1590/S0100-204X2005000400013; SMITH GC, 1978, J ANIM SCI, V46, P1229, DOI 10.2527/jas1978.4651229x; SOLOMON MB, 1991, J ANIM SCI, V69, P4055, DOI 10.2527/1991.69104055x; SOLOMON MB, 1992, J ANIM SCI, V70, P2746, DOI 10.2527/1992.7092746x; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Talpur FN, 2008, MEAT SCI, V80, P819, DOI 10.1016/j.meatsci.2008.03.028; Todaro M, 2004, SMALL RUMINANT RES, V54, P191, DOI 10.1016/j.smallrumres.2003.11.011; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Van Niekerk W. A., 1988, SMALL RUMINANT RES, V1, P355, DOI [10.1016/0921-4488(88)90061-2, DOI 10.1016/0921-4488(88)90061-2]; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vicenti A., 2001, Zootecnica e Nutrizione Animale, V27, P23; Webb EC, 2005, SMALL RUMINANT RES, V60, P153, DOI 10.1016/j.smallrumres.2005.06.009	56	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119756	10.1371/journal.pone.0119756	http://dx.doi.org/10.1371/journal.pone.0119756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789610	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400101
J	Tao, Y; Ruan, HZ; Guo, X; Li, LX; Shen, WH				Tao, Yi; Ruan, Hangze; Guo, Xia; Li, Lixin; Shen, Wanhua			HDAC1 Regulates the Proliferation of Radial Glial Cells in the Developing Xenopus Tectum	PLOS ONE			English	Article							HISTONE DEACETYLASES 1; NEURAL STEM-CELLS; IN-VIVO; DEVELOPMENTAL REFINEMENT; RECEPTIVE-FIELDS; MEMORY FORMATION; GENE-EXPRESSION; VISUAL-SYSTEM; NEUROGENESIS; ACETYLATION	In the developing central nervous system (CNS), progenitor cells differentiate into progeny to form functional neural circuits. Radial glial cells (RGs) are a transient progenitor cell type that is present during neurogenesis. It is thought that a combination of neural trophic factors, neurotransmitters and electrical activity regulates the proliferation and differentiation of RGs. However, it is less clear how epigenetic modulation changes RG proliferation. We sought to explore the effect of histone deacetylase (HDAC) activity on the proliferation of RGs in the visual optic tectum of Xenopus laevis. We found that the number of BrdU-labeled precursor cells along the ventricular layer of the tectum decrease developmentally from stage 46 to stage 49. The co-labeling of BrdU-positive cells with brain lipid-binding protein (BLBP), a radial glia marker, showed that the majority of BrdU-labeled cells along the tectal midline are RGs. BLBP-positive cells are also developmentally decreased with the maturation of the brain. Furthermore, HDAC1 expression is developmentally down-regulated in tectal cells, especially in the ventricular layer of the tectum. Pharmacological blockade of HDACs using Trichostatin A (TSA) or Valproic acid (VPA) decreased the number of BrdU-positive, BLBP-positive and co-labeling cells. Specific knockdown of HDAC1 by a morpholino (HDAC1-MO) decreased the number of BrdU-and BLBP-labeled cells and increased the acetylation level of histone H4 at lysine 12 (H4K12). The visual deprivation-induced increase in BrdU-and BLBP-positive cells was blocked by HDAC1 knockdown at stage 49 tadpoles. These data demonstrate that HDAC1 regulates radial glia cell proliferation in the developing optical tectum of Xenopus laevis.	[Tao, Yi; Li, Lixin] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China; [Ruan, Hangze; Guo, Xia; Shen, Wanhua] Hangzhou Normal Univ, Coll Life & Environm Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China	Nanjing Medical University; Hangzhou Normal University	Li, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	lilixin2@hotmail.com; shen@hznu.edu.cn	Shen, Wanhua/B-5554-2011	Shen, Wanhua/0000-0002-5178-9561	National Natural Science Foundation of China [81171147, 31271176]; Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration; "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province [RC201156]; "Six Categories of Key Person" Research Foundation of Jiangsu Province [16 069]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Science Foundation for Hangzhou "131" Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration; "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province; "Six Categories of Key Person" Research Foundation of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science Foundation for Hangzhou "131" Talents	This work was supported by grants from the National Natural Science Foundation of China (No. 81171147 to LL and No. 31271176 to WS), the Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration to YT, the "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province (No. RC201156 to LL), the "Six Categories of Key Person" Research Foundation of Jiangsu Province (No. 16 069 to LL), the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. JX10231801 to LL), and the Science Foundation for Hangzhou "131" Talents to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bestman JE, 2012, J COMP NEUROL, V520, P401, DOI 10.1002/cne.22795; D'Amico LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066487; D'Amico LA, 2011, BRAIN RES, V1405, P31, DOI 10.1016/j.brainres.2011.06.032; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dong W, 2012, J NEUROSCI, V32, P16872, DOI 10.1523/JNEUROSCI.2372-12.2012; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; KEATING MJ, 1987, NEUROSCIENCE, V21, P519, DOI 10.1016/0306-4522(87)90138-2; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; McKeown CR, 2013, J COMP NEUROL, V521, P2262, DOI 10.1002/cne.23283; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Nieuwkoop P, 1956, NORMAL TABLE OF XENO; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Sharma P, 2010, NEURON, V68, P442, DOI 10.1016/j.neuron.2010.09.028; Shen WH, 2014, CELL REP, V6, P737, DOI 10.1016/j.celrep.2014.01.024; Shen WH, 2011, J NEUROPHYSIOL, V106, P2285, DOI 10.1152/jn.00641.2011; Shen WH, 2009, J NEUROSCI, V29, P5032, DOI 10.1523/JNEUROSCI.5331-08.2009; Sild M, 2011, NEUROSCIENTIST, V17, P288, DOI 10.1177/1073858410385870; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tremblay M, 2009, J NEUROSCI, V29, P14066, DOI 10.1523/JNEUROSCI.3542-09.2009; Tseng AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026382; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshida M, 2001, DEV NEUROSCI-BASEL, V23, P299, DOI 10.1159/000048713; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	56	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120118	10.1371/journal.pone.0120118	http://dx.doi.org/10.1371/journal.pone.0120118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789466	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400130
J	Brahma, B; Kumar, S; De, BC; Mishra, P; Patra, MC; Gaur, D; Chopra, M; Gautam, D; Mahanty, S; Malik, H; Malakar, D; Datta, TK; De, S				Brahma, Biswajit; Kumar, Sushil; De, Bidhan Chandra; Mishra, Purusottam; Patra, Mahesh Chandra; Gaur, Deepak; Chopra, Meenu; Gautam, Devika; Mahanty, Sourav; Malik, Hrudananda; Malakar, Dhruba; Datta, Tirtha Kumar; De, Sachinandan			Comparative Genomic Analysis of Buffalo (Bubalus bubalis) NOD1 and NOD2 Receptors and Their Functional Role in In-Vitro Cellular Immune Response	PLOS ONE			English	Article							DELTA T-CELLS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; MURAMYL DIPEPTIDE; NUCLEOTIDE-BINDING; CRITICAL RESIDUES; PROTEIN MODELS; SENSORS NOD1; GAMMA	Nucleotide binding and oligomerization domain (NOD)-like receptors (NLRs) are innate immune receptors that recognize bacterial cell wall components and initiate host immune response. Structure and function of NLRs have been well studied in human and mice, but little information exists on genetic composition and role of these receptors in innate immune system of water buffalo-a species known for its exceptional disease resistance. Here, a comparative study on the functional domains of NOD1 and NOD2 was performed across different species. The NOD mediated in-vitro cellular responses were studied in buffalo peripheral blood mononuclear cells, resident macrophages, mammary epithelial, and fibroblast cells. Buffalo NOD1 (buNOD1) and buNOD2 showed conserved domain architectures as found in other mammals. The domains of buNOD1 and buNOD2 showed analogy in secondary and tertiary conformations. Constitutive expressions of NODs were ubiquitous in different tissues. Following treatment with NOD agonists, peripheral lymphocytes showed an IFN-gamma response along-with production of pro-inflammatory cytokines. Alveolar macrophages and mammary epithelial cells showed NOD mediated in-vitro immune response through NF-kappa B dependent pathway. Fibroblasts showed pro-inflammatory cytokine response following agonist treatment. Our study demonstrates that both immune and non-immune cells could generate NOD-mediated responses to pathogens though the type and magnitude of response depend on the cell types. The structural basis of ligand recognition by buffalo NODs and knowledge of immune response by different cell types could be useful for development of non-infective innate immune modulators and next generation anti-inflammatory compounds.	[Brahma, Biswajit; Kumar, Sushil; De, Bidhan Chandra; Mishra, Purusottam; Patra, Mahesh Chandra; Gaur, Deepak; Chopra, Meenu; Gautam, Devika; Mahanty, Sourav; Malik, Hrudananda; Malakar, Dhruba; Datta, Tirtha Kumar; De, Sachinandan] Natl Dairy Res Inst, Anim Genom Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Brahma, Biswajit] SKUAST Jammu, Krishi Vigyan Kendra, Jammu, India; [De, Bidhan Chandra] Kazan Volga Reg Fed Univ, Dept Pharmaceut Res, Kazan, Russia; [De, Bidhan Chandra] Kazan Volga Reg Fed Univ, Educ Ctr, Kazan, Russia	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); Kazan Federal University; Kazan Federal University	De, S (corresponding author), Natl Dairy Res Inst, Anim Genom Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	sachinandan@ndri.res.in	DE, BIDHAN CHANDRA/P-1606-2015; Malik, Hrudananda/AAU-1515-2020; Patra, Mahesh/I-9746-2014	DE, BIDHAN CHANDRA/0000-0002-9379-8909; Malik, Hrudananda/0000-0003-1213-4455; Brahma, Biswajit/0000-0003-0052-5029; De, Sachinandan/0000-0002-3182-0904; Patra, Mahesh/0000-0003-0471-6236	Department of Biotechnology [BT/PR3111/AAQ/1/474/2011]; Indian Council of Agricultural Research (NICRA/NDRI component)	Department of Biotechnology; Indian Council of Agricultural Research (NICRA/NDRI component)	This study was supported by the Department of Biotechnology; (http://dbtindia.nic.in/; No.: BT/PR3111/AAQ/1/474/2011); and the Indian Council of Agricultural Research (http://www.icar.org.in/; NICRA/NDRI component). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Council N.R., 1981, WATER BUFFALO NEW PR; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; FAO, 2000, WAT BUFF ASS UND, P1; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Garcia VE, 1998, J IMMUNOL, V160, P4322; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goldammer T, 2004, CLIN DIAGN LAB IMMUN, V11, P174, DOI 10.1128/CDLI.11.1.174-185.2004; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kerns HMM, 2009, CELL IMMUNOL, V257, P38, DOI 10.1016/j.cellimm.2009.02.004; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Marischen L, 2011, SCAND J IMMUNOL, V74, P126, DOI 10.1111/j.1365-3083.2011.02560.x; Mayle S, 2014, J BIOL CHEM, V289, P22900, DOI 10.1074/jbc.M114.557900; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Monie TP, 2013, TRENDS BIOCHEM SCI, V38, P131, DOI 10.1016/j.tibs.2013.01.001; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; O'Neill LAJ, 2011, J LEUKOCYTE BIOL, V89, P173, DOI 10.1189/jlb.0910521; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; R Core Team, 2021, R LANGUAGE ENV STAT; Richardt-Pargmann D, 2011, IMMUNOBIOLOGY, V216, P12, DOI 10.1016/j.imbio.2010.03.011; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Shigeoka AA, 2010, J IMMUNOL, V184, P2297, DOI 10.4049/jimmunol.0903065; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089788; SKEEN MJ, 1995, J IMMUNOL, V154, P5832; Sorbara MT, 2013, IMMUNITY, V39, P858, DOI 10.1016/j.immuni.2013.10.013; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Uehara A, 2008, CLIN VACCINE IMMUNOL, V15, P1060, DOI 10.1128/CVI.00137-08; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Ueta C, 1996, EUR J IMMUNOL, V26, P3066, DOI 10.1002/eji.1830261237; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1	79	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119178	10.1371/journal.pone.0119178	http://dx.doi.org/10.1371/journal.pone.0119178			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786158	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500079
J	Chen, J; Kang, Q; Jiang, WH; Fan, J; Zhang, MD; Yu, SY; Zhang, C				Chen, Jue; Kang, Qing; Jiang, Wenhui; Fan, Juan; Zhang, Mingdao; Yu, Shunying; Zhang, Chen			The 5-HTTLPR Confers Susceptibility to Anorexia Nervosa in Han Chinese: Evidence from a Case-Control and Family-Based Study	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; LINKED POLYMORPHIC REGION; EATING-DISORDERS; RISK-FACTORS; PSYCHOPATHOLOGICAL TRAITS; ASSOCIATION; DEPRESSION; PROMOTER; BULIMIA; WEIGHT	Accumulating evidence has implied that serotonin system dysfunction may be involved in the etiology of anorexia nervosa (AN). Serotonin-transporter-linked promoter region (5-HTTLPR) polymorphism is the genetic variant coding for the serotonin transporter and has a modulatory effect on its expression. This study aimed to investigate the possible association between the 5-HTTLPR and the susceptibility and severity of AN in Han Chinese using a case-control (255 patients and 351 controls) and family based study (198 trios). Eating disorder examination was used to measure the severity of AN behavioral symptoms. For the case-control study, the 5-HTTLPR showed significant association with AN in our sample (genotypic P = 0.03). The frequency of S allele was significantly higher in patients than that in controls (OR = 1.38, 95% CI: 1.06-1.79, P = 0.017). For the family-based study, the S allele of 5-HTTLPR was preferentially transmitted rather than non-transmitted from the parents to affected offspring (P = 0.013). The results of ANCOVA test revealed no significant association between the 5-HTTLPR polymorphism and severity of AN. Our findings suggested that 5-HTTLPR is able to confer susceptibility to AN in Han Chinese.	[Chen, Jue; Kang, Qing; Jiang, Wenhui; Fan, Juan; Zhang, Mingdao; Yu, Shunying; Zhang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yu, SY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	yushuny@yahoo.com; zhangchen645@gmail.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81201055]; National Key Clinical Disciplines at Shanghai Mental Health Center [OMA-MH2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Disciplines at Shanghai Mental Health Center	This work was supported by the National Natural Science Foundation of China (81201055) and the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH2011-873).	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013; Bailer UF, 2007, PSYCHOPHARMACOLOGY, V195, P315, DOI 10.1007/s00213-007-0896-7; Blaya C, 2010, NEUROSCI LETT, V485, P11, DOI 10.1016/j.neulet.2010.08.042; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Castellini G, 2012, AM J MED GENET B, V159B, P491, DOI 10.1002/ajmg.b.32052; Denys D, 2006, J AFFECT DISORDERS, V91, P39, DOI 10.1016/j.jad.2005.12.011; Di Bella D, 2000, MOL PSYCHIATR, V5, P233, DOI 10.1038/sj.mp.4000689; Fairburn CG, 1999, ARCH GEN PSYCHIAT, V56, P468, DOI 10.1001/archpsyc.56.5.468; Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006; Fuglset TS, 2015, NEUROCASE, V21, P169, DOI 10.1080/13554794.2013.878728; Fumeron F, 2001, MOL PSYCHIATR, V6, P9, DOI 10.1038/sj.mp.4000824; Gadow KD, 2013, PROG NEURO-PSYCHOPH, V40, P292, DOI 10.1016/j.pnpbp.2012.10.019; Gauthier C, 2014, PSYCHONEUROENDOCRINO, V39, P170, DOI 10.1016/j.psyneuen.2013.09.009; Gervasini G, 2013, J CLIN PSYCHOPHARM, V33, P551, DOI 10.1097/JCP.0b013e3182970469; Gervasini G, 2012, J CLIN PSYCHOPHARM, V32, P426, DOI 10.1097/JCP.0b013e3182539f2b; Giordano GD, 2001, J ENDOCRINOL INVEST, V24, P510, DOI 10.1007/BF03343884; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Grilo CM, 2004, INT J EAT DISORDER, V35, P80, DOI 10.1002/eat.10238; Heils A, 1996, J NEUROCHEM, V66, P2621; Hinney A, 1997, LIFE SCI, V61, pPL295, DOI 10.1016/S0024-3205(97)00888-6; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Klump KL, 2005, INT J EAT DISORDER, V37, pS43, DOI 10.1002/eat.20116; Kotte A, 2013, AM J MED GENET B, V162, P718, DOI 10.1002/ajmg.b.32171; Lauzurica N, 2003, NEUROSCI LETT, V352, P226, DOI 10.1016/j.neulet.2003.08.058; Lee Y, 2010, INT J EAT DISORDER, V43, P498, DOI 10.1002/eat.20732; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lohoff FW, 2013, PHARMACOGENOMICS J, V13, P464, DOI 10.1038/tpj.2012.33; Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004; Mainz V, 2012, PSYCHOSOM MED, V74, P574, DOI 10.1097/PSY.0b013e31824ef10e; Matsushita S, 2004, AM J MED GENET B, V128B, P114, DOI 10.1002/ajmg.b.30022; Mehta D, 2012, J AFFECT DISORDERS, V136, P1192, DOI 10.1016/j.jad.2011.11.042; Monteleone P, 2008, PHARMACOGENOMICS, V9, P1487, DOI 10.2217/14622416.9.10.1487; Nisoli E, 2007, EAT WEIGHT DISORD-ST, V12, P91, DOI 10.1007/BF03327583; Pike KM, 2008, PSYCHOL MED, V38, P1443, DOI 10.1017/S0033291707002310; Ricca V, 2004, NEUROSCI LETT, V365, P92, DOI 10.1016/j.neulet.2004.04.057; Rizvi SL, 2000, INT J EAT DISORDER, V28, P311, DOI 10.1002/1098-108X(200011)28:3<311::AID-EAT8>3.0.CO;2-K; Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701; Saiz PA, 2007, PROG NEURO-PSYCHOPH, V31, P741, DOI 10.1016/j.pnpbp.2007.01.012; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sundaramurthy D, 2000, AM J MED GENET, V96, P53, DOI 10.1002/(SICI)1096-8628(20000207)96:1<53::AID-AJMG11>3.0.CO;2-X; Wankerl M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.37; Xu J, 2013, LUPUS, V22, P1001, DOI 10.1177/0961203313498793; Zhang C, 2014, AM J MED GENET B, V165, P564, DOI 10.1002/ajmg.b.32259; Zhang C, 2014, PROG NEURO-PSYCHOPH, V50, P110, DOI 10.1016/j.pnpbp.2013.12.010; Zhang C, 2009, NEUROSCI LETT, V462, P308, DOI 10.1016/j.neulet.2009.06.085	48	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119378	10.1371/journal.pone.0119378	http://dx.doi.org/10.1371/journal.pone.0119378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785698	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500100
J	Ren, SP; Chai, L; Wang, CY; Li, CL; Ren, QQ; Yang, LH; Wang, FM; Qiao, ZX; Li, WJ; He, M; Riker, AI; Han, Y; Yu, Q				Ren, Suping; Chai, Lina; Wang, Chunyan; Li, Changlan; Ren, Qiquan; Yang, Lihua; Wang, Fumei; Qiao, Zhixin; Li, Weijing; He, Min; Riker, Adam I.; Han, Ying; Yu, Qun			Human Malignant Melanoma-Derived Progestagen-Associated Endometrial Protein Immunosuppresses T Lymphocytes In Vitro	PLOS ONE			English	Article							PLACENTAL PROTEIN-14; EMBRYO IMPLANTATION; GLYCODELIN-A; ACTIVATION; EXPRESSION; GENE; DIFFERENTIATION; SUPPRESSION; METASTASIS; INHIBITION	Progestagen-associated endometrial protein (PAEP) is a glycoprotein of the lipocalin family that acts as a negative regulator of T cell receptor-mediated activation. However, the function of tumor-derived PAEP on the human immune system in the tumor microenvironment is unknown. PAEP is highly expressed in intermediate and thick primary melanomas (Breslow's 2.5mm or greater) and metastatic melanomas, correlating with its expression in daughter cell lines established in vitro. The current study investigates the role of melanoma cell-secreted PAEP protein in regulating T cell function. Upon the enrichment of CD3(+), CD4(+) and CD8(+) T cells from human peripheral blood mononuclear cells, each subset was then mixed with either melanoma-derived PAEP protein or PAEP-poor supernatant of gene-silenced tumor cells. IL-2 and IFN-gamma secretion of CD4(+) T cells significantly decreased with the addition of PAEP-rich supernatant. And the addition of PAEP-positive cell supernatant to activated lymphocytes significantly inhibited lymphocyte proliferation and cytotoxic T cell activity, while increasing lymphocyte apoptosis. Our result suggests that melanoma cell-secreted PAEP protein immunosuppresses the activation, proliferation and cytotoxicity of T lymphocytes, which might partially explain the mechanism of immune tolerance induced by melanoma cells within the tumor microenvironment.	[Ren, Suping; Chai, Lina; Wang, Chunyan; Li, Changlan; Qiao, Zhixin; Li, Weijing; He, Min; Han, Ying; Yu, Qun] Beijing Inst Transfus Med, Dept Immunohematol, Beijing, Peoples R China; [Wang, Chunyan] Beijing 307 Hosp, Dept Poisoning Treatment, Beijing, Peoples R China; [Ren, Qiquan; Yang, Lihua; Wang, Fumei] Peoples Hosp Anqiu City, Shandong, Peoples R China; [Riker, Adam I.] Advocate Christ Med Ctr, Advocate Canc Inst, Oak Lawn, IL USA	Fifth Medical Center of Chinese PLA General Hospital	Ren, SP (corresponding author), Beijing Inst Transfus Med, Dept Immunohematol, Beijing, Peoples R China.	rensp12@yahoo.com; yuqun1970@gmail.com	Ren, Suping/AAC-9167-2020		National Natural Science Foundation of China [PDRC-81071709]; Science and Technology Project of Beijing Municipal [Z141100000214003]; Program for the 12th Five-year Plan of China [2012ZX10001003]; National Scientific and Technological Major Project for Significant New Drugs Development [2011ZXJ09302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Beijing Municipal; Program for the 12th Five-year Plan of China; National Scientific and Technological Major Project for Significant New Drugs Development	This research was supported by grants from the National Natural Science Foundation of China (PDRC-81071709), the Science and Technology Project of Beijing Municipal (Z141100000214003), the Program for the 12th Five-year Plan of China (2012ZX10001003) and the National Scientific and Technological Major Project for Significant New Drugs Development (2011ZXJ09302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobinet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051716; Chai LN, 2013, MOL MED REP, V8, P1390, DOI 10.3892/mmr.2013.1679; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Chen KY, 2012, IMMUNOL RES, V53, P182, DOI 10.1007/s12026-012-8295-5; Connor JP, 2000, GYNECOL ONCOL, V79, P216, DOI 10.1006/gyno.2000.5941; Cruikshank WW, 1996, J IMMUNOL, V157, P5240; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hoozemans DA, 2004, REPROD BIOMED ONLINE, V9, P692, DOI 10.1016/S1472-6483(10)61781-6; Itzhaki O, 2013, IMMUNOTHERAPY-UK, V5, P79, DOI 10.2217/imt.12.143; Jayachandran R, 2004, J BIOL CHEM, V279, P8585, DOI 10.1074/jbc.M310480200; Jeschke U, 2006, HISTOPATHOLOGY, V48, P394, DOI 10.1111/j.1365-2559.2006.02351.x; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Mandelin E, 2003, CANCER RES, V63, P6258; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; OEHNINGER S, 1995, FERTIL STERIL, V63, P377; OKAMOTO N, 1991, AM J REPROD IMMUNOL, V26, P137, DOI 10.1111/j.1600-0897.1991.tb00713.x; Panelli MC, 2000, J IMMUNOL, V164, P4382, DOI 10.4049/jimmunol.164.8.4382; Poggi A, 2006, ARCH IMMUNOL THER EX, V54, P323, DOI 10.1007/s00005-006-0038-7; Rachmilewitz J, 1999, CELL IMMUNOL, V191, P26, DOI 10.1006/cimm.1998.1408; Rachmilewitz J, 2001, BLOOD, V98, P3727, DOI 10.1182/blood.V98.13.3727; Ren SP, 2006, CANCER IMMUNOL IMMUN, V55, P375, DOI 10.1007/s00262-005-0011-z; Ren Su-Ping, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P54; Ren SP, 2010, J CELL MOL MED, V14, P1432, DOI 10.1111/j.1582-4934.2009.00922.x; Ren Suping, 2008, Cancer Control, V15, P202; Rutkowski MR, 2012, CELL IMMUNOL, V278, P21, DOI 10.1016/j.cellimm.2012.06.014; Seppala M, 2009, EUR J ENDOCRINOL, V160, P121, DOI 10.1530/EJE-08-0756; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shabani N, 2005, ANTICANCER RES, V25, P1761; Sheu BC, 2009, FRONT BIOSCI-LANDMRK, V14, P1571, DOI 10.2741/3325; Tseng L, 2002, FRONT BIOSCI, V7, pD1566, DOI 10.2741/tseng; Uchida H, 2007, ENDOCRINOLOGY, V148, P896, DOI 10.1210/en.2006-0896; Vigne JL, 2001, J BIOL CHEM, V276, P17101, DOI 10.1074/jbc.M010451200; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Zhang M, 2013, CLIN CANCER RES, V19, P247, DOI 10.1158/1078-0432.CCR-12-2753	36	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119038	10.1371/journal.pone.0119038	http://dx.doi.org/10.1371/journal.pone.0119038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785839	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500068
J	Ryzak, M; Bieganowski, A; Polakowski, C				Ryzak, Magdalena; Bieganowski, Andrzej; Polakowski, Cezary			Effect of Soil Moisture Content on the Splash Phenomenon Reproducibility	PLOS ONE			English	Article							SINGLE RAINDROPS; KINETIC-ENERGY; DETACHMENT; EROSION; IMPACT; EROSIVITY; DISTANCE; FORCE	One of the methods for testing splash (the first phase of water erosion) may be an analysis of photos taken using so-called high-speed cameras. The aim of this study was to determine the reproducibility of measurements using a single drop splash of simulated precipitation. The height from which the drops fell resulted in a splash of 1.5 m. Tests were carried out using two types of soil: Eutric Cambisol (loamy silt) and Orthic Luvisol (sandy loam); three initial pressure heads were applied equal to 16 kPa, 3.1 kPa, and 0.1 kPa. Images for one, five, and 10 drops were recorded at a rate of 2000 frames per second. It was found that (i) the dispersion of soil caused by the striking of the 1st drop was significantly different from the splash impact caused by subsequent drops; (ii) with every drop, the splash phenomenon proceeded more reproducibly, that is, the number of particles of soil and/or water that splashed were increasingly close to each other; (iii) the number of particles that were detached during the splash were strongly correlated with its surface area; and (iv) the higher the water film was on the surface the smaller the width of the crown was.	[Ryzak, Magdalena; Bieganowski, Andrzej; Polakowski, Cezary] Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Ryzak, M (corresponding author), Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland.	m.ryzak@ipan.lublin.pl	Polakowski, Cezary/H-7294-2013	Polakowski, Cezary/0000-0002-1658-8334; Ryzak, Magdalena/0000-0002-6400-5375; Bieganowski, Andrzej/0000-0002-3571-3241	National Centre for Science [N N310777640]; National Science Centre (Poland) [DEC-2012/07/N/ST10/03280];  [IP2011 047471]	National Centre for Science; National Science Centre (Poland); 	The study was partially funded by the budget for science within the framework of Project No. IP2011 047471 (2011-2014), by the National Centre for Science within the framework of Project No. N N310777640 (2011-2014) and from the National Science Centre (Poland), based on decision no. DEC-2012/07/N/ST10/03280 (2013-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, EARTH SURF PROC LAND, V38, P1225, DOI 10.1002/esp.3364; ALDURRAH M, 1981, SOIL SCI SOC AM J, V45, P949, DOI 10.2136/sssaj1981.03615995004500050026x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P1086, DOI 10.2136/sssaj1982.03615995004600050040x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P836, DOI 10.2136/sssaj1982.03615995004600040034x; Bieganowski A, 2013, INT AGROPHYS, V27, P335, DOI 10.2478/intag-2013-0003; BRADFORD JM, 1986, SOIL SCI SOC AM J, V50, P1547, DOI 10.2136/sssaj1986.03615995005000060033x; Brodowski R, 2000, ACTA AGROPHYSICA, V16, P255; EPEMA GF, 1983, CATENA, P1; FERREIRA AG, 1985, SOIL SCI SOC AM J, V49, P1537, DOI 10.2136/sssaj1985.03615995004900060041x; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Ghahramani A, 2012, EARTH SURF PROC LAND, V37, P473, DOI 10.1002/esp.2253; Glinski J, 2013, SOIL SCI ANNU, V64, P67, DOI 10.2478/ssa-2013-0012; Govers G., 1991, Catena, Supplement, P15; Imerson AC, 1981, CATENA, V8, P83; International Organization for Standardization, 2007, ISO IEC GUID 99 INT; Issa OM, 2006, EARTH SURF PROC LAND, V31, P929, DOI 10.1002/esp.1303; Jayawardena AW, 2000, HYDROL PROCESS, V14, P37, DOI [10.1002/(SICI)1099-1085(200001)14:1<37::AID-HYP908>3.0.CO;2-M, 10.1002/(SICI)1099-1085(200001)14:1&lt;37::AID-HYP908&gt;3.0.CO;2-M]; Jomaa S, 2010, J HYDROL, V395, P117, DOI 10.1016/j.jhydrol.2010.10.021; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Leguedois S, 2005, SOIL SCI SOC AM J, V69, P30, DOI 10.2136/sssaj2005.0030; Long EJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032201; Mouzai L, 2011, EARTH SURF PROC LAND, V36, P87, DOI 10.1002/esp.2021; Mouzai L, 2003, J HYDRAUL RES, V41, P61, DOI 10.1080/00221680309499929; NEARING MA, 1987, SOIL SCI SOC AM J, V51, P425, DOI 10.2136/sssaj1987.03615995005100020031x; NEARING MA, 1986, SOIL SCI SOC AM J, V50, P1532, DOI 10.2136/sssaj1986.03615995005000060030x; NEARING MA, 1985, SOIL SCI SOC AM J, V49, P547, DOI 10.2136/sssaj1985.03615995004900030003x; PALMER R., 1964, Publ. int. Ass. sci. Hydrol., V65, P141; Paluszek J, 2013, SOIL SCI ANNU, V64, P41, DOI 10.2478/ssa-2013-0008; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; Planchon O, 2010, SOIL SCI SOC AM J, V74, P1092, DOI 10.2136/sssaj2009.0063; Rejman J, 2010, LAND DEGRAD DEV, V21, P401, DOI 10.1002/ldr.963; Ryzak M, 2012, SENSORS-BASEL, V12, P11527, DOI 10.3390/s120911527; Salles C, 2000, WATER RESOUR RES, V36, P2721, DOI 10.1029/2000WR900024; SAVAT J, 1981, EARTH SURF PROC LAND, V6, P275, DOI 10.1002/esp.3290060308; SHARMA PP, 1993, SOIL SCI SOC AM J, V57, P674, DOI 10.2136/sssaj1993.03615995005700030007x; SHARMA PP, 1989, SOIL SCI SOC AM J, V53, P1005, DOI 10.2136/sssaj1989.03615995005300040003x; SHARMA PP, 1991, SOIL SCI SOC AM J, V55, P301, DOI 10.2136/sssaj1991.03615995005500020001x; TERRY JP, 1993, EARTH SURF PROC LAND, V18, P519, DOI 10.1002/esp.3290180605; van Dijk AIJM, 2002, SOIL SCI SOC AM J, V66, P1466, DOI 10.2136/sssaj2002.1466	40	24	24	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119269	10.1371/journal.pone.0119269	http://dx.doi.org/10.1371/journal.pone.0119269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785859	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500093
J	Chun, SM; Lee, JY; Choi, J; Lee, JH; Hwang, JJ; Kim, CS; Suh, YA; Jang, SJ				Chun, Sung-Min; Lee, Ji-Young; Choi, Jene; Lee, Je-Hwan; Hwang, Jung Jin; Kim, Chung-Soo; Suh, Young-Ah; Jang, Se Jin			Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; GROWTH-FACTOR RECEPTOR; DNA METHYLATION; C-MYC; LYMPHOMA; DEGRADATION; VORINOSTAT; THERAPY; BIOLOGY	Histone modification plays a pivotal role on gene regulation, as regarded as global epigenetic markers, especially in tumor related genes. Hence, chemical approaches targeting histone- modifying enzymes have emerged onto the main stage of anticancer drug discovery. Here, we investigated the therapeutic potentials and mechanistic roles of the recently developed histone deacetylase inhibitor, CG200745, in non-small cell lung cancer cells. Treatment with CG200745 increased the global level of histone acetylation, resulting in the inhibition of cell proliferation. ChIP-on-chip analysis with an H4K16ac antibody showed altered H4K16 acetylation on genes critical for cell growth inhibition, although decreased at the transcription start site of a subset of genes. Altered H4K16ac was associated with changes in mRNA expression of the corresponding genes, which were further validated in quantitative RT-PCR and western blotting assays. Our results demonstrated that CG200745 causes NSCLC cell growth inhibition through epigenetic modification of critical genes in cancer cell survival, providing pivotal clues as a promising chemotherapeutics against lung cancer.	[Chun, Sung-Min; Choi, Jene; Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Ji-Young; Hwang, Jung Jin; Suh, Young-Ah] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Lee, Je-Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Kim, Chung-Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Suh, YA (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.	ysuh@amc.seoul.kr; jangsejin@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014	Chun, Sung-Min/0000-0002-3357-1382	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI06C0868, HI10C2014]; Leading Foreign Research Institute Recruitment Program; Basic Research Promotion Fund; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2011-0030105, KRF-2008-355-E00006, NRF-2014R1A1A2006192]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Leading Foreign Research Institute Recruitment Program; Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)	Supported grants for the study were the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI06C0868, HI10C2014), Leading Foreign Research Institute Recruitment Program, Basic Research Promotion Fund, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2011-0030105, KRF-2008-355-E00006, NRF-2014R1A1A2006192). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079781; Dai Yan, 2008, Transl Oncogenomics, V3, P53; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ficner R, 2009, CURR TOP MED CHEM; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Hwang JJ, 2012, INVEST NEW DRUG, V30, P1434, DOI 10.1007/s10637-011-9718-1; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kim MJ, 2012, ANTICANCER RES, V32, P3161; Kouraklis G., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P477, DOI 10.2174/1568011023353921; Lai CJ, 2010, CANCER RES, V70, P3647, DOI 10.1158/0008-5472.CAN-09-3360; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Oh ET, 2012, INVEST NEW DRUG, V30, P435, DOI 10.1007/s10637-010-9568-2; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Paluszczak J, 2006, J APPL GENET, V47, P365, DOI 10.1007/BF03194647; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Sonnemann J, 2014, BRIT J CANCER, V110, P656, DOI 10.1038/bjc.2013.742; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhu JD, 2009, INT J BIOCHEM CELL B, V41, P147, DOI 10.1016/j.biocel.2008.09.003; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440	31	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119379	10.1371/journal.pone.0119379	http://dx.doi.org/10.1371/journal.pone.0119379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781604	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600061
J	Linke, SJ; Frings, A; Ren, L; Gomolka, A; Schumacher, U; Reimer, R; Hansen, NO; Jowett, N; Richard, G; Miller, RJD				Linke, Stephan J.; Frings, Andreas; Ren, Ling; Gomolka, Amadeus; Schumacher, Udo; Reimer, Rudolph; Hansen, Nils-Owe; Jowett, Nathan; Richard, Gisbert; Miller, R. J. Dwayne			A New Technology for Applanation Free Corneal Trephination: The Picosecond Infrared Laser (PIRL)	PLOS ONE			English	Article							EXCIMER-LASER; PERSPECTIVES; WAVELENGTH; ABLATION	The impact of using a Femtosecond laser on final functional results of penetrating keratoplasty is low. The corneal incisions presented here result from laser ablations with ultrafast desorption by impulsive vibrational excitation (DIVE). The results of the current study are based on the first proof-of-principle experiments using a mobile, newly introduced picosecond infrared laser system, and indicate that wavelengths in the mid-infrared range centered at 3 mu m are efficient for obtaining applanation-free deep cuts on porcine corneas.	[Linke, Stephan J.; Frings, Andreas; Gomolka, Amadeus; Richard, Gisbert] Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, D-20246 Hamburg, Germany; [Linke, Stephan J.] CareVis Clin Baviera Germany & Austria, D-20246 Hamburg, Germany; [Ren, Ling; Hansen, Nils-Owe; Jowett, Nathan; Miller, R. J. Dwayne] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf UKE, Dept Anat & Expt Morphol, D-20246 Hamburg, Germany; [Reimer, Rudolph] Univ Med Ctr Hamburg Eppendorf UKE, Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20246 Hamburg, Germany; [Jowett, Nathan] Univ Med Ctr Hamburg Eppendorf UKE, Dept Otorhinolaryngol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Frings, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Martinistr 52, D-20246 Hamburg, Germany.	afrings@uke.de		Jowett, Nate/0000-0002-5242-0264	European Research Council [ERC-adG-2011-291630]; CareVision/Clinica	European Research Council(European Research Council (ERC)European Commission); CareVision/Clinica	This study was funded by the European Research Council Advanced Investigator Grant "Miller: ERC-adG-2011-291630: SUREPIRL, Picosecond Infrared Laser for Scar Free Surgery with Preservation of Tissue Structure and Recognition of Tissue Type and Boundaries." CareVision/Clinica provided support in the form of salaries for authors Stephan J. Linke and Gisbert Richard, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amini-Nik S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013053; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Birnbaum F, 2011, OPHTHALMOLOGE, V108, P807, DOI 10.1007/s00347-011-2334-9; Birnbaum F, 2010, OPHTHALMOLOGE, V107, P186, DOI 10.1007/s00347-009-2092-0; Birnbaum F, 2013, GRAEF ARCH CLIN EXP, V251, P95, DOI 10.1007/s00417-012-2054-0; Bottcher A, 2013, LARYNGOSCOPE, V123, P2770, DOI 10.1002/lary.24124; Chamberlain WD, 2011, OPHTHALMOLOGY, V118, P486, DOI 10.1016/j.ophtha.2010.08.002; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Crotti C, 2013, INVEST OPHTH VIS SCI, V54, P3340, DOI 10.1167/iovs.12-10694; Franjic K, 2010, PHYS CHEM CHEM PHYS, V12, P5225, DOI 10.1039/c000359j; Franjic K, 2009, OPT EXPRESS, V17, P22937, DOI 10.1364/OE.17.022937; Joos K, 1996, P SOC PHOTO-OPT INS, V2673, P89, DOI 10.1117/12.240051; Maier P, 2012, CORNEA, V31, P963, DOI 10.1097/ICO.0b013e3182400048; NAUMANN GOH, 1993, KLIN MONATSBL AUGENH, V203, P252, DOI 10.1055/s-2008-1045677; Naydis I, 2011, OPHTHALMOLOGE, V108, P252, DOI 10.1007/s00347-010-2272-y; OSTERTAG M, 1995, P SOC PHOTO-OPT INS, V2391, P138, DOI 10.1117/12.209876; Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c; Peyrot DA, 2010, J REFRACT SURG, V26, P786, DOI 10.3928/1081597X-20100921-04; Plamann K, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084002; Reinhard T, 2011, OPHTHALMOLOGE, V108, P805, DOI 10.1007/s00347-011-2329-6; Seitz B, 2004, OPHTHALMOLOGE, V101, P478, DOI 10.1007/s00347-003-0900-5; Seitz B, 2011, OPHTHALMOLOGE, V108, P817, DOI 10.1007/s00347-011-2333-x; Seitz B, 1999, OPHTHALMOLOGY, V106, P1156, DOI 10.1016/S0161-6420(99)90265-8; STERN D, 1989, ARCH OPHTHALMOL-CHIC, V107, P587, DOI 10.1001/archopht.1989.01070010601038; Szentmary N, 2007, CURR EYE RES, V32, P953, DOI 10.1080/02713680701689781; Szentmary N, 2007, CORNEA, V26, P414, DOI 10.1097/ICO.0b013e3180303b16; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Walker R, 1997, J Biomed Opt, V2, P204, DOI 10.1117/12.268951	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120944	10.1371/journal.pone.0120944	http://dx.doi.org/10.1371/journal.pone.0120944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781907	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600192
J	Motta, SS; Cluzel, P; Aldana, M				Sandoval Motta, Santiago; Cluzel, Philippe; Aldana, Maximino			Adaptive Resistance in Bacteria Requires Epigenetic Inheritance, Genetic Noise, and Cost of Efflux Pumps	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; MAR OPERON; EVOLUTION; REPRESSOR	Adaptive resistance emerges when populations of bacteria are subjected to gradual increases of antibiotics. It is characterized by a rapid emergence of resistance and fast reversibility to the non-resistant phenotype when the antibiotic is removed from the medium. Recent work shows that adaptive resistance requires epigenetic inheritance and heterogeneity of gene expression patterns that are, in particular, associated with the production of porins and efflux pumps. However, the precise mechanisms by which inheritance and variability govern adaptive resistance, and what processes cause its reversibility remain unclear. Here, using an efflux pump regulatory network (EPRN) model, we show that the following three mechanisms are essential to obtain adaptive resistance in a bacterial population: 1) intrinsic variability in the expression of the EPRN transcription factors; 2) epigenetic inheritance of the transcription rate of EPRN associated genes; and 3) energetic cost of the efflux pumps activity that slows down cell growth. While the first two mechanisms acting together are responsible for the emergence and gradual increase of the resistance, the third one accounts for its reversibility. In contrast with the standard assumption, our model predicts that adaptive resistance cannot be explained by increased mutation rates. Our results identify the molecular mechanism of epigenetic inheritance as the main target for therapeutic treatments against the emergence of adaptive resistance. Finally, our theoretical framework unifies known and newly identified determinants such as the burden of efflux pumps that underlie bacterial adaptive resistance to antibiotics.	[Sandoval Motta, Santiago; Aldana, Maximino] UNAM, Inst Ciencias Fis, Cuernavaca, Morelos, Mexico; [Cluzel, Philippe] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Universidad Nacional Autonoma de Mexico; Harvard University	Aldana, M (corresponding author), UNAM, Inst Ciencias Fis, Cuernavaca, Morelos, Mexico.	max@fis.unam.mx	Aldana, Maximino/D-9372-2017	Aldana, Maximino/0000-0002-3419-6641	Programa de Doctorado en Ciencias Biomedicas-UNAM; Centro de Ciencias Genomicas-UNAM; Consejo Nacional de Ciencia y Tecnologia-Mexico [269040/220732]; Direccion General de Asuntos del Personal Academico-UNAM through the Programa de Apoyos para la Superacion del Personal Academico; Fundacion Mexico in Harvard; Consejo Nacional de Ciencia y Tecnologia [129471]	Programa de Doctorado en Ciencias Biomedicas-UNAM; Centro de Ciencias Genomicas-UNAM; Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM through the Programa de Apoyos para la Superacion del Personal Academico; Fundacion Mexico in Harvard; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	SS acknowledges the Programa de Doctorado en Ciencias Biomedicas-UNAM, Centro de Ciencias Genomicas-UNAM and Consejo Nacional de Ciencia y Tecnologia-Mexico for support though a PhD fellowship (269040/220732). MA acknowledges Direccion General de Asuntos del Personal Academico-UNAM financial support, through the Programa de Apoyos para la Superacion del Personal Academico for a sabbatical fellowship, and Fundacion Mexico in Harvard for the Antonio Madero 2011-2012 fellowship. This work was also partly supported by a Consejo Nacional de Ciencia y Tecnologia grant, number 129471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Barclay ML, 1992, ANTIMICROB AGENTS CH; Braoudaki M, 2004, J CLIN MICROBIOL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Cohen SP, 1989, ANTIMICROB AGENTS CH; Fernandez L, 2012, CLIN MICROBIOLOGY RE; GEORGE AM, 1983, J BACTERIOL, V155, P531, DOI 10.1128/JB.155.2.531-540.1983; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; Hermsen R, 2012, P NATL ACAD SCI USA, V109, P10775, DOI 10.1073/pnas.1117716109; Klaas M, 2009, BIOCH BIOPHYSICA ACT; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Levin BR, 2000, GENETICS, V154, P985; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lobner-Olesen A, 2005, CURRENT OPINION MICR; Lobner-Olesen A, 2003, PNAS; Low DA, 2001, INFECT IMMUN; Ma D, 1996, MOL MICROBIOL; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Mazzariol A, 2000, ANTIMICROB AGENTS CH; Nikaido H., 1996, J BACTERIOLOGY, V178; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oethinger M, 1998, ANTIMICROB AGENTS CH, V42, P2089, DOI 10.1128/AAC.42.8.2089; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pigliucci M, 2003, EVOLUTION, V57, P1455; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Rando OJ, 2007, CELL; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Sanchez-Romero MA, 2014, P NATL ACAD SCI US; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Toprak E, 2011, NAT GENET; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Webber MA, 2003, J ANTIMICROB CHEMOTH; Wood KB, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-48; Yu EW, 2003, J BACTERIOL	40	45	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118464	10.1371/journal.pone.0118464	http://dx.doi.org/10.1371/journal.pone.0118464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781931	gold, Green Published			2022-12-26	WOS:000351284600023
J	Wang, L; Wang, SM; Fu, XJ; Sun, L				Wang, Lu; Wang, Shumei; Fu, Xuejun; Sun, Li			Characteristics of an R-Phycoerythrin with Two gamma Subunits Prepared from Red Macroalga Polysiphonia urceolata	PLOS ONE			English	Article							ENERGY-TRANSFER; CRYSTAL-STRUCTURE; PHYCOBILISOMES; PURIFICATION; COMPLEX; ALGAE	An R-phycoerythrin (R-PE) was isolated by gel filtrations on Sepharose CL-4B and Sephadex G-150 from the phycobiliprotein extract of the marine red macroalga Polysiphonia urceolata Grev and further purified by ion exchange chromatography on DEAE-Sepharose Fast Flow. The purified R-PE showed three absorption peaks at 498 nm, 538 nm, 566 nm and one fluorescent emission maximum at 577 nm. Although the R-PE showed a single band on the examination by native PAGE, it exhibited two very close bands at pH about 4.7 in native isoelectric focusing (IEF). Polypeptide analysis of the R-PE demonstrated that it contained four chromophore-carrying subunits, alpha(18.2), beta(20.6),gamma(31.6) (gamma'),gamma(34.6) (gamma), and no color-less polypeptide; its subunit composition was 6 alpha(18.2):6 beta(20.6):1 gamma(31.6):2 gamma(34.6). The alpha and beta subunits were distributed within a acidic pH range from 5.0 to 6.0 in denaturing IEF and the. subunits were in a basic pH range from 7.6 to 8.1. These results reveal that the prepared R-PE may exist in two hexamers of. (alpha beta)(3) gamma(alpha beta)(3) gamma' and gamma(alpha beta)(3) gamma'(alpha beta)(3)gamma and that the R-PE participate in the rod domain assembly of P. urceolata phycobilisomes by stacking each of its trimer (alpha beta)(3) face-to-face with the aid of one gamma subunit (gamma or gamma').	[Wang, Lu; Fu, Xuejun; Sun, Li] Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China; [Wang, Shumei] Yantai Univ, Coll Photo Elect Informat Sci & Technol, Yantai, Peoples R China	Yantai University; Yantai University	Sun, L (corresponding author), Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China.	sunliytu@aliyun.com			National Natural Science Foundation of China [30571720, 40976083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work had been supported by the National Natural Science Foundation of China (30571720, 40976083). The authors have not obtained new funding since the subjects completed two years ago. Therefore, there are no current funding sources for this study and no funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Amersham Biosciences, 2006, HDB REF; Amersham Biosciences, 2007, HDB REF; Amersham Biosciences, 2000, AM BOISCH HDB, V18-1020-90; [Anonymous], [No title captured]; APT KE, 1993, J BIOL CHEM, V268, P16208; Bermejo R, 2003, J CHROMATOGR B, V790, P317, DOI 10.1016/S1570-0232(03)00168-5; Bienvenut WV, 2005, ACCELERATION IMPROVE, P225; Broadhurst AV, 1997, CURRENT PROTOCOLS PR; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; Coligan JE, 2003, CHEM ANAL CURRENT PR; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Galland-Irmouli AV, 2000, J CHROMATOGR B, V739, P117, DOI 10.1016/S0378-4347(99)00433-8; GANTT E, 1973, BIOCHIM BIOPHYS ACTA, V292, P858, DOI 10.1016/0005-2728(73)90036-4; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1986, BIOPHYS J, V49, P115, DOI 10.1016/S0006-3495(86)83616-5; HOLZWARTH AR, 1991, PHYSIOL PLANTARUM, V83, P518, DOI 10.1111/j.1399-3054.1991.tb00129.x; Jiang T, 2001, BIOPHYS J, V81, P1171, DOI 10.1016/S0006-3495(01)75774-8; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2005, J BIOTECHNOL, V116, P91, DOI 10.1016/j.jbiotec.2004.09.017; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Niu JF, 2006, PROTEIN EXPRES PURIF, V49, P23, DOI 10.1016/j.pep.2006.02.001; Ping W., 2000, PROGR PHYSL SCI, V31, P82; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Ritter S, 1997, PROTEIN PEPTIDE LETT, V4, P69; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Rossano R, 2003, J BIOTECHNOL, V101, P289, DOI 10.1016/S0168-1656(03)00002-6; Sidler W., 2004, MOL BIOL CYANOBACTER, P139; Simpson RJ, 2003, PROTEINS PROTEOMICS; SIMPSON RJ, 2004, PURIFYING PROTEINS P; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Su HN, 2010, PHOTOSYNTH RES, V106, P73, DOI 10.1007/s11120-010-9560-x; Sun L, 2004, J PHOTOCH PHOTOBIO B, V76, P1, DOI 10.1016/j.jphotobiol.2004.07.003; Sun L, 2003, J PHOTOCH PHOTOBIO B, V72, P45, DOI 10.1016/j.jphotobiol.2003.07.006; Sun L, 2003, IEEE J SEL TOP QUANT, V9, P177, DOI 10.1109/JSTQE.2003.812499; Sun L, 2000, PHOTOSYNTHETICA, V38, P601, DOI 10.1023/A:1012417725304; Sun L, 2009, HDB CYANOBACTERIA BI, P85; Sun L, 2011, J PHYCOL, V47, P1304, DOI 10.1111/j.1529-8817.2011.01067.x; Yu LH, 1990, ACTA BIOCH BIOPH SIN, V22, P221; [郑蔚然 ZHENG WeiranDING Yu-ting], 2008, [微生物学杂志, Journal of Mirobiology], V28, P70; Zimny-Arndt Ursula, 2009, V492, P65, DOI 10.1007/978-1-59745-493-3_4	44	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120333	10.1371/journal.pone.0120333	http://dx.doi.org/10.1371/journal.pone.0120333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781487	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600150
J	Chen, DZ; Koh, V; Sng, C; Aquino, MC; Chew, P				Chen, David Z.; Koh, Victor; Sng, Chelvin; Aquino, Maria C.; Chew, Paul			Complications and Outcomes of Primary Phacotrabeculectomy with Mitomycin C in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							LASER SUTURE LYSIS; ANGLE-CLOSURE GLAUCOMA; INTRAOCULAR-PRESSURE; CATARACT-EXTRACTION; LENS IMPLANTATION; TRABECULECTOMY; SURGERY; PHACOEMULSIFICATION; 5-FLUOROURACIL; MORPHOLOGY	Purpose To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome. Methods Retrospective review of 160 consecutive patients with POAG (n = 105) and PACG (n = 55), who underwent primary phacotrabeculectomy with MMC at the National University Hospital, Singapore, from January 1, 2008 to December 31, 2010. Data was collected using a standardized form that included patient demographic information, ocular characteristics and postoperative complications, including hypotony (defined as intraocular pressure < 6 mmHg), shallow anterior chamber (AC) and hyphema. Results The mean age +/- standard deviation (SD) of patients was 68.2 +/- 8.2 years. No patient lost light perception during duration of follow-up. 77% of the postoperative complications occurred within the first month only. The commonest complications were hypotony (n = 41, 25.6%), hyphema (n = 16, 10.0%) and shallow AC (n = 16, 10.0%). Five patients (3.1%) required reoperation for their complications. Early hypotony (defined as hypotony < 30 days postoperatively) was an independent risk factor for surgical failure (hazard ratio [HR], 5.1; 95% CI, 1.6-16.2; p = 0.01). Hypotony with another complication was also a risk factor for surgical failure (p < 0.02). Conclusions Hypotony, hyphema and shallow AC were the commonest postoperative complications in POAG and PACG patients after phacotrabeculectomy with MMC. Most complications were transient and self-limiting. Early hypotony within the first month was a significant risk factor for surgical failure.	[Chen, David Z.; Koh, Victor; Sng, Chelvin; Aquino, Maria C.; Chew, Paul] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Chen, David Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Chen, DZ (corresponding author), Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore.	dzychen18@gmail.com	Chen, David/ABF-6773-2020	Chen, David/0000-0002-2153-3100; Sng, Chelvin/0000-0002-9837-6019				Aykan U, 2007, J GLAUCOMA, V16, P240, DOI 10.1097/IJG.0b013e31802d6ded; Belyea DA, 1997, J GLAUCOMA, V6, P90; Benson SE, 2005, BMC OPHTHALMOL, V5, P5; Blackwell B, 2001, ARCH OPHTHALMOL-CHIC, V119, P1771; Budenz DL, 1999, OPHTHALMIC SURG LAS, V30, P367; Buys YM, 2008, OPHTHALMOLOGY, V115, P1130, DOI 10.1016/j.ophtha.2007.09.007; Casson RJ, 2001, J CATARACT REFR SURG, V27, P1854, DOI 10.1016/S0886-3350(01)01127-0; Chia WLA, 1998, AUST NZ J OPHTHALMOL, V26, P19, DOI 10.1046/j.1440-1606.1998.00074.x; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; Husain R, 2012, ARCH OPHTHALMOL-CHIC, V130, P165, DOI 10.1001/archophthalmol.2011.329; Kapetansky FM, 2003, J GLAUCOMA, V12, P316, DOI 10.1097/00061198-200308000-00005; Khamar MB, 2014, INDIAN J OPHTHALMOL, V62, P711, DOI 10.4103/0301-4738.136227; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; KUPIN TH, 1995, AM J OPHTHALMOL, V119, P30, DOI 10.1016/S0002-9394(14)73810-3; Law SK, 2009, AM J OPHTHALMOL, V148, P685, DOI 10.1016/j.ajo.2009.05.032; Murthy SK, 2006, CAN J OPHTHALMOL, V41, P51, DOI 10.1016/S0008-4182(06)80067-0; Nassiri N, 2008, CORNEA, V27, P889, DOI 10.1097/ICO.0b013e31817618b0; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ralli M, 2006, J GLAUCOMA, V15, P60, DOI 10.1097/01.ijg.0000195929.94922.a2; Rhee DJ, 1999, J CATARACT REFR SURG, V25, P546, DOI 10.1016/S0886-3350(99)80053-4; Shaarawy TM, 2009, GUIDELINES ON DESIGN; Shingleton BJ, 2001, J CATARACT REFR SURG, V27, P524, DOI 10.1016/S0886-3350(00)00641-6; Shingleton BJ, 2007, J CATARACT REFR SURG, V33, P1953, DOI 10.1016/j.jcrs.2007.06.039; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Sng CCA, 2011, EYE, V25, P619, DOI 10.1038/eye.2011.31; Tan YL, 2011, ARCH OPHTHALMOL-CHIC, V129, P987, DOI 10.1001/archophthalmol.2011.71; Tham CCY, 2008, OPHTHALMOLOGY, V115, P2167, DOI 10.1016/j.ophtha.2008.06.016; Wong JS, 1998, AUST NZ J OPHTHALMOL, V26, P283, DOI 10.1111/j.1442-9071.1998.tb01331.x	31	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118852	10.1371/journal.pone.0118852	http://dx.doi.org/10.1371/journal.pone.0118852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775362	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500045
J	Xie, J; Owen, T; Xia, K; Singh, AV; Tou, E; Li, LY; Arduini, B; Li, HM; Wan, LQ; Callahan, B; Wang, CY				Xie, Jian; Owen, Timothy; Xia, Ke; Singh, Ajay Vikram; Tou, Emiley; Li, Lingyun; Arduini, Brigitte; Li, Hongmin; Wan, Leo Q.; Callahan, Brian; Wang, Chunyu			Zinc Inhibits Hedgehog Autoprocessing LINKING ZINC DEFICIENCY WITH HEDGEHOG ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; TRACE-ELEMENTS; SPECTRUM; AUTISM; GENE; TRANSPORTER; ASTROCYTES	Zinc is an essential trace element with wide-ranging biological functions, whereas the Hedgehog (Hh) signaling pathway plays crucial roles in both development and disease. Here we show that there is a mechanistic link between zinc and Hh signaling. The upstream activator of Hh signaling, the Hh ligand, originates from Hh autoprocessing, which converts the Hh precursor protein to the Hh ligand. In an in vitro Hh autoprocessing assay we show that zinc inhibits Hh autoprocessing with a K-i of 2 mu M. We then demonstrate that zinc inhibits Hh autoprocessing in a cellular environment with experiments in primary rat astrocyte culture. Solution NMR reveals that zinc binds the active site residues of the Hh autoprocessing domain to inhibit autoprocessing, and isothermal titration calorimetry provided the thermodynamics of the binding. In normal physiology, zinc likely acts as a negative regulator of Hh autoprocessing and inhibits the generation of Hh ligand and Hh signaling. In many diseases, zinc deficiency and elevated level of Hh ligand co-exist, including prostate cancer, lung cancer, ovarian cancer, and autism. Our data suggest a causal relationship between zinc deficiency and the overproduction of Hh ligand.	[Xie, Jian; Wang, Chunyu] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Troy, NY 12180 USA; [Xia, Ke; Li, Lingyun; Wang, Chunyu] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Singh, Ajay Vikram; Wan, Leo Q.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Tou, Emiley; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Xie, Jian; Arduini, Brigitte; Wan, Leo Q.; Wang, Chunyu] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Owen, Timothy; Callahan, Brian] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; Wadsworth Center	Wang, CY (corresponding author), Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA.	wangc5@rpi.edu	Singh, Ajay/AAF-4414-2020; Wang, Chunyu/AAH-5952-2019; Li, Hongmin/ABI-2439-2020; Wan, Leo/D-7634-2016	Li, Hongmin/0000-0002-8684-5308; xia, ke/0000-0001-9699-9901; Wang, Chunyu/0000-0001-5165-7959; Wan, Leo/0000-0001-8371-5623; Arduini, Brigitte/0000-0002-8587-3518; Callahan, Brian/0000-0003-4826-0162; Tou, Emiley/0000-0003-2992-4269	National Institutes of Health (NIGMS) [R01GM081408]; Department of Defense [W81XWH-14-1-0155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081408] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081408 (NIGMS; to C. W.). This work was also supported in part through Department of Defense Grant W81XWH-14-1-0155 (to B. C.).	Abramoff MD., 2004, BIOPHOTONICS INT, V2004, P1; Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; Atwood SX, 2014, CANCER CELL, V25, P133, DOI 10.1016/j.ccr.2014.01.027; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Bjorklund G, 2013, ACTA NEUROBIOL EXP, V73, P225; Blnur N., 1986, CLIN CHEM, V32, P101; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Carvalho ML, 2007, SPECTROCHIM ACTA B, V62, P1004, DOI 10.1016/j.sab.2007.03.030; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Costello LC, 2011, J BIOL INORG CHEM, V16, P3, DOI 10.1007/s00775-010-0736-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Elder LM, 2008, J AUTISM DEV DISORD, V38, P1104, DOI 10.1007/s10803-007-0495-9; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118; Gumulec J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099790; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hessels AM, 2015, METALLOMICS, V7, P258, DOI 10.1039/c4mt00179f; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kolenko V, 2013, NAT REV UROL, V10, P219, DOI 10.1038/nrurol.2013.43; Kubala-Kukus A, 1999, NUCL INSTRUM METH B, V150, P193, DOI 10.1016/S0168-583X(98)01057-X; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; McGinnis WR, 2005, ALTERN THER HEALTH M, V11, P19; Memon AUR, 2007, CLIN CHIM ACTA, V379, P66, DOI 10.1016/j.cca.2006.12.009; Mongin AA, 2011, AM J PHYSIOL-CELL PH, V301, pC814, DOI 10.1152/ajpcell.00035.2011; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Owen TS, 2015, CHEMBIOCHEM, V16, P55, DOI 10.1002/cbic.201402421; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Priya MDL, 2011, BIOL TRACE ELEM RES, V142, P148, DOI 10.1007/s12011-010-8766-2; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Segawa S, 2014, LIFE SCI, V94, P137, DOI 10.1016/j.lfs.2013.11.007; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; White S, 2009, NEUROPSYCHOLOGIA, V47, P1274, DOI 10.1016/j.neuropsychologia.2009.01.012; Xia YP, 2012, NEUROSCIENCE, V209, P1, DOI 10.1016/j.neuroscience.2012.02.019; Xie J, 2014, BIOMOL NMR ASSIGN, V8, P279, DOI 10.1007/s12104-013-9500-8; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang LL, 2012, BIOL TRACE ELEM RES, V148, P7, DOI 10.1007/s12011-012-9336-6; Zhang LY, 2009, MOL BIOSYST, V5, P644, DOI 10.1039/b903144h; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	64	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11591	11600		10.1074/jbc.M114.623264	http://dx.doi.org/10.1074/jbc.M114.623264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787080	Green Published, hybrid			2022-12-26	WOS:000353719400034
J	Yang, H; Chen, HH; Guo, HW; Li, W; Tang, JM; Xu, BJ; Sun, MN; Ding, GX; Jiang, L; Cui, D; Zheng, XQ; Duan, Y				Yang, Hui; Chen, Huanhuan; Guo, Hongwei; Li, Wen; Tang, Jinmei; Xu, Bojin; Sun, Minne; Ding, Guoxian; Jiang, Lin; Cui, Dai; Zheng, Xuqin; Duan, Yu			Molecular Mechanisms of 2, 3', 4, 4', 5-Pentachlorobiphenyl-Induced Thyroid Dysfunction in FRTL-5 Cells	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER EXPRESSION; POLYCHLORINATED BIPHENYL CONGENERS; GENE-EXPRESSION; ACTIVATION; THYROTROPIN; EXPOSURE; PROLIFERATION; CONTAMINANTS; CONSEQUENCES; INHIBITION	Polychlorinated biphenyls (PCBs) can severely interfere with multiple animals and human systems. To explore the molecular mechanisms underlying 2, 30, 4, 40, 5-pentachlorobiphenyl (PCB118)-induced thyroid dysfunction, Fischer rat thyroid cell line-5(FRTL-5) cells were treated with either different concentrations of PCB118 or dimethyl sulfoxide (DMSO). The effects of PCB118 on FRTL-5 cells viability and apoptosis were assessed by using a Cell Counting Kit-8 assay and apoptosis assays, respectively. Quantitative real-time polymerase chain reaction was used to quantify protein kinase B (Akt), Forkhead box protein O3a (FoxO3a), and sodium/iodide symporter (NIS) mRNA expression levels. Western blotting was used to detect Akt, phospho-Akt (p-Akt), FoxO3a, phospho-FoxO3a (p-FoxO3a), and NIS protein levels. Luciferase reporter gene technology was used to detect the transcriptional activities of FoxO3a and NIS promoters. The effects of the constitutively active Akt (CA-Akt) and dominant-negative Akt (DN-Akt) plasmids on p-Akt, p-FoxO3a, and NIS levels were examined in PCB118-treated FRTL-5 cells. The effects of FoxO3a siRNA on FoxO3a, p-FoxO3a, and NIS protein levels were examined in the PCB118-treated FRTL-5 cells. The effects of pcDNA3 (plsmid vectors designed for high-level stable and transient expression in mammalian host)-FoxO3a on NIS promoter activity were examined in the PCB118-treated FRTL-5 cells. Our results indicated that relatively higher PCB118 concentrations can inhibit cell viability in a concentration-and time-dependent manner. Akt, p-Akt, and p-FoxO3a protein or mRNA levels increased significantly in PCB118-treated groups and NIS protein and mRNA levels decreased considerably compared with the control groups. FoxO3a promoter activity increased significantly, whereas NIS promoter activity decreased. These effects on p-FoxO3a and NIS could be decreased by the DN-Akt plasmid, enhanced by the CA-Akt plasmid, and blocked by FoxO3a siRNA. The overexpressed FoxO3a could reduce NIS promoter activity. Our results suggested that PCB118 induces thyroid cell dysfunction through the Akt/FoxO3a/NIS signaling pathway.	[Yang, Hui; Chen, Huanhuan; Guo, Hongwei; Li, Wen; Tang, Jinmei; Xu, Bojin; Sun, Minne; Jiang, Lin; Cui, Dai; Zheng, Xuqin; Duan, Yu] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Ding, Guoxian] Nanjing Med Univ, Affiliated Hosp 1, Dept Gerontol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Duan, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	duanyu@medmail.com.cn	Cui, Dai/ABD-7918-2021; tang, jinmei/AFL-9035-2022; tang, jinmei/AAG-9650-2022	Cui, Dai/0000-0001-5534-9558; 	Natural Science Foundation of China (NSFC) [81170726]; Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [20110312]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundation of China (NSFC 81170726), Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu 2011), and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (20110312). The project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anati L, 2010, TOXICOL APPL PHARM, V249, P166, DOI 10.1016/j.taap.2010.09.004; ARNOLD DL, 1995, FOOD CHEM TOXICOL, V33, P457, DOI 10.1016/0278-6915(95)00018-W; Bauer TM, 2014, PHARMACOL THERAPEUT, P8; Bloom MS, 2003, ENVIRON RES, V93, P52, DOI 10.1016/S0013-9351(02)00085-3; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dal Col J, 2008, BLOOD, V111, P5142, DOI 10.1182/blood-2007-07-103481; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Golden R, 2009, CRIT REV TOXICOL, V39, P299, DOI 10.1080/10408440802291521; Guerrieri F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.302; Howard AS, 2003, TOXICOL APPL PHARM, V190, P72, DOI 10.1016/S0041-008X(03)00156-X; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kawashima A, 2011, ENDOCRINOLOGY, V152, P1702, DOI 10.1210/en.2010-1132; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Kogai T, 2008, J ENDOCRINOL, V199, P243, DOI [10.1677/JOE-08-0333, 10.1677/JOE-08-0333e]; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Liu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037096; Liu YY, 2012, ENDOCR-RELAT CANCER, V19, P291, DOI 10.1530/ERC-11-0288; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031729; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MCFARLAND VA, 1989, ENVIRON HEALTH PERSP, V81, P225, DOI 10.2307/3430833; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Merritt RL, 2007, J TOXICOL ENV HEAL A, V70, P19, DOI 10.1080/15287390600748807; Ohashi E, 2006, J VET MED SCI, V68, P797, DOI 10.1292/jvms.68.797; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Pocar P, 2006, TOXICOL SCI, V89, P408, DOI 10.1093/toxsci/kfj042; Portigal CL, 2002, TOXICOL APPL PHARM, V179, P185, DOI 10.1006/taap.2002.9371; Rankouhi TR, 2004, TOXICOL SCI, V81, P90, DOI 10.1093/toxsci/kfh176; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rolland RM, 2000, J WILDLIFE DIS, V36, P615, DOI 10.7589/0090-3558-36.4.615; Rosich L, 2014, ONCOTARGET, V5, P6788, DOI 10.18632/oncotarget.2253; Sanchez-Alonso JA, 2003, TOXICOL LETT, V144, P337, DOI 10.1016/S0378-4274(03)00238-8; Sastre-Perona A, 2014, MOL ENDOCRINOL, V28, P681, DOI 10.1210/me.2013-1377; Serrano-Nascimento C, 2014, ENDOCRINOLOGY, V155, P1145, DOI 10.1210/en.2013-1665; Tang JM, 2013, EXP TOXICOL PATHOL, V65, P989, DOI 10.1016/j.etp.2013.02.001; Tarkowski S, 1996, Int J Occup Med Environ Health, V9, P1; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Venkatesha VA, 2010, TOXICOL LETT, V196, P110, DOI 10.1016/j.toxlet.2010.04.005; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Weidinger C, 2011, J CLIN ENDOCR METAB, V96, pE1361, DOI 10.1210/jc.2010-2453; Zaballos MA, 2008, MOL ENDOCRINOL, V22, P1183, DOI 10.1210/me.2007-0093; Zhao GF, 2009, SCI TOTAL ENVIRON, V407, P4831, DOI 10.1016/j.scitotenv.2009.05.031; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679	50	12	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120133	10.1371/journal.pone.0120133	http://dx.doi.org/10.1371/journal.pone.0120133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789747	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400132
J	Akib, NAM; Tam, BM; Phumee, P; Abidin, MZ; Tamadoni, S; Mather, PB; Nor, SAM				Akib, Noor Adelyna Mohammed; Tam, Bui Minh; Phumee, Preeda; Abidin, Muchlisin Zainal; Tamadoni, Saied; Mather, Peter B.; Nor, Siti Azizah Mohd			High Connectivity in Rastrelliger kanagurta: Influence of Historical Signatures and Migratory Behaviour Inferred from mtDNA Cytochrome b	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MARINE FISHES; DEMOGRAPHIC HISTORY; THUNNUS-ALBACARES; SOUTHEAST-ASIA; YELLOWFIN TUNA; SEA LEVELS; DIVERSITY; GROWTH; DIFFERENTIATION	Phylogeographic patterns and population structure of the pelagic Indian mackerel, Rastrelliger kanagurta were examined in 23 populations collected from the Indonesian-Malaysian Archipelago (IMA) and the West Indian Ocean (WIO). Despite the vast expanse of the IMA and neighbouring seas, no evidence for geographical structure was evident. An indication that R. kanagurta populations across this region are essentially panmictic. This study also revealed that historical isolation was insufficient for R. kanagurta to attain migration drift equilibrium. Two distinct subpopulations were detected between the WIO and the IMA (and adjacent populations); interpopulation genetic variation was high. A plausible explanation for the genetic differentiation observed between the IMA and WIO regions suggest historical isolation as a result of fluctuations in sea levels during the late Pleistocene. This occurrence resulted in the evolution of a phylogeographic break for this species to the north of the Andaman Sea.	[Akib, Noor Adelyna Mohammed] Univ Sains Malaysia, Ctr Global Sustainabil Studies, George Town, Malaysia; [Tam, Bui Minh] Can Tho Univ, Coll Aquaculture & Fisheries, Can Tho City, Vietnam; [Phumee, Preeda] Rajamangala Univ Technol, Fac Sci & Fisheries & Technol, Trang, Thailand; [Abidin, Muchlisin Zainal] Univ Syiah Kuala, Fac Marine & Fishery, Dept Aquaculture, Jl T Nyak Arief Darussal, Banda Aceh, Indonesia; [Tamadoni, Saied] Persian Gulf & Oman Sea Ecol Res Inst, Bandar Abbass, Iran; [Mather, Peter B.] Queensland Univ Technol, Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Ctr Marine & Coastal Studies, George Town, Malaysia	Universiti Sains Malaysia; Can Tho University; Rajamangala University of Technology Thanyaburi; Universitas Syiah Kuala; Queensland University of Technology (QUT); Universiti Sains Malaysia; Universiti Sains Malaysia	Akib, NAM (corresponding author), Univ Sains Malaysia, Ctr Global Sustainabil Studies, George Town, Malaysia.	adelyna@usm.my	Muchlisin, Zainal A./H-9599-2019; Muchlisin, Zainal Abidin/E-2317-2015; Nor, Siti Azizah Mohd/A-8275-2011	Muchlisin, Zainal A./0000-0002-0858-1853; Muchlisin, Zainal Abidin/0000-0002-0858-1853; Tamadoni Jahromi, Saeid/0000-0001-9245-8745	Universiti Sains Malaysia [1001/PBIOLOGI/815051, 1001/PPANTAI/844103]	Universiti Sains Malaysia(Universiti Sains Malaysia)	Universiti Sains Malaysia funded this project under the Research University Grant (1001/PBIOLOGI/815051) and the Postgraduate Research Grant Scheme (1001/PPANTAI/844103).	Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Ahmad Faisal G, 2012, ASIAN J BIOL BIOTECH, V1, pe100; Arnason U, 1996, MOL BIOL EVOL, V13, P407, DOI 10.1093/oxfordjournals.molbev.a025599; Arnaud S, 1999, MAR BIOL, V135, P699, DOI 10.1007/s002270050671; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bird MI, 2006, PALAEOGEOGR PALAEOCL, V241, P531, DOI 10.1016/j.palaeo.2006.05.003; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Cardenas L, 2005, MOL PHYLOGENET EVOL, V35, P496, DOI 10.1016/j.ympev.2005.01.011; Chen CA, 2004, MAR BIOTECHNOL, V6, P312, DOI 10.1007/s10126-003-0028-2; COLLETTE BB, 1984, FISH B-NOAA, V82, P545; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Darlina MN, 2011, GENET MOL RES, V10, P2078, DOI 10.4238/vol10-3gmr1249; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Frankel OH, 1981, CONSERVATION EVOLUTI; Franklin I.R., 1980, CONSERVATION BIOL EV; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Han ZQ, 2008, AFR J BIOTECHNOL, V7, P1774; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Jayasankar P., 2004, Asian Fisheries Science, V17, P201; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Mansor MI, 1996, FISHERIES B, V99; Mansor MI, 1989, FISHERIES B, V59; MCMILLAN WO, 1995, P ROY SOC B-BIOL SCI, V260, P229, DOI 10.1098/rspb.1995.0085; Menezes Maria R., 1995, Indian Journal of Fisheries, V40, P135; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nelson JS, 2000, MAR BIOL, V137, P727, DOI 10.1007/s002270000379; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; O'Reilly PT, 1998, ANIM GENET, V29, P363, DOI 10.1046/j.1365-2052.1998.295359.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; POGSON GH, 1995, GENETICS, V139, P375; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D., 2004, COLLAPSE VER 1 2 TOO; Rambaut A., 2007, TRACER V1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; Rousset F, 1997, GENETICS, V145, P1219; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Schneider S, 1999, GENETICS, V152, P1079; SCOLES DR, 1993, FISH B-NOAA, V91, P690; Shankar D, 2002, PROG OCEANOGR, V52, P63, DOI 10.1016/S0079-6611(02)00024-1; SLATKIN M, 1991, GENETICS, V129, P555; Sun P, 2012, BIOCHEM SYST ECOL, V43, P54, DOI 10.1016/j.bse.2012.02.028; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Tjia H.D., 1996, TECTONIC EVOLUTION S, V106, P291, DOI DOI 10.1144/GSL.SP.1996.106.01.19; Tzeng TD, 2007, ZOOL STUD, V46, P656; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang L, 2011, INT J MOL SCI, V12, P4378, DOI 10.3390/ijms12074378; WARD RD, 1994, REV FISH BIOL FISHER, V4, P300, DOI 10.1007/BF00042907; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; Ward Robert D., 2002, P200, DOI 10.1002/9780470693803.ch9; Wright S, 1931, GENETICS, V16, P0097; Zhang JB, 2006, ICES J MAR SCI, V63, P693, DOI 10.1016/j.icesjms.2006.01.004	77	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119749	10.1371/journal.pone.0119749	http://dx.doi.org/10.1371/journal.pone.0119749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786216	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500128
J	Kriticos, DJ; Ota, N; Hutchison, WD; Beddow, J; Walsh, T; Tay, WT; Borchert, DM; Paula-Moreas, SV; Czepak, C; Zalucki, MP				Kriticos, Darren J.; Ota, Noboru; Hutchison, William D.; Beddow, Jason; Walsh, Tom; Tay, Wee Tek; Borchert, Daniel M.; Paula-Moreas, Silvana V.; Czepak, Cecilia; Zalucki, Myron P.			The Potential Distribution of Invading Helicoverpa armigera in North America: Is It Just a Matter of Time?	PLOS ONE			English	Article							NEW-SOUTH-WALES; HELIOTHIS-PUNCTIGERA WALLENGREN; LIGHT-TRAP DATA; LEPIDOPTERA-NOCTUIDAE; HUBNER LEPIDOPTERA; HOST-PLANT; COTTON BOLLWORM; INSECTICIDE RESISTANCE; SPRING EMERGENCE; SPP. LEPIDOPTERA	Helicoverpa armigera has recently invaded South and Central America, and appears to be spreading rapidly. We update a previously developed potential distribution model to highlight the global invasion threat, with emphasis on the risks to the United States. The continued range expansion of H. armigera in Central America is likely to change the invasion threat it poses to North America qualitatively, making natural dispersal from either the Caribbean islands or Mexico feasible. To characterise the threat posed by H. armigera, we collated the value of the major host crops in the United States growing within its modelled potential range, including that area where it could expand its range during favourable seasons. We found that the annual value of crops that would be exposed to H. armigera totalled approximately US$ 78 billion p.a., with US$ 843 million p.a. worth growing in climates that are optimal for the pest. Elsewhere, H. armigera has developed broad-spectrum pesticide resistance; meaning that if it invades the United States, protecting these crops from significant production impacts could be challenging. It may be cost-effective to undertake preemptive biosecurity activities such as slowing the spread of H. armigera throughout the Americas, improving the system for detecting H. armigera, and methods for rapid identification, especially distinguishing between H. armigera, H. zea and potential H. armigera x H. zea hybrids. Developing biological control programs, especially using inundative techniques with entomopathogens and parasitoids could slow the spread of H. armigera, and reduce selective pressure for pesticide resistance. The rapid spread of H. armigera through South America into Central America suggests that its spread into North America is a matter of time. The likely natural dispersal routes preclude aggressive incursion responses, emphasizing the value of preparatory communication with agricultural producers in areas suitable for invasion by H. armigera.	[Kriticos, Darren J.; Walsh, Tom; Tay, Wee Tek] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.; Zalucki, Myron P.] Univ Queensland, Fac Sci, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Ota, Noboru] CSIRO, Wembley, WA, Australia; [Hutchison, William D.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Beddow, Jason] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Borchert, Daniel M.] Plant Epidemiol & Risk Anal Lab, Anim & Plant Hlth Inspect Service, Plant Protect & Quarantine, Ctr Plant Hlth Sci & Technol, Raleigh, NC USA; [Paula-Moreas, Silvana V.] Embrapa Cerrados, Planaltina, DF, Brazil; [Czepak, Cecilia] Univ Fed Goias, Escola Agron & Engn Alimentos, BR-131 Goiania, Go, Brazil	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Goias	Kriticos, DJ (corresponding author), CSIRO, GPO Box 1700, Canberra, ACT, Australia.	darren.kriticos@csiro.au	Walsh, Thomas K/C-1263-2009; Tay, Wee Tek/C-1818-2008; Ota, Noboru/ABE-4698-2020; Kriticos, Darren J/A-4170-2008; Zalucki, Myron P/G-7983-2012; Tay, Wee Tek/GPF-6142-2022; czepak, cecilia/ABI-8498-2020	Walsh, Thomas K/0000-0001-8425-0135; Tay, Wee Tek/0000-0002-8451-0811; Kriticos, Darren J/0000-0003-2599-8105; Zalucki, Myron P/0000-0001-9603-7577; Tay, Wee Tek/0000-0002-8451-0811; czepak, cecilia/0000-0002-7508-7986; , Noboru/0000-0002-8759-9030; Hutchison, William D./0000-0001-9605-2996	Cotton Inc.; Commonwealth Scientific and Industrial Research Organisation; University of Queensland	Cotton Inc.; Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Queensland(University of Queensland)	DJK and MPZ were partly financially supported by Cotton Inc., but otherwise were supported by their employers, the Commonwealth Scientific and Industrial Research Organisation and The University of Queensland respectively with non-specific funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp PGG, 1991, HELIOTHIS RES METHOD, P90, DOI DOI 10.1007/978-1-4612-3016-8_8; Bai Lixin, 1997, Acta Phytophylacica Sinica, V24, P1; Baker GH, 2011, B ENTOMOL RES, V101, P9, DOI 10.1017/S0007485310000106; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bues R, 2005, CROP PROT, V24, P814, DOI 10.1016/j.cropro.2005.01.006; CABI, 1993, HEL ARM HUBN; CABI, 2013, HEL ARM HUBN; COAKER T. H., 1959, BULL ENT RES, V50, P487, DOI 10.1017/S0007485300053062; Correa-Ferreira BS, 2014, INIMIGOS NATURAIS HE, P80; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Dosdall L, 2001, ORIGINS INFESTATIONS, P95; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Duffield SJ, 2005, AUST J ENTOMOL, V44, P316, DOI 10.1111/j.1440-6055.2005.00486.x; EMBRAPA, 2013, NOT TECN RES TRAB IN, DOI 10.13140/RG.2.1.294667685; EVANS D. E., 1964, Empire Cotton Growing Review, V41, P202; FARROW RA, 1987, AUST J ZOOL, V35, P1, DOI 10.1071/ZO9870001; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; FITT GP, 1990, J ECON ENTOMOL, V83, P1827, DOI 10.1093/jee/83.5.1827; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Ge F, 2005, ENTOMOL EXP APPL, V116, P1, DOI 10.1111/j.1570-7458.2005.00305.x; GREGG PC, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P151; Hardwick D. F., 1965, MEM ENTOMOL SOC CAN, V97, P5, DOI DOI 10.4039/ENTM9740FV; HMIMINA M, 1993, J APPL ENTOMOL, V116, P273, DOI 10.1111/j.1439-0418.1993.tb01196.x; Hutchison W., 2007, PLANT HLTH PROGR, DOI [10.1094/PHP-2007-0719-02-RV, DOI 10.1094/PHP-2007-0719-02-RV]; Jadhav D. R., 2013, Asian Journal of Agricultural Sciences, V5, P40; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 2001, APPL ENTOMOL ZOOL, V36, P427, DOI 10.1303/aez.2001.427; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lammers J. W., 2007, REPORT PEST RISK ANA; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; LINGREN PD, 1994, ENVIRON ENTOMOL, V23, P562, DOI 10.1093/ee/23.3.562; Liu ZD, 2010, ENVIRON ENTOMOL, V39, P552, DOI 10.1603/EN09129; Lu ZZ, 2013, J PEST SCI, V86, P695, DOI 10.1007/s10340-013-0517-7; Maelzer D, 1996, B ENTOMOL RES, V86, P547, DOI 10.1017/S0007485300039341; Maelzer DA, 1999, B ENTOMOL RES, V89, P455, DOI 10.1017/S0007485399000590; Maelzer DA, 2000, B ENTOMOL RES, V90, P133, DOI 10.1017/S0007485300000249; Manjunath TM, 1989, INDIA ASSESSMENT THE; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Matthews M, 1999, HELIOTHINE MOTHS AUS; Michael PJ, 1980, ENTOMOLOGICAL REV CO; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; Mironidis GK, 2010, ENVIRON ENTOMOL, V39, P1068, DOI 10.1603/EN09148; Morey AC, 2012, ENVIRON ENTOMOL, V41, P172, DOI 10.1603/EN11026; Murray DAH, 1991, INVESTIGATIONS DEV S; Nibouche S, 1998, ENTOMOL EXP APPL, V87, P271, DOI 10.1023/A:1003234203159; North American Plant Protection Organization, 2014, DET OLD WORLD BOLLW; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Perkins LE, 2010, B ENTOMOL RES, V100, P591, DOI 10.1017/S0007485309990654; Perkins LE, 2009, ARTHROPOD-PLANT INTE, V3, P173, DOI 10.1007/s11829-009-9069-4; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; Rochester WA, 2002, COMPUT ELECTRON AGR, V35, P139, DOI 10.1016/S0168-1699(02)00015-7; Rochester WA, 1996, ECOL MODEL, V86, P151, DOI 10.1016/0304-3800(95)00043-7; ROOME RE, 1979, B ENTOMOL RES, V69, P149, DOI 10.1017/S0007485300017983; Schellhorn NA, 2008, AUST J EXP AGR, V48, P1549, DOI 10.1071/EA08112; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Sharma H.C., 2005, HELIOTHIS HELICOVERP; Shimizu K, 2006, APPL ENTOMOL ZOOL, V41, P151, DOI 10.1303/aez.2006.151; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Sisterson MS, 2005, J ECON ENTOMOL, V98, P1751, DOI 10.1603/0022-0493-98.6.1751; Soleimannejad S, 2010, J ECON ENTOMOL, V103, P1420, DOI 10.1603/EC10022; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; TOPPER CP, 1987, B ENTOMOL RES, V77, P525, DOI 10.1017/S0007485300012013; Torres-Vila LM, 2002, CROP PROT, V21, P1003, DOI 10.1016/S0261-2194(02)00081-9; Venette R. C., 2003, MINIRISK ASSESSMENT; Westbrook JK, 1999, AGR FOREST METEOROL, V97, P263, DOI 10.1016/S0168-1923(99)00071-4; WILSON AGL, 1979, B ENTOMOL RES, V69, P97, DOI 10.1017/S0007485300017934; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu Kongming, 2000, Acta Phytophylacica Sinica, V27, P23; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; You L, 2014, SPATIAL PRODUCTION A; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; ZALUCKI MP, 1994, AUST J ZOOL, V42, P329, DOI 10.1071/ZO9940329; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zalucki MP, 2009, AUST J ENTOMOL, V48, P85, DOI 10.1111/j.1440-6055.2009.00690.x; Zhou XF, 2000, ENVIRON ENTOMOL, V29, P1289, DOI 10.1603/0046-225X-29.6.1289; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	92	131	142	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119618	10.1371/journal.pone.0119618	http://dx.doi.org/10.1371/journal.pone.0119618			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786260	Green Published, gold			2022-12-26	WOS:000352138500121
J	Reguzova, A; Antonets, D; Karpenko, L; Ilyichev, A; Maksyutov, R; Bazhan, S				Reguzova, Alena; Antonets, Denis; Karpenko, Larisa; Ilyichev, Alexander; Maksyutov, Rinat; Bazhan, Sergei			Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HLA CLASS-I; DNA VACCINES; ANTIVIRAL PROTECTION; MEMBRANE-PROTEIN; CYTOPLASMIC TAIL; FLANKING REGION; DENDRITIC CELLS; LIMP-II; ANTIGEN	A successful HIV vaccine in addition to induction of antibody responses should elicit effective T cell responses. Here we described possible strategies for rational design of T-cell vaccine capable to induce high levels of both CD4+ and CD8+ T-cell responses. We developed artificial HIV-1 polyepitope T-cell immunogens based on the conserved natural CD8+ and CD4+ T cell epitopes from different HIV-1 strains and restricted by the most frequent major human leukocyte antigen (HLA) alleles. Designed immunogens contain optimized core polyepitope sequence and additional "signal" sequences which increase epitope processing and presentation to CD8+ and CD4+ T-lymphocytes: N-terminal ubiquitin, N-terminal signal peptide and C-terminal tyrosine motif of LAMP-1 protein. As a result we engineered three T cell immunogens - TCI-N, TCI-N2, and TCI-N3, with different combinations of signal sequences. All designed immunogens were able to elicit HIV-specific CD4+ and CD8+ T cell responses following immunization. Attachment of either ubiquitin or ER-signal/LAMP-1 sequences increased both CD4+ and CD8+ mediated HIV-specific T cell responses in comparison with polyepitope immunogen without any additional signal sequences. Moreover, TCI-N3 polyepitope immunogen with ubiquitin generated highest magnitude of HIV-specific CD4+ and CD8+ T cell responses in our study. Obtained data suggests that attachment of signal sequences targeting polyepitope immunogens to either MHC class I or MHC class II presentation pathways may improve immunogenicity of T-cell vaccines. These results support the strategy of the rational T cell immunogen design and contribute to the development of effective HIV-1 vaccine.	[Reguzova, Alena; Antonets, Denis; Karpenko, Larisa; Ilyichev, Alexander; Maksyutov, Rinat; Bazhan, Sergei] State Res Ctr Virol & Biotechnol Vector, Koltsov 630559, Novosibirsk Reg, Russia	State Research Center of Virology & Biotechnology VECTOR	Bazhan, S (corresponding author), State Res Ctr Virol & Biotechnol Vector, Koltsov 630559, Novosibirsk Reg, Russia.	bazhan@vector.nsc.ru	Karpenko, Larisa Ivanovna/A-9682-2014; Antonets, Denis V/N-2549-2013; Antonets, Denis/AAF-5359-2019; Ilyichev, Alexander/AAT-9390-2020; Ilyicheva, Tatyana N./B-1327-2012; Bazhan, Sergei I/A-5774-2014	Antonets, Denis V/0000-0002-1823-9701; Antonets, Denis/0000-0002-1823-9701; Ilyichev, Alexander/0000-0001-5356-0843; Ilyicheva, Tatyana N./0000-0002-2354-7688; Bazhan, Sergei I/0000-0002-6016-4002; Karpenko, Larisa/0000-0003-4365-8809	Russian Foundation for Basic Research [12-04-00857-a]; Russian Science Foundation [14-14-00660]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The part of work concerning immunogens design and DNA vaccine construction was supported by grant 12-04-00857-a from Russian Foundation for Basic Research (www.rfbr.ru). The study of the HIV-specific immune response and data analysis were supported by Russian Science Foundation grant 14-14-00660 (www.rscf.ru).	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Andersson HA, 2004, MOL THER, V10, P432, DOI 10.1016/j.ymthe.2004.05.035; [Anonymous], 2014, R LANG ENV STAT COMP; Anton LC, 1997, J IMMUNOL, V158, P2535; Antonets DV, 2010, MOL BIOL+, V44, P119, DOI 10.1134/S0026893310010152; Antonets Denis V, 2013, BMC Res Notes, V6, P407, DOI 10.1186/1756-0500-6-407; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bauer R, 2006, J ALLERGY CLIN IMMUN, V118, P269, DOI 10.1016/j.jaci.2006.03.033; Bazhan SI, 2010, MOL IMMUNOL, V47, P1507, DOI 10.1016/j.molimm.2010.01.020; Bazhan SI, 2004, VACCINE, V22, P1672, DOI 10.1016/j.vaccine.2003.09.048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Bonini C, 2001, J IMMUNOL, V166, P5250, DOI 10.4049/jimmunol.166.8.5250; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Cardinaud S, 2009, AIDS, V23, P1945, DOI 10.1097/QAD.0b013e32832fae88; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Dennes A, 2002, J BIOL CHEM, V277, P12288, DOI 10.1074/jbc.M112295200; Esparza J, 2012, EXPERT REV VACCINES, V11, P539, DOI [10.1586/ERV.12.21, 10.1586/erv.12.21]; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRANT EP, 1995, J IMMUNOL, V155, P3750; Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946; Hanke T, 2011, EUR J IMMUNOL, V41, P3390, DOI 10.1002/eji.201190072; Haucke V, 2003, DEV CELL, V4, P153, DOI 10.1016/S1534-5807(03)00026-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Ji HX, 1999, HUM GENE THER, V10, P2727, DOI 10.1089/10430349950016474; Karpenko LI, 2007, VACCINE, V25, P4312, DOI 10.1016/j.vaccine.2007.02.058; Karpenko LI, 2014, EXPERT REV VACCINES, V13, P155, DOI 10.1586/14760584.2014.861748; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Koup RA, 2011, COLD SPRING HARBOR P, V1, DOI [10.1101/cshperspect.a009316, DOI 10.1101/CSHPERSPECT.A009316]; LALVANI A, 1994, RES IMMUNOL, V145, P461, DOI 10.1016/S0923-2494(94)80177-0; Leitner WW, 2003, J CLIN INVEST, V112, P22, DOI 10.1172/JCI200319069; Li FS, 2007, CURR HIV RES, V5, P97, DOI 10.2174/157016207779316260; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; OGATA S, 1994, J BIOL CHEM, V269, P5210; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RAMMENSEE HG, 1993, CURR OPIN IMMUNOL, V5, P35, DOI 10.1016/0952-7915(93)90078-7; Reuter MA, 2012, CYTOKINE GROWTH F R, V23, P181, DOI 10.1016/j.cytogfr.2012.05.005; Rodriguez F, 1998, J VIROL, V72, P5174, DOI 10.1128/JVI.72.6.5174-5181.1998; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Rodriguez F, 2001, J VIROL, V75, P10421, DOI 10.1128/JVI.75.21.10421-10430.2001; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Sette A, 1998, CURR OPIN IMMUNOL, V10, P478, DOI 10.1016/S0952-7915(98)80124-6; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Thalhamer J, 2012, GENE VACCINES, P1, DOI 10.1007/978-3-7091-0439-2; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Uebel S, 1999, CURR OPIN IMMUNOL, V11, P203, DOI 10.1016/S0952-7915(99)80034-X; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Weinberger EE, 2013, VACCINE, V31, P6113, DOI 10.1016/j.vaccine.2013.08.005; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	65	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116412	10.1371/journal.pone.0116412	http://dx.doi.org/10.1371/journal.pone.0116412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786238	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500007
J	Zeng, Y; Liu, Y; Shang, J; Ma, JW; Wang, R; Deng, L; Guo, YM; Zhong, F; Bai, MF; Zhang, SJ; Wu, DC				Zeng, Yun; Liu, Yang; Shang, Jin; Ma, Jingwen; Wang, Rong; Deng, Lei; Guo, Youmin; Zhong, Fan; Bai, Mingfeng; Zhang, Shaojuan; Wu, Daocheng			Phosphorescence Monitoring of Hypoxic Microenvironment in Solid-Tumors to Evaluate Chemotherapeutic Effects Using the Hypoxia-Sensitive Iridium (III) Coordination Compound	PLOS ONE			English	Article							ANTI-VEGF TREATMENT; LUNG-CANCER; IN-VITRO; CISPLATIN; RESISTANCE; GROWTH; CELLS; NORMALIZATION; ANGIOGENESIS; PET/CT	Objectives To utilize phosphorescence to monitor hypoxic microenvironment in solid-tumors and investigate cancer chemotherapeutic effects in vivo. Methods A hypoxia-sensitive probe named BTP was used to monitor hypoxic microenvironment in solid-tumors. The low-dose metronomic treatment with cisplatin was used in anti-angiogenetic chemotherapeutic programs. The phosphorescence properties of BTP were detected by a spectrofluorometer. BTP cytotoxicity utilized cell necrosis and apoptosis, which were evaluated by trypan blue dye exclusion and Hoechst33342 plus propidium iodide assays. Tumor-bearing mouse models of colon adenocarcinoma were used for tumor imaging in vivo. Monitoring of the hypoxic microenvironment in tumors was performed with a Maestro 2 fluorescence imaging system. Tumor tissues in each group were harvested regularly and treated with pathological hematoxylin and eosin and immunohistochemical staining to confirm imaging results. Results BTP did not feature obvious cytotoxicity for cells, and tumor growth in low-dose metronomic cisplatin treated mice was significantly inhibited by chemotherapy. Hypoxic levels significantly increased due to cisplatin, as proven by the expression level of related proteins. Phosphorescence intensity in the tumors of mice in the cisplatin group was stronger and showed higher contrast than that in tumors of saline treated mice. Conclusions We develop a useful phosphorescence method to evaluate the chemotherapeutic effects of cisplatin. The proposed method shows potential as a phosphorescence imaging approach for evaluating chemotherapeutic effects in vivo, especially anti-angiogenesis.	[Zeng, Yun; Ma, Jingwen; Wu, Daocheng] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Liu, Yang; Zhong, Fan] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Liu, Yang; Zhong, Fan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Shang, Jin; Wang, Rong; Deng, Lei; Guo, Youmin; Zhang, Shaojuan] Xi An Jiao Tong Univ, Dept Radiol, Affiliated Hosp 1, Xian 710049, Peoples R China; [Bai, Mingfeng; Zhang, Shaojuan] Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA USA	Xi'an Jiaotong University; Fudan University; Fudan University; Xi'an Jiaotong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, SJ (corresponding author), Xi An Jiao Tong Univ, Dept Radiol, Affiliated Hosp 1, Xian 710049, Peoples R China.	zhangs2@upmc.edu; wudaocheng@mail.xjtu.edu.cn	ZENG, YUN/A-9785-2018; Wu, Daocheng/H-5661-2017	ZENG, YUN/0000-0002-5747-3349; Liu, Yang/0000-0003-3849-9049; Wu, Daocheng/0000-0002-6183-539X				Adamski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065304; Bocci G, 2002, CANCER RES, V62, P6938; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carlin S, 2012, J NUCL MED, V53, P1171, DOI 10.2967/jnumed.111.099770; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoigebazar Lathika, 2013, Recent Results Cancer Res, V194, P285, DOI 10.1007/978-3-642-27994-2_15; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kizaka-Kondoh S, 2009, J TOXICOL PATHOL, V22, P93, DOI 10.1293/tox.22.93; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Lakowicz J. R., 2007, PRINCIPLES FLUORESCE, P54; Lamansky S, 2001, J AM CHEM SOC, V123, P4304, DOI 10.1021/ja003693s; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Li N, 2012, J CANCER RES CLIN, V138, P1131, DOI 10.1007/s00432-012-1189-z; Lyons MA, 1999, INT J BIOCHEM CELL B, V31, P369, DOI 10.1016/S1357-2725(98)00123-X; Minagawa Y, 2011, ANN NUCL MED, V25, P339, DOI 10.1007/s12149-011-0471-5; Mortensen LS, 2012, RADIOTHER ONCOL, V105, P14, DOI 10.1016/j.radonc.2012.09.015; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Ren Y, 2012, INVEST RADIOL, V47, P25, DOI 10.1097/RLI.0b013e31823a82f6; Segard T, 2013, CLIN NUCL MED, V38, P1, DOI 10.1097/RLU.0b013e3182708777; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen FZ, 2010, INT J EXP PATHOL, V91, P10, DOI 10.1111/j.1365-2613.2009.00684.x; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; Tonini Giuseppe, 2007, Future Oncol, V3, P183, DOI 10.2217/14796694.3.2.183; VAUPEL P, 1991, CANCER RES, V51, P3316; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Yoshihara T, 2015, J PHOTOCH PHOTOBIO A, V299, P172, DOI 10.1016/j.jphotochem.2014.11.004; Zeng Y, 2013, NANOSCALE, V5, P12633, DOI 10.1039/c3nr04349e; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	42	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121293	10.1371/journal.pone.0121293	http://dx.doi.org/10.1371/journal.pone.0121293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786221	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352138500208
J	Damalas, D; Maravelias, CD; Osio, GC; Maynou, F; Sbrana, M; Sartor, P				Damalas, Dimitrios; Maravelias, Christos D.; Osio, Giacomo C.; Maynou, Francesc; Sbrana, Mario; Sartor, Paolo			"Once upon a Time in the Mediterranean" Long Term Trends of Mediterranean Fisheries Resources Based on Fishers' Traditional Ecological Knowledge	PLOS ONE			English	Article							JOHN DORY; DEMERSAL; CONSEQUENCES; ANECDOTES; DECLINE; MESH	We investigate long-term changes in the Mediterranean marine resources driving the trawl fisheries by analysing fishers' perceptions (Traditional Ecological Knowledge, TEK) throughout the Mediterranean Sea during the last 80 years. To this end, we conducted an extended set of interviews with experienced fishers that enabled us to classify species (or taxa) as 'decreasing' or 'increasing' both in terms of abundance, as well as average size in the catch. The aspect that most clearly emerged in all the investigated areas over time was the notable increase of fishing capacity indicators, such as engine power and fishing depth range. Atlantic mackerel, poor cod, scorpionfishes, striped seabream, and John Dory demonstrated a decreasing trend in the fishers' perceived abundance, while Mediterranean parrotfish, common pandora, cuttlefish, blue and red shrimp, and mullets gave indications of an increasing temporal trend. Although, as a rule, trawler captains did not report any cataclysmic changes (e.g. extinctions), when they were invited to estimate total catches, a clear decreasing pattern emerged; this being a notable finding taking into account the steep escalation of fishing efficiency during the past century. The overall deteriorating status of stocks in most Mediterranean regions calls for responsible management and design of rebuilding plans. This should include historical information accounting for past exploitation patterns that could help defining a baseline of fish abundance prior to heavy industrial fisheries exploitation.	[Damalas, Dimitrios; Osio, Giacomo C.] European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Fisheries & Aquaculture Sect,Maritime Affairs Uni, Via E Fermi 2749, I-21027 Ispra, Italy; [Damalas, Dimitrios; Maravelias, Christos D.] Hellen Ctr Marine Res, Anavissos 19013, Attica, Greece; [Maynou, Francesc] CSIC, Inst Ciencias Mar, E-08003 Barcelona, Spain; [Sbrana, Mario; Sartor, Paolo] Consorzio Ctr Interuniv Biol Marina Ecol Applicat, I-57128 Livorno, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Hellenic Centre for Marine Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Damalas, D (corresponding author), European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Fisheries & Aquaculture Sect,Maritime Affairs Uni, Via E Fermi 2749, I-21027 Ispra, Italy.	shark@hcmr.gr	Maravelias, Christos/W-4151-2019; Maynou, Francesc/A-6433-2011	Maynou, Francesc/0000-0001-7200-6485; Maravelias, Christos/0000-0002-2440-3707; SARTOR, PAOLO/0000-0001-7239-8255; Sbrana, Mario/0000-0002-9562-8372	European Commission [MARE/2008/11: Lot 4]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The data acquisition was supported by the European Commission through project EVOMED ("The 20th Century evolution of Mediterranean exploited demersal resources under increasing fishing disturbance and environmental change" (no MARE/2008/11: Lot 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Audzijonyte A, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1103; Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Bahamon N, 2006, FISH RES, V81, P15, DOI 10.1016/j.fishres.2006.05.020; Berthelot S, 1868, ETUDE PECHES MARITIM, DOI [10.1542/peds.2010-2442, DOI 10.1542/PEDS.2010-2442]; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; Briand F., 2008, CIESM WORKSHOP MONOG, V33, P168; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardinale M, 2013, DG MARE EC 17 SEPT; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Collette B, IUCN 2013 IUCN RED L; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Damalas D, 2014, REV FISH SCI AQUAC, V22, P112, DOI 10.1080/10641262.2013.839620; Desse J, 1994, FOUILLES RECENTES KH, P335; Dunn MR, 2001, ICES J MAR SCI, V58, P96, DOI 10.1006/jmsc.2000.0993; EC (European Commission), 2008, OFFICIAL J EUROPEA L, V60; EC (European Commission), 2000, OFFICIAL J EUROPEA L, V176; FAO, 2014, GLOB PROD STAT 1950; Farrugio H, 1993, SCI MAR, V57, P105; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Haedrich RL, 1997, FISH RES, V31, P229, DOI 10.1016/S0165-7836(97)00023-4; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Joutard P, 1983, HIST ED, V25, P137; Jukic-Peladic S, 2001, FISH RES, V53, P95, DOI 10.1016/S0165-7836(00)00232-0; Katsanevakis S, 2009, FISH OCEANOGR, V18, P439, DOI 10.1111/j.1365-2419.2009.00523.x; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lozano JA, 1993, HIST ORAL; Matta F, 1958, B PESCA PISC IDROBIO, VXXXIV; Matta F, 1954, B PESCA PISCIC IDROB, P9; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NHRF, 2010, FISH GREEK SEAS; Osio GC., 2012, THESIS; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Sala A, 2008, FISH RES, V93, P8, DOI 10.1016/j.fishres.2008.02.003; Sanez-Reguart A, 1795, DICCIONARIO HIST ART, V5; Sarda Francesc, 2003, Journal of Northwest Atlantic Fishery Science, V31, P127; Sartor P, 2011, SI2539097; Swartz W, 2011, PLOS ONE, V5; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Vrgoc N, 2006, J APPL ICHTHYOL, V22, P205, DOI 10.1111/j.1439-0426.2006.00733.x; Wood S., 2011, R PACKAGE VERSION, V0, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	52	21	22	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119330	10.1371/journal.pone.0119330	http://dx.doi.org/10.1371/journal.pone.0119330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781459	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600060
J	Julian, E; Baelo, A; Gavalda, J; Torrents, E				Julian, Esther; Baelo, Aida; Gavalda, Joan; Torrents, Eduard			Methyl-Hydroxylamine as an Efficacious Antibacterial Agent That Targets the Ribonucleotide Reductase Enzyme	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; BACILLUS-ANTHRACIS; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; RADICAL SCAVENGERS; MURINE MACROPHAGES; ELECTRON-TRANSFER; ESCHERICHIA-COLI; GENE-EXPRESSION	The emergence of multidrug-resistant bacteria has encouraged vigorous efforts to develop antimicrobial agents with new mechanisms of action. Ribonucleotide reductase (RNR) is a key enzyme in DNA replication that acts by converting ribonucleotides into the corresponding deoxyribonucleotides, which are the building blocks of DNA replication and repair. RNR has been extensively studied as an ideal target for DNA inhibition, and several drugs that are already available on the market are used for anticancer and antiviral activity. However, the high toxicity of these current drugs to eukaryotic cells does not permit their use as antibacterial agents. Here, we present a radical scavenger compound that inhibited bacterial RNR, and the compound's activity as an antibacterial agent together with its toxicity in eukaryotic cells were evaluated. First, the efficacy of N-methyl-hydroxylamine (M-HA) in inhibiting the growth of different Gram-positive and Gram-negative bacteria was demonstrated, and no effect on eukaryotic cells was observed. M-HA showed remarkable efficacy against Mycobacterium bovis BCG and Pseudomonas aeruginosa. Thus, given the M-HA activity against these two bacteria, our results showed that M-HA has intracellular antimycobacterial activity against BCG-infected macrophages, and it is efficacious in partially disassembling and inhibiting the further formation of P. aeruginosa biofilms. Furthermore, M-HA and ciprofloxacin showed a synergistic effect that caused a massive reduction in a P. aeruginosa biofilm. Overall, our results suggest the vast potential of M-HA as an antibacterial agent, which acts by specifically targeting a bacterial RNR enzyme.	[Julian, Esther] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Bellaterra, Spain; [Baelo, Aida; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies, Barcelona, Spain; [Gavalda, Joan] Hosp Univ Vall dHebron, Vall dHebron Res Inst, Infect Dis Res Lab, Dept Infect Dis, Barcelona, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies, Baldiri Reixac 15-21, Barcelona, Spain.	etorrents@ibecbarcelona.eu	Julián, Esther/E-9216-2013; Torrents, Eduard/C-7184-2008	Julián, Esther/0000-0002-6558-3978; Torrents, Eduard/0000-0002-3010-1609; Gavalda, Joan/0000-0002-9829-3141	Ministerio de Economia y Competitividad [BFU2011-24066]; Generalitat de Catalunya [2009SGR66, 2014SGR1442, 2009SGR-108]; Instituto de Ivestigacion Carlos III [IIIPI10/01438]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Ivestigacion Carlos III	Funding provided by BFU2011-24066. Ministerio de Economia y Competitividad. Principal investigator: Dr. Eduard Torrents. 2009SGR66 and 2014SGR1442 from the Generalitat de Catalunya to Eduard Torrents. 2009SGR-108 from the Generalitat de Catalunya to Dr. Esther Julian. IIIPI10/01438 from the Instituto de Ivestigacion Carlos III. Principal Investigator Dr. Esther Julian. ERA-Net pathogenomics from the Ministerio de Economia y Competitividad. Principal investigator: Dr. Eduard Torrents. Catalan and Spanish cystic foundation federations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Aye Y, 2014, ONCOGENE IN PRESS; Basu A, 2012, CURR TOP MED CHEM, V12, P2827; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Cui W, 2003, J ENDOTOXIN RES, V9, P225, DOI 10.1179/096805103225001422; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dochertyl JJ, 2007, J ANTIMICROB CHEMOTH, V59, P1182, DOI 10.1093/jac/dkm099; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; GEREZ C, 1992, BIOCHEMISTRY-US, V31, P780, DOI 10.1021/bi00118a020; Hammerstad M, 2014, J BIOL INORG CHEM, V19, P893, DOI 10.1007/s00775-014-1121-x; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Luo JH, 2011, ARCH BIOCHEM BIOPHYS, V516, P29, DOI 10.1016/j.abb.2011.09.003; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Moorthy NSHN, 2013, MINI-REV MED CHEM, V13, P1862, DOI 10.2174/13895575113136660090; Navarra P, 1997, J PHARMACOL EXP THER, V280, P477; Navarra P, 2006, J NEUROIMMUNOL, V179, P94, DOI 10.1016/j.jneuroim.2006.06.007; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Payne DJ, 2008, SCIENCE, V321, P1644, DOI 10.1126/science.1164586; Peteroy-Kelly M, 2001, INFECT IMMUN, V69, P5823, DOI 10.1128/IAI.69.9.5823-5831.2001; Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z; Secanella-Fandos S, 2013, J UROLOGY, V189, P711, DOI 10.1016/j.juro.2012.09.049; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stanley SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003946; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tolker-Nielsen T, 2011, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc01b02s21, DOI 10.1002/9780471729259.MC01B02S21]; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; Trifilieff A, 2000, J IMMUNOL, V165, P1526, DOI 10.4049/jimmunol.165.3.1526; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Weinberg A, 2001, CLIN DIAGN LAB IMMUN, V8, P702, DOI 10.1128/CDLI.8.4.702-705.2001	54	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122049	10.1371/journal.pone.0122049	http://dx.doi.org/10.1371/journal.pone.0122049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782003	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600215
J	Kathuria, S; Sharma, C; Singh, PK; Agarwal, P; Agarwal, K; Hagen, F; Meis, JF; Chowdhary, A				Kathuria, Shallu; Sharma, Cheshta; Singh, Pradeep Kumar; Agarwal, Puneet; Agarwal, Kshitij; Hagen, Ferry; Meis, Jacques F.; Chowdhary, Anuradha			Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Isolates in Delhi, India: Evidence of Genetic Diversity by Amplified Fragment Length Polymorphism and Microsatellite Typing	PLOS ONE			English	Article							EMERGING FUNGAL PATHOGEN; AMPHOTERICIN-B; MIC DISTRIBUTIONS; CUTOFF VALUES; FUMIGATUS; INFECTIONS; SPP.; VORICONAZOLE; RESISTANCE; PATIENT	Aspergillus terreus is emerging as an etiologic agent of invasive aspergillosis in immuno-compromised individuals in several medical centers in the world. Infections due to A. terreus are of concern due to its resistance to amphotericin B, in vivo and in vitro, resulting in poor response to antifungal therapy and high mortality. Herein we examined a large collection of molecularly characterized, geographically diverse A. terreus isolates (n = 140) from clinical and environmental sources in India for the occurrence of cryptic A. terreus species. The population structure of the Indian A. terreus isolates and their association with those outside India was determined using microsatellite based typing (STR) technique and Amplified Fragment Length Polymorphism analysis (AFLP). Additionally, in vitro antifungal susceptibility of A. terreus isolates was determined against 7 antifungals. Sequence analyses of the calmodulin locus identified the recently described cryptic species A. hortai, comprising 1.4% of Aspergillus section Terrei isolates cultured from cases of aspergilloma and probable invasive aspergillosis not reported previously. All the nine markers used for STR typing of A. terreus species complex proved to be highly polymorphic. The presence of high genetic diversity revealing 75 distinct genotypes among 101 Indian A. terreus isolates was similar to the marked heterogeneity noticed in the 47 global A. terreus population exhibiting 38 unique genotypes mainly among isolates from North America and Europe. Also, AFLP analysis showed distinct banding patterns for genotypically diverse A. terreus isolates. Furthermore, no correlation between a particular genotype and amphotericin B susceptibility was observed. Overall, 8% of the A. terreus isolates exhibited low MICs of amphotericin B. All the echinocandins and azoles (voriconazole, posaconazole and isavuconazole) demonstrated high potency against all the isolates. The study emphasizes the need of molecular characterization of A. terreus species complex isolates to better understand the ecology, acquisition and transmission of this species.	[Kathuria, Shallu; Sharma, Cheshta; Singh, Pradeep Kumar; Chowdhary, Anuradha] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Agarwal, Puneet] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Pulm Med, Delhi 110007, India; [Agarwal, Kshitij] Rajan Babu Inst Pulm Med & TB, Dept Pulm Med, Delhi, India; [Hagen, Ferry; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands	University of Delhi; University of Delhi; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Chowdhary, A (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India.	dranuradha@hotmail.com	Meis, Jacques F/A-9241-2010; Sharma, Cheshta/J-7966-2019; Kathuria, Shallu/AAN-5835-2020; Hagen, Ferry/B-9044-2009; Chowdhary, Anuradha/ABF-1252-2020	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; Chowdhary, Anuradha/0000-0002-2028-7462; Singh, Pradeep Kumar/0000-0003-1492-598X; Sharma, Cheshta/0000-0003-3216-263X	Astellas; Basilea; Merck; University Grants Commission Research fellowship, Delhi, India [F.2-15/2003 SA-I]	Astellas(Astellas Pharmaceuticals); Basilea; Merck(Merck & Company); University Grants Commission Research fellowship, Delhi, India	JFM received grants from Astellas, Basilea and Merck. CS is supported by a University Grants Commission Research fellowship (F.2-15/2003 SA-I), Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabatzis M, 2013, MYCOLOGIA, V105, P71, DOI 10.3852/11-426; Arendrup MC, 2012, J INFECT DIS, V206, P981, DOI 10.1093/infdis/jis442; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Auberger J, 2008, DIAGN MICR INFEC DIS, V62, P336, DOI 10.1016/j.diagmicrobio.2008.06.012; Baddley JW, 2003, J CLIN MICROBIOL, V41, P5525, DOI 10.1128/JCM.41.12.5525-5529.2003; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2009, EUKARYOT CELL, V8, P713, DOI 10.1128/EC.00272-08; Blum G, 2008, CLIN MICROBIOL INFEC, V14, P1146, DOI 10.1111/j.1469-0691.2008.02099.x; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; Chowdhary A, 2013, MYCOSES, V56, P1, DOI 10.1111/j.1439-0507.2012.02190.x; Chowdhary A, 2014, FUTURE MICROBIOL, V9, P697, DOI 10.2217/fmb.14.27; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; Chowdhary A, 2013, J CLIN MICROBIOL, V51, P585, DOI 10.1128/JCM.02943-12; Clinical and Laboratory Standards Institute (CLSI), 2008, CLSI DOCUMENT M38 A2; de Valk HA, 2007, J CLIN MICROBIOL, V45, P1415, DOI 10.1128/JCM.02423-06; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; DESHAZO RD, 1995, J ALLERGY CLIN IMMUN, V96, P24, DOI 10.1016/S0091-6749(95)70029-3; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P5150, DOI 10.1128/AAC.00686-11; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P2855, DOI 10.1128/AAC.01730-10; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hachem R, 2014, J ANTIMICROB CHEMOTH, V69, P3148, DOI 10.1093/jac/dku241; Hadrich I, 2013, MED MYCOL, V51, P586, DOI 10.3109/13693786.2012.761359; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x; LANGERON Maurice, 1922, Bulletin de la Societe de Pathologie Exotique, V15, P383; Lass-Florl C, 2007, J CLIN MICROBIOL, V45, P2686, DOI 10.1128/JCM.00917-07; Lass-Florl C, 2009, ANTIMICROB AGENTS CH, V53, P794, DOI 10.1128/AAC.00335-08; Lass-Florl C, 2000, J HOSP INFECT, V46, P31, DOI 10.1053/jhin.2000.0799; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Maertens J, 2004, BRIT J HAEMATOL, V126, P852, DOI 10.1111/j.1365-2141.2004.05140.x; Mutschlechner W, 2013, MED MYCOL, V51, P876, DOI 10.3109/13693786.2013.793458; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Pfaller M, 2011, J CLIN MICROBIOL, V49, P586, DOI 10.1128/JCM.02136-10; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P1032, DOI 10.1128/AAC.46.4.1032-1037.2002; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Raper KB, 1965, THE GENUS ASPERGILLU; Rougeron A, 2014, CLIN MICROBIOL INFEC, V20, P327, DOI 10.1111/1469-0691.12323; Ruping MJGT, 2011, J HOSP INFECT, V78, P226, DOI 10.1016/j.jhin.2011.01.020; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Salas V, 2013, ANTIMICROB AGENTS CH, V57, P1532, DOI 10.1128/AAC.01436-12; Salas V, 2011, ANTIMICROB AGENTS CH, V55, P676, DOI 10.1128/AAC.00736-10; Samson RA, 2011, STUD MYCOL, P39, DOI 10.3114/sim.2011.69.04; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P3217, DOI 10.1128/AAC.48.9.3217-3225.2004; Sutton DA, 1999, J CLIN MICROBIOL, V37, P2343, DOI 10.1128/JCM.37.7.2343-2345.1999; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tortorano AM, 2008, J CHEMOTHERAPY, V20, P756, DOI 10.1179/joc.2008.20.6.756; Verweij PE, 1996, J CLIN MICROBIOL, V34, P2595, DOI 10.1128/JCM.34.10.2595-2597.1996; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210	49	44	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118997	10.1371/journal.pone.0118997	http://dx.doi.org/10.1371/journal.pone.0118997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781896	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600042
J	Li, H; Guo, XX; Wang, CY; Ji, WQ				Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan			Spontaneous and Divergent Hexaploid Triticales Derived from Common Wheat x Rye by Complete Elimination of D-Genome Chromosomes	PLOS ONE			English	Article							OCTOPLOID TRITICALE; CYTOSINE METHYLATION; SECALE-CEREALE; ALLOPOLYPLOIDS; POLYPLOIDY; EVOLUTION; GLUTENIN; CULTIVARS; RESPONSES; HYBRIDS	Background Hexaploid triticale could be either synthesized by crossing tetraploid wheat with rye, or developed by crossing hexaploid wheat with a hexaploid triticale or an octoploid triticale. Methodology/Principal Findings Here two hexaploid triticales with great morphologic divergence derived from common wheat cultivar M8003 (Triticum aestivum L.) x Austrian rye (Secale cereale L.) were reported, exhibiting high resistance for powdery mildew and stripe rust and potential for wheat improvement. Sequential fluorescence in situ hybridization (FISH) and genomic in situ hybridization (GISH) karyotyping revealed that D-genome chromosomes were completely eliminated and the whole A-genome, B-genome and R-genome chromosomes were retained in both lines. Furthermore, plentiful alterations of wheat chromosomes including 5A and 7B were detected in both triticales and additionally altered 5B, 7A chromosome and restructured chromosome 2A was assayed in N9116H and N9116M, respectively, even after selfing for several decades. Besides, meiotic asynchrony was displayed and a variety of storage protein variations were assayed, especially in the HMW/LMW-GS region and secalins region in both triticales. Conclusion This study confirms that whole D-genome chromosomes could be preferentially eliminated in the hybrid of common wheat x rye, "genome shock" was accompanying the allopolyploidization of nascent triticales, and great morphologic divergence might result from the genetic variations. Moreover, new hexaploid triticale lines contributing potential resistance resources for wheat improvement were produced.	[Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Ji, WQ (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Ji, WQ (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	chywang2004@126.com; jiwanquan2008@126.com		LI, HAO/0000-0001-8271-9163	Key Technologies RAMP;D Program of China [2013BAD01B02-6]; National Basic Research 973 Program of China [2011CB944601]; Zhongying Tang Foundation of USA	Key Technologies RAMP;D Program of China; National Basic Research 973 Program of China(National Basic Research Program of China); Zhongying Tang Foundation of USA	This work was supported by Key Technologies R&D Program of China (grant number 2013BAD01B02-6), the National Basic Research 973 Program of China (grant number 2011CB944601) and Zhongying Tang Foundation of USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiour N, 2002, EUPHYTICA, V123, P295, DOI 10.1023/A:1015092613786; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Cheng ZJ, 2002, GENES GENET SYST, V77, P23, DOI 10.1266/ggs.77.23; De Bustos A, 2003, THEOR APPL GENET, V107, P74, DOI 10.1007/s00122-003-1234-z; Dennett AL, 2013, EUPHYTICA, V194, P235, DOI 10.1007/s10681-013-0950-y; Dou QW, 2006, THEOR APPL GENET, V114, P41, DOI 10.1007/s00122-006-0408-x; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; FOX PN, 1990, EUPHYTICA, V47, P57, DOI 10.1007/BF00040364; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Guedes-Pinto H., 1996, TRITICALE TODAY TOMO; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Han FP, 2003, GENOME, V46, P716, DOI [10.1139/g03-049, 10.1139/G03-049]; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Hao M, 2013, EUPHYTICA, V193, P347, DOI 10.1007/s10681-013-0930-2; Kalinka A, 2010, NUCLEUS CALCUTTA, V53, P69, DOI 10.1007/s13237-010-0002-0; Li H, 2014, GENOME, V57, P89, DOI 10.1139/gen-2013-0153; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Lukaszewski A. J., 1987, Plant Breeding Reviews, V5, P41; LUKASZEWSKI AJ, 1983, THEOR APPL GENET, V64, P239, DOI 10.1007/BF00303771; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCINTYRE CL, 1990, GENOME, V33, P635, DOI 10.1139/g90-094; Mikhailova L. A., 2009, Russian Agricultural Sciences, V35, P320, DOI 10.3103/S1068367409050097; Muntzing A., 1979, FORTSCHRITTE PFLANZE; MUNTZING A, 1963, P 2 INT WHEAT GEN S, V2, P291; NAKAGOSHI N, 1984, Journal of Science of the Hiroshima University Series B Division 2 (Botany), V19, P1; Oettler G, 2005, J AGR SCI-CAMBRIDGE, V143, P329, DOI 10.1017/S0021859605005290; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Salmanowicz BP, 2007, J APPL GENET, V48, P347, DOI 10.1007/BF03195231; Sasaki M, 1985, P 15 INT GRASSL C KY, P253; SCOLES GJ, 1974, Z PFLANZENZUCHT, V73, P13; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110282; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tang ZX, 2012, J PLANT RES, V125, P283, DOI 10.1007/s10265-011-0432-z; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; WEIMARCK A, 1974, HEREDITAS, V77, P281; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Yuan ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023511; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zhou JP, 2012, GENET RESOUR CROP EV, V59, P1161, DOI 10.1007/s10722-011-9751-0	49	19	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120421	10.1371/journal.pone.0120421	http://dx.doi.org/10.1371/journal.pone.0120421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781330	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600159
J	Toufaily, C; Lokossou, AG; Vargas, A; Rassart, E; Barbeau, B				Toufaily, Chirine; Lokossou, Adjimon Gatien; Vargas, Amandine; Rassart, Eric; Barbeau, Benoit			A CRE/AP-1-Like Motif Is Essential for Induced Syncytin-2 Expression and Fusion in Human Trophoblast-Like Model	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; HUMAN PLACENTA; HERV-W; ENV GLYCOPROTEIN; ENVELOPE PROTEIN; RECEPTOR ASCT2; CELL-FUSION; BEWO CELLS; IN-VIVO; GENE	Syncytin-2 is encoded by the envelope gene of Endogenous Retrovirus-FRD (ERVFRD-1) and plays a critical role in fusion of placental trophoblasts leading to the formation of the multinucleated syncytiotrophoblast. Its expression is consequently regulated in a strict manner. In the present study, we have identified a forskolin-responsive region located between positions -300 to -150 in the Syncytin-2 promoter region. This 150 bp region in the context of a minimal promoter mediated an 80-fold induction of promoter activity following forskolin stimulation. EMSA analyses with competition experiments with nuclear extracts from for-skolin-stimulated BeWo cells demonstrated that the -211 to -177 region specifically bound two forskolin-induced complexes, one of them containing a CRE/AP-1-like motif. Site-directed mutagenesis of the CRE/AP-1 binding site in the context of the Syncytin-2 promoter or a heterologous promoter showed that this motif was mostly essential for forskolin-induced promoter activity. Transfection experiments with dominant negative mutants and constitutively activated CREB expression vectors in addition to Chromatin Immunoprecipitation suggested that a CREB family member, CREB2 was binding and acting through the CRE/AP-1 motif. We further demonstrated the binding of JunD to this same motif. Similar to forskolin and soluble cAMP, CREB2 and JunD overexpression induced Syncytin-2 promoter activity in a CRE/AP-1-dependent manner and Syncytin-2 expression. In addition, BeWo cell fusion was induced by both CREB2 and JunD overexpression, while being repressed following silencing of either gene. These results thereby demonstrate that induced expression of Syncytin-2 is highly dependent on the interaction of bZIP-containing transcription factors to a CRE/AP-1 motif and that this element is important for the regulation of Syncytin-2 expression, which results in the formation of the peripheral syncytiotrophoblast layer.	[Barbeau, Benoit] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; Univ Quebec, Ctr Rech BioMed, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Barbeau, B (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	barbeau.benoit@uqam.ca	Barbeau, Benoit/A-1174-2010; LOKOSSOU, Gatien Adjimon/J-7008-2015	Barbeau, Benoit/0000-0002-4108-8155; LOKOSSOU, Gatien Adjimon/0000-0001-7269-7183; Toufaily, Chirine/0000-0002-6845-141X	National Sciences and Engineering Research Council of Canada (NSERC) [298527]; institutional FARE scholarship; NSERC Graham Bell Ph.D. scholarship; Canada Research Chair in Human Retrovirology	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); institutional FARE scholarship; NSERC Graham Bell Ph.D. scholarship; Canada Research Chair in Human Retrovirology	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC) (#298527) (BB). CT was supported by an institutional FARE scholarship. AV was supported by a NSERC Graham Bell Ph.D. scholarship. BB holds a Canada Research Chair in Human Retrovirology (Tier 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Blaise S, 2004, J VIROL, V78, P1050, DOI 10.1128/JVI.78.2.1050-1054.2004; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Caselli E, 2012, AIDS RES HUM RETROV, V28, P907, DOI [10.1089/AID.2011.0252, 10.1089/aid.2011.0252]; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Knerr I, 2003, AM J OBSTET GYNECOL, V189, P583, DOI 10.1067/S0002-9378(03)00538-6; Knerr I, 2004, MOL HUM REPROD, V10, P581, DOI 10.1093/molehr/gah070; Kudaka W, 2008, PLACENTA, V29, P282, DOI 10.1016/j.placenta.2007.11.009; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Lacroix MC, 2002, ENDOCRINE, V19, P73, DOI 10.1385/ENDO:19:1:73; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Langlois M, 2004, VIROLOGY, V329, P395, DOI 10.1016/j.virol.2004.09.003; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Mu YX, 2011, VIRUS RES, V156, P81, DOI 10.1016/j.virusres.2011.01.001; Muyan M, 1997, PLACENTA, V18, P237, DOI 10.1016/S0143-4004(97)80056-2; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhou Z, 2014, PLACENTA, V35, P907, DOI 10.1016/j.placenta.2014.07.017; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	60	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121468	10.1371/journal.pone.0121468	http://dx.doi.org/10.1371/journal.pone.0121468			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781974	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600205
J	Fonseca, BF; Predes, D; Cerqueira, DM; Reis, AH; Amado, NG; Cayres, MCL; Kuster, RM; Oliveira, FL; Mendes, FA; Abreu, JG				Fonseca, Barbara F.; Predes, Danilo; Cerqueira, Debora M.; Reis, Alice H.; Amado, Nathalia G.; Cayres, Marina C. L.; Kuster, Ricardo M.; Oliveira, Felipe L.; Mendes, Fabio A.; Abreu, Jose G.			Derricin and Derricidin Inhibit Wnt/beta-Catenin Signaling and Suppress Colon Cancer Cell Growth In Vitro	PLOS ONE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; WNT PATHWAY; ACTIVATION; MODULATORS; CHALCONES; POTENT; PROLIFERATION; FLAVONOIDS; QUERCETIN	Overactivation of the Wnt/beta-catenin pathway in adult tissues has been implicated in many diseases, such as colorectal cancer. Finding chemical substances that can prevent this phenomenon is an emerging problem. Recently, several natural compounds have been described as Wnt/beta-catenin inhibitors and might be promising agents for the control of carcinogenesis. Here, we describe two natural substances, derricin and derricidin, belonging to the chalcone subclass, that show potent transcriptional inhibition of the Wnt/beta-catenin pathway. Both chalcones are able to affect the cell distribution of beta-catenin, and inhibit Wnt-specific reporter activity in HCT116 cells and in Xenopus embryos. Derricin and derricidin also strongly inhibited canonical Wnt activity in vitro, and rescued the Wnt-induced double axis phenotype in Xenopus embryos. As a consequence of Wnt/beta-catenin inhibition, derricin and derricidin treatments reduce cell viability and lead to cell cycle arrest in colorectal cancer cell lines. Taken together, our results strongly support these chalcones as novel negative modulators of the Wnt/beta-catenin pathway and colon cancer cell growth in vitro.	[Fonseca, Barbara F.; Predes, Danilo; Cerqueira, Debora M.; Reis, Alice H.; Amado, Nathalia G.; Cayres, Marina C. L.; Oliveira, Felipe L.; Mendes, Fabio A.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Kuster, Ricardo M.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Cerqueira, Debora Malta/AAB-6204-2020; Kuster, Ricardo/AAG-3975-2019; Oliveira, Felipe L/H-9902-2012; Predes, Danilo/J-7558-2015; Cerqueira, Debora Malta/CAF-4323-2022; Mendes, Fabio/J-6911-2015; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021	Predes, Danilo/0000-0003-1864-0324; Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755; Kuster, Ricardo Machado/0000-0002-8961-5348; Reis, Alice/0000-0002-7431-5502; Leite de Oliveira, Felipe/0000-0001-6193-1616; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606; Fonseca, Barbara/0000-0001-6403-4099	Brazilian funding agency Conselho Nacional de Desenvolvimento cientifico e Tecnologico; Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel superior	Brazilian funding agency Conselho Nacional de Desenvolvimento cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Brazilian funding agencies Conselho Nacional de Desenvolvimento cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Coordenacao de Aperfeicoamento de Pessoal de Nivel superior.	Amado NG, 2014, J BIOL CHEM, V289, P35456, DOI 10.1074/jbc.M114.621599; Amado NG, 2014, INT J MOL SCI, V15, P12094, DOI 10.3390/ijms150712094; Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cunha GMD, 2003, PHYTOTHER RES, V17, P155, DOI 10.1002/ptr.1096; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; De Mello J F, 1974, Rev Inst Antibiot (Recife), V14, P39; Dimmock JR, 1999, CURR MED CHEM, V6, P1125; DONASCIM.MC, 1972, PHYTOCHEMISTRY, V11, P3023, DOI 10.1016/0031-9422(72)80097-9; Han JB, 2013, MOL CANCER RES, V11, P207, DOI 10.1158/1541-7786.MCR-12-0670; Hua ZH, 2013, J MED CHEM, V56, P10003, DOI 10.1021/jm401317z; Ji T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-55; Jing H, 2010, CANCER LETT, V294, P167, DOI 10.1016/j.canlet.2010.01.035; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leow PC, 2014, EUR J MED CHEM, V71, P67, DOI 10.1016/j.ejmech.2013.10.073; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Narwal M, 2013, J MED CHEM, V56, P7880, DOI 10.1021/jm401463y; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Park S, 2013, BIOL PHARM BULL, V36, P1040, DOI 10.1248/bpb.b13-00158; Pericleous M, 2013, J GASTROINTEST ONCOL, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sparks AB, 1998, CANCER RES, V58, P1130; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; VINDELOV LL, 1985, EUR J RESPIR DIS, V66, P313; Wang HJ, 2012, TECHNOLOGICAL ENTREPRENEURSHIP IN CHINA: HOW DOES IT WORK, P1; Wenzel H, 2000, CANCER RES, V60, P3823; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097	41	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120919	10.1371/journal.pone.0120919	http://dx.doi.org/10.1371/journal.pone.0120919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775405	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500199
J	Petermann, JS; Kratina, P; Marino, NAC; MacDonald, AAM; Srivastava, DS				Petermann, Jana S.; Kratina, Pavel; Marino, Nicholas A. C.; MacDonald, A. Andrew M.; Srivastava, Diane S.			Resources Alter the Structure and Increase Stochasticity in Bromeliad Microfauna Communities	PLOS ONE			English	Article							BETA DIVERSITY; METACOMMUNITY STRUCTURE; RELATIVE IMPORTANCE; SPECIES COMPOSITION; PLANT BIODIVERSITY; SCALE-DEPENDENCE; DISPERSAL; PREDATORS; PREY; PRODUCTIVITY	Although stochastic and deterministic processes have been found to jointly shape structure of natural communities, the relative importance of both forces may vary across different environmental conditions and across levels of biological organization. We tested the effects of abiotic environmental conditions, altered trophic interactions and dispersal limitation on the structure of aquatic microfauna communities in Costa Rican tank bromeliads. Our approach combined natural gradients in environmental conditions with experimental manipulations of bottom-up interactions (resources), top-down interactions (predators) and dispersal at two spatial scales in the field. We found that resource addition strongly increased the abundance and reduced the richness of microfauna communities. Community composition shifted in a predictable way towards assemblages dominated by flagellates and ciliates but with lower abundance and richness of algae and amoebae. While all functional groups responded strongly and predictably to resource addition, similarity among communities at the species level decreased, suggesting a role of stochasticity in species-level assembly processes. Dispersal limitation did not affect the communities. Since our design excluded potential priority effects we can attribute the differences in community similarity to increased demographic stochasticity of resource-enriched communities related to erratic changes in population sizes of some species. In contrast to resources, predators and environmental conditions had negligible effects on community structure. Our results demonstrate that bromeliad microfauna communities are strongly controlled by bottom-up forces. They further suggest that the relative importance of stochasticity may change with productivity and with the organizational level at which communities are examined.	[Petermann, Jana S.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Petermann, Jana S.] Salzburg Univ, Dept Ecol & Evolut, A-5020 Salzburg, Austria; [Kratina, Pavel] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Marino, Nicholas A. C.] Univ Fed Rio de Janeiro, Inst Biol, Dept Ecol, Rio De Janeiro, RJ, Brazil; [MacDonald, A. Andrew M.; Srivastava, Diane S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [MacDonald, A. Andrew M.; Srivastava, Diane S.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	Free University of Berlin; Salzburg University; University of London; Queen Mary University London; Universidade Federal do Rio de Janeiro; University of British Columbia; University of British Columbia	Petermann, JS (corresponding author), Free Univ Berlin, Inst Biol, Konigin Luise Str 1-3, D-14195 Berlin, Germany.	jana.petermann@fu-berlin.de	Marino, Nicholas A.C./L-8286-2015; Kratina, Pavel/O-5192-2019; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013	Marino, Nicholas A.C./0000-0002-5702-5466; Kratina, Pavel/0000-0002-9144-7937; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656	Swiss National Science Foundation [PBZHP3-128263]; Velux Foundation [651]; National Geographic Society [8833]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	JSP was supported by grants from the Swiss National Science Foundation (PBZHP3-128263, www.snf.ch), the Velux Foundation (651, www.veluxstiftung.ch) and the National Geographic Society (8833, www.nationalgeographic.com). PK was supported by Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserccrsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Benzing D.H., 1990, VASCULAR EPIPHYTES; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; de Boer MK, 2014, OIKOS, V123, P762, DOI 10.1111/j.1600-0706.2013.00927.x; Declerck SAJ, 2013, ISME J, V7, P533, DOI 10.1038/ismej.2012.138; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Foissner W., 2009, PROTIST DIVERSITY GE; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardezi T, 2008, AM NAT, V171, P800, DOI 10.1086/587520; Gilbert B, 2008, OIKOS, V117, P944, DOI 10.1111/j.0030-1299.2008.16300.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Howeth JG, 2010, J ANIM ECOL, V79, P1000, DOI 10.1111/j.1365-2656.2010.01715.x; Hoyle M, 2004, OIKOS, V105, P359, DOI 10.1111/j.0030-1299.2004.12832.x; Hubbell Stephen P., 2001, V32, pi; Kneitel JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041809; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Laybourn-Parry J., 1992, PROTOZOAN PLANKTON E; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Mata TM, 2013, OIKOS, V122, P149, DOI 10.1111/j.1600-0706.2012.20401.x; NAEEM S, 1990, ECOLOGY, V71, P1422, DOI 10.2307/1938279; Ngai JT, 2008, ECOSCIENCE, V15, P160, DOI 10.2980/15-2-3098; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oksanen J., 2016, R PACKAG; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Simonis JL, 2014, ECOLOGY, V95, P1545, DOI 10.1890/13-1185.1; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Starzomski BM, 2010, ECOL ENTOMOL, V35, P53, DOI 10.1111/j.1365-2311.2009.01155.x; Steiner CF, 2004, ECOLOGY, V85, P107, DOI 10.1890/03-3010; terHorst CP, 2011, J EVOLUTION BIOL, V24, P36, DOI 10.1111/j.1420-9101.2010.02140.x; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tilman D., 1982, Monographs in Population Biology, pi; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Walker E D, 2010, Community Ecol, V11, P171, DOI 10.1556/ComEc.11.2010.2.5; WALLACE JB, 1980, ANNU REV ENTOMOL, V25, P103, DOI 10.1146/annurev.en.25.010180.000535; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	60	7	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118952	10.1371/journal.pone.0118952	http://dx.doi.org/10.1371/journal.pone.0118952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775464	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500056
J	Tao-Cheng, JH; Yang, YJ; Reese, TS; Dosemeci, A				Tao-Cheng, Jung-Hwa; Yang, Yijung; Reese, Thomas S.; Dosemeci, Ayse			Differential Distribution of Shank and GKAP at the Postsynaptic Density	PLOS ONE			English	Article							EXCITATORY SYNAPSES; PROTEINS; HOMER; COMPLEX; FAMILY	Shank and GKAP are scaffold proteins and binding partners at the postsynaptic density (PSD). The distribution and dynamics of Shank and GKAP were studied in dissociated hippocampal cultures by pre-embedding immunogold electron microscopy. Antibodies against epitopes containing their respective mutual binding sites were used to verify the expected juxtapositioning of Shank and GKAP. If all Shank and GKAP molecules at the PSD were bound to each other, the distribution of label for the two proteins should coincide. However, labels for the mutual binding sites showed significant differences in distribution, with a narrow distribution for GKAP located close to the postsynaptic membrane, and a wider distribution for Shank extending deeper into the cytoplasm. Upon depolarization with high K+, neither the intensity nor distribution of label for GKAP changed, but labeling intensity for Shank at the PSD increased to similar to 150% of controls while the median distance of label from postsynaptic membrane increased by 7.5 nm. These results indicate a preferential recruitment of Shank to more distal parts of the PSD complex. Conversely, upon incubation in Ca2+-free medium containing EGTA, the labeling intensity of Shank at the PSD decreased to similar to 70% of controls and the median distance of label from postsynaptic membrane decreased by 9 nm, indicating a preferential loss of Shank molecules in more distal parts of the PSD complex. These observations identify two pools of Shank at the PSD complex, one relatively stable pool, closer to the postsynaptic membrane that can bind to GKAP, and another more dynamic pool at a location too far away to bind to GKAP.	[Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bethesda, MD 20892 USA; [Yang, Yijung; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tao-Cheng, JH (corresponding author), NINDS, EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	chengs@ninds.nih.gov			Intramural Research Program of the National Institute of Neurological Disorders and Stroke; National Institutes of Health, United States of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, United States of America.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Boeckers TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/s00441-006-0274-5; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Moutin E, 2012, J CELL SCI, V125, P2030, DOI 10.1242/jcs.098160; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Peters A., 1991, FINE STRUCTURE NERVO; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; Tao-Cheng JH, 2010, NEUROSCIENCE, V168, P11, DOI 10.1016/j.neuroscience.2010.03.041; Tao-Cheng JH, 2014, BIOCHEM BIOPH RES CO, V450, P808, DOI 10.1016/j.bbrc.2014.06.049; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2	25	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118750	10.1371/journal.pone.0118750	http://dx.doi.org/10.1371/journal.pone.0118750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775468	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500038
J	Nakai, T; Ito, H; Kobayashi, K; Takahashi, Y; Hori, H; Tsubaki, M; Tanizawa, K; Okajima, T				Nakai, Tadashi; Ito, Hiroto; Kobayashi, Kazuo; Takahashi, Yasuhiro; Hori, Hiroshi; Tsubaki, Motonari; Tanizawa, Katsuyuki; Okajima, Toshihide			The Radical S-Adenosyl-L-methionine Enzyme QhpD Catalyzes Sequential Formation of Intra-protein Sulfur-to-Methylene Carbon Thioether Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOHEMOPROTEIN AMINE DEHYDROGENASE; 4FE-4S CLUSTERS; PARACOCCUS-DENITRIFICANS; PSEUDOMONAS-PUTIDA; POSTTRANSLATIONAL MODIFICATION; BIOTIN SYNTHASE; IRON; BIOSYNTHESIS; BIOGENESIS; COFACTOR	The bacterial enzyme designated QhpD belongs to the radical S-adenosyl-L-methionine (SAM) superfamily of enzymes and participates in the post-translational processing of quinohemoprotein amine dehydrogenase. QhpD is essential for the formation of intra-protein thioether bonds within the small subunit (maturated QhpC) of quinohemoprotein amine dehydrogenase. We overproduced QhpD from Paracoccus denitrificans as a stable complex with its substrate QhpC, carrying the 28-residue leader peptide that is essential for the complex formation. Absorption and electron paramagnetic resonance spectra together with the analyses of iron and sulfur contents suggested the presence of multiple (likely three) [4Fe-4S] clusters in the purified and reconstituted QhpD. In the presence of a reducing agent (sodium dithionite), QhpD catalyzed the multiple-turnover reaction of reductive cleavage of SAM into methionine and 5'-deoxyadenosine and also the single-turnover reaction of intra-protein sulfur-to-methylene carbon thioether bond formation in QhpC bound to QhpD, producing a multiknotted structure of the polypeptide chain. Homology modeling and mutagenic analysis revealed several conserved residues indispensable for both in vivo and in vitro activities of QhpD. Our findings uncover another challenging reaction catalyzed by a radical SAM enzyme acting on a ribosomally translated protein substrate.	[Nakai, Tadashi; Ito, Hiroto; Kobayashi, Kazuo; Tanizawa, Katsuyuki; Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Takahashi, Yasuhiro] Saitama Univ, Div Life Sci, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Hori, Hiroshi; Tsubaki, Motonari] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Tanizawa, Katsuyuki] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic	Osaka University; Saitama University; Kobe University; Palacky University Olomouc	Okajima, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	tokajima@sanken.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012; Nakai, Tadashi/F-8047-2010; Takahashi, Yasuhiro/F-1119-2011	Kobayashi, Kazuo/0000-0002-5586-9112; Nakai, Tadashi/0000-0001-9770-8168; Takahashi, Yasuhiro/0000-0002-0588-6045; Okajima, Toshihide/0000-0003-1733-9580	Japan Society for the Promotion of Science [24658288, 23570135]; Operational Program Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/20.0165]; Network Joint Research Center for Materials and Devices	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Operational Program Education for Competitiveness-European Social Fund(European Social Fund (ESF)); Network Joint Research Center for Materials and Devices	This work was supported by Japan Society for the Promotion of Science Grants-in-aid for Scientific Research, Challenging Exploratory Research 24658288 (to T. O.) and Category C 23570135 (to T. N.), the Operational Program Education for Competitiveness-European Social Fund Project CZ.1.07/2.3.00/20.0165) (to K. T.), and by Network Joint Research Center for Materials and Devices.	Adachi O, 1998, BIOSCI BIOTECH BIOCH, V62, P469, DOI 10.1271/bbb.62.469; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chang CH, 1996, BIOCHEMISTRY-US, V35, P11081, DOI 10.1021/bi960850k; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moore BN, 2012, PHYS CHEM CHEM PHYS, V14, P3148, DOI 10.1039/c2cp23443b; Nakai T, 2014, BIOCHEMISTRY-US, V53, P895, DOI 10.1021/bi401625m; Nakai T, 2012, J BIOL CHEM, V287, P6530, DOI 10.1074/jbc.M111.324756; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b	55	34	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11144	11166		10.1074/jbc.M115.638320	http://dx.doi.org/10.1074/jbc.M115.638320			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778402	Green Published, hybrid			2022-12-26	WOS:000353404500048
J	Bae, SH; Han, HW; Moon, J				Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook			Functional Analysis of the Molecular Interactions of TATA Box-Containing Genes and Essential Genes	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGES; INTERACTION NETWORKS; METABOLISM; STRESS; GENOME; IDENTIFICATION; EXPRESSION; PROMOTERS; PATHWAY	Genes can be divided into TATA-containing genes and TATA-less genes according to the presence of TATA box elements at promoter regions. TATA-containing genes tend to be stress-responsive, whereas many TATA-less genes are known to be related to cell growth or "housekeeping" functions. In a previous study, we demonstrated that there are striking differences among four gene sets defined by the presence of TATA box (TATA-containing) and essentiality (TATA-less) with respect to number of associated transcription factors, amino acid usage, and functional annotation. Extending this research in yeast, we identified KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways that are statistically enriched in TATA-containing or TATA-less genes and evaluated the possibility that the enriched pathways are related to stress or growth as reflected by the individual functions of the genes involved. According to their enrichment for either of these two gene sets, we sorted KEGG pathways into TATA-containing-gene-enriched pathways (TEPs) and essential- gene-enriched pathways (EEPs). As expected, genes in TEPs and EEPs exhibited opposite results in terms of functional category, transcriptional regulation, codon adaptation index, and network properties, suggesting the possibility that the bipolar patterns in these pathways also contribute to the regulation of the stress response and to cell survival. Our findings provide the novel insight that significant enrichment of TATA-binding or TATA-less genes defines pathways as stress-responsive or growth-related.	[Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook] CHA Univ, Dept Bioengn, Coll Life Sci, Seoul, South Korea; [Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook] Gangnam CHA Gen Hosp, Gen Res Inst, Seoul, South Korea	Pochon Cha University	Moon, J (corresponding author), CHA Univ, Dept Bioengn, Coll Life Sci, Seoul, South Korea.	jmoon@cha.ac.kr			Ministry of health and welfare [A120300]; Korea Science and Engineering Foundation [2011-0013280]	Ministry of health and welfare(Ministry of Health, Labour and Welfare, Japan); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Ministry of health and welfare, A120300, http://english.mw.go.kr/front_eng/index.jsp (JM), and Korea Science and Engineering Foundation, 2011-0013280, www.nrf.re.kr (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Choi JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003002; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Han HW, 2013, FEBS LETT, V587, P444, DOI 10.1016/j.febslet.2012.12.030; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Savinkova LK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P117, DOI 10.1134/S0006297909020011; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu G, 2005, MICROBIOL-SGM, V151, P2175, DOI 10.1099/mic.0.27833-0; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029	22	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120848	10.1371/journal.pone.0120848	http://dx.doi.org/10.1371/journal.pone.0120848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789484	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400180
J	Hsu, KH; Ho, CC; Hsia, TC; Tseng, JS; Su, KY; Wu, MF; Chiu, KL; Yang, TY; Chen, KC; Ooi, H; Wu, TC; Chen, HJ; Chen, HY; Chang, CS; Hsu, CP; Hsia, JY; Chuang, CY; Lin, CH; Chen, JJW; Chen, KY; Liao, WY; Shih, JY; Yu, SL; Yu, CJ; Yang, PC; Chang, GC				Hsu, Kuo-Hsuan; Ho, Chao-Chi; Hsia, Te-Chun; Tseng, Jeng-Sen; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen			Identification of Five Driver Gene Mutations in Patients with Treatment-Naive Lung Adenocarcinoma in Taiwan	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EML4-ALK FUSION GENE; KINASE INHIBITOR; EGFR MUTATIONS; CANCER; IMPACT; KRAS; GEFITINIB; PATHWAYS; SURVIVAL	Background It is important to select appropriate targeted therapies for subgroups of patients with lung adenocarcinoma who have specific gene alterations. Methods This prospective study was a multicenter project conducted in Taiwan for assessment of lung adenocarcinoma genetic tests. Five oncogenic drivers, including EGFR, KRAS, BRAF, HER2 and EML4-ALK fusion mutations, were tested. EGFR, KRAS, BRAF and HER2 mutations were assessed by MALDI-TOF MS (Cohort 1). EML4-ALK translocation was tested by Ventana method in EGFR-wild type patients (Cohort 2). Results From August 2011 to November 2013, a total of 1772 patients with lung adenocarcinoma were enrolled. In Cohort 1 analysis, EGFR, KRAS, HER2 and BRAF mutations were identified in 987 (55.7%), 93 (5.2%), 36 (2.0%) and 12 (0.7%) patients, respectively. Most of these mutations were mutually exclusive, except for co-mutations in seven patients (3 with EGFR + KRAS, 3 with EGFR + HER2 and 1 with KRAS + BRAF). In Cohort 2 analysis, 29 of 295 EGFR-wild type patients (9.8%) were positive for EML4-ALK translocation. EGFR mutations were more common in female patients and non-smokers and KRAS mutations were more common in male patients and smokers. Gender and smoking status were not correlated significantly with HER2, BRAF and EML4-ALK mutations. EML4-ALK translocation was more common in patients with younger age. Conclusion This was the first study in Taiwan to explore the incidence of five oncogenic drivers in patients with lung adenocarcinoma and the results could be valuable for physicians in consideration of targeted therapy and inclusion of clinical trials.	[Hsu, Kuo-Hsuan] Taichung Vet Gen Hosp, Dept Internal Med, Div Crit Care & Resp Therapy, Taichung, Taiwan; [Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Chen, Jeremy J. W.; Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Ho, Chao-Chi; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei 100, Taiwan; [Ho, Chao-Chi; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsia, Te-Chun] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Hsia, Te-Chun; Chen, Hung-Jen] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Su, Kang-Yi; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Su, Kang-Yi; Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Wu, Ming-Fang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Med Oncol, Taichung 40201, Taiwan; [Wu, Ming-Fang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taichung 40201, Taiwan; [Wu, Ming-Fang; Wu, Tzu-Chin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chiu, Kuo-Liang] Taichung Tzu Chi Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chiu, Kuo-Liang] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan; [Yang, Tsung-Ying; Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Ooi, Hean] Taichung Tzu Chi Hosp, Dept Crit Care Med, Taichung, Taiwan; [Ooi, Hean] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Ooi, Hean] China Med Univ, Dept Med Res, China Med Univ Hosp, Taichung, Taiwan; [Ooi, Hean] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wu, Tzu-Chin] Chung Shan Med Univ Hosp, Div Pulm Med, Taichung 40201, Taiwan; [Chen, Hung-Jen] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Chen, Hsuan-Yu; Chang, Chi-Sheng] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung] Taichung Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taichung, Taiwan; [Hsu, Chung-Ping] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shih, Jin-Yuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Central Taiwan University Science & Technology; China Medical University Taiwan; China Medical University Hospital - Taiwan; Tzu Chi University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Yu, SL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	slyu@ntu.edu.tw; jefferycjyu@ntu.edu.tw; august@vghtc.gov.tw	Chen, Hsuan-Yu/AAE-8428-2019; Liao, Wei-Yu/HGE-3881-2022; SU, KANG-YI/GNM-5753-2022	SU, KANG-YI/0000-0002-6538-9526; LIAO, WEI-YU/0000-0001-6383-3470; Yu, Chong-Jen/0000-0001-5664-9392; Tseng, Jeng-Sen/0000-0003-2341-4495; YANG, PAN-CHYR/0000-0001-6330-6048; YU, SUNG-LIANG/0000-0003-4535-9036; HO, CHAO-CHI/0000-0002-8156-2413; Chen, Jeremy J.W./0000-0003-1049-3825; Wu, Ming-Fang/0000-0002-7208-7067				An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Barlesi F, 2013, J CLIN ONCOL, V31; Bell DW, 2008, CLIN CANCER RES, V14, P4079, DOI 10.1158/1078-0432.CCR-07-5030; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cardarella S, 2013, AM J RESP CRIT CARE, V188, P770, DOI 10.1164/rccm.201305-0843PP; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101354; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Edge SB, 2009, AJCC CANC STAGING HD; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Izar B, 2014, J THORAC ONCOL, V9, P1363, DOI 10.1097/JTO.0000000000000266; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murakami Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00024; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Planchard D, 2014, ANN ONCOL, V25, P1, DOI [10.1093/annonc/mdu438, DOI 10.1093/ANNONC/MDU438]; RODENHUIS S, 1992, CANCER RES, V52, pS2665; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Shimamura T, 2006, CANCER RES, V66, P6487, DOI 10.1158/0008-5472.CAN-06-0971; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Sun JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064816; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tsai TH, 2012, EUR RESPIR J, V39, P677, DOI 10.1183/09031936.00043511; Tseng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107160; West H, 2009, CHEST, V136, P1112, DOI 10.1378/chest.08-2484; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295	41	75	77	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120852	10.1371/journal.pone.0120852	http://dx.doi.org/10.1371/journal.pone.0120852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789627	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400181
J	Stavale, EJ; Vu, H; Sampath, A; Ramstedt, U; Warfield, KL				Stavale, Eric J.; Hong Vu; Sampath, Aruna; Ramstedt, Urban; Warfield, Kelly L.			In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4	PLOS ONE			English	Article							N-LINKED GLYCANS; HEMAGGLUTININ; GLYCOPROTEIN; CALNEXIN; CASTANOSPERMINE; CELGOSIVIR; INFECTION; EFFICACY; GLYCOSYLATION; ASSOCIATION	Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) alpha-glucosidases I and II and is a potent, host-targeted antiviral candidate. The mechanism of action for the antiviral activity of iminosugars is proposed to be inhibition of ER alpha-glucosidases leading to misfolding of critical viral glycoproteins. These misfolded glycoproteins would then be incorporated into defective virus particles or targeted for degradation resulting in a reduction of infectious progeny virions. UV-4, and its hydrochloride salt known as UV-4B, is highly potent against dengue virus in vitro and promotes complete survival in a lethal dengue virus mouse model. In the current studies, UV-4 was shown to be highly efficacious via oral gavage against both oseltamivir-sensitive and -resistant influenza A (H1N1) infections in mice even if treatment was initiated as late as 48-72 hours after infection. The minimal effective dose was found to be 80-100 mg/kg when administered orally thrice daily. UV-4 treatment did not affect the development of protective antibody responses after either influenza infection or vaccination. Therefore, UV-4 is a promising candidate for further development as a therapeutic intervention against influenza.	[Stavale, Eric J.; Hong Vu] Integrated Biotherapeut Inc, Gaithersburg, MD USA; [Sampath, Aruna; Ramstedt, Urban; Warfield, Kelly L.] Unither Virol LLC, Silver Spring, MD 20910 USA		Warfield, KL (corresponding author), Unither Virol LLC, Silver Spring, MD 20910 USA.	kwarfield@unithervirology.com			NIAID DMID - Unither Virology, LLC. [HHSN272201100030C]	NIAID DMID - Unither Virology, LLC.	The studies described here were partially funded by NIAID DMID (http://www.niaid.nih.gov/ABOUT/ORGANIZATION/DMID/Pages/default.aspx) contract HHSN272201100030C with the remainder of the studies being sponsored directly by Unither Virology, LLC. NIAID approved study designs performed under their contract but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Unither Virology provided support in the form of salaries for authors AS, UR, and KLW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. EJS and HV are employees of Integrated Biotherapeutics, Inc. Integrated Biotherapeutics, Inc., provided support in the form of salaries for authors EJS and HV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmatoug N, 2011, J INHERIT METAB DIS, V34, P991, DOI 10.1007/s10545-011-9368-7; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRIDGES CG, 1995, GLYCOBIOLOGY, V5, P249, DOI 10.1093/glycob/5.2.249; Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; DATEMA R, 1984, ARCH VIROL, V81, P25, DOI 10.1007/BF01309294; Durantel D, 2009, CURR OPIN INVEST DR, V10, P860; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hierholzer J. C., 1996, VIROLOGY METHODS MAN, P25; HORZINEK MC, 1985, KOMPENDIUM ALLGEMEIN; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Hussain S, 2014, J ANTIMICROB CHEMOTH; Karaivanova VK, 1998, GLYCOBIOLOGY, V8, P725, DOI 10.1093/glycob/8.7.725; Loregian A, 2014, CELL MOL LIFE SCI; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; MCDOWELL W, 1987, VIROLOGY, V161, P37, DOI 10.1016/0042-6822(87)90168-1; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Pascua PNQ, 2014, CLIN EXP VACCINE RES, V3, P140, DOI 10.7774/cevr.2014.3.2.140; Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004; ROMERO PA, 1983, VIROLOGY, V130, P238, DOI 10.1016/0042-6822(83)90133-2; RUPRECHT RM, 1989, J ACQ IMMUN DEF SYND, V2, P149; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Saito T, 2000, J VET MED SCI, V62, P575, DOI 10.1292/jvms.62.575; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Watanabe T, 2014, TRENDS MICROBIOLOGY; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80	37	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121662	10.1371/journal.pone.0121662	http://dx.doi.org/10.1371/journal.pone.0121662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786028	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500214
J	Vehkala, M; Shubin, M; Connor, TR; Thomson, NR; Corander, J				Vehkala, Minna; Shubin, Mikhail; Connor, Thomas R.; Thomson, Nicholas R.; Corander, Jukka			Novel R Pipeline for Analyzing Biolog Phenotypic Microarray Data	PLOS ONE			English	Article							COMMUNITY; SAMPLES	Data produced by Biolog Phenotype MicroArrays are longitudinal measurements of cells' respiration on distinct substrates. We introduce a three-step pipeline to analyze phenotypic microarray data with novel procedures for grouping, normalization and effect identification. Grouping and normalization are standard problems in the analysis of phenotype microarrays defined as categorizing bacterial responses into active and non-active, and removing systematic errors from the experimental data, respectively. We expand existing solutions by introducing an important assumption that active and non-active bacteria manifest completely different metabolism and thus should be treated separately. Effect identification, in turn, provides new insights into detecting differing respiration patterns between experimental conditions, e.g. between different combinations of strains and temperatures, as not only the main effects but also their interactions can be evaluated. In the effect identification, the multilevel data are effectively processed by a hierarchical model in the Bayesian framework. The pipeline is tested on a data set of 12 phenotypic plates with bacterium Yersinia enterocolitica. Our pipeline is implemented in R language on the top of opm R package and is freely available for research purposes.	[Vehkala, Minna; Shubin, Mikhail; Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Connor, Thomas R.; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Helsinki; Wellcome Trust Sanger Institute; Cardiff University; University of London; London School of Hygiene & Tropical Medicine	Vehkala, M (corresponding author), Univ Helsinki, Dept Math & Stat, Helsinki, Finland.	minna.vehkala@helsinki.fi	Connor, Thomas/ABD-6533-2021; Thomson, Nicholas R/P-5988-2014; Connor, Thomas/ABE-5989-2020	Thomson, Nicholas R/0000-0002-4432-8505; Connor, Thomas/0000-0003-2394-6504	ERC [239784]; AoF [251170]; Wellcome Trust [098051]	ERC(European Research Council (ERC)European Commission); AoF; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by ERC grant no. 239784 and AoF grant no. 251170. TC and NRT were funded by Wellcome Trust, grant no. 098051 to Wellcome Trust Sanger Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli S, 2014, FEMS MICROBIOLOGY LE, P1; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borglin S, 2011, CURRENT OPINION BIOT, V23, P1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeNittis M, 2011, LETT APPL MICROBIOL, V52, P96, DOI 10.1111/j.1472-765X.2010.02961.x; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Garland JL, 2001, SOIL BIOL BIOCHEM, V33, P1059, DOI 10.1016/S0038-0717(01)00011-6; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; Laajala TD, 2012, CLIN CANCER RES, V18, P4385, DOI 10.1158/1078-0432.CCR-11-3215; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lindstrom JE, 1998, SOIL BIOL BIOCHEM, V30, P231, DOI 10.1016/S0038-0717(97)00113-2; Reuter S, 2014, P NATL ACAD SCI USA, V111, P6768, DOI 10.1073/pnas.1317161111; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Weber KP, 2007, J MICROBIOL METH, V69, P461, DOI 10.1016/j.mimet.2007.02.013	20	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118392	10.1371/journal.pone.0118392	http://dx.doi.org/10.1371/journal.pone.0118392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786143	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000352138500030
J	Watanabe, S; Tanimoto, Y; Nishiwaki, H; Watanabe, Y				Watanabe, Seiya; Tanimoto, Yoshiaki; Nishiwaki, Hisashi; Watanabe, Yasuo			Identification and Characterization of Bifunctional Proline Racemase/Hydroxyproline Epimerase from Archaea: Discrimination of Substrates and Molecular Evolution	PLOS ONE			English	Article							TRANS-3-HYDROXY-L-PROLINE DEHYDRATASE; TRYPANOSOMA-CRUZI; CRYSTAL-STRUCTURE; DEHYDROGENASE; RACEMASE; METABOLISM	Proline racemase (ProR) is a member of the pyridoxal 5'-phosphate-independent racemase family, and is involved in the Stickland reaction (fermentation) in certain clostridia as well as the mechanisms underlying the escape of parasites from host immunity in eukaryotic Trypanosoma. Hydroxyproline epimerase (HypE), which is in the same protein family as ProR, catalyzes the first step of the trans-4-hydroxy-L-proline metabolism of bacteria. Their substrate specificities were previously considered to be very strict, in spite of similarities in their structures and catalytic mechanisms, and no racemase/epimerase from the ProR superfamily has been found in archaea. We here characterized the ProR-like protein (OCC_00372) from the hyperthermophilic archaeon, Thermococcus litoralis (TlProR). This protein could reversibly catalyze not only the racemization of proline, but also the epimerization of 4-hydroxyproline and 3-hydroxyproline with similar kinetic constants. Among the four (putative) ligand binding sites, one amino acid substitution was detected between TlProR (tryptophan at the position of 241) and natural ProR (phenylalanine). TheW241F mutant showed a significant preference for proline over hydroxyproline, suggesting that this (hydrophobic and bulky) tryptophan residue played an importance role in the recognition of hydroxyproline (more hydrophilic and bulky than proline), and substrate specificity for hydroxyproline was evolutionarily acquired separately between natural HypE and ProR. A phylogenetic analysis indicated that such unique broad substrate specificity was derived from an ancestral enzyme of this superfamily.	[Watanabe, Seiya; Tanimoto, Yoshiaki; Nishiwaki, Hisashi; Watanabe, Yasuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Ehime University	Watanabe, S (corresponding author), Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan.	irab@agr.ehime-u.ac.jp						Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Berneman A., 2010, J MICROBIAL BIOCH TE, V2, P139; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; FINLAY TH, 1970, J BIOL CHEM, V245, P5248; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Jackson S, 2006, J BACTERIOL, V188, P8487, DOI 10.1128/JB.01370-06; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Long ZQ, 2001, BIOCHEM BIOPH RES CO, V281, P317, DOI 10.1006/bbrc.2001.4353; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; NEUNER A, 1990, ARCH MICROBIOL, V153, P205, DOI 10.1007/BF00247822; Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Sakuraba H, 2012, J BIOL CHEM, V287, P20070, DOI 10.1074/jbc.M111.319038; Sambrook J., 2001, MOL CLONING LAB MANU; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Visser WF, 2012, J BIOL CHEM, V287, P21654, DOI 10.1074/jbc.M112.363218; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2015, J BIOTECHNOL, V199, P9, DOI 10.1016/j.jbiotec.2015.01.026; Watanabe S, 2014, FEBS OPEN BIO, V4, P617, DOI 10.1016/j.fob.2014.07.005; Watanabe S, 2014, FEBS OPEN BIO, V4, P240, DOI 10.1016/j.fob.2014.02.010; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; White CE, 2012, MOL MICROBIOL, V85, P1133, DOI 10.1111/j.1365-2958.2012.08164.x; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275	33	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120349	10.1371/journal.pone.0120349	http://dx.doi.org/10.1371/journal.pone.0120349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786142	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500167
J	Cao, DH; Jiang, J; Tsukamoto, T; Liu, RM; Ma, L; Jia, ZF; Kong, F; Oshima, M; Cao, XY				Cao, Donghui; Jiang, Jing; Tsukamoto, Tetsuya; Liu, Ruming; Ma, Lin; Jia, Zhifang; Kong, Fei; Oshima, Masanobu; Cao, Xueyuan			Canolol Inhibits Gastric Tumors Initiation and Progression through COX-2/PGE2 Pathway in K19-C2mE Transgenic Mice	PLOS ONE			English	Article							PROSTAGLANDIN E-2; 4-VINYL-2,6-DIMETHOXYPHENOL CANOLOL; OXIDATIVE STRESS; HELICOBACTER-PYLORI; COLORECTAL-CANCER; CARCINOMA CELLS; COLON-CANCER; RECEPTOR; PREVENTION; EP2	4-vinyl-2, 6-dimethoxyphenol (canolol) is an antioxidant phenolic compound extracted from crude canola oil. In current research, K19-C2mE transgenic mice, developing hyperplastic tumors spontaneously in the glandular stomach, were used to study the mechanisms involved in the anti-inflammation and anti-tumor effects of canolol. Tg mice receiving canolol diet had a reduced tumor incidence, to 41.2%, compared with Non-treatment Tg mice, 77.8% of which had gastric tumor (P= 0.002). Besides that, the mean tumor diameter was decreased from 6.5mm to 4.5mm (P< 0.001) after canolol administration. COX-2/PGE2 pathway is known to play pivotal role in inflammation-induced gastric tumorigenesis. The neutrophils and lymphocytes infiltration was suppressed significantly, and the mRNA levels of the proinflammatory cytokines COX-2, IL-1 beta and IL-12b were also downregulated in gastric mucosa. Additionally, immunohistochemical analysis showed that COX-2, EP2, Gas and beta-catenin, key factors involving in PGE2 signal transduction, were positive staining with higher H scores in Non-treatment Tg mice, while the expressions were suppressed significantly by 0.1% canolol (P< 0.001). In addition, tumor-suppressor miR-7 was reactivated after canolol administration, and COX-2 was showed to be a functional target of miR-7 to suppress the tumor progression. In conclusion, canolol could inhibit the gastritis-related tumor initiation and progression, and the suppression effect was correlated with the blocking up of canonical COX-2/PGE2 signaling pathway and might be regulated by miR-7.	[Cao, Donghui; Jiang, Jing; Jia, Zhifang; Kong, Fei] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China; [Tsukamoto, Tetsuya] Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol 1, Toyoake, Aichi 47011, Japan; [Liu, Ruming; Ma, Lin; Cao, Xueyuan] Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China; [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 920, Japan	Jilin University; Fujita Health University; Jilin University; Kanazawa University	Cao, XY (corresponding author), Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China.	caoxy@aliyun.com	Oshima, Masanobu/F-9958-2014; Tsukamoto, Tetsuya/ABD-4397-2020	Oshima, Masanobu/0000-0002-3304-0004; Tsukamoto, Tetsuya/0000-0002-7502-8724	National Natural Science Foundation of China [81273065, 81072369]; Norman Bethune Program of Jilin University [2013025]; Youth Foundation of The First Hospital of Jilin University [JDYY42013018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Norman Bethune Program of Jilin University; Youth Foundation of The First Hospital of Jilin University	This work was supported by National Natural Science Foundation of China (81273065, XYC), National Natural Science Foundation of China (81072369, JJ), Norman Bethune Program of Jilin University (2013025, JJ), The Youth Foundation of The First Hospital of Jilin University (JDYY42013018, DHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao X, 2008, INT J CANCER, V122, P1445, DOI 10.1002/ijc.23245; Cathcart MC, 2012, BBA-REV CANCER, V1825, P49, DOI 10.1016/j.bbcan.2011.09.004; Dong X, 2011, MOL VIS, V17, P2040; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fang J, 2013, CARCINOGENESIS, V34, P2833, DOI 10.1093/carcin/bgt309; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Harris RE, 2005, ONCOL REP, V13, P559; Hedin L, 2013, ROLE OF PROSTAGLANDI; Hull MA, 2004, MOL CANCER THER, V3, P1031; Jiang JX, 2013, J PHARMACOL EXP THER, V344, P360, DOI 10.1124/jpet.112.200444; Jiang J, 2013, ONCOL LETT, V5, P1562, DOI 10.3892/ol.2013.1230; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Kong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041523; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Kuwahara H, 2009, MICROBIOL IMMUNOL, V53, P1, DOI 10.1111/j.1348-0421.2008.00089.x; Manuel D, 2012, BIOCHEM J, V443, P451, DOI [10.1042/BJ20111052, DOI 10.1042/BJ20111052]; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rial NS, 2009, INT J CANCER, V124, P2270, DOI 10.1002/ijc.24226; Seno H, 2002, CANCER RES, V62, P506; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tsai JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086537; Tsuchiya S, 2003, GENES CELLS, V8, P747, DOI 10.1046/j.1365-2443.2003.00672.x; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xu L, 2012, MOL BIOL CELL	34	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120938	10.1371/journal.pone.0120938	http://dx.doi.org/10.1371/journal.pone.0120938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781635	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600191
J	Lopez-Delgado, JC; Esteve, F; Manez, R; Torrado, H; Carrio, ML; Rodriguez-Castro, D; Farrero, E; Javierre, C; Skaltsa, K; Ventura, JL				Carlos Lopez-Delgado, Juan; Esteve, Francisco; Manez, Rafael; Torrado, Herminia; Carrio, Maria L.; Rodriguez-Castro, David; Farrero, Elisabet; Javierre, Casimiro; Skaltsa, Konstantina; Ventura, Josep L.			The Influence of Body Mass Index on Outcomes in Patients Undergoing Cardiac Surgery: Does the Obesity Paradox Really Exist?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; HEART-FAILURE; RISK-FACTOR; MORTALITY; COMPLICATIONS; INFLAMMATION; ASSOCIATION; VENTILATION; PROGRESSION	Purpose Obesity influences risk stratification in cardiac surgery in everyday practice. However, some studies have reported better outcomes in patients with a high body mass index (BMI): this is known as the obesity paradox. The aim of this study was to quantify the effect of diverse degrees of high BMI on clinical outcomes after cardiac surgery, and to assess the existence of an obesity paradox in our patients. Methods A total of 2,499 consecutive patients requiring all types of cardiac surgery with cardiopulmonary bypass between January 2004 and February 2009 were prospectively studied at our institution. Patients were divided into four groups based on BMI: normal weight (18.5-24.9 kg.m(-2); n = 523; 21.4%), overweight (25-29.9kg.m(-2); n = 1150; 47%), obese (>= 30-<= 34.9kg.m(-2); n = 624; 25.5%) and morbidly obese (>= 35kg.m(-2); n = 152; 6.2%). Follow-up was performed in 2,379 patients during the first year. Results After adjusting for confounding factors, patients with higher BMI presented worse oxygenation and better nutritional status, reflected by lower PaO2/FiO(2) at 24h and higher albumin levels 48h after admission respectively. Obese patients showed a higher risk for Perioperative Myocardial Infarction (OR: 1.768; 95% CI: 1.035-3.022; p = 0.037) and septicaemia (OR: 1.489; 95% CI: 1.282-1.997; p = 0.005). In-hospital mortality was 4.8% (n = 118) and 1-year mortality was 10.1% (n = 252). No differences were found regarding in-hospital mortality between BMI groups. The overweight group showed better 1-year survival than normal weight patients (91.2% vs. 87.6%; Log Rank: p = 0.029. HR: 1.496; 95% CI: 1.062-2.108; p = 0.021). Conclusions In our population, obesity increases Perioperative Myocardial Infarction and septicaemia after cardiac surgery, but does not influence in-hospital mortality. Although we found better 1-year survival in overweight patients, our results do not support any protective effect of obesity in patients undergoing cardiac surgery.	[Carlos Lopez-Delgado, Juan; Esteve, Francisco; Manez, Rafael; Torrado, Herminia; Carrio, Maria L.; Rodriguez-Castro, David; Farrero, Elisabet; Ventura, Josep L.] Hosp Univ Bellvitge, Dept Intens Care, IDIBELL Inst Invest Biomed Bellvitge, Biomed Invest Inst Bellvitge, C Feixa Llarga S-N, Barcelona 08907, Spain; [Javierre, Casimiro] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [Skaltsa, Konstantina] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; University of Barcelona	Lopez-Delgado, JC (corresponding author), Hosp Univ Bellvitge, Dept Intens Care, IDIBELL Inst Invest Biomed Bellvitge, Biomed Invest Inst Bellvitge, C Feixa Llarga S-N, Barcelona 08907, Spain.	juancarloslopezde@hotmail.com	Lopez-Delgado, Juan Carlos/ABF-3341-2020	Lopez-Delgado, Juan Carlos/0000-0003-3324-1129; Manez, Rafael/0000-0002-0884-5564				Ahmed D, 2011, J CARDIOVASC SURG, V52, P99; Aldenkortt M, 2012, BRIT J ANAESTH, V109, P493, DOI 10.1093/bja/aes338; Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Sa MPBD, 2012, REV BRAS CIR CARDIOV, V27, P217, DOI 10.5935/1678-9741.20120037; Birkmeyer NJO, 1998, CIRCULATION, V97, P1689, DOI 10.1161/01.CIR.97.17.1689; Campbell DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081798; Cook TM, 2012, BRIT J ANAESTH, V109, pI68, DOI 10.1093/bja/aes393; Dossett LA, 2009, SURG INFECT, V10, P137, DOI 10.1089/sur.2008.028; Eagle Kim A, 2004, Circulation, V110, pe340; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Gabrielle F, 1997, EUR J CARDIO-THORAC, V11, P406, DOI 10.1016/S1010-7940(96)01110-4; Golia E, 2014, WORLD J CARDIOL, V6, P539, DOI 10.4330/wjc.v6.i7.539; Gustafsson F, 2005, EUR HEART J, V26, P58, DOI 10.1093/eurheartj/ehi022; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Kilger E, 2011, MINERVA ANESTESIOL, V77, P268; Klasen J, 2004, OBES SURG, V14, P275, DOI 10.1381/096089204322857708; Kunt AG, 2013, INTERACT CARDIOV TH, V16, P625, DOI 10.1093/icvts/ivt022; Kurabayashi M, 2010, CIRC J, V74, P2066, DOI 10.1253/circj.CJ-10-0336; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Silva PL, 2012, MINERVA ANESTESIOL, V78, P1136; Martinez-Comendador JM, 2009, EUR J CARDIO-THORAC, V36, P998, DOI 10.1016/j.ejcts.2009.05.022; Martino JL, 2011, CHEST, V140, P1198, DOI 10.1378/chest.10-3023; McGill HC, 2002, CIRCULATION, V105, P2712, DOI 10.1161/01.CIR.0000018121.67607.CE; Mohamed-Ali V, 1999, AM J PHYSIOL-ENDOC M, V277, pE971, DOI 10.1152/ajpendo.1999.277.6.E971; Moulton MJ, 1996, CIRCULATION, V94, P87; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Pietrucha AZ, 2011, ADV MED SCI-POLAND, V56, P241, DOI 10.2478/v10039-011-0054-7; Rahmanian PB, 2010, ANN THORAC SURG, V90, P1221, DOI 10.1016/j.athoracsur.2010.05.015; Ranucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093992; Rapp-Kesek D, 2004, CLIN NUTR, V23, P1398, DOI 10.1016/j.clnu.2004.06.006; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; Stamou SC, 2011, ANN THORAC SURG, V91, P42, DOI 10.1016/j.athoracsur.2010.08.047; Tosa S, 2009, INT HEART J, V50, P173, DOI 10.1536/ihj.50.173; Vaduganathan M, 2012, AM J CARDIOL, V110, P1667, DOI 10.1016/j.amjcard.2012.07.041; Valentijn TM, 2013, SURG-J R COLL SURG E, V11, P169, DOI 10.1016/j.surge.2013.02.003; Wurzinger B, 2010, WIEN KLIN WOCHENSCHR, V122, P31, DOI 10.1007/s00508-009-1241-4	40	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118858	10.1371/journal.pone.0118858	http://dx.doi.org/10.1371/journal.pone.0118858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781994	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600035
J	Sun, WJ; Yu, YQ; Yuan, JQ; Li, CW; Liu, TT; Lin, DD; Lau, A; Zhong, CK; Xu, T; Shan, GL				Sun, Wenjie; Yu, Yaqin; Yuan, Jingqin; Li, Changwei; Liu, Tingting; Lin, Dongdong; Lau, Abby; Zhong, Chongke; Xu, Tan; Shan, GuangLiang			Sleep Duration and Quality among Different Occupations-China National Study	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; LIFE-STYLE; PREVALENCE; DISPARITIES; INDUSTRY; WOMEN	Objective To examine the associations between occupation, sleep duration and sleep quality. Methods The data for this study was extracted from data collected from the 2008 Chinese Suboptimal Health Study. Our study sample consisted of 18,316 Chinese subjects aged 18-65. Occupation and other relevant characteristics to sleep were collected. We used the Pittsburgh Sleep Quality Index (PSQI) to measure sleep quality and multiple logistic regression models to examine the association of occupation with shortened sleep duration and poor sleep quality. Results Farmers had the longest sleep duration (mean=8.22 hours) while the civil servants had the shortest sleep duration (mean=7.85 hours). Farmers also had the best sleep quality (mean score=3.74) while professional workers had the worst sleep quality (mean score=4.87). Compared to civil servants, the OR of shortened sleep duration and poor sleep quality for blue collar workers is 1.39 (95% CI: 1.11-1.73) and 1.28 (95%-CI: 1.15-1.42), respectively, after adjusting for age, sex, marital status, education, area, smoking, drinking, pain, and health status. Conclusion sleep duration and quality varied among different Chinese occupation populations. The blue collar workers are more likely to have shortened sleep duration and poor sleep quality.	[Sun, Wenjie] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan 528458, Peoples R China; [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Yu, Yaqin] Jilin Univ, Sch Publ Hlth, Dept Epidemiol, Changchun 130021, Peoples R China; [Yuan, Jingqin] Ningxia Autonomous Reg Dept Publ Hlth, Yinchuan 750001, Ningxia, Peoples R China; [Li, Changwei; Xu, Tan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Liu, Tingting] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Lin, Dongdong] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70112 USA; [Lau, Abby] Tulane Univ, Dept Infect Dis, Sch Med, New Orleans, LA 70112 USA; [Zhong, Chongke; Xu, Tan] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou 215123, Jiangsu, Peoples R China; [Shan, GuangLiang] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Shan, GuangLiang] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China	Guangdong Pharmaceutical University; Tulane University; Jilin University; Tulane University; Emory University; Tulane University; Tulane University; Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, T (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.	xutan@suda.edu.cn; guangliang_shan@hotmail.com	Zhong, Chongke/AAI-6454-2020; Li, Changwei/S-5615-2016; Lin, Dongdong/A-8337-2017; Sun, Wenjie/I-7692-2013; Liu, Tingting/S-3995-2016	Li, Changwei/0000-0002-9203-304X; Liu, Tingting/0000-0002-7348-809X	National High Technology Research and Development Program of China (863 Program) [2006AA02Z428]; Fogarty International Center of the National Institutes of Health [D43TW009107]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by National High Technology Research and Development Program of China (863 Program) (NO. 2006AA02Z428) and Fogarty International Center of the National Institutes of Health under Award Number D43TW009107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders MP, 2013, EUR J PUBLIC HLTH; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chien Pei-Li, 2013, Sleep Disord, V2013, P283490, DOI 10.1155/2013/283490; Gamaldo AA, 2014, J CLIN SLEEP MED, V10, P725, DOI 10.5664/jcsm.3858; Geroldi C, 1996, GERONTOLOGY, V42, P163; Gildner TE, 2014, AM J HUM BIOL; Hoefelmann LP, 2012, SLEEP MED, V13, P1198, DOI 10.1016/j.sleep.2012.05.009; Jackson CL, 2014, SOC SCI MED, V118, P71, DOI 10.1016/j.socscimed.2014.07.059; Jackson CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-552; Jean-Louis G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-290; Luckhaupt SE, 2010, SLEEP, V33, P149, DOI 10.1093/sleep/33.2.149; Luo JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081261; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Peltzer K, 2014, SLEEP BREATH; Tom SE, 2013, WOMEN HEALTH ISS, V23, pE295, DOI 10.1016/j.whi.2013.06.002; Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508; Wu MC, 2012, PREV MED, V55, P305, DOI 10.1016/j.ypmed.2012.07.013; Zhan YQ, 2014, SLEEP MED, V15, P833, DOI 10.1016/j.sleep.2014.02.006; Zizi F, 2012, AM J MED, V125, P162, DOI 10.1016/j.amjmed.2011.08.020	20	28	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117700	10.1371/journal.pone.0117700	http://dx.doi.org/10.1371/journal.pone.0117700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782005	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600015
J	Yu, J; Liang, XL; Wang, ZK; Guo, X; Sun, TM; Guo, XJ				Yu, Jia; Liang, Xinlei; Wang, Zhaokun; Guo, Xin; Sun, Tiemin; Guo, Xingjie			Separation of Folinic Acid Diastereomers in Capillary Electrophoresis Using a New Cationic beta-Cyclodextrin Derivative	PLOS ONE			English	Article							CHIRAL SEPARATION; ELECTROMIGRATION TECHNIQUES; THEORETICAL ASPECTS; ENANTIOMERS; SINGLE	A method for the separation of folinic acid diastereomers by capillary electrophoresis in chiral separation media was developed. Aiming to achieve a good separation of the anionic analytes, a newly synthesized cationic beta-cyclodextrin derivative, mono-6-deoxy-6-piperdine-beta-cyclodextrin, was applied as the chiral selector. The effect of background electrolyte pH, the concentration of the cyclodextrin additive, and organic modifier on the separation was investigated. A good separation of folinic acid diastereomers was obtained with 30 mmol/L phosphate buffer at pH 6.50 containing 6.0 mmol/L of mono-6-deoxy-6-piperdine-beta-cyclodextrin in 10% acetonitrile. Based on the capillary electrophoresis data, the binding constants of each diastereomer with mono-6-deoxy-6-piperdine-beta-cyclodextrin were determined. Moreover, a computational modeling study, using the semi-empirical PM3 method, was used to discuss the possible mechanism of separation of folinic acid with mono-6deoxy-6-piperdine-beta-cyclodextrin.	[Yu, Jia; Liang, Xinlei; Wang, Zhaokun; Guo, Xingjie] Shenyang Pharmaceut Univ, Minist Educ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning Provin, Peoples R China; [Guo, Xin; Sun, Tiemin] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Liaoning Provin, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Guo, XJ (corresponding author), Shenyang Pharmaceut Univ, Minist Educ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning Provin, Peoples R China.	syykdx410@163.com			National Natural Science Foundation of China [81273476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81273476). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Azzam KM, 2010, ANAL CHIM ACTA, V674, P249, DOI 10.1016/j.aca.2010.06.046; Aturki Z, 2003, J SEP SCI, V26, P844, DOI 10.1002/jssc.200301480; Bertrand R, 1988, Adv Exp Med Biol, V244, P13; Gubitz G, 2008, J CHROMATOGR A, V1204, P140, DOI 10.1016/j.chroma.2008.07.071; Koval D, 2003, J SEP SCI, V26, P653, DOI 10.1002/jssc.200301382; PENN SG, 1995, J PHYS CHEM-US, V99, P3875, DOI 10.1021/j100011a065; Scriba GKE, 2002, J PHARMACEUT BIOMED, V27, P373, DOI 10.1016/S0731-7085(01)00653-7; Servais AC, 2012, J CHROMATOGR A, V1232, P59, DOI 10.1016/j.chroma.2011.10.010; STRAW JA, 1984, CANCER RES, V44, P3114; Suliman FO, 2012, J MOL STRUCT, V1019, P43, DOI 10.1016/j.molstruc.2012.03.055; Vespalec R, 2000, CHEM REV, V100, P3715, DOI 10.1021/cr9411583; Wan H, 2000, J CHROMATOGR A, V875, P43, DOI 10.1016/S0021-9673(99)01209-1; WREN SAC, 1992, J CHROMATOGR, V603, P235, DOI 10.1016/0021-9673(92)85366-2; WREN SAC, 1993, J CHROMATOGR, V635, P113, DOI 10.1016/0021-9673(93)83120-H; Xiao Y, 2010, J SEP SCI, V33, P1797, DOI 10.1002/jssc.200900732; Yu J, 2014, BIOMED CHROMATOGR, V28, P868, DOI 10.1002/bmc.3187	16	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120216	10.1371/journal.pone.0120216	http://dx.doi.org/10.1371/journal.pone.0120216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781478	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600140
J	Bancks, MP; Odegaard, AO; Koh, WP; Yuan, JM; Gross, MD; Pereira, MA				Bancks, Michael P.; Odegaard, Andrew O.; Koh, Woon-Puay; Yuan, Jian-Min; Gross, Myron D.; Pereira, Mark A.			Glycated Hemoglobin and Incident Type 2 Diabetes in Singaporean Chinese Adults: The Singapore Chinese Health Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HBA1C; RISK; A1C; HBA(1C); DIAGNOSIS; WOMEN	Background The American Diabetes Association recently included glycated hemoglobin in the diagnostic criteria for diabetes, but research on the utility of this biomarker in Southeast Asians is scant. The aim of this study was to evaluate the association between percent HbA1c and incident diabetes in an Asian population of adult men and women without reported diabetes. Methods Data analysis of 5,770 men and women enrolled in the Singapore Chinese Health Study who provided a blood sample at the follow-up I visit (1999-2004) and had no cancer and no reported history of diabetes or cardiovascular disease events. Diabetes was defined as self-report of physician diagnosis, identified at the follow-up II visit (2006-2010). Results Hazard ratios (and 95% confidence intervals) for incident diabetes by 5 categories of HbA1c were estimated with Cox regression models and continuous HbA1c with cubic spline analysis. Compared to individuals with an HbA1c <= 5.7% (<= 39 mmol/mol), individuals with HbA1c 5.8-5.9% (40-41 mmol/mol), 6.0-6.1% (42-43 mmol/mol), 6.2-6.4% (44-47 mmol/mol), and >= 6.5% (>= 48 mmol/mol) had significantly increased risk for incident diabetes during follow- up. In cubic spline analysis, levels below 5.7% HbA1c were not significantly associated with incident diabetes. Conclusions Our study found a strong and graded association with HbA1c 5.8% and above with incident diabetes in Chinese men and women.	[Bancks, Michael P.; Odegaard, Andrew O.; Gross, Myron D.; Pereira, Mark A.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bancks, MP (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	banck005@umn.edu		Yuan, Jian-Min/0000-0002-4620-3108; Pereira, Mark/0000-0002-6704-5276; Bancks, Michael/0000-0003-3694-6060	National Institutes of Health (NIH) [R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; NIH [R01 DK080720]; NIH Training Grant [T32HL007779]; NATIONAL CANCER INSTITUTE [R01CA144034, R35CA053890, R01CA080205, R01CA055069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007779] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The parent cohort study - Singapore Chinese Health Study was supported by National Institutes of Health (NIH) grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The measurement of glycated hemoglobin (HbA1c) was supported by NIH grant R01 DK080720. MB was supported by the NIH Training Grant T32HL007779 to conduct the current work (URL: http://www.nih.gov/science/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boltri JM, 2005, ETHNIC DIS, V15, P562; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; George PP, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-44; Heianza Y, 2012, DIABETIC MED, V29, pE279, DOI 10.1111/j.1464-5491.2012.03686.x; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Hughes RCE, 2014, DIABETES CARE, V37, P2953, DOI 10.2337/dc14-1312; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Law LSC, 2011, DIABETES RES CLIN PR, V91, pE53, DOI 10.1016/j.diabres.2010.11.014; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Ministry of Health Singapore, 2014, MOH CLIN PRACT GUID; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979; Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Ramachandran A, 2012, DIABETIC MED, V29, P94, DOI 10.1111/j.1464-5491.2011.03392.x; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sevket O, 2014, J OBSTET GYNAECOL, V34, P690, DOI 10.3109/01443615.2014.925855; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Venkataraman K, 2012, DIABETIC MED, V29, P911, DOI 10.1111/j.1464-5491.2012.03599.x; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119884	10.1371/journal.pone.0119884	http://dx.doi.org/10.1371/journal.pone.0119884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775375	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000351183500136
J	Downs, CT; Awuah, A; Jordaan, M; Magagula, L; Mkhize, T; Paine, C; Raymond-Bourret, E; Hart, LA				Downs, Colleen T.; Awuah, Adwoa; Jordaan, Maryna; Magagula, Londiwe; Mkhize, Truth; Paine, Christine; Raymond-Bourret, Esmaella; Hart, Lorinda A.			Too Hot to Sleep? Sleep Behaviour and Surface Body Temperature of Wahlberg's Epauletted Fruit Bat	PLOS ONE			English	Article							EPOMOPHORUS-WAHLBERGI; CLIMATE-CHANGE; THERMOREGULATION; RISK; WAKE	The significance of sleep and factors that affect it have been well documented, however, in light of global climate change the effect of temperature on sleep patterns has only recently gained attention. Unlike many mammals, bats (order: Chiroptera) are nocturnal and little is known about their sleep and the effects of ambient temperature (T-a) on their sleep. Consequently we investigated seasonal temperature effects on sleep behaviour and surface body temperature of free-ranging Wahlberg's epauletted fruit bat, Epomophorus wahlbergi, at a tree roost. Sleep behaviours of E. wahlbergi were recorded, including: sleep duration and sleep incidences (i.e. one eye open and both eyes closed). Sleep differed significantly across all the individuals in terms of sleep duration and sleep incidences. Individuals generally spent more time awake than sleeping. The percentage of each day bats spent asleep was significantly higher during winter (27.6%), compared with summer (15.6%). In summer, 20.7% of the sleeping bats used one eye open sleep, and this is possibly the first evidence of one-eye-sleep in non-marine mammals. Sleep duration decreased with extreme heat as bats spent significantly more time trying to cool by licking their fur, spreading their wings and panting. Skin temperatures of E. wahlbergi were significantly higher when T-a was >= 35 degrees C and no bats slept at these high temperatures. Consequently extremely hot days negatively impact roosting fruit bats, as they were forced to be awake to cool themselves. This has implications for these bats given predicted climate change scenarios.	[Downs, Colleen T.; Awuah, Adwoa; Jordaan, Maryna; Magagula, Londiwe; Mkhize, Truth; Paine, Christine; Raymond-Bourret, Esmaella; Hart, Lorinda A.] Univ KwaZulu Natal, Sch Life Sci, ZA-3209 Pietermaritzburg, South Africa	University of Kwazulu Natal	Downs, CT (corresponding author), Univ KwaZulu Natal, Sch Life Sci, P Bag X01, ZA-3209 Pietermaritzburg, South Africa.	Downs@ukzn.ac.za	Hart, Lorinda A/A-8391-2019; Downs, Colleen T./A-7770-2010	Downs, Colleen T./0000-0001-8334-1510; Hart, Lorinda/0000-0002-3942-0374				Acerbi A, 2011, ANIM BEHAV, V81, P801, DOI 10.1016/j.anbehav.2011.01.015; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Baxter C, 2014, BRISBANE TIMES  0106; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; BESHIR MY, 1981, APPL ERGON, V12, P29, DOI 10.1016/0003-6870(81)90091-0; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Burbank RC, 1934, J PHYSIOL-LONDON, V82, P459, DOI 10.1113/jphysiol.1934.sp003197; Cameron GN, 2001, J MAMMAL, V82, P652, DOI 10.1644/1545-1542(2001)082<0652:GWEOGC>2.0.CO;2; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Capellini I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004609; Dawson TJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P374, DOI 10.1086/316751; Downs CT, 2012, J THERM BIOL, V37, P144, DOI 10.1016/j.jtherbio.2011.12.003; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunnett GE, 1953, BR J ANIM BEHAV, V1, P91; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Flanigan W.F., 1972, SLEEPING BRAIN PERSP, P14; Fuchs T, 2006, ANIM BEHAV, V72, P951, DOI 10.1016/j.anbehav.2006.03.008; HAINSWORTH FR, 1972, CAN J PHYSIOL PHARM, V50, P172, DOI 10.1139/y72-026; Heller C., 2005, PRINCIPLES PRACTICE, P292, DOI DOI 10.1016/B0-72-160797-7/50031-8; HERREID CF, 1967, PHYSIOL ZOOL, V40, P1; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; Jhaveri KA, 2007, BRAIN BEHAV IMMUN, V21, P975, DOI 10.1016/j.bbi.2007.03.007; Jordaan LA, 2012, BIOL INVASIONS, V14, P959, DOI 10.1007/s10530-011-0131-7; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Maloney SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P385, DOI 10.1086/316677; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; McNab B.K., 1982, P151; Monadjem A., 2010, BATS SO AFRICA BIOGE; Mukesh ASRP, 2012, TELEGRAPH; Okamoto-Mizuno K, 2005, PHYSIOL BEHAV, V83, P759, DOI 10.1016/j.physbeh.2004.09.009; Pinjarkar V, 2010, TIMES INDIA; Preston BT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-7; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 2000, NEUROSCI BIOBEHAV R, V24, P817, DOI 10.1016/S0149-7634(00)00039-7; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; REEDER WG, 1951, J MAMMAL, V32, P389, DOI 10.2307/1375787; Rogers N L, 2001, Semin Clin Neuropsychiatry, V6, P295, DOI 10.1053/scnp.2001.27907; Rollinson DP, 2014, AFR ZOOL, V49, P173, DOI 10.3377/004.049.0218; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Sinha RK, 2006, PHYSIOL BEHAV, V89, P364, DOI 10.1016/j.physbeh.2006.06.022; Sinha Rakesh Kumar, 2008, J Clin Monit Comput, V22, P261, DOI 10.1007/s10877-008-9128-x; Sinha RK, 2004, MED BIOL ENG COMPUT, V42, P282, DOI 10.1007/BF02344701; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solomon S., 2007, PHYS SCI BASIS WORKI; Steinmeyer C, 2010, ANIM BEHAV, V80, P853, DOI 10.1016/j.anbehav.2010.08.005; THOMAS SP, 1991, AM J PHYSIOL, V260, pR960, DOI 10.1152/ajpregu.1991.260.5.R960; Thomas T C, 2000, Sleep Res Online, V3, P141; Thomson SC, 1998, PHILOS T ROY SOC B, V353, P1595, DOI 10.1098/rstb.1998.0312; Thomson SC, 1999, J COMP PHYSIOL B, V169, P187, DOI 10.1007/s003600050210; VANTWYVER H, 1970, ELECTROEN CLIN NEURO, V29, P181, DOI 10.1016/0013-4694(70)90121-5; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zepelin H, 1994, PRINCIPLES PRACTICE, P91; Zhao XD, 2010, BEHAV BRAIN RES, V208, P497, DOI 10.1016/j.bbr.2009.12.027	60	15	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119419	10.1371/journal.pone.0119419	http://dx.doi.org/10.1371/journal.pone.0119419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775371	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500091
J	Apellaniz, B; Rujas, E; Serrano, S; Morante, K; Tsumoto, K; Caaveiro, JMM; Jimenez, MA; Nieva, JL				Apellaniz, Beatriz; Rujas, Edurne; Serrano, Soraya; Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.; Angeles Jimenez, M.; Nieva, Jose L.			The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; SPANNING DOMAIN; SECONDARY STRUCTURE; CHEMICAL-SHIFT; NMR STRUCTURE; FUSION; ANTIBODY; EPITOPE; SEQUENCE	The membrane-proximal external region (MPER) C-terminal segment and the transmembrane domain (TMD) of gp41 are involved in HIV-1 envelope glycoprotein-mediated fusion and modulation of immune responses during viral infection. However, the atomic structure of this functional region remains unsolved. Here, based on the high resolution NMR data obtained for peptides spanning the C-terminal segment of MPER and the TMD, we report two main findings: (i) the conformational variability of the TMD helix at a membrane-buried position; and (ii) the existence of an uninterrupted alpha-helix spanning MPER and the N-terminal region of the TMD. Thus, our structural data provide evidence for the bipartite organization of TMD predicted by previous molecular dynamics simulations and functional studies, but they do not support the breaking of the helix at Lys-683, as was suggested by some models to mark the initiation of the TMD anchor. Antibody binding energetics examined with isothermal titration calorimetry and humoral responses elicited in rabbits by peptide-based vaccines further support the relevance of a continuous MPER-TMD helix for immune recognition. We conclude that the transmembrane anchor of HIV-1 envelope is composed of two distinct subdomains: 1) an immunogenic helix at the N terminus also involved in promoting membrane fusion; and 2) an immunosuppressive helix at the C terminus, which might also contribute to the late stages of the fusion process. The unprecedented high resolution structural data reported here may guide future vaccine and inhibitor developments.	[Apellaniz, Beatriz; Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, UPV EHU, CSIC, Biophys Unit, Bilbao 48080, Spain; [Apellaniz, Beatriz; Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao 48080, Spain; [Rujas, Edurne; Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Serrano, Soraya; Angeles Jimenez, M.] CSIC, Inst Phys Chem Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Caaveiro, JMM (corresponding author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; majimenez@iqfr.csic.es; joseluis.nieva@ehu.es	Rujas, Edurne/AGV-1475-2022; Caaveiro, Jose/J-2790-2013; Apellaniz, Beatriz/E-9291-2012; Rujas, Edurne/GXG-7368-2022; Rujas, Edurne/P-1969-2018; Nieva, Jose L/Q-2063-2019; Jimenez, M. Angeles/C-7193-2008	Caaveiro, Jose/0000-0001-5568-2369; Nieva, Jose L/0000-0001-6446-5649; Jimenez, M. Angeles/0000-0001-6835-5850; Rujas, Edurne/0000-0002-4465-5071; APELLANIZ, BEATRIZ/0000-0003-1573-5440; Morante, Koldo/0000-0002-9877-9168	National Institutes of Health [R01 AI097051]; Canadian Institutes of Health Research [MOP-114941]; Spanish MINECO [CTQ2011-22514]; Basque Government [IT838-13]; Japan Society for the Promotion of Science [25249115]; Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish MINECO(Spanish Government); Basque Government(Basque Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI097051 (to J. L. N.). This work was also supported by Canadian Institutes of Health Research Grant MOP-114941 (to J. L. N.), Spanish MINECO Grant CTQ2011-22514 (to M. A. J.), Basque Government Grant IT838-13 (to J. L. N.), and Japan Society for the Promotion of Science Project 25249115 (to K. T. and J. M. M. C.).; Recipient of a predoctoral fellowship from the Basque Government.; Recipient of a predoctoral fellowship from the Spanish MINECO.; Supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan.	Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Apellaniz B, 2009, BIOCHEMISTRY-US, V48, P5320, DOI 10.1021/bi900504t; Ashkenazi A, 2013, TRENDS BIOCHEM SCI, V38, P345, DOI 10.1016/j.tibs.2013.04.003; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Baker MK, 2014, BBA-BIOMEMBRANES, V1838, P1396, DOI 10.1016/j.bbamem.2014.01.009; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gangupomu VK, 2010, BIOPHYS J, V99, P3438, DOI 10.1016/j.bpj.2010.09.054; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kim M, 2013, J BIOL CHEM, V288, P31888, DOI 10.1074/jbc.M113.494609; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; Liu SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-100; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Reuven EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004248; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Serrano S, 2014, J BIOL CHEM, V289, P6565, DOI 10.1074/jbc.M113.527747; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Sun ZYJ, 2014, J MOL BIOL, V426, P1095, DOI 10.1016/j.jmb.2013.09.030; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; van Gils MJ, 2014, TRENDS MICROBIOL, V22, P550, DOI 10.1016/j.tim.2014.08.006; Venditto VJ, 2013, CLIN VACCINE IMMUNOL, V20, P39, DOI 10.1128/CVI.00615-12; Vila R, 2000, PROTEIN SCI, V9, P627; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	78	37	37	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					12999	13015		10.1074/jbc.M115.644351	http://dx.doi.org/10.1074/jbc.M115.644351			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25787074	Green Published, hybrid			2022-12-26	WOS:000354975700003
J	Janda, A; Eryilmaz, E; Nakouzi, A; Pohl, MA; Bowen, A; Casadevall, A				Janda, Alena; Eryilmaz, Ertan; Nakouzi, Antonio; Pohl, Mary Ann; Bowen, Anthony; Casadevall, Arturo			Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antigen; Immunoglobulin A (IgA); Immunoglobulin E (IgE); Nuclear Magnetic Resonance (NMR); Peptides; Isotype	IMMUNOGLOBULIN CONSTANT; ANTIGEN-BINDING; FINE SPECIFICITY; ANTIBODIES; ISOTYPE; AFFINITY; MURINE; NMR; SPECTROSCOPY; CONTRIBUTES	Background: Ig , , and constant regions can affect Ag specificity, but this is unknown for IgE. Results: IgE and IgA variable regions differ in specificity and cleavage rates compared with each other and IgG subclasses. Conclusion: Like IgG subclasses, the IgA and IgE constant regions can affect Ag binding specificities. Significance: These results extend the principle that the constant region can affect variable region specificity to IgE. In recent years several groups have shown that isotype switching from IgM to IgG to IgA can affect the affinity and specificity of antibodies sharing identical variable (V) regions. However, whether the same applies to IgE is unknown. In this study we compared the fine specificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and found that these differed in specificity from each other. The IgE and IgA paratopes were probed by nuclear magnetic resonance spectroscopy with N-15-labeled peptide mimetics of cryptococcal polysaccharide antigen (Ag). IgE was found to cleave the peptide at a much faster rate than V region-identical IgG subclasses and IgA, consistent with an altered paratope. Both IgE and IgA were opsonic for C. neoformans and protected against infection in mice. In summary, V-region expression in the context of the E constant (C) region results in specificity changes that are greater than observed for comparable IgG subclasses. These results raise the possibility that expression of certain V regions in the context of and E C regions affects their function and contributes to the special properties of those isotypes.	[Janda, Alena; Nakouzi, Antonio; Pohl, Mary Ann; Bowen, Anthony; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Eryilmaz, Ertan] Boehringer Ingelheim Pharmaceut Inc, Biotherapeut, Ridgefield, CT 06877 USA	Yeshiva University; Albert Einstein College of Medicine; Boehringer Ingelheim	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu	Regan, Clinton/E-6250-2012; Bowen, Anthony/O-4982-2015; Markmann, Alena Janda/AAD-7310-2019	Bowen, Anthony/0000-0003-1064-8372; Markmann, Alena Janda/0000-0003-3656-9322	National Institutes of Health [HL059842, AI033774, AI052733, AI033142, T32-GM007288, R37-AI033142]; Institutional AIDS Training Grant [T32-AI007501]; Medical Scientist Training Program Training Grant [T32-GM007288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, T32AI007501, R37AI033142, R01AI052733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional AIDS Training Grant; Medical Scientist Training Program Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059842, AI033774, AI052733, and AI033142.; Supported by Institutional AIDS Training Grant T32-AI007501 and the Medical Scientist Training Program Training Grant T32-GM007288.; Supported by National Institutes of Health Awards T32-GM007288 and R37-AI033142.	[Anonymous], 2013, MOL OP ENV MOE VERS; [Anonymous], 2008, AMBER 10; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1993, J IMMUNOL, V150, P2231; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Feldmesser Marta, 1998, Frontiers in Bioscience, V3, pD136; GREENSPAN NS, 1993, SPRINGER SEMIN IMMUN, V15, P275; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karagiannis SN, 2012, CANCER IMMUNOL IMMUN, V61, P1547, DOI 10.1007/s00262-011-1162-8; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; MUKHERJEE S, 1995, INFECT IMMUN, V63, P573, DOI 10.1128/IAI.63.2.573-579.1995; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; Pritsch O, 2000, EUR J IMMUNOL, V30, P3387, DOI 10.1002/1521-4141(2000012)30:12<3387::AID-IMMU3387>3.0.CO;2-K; Reitan SK, 2002, P NATL ACAD SCI USA, V99, P7588, DOI 10.1073/pnas.052150899; REITAN SK, 1995, EUR J IMMUNOL, V25, P1601, DOI 10.1002/eji.1830250620; ROBERTSON MW, 1988, MOL IMMUNOL, V25, P103, DOI 10.1016/0161-5890(88)90057-0; ROUZER CA, 1982, P NATL ACAD SCI-BIOL, V79, P5656, DOI 10.1073/pnas.79.18.5656; Sapparapu G, 2012, J BIOL CHEM, V287, P36096, DOI 10.1074/jbc.M112.401075; Spira G, 1996, CLIN EXP IMMUNOL, V105, P436, DOI 10.1046/j.1365-2249.1996.d01-786.x; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Xia YM, 2012, J AUTOIMMUN, V39, P398, DOI 10.1016/j.jaut.2012.06.005; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407	44	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12090	12100		10.1074/jbc.M114.618975	http://dx.doi.org/10.1074/jbc.M114.618975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778397	Green Published, hybrid			2022-12-26	WOS:000354388600024
J	Ke, YF; Wu, YX; Cui, X; Liu, X; Yu, M; Yang, CB; Li, XR				Ke, Yifeng; Wu, Yixiang; Cui, Xuan; Liu, Xun; Yu, Min; Yang, Chunbo; Li, Xiaorong			Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITIES; SUBCONJUNCTIVAL INJECTION; SULFATED POLYSACCHARIDES; BLETILLA-STRIATA; HYALURONIC-ACID; IN-VITRO; NEOVASCULARIZATION; EYE; PROLIFERATION; THROMBOSPONDIN-1	Corneal chemical burns are common ophthalmic injuries that may result in permanent visual impairment. Although significant advances have been achieved on the treatment of such cases, the structural and functional restoration of a chemical burn-injured cornea remains challenging. The applications of polysaccharide hydrogel and subconjunctival injection of mesenchymal stem cells (MSCs) have been reported to promote the healing of corneal wounds. In this study, polysaccharide was extracted from Hardy Orchid and mesenchymal stem cells (MSCs) were derived from Sprague-Dawley rats. Supplementation of the polysaccharide significantly enhanced the migration rate of primarily cultured rat corneal epithelial cells. We examined the therapeutic effects of polysaccharide in conjunction with MSCs application on the healing of corneal alkali burns in rats. Compared with either treatment alone, the combination strategy resulted in significantly better recovery of corneal epithelium and reduction in inflammation, neovascularization and opacity of healed cornea. Polysaccharide and MSCs acted additively to increase the expression of anti-inflammatory cytokine (TGF-beta), antiangiogenic cytokine (TSP-1) and decrease those promoting inflammation (TNF-alpha), chemotaxis (MIP-1 alpha and MCP-1) and angiogenesis (VEGF and MMP-2). This study provided evidence that Hardy Orchid derived polysaccharide and MSCs are safe and effective treatments for corneal alkali burns and that their benefits are additive when used in combination. We concluded that combination therapy with polysaccharide and MSCs is a promising clinical treatment for corneal alkali burns and may be applicable for other types of corneal disorder.	[Ke, Yifeng; Wu, Yixiang; Cui, Xuan; Liu, Xun; Yang, Chunbo; Li, Xiaorong] Tianjin Med Univ, Hosp Eye, Coll Optometry, Inst Eye, Tianjin, Peoples R China; [Yu, Min] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yang, CB (corresponding author), Tianjin Med Univ, Hosp Eye, Coll Optometry, Inst Eye, Tianjin, Peoples R China.	yangcbxh@gmail.com; xiaorli@163.com			National Sciences Foundation of China [81371037]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the grant from National Sciences Foundation of China (81371037); http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; ANSETH A, 1962, INVEST OPHTH VISUAL, V1, P195; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Barabino S, 2014, EUR J OPHTHALMOL, V24, P173, DOI 10.5301/ejo.5000355; Bhatia SK, 2007, CURR EYE RES, V32, P1045, DOI 10.1080/02713680701767876; Blackmore SJ, 2010, CONTACT LENS ANTERIO, V33, P239, DOI 10.1016/j.clae.2010.06.004; Brodovsky SC, 2000, OPHTHALMOLOGY, V107, P1829, DOI 10.1016/S0161-6420(00)00289-X; Coura CO, 2012, BASIC CLIN PHARMACOL, V110, P335, DOI 10.1111/j.1742-7843.2011.00811.x; Daniels JT, 2016, STEM CELL REV, V2, P247; Diao HJ, 2008, J BIOSCI BIOENG, V105, P85, DOI 10.1263/jbb.105.85; Fish R, 2010, CURR OPIN OPHTHALMOL, V21, P317, DOI 10.1097/ICU.0b013e32833a8da2; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; INOUE M, 1993, INVEST OPHTH VIS SCI, V34, P2313; Jiang TS, 2010, MOL VIS, V16, P1304; Kuckelkorn R, 2002, ACTA OPHTHALMOL SCAN, V80, P4, DOI 10.1034/j.1600-0420.2002.800102.x; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; MEYER K, 1953, J BIOL CHEM, V205, P611; Nakamura M, 1999, CORNEA, V18, P686, DOI 10.1097/00003226-199911000-00011; NAKAMURA M, 1994, J CELL PHYSIOL, V159, P415, DOI 10.1002/jcp.1041590305; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Park CM, 2014, FOOD CHEM TOXICOL, V66, P56, DOI 10.1016/j.fct.2014.01.019; Rodrigues JAG, 2012, PHARMACOL REP, V64, P282, DOI 10.1016/S1734-1140(12)70766-1; Sener E, 2011, CURR EYE RES, V36, P1005, DOI 10.3109/02713683.2011.601840; Sheng XH, 2011, NEUROSCI LETT, V503, P37, DOI 10.1016/j.neulet.2011.08.003; Singh Parul, 2013, Oman J Ophthalmol, V6, P83, DOI 10.4103/0974-620X.116624; SONODA Y, 1993, J IMMUNOL, V150, P1727; Stevenson W, 2012, OCUL SURF, V10, P67, DOI 10.1016/j.jtos.2012.01.005; Su WR, 2011, GRAEF ARCH CLIN EXP, V249, P421, DOI 10.1007/s00417-010-1539-y; Sun LX, 2011, J PHARM PHARMACOL, V63, P1595, DOI 10.1111/j.2042-7158.2011.01367.x; Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Wu XG, 2012, J OCUL PHARMACOL TH, V28, P369, DOI 10.1089/jop.2011.0200; Yang GH, 2010, VET OPHTHALMOL, V13, P144, DOI 10.1111/j.1463-5224.2010.00771.x; Yang LL, 2009, MOL VIS, V15, P1951; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Yoon SY, 2013, CORNEA, V32, P1488, DOI 10.1097/ICO.0b013e3182a48009; Zak S, 2008, INT J COLORECTAL DIS, V23, P297, DOI 10.1007/s00384-007-0397-5; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002; Zhou L, 2006, ONCOGENE, V25, P536, DOI 10.1038/sj.onc.1209069	43	45	50	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119725	10.1371/journal.pone.0119725	http://dx.doi.org/10.1371/journal.pone.0119725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789487	Green Submitted, gold, Green Published			2022-12-26	WOS:000351425400100
J	Shah, N; Singh, R; Sarangi, U; Saxena, N; Chaudhary, A; Kaur, G; Kaul, SC; Wadhwa, R				Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaur, Gurcharan; Kaul, Sunil C.; Wadhwa, Renu			Combinations of Ashwagandha Leaf Extracts Protect Brain-Derived Cells against Oxidative Stress and Induce Differentiation	PLOS ONE			English	Article							WITHANIA-SOMNIFERA; MITOCHONDRIAL DYSFUNCTION; WITHAFERIN-A; CANCER-CELLS; ALCOHOLIC EXTRACT; GLUTAMATE; IDENTIFICATION; CONCOMITANT; COMPONENTS; INHIBITOR	Background Ashwagandha, a traditional Indian herb, has been known for its variety of therapeutic activities. We earlier demonstrated anticancer activities in the alcoholic and water extracts of the leaves that were mediated by activation of tumor suppressor functions and oxidative stress in cancer cells. Low doses of these extracts were shown to possess neuroprotective activities in vitro and in vivo assays. Methodology/Principal Findings We used cultured glioblastoma and neuroblastoma cells to examine the effect of extracts (alcoholic and water) as well as their bioactive components for neuroprotective activities against oxidative stress. Various biochemical and imaging assays on the marker proteins of glial and neuronal cells were performed along with their survival profiles in control, stressed and recovered conditions. We found that the extracts and one of the purified components, withanone, when used at a low dose, protected the glial and neuronal cells from oxidative as well as glutamate insult, and induced their differentiation per se. Furthermore, the combinations of extracts and active component were highly potent endorsing the therapeutic merit of the combinational approach. Conclusion Ashwagandha leaf derived bioactive compounds have neuroprotective potential and may serve as supplement for brain health.	[Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki 3058562, Japan; [Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Guru Nanak Dev University	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Chaudhary, Anupama/AAF-8156-2020; Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; Kaur, Gurcharan/V-6033-2019	Chaudhary, Anupama/0000-0001-9619-8813; Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; 	Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant; Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan	Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant; Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant. Navjot Shah and Rumani Singh were supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Carlo M, 2012, FREE RADICAL RES, V46, P1327, DOI 10.3109/10715762.2012.714466; Dobrek L, 2011, POSTEP HIG MED DOSW, V65, P338; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030890; Grover A, 2012, INT J BIOCHEM CELL B, V44, P496, DOI 10.1016/j.biocel.2011.11.021; Gupta MS, 2006, PHARM BIOL, V44, P263, DOI 10.1080/13880200600713949; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Hahm ER, 2013, CANCER LETT, V334, P101, DOI 10.1016/j.canlet.2012.08.026; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Jeyanthi Thangavel, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P61; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Matute C, 2011, J ANAT, V219, P53, DOI 10.1111/j.1469-7580.2010.01339.x; Nakatsu Y, 2009, TOXICOL APPL PHARM, V240, P292, DOI 10.1016/j.taap.2009.06.024; Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Wadegaonkar VP, 2013, J BIOTECHNOL, V168, P229, DOI 10.1016/j.jbiotec.2013.08.028; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Yan J, 2010, BRAIN RES, V1347, P132, DOI 10.1016/j.brainres.2010.05.074; Yu Y, 2009, BIOCHEM PHARMACOL, V79, P542; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120554	10.1371/journal.pone.0120554	http://dx.doi.org/10.1371/journal.pone.0120554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789768	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400162
J	Zhao, BS; Song, XR; Hu, PY; Meng, LX; Tan, YH; She, YJ; Ding, YY				Zhao, Bai-Song; Song, Xing-Rong; Hu, Pei-Ying; Meng, Ling-Xin; Tan, Yong-Hong; She, Ying-Jun; Ding, Yuan-Yuan			Hyperbaric Oxygen Treatment at Various Stages following Chronic Constriction Injury Produces Different Antinociceptive Effects via Regulation of P2X(4)R Expression and Apoptosis	PLOS ONE			English	Article							PREDOMINANTLY NEUROPATHIC ORIGIN; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; CHRONIC PAIN; GENERAL-POPULATION; NERVE INJURY; P2X4 RECEPTORS; UP-REGULATION; RAT MODEL; MICROGLIA	Purpose The aims of this study were to investigate the effect of hyperbaric oxygen (HBO) treatment at various stages following chronic constriction injury (CCI) and to explore the underlying mechanisms of HBO treatment. Methods Forty adult male Sprague-Dawley rats were randomly assigned to five groups (n = 8 for each group): the sham group, CCI group, HBO1 group, HBO2 group, and HBO3 group. Neuropathic pain was induced by CCI of the sciatic nerve. HBO treatment began on postoperative days 1, 6, and 11 and continued for 5 days. The mechanical withdrawal threshold and thermal withdrawal latency were tested on preoperative day 3 and postoperative days 1, 3, 5, 7, 10, 14, and 21. The expression of P2X(4)R was determined by immunohistochemistry and western blot analysis. Cell apoptosis was measured using TUNEL staining. The expression of caspase 3 was measured using reverse transcription polymerase chain reaction (RT-PCR). Electron microscopy was used to determine the ultrastructural changes. Results Early HBO treatment beginning on postoperative day 1 produced a persistent antinociceptive effect and inhibited the CCI-induced increase in the expression of P2X(4)R without changing CCI-induced apoptosis. In contrast, late HBO treatment beginning on postoperative day 11 produced a persistent antinociceptive effect and inhibited CCI-induced apoptosis and upregulation of caspase-3 without changing the expression of P2X(4)R. In addition, late HBO treatment reduced CCI-induced ultrastructural damage. However, HBO treatment beginning on postoperative day 6 produced a transient antinociceptive effect without changing the expression of P2X(4)R or CCI-induced apoptosis. Conclusion HBO treatment at various stages following CCI can produce antinociceptive effects via different mechanisms. Early HBO treatment is associated with inhibition of P2X(4)R expression, and late HBO treatment is associated with inhibition of cell apoptosis.	[Zhao, Bai-Song; Song, Xing-Rong; Hu, Pei-Ying; Tan, Yong-Hong; She, Ying-Jun] Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510623, Guangdong, Peoples R China; [Meng, Ling-Xin; Ding, Yuan-Yuan] China Med Univ, Shengjing Hosp, Dept Pain, Shenyang 110004, Peoples R China	China Medical University	Song, XR (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510623, Guangdong, Peoples R China.	zhaobaisong819@163.com	ding, yy/HHS-9589-2022		BBraun Anesthesia Scientific Research Fund [F10-205-1-41, BBF 2012-012]; Science and Technology Plan Project	BBraun Anesthesia Scientific Research Fund; Science and Technology Plan Project	This work is supported by the Science and Technology Plan Project and BBraun Anesthesia Scientific Research Fund (grant no. F10-205-1-41 and BBF 2012-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Attal N, 2011, PAIN, V152, P2836, DOI 10.1016/j.pain.2011.09.014; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dayan K, 2012, LIFE SCI, V90, P360, DOI 10.1016/j.lfs.2011.12.005; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Erturk A, 2014, J NEUROSCI, V34, P1672, DOI 10.1523/JNEUROSCI.3121-13.2014; Gibbons CR, 2013, BRAIN RES, V1537, P111, DOI 10.1016/j.brainres.2013.08.050; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Helms A, 2011, UNDERSEA HYPERBAR M, V38, P309; Inoue K, 2012, CNS NEUROL DISORD-DR, V11, P699, DOI 10.2174/187152712803581065; Ishihara H, 2001, J Orthop Sci, V6, P385, DOI 10.1007/s007760170003; Li FH, 2011, ANESTH ANALG, V113, P626, DOI 10.1213/ANE.0b013e31821f9544; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nakai K, 2010, NEUROREPORT, V21, P559, DOI 10.1097/WNR.0b013e32833980b2; Ohayon MM, 2012, J PSYCHIATR RES, V46, P444, DOI 10.1016/j.jpsychires.2012.01.001; Sanchez EC, 2007, NEUROL RES, V29, P184, DOI 10.1179/016164107X181824; Schwab JM, 2005, J NEUROIMMUNOL, V163, P185, DOI 10.1016/j.jneuroim.2005.02.016; Sekiguchi M, 2009, EUR SPINE J, V18, P1978, DOI 10.1007/s00586-009-1064-z; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Smith BH, 2012, CURR PAIN HEADACHE R, V16, P191, DOI 10.1007/s11916-012-0256-0; SUGIMOTO T, 1990, PAIN, V42, P205, DOI 10.1016/0304-3959(90)91164-E; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010; Yamashita S, 2009, BRAIN RES, V1301, P171, DOI 10.1016/j.brainres.2009.08.096; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhang Z, 2008, NEUROSCIENCE, V152, P495, DOI 10.1016/j.neuroscience.2007.12.042; Zhao BS, 2014, J MOL NEUROSCI, V53, P251, DOI 10.1007/s12031-013-0213-3	38	13	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120122	10.1371/journal.pone.0120122	http://dx.doi.org/10.1371/journal.pone.0120122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789619	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400131
J	Gutschalk, A; Rupp, A; Dykstra, AR				Gutschalk, Alexander; Rupp, Andre; Dykstra, Andrew R.			Interaction of Streaming and Attention in Human Auditory Cortex	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; BRAIN POTENTIALS; FREQUENCY SEPARATION; SELECTIVE ATTENTION; SEGREGATION; INTERVALS; PATTERN; MONKEY; SOUND; CUES	Serially presented tones are sometimes segregated into two perceptually distinct streams. An ongoing debate is whether this basic streaming phenomenon reflects automatic processes or requires attention focused to the stimuli. Here, we examined the influence of focused attention on streaming-related activity in human auditory cortex using magnetoencephalography (MEG). Listeners were presented with a dichotic paradigm in which left-ear stimuli consisted of canonical streaming stimuli (ABA_ or ABAA) and right-ear stimuli consisted of a classical oddball paradigm. In phase one, listeners were instructed to attend the right-ear oddball sequence and detect rare deviants. In phase two, they were instructed to attend the left ear streaming stimulus and report whether they heard one or two streams. The frequency difference (Delta F) of the sequences was set such that the smallest and largest Delta F conditions generally induced one-and two-stream percepts, respectively. Two intermediate Delta F conditions were chosen to elicit bistable percepts (i.e., either one or two streams). Attention enhanced the peak-to-peak amplitude of the P1-N1 complex, but only for ambiguous Delta F conditions, consistent with the notion that automatic mechanisms for streaming tightly interact with attention and that the latter is of particular importance for ambiguous sound sequences.	[Gutschalk, Alexander; Rupp, Andre; Dykstra, Andrew R.] Heidelberg Univ, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Gutschalk, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Alexander.Gutschalk@med.uni-heidelberg.de			Bundesministerium fur Bildung und Forschung (BMBF) [01EV0712]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Research supported by Bundesministerium fur Bildung und Forschung (BMBF grant 01EV0712 to A. Gutschalk). Open access publishing supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1993, PSYCHOPHYSIOLOGY, V30, P572, DOI 10.1111/j.1469-8986.1993.tb02083.x; ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Bendixen A, 2013, CLIN NEUROPHYSIOL, V124, P928, DOI 10.1016/j.clinph.2012.11.012; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Carl D, 2013, EXP BRAIN RES, V224, P557, DOI 10.1007/s00221-012-3333-z; Carlyon RP, 2003, PERCEPTION, V32, P1393, DOI 10.1068/p5035; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Deike S, 2010, HEARING RES, V265, P30, DOI 10.1016/j.heares.2010.03.005; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gutschalk A, 2004, EUR J NEUROSCI, V20, P3141, DOI 10.1111/j.1460-9568.2004.03767.x; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; Gutschalk A, 2014, HEARING RES, V307, P98, DOI 10.1016/j.heares.2013.08.003; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; Hill KT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00158; Hill KT, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-85; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; MILLER GA, 1950, J ACOUST SOC AM, V22, P637, DOI 10.1121/1.1906663; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rif J., 1991, CLIN NEUROPHYSIOL, V79, P464, DOI [10.1016/0013-4694(91)90166-2, DOI 10.1016/0013-4694(91)90166-2]; Schadwinkel S, 2011, J NEUROPHYSIOL, V105, P1977, DOI 10.1152/jn.00461.2010; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Sussman E, 2007, HEARING RES, V225, P117, DOI 10.1016/j.heares.2006.12.013; Sussman E, 1999, PSYCHOPHYSIOLOGY, V36, P22, DOI 10.1017/S0048577299971056; Szalardy O, 2013, BIOL PSYCHOL, V93, P97, DOI 10.1016/j.biopsycho.2013.01.015; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722	37	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118962	10.1371/journal.pone.0118962	http://dx.doi.org/10.1371/journal.pone.0118962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785997	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500061
J	Russell, M; West, DJ; Briggs, MA; Bracken, RM; Cook, CJ; Giroud, T; Gill, N; Kilduff, LP				Russell, Mark; West, Daniel J.; Briggs, Marc A.; Bracken, Richard M.; Cook, Christian J.; Giroud, Thibault; Gill, Nicholas; Kilduff, Liam P.			A Passive Heat Maintenance Strategy Implemented during a Simulated Half-Time Improves Lower Body Power Output and Repeated Sprint Ability in Professional Rugby Union Players	PLOS ONE			English	Article							SOCCER MATCH-PLAY; WARM-UP; MUSCLE TEMPERATURE; CARBOHYDRATE INGESTION; PERFORMANCE; EXERCISE; VALIDITY; METABOLISM; 2ND-HALF; PROTOCOL	Reduced physical performance has been observed following the half-time period in team sports players, likely due to a decrease in muscle temperature during this period. We examined the effects of a passive heat maintenance strategy employed between successive exercise bouts on core temperature (Tcore) and subsequent exercise performance. Eighteen professional Rugby Union players completed this randomised and counter-balanced study. After a standardised warm-up (WU) and 15 min of rest, players completed a repeated sprint test (RSSA 1) and countermovement jumps (CMJ). Thereafter, in normal training attire (Control) or a survival jacket (Passive), players rested for a further 15 min (simulating a typical half-time) before performing a second RSSA (RSSA 2) and CMJ's. Measurements of Tcore were taken at baseline, post-WU, pre-RSSA 1, post-RSSA 1 and pre-RSSA 2. Peak power output (PPO) and repeated sprint ability was assessed before and after the simulated half-time. Similar Tcore responses were observed between conditions at baseline (Control: 37.06 +/- 0.05 degrees C; Passive: 37.03 +/- 0.05 degrees C) and for all other Tcore measurements taken before half-time. After the simulated half-time, the decline in Tcore was lower (-0.74 +/- 0.08% vs. -1.54 +/- 0.06%, p<0.001) and PPO was higher (5610 +/- 105Wvs. 5440 +/- 105W, p<0.001) in the Passive versus Control condition. The decline in PPO over half-time was related to the decline in Tcore (r = 0.632, p = 0.005). In RSSA 2, best, mean and total sprint times were 1.39 +/- 0.17% (p<0.001), 0.55 +/- 0.06% (p<0.001) and 0.55 +/- 0.06%(p<0.001) faster for Passive versus Control. Passive heat maintenance reduced declines in Tcore that were observed during a simulated half-time period and improved subsequent PPO and repeated sprint ability in professional Rugby Union players.	[Russell, Mark; West, Daniel J.; Briggs, Marc A.] Northumbria Univ, Dept Sport Exercise & Rehabil, Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Bracken, Richard M.; Gill, Nicholas; Kilduff, Liam P.] Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr A STEM, Hlth & Sport Portfolio, Swansea, W Glam, Wales; [Cook, Christian J.] Bangor Univ, Sch Sport Hlth & Exercise Sci, Bangor, Gwynedd, Wales; [Giroud, Thibault] Biarritz Olymp Rugby, Biarritz, France	Northumbria University; Swansea University; Bangor University	Kilduff, LP (corresponding author), Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr A STEM, Hlth & Sport Portfolio, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Russell, Mark/M-1652-2019; Bracken, Rich/AAC-2586-2021; West, Daniel/O-4127-2014	Russell, Mark/0000-0002-7305-1090; Bracken, Rich/0000-0002-6986-6449; Cook, Christian/0000-0001-9677-0306; Briggs, Marc/0000-0001-5920-7223; West, Daniel/0000-0003-2246-4925				Allen PB, 2010, J TRAUMA, V69, pS154, DOI 10.1097/TA.0b013e3181e45ba5; BENNETT AF, 1984, AM J PHYSIOL, V247, pR217, DOI 10.1152/ajpregu.1984.247.2.R217; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cook C, 2013, INT J SPORT PHYSIOL, V8, P213, DOI 10.1123/ijspp.8.2.213; DAVIES CTM, 1983, J APPL PHYSIOL, V55, P191, DOI 10.1152/jappl.1983.55.1.191; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; EDWARDS RHT, 1972, J PHYSIOL-LONDON, V220, P335, DOI 10.1113/jphysiol.1972.sp009710; Faulkner SH, 2013, MED SCI SPORT EXER, V45, P359, DOI 10.1249/MSS.0b013e31826fba7f; Febbraio MA, 1996, AM J PHYSIOL-REG I, V271, pR1251, DOI 10.1152/ajpregu.1996.271.5.R1251; Hatze H, 1998, J APPL BIOMECH, V14, P127, DOI 10.1123/jab.14.2.127; HILL DK, 1972, J PHYSIOL-LONDON, V221, P161, DOI 10.1113/jphysiol.1972.sp009746; Kilduff LP, 2013, J SCI MED SPORT, V16, P482, DOI 10.1016/j.jsams.2012.11.889; Lovell R, 2013, SCAND J MED SCI SPOR, V23, P105, DOI 10.1111/j.1600-0838.2011.01353.x; MacDonald M, 1997, J APPL PHYSIOL, V83, P1318, DOI 10.1152/jappl.1997.83.4.1318; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Owen NJ, 2014, J STRENGTH COND RES, V28, P1552, DOI 10.1519/JSC.0000000000000311; Rampinini E, 2007, INT J SPORTS MED, V28, P228, DOI 10.1055/s-2006-924340; Russell M, 2011, INT J SPORTS MED, V32, P511, DOI 10.1055/s-0031-1273742; Russell M, 2015, SPORTS MED, V45, P353, DOI 10.1007/s40279-014-0297-0; Russell M, 2014, J ATHL TRAINING, V49, P447, DOI 10.4085/1062-6050-49.3.12; Russell M, 2012, J STRENGTH COND RES, V26, P2593, DOI 10.1519/JSC.0b013e31823f284e; Russell M, 2012, J SCI MED SPORT, V15, P348, DOI 10.1016/j.jsams.2011.12.006; SARGEANT AJ, 1987, EUR J APPL PHYSIOL, V56, P693, DOI 10.1007/BF00424812; Smart D, 2014, EUR J SPORT SCI, V14, pS8, DOI 10.1080/17461391.2011.635812; Sugiura K, 1998, MED SCI SPORT EXER, V30, P1624, DOI 10.1097/00005768-199811000-00011; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; West DJ, 2013, J SCI MED SPORT, V16, P172, DOI 10.1016/j.jsams.2012.06.002; West DJ, 2011, J STRENGTH COND RES, V25, P3070, DOI 10.1519/JSC.0b013e318212dcd5; Weston M, 2011, INT J SPORT PHYSIOL, V6, P174, DOI 10.1123/ijspp.6.2.174	30	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119374	10.1371/journal.pone.0119374	http://dx.doi.org/10.1371/journal.pone.0119374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785393	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352138500098
J	Vockenhuber, MP; Heueis, N; Suess, B				Vockenhuber, Michael-Paul; Heueis, Nona; Suess, Beatrix			Identification of metE as a Second Target of the sRNA scr5239 in Streptomyces coelicolor	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; METABOLISM; METHIONINE; EXPRESSION; GENE; PREDICTION; BACTERIA; BINDING; ROLES	While transcriptional regulation of the primary and secondary metabolism of the model organism Streptomyces coelicolor is well studied, little is still known about the role small noncoding RNAs (sRNAs) play in regulating gene expression in this organism. Here, we report the identification of a second target of the sRNA scr5239, an sRNA highly conserved in streptomycetes. The 159 nt long sRNA binds its target, the mRNA of the cobalamin independent methionine synthase metE (SCO0985), at the 5' end of its open reading frame thereby repressing translation. We show that a high methionine level induces expression of scr5239 itself. This leads, in a negative feedback loop, to the repression of methionine biosynthesis. In contrast to the first reported target of this sRNA, the agarase dagA, this interaction seems to be conserved in a wide number of streptomycetes.	[Vockenhuber, Michael-Paul; Heueis, Nona; Suess, Beatrix] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Technical University of Darmstadt	Vockenhuber, MP (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	vockenhuber@bio.tu-darmstadt.de; bsuess@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft; priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1;  [SU402/2-1];  [SU402/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1; ; 	The study was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de), priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1 and the grants SU402/2-1 and 2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Heueis N, 2014, RNA BIOL, V11, P464, DOI 10.4161/rna.28262; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SH, 2012, J BACTERIOL, V194, P6837, DOI 10.1128/JB.00695-12; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Mattatall NR, 1996, J BACTERIOL, V178, P2272, DOI 10.1128/jb.178.8.2272-2278.1996; Moody MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-558; Muller M, 2006, NUCLEIC ACIDS RES, V34, P2607, DOI 10.1093/nar/gkl347; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reining A, 2013, NATURE, V499, P355, DOI 10.1038/nature12378; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x; Rudolph MM, 2013, MICROBIOL-SGM, V159, P1416, DOI 10.1099/mic.0.067322-0; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Song TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101280; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Torres-Quesada O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068147; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Watson PY, 2011, NAT STRUCT MOL BIOL, V18, P359, DOI 10.1038/nsmb.1989; Wright PR, 2013, P NATL ACAD SCI USA, V110, pE3487, DOI 10.1073/pnas.1303248110	41	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120147	10.1371/journal.pone.0120147	http://dx.doi.org/10.1371/journal.pone.0120147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785836	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500157
J	Brulhart-Meynet, MC; Braunersreuther, V; Brinck, J; Montecucco, F; Prost, JC; Thomas, A; Galan, K; Pelli, G; Pedretti, S; Vuilleumier, N; Mach, F; Lecour, S; James, RW; Frias, MA				Brulhart-Meynet, Marie-Claude; Braunersreuther, Vincent; Brinck, Jonas; Montecucco, Fabrizio; Prost, Jean-Christophe; Thomas, Aurelien; Galan, Katia; Pelli, Graziano; Pedretti, Sarah; Vuilleumier, Nicolas; Mach, Francois; Lecour, Sandrine; James, Richard W.; Frias, Miguel A.			Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS; ACUTE CORONARY SYNDROMES; SPHINGOSINE 1-PHOSPHATE; ISCHEMIA/REPERFUSION INJURY; RABBIT HEART; ATHEROSCLEROSIS; PROTECT	Background New evidence shows that high density lipoproteins (HDL) have protective effects beyond their role in reverse cholesterol transport. Reconstituted HDL (rHDL) offer an attractive means of clinically exploiting these novel effects including cardioprotection against ischemia reperfusion injury (IRI). However, basic rHDL composition is limited to apolipoprotein AI (apoAI) and phospholipids; addition of bioactive compound may enhance its beneficial effects. Objective The aim of this study was to investigate the role of rHDL in post-ischemic model, and to analyze the potential impact of sphingosine-1-phosphate (S1P) in rHDL formulations. Methods and Results The impact of HDL on IRI was investigated using complementary in vivo, ex vivo and in vitro IRI models. Acute post-ischemic treatment with native HDL significantly reduced infarct size and cell death in the ex vivo, isolated heart (Langendorff) model and the in vivo model (-48%, p<0.01). Treatment with rHDL of basic formulation (apoAI + phospholipids) had a non-significant impact on cell death in vitro and on the infarct size ex vivo and in vivo. In contrast, rHDL containing S1P had a highly significant, protective influence ex vivo, and in vivo (-50%, p<0.01). This impact was comparable with the effects observed with native HDL. Pro-survival signaling proteins, Akt, STAT3 and ERK1/2 were similarly activated by HDL and rHDL containing S1P both in vitro (isolated cardiomyocytes) and in vivo. Conclusion HDL afford protection against IRI in a clinically relevant model (post-ischemia). rHDL is significantly protective if supplemented with S1P. The protective impact of HDL appears to target directly the cardiomyocyte.	[Brulhart-Meynet, Marie-Claude; Brinck, Jonas; James, Richard W.; Frias, Miguel A.] Fac Med, Dept Internal Med, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland; [Braunersreuther, Vincent; Montecucco, Fabrizio; Galan, Katia; Pelli, Graziano; Mach, Francois] Univ Hosp Geneva, Dept Internal Med, Div Cardiol, Geneva, Switzerland; [Braunersreuther, Vincent; Montecucco, Fabrizio; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Genet & Lab Med, Serv Lab Med, Geneva, Switzerland; [Montecucco, Fabrizio; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Montecucco, Fabrizio] Univ Genoa, IRCCS Azienda Osped Univ San Martino, IST Inst Nazl Ric Cancro, Clin Internal Med 1,Dept Internal Med,Sch Med, Genoa, Italy; [Prost, Jean-Christophe; Thomas, Aurelien] Univ Lausanne, CURML, Toxicol Unit, Lausanne, Switzerland; [Pedretti, Sarah; Lecour, Sandrine] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Genoa; IRCCS AOU San Martino IST; University of Lausanne; University of Cape Town	Frias, MA (corresponding author), Fac Med, Dept Internal Med, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland.	Miguel.Frias@unige.ch	Montecucco, Fabrizio/K-8543-2016; Brinck, Jonas/L-7924-2018	Montecucco, Fabrizio/0000-0003-0823-8729; , Nicolas/0000-0002-1122-438X; Thomas, Aurelien/0000-0001-6790-2285; , sandrine/0000-0003-1942-8974; Prost, Jean-Christophe/0000-0002-8820-706X	Swiss South African Joint Research Programme [JRP 16]; Swiss National Science Foundation (SNSF) [31-135221]; Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques; National Research Foundation; University of Cape Town; South African Medical Research Council; Swiss National Science Foundation [32003B_134963/1, 310030_118245]	Swiss South African Joint Research Programme; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques; National Research Foundation; University of Cape Town; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported in part by the Swiss South African Joint Research Programme (JRP 16) to SL and RWJ; the Swiss National Science Foundation (SNSF grant 31-135221 to RWJ); Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques to MAF; and the National Research Foundation, the University of Cape Town, and South African Medical Research Council to SL. This work was also supported by Swiss National Science Foundation Grants to Dr. F. Montecucco (#32003B_134963/1) and to Prof. F. Mach (#310030_118245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Calabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A; Chenevard R, 2012, CARDIOVASC THER, V30, pe51, DOI 10.1111/j.1755-5922.2010.00221.x; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Frias MA, 2013, ATHEROSCLEROSIS, V228, P110, DOI 10.1016/j.atherosclerosis.2013.02.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; JAMES RW, 1989, BIOCHIM BIOPHYS ACTA, V1002, P292, DOI 10.1016/0005-2760(89)90343-3; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kiya Y, 2009, ATHEROSCLEROSIS, V203, P137, DOI 10.1016/j.atherosclerosis.2008.05.056; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Marchesi M, 2004, J PHARMACOL EXP THER, V311, P1023, DOI 10.1124/jpet.104.070789; Marchesi M, 2008, ATHEROSCLEROSIS, V197, P572, DOI 10.1016/j.atherosclerosis.2007.08.028; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Nieuwdorp M, 2008, DIABETOLOGIA, V51, P1081, DOI 10.1007/s00125-008-0975-2; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Rossoni G, 2004, J PHARMACOL EXP THER, V308, P79, DOI 10.1124/jpet.103.057141; Sattler K, 2014, CELL PHYSIOL BIOCHEM, V34, P172, DOI 10.1159/000362993; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Smith RM, 2002, CARDIOVASC RES, V55, P553, DOI 10.1016/S0008-6363(02)00283-3; Somers SJ, 2012, CARDIOVASC DRUG THER, V26, P227, DOI 10.1007/s10557-012-6376-2; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; Tao R, 2010, AM J PHYSIOL-HEART C, V298, pH1022, DOI 10.1152/ajpheart.00902.2009; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135	28	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119664	10.1371/journal.pone.0119664	http://dx.doi.org/10.1371/journal.pone.0119664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781943	gold, Green Published			2022-12-26	WOS:000351284600083
J	Merrick, CJ; Jiang, RHY; Skillman, KM; Samarakoon, U; Moore, RM; Dzikowski, R; Ferdig, MT; Duraisingh, MT				Merrick, Catherine J.; Jiang, Rays H. Y.; Skillman, Kristen M.; Samarakoon, Upeka; Moore, Rachel M.; Dzikowski, Ron; Ferdig, Michael T.; Duraisingh, Manoj T.			Functional Analysis of Sirtuin Genes in Multiple Plasmodium falciparum Strains	PLOS ONE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; CHONDROITIN SULFATE-A; VIRULENCE GENES; ANTIGENIC VARIATION; MALARIA PARASITES; DIFFERENTIAL EXPRESSION; TELOMERE LENGTH; VARIANT ANTIGEN; ARRAY CGH; TRANSCRIPTION	Plasmodium falciparum, the causative agent of severe human malaria, employs antigenic variation to avoid host immunity. Antigenic variation is achieved by transcriptional switching amongst polymorphic var genes, enforced by epigenetic modification of chromatin. The histone-modifying 'sirtuin' enzymes PfSir2a and PfSir2b have been implicated in this process. Disparate patterns of var expression have been reported in patient isolates as well as in cultured strains. We examined var expression in three commonly used laboratory strains (3D7, NF54 and FCR-3) in parallel. NF54 parasites express significantly lower levels of var genes compared to 3D7, despite the fact that 3D7 was originally a clone of the NF54 strain. To investigate whether this was linked to the expression of sirtuins, genetic disruption of both sirtuins was attempted in all three strains. No dramatic changes in var gene expression occurred in NF54 or FCR-3 following PfSir2b disruption, contrasting with previous observations in 3D7. In 3D7, complementation of the PfSir2a genetic disruption resulted in a significant decrease in previously-elevated var gene expression levels, but with the continued expression of multiple var genes. Finally, rearranged chromosomes were observed in the 3D7 PfSir2a knockout line. Our results focus on the potential for parasite genetic background to contribute to sirtuin function in regulating virulence gene expression and suggest a potential role for sirtuins in maintaining genome integrity.	[Merrick, Catherine J.; Jiang, Rays H. Y.; Skillman, Kristen M.; Moore, Rachel M.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Samarakoon, Upeka; Ferdig, Michael T.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,IMRIC, IL-91010 Jerusalem, Israel	Harvard University; Harvard T.H. Chan School of Public Health; University of Notre Dame; Hebrew University of Jerusalem	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu	Dzikowski, Ron/HHZ-2430-2022; Ferdig, Michael/C-6627-2016; Merrick, Catherine/AAD-9154-2022	Merrick, Catherine/0000-0001-7583-2176	Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award; Charles H. Hood Foundation; NIH [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071121] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award; Charles H. Hood Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award to MTD, a Charles H. Hood Foundation fellowship to CJM, and by NIH Grant AI071121 to MTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brancucci NMB, 2014, CELL HOST MICROBE, V16, P165, DOI 10.1016/j.chom.2014.07.004; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Coleman BI, 2014, CELL HOST MICROBE, V16, P177, DOI 10.1016/j.chom.2014.06.014; CORCORAN LM, 1986, CELL, V44, P87, DOI 10.1016/0092-8674(86)90487-3; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fastman Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034168; Fernandez V, 2002, MOL BIOCHEM PARASIT, V121, P195, DOI 10.1016/S0166-6851(02)00038-5; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Frank M, 2006, INT J PARASITOL, V36, P975, DOI 10.1016/j.ijpara.2006.05.007; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HernandezRivas R, 1997, MEM I OSWALDO CRUZ, V92, P815, DOI 10.1590/S0074-02761997000600017; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; KEMP DJ, 1985, NATURE, V315, P347, DOI 10.1038/315347a0; Kirkman LA, 1996, EXP PARASITOL, V83, P147, DOI 10.1006/expr.1996.0058; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Mancio-Silva L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2539; Merrick CJ, 2007, EUKARYOT CELL, V6, P2081, DOI 10.1128/EC.00114-07; Merrick CJ, 2010, INT J PARASITOL, V40, P35, DOI 10.1016/j.ijpara.2009.06.012; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tan JC, 2009, GENOMICS, V93, P543, DOI 10.1016/j.ygeno.2009.02.007; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001	62	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118865	10.1371/journal.pone.0118865	http://dx.doi.org/10.1371/journal.pone.0118865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780929	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351284600036
J	O'Connor, C; Campos, J; Osinski, JM; Gronostajski, RM; Michie, AM; Keeshan, K				O'Connor, Caitriona; Campos, Joana; Osinski, Jason M.; Gronostajski, Richard M.; Michie, Alison M.; Keeshan, Karen			Nfix Expression Critically Modulates Early B Lymphopoiesis and Myelopoiesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EBF; C/EBP-ALPHA; MULTIPOTENT PROGENITORS; CELL DIFFERENTIATION; LINEAGE COMMITMENT; REGULATORY ELEMENT; DISTAL ENHANCER; STEM-CELLS; PU.1; PROTEINS	The commitment of stem and progenitor cells toward specific hematopoietic lineages is tightly controlled by a number of transcription factors that regulate differentiation programs via the expression of lineage restricting genes. Nuclear factor one (NFI) transcription factors are important in regulating hematopoiesis and here we report an important physiological role of NFIX in B-and myeloid lineage commitment and differentiation. We demonstrate that NFIX acts as a regulator of lineage specification in the haematopoietic system and the expression of Nfix was transcriptionally downregulated as B cells commit and differentiate, whilst maintained in myeloid progenitor cells. Ectopic Nfix expression in vivo blocked early B cell development stage, coincident with the stage of its downregulation. Furthermore, loss of Nfix resulted in the perturbation of myeloid and lymphoid cell differentiation, and a skewing of gene expression involved in lineage fate determination. Nfix was able to promote myeloid differentiation of total bone marrow cells under B cell specific culture conditions but not when expressed in the hematopoietic stem cell (HSPC), consistent with its role in HSPC survival. The lineage choice determined by Nfix correlated with transcriptional changes in a number of genes, such as E2A, C/EBP, and Id genes. These data highlight a novel and critical role for NFIX transcription factor in hematopoiesis and in lineage specification.	[O'Connor, Caitriona; Campos, Joana; Michie, Alison M.; Keeshan, Karen] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland; [Osinski, Jason M.; Gronostajski, Richard M.] SUNY Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA; [Osinski, Jason M.; Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA	University of Glasgow; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Keeshan, K (corresponding author), Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland.	Karen.keeshan@glasgow.ac.uk	Keeshan, Karen/L-5615-2013	Keeshan, Karen/0000-0001-7266-0890; O'Connor, Caitriona/0000-0002-7638-9804; Michie, Alison/0000-0002-5404-475X	Kay Kendall foundation [KKL501]; Howat foundation; Children with Cancer UK; Science Foundation Ireland PIYRA; Marie Curie EU-FP7-PEOPLE-IRG; Children's Leukaemia Research Project grant; MRC [MR/K014854/1]; Medical Research Council [MR/K014854/1, G0601099] Funding Source: researchfish; MRC [G0601099] Funding Source: UKRI	Kay Kendall foundation; Howat foundation; Children with Cancer UK; Science Foundation Ireland PIYRA(Science Foundation Ireland); Marie Curie EU-FP7-PEOPLE-IRG; Children's Leukaemia Research Project grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to thank the Kay Kendall foundation (KKL501), and the Howat foundation for Flow cytometry facility funding. KK was supported by funds from the Howat Foundation, Children with Cancer UK, Science Foundation Ireland PIYRA award and Marie Curie EU-FP7-PEOPLE-IRG. This work was also supported by Children's Leukaemia Research Project grant (CO) and an MRC project grant (MR/K014854/1; AMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Holmfeldt P, 2013, BLOOD; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Nakagawa R, 2012, EUR J IMMUNOL, V42, P1005, DOI 10.1002/eji.201141442; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Starnes LM, 2010, LEUKEMIA, V24, P1220, DOI 10.1038/leu.2010.78; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120102	10.1371/journal.pone.0120102	http://dx.doi.org/10.1371/journal.pone.0120102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780920	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000351284600126
J	Romagnan, JB; Legendre, L; Guidi, L; Jamet, JL; Jamet, D; Mousseau, L; Pedrotti, ML; Picheral, M; Gorsky, G; Sardet, C; Stemmann, L				Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Jamet, Jean-Louis; Jamet, Dominique; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Sardet, Christian; Stemmann, Lars			Comprehensive Model of Annual Plankton Succession Based on the Whole-Plankton Time Series Approach	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN-SEA; VILLEFRANCHE-SUR-MER; LIGURIAN SEA; GRAZING IMPACT; HYDROGRAPHIC CONDITIONS; MARINE ECOSYSTEMS; TROPHIC CASCADES; LIFE-CYCLES; PEG-MODEL; PHYTOPLANKTON	Ecological succession provides a widely accepted description of seasonal changes in phytoplankton and mesozooplankton assemblages in the natural environment, but concurrent changes in smaller (i.e. microbes) and larger (i.e. macroplankton) organisms are not included in the model because plankton ranging from bacteria to jellies are seldom sampled and analyzed simultaneously. Here we studied, for the first time in the aquatic literature, the succession of marine plankton in the whole-plankton assemblage that spanned 5 orders of magnitude in size from microbes to macroplankton predators (not including fish or fish larvae, for which no consistent data were available). Samples were collected in the northwestern Mediterranean Sea (Bay of Villefranche) weekly during 10 months. Simultaneously collected samples were analyzed by flow cytometry, inverse microscopy, FlowCam, and ZooScan. The whole-plankton assemblage underwent sharp reorganizations that corresponded to bottom-up events of vertical mixing in the water-column, and its development was top-down controlled by large gelatinous filter feeders and predators. Based on the results provided by our novel whole-plankton assemblage approach, we propose a new comprehensive conceptual model of the annual plankton succession (i.e. whole plankton model) characterized by both stepwise stacking of four broad trophic communities from early spring through summer, which is a new concept, and progressive replacement of ecological plankton categories within the different trophic communities, as recognised traditionally.	[Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Stemmann, Lars] Univ Paris 06, Sorbonne Univ, UMR LOV 7093, F-75005 Paris, France; [Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Stemmann, Lars] CNRS, UMR LOV 7093, F-75005 Paris, France; [Sardet, Christian] Univ Paris 06, Sorbonne Univ, UMR BioDev 7009, F-75005 Paris, France; [Sardet, Christian] CNRS, UMR BioDev 7009, F-75005 Paris, France; [Jamet, Jean-Louis; Jamet, Dominique] Univ Sud Toulon Var, F-83000 La Garde, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Romagnan, JB (corresponding author), Univ Paris 06, Sorbonne Univ, UMR LOV 7093, F-75005 Paris, France.	romagnan@obs-vlfr.fr	Jamet, Jean-Louis JLJ/G-9893-2013; Guidi, Lionel/B-3977-2012; JAMET, Dominique/AAT-9861-2021; stemmann, lars/Q-8458-2019; stemmann, lars/E-6899-2011	Jamet, Jean-Louis JLJ/0000-0002-2296-6231; Guidi, Lionel/0000-0002-6669-5744; JAMET, Dominique/0000-0003-2575-3722; stemmann, lars/0000-0001-8935-4531; Gorsky, Gabriel/0000-0002-1099-8711	Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres; European Union [262584]	Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres; European Union(European Commission)	JBR received funding from Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres. Euromediterranee doctoral fellowship. JBR received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no262584, JERICO. MP and LS received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no262584, JERICO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TFH, 1977, ECOLOGY, V58, P1076, DOI 10.2307/1936927; Andersen V., 1998, P125; Barber RT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002726; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; BOUCHER J, 1987, J MAR RES, V45, P133, DOI 10.1357/002224087788400891; BUSTILLOSGUZMAN J, 1995, MAR ECOL PROG SER, V124, P247, DOI 10.3354/meps124247; Calbet A, 2001, J PLANKTON RES, V23, P319, DOI 10.1093/plankt/23.3.319; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; CLAUSTRE H, 1989, J EXP MAR BIOL ECOL, V129, P17, DOI 10.1016/0022-0981(89)90060-9; D'Alcala MR, 2004, SCI MAR, V68, P65; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Deibel D, 2012, ICES J MAR SCI, V69, P358, DOI 10.1093/icesjms/fsr159; Dubischar CD, 1997, DEEP-SEA RES PT II, V44, P415, DOI 10.1016/S0967-0645(96)00064-1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Falkowski PG, 2003, GLO CH IGBP, P99; Fernex FE, 1996, ESTUAR COAST SHELF S, V43, P359, DOI 10.1006/ecss.1996.0075; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FERRIERPAGES C, 1994, MAR ECOL PROG SER, V108, P283, DOI 10.3354/meps108283; Garcia-Comas C, 2011, J MARINE SYST, V87, P216, DOI 10.1016/j.jmarsys.2011.04.003; Gasparini S, 2013, PLANKTON IDENTIFIER; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Gomez F, 2003, J PLANKTON RES, V25, P323, DOI 10.1093/plankt/25.4.323; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Haskell AGE, 1999, J PLANKTON RES, V21, P1725, DOI 10.1093/plankt/21.9.1725; Hay S, 2006, CURR BIOL, V16, pR679, DOI 10.1016/j.cub.2006.08.010; Hereu CM, 2006, MAR ECOL PROG SER, V318, P123, DOI 10.3354/meps318123; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; Jamet JL, 2005, MAR FRESHWATER RES, V56, P69, DOI 10.1071/MF04102; Landry MR, 2002, HYDROBIOLOGIA, V480, P29, DOI 10.1023/A:1021272731737; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; LEVASSEUR M, 1984, MAR ECOL PROG SER, V19, P211, DOI 10.3354/meps019211; Licandro P, 2006, LIMNOL OCEANOGR, V51, P1832, DOI 10.4319/lo.2006.51.4.1832; Madin LP, 2006, DEEP-SEA RES PT I, V53, P804, DOI 10.1016/j.dsr.2005.12.018; Mann KH, 2006, DYNAMICS MARINE ECOS; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Margalef R., 1967, Oceanography and Marine Biology, V5, P257; Margalef R., 1968, PERSPECTIVES ECOLOGI; Margalef R., 1958, PERSPECTIVES MARINE, P323; Marie D, 1999, CURRENT PROTOCOLS CY; Marty JC, 2010, BIOGEOSCIENCES, V7, P2117, DOI 10.5194/bg-7-2117-2010; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Molinero JC, 2008, J MARINE SYST, V69, P271, DOI 10.1016/j.jmarsys.2005.11.023; NIVAL P, 1976, ANN I OCEANOGR PARIS, V52, P57; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; ODUM EP, 1977, SCIENCE, V195, P1289, DOI 10.1126/science.195.4284.1289; Piterbarg L, 2014, J MARINE SYST, V129, P381, DOI 10.1016/j.jmarsys.2013.08.003; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ryther JH, 1963, MARINE BIOL 1, P25; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2008, INT REV HYDROBIOL, V93, P506, DOI 10.1002/iroh.200711039; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; SOURNIA A, 1990, OCEANOL ACTA, V13, P413; Stemmann L, 2008, J MARINE SYST, V70, P1, DOI 10.1016/j.jmarsys.2007.02.014; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277	61	27	28	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119219	10.1371/journal.pone.0119219	http://dx.doi.org/10.1371/journal.pone.0119219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780912	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600056
J	Marquez, M; Romero-Cores, P; Montes-Oca, M; Martin-Aspas, A; Soto-Cardenas, MJ; Guerrero, F; Fernandez-Gutierrez, C; Giron-Gonzalez, JA				Marquez, Mercedes; Romero-Cores, Paula; Montes-Oca, Monserrat; Martin-Aspas, Andres; Soto-Cardenas, Maria-Jose; Guerrero, Francisca; Fernandez-Gutierrez, Clotilde; Giron-Gonzalez, Jose-Antonio			Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; REGULATORY T-CELLS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PLASMA-LEVELS; CD4; INDIVIDUALS; CIRRHOSIS; RECOVERY; COUNTS	Objectives We have analyzed the parameters (bacterial translocation, immune activation and regulation, presence of HCV coinfection) which could be implicated in an inappropriate immune response from individuals with chronic HIV infection. The influence of them on the evolution of CD4+ T cell count has been investigated. Patients and methods Seventy HIV-infected patients [monoinfected by HIV (n = 20), HCV-coinfected (with (n = 25) and without (n = 25) liver cirrhosis)] and 25 healthy controls were included. Median duration of HIV infection was 20 years. HIV- and HCV-related parameters, as well as markers relative to bacterial translocation, monocyte and lymphocyte activation and regulation were considered as independent variables. Dependent variables were the increase of CD4+ T cell count during the follow-up (12 months). Results Increased values of bacterial translocation, measured by lipopolysaccharide-binding protein, monocyte and lymphocyte activation markers and T regulatory lymphocytes were detected in HIV-monoinfected and HIV/HCV coinfected patients. Serum sCD14 and IL-6 were increased in HIV/HCV-coinfected patients with liver cirrhosis in comparison with those with chronic hepatitis or HIV-monoinfected individuals. Time with undetectable HIV load was not related with these parameters. The presence of cirrhosis was negatively associated with a CD4+ T cell count increase. Conclusion In patients with a chronic HIV infection, a persistent increase of lipopolysaccharide-binding protein and monocyte and lymphocyte modifications are present. HCV-related cirrhosis is associated with more elevated serum concentrations of monocyte-derived markers. Cirrhosis influences the continued immune reconstitution of these patients.	[Marquez, Mercedes; Romero-Cores, Paula; Montes-Oca, Monserrat; Martin-Aspas, Andres; Soto-Cardenas, Maria-Jose; Guerrero, Francisca; Giron-Gonzalez, Jose-Antonio] Univ Cadiz, Hosp Univ Puerta Mar, Serv Med Interna Enfermedades Infecciosas, Cadiz, Spain; [Fernandez-Gutierrez, Clotilde] Univ Cadiz, Hosp Univ Puerta Mar, Microbiol Serv, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Giron-Gonzalez, JA (corresponding author), Univ Cadiz, Hosp Univ Puerta Mar, Serv Med Interna Enfermedades Infecciosas, Cadiz, Spain.	joseantonio.giron@uca.es	Girón-González, José-Antonio/H-3990-2014; Girón-González, José-Antonio/AAG-4199-2020	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Martin-Aspas, Andres/0000-0002-3086-9095; Fernandez Gutierrez del Alamo, Clotilde/0000-0003-2664-3103; Marquez-Coello, Mercedes/0000-0003-3948-6258	Instituto de Salud Carlos III [PI08/0869, PI11/00605]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been performed with grants from the Instituto de Salud Carlos III (PI08/0869 and PI11/00605). Jose A. Giron-Gonzalez has a grant for "Intensificacion de Actividad Investigadora" 2013, Servicio Andaluz de Salud, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Antonucci G, 2005, CLIN INFECT DIS, V40, pE101, DOI 10.1086/430445; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Arjona MMD, 2011, JAIDS-J ACQ IMM DEF, V56, P420, DOI 10.1097/QAI.0b013e31820ef408; DeHovitz JA, 2000, J INFECT DIS, V182, P1527, DOI 10.1086/315875; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hsu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077479; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lange CG, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg071; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Marquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore DM, 2006, HIV MED, V7, P383, DOI 10.1111/j.1468-1293.2006.00397.x; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Ping Y, 2003, CLIN IMMUNOL, V106, P95; Pitrak DL, 2001, AIDS, V15, P1317, DOI 10.1097/00002030-200107060-00018; Rallon NI, 2009, CLIN EXP IMMUNOL, V155, P35, DOI 10.1111/j.1365-2249.2008.03797.x; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schumann RR, 2000, CHEM IMMUNOL, V74, P42; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961	44	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119568	10.1371/journal.pone.0119568	http://dx.doi.org/10.1371/journal.pone.0119568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775475	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500101
J	Borst, J; Marquering, HA; Beenen, LFM; Berkhemer, OA; Dankbaar, JW; Riordan, AJ; Majoie, CBLM				Borst, Jordi; Marquering, Henk A.; Beenen, Ludo F. M.; Berkhemer, Olvert A.; Dankbaar, Jan Willem; Riordan, Alan J.; Majoie, Charles B. L. M.		MR CLEAN Investigators	Effect of Extended CT Perfusion Acquisition Time on Ischemic Core and Penumbra Volume Estimation in Patients with Acute Ischemic Stroke due to a Large Vessel Occlusion	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CEREBRAL-BLOOD-FLOW; QUANTITATIVE ASSESSMENT; DIFFUSION MISMATCH; INFARCT CORE; SELECTION; BRAIN; THERAPY; MRI; REVASCULARIZATION	Background and Purpose It has been suggested that CT Perfusion acquisition times <60 seconds are too short to capture the complete in and out-wash of contrast in the tissue, resulting in incomplete time attenuation curves. Yet, these short acquisitions times are not uncommon in clinical practice. The purpose of this study was to investigate the occurrence of time attenuation curve truncation in 48 seconds CT Perfusion acquisition and to quantify its effect on ischemic core and penumbra estimation in patients with acute ischemic stroke due to a proximal intracranial arterial occlusion of the anterior circulation. Materials and Methods We analyzed CT Perfusion data with 48 seconds and extended acquisition times, assuring full time attenuation curves, of 36 patients. Time attenuation curves were classified as complete or truncated. Ischemic core and penumbra volumes resulting from both data sets were compared by median paired differences and interquartile ranges. Controlled experiments were performed using a digital CT Perfusion phantom to investigate the effect of time attenuation curve truncation on ischemic core and penumbra estimation. Results In 48 seconds acquisition data, truncation was observed in 24 (67%) cases for the time attenuation curves in the ischemic core, in 2 cases for the arterial input function and in 5 cases for the venous output function. Analysis of extended data resulted in smaller ischemic cores and larger penumbras with a median difference of 13.2 (IQR: 4.3-26.0) ml (P<0.001) and; 12.4 (IQR: 4.1-25.7) ml (P<0.001), respectively. The phantom data showed increasing ischemic core overestimation with increasing tissue time attenuation curve truncation. Conclusions Truncation is common in patients with large vessel occlusion and results in repartitioning of the area of hypoperfusion into larger ischemic core and smaller penumbra estimations. Phantom experiments confirmed that truncation results in overestimation of the ischemic core.	[Borst, Jordi; Marquering, Henk A.; Beenen, Ludo F. M.; Berkhemer, Olvert A.; Majoie, Charles B. L. M.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Dankbaar, Jan Willem; Riordan, Alan J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Borst, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.borst@amc.uva.nl	Jenniskens, S.F.M./L-4415-2015; Beenen, Ludo F/AAA-3114-2021; van Dijk, Ewoud J/J-7951-2012	Beenen, Ludo F/0000-0001-9204-1026; Brouwer, Patrick A./0000-0003-0041-2833; Dippel, Diederik/0000-0002-9234-3515; Marquering, Henk/0000-0002-1414-6313	ITEA2 project, MEDUSA - Medical Distributed Utilization of Services Applications [10004]	ITEA2 project, MEDUSA - Medical Distributed Utilization of Services Applications	Part of this research has been sponsored by the ITEA2 project, label 10004: MEDUSA - Medical Distributed Utilization of Services & Applications (https://itea3.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Campbell BCV, 2012, STROKE, V43, P2648, DOI 10.1161/STROKEAHA.112.660548; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Cortijo E, 2014, ACTA NEUROL SCAND, V129, P178, DOI 10.1111/ane.12160; d'Esterre CD, 2012, ACTA RADIOL, V53, P461, DOI 10.1258/ar.2012.110582; Delpolyi AR, 2012, J MAGN RESON IMAGING, V36, P1083, DOI 10.1002/jmri.23740; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Fahmi F, 2014, MED BIOL ENG COMPUT, V52, P141, DOI 10.1007/s11517-013-1125-7; Fahmi F, 2013, EUR J RADIOL, V82, P2334, DOI 10.1016/j.ejrad.2013.08.039; Ferreira RM, 2010, AM J ROENTGENOL, V194, P1330, DOI 10.2214/AJR.09.2845; Fieselmann A, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/467563; Finitsis S, 2014, NEURORADIOLOGY, V56, P325, DOI 10.1007/s00234-014-1329-z; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; Fransen PSS, 2014, ME CLEAN MULTICENTER; Hu CH, 2007, CLIN IMAG, V31, P151, DOI 10.1016/j.clinimag.2007.01.008; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kim JJ, 2010, AM J NEURORADIOL, V31, P91, DOI 10.3174/ajnr.A1768; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Leiva-Salinas C, 2011, AM J ROENTGENOL, V196, P53, DOI 10.2214/AJR.10.5705; Lev MH, 2013, RADIOLOGY, V266, P22, DOI 10.1148/radiol.12121355; Lin LT, 2014, STROKE, V45, P1727, DOI 10.1161/STROKEAHA.114.005419; Mangla R, 2014, EMERG RADIOL, V21, P49, DOI 10.1007/s10140-013-1125-9; Marquering HA, 2013, CLIN NEUROL NEUROSUR, V115, P1591, DOI 10.1016/j.clineuro.2013.02.008; Mui K, 2011, AM J NEURORADIOL, V32, P846, DOI 10.3174/ajnr.A2415; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Riordan AJ, 2011, MED PHYS, V38, P3212, DOI 10.1118/1.3592639; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Saake M, 2014, CLIN NEUROL NEUROSUR, V121, P39, DOI 10.1016/j.clineuro.2014.03.007; Sanak D, 2006, NEURORADIOLOGY, V48, P632, DOI 10.1007/s00234-006-0105-0; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Schaefer PW, 2009, STROKE, V40, P2875, DOI 10.1161/STROKEAHA.109.547679; Schellinger PD, 2010, NEUROLOGY, V75, P177, DOI 10.1212/WNL.0b013e3181e7c9dd; Smit EJ, 2013, STROKE, V44, P2194, DOI 10.1161/STROKEAHA.111.000675; Smith WS, 2003, AM J NEURORADIOL, V24, P688; Turk AS, 2013, J NEUROINTERV SURG, V5, P523, DOI 10.1136/neurintsurg-2012-010491; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Waaijer A, 2007, RADIOLOGY, V245, P541, DOI 10.1148/radiol.2451061493; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2008, STROKE, V39, P1621, DOI 10.1161/STROKEAHA.107.512319; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Yoo AJ, 2013, J NEUROINTERV SURG, V5, P1, DOI 10.1136/neurintsurg-2013-010741; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	46	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119409	10.1371/journal.pone.0119409	http://dx.doi.org/10.1371/journal.pone.0119409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789631	Green Published, gold			2022-12-26	WOS:000351425400081
J	Alsayegh, KN; Gadepalli, VS; Iyer, S; Rao, RR				Alsayegh, Khaled N.; Gadepalli, Venkat S.; Iyer, Shilpa; Rao, Raj R.			Knockdown of CDK2AP1 in Primary Human Fibroblasts Induces p53 Dependent Senescence	PLOS ONE			English	Article							PROSTATE-CANCER; CELL-GROWTH; P12(DOC-1); ARF; TRANSCRIPTION; SUPPRESSOR; EXPRESSION; PROTEIN	Cyclin Dependent Kinase-2 Associated Protein-1 (CDK2AP1) is known to be a tumor suppressor that plays a role in cell cycle regulation by sequestering monomeric CDK2, and targeting it for proteolysis. A reduction of CDK2AP1 expression is considered to be a negative prognostic indicator in patients with oral squamous cell carcinoma and also associated with increased invasion in human gastric cancer tissue. CDK2AP1 overexpression was shown to inhibit growth, reduce invasion and increase apoptosis in prostate cancer cell lines. In this study, we investigated the effect of CDK2AP1 downregulation in primary human dermal fibroblasts. Using a short-hairpin RNA to reduce its expression, we found that knockdown of CDK2AP1in primary human fibroblasts resulted in reduced proliferation and in the induction of senescence associated beta-galactosidase activity. CDK2AP1 knockdown also resulted in a significant reduction in the percentage of cells in the S phase and an accumulation of cells in the G1 phase of the cell cycle. Immunocytochemical analysis also revealed that the CDK2AP1 knockdown significantly increased the percentage of cells that exhibited gamma-H2AX foci, which could indicate presence of DNA damage. CDK2AP1 knockdown also resulted in increased mRNA levels of p53, p21, BAX and PUMA and p53 protein levels. In primary human fibroblasts in which p53 and CDK2AP1 were simultaneously downregulated, there was: (a) no increase in senescence associated beta-galactosidase activity, (b) decrease in the number of cells in the G1-phase and increase in number of cells in the S-phase of the cell cycle, and (c) decrease in the mRNA levels of p21, BAX and PUMA when compared with CDK2AP1 knockdown only fibroblasts. Taken together, this suggests that the observed phenotype is p53 dependent. We also observed a prominent increase in the levels of ARF protein in the CDK2AP1 knockdown cells, which suggests a possible role of ARF in p53 stabilization following CDK2AP1 knockdown. Altogether, our results show that knockdown of CDK2AP1 in primary human fibroblasts reduced proliferation and induced premature senescence, with the observed phenotype being p53 dependent.	[Alsayegh, Khaled N.; Rao, Raj R.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Alsayegh, Khaled N.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Gadepalli, Venkat S.; Rao, Raj R.] Virginia Commonwealth Univ, Integrated Life Sci Program, Richmond, VA 23284 USA; [Iyer, Shilpa; Rao, Raj R.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Life Sci Program, Richmond, VA 23284 USA; [Iyer, Shilpa; Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Rao, Raj R.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University; King Saud Bin Abdulaziz University for Health Sciences; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Rao, RR (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	rrrao@vcu.edu	Rao, Raj/AAW-4308-2021	Iyer, Shilpa/0000-0001-6287-2232	NSF-CAREER [074556]; NIH CTSA [UL1TR000058]; VCU's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080157] Funding Source: NIH RePORTER	NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VCU's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NSF-CAREER 074556 (R. Rao) and NIH CTSA UL1TR000058 (R. Rao and S. Iyer) by VCU's Center for Clinical and Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, BIOTECHNOL PROGR, V26, P1126, DOI 10.1002/btpr.412; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Choi MG, 2009, EUR SURG RES, V42, P223, DOI 10.1159/000208521; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evangelou K, 2013, CELL DEATH DIFFER, V20, P1485, DOI 10.1038/cdd.2013.76; Gadepalli Venkat S, 2013, Methods Mol Biol, V962, P183, DOI 10.1007/978-1-62703-236-0_15; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Peng H, 2006, NEOPLASIA, V8, P1028, DOI 10.1593/neo.06580; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Xu YG, 2014, NEUROL RES, V36, P659, DOI 10.1179/1743132813Y.0000000298; Zolochevska O, 2009, PROSTATE, V69, P1586, DOI 10.1002/pros.21007	22	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120782	10.1371/journal.pone.0120782	http://dx.doi.org/10.1371/journal.pone.0120782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785833	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500189
J	Liu, Y; Chotai, S; Chen, M; Jin, S; Qi, ST; Pan, J				Liu, Yi; Chotai, Silky; Chen, Ming; Jin, Shi; Qi, Song-tao; Pan, Jun			Preoperative Radiologic Classification of Convexity Meningioma to Predict the Survival and Aggressive Meningioma Behavior	PLOS ONE			English	Article							PERITUMORAL BRAIN EDEMA; INTRACRANIAL MENINGIOMAS; MALIGNANT MENINGIOMAS; RECURRENCE; PROBABILITY; LOCATION; SUBTYPES; MRI	Background A subgroup of meningioma demonstrates clinical aggressive behavior. We set out to determine if the radiological parameters can predict histopathological aggressive meningioma, and propose a classification to predict survival and aggressive meningioma behavior. Methods A retrospective review of medical records was conducted for patients who underwent surgical resection of their convexity meningioma. WHO-2007 grading was used for histopathological diagnosis. Preoperative radiologic parameters were analyzed, each parameter was scored 0 or 1. Signal intensity on diffusion weighted MRI (DWI) (hyperintensity=1), heterogeneity on T1-weighted gadolinium enhanced MRI (heterogeneity=1), disruption of arachnoid at brain-tumor interface=1 and peritumoral edema (PTE) on T2-weighted MRI (presence of PTE=1) and tumor shape (irregular shape=1). Multivariate logistic regression analyses were conducted to determine association of radiological parameters to histopathological grading. Kaplan-Meier and Cox regression models were used to determine the association of scoring system to overall survival and progression free survival (PFS). Reliability of the classification was tested using Kappa co-efficient analysis. Results Hyperintensity on DWI, disruption of arachnoid at brain-tumor interface, PTE, heterogenicitiy on T1-weighted enhanced MRI and irregular tumor shape were independent predictors of non-grade I meningioma. Mean follow-up period was 94.6 months (range, 12-117 months). Median survival and PFS in groups-I, II and III was 114.1 +/- 1.2 and 115.7 +/- 0.8, 88 +/- 3.3 and 58.5 +/- 3.9, 43.2 +/- 5.1 and 18.2 +/- 1.7 months respectively. In cox regression analysis model, age (P<0.0001, OR-1.039, CI-1.017-0.062), WHO non-grade-I meningioma (P=0.017, OR-3.014, CI-1.217-7.465), radiological classification groups II (P=0.002, OR-6.194, CI-1.956-19.610) and III (P<0.0001, OR-21.658, CI-5.701-82.273) were independent predictors of unfavorable survival outcomes. Conclusions Preoperative radiological classification can be used as a supplement to the histopathological grading. Group-I meningiomas demonstrate benign radiological, histopathological and clinical features; group-III demonstrates aggressive features. Group-II meningiomas demonstrate intermediate features; the need for more aggressive follow-up and/or treatment should be further investigated.	[Liu, Yi; Chotai, Silky; Chen, Ming; Jin, Shi; Qi, Song-tao; Pan, Jun] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	liuyi86818@126.com; panjundu@hotmail.com	Pan, Jun/GQQ-7313-2022					ALVAREZ F, 1987, NEUROSURGERY, V20, P688, DOI 10.1227/00006123-198705000-00003; Ayerbe J, 1999, ACTA NEUROCHIR, V141, P921, DOI 10.1007/s007010050398; Bitzer M, 1997, ACTA NEUROCHIR, V139, P1136, DOI 10.1007/BF01410973; Bitzer M, 1997, J NEUROSURG, V87, P368, DOI 10.3171/jns.1997.87.3.0368; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; BRADAC GB, 1986, NEURORADIOLOGY, V28, P304, DOI 10.1007/BF00333435; CHEN TC, 1992, NEUROSURGERY, V31, P1015, DOI 10.1227/00006123-199212000-00005; DEVRIES J, 1993, ACTA NEUROCHIR, V125, P34, DOI 10.1007/BF01401825; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Filippi CG, 2001, AM J NEURORADIOL, V22, P65; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hashiba T, 2006, BRAIN TUMOR PATHOL, V23, P49, DOI 10.1007/s10014-006-0199-4; Hasseleid BF, 2012, J NEUROSURG, V117, P999, DOI 10.3171/2012.9.JNS12294; HIYAMA H, 1994, ACTA NEUROCHIR, V129, P31, DOI 10.1007/BF01400870; Holodny AI, 1999, NEURORADIOLOGY, V41, P820, DOI 10.1007/s002340050848; Ildan F, 1999, J NEUROSURG, V91, P384, DOI 10.3171/jns.1999.91.3.0384; Ildan F, 2007, SKULL BASE-INTERD AP, V17, P157, DOI 10.1055/s-2007-970554; INAMURA T, 1992, NEUROSURGERY, V31, P179, DOI 10.1227/00006123-199208000-00002; JAASKELAINEN J, 1986, SURG NEUROL, V26, P461, DOI 10.1016/0090-3019(86)90259-4; Jensen R, 2012, NEUROSURGERY, V71, P146, DOI 10.1227/NEU.0b013e3182567886; KAPLAN RD, 1992, J COMPUT ASSIST TOMO, V16, P366, DOI 10.1097/00004728-199205000-00006; Kawahara Y, 2012, J NEURO-ONCOL, V108, P147, DOI 10.1007/s11060-012-0809-4; Lee KJ, 2008, SURG NEUROL, V69, P350, DOI 10.1016/j.surneu.2007.03.027; Lobato RD, 1996, ACTA NEUROCHIR, V138, P485, DOI 10.1007/BF01411166; Mantle RE, 1999, J NEUROSURG, V91, P375, DOI 10.3171/jns.1999.91.3.0375; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; McGovern SL, 2010, J NEUROSURG, V112, P925, DOI 10.3171/2009.9.JNS09617; Nakamura M, 2006, NEUROSURGERY, V58, P626, DOI 10.1227/01.NEU.0000197104.78684.5D; Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455; NAKASU S, 1990, SURG NEUROL, V33, P105, DOI 10.1016/0090-3019(90)90019-L; NEW PFJ, 1982, AM J NEURORADIOL, V3, P267; Ohba S, 2011, J NEUROSURG, V114, P1278, DOI 10.3171/2010.11.JNS10701; Otsuka S, 2004, J NEURO-ONCOL, V70, P349, DOI 10.1007/s11060-004-9164-4; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 2007, WHO CLASSIFICATION T, P164; Qi ST, 2012, J NEUROSURG, V117, P645, DOI 10.3171/2012.6.JNS111987; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y; Sanverdi SE, 2012, EUR J RADIOL, V81, P2389, DOI 10.1016/j.ejrad.2011.06.031; Simis A, 2008, SURG NEUROL, V70, P471, DOI 10.1016/j.surneu.2008.03.006; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; Tamiya T, 2001, NEUROSURGERY, V49, P1046, DOI 10.1097/00006123-200111000-00003; Vranic A, 2010, NEUROSURGERY, V67, P1124, DOI 10.1227/NEU.0b013e3181eb95b7; Watanabe Y, 2013, EUR J RADIOL, V82, P658, DOI 10.1016/j.ejrad.2012.11.037; Weber DC, 2010, CURR OPIN NEUROL, V23, P563, DOI 10.1097/WCO.0b013e328340441e; Yashioka H, 1999, CANCER-AM CANCER SOC, V85, P936, DOI 10.1002/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J	47	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118908	10.1371/journal.pone.0118908	http://dx.doi.org/10.1371/journal.pone.0118908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786236	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500056
J	Nishi, SPE; Zhang, W; Kuo, YF; Sharma, G				Nishi, Shawn P. E.; Zhang, Wei; Kuo, Yong-Fang; Sharma, Gulshan			Oxygen Therapy Use in Older Adults with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GENDER-DIFFERENCE; SEX-DIFFERENCES; COPD; REHABILITATION; CARE; ADHERENCE	Rationale Oxygen therapy improves survival and function in severely hypoxemic chronic obstructive pulmonary disease (COPD) patients based on two landmark studies conducted over 40 years ago. We hypothesize that oxygen users in the current era may be very different. We examined trends and subject characteristics associated with oxygen therapy use from 2001-2010 in the United States. Methods We examined Medicare beneficiaries with COPD who received oxygen from 2001 to 2010. COPD subjects were identified by: 1) >= 2 outpatient visits >30 days apart within one year with an encounter diagnosis of COPD; or 2) an acute care hospitalization with COPD as the primary or secondary discharge diagnosis. Oxygen therapy and sustained oxygen therapy were defined as >= 1 and >= 11 claims for oxygen, respectively, in the durable medical equipment file in a calendar year. Primary outcome measures were factors associated with oxygen therapy and sustained oxygen therapy over the study period. Results Oxygen therapy increased from 33.7% in 2001 to 40.5% in 2010 (p-value of trend <0.001). Sustained oxygen therapy use increased from 19.5% in 2001, peaked in 2008 to 26.9% and declined to 18.5% in 2010. The majority of subjects receiving oxygen therapy and sustained oxygen therapy were female. Besides gender, factors associated with any oxygen use or sustained oxygen therapy were non-Hispanic white race, low socioeconomic status and >= 2 comorbidities. Conclusions Any oxygen use among fee-for service Medicare beneficiaries with COPD is high. Current users of oxygen are older females with multiple comorbidities. Decline in sustained oxygen therapy use after 2008 may be related to reimbursement policy change.	[Nishi, Shawn P. E.; Zhang, Wei; Sharma, Gulshan] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA; [Kuo, Yong-Fang; Sharma, Gulshan] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Nishi, SPE (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA.	spnishi@utmb.edu	Nishi, Shawn/AAH-6998-2019; Sharma, Gulshan/AAC-5804-2019	Nishi, Shawn/0000-0002-7510-2664	Agency for Healthcare Research and Quality [R01-HS020642]; Patient Centered Outcomes Research Institute [HS02213401]; National Center for Advancing Translational Sciences [UL1TR000071]; Claude D. Pepper OAIC grant [5P30-AG024832]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020642] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Claude D. Pepper OAIC grant; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Agency for Healthcare Research and Quality (R01-HS020642) and by the Patient Centered Outcomes Research Institute (HS02213401). Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences. Claude D. Pepper OAIC grant # 5P30-AG024832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPUNONU B, 1994, AM J MED SCI, V308, P244; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 2013, DETAILS EXPANSION CO; [Anonymous], AM REV RESP DIS, P721; Borak J, 1996, Monaldi Arch Chest Dis, V51, P7; C. f. D. C. a. P. U. S. D. o. H. a. H. Services, 2011, BEH RISK FACT SURV U; Chaney JC, 2002, CHEST, V122, P1661, DOI 10.1378/chest.122.5.1661; Chapman KR, 2004, CLIN CHEST MED, V25, P331, DOI 10.1016/j.ccm.2004.01.003; Doherty DE, 2006, RESPIR CARE, V51, P519; Dransfield MT, 2006, RESP MED, V100, P1110, DOI 10.1016/j.rmed.2005.09.019; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FLENLEY DC, 1981, LANCET, V1, P681; GOLD, 2011, GLOB STRAT DIAGN MAN; Guyatt GH, 2000, CHEST, V118, P1303, DOI 10.1378/chest.118.5.1303; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; Hayton C, 2013, RESP MED, V107, P401, DOI 10.1016/j.rmed.2012.11.016; Johnston K, 2010, PHYSIOTHER CAN, V62, P368, DOI 10.3138/physio.62.4.368; Keating A, 2011, CHRON RESP DIS, V8, P89, DOI 10.1177/1479972310393756; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; MEDICARE HOME OXYGEN, 2011, REF PAYM METH HAS PO; MORRISON D, 1995, THORAX, V50, P1103, DOI 10.1136/thx.50.10.1103; Mularski RA, 2006, CHEST, V130, P1844, DOI 10.1378/chest.130.6.1844; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oba Y, 2000, Respir Care, V45, P401; ODONOHUE WJ, 1995, CHEST, V107, P301, DOI 10.1378/chest.107.2.301; Prescott E, 1997, EUR RESPIR J, V10, P822; Ringbaek TJ, 2006, RESP MED, V100, P218, DOI 10.1016/j.rmed.2005.04.023; Ringbaek TJ, 2013, RESP MED; Strom K, 1993, Monaldi Arch Chest Dis, V48, P473; Suh DC, 2008, RESP CARE, V53, P1461; Wisely C, 2013, 5 THINGS PHYS PATIEN; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; Zielinski J, 1998, CHEST, V113, P65, DOI 10.1378/chest.113.1.65	34	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120684	10.1371/journal.pone.0120684	http://dx.doi.org/10.1371/journal.pone.0120684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785586	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500187
J	Patel, AS; Song, JW; Chu, SG; Mizumura, K; Osorio, JC; Shi, Y; El-Chemaly, S; Lee, CG; Rosas, IO; Elias, JA; Choi, AMK; Morse, D				Patel, Avignat S.; Song, Jin Woo; Chu, Sarah G.; Mizumura, Kenji; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Lee, Chun Geun; Rosas, Ivan O.; Elias, Jack A.; Choi, Augustine M. K.; Morse, Danielle			Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor-Beta1 in Pulmonary Fibrosis	PLOS ONE			English	Article							PINK1-DEFICIENT MICE; DAMAGED MITOCHONDRIA; MITOPHAGY; PARKIN; PROMOTES; DEGRADATION; ACTIVATION; AUTOPHAGY; DISEASES; RECRUITMENT	Background Epithelial cell death is a major contributor to fibrogenesis in the lung. In this study, we sought to determine the function of mitochondria and their clearance (mitophagy) in alveolar epithelial cell death and fibrosis. Methods We studied markers of mitochondrial injury and the mitophagy marker, PTEN-induced putative kinase 1 (PINK1), in IPF lung tissues by Western blotting, transmission electron microscopy (TEM), and immunofluorescence. In vitro experiments were carried out in lung epithelial cells stimulated with transforming growth factor-beta 1 (TGF-beta 1). Changes in cell function were measured by Western blotting, flow cytometry and immunofluorescence. In vivo experiments were performed using the murine bleomycin model of lung fibrosis. Results Evaluation of IPF lung tissue demonstrated increased PINK1 expression by Western blotting and immunofluorescence and increased numbers of damaged mitochondria by TEM. In lung epithelial cells, TGF-beta 1 induced mitochondrial depolarization, mitochondrial ROS, and PINK1 expression; all were abrogated by mitochondrial ROS scavenging. Finally, Pink1(-/-) mice were more susceptible than control mice to bleomycin induced lung fibrosis. Conclusion TGF-beta 1 induces lung epithelial cell mitochondrial ROS and depolarization and stabilizes the key mitophagy initiating protein, PINK1. PINK1 ameliorates epithelial cell death and may be necessary to limit fibrogenesis.	[Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Harvard Univ, Sch Med, Boston, MA USA; [Song, Jin Woo] Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Lee, Chun Geun] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA; [Rosas, Ivan O.] Lovelace Resp Res Inst, Pulm Fibrosis Program, Albuquerque, NM USA; [Elias, Jack A.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Mizumura, Kenji; Choi, Augustine M. K.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Ulsan; Asan Medical Center; Yale University; Lovelace Respiratory Research Institute; Brown University; Cornell University	Song, JW (corresponding author), Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	jwsong@amc.seoul.kr	song, jin woo/AAW-3876-2021; Lee, Chun Geun/AAC-2838-2021; Song, Jin/HHS-8731-2022	Osorio, Juan C/0000-0001-8090-1551; Lee, Chun Geun/0000-0002-9514-3658; Mizumura, Kenji/0000-0001-8532-9670	NIH [R01HL087122-01, P01HL114501]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A1064957]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [14-495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087122, P01HL114501, F32HL124884] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.M. was supported by NIH Grant R01HL087122-01. JWS was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A1064957) and by a grant (14-495) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. I. O.R. and A.M.K.C were supported by NIH Grant P01HL114501. The funders had no roles in study design, data colelction and analysis, decision to publish, or preparation of the manuscript.	Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Baker TA, 2014, PHYSIOL RES, V63, P311, DOI 10.33549/physiolres.932607; Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pociask DA, 2004, LAB INVEST, V84, P1013, DOI 10.1038/labinvest.3700109; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	40	118	122	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121246	10.1371/journal.pone.0121246	http://dx.doi.org/10.1371/journal.pone.0121246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785991	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500206
J	Planillo, A; Kramer-Schadt, S; Malo, JE				Planillo, Aimara; Kramer-Schadt, Stephanie; Malo, Juan E.			Transport Infrastructure Shapes Foraging Habitat in a Raptor Community	PLOS ONE			English	Article							MODEL SELECTION; ROAD VERGES; POPULATIONS; CONSERVATION; ABUNDANCE; RESPONSES; ECOLOGY; URBANIZATION; CONSEQUENCES; PARAMETERS	Transport infrastructure elements are widespread and increasing in size and length in many countries, with the subsequent alteration of landscapes and wildlife communities. Nonetheless, their effects on habitat selection by raptors are still poorly understood. In this paper, we analyzed raptors' foraging habitat selection in response to conventional roads and high capacity motorways at the landscape scale, and compared their effects with those of other variables, such as habitat structure, food availability, and presence of potential interspecific competitors. We also analyzed whether the raptors' response towards infrastructure depends on the spatial scale of observation, comparing the attraction or avoidance behavior of the species at the landscape scale with the response of individuals observed in the proximity of the infrastructure. Based on ecological hypotheses for foraging habitat selection, we built generalized linear mixed models, selected the best models according to Akaike Information Criterion and assessed variable importance by Akaike weights. At the community level, the traffic volume was the most relevant variable in the landscape for foraging habitat selection. Abundance, richness, and diversity values reached their maximum at medium traffic volumes and decreased at highest traffic volumes. Individual species showed different degrees of tolerance toward traffic, from higher abundance in areas with high traffic values to avoidance of it. Medium-sized opportunistic raptors increased their abundance near the traffic infrastructures, large scavenger raptors avoided areas with higher traffic values, and other species showed no direct response to traffic but to the presence of prey. Finally, our cross-scale analysis revealed that the effect of transport infrastructures on the behavior of some species might be detectable only at a broad scale. Also, food availability may attract raptor species to risky areas such as motorways.	[Planillo, Aimara; Malo, Juan E.] Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain; [Kramer-Schadt, Stephanie] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany	Autonomous University of Madrid; Leibniz Institut fur Zoo und Wildtierforschung	Planillo, A (corresponding author), Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain.	aimara.planillo@uam.es	Arrazola, Juan Esteban Malo/Q-4819-2019; Planillo, Aimara/AAH-9886-2019; Kramer-Schadt, Stephanie/A-8778-2013; Malo, Juan E/K-8305-2014	Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Planillo, Aimara/0000-0001-6763-9923; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Malo, Juan E/0000-0002-6033-5035	Basque Government; Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation [CENIT-2008 1016]; Comunidad de Madrid through the REMEDINAL Research Network [S-2009/AMB/1783]; European Social Fund through the REMEDINAL Research Network [S-2009/AMB/1783]	Basque Government(Basque Government); Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid through the REMEDINAL Research Network; European Social Fund through the REMEDINAL Research Network	AP was supported by a PhD grant of the Basque Government. This study forms part of the CENIT-OASIS Project funded by a consortium of companies supported by the Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation (CENIT-2008 1016). The Comunidad de Madrid, together with the European Social Fund, supports the TEG research group through the REMEDINAL Research Network (S-2009/AMB/1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barrientos R, 2012, DIVERS DISTRIB, V18, P635, DOI 10.1111/j.1472-4642.2011.00850.x; Barton K., 2014, MULTIMODEL INFERENCE; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Beja P, 2009, EUR J WILDLIFE RES, V55, P227, DOI 10.1007/s10344-008-0236-1; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; BENNETT AF, 1990, LANDSCAPE ECOL, V4, P109, DOI 10.1007/BF00132855; Bernis F, 1974, ARDEOLA, V19, P225; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BLANCO G, 1994, J RAPTOR RES, V28, P242; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Bolker B, 2012, OWLS EXAMPLE ZERO IN; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cody M.L., 1985, P3; Crawley M.J., 2007, R BOOK; Dean WRJ, 2003, OSTRICH, V74, P181, DOI 10.2989/00306520309485391; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Delibes M., 1984, Ardeola, V31, P115; Delibes M, 2001, ECOL LETT, V4, P401, DOI 10.1046/j.1461-0248.2001.00254.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Diaz M., 1996, AVES IBERICAS; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2009, ECOL SOC, V14; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; Garcia-Heras MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080523; Gomes L, 2009, ECOL RES, V24, P355, DOI 10.1007/s11284-008-0515-z; Grilo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043811; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; IUCN, 2013, IUCN RED LIST THREAT; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KNIGHT RL, 1993, J WILDLIFE MANAGE, V57, P266, DOI 10.2307/3809423; Lambertucci SA, 2009, BIODIVERS CONSERV, V18, P2063, DOI 10.1007/s10531-008-9573-3; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Madrono A., 2004, LIBRO ROJO AVES ESPA; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Manly B., 2007, RESOURCE SELECTION A; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Moller Anders Pape, 2011, Zoological Research, V32, P115, DOI 10.3724/SP.J.1141.2011.02115; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Morelli Federico, 2011, Journal of Mediterranean Ecology, V11, P21; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Palomino D, 2007, LANDSCAPE URBAN PLAN, V83, P268, DOI 10.1016/j.landurbplan.2007.04.011; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Reijnen R, 1996, BIOL CONSERV, V75, P255, DOI 10.1016/0006-3207(95)00074-7; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rosa S., 2007, INT C EC TRANSP, P562; Ruiz-Capillas P, 2013, ECOSYSTEMS, V16, P617, DOI 10.1007/s10021-013-9634-7; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Sanchez-Zapata JA, 1999, J APPL ECOL, V36, P254, DOI 10.1046/j.1365-2664.1999.00396.x; Sergio F, 2003, BIOL CONSERV, V112, P351, DOI 10.1016/S0006-3207(02)00332-4; Skaug H, 2012, GEN LINEAR MIXED MOD; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Veiga J.P., 1986, Raptor Research, V20, P120; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuberogoitia I, 2010, ORNIS FENNICA, V87, P52; Zuur Alain F., 2009, P1	82	13	14	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118604	10.1371/journal.pone.0118604	http://dx.doi.org/10.1371/journal.pone.0118604			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786218	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500039
J	Qian, YY; Zhong, P; Liang, DD; Xu, Z; Skibba, M; Zeng, CL; Li, XK; Wei, TM; Wu, LP; Liang, G				Qian, Yuanyuan; Zhong, Peng; Liang, Dandan; Xu, Zheng; Skibba, Melissa; Zeng, Chunlai; Li, Xiaokun; Wei, Tiemin; Wu, Lianpin; Liang, Guang			A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; HEART-FAILURE; INDUCED INFLAMMATION; IN-VITRO; HYPERTROPHY; DYSFUNCTION; INHIBITION; NRF2; EXPRESSION	Obesity is strongly associated with the cause of structural and functional changes of the heart in both human and animal models. Oxidative stress and inflammation play a critical role in the development of obesity-induced cardiac disorders. Curcumin is a natural product from Curcuma Longa with multiple bioactivities. In our previous study, in order to reach better anti-inflammatory and anti-oxidant dual activities, we designed a new mono-carbonyl curcumin analog, Y20, via the structural modification with both trifluoromethyl and bromine. This study was designed to investigate the protective effects of Y20 on obesity-induced cardiac injury and its underlying mechanisms. In high fat diet-fed rats, oral administration of Y20 at 20 mg/kg or curcumin at 50 mg/kg significantly decreased the cardiac inflammation and oxidative stress and eventually improved the cardiac remodeling by mitigating cardiac disorganization, hypertrophy, fibrosis and apoptosis. Y20 at 20 mg/kg showed comparable and even stronger bioactivities than curcumin at 50 mg/kg. The beneficial actions of Y20 are closely associated with its ability to increase Nrf2 expression and inhibit NF-kappa B activation. Taken together, these results suggest that Y20 may have a great therapeutic potential in the treatment of obesity-induced cardiac injury using Nrf2 and NF-kappa B as the therapeutic targets for treating obesity-related disorders.	[Qian, Yuanyuan; Zhong, Peng; Liang, Dandan; Xu, Zheng; Skibba, Melissa; Li, Xiaokun; Liang, Guang] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Zhong, Peng; Zeng, Chunlai; Wei, Tiemin] Wenzhou Med Univ, Affiliated Hosp 5, Dept Cardiol, Lishui, Zhejiang, Peoples R China; [Wu, Lianpin] Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, LP (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China.	wzwlp@sina.com; wzmcliangguang@163.com			Natural Science Funding of China [21272179]; Natural Science Funding of Zhejiang Province [LY13H160022]; CIHR China-Canada Joint Health Research Initiative [81261120560]; Zhejiang Department of Health; Zhejiang Key Group in Scientific Innovation [2010R50042]	Natural Science Funding of China; Natural Science Funding of Zhejiang Province; CIHR China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR)); Zhejiang Department of Health; Zhejiang Key Group in Scientific Innovation	This study was supported by the Natural Science Funding of China (21272179 to G.L.), Natural Science Funding of Zhejiang Province (LY13H160022), CIHR China-Canada Joint Health Research Initiative (81261120560), High-level Innovative Talent Funding of Zhejiang Department of Health (to G.L. and C.Z.), and Zhejiang Key Group in Scientific Innovation (2010R50042 to X.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4; Aurigemma GP, 2013, CIRC-CARDIOVASC IMAG, V6, P142, DOI 10.1161/CIRCIMAGING.111.964627; Ballal K, 2010, MOL CELL BIOCHEM, V344, P221, DOI 10.1007/s11010-010-0546-y; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cavalera M, 2014, TRANSL RES, V164, P323, DOI 10.1016/j.trsl.2014.05.001; Fukuda M, 2010, J PHARMACOL EXP THER, V335, P70, DOI 10.1124/jpet.110.170373; He HJ, 2012, WORLD J DIABETES, V3, P94, DOI 10.4239/wjd.v3.i5.94; Hilfiker-Klemer D, 2006, J AM COLL CARDIOL, V48, pA56, DOI 10.1016/j.jacc.2006.07.007; Hu P, 2013, CELL BIOL INT, V37, P443, DOI 10.1002/cbin.10050; Huynh K, 2012, DIABETOLOGIA, V55, P1544, DOI 10.1007/s00125-012-2495-3; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Justino GC, 2009, J MASS SPECTROM, V44, P1459, DOI 10.1002/jms.1630; Ko HJ, 2009, DIABETES, V58, P2536, DOI 10.2337/db08-1361; Kupper FC, 2013, J EXP BOT, V64, P2653, DOI 10.1093/jxb/ert110; Lee JE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-111; Liang G, 2009, EUR J MED CHEM, V44, P915, DOI 10.1016/j.ejmech.2008.01.031; Ma YG, 2012, EXPERT OPIN DRUG DIS, V7, P711, DOI 10.1517/17460441.2012.694862; Madonna R, 2013, INT J IMMUNOPATH PH, V26, P59, DOI 10.1177/039463201302600106; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Pan Y, 2014, DIABETES, V63, P3497, DOI 10.2337/db13-1577; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Pongchaidecha A, 2009, NUTRITION, V25, P870, DOI 10.1016/j.nut.2009.02.001; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rial NS, 2012, MED HYPOTHESES, V78, P29, DOI 10.1016/j.mehy.2011.09.034; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Seo HA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/184598; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Zeng CL, 2015, J MOL CELL CARDIOL, V79, P1, DOI 10.1016/j.yjmcc.2014.10.002; Zhao CG, 2013, CURR PHARM DESIGN, V19, P2114; Zhao CG, 2010, BIOORGAN MED CHEM, V18, P2388, DOI 10.1016/j.bmc.2010.03.001	42	35	35	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120215	10.1371/journal.pone.0120215	http://dx.doi.org/10.1371/journal.pone.0120215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786209	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500160
J	Schwing, PT; Romero, IC; Brooks, GR; Hastings, DW; Larson, RA; Hollander, DJ				Schwing, Patrick T.; Romero, Isabel C.; Brooks, Gregg R.; Hastings, David W.; Larson, Rebekka A.; Hollander, David J.			A Decline in Benthic Foraminifera following the Deepwater Horizon Event in the Northeastern Gulf of Mexico	PLOS ONE			English	Article							CONTINENTAL-SHELF; INDICATORS; DENITRIFICATION; CONTAMINATION; SEDIMENTS; RESPONSES; SURVIVAL; BATHYAL; BIOMASS; FATE	Sediment cores were collected from three sites (1000-1200 m water depth) in the north-eastern Gulf of Mexico from December 2010 to June 2011 to assess changes in benthic foraminiferal density related to the Deepwater Horizon (DWH) event (April-July 2010, 1500 m water depth). Short-lived radioisotope geochronologies (Pb-210, Th-234), organic geochemical assessments, and redox metal concentrations were determined to relate changes in sediment accumulation rate, contamination, and redox conditions with benthic foraminiferal density. Cores collected in December 2010 indicated a decline in density (80-93%). This decline was characterized by a decrease in benthic foraminiferal density and benthic foraminiferal accumulation rate (BFAR) in the surface 10 mm relative to the down-core mean in all benthic foraminifera, including the dominant genera (Bulimina spp., Uvigerina spp., and Cibicidoides spp.). Cores collected in February 2011 documented a site-specific response. There was evidence of a recovery in the benthic foraminiferal density and BFAR at the site closest to the wellhead (45 NM, NE). However, the site farther afield (60 NM, NE) recorded a continued decline in benthic foraminiferal density and BFAR down to near-zero values. This decline in benthic foraminiferal density occurred simultaneously with abrupt increases in sedimentary accumulation rates, polycyclic aromatic hydrocarbon (PAH) concentrations, and changes in redox conditions. Persistent reducing conditions (as many as 10 months after the event) in the surface of these core records were a possible cause of the decline. Another possible cause was the increase (2-3 times background) in PAH's, which are known to cause benthic foraminifera mortality and inhibit reproduction. Records of benthic foraminiferal density coupled with short-lived radionuclide geochronology and organic geochemistry were effective in quantifying the benthic response and will continue to be a valuable tool in determining the long-term effects of the DWH event on a larger spatial scale.	[Schwing, Patrick T.; Romero, Isabel C.; Larson, Rebekka A.; Hollander, David J.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brooks, Gregg R.; Hastings, David W.; Larson, Rebekka A.] Eckerd Coll, St Petersburg, FL 33733 USA	State University System of Florida; University of South Florida	Schwing, PT (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	pschwing@mail.usf.edu	Schwing, Patrick/AAK-8593-2020	Schwing, Patrick/0000-0001-8466-4952; Romero, Isabel C./0000-0002-8590-5989	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; Gulf of Mexico Research Initiative (GOMRI); Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; Gulf of Mexico Research Initiative (GOMRI); Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	This research received funding from these sources: The British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program provided funding for several of the initial research cruises and laboratory analyses during 2010 and 2011. http://www.fio.usf.edu (PS, IR, GB, DWH, RL, DJH). The Gulf of Mexico Research Initiative (GOMRI), specifically the Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE) and the Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia, provided funding in support of field, laboratory, and personnel efforts. http://gulfresearchinitiative.org (PS, IR, GB, DWH, RL, DJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach AV, 1999, J FORAMIN RES, V29, P173; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; [Anonymous], 1951, GEOLOGICAL SOC AM ME; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Bejarano AC, 2010, ENVIRON POLLUT, V158, P1561, DOI 10.1016/j.envpol.2009.12.019; Bernhard JM, 1996, MAR MICROPALEONTOL, V28, P5, DOI 10.1016/0377-8398(95)00036-4; Bernhard JM, 2008, DEEP-SEA RES PT II, V55, P2617, DOI 10.1016/j.dsr2.2008.07.011; BERNSTEIN BB, 1978, LIMNOL OCEANOGR, V23, P401, DOI 10.4319/lo.1978.23.3.0401; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brooks GR, 2014, P ASS SCI LIMN OC HO; Buzas MA, 2007, MAR MICROPALEONTOL, V65, P43, DOI 10.1016/j.marmicro.2007.05.006; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; CORLISS B, 1993, GEOLOGY, V21, P991, DOI 10.1130/0091-7613(1993)021<0991:RGODSB>2.3.CO;2; CULVER SJ, 1983, J FORAMIN RES, V13, P21, DOI 10.2113/gsjfr.13.1.21; Cutshall NH, 1983, DIRECT ANAL 210PB SE; DENNE RA, 1991, MAR MICROPALEONTOL, V17, P173, DOI 10.1016/0377-8398(91)90013-V; Denoyelle M, 2010, MAR POLLUT BULL, V60, P2007, DOI 10.1016/j.marpolbul.2010.07.024; Di Leonardo R, 2007, SCI TOTAL ENVIRON, V388, P168, DOI 10.1016/j.scitotenv.2007.08.009; Eichler PPB, 2012, MAR POLLUT BULL, V64, P22, DOI 10.1016/j.marpolbul.2011.10.032; EPA, 2007, 8015C EPA, P1; Ernst SR, 2006, MAR MICROPALEONTOL, V61, P76, DOI 10.1016/j.marmicro.2006.05.005; Geslin E, 2004, MAR MICROPALEONTOL, V53, P227, DOI 10.1016/j.marmicro.2004.05.010; Geslin E, 2011, J EXP MAR BIOL ECOL, V396, P108, DOI 10.1016/j.jembe.2010.10.011; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; Gross O, 2000, J FORAMIN RES, V32, P414; Handwerger DA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000850; Hastings DW, 2016, DEEP-SEA RES PT II, V129, P167, DOI 10.1016/j.dsr2.2014.12.009; HERGUERA JC, 1991, GEOLOGY, V19, P1173, DOI 10.1130/0091-7613(1991)019<1173:PFBFAG>2.3.CO;2; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Khare N, 2000, ONGC B, V37, P53; KITTO ME, 1991, APPL RADIAT ISOTOPES, V42, P835, DOI 10.1016/0883-2889(91)90221-L; Koho KA, 2011, FEMS MICROBIOL ECOL, V75, P273, DOI 10.1111/j.1574-6941.2010.01010.x; Langlet D, 2013, BIOGEOSCIENCES DISCU, V10, P9243; Martinez-Colon M, 2009, J FORAMIN RES, V39, P278, DOI 10.2113/gsjfr.39.4.278; Mojtahid M, 2006, MAR MICROPALEONTOL, V61, P58, DOI 10.1016/j.marmicro.2006.05.004; Moodley L, 1998, MAR MICROPALEONTOL, V34, P91, DOI 10.1016/S0377-8398(97)00044-3; Osterman LE, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(02)00352-9; Paris CB, 2012, ENVIRON SCI TECHNOL, V46, P13293, DOI 10.1021/es303197h; Parker F. L., 1954, B MUS COMP ZOOL HARV, V111, P453; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; POAG CW, 1984, PALAEOGEOGR PALAEOCL, V48, P25, DOI 10.1016/0031-0182(84)90090-7; Risgaard-Petersen N, 2006, NATURE, V443; Romero IC, 2014, P ASS SCI LIMN OC HO, P16336; Rowe G. T., 2009, 2009039 OCS MMS US D; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SCOTT DB, 1980, J PALEONTOL, V54, P814; Sen Gupta B. K., 2009, 2009013 OCS MMS US D, P385; SENGUPTA BK, 1994, GEO-MAR LETT, V14, P88, DOI 10.1007/BF01203719; Thibodeaux LJ, 2011, ENVIRON ENG SCI, V28, P87, DOI 10.1089/ees.2010.0276; Valsangkar AB, 2007, CURRENT SCI, V92, P5; VERSCHUREN D, 1993, LIMNOL OCEANOGR, V38, P1796, DOI 10.4319/lo.1993.38.8.1796; Yanko V, 1999, MODERN FORAMINIFERA, P217; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	56	29	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120565	10.1371/journal.pone.0120565	http://dx.doi.org/10.1371/journal.pone.0120565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785988	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500182
J	Wynn, JK; Roach, BJ; Lee, J; Horan, WP; Ford, JM; Jimenez, AM; Green, MF				Wynn, Jonathan K.; Roach, Brian J.; Lee, Junghee; Horan, William P.; Ford, Judith M.; Jimenez, Amy M.; Green, Michael F.			EEG Findings of Reduced Neural Synchronization during Visual Integration in Schizophrenia	PLOS ONE			English	Article							GESTALT PERCEPTION; ILLUSORY CONTOURS; BIPOLAR DISORDER; INTERNEURONS; MODULATION; RESPONSES; COGNITION; DYNAMICS; DEFICITS	Schizophrenia patients exhibit well-documented visual processing deficits. One area of disruption is visual integration, the ability to form global objects from local elements. However, most studies of visual integration in schizophrenia have been conducted in the context of an active attention task, which may influence the findings. In this study we examined visual integration using electroencephalography (EEG) in a passive task to elucidate neural mechanisms associated with poor visual integration. Forty-six schizophrenia patients and 30 healthy controls had EEG recorded while passively viewing figures comprised of real, illusory, or no contours. We examined visual P100, N100, and P200 event-related potential (ERP) components, as well as neural synchronization in the gamma (30-60 Hz) band assessed by the EEG phase locking factor (PLF). The N100 was significantly larger to illusory vs. no contour, and illusory vs. real contour stimuli while the P200 was larger only to real vs. illusory stimuli; there were no significant interactions with group. Compared to controls, patients failed to show increased phase locking to illusory versus no contours between 40-60 Hz. Also, controls, but not patients, had larger PLF between 30-40 Hz when viewing real vs. illusory contours. Finally, the positive symptom factor of the BPRS was negatively correlated with PLF values between 40-60 Hz to illusory stimuli, and with PLF between 30-40 Hz to real contour stimuli. These results suggest that the pattern of results across visual processing conditions is similar in patients and controls. However, patients have deficits in neural synchronization in the gamma range during basic processing of illusory contours when attentional demand is limited.	[Wynn, Jonathan K.; Lee, Junghee; Horan, William P.; Jimenez, Amy M.; Green, Michael F.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Wynn, Jonathan K.; Lee, Junghee; Horan, William P.; Green, Michael F.] Univ Calif Los Angeles, Psychiat & Biobehav Sci, Los Angeles, CA USA; [Roach, Brian J.; Ford, Judith M.] Vet Affairs San Francisco Med Ctr, San Francisco, CA USA; [Ford, Judith M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Wynn, JK (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	jkwynn@ucla.edu	Lee, Junghee/AAX-6124-2021; Jimenez, Amy M./AAX-6262-2021; Wynn, Jonathan/H-3749-2014	Lee, Junghee/0000-0001-9567-8700; Wynn, Jonathan/0000-0002-1763-8540; Jimenez, Amy/0000-0001-6077-1307; Roach, Brian/0000-0002-3264-1465	VA Career Development Award; NIMH [MH43292, MH065707]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043292, R29MH043292, R01MH065707] Funding Source: NIH RePORTER	VA Career Development Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study came from a VA Career Development Award to Jonathan K. Wynn, Ph.D., and NIMH Grants MH43292 and MH065707 (PI: Michael F. Green, Ph.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N., 1984, SCALE ASSESSMENT POS; Angelucci A, 2002, J NEUROSCI, V22, P8633; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Di Russo F, 1999, VISION RES, V39, P2975, DOI 10.1016/S0042-6989(99)00031-0; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; First M.B., 2014, STRUCTURED CLIN INTE; First M. D., 1996, USERS GUIDE STRUCTUR; Foxe JJ, 2005, CEREB CORTEX, V15, P1914, DOI 10.1093/cercor/bhi069; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Herrmann CS, 2001, VIS COGN, V8, P593, DOI 10.1080/13506280143000142; Herrmann CS, 2001, NEUROREPORT, V12, P901, DOI 10.1097/00001756-200104170-00007; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Ikeda C, 2011, NEUROPSYCHOBIOLOGY, V64, P231, DOI 10.1159/000327706; Jahshan C, 2012, BIOL PSYCHIAT, V71, p81S; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Keane BP, 2014, NEUROPSYCHOLOGIA, V65, P221, DOI 10.1016/j.neuropsychologia.2014.10.031; Keane BP, 2014, NEUROPSYCHOLOGIA, V56, P302, DOI 10.1016/j.neuropsychologia.2014.02.001; Kopelowicz A, 2008, PSYCHOPATHOLOGY, V41, P77, DOI 10.1159/000111551; Kruggel F, 2001, NEUROIMAGE, V14, P1327, DOI 10.1006/nimg.2001.0948; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Makin ADJ, 2011, NEUROPSYCHOLOGIA, V49, P2798, DOI 10.1016/j.neuropsychologia.2011.06.001; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pernet C, 2003, COGNITIVE BRAIN RES, V17, P327, DOI 10.1016/S0926-6410(03)00134-4; SHIPLEY TF, 1992, PERCEPT PSYCHOPHYS, V52, P97, DOI 10.3758/BF03206762; Silverstein SM, 2012, SCHIZOPHRENIA BULL, V38, P125, DOI 10.1093/schbul/sbr141; Spencer KM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00068; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Ventura J, 1995, SYMPTOM DIMENSIONS R; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Wynn JK, 2013, PSYCHOL MED, V43, P109, DOI 10.1017/S0033291712001006; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	45	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119849	10.1371/journal.pone.0119849	http://dx.doi.org/10.1371/journal.pone.0119849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785939	gold, Green Published			2022-12-26	WOS:000352138500134
J	Stetter, MG; Schmid, K; Ludewig, U				Stetter, Markus G.; Schmid, Karl; Ludewig, Uwe			Uncovering Genes and Ploidy Involved in the High Diversity in Root Hair Density, Length and Response to Local Scarce Phosphate in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; P-I STARVATION; PHOSPHORUS AVAILABILITY; AUXIN; ETHYLENE; ELONGATION; PLANTS; ARCHITECTURE; ACQUISITION; ACCESSIONS	Plant root hairs increase the root surface to enhance the uptake of sparingly soluble and immobile nutrients, such as the essential nutrient phosphorus, from the soil. Here, root hair traits and the response to scarce local phosphorus concentration were studied in 166 accessions of Arabidopsis thaliana using split plates. Root hair density and length were correlated, but highly variable among accessions. Surprisingly, the well-known increase in root hair density under low phosphorus was mostly restricted to genotypes that had less and shorter root hairs under P sufficient conditions. By contrast, several accessions with dense and long root hairs even had lower hair density or shorter hairs in local scarce phosphorus. Furthermore, accessions with whole-genome duplications developed more dense but phosphorus-insensitive root hairs. The impact of genome duplication on root hair density was confirmed by comparing tetraploid accessions with their diploid ancestors. Genomewide association mapping identified candidate genes potentially involved in root hair responses tp scarce local phosphate. Knock-out mutants in identified candidate genes (CYR1, At1g32360 and RLP48) were isolated and differences in root hair traits in the mutants were confirmed. The large diversity in root hair traits among accessions and the diverse response when local phosphorus is scarce is a rich resource for further functional analyses.	[Stetter, Markus G.; Ludewig, Uwe] Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, D-70593 Stuttgart, Germany; [Stetter, Markus G.; Schmid, Karl] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Ludewig, U (corresponding author), Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany.	u.ludewig@uni-hohenheim.de	Stetter, Markus G/ABA-8503-2021	Stetter, Markus G/0000-0001-7136-0589	Hohenheim-Rehovot	Hohenheim-Rehovot	This work was partially financed by a Hohenheim-Rehovot partnership grant to UL, and by regular University expenses from the University of Hohenheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2004, PLANT PHYSIOL, V134, P1135, DOI 10.1104/pp.103.034660; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bates TR, 2001, PLANT SOIL, V236, P243, DOI 10.1023/A:1012791706800; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Chen ZH, 2007, BIOCHEM J, V405, P191, DOI 10.1042/BJ20070102; Chen ZH, 2008, PLANT CELL PHYSIOL, V49, P1902, DOI 10.1093/pcp/pcn157; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Datta S, 2011, PLANT SOIL, V346, P1, DOI 10.1007/s11104-011-0845-4; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; DEIKMAN J, 1995, PLANTA, V195, P440, DOI 10.1007/BF00202603; FOEHSE D, 1983, PLANT SOIL, V74, P359, DOI 10.1007/BF02181353; Gahoonia TS, 2003, PLANT CELL ENVIRON, V26, P1759, DOI 10.1046/j.1365-3040.2003.01093.x; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Jones VAS, 2012, ANN BOT-LONDON, V110, P205, DOI 10.1093/aob/mcs136; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; Lan P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r67; Lei M, 2011, NEW PHYTOL, V189; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Miura K, 2011, PLANT PHYSIOL, V155, P1000, DOI 10.1104/pp.110.165191; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Narang RA, 2000, PLANT PHYSIOL, V124, P1786, DOI 10.1104/pp.124.4.1786; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Savage N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075452; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang HY, 2014, PLANT CELL ENVIRON, V37, P1404, DOI 10.1111/pce.12244	39	38	39	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120604	10.1371/journal.pone.0120604	http://dx.doi.org/10.1371/journal.pone.0120604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781967	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600174
J	Jones-Hall, YL; Kozik, A; Nakatsu, C				Jones-Hall, Yava L.; Kozik, Ariangela; Nakatsu, Cindy			Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; ALPHA-DEFICIENT MICE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOME; TNF-ALPHA; PATHOGENESIS; BACTERIA; GENETICS; THERAPY	Inflammatory bowel disease (IBD) is associated with prolonged, excess secretions of Tumor Necrosis Factor (TNF). Many patients with IBD have successful management of IBD symptoms by blocking TNF secretion or signaling. However, some patients are non-responsive to this therapy, eventually become refractory to therapy, or Alterations in the microbiota that are associated with the lack of TNF could be a contributing cause of this therapeutic insufficiency seen in some patients. Here we use wildtype (WT) and mice lacking Tnf (Tnf(-/-)) in an acute TNBS colitis model to investigate the role of TNF in colitis and how its presence or absence affects the colonic microbiota. As expected, Tnf(-/-) had less severe inflammation than WT mice. Microbiome analysis revealed significant Tnf dependent-differences in alpha and beta diversity. There were also notable differences in many species that were also primarily Tnf dependent. Taken together, our data indicates that TNF contributes significantly to the inflammation and microbiotal alterations in that occur in IBD.	[Jones-Hall, Yava L.; Kozik, Ariangela] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Nakatsu, Cindy] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Kozik, Ariangela] Purdue Univ, Interdisciplinary Life Sci Program PULSe, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jones-Hall, YL (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	yljones@purdue.edu	Kozik, Ariangela/AAV-2395-2021	Kozik, Ariangela/0000-0003-2322-4085; Jones-Hall, Yava/0000-0003-4030-9830				Abreu C, 2013, J CROHNS COLITIS, V10; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Bel S, 2014, P NATL ACAD SCI USA, V111, P4964, DOI 10.1073/pnas.1319114111; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Bushman FD, 2013, ANAEROBE, V30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Colombel JF, 2004, GASTROENTEROLOGY, V126, P19, DOI 10.1053/j.gastro.2003.10.047; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Feagan B G, 2001, Can J Clin Pharmacol, V8, P188; Fries Walter, 2008, Int J Med Sci, V5, P169; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jain VV, 2006, RESP MED, V100, P1291, DOI 10.1016/j.rmed.2005.09.020; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masuda H, 1995, J Clin Lab Immunol, V46, P111; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Oliva S, 2012, ALIMENT PHARM THER, V35, P327, DOI 10.1111/j.1365-2036.2011.04939.x; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Sarowska J, 2013, ADV CLIN EXP MED, V22, P759; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sha SM, 2013, DIAGN MICR INFEC DIS, V75, P245, DOI 10.1016/j.diagmicrobio.2012.11.022; Shen C, 2007, INFLAMM BOWEL DIS, V13, P308, DOI 10.1002/ibd.20005; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thukral Chandrashekhar, 2005, Curr Treat Options Gastroenterol, V8, P223, DOI 10.1007/s11938-005-0014-z; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van Deventer SJH, 1997, ALIMENT PHARM THERAP, V11, P116; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wood KL, 2003, AM J RESP CRIT CARE, V167, P1279, DOI 10.1164/rccm.200206-563OC; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	65	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119441	10.1371/journal.pone.0119441	http://dx.doi.org/10.1371/journal.pone.0119441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775453	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500092
J	Bianco, E; Nevado, B; Ramos-Onsins, SE; Perez-Enciso, M				Bianco, Erica; Nevado, Bruno; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel			A Deep Catalog of Autosomal Single Nucleotide Variation in the Pig	PLOS ONE			English	Article							DOMESTIC PIG; SELECTION; SEQUENCE; REVEALS; GENOMES; VARIANTS; DISTINCT; FORMAT	A comprehensive catalog of variability in a given species is useful for many important purposes, e. g., designing high density arrays or pinpointing potential mutations of economic or physiological interest. Here we provide a genomewide, worldwide catalog of single nucleotide variants by simultaneously analyzing the shotgun sequence of 128 pigs and five suid outgroups. Despite the high SNP missing rate of some individuals (up to 88%), we retrieved over 48 million high quality variants. Of them, we were able to assess the ancestral allele of more than 39M biallelic SNPs. We found SNPs in 21,455 out of the 25,322 annotated genes in pig assembly 10.2. The annotation showed that more than 40% of the variants were novel variants, not present in dbSNP. Surprisingly, we found a large variability in transition /transversion rate along the genome, which is very well explained (R-2=0.79) primarily by genome differences in in CpG content and recombination rate. The number of SNPs per window also varied but was less dependent of known factors such as gene density, missing rate or recombination (R-2=0.48). When we divided the samples in four groups, Asian wild boar (ASWB), Asian domestics (ASDM), European wild boar (EUWB) and European domestics (EUDM), we found a marked correlation in allele frequencies between domestics and wild boars within Asia and within Europe, but not across continents, due to the large evolutive distance between pigs of both continents (similar to 1.2 MYA). In general, the porcine species showed a small percentage of SNPs exclusive of each population group. EUWB and EUDM were predicted to harbor a larger fraction of potentially deleterious mutations, according to the SIFT algorithm, than Asian samples, perhaps a result of background selection being less effective due to a lower effective population size in Europe.	[Bianco, Erica; Nevado, Bruno; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] CSIC IRTA UAB UB Consortium, Ctr Res Agr Genom, Bellaterra, Spain; [Bianco, Erica; Nevado, Bruno; Perez-Enciso, Miguel] Univ Autonoma Barcelona, Dept Anim Sci, Bellaterra, Spain; [Perez-Enciso, Miguel] Inst Catala Recerca & Estudis Avancats, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Autonomous University of Barcelona; ICREA	Perez-Enciso, M (corresponding author), CSIC IRTA UAB UB Consortium, Ctr Res Agr Genom, Bellaterra, Spain.	miguel.perez@uab.es	Perez-Enciso, Miguel/H-6057-2015; Bianco, Erica/K-5361-2015; Ramos-Onsins, Sebastian/B-4822-2015	Perez-Enciso, Miguel/0000-0003-3524-995X; Bianco, Erica/0000-0002-8967-2203; Ramos-Onsins, Sebastian/0000-0002-1776-140X; Nevado, Bruno/0000-0002-9765-2907	Ministry of Economy and Science, Spain [AGL2010-14822, AGL2013-41834-R]	Ministry of Economy and Science, Spain	This work was funded by AGL2010-14822 and AGL2013-41834-R (Ministry of Economy and Science, Spain) to MPE and SERO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bosse M, 2014, MOL ECOL, V23, P4089, DOI 10.1111/mec.12807; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Burgos-Paz W, 2013, HEREDITY, V110, P321, DOI 10.1038/hdy.2012.109; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Giuffra E, 2000, GENETICS, V154, P1785; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Neuman JA, 2013, BRIEF BIOINFORM, V14, P46, DOI 10.1093/bib/bbs013; Nevado B, 2015, MOL ECOL RESOUR, V15, P99, DOI 10.1111/1755-0998.12286; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Perez-Enciso M, 2014, J ANIM BREED GENET, V131, P85, DOI 10.1111/jbg.12074; Porter V., 1993, Pigs. A handbook to the breeds of the world.; Ramirez O, 2015, HEREDITY, V114, P175, DOI 10.1038/hdy.2014.81; Ramos-Onsins S, 2014, MSTATSPOP; Ramos-Onsins SE, 2014, HEREDITY, V113, P471, DOI 10.1038/hdy.2014.68; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sarkar D, 2003, LATTICE GRAPHICS; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Team R, 2013, R LANG ENV STAT COMP; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118867	10.1371/journal.pone.0118867	http://dx.doi.org/10.1371/journal.pone.0118867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789620	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400051
J	Bose, O; Baluk, P; Looney, MR; Cheng, LE; McDonald, DM; Caughey, GH; Krummel, MF				Bose, Oishee; Baluk, Peter; Looney, Mark R.; Cheng, Laurence E.; McDonald, Donald M.; Caughey, George H.; Krummel, Matthew F.			Mast Cells Present Protrusions into Blood Vessels upon Tracheal Allergen Challenge in Mice	PLOS ONE			English	Article							IMMUNE-SYSTEM; IN-VIVO; DENDRITIC CELLS; LUNG; ASTHMA	Mast cells (MC) and myeloid dendritic cells (DC) act proximally in detecting and processing antigens and immune insults. We sought to understand their comparative dynamic behavior with respect to the airway epithelium in the steady state and in response to an allergic stimulus in mouse trachea. We devised methods to label MC in living trachea and to demonstrate that MC and DC occupy distinct layers of the tracheal mucosa, with DC being closer to the lumen. DC numbers doubled after allergen challenge, but MC numbers remained stable. MC and DC migrated minimally in either steady state or allergen-challenge conditions, and their interactions with one another appeared to be stochastic and relatively infrequent. While DC, unlike MC, exhibited probing behaviors involving dendrites, these projections did not cross the epithelium into the airway lumen. MC typically were located too far from the epithelial surface to contact the tracheal lumen. However, MC had protrusions toward and into blood vessels, likely to load with IgE. Thus, DC and MC occupy distinct niches and engage in sessile surveillance in the mouse trachea. Little or no access of these cell types to the airway lumen suggests that trans-epithelial transport of proteins in the steady state would be required for them to access luminal antigens.	[Bose, Oishee; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Baluk, Peter; McDonald, Donald M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Baluk, Peter; McDonald, Donald M.; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caughey, GH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	george.caughey@ucsf.edu; matthew.krummel@ucsf.edu			National Institutes of Health [HL024136, U19AI077439]; National Heart Lung and Blood Institute [HL059157]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127402, P01HL024136, R01HL059157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants HL024136 (Caughey, Krummel, McDonald), U19AI077439 (Krummel), and HL059157 (McDonald) from the National Heart Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lelkes E, 2014, TRENDS IMMUNOL, V35, P379, DOI 10.1016/j.it.2014.05.005; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Thornton Emily E, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1228s60; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667	18	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118513	10.1371/journal.pone.0118513	http://dx.doi.org/10.1371/journal.pone.0118513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789765	Green Published, gold			2022-12-26	WOS:000351425400032
J	Cucinotta, FA				Cucinotta, Francis A.			A New Approach to Reduce Uncertainties in Space Radiation Cancer Risk Predictions	PLOS ONE			English	Article							INDUCTION; MICE; CARCINOGENESIS; IRRADIATION; CARCINOMA; SPECTRUM; PARTICLE; RAT	The prediction of space radiation induced cancer risk carries large uncertainties with two of the largest uncertainties being radiation quality and dose-rate effects. In risk models the ratio of the quality factor (QF) to the dose and dose-rate reduction effectiveness factor (DDREF) parameter is used to scale organ doses for cosmic ray proton and high charge and energy (HZE) particles to a hazard rate for gamma-rays derived from human epidemiology data. In previous work, particle track structure concepts were used to formulate a space radiation QF function that is dependent on particle charge number Z, and kinetic energy per atomic mass unit, E. QF uncertainties where represented by subjective probability distribution functions (PDF) for the three QF parameters that described its maximum value and shape parameters for Z and E dependences. Here I report on an analysis of a maximum QF parameter and its uncertainty using mouse tumor induction data. Because experimental data for risks at low doses of gamma-rays are highly uncertain which impacts estimates of maximum values of relative biological effectiveness (RBEmax), I developed an alternate QF model, denoted QF(gamma Acute) where QFs are defined relative to higher acute gamma-ray doses (0.5 to 3 Gy). The alternate model reduces the dependence of risk projections on the DDREF, however a DDREF is still needed for risk estimates for high-energy protons and other primary or secondary sparsely ionizing space radiation components. Risk projections (upper confidence levels (CL)) for space missions show a reduction of about 40% (CL similar to 50%) using the QF(gamma Acute) model compared the QFs based on RBEmax and about 25% (CL similar to 35%) compared to previous estimates. In addition, I discuss how a possible qualitative difference leading to increased tumor lethality for HZE particles compared to low LET radiation and background tumors remains a large uncertainty in risk estimates.	Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA.	francis.cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020		University of Nevada, Las Vegas; Department of Energy	University of Nevada, Las Vegas; Department of Energy(United States Department of Energy (DOE))	The University of Nevada, Las Vegas and the Department of Energy partially funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpen E.L., 1993, RADIAT RES, V88, P132, DOI DOI 10.2307/3575758; [Anonymous], [No title captured]; Barcellos-Hoff MH, 2009, HEALTH PHYS, V97, P446, DOI 10.1097/HP.0b013e3181b08a10; Barkas H, 1963, NUCL RES EMULSIONS; BEIR VII, 2006, HLTH RISKS EXP LOW L; Bissell M, 1997, LBNL PUBLICATION; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2013, SPACE RAD CANC RISK; Cucinotta FA, 1994, TP19943412 NASA; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Datta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059295; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Edwards A. A., 1999, Journal of Radiological Protection, V19, P93, DOI 10.1088/0952-4746/19/2/201; EDWARDS AA, 1975, PHYS MED BIOL, V20, P395, DOI 10.1088/0031-9155/20/3/004; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; FRY RJM, 1987, ADV RADIAT BIOL, V13, P31; GRAHN D, 1992, RADIAT RES, V129, P19, DOI 10.2307/3577899; Hada M, 2014, RADIAT RES, V182, P368, DOI 10.1667/RR13721.1; ICRP, 2003, ICRP PUBL; Illa-Bochaca I, 2014, CANCER RES, V74, P7137, DOI 10.1158/0008-5472.CAN-14-1212; Imaoka T, 2007, INT J RADIAT ONCOL, V69, P194, DOI 10.1016/j.ijrobp.2007.05.026; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; KATZ R, 1971, RADIAT RES, V47, P402, DOI 10.2307/3573247; NAS, 1996, RAD HAZ CREWS INT MI; NAS/NRC, 2012, TECHNICAL EVALUATION; National Council on Radiation Protection and Measurements (NCRP), 1997, 126 NCRP; NCRP, 2000, 132 NCRP; NCRP, 2014, RAD PROT SPAC ACT SU; NCRP, 1989, 98 NCRP; NCRP, 1990, 104 NCRP; NCRP, 2006, 153 NCRP; NCRP, 2010, 167 NCRP; NRC, 2008, MANAGING SPACE RAD R, DOI DOI 10.17226/12045; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; SMITH AB, 1957, PHYS REV, V108, P411, DOI 10.1103/PhysRev.108.411; Trani D, 2010, RADIAT ENVIRON BIOPH, V49, P389, DOI 10.1007/s00411-010-0292-2; ULLRICH RL, 1979, RADIAT RES, V80, P325, DOI 10.2307/3575061; ULLRICH RL, 1977, RADIAT RES, V72, P487, DOI 10.2307/3574612; ULLRICH RL, 1983, RADIAT RES, V93, P506, DOI 10.2307/3576029; ULLRICH RL, 1984, RADIAT RES, V97, P587, DOI 10.2307/3576150; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD UN; Weil MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104819; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1	46	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120717	10.1371/journal.pone.0120717	http://dx.doi.org/10.1371/journal.pone.0120717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789764	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400172
J	Llopart, A				Llopart, Ana			Parallel Faster-X Evolution of Gene Expression and Protein Sequences in Drosophila: Beyond Differences in Expression Properties and Protein Interactions	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; PHYLOGENETIC ANALYSIS; RECOMBINATION RATE; RAPID EVOLUTION; SEX-CHROMOSOMES; LINKED GENES; CODON USAGE; PATTERNS	Population genetics models predict that the X (or Z) chromosome will evolve at faster rates than the autosomes in XY (or ZW) systems. Studies of molecular evolution using large datasets in multiple species have provided evidence supporting this faster-X effect in protein-coding sequences and, more recently, in transcriptomes. However, X-linked and autosomal genes differ significantly in important properties besides hemizygosity in males, including gene expression levels, tissue specificity in gene expression, and the number of interactions in which they are involved (i.e., protein-protein or DNA-protein interactions). Most important, these properties are known to correlate with rates of evolution, which raises the question of whether differences between the X chromosome and autosomes in gene properties, rather than hemizygosity, are sufficient to explain faster-X evolution. Here I investigate this possibility using whole genome sequences and transcriptomes of Drosophila yakuba and D. santomea and show that this is not the case. Additional factors are needed to account for faster-X evolution of both gene expression and protein-coding sequences beyond differences in gene properties, likely a higher incidence of positive selection in combination with the accumulation of weakly deleterious mutations.	[Llopart, Ana] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Llopart, Ana] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA USA	University of Iowa; University of Iowa	Llopart, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	ana-llopart@uiowa.edu			US National Science Foundation [DEB 1354921]; University of Iowa; Direct For Biological Sciences [1354921] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); University of Iowa; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partially funded by US National Science Foundation DEB 1354921 grant and University of Iowa funds to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, GENETICS, V156, P1879; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Betancourt AJ, 2002, MOL BIOL EVOL, V19, P1816, DOI 10.1093/oxfordjournals.molbev.a004006; Blankenberg D, 2001, GALAXY WEB BASED GEN, DOI [10.1002/0471142700.nca01bs00, DOI 10.1002/0471142700.NCA01BS00]; Campos JL, 2014, MOL BIOL EVOL, V31, P1010, DOI 10.1093/molbev/msu056; Campos JL, 2013, MOL BIOL EVOL, V30, P811, DOI 10.1093/molbev/mss222; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; Catalan A, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-654; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Charlesworth B, 2012, GENETICS, V191, P233, DOI 10.1534/genetics.111.138073; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeron JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004434; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Connallon T, 2007, MOL BIOL EVOL, V24, P2566, DOI 10.1093/molbev/msm199; Counterman BA, 2004, EVOLUTION, V58, P656, DOI 10.1111/j.0014-3820.2004.tb01688.x; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Ellegren H, 2009, P ROY SOC B-BIOL SCI, V276, P361, DOI 10.1098/rspb.2008.1135; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garrigan D, 2014, GENOME BIOL EVOL, V6, P2444, DOI 10.1093/gbe/evu198; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gillespie JH, 2000, GENETICS, V155, P909; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grath S, 2012, GENOME BIOL EVOL, V4, P346, DOI 10.1093/gbe/evs012; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hansen Matthew E B, 2013, Int J Evol Biol, V2013, P545392, DOI 10.1155/2013/545392; Herrig DK, 2014, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0025537, DOI 10.1002/9780470015902.A0025537]; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Hvilsom C, 2012, P NATL ACAD SCI USA, V109, P2054, DOI 10.1073/pnas.1106877109; Jaquiery J, 2012, MOL BIOL EVOL, V29, P837, DOI 10.1093/molbev/msr252; Jiang ZF, 2009, GENETICS, V183, P1175, DOI 10.1534/genetics.109.105775; Jovelin R, 2013, J MOL EVOL, V77, P206, DOI 10.1007/s00239-013-9588-6; Kayserili MA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003200; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kousathanas A, 2014, GENETICS, V196, P1131, DOI 10.1534/genetics.113.158246; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llopart A, 2005, EVOLUTION, V59, P2602, DOI 10.1111/j.0014-3820.2005.tb00972.x; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Llopart A, 2012, MOL BIOL EVOL, V29, P3873, DOI 10.1093/molbev/mss190; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Mank JE, 2007, GENOME RES, V17, P618, DOI 10.1101/gr.6031907; Mank JE, 2010, MOL BIOL EVOL, V27, P661, DOI 10.1093/molbev/msp282; Mank JE, 2010, EVOLUTION, V64, P663, DOI 10.1111/j.1558-5646.2009.00853.x; Marais G, 2004, J MOL EVOL, V59, P771, DOI 10.1007/s00239-004-2671-2; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P1007, DOI 10.1093/gbe/evs077; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003013; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Meisel RP, 2011, MOL BIOL EVOL, V28, P1893, DOI 10.1093/molbev/msr010; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Muller Lena, 2012, Int J Evol Biol, V2012, P963976, DOI 10.1155/2012/963976; Musters H, 2006, J MOL EVOL, V62, P693, DOI 10.1007/s00239-005-0165-5; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pal C, 2001, GENETICS, V158, P927; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Perry JC, 2014, MOL BIOL EVOL, V31, P1206, DOI 10.1093/molbev/msu072; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; Sackton TB, 2014, EVOLUTION; Singh ND, 2008, MOL BIOL EVOL, V25, P454, DOI 10.1093/molbev/msm275; Singh ND, 2005, GENETICS, V171, P145, DOI 10.1534/genetics.105.043497; Singh ND, 2005, J MOL EVOL, V61, P315, DOI 10.1007/s00239-004-0287-1; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Thornton K, 2006, GENOME RES, V16, P498, DOI 10.1101/gr.4447906; Thornton K, 2005, MOL BIOL EVOL, V22, P273, DOI 10.1093/molbev/msi015; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Veeramah KR, 2014, MOL BIOL EVOL; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643; Vicoso B, 2009, GENETICS, V181, P1699, DOI 10.1534/genetics.108.098004; Vicoso B, 2009, EVOLUTION, V63, P2413, DOI 10.1111/j.1558-5646.2009.00719.x; Vicoso B, 2008, GENET RES, V90, P421, DOI 10.1017/S0016672308009804; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223	95	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116829	10.1371/journal.pone.0116829	http://dx.doi.org/10.1371/journal.pone.0116829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789611	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400021
J	Chang, HHD; Xu, Y; Lai, HY; Yang, XY; Tseng, CC; Lai, YJJ; Pan, Y; Zhou, E; Johnson, MD; Wang, JK; Lin, CY				Chang, Hsiang-Hua D.; Xu, Yuan; Lai, Hongyu; Yang, Xiaoyu; Tseng, Chun-Che; Lai, Ying-Jung J.; Pan, Yu; Zhou, Emily; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; SERINE-PROTEASE INHIBITOR; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; HUMAN TISSUES; EXPRESSION; CARCINOMA; DOMAIN; LINES	The type 2 transmembrane serine protease matriptase is under tight control primarily by the actions of the integral membrane Kunitz-type serine protease inhibitor HAI-1. Growing evidence indicates that HAI-2 might also be involved in matriptase inhibition in some contexts. Here we showed that matriptase inhibition by HAI-2 depends on the subcellular localizations of HAI-2, and is observed in breast cancer cells but not in mammary epithelial cells. HAI-2 is co-expressed with matriptase in 21 out of 26 human epithelial and carcinoma cells examined. HAI-2 is also a potent matriptase inhibitor in solution, but in spite of this, HAI-2 inhibition of matriptase is not observed in all contexts where HAI-2 is expressed, unlike what is seen for HAI-1. Induction of matriptase zymogen activation in mammary epithelial cells results in the formation of matriptase-HAI-1 complexes, but matriptase-HAI-2 complexes are not observed. In breast cancer cells, however, in addition to the appearance of matriptase-HAI-1 complex, three different matriptase-HAI-2 complexes, are formed following the induction of matriptase activation. Immunofluorescent staining reveals that activated matriptase is focused at the cell-cell junctions upon the induction of matriptase zymogen activation in both mammary epithelial cells and breast cancer cells. HAI-2, in contrast, remains localized in vesicle/granule-like structures during matriptase zymogen activation in human mammary epithelial cells. In breast cancer cells, however, a proportion of the HAI-2 reaches the cell surface where it can gain access to and inhibit active matriptase. Collectively, these data suggest that matriptase inhibition by HAI-2 requires the translocation of HAI-2 to the cell surface, a process which is observed in some breast cancer cells but not in mammary epithelial cells.	[Chang, Hsiang-Hua D.; Xu, Yuan; Lai, Hongyu; Yang, Xiaoyu; Tseng, Chun-Che; Lai, Ying-Jung J.; Pan, Yu; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Tseng, Chun-Che] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Zhou, Emily] Thomas Jefferson High Sch Sci & Technol, Alexandria, VA 22046 USA	Georgetown University; National Defense Medical Center; Carleton College	Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	jkwang@ndmctsgh.edu.tw	Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [DOD97-13-02]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to M. Johnson and C.-Y. Lin), and Taiwan Department of Defense Grant DOD97-13-02 (to J.-K. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Chu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092244; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HEO DS, 1989, CANCER RES, V49, P5167; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; TEICHER BA, 1987, CANCER RES, V47, P388; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YASUMURA S, 1993, CANCER RES, V53, P1461	32	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120489	10.1371/journal.pone.0120489	http://dx.doi.org/10.1371/journal.pone.0120489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786220	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500176
J	Deshpande, S; Pfohl, T				Deshpande, Siddharth; Pfohl, Thomas			Real-Time Dynamics of Emerging Actin Networks in Cell-Mimicking Compartments	PLOS ONE			English	Article							F-ACTIN; INTERNAL-STRESS; TRANSPORT; FILAMENTS; MYOSIN	Understanding the cytoskeletal functionality and its relation to other cellular components and properties is a prominent question in biophysics. The dynamics of actin cytoskeleton and its polymorphic nature are indispensable for the proper functioning of living cells. Actin bundles are involved in cell motility, environmental exploration, intracellular transport and mechanical stability. Though the viscoelastic properties of actin-based structures have been extensively probed, the underlying microstructure dynamics, especially their disassembly, is not fully understood. In this article, we explore the rich dynamics and emergent properties exhibited by actin bundles within flow-free confinements using a microfluidic setup and epifluorescence microscopy. After forming entangled actin filaments within cellsized quasi two-dimensional confinements, we induce their bundling using three different fundamental mechanisms: counterion condensation, depletion interactions and specific protein-protein interactions. Intriguingly, long actin filaments form emerging networks of actin bundles via percolation leading to remarkable properties such as stress generation and spindle-like intermediate structures. Simultaneous sharing of filaments in different links of the network is an important parameter, as short filaments do not form networks but segregated clusters of bundles instead. We encounter a hierarchical process of bundling and its subsequent disassembly. Additionally, our study suggests that such percolated networks are likely to exist within living cells in a dynamic fashion. These observations render a perspective about differential cytoskeletal responses towards numerous stimuli.	[Deshpande, Siddharth; Pfohl, Thomas] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Pfohl, T (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	thomas.pfohl@unibas.ch	Pfohl, Thomas/D-7296-2016; Deshpande, Siddharth/Y-3825-2019; Deshpande, Siddharth/ABA-9055-2020	Pfohl, Thomas/0000-0002-7879-5216; Deshpande, Siddharth/0000-0002-7137-8962	Swiss National Science Foundation [SNF 200020_141270]; Swiss Nanoscience Institute (SNI)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Nanoscience Institute (SNI)	SD and TP received financial support from the Swiss National Science Foundation, grant number SNF 200020_141270. Financial support from the Swiss Nanoscience Institute (SNI) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts A, 2008, MOL BIOL CELL; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Brangbour C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000613; BURLACU S, 1992, AM J PHYSIOL, V262, pC569, DOI 10.1152/ajpcell.1992.262.3.C569; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Deshpande S, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4752245; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Honda M, 1999, J MOL BIOL, V287, P293, DOI 10.1006/jmbi.1999.2592; Howard J., 2001, MECH MOTOR PROTEINS; Huber F, 2013, ADV PHYS, V62, P1, DOI 10.1080/00018732.2013.771509; Janmey PA, 1999, ACTIN FILAMENTS BIOP; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; Koster S, 2009, CELL MOTIL CYTOSKEL, V66, P771, DOI 10.1002/cm.20336; Koster S, 2005, J PHYS-CONDENS MAT, V17, pS4091, DOI 10.1088/0953-8984/17/49/006; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.088102; Lieleg O, 2011, NAT MATER, V10, P236, DOI [10.1038/nmat2939, 10.1038/NMAT2939]; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lieleg O, 2010, SOFT MATTER, V6, P218, DOI 10.1039/b912163n; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Maloney MT, 2011, DEV NEUROBIOL, V71, P795, DOI 10.1002/dneu.20908; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; PODOLSKI JL, 1990, J BIOL CHEM, V265, P1312; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; ROMANI A, 1993, MINER ELECTROL METAB, V19, P282; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; Schmoller KM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1134; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; Schmoller KM, 2008, SOFT MATTER, V4, P2365, DOI 10.1039/b808582j; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Steinhauser D, 2012, ACS MACRO LETT, V1, P541, DOI 10.1021/mz3000539; Strehle D, 2011, EUR BIOPHYS J BIOPHY, V40, P93, DOI 10.1007/s00249-010-0621-z; Streichfuss M, 2011, NANO LETT, V11, P3676, DOI 10.1021/nl201630y; Takiguchi K, 2011, LANGMUIR, V27, P11528, DOI 10.1021/la2016287; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389	41	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116521	10.1371/journal.pone.0116521	http://dx.doi.org/10.1371/journal.pone.0116521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785606	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500009
J	Filou, S; Korpetinou, A; Kyriakopoulou, D; Bounias, D; Stavropoulos, M; Ravazoula, P; Papachristou, DJ; Theocharis, AD; Vynios, DH				Filou, Serafula; Korpetinou, Aggeliki; Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael; Ravazoula, Panagiota; Papachristou, Dionysios J.; Theocharis, Achilleas D.; Vynios, Demitrios H.			ADAMTS Expression in Colorectal Cancer	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; HUMAN GLIOBLASTOMAS; FAMILY; VERSICAN; METALLOPROTEINASES; DISINTEGRIN; CARCINOMAS; ACCUMULATION; DECORIN	ADAMTSs are a family of secreted proteinases that share the metalloproteinase domain with matrix metalloproteinases (MMPs). By acting on a large panel of extracellular substrates, they control several cell functions such as fusion, adhesion, proliferation and migration. Through their thrombospondin motifs they also possess anti-angiogenic properties. We investigated whether ADAMTSs participate in colorectal cancer progression and invasion. Their expression was investigated at both mRNA and protein levels. Using RT-PCR, the expression of ADAMTS-1, -4, -5 and ADAMTS-20 was estimated in colorectal tumors of different cancer stage and anatomic site and 3 cell lines of different aggressiveness. An overexpression of ADAMTS-4 and -5 was observed, especially in tissue samples, whereas ADAMTS-1 and -20 were found to be down-regulated. Western blot analysis further supported the RT-PCR findings, revealing in addition the degradation of ADAMTS-1 and -20 in cancer. In situ expression and localization of ADAMTS-1, -4, -5 and -20 was also investigated by immunohistochemical analysis. Our data suggest a positive correlation between ADAMTS-4 and -5 expression and cancer progression, in contrast with the anti-angiogenic members of the family, ADAMTS-1 and -20, which were found to be down-regulated. Our findings support the notion that overexpression of ADAMTS-4 and ADAMTS-5 in colorectal cancer might be a possible invasive mechanism of cancer cells in order to degrade proteoglycans of ECM.	[Filou, Serafula; Korpetinou, Aggeliki; Theocharis, Achilleas D.; Vynios, Demitrios H.] Univ Patras, Dept Chem, Biochem Lab, Biochem Biochem Anal & Matrix Pathobiol Res Grp, Patras, Greece; [Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael] Sch Hlth Sci, Dept Surg, Patras, Greece; [Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael] Univ Hosp Patras, Patras, Greece; [Ravazoula, Panagiota] Univ Hosp Patras, Dept Histopathol, Patras, Greece; [Papachristou, Dionysios J.] Univ Patras, Dept Med, Anat Histol & Embryol Lab, Patras, Greece	University of Patras; University of Patras; University of Patras; University of Patras	Vynios, DH (corresponding author), Univ Patras, Dept Chem, Biochem Lab, Biochem Biochem Anal & Matrix Pathobiol Res Grp, Patras, Greece.	vynios@chemistry.upatras.gr	theocharis, achilleas/F-6903-2010					Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Bouga H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-499; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Choi GCG, 2014, MOL CANCER RES, V12, P228, DOI 10.1158/1541-7786.MCR-13-0195; Cin PD, 1999, GENE CHROMOSOME CANC, V24, P94, DOI 10.1002/(SICI)1098-2264(199901)24:1<94::AID-GCC14>3.0.CO;2-2; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; El-Rifai W, 2001, NEOPLASIA, V3, P173, DOI 10.1038/sj.neo.7900158; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Filou S, 2013, BIOCHIMIE, V95, P725, DOI 10.1016/j.biochi.2012.10.022; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hough RE, 2001, BRIT J CANCER, V84, P499, DOI 10.1054/bjoc.2000.1638; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lind GE, 2006, CELL ONCOL, V28, P259; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mukaratirwa S, 2004, J COMP PATHOL, V131, P259, DOI 10.1016/j.jcpa.2004.04.007; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; PEDEUTOUR F, 1994, GENOMICS, V22, P512, DOI 10.1006/geno.1994.1424; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Przemyslaw L, 2013, BMB REP, V46, P139, DOI 10.5483/BMBRep.2013.46.3.176; Rao N, 2013, INT J CANCER, V133, P294, DOI 10.1002/ijc.28037; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Sawaji Y, 2008, ARTHRITIS RHEUM, V58, P3498, DOI 10.1002/art.24025; Skandalis SS, 2006, BIOCHIMIE, V88, P1135, DOI 10.1016/j.biochi.2006.03.011; Skandalis SS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-314; Thirunavukkarasu K, 2006, BIOCHEM BIOPH RES CO, V345, P197, DOI 10.1016/j.bbrc.2006.04.023; Tsara ME, 2002, ANTICANCER RES, V22, P2893; Van Der Jagt MFP, 2010, J SURG ONCOL, V101, P259, DOI 10.1002/jso.21462; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	36	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121209	10.1371/journal.pone.0121209	http://dx.doi.org/10.1371/journal.pone.0121209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786261	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500201
J	Gross, CM; Rafikov, R; Kumar, S; Aggarwal, S; Ham, PB; Meadows, ML; Cherian-Shaw, M; Kangath, A; Sridhar, S; Lucas, R; Black, SM				Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Aggarwal, Saurabh; Ham, P. Benson, III; Meadows, Mary Louise; Cherian-Shaw, Mary; Kangath, Archana; Sridhar, Supriya; Lucas, Rudolf; Black, Stephen M.			Endothelial Nitric Oxide Synthase Deficient Mice Are Protected from Lipopolysaccharide Induced Acute Lung Injury	PLOS ONE			English	Article							ARGININE METHYL-ESTER; KAPPA-B-ALPHA; ASYMMETRIC DIMETHYLARGININE; RESPIRATORY-DISTRESS; PULMONARY-CIRCULATION; ENDOGENOUS INHIBITOR; INDUCIBLE ISOFORM; ENDOTOXIC-SHOCK; CECAL LIGATION; MOUSE MODEL	Lipopolysaccharide (LPS) derived from the outer membrane of gram-negative bacteria induces acute lung injury (ALI) in mice. This injury is associated with lung edema, inflammation, diffuse alveolar damage, and severe respiratory insufficiency. We have previously reported that LPS-mediated nitric oxide synthase (NOS) uncoupling, through increases in asymmetric dimethylarginine (ADMA), plays an important role in the development of ALI through the generation of reactive oxygen and nitrogen species. Therefore, the focus of this study was to determine whether mice deficient in endothelial NOS (eNOS(-/-)) are protected against ALI. In both wild-type and eNOS(-/-) mice, ALI was induced by the intratracheal instillation of LPS (2 mg/kg). After 24 hours, we found that eNOS(-/-)mice were protected against the LPS mediated increase in inflammatory cell infiltration, inflammatory cytokine production, and lung injury. In addition, LPS exposed eNOS(-/-) mice had increased oxygen saturation and improved lung mechanics. The protection in eNOS(-/-) mice was associated with an attenuated production of NO, NOS derived superoxide, and peroxynitrite. Furthermore, we found that eNOS(-/-) mice had less RhoA activation that correlated with a reduction in RhoA nitration at Tyr(34). Finally, we found that the reduction in NOS uncoupling in eNOS(-/-) mice was due to a preservation of dimethylarginine dimethylaminohydrolase (DDAH) activity that prevented the LPS-mediated increase in ADMA. Together our data suggest that eNOS derived reactive species play an important role in the development of LPS-mediated lung injury.	[Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Aggarwal, Saurabh; Ham, P. Benson, III; Meadows, Mary Louise; Cherian-Shaw, Mary; Kangath, Archana; Sridhar, Supriya; Lucas, Rudolf; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA.	sblack@gru.edu	Rafikov, Ruslan/AAG-9352-2019; Lucas, Rudolf/ABA-3011-2020	Lucas, Rudolf/0000-0003-3805-8868; Rafikov, Ruslan/0000-0001-5950-4076	 [P01HL0101902];  [HL60190];  [HL67841];  [HL094609];  [12PRE12060224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL094609, R01HL060190, R01HL067841] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All our funding sources are as follows: P01HL0101902 (SMB), HL60190 (SMB), and HL67841 (SMB) and HL094609 (RL) 12PRE12060224 (CG) AHA SDG (RR) and that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2007, INTENS CARE MED, V33, P503, DOI 10.1007/s00134-006-0497-7; Aggarwal S, 2014, J BIOL CHEM, V289, P7948, DOI 10.1074/jbc.M113.534313; Aggarwal S, 2014, AM J RESP CELL MOL, V50, P614, DOI 10.1165/rcmb.2013-0193OC; Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161; Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692; Arkovitz MS, 1996, J PEDIATR SURG, V31, P1009, DOI 10.1016/S0022-3468(96)90075-5; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bloomfield GL, 1997, CRIT CARE MED, V25, P584, DOI 10.1097/00003246-199704000-00006; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; BUXTON ILO, 1993, CIRC RES, V72, P387, DOI 10.1161/01.RES.72.2.387; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; DEKIMPE SJ, 1995, BRIT J PHARMACOL, V114, P1317; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Feletou M, 2001, AM J PHYSIOL-LUNG C, V281, pL258, DOI 10.1152/ajplung.2001.281.1.L258; Han RNN, 2004, CIRC RES, V94, P1115, DOI 10.1161/01.RES.0000125624.85852.1E; Iuvone T, 1996, LIFE SCI, V59, pPL207; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Kengatharan KM, 1996, BRIT J PHARMACOL, V119, P1411, DOI 10.1111/j.1476-5381.1996.tb16053.x; Koizumi T, 2004, ANESTHESIOLOGY, V101, P59, DOI 10.1097/00000542-200407000-00011; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lange M, 2011, BIOCHEM BIOPH RES CO, V404, P877, DOI 10.1016/j.bbrc.2010.12.078; Lange M, 2010, ANESTHESIOLOGY, V113, P1376, DOI 10.1097/ALN.0b013e3181fc5588; Lange M, 2010, BIOCHEM BIOPH RES CO, V399, P286, DOI 10.1016/j.bbrc.2010.07.071; Lange M, 2009, CRIT CARE MED, V37, P223, DOI 10.1097/CCM.0b013e3181926104; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Miller AA, 2005, AM J PHYSIOL-LUNG C, V289, pL299, DOI 10.1152/ajplung.00022.2005; Okamoto I, 2000, AM J RESP CRIT CARE, V162, P716, DOI 10.1164/ajrccm.162.2.9907039; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; PETERSON DA, 1992, BIOCHEM BIOPH RES CO, V187, P797, DOI 10.1016/0006-291X(92)91266-S; PHENG LH, 1995, INFLAMMATION, V19, P599, DOI 10.1007/BF01539139; POU S, 1992, J BIOL CHEM, V267, P24173; Qin LZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/932340; Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596; Ruetten H, 1996, BRIT J PHARMACOL, V118, P261, DOI 10.1111/j.1476-5381.1996.tb15397.x; Sharma S, 2013, PEDIATR RES, V74, P39, DOI 10.1038/pr.2013.71; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008; Speyer CL, 2003, AM J PATHOL, V163, P2319, DOI 10.1016/S0002-9440(10)63588-2; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Steudel W, 1998, J CLIN INVEST, V101, P2468, DOI 10.1172/JCI2356; Steudel W, 1997, CIRC RES, V81, P34, DOI 10.1161/01.RES.81.1.34; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Suda O, 2002, CIRCULATION, V106, P1729, DOI 10.1161/01.CIR.0000029749.16101.44; VALLANCE P, 1992, LANCET, V339, P572; Vo PA, 2005, J BIOL CHEM, V280, P7236, DOI 10.1074/jbc.M411317200; Vromen A, 1996, SHOCK, V6, P248, DOI 10.1097/00024382-199610000-00004; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Worrall NK, 1997, AM J PHYSIOL-HEART C, V273, pH2565, DOI 10.1152/ajpheart.1997.273.6.H2565; Wu CH, 2003, J TRAUMA, V55, P540, DOI 10.1097/01.TA.0000033496.62796.3B; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Zeidler PC, 2004, TOXICOL APPL PHARM, V195, P45, DOI 10.1016/j.taap.2003.10.005	74	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119918	10.1371/journal.pone.0119918	http://dx.doi.org/10.1371/journal.pone.0119918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786132	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500143
J	Jung, S; von Thulen, T; Laukemper, V; Pigisch, S; Hangel, D; Wagner, H; Kaufmann, A; Bauer, S				Jung, Stephanie; von Thuelen, Tina; Laukemper, Viktoria; Pigisch, Stephanie; Hangel, Doris; Wagner, Hermann; Kaufmann, Andreas; Bauer, Stefan			A Single Naturally Occurring 2 '-O-Methylation Converts a TLR7-and TLR8-Activating RNA into a TLR8-Specific Ligand	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; IN-VIVO; INTERFERING RNA; MODIFIED SIRNAS; MESSENGER-RNA; RIBOSOMAL-RNA; CUTTING EDGE; STRANDED-RNA; RECOGNITION	TLR7 and TLR8 recognize RNA from pathogens and lead to subsequent immune stimulation. Here we demonstrate that a single naturally occurring 2'-O-methylation within a synthetic 18s rRNA derived RNA sequence prevents IFN-alpha production, however secretion of proinflammatory cytokines such as IL-6 is not impaired. By analysing TLR-deficient plasmacytoid dendritic cells and performing HEK293 genetic complementation assays we could demonstrate that the single 2'-O-methylation containing RNA still activated TLR8 but not TLR7. Therefore this specific 2'-O-ribose methylation in rRNA converts a TLR7 / TLR8 ligand to an exclusively TLR8-specific ligand. Interestingly, other modifications at this position such as 2'-O-deoxy or 2'-fluoro had no strong modulating effect on TLR7 or TLR8 activation suggesting an important role of 2'-O-methylation for shaping differential TLR7 or TLR8 activation.	[Jung, Stephanie; von Thuelen, Tina; Laukemper, Viktoria; Kaufmann, Andreas; Bauer, Stefan] Univ Marburg, Inst Immunol, BMFZ, D-35032 Marburg, Germany; [Pigisch, Stephanie; Hangel, Doris; Wagner, Hermann] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany	Philipps University Marburg; Technical University of Munich	Bauer, S (corresponding author), Univ Marburg, Inst Immunol, BMFZ, Robert Koch Str 17, D-35032 Marburg, Germany.	stefan.bauer@staff.uni-marburg.de	Jung, Stephanie/AAC-4902-2022	Jung, Stephanie/0000-0002-1454-9358; Bauer, Stefan/0000-0002-8462-1845	German Center for Infection Research (DZIF); DFG [BA 1618/5-1]; Behring Rontgen Stiftung [56-0034]; German National Academic Foundation;  [Transregio-84];  [SFB1021]	German Center for Infection Research (DZIF); DFG(German Research Foundation (DFG)); Behring Rontgen Stiftung; German National Academic Foundation; ; 	SB was funded by Transregio-84, the German Center for Infection Research (DZIF), SFB1021, DFG grant BA 1618/5-1 and grant 56-0034 from the Behring Rontgen Stiftung. SJ was funded by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachellerie JP, 1997, TRENDS BIOCHEM SCI, V22, P257, DOI 10.1016/S0968-0004(97)01057-8; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eberle F, 2008, J IMMUNOL, V180, P3229, DOI 10.4049/jimmunol.180.5.3229; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hamm S, 2010, IMMUNOBIOLOGY, V215, P559, DOI 10.1016/j.imbio.2009.09.003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Jurk M, 2006, EUR J IMMUNOL, V36, P1815, DOI 10.1002/eji.200535806; Kaiser S, 2014, RNA, V20, P1351, DOI 10.1261/rna.044024.113; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Savage P, 1996, BRIT J CANCER, V74, P1482, DOI 10.1038/bjc.1996.569; Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208	40	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120498	10.1371/journal.pone.0120498	http://dx.doi.org/10.1371/journal.pone.0120498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785446	Green Published, gold			2022-12-26	WOS:000352138500178
J	Lanz, TA; Joshi, JJ; Reinhart, V; Johnson, K; Grantham, LE; Volfson, D				Lanz, Thomas A.; Joshi, J. Julie; Reinhart, Veronica; Johnson, Kjell; Grantham, Lonnie E., II; Volfson, Dmitri			STEP Levels Are Unchanged in Pre-Frontal Cortex and Associative Striatum in Post-Mortem Human Brain Samples from Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder	PLOS ONE			English	Article							EXPRESSION; PROTEIN	Increased protein levels of striatal-enriched tyrosine phosphatase (STEP) have recently been reported in postmortem schizophrenic cortex. The present study sought to replicate this finding in a separate cohort of postmortem samples and to extend observations to striatum, including subjects with bipolar disorder and major depressive disorder in the analysis. No statistically significant changes between disease and control subjects were found in STEP mRNA or protein levels in dorsolateral prefrontal cortex or associative striatum. Although samples were matched for several covariates, postmortem interval correlated negatively with STEP protein levels, emphasizing the importance of including these analyses in postmortem studies.	[Lanz, Thomas A.; Joshi, J. Julie; Reinhart, Veronica; Volfson, Dmitri] Pfizer Res & Dev, Cambridge, MA 02139 USA; [Johnson, Kjell; Grantham, Lonnie E., II] Arbor Analyt, Ann Arbor, MI USA	Pfizer	Lanz, TA (corresponding author), Pfizer Res & Dev, Cambridge, MA 02139 USA.	Thomas.a.lanz@pfizer.com		Volfson, Dmitri/0000-0002-5167-7834; Lanz, Thomas/0000-0003-2483-3122	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	Authors were employed by Pfizer, Inc., where the work was funded internally. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Carty NC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.63; Curley AA, 2011, AM J PSYCHIAT, V168, P921, DOI 10.1176/appi.ajp.2011.11010052; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; Glausier JR, 2014, BIOL PSYCHIAT; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Lin CH, 2012, PHARMACOL BIOCHEM BE, V100, P665, DOI 10.1016/j.pbb.2011.03.023; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Reinhart VL, 2014, NEUROSCIENCE, V278, P62, DOI 10.1016/j.neuroscience.2014.08.002; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008	17	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121744	10.1371/journal.pone.0121744	http://dx.doi.org/10.1371/journal.pone.0121744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786133	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500215
J	Saccenti, E; van Duynhoven, J; Jacobs, DM; Smilde, AK; Hoefsloot, HCJ				Saccenti, Edoardo; van Duynhoven, John; Jacobs, Doris M.; Smilde, Age K.; Hoefsloot, Huub C. J.			Strategies for Individual Phenotyping of Linoleic and Arachidonic Acid Metabolism Using an Oral Glucose Tolerance Test	PLOS ONE			English	Article							FAT	The ability to restore homeostasis upon environmental challenges has been proposed as a measure for health. Metabolic profiling of plasma samples during the challenge response phase should offer a profound view on the flexibility of a phenotype to cope with daily stressors. Current data modeling approaches, however, struggle to extract biological descriptors from time-resolved metabolite profiles that are able to discriminate between different phenotypes. Thus, for the case of oxylipin responses in plasma upon an oral glucose tolerance test we developed a modeling approach that incorporates a priori biological pathway knowledge. The degradation pathways of arachidonic and linoleic acids were modeled using a regression model based on a pseudo-steady-state approximated model, resulting in a parameter A that summarizes the relative enzymatic activity in these pathways. Analysis of the phenotypic parameters As suggests that different phenotypes can be discriminated according to preferred relative activity of the arachidonic and linoleic pathway. Correlation analysis shows that there is little or no competition between the arachidonic and linoleic acid pathways, although they share the same enzymes.	[Saccenti, Edoardo] Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Saccenti, Edoardo; Smilde, Age K.; Hoefsloot, Huub C. J.] Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands; [van Duynhoven, John; Jacobs, Doris M.] Unilever Res Labs, Vlaardingen, Netherlands; [van Duynhoven, John] Univ Wageningen & Res Ctr, Biophys Lab, Wageningen, Netherlands; [Saccenti, Edoardo; van Duynhoven, John; Jacobs, Doris M.; Smilde, Age K.; Hoefsloot, Huub C. J.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; University of Amsterdam; Unilever; Wageningen University & Research	Hoefsloot, HCJ (corresponding author), Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands.	h.c.j.hoefsloot@uva.nl	van Duynhoven, John/F-8935-2011	van Duynhoven, John/0000-0001-9769-0113; Saccenti, Edoardo/0000-0001-8284-4829; Smilde, Age/0000-0002-3052-4644	Netherlands Metabolomics Centre (NMC) - Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research	Netherlands Metabolomics Centre (NMC) - Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research	This project was financed by The Netherlands Metabolomics Centre (NMC), which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research. DJ and JvD are employees of Unilever, a company that markets food products enriched with unsaturated fatty acids. Unilever provided support in the form of salaries for authors JvD and DJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, EXPERT REV CLIN IMMU, V5, P145, DOI 10.1586/1744666X.5.2.145; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Apgar JF, 2010, MOL BIOSYST, V6, P1890, DOI 10.1039/b918098b; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; GRIFFITHS AJ, 1994, AM J CLIN NUTR, V59, P53, DOI 10.1093/ajcn/59.1.53; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Nestorov IA, 1998, J PHARMACOKINET BIOP, V26, P21, DOI 10.1023/A:1023272707390; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Saccenti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106077; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; Smilowitz JT, 2013, MOL NUTR FOOD RES, V57, P1319, DOI 10.1002/mnfr.201200808; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stephanopoulos G., 1998, METAB ENG; Strassburg K, 2014, MOL NUTR FOOD RES, V58, P591, DOI 10.1002/mnfr.201300321; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5; van Ommen B, 2010, GENES NUTR, V5, P189, DOI 10.1007/s12263-010-0167-9; Vance DE, 2008, N COMP BIOC, P1; Vis D., 2014, METABOLOMICS, P1, DOI DOI 10.5339/GCSP.2014.4; Wopereis S, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-44; Zhang HJ, 2007, EXPERT OPIN DRUG MET, V3, P667, DOI 10.1517/17425225.3.5.667	30	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119856	10.1371/journal.pone.0119856	http://dx.doi.org/10.1371/journal.pone.0119856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786212	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500136
J	Tokuda, S; Furuse, M				Tokuda, Shinsaku; Furuse, Mikio			Claudin-2 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Claudin-2 Independently Determines the Leaky Property of Tight Junctions in MDCK Cells	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; ZONULAE-OCCLUDENTES; EPITHELIAL-CELLS; EXPRESSION; STRANDS; CATION; DNA; IDENTIFICATION; PERMEABILITY; SELECTIVITY	Tight junctions (TJs) regulate the movements of substances through the paracellular pathway, and claudins are major determinants of TJ permeability. Claudin-2 forms high conductive cation pores in TJs. The suppression of claudin-2 expression by RNA interference in Madin-Darby canine kidney (MDCK) II cells (a low-resistance strain of MDCK cells) was shown to induce a three-fold increase in transepithelial electrical resistance (TER), which, however, was still lower than in high-resistance strains of MDCK cells. Because RNA interference-mediated knockdown is not complete and only reduces gene function, we considered the possibility that the remaining claudin-2 expression in the knockdown study caused the lower TER in claudin-2 knockdown cells. Therefore, we investigated the effects of claudin-2 knockout in MDCK II cells by establishing claudin-2 knockout clones using transcription activator-like effector nucleases (TALENs), a recently developed genome editing method for gene knockout. Surprisingly, claudin-2 knockout increased TER by more than 50-fold in MDCK II cells, and TER values in these cells (3000-4000 Omega.cm(2)) were comparable to those in the high-resistance strains of MDCK cells. Claudin-2 re-expression restored the TER of claudin-2 knockout cells dependent upon claudin-2 protein levels. In addition, we investigated the localization of claudin-1, -2, -3, -4, and -7 at TJs between control MDCK cells and their respective knockout cells using their TALENs. Claudin-2 and -7 were less efficiently localized at TJs between control and their knockout cells. Our results indicate that claudin-2 independently determines the 'leaky' property of TJs in MDCK II cells and suggest the importance of knockout analysis in cultured cells.	[Tokuda, Shinsaku; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; [Furuse, Mikio] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tokuda, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan.	furuse@nips.ac.jp		Furuse, Mikio/0000-0003-2847-8156	Japan Society for the Promotion of Science (JSPS) [LS084]; JSPS [26291043]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) [LS084 to M.F.];the Grant-in-Aid for Scientific Research (B) from JSPS [26291043 to M.F.] URL: http://www.jsps.go.jp/.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; CEREIJIDO M, 1983, J EXP BIOL, V106, P205; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Li WY, 2004, AM J PHYSIOL-RENAL, V286, pF1063, DOI 10.1152/ajprenal.00384.2003; Lim TS, 2008, J MOL BIOL, V381, P681, DOI 10.1016/j.jmb.2008.06.009; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; RICHARDSON JCW, 1981, BIOCHIM BIOPHYS ACTA, V673, P26, DOI 10.1016/0304-4165(81)90307-X; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2010, BIOCHEM BIOPH RES CO, V393, P390, DOI 10.1016/j.bbrc.2010.02.002; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Yu ASL, 2010, J BIOL CHEM, V285, P37060, DOI 10.1074/jbc.M110.146621; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	46	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119869	10.1371/journal.pone.0119869	http://dx.doi.org/10.1371/journal.pone.0119869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781928	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600103
J	Wang, F; Wang, XJ; Yu, XL; Fu, L; Liu, YY; Ma, LX; Zhai, C				Wang, Fei; Wang, Xiaojuan; Yu, Xiaolan; Fu, Lin; Liu, Yunyun; Ma, Lixin; Zhai, Chao			High-Level Expression of Endo-beta-N-Acetylglucosaminidase H from Streptomyces plicatus in Pichia pastoris and Its Application for the Deglycosylation of Glycoproteins	PLOS ONE			English	Article							BACTERIAL PNGASE F; HUMAN ERYTHROPOIETIN; RECOMBINANT PROTEINS; ENDOGLYCOSIDASE-H; ESCHERICHIA-COLI; YEAST; GLYCOSYLATION; CLONING; GENE; PURIFICATION	Endo-beta-N-acetylglucosaminidase H (Endo H, EC3.2.1.96) is a glycohydrolase that is widely used in the study of glycoproteins. The present study aimed to assess the effect of high-level endo-beta-N-acetylglucosaminidase H expression in Pichia pastoris. The DNA coding sequence of this enzyme was optimized based on the codon usage bias of Pichia pastoris and synthesized through overlapping PCR. This novel gene was cloned into a pHBM905A vector and introduced into Pichia pastoris GS115 for secretary expression. The yield of the target protein reached approximately 397 mg/l after a 6-d induction with 1% (v/v) methanol in shake flasks, which is much higher than that observed upon heterologous expression in Escherichia coli and silkworm. This recombinant enzyme was purified and its enzymatic features were studied. Its specific activity was 461573 U/mg. Its optimum pH and temperature were pH 5.5 and 37 degrees C, respectively. Moreover, our study showed that the N-linked glycan side-chains of several recombinant proteins expressed in Pichia pastoris can be efficiently removed through either the co-fermentation of this recombinant strain with strains expressing substrates or by mixing the cell culture supernatants of the endo-beta-N-acetylglucosaminidase H expressing strain with strains expressing substrates after fermentation. This is the first report of high-level endo-beta-N-acetylglucosaminidase H expression in Pichia pastoris and the application of this enzyme in the deglycosylation of raw glycoproteins heterologously expressed in Pichia pastoris using simplified methods.	[Wang, Fei; Wang, Xiaojuan; Yu, Xiaolan; Fu, Lin; Liu, Yunyun; Ma, Lixin; Zhai, Chao] Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China	Hubei University	Ma, LX (corresponding author), Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China.	malixing@hubu.edu.cn; chaozhai@hotmail.com			National Natural Science Foundation of China [31100057, 31172320, 31340036]; National 973 Program of China [2013CB910801]; Nature Science Fund for Creative Research Groups of Hubei Province of China [2012FFA034]; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department [2014070504020239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Nature Science Fund for Creative Research Groups of Hubei Province of China; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department	Funding provided by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Chao Zhai received the funding: No31100057; Xiaolan yu received the funding: No. 31172320 and 31340036; National 973 Program of China (http://www.973.gov.cn/AreaAppl.aspx), Lixin Ma received the funding: No. 2013CB910801; Nature Science Fund for Creative Research Groups of Hubei Province of China (http://www.hbstd.gov.cn/), Lixin Ma received the funding: No. 2012FFA034; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department (http://www.whst.gov.cn/), Lixin Ma received the funding: No. 2014070504020239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; BUCKHOLZ RG, 1991, BIO-TECHNOL, V9, P1067, DOI 10.1038/nbt1191-1067; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHEN GQ, 1994, J AM CHEM SOC, V116, P8799, DOI 10.1021/ja00098a045; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; ELLIOTT S, 1989, GENE, V79, P167, DOI 10.1016/0378-1119(89)90102-9; Frisch E, 2013, ANAL BIOCHEM, V433, P65, DOI 10.1016/j.ab.2012.10.015; Frisch E, 2011, ELECTROPHORESIS, V32, P3510, DOI 10.1002/elps.201100250; Geisse S, 1996, PROTEIN EXPRES PURIF, V8, P271, DOI 10.1006/prep.1996.0101; Guo HB, 2002, CANCER RES, V62, P6837; Kim YK, 2005, BIOTECHNOL BIOENG, V92, P452, DOI 10.1002/bit.20605; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Lisowska E, 2012, ELS; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mamedov T, 2013, BIOENGINEERED, V4, P338, DOI 10.4161/bioe.23449; Mamedov T, 2012, PLANT BIOTECHNOL J, V10, P773, DOI 10.1111/j.1467-7652.2012.00694.x; Milek RLB, 2000, VACCINE, V18, P1402, DOI 10.1016/S0264-410X(99)00392-8; Mitsudome T, 2014, APPL BIOCHEM BIOTECH, V172, P3978, DOI 10.1007/s12010-014-0814-5; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rao B, 2010, YEAST, V27, P285, DOI 10.1002/yea.1753; ROBBINS PW, 1981, J BIOL CHEM, V256, P640; Sambrook J., 2001, MOL CLONING LAB MANU; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; TARENTINO AL, 1976, J BIOL CHEM, V251, P6537; TRIMBLE RB, 1978, J BIOL CHEM, V253, P4508; TRUMBLY RJ, 1985, J BIOL CHEM, V260, P5683; Zhang GM, 2006, BIOCATAL BIOTRANSFOR, V24, P371, DOI 10.1080/10242420600768771	33	17	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120458	10.1371/journal.pone.0120458	http://dx.doi.org/10.1371/journal.pone.0120458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781897	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600162
J	Sutherland, JM; Sobinoff, AP; Fraser, BA; Redgrove, KA; Davidson, TL; Siddall, NA; Koopman, P; Hime, GR; McLaughlin, EA				Sutherland, Jessie M.; Sobinoff, Alexander P.; Fraser, Barbara A.; Redgrove, Kate A.; Davidson, Tara-Lynne; Siddall, Nicole A.; Koopman, Peter; Hime, Gary R.; McLaughlin, Eileen A.			RNA binding protein Musashi-1 directly targets Msi2 and Erh during early testis germ cell development and interacts with IPO5 upon translocation to the nucleus	FASEB JOURNAL			English	Article						MSI1; posttranscriptional regulation; RBP; spermatogenesis	MESSENGER-RNA; IMPORTIN BETA; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; TRANSLATION; ENHANCER; ABSENCE; NEURONS; CYCLE; FATE	Controlled gene regulation during gamete development is vital for maintaining reproductive potential. During the process of gamete development, male germ cells experience extended periods of inactive transcription despite requirements for continued growth and differentiation. Spermatogenesis therefore provides an ideal model to study the effects of posttranscriptional control on gene regulation. During spermatogenesis posttranscriptional regulation is orchestrated by abundantly expressed RNA-binding proteins. One such group of RNA binding proteins is the Musashi family, previously identified as a critical regulator of testis germ cell development and meiosis in Drosophila and also shown to be vital to sperm development and reproductive potential in the mouse. We focus in depth on the role and function of the vertebrate Musashi ortholog Musashi-1 (MSI1). Through detailed expression studies and utilizing our novel transgenic Msi1 testis-specific overexpression model, we have identified 2 unique RNA-binding targets of MSI1 in spermatogonia, Msi2 and Erh, and have demonstrated a role for MSI1 in translational regulation. We have also provided evidence to suggest that nuclear import protein, IPO5, facilitates the nuclear translocation of MSI1 to the transcriptionally silenced XY chromatin domain in meiotic pachytene spermatocytes, resulting in the release of MSI1 RNA-binding targets. This firmly establishes MSI1 as a master regulator of posttranscriptional control during early spermatogenesis and highlights the significance of the subcellular localization of RNA binding proteins in relation to their function.	[Sutherland, Jessie M.; Sobinoff, Alexander P.; Fraser, Barbara A.; Redgrove, Kate A.; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Davidson, Tara-Lynne; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Siddall, Nicole A.; Hime, Gary R.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	University of Newcastle; University of Queensland; University of Melbourne	McLaughlin, EA (corresponding author), Univ Newcastle, Prior Res Ctr Chem Biol, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	eileen.mclaughlin@newcastle.edu.au	McLaughlin, Eileen/AAF-5588-2021; Koopman, Peter A/C-9416-2009; McLaughlin, Eileen A/G-7620-2013; Hime, Gary/B-7162-2015	Koopman, Peter A/0000-0001-6939-0914; McLaughlin, Eileen/0000-0002-5837-3876; Sobinoff, Alexander/0000-0001-6679-5211; Redgrove, Kate/0000-0002-9229-299X; Hime, Gary/0000-0003-4732-3184; Sutherland, Jessie/0000-0001-9672-2371	Australian Research Council; National Health and Medical Research Council; Hunter Medical Research Institute; ARC Centre of Excellence in Biotechnology; Australian Postgraduate Award Ph.D. scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; ARC Centre of Excellence in Biotechnology(Australian Research Council); Australian Postgraduate Award Ph.D. scholarship	Financial assistance was provided to E.A.M. and G.R.H. by the Australian Research Council, National Health and Medical Research Council, and Hunter Medical Research Institute. Additional support was provided the ARC Centre of Excellence in Biotechnology (to E.A.M., P.K., and G.R.H.). J.M.S. is supported by an Australian Postgraduate Award Ph.D. scholarship.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271; Davies RG, 2013, BBA-MOL CELL RES, V1833, P3436, DOI 10.1016/j.bbamcr.2013.05.015; Fineberg K, 2003, BIOCHEMISTRY-US, V42, P2625, DOI 10.1021/bi0206199; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; GU W, 1995, MOL REPROD DEV, V40, P273, DOI 10.1002/mrd.1080400303; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Itman C, 2009, SEMIN CELL DEV BIOL, V20, P607, DOI 10.1016/j.semcdb.2009.05.002; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawase S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-14; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Li SM, 1998, J BIOL CHEM, V273, P31191, DOI 10.1074/jbc.273.47.31191; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Nickerson PEB, 2011, EXP EYE RES, V92, P344, DOI 10.1016/j.exer.2011.02.002; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009; Sobinoff AP, 2010, TOXICOL SCI, V118, P653, DOI 10.1093/toxsci/kfq272; Sutherland JM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115261; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110	49	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2759	2768		10.1096/fj.14-265868	http://dx.doi.org/10.1096/fj.14-265868			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782991				2022-12-26	WOS:000356859100008
J	Omoto, S; Guo, HY; Talekar, GR; Roback, L; Kaiser, WJ; Mocarski, ES				Omoto, Shinya; Guo, Hongyan; Talekar, Ganesh R.; Roback, Linda; Kaiser, William J.; Mocarski, Edward S.			Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MIXED LINEAGE KINASE; MITOCHONDRIA-LOCALIZED INHIBITOR; RIBONUCLEOTIDE REDUCTASE HOMOLOG; VIRION-ASSOCIATED PROTEIN; PROGRAMMED CELL-DEATH; DOMAIN-LIKE PROTEIN; MURINE CYTOMEGALOVIRUS	Necroptosis is an alternate programmed cell death pathway that is unleashed by caspase-8 compromise and mediated by receptor-interacting protein kinase 3 (RIP3). Murine cytomegalovirus (CMV) and herpes simplex virus (HSV) encode caspase-8 inhibitors that prevent apoptosis together with competitors of RIP homotypic interaction motif (RHIM)-dependent signal transduction to interrupt the necroptosis. Here, we show that pro-necrotic murine CMV M45 mutant virus drives virus-induced necroptosis during nonproductive infection of RIP3-expressing human fibroblasts, whereas WT virus does not. Thus, M45-encoded RHIM competitor, viral inhibitor of RIP activation, sustains viability of human cells like it is known to function in infected mouse cells. Importantly, human CMV is shown to block necroptosis induced by either TNF or M45 mutant murine CMV in RIP3-expressing human cells. Human CMV blocks TNF-induced necroptosis after RIP3 activation and phosphorylation of the mixed lineage kinase domain-like (MLKL) pseudokinase. An early, IE1-regulated viral gene product acts on a necroptosis step that follows MLKL phosphorylation prior to membrane leakage. This suppression strategy is distinct from RHIM signaling competition by murine CMV or HSV and interrupts an execution process that has not yet been fully elaborated.	[Omoto, Shinya; Guo, Hongyan; Talekar, Ganesh R.; Roback, Linda; Kaiser, William J.; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, 1462 Clifton Rd,Suite 429, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020	Omoto, Shinya/0000-0002-2730-3912	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118853, R01AI020211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI118853, R01 AI020211] Funding Source: Medline; NIH HHS [DP5 OD012198] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Baillie J, 2003, J VIROL, V77, P7007, DOI 10.1128/JVI.77.12.7007-7016.2003; Berger AK, 2013, MBIO, V4, DOI 10.1128/mBio.00178-13; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cam M, 2010, CELL DEATH DIFFER, V17, P655, DOI 10.1038/cdd.2009.147; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cicin-Sain L, 2008, J VIROL, V82, P2056, DOI 10.1128/JVI.01803-07; Crosby LN, 2013, VIROLOGY, V436, P274, DOI 10.1016/j.virol.2012.12.002; Daley-Bauer LP, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P363; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dufour F, 2011, APOPTOSIS, V16, P256, DOI 10.1007/s10495-010-0560-2; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2012, CELL CYCLE, V11, P460, DOI 10.4161/cc.11.3.19060; Fleming P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003192; Fliss PM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002517; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; Green DR, 2012, TRENDS CELL BIOL, V22, P555, DOI 10.1016/j.tcb.2012.08.008; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Hahn G, 2002, J VIROL, V76, P9551, DOI 10.1128/JVI.76.18.9551-9555.2002; Handke W, 2013, J VIROL, V87, P3592, DOI 10.1128/JVI.02657-12; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Kaarbo M, 2011, MITOCHONDRION, V11, P935, DOI 10.1016/j.mito.2011.08.008; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2013, CURR OPIN VIROL, V3, P296, DOI 10.1016/j.coviro.2013.05.019; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Krause E, 2014, J VIROL, V88, P9963, DOI 10.1128/JVI.00684-14; LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; Lembo D, 2009, TRENDS BIOCHEM SCI, V34, P25, DOI 10.1016/j.tibs.2008.09.008; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Manning WC, 1998, J VIROL METHODS, V73, P31, DOI 10.1016/S0166-0934(98)00034-2; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; McCormick AL, 2008, CURR TOP MICROBIOL, V325, P281; McCormick AL, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P264; McCormick AL, 2013, VIROLOGY, V435, P250, DOI 10.1016/j.virol.2012.08.042; McCormick AL, 2010, J VIROL, V84, P5108, DOI 10.1128/JVI.01345-09; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Omoto S, 2013, J VIROL, V87, P8651, DOI 10.1128/JVI.01052-13; Patrone M, 2003, J GEN VIROL, V84, P3359, DOI 10.1099/vir.0.19452-0; Paulus C, 2009, VIRUSES-BASEL, V1, P760, DOI 10.3390/v1030760; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seirafian S, 2014, J GEN VIROL, V95, P933, DOI 10.1099/vir.0.058313-0; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Smith W, 2013, CELL HOST MICROBE, V13, P324, DOI 10.1016/j.chom.2013.02.003; Sridharan H, 2014, TRENDS MICROBIOL, V22, P199, DOI 10.1016/j.tim.2014.01.005; Stinski MF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P241; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; WALKER D, 1987, ARCH VIROL, V92, P103, DOI 10.1007/BF01310066; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	99	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11635	11648		10.1074/jbc.M115.646042	http://dx.doi.org/10.1074/jbc.M115.646042			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25778401	Green Published, hybrid			2022-12-26	WOS:000353719400038
J	Scheerer, P; Zhang, F; Kalms, J; von Stetten, D; Krauss, N; Oberpichler, I; Lamparter, T				Scheerer, Patrick; Zhang, Fan; Kalms, Jacqueline; von Stetten, David; Krauss, Norbert; Oberpichler, Inga; Lamparter, Tilman			The Class III Cyclobutane Pyrimidine Dimer Photolyase Structure Reveals a New Antenna Chromophore Binding Site and Alternative Photoreduction Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BLUE-LIGHT PHOTORECEPTORS; DNA PHOTOLYASE; CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; MACROMOLECULAR CRYSTALLOGRAPHY; ELECTRON-TRANSFER; CRYPTOCHROME; REPAIR; TRYPTOPHAN	Photolyases are proteins with an FAD chromophore that repair UV-induced pyrimidine dimers on the DNA in a light-dependent manner. The cyclobutane pyrimidine dimer class III photolyases are structurally unknown but closely related to plant cryptochromes, which serve as blue-light photoreceptors. Here we present the crystal structure of a class III photolyase termed photolyase-related protein A (PhrA) of Agrobacterium tumefaciens at 1.67-angstrom resolution. PhrA contains 5,10-methenyltetrahydrofolate (MTHF) as an antenna chromophore with a unique binding site and mode. Two Trp residues play pivotal roles for stabilizing MTHF by a double pi-stacking sandwich. Plant cryptochrome I forms a pocket at the same site that could accommodate MTHF or a similar molecule. The PhrA structure and mutant studies showed that electrons flow during FAD photoreduction proceeds via two Trp triads. The structural studies on PhrA give a clearer picture on the evolutionary transition from photolyase to photoreceptor.	[Scheerer, Patrick; Kalms, Jacqueline] Univ Med Berlin, Inst Med Phys & Biophys CC2, AG Prot Xray Crystallog & Signal Transduct, Charite, D-10117 Berlin, Germany; [Zhang, Fan; Oberpichler, Inga; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, D-76131 Karlsruhe, Germany; [von Stetten, David] European Synchroton Radiat Facil, Struct Biol Grp, F-38043 Grenoble 9, France; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); University of London; Queen Mary University London	Scheerer, P (corresponding author), Univ Med Berlin, Inst Med Phys & Biophys CC2, AG Prot Xray Crystallog & Signal Transduct, Charite, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; oberpichler@gsl.uni-luebeck.de; tilman.lamparter@kit.edu	; Lamparter, Tilman/E-4421-2013	von Stetten, David/0000-0001-7906-9788; Lamparter, Tilman/0000-0003-4327-9737; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft (DFG) [799/8-1, SFB 740-B6, SFB 1078-B6]; China Scholarship Council; Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field [D3/E3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant 799/8-1 (to T. L.), and SFB 740-B6 and SFB 1078-B6 (to P. S.), and grants from the China Scholarship Council (to F. Z.), Karlsruhe House of Young Scientists (to F. Z.), and DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3-1 (to P. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biskup T, 2013, J BIOL CHEM, V288, P9249, DOI 10.1074/jbc.M112.417725; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Burney S, 2012, ANGEW CHEM INT EDIT, V51, P9356, DOI 10.1002/anie.201203476; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cowtan K, 2011, ACTA CRYSTALLOGR D, V67, P233, DOI 10.1107/S0907444911007578; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hoang N, 2008, MOL PLANT, V1, P68, DOI 10.1093/mp/ssm008; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; Juhas M, 2014, FEBS J, V281, P2299, DOI 10.1111/febs.12782; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Klar T, 2006, CHEMBIOCHEM, V7, P1798, DOI 10.1002/cbic.200600206; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Liu ZY, 2013, P NATL ACAD SCI USA, V110, P12966, DOI 10.1073/pnas.1311073110; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Selby CP, 2012, BIOCHEMISTRY-US, V51, P167, DOI 10.1021/bi201536w; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110	67	36	36	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11504	11514		10.1074/jbc.M115.637868	http://dx.doi.org/10.1074/jbc.M115.637868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25784552	Green Published, hybrid			2022-12-26	WOS:000353719400026
J	Huang, HY; Zhang, WT; Jiang, WY; Chen, SZ; Liu, Y; Ge, X; Li, X; Dang, YJ; Wen, B; Liu, XH; Lu, HJ; Tang, QQ				Huang, Hai-Yan; Zhang, Wen-Ting; Jiang, Wen-Yan; Chen, Su-Zhen; Liu, Yang; Ge, Xin; Li, Xi; Dang, Yong-Jun; Wen, Bo; Liu, Xiao-Hui; Lu, Hao-Jie; Tang, Qi-Qun			RhoGDI beta Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; PLAYS OPPOSING ROLES; ACTIN STRESS FIBERS; ADIPOSE-TISSUE; COMMITTED PREADIPOCYTES; FAMILY GTPASES; LYSYL OXIDASE; 10T1/2 CELLS; MARROW; EXPRESSION	The integration of signals involved in deciding the fate of mesenchymal stem cells is largely unknown. We used proteomics profiling to identify RhoGDI beta, an inhibitor of the small G-protein Rho family, as a component that regulates commitment of C3H10T1/2 mesenchymal stem cells to the adipocyte or smooth muscle cell lineage in response to bone morphogenetic protein 4 (BMP4). RhoGDI beta is notably down-regulated during BMP4-induced adipocytic lineage commitment of C3H10T1/2 mesenchymal stem cells, and this involves the cytoskeleton-associated protein lysyl oxidase. Excess RhoGDI beta completely prevents BMP4-induced commitment to the adipocyte lineage and simultaneously stimulates smooth muscle cell commitment by suppressing the activation of Rac1. Overexpression of RhoGDI beta induces stress fibers of F-actin by a process involving phosphomyosin light chain, indicating that cytoskeletal tension regulated by RhoGDI beta contributes to determining adipocyte versus myocyte commitment. Furthermore, the overexpression of RacV12 (constitutively active form of Rac1) totally rescues the inhibition of adipocyte commitment by RhoGDI beta, simultaneously preventing formation of the smooth muscle-like phenotype and disrupting the stress fibers in cells overexpressing RhoGDI beta. Collectively, these results indicate that RhoGDI beta functions as a novel BMP4 signaling target that regulates adipogenesis and myogensis.	[Huang, Hai-Yan; Zhang, Wen-Ting; Jiang, Wen-Yan; Chen, Su-Zhen; Liu, Yang; Ge, Xin; Li, Xi; Dang, Yong-Jun; Wen, Bo; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Liu, Xiao-Hui; Lu, Hao-Jie] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Huang, HY (corresponding author), Fudan Univ, Minist Educ, Key Lab Metab & Mol Med, Shanghai 200032, Peoples R China.	haiyanhuang@shmu.edu.cn; qqtang@shmu.edu.cn	Lu, Hao/GQH-3203-2022; Wen, Bo/P-5332-2019; dang, yongjun/M-6531-2016	Wen, Bo/0000-0003-0394-7366; dang, yongjun/0000-0001-7237-1132	National Key Basic Research Project [2011CB910201]; National Natural Science Foundation [31030048C 120114, 81390350, 31271489, 81170781]; Shanghai Leading Academic Discipline Project [B110]	National Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported in part by National Key Basic Research Project Grant 2011CB910201, the State Key Program of National Natural Science Foundation Grant 31030048C 120114, and National Natural Science Foundation Grant 81390350 (to Q. Q. T.) and Grants 31271489 and 81170781 (to H. H.). The Department of Biochemistry is supported by Shanghai Leading Academic Discipline Project, Project number B110.	BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huang HY, 2013, STEM CELL RES, V10, P278, DOI 10.1016/j.scr.2012.12.005; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOHNSON PR, 1978, METABOLISM, V27, P1941, DOI 10.1016/S0026-0495(78)80011-0; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rivero F, 2002, EMBO J, V21, P4539, DOI 10.1093/emboj/cdf449; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang SS, 2013, INT J BIOCHEM CELL B, V45, P1825, DOI 10.1016/j.biocel.2013.06.003; Yin JW, 2012, GENE DEV, V26, P2192, DOI 10.1101/gad.192666.112; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Yu ZK, 1997, OBES RES, V5, P9, DOI 10.1002/j.1550-8528.1997.tb00277.x	47	13	13	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11119	11129		10.1074/jbc.M114.608075	http://dx.doi.org/10.1074/jbc.M114.608075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778399	Green Published, hybrid			2022-12-26	WOS:000353404500046
J	Kocarnik, JM; Park, SL; Han, JL; Dumitrescu, L; Cheng, IN; Wilkens, LR; Schumacher, FR; Kolonel, L; Carlson, CS; Crawford, DC; Goodloe, RJ; Dilks, HH; Baker, P; Richardson, D; Matise, TC; Ambite, JL; Song, FJ; Qureshi, AA; Zhang, MF; Duggan, D; Hutter, C; Hindorff, L; Bush, WS; Kooperberg, C; Le Marchand, L; Peters, U				Kocarnik, Jonathan M.; Park, S. Lani; Han, Jiali; Dumitrescu, Logan; Cheng, Iona; Wilkens, Lynne R.; Schumacher, Fredrick R.; Kolonel, Laurence; Carlson, Chris S.; Crawford, Dana C.; Goodloe, Robert J.; Dilks, Holli H.; Baker, Paxton; Richardson, Danielle; Matise, Tara C.; Ambite, Jose Luis; Song, Fengju; Qureshi, Abrar A.; Zhang, Mingfeng; Duggan, David; Hutter, Carolyn; Hindorff, Lucia; Bush, William S.; Kooperberg, Charles; Le Marchand, Loic; Peters, Ulrike			Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; WIDE ASSOCIATION; PROSTATE-CANCER; SUSCEPTIBILITY LOCI; NURSES HEALTH; VARIANTS; PIGMENTATION; METAANALYSIS; GENETICS; 5P15.33	Background Several regions of the genome show pleiotropic associations with multiple cancers. We sought to evaluate whether 181 single-nucleotide polymorphisms previously associated with various cancers in genome-wide association studies were also associated with melanoma risk. Methods We evaluated 2,131 melanoma cases and 20,353 controls from three studies in the Population Architecture using Genomics and Epidemiology (PAGE) study (EAGLE-BioVU, MEC, WHI) and two collaborating studies (HPFS, NHS). Overall and sex-stratified analyses were performed across studies. Results We observed statistically significant associations with melanoma for two lung cancer SNPs in the TERT-CLPTM1L locus (Bonferroni-corrected p<2.8x10(-4)), replicating known pleiotropic effects at this locus. In sex-stratified analyses, we also observed a potential male-specific association between prostate cancer risk variant rs12418451 and melanoma risk (OR=1.22, p=8.0x10(-4)). No other variants in our study were associated with melanoma after multiple comparisons adjustment (p>2.8e(-4)). Conclusions We provide confirmatory evidence of pleiotropic associations with melanoma for two SNPs previously associated with lung cancer, and provide suggestive evidence for a male-specific association with melanoma for prostate cancer variant rs12418451. This SNP is located near TPCN2, an ion transport gene containing SNPs which have been previously associated with hair pigmentation but not melanoma risk. Previous evidence provides biological plausibility for this association, and suggests a complex interplay between ion transport, pigmentation, and melanoma risk that may vary by sex. If confirmed, these pleiotropic relationships may help elucidate shared molecular pathways between cancers and related phenotypes.	[Kocarnik, Jonathan M.; Carlson, Chris S.; Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Park, S. Lani; Schumacher, Fredrick R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Han, Jiali] Indiana Univ, Melvin & Bren Simon Canc Ctr, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Dumitrescu, Logan; Goodloe, Robert J.; Dilks, Holli H.; Baker, Paxton; Richardson, Danielle; Bush, William S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Dumitrescu, Logan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA USA; [Wilkens, Lynne R.; Kolonel, Laurence; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Crawford, Dana C.] Case Western Reserve Univ, Dept Epidemiol, Cleveland, OH 44106 USA; [Crawford, Dana C.] Case Western Reserve Univ, Biosta Inst Computat Biol, Cleveland, OH 44106 USA; [Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Ambite, Jose Luis] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Song, Fengju] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol, Tianjin, Peoples R China; [Song, Fengju] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Qureshi, Abrar A.; Zhang, Mingfeng] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Hutter, Carolyn] NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Bush, William S.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	Fred Hutchinson Cancer Center; University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Cancer Prevention Institute of California; Cancer Research Center of Hawaii; University of Hawaii System; Case Western Reserve University; Case Western Reserve University; Rutgers State University New Brunswick; University of Southern California; Tianjin Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University	Kocarnik, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	jkocarni@fhcrc.org	Crawford, Dana/O-5578-2019; Schumacher, Fredrick/R-6043-2019; Bush, William/N-1369-2019	Crawford, Dana/0000-0002-6437-6248; Schumacher, Fredrick/0000-0002-3073-7463; Bush, William/0000-0002-9729-6519; Ambite, Jose Luis/0000-0003-0087-080X	National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" through the NHGRI PAGE program [U01HG004798-01]; NCATS/NIH [UL1 TR000445]; Multiethnic Cohort study (MEC) [U01HG004802]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program [U01HG004790]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; PAGE Coordinating Center [U01HG004801-01]; National Institutes of Mental Health; NCI [R25CA94880]; NIH [CA122838, CA87969, CA055075, CA49449, CA100264, CA093459]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007376, U01HG004803, U01HG004801, U01HG007419, U01HG004802, U01HG004790, U01HG004798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" through the NHGRI PAGE program; NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Multiethnic Cohort study (MEC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; PAGE Coordinating Center; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center), and their respective NHGRI ARRA supplements. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report results from collaboration between the following studies: The "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" is funded through the NHGRI PAGE program (U01HG004798-01 and its NHGRI ARRA supplement). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical; Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. The Vanderbilt University Center for Human Genetics Research, Computational Genomics Core provided computational and/or analytical support for this work; The Multiethnic Cohort study (MEC) characterization of epidemiological architecture is funded through the NHGRI PAGE program (U01HG004802 and its NHGRI ARRA supplement). The MEC study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). Funding support for the "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program (U01HG004790 and its NHGRI ARRA supplement). The WHI program is funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The authors thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at: http://www.whiscience.org/publications/WHI_investigators_ shortlist.pdf. Assistance with phenotype harmonization, SNP selection and annotation, data cleaning, data management, integration and dissemination, and general study coordination was provided by the PAGE Coordinating Center (U01HG004801-01 and its NHGRI ARRA supplement). The National Institutes of Mental Health also contributes to the support for the Coordinating Center. Author JMK was supported by grant R25CA94880 from NCI. The Nurses' Health Study and the Health Professionals Followup Study were funded by NIH grants CA122838, CA87969, CA055075, CA49449, CA100264, and CA093459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Bush William S, 2013, Pac Symp Biocomput, P373; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gruber SB, 2006, CANC EPIDEMIOLOGY PR, P1126; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howlader N, 2013, SEER CANC STAT REV 1; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Kim NH, 2012, J INVEST DERMATOL, V132, P2622, DOI 10.1038/jid.2012.175; Kocarnik JM, 2014, J INVEST DERMATOL, V134, P2049, DOI 10.1038/jid.2014.53; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tadokoro T, 2003, PIGM CELL RES, V16, P190, DOI 10.1034/j.1600-0749.2003.00019.x; Tao S, 2012, CARCINOGENESIS, V33, P598, DOI 10.1093/carcin/bgr316; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120491	10.1371/journal.pone.0120491	http://dx.doi.org/10.1371/journal.pone.0120491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789475	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400160
J	Alarcon, D; Cavieres, LA				Alarcon, Diego; Cavieres, Lohengrin A.			In the Right Place at the Right Time: Habitat Representation in Protected Areas of South American Nothofagus-Dominated Plants after a Dispersal Constrained Climate Change Scenario	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SPECIES DISTRIBUTIONS; GENETIC DIVERSITY; SPATIAL-PATTERNS; RESERVE NETWORKS; RAIN-FOREST; CONSERVATION; CHILE; PREDICTIONS; HISTORY	In order to assess the effects of climate change in temperate rainforest plants in southern South America in terms of habitat size, representation in protected areas, considering also if the expected impacts are similar for dominant trees and understory plant species, we used niche modeling constrained by species migration on 118 plant species, considering two groups of dominant trees and two groups of understory ferns. Representation in protected areas included Chilean national protected areas, private protected areas, and priority areas planned for future reserves, with two thresholds for minimum representation at the country level: 10% and 17%. With a 10% representation threshold, national protected areas currently represent only 50% of the assessed species. Private reserves are important since they increase up to 66% the species representation level. Besides, 97% of the evaluated species may achieve the minimum representation target only if the proposed priority areas were included. With the climate change scenario representation levels slightly increase to 53%, 69%, and 99%, respectively, to the categories previously mentioned. Thus, the current location of all the representation categories is useful for overcoming climate change by 2050. Climate change impacts on habitat size and representation of dominant trees in protected areas are not applicable to understory plants, highlighting the importance of assessing these effects with a larger number of species. Although climate change will modify the habitat size of plant species in South American temperate rainforests, it will have no significant impact in terms of the number of species adequately represented in Chile, where the implementation of the proposed reserves is vital to accomplish the present and future minimum representation. Our results also show the importance of using migration dispersal constraints to develop more realistic future habitat maps from climate change predictions.	[Alarcon, Diego; Cavieres, Lohengrin A.] Univ Concepcion, Dept Bot, Concepcion, Chile; [Alarcon, Diego; Cavieres, Lohengrin A.] Inst Ecol & Biodiversidad, Santiago, Chile	Universidad de Concepcion	Alarcon, D (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	chilebosque@gmail.com	Cavieres, Lohengrin/A-9542-2010; Alarcon, Diego/I-1990-2016	Cavieres, Lohengrin/0000-0001-9122-3020; Alarcon, Diego/0000-0003-3751-047X	Chilean National Commission for Scientific and Technological Research; Institute of Ecology and Biodiversity (IEB) - [FICM P05-002, PFB-023]	Chilean National Commission for Scientific and Technological Research; Institute of Ecology and Biodiversity (IEB) -	DA received funding from the Chilean National Commission for Scientific and Technological Research (http://www.conicyt.cl) as a doctoral grant. DA and LAC received funding from the Institute of Ecology and Biodiversity (IEB, http://www.ieb-chile.cl) funded by projects FICM P05-002 and PFB-023. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aguayo M, 2009, REV CHIL HIST NAT, V82, P361, DOI 10.4067/S0716-078X2009000300004; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andrew ME, 2014, ENVIRON REV, V22, P135, DOI 10.1139/er-2013-0056; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; Armesto JJ, 2001, AUSTRAL ECOL, V26, P311, DOI 10.1046/j.1442-9993.2001.01116.x; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; CONAF/CONAMA/BIRF, 1999, CAT EV REC VEG NAT C; CONAMA, 2005, PLAN ACC PAIS IMPL E; Cuevas JG, 2000, J ECOL, V88, P840, DOI 10.1046/j.1365-2745.2000.00497.x; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; Donoso C., 1993, ECOLOGIA FORESTAL; Donoso C, 1998, SILVICULTURA DE LOS; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Echeverria C, 2012, APPL GEOGR, V32, P822, DOI 10.1016/j.apgeog.2011.08.014; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Escobar B., 2006, AUTOECOLOGIA ESPECIE, P345; Figueroa JA, 2003, PLANT ECOL, V166, P227, DOI 10.1023/A:1023286521721; Gajardo R., 1994, VEGETACION NATURAL C; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hechenleitner P., 2005, PLANTAS AMENAZADAS C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Jackson SF, 2008, ECOL APPL, V18, P1050, DOI 10.1890/07-0662.1; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loehle C, 2000, AM NAT, V156, P14, DOI 10.1086/303369; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Ministerio de Agricultura de Chile, 2014, SIST INF TERR; Ministerio del Medio Ambiente de Chile, 2014, INFR DAT ESP; Moilanen A, 2013, DIVERS DISTRIB, V19, P171, DOI 10.1111/ddi.12000; Moreira-Munoz A, 2011, PLANT VEG, V5, P293, DOI 10.1007/978-90-481-8748-5_11; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nunez-Avila MC, 2013, J ECOL, V101, P1439, DOI 10.1111/1365-2745.12148; Pauchard A, 2002, NAT AREA J, V22, P318; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez J, 2008, HIGH RESOLUTION STAT; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez R., 1995, FLORA CHILE, V1, P119, DOI DOI 10.1007/S12228-009-9078-8; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SINIA, 2012, CUB LOC AR SILV PROT; Smith-Ramirez C, 2007, BIODIVERSITY LOSS AND CONSERVATION IN FRAGMENTED FOREST LANDSCAPES: THE FORESTS OF MONTANE MEXICO AND TEMPERATE SOUTH AMERICA, P102, DOI 10.1079/9781845932619.0102; Squeo FA, 2012, PLANT ECOL DIVERS, V5, P233, DOI 10.1080/17550874.2012.679012; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; TRYON R, 1970, Biotropica, V2, P76, DOI 10.2307/2989765; TRYON R, 1986, BOT REV, V52, P117, DOI 10.1007/BF02860999; Vergara R, 2014, ECOL EVOL, V4, P2450, DOI 10.1002/ece3.1108; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106; Zuloaga FO., 2008, MONOGR SYST BOT MISS, V107, P136	72	18	18	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119952	10.1371/journal.pone.0119952	http://dx.doi.org/10.1371/journal.pone.0119952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786226	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500144
J	Chesov, D; Lange, C; Daduna, F; Crudu, V; Preyer, R; Ernst, M; Kalsdorf, B				Chesov, Dumitru; Lange, Christoph; Daduna, Franziska; Crudu, Valeriu; Preyer, Rosemarie; Ernst, Martin; Kalsdorf, Barbara			Combined Antigen-Specific Interferon-gamma and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							T-CELL RESPONSES; TBNET CONSENSUS STATEMENT; LATENT TUBERCULOSIS; IFN-GAMMA; ACTIVE TB; IMMUNODIAGNOSIS; INDIVIDUALS; CYTOKINES; PROFILE; DISEASE	Background To evaluate interleukin (IL)-2 and interferon (IFN)-gamma secreting T-cells in parallel for the differentiation of latent infection with Mycobacterium tuberculosis infection (LTBI) from active tuberculosis. Methods Following ex-vivo stimulation of peripheral blood mononuclear cells (PBMC) with M. tuberculosis-specific antigens early secretory antigenic target (ESAT)-6 and culture filtrate protein (CFP)-10, immune responses were assessed by enzyme-linked immunospot IFN-. release assay (EliSpot-IGRA) and a novel dual cytokine detecting fluorescence-linked immunospot (FluoroSpot) in 18 patients with pulmonary tuberculosis, 10 persons with previously cured tuberculosis, 25 individuals with LTBI and 16 healthy controls. Results Correlation of IFN-gamma(+) spot-forming cells in EliSpot-IGRA and FluoroSpot were R-2 = 0.67 for ESAT-6 and R-2 = 0.73 for CFP-10. The number of IL-2-IFN-gamma(+) producing cells was higher in patients with tuberculosis compared with past tuberculosis (CFP-10-induced p = 0.0068) or individuals with LTBI (ESAT-6-induced p = 0.0136). A cutoff value of >16 CFP-10-induced IFN-gamma(+) secreting cells/200.000 PBMC in the EliSpot-IGRA discriminated with highest sensitivity and specificity (89% and 76%, respectively). However, overlap in cytokine responses precludes distinction between the cohorts on an individual basis. Conclusions Combined analysis of IFN-gamma and IL-2 secretion by antigen specific T-cells does not allow a reliable differentiation between different states of M. tuberculosis infection in clinical practice.	[Chesov, Dumitru] State Univ Med & Pharm Nicolae Testemitanu, Div Pneumol & Allergol, Kishinev, Moldova; [Chesov, Dumitru; Lange, Christoph; Daduna, Franziska; Kalsdorf, Barbara] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Lange, Christoph; Daduna, Franziska; Kalsdorf, Barbara] German Ctr Infect Res, TB Unit, Borstel, Germany; [Lange, Christoph] Med Univ Lubeck, Int Hlth Infect Dis, D-23538 Lubeck, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden; [Crudu, Valeriu] Inst Phthisiopneumol Chiril Draganiuc, Lab Microbiol & Morphol TB, Kishinev, Moldova; [Preyer, Rosemarie] Autoimmun Diagnost GmbH, Strassberg, Germany; [Ernst, Martin] Res Ctr Borstel, Div Immune Cell Analyt, Borstel, Germany	Nicolae Testemitanu State University of Medicine & Pharmacy; Forschungszentrum Borstel; German Center for Infection Research; University of Lubeck; Karolinska Institutet; Forschungszentrum Borstel	Lange, C (corresponding author), Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany.	clange@fz-borstel.de	Chesov, Dumitru/AAR-5114-2020; Lange, Christoph/J-6289-2012	Chesov, Dumitru/0000-0001-6203-5020; Lange, Christoph/0000-0002-9691-4741	ERS Walther Guerrero CiqueroTuberculosis Fellowship [STRTF 2013-2889]; German Center for Infection Research (DZIF)	ERS Walther Guerrero CiqueroTuberculosis Fellowship; German Center for Infection Research (DZIF)	Dumitru Chesov is the recipient of ERS Walther Guerrero CiqueroTuberculosis Fellowship (STRTF 2013-2889). Christoph Lange and Barbara Kalsdorf are supported by the German Center for Infection Research (DZIF). FluoroSpot reagents have been provided by Autoimmun Diagnostika (AID) GmbH, (Strassberg, Germany). The funder provided support in the form of salaries for authors [Rosemarie Preyer], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Essone PN, 2014, RESPIRATION, V88, P251, DOI 10.1159/000365816; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lobue PA, 2012, JAMA-J AM MED ASSOC, V308, P241, DOI 10.1001/jama.2012.7511; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; Oxford Immunotec Limited, 2013, T SPOT TB PACK INS; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Rovina N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/464039; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 20; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; World Health Organization, 2014, GLOB TUB REP	26	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120006	10.1371/journal.pone.0120006	http://dx.doi.org/10.1371/journal.pone.0120006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785445	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500146
J	Hall, ML; Ferreira, VS; Mayberry, RI				Hall, Matthew L.; Ferreira, Victor S.; Mayberry, Rachel I.			Syntactic Priming in American Sign Language	PLOS ONE			English	Article							2ND-LANGUAGE ACQUISITION; 1ST-LANGUAGE ACQUISITION; CRITICAL PERIOD; LEXICAL ACCESS; DEAF SIGNERS; BILINGUALS; AGE; REPRESENTATIONS; COMPREHENSION; ORGANIZATION	Psycholinguistic studies of sign language processing provide valuable opportunities to assess whether language phenomena, which are primarily studied in spoken language, are fundamentally shaped by peripheral biology. For example, we know that when given a choice between two syntactically permissible ways to express the same proposition, speakers tend to choose structures that were recently used, a phenomenon known as syntactic priming. Here, we report two experiments testing syntactic priming of a noun phrase construction in American Sign Language (ASL). Experiment 1 shows that second language (L2) signers with normal hearing exhibit syntactic priming in ASL and that priming is stronger when the head noun is repeated between prime and target (the lexical boost effect). Experiment 2 shows that syntactic priming is equally strong among deaf native L1 signers, deaf late L1 learners, and hearing L2 signers. Experiment 2 also tested for, but did not find evidence of, phonological or semantic boosts to syntactic priming in ASL. These results show that despite the profound differences between spoken and signed languages in terms of how they are produced and perceived, the psychological representation of sentence structure (as assessed by syntactic priming) operates similarly in sign and speech.	[Hall, Matthew L.] Univ Connecticut, Linguist, Storrs, CT 06269 USA; [Ferreira, Victor S.] Univ Calif San Diego, Psychol, San Diego, CA USA; [Mayberry, Rachel I.] Univ Calif San Diego, Linguist, San Diego, CA USA	University of Connecticut; University of California System; University of California San Diego; University of California System; University of California San Diego	Hall, ML (corresponding author), Univ Connecticut, Linguist, Storrs, CT 06269 USA.	matthall.research@gmail.com			National Institutes of Health (NIH) [R01DC012797, HD051030, 5T32DC000041-19]; Rita L. Atkinson Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012797] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita L. Atkinson Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research reported here was supported in part by National Institutes of Health (NIH) grants R01DC012797, HD051030, and 5T32DC000041-19 and also by the Rita L. Atkinson Graduate Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CL, 1970, FOUND LANG, V6, P197; Baus C, 2008, COGNITION, V108, P856, DOI 10.1016/j.cognition.2008.05.012; Bellugi U, 1983, Hum Neurobiol, V2, P155; Bernolet S, 2007, J EXP PSYCHOL LEARN, V33, P931, DOI 10.1037/0278-7393.33.5.931; Bernolet S, 2013, COGNITION, V127, P287, DOI 10.1016/j.cognition.2013.02.005; Bernolet S, 2012, BILING-LANG COGN, V15, P503, DOI 10.1017/S1366728911000162; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Boudreault P, 2006, LANG COGNITIVE PROC, V21, P608, DOI 10.1080/01690960500139363; Brentari Diane, 1998, PROSODIC MODEL SIGN; Carreiras M, 2008, J MEM LANG, V58, P100, DOI 10.1016/j.jml.2007.05.004; Cecchetto C, 2004, GLOW NEWSLETTER, V52, P30; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Cormier K, 2012, COGNITION, V124, P50, DOI 10.1016/j.cognition.2012.04.003; DAMASIO A, 1986, NATURE, V322, P363, DOI 10.1038/322363a0; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dye M. W. G., 2006, LAB PHONOL, V8, P243; EMMOREY K, 1991, J PSYCHOLINGUIST RES, V20, P365, DOI 10.1007/BF01067970; EMMOREY K, 1990, PERCEPT MOTOR SKILL, V71, P1227, DOI 10.2466/PMS.71.7.1227-1252; EMMOREY K, 1995, APPL PSYCHOLINGUIST, V16, P1, DOI 10.1017/S0142716400006391; Fernald TB., 2000, SIGN LANG LINGUIST, V3, P3, DOI [10.1075/sll.3.1.03fer, DOI 10.1075/SLL.3.1.03FER]; Flett S., 2003 LING POSTGR C U; Geraci Carlo, 2013, RIGHTWARD MOVEMENT C, P211, DOI [10.1075/la.200.08ger, DOI 10.1075/LA.200.08GER]; Greenberg JH, 1966, UNIVERSALS LANG, P73; Hall ML, 2012, SIGN LANG LINGUIST, V15, P104, DOI 10.1075/sll.15.1.05hal; Hickok G, 1996, APHASIOLOGY, V10, P577, DOI 10.1080/02687039608248438; Hickok G, 1996, NATURE, V381, P699, DOI 10.1038/381699a0; Hickok G, 1997, REV NEUROSCIENCE, V8, P205; Hohenberger A., 2002, MODALITY STRUCTURE S, P112; Keenan Edward L., 1976, SUBJECT TOPIC, P303; Lehmann Christian, 1988, AGREEMENT NATURAL LA, P55; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liddell S., 1989, SIGN LANGUAGE STUDIE, V64, P197; MacLaughlin D., 1997, THESIS BOSTON U; MacSweeney M, 2006, HUM BRAIN MAPP, V27, P63, DOI 10.1002/hbm.20167; Mayberry RI, 2011, BRAIN LANG, V119, P16, DOI 10.1016/j.bandl.2011.05.007; Mayberry RI, 2002, NATURE, V417, P38, DOI 10.1038/417038a; MAYBERRY RI, 1993, J SPEECH HEAR RES, V36, P1258, DOI 10.1044/jshr.3606.1258; MAYBERRY RI, 1989, MEM COGNITION, V17, P740, DOI 10.3758/BF03202635; MAYBERRY RI, 1991, J MEM LANG, V30, P486, DOI 10.1016/0749-596X(91)90018-F; Meir I, 2007, J LINGUIST, V43, P531, DOI 10.1017/S0022226707004768; Morford JP, 2011, LANG LEARN DEV, V7, P149, DOI 10.1080/15475441.2011.543393; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; Neidle C, 1998, LANGUAGE, V74, P819, DOI 10.2307/417004; Neidle C., 2000, SYNTAX AM SIGN LANGU; Newkirk Don, 1980, ERRORS LINGUISTIC PE, P165; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; Orfanidou E, 2009, MEM COGNITION, V37, P302, DOI 10.3758/MC.37.3.302; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Sakai KL, 2005, BRAIN, V128, P1407, DOI 10.1093/brain/awh465; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W., 1989, PHONOLOGICAL REPRESE; Santesteban M, 2010, J MEM LANG, V63, P347, DOI 10.1016/j.jml.2010.07.001; Scheepers C., 2010, 6 INT WORKSH LANG PR; Schoonbaert S, 2007, J MEM LANG, V56, P153, DOI 10.1016/j.jml.2006.10.002; Soderfeldt B, 1997, NEUROLOGY, V49, P82, DOI 10.1212/WNL.49.1.82; Stokoe WC, 1960, STUD LINGUIST, P7; Sutton-Spence Rachel, 1999, LINGUISTICS BRIT SIG; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Thompson R, 2005, PSYCHOL SCI, V16, P856, DOI 10.1111/j.1467-9280.2005.01626.x; Tooley KM, 2009, J EXP PSYCHOL LEARN, V35, P19, DOI 10.1037/a0013984; Vinson DP, 2010, PSYCHOL SCI, V21, P1158, DOI 10.1177/0956797610377340	64	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119611	10.1371/journal.pone.0119611	http://dx.doi.org/10.1371/journal.pone.0119611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786230	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500120
J	Nystrom, J; Stenkvist, J; Haggblom, A; Weiland, O; Nowak, P				Nystrom, Jessica; Stenkvist, Jenny; Haggblom, Amanda; Weiland, Ola; Nowak, Piotr			Low Levels of Microbial Translocation Marker LBP Are Associated with Sustained Viral Response after Anti-HCV Treatment in HIV-1/HCV Co-Infected Patients	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASES; T-CELL-ACTIVATION; HEPATITIS-C; MACROPHAGE ACTIVATION; MOLECULAR-MECHANISMS; COINFECTED PATIENTS; ENDOTOXEMIA; HIV	Background Microbial translocation (MT) contributes to immune activation during HIV and HCV infections. We investigated the kinetics of MT markers during anti-HCV and anti-HIV treatments, and if baseline plasma levels of lipopolysaccharide (LPS), lipopolysaccharide binding protein (LBP) and soluble CD14 (sCD14) could predict anti-HCV treatment outcome. Methods Plasma from 78 HIV-infected patients was evaluated for LPS, LBP and sCD14. The patients starting anti-HCV treatment (with ongoing antiretroviral (ART) treatment) were categorized into sustained viral responders (SVR; n = 21) or non-responders (NR; n = 15) based on treatment outcome. ART starting subjects-were categorized into chronically HCV-infected (CH; n = 24) and mono-infected (HIV; n = 18), based on the HCV infection status. Samples were collected before start (at baseline) of pegylated-interferon-alpha/ribavirin (peg-IFN/RBV) or antiretroviral-therapy and two years after treatment start (at follow up). chi(2)-test, non-parametric statistics and logistic regression were applied to determine the associations with treatment response and changes of the soluble markers. Results Plasma levels of LPS and sCD14 were elevated in all subjects before antiviral-treatment but remained unchanged at follow-up. Elevated levels of LBP were present in patients with HIV and HIV/HCV co-infection and were reduced by ART. Additionally, higher levels of LBP were present at baseline in NR vs. SVR. Higher levels of LBP at baseline were associated with non-response to peg-IFN/RBV treatment in both bivariate (OR: 0.19 95% CI: 0.06-0.31, p = 0.004) and multivariate analysis (OR: 1.43, 95% CI: 1.1-1.86, p = 0.07). Conclusion In HIV/HCV co-infected patients high baseline LBP levels are associated with non-response to peg-IFN/RBV therapy. Plasma LBP (decreased by ART) may be a more relevant MT marker than LPS and sCD14.	[Nystrom, Jessica; Nowak, Piotr] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Stenkvist, Jenny; Haggblom, Amanda; Weiland, Ola; Nowak, Piotr] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Nystrom, J (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.	jessica.nystrom@ki.se		Weiland, Ola/0000-0002-6934-9724; Nowak, Piotr/0000-0003-2747-0734	Swedish society for medical research; Ake Wiberg foundation; Swedish Research Council; Karolinska Institutet/Sodertorn University	Swedish society for medical research; Ake Wiberg foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet/Sodertorn University	This study was supported by grants from Swedish society for medical research, Ake Wiberg foundation, Swedish Research Council and Karolinska Institutet/Sodertorn University (postdoctoral grant to JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Anadol E, 2014, HEPATOLOGY; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony DD, 2012, J INFECT DIS, V206, P969, DOI 10.1093/infdis/jis434; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Balagopal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041258; BIGATELLO LM, 1987, AM J GASTROENTEROL, V82, P11; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Arjona MMD, 2011, JAIDS-J ACQ IMM DEF, V56, P420, DOI 10.1097/QAI.0b013e31820ef408; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; GAETA GB, 1982, DIGESTION, V23, P239, DOI 10.1159/000198756; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GELLER DA, 1993, ARCH SURG-CHICAGO, V128, P22; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Han DW, 2002, WORLD J GASTROENTERO, V8, P961, DOI 10.3748/wjg.v8.i6.961; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Isayama F, 2006, AM J PHYSIOL-GASTR L, V290, pG1318, DOI 10.1152/ajpgi.00405.2005; Jirillo E, 1998, IMMUNOPHARM IMMUNOT, V20, P1, DOI 10.3109/08923979809034805; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; LEVIN J, 1970, J LAB CLIN MED, V75, P903; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Malherbe G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/198413; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Resino S, 2012, CURR OPIN INFECT DIS, V25, P564, DOI 10.1097/QCO.0b013e32835635df; Resino S, 2011, J INFECTION, V63, P402, DOI 10.1016/j.jinf.2011.07.017; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shah AG, 2011, DIGEST DIS SCI, V56, P3038, DOI 10.1007/s10620-011-1710-2; Shin WG, 2008, DIGEST LIVER DIS, V40, P267, DOI 10.1016/j.dld.2007.10.011; Sozinov AS, 2002, B EXP BIOL MED+, V133, P153, DOI 10.1023/A:1015546821875; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stuyver L, 1996, J CLIN MICROBIOL, V34, P2259, DOI 10.1128/JCM.34.9.2259-2266.1996; Taiwo B, 2013, J ANTIMICROB CHEMOTH, V68, P1857, DOI 10.1093/jac/dkt120; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Urbaschek R, 2001, ALCOHOL CLIN EXP RES, V25, P261; Vesterbacka J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055038; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Wiese S, 2014, LIVER INT, V34, pE19, DOI 10.1111/liv.12428; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3	59	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118643	10.1371/journal.pone.0118643	http://dx.doi.org/10.1371/journal.pone.0118643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785448	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500041
J	Yang, SS; He, Y; Liu, M; Wang, YY; Wu, L; Wang, JH; Zhang, D; Zeng, J; Jiang, B; Li, XY				Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing; Jiang, Bin; Li, Xiaoying			Changes in and Patterns of Smoking Exposure in an Elderly Urban Population in Beijing: 2001-2010	PLOS ONE			English	Article							PASSIVE SMOKING; CIGARETTE-SMOKING; TOBACCO USE; PREVALENCE; RISK; MORTALITY; BEHAVIOR; DISEASE; COHORT; ADULTS	Objective The study aims to explore the patterns and changes of active and passive smoking in the elderly population. Methods Two cross-sectional surveys with representative samples of urban populations, aged between 60 and 95 years old, were conducted in 2001 and 2010 in Beijing. A current smoker was defined as a person who smoked a tobacco product at the time of the survey, and a passive smoker was defined as a person who had been exposed to smoke exhaled by a smoker for more than 15 minutes per day more than once per week. Results A total of 2,277 participants in 2001 and 2,102 participants in 2010 completed the survey. The current smoking prevalence changed slightly in males (24.7 vs. 21.2%, P = 0.081), while the prevalence in females decreased significantly from 8.8% (95% CI: 7.3-10.3%) in 2001 to 4.1% (95% CI: 3.0-5.2%) in 2010 (P<0.001). The prevalence of passive smoking was 30.5% (95% CI: 28.6-32.4%) in 2001 and 30.0% (95% CI: 28.1-32.0%) in 2010. The main source of secondhand smoke switched from a spouse in 2001 to offspring in 2010. This trend was observed in both sexes. Passive smoking in males from a smoking spouse decreased from 5.7% to 2.4% (P<0.001), while that from smoking offspring increased from 7.3 to 14.5%(P<0.001). Passive smoking in females from a spouse decreased from 30.6 to 17.6%, while that from offspring increased from 5.3 to 15.4% (P<0.001). Conclusion Offspring became the main source of secondhand smoke for the elderly. Our findings demonstrated the importance of implementing smoking prevention programs, to educate older adults who live with a smoking spouse and/or offspring.	[Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing 100853, Peoples R China; [Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing 100853, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing 100853, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Chinese Tradit Med & Acupuncture, Beijing 100853, Peoples R China; [Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Yang, Shanshan] Jinan Mil Area CDC, Jinan 250014, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yhe301@sina.com	Zeng, jing/AGY-9325-2022; 刘, 淼/X-1216-2019	Zeng, jing/0000-0002-4736-4210; Liu, Miao/0000-0002-7975-6702; He, Yao/0000-0001-6205-7895	National Natural Science Foundation of China [81373080]; Beijing Municipal Science and Technology Commission [Z121107001012070, D121100004912003]; Chinese PLA General Hospital Doctor Innovation Foundation [13BCZ07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Chinese PLA General Hospital Doctor Innovation Foundation	This study was supported by the National Natural Science Foundation of China (81373080, http://www.nsfc.gov.cn/), received by YH), Beijing Municipal Science and Technology Commission (Z121107001012070, D121100004912003, http://www.bjkw.gov.cn/n8785584/index.html, received by YH) and Chinese PLA General Hospital Doctor Innovation Foundation (13BCZ07, http://www.301hospital.com.cn/index.php, received by SSY). The funders had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Desormais I, 2014, EUR J PREV CARDIOL; Gallus S, 2014, EUR J CANCER PREV, V23, P177, DOI 10.1097/CEJ.0000000000000009; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; HE Y, 1989, Zhonghua Yufang Yixue Zazhi, V23, P19; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; He Y, 2014, AM J EPIDEMIOL, V179, P1060, DOI 10.1093/aje/kwu011; He Y, 2012, CHEST, V142, P909, DOI 10.1378/chest.11-2884; Hovell ME, 2009, NICOTINE TOB RES, V11, P1254, DOI 10.1093/ntr/ntp133; Jemal A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-512; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jiang Yuan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1181; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Kim SK, 2013, ARCH GERONTOL GERIAT, V56, P214, DOI 10.1016/j.archger.2012.08.018; Lam TH, 2012, ARCH INTERN MED, V172, P845, DOI 10.1001/archinternmed.2012.1927; Lam TH, 2014, ADDICTION; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Lugo A, 2013, INT J ENV RES PUB HE, V10, P4418, DOI 10.3390/ijerph10094418; Marinho V, 2010, CAD SAUDE PUBLICA, V26, P2213, DOI 10.1590/S0102-311X2010001200002; Markides KS, 1999, PREV MED, V28, P251, DOI 10.1006/pmed.1998.0411; McNeill A, 2014, UNDERSTANDING INCREA; Michalopoulos A, 2005, TOB INDUC DIS, V3, P30; Nishino Y, 2014, PREV MED; Nwhator SO, 2012, J PUBLIC HEALTH POL, V33, P16, DOI 10.1057/jphp.2011.58; Park S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-406; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Simoni M, 2003, EUR RESPIR J, V21, p15S, DOI 10.1183/09031936.03.00403603; Soliman S, 2004, AM J PUBLIC HEALTH, V94, P314, DOI 10.2105/AJPH.94.2.314; STELL PM, 1972, LANCET, V1, P617; Tresch DD, 1996, CLIN GERIATR MED, V12, P23, DOI 10.1016/S0749-0690(18)30241-6; US Department of Health Human Services, 2014, HLTHH CONS SMOK 50 Y; WATSON WL, 1954, CANCER-AM CANCER SOC, V7, P245, DOI 10.1002/1097-0142(195403)7:2<245::AID-CNCR2820070206>3.0.CO;2-V; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 1984, WHO M HELD WINN CAN; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4; Zhang DM, 2013, BIOMED ENVIRON SCI, V26, P453, DOI 10.3967/0895-3988.2013.06.006	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118500	10.1371/journal.pone.0118500	http://dx.doi.org/10.1371/journal.pone.0118500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785722	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500035
J	Carnesecchi, J; Malbouyres, M; de Mets, R; Balland, M; Beauchef, G; Vie, K; Chamot, C; Lionnet, C; Ruggiero, F; Vanacker, JM				Carnesecchi, Julie; Malbouyres, Marilyne; de Mets, Richard; Balland, Martial; Beauchef, Gallic; Vie, Katell; Chamot, Christophe; Lionnet, Claire; Ruggiero, Florence; Vanacker, Jean-Marc			Estrogens Induce Rapid Cytoskeleton Re-Organization in Human Dermal Fibroblasts via the Non-Classical Receptor GPR30	PLOS ONE			English	Article							ACTIN CYTOSKELETON; POTENTIAL ROLE; UP-REGULATION; SEX STEROIDS; SKIN; ESTRADIOL; 17-BETA-ESTRADIOL; CELLS; TAMOXIFEN; COLLAGEN	The post-menopausal decrease in estrogen circulating levels results in rapid skin deterioration pointing out to a protective effect exerted by these hormones. The identity of the skin cell type responding to estrogens is unclear as are the cellular and molecular processes they elicit. Here, we reported that lack of estrogens induces rapid re-organization of the human dermal fibroblast cytoskeleton resulting in striking cell shape change. This morphological change was accompanied by a spatial re-organization of focal adhesion and a substantial reduction of their number as evidenced by vinculin and actin co-staining. Cell morphology and cytoskeleton organization was fully restored upon 17 beta-estradiol (E2) addition. Treatment with specific ER antagonists and cycloheximide respectively showed that the E2 acts independently of the classical Estrogen Receptors and that cell shape change is mediated by non-genomic mechanisms. E2 treatment resulted in a rapid and transient activation of ERK1/2 but not Src or PI3K. We show that human fibroblasts express the nonclassical E2 receptor GPR30 and that its agonist G-1 phenocopies the effect of E2. Inhibiting GPR30 through treatment with the G-15 antagonist or specific shRNA impaired E2 effects. Altogether, our data reveal a novel mechanism by which estrogens act on skin fibroblast by regulating cell shape through the non-classical G protein-coupled receptor GPR30 and ERK1/2 activation.	[Carnesecchi, Julie; Malbouyres, Marilyne; Ruggiero, Florence; Vanacker, Jean-Marc] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon, France; [de Mets, Richard; Balland, Martial] Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France; [Beauchef, Gallic; Vie, Katell] Lab Clarins, Pontoise, France; [Chamot, Christophe; Lionnet, Claire] PLATIM, US8, BioSci Gerland UMS3444, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vanacker, JM (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr		Balland, martial/0000-0002-6585-9735; Carnesecchi, Julie/0000-0002-3872-2215; RUGGIERO, Florence/0000-0003-2915-5359	Clarins Laboratories	Clarins Laboratories(Randox Laboratories)	This work was funded by Clarins Laboratories. The funder provided support in the form of salaries for authors GB and KV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (in the section "contributed materials/reagents") are articulated in the 'author contributions' section.	Affinito P, 1999, MATURITAS, V33, P239, DOI 10.1016/S0378-5122(99)00077-8; Ashcroft GS, 2003, AM J CLIN DERMATOL, V4, P737, DOI 10.2165/00128071-200304110-00002; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; DEPASQUALE JA, 1994, J CELL SCI, V107, P1241; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Flamini MI, 2009, MOL HUM REPROD, V15, P675, DOI 10.1093/molehr/gap045; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Ge CT, 2012, ENDOCRINOLOGY, V153, P3504, DOI 10.1210/en.2012-1200; Giretti MS, 2008, STEROIDS, V73, P895, DOI 10.1016/j.steroids.2008.01.011; Haczynski J, 2004, INT J MOL MED, V13, P903; HASSELQUIST MB, 1980, J CLIN ENDOCR METAB, V50, P76, DOI 10.1210/jcem-50-1-76; Hattori T, 2011, J INVEST DERMATOL, V131, P1469, DOI 10.1038/jid.2011.63; Hirahara Y, 2013, NEUROSCIENCE, V235, P187, DOI 10.1016/j.neuroscience.2012.12.070; Kim DH, 2013, CELL ADHES MIGR, V7, P293, DOI 10.4161/cam.24804; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Le Romancer M, 2010, STEROIDS, V75, P560, DOI 10.1016/j.steroids.2010.01.013; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066; Muthukumaran P, 2012, BIOCHEM BIOPH RES CO, V423, P503, DOI 10.1016/j.bbrc.2012.05.149; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Pelletier G, 2004, HISTOL HISTOPATHOL, V19, P629, DOI 10.14670/HH-19.629; Phillips TJ, 2008, J AM ACAD DERMATOL, V59, P397, DOI 10.1016/j.jaad.2008.05.009; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rittie L, 2008, ARCH DERMATOL, V144, P1129, DOI 10.1001/archderm.144.9.1129; Sanchez AM, 2012, J NEUROENDOCRINOL, V24, P195, DOI 10.1111/j.1365-2826.2011.02258.x; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; SAPINO A, 1986, CANCER RES, V46, P2526; Shah M G, 2001, Am J Clin Dermatol, V2, P143; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Stevenson S, 2007, CLIN INTERV AGING, V2, P283; Surazynski A, 2003, INT J MOL MED, V12, P803; Thornton MJ, 2013, DERM-ENDOCRINOL, V5, P264, DOI 10.4161/derm.23872; Thornton MJ, 2005, EXPERT OPIN THER TAR, V9, P617, DOI 10.1517/14728222.9.3.617; Thornton MJ, 2003, EXP DERMATOL, V12, P181, DOI 10.1034/j.1600-0625.2003.120209.x; TORRESALEMAN I, 1992, GLIA, V6, P180, DOI 10.1002/glia.440060305; Tsoureli-Nikita E, 2006, PHOTOCH PHOTOBIO SCI, V5, P160, DOI 10.1039/b507492d; Tsui KH, 2011, TAIWAN J OBSTET GYNE, V50, P474, DOI 10.1016/j.tjog.2011.10.013; Wend Korinna, 2012, Front Endocrinol (Lausanne), V3, P19, DOI 10.3389/fendo.2012.00019	52	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120672	10.1371/journal.pone.0120672	http://dx.doi.org/10.1371/journal.pone.0120672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781607	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600181
J	Kim, M; Jung, S; Lee, SH; Lee, JH				Kim, Minjoo; Jung, Saem; Lee, Sang-Hyun; Lee, Jong Ho			Association between Arterial Stiffness and Serum L-Octanoylcarnitine and Lactosylceramide in Overweight Middle-Aged Subjects: 3-Year Follow-Up Study	PLOS ONE			English	Article							BODY-MASS INDEX; AMINO-ACID-METABOLISM; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; FATTY-ACID; LIQUID-CHROMATOGRAPHY; OBESITY; PLASMA; EXPRESSION	Existing data on the association between being overweight and cardiovascular morbidity and mortality risk in adults are inconsistent. We prospectively and longitudinally investigated the effects of weight on arterial stiffness and plasma metabolites in middle-aged subjects (aged 40-55 years). A group of 59 individuals who remained within the range of overweight during repeated measurements over a 3-year period was compared with a control group of 59 normal weight subjects who were matched for age and gender. Changes in metabolites by UPLC-LTQ-Orbitrap mass spectrometry and changes in brachial-ankle pulse wave velocity (ba-PWV) were examined. At baseline, the overweight group showed higher BMI, waist circumference, triglyceride, free fatty acid (FFA), glucose, insulin, and hs-CRP, and lower HDL-cholesterol than controls. After 3 years, the changes in waist circumference, diastolic and systolic blood pressure (DBP and SBP), triglyceride, FFA, glucose, insulin, hs-CRP, and ba-PWV observed in the overweight group were significantly different from those in the control group after adjusting for baseline levels. Furthermore, the overweight group showed greater increases in L-octanoylcarnitine (q=0.006) and decanoylcarnitine (q=0.007), and higher peak intensities of L-leucine, L-octanoylcarnitine, and decanoylcarnitine. Multiple linear regression analysis showed that the change in ba-PWV was independently and positively associated with changes in L-octanoylcarnitine, lactosylceramide, and SBP, and with baseline BMI. Our results indicate that the duration of overweight is an important aggravating factor for arterial stiffness, especially during middle age. Additionally, an age-related increase in plasma L-octanoylcarnitine, lactosylceramide, SBP, and baseline BMI are independent predictors of increased arterial stiffness in middle-aged individuals.	[Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea; [Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Brain Korea PLUS Project 21, Seoul 120749, South Korea; [Lee, Sang-Hyun] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Family Practice, Goyang, South Korea; [Lee, Jong Ho] Yonsei Univ, Res Inst Sci Aging, Seoul 120749, South Korea	Yonsei University; Yonsei University; NHIS Ilsan Hospital; Yonsei University	Lee, JH (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Bio-Synergy Research Projects [NRF-2012M3A9C4048762]; Mid-Career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-20100015017]	Bio-Synergy Research Projects; Mid-Career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This work is supported by the Bio-Synergy Research Projects (NRF-2012M3A9C4048762) and Mid-Career Researcher Program (NRF-20100015017) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Ahn Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-61; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Chakraborti S, 2003, CELL SIGNAL, V15, P637, DOI 10.1016/S0898-6568(02)00144-4; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; De Guzman JM, 2013, AGE, V35, P1091, DOI 10.1007/s11357-012-9430-x; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; HOPPEL CL, 1980, AM J PHYSIOL, V238, pE409, DOI 10.1152/ajpendo.1980.238.5.E409; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kangas P, 2013, METABOLISM, V62, P1114, DOI 10.1016/j.metabol.2013.02.009; 최현정, 2005, [Journal of THE KOREAN DIETETIC ASSOCIATION, 대한영양사협회 학술지], V11, P159; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim OY, 2013, CLIN EXP HYPERTENS, V35, P382, DOI 10.3109/10641963.2012.739232; Kolade OO, 2012, INT J OBESITY, V36, P93, DOI 10.1038/ijo.2011.79; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Madonna R, 2012, REV ESP CARDIOL, V65, P309, DOI [10.1016/j.rec.2011.11.009, 10.1016/j.recesp.2011.11.010]; Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McDonough C, 2013, DIABETES OBES METAB, V15, P342, DOI 10.1111/dom.12033; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; Redman LM, 2011, J CLIN ENDOCR METAB, V96, pE312, DOI 10.1210/jc.2010-1971; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Yang L, 2008, CHEM RES TOXICOL, V21, P2280, DOI 10.1021/tx800225q; 심연정, 2009, Journal of Nutrition and Health, V42, P577; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	48	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119519	10.1371/journal.pone.0119519	http://dx.doi.org/10.1371/journal.pone.0119519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781947	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600073
J	Large, SI; Fay, G; Friedland, KD; Link, JS				Large, Scott I.; Fay, Gavin; Friedland, Kevin D.; Link, Jason S.			Quantifying Patterns of Change in Marine Ecosystem Response to Multiple Pressures	PLOS ONE			English	Article							FISH COMMUNITY; ECOLOGICAL INDICATORS; CLIMATE; MANAGEMENT; FISHERIES; THRESHOLDS; TRENDS; SIZE; CLASSIFICATION; CONSERVATION	The ability to understand and ultimately predict ecosystem response to multiple pressures is paramount to successfully implement ecosystem-based management. Thresholds shifts and nonlinear patterns in ecosystem responses can be used to determine reference points that identify levels of a pressure that may drastically alter ecosystem status, which can inform management action. However, quantifying ecosystem reference points has proven elusive due in large part to the multi-dimensional nature of both ecosystem pressures and ecosystem responses. We used ecological indicators, synthetic measures of ecosystem status and functioning, to enumerate important ecosystem attributes and to reduce the complexity of the Northeast Shelf Large Marine Ecosystem (NES LME). Random forests were used to quantify the importance of four environmental and four anthropogenic pressure variables to the value of ecological indicators, and to quantify shifts in aggregate ecological indicator response along pressure gradients. Anthropogenic pressure variables were critical defining features and were able to predict an average of 8-13% (up to 25-66% for individual ecological indicators) of the variation in ecological indicator values, whereas environmental pressures were able to predict an average of 1-5 % (up to 9-26% for individual ecological indicators) of ecological indicator variation. Each pressure variable predicted a different suite of ecological indicator's variation and the shapes of ecological indicator responses along pressure gradients were generally nonlinear. Threshold shifts in ecosystem response to exploitation, the most important pressure variable, occurred when commercial landings were 20 and 60% of total surveyed biomass. Although present, threshold shifts in ecosystem response to environmental pressures were much less important, which suggests that anthropogenic pressures have significantly altered the ecosystem structure and functioning of the NES LME. Gradient response curves provide ecologically informed transformations of pressure variables to explain patterns of ecosystem structure and functioning. By concurrently identifying thresholds for a suite of ecological indicator responses to multiple pressures, we demonstrate that ecosystem reference points can be evaluated and used to support ecosystem-based management.	[Large, Scott I.; Fay, Gavin; Link, Jason S.] NOAA Fisheries, Woods Hole, MA USA; [Friedland, Kevin D.] NOAA Fisheries, Narragansett, RI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Large, SI (corresponding author), ICES Secretariat, Copenhagen, Denmark.	largesi@gmail.com		Fay, Gavin/0000-0003-0425-9952; Link, Jason/0000-0003-2740-7161; Large, Scott/0000-0001-7199-9972	Fisheries and the Environment Program	Fisheries and the Environment Program	This study was supported by the Fisheries and the Environment Program (JSL and KDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; Baker MR, 2014, DEEP-SEA RES PT II, V109, P215, DOI 10.1016/j.dsr2.2014.03.001; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Blanchard JL, 2005, ICES J MAR SCI, V62, P405, DOI 10.1016/j.icesjms.2005.01.006; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bundy A, 2010, ICES J MAR SCI, V67, P745, DOI 10.1093/icesjms/fsp283; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Ecosystem Assessment Program (EcoAP), 2011, 1207 NE FISH SCI CTR, V12-07, P38; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gaichas SK, 2012, MAR ECOL PROG SER, V459, P159, DOI 10.3354/meps09841; Gislason H, 1998, ICES J MAR SCI, V55, P362, DOI 10.1006/jmsc.1997.0323; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hall S, 1999, BLACKWELL SCI OXFORD; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Large SI, 2013, ICES J MAR SCI, V70, P755, DOI 10.1093/icesjms/fst067; Large SI, 2015, MAR ECOL PROG SER; Link J, 2002, NEFSC ECOSYST STATUS, V2, P245; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2012, MAR ECOL PROG SER, V459, P293, DOI 10.3354/meps09829; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Link JS, 2002, FISH B-NOAA, V100, P381; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Link JS, 2000, NMFSNE15 NOAA; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Methratta ET, 2006, N AM J FISH MANAGE, V26, P473, DOI 10.1577/M05-041.1; Mills KE, 2013, GLOBAL CHANGE BIOL, V19, P3046, DOI 10.1111/gcb.12298; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; NEFC, 1988, EV BOTT TRAWL SURV P; NEFSC, 1998, NMFSNE115 NOAA, P149; NEFSC (Northeast Fisheries Science Center), 2009, EC STAT REP NE US CO, P34; Nicholson MD, 2004, ICES J MAR SCI, V61, P35, DOI 10.1016/j.icesjms.2003.09.004; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pitcher CR, 2012, J APPL ECOL, V49, P670, DOI 10.1111/j.1365-2664.2012.02148.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rice J, 1996, ICES J MAR SCI, V53, P1214, DOI 10.1006/jmsc.1996.0146; Rice JC, 2009, ICES J MAR SCI, V66, P433, DOI 10.1093/icesjms/fsp021; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Shin YJ, 2010, ICES J MAR SCI, V67, P717, DOI 10.1093/icesjms/fsp287; Slocombe DS, 1998, ENVIRON MANAGE, V22, P483, DOI 10.1007/s002679900121; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Trenkel VM, 2003, CAN J FISH AQUAT SCI, V60, P67, DOI 10.1139/F02-163	57	42	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119922	10.1371/journal.pone.0119922	http://dx.doi.org/10.1371/journal.pone.0119922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781166	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600108
J	Ott, C; Dorsch, E; Fraunholz, M; Straub, S; Kozjak-Pavlovic, V				Ott, Christine; Dorsch, Eva; Fraunholz, Martin; Straub, Sebastian; Kozjak-Pavlovic, Vera			Detailed Analysis of the Human Mitochondrial Contact Site Complex Indicate a Hierarchy of Subunits	PLOS ONE			English	Article							OUTER-MEMBRANE; CRISTAE MORPHOLOGY; PROTEIN; BIOGENESIS; MITOFILIN; ORGANIZATION; SAM50; COMPONENT; METAXIN	Mitochondrial inner membrane folds into cristae, which significantly increase its surface and are important for mitochondrial function. The stability of cristae depends on the mitochondrial contact site (MICOS) complex. In human mitochondria, the inner membrane MICOS complex interacts with the outer membrane sorting and assembly machinery (SAM) complex, to form the mitochondrial intermembrane space bridging complex (MIB). We have created knockdown cell lines of most of the MICOS and MIB components and have used them to study the importance of the individual subunits for the cristae formation and complex stability. We show that the most important subunits of the MIB complex in human mitochondria are Mic60/Mitofilin, Mic19/CHCHD3 and an outer membrane component Sam50. We provide additional proof that ApoO indeed is a subunit of the MICOS and MIB complexes and propose the name Mic23 for this protein. According to our results, Mic25/CHCHD6, Mic27/ApoOL and Mic23/ApoO appear to be periphery subunits of the MICOS complex, because their depletion does not affect cristae morphology or stability of other components.	[Ott, Christine; Dorsch, Eva; Fraunholz, Martin; Straub, Sebastian; Kozjak-Pavlovic, Vera] Univ Wurzburg, Chair Microbiol, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Kozjak-Pavlovic, V (corresponding author), Univ Wurzburg, Chair Microbiol, Bioctr, D-97070 Wurzburg, Germany.	vera.kozjak@uni-wuerzburg.de	Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Fraunholz, Martin/0000-0002-4581-6244	 [KO3882/1-1];  [SFB630]	; 	This work is supported by KO3882/1-1, http://www.dfg.de/, and SFB630, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kozjak-Pavlovic V, 2014, J MOL BIOL, V426, P908, DOI 10.1016/j.jmb.2013.12.001; Kozjak-Pavlovic V, 2011, J BIOL CHEM, V286, P27019, DOI 10.1074/jbc.M111.232249; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052	27	83	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120213	10.1371/journal.pone.0120213	http://dx.doi.org/10.1371/journal.pone.0120213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781180	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600138
J	Papinutto, N; Schlaeger, R; Panara, V; Zhu, AH; Caverzasi, E; Stern, WA; Hauser, SL; Henry, RG				Papinutto, Nico; Schlaeger, Regina; Panara, Valentina; Zhu, Alyssa H.; Caverzasi, Eduardo; Stern, William A.; Hauser, Stephen L.; Henry, Roland G.			Age, Gender and Normalization Covariates for Spinal Cord Gray Matter and Total Cross-Sectional Areas at Cervical and Thoracic Levels: A 2D Phase Sensitive Inversion Recovery Imaging Study	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; SURFACE-BASED ANALYSIS; IN-VIVO; GREY-MATTER; ATROPHY; SEGMENTATION; MRI; DISABILITY; VOLUME; BRAIN	The source of inter-subject variability and the influence of age and gender on morphometric characteristics of the spinal cord, such as the total cross-sectional area (TCA), the gray matter (GM) and white matter (WM) areas, currently remain under investigation. Understanding the effect of covariates such as age, gender, brain volumes, and skull-and vertebra-derived metrics on cervical and thoracic spinal cord TCA and GM areas in healthy subjects would be fundamental for exploring compartment specific changes in neurological diseases affecting the spinal cord. Using Magnetic Resonance Imaging at 3T we investigated 32 healthy subjects using a 2D phase sensitive inversion recovery sequence and we measured TCA, GM and WM areas at 4 cervical and thoracic levels of the spinal cord. We assessed age and gender relationships of cord measures and explored associations between cord measures and a) brain volumes and b) skull-and vertebra-derived metrics. Age and gender had a significant effect on TCA, WM and GM areas (with women and elderly having smaller values than men and younger people respectively), but not on the GM area/TCA ratio. The total intracranial volume and C3 vertebra dimensions showed the highest correlations with cord measures. When used in multi-regression models, they reduced cord areas group variability by approximately a third. Age and gender influences on cord measures and normalization strategies here presented might be of use in the study of compartment specific changes in various neurological diseases affecting the spinal cord.	[Papinutto, Nico; Schlaeger, Regina; Zhu, Alyssa H.; Caverzasi, Eduardo; Stern, William A.; Hauser, Stephen L.; Henry, Roland G.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Schlaeger, Regina] Univ Basel, Dept Neurol, Basel, Switzerland; [Panara, Valentina] Univ G DAnnunzio, ITAB Inst Adv Biomed Technol, Chieti, Italy; [Henry, Roland G.] Univ Calif San Francisco, Bioengn Grad Grp, San Francisco, CA 94143 USA; [Henry, Roland G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Henry, Roland G.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Basel; G d'Annunzio University of Chieti-Pescara; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Papinutto, N (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	nico.papinutto@ucsf.edu	Hauser, Stephen L/J-2978-2016; Caverzasi, Eduardo/P-1707-2019; Panara, Valentina/AAB-2744-2019	Panara, Valentina/0000-0001-9655-3926; Caverzasi, Eduardo/0000-0002-0350-0460	National Institutes of Health [R01 NS049477, 1U19A1067152]; National Multiple Sclerosis Society [RG 2899-D11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (R01 NS049477; 1U19A1067152), and the National Multiple Sclerosis Society (RG 2899-D11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, NEUROIMAGE, V36, P728, DOI 10.1016/j.neuroimage.2007.03.048; Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Asman AJ, 2013, LECT NOTES COMPUT SC, V8149, P759, DOI 10.1007/978-3-642-40811-3_95; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Cadotte D. W., 2014, AJNR AM J NEURORADIO; Cronin CG, 2009, CLIN RADIOL, V64, P64, DOI 10.1016/j.crad.2008.03.012; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Engl C, 2013, NEURORADIOLOGY, V55, P963, DOI 10.1007/s00234-013-1204-3; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Furby J, 2008, MULT SCLER J, V14, P1068, DOI 10.1177/1352458508093617; Gilmore CP, 2009, BRAIN PATHOL, V19, P642, DOI 10.1111/j.1750-3639.2008.00228.x; Grados F, 2009, JOINT BONE SPINE, V76, P241, DOI 10.1016/j.jbspin.2008.07.017; Healy BC, 2012, J NEUROIMAGING, V22, pE12, DOI 10.1111/j.1552-6569.2011.00629.x; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Ishikawa M, 2003, SPINAL CORD, V41, P159, DOI 10.1038/sj.sc.3101375; Israel H, 2005, ARCH NEUROL-CHICAGO, V62, P1157, DOI 10.1001/archneur.62.7.1157; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kearney H, 2013, MULT SCLER RELAT DIS, V2, P103, DOI 10.1016/j.msard.2012.09.005; Kearney H, 2014, J MAGN RESON IMAGING, V39, P617, DOI 10.1002/jmri.24194; Klein JP, 2011, AM J NEURORADIOL, V32, P1138, DOI 10.3174/ajnr.A2459; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lukas C, 2013, RADIOLOGY, V269, P541, DOI 10.1148/radiol.13122566; Mamata H, 2005, J MAGN RESON IMAGING, V22, P38, DOI 10.1002/jmri.20357; Mann RS, 2007, J MAGN RESON IMAGING, V26, P61, DOI 10.1002/jmri.20959; Oh J, 2014, J NEUROIMAGING, V24, P577, DOI 10.1111/jon.12097; Papinutto N, 2015, J MAGN RESON IMAGING, V42, P698, DOI 10.1002/jmri.24819; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Powers JM, 2000, J NEUROPATH EXP NEUR, V59, P89, DOI 10.1093/jnen/59.2.89; Rashid W, 2006, J MAGN RESON IMAGING, V23, P473, DOI 10.1002/jmri.20545; Rocca MA, 2011, NEUROLOGY, V76, P2096, DOI 10.1212/WNL.0b013e31821f46b8; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; Schlaeger R, 2014, ANN NEUROL, V76, P568, DOI 10.1002/ana.24241; SHERMAN JL, 1990, AM J NEURORADIOL, V11, P369; Singh Kern, 2005, Spine J, V5, P615, DOI 10.1016/j.spinee.2005.05.385; Song F, 2008, J NEUROIMAGING, V18, P320, DOI 10.1111/j.1552-6569.2007.00222.x; Taso M, 2014, MAGN RESON MATER PHY, V27, P257, DOI 10.1007/s10334-013-0403-6; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; Vaithianathar L, 2003, J NEUROL, V250, P307, DOI 10.1007/s00415-003-1001-8; Vedantam A, 2013, J MAGN RESON IMAGING, V38, P861, DOI 10.1002/jmri.24039; Wang K, 2014, EUR J RADIOL, V83, P2196, DOI 10.1016/j.ejrad.2014.09.010; Yanase M, 2006, J SPINAL DISORD TECH, V19, P125, DOI 10.1097/01.bsd.0000181294.67212.79; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544; Zivadinov R, 2008, AM J NEURORADIOL, V29, P319, DOI 10.3174/ajnr.A0813	47	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118576	10.1371/journal.pone.0118576	http://dx.doi.org/10.1371/journal.pone.0118576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781178	gold, Green Published			2022-12-26	WOS:000351284600028
J	Rajput, A; Gupta, AK; Kumar, M				Rajput, Akanksha; Gupta, Amit Kumar; Kumar, Manoj			Prediction and Analysis of Quorum Sensing Peptides Based on Sequence Features	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; TO-CELL COMMUNICATION; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS; TRYPTOPHAN RESIDUES; SIGNALING PEPTIDES; ANTIVIRAL PEPTIDES; CYSTEINE RESIDUES; PROTEIN	Quorum sensing peptides (QSPs) are the signaling molecules used by the Gram-positive bacteria in orchestrating cell-to-cell communication. In spite of their enormous importance in signaling process, their detailed bioinformatics analysis is lacking. In this study, QSPs and non-QSPs were examined according to their amino acid composition, residues position, motifs and physicochemical properties. Compositional analysis concludes that QSPs are enriched with aromatic residues like Trp, Tyr and Phe. At the N-terminal, Ser was a dominant residue at maximum positions, namely, first, second, third and fifth while Phe was a preferred residue at first, third and fifth positions from the C-terminal. A few motifs from QSPs were also extracted. Physicochemical properties like aromaticity, molecular weight and secondary structure were found to be distinguishing features of QSPs. Exploiting above properties, we have developed a Support Vector Machine (SVM) based predictive model. During 10-fold cross-validation, SVM achieves maximum accuracy of 93.00%, Mathew's correlation coefficient (MCC) of 0.86 and Receiver operating characteristic (ROC) of 0.98 on the training/testing dataset (T200p+200n). Developed models performed equally well on the validation dataset (V20p+20n). The server also integrates several useful analysis tools like "QSMotifScan", "ProtFrag", "MutGen" and "PhysicoProp". Our analysis reveals important characteristics of QSPs and on the basis of these unique features, we have developed a prediction algorithm "QSPpred" (freely available at: http://crdd.osdd.net/servers/qsppred).	[Rajput, Akanksha; Gupta, Amit Kumar; Kumar, Manoj] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumar, M (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39-A, Chandigarh 160036, India.	manojk@imtech.res.in	Gupta, Amit K/M-4358-2017; Kumar, Manoj/G-1274-2010	Gupta, Amit K/0000-0002-8395-1201; Kumar, Manoj/0000-0003-3769-052X; RAJPUT, AKANKSHA/0000-0001-8176-6697	Council of Scientific and Industrial Research, India; Department of Biotechnology, Government of India [GAP0001]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research, India, (http://www.csir.res.in/); Department of Biotechnology, Government of India, (http://dbtindia.nic.in/index.asp) (GAP0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brurberg MB, 1997, MOL MICROBIOL, V26, P347, DOI 10.1046/j.1365-2958.1997.5821951.x; Chang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070166; CLEWELL DB, 1989, PLASMID, V21, P175, DOI 10.1016/0147-619X(89)90041-3; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Garsin DA, 2004, SCIENCE, V306, P2202, DOI 10.1126/science.1107236; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Guo Xiaopeng, 2011, Weishengwu Xuebao, V51, P1200; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Haag AF, 2012, J BIOL CHEM, V287, P10791, DOI 10.1074/jbc.M111.311316; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Jimenez JC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00127; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kramer R., 2009, BACTERIAL SIGNALING; Kumar S, 2013, MBIO, V4, DOI 10.1128/mBio.00314-13; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174; Martin CA, 2008, EUR J CLIN MICROBIOL, V27, P635, DOI 10.1007/s10096-008-0489-3; Meitzler JL, 2013, J BIOL CHEM, V288, P7147, DOI 10.1074/jbc.M112.414797; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakayama J, 2007, J BACTERIOL, V189, P1358, DOI 10.1128/JB.00969-06; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ni NT, 2009, MED RES REV, V29, P65, DOI 10.1002/med.20145; Nishiguchi K, 2009, J BACTERIOL, V191, P641, DOI 10.1128/JB.01029-08; Paggi RA, 2003, FEMS MICROBIOL LETT, V221, P49, DOI 10.1016/S0378-1097(03)00174-5; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Qureshi A, 2014, NUCLEIC ACIDS RES, V42, pD1147, DOI 10.1093/nar/gkt1191; Rasmussen A, 2007, BIOCHEMISTRY-US, V46, P10899, DOI 10.1021/bi701056k; Samanta U, 2001, PROTEIN ENG, V14, P7, DOI 10.1093/protein/14.1.7; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stalmans S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071752; Steiner E, 2012, APPL ENVIRON MICROB, V78, P1113, DOI 10.1128/AEM.06376-11; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Syvitski RT, 2007, J BACTERIOL, V189, P1441, DOI 10.1128/JB.00832-06; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Tian XL, 2009, BIOL PROCED ONLINE, V11, P207, DOI 10.1007/s12575-009-9009-9; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wynendaele E, 2012, MED HYPOTHESES, V78, P814, DOI 10.1016/j.mehy.2012.03.018; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120066	10.1371/journal.pone.0120066	http://dx.doi.org/10.1371/journal.pone.0120066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781990	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600124
J	Vanneste, S; Van de Heyning, P; De Ridder, D				Vanneste, Sven; Van de Heyning, Paul; De Ridder, Dirk			Tinnitus: A Large VBM-EEG Correlational Study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VOXEL-BASED MORPHOMETRY; ANTERIOR THALAMUS; COCHLEAR NUCLEUS; AUDITORY-CORTEX; PHANTOM SOUND; TOMOGRAPHY; DISTRESS; EPILEPSY; LOCALIZATION	A surprising fact in voxel-based morphometry (VBM) studies performed in tinnitus is that not one single region is replicated in studies of different centers. The question then rises whether this is related to the low sample size of these studies, the selection of non-representative patient subgroups, or the absence of stratification according to clinical characteristics. Another possibility is that VBM is not a good tool to study functional pathologies such as tinnitus, in contrast to pathologies like Alzheimer's disease where it is known the pathology is related to cell loss. In a large sample of 154 tinnitus patients VBM and QEEG (Quantitative Electroencephalography) was performed and evaluated by a regression analysis. Correlation analyses are performed between VBM and QEEG data. Uncorrected data demonstrated structural differences in grey matter in hippocampal and cerebellar areas related to tinnitus related distress and tinnitus duration. After control for multiple comparisons, only cerebellar VBM changes remain significantly altered. Electrophysiological differences are related to distress, tinnitus intensity, and tinnitus duration in the subgenual anterior cingulate cortex, dorsal anterior cingulate cortex, hippocampus, and parahippocampus, which confirms previous results. The absence of QEEG-VBM correlations suggest functional changes are not reflected by co-occurring structural changes in tinnitus, and the absence of VBM changes (except for the cerebellum) that survive correct statistical analysis in a large study population suggests that VBM might not be very sensitive for studying tinnitus.	[Vanneste, Sven; Van de Heyning, Paul] Univ Antwerp, Fac Med, Dept Translat Neurosci, B-2020 Antwerp, Belgium; [Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Van de Heyning, Paul] Univ Antwerp Hosp, ENT Dept, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand	University of Antwerp; University of Texas System; University of Texas Dallas; University of Antwerp; University of Otago	Vanneste, S (corresponding author), Univ Antwerp, Fac Med, Dept Translat Neurosci, B-2020 Antwerp, Belgium.	ven.vanneste@utdallas.edu	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Research Foundation Flanders (FWO); Tinnitus Research Initiative (TRI); Antwerp University TOP Project	Research Foundation Flanders (FWO)(FWO); Tinnitus Research Initiative (TRI); Antwerp University TOP Project	This work was supported by the Research Foundation Flanders (FWO), the Tinnitus Research Initiative (TRI) and Antwerp University TOP Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kareem IA, 2011, J MAGN RESON IMAGING, V33, P24, DOI 10.1002/jmri.22391; Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Axelsson Alf, 2000, Noise Health, V2, P47; Betting LE, 2010, HUM BRAIN MAPP, V31, P1327, DOI 10.1002/hbm.20944; Boyen K, 2012, HEAR RES; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; British Society of Audiology, 2008, REC PROC PUR TON AIR; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Congedo M, 2002, EUREKA VERSION 3 0; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Dille MF, 2010, J AM ACAD AUDIOL, V21, P409, DOI 10.3766/jaaa.21.6.6; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; HILLER W, 1992, J PSYCHOSOM RES, V36, P337, DOI 10.1016/0022-3999(92)90070-I; HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Koepp MJ, 2005, LANCET NEUROL, V4, P42, DOI 10.1016/S1474-4422(04)00965-2; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Li J, 2011, NEUROSCI BIOBEHAV RE; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Mahoney CJ, 2011, J NEUROL NEUROSURG P; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Meeus O, 2007, B-ENT, P11; Meeus O., 2011, OTOL NEUROTOL; Meeus O., 2009, EUR ARCH OTO-RHINO-L; Melcher JR, 2012, HEAR RES; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schecklmann M, 2013, BRAIN STRUCT FUNCT, V218, P1061, DOI 10.1007/s00429-013-0520-z; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Shulman A, 1999, Int Tinnitus J, V5, P92; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S., 2011, NEUROSCIENCE; Vanneste S., 2010, CLIN NEUROPHYSIOL; Vanneste S, 2014, CEREB CORTEX, V24, P2268, DOI 10.1093/cercor/bht068; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Vanneste S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031182; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	88	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115122	10.1371/journal.pone.0115122	http://dx.doi.org/10.1371/journal.pone.0115122			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781934	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600003
J	Yamagami, K; Yamamoto, T; Sakai, S; Mioka, T; Sano, T; Igarashi, Y; Tanaka, K				Yamagami, Kanako; Yamamoto, Takaharu; Sakai, Shota; Mioka, Tetsuo; Sano, Takamitsu; Igarashi, Yasuyuki; Tanaka, Kazuma			Inositol Depletion Restores Vesicle Transport in Yeast Phospholipid Flippase Mutants	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSLOCASE; SPHINGOLIPID SYNTHESIS; PHOSPHATIDIC-ACID; POLARIZED GROWTH; GENE DISRUPTION	In eukaryotic cells, type 4 P-type ATPases function as phospholipid flippases, which translocate phospholipids from the exoplasmic leaflet to the cytoplasmic leaflet of the lipid bilayer. Flippases function in the formation of transport vesicles, but the mechanism remains unknown. Here, we isolate an arrestin-related trafficking adaptor, ART5, as a multicopy suppressor of the growth and endocytic recycling defects of flippase mutants in budding yeast. Consistent with a previous report that Art5p downregulates the inositol transporter Itr1p by endocytosis, we found that flippase mutations were also suppressed by the disruption of ITR1, as well as by depletion of inositol from the culture medium. Interestingly, inositol depletion suppressed the defects in all five flippase mutants. Inositol depletion also partially restored the formation of secretory vesicles in a flippase mutant. Inositol depletion caused changes in lipid composition, including a decrease in phosphatidylinositol and an increase in phosphatidylserine. A reduction in phosphatidylinositol levels caused by partially depleting the phosphatidylinositol synthase Pis1p also suppressed a flippase mutation. These results suggest that inositol depletion changes the lipid composition of the endosomal/TGN membranes, which results in vesicle formation from these membranes in the absence of flippases.	[Yamagami, Kanako; Yamamoto, Takaharu; Mioka, Tetsuo; Sano, Takamitsu; Tanaka, Kazuma] Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido, Japan; [Sakai, Shota; Igarashi, Yasuyuki] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido, Japan; [Sakai, Shota; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tanaka, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido, Japan.	k-tanaka@igm.hokudai.ac.jp	Tanaka, Kazuma/A-4240-2012	Mioka, Tetsuo/0000-0002-4653-1718	Japan Society for the Promotion of Science KAKENHI [21570192, 21370085]; Grants-in-Aid for Scientific Research [25840064] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grants 21570192 (TY) and 21370085 (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER GW, 1977, J BIOL CHEM, V252, P8684; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guthrie G., 1991, METHOD ENZYMOL, V194, P1; Hachiro T, 2013, J BIOL CHEM, V288, P3594, DOI 10.1074/jbc.M112.416263; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jani NM, 2009, FEMS YEAST RES, V9, P552, DOI 10.1111/j.1567-1364.2009.00514.x; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mioka T, 2014, MICROBIOLOGYOPEN, V3, P803, DOI 10.1002/mbo3.211; Misu K, 2003, MOL BIOL CELL, V14, P730, DOI 10.1091/mbc.E02-06-0314; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sakane H, 2006, CELL STRUCT FUNCT, V31, P87, DOI 10.1247/csf.06021; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Xu Q, 2012, FEBS LETT, V586, P1803, DOI 10.1016/j.febslet.2012.05.018; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	83	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120108	10.1371/journal.pone.0120108	http://dx.doi.org/10.1371/journal.pone.0120108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781026	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600127
J	Carta, G; Murru, E; Lisai, S; Sirigu, A; Piras, A; Collu, M; Batetta, B; Gambelli, L; Banni, S				Carta, Gianfranca; Murru, Elisabetta; Lisai, Sara; Sirigu, Annarita; Piras, Antonio; Collu, Maria; Batetta, Barbara; Gambelli, Luisa; Banni, Sebastiano			Dietary Triacylglycerols with Palmitic Acid in the sn-2 Position Modulate Levels of N-Acylethanolamides in Rat Tissues	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ESSENTIAL FATTY ACIDS; 5,8,11-EICOSATRIENOIC ACID; PPAR-ALPHA; RISK; OBESITY; OLEOYLETHANOLAMIDE; METABOLISM; OVERWEIGHT; ENDOCANNABINOIDS	Background Several evidences suggest that the position of palmitic acid (PA) in dietary triacylglycerol (TAG) influences different biological functions. We aimed at evaluating whether dietary fat with highly enriched (87%) PA in sn-2 position (Hsn-2 PA), by increasing PA incorporation into tissue phospholipids (PL), modifies fatty acid profile and biosynthesis of fatty acid-derived bioactive lipids, such as endocannabinoids and their congeners. Study Design Rats were fed for 5 weeks diets containing Hsn-2 PA or fat with PA randomly distributed in TAG with 18.8% PA in sn-2 position (Lsn-2 PA), and similar total PA concentration. Fatty acid profile in different lipid fractions, endocannabinoids and congeners were measured in intestine, liver, visceral adipose tissue, muscle and brain. Results Rats on Hsn-2 PA diet had lower levels of anandamide with concomitant increase of its congener palmitoylethanolamide and its precursor PA into visceral adipose tissue phospholipids. In addition, we found an increase of oleoylethanolamide, an avid PPAR alpha ligand, in liver, muscle and brain, associated to higher levels of its precursor oleic acid in liver and muscle, probably derived by elongation and further delta 9 desaturation of PA. Changes in endocannabinoids and congeners were associated to a decrease of circulating TNF alpha after LPS challenge, and to an improved feed efficiency. Conclusions Dietary Hsn-2 PA, by modifying endocannabinoids and congeners biosynthesis in different tissues may potentially concur in the physiological regulation of energy metabolism, brain function and body fat distribution.	[Carta, Gianfranca; Murru, Elisabetta; Lisai, Sara; Sirigu, Annarita; Piras, Antonio; Collu, Maria; Batetta, Barbara; Banni, Sebastiano] Univ Cagliari, Dipartimento Sci Biomed, Cagliari, Italy; [Gambelli, Luisa] Loders Croklaan Europe, Wormerveer, Netherlands	University of Cagliari	Banni, S (corresponding author), Univ Cagliari, Dipartimento Sci Biomed, Cagliari, Italy.	banni@unica.it	Murru, Elisabetta/AAW-4909-2021; Banni, Sebastiano/F-1906-2018; Carta, Gianfranca/AAB-8947-2022; Collu, Maria/F-7113-2012	Banni, Sebastiano/0000-0003-4805-1387; Carta, Gianfranca/0000-0002-3527-4197; Murru, Maria Elisabetta/0000-0002-7394-5780; Batetta, Barbara/0000-0001-6932-778X; Collu, Maria/0000-0001-5406-2934	Loders Croklaan Europe, Wormerveer, The Netherlands; Loders Croklaan Europe	Loders Croklaan Europe, Wormerveer, The Netherlands(Netherlands Government); Loders Croklaan Europe	Loders Croklaan Europe, Wormerveer, The Netherlands, co-funded the study. Loders Croklaan Europe, whose company provided funding towards this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annuzzi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-43; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Banni S, 1996, J NUTR BIOCHEM, V7, P150, DOI 10.1016/0955-2863(95)00193-X; Banni S, 2001, J LIPID RES, V42, P1056; Banni S, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-7; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P248, DOI 10.1016/0005-2760(91)90101-M; Contreras AV, 2013, ADV NUTR, V4, P439, DOI 10.3945/an.113.003798; DEWEY KG, 1993, AM J CLIN NUTR, V57, P140, DOI 10.1093/ajcn/57.2.140; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; FULCO AJ, 1959, J BIOL CHEM, V234, P1411; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hoareau L, 2009, OBESITY, V17, P431, DOI 10.1038/oby.2008.591; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Innis SM, 2013, PROSTAG LEUKOTR ESS, V89, P145, DOI 10.1016/j.plefa.2013.03.003; Innis SM, 2011, ADV NUTR, V2, P275, DOI 10.3945/an.111.000448; Ip C, 1999, J NUTR, V129, P2135, DOI 10.1093/jn/129.12.2135; Karaliota S, 2009, OBESITY, V17, P1830, DOI 10.1038/oby.2009.177; Kien CL, 2013, DIABETES, V62, P1054, DOI 10.2337/db12-0363; Le HD, 2009, PROSTAG LEUKOTR ESS, V81, P165, DOI 10.1016/j.plefa.2009.05.020; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mantovani G, 1997, EUR J CANCER, V33, P602, DOI 10.1016/S0959-8049(96)00486-8; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; MEAD JF, 1956, J BIOL CHEM, V219, P705; Melis M, 2013, CNS NEUROL DISORD-DR, V12, P70, DOI 10.2174/1871527311312010012; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Melis MP, 2001, EUR J LIPID SCI TECH, V103, P617, DOI 10.1002/1438-9312(200109)103:9<617::AID-EJLT6170>3.3.CO;2-3; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; OAKLEY JR, 1977, ARCH DIS CHILD, V52, P79, DOI 10.1136/adc.52.1.79; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Petrosino S, 2010, BIOCHIMIE, V92, P724, DOI 10.1016/j.biochi.2010.01.006; Quigley MA, 2006, AM J EPIDEMIOL, V163, P870, DOI 10.1093/aje/kwj134; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Samulin J, 2008, COMP BIOCHEM PHYS B, V151, P147, DOI 10.1016/j.cbpb.2008.06.010; Sarro-Ramirez Andrea, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P88; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Young BE, 2012, ADV NUTR, V3, P675, DOI 10.3945/an.112.002238	51	38	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120424	10.1371/journal.pone.0120424	http://dx.doi.org/10.1371/journal.pone.0120424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775474	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500173
J	Jank, T; Trillhaase, C; Brozda, N; Steinemann, M; Schwan, C; Suss, R; Aktories, K				Jank, Thomas; Trillhaase, Christoph; Brozda, Natalia; Steinemann, Marcus; Schwan, Carsten; Suess, Regine; Aktories, Klaus			Intracellular plasma membrane guidance of Photorhabdus asymbiotica toxin is crucial for cell toxicity	FASEB JOURNAL			English	Article						Rho GTPase; heterotrimeric G protein; glycosyltransferase; deamidation; membrane localization domain	PASTEURELLA-MULTOCIDA TOXIN; CLOSTRIDIUM-DIFFICILE TOXIN; LEGIONELLA-PNEUMOPHILA; LIVING CELLS; RHO-PROTEINS; GLUCOSYLATION; BINDING; HOST; LOCALIZATION; LUMINESCENS	The bacterial toxin Photorhabdus asymbiotica toxin (PaTox) modifies Rho proteins by tyrosine GlcNAcylation and heterotrimeric G alpha proteins by deamidation. Inactivation of Rho proteins results in F-actin disassembly in host cells. Here, we analyzed the subcellular distribution of PaTox and show that the glycosyltransferase domain of PaTox associates with the negatively charged inner surface of the plasma membrane. Localization studies with site-directed mutants, liposome precipitation analysis, lipid overlay assays, and confocal time-lapse microscopy revealed that a patch of positively charged lysine and arginine residues located on helix alpha 1 of the glycosyltransferase is essential for membrane attachment. Using a helix1 deletion mutant, we show that plasma membrane localization of PaTox is essential for cytotoxicity and proved this by substitution of helix1 by an N-terminal myristoylation signal peptide, which restored plasma membrane localization and cytotoxicity. Furthermore, we also show that the intracellular deamidase activity of PaTox depends on the presence of the membrane localization domain. Comparison of PaTox membrane-binding domain with the 4-helix-bundle membrane-binding domain of Pasteurella multocida toxin, Vibrio cholerae multifunctional autoprocessing repeats-in-toxin, and clostridial glucosylating toxins revealed similar spatial geometry and charge distribution but different structural topology, indicating convergent evolution of toxin domains for optimized host target interaction.	[Jank, Thomas; Trillhaase, Christoph; Brozda, Natalia; Steinemann, Marcus; Schwan, Carsten; Aktories, Klaus] Univ Freiburg, Dept Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Suess, Regine] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, D-79104 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Jank, T (corresponding author), Univ Freiburg, Dept Expt & Clin Pharmacol & Toxicol, Albertstr 25, D-79104 Freiburg, Germany.	jank@pharmakol.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739	Deutsche Forschungsgemeinschaft [Collaborative Research Center 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	The authors thank Peter Gebhardt for excellent technical assistance, Birgit Erhard for liposome preparation, Thilo Nolke for supporting microscopic analysis, and Frederick Schlosser for help in initial cloning. This work was supported by the Deutsche Forschungsgemeinschaft Collaborative Research Center 746 and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Antic I, 2014, PROTEINS, V82, P2643, DOI 10.1002/prot.24628; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kamitani S, 2011, FEBS J, V278, P2702, DOI 10.1111/j.1742-4658.2011.08197.x; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Peel MM, 1999, J CLIN MICROBIOL, V37, P3647, DOI 10.1128/JCM.37.11.3647-3653.1999; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	52	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2789	2802		10.1096/fj.14-269381	http://dx.doi.org/10.1096/fj.14-269381			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782990				2022-12-26	WOS:000356859100011
J	Baldy, V; Thiebaut, G; Fernandez, C; Sagova-Mareckova, M; Korboulewsky, N; Monnier, Y; Perez, T; Tremolieres, M				Baldy, Virginie; Thiebaut, Gabrielle; Fernandez, Catherine; Sagova-Mareckova, Marketa; Korboulewsky, Nathalie; Monnier, Yogan; Perez, Thierry; Tremolieres, Michele			Experimental Assessment of the Water Quality Influence on the Phosphorus Uptake of an Invasive Aquatic Plant: Biological Responses throughout Its Phenological Stage	PLOS ONE			English	Article							ELODEA-NUTTALLII; ST-JOHN; GROWTH LIMITATION; RANUNCULUS-PELTATUS; FLOODPLAIN FRANCE; RUNNING WATERS; GENUS ELODEA; MACROPHYTES; PLASTICITY; NUTRIENTS	Understanding how an invasive plant can colonize a large range of environments is still a great challenge in freshwater ecology. For the first time, we assessed the relative importance of four factors on the phosphorus uptake and growth of an invasive macrophyte Elodea nuttallii (Planch.) St. John. This study provided data on its phenotypic plasticity, which is frequently suggested as an important mechanism but remains poorly investigated. The phosphorus uptake of two Elodea nuttallii subpopulations was experimentally studied under contrasting environmental conditions. Plants were sampled in the Rhine floodplain and in the Northern Vosges mountains, and then maintained in aquaria in hard (Rhine) or soft (Vosges) water. Under these conditions, we tested the influence of two trophic states (eutrophic state, 100 mu g.l(-1) P-PO43- and hypertrophic state, 300 mu g.l(-1) P-PO43-) on the P metabolism of plant subpopulations collected at three seasons (winter, spring and summer). Elodea nuttallii was able to absorb high levels of phosphorus through its shoots and enhance its phosphorus uptake, continually, after an increase of the resource availability (hypertrophic > eutrophic). The lowest efficiency in nutrient use was observed in winter, whereas the highest was recorded in spring, what revealed thus a storage strategy which can be beneficial to new shoots. This experiment provided evidence that generally, the water trophic state is the main factor governing P uptake, and the mineral status (softwater > hardwater) of the stream water is the second main factor. The phenological stage appeared to be a confounding factor to P level in water. Nonetheless, phenology played a role in P turnover in the plant. Finally, phenotypic plasticity allows both subpopulations to adapt to a changing environment.	[Baldy, Virginie; Tremolieres, Michele] UdS, CNRS, Inst Bot, LHyGeS,UMR 7517, F-67083 Strasbourg, France; [Baldy, Virginie; Fernandez, Catherine; Korboulewsky, Nathalie; Monnier, Yogan; Perez, Thierry] Aix Marseille Univ, CNRS, IRD, Avignon Univ,IMBE,UMR 7263, F-13331 Marseille 03, France; [Thiebaut, Gabrielle] CNRS, UMR 6553, Lab Ecosyst Biodivers Evolut ECOBIO, F-35042 Rennes, France; [Sagova-Mareckova, Marketa] Res Inst Crop Prod, Epidemiol & Ecol Microorganisms, CR-16106 Prague, Czech Republic; [Korboulewsky, Nathalie] Irstea, UR EFNO, Ctr Nogent Sur Vernisson, F-45290 Nogent Sur Vernisson, France; [Monnier, Yogan] INRA, UMR AMAP, F-34000 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Avignon Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Czech Crop Research Institute (CRI); INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Baldy, V (corresponding author), UdS, CNRS, Inst Bot, LHyGeS,UMR 7517, 28 Rue Goethe, F-67083 Strasbourg, France.	virginie.baldy@imbe.fr	FERNANDEZ, Catherine/A-2556-2009; Mareckova, Marketa/D-9898-2017; Mareckova, Marketa/AAD-7361-2021	FERNANDEZ, Catherine/0000-0002-6868-4774; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570; BALDY, Virginie/0000-0002-4048-5132; Korboulewsky, Nathalie/0000-0002-6017-1114	national research Programme "Environnement, Vie et Societes" of the CNRS; Ministry of Education, Youth and Sports of the Czech Republic [ME 09077]	national research Programme "Environnement, Vie et Societes" of the CNRS; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the national research Programme "Environnement, Vie et Societes" of the CNRS and Ministry of Education, Youth and Sports of the Czech Republic, ME 09077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFNOR, 1986, T90023 NF AFNOR, P270; Angelstein S, 2008, AQUAT BIOL, V3, P209, DOI 10.3354/ab00080; Baldy V, 2007, HYDROBIOLOGIA, V575, P343, DOI 10.1007/s10750-006-0380-0; Barrat-Segretain MH, 2001, ARCH HYDROBIOL, V152, P237; Best EPH, 1996, FRESHWATER BIOL, V36, P33, DOI 10.1046/j.1365-2427.1996.d01-474.x; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; BOWES G, 1989, AQUAT BOT, V34, P233, DOI 10.1016/0304-3770(89)90058-2; CARPENTER S R, 1977, Aquatic Botany, V3, P239, DOI 10.1016/0304-3770(77)90026-2; Chambers PA, 2001, FRESHWATER BIOL, V46, P1121, DOI 10.1046/j.1365-2427.2001.00794.x; COOK CDK, 1985, AQUAT BOT, V21, P111, DOI 10.1016/0304-3770(85)90084-1; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DAWSON F H, 1976, Aquatic Botany, V2, P51, DOI 10.1016/0304-3770(76)90007-3; Demars BOL, 2007, FRESHWATER BIOL, V52, P2073, DOI 10.1111/j.1365-2427.2007.01817.x; Di Nino F, 2007, FUND APPL LIMNOL, V168, P335, DOI 10.1127/1863-9135/2007/0168-0335; Di Nino F, 2008, THESIS U METZ; Dykyjova D, 1979, ALGAL ASSAYS, P131; Engelhardt KAM, 2002, ECOLOGY, V83, P2911; Garbey C, 2004, PLANT ECOL, V173, P125, DOI 10.1023/B:VEGE.0000026336.44576.ff; Garbey C, 2004, FRESHWATER BIOL, V49, P346, DOI 10.1111/j.1365-2427.2004.01188.x; GERLOFF GC, 1966, LIMNOL OCEANOGR, V11, P529, DOI 10.4319/lo.1966.11.4.0529; Golterman HL, 1994, ANN LIMNOL-INT J LIM, V30, P221, DOI 10.1051/limn/1994017; Greulich S, 2006, HYDROBIOLOGIA, V570, P249, DOI 10.1007/s10750-006-0188-y; Grime J.P., 1988, PLANT EVOLUTIONARY B, P371, DOI DOI 10.1007/978-94-009-1207-6_14; James CS, 2006, AQUAT BOT, V84, P347, DOI 10.1016/j.aquabot.2006.01.002; JONES RL, 1993, J EXP BOT, V44, P207; KUNII H, 1984, AQUAT BOT, V18, P239, DOI 10.1016/0304-3770(84)90065-2; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; MABERLY SC, 1983, J ECOL, V71, P705, DOI 10.2307/2259587; Madsen TV, 2002, FRESHWATER BIOL, V47, P283, DOI 10.1046/j.1365-2427.2002.00802.x; Mony C, 2007, PLANT ECOL, V191, P109, DOI 10.1007/s11258-006-9219-z; Pelton DK, 1998, FRESHWATER BIOL, V39, P285, DOI 10.1046/j.1365-2427.1998.00281.x; Pietro KC, 2006, ECOL ENG, V27, P290, DOI 10.1016/j.ecoleng.2006.05.014; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Robach F, 1995, ACTA BOT GALLICA, V142, P719, DOI 10.1080/12538078.1995.10515296; SELL Y, 1959, B ASS PHIL ALS LORR, V10, P121; SIMPSON D A, 1988, Watsonia, V17, P121; Simpson DA., 1984, WATSONIA J BOT SOC I, V15, P1; SIMPSON PS, 1986, AQUAT BOT, V24, P1, DOI 10.1016/0304-3770(86)90112-9; Szabo S, 2010, FRESHWATER BIOL, V55, P681, DOI 10.1111/j.1365-2427.2009.02308.x; Thiebaut G, 2005, WATER RES, V39, P3385, DOI 10.1016/j.watres.2005.05.036; Thiebaut G, 2003, ANN LIMNOL-INT J LIM, V39, P307, DOI 10.1051/limn/2003025; Thiebaut Gabrielle, 2008, V7, P31; van Wijk MT, 2003, J ECOL, V91, P664, DOI 10.1046/j.1365-2745.2003.00788.x; VANWIJK RJ, 1989, AQUAT BOT, V35, P319, DOI 10.1016/0304-3770(89)90005-3; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; WELSH RPH, 1979, NEW PHYTOL, V82, P645, DOI 10.1111/j.1469-8137.1979.tb01659.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	47	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118844	10.1371/journal.pone.0118844	http://dx.doi.org/10.1371/journal.pone.0118844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785687	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500051
J	Begum, H; Spindel, JE; Lalusin, A; Borromeo, T; Gregorio, G; Hernandez, J; Virk, P; Collard, B; McCouch, SR				Begum, Hasina; Spindel, Jennifer E.; Lalusin, Antonio; Borromeo, Teresita; Gregorio, Glenn; Hernandez, Jose; Virk, Parminder; Collard, Bertrand; McCouch, Susan R.			Genome-Wide Association Mapping for Yield and Other Agronomic Traits in an Elite Breeding Population of Tropical Rice (Oryza sativa)	PLOS ONE			English	Article							CONTROLLING HEADING DATE; FLOWERING TIME; COMPLEX TRAITS; PLANT HEIGHT; SELECTION; GENE; LOCUS; ORTHOLOG; OSMADS50; HD3A	Genome-wide association mapping studies (GWAS) are frequently used to detect QTL in diverse collections of crop germplasm, based on historic recombination events and linkage disequilibrium across the genome. Generally, diversity panels genotyped with high density SNP panels are utilized in order to assay a wide range of alleles and haplotypes and to monitor recombination breakpoints across the genome. By contrast, GWAS have not generally been performed in breeding populations. In this study we performed association mapping for 19 agronomic traits including yield and yield components in a breeding population of elite irrigated tropical rice breeding lines so that the results would be more directly applicable to breeding than those from a diversity panel. The population was genotyped with 71,710 SNPs using genotyping-by-sequencing (GBS), and GWAS performed with the explicit goal of expediting selection in the breeding program. Using this breeding panel we identified 52 QTL for 11 agronomic traits, including large effect QTLs for flowering time and grain length/grain width/grain-length-breadth ratio. We also identified haplotypes that can be used to select plants in our population for short stature (plant height), early flowering time, and high yield, and thus demonstrate the utility of association mapping in breeding populations for informing breeding decisions. We conclude by exploring how the newly identified significant SNPs and insights into the genetic architecture of these quantitative traits can be leveraged to build genomic-assisted selection models.	[Begum, Hasina; Gregorio, Glenn; Collard, Bertrand] Int Rice Res Inst, Los Banos, Philippines; [Spindel, Jennifer E.; McCouch, Susan R.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA; [Lalusin, Antonio; Borromeo, Teresita; Hernandez, Jose] Univ Philippines Los Banos, Crop Sci Cluster, Los Banos, Philippines; [Virk, Parminder] Ctr Int Agr Trop, Cali, Colombia	CGIAR; International Rice Research Institute (IRRI); Cornell University; University of the Philippines System; University of the Philippines Los Banos; Alliance; International Center for Tropical Agriculture - CIAT	McCouch, SR (corresponding author), Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA.	srm4@cornell.edu	Spindel, Jennifer/F-1373-2017	Collard, Bertrand/0000-0003-2566-4148	NSF PGRP [102655]; Global Diversity Trust; NSF graduate research fellowship; Organization for Women in Science for the Developing World (OWSD); Japan Government via the Japan Rice Breeding Project at IRRI	NSF PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Global Diversity Trust; NSF graduate research fellowship(National Science Foundation (NSF)); Organization for Women in Science for the Developing World (OWSD); Japan Government via the Japan Rice Breeding Project at IRRI	Funding was provided by NSF PGRP #102655 to SMc, Global Diversity Trust to SMc, an NSF graduate research fellowship to JS, the Organization for Women in Science for the Developing World (OWSD) for the PhD scholarship for HB, and the Japan Government via the Japan Rice Breeding Project at IRRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Faraway J.J., 2002, PRACTICAL REGRESSION; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Gregorio G. B., 2013, SABRAO Journal of Breeding and Genetics, V45, P31; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Meuwissen THE, 2001, GENETICS, V157, P1819; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Spindel J, 2014, PLOS GENETI IN PRESS; Spindel J, 2013, THEOR APPL GENET, P1, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Walsh MLaB, 1998, GENETICS ANAL QUANTI; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang W., 2014, NAT COMMUN, V5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yonemaru J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-346; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang ZH, 2014, PLOS ONE, V9; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	44	107	112	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119873	10.1371/journal.pone.0119873	http://dx.doi.org/10.1371/journal.pone.0119873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785447	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500138
J	Bouchut, A; Chawla, AR; Jeffers, V; Hudmon, A; Sullivan, WJ				Bouchut, Anne; Chawla, Aarti R.; Jeffers, Victoria; Hudmon, Andy; Sullivan, William J., Jr.			Proteome-Wide Lysine Acetylation in Cortical Astrocytes and Alterations That Occur during Infection with Brain Parasite Toxoplasma gondii	PLOS ONE			English	Article							NEUROPROTECTIVE FACTOR; METABOLIC PATHWAYS; DIVERSE FUNCTION; B GPNMB; PROTEINS; NEURONS; MODULATION; ACETYLOME; ALPHA; ACETYLTRANSFERASE	Lysine acetylation is a reversible post-translational modification (PTM) that has been detected on thousands of proteins in nearly all cellular compartments. The role of this widespread PTM has yet to be fully elucidated, but can impact protein localization, interactions, activity, and stability. Here we present the first proteome-wide survey of lysine acetylation in cortical astrocytes, a subtype of glia that is a component of the blood-brain barrier and a key regulator of neuronal function and plasticity. We identified 529 lysine acetylation sites across 304 proteins found in multiple cellular compartments that largely function in RNA processing/transcription, metabolism, chromatin biology, and translation. Two hundred and seventy-seven of the acetylated lysines we identified on 186 proteins have not been reported previously in any other cell type. We also mapped an acetylome of astrocytes infected with the brain parasite, Toxoplasma gondii. It has been shown that infection with T. gondii modulates host cell gene expression, including several lysine acetyltransferase (KAT) and deacetylase (KDAC) genes, suggesting that the host acetylome may also be altered during infection. In the T. gondii-infected astrocytes, we identified 34 proteins exhibiting a level of acetylation >2-fold and 24 with a level of acetylation <2-fold relative to uninfected astrocytes. Our study documents the first acetylome map for cortical astrocytes, uncovers novel lysine acetylation sites, and demonstrates that T. gondii infection produces an altered acetylome.	[Bouchut, Anne; Jeffers, Victoria; Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Chawla, Aarti R.; Hudmon, Andy] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Sullivan, WJ (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.	wjsulliv@iu.edu		Jeffers, Victoria/0000-0003-1233-1088	National Institutes of Health [NS078171, AI106435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this study was provided by funding from the National Institutes of Health (http://www.nih.gov/), NS078171 (AH) and AI106435 (to WJS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Ablack JNG, 2012, J VIROL, V86, P8198, DOI 10.1128/JVI.00289-12; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Andoh A, 2000, INT J MOL MED, V6, P51; [Anonymous], 2012, NUCL ACIDS RES; [Anonymous], 2005, EMBO J; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashpole NM, 2013, J BIOL CHEM, V288, P14599, DOI 10.1074/jbc.M113.466235; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bhatti MM, 2005, J BIOL CHEM, V280, P5902, DOI 10.1074/jbc.M410656200; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Du J, 2014, J BIOL CHEM, V289, P12578, DOI 10.1074/jbc.M113.544718; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Foster DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067513; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Halonen SK, 2001, INFECT IMMUN, V69, P5573, DOI 10.1128/IAI.69.9.5573-5576.2001; Han D, 2014, PROTEOMICS, V14, P1604, DOI 10.1002/pmic.201300495; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu XF, 2013, J CELL BIOCHEM, V114, P2729, DOI 10.1002/jcb.24621; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUNTER CA, 1992, EUR J IMMUNOL, V22, P2317, DOI 10.1002/eji.1830220921; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lundgren DH, 2009, PROTEIN IDENTIFICATI; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; PALFREYMAN JW, 1979, J NEUROL SCI, V41, P101, DOI 10.1016/0022-510X(79)90144-8; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Rao RSP, 2014, TRENDS PLANT SCI, V19, P550, DOI 10.1016/j.tplants.2014.05.001; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Scheidegger A, 2005, J PARASITOL, V91, P307, DOI 10.1645/GE-379R; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SIMS TA, 1989, BRIT J EXP PATHOL, V70, P317; Skorupa A, 2013, J PROTEOMICS, V91, P274, DOI 10.1016/j.jprot.2013.07.028; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Strack A, 2002, ACTA NEUROPATHOL, V103, P458, DOI 10.1007/s00401-001-0491-7; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang XQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-228; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010; Wu SP, 2010, AM J PHYSIOL-GASTR L, V298, pG784, DOI 10.1152/ajpgi.00526.2009; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yang JW, 2005, NEUROCHEM INT, V47, P159, DOI 10.1016/j.neuint.2005.04.017; Yin P, 2012, J PROTEOME RES, V11, P3965, DOI 10.1021/pr201066t; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z	99	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117966	10.1371/journal.pone.0117966	http://dx.doi.org/10.1371/journal.pone.0117966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786129	Green Published, gold			2022-12-26	WOS:000352138500021
J	Czaprowski, D; Kedra, A; Pawlowska, P; Kolwicz-Ganko, A; Leszczewska, J; Tyrakowski, M				Czaprowski, Dariusz; Kedra, Agnieszka; Pawlowska, Paulina; Kolwicz-Ganko, Aleksandra; Leszczewska, Justyna; Tyrakowski, Marcin			The Examination of the Musculoskeletal System Based Only on the Evaluation of Pelvic-Hip Complex Muscle and Trunk Flexibility May Lead to Failure to Screen Children for Generalized Joint Hypermobility	PLOS ONE			English	Article							STRAIGHT-LEG RAISE	Objective The aim of the study was to evaluate whether the clinical assessment of the pelvic-hip complex muscle and trunk flexibility is sufficient for diagnosing generalized joint hypermobility (GJH). Design A cross-sectional study. Setting Center of Body Posture in Olsztyn, North East Poland. Participants The study included 136 females and 113 males aged 10-13 years. Main outcome measures In order to assess muscle flexibility, the straight leg raise (SLR) test (for hamstring) and modified Thomas test for one-(O-JHF) and two-joint (T-JHF) hip flexors were performed. To evaluate trunk flexibility the fingertip-to-floor (FTF) and lateral trunk flexion (LTF) tests were used. The GJH occurrence was assessed with the use of nine-point Beighton scale (threshold value >= 5 points for females, >= 4 for males). The analysis was carried out separately for females and males. Results There were no significant differences between females with versus without GJH, and males with versus without GJH regarding SLR (p = 0.86, p = 0.19 for females and males, respectively), O-JHF (p = 0.89, p = 0.35 for females and males, respectively), T-JHF (p = 0.77, p = 0.4 for females and males, respectively), FTF (p = 0.19, p = 0.84 for females and males, respectively) and LTF (p = 0.58, p = 0.35 for females and males, respectively) tests results. Conclusions Clinical examination of the pelvic-hip complex muscles and trunk flexibility by use of SLR, O-JHF, T-JHF, FTF and LTF revealed to be insufficient in diagnosing GJH in children aged 10-13 years. Thus, the Beighton scale should be considered a standard element of physiotherapeutic examination of the musculoskeletal system in children and youth.	[Czaprowski, Dariusz] Univ Phys Educ, Dept Rehabil, PL-00968 Warsaw, Poland; [Czaprowski, Dariusz] Jozef Rusiecki Univ Coll Olsztyn, Dept Physiotherapy, PL-10243 Olsztyn, Poland; [Kedra, Agnieszka] Jozef Pilsudski Univ Phys Educ Warsaw, Fac Phys Educ & Sport Biala Podlaska, Dept Posture Correct & Compensat, PL-21500 Biala Podlaska, Poland; [Pawlowska, Paulina; Kolwicz-Ganko, Aleksandra; Leszczewska, Justyna] Univ Phys Educ, Dept Phys Educ, PL-00968 Warsaw, Poland; [Tyrakowski, Marcin] Ctr Postgrad Med Educ Warsaw, Dept Orthoped Pediat Orthoped & Traumatol, PL-05400 Otwock, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Czaprowski, D (corresponding author), Univ Phys Educ, Dept Rehabil, Marymoncka 34, PL-00968 Warsaw, Poland.	dariusz.czaprowski@interia.pl						Anderson B., 2000, STRETCHING; [Anonymous], 2004, PHYSIOTHERAPY, DOI DOI 10.1016/J.PHYSI0.2004.02.009; Armiger P, 2010, STRETCHING FUNCTIONA; Beighton P, 1999, HYPERMOBILITY JOINTS; Boyd BS, 2012, PHYSIOTHERAPY, V98, P174, DOI 10.1016/j.physio.2011.04.352; Chaitow L, 2006, MUSCLE ENERGY TECHNI; Cornbleet SL, 1996, PHYS THER, V76, P850, DOI 10.1093/ptj/76.8.850; Czaprowski Dariusz, 2012, Ortop Traumatol Rehabil, V14, P407, DOI 10.5604/15093492.1016368; Czaprowski D, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-22; Davis DS, 2005, J STRENGTH COND RES, V19, P27; Gablankowski A, 1994, STRECHING AT SCH; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Greenwood NL, 2011, MANUAL THER, V16, P623, DOI 10.1016/j.math.2011.07.005; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hakim A, 2010, HYPERMOBILITY FIBROM, P6; HOWELL DW, 1984, AM J SPORT MED, V12, P278, DOI 10.1177/036354658401200407; Juhas I., 2011, PHYS CULTURE, V65, P42; Keer R., 2003, HYPERMOBILITY SYNDRO; Kendall F.P., 2005, MUSCLES TESTING FUNC, Vfifth; Kerr AJ, 2000, PHYSIOTHERAPY, V86, P313, DOI DOI 10.1016/S0031-9406(05)61005-X; Kisner C, 2012, THERAPEUTIC EXERCISE, V6th; Lamari Neuseli Marino, 2005, Sao Paulo Med. J., V123, P119; Magee DJ, 2011, ORTHOPEDIC PHYS ASSE; Medina FMS, 2007, J SPORT MED PHYS FIT, V47, P304; Murray KJ, 2006, BEST PRACT RES CL RH, V20, P329, DOI 10.1016/j.berh.2005.12.003; Raisin L, 2006, STRETCHING EVERYONE; Russek LN, 1999, PHYS THER, V79, P591, DOI 10.1093/ptj/79.6.591; Russek LN, 2000, PHYS THER, V80, P386, DOI 10.1093/ptj/80.4.386; Sherry DD, 2001, TXB PEDIAT RHEUMATOL, P362; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sjolie AN, 2004, SCAND J MED SCI SPOR, V14, P168, DOI 10.1111/j.1600-0838.2003.00334.x; Smits-Engelsman B, 2011, J PEDIATR-US, V158, P130, DOI 10.1016/j.jpeds.2010.07.021; Solberg G., 2008, POSTURAL DISORDERS M, V2n; Streiner D, 2008, HLTH MEASUREMENT SCA, V4; Vougiouka O, 2000, EUR J PEDIATR, V159, P628, DOI 10.1007/PL00008391; Young W, 2004, J SCI MED SPORT, V7, P23, DOI 10.1016/S1440-2440(04)80040-9; [No title captured]	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121360	10.1371/journal.pone.0121360	http://dx.doi.org/10.1371/journal.pone.0121360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786251	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500209
J	Huang, XH; Leggas, M; Dickson, RC				Huang, Xinhe; Leggas, Markos; Dickson, Robert C.			Drug Synergy Drives Conserved Pathways to Increase Fission Yeast Lifespan	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; MAP KINASE PATHWAY; STRESS-RESPONSE; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; PROTEIN-KINASE; TORC1; EXTENDS; MTOR; METABOLISM	Aging occurs over time with gradual and progressive loss of physiological function. Strategies to reduce the rate of functional loss and mitigate the subsequent onset of deadly age-related diseases are being sought. We demonstrated previously that a combination of rapamycin and myriocin reduces age-related functional loss in the Baker's yeast Saccharomyces cerevisiae and produces a synergistic increase in lifespan. Here we show that the same drug combination also produces a synergistic increase in the lifespan of the fission yeast Schizosaccharomyces pombe and does so by controlling signal transduction pathways conserved across a wide evolutionary time span ranging from yeasts to mammals. Pathways include the target of rapamycin complex 1 (TORC1) protein kinase, the protein kinase A (PKA) and a stress response pathway, which in fission yeasts contains the Sty1 protein kinase, an ortholog of the mammalian p38 MAP kinase, a type of Stress Activated Protein Kinase (SAPK). These results along with previous studies in S. cerevisiae support the premise that the combination of rapamycin and myriocin enhances lifespan by regulating signaling pathways that couple nutrient and environmental conditions to cellular processes that fine-tune growth and stress protection in ways that foster long term survival. The molecular mechanisms for fine-tuning are probably species-specific, but since they are driven by conserved nutrient and stress sensing pathways, the drug combination may enhance survival in other organisms.	[Huang, Xinhe; Dickson, Robert C.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Huang, Xinhe; Dickson, Robert C.] Univ Kentucky, Coll Med, Lucille Markey Canc Ctr, Lexington, KY USA; [Leggas, Markos] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Leggas, Markos] Univ Kentucky, Coll Pharm, Lucille Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Huang, XH (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China.	2196000@qq.com; bobd@uky.edu	Leggas, Markos/E-6618-2011	Leggas, Markos/0000-0003-4314-4533	NIH/NIA [AG024377]; National Institute of General Medical Sciences [P20GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024377, R56AG024377] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the NIH/NIA grant AG024377 to RCD and by the National Institute of General Medical Sciences grant P20GM103486 to Louis Hersh. The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Blagosklonny MV, 2011, AGING-US, V3, P1051, DOI 10.18632/aging.100411; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Chen BR, 2009, EXP GERONTOL, V44, P493, DOI 10.1016/j.exger.2009.04.004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Das J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003350; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Degols G, 1996, MOL CELL BIOL, V16, P2870; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; GRECO WR, 1990, CANCER RES, V50, P5318; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HOFFMAN CS, 1990, GENETICS, V124, P807; Huang XH, 2014, BBA-MOL CELL BIOL L, V1841, P657, DOI 10.1016/j.bbalip.2013.08.006; Huang XH, 2013, AGING CELL, V12, P652, DOI 10.1111/acel.12090; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu J, 2013, AGING CELL, V12, P833, DOI 10.1111/acel.12107; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Ohtsuka H, 2008, FEMS YEAST RES, V8, P520, DOI 10.1111/j.1567-1364.2008.00379.x; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; PLUMMER JL, 1990, J PHARMACOL METHOD, V23, P297, DOI 10.1016/0160-5402(90)90058-S; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rallis C, 2014, BIOL OPEN, V3, P161, DOI 10.1242/bio.20147245; Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Roux AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000408; Sanso M, 2011, MOL MICROBIOL, V82, P542, DOI 10.1111/j.1365-2958.2011.07851.x; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Swinnen E, 2014, FEMS YEAST RES, V14, P17, DOI 10.1111/1567-1364.12097; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	71	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121877	10.1371/journal.pone.0121877	http://dx.doi.org/10.1371/journal.pone.0121877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786258	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500217
J	Janbaz, KH; Ahsan, MZ; Saqib, F; Imran, I; Zia-Ul-Haq, M; Rashid, MA; Jaafar, HZE; Moga, M				Janbaz, Khalid Hussain; Ahsan, Muhammad Zaeem; Saqib, Fatima; Imran, Imran; Zia-Ul-Haq, Muhammad; Rashid, Muhammad Abid; Jaafar, Hawa Z. E.; Moga, Marius			Scientific Basis for Use of Pyrus pashia Buch.-Ham. ex D. Don. Fruit in Gastrointestinal, Respiratory and Cardiovascular Ailments	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; MEDICINAL-PLANTS; IN-VITRO; PHARMACOLOGICAL BASIS; ANTIOXIDANT; CALCIUM; BRONCHODILATOR; COMMUNITIES; DISTRICT; EXTRACT	Background Pyrus pashia Buch.-Ham. ex D. Don. has been used conventionally by many communities in the Himalayan region for the management of gastrointestinal, respiratory, and vascular complications. Set against this background, this study was carried out to justify the scientific basis to validate folkloric uses of fruits of Pyrus pashia Buch.-Ham. ex D. Don. (Pp.Cr) in traditional systems of medicine. Methods The crude ethanol extract of fruits of Pyrus pashia Buch.-Ham. ex D. Don. (Pp.Cr) was tested in vitro on isolated rabbit jejunum, tracheal, and aorta preparations. The responses of tissues were recorded using isotonic transducers coupled with a PowerLab data acquisition system. Results The Pp.Cr on application (0.01-5.0 mg/ml) to isolated rabbit jejunum preparation exhibited relaxation through decrease in magnitude and frequency of spontaneous contractions. The Pp.Cr also exerted a relaxant (0.01-5.0 mg/ml) effect on K+(80 mM) induced contractions in isolated rabbit jejunum preparations and caused shifting of the Ca2+ curves (1.0-3.0 mg/ml) toward right in a manner similar to that of verapamil (3 mu M), possibly suggesting presence of Ca2+ channel blocking activity. Subsequently, Pp.Cr in a concentration-dependent fashion (0.01-10.0 mg/ml) caused relaxation of CCh (1 mu M) and K+ (80 mM) induced contractions in isolated rabbit tracheal preparations in a manner comparable to that of dicyclomine, suggesting that the observed relaxant effect is likely to be mediated through antimuscarinic and/or Ca2+ channel blocking activities. Moreover, when evaluated against isolated rabbit aortic preparations, the Pp.Cr in concentrations up to 10 mg/ml exhibited a contractile response that was found to be abolished subsequent to pretreatment of isolated tissue preparation with cyproheptadine (1 mu M), phentolamine (1 mu M), and losartan (1 mu M), suggesting that Pp.Cr may have some alpha-adrenergic, muscarinic, serotonergic, and angiotensin II activities. Conclusions The aqueous ethanolic extract of Pyrus pashia (Pp.Cr) exhibited spasmolytic, bronchodilator, and vaso-constrictive activities possibly through different mechanisms. The spasmolytic and bronchodilator activities are likely to be mediated through blockade of Ca2+ channels, while vasoconstrictive activity may be due to presence of a alpha-adrenergic, muscarinic, serotonergic, and angiotensin II agonistic component.	[Janbaz, Khalid Hussain; Ahsan, Muhammad Zaeem; Saqib, Fatima; Imran, Imran] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Zia-Ul-Haq, Muhammad] Patent Off, Karachi, Pakistan; [Rashid, Muhammad Abid] Univ Agr Faisalabad, Dept Chem & Biochem, Faisalabad, Pakistan; [Jaafar, Hawa Z. E.] Fac Agr, Dept Crop Sci, Selangor, Malaysia; [Moga, Marius] Transilvania Univ Brasov, Dept Med, Brasov, Romania	Bahauddin Zakariya University; University of Agriculture Faisalabad; Universiti Putra Malaysia; Transylvania University of Brasov	Zia-Ul-Haq, M (corresponding author), Patent Off, Karachi, Pakistan.	ahirzia@gmail.com; hawazej@gmail.com	Ahsan, Muhammad Zaeem/GRF-3151-2022; Rashid, Muhammad Abid/G-8109-2015; Janbaz, Khalid Hussain/L-2426-2015; MOGA, MARIUS ALEXANDRU/AHC-2310-2022; Imran, Imran/AAL-5734-2020; Rashid, Muhammad Abid/C-2800-2015; Zia-Ul-Haq, Muhammad/J-1798-2015	Ahsan, Muhammad Zaeem/0000-0002-7367-3818; Imran, Imran/0000-0003-1337-8574; Rashid, Muhammad Abid/0000-0002-3053-2767; saqib, fatima/0000-0001-6242-7147				Abbasi AM, 2013, J ETHNOPHARMACOL, V148, P528, DOI 10.1016/j.jep.2013.04.050; Ahmad Z, 2007, COUNTRY REPORT PLANT; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; BRADING AF, 1980, BRIT J PHARMACOL, V70, P229, DOI 10.1111/j.1476-5381.1980.tb07928.x; CHALLICE JS, 1968, PHYTOCHEMISTRY, V7, P1781, DOI 10.1016/S0031-9422(00)86651-0; CHAMBERS R., 1979, J ETHNOPHARMACOL, V10, P1, DOI DOI 10.1016/0378-8741(79)90013-8; Chaudhary MA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-166; Council NR, 2010, GUIDE CARE USE LAB A, DOI 10.17226/5140; Farooquee Nehal A., 2004, Journal of Human Ecology, V16, P33; FARRE AJ, 1991, GEN PHARMACOL, V22, P177, DOI 10.1016/0306-3623(91)90331-Y; FLECKENSTEIN A, 1977, ANNU REV PHARMACOL, V17, P149, DOI 10.1146/annurev.pa.17.040177.001053; Gilani AH, 2005, LIFE SCI, V76, P3089, DOI 10.1016/j.lfs.2004.12.021; Gilani SN, 2010, PHYTOTHER RES, V24, P553, DOI 10.1002/ptr.2979; GODFRAIND T, 1986, PHARMACOL REV, V38, P321; Guven K, 2006, PHARM BIOL, V44, P79, DOI 10.1080/13880200600591253; Hussein FTK, 1983, MED PLANTS LIBYA, P7; Janbaz KH, 2013, J PHYSIOL PHARMACOL, V64, P479; Janbaz KH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-71; Janbaz Khalid Hussain, 2012, Evid Based Complement Alternat Med, V2012, P735653, DOI 10.1155/2012/735653; Jiangsu New Medical College, 1986, DICT CHIN TRAD MED; JOSHI AR, 1990, ECON BOT, V44, P71, DOI 10.1007/BF02861069; Kala CP, 2002, MED PLANTS INDIAN TR; Karaki H, 1997, PHARMACOL REV, V49, P157; KARAKI H, 1988, LIFE SCI, V42, P111, DOI 10.1016/0024-3205(88)90674-1; Khandelwal R, 2008, ORIENT J CHEM, V24, P773; Lama Y C, 2001, MED PLANTS DOLPO AMC; MAGA JA, 1978, CRC CR REV FOOD SCI, V10, P323, DOI 10.1080/10408397809527255; Main A., 2001, PAK J BIOL SCI, V4, P1101, DOI DOI 10.3923/pjbs.2001.1101.1107; MANANDHAR N P, 1990, International Journal of Crude Drug Research, V28, P17; Manandhar Narayan P., 1994, Fitoterapia, V65, P7; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Meyers KJ, 2003, J AGR FOOD CHEM, V51, P6887, DOI 10.1021/jf034506n; Nakul Chettri, 2005, Lyonia, V8, P89; Nassar MI, 2011, CARBOHYD RES, V346, P64, DOI 10.1016/j.carres.2010.11.007; Prajapati N.D, 2003, PLANT PHYSL FUNDAMEN, P1; Saklani S, 2012, INT J PHARM SCI RES, V3, P268, DOI 10.13040/IJPSR.0975-8232.3(1).268-72; Sarla Saklani, 2012, Journal of Pharmacy Research, V5, P3030; Shinwari M.I., 1998, HAMDARD MED, V42, P5; Shrestha PM, 2003, J ETHNOPHARMACOL, V86, P81, DOI 10.1016/S0378-8741(03)00051-5; Shui GH, 2002, J CHROMATOGR A, V977, P89, DOI 10.1016/S0021-9673(02)01345-6; SINGH MP, 1979, ECON BOT, V33, P185, DOI 10.1007/BF02858287; Thapa B, 1997, ANIM FEED SCI TECH, V67, P97, DOI 10.1016/S0377-8401(96)01129-7; Tona L, 1998, J ETHNOPHARMACOL, V61, P57, DOI 10.1016/S0378-8741(98)00015-4; Tsering J, 2012, INT J PHARM SCI RES, V3, P2721, DOI 10.13040/IJPSR.0975-8232.3(8).2721-25; VAN ROSSUM J. M., 1963, ARCH INTERNATL PHARMACODYN ET THER, V143, P299; Zia-Ul-Haq M, 2013, OXID COMMUN, V36, P15; Zia-Ul-Haq M, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-23; Zia-Ul-Haq M, 2013, ACTA BOT CROAT, V72, P133, DOI 10.2478/v10184-012-0005-9; Zia-Ul-Haq M, 2013, TURK J BIOL, V37, P25, DOI 10.3906/biy-1204-38; Zia-Ul-Haq M, 2013, PAK J PHARM SCI, V26, P185; Zia-Ul-Haq M, 2013, MOLECULES, V18, P2005, DOI 10.3390/molecules18022005	51	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118605	10.1371/journal.pone.0118605	http://dx.doi.org/10.1371/journal.pone.0118605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786248	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500040
J	Kraemer, MMS; Kraemer, AS; Stebner, F; Bickel, DJ; Rust, J				Kraemer, Monica M. Solorzano; Kraemer, Atahualpa S.; Stebner, Frauke; Bickel, Daniel J.; Rust, Jes			Entrapment Bias of Arthropods in Miocene Amber Revealed by Trapping Experiments in a Tropical Forest in Chiapas, Mexico	PLOS ONE			English	Article							DOMINICAN-REPUBLIC AMBER; FOSSIL PSYCHODIDAE; BODY-SIZE; TAPHONOMY; EVOLUTION; DIPTERA; RESIN; CAESALPINIOIDEAE; PALEOECOLOGY; PRESERVATION	All entomological traps have a capturing bias, and amber, viewed as a trap, is no exception. Thus the fauna trapped in amber does not represent the total existing fauna of the former amber forest, rather the fauna living in and around the resin producing tree. In this paper we compare arthropods from a forest very similar to the reconstruction of the Miocene Mexican amber forest, and determine the bias of different trapping methods, including amber. We also show, using cluster analyses, measurements of the trapped arthropods, and guild distribution, that the amber trap is a complex entomological trap not comparable with a single artificial trap. At the order level, the most similar trap to amber is the sticky trap. However, in the case of Diptera, at the family level, the Malaise trap is also very similar to amber. Amber captured a higher diversity of arthropods than each of the artificial traps, based on our study of Mexican amber from the Middle Miocene, a time of climate optimum, where temperature and humidity were probably higher than in modern Central America. We conclude that the size bias is qualitatively independent of the kind of trap for non-extreme values. We suggest that frequent specimens in amber were not necessarily the most frequent arthropods in the former amber forest. Selected taxa with higher numbers of specimens appear in amber because of their ecology and behavior, usually closely related with a tree-inhabiting life. Finally, changes of diversity from the Middle Miocene to Recent time in Central and South America can be analyzed by comparing the rich amber faunas from Mexico and the Dominican Republic with the fauna trapped using sticky and Malaise traps in Central America.	[Kraemer, Monica M. Solorzano; Stebner, Frauke; Rust, Jes] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Kraemer, Atahualpa S.] Univ Nacl Autonoma Mexico, Dept Fis, Fac Ciencias, Mexico City 04510, DF, Mexico; [Kraemer, Monica M. Solorzano] Senckenberg Forschungsinst & Nat Museum, Frankfurt, Germany; [Bickel, Daniel J.] Australian Museum, Sydney, NSW 2010, Australia	University of Bonn; Universidad Nacional Autonoma de Mexico; Senckenberg Gesellschaft fur Naturforschung (SGN); Australian Museum	Kraemer, MMS (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	monica.solorzano-kraemer@senckenberg.de	Kraemer, Atahualpa Solórzano/GQQ-2931-2022	Kraemer, Atahualpa/0000-0001-8146-2124; Solorzano Kraemer, Monica Morayma/0000-0003-3065-119X	German Research Foundation (DFG) [SO894/3-1]; Spanish Ministry of Economy and Competitiveness [GL2011-23948 AMBARES]	German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was possible thanks to a postdoctoral fellowship awarded to M.M.S.K., No. SO894/3-1 from the German Research Foundation (DFG) and the Spanish Ministry of Economy and Competitiveness GL2011-23948 AMBARES 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; Bickel D.J., 2009, MANUAL CENTRAL AM DI, V1, P671; Bickel DJ, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P888; BISHOP JE, 1969, ECOLOGY, V50, P371, DOI 10.2307/1933885; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; Breedlove D. E., 1986, LISTADOS FLORISTICOS; Breton G, 2014, B SOC GEOL MEX, V66, P199, DOI 10.18268/BSGM2014v66n1a14; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brues CT, 1933, AM NAT, V67, P385, DOI 10.1086/280501; Carabias Lillo J, 1999, PRORAMA MANEJO RESER; Coty D, 2013, INSECT EVOLUTION IN AN AMBERIFEROUS AND STONE ALPHABET, P13; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; dos Santos BB, 2010, ACTA BOT BRAS, V24, P243, DOI 10.1590/S0102-33062010000100026; DUNLOP J. A., 2008, REV IBERICA ARACNOLO, V15, P9; Duran-Ruiz C, 2013, CAN J EARTH SCI, V50, P495, DOI 10.1139/cjes-2012-0166; Evenhuis N.L., 1994, CATALOGUE FOSSIL FLI; FEARNSIDE PM, 1989, BIOSCIENCE, V39, P387, DOI 10.2307/1311068; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Grimaldi DA., 1996, AMBER WINDOW; Grimaldi David, 2005, pi; Grund M, 2006, THESIS U BONN; Grund M, 2006, PALAEOGEOGR PALAEOCL, V241, P410, DOI 10.1016/j.palaeo.2006.04.005; HENWOOD AA, 1993, LETHAIA, V26, P237, DOI 10.1111/j.1502-3931.1993.tb01525.x; Henwood Alison, 1993, Modern Geology, V19, P35; Hoffeins Christel, 2004, Studia Dipterologica, V10, P381; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Kaandorp RJG, 2005, PALAEOGEOGR PALAEOCL, V221, P1, DOI 10.1016/j.palaeo.2004.12.024; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; LANGENHEIM JH, 1974, BRITTONIA, V26, P3, DOI 10.2307/2805914; LANGENHEIM JH, 1967, J ARNOLD ARBORETUM, V48, P203; LANGENHEIM JH, 1979, BIOCHEM SYST ECOL, V7, P21, DOI 10.1016/0305-1978(79)90036-X; Larsson SG., 1978, BALTIC AMBER PALAEOB; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; Martinez-Hernandez E., 1992, INSTITUTO GEOLOG IA, V10, P54; McKay WAB, 2013, PLANT PHYSIOL, V133, P368; Meades L, 2002, AUSTRAL ECOL, V27, P451, DOI 10.1046/j.1442-9993.2002.01199.x; Medeiros LCD, 1999, STUD NEOTROP FAUNA E, V34, P76, DOI 10.1076/snfe.34.2.76.2103; MENESESROCHA JJ, 2001, AAPG MEMOIR, V75, P183; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Penney D, 2005, PALAEOGEOGR PALAEOCL, V223, P1, DOI 10.1016/j.palaeo.2005.03.022; Penney D, 2002, PALEOBIOLOGY, V28, P389, DOI 10.1666/0094-8373(2002)028<0389:PODAPS>2.0.CO;2; Penney D, 2006, BIOL LETTERS, V2, P266, DOI 10.1098/rsbl.2006.0442; Penney David, 2010, P22; Perrichot Vincent, 2010, P192; PIKE EM, 1993, PALAIOS, V8, P411, DOI 10.2307/3515016; Poinar G, 2002, BOT J LINN SOC, V139, P125, DOI 10.1046/j.1095-8339.2002.00053.x; Poinar GO., 1992, LIFE AMBER; Poinar Jr. G.O., 1999, AMBER FOREST; Poinar R, 1994, QUEST LIFE AMBER; QUATE LW, 1961, J PALEONTOL, V35, P949; QUATE LW, 1963, J PALEONTOL, V37, P110; Ragazzi E., 2011, ENCY GEOBIOLOGY, P24, DOI [DOI 10.1007/978-1-4020-9212-1_9, 10.1007/978-1-4020-9212-1_9]; Solorzano Kraemer Monica M., 2010, P42; Sontag Elzbieta, 2003, Acta Zoologica Cracoviensia, V46, P431; Stebner F, 2014, PALAEONTO A IN PRESS; Tappert R, 2013, GEOCHIM COSMOCHIM AC, V121, P240, DOI 10.1016/j.gca.2013.07.011; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; Wichard W, 2009, WASSERINSEKTEN BALTI; Wilf P, 2005, P NATL ACAD SCI USA, V102, P8944, DOI 10.1073/pnas.0500516102; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; Zherikhin VV, 2009, PALEONTOL J+, V43, P987, DOI 10.1134/S0031030109090019	65	46	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118820	10.1371/journal.pone.0118820	http://dx.doi.org/10.1371/journal.pone.0118820			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785584	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500050
J	Lu, MS; Fang, YJ; Pan, ZZ; Zhong, X; Zheng, MC; Chen, YM; Zhang, CX				Lu, Min-Shan; Fang, Yu-Jing; Pan, Zhi-Zhong; Zhong, Xiao; Zheng, Mei-Chun; Chen, Yu-Ming; Zhang, Cai-Xia			Choline and Betaine Intake and Colorectal Cancer Risk in Chinese Population: A Case-Control Study	PLOS ONE			English	Article							BREAST-CANCER; DNA METHYLATION; WOMEN; NUTRIENT; ADULTS; MEN	Background Few studies have examined the association of choline and betaine intake with colorectal cancer risk, although they might play an important role in colorectal cancer development because of their role as methyl donors. The aim of this study was to examine the relationship between consumption of choline and betaine and colorectal cancer risk in a Chinese population. Methodology/Principal Findings A case-control study was conducted between July 2010 and December 2013 in Guangzhou, China. Eight hundred and ninety consecutively recruited colorectal cancer cases were frequency matched to 890 controls by age (5-year interval) and sex. Dietary information was assessed with a validated food frequency questionnaire by face-to-face interviews. The logistic regression model was used to estimate multivariate odds ratios (ORs) and 95% confidence intervals (CIs). Total choline intake was inversely associated with colorectal cancer risk after adjustment for various lifestyle and dietary factors. The multivariate-adjusted OR was 0.54 (95% CI = 0.37-0.80, Ptrend <0.01) comparing the highest with the lowest quartile. No significant associations were observed for betaine or total choline+betaine intakes. For choline-containing compounds, lower colorectal cancer risk was associated with higher intakes of choline from phosphatidylcholine, glycerophosphocholine and sphingomyelin but not for free choline and phosphocholine. The inverse association of total choline intake with colorectal cancer risk was observed in both men and women, colon and rectal cancer. These inverse associations were not modified by folate intake. Conclusions These results indicate that high intake of total choline is associated with a lower risk of colorectal cancer.	[Lu, Min-Shan; Zhong, Xiao; Chen, Yu-Ming; Zhang, Cai-Xia] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing; Pan, Zhi-Zhong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Mei-Chun] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn; zhangcx3@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University [51000-3181301]; Danone Nutrition Research and Education Foundation [DIC2011-03]	Sun Yat-sen University; Danone Nutrition Research and Education Foundation(Danone Nutricia)	This study was jointly supported by the Sun Yat-sen University Hundred Talents Program (51000-3181301) and Danone Nutrition Research and Education Foundation (No: DIC2011-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho E, 2010, BRIT J CANCER, V102, P489, DOI 10.1038/sj.bjc.6605510; Cho E, 2008, CANCER EPIDEM BIOMAR, V16, P2787; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Jacob RA, 1999, J NUTR, V129, P712, DOI 10.1093/jn/129.3.712; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Kotsopoulos J, 2010, EUR J CLIN NUTR, V64, P111, DOI 10.1038/ejcn.2009.109; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lee JE, 2011, AM J CLIN NUTR, V93, P817, DOI 10.3945/ajcn.110.007781; Lee JE, 2010, CANCER EPIDEM BIOMAR, V19, P884, DOI 10.1158/1055-9965.EPI-09-1295; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Richman EL, 2012, AM J CLIN NUTR, V96, P855, DOI 10.3945/ajcn.112.039784; Wan D, 2001, GUANGDONG MED J, V07, P557; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xu An-gao, 2006, Zhonghua Yi Xue Za Zhi, V86, P272; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Ying J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054561; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P2918; Zeisel SH, 2003, J NUTR, V133, P1302; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686; Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhong X, 2013, EUR J CANCER PREV, V22, P438, DOI 10.1097/CEJ.0b013e32835e88c4	27	21	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118661	10.1371/journal.pone.0118661	http://dx.doi.org/10.1371/journal.pone.0118661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785727	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500043
J	Medina-Trillo, C; Sanchez-Sanchez, F; Aroca-Aguilar, JD; Ferre-Fernandez, JJ; Morales, L; Mendez-Hernandez, CD; Blanco-Kelly, F; Ayuso, C; Garcia-Feijoo, J; Escribano, J				Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Blanco-Kelly, Fiona; Ayuso, Carmen; Garcia-Feijoo, Julian; Escribano, Julio			Hypo-and Hypermorphic FOXC1 Mutations in Dominant Glaucoma: Transactivation and Phenotypic Variability	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; PRIMARY CONGENITAL GLAUCOMA; FORKHEAD/WINGED-HELIX GENE; AXENFELD-RIEGER-SYNDROME; ANTERIOR-CHAMBER; FUNCTIONAL ANALYSES; CYTOCHROME P4501B1; MISSENSE MUTATIONS; SPANISH PATIENTS; CYP1B1	Dominant glaucoma, a heterogeneous, infrequent and irreversible optic neuropathy, is often associated with elevated intraocular pressure and early-onset. The role of FOXC1 in this type of glaucoma was investigated in twelve Spanish probands via nucleotide variation screening of its proximal promoter and unique exon. Functional evaluations of the identified variants included analyses of the transcriptional activity, protein stability, DNA binding ability and subcellular localization. Four different mutations that were identified in four probands (33.3%) were associated with remarkable phenotypic variability and were functionally classified as either hypermorphic (p.Y47X, p.Q106X and p.G447_G448insDG) or hypomorphic (p.I126S) alleles. To the best of our knowledge, three of the variants are novel (p.Y47X, p.I126S and p.G447_G448insDG) and, in addition, hypermorphic FOXC1 mutations are reported herein for the first time. The presence of an intact N-terminal activation domain in the truncated proteins p.Y47X and p.Q106X may underlie their associated transactivation hyperactivity by a gain-of-function mechanism involving dysregulated protein-protein interactions. Similarly, alteredmolecular interactionsmay also lead to increased p.G447_G448insDG activity. In contrast, the partial loss-of-function associated with p.I126S was due to impaired protein stability, DNA binding, protein phosphorylation and subcellular distribution. These results support that moderate and variable FOXC1 transactivation changes are associated with moderate goniodysgenesis, dominant glaucoma and remarkable phenotypic variability.	[Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain; [Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Escribano, Julio] Inst Salud Carlos III, Cooperat Res Network Age Related Ocular Pathol Vi, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Blanco-Kelly, Fiona; Ayuso, Carmen] IIS FJD, Serv Genet, Madrid, Spain; [Blanco-Kelly, Fiona; Ayuso, Carmen] CIBERER, Madrid, Spain	Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain.	julio.escribano@uclm.es	Mendez-Hernandez, Carmen/D-6385-2017; Fernandez, Jesus J Ferre/AAA-3760-2021; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; , francisco/ABF-7718-2021; GARCIA FEIJOO, JULIAN/G-9762-2017	Mendez-Hernandez, Carmen/0000-0003-3413-5248; Fernandez, Jesus J Ferre/0000-0002-9511-2894; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Blanco-Kelly, Fiona/0000-0003-0052-5651; Ayuso, Carmen/0000-0002-9242-7065; GARCIA FEIJOO, JULIAN/0000-0002-7772-5718	Regional Ministry of Health [GCS-2006_C/12]; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" [PAI-05-002, PCI08-0036]; Instituto de Salud Carlos III [RD07/0062/0014, RD12/0034/0003, PI11/00662]	Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha"; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study has been supported by research grants from the Regional Ministry of Health (GCS-2006_C/12), the Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" (PAI-05-002 and PCI08-0036), and the "Instituto de Salud Carlos III" (RD07/0062/0014, RD12/0034/0003 and PI11/00662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Campos-Mollo E, 2009, MOL VIS, V15, P417; Chakrabarti S, 2005, MOL VIS, V11, P111; Chakrabarti S, 2009, INVEST OPHTH VIS SCI, V50, P75, DOI 10.1167/iovs.08-2253; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; JERNDAL T, 1983, AM J HUM GENET, V35, P645; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Komatireddy S, 2003, MOL VIS, V9, P43; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Papadopoulos M., 2013, CHILDHOOD GLAUCOMA, P15, DOI [10.1186/1687-9856-2013-15, DOI 10.1186/1687-9856-2013-15]; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Perry LP, 2012, J AAPOS, V16, P565, DOI 10.1016/j.jaapos.2012.06.012; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Saleem RA, 2004, NUCLEIC ACIDS RES, V32, P4182, DOI 10.1093/nar/gkh742; Saleem RA, 2003, HUM MOL GENET, V12, P2993, DOI 10.1093/hmg/ddg324; Saleem RA, 2003, INVEST OPHTH VIS SCI, V44, P4608, DOI 10.1167/iovs.03-0090; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Simha N, 1989, Bull Soc Ophtalmol Fr, V89, P1149; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Walter MA, 2003, INVEST OPHTH VIS SCI, V44, P1402, DOI 10.1167/iovs.02-0618; Weisschuh N, 2008, CLIN GENET, V74, P476, DOI 10.1111/j.1399-0004.2008.01025.x; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098	52	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119272	10.1371/journal.pone.0119272	http://dx.doi.org/10.1371/journal.pone.0119272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786029	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500094
J	Ye, TQ; Wang, Q; Zhang, Y; Song, XF; Yang, DC; Li, D; Li, D; Su, LN; Yang, YJ; Ma, ST				Ye, Tingqiao; Wang, Qiang; Zhang, Yan; Song, Xiaofeng; Yang, Dachun; Li, De; Li, Dan; Su, Linan; Yang, Yongjian; Ma, Shuangtao			Over-Expression of Calpastatin Inhibits Calpain Activation and Attenuates Post-Infarction Myocardial Remodeling	PLOS ONE			English	Article							HEART-FAILURE; FAILING HEART; ACE-INHIBITOR; INFARCTION; HYPERTROPHY; DYSTROPHIN; FIBROSIS; SYSTEM; TYPE-1; AT(1)	Background Calpain is activated following myocardial infarction and ablation of calpastatin (CAST), an endogenous inhibitor of calpains, promotes left ventricular remodeling after myocardial infarction (MI). The present study aimed to investigate the effect of transgenic overexpression of CAST on the post-infarction myocardial remodeling process. Method We established transgenic mice (TG) ubiquitously over-expressing human CAST protein and produced MI in TG mice and C57BL/6J wild-type (WT) littermates. Results The CAST protein expression was profoundly upregulated in the myocardial tissue of TG mice compared with WT littermates (P < 0.01). Overexpression of CAST significantly reduced the infarct size (P < 0.01) and blunted MI-induced interventricular hypertrophy, global myocardial fibrosis and collagen I and collagen III deposition, hypotension and hemodynamic disturbances at 21 days after MI. Moreover, the MI-induced up-regulation and activation of calpains were obviously attenuated in CAST TG mice. MI-induced down-regulation of CAST was partially reversed in TG mice. Additionally, the MI-caused imbalance of matrix metalloproteinases and their inhibitors was improved in TG mice. Conclusions Transgenic over-expression of CAST inhibits calpain activation and attenuates post-infarction myocardial remodeling.	[Ye, Tingqiao; Wang, Qiang; Zhang, Yan; Song, Xiaofeng; Yang, Dachun; Li, De; Li, Dan; Su, Linan; Yang, Yongjian; Ma, Shuangtao] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China		Yang, YJ (corresponding author), Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	yangyongjian38@yahoo.com; ma.shuangtao@gmail.com	Ma, Shuangtao/L-5543-2016	Ma, Shuangtao/0000-0001-7582-8724; Yang, Yongjian/0000-0003-1268-166X	Natural Science Foundation of China [81070191]; Chengdu Military General Hospital [2011YG-A11]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chengdu Military General Hospital	This work was supported by a grant from the Natural Science Foundation of China (No. 81070191) and a grant from the Chengdu Military General Hospital (No. 2011YG-A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; French Brent A, 2007, Drug Discov Today Dis Mech, V4, P185, DOI 10.1016/j.ddmec.2007.12.006; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Inserte J, 2012, CARDIOVASC RES, V96, P9, DOI 10.1093/cvr/cvs245; Kudo-Sakamoto Y, 2014, J BIOL CHEM, V289, P19408, DOI 10.1074/jbc.M114.567206; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Ma J, 2012, J BIOL CHEM, V287, P27480, DOI 10.1074/jbc.M112.358929; Ma ST, 2014, INT J CARDIOL, V175, P206, DOI 10.1016/j.ijcard.2014.04.256; Ma ST, 2012, EXP THER MED, V4, P545, DOI 10.3892/etm.2012.620; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Wang Q, 2014, AM J HYPERTENS, V27, P1521, DOI 10.1093/ajh/hpu068; Wang YP, 2013, CARDIOVASC RES, V98, P381, DOI 10.1093/cvr/cvt048; Yang DC, 2009, BIOCHEM BIOPH RES CO, V388, P606, DOI 10.1016/j.bbrc.2009.08.073; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7	21	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120178	10.1371/journal.pone.0120178	http://dx.doi.org/10.1371/journal.pone.0120178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786109	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500159
J	Zakirova, Z; Tweed, M; Crynen, G; Reed, J; Abdullah, L; Nissanka, N; Mullan, M; Mullan, MJ; Mathura, V; Crawford, F; Ait-Ghezala, G				Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Reed, Jon; Abdullah, Laila; Nissanka, Nadee; Mullan, Myles; Mullan, Michael J.; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania			Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; CHEMICAL WEAPONS FALLOUT; PYRIDOSTIGMINE BROMIDE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DISTANCE TRANSIT; RAT-BRAIN; STRESS; DYSFUNCTION; VETERANS	Gulf War Illness (GWI) is a chronic multisymptom illness with a central nervous system component such as memory deficits, neurological, and musculoskeletal problems. There are ample data that demonstrate that exposure to Gulf War (GW) agents, such as pyridostigmine bromide (PB) and pesticides such as permethrin (PER), were key contributors to the etiology of GWI post deployment to the Persian GW. In the current study, we examined the consequences of acute (10 days) exposure to PB and PER in C57BL6 mice. Learning and memory tests were performed at 18 days and at 5 months post-exposure. We investigated the relationship between the cognitive phenotype and neuropathological changes at short and long-term time points post-exposure. No cognitive deficits were observed at the short-term time point, and only minor neuropathological changes were detected. However, cognitive deficits emerged at the later time point and were associated with increased astrogliosis and reduction of synaptophysin staining in the hippocampi and cerebral cortices of exposed mice, 5 months post exposure. In summary, our findings in this mouse model of GW agent exposure are consistent with some GWI symptom manifestations, including delayed onset of symptoms and CNS disturbances observed in GWI veterans.	[Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Reed, Jon; Abdullah, Laila; Mullan, Myles; Mullan, Michael J.; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania] Roskamp Inst, Sarasota, FL 34243 USA; [Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Abdullah, Laila; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Zakirova, Zuchra; Tweed, Miles; Reed, Jon; Abdullah, Laila; Crawford, Fiona; Ait-Ghezala, Ghania] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Nissanka, Nadee] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Open University - UK; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; University of Miami	Zakirova, Z (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.	zzakirova@roskampinstitute.net		Crynen, Gogce/0000-0001-6066-9900; Ait-Ghezala, Ghania/0000-0002-9836-8617; Nissanka, Nadee/0000-0002-4639-7192	Congressionally Directed Medical Research Program [GW100076]; VA merit award	Congressionally Directed Medical Research Program(United States Department of Defense); VA merit award(US Department of Veterans Affairs)	This research was funded by a Congressionally Directed Medical Research Program award to Dr. Ait-Ghezala (GW100076), VA merit award to Dr. Fiona Crawford and by the Roskamp Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman A, 2002, NEUROBIOL DIS, V10, P306, DOI 10.1006/nbdi.2002.0524; Abdel-Rahman A, 2004, J TOXICOL ENV HEAL A, V67, P163, DOI 10.1080/15287390490264802; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abou-Donia MB, 2004, PHARMACOL BIOCHEM BE, V77, P253, DOI 10.1016/j.pbb.2003.10.018; Abou-Donia MB, 2001, TOXICOL SCI, V60, P305, DOI 10.1093/toxsci/60.2.305; Amato AA, 1997, JAMA-J AM MED ASSOC, V278, P384, DOI 10.1001/jama.1997.03550050046022; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Axmacher N, 2009, J NEUROSCI, V29, P1052, DOI 10.1523/JNEUROSCI.5277-08.2009; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Brimfield AA, 2012, PROG MOL BIOL TRANSL, V112, P209, DOI 10.1016/B978-0-12-415813-9.00007-6; BROCK TO, 1987, J NEUROSCI, V7, P931; Cardenas H, 2003, BRAIN RES, V985, P89, DOI 10.1016/S0006-8993(03)03172-X; Chaney LA, 2002, INT J TOXICOL, V21, P287, DOI 10.1080/10915810290096450; Dahlgren JG, 2004, J TOXICOL-CLIN TOXIC, V42, P579, DOI 10.1081/CLT-200026979; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Everson MP, 1999, ANN NY ACAD SCI, V876, P413, DOI 10.1111/j.1749-6632.1999.tb07665.x; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fulco CE, 2003, GULF WAR HLTH, V2; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gillette JS, 2003, TOXICOL APPL PHARM, V192, P287, DOI 10.1016/S0041-008X(03)00326-0; Golomb B.A, 2012, NATURE PRECEDINGS; Graves J. C., 2008, GULF WAR ILLNESS HLT; Hailer NP, 2001, EUR J NEUROSCI, V14, P315, DOI 10.1046/j.0953-816x.2001.01649.x; Haley RW, 2013, NEUROEPIDEMIOLOGY, V40, P178, DOI 10.1159/000345124; Haley RW, 1997, AM J EPIDEMIOL, V146, P695; Harrell FE, 2001, REGRESSION MODELING; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; Hilborne LH, 2005, EXAMINING POSSIBLE C; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; Katz MH, 2011, MULTIVARIABLE ANAL P; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Krengel M, 2008, NEUROPSYCHOLOGICAL F; Lallement G, 1998, J PHYSIOLOGY-PARIS, V92, P369, DOI 10.1016/S0928-4257(99)80007-2; Lee LW, 2003, NEUROMOL MED, V4, P179, DOI 10.1385/NMM:4:3:179; Li XF, 2011, RADIOLOGY, V261, P218, DOI 10.1148/radiol.11101715; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Menon PM, 2004, BRAIN RES, V1009, P189, DOI 10.1016/j.brainres.2004.02.063; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Ojo B, 2012, BRAIN BEHAV IMMUN, V26, P778, DOI 10.1016/j.bbi.2011.09.013; Ojo JO, 2013, NEUROPATHOLOGY; Page WF, 2005, MIL MED, V170, P935, DOI 10.7205/MILMED.170.11.935; Parihar VK, 2013, NEUROPSYCHOPHARMACOL; Pirttimaki TM, 2013, NEUROSCIENTIST, V19, P604, DOI 10.1177/1073858413504999; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Rayhan RU, 2013, AM J TRANSL RES, V5, P212; Roy TS, 2005, DEV BRAIN RES, V155, P71, DOI 10.1016/j.devbrainres.2004.12.004; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; Slotkin TA, 2008, BRAIN RES BULL, V75, P640, DOI 10.1016/j.brainresbull.2007.10.008; Slotkin TA, 2006, ENVIRON HEALTH PERSP, V114, P1542, DOI 10.1289/ehp.9337; Speed HE, 2012, TOXICOL SCI, V125, P196, DOI 10.1093/toxsci/kfr253; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sunyer B., 2007, NATURE PROTOCOL EXCH; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tillman GD, 2012, NEUROTOXICOLOGY, V33, P1096, DOI 10.1016/j.neuro.2012.06.001; Tuite JJ, 2013, NEUROEPIDEMIOLOGY, V40, P160, DOI 10.1159/000345123; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Veena J, 2011, J Nat Sci Biol Med, V2, P26, DOI 10.4103/0976-9668.82312; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; von Bohlen und Halbach O, 2013, CELL TISSUE RES, V354, P41, DOI 10.1007/s00441-012-1547-9; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Wille T, 2011, CHEM-BIOL INTERACT, V190, P79, DOI 10.1016/j.cbi.2011.02.022; WILLIAMSON EG, 1989, ECOTOX ENVIRON SAFE, V18, P27, DOI 10.1016/0147-6513(89)90089-4; World Health Organization, 2009, WHO SPEC EV PUBL HLT	78	56	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119579	10.1371/journal.pone.0119579	http://dx.doi.org/10.1371/journal.pone.0119579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785457	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500114
J	Arredondo, A; Aviles, R				Arredondo, Armando; Aviles, Raul			Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems	PLOS ONE			English	Article							LATIN-AMERICA; HYPERTENSION; PREVALENCE; BURDEN	Background The need to integrate economic and epidemiological aspects in the clinical perspective leads to a proposal for the analysis of health disparities and to an evaluation of the health services and of the new challenges which are now being faced by health system reforms in middle income countries. Objective To identify the epidemiological changes, the demand for health services and economic burden from chronic diseases (diabetes and hypertension) in a middle income county. Methods We conducted longitudinal analyses of costs and epidemiological changes for diabetes and hypertension in the Mexican health system. The study population included both the insured and uninsured populations. The cost-evaluation method was used, based on the instrumentation and consensus techniques. To estimate the epidemiological changes and financial consequences for 2014-2016, six models were constructed according to the Box-Jenkins technique, using confidence intervals of 95%, and the Box-Pierce test. Results Regarding epidemiological changes expected in both diseases for 2014 vs. 2016, an increase is expected, although results predict a greater increase for diabetes, 8-12% in all three studied institutions, (p < .05). Indeed, in the case of diabetes, the increase was 41469 cases for uninsured population (SSA) and 65737 for the insured population (IMSS and ISSSTE). On hypertension cases the increase was 38109 for uninsured vs 62895 for insured. Costs in US$ ranged from $699 to $748 for annual case management per patient in the case of diabetes, and from $485 to $622 in patients with hypertension. Comparing financial consequences of health services required by insured and uninsured populations, the greater increase (23%) will be for the insured population (p < .05). The financial requirements of both diseases will amount to 19.5% of the total budget for the uninsured and 12.5% for the insured population. Conclusions If the risk factors and the different health care models remain as they currently are, the economic impact of expected epidemiological changes on the social security system will be particularly strong. Another relevant challenge is the appearance of internal competition in the use and allocation of financial resources with programs for other chronic and infectious diseases.	[Arredondo, Armando; Aviles, Raul] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Arredondo, A (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	armando.arredondo@umontreal.ca						Aboderin I, 2001, M EXP 2 4 MAY 2001, P33; Amos AF, 2010, DIABETES MED 1997 S5, V14, P51, DOI DOI 10.1002/(SICI)1096-9136(199712)14:5+; Arredondo A., 2009, TEMAS SELECTOS SISTE, P101; Arredondo Armando, 2013, Am J Public Health, V103, pe1, DOI 10.2105/AJPH.2012.301106; Arredondo A, 2014, AM J HYPERTENS, V27, P635, DOI 10.1093/ajh/hpu010; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Arredondo A, 2011, VALUE HEALTH, V14, pS85, DOI 10.1016/j.jval.2011.05.022; Banco de Mexico, 2014, IND NAC PREC SERV ME, P57, DOI [10.1016/j.jphotobiol.2014.11.014, DOI 10.1016/J.JPHOTOBIOL.2014.11.014]; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Barquera S, 2013, GLOBAL HLTH GOVERNAN, V9, P1744; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Brealey R., 1993, FUNDAMENTOS FINANCIA, P43, DOI [10.1055/s-0031-1275710, DOI 10.1055/S-0031-1275710]; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Cercone J, 2014, BANCO MUNDIAL IESE, V2, P6; dos Santos JC, 2012, REV ESC ENFERM USP, V46, P1125, DOI 10.1590/S0080-62342012000500013; Elliott WJ, 1996, POSTGRAD MED, V99, P241, DOI 10.1080/00325481.1996.11946111; Frenk J, 1994, DEMANDA OFERTA SERVI, P18; Galvez A, 2007, ESTUDIOS DE SOMBRA, P13; Garcia C, 2001, SALUD PUBLICA MEXICO, V4, P415; Gaziano TA, 2010, INT AM DEV BANK, P54; Glassman A, 2010, HEALTH AFFAIR, V29, P2142, DOI 10.1377/hlthaff.2010.1038; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Instituto Nacional de Salud Publica, 2014, MET EST DEM ESP ENF, P34; Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR 201, P74; International Diabetes Federation, 2010, DECL INT LAW PRINC R, P29; Johnson Samuel, 2013, J Med Econ, V16, P1414, DOI 10.3111/13696998.2013.849713; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray A, 2005, STAT MODELLING GLIM, P112; Peckham R, 2014, J PUBLIC HEALTH-UK, V36, P13, DOI 10.1093/pubmed/fdt083; Quentin T, 2013, WORLD BANK TECHNICAL; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Snowdon A., 2012, MEASURING WHAT MATTE, P12; SSA, 2013, PROGR SECT SAL PLAN; SSA, 2013, REP AN CAS ENG CRON, P1, DOI [10.7334/psicothema2012.167, DOI 10.7334/PSICOTHEMA2012.167]; SSA IMSS ISSSTE, 2014, B INF EST CAS MORB H, P57; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Teixeira JC, 2012, REV PANAM SALUD PUBL, V32, P419, DOI 10.1590/S1020-49892012001400005; Villarreal-Rios E, 2002, SALUD PUBLICA MEXICO, V44, P7, DOI 10.1590/S0036-36342002000100001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2009, GUID ASS SOC EC IMP, P37; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	41	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118611	10.1371/journal.pone.0118611	http://dx.doi.org/10.1371/journal.pone.0118611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781625	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600031
J	Chen, YC; Chang, JG; Jong, YJ; Liu, TY; Yuo, CY				Chen, Yu-Chia; Chang, Jan-Gowth; Jong, Yuh-Jyh; Liu, Ting-Yuan; Yuo, Chung-Yee			High Expression Level of Tra2-beta 1 Is Responsible for Increased SMN2 Exon 7 Inclusion in the Testis of SMA Mice	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON SMN; GENE-PRODUCT; SPLICING ENHANCER; SINGLE NUCLEOTIDE; MESSENGER-RNA; MOUSE MODEL; SURVIVAL; COMPLEX; COMPONENT	Spinal muscular atrophy (SMA) is an inherited neuromuscular disease caused by deletion or mutation of SMN1 gene. All SMA patients carry a nearly identical SMN2 gene, which produces low level of SMN protein due to mRNA exon 7 exclusion. Previously, we found that the testis of SMA mice (smn(-/-) SMN2) expresses high level of SMN2 full-length mRNA, indicating a testis-specific mechanism for SMN2 exon 7 inclusion. To elucidate the underlying mechanism, we established primary cultures of testis cells from SMA mice and analyzed them for SMN2 exon 7 splicing. We found that primary testis cells after a 2-hour culture still expressed high level of SMN2 full-length mRNA, but the level decreased after longer cultures. We then compared the protein levels of relevant splicing factors, and found that the level of Tra2-beta 1 also decreased during testis cell culture, correlated with SMN2 full-length mRNA downregulation. In addition, the testis of SMA mice expressed the highest level of Tra2-beta 1 among the many tissues examined. Furthermore, overexpression of Tra2-beta 1, but not ASF/SF2, increased SMN2 minigene exon 7 inclusion in primary testis cells and spinal cord neurons, whereas knockdown of Tra2-beta 1 decreased SMN2 exon 7 inclusion in primary testis cells of SMA mice. Therefore, our results indicate that high expression level of Tra2-beta 1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice. This study also suggests that the expression level of Tra2-beta 1 may be a modifying factor of SMA disease and a potential target for SMA treatment.	[Chen, Yu-Chia; Jong, Yuh-Jyh; Liu, Ting-Yuan] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ, Sch Med, Taichung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Clin Lab, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yuo, Chung-Yee] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Yuo, CY (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	m815006@kmu.edu.tw			Ministry of Science and Technology, Taiwan, R. O. C. [NSC98-2320-B-037-025-MY3, NSC98-2321-B-037-062-, NSC99-2321-B-037-002-, NSC100-2321-B-039-007-]	Ministry of Science and Technology, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan)	CYY was supported by the Ministry of Science and Technology, Taiwan, R. O. C. (NSC98-2320-B-037-025-MY3). JGC was supported by the Ministry of Science and Technology, Taiwan, R. O. C. (NSC98-2321-B-037-062-), (NSC99-2321-B-037-002-), (NSC100-2321-B-039-007-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Coady TH, 2011, WIRES RNA, V2, P546, DOI 10.1002/wrna.76; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Helmken C, 2000, HUM GENET, V107, P554, DOI 10.1007/s004390000409; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ogino S, 2002, AM J MED GENET, V110, P301, DOI 10.1002/ajmg.10425; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120721	10.1371/journal.pone.0120721	http://dx.doi.org/10.1371/journal.pone.0120721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781985	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600185
J	Liu-Seifert, H; Andersen, SW; Lipkovich, I; Holdridge, KC; Siemers, E				Liu-Seifert, Hong; Andersen, Scott W.; Lipkovich, Ilya; Holdridge, Karen C.; Siemers, Eric			A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer's Disease	PLOS ONE			English	Article							DOUBLE-BLIND; TRIAL; SOLANEZUMAB; PROGRESSION; SAFETY	One method for demonstrating disease modification is a delayed-start design, consisting of a placebo-controlled period followed by a delayed-start period wherein all patients receive active treatment. To address methodological issues in previous delayed-start approaches, we propose a new method that is robust across conditions of drug effect, discontinuation rates, and missing data mechanisms. We propose a modeling approach and test procedure to test the hypothesis of noninferiority, comparing the treatment difference at the end of the delayed-start period with that at the end of the placebo-controlled period. We conducted simulations to identify the optimal noninferiority testing procedure to ensure the method was robust across scenarios and assumptions, and to evaluate the appropriate modeling approach for analyzing the delayed-start period. We then applied this methodology to Phase 3 solanezumab clinical trial data for mild Alzheimer's disease patients. Simulation results showed a testing procedure using a proportional noninferiority margin was robust for detecting disease-modifying effects; conditions of high and moderate discontinuations; and with various missing data mechanisms. Using all data from all randomized patients in a single model over both the placebo-controlled and delayed-start study periods demonstrated good statistical performance. In analysis of solanezumab data using this methodology, the noninferiority criterion was met, indicating the treatment difference at the end of the placebo-controlled studies was preserved at the end of the delayed-start period within a pre-defined margin. The proposed noninferiority method for delayed-start analysis controls Type I error rate well and addresses many challenges posed by previous approaches. Delayed-start studies employing the proposed analysis approach could be used to provide evidence of a disease-modifying effect. This method has been communicated with FDA and has been successfully applied to actual clinical trial data accrued from the Phase 3 clinical trials of solanezumab.	[Liu-Seifert, Hong; Andersen, Scott W.; Lipkovich, Ilya; Holdridge, Karen C.; Siemers, Eric] Eli Lilly & Co, Indianapolis, IN 46285 USA	Eli Lilly	Liu-Seifert, H (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	liu-seifert_hong@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Funding was provided by Eli Lilly and Company. Eli Lilly and Company was the funding source and was involved in all stages of the study conduct and analysis.	American Psychiatric Association, 2000, DIAGN STAT MAN TEXT; [Anonymous], 2010, WORLD ALZHEIMER REPO; Balding DJ, 2004, APPL LONGITUDINAL AN; Bhattaram VA, 2009, AAPS J, V11, P456, DOI 10.1208/s12248-009-9123-2; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Carlson C, 2013, ALZHEIMERS DEMENT SU, V9, P139; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FDA, 2010, GUID IND NON CLIN TR; [FDA Research CfDEa], 2013, GUID IND ALZH DIS DE; Food and Drug Administration. Center for Drug Evaluation and Research (CDER), 2011, PER CENTR NERV SYST; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; Ito K, 2010, ALZHEIMERS DEMENT, V6, P39, DOI 10.1016/j.jalz.2009.05.665; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Katz Russell, 2004, NeuroRx, V1, P307, DOI 10.1007/BF03206615; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Mallinckrodt CH, 2013, PREVENTION TREATMENT; Mallinckrodt CH, 2012, ESSENTIALS CNS DRUG; Mallinckrodt CH, 2008, DRUG INF J, V42, P303, DOI 10.1177/009286150804200402; Mani RB, 2008, ISCTM AUT M TOR CAN; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Molenberghs G., 2007, MISSING DATA CLIN ST; National Research Council, 2010, PREVENTION TREATMENT; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Schwartz TA, 2006, STAT MED, V25, P3396, DOI 10.1002/sim.2651; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Uenaka K, 2012, CLIN NEUROPHARMACOL, V35, P25, DOI 10.1097/WNF.0b013e31823a13d3; Verbeke G, 2000, LINEAR MIXED MODELS; Wilcock GK, 2000, BRIT MED J, V321, P1; Zhang RY, 2011, CLIN TRIALS, V8, P5, DOI 10.1177/1740774510392255	35	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119632	10.1371/journal.pone.0119632	http://dx.doi.org/10.1371/journal.pone.0119632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781335	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600079
J	Kwon, J; Namgoong, S; Kim, NH				Kwon, Jeongwoo; Namgoong, Suk; Kim, Nam-Hyung			CRISPR/Cas9 as Tool for Functional Study of Genes Involved in Preimplantation Embryo Development	PLOS ONE			English	Article							ONE-STEP GENERATION; GENOME; KNOCKOUT; MOUSE; ZEBRAFISH; PIGS; KNOCKDOWN; INJECTION; OOCYTES; CELLS	The CRISPR/Cas9 system has proven to be an efficient gene-editing tool for genome modification of cells and organisms. However, the applicability and efficiency of this system in pig embryos have not been studied in depth. Here, we aimed to remove porcine OCT4 function as a model case using the CRISPR/Cas9 system. Injection of Cas9 and single-guide RNA (sgRNA) against OCT4 decreased the percentages of OCT4-positive embryos to 37-50% of total embryos, while similar to 100% of control embryos exhibited clear OCT4 immunostaining. We assessed the mutation status near the guide sequence using polymerase chain reaction (PCR) and DNA sequencing, and a portion of blastocysts (20% in exon 2 and 50% in exon 5) had insertions/deletions near protospacer-adjacent motifs (PAMs). Different target sites had frequent deletions, but different concentrations of sgRNA made no impact. OCT4 mRNA levels dramatically decreased at the 8-cell stage, and they were barely detectable in blastocysts, while mRNA levels of other genes, including NANOG, and CDX2 were not affected. In addition, the combination of two sgRNAs led to large-scale deletion (about 1.8 kb) in the same chromosome. Next, we injected an enhanced green fluorescent protein (eGFP) vector targeting the OCT4 exon with Cas9 and sgRNA to create a knockin. We confirmed eGFP fluorescence in blastocysts in the inner cell mass, and also checked the mutation status using PCR and DNA sequencing. A significant portion of blastocysts had eGFP sequence insertions near PAM sites. The CRISPR/CAS9 system provides a good tool for gene functional studies by deleting target genes in the pig.	[Kwon, Jeongwoo; Namgoong, Suk; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea	Chungbuk National University	Namgoong, S (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea.	suknamgoong@chungbuk.ac.kr; nhkim@chungbuk.ac.kr			Next Generation Biogreen 21 Program, RDA, Republic of Korea [PJ011126]	Next Generation Biogreen 21 Program, RDA, Republic of Korea	This study was supported by a grant from the Next Generation Biogreen 21 Program (PJ011126), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer TO, 2014, NAT PROTOC, V9, P2823, DOI 10.1038/nprot.2014.187; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.5; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hacking DF, 2008, EARLY HUM DEV, V84, P821, DOI 10.1016/j.earlhumdev.2008.09.011; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Heo Y, 2014, STEM CELLS DEV; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Hyttel P, 2000, BIOL REPROD, V63, P1848, DOI 10.1095/biolreprod63.6.1848; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kanzler B, 2003, MECH DEVELOP, V120, P1423, DOI 10.1016/j.mod.2003.09.008; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kukulski W, 2012, METHOD CELL BIOL, V111, P235, DOI 10.1016/B978-0-12-416026-2.00013-3; Landecker H, 2009, NAT METHODS, V6, P707, DOI 10.1038/nmeth1009-707; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Narbonne P, 2012, CURR OPIN GENET DEV, V22, P450, DOI 10.1016/j.gde.2012.09.002; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Sakurai N, 2013, J REPROD DEVELOP, V59, P353, DOI 10.1262/jrd.2013-003; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zheng Z, 2013, J REPROD DEVELOP, V59, P557, DOI 10.1262/jrd.2013-050; Zhou NR, 2014, ANIM REPROD SCI, V148, P153, DOI 10.1016/j.anireprosci.2014.06.002; Zhou X, 2014, GENERATION CRISPR CA	57	10	11	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120501	10.1371/journal.pone.0120501	http://dx.doi.org/10.1371/journal.pone.0120501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775469	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500182
J	Zhang, C; Nygaard, M; Haxholm, GW; Boutillon, F; Bernadet, M; Hoos, S; England, P; Broutin, I; Kragelund, BB; Goffin, V				Zhang, Chi; Nygaard, Mads; Haxholm, Gitte W.; Boutillon, Florence; Bernadet, Marie; Hoos, Sylviane; England, Patrick; Broutin, Isabelle; Kragelund, Birthe B.; Goffin, Vincent			A Residue Quartet in the Extracellular Domain of the Prolactin Receptor Selectively Controls Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Cell Surface Receptor; Cytokine; Extracellular Signal-regulated Kinase (ERK); Nuclear Magnetic Resonance (NMR); STAT Transcription Factor	GROWTH-HORMONE; CYTOKINE RECEPTORS; BREAST-CANCER; WSXWS MOTIF; DIMERIZATION; AFFINITY; PATHWAY; ERYTHROPOIETIN; IDENTIFICATION; VARIANTS	Cytokine receptors elicit several signaling pathways, but it is poorly understood how they select and discriminate between them. We have scrutinized the prolactin receptor as an archetype model of homodimeric cytokine receptors to address the role of the extracellular membrane proximal domain in signal transfer and pathway selection. Structure-guided manipulation of residues involved in the receptor dimerization interface identified one residue (position 170) that in cell-based assays profoundly altered pathway selectivity and species-specific bio-characteristics. Subsequent in vitro spectroscopic and nuclear magnetic resonance analyses revealed that this residue was part of a residue quartet responsible for specific local structural changes underlying these effects. This included alteration of a novel aromatic T-stack within the membrane proximal domain, which promoted selective signaling affecting primarily the MAPK (ERK1/2) pathway. Importantly, activation of the MAPK pathway correlated with in vitro stabilities of ternary ligandreceptor complexes, suggesting a threshold mean lifetime of the complex necessary to achieve maximal activation. No such dependence was observed for STAT5 signaling. Thus, this study establishes a residue quartet in the extracellular membrane proximal domain of homodimeric cytokine receptors as a key regulator of intracellular signaling discrimination.	[Zhang, Chi; Boutillon, Florence; Bernadet, Marie; Goffin, Vincent] INSERM, U1151, Inst Necker Enfants Malad, Equipe Physiopathol Hormones PRL GH, F-75993 Paris 14, France; [Zhang, Chi; Boutillon, Florence; Bernadet, Marie; Broutin, Isabelle; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Nygaard, Mads; Haxholm, Gitte W.; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark; [Hoos, Sylviane; England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, Plateforme Biophys Macromol & Ieurs Interact, F-75015 Paris, France; [Broutin, Isabelle] CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75006 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Goffin, V (corresponding author), INSERM, U1151, INEM, Equipe PRL GH Pathophysiol Translat Approache,Fac, Batiment Leriche Porte 9, F-75993 Paris 14, France.	vincent.goffin@inserm.fr	Broutin, Isabelle/A-2003-2017; GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; Nygaard, Mads Morup/0000-0003-1642-4724; ENGLAND, Patrick/0000-0001-6410-5918	Danish Cancer Society; Danish Research Councils for Health and Disease [09-072179, 12-125862]; Novo Nordic Foundation; Ligue Contre le Cancer Grant [RS11/75-26]; University Paris Descartes Grant [990 UMRS 845/2011/02]; Agence Nationale de la Recherche [ANR-07-PCVI-0029]; Ministere de l'Education Nationale de la Recherche et de la Technologie; Fondation ARC	Danish Cancer Society(Danish Cancer Society); Danish Research Councils for Health and Disease; Novo Nordic Foundation(Novo Nordisk Foundation); Ligue Contre le Cancer Grant; University Paris Descartes Grant; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Education Nationale de la Recherche et de la Technologie; Fondation ARC	This work was supported by the Danish Cancer Society grants (to B. B. K.), Danish Research Councils for Health and Disease Grants 09-072179 and 12-125862 (to B. B. K.), the Novo Nordic Foundation (to B. B. K.), Ligue Contre le Cancer Grant RS11/75-26 (to I. B.), University Paris Descartes Grant 990 UMRS 845/2011/02 (to V. G. and I. B.), and the Agence Nationale de la Recherche Grant ANR-07-PCVI-0029 (to V. G.).; Recipient of fellowships from the Ministere de l'Education Nationale de la Recherche et de la Technologie and from the Fondation ARC.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2003, ENDOCRINE, V20, P177, DOI 10.1385/ENDO:20:1-2:177; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Broutin I, 2010, J BIOL CHEM, V285, P8422, DOI 10.1074/jbc.M109.089128; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Courtillot C, 2010, J CLIN ENDOCR METAB, V95, P271, DOI 10.1210/jc.2009-1494; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gertler A, 2002, MOL GENET METAB, V75, P189, DOI 10.1006/mgme.2002.3303; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 2010, METHOD ENZYMOL, V484, P329, DOI [10.1016/S0076-6879(10)84017-0, 10.1016/B978-0-12-381298-8.00017-4]; Hansen MJK, 2011, J MOL RECOGNIT, V24, P533, DOI 10.1002/jmr.1064; Helman D, 2001, J ENDOCRINOL, V169, P43, DOI 10.1677/joe.0.1690043; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; KARNITZ LM, 1995, CURR OPIN IMMUNOL, V7, P320, DOI 10.1016/0952-7915(95)80105-7; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; LEBRUN JJ, 1995, P NATL ACAD SCI USA, V92, P4031, DOI 10.1073/pnas.92.9.4031; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Li W, 2013, MOL CELL ENDOCRINOL, V376, P51, DOI 10.1016/j.mce.2013.06.008; Li Y, 2005, J MOL ENDOCRINOL, V35, P411, DOI 10.1677/jme.1.01798; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; Millot GA, 2004, CELL SIGNAL, V16, P355, DOI 10.1016/j.cellsig.2003.08.010; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Olsen JG, 2014, CYTOKINE GROWTH F R, V25, P337, DOI 10.1016/j.cytogfr.2014.04.007; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tallet Estelle, 2011, Front Endocrinol (Lausanne), V2, P29, DOI 10.3389/fendo.2011.00029; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; van Agthoven J, 2010, J MOL BIOL, V404, P112, DOI 10.1016/j.jmb.2010.09.036; Wan Y, 2004, J BIOL CHEM, V279, P44775, DOI 10.1074/jbc.M406092200; Yang N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3467; Zhang C, 2015, MOL CELL ENDOCRINOL, V401, P173, DOI 10.1016/j.mce.2014.12.006	45	3	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11890	11904		10.1074/jbc.M115.639096	http://dx.doi.org/10.1074/jbc.M115.639096			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25784554	Green Published, hybrid			2022-12-26	WOS:000354388600008
J	Romagnuolo, R; Scipione, CA; Boffa, MB; Marcovina, SM; Seidah, NG; Koschinsky, ML				Romagnuolo, Rocco; Scipione, Corey A.; Boffa, Michael B.; Marcovina, Santica M.; Seidah, Nabil G.; Koschinsky, Marlys L.			Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-BINDING SITES; EVOLOCUMAB AMG 145; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; HUMAN APOLIPOPROTEIN(A); PLASMINOGEN ACTIVATION; REDUCES LIPOPROTEIN(A); CARDIOVASCULAR RISK; LP(A) LIPOPROTEIN	Elevated levels of lipoprotein(a) (Lp(a)) have been identified as an independent risk factor for coronary heart disease. Plasma Lp(a) levels are reduced by monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). However, the mechanism of Lp(a) catabolism in vivo and the role of PCSK9 in this process are unknown. We report that Lp(a) internalization by hepatic HepG2 cells and primary human fibroblasts was effectively reduced by PCSK9. Overexpression of the low density lipoprotein (LDL) receptor (LDLR) in HepG2 cells dramatically increased the internalization of Lp(a). Internalization of Lp(a) was markedly reduced following treatment of HepG2 cells with a function-blocking monoclonal antibody against the LDLR or the use of primary human fibroblasts from an individual with familial hypercholesterolemia; in both cases, Lp(a) internalization was not affected by PCSK9. Optimal Lp(a) internalization in both hepatic and primary human fibroblasts was dependent on the LDL rather than the apolipoprotein(a) component of Lp(a). Lp(a) internalization was also dependent on clathrin-coated pits, and Lp(a) was targeted for lysosomal and not proteasomal degradation. Our data provide strong evidence that the LDLR plays a role in Lp(a) catabolism and that this process can be modulated by PCSK9. These results provide a direct mechanism underlying the therapeutic potential of PCSK9 in effectively lowering Lp(a) levels.	[Romagnuolo, Rocco; Scipione, Corey A.; Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Marcovina, Santica M.] Univ Washington, Northwest Lipid Metab & Diabet Res Labs, Seattle, WA 98109 USA; [Seidah, Nabil G.] Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Windsor; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Koschinsky, ML (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	mlk@uwindsor.ca	Seidah, Nabil/I-3596-2013; Boffa, Michael/N-6539-2019; Scipione, Corey A/AAH-2200-2019	Seidah, Nabil/0000-0001-6503-9342; Boffa, Michael/0000-0003-1211-3064; Scipione, Corey A/0000-0002-0052-8038; Koschinsky, Marlys/0000-0002-2643-2288	Canadian Institutes of Health Research [126076, 102741]; Heart and Stroke Foundation of Canada [G-13-0003091]; Canada Foundation for Innovation/Ontario Ministry of Research and Innovation; Canada Research Chair Program [216684]; Leducq Foundation [13 CVD 03]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation/Ontario Ministry of Research and Innovation; Canada Research Chair Program(Canada Research Chairs); Leducq Foundation(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grants 126076 (to M. L. K. and M. B. B.) and 102741 (to N. G. S.), Heart and Stroke Foundation of Canada Grant G-13-0003091 (to M. L. K.), the Canada Foundation for Innovation/Ontario Ministry of Research and Innovation (to M. L. K. and M. B. B.), Canada Research Chair Program Grant 216684 (to N. G. S.), and Leducq Foundation Grant 13 CVD 03 (to N. G. S.). S. M. M. and M. L. K. are members of an advisory board to Sanofi SA.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bea AM, 2014, CLIN INVEST ARTERIOS, V26, P176, DOI 10.1016/j.arteri.2014.01.001; Becker L, 2004, J BIOL CHEM, V279, P2679, DOI 10.1074/jbc.M309414200; Becker L, 2003, J BIOL CHEM, V278, P14074, DOI 10.1074/jbc.M212855200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0360-6; Cain WJ, 2005, J LIPID RES, V46, P2681, DOI 10.1194/jlr.M500249-JLR200; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ERNST A, 1995, J BIOL CHEM, V270, P6227, DOI 10.1074/jbc.270.11.6227; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FLOREN CH, 1981, BIOCHEM BIOPH RES CO, V102, P636, DOI 10.1016/S0006-291X(81)80179-9; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GABEL BR, 1995, BIOCHEMISTRY-US, V34, P15777, DOI 10.1021/bi00048a023; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gaudet D, 2014, AM J CARDIOL, V114, P711, DOI 10.1016/j.amjcard.2014.05.060; GHISELLI G, 1992, METABOLISM, V41, P833, DOI 10.1016/0026-0495(92)90163-5; Gonbert S, 2002, ATHEROSCLEROSIS, V164, P305, DOI 10.1016/S0021-9150(02)00072-2; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HAVEKES L, 1981, FEBS LETT, V132, P169, DOI 10.1016/0014-5793(81)81153-2; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HOFMANN SL, 1990, J CLIN INVEST, V85, P1542, DOI 10.1172/JCI114602; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kraft HG, 2000, ARTERIOSCL THROM VAS, V20, P522, DOI 10.1161/01.ATV.20.2.522; KREMPLER F, 1983, J CLIN INVEST, V71, P1431, DOI 10.1172/JCI110896; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; MARZ W, 1993, FEBS LETT, V325, P271, DOI 10.1016/0014-5793(93)81087-G; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1995, THROMB HAEMOSTASIS, V73, P458; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nguyen AT, 2006, J LIPID RES, V47, P1399, DOI 10.1194/jlr.M600130-JLR200; Niemeier A, 1999, ARTERIOSCL THROM VAS, V19, P552, DOI 10.1161/01.ATV.19.3.552; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; RADER DJ, 1994, J CLIN INVEST, V93, P2758, DOI 10.1172/JCI117292; RADER DJ, 1995, J CLIN INVEST, V95, P1403, DOI 10.1172/JCI117794; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Romagnuolo R, 2014, J LIPID RES, V55, P625, DOI 10.1194/jlr.M036566; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SOUTAR AK, 1991, J CLIN INVEST, V88, P483, DOI 10.1172/JCI115329; Stein EA, 2014, EUR HEART J, V35, P2249, DOI 10.1093/eurheartj/ehu085; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Tam SP, 1996, J LIPID RES, V37, P518; Theuerle J. D., 2009, THESIS QUEENS U KING; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Tziomalos K, 2009, CURR OPIN CARDIOL, V24, P351, DOI 10.1097/HCO.0b013e32832ac21a; van Wissen S, 2003, HEART, V89, P893, DOI 10.1136/heart.89.8.893; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Yang XP, 2013, J LIPID RES, V54, P2450, DOI 10.1194/jlr.M038877; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	65	142	156	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11649	11662		10.1074/jbc.M114.611988	http://dx.doi.org/10.1074/jbc.M114.611988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25778403	Green Published, hybrid			2022-12-26	WOS:000353719400039
J	Silva, KAS; Dong, JL; Dong, YJ; Dong, YL; Schor, N; Tweardy, DJ; Zhang, LP; Mitch, WE				Santos Silva, Kleiton Augusto; Dong, Jiangling; Dong, Yanjun; Dong, Yanlan; Schor, Nestor; Tweardy, David J.; Zhang, Liping; Mitch, William E.			Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; PROTEIN-DEGRADATION; TRANSCRIPTION FACTORS; CATABOLIC CONDITIONS; MYOSTATIN GENE; UP-REGULATION; KAPPA-B; PATHWAY; EXPRESSION; ATROPHY	Cachexia occurs in patients with advanced cancers. Despite the adverse clinical impact of cancer-induced muscle wasting, pathways causing cachexia are controversial, and clinically reliable therapies are not available. A trigger of muscle protein loss is the Jak/Stat pathway, and indeed, we found that conditioned medium from C26 colon carcinoma (C26) or Lewis lung carcinoma cells activates Stat3 (p-Stat3) in C2C12 myotubes. We identified two proteolytic pathways that are activated in muscle by p-Stat3; one is activation of caspase-3, and the other is p-Stat3 to myostatin, MAFbx/Atrogin-1, and MuRF-1 via CAAT/enhancer-binding protein delta (C/EBP delta). Using sequential deletions of the caspase-3 promoter and CHIP assays, we determined that Stat3 activation increases caspase-3 expression in C2C12 cells. Caspase-3 expression and proteolytic activity were stimulated by p-Stat3 in muscles of tumor-bearing mice. In mice with cachexia caused by Lewis lung carcinoma or C26 tumors, knock-out of p-Stat3 in muscle or with a small chemical inhibitor of p-Stat3 suppressed muscle mass losses, improved protein synthesis and degradation in muscle, and increased body weight and grip strength. Activation of p-Stat3 stimulates a pathway from C/EBP delta to myostatin and expression of MAFbx/Atrogin-1 and increases the ubiquitin-proteasome system. Indeed, C/EBP delta KO decreases the expression of MAFbx/Atrogin-1 and myostatin, while increasing muscle mass and grip strength. In conclusion, cancer stimulates p-Stat3 in muscle, activating protein loss by stimulating caspase-3, myostatin, and the ubiquitin-proteasome system. These results could lead to novel strategies for preventing cancer-induced muscle wasting.	[Santos Silva, Kleiton Augusto; Dong, Jiangling; Dong, Yanjun; Dong, Yanlan; Zhang, Liping; Mitch, William E.] Baylor Coll Med, Div Nephrol, Dept Med, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Med, Sect Infect Dis, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Santos Silva, Kleiton Augusto; Schor, Nestor] Univ Fed Sao Paulo, Dept Med, Div Nephrol, BR-04023900 Sao Paulo, Brazil; [Dong, Jiangling] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China; [Dong, Yanjun] Capital Med Univ, An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidade Federal de Sao Paulo (UNIFESP); Sichuan University; Capital Medical University	Zhang, LP (corresponding author), Baylor Coll Med, Div Nephrol, Dept Med, One Baylor Plaza,M-S BCM 395,ABBR R705, Houston, TX 77030 USA.	lipingz@bcm.edu	Tweardy, David/L-3929-2019; dong, jiangling/GYJ-4337-2022	Silva, Kleiton/0000-0001-8230-0012; Dong, Yanjun/0000-0001-6396-8949; Dong, Jiangling/0000-0001-9742-2469	Satellite Health; American Diabetic Association [1-11-BS-194]; Diabetes Research Center at Baylor College of Medicine [P30-DK079638]; National Institutes of Health [R37 DK37175, P50 CA058183, P50 CA097007, R21 CA149783]; Cancer Prevention and Research Institute of Texas [RP100421]; Alkek Foundation; Dan L. Duncan Cancer Center; Sao Paulo Research Foundation [FAPESP 2012/03142-8]; NATIONAL CANCER INSTITUTE [R21CA149783, P50CA097007, P50CA058183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK037175, R37DK037175] Funding Source: NIH RePORTER	Satellite Health; American Diabetic Association(American Diabetes Association); Diabetes Research Center at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Alkek Foundation; Dan L. Duncan Cancer Center; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by the generous support of Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health, American Diabetic Association (1-11-BS-194), and the Pilot/Feasibility award of the Diabetes Research Center (P30-DK079638) at Baylor College of Medicine (to L. Z.). This work was also supported by National Institutes of Health Grants R37 DK37175 (to W. E. M.) and P50 CA058183, P50 CA097007, and R21 CA149783, Cancer Prevention and Research Institute of Texas Grant RP100421, and Grants from the Alkek Foundation and the Dan L. Duncan Cancer Center (to D. T.), and by a fellowship from the Sao Paulo Research Foundation (FAPESP 2012/03142-8) (to K. A. S. S.).	Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; ALVESTRAND A, 1983, CLIN NEPHROL, V19, P67; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; CLARK AS, 1983, BIOCHEM J, V212, P649, DOI 10.1042/bj2120649; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FUJIMOTOOUCHI K, 1995, INT J CANCER, V61, P522, DOI 10.1002/ijc.2910610416; Gilabert M, 2014, J CELL PHYSIOL, V229, P1437, DOI 10.1002/jcp.24580; Glass DJ, 2007, J CLIN INVEST, V117, P2388, DOI 10.1172/JCI33379; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MORRISON SD, 1976, PHYSIOL BEHAV, V17, P705, DOI 10.1016/0031-9384(76)90173-6; Puppa MJ, 2014, FASEB J, V28, P998, DOI 10.1096/fj.13-240580; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Staiger J, 2009, CARCINOGENESIS, V30, P832, DOI 10.1093/carcin/bgn273; Thomas S. S., 2013, KIDNEY INT; Tisdale M J, 1998, Curr Opin Clin Nutr Metab Care, V1, P253, DOI 10.1097/00075197-199805000-00003; Tisdale MJ, 2010, CELL, V142, P511, DOI 10.1016/j.cell.2010.08.004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Watchorn TM, 2005, INT J ONCOL, V27, P1105; Weil WM, 2007, BULL HOSP JT DIS, V65, P72; White J, 2012, ITE J, V82, P14; Workeneh BT, 2006, J AM SOC NEPHROL, V17, P3233, DOI 10.1681/ASN.2006020131; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	50	131	139	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11177	11187		10.1074/jbc.M115.641514	http://dx.doi.org/10.1074/jbc.M115.641514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25787076	hybrid, Green Published			2022-12-26	WOS:000353404500050
J	Ang, LF; Por, LY; Yam, MF				Ang, Lee Fung; Por, Lip Yee; Yam, Mun Fei			Development of an Amperometric-Based Glucose Biosensor to Measure the Glucose Content of Fruit	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; IMMOBILIZATION; ELECTRODE; OXIDASE; CHITIN; FILMS; FLOW	An amperometric enzyme-electrode was introduced where glucose oxidase (GOD) was immobilized on chitosan membrane via crosslinking, and then fastened on a platinum working electrode. The immobilized enzyme showed relatively high retention activity. The activity of the immobilized enzyme was influenced by its loading, being suppressed when more than 0.6 mg enzyme was used in the immobilization. The biosensor showing the highest response to glucose utilized 0.21 ml/cm(2) thick chitosan membrane. The optimum experimental conditions for the biosensors in analysing glucose dissolved in 0.1 M phosphate buffer (pH 6.0) were found to be 35 degrees C and 0.6 V applied potential. The introduced biosensor reached a steady-state current at 60 s. The apparent Michaelis-Menten constant (K-M(app)) of the biosensor was 14.2350 mM, and its detection limit was 0.05 mM at s/n > 3, determined experimentally. The RSD of repeatability and reproducibility of the biosensor were 2.30% and 3.70%, respectively. The biosensor was showed good stability; it retained similar to 36% of initial activity after two months of investigation. The performance of the biosensors was evaluated by determining the glucose content in fruit homogenates. Their accuracy was compared to that of a commercial glucose assay kit. There was no significance different between two methods, indicating the introduced biosensor is reliable.	[Ang, Lee Fung; Yam, Mun Fei] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia; [Por, Lip Yee] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia	Universiti Sains Malaysia; Universiti Malaya	Yam, MF (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia.	yammunfei@yahoo.com	POR, LIP YEE/B-5309-2010	POR, LIP YEE/0000-0001-5865-1533	Malaysia Toray Science Foundation (MTSF) [304, PFARMASI 650295, T102]; High Impact Research Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/FCSIT/15]	Malaysia Toray Science Foundation (MTSF); High Impact Research Grant from the University of Malaya	This project was supported by research grant from the Malaysia Toray Science Foundation (MTSF) (Grant No. 304, PFARMASI 650295, T102) and High Impact Research Grant (UM.C/625/1/HIR/MOHE/FCSIT/15) from the University of Malaya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean LS, 2005, THIN SOLID FILMS, V477, P104, DOI 10.1016/j.tsf.2004.08.156; BRIGHT HJ, 1969, J BIOL CHEM, V244, P3625; Chen C, 2006, BIOSENS BIOELECTRON, V22, P639, DOI 10.1016/j.bios.2006.01.023; Gamburzev S, 1996, SENSOR ACTUAT B-CHEM, V30, P179, DOI 10.1016/0925-4005(96)80046-3; Hsieh BC, 2003, MAR BIOTECHNOL, V5, P119, DOI 10.1007/s10126-002-0094-x; Hu SS, 1999, ANAL SCI, V15, P585, DOI 10.2116/analsci.15.585; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Li J, 1996, ANAL CHIM ACTA, V335, P137, DOI 10.1016/S0003-2670(96)00337-6; Lim SH, 2005, BIOSENS BIOELECTRON, V20, P2341, DOI 10.1016/j.bios.2004.08.005; Lin JH, 2007, ANAL BIOCHEM, V360, P288, DOI 10.1016/j.ab.2006.10.030; Magalhaes JMCS, 1998, TALANTA, V47, P183, DOI 10.1016/S0039-9140(98)00066-6; Mishima Y, 2000, SENSOR ACTUAT B-CHEM, V65, P343, DOI 10.1016/S0925-4005(99)00471-2; Muzzarelli R.A, 1983, CARBOHYD POLYM, V3, P53, DOI 10.1016/0144-8617(83)90012-7; Muzzarelli RAA., 1973, NATURAL CHELATING PO; Sakuragawa A, 1998, ANAL CHIM ACTA, V374, P191, DOI 10.1016/S0003-2670(98)00469-3; SHU FR, 1976, ANAL CHEM, V48, P1679, DOI 10.1021/ac50006a014; Singhal R, 2002, SENSOR ACTUAT B-CHEM, V86, P42, DOI 10.1016/S0925-4005(02)00145-4; Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1081/AL-100103209; Wang G, 2003, BIOSENS BIOELECTRON, V18, P335, DOI 10.1016/S0956-5663(02)00152-5; Wang G, 2002, BIOELECTROCHEMISTRY, V57, P33, DOI 10.1016/S1567-5394(01)00174-8; Wang HS, 2005, SENSORS-BASEL, V5, P266, DOI 10.3390/s5040266; Ward WK, 2002, BIOSENS BIOELECTRON, V17, P181, DOI 10.1016/S0956-5663(01)00268-8; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Xu JJ, 2000, ANAL CHIM ACTA, V423, P101, DOI 10.1016/S0003-2670(00)01098-9; Xue HG, 2003, SYNTHETIC MET, V135, P831, DOI 10.1016/S0379-6779(02)00919-0; Yang YH, 2004, ANAL CHIM ACTA, V525, P213, DOI 10.1016/j.aca.2004.07.071; Yang YM, 2004, ENZYME MICROB TECH, V34, P126, DOI 10.1016/j.enzmictec.2003.09.007; Yusof NA, 2002, SENSOR ACTUAT B-CHEM, V86, P127, DOI 10.1016/S0925-4005(02)00157-0; Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3; Zhou GJ, 2002, SENSOR ACTUAT B-CHEM, V81, P334, DOI 10.1016/S0925-4005(01)00978-9	31	48	48	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0111859	10.1371/journal.pone.0111859	http://dx.doi.org/10.1371/journal.pone.0111859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789757	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400002
J	Paech, D; Burth, S; Windschuh, J; Meissner, JE; Zaiss, M; Eidel, O; Kickingereder, P; Nowosielski, M; Wiestler, B; Sahm, F; Floca, RO; Neumann, JO; Wick, W; Heiland, S; Bendszus, M; Schlemmer, HP; Ladd, ME; Bachert, P; Radbruch, A				Paech, Daniel; Burth, Sina; Windschuh, Johannes; Meissner, Jan-Eric; Zaiss, Moritz; Eidel, Oliver; Kickingereder, Philipp; Nowosielski, Martha; Wiestler, Benedikt; Sahm, Felix; Floca, Ralf Omar; Neumann, Jan-Oliver; Wick, Wolfgang; Heiland, Sabine; Bendszus, Martin; Schlemmer, Heinz-Peter; Ladd, Mark Edward; Bachert, Peter; Radbruch, Alexander			Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology	PLOS ONE			English	Article							EXCHANGE SATURATION-TRANSFER; TUMORS IN-VIVO; HUMAN BRAIN; MAGNETIZATION-TRANSFER; PERITUMORAL EDEMA; TRANSFER CEST; WEIGHTED MRI; GLIOMA; PH; SPECTROSCOPY	Objective To explore the correlation between Nuclear Overhauser Enhancement (NOE)-mediated signals and tumor cellularity in glioblastoma utilizing the apparent diffusion coefficient (ADC) and cell density from histologic specimens. NOE is one type of chemical exchange saturation transfer (CEST) that originates from mobile macromolecules such as proteins and might be associated with tumor cellularity via altered protein synthesis in proliferating cells. Patients and Methods For 15 patients with newly diagnosed glioblastoma, NOE-mediated CEST-contrast was acquired at 7 Tesla (asymmetric magnetization transfer ratio (MTRasym) at 3.3ppm, B1 = 0.7 mu T). Contrast enhanced T1 (CE-T1), T2 and diffusion-weighted MRI (DWI) were acquired at 3 Tesla and coregistered. The T2 edema and the CE-T1 tumor were segmented. ADC and MTRasym values within both regions of interest were correlated voxelwise yielding the correlation coefficient r(Spearman) (r(Sp)). In three patients who underwent stereotactic biopsy, cell density of 12 specimens per patient was correlated with corresponding MTRasym and ADC values of the biopsy site. Results Eight of 15 patients showed a weak or moderate positive correlation of MTRasym and ADC within the T2 edema (0.16 <= r(Sp)<= 0.53, p< 0.05). Seven correlations were statistically insignificant (p>0.05, n = 4) or yielded r(Sp)approximate to 0 (p< 0.05, n = 3). No trend towards a correlation between MTRasym and ADC was found in CE-T1 tumor (-0.31<r(Sp)<0.28,p< 0.05, n = 9; p>0.05, n = 6). The biopsy-analysis within CE-T1 tumor revealed a strong positive correlation between tumor cellularity and MTRasym values in two of the three patients (r(Sp)(patient3) = 0.69 and r(S)(patient15) = 0.87, p<0.05), while the correlation of ADC and cellularity was heterogeneous (r(Sp)(patient3) = 0.545 (p = 0.067), r(Sp)(patient4) = -0.021 (p = 0.948), r(Sp)(patient15) = -0.755 (p = 0.005)). Discussion NOE-imaging is a new contrast promising insight into pathophysiologic processes in glioblastoma regarding cell density and protein content, setting itself apart from DWI. Future studies might be based on the assumption that NOE-mediated CEST visualizes cellularity more accurately than ADC, especially in the CE-T1 tumor region.	[Paech, Daniel; Burth, Sina; Eidel, Oliver; Kickingereder, Philipp; Heiland, Sabine; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany; [Paech, Daniel; Burth, Sina; Meissner, Jan-Eric; Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Neurooncol Imaging, Heidelberg, Germany; [Windschuh, Johannes; Meissner, Jan-Eric; Zaiss, Moritz; Ladd, Mark Edward; Bachert, Peter] Deutsch Krebsforschungszentrum DKFZ, Dept Med Phys Radiol, Heidelberg, Germany; [Nowosielski, Martha] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Germany; [Sahm, Felix] Heidelberg Univ, Dept Neuropathol, Med Ctr, Heidelberg, Germany; [Floca, Ralf Omar; Schlemmer, Heinz-Peter] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany; [Neumann, Jan-Oliver] Heidelberg Univ, Dept Neurosurg, Med Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Radbruch, A (corresponding author), Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021; Sahm, Felix/GQY-8202-2022; Nowosielski, Martha/AAD-5442-2022; Vollmuth, Philipp/AAK-3267-2021	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Paech, Daniel/0000-0001-5755-6833; Zaiss, Moritz/0000-0001-9780-3616; Ladd, Mark/0000-0002-4128-9440; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Radbruch, Alexander/0000-0001-6238-6525; Wiestler, Benedikt/0000-0002-2963-7772	"Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ)	"Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ)	This study was supported by a grant from the "Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AUT NUCL COUNT PLUG; Bentaib A, 2015, J PROTEOMICS, V113, P292, DOI 10.1016/j.jprot.2014.09.019; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Cramer W, 1916, J PHYSIOL-LONDON, V50, P322; Crawford FW, 2009, J NEURO-ONCOL, V91, P337, DOI 10.1007/s11060-008-9719-x; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Floca R, 2010, IFMBE PROC, V25, P1105; Gerweck LE, 1996, CANCER RES, V56, P1194; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; Hattingen E, 2011, NEURO-ONCOLOGY, V13, P1349, DOI 10.1093/neuonc/nor132; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Iwadate Y, 2004, CANCER RES, P64; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Jones CK, 2013, NEUROIMAGE, V77, P114, DOI 10.1016/j.neuroimage.2013.03.047; Kalkanis SN, 2014, J NEURO-ONCOL, V116, P477, DOI 10.1007/s11060-013-1326-9; KALLINOWSKI F, 1988, BRIT J CANCER, V58, P314, DOI 10.1038/bjc.1988.210; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Lu S, 2003, AM J NEURORADIOL, V24, P937; Morita KI, 2005, J NEUROSURG, V102, P336, DOI 10.3171/jns.2005.102.2.0336; Murakami R, 2007, RADIOLOGY, V243, P493, DOI 10.1148/radiol.2432060450; Nolden M, 2013, INT J COMPUT ASS RAD, V8, P607, DOI 10.1007/s11548-013-0840-8; OBERHAENSLI RD, 1986, LANCET, V2, P8, DOI 10.1016/S0140-6736(86)92558-4; Paech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104181; Pope WB, 2012, J NEURO-ONCOL, V108, P491, DOI 10.1007/s11060-012-0847-y; Radbruch A, 2013, EUR J RADIOL, V82, P552, DOI 10.1016/j.ejrad.2012.11.002; Saraswathy S, 2009, J NEURO-ONCOL, V91, P69, DOI 10.1007/s11060-008-9685-3; Schmitt B, 2011, RADIOLOGY, V260, P257, DOI 10.1148/radiol.11101841; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sun PZ, 2008, MAGN RESON MED, V59, P1175, DOI 10.1002/mrm.21591; Sun PZ, 2007, MAGN RESON MED, V57, P405, DOI 10.1002/mrm.21151; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; VAUPEL P, 1989, CANCER RES, V49, P6449; Vinogradov E, 2013, J MAGN RESON, V229, P155, DOI 10.1016/j.jmr.2012.11.024; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang SL, 2012, J COMPUT ASSIST TOMO, V36, P739, DOI 10.1097/RCT.0b013e3182685436; Wu RH, 2012, CONTRAST MEDIA MOL I, V7, P384, DOI 10.1002/cmmi.505; Xu J, 2014, NMR BIOMED; Zaiss M, 2014, NMR BIOMED, V27, P240, DOI 10.1002/nbm.3054; Zaiss M, 2013, PHYS MED BIOL, V58, pR221, DOI 10.1088/0031-9155/58/22/R221; Zaiss M, 2013, NMR BIOMED, V26, P1815, DOI 10.1002/nbm.3021; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	58	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121220	10.1371/journal.pone.0121220	http://dx.doi.org/10.1371/journal.pone.0121220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789657	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400192
J	Babinsky, VN; Hannan, FM; Youhanna, SC; Marechal, C; Jadoul, M; Devuyst, O; Thakker, RV				Babinsky, Valerie N.; Hannan, Fadil M.; Youhanna, Sonia C.; Marechal, Celine; Jadoul, Michel; Devuyst, Olivier; Thakker, Rajesh V.			Association Studies of Calcium-Sensing Receptor (CaSR) Polymorphisms with Serum Concentrations of Glucose and Phosphate, and Vascular Calcification in Renal Transplant Recipients	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR 23; EXTRACELLULAR CALCIUM; CARDIOVASCULAR EVENTS; ASYMPTOMATIC SUBJECTS; PARATHYROID-HORMONE; RISK-FACTORS; PROGRESSION; PHOSPHORUS; CELLS	Background Cardiovascular disease is the major cause of death in renal transplant recipients (RTRs) and linked to arterial calcification. The calcium-sensing receptor (CaSR), a G-protein coupled receptor, plays a pivotal role in extracellular calcium homeostasis and is expressed in the intimal and medial layers of the arterial wall. We investigated whether common CASR gene variants are predictors for aortic and coronary artery calcification or influence risk factors such as serum calcium, phosphate and glucose concentrations in RTRs. Methods Two hundred and eighty four RTRs were investigated for associations between three CASR promoter region single nucleotide polymorphisms (SNPs) (rs115759455, rs7652589, rs1501899), three non-synonymous CASR coding region SNPs (A986S, R990G, Q1011E), and aortic and coronary artery calcium mass scores, cardiovascular outcomes and calcification risk factors that included serum phosphate, calcium, total cholesterol and glucose concentrations. Results Multivariate analysis revealed that RTRs homozygous for the minor allele (SS) of the A986S SNP, when compared to those homozygous for the major allele (AA), had raised serum glucose concentrations (8.7 +/- 5.4 vs. 5.7 +/- 2.1 mmol/L, P<0.05). In addition, RTRs who were heterozygous (CT) at the rs115759455 SNP, when compared to those homozygous for the major allele (CC), had higher serum phosphate concentrations (1.1 +/- 0.3 vs. 1.0 +/- 0.2 mmol/ L, P<0.05). CASR SNPs were not significant determinants for aortic or coronary artery calcification, and were not associated with cardiovascular outcomes or mortality in this RTR cohort. Conclusions Common CASR SNPs may be independent predictors of serum glucose and phosphate concentrations, but are not determinants of vascular calcification or cardiovascular outcomes.	[Babinsky, Valerie N.; Hannan, Fadil M.; Thakker, Rajesh V.] Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England; [Youhanna, Sonia C.; Devuyst, Olivier] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Physiol, Zurich, Switzerland; [Marechal, Celine; Jadoul, Michel; Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, Clin Univ St Luc, B-1200 Brussels, Belgium	University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Thakker, RV (corresponding author), Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk		Devuyst, Olivier/0000-0003-3744-4767; Thakker, Rajesh/0000-0002-1438-3220; youhanna, sonia/0000-0002-9376-8478; Hannan, Fadil/0000-0002-2975-5170	United Kingdom Medical Research Council (MRC) [G1000467]; European Commission [FP7-264663, FP7-305608]; FNRS; FRSM; NCCR Kidney; Gebert Ruf Stiftung [GRS-038/12]; MRC [MR/K006312/1, G1000467] Funding Source: UKRI; Medical Research Council [G1000467, MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10091] Funding Source: researchfish	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); NCCR Kidney; Gebert Ruf Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the United Kingdom Medical Research Council (MRC) programme grant - G1000467 (to FMH and RVT); the European Commission Seventh Framework Programme (FP7-264663 (to VNB) and FP7-305608 (EURenOmics) (to OD)); the FNRS and FRSM, the NCCR Kidney. CH program (Swiss National Science Foundation), and the Gebert Ruf Stiftung (Project GRS-038/12) (to OD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2009, CARDIOVASC RES, V81, P260, DOI 10.1093/cvr/cvn279; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Cifuentes M, 2008, MOL CELL BIOCHEM, V319, P17, DOI 10.1007/s11010-008-9872-8; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gauderman W, 2006, QUANTO 1 2 A COMPUTE; Gray E, 2006, J ENDOCRINOL, V190, P703, DOI 10.1677/joe.1.06891; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Kim KJ, 2013, HEART, V99, P1113, DOI 10.1136/heartjnl-2013-303631; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Marz W, 2007, J CLIN ENDOCR METAB, V92, P2363, DOI 10.1210/jc.2006-0071; Malecki R, 2013, J PHYSIOL PHARMACOL, V64, P521; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; Marechal C, 2011, CLIN J AM SOC NEPHRO, V6, P974, DOI 10.2215/CJN.06150710; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; Nguyen PTH, 2007, AM J NEPHROL, V27, P329, DOI 10.1159/000102978; Nguyen PTH, 2010, NEPHROL DIAL TRANSPL, V25, P3773, DOI 10.1093/ndt/gfq268; O'Donnell CJ, 2002, CIRCULATION, V106, P337, DOI 10.1161/01.CIR.0000022663.26468.5B; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Parkash J, 2011, LIFE SCI, V88, P440, DOI 10.1016/j.lfs.2010.12.022; Quinn SJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE310, DOI 10.1152/ajpendo.00460.2012; Rampersaud E, 2008, AM J EPIDEMIOL, V168, P1016, DOI 10.1093/aje/kwn211; Ranjzad F, 2011, J ASSIST REPROD GEN, V28, P225, DOI 10.1007/s10815-010-9506-4; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Scillitani A, 2004, J CLIN ENDOCR METAB, V89, P5634, DOI 10.1210/jc.2004-0129; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Squires PE, 2000, DIABETES, V49, P409, DOI 10.2337/diabetes.49.3.409; Vezzoli G, 2011, EUR J ENDOCRINOL, V164, P421, DOI 10.1530/EJE-10-0915; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Yano S, 2000, NEPHRON, V85, P317, DOI 10.1159/000045681; Yoshikawa K, 2013, CLIN EXP NEPHROL, V17, P882, DOI 10.1007/s10157-013-0785-9; Zhang Y, 2006, AM J HUM GENET, V79, P313, DOI 10.1086/506276; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119459	10.1371/journal.pone.0119459	http://dx.doi.org/10.1371/journal.pone.0119459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786244	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000352138500105
J	Chen, XS; Cao, CS; Deng, ZM; Xie, YH; Li, F; Hou, ZY; Li, X				Chen, Xinsheng; Cao, Chenshu; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu			Assessment of Regeneration Potential in the Clonal Macrophyte Miscanthus sacchariflorus (Poaceae) after Burial Disturbance Based on Bud Bank Size and Sprouting Capacity	PLOS ONE			English	Article							VEGETATIVE REPRODUCTION; MERISTEM LIMITATION; GROWTH; SHOOT; WATER; CLASSIFICATION; PROPAGATION; RECRUITMENT; DEMOGRAPHY; TENUIS	The demography of the bud bank and its sprouting capacity are important for understanding the population dynamics of clonal plants and their potential responses to disturbances. To this end, we investigated the size and composition of the bud bank of Miscanthus sacchariflorus (Maxim.) Hack. immediately after flooding (November), in winter (January), in spring (March), and before flooding (May) in the wetlands of Dongting Lake. We then examined the sprouting capacity of axillary buds after sediment burial at 0, 5, 10, 15, and 20 cm. Total bud density of M. sacchariflorus ranged from 2524 buds m(-2) in November to 4293 buds m(-2) in March. Rhizome segments with inactive axillary buds, which represented the majority of the bud population (88.7% in November, 93.3% in May), did not sprout during the 140 days of the experiment (n = 250). The sprouting ratio was the highest for active axillary buds buried at 0 cm (64%) and decreased when buried at 10-20 cm (34%-40%). Due to the large number of active axillary buds in the bud bank (211-277 buds m(-2) from November to the following March), M. sacchariflorus could completely replace its aboveground shoot population, except in May (142 buds m(-2)). Increasing burial depth delayed bud emergence and reduced the growth period of shoots; however, burial depth did not affect the resulting plant height and only reduced the accumulated biomass at 20 cm. Therefore, the belowground bud bank and its strong sprouting capacity are important factors in the maintenance of local populations and colonization of new habitats for M. sacchariflorus after burial disturbances. The present methodology, which combined measurements of bud bank demography and sprouting capacity, may reflect the regeneration potential of clonal plants after burial disturbances.	[Chen, Xinsheng; Cao, Chenshu; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Chen, Xinsheng; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu] Chinese Acad Sci, Inst Subtrop Agr, Dongting Lake Stn Wetland Ecosyst Res, Yueyang, Hunan, Peoples R China; [Cao, Chenshu] Shangqiu Polytech, Dept Garden & Food Proc, Shangqiu, Henan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Xie, YH (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	yonghongxie@163.com	LI, feng/HIR-1703-2022	, Xinsheng/0000-0002-3720-247X	Basic Work Program of the Ministry of Science and Technology of China [2013FY111800]; National Natural Science Foundation of China [31000143]; Hunan Provincial Natural Science Foundation of China [14JJ2137]	Basic Work Program of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This research is supported by the Basic Work Program of the Ministry of Science and Technology of China (2013FY111800) to YHX, the National Natural Science Foundation of China (31000143) to XSC, and the Hunan Provincial Natural Science Foundation of China (14JJ2137) to XSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CJ, 2009, BIOMASS BIOENERG, V33, P752, DOI 10.1016/j.biombioe.2009.01.005; Becker GF, 1997, J ARID ENVIRON, V35, P233, DOI 10.1006/jare.1995.0130; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Benson EJ, 2004, AM J BOT, V91, P416, DOI 10.3732/ajb.91.3.416; Benson EJ, 2006, PLANT ECOL, V187, P163, DOI 10.1007/s11258-005-0975-y; Bonser SP, 1996, OIKOS, V77, P347, DOI 10.2307/3546076; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Chen S, 2006, FLORA CHINA, V12, P165; Chen X, 2009, ANN BOT-LONDON, V104, P1057, DOI 10.1093/aob/mcp198; Chen XS, 2015, AQUAT BOT, V122, P9, DOI 10.1016/j.aquabot.2014.12.006; Chen XS, 2014, NORD J BOT, V32, P251, DOI 10.1111/j.1756-1051.2013.00094.x; Chen XS, 2014, AQUAT ECOL, V48, P409, DOI 10.1007/s10452-014-9493-0; Chen XS, 2014, PAK J BOT, V46, P881; Dalgleish HJ, 2006, NEW PHYTOL, V171, P81, DOI 10.1111/j.1469-8137.2006.01739.x; Decruyenaere JG, 2001, WEED SCI, V49, P760, DOI 10.1614/0043-1745(2001)049[0760:SOCPIG]2.0.CO;2; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; Deng ZM, 2013, AQUAT BOT, V104, P121, DOI 10.1016/j.aquabot.2012.08.004; Deng ZF, 2008, ESTUAR COAST SHELF S, V76, P818, DOI 10.1016/j.ecss.2007.08.008; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023942; Gao J F, 2001, ACTA GEOGRAPHICA SIN, V56, P269; Harper J. L, 1977, POPULATION BIOL PLAN; [黄菊梅 Huang Jumei], 2013, [气象科学, Journal of the Meteorological Sciences], V33, P457; [黄群 Huang Qun], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P922; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KLIMES L, 1993, VEGETATIO, V109, P153, DOI 10.1007/BF00044747; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Klimesova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088093; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Li XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084657; Manzur ME, 2009, ANN BOT-LONDON, V104, P1163, DOI 10.1093/aob/mcp203; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; MCKONE MJ, 1993, OIKOS, V67, P184, DOI 10.2307/3545109; Nishihiro J, 2004, AQUAT BOT, V79, P333, DOI 10.1016/j.aquabot.2004.05.005; Ott JP, 2012, PLANT ECOL, V213, P1437, DOI 10.1007/s11258-012-0102-9; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; TUOMI J, 1994, ECOLOGY, V75, P1429, DOI 10.2307/1937466; Vesk PA, 2004, OIKOS, V106, P200, DOI 10.1111/j.0030-1299.2004.13204.x; Weber E, 2011, BIOL INVASIONS, V13, P2947, DOI 10.1007/s10530-011-9977-y; Xie YongHong, 2008, Research of Agricultural Modernization, V29, P684; ZASADA JC, 1994, CAN J FOREST RES, V24, P272, DOI 10.1139/x94-039; Zhang JT, 2009, BOTANY, V87, P1242, DOI 10.1139/B09-080	41	7	8	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120846	10.1371/journal.pone.0120846	http://dx.doi.org/10.1371/journal.pone.0120846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785628	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500195
J	Wang, SQ; Tu, J; Wang, L; Lu, ZH				Wang, Shengqin; Tu, Jing; Wang, Lei; Lu, Zuhong			Entropy-Based Model for MiRNA Isoform Analysis	PLOS ONE			English	Article							MICRORNAS; ISOMIRS; SEQUENCE; IDENTIFICATION; REPERTOIRE; BIOGENESIS; COMPLEXITY; GENERATION; ENRICHMENT; DISCOVERY	MiRNAs have been widely studied due to their important post-transcriptional regulatory roles in gene expression. Many reports have demonstrated the evidence of miRNA isoform products (isomiRs) in high-throughput small RNA sequencing data. However, the biological function involved in these molecules is still not well investigated. Here, we developed a Shannon entropy-based model to estimate isomiR expression profiles of high-throughput small RNA sequencing data extracted from miRBase webserver. By using the Kolmogorov-Smirnov statistical test (KS test), we demonstrated that the 5p and 3p miRNAs present more variants than the single arm miRNAs. We also found that the isomiR variant, except the 3' isomiR variant, is strongly correlated with Minimum Free Energy (MFE) of pre-miRNA, suggesting the intrinsic feature of pre-miRNA should be one of the important factors for the miRNA regulation. The functional enrichment analysis showed that the miRNAs with high variation, particularly the 5' end variation, are enriched in a set of critical functions, supporting these molecules should not be randomly produced. Our results provide a probabilistic framework for miRNA isoforms analysis, and give functional insights into pre-miRNA processing.	[Wang, Shengqin; Tu, Jing; Wang, Lei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Wang, Shengqin] Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Water Environm & Marine Bio, Wenzhou 325035, Peoples R China; [Lu, Zuhong] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100781, Peoples R China	Southeast University - China; Wenzhou University; Peking University	Lu, ZH (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	zhlu@seu.edu.cn		Tu, Jing/0000-0002-1310-5915; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [61227803]; National Basic Research Program of China [2012CB316501]; Natural Science Foundation of Jiangsu Province of China [BK2012331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (61227803), the National Basic Research Program of China (project 2012CB316501), and the Natural Science Foundation of Jiangsu Province of China (BK2012331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Chang HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S18; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo L, 2014, GENE, V533, P149, DOI 10.1016/j.gene.2013.09.102; Guo L, 2013, GENE, V527, P624, DOI 10.1016/j.gene.2013.06.083; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Hinton A, 2014, STEM CELLS; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Langenberger D, 2012, BIOINFORMATICS, V28, P17, DOI 10.1093/bioinformatics/btr598; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tan GC, 2014, NUCL ACIDS RES; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Wang SQ, 2014, ARCHAEA, V2014, DOI 10.1155/2014/671059; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118856	10.1371/journal.pone.0118856	http://dx.doi.org/10.1371/journal.pone.0118856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785816	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500052
J	Ye, T; Zhen, JH; Du, Y; Zhou, JK; Peng, A; Vaziri, ND; Mohan, C; Xu, Y; Zhou, XJ				Ye, Ting; Zhen, Junhui; Du, Yong; Zhou, Jason K.; Peng, Ai; Vaziri, Nosratola D.; Mohan, Chandra; Xu, Yan; Zhou, Xin J.			Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate Restores Nrf2 Activity and Ameliorates Crescentic Glomerulonephritis	PLOS ONE			English	Article							ROSIGLITAZONE; PATHWAY; LUPUS; INFLAMMATION; AUTOANTIGEN; EXPRESSION; PROTECTION; INDUCTION; DISEASE; STRESS	Crescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG, 50 mg/kg BW/day x3weeks), a potent antiinflammatory and anti-oxidant agent, on experimental crescentic GN induced in 129/svJ mice by administration of rabbit anti-mouse glomerular basement membrane sera. Routine histology and key molecules involved in inflammatory and redox signaling were studied. EGCG treatment significantly reduced mortality, decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. The improvements in renal function and histology were accompanied by the restoration of Nrf2 signaling (which was impaired in vehicle-treated mice) as shown by increased nuclear translocation of Nrf2 and cytoplasmic glutamate cysteine ligase catalytic subunit, glutamate cysteine ligase modifier subunit, and glutathione peroxidase. EGCG-treated mice also showed reduction in p-Akt, p-JNK, p-ERK1/2 and p-P38 as well as restoration of PPAR. and SIRT1 levels. Lower dose of EGCG (25 mg/kg BW/day x2 weeks) treatment also significantly decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. Thus, our data illustrate the efficacy of EGCG in reversing the progression of crescentic GN in mice by targeting multiple signaling and inflammatory pathways as well as countering oxidative stress.	[Ye, Ting] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Hubei, Peoples R China; [Ye, Ting; Zhen, Junhui; Zhou, Xin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Zhen, Junhui] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Du, Yong; Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Du, Yong; Zhou, Jason K.; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Div Rheumatol, Dallas, TX 75390 USA; [Peng, Ai] Tongji Univ, Sch Med, Ctr Nephrol & Clin Metabol, Dept Nephrol & Rheumatol,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Vaziri, Nosratola D.] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA USA; [Xu, Yan] Qingdao Univ, Affiliated Hosp, Dept Nephrol, Qingdao 266071, Shandong, Peoples R China; [Zhou, Xin J.] Pathologist BioMed Labs, Renal Path Diagnost, Lewisville, TX USA; [Zhou, Xin J.] Baylor Univ, Med Ctr, Dept Pathol, Dallas, TX USA	Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shandong University; University of Houston System; University of Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tongji University; University of California System; University of California Irvine; Qingdao University; Baylor University; Baylor University Medical Center	Mohan, C (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	cmohan@central.uh.edu; xuyan67@126.com; jzhou@pbmlabs.com	Mohan, Chandra/GPX-8233-2022; DU, YONG/B-9964-2011; ye, ting/HGC-5924-2022	DU, YONG/0000-0003-1687-9024	NIH [R21 AT004436]; Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported in part by grants from NIH (R21 AT004436) and by funds from the Drs. George and Anne Race Distinguished Professorship in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Copple IM, 2010, HDB EXP PHARM, V196, P233, DOI DOI 10.1007/978-3-642-00663-0_; Goodin MG, 2002, TOXICOL SCI, V69, P354, DOI 10.1093/toxsci/69.2.354; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kincaid-Smith P, 2008, NEPHROLOGY, V13, P58, DOI 10.1111/j.1440-1797.2007.00903.x; Lu H, 2010, AM J PHYSIOL-RENAL, V299, pF445, DOI 10.1152/ajprenal.00583.2009; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Miyazaki Y, 2007, KIDNEY INT, V72, P1367, DOI 10.1038/sj.ki.5002516; Moroni G, 2014, AUTOIMMUN REV, V13, P723, DOI 10.1016/j.autrev.2014.02.007; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peng A, 2011, KIDNEY INT, V80, P601, DOI 10.1038/ki.2011.121; REHAN A, 1984, LAB INVEST, V51, P396; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Turner JE, 2011, KIDNEY INT, V80, P563, DOI 10.1038/ki.2011.173; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Wu TF, 2014, ARTHRITIS RHEUMATOL, V66, P3129, DOI 10.1002/art.38782; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14; Zhou XJ, 2000, LAB INVEST, V80, P1905, DOI 10.1038/labinvest.3780200; Zhou XJ, 2009, SILVAS DIAGNOSTIC RE, P178; Zinellu A, 2005, ANAL BIOCHEM, V342, P186, DOI 10.1016/j.ab.2005.01.045	41	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119543	10.1371/journal.pone.0119543	http://dx.doi.org/10.1371/journal.pone.0119543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785827	gold, Green Published			2022-12-26	WOS:000352138500109
J	Bush, PC; Mainen, ZF				Bush, Paul C.; Mainen, Zachary F.			Columnar Architecture Improves Noise Robustness in a Model Cortical Network	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION COLUMNS; MICRO-ORGANIZATION; SPATIAL-FREQUENCY; SYNAPTIC STRENGTH; SINGLE NEURONS; LAYER 4; CAT; INHIBITION; CONNECTIVITY	Cortical columnar architecture was discovered decades ago yet there is no agreed upon explanation for its function. Indeed, some have suggested that it has no function, it is simply an epiphenomenon of developmental processes. To investigate this problem we have constructed a computer model of one square millimeter of layer 2/3 of the primary visual cortex (V1) of the cat. Model cells are connected according to data from recent paired cell studies, in particular the connection probability between pyramidal cells is inversely proportional both to the distance separating the cells and to the distance between the preferred parameters (features) of the cells. We find that these constraints, together with a columnar architecture, produce more tightly clustered populations of cells when compared to the random architecture seen in, for example, rodents. This causes the columnar network to converge more quickly and accurately on the pattern representing a particular stimulus in the presence of noise, suggesting that columnar connectivity functions to improve pattern recognition in cortical circuits. The model also suggests that synaptic failure, a phenomenon exhibited by weak synapses, may conserve metabolic resources by reducing transmitter release at these connections that do not contribute to network function.	[Bush, Paul C.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud	Bush, PC (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	paul.bush@neuro.fchampalimaud.org		Mainen, Zachary/0000-0001-7913-9109	Champalimaud Foundation	Champalimaud Foundation	This study was supported by the Champalimaud Foundation, http://www.fchampalimaud.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Almeida LEF, 2009, J NEUROSCI, V29, P12702, DOI 10.1523/JNEUROSCI.1166-09.2009; Bernacchia A, 2013, NEURAL COMPUT, V25, P1732, DOI 10.1162/NECO_a_00451; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2007, J NEUROSCI, V27, P12242, DOI 10.1523/JNEUROSCI.3753-07.2007; Boucsein C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00032; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Cano-Colino M, 2014, CEREB CORTEX, V24, P2449, DOI 10.1093/cercor/bht096; Carandini M, 1997, J NEUROSCI, V17, P8621; da Costa NM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00016; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gupta N, 2011, CURR BIOL, V21, pR504, DOI 10.1016/j.cub.2011.05.044; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Knoblauch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096485; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koch C, 1989, METHODS IN NEURONAL; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Martin KAC, 2013, J NEUROSCI, V33, P7325, DOI 10.1523/JNEUROSCI.4071-12.2013; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nauhaus I, 2012, NAT NEUROSCI, V15, P1683, DOI 10.1038/nn.3255; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; ORBAN GA, 1990, P NATL ACAD SCI USA, V87, P1134, DOI 10.1073/pnas.87.3.1134; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Palm G, 2013, NEURAL NETWORKS, V37, P163, DOI 10.1016/j.neunet.2012.08.013; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Poggio T., 2012, NATURE PRECEDINGS; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Rolls E.T., 2008, MEMORY ATTENTION DEC; Rumelhart D.E., 1988, PARALLEL DISTRIBUTED, V1, DOI [10.1016/B978-1-4832-1446-7.50010-8, DOI 10.1016/B978-1-4832-1446-7.50010-8]; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; Sippy T, 2013, J NEUROSCI, V33, P9813, DOI 10.1523/JNEUROSCI.4579-12.2013; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Womelsdorf T, 2012, P NATL ACAD SCI USA, V109, P4302, DOI 10.1073/pnas.1114223109; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	70	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119072	10.1371/journal.pone.0119072	http://dx.doi.org/10.1371/journal.pone.0119072			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781314	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600049
J	Ebina, H; Kanemura, Y; Misawa, N; Sakuma, T; Kobayashi, T; Yamamoto, T; Koyanagi, Y				Ebina, Hirotaka; Kanemura, Yuka; Misawa, Naoko; Sakuma, Tetsushi; Kobayashi, Tomoko; Yamamoto, Takashi; Koyanagi, Yoshio			A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector	PLOS ONE			English	Article							CD4(+) T-CELLS; REAL-TIME PCR; BINDING SPECIFICITY; GENE CORRECTION; CCR5; NUCLEASES; EFFICIENCY; INFECTION; STEM	DNA-editing technology has made it possible to rewrite genetic information in living cells. Human immunodeficiency virus (HIV) provirus, an integrated form of viral complementary DNA in host chromosomes, could be a potential target for this technology. We recently reported that HIV proviral DNA could be excised from the chromosomal DNA of HIV-based lentiviral DNA-transduced T cells after multiple introductions of a clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 endonuclease system targeting HIV long terminal repeats (LTR). Here, we generated a more efficient strategy that enables the excision of HIV proviral DNA using customized transcription activator-like effector nucleases (TALENs) targeting the same HIV LTR site. A single transfection of TALEN-encoding mRNA, prepared from in vitro transcription, resulted in more than 80% of lentiviral vector DNA being successfully removed from the T cell lines. Furthermore, we developed a lentiviral vector system that takes advantage of the efficient proviral excision with TALENs and permits the simple selection of gene-transduced and excised cells in T cell lines.	[Ebina, Hirotaka; Kanemura, Yuka; Misawa, Naoko; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Sakyo Ku, Kyoto 6068507, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 7398526, Japan; [Kobayashi, Tomoko] Tokyo Univ Agr, Fac Agr, Dept Anim Sci, Hlth Anim Lab, Atsugi, Kanagawa 2430034, Japan	Kyoto University; Hiroshima University; Tokyo University of Agriculture	Ebina, H (corresponding author), Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068507, Japan.	hebina@virus.kyoto-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Japan Society for the Promotion of Science [B24790438, B24390112, S22220007, 26670168]; Ministry of Education, Culture, Sports, Science and Technology [24115008]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26670168] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists B24790438, Grant-in-Aid for Scientific Research B24390112, Grant-in-Aid for Scientific Research S22220007, Grant-in-Aid for Challenging Exploratory Research 26670168); the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Innovative Areas 24115008); and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ebina H, 2012, VIROLOGY, V427, P44, DOI 10.1016/j.virol.2012.02.004; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Godbey WT, 2008, BIOTECHNOL BIOENG, V100, P765, DOI 10.1002/bit.21811; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kawano Y, 1997, J VIROL, V71, P8456, DOI 10.1128/JVI.71.11.8456-8466.1997; Kawano Y, 2004, J VIROL, V78, P11352, DOI 10.1128/JVI.78.20.11352-11359.2004; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; MIYOSHI I, 1982, GANN MONOGR CANC RES, P219; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pelascini LPL, 2013, HUM GENE THER METHOD, V24, P399, DOI 10.1089/hgtb.2013.107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shinoda Y, 2009, VIRUS GENES, V39, P165, DOI 10.1007/s11262-009-0382-x; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamamoto SP, 2011, MICROBES INFECT, V13, P339, DOI 10.1016/j.micinf.2010.12.002	46	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120047	10.1371/journal.pone.0120047	http://dx.doi.org/10.1371/journal.pone.0120047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781496	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600120
J	Lee, CH; Jin, MU; Jung, HM; Lee, JT; Kwon, TG				Lee, Chang-Hwan; Jin, Myoung Uk; Jung, Hong-Moon; Lee, Jung-Tae; Kwon, Tae-Geon			Effect of Dual Treatment with SDF-1 and BMP-2 on Ectopic and Orthotopic Bone Formation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST PROGENITOR CELLS; MARROW STROMAL CELLS; MORPHOGENETIC PROTEIN-2; FACTOR-I; GROWTH-FACTOR; REGENERATION; DIFFERENTIATION; RECRUITMENT; MIGRATION	Purposes The potent stem cell homing factor stromal cell-derived factor-1 (SDF-1) actively recruits mesenchymal stem cells from circulation and from local bone marrow. It is well established that bone morphogenetic protein-2 (BMP-2) induces ectopic and orthotopic bone formation. However, the exact synergistic effects of BMP-2 and SDF-1 in ectopic and orthotopic bone regeneration models have not been fully investigated. The purpose of this study was to evaluate the potential effects of simultaneous SDF-1 and BMP-2 treatment on bone formation. Materials and Methods Various doses of SDF-1 were loaded onto collagen sponges with or without BMP-2. These sponges were implanted into subcutaneous pockets and critical-size calvarial defects in C57BL/6 mice. The specimens were harvested 4 weeks post-surgery and the degree of bone formation in specimens was evaluated by histomorphometric and radiographic density analyses. Osteogenic potential and migration capacity of mesenchymal cells and capillary tube formation of endothelial cells following dual treatment with SDF-1 and BMP-2 were evaluated with in vitro assays. Results SDF-1-only-treated implants did not yield significant in vivo bone formation and SDF-1 treatment did not enhance BMP-2-induced ectopic and orthotopic bone regeneration. In vitro experiments showed that concomitant use of BMP-2 and SDF-1 had no additive effect on osteoblastic differentiation, cell migration or angiogenesis compared to BMP-2 or SDF-1 treatment alone. Conclusions These findings imply that sequence-controlled application of SDF-1 and BMP-2 must be further investigated for the enhancement of robust osteogenesis in bone defects.	[Lee, Chang-Hwan; Jung, Hong-Moon; Lee, Jung-Tae; Kwon, Tae-Geon] Kyungpook Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Daegu, South Korea; [Jin, Myoung Uk] Kyungpook Natl Univ, Sch Dent, Dept Conservat Dent, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Kwon, TG (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Daegu, South Korea.	kwondk@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012-0009330]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2012-0009330).	Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Epstein Nancy E, 2013, Surg Neurol Int, V4, pS106, DOI 10.4103/2152-7806.109452; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Higashino K, 2011, TISSUE ENG PT A, V17, P523, DOI 10.1089/ten.tea.2010.0168; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Jagodzinski M, 2013, ADV BIOCHEM ENG BIOT, V130, P69, DOI 10.1007/10_2012_145; Jin QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097035; Kaewsrichan J, 2011, ARCH ORAL BIOL, V56, P90, DOI 10.1016/j.archoralbio.2010.09.003; Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kucia M, 2004, J MOL HISTOL, V35, P233; Liu YS, 2014, BIOMATERIALS, V35, P4489, DOI 10.1016/j.biomaterials.2014.02.025; Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Mori T, 2004, MOL CANCER THER, V3, P29; Noordzij M, 2011, NEPHRON CLIN PRACT, V118, pC319, DOI 10.1159/000322830; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Raida M, 2006, INT J MOL MED, V18, P735; Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.tea.2011.0380, 10.1089/ten.TEA.2011.0380]; Trubiani O, 2008, J CELL PHYSIOL, V214, P706, DOI 10.1002/jcp.21266; Walker David H, 2002, Neurosurg Focus, V13, pe3; Wise JK, 2012, TISSUE ENG PT A, V18, P861, DOI [10.1089/ten.tea.2011.0187, 10.1089/ten.TEA.2011.0187]; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zwingenberger S, 2014, TISSUE ENG PT A, V20, P810, DOI 10.1089/ten.TEA.2013.0222	37	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120051	10.1371/journal.pone.0120051	http://dx.doi.org/10.1371/journal.pone.0120051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781922	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600122
J	Liu, M; Gao, J; Yin, FQ; Gong, GS; Qin, C; Ye, KH; Zhang, M; Sun, XF; Zhou, Y; Zhang, YJ				Liu, Ming; Gao, Jian; Yin, Fuqiang; Gong, Guoshu; Qin, Cheng; Ye, Kunhao; Zhang, Min; Sun, Xiaofang; Zhou, You; Zhang, Youju			Transcriptome Analysis of Maize Leaf Systemic Symptom Infected by Bipolaris zeicola	PLOS ONE			English	Article							COCHLIOBOLUS-CARBONUM; GENE-EXPRESSION; ARABIDOPSIS; CORN; RESISTANCE; POPULATIONS; LEAVES; TEMPERATURE; COMPLEXITY; DIVERSITY	Bipolaris zeicola is a fungal pathogen that causes Northern corn leaf spot (NCLS), which is a serious foliar disease in maize and one of the most significant pathogens affecting global food security. Here, we report a genome-wide transcriptional profile analysis using next-generation sequencing (NGS) of maize leaf development after inoculation with B. zeicola. We performed High-Throughput Digital Gene Expression analysis to identify differentially expressed genes (DEGs) in resistant inbred Mo17 lines after infection with B. zeicola at four successive disease development stages-CP (contact period), PP (penetration period), IP (incubation period), and DP (disease period); the expression of the genes was compared with those in a CK (mock-treatment) control. In addition, a sensitive maize line (Zheng58) was used for the comparisons with the Mo17. Among all tested genes, 466 differentially expressed genes were identified in all libraries, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of these genes suggested that they are involved in many biological processes related to systemic symptom development, such as plant hormone signal transduction, starch and sucrose metabolism, phenylpropanoid biosynthesis and photosynthesis. Our systematic analysis provides comprehensive transcriptomic information regarding systemic symptom development in fungal-infected plants. This information will help in furthering our understanding of the detailed mechanisms of plant responses to fungal infection.	[Liu, Ming; Gao, Jian; Yin, Fuqiang; Gong, Guoshu; Ye, Kunhao; Zhang, Min; Sun, Xiaofang; Zhou, You; Zhang, Youju] Sichuan Agr Univ, Coll Agr Sci, Chengdu, Peoples R China; [Liu, Ming; Yin, Fuqiang] Xichang Coll, Sch Agr Sci, Xichang, Peoples R China; [Qin, Cheng] Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China; [Qin, Cheng] Sichuan Agr Univ, Maize Res Inst, Wenjiang, Sichuan, Peoples R China	Sichuan Agricultural University; Xichang College; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Gong, GS (corresponding author), Sichuan Agr Univ, Coll Agr Sci, Chengdu, Peoples R China.	guoshugong@126.com		Qin, Cheng/0000-0002-8519-4697; gao, jian/0000-0001-7636-911X	Sichuan Innovational Team of Industry Technology System of Modern Agriculture	Sichuan Innovational Team of Industry Technology System of Modern Agriculture	Support was provided by the Sichuan Innovational Team of Industry Technology System of Modern Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Blake JA, 2008, CURRENT PROTOCOLS IN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broglie KE, 2008, WO Patent, Patent No. [2,008,157,432, 2008157432]; COMSTOCK JC, 1973, PHYTOPATHOLOGY, V63, P24, DOI 10.1094/Phyto-63-24; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; GILBERT HS, 1984, ANAL BIOCHEM, V137, P282, DOI 10.1016/0003-2697(84)90086-1; HAMID AH, 1982, PHYTOPATHOLOGY, V72, P1166, DOI 10.1094/Phyto-72-1166; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; HOLLEY RN, 1989, PLANT DIS, V73, P562, DOI 10.1094/PD-73-0562; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jambunathan N, 2006, PLANTA, V224, P1, DOI 10.1007/s00425-005-0183-y; JONES MJ, 1993, PHYTOPATHOLOGY, V83, P366, DOI 10.1094/Phyto-83-366; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; LEONARD KJ, 1990, PHYTOPATHOLOGY, V80, P1154, DOI 10.1094/Phyto-80-1154; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liu Y, 1999, PLANT PROT, V25, P53; LODGE DJ, 1984, CAN J BOT, V62, P995, DOI 10.1139/b84-138; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Multani DS, 1998, P NATL ACAD SCI USA, V95, P1686, DOI 10.1073/pnas.95.4.1686; Mwangi S. M., 1998, THESIS VIRGINIA POLY; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Sadasivam S., 1992, MANICKAM A BIOCHEMIC, V256; SCHENCK NC, 1974, PHYTOPATHOLOGY, V64, P619, DOI 10.1094/Phyto-64-619; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; SUMNER DR, 1974, PHYTOPATHOLOGY, V64, P168; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; UPADHYAYA A, 1985, J PLANT PHYSIOL, V121, P453, DOI 10.1016/S0176-1617(85)80081-X; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058969; WELZ HG, 1995, EUR J PLANT PATHOL, V101, P301, DOI 10.1007/BF01874786; WELZ HG, 1993, PHYTOPATHOLOGY, V83, P593, DOI 10.1094/Phyto-83-593; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; ZAUBERMAN G, 1991, SCI HORTIC-AMSTERDAM, V47, P89, DOI 10.1016/0304-4238(91)90030-3	52	9	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119858	10.1371/journal.pone.0119858	http://dx.doi.org/10.1371/journal.pone.0119858			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781606	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600101
J	Patrono, E; Di Segni, M; Patella, L; Andolina, D; Valzania, A; Latagliata, EC; Felsani, A; Pompili, A; Gasbarri, A; Puglisi-Allegra, S; Ventura, R				Patrono, Enrico; Di Segni, Matteo; Patella, Loris; Andolina, Diego; Valzania, Alessandro; Latagliata, Emanuele Claudio; Felsani, Armando; Pompili, Assunta; Gasbarri, Antonella; Puglisi-Allegra, Stefano; Ventura, Rossella			When Chocolate Seeking Becomes Compulsion: Gene-Environment Interplay	PLOS ONE			English	Article							INDUCED CORTICOSTERONE SECRETION; CONDITIONED PLACE PREFERENCE; STRESS-INDUCED SENSITIZATION; EXCESSIVE SUGAR INTAKE; DOPAMINE D2 RECEPTOR; INBRED MOUSE STRAINS; DRUG-ADDICTION; ANIMAL-MODEL; EATING-DISORDERS; FOOD ADDICTION	Background Eating disorders appear to be caused by a complex interaction between environmental and genetic factors, and compulsive eating in response to adverse circumstances characterizes many eating disorders. Materials and Methods We compared compulsion-like eating in the form of conditioned suppression of palatable food-seeking in adverse situations in stressed C57BL/6J and DBA/2J mice, two well-characterized inbred strains, to determine the influence of gene-environment interplay on this behavioral phenotype. Moreover, we tested the hypothesis that low accumbal D2 receptor (R) availability is a genetic risk factor of food compulsion-like behavior and that environmental conditions that induce compulsive eating alter D2R expression in the striatum. To this end, we measured D1R and D2R expression in the striatum and D1R, D2R and alpha 1R levels in the medial prefrontal cortex, respectively, by western blot. Results Exposure to environmental conditions induces compulsion-like eating behavior, depending on genetic background. This behavioral pattern is linked to decreased availability of accumbal D2R. Moreover, exposure to certain environmental conditions upregulates D2R and downregulates alpha 1R in the striatum and medial prefrontal cortex, respectively, of compulsive animals. These findings confirm the function of gene-environment interplay in the manifestation of compulsive eating and support the hypothesis that low accumbal D2R availability is a "constitutive" genetic risk factor for compulsion-like eating behavior. Finally, D2R upregulation and alpha 1R downregulation in the striatum and medial prefrontal cortex, respectively, are potential neuroadaptive responses that parallel the shift from motivated to compulsive eating.	[Di Segni, Matteo; Andolina, Diego; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Santa Lucia Fdn, Rome, Italy; [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Ctr Daniel Bovet, I-00185 Rome, Italy; [Patrono, Enrico; Patella, Loris; Andolina, Diego; Pompili, Assunta; Gasbarri, Antonella] Univ Aquila, Dept Appl Clin Sci & Biotechnol, Coppito, Italy; [Felsani, Armando] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR)	Ventura, R (corresponding author), Santa Lucia Fdn, Rome, Italy.	rossella.ventura@uniroma1.it	Ventura, Rossella/AAA-8816-2019; Felsani, Armando/D-1784-2010; Di Segni, Matteo/K-6000-2016; Puglisi-Allegra, Stefano/ABI-7468-2020	Ventura, Rossella/0000-0002-7601-8683; Felsani, Armando/0000-0001-8851-6295; Di Segni, Matteo/0000-0002-1453-579X; Puglisi-Allegra, Stefano/0000-0002-9433-2000; Gasbarri, Antonella/0000-0003-0708-6524; Patrono, Enrico/0000-0002-9056-9537; Emanuele Claudio, Latagliata/0000-0001-8402-2757	Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo [C26A13L3PZ]; FIRB, Italy [RBFR10RZ0N_001]	Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo; FIRB, Italy(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo 2013 (C26A13L3PZ); FIRB 2010 (RBFR10RZ0N_001), Italy.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Alsio J, 2012, FRONT NEUROENDOCRIN, V33, P127, DOI 10.1016/j.yfrne.2012.01.002; Andolina D, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu074; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Bello NT, 2010, PHARMACOL BIOCHEM BE, V97, P25, DOI 10.1016/j.pbb.2010.04.016; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bulik CM, 2005, J PSYCHIATR NEUROSCI, V30, P335; Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5; CABIB S, 1985, BEHAV NEURAL BIOL, V44, P239, DOI 10.1016/S0163-1047(85)90254-7; Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Campbell IC, 2011, NEUROSCI BIOBEHAV R, V35, P784, DOI 10.1016/j.neubiorev.2010.09.012; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cifani C, 2009, PSYCHOPHARMACOLOGY, V204, P113, DOI 10.1007/s00213-008-1442-y; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Colelli V, 2010, GENES BRAIN BEHAV, V9, P703, DOI 10.1111/j.1601-183X.2010.00604.x; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Elmer GI, 2010, PSYCHOPHARMACOLOGY, V208, P309, DOI 10.1007/s00213-009-1732-z; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fallon S, 2007, NEUROCHEM RES, V32, P1772, DOI 10.1007/s11064-007-9343-8; Fetsko LA, 2003, BRAIN RES, V967, P191, DOI 10.1016/S0006-8993(02)04277-4; Fish E, 2010, TCE-THE CHEM ENG, P2; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028; Gubner NR, 2010, ALCOHOL CLIN EXP RES, V34, P1353, DOI 10.1111/j.1530-0277.2010.01219.x; Hadad NA, 2014, PSYCHOPHARMACOLOGY, V231, P1897, DOI 10.1007/s00213-014-3461-1; Hagan MM, 2003, INT J EAT DISORDER, V34, P183, DOI 10.1002/eat.10168; Halpern CH, 2013, J NEUROSCI, V33, P7122, DOI 10.1523/JNEUROSCI.3237-12.2013; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Hoebel BG, 2009, J ADDICT MED, V3, P33, DOI 10.1097/ADM.0b013e31819aa621; Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalra SP, 2004, J ADDICT DIS, V23, P5, DOI 10.1300/J069v23n03_02; Latagliata EC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-15; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Olsen CM, 2011, NEUROPHARMACOLOGY, V61, P1109, DOI 10.1016/j.neuropharm.2011.03.010; Orsini C, 2005, PSYCHOPHARMACOLOGY, V181, P327, DOI 10.1007/s00213-005-2259-6; Orsini C, 2008, PSYCHOPHARMACOLOGY, V198, P287, DOI 10.1007/s00213-008-1137-4; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Parker G, 2006, J AFFECT DISORDERS, V92, P149, DOI 10.1016/j.jad.2006.02.007; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; Petrovich GD, 2007, J NEUROSCI, V27, P6436, DOI 10.1523/JNEUROSCI.5001-06.2007; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Puglisi-Allegra S, 2012, REV NEUROSCIENCE, V23, P509, DOI 10.1515/revneuro-2012-0076; Puglisi-Allegra S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00031; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Rolls ET, 2008, ACTA PHYSIOL HUNG, V95, P131, DOI 10.1556/APhysiol.95.2008.2.1; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; Rutter M, 2008, J ABNORM CHILD PSYCH, V36, P969, DOI 10.1007/s10802-008-9256-2; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4; Solecki W, 2009, PSYCHOPHARMACOLOGY, V207, P245, DOI 10.1007/s00213-009-1672-7; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2011, CURR TOP BEHAV NEURO, V6, P81, DOI 10.1007/7854_2010_89; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Szklarczyk K, 2012, GENES BRAIN BEHAV, V11, P977, DOI 10.1111/j.1601-183X.2012.00850.x; Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030; Tomer R, 2008, BIOL PSYCHOL, V77, P98, DOI 10.1016/j.biopsycho.2007.08.001; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; van den Bos R, 2006, BEHAV BRAIN RES, V171, P350, DOI 10.1016/j.bbr.2006.03.035; van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Ward RD, 2012, NEUROPSYCHOPHARMACOL, V37, P1699, DOI 10.1038/npp.2012.15; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227; Zhang XY, 2005, BIOL PSYCHIAT, V57, P1202, DOI 10.1016/j.biopsych.2005.02.003	98	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120191	10.1371/journal.pone.0120191	http://dx.doi.org/10.1371/journal.pone.0120191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781028	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600137
J	Tian, Y; Choi, CH; Li, QK; Rahmatpanah, FB; Chen, X; Kim, SR; Veltri, R; Chia, D; Zhang, Z; Mercola, D; Zhang, H				Tian, Yuan; Choi, Caitlin H.; Li, Qing Kay; Rahmatpanah, Farah B.; Chen, Xin; Kim, Sara Ruth; Veltri, Robert; Chia, David; Zhang, Zhen; Mercola, Dan; Zhang, Hui			Overexpression of Periostin in Stroma Positively Associated with Aggressive Prostate Cancer	PLOS ONE			English	Article							EXPRESSION; PROGRESSION; PROTEIN; MICROENVIRONMENT; METASTASIS	Background Periostin is an important extracellular matrix protein involved in cell development and adhesion. Previously, we identified periostin to be up-regulated in aggressive prostate cancer (CaP) using quantitative glycoproteomics and mass spectrometry. The expression of periostin was further evaluated in primary radical prostatectomy (RP) prostate tumors and adjacent non-tumorous prostate tissues using immunohistochemistry (IHC). Our IHC results revealed a low background periostin levels in the adjacent non-tumorous prostate tissues, but overexpressed periostin levels in the peritumoral stroma of primary CaP tumors. Methods In this study, periostin expression in CaP was further examined on multiple tissue microarrays (TMAs), which were conducted in four laboratories. To achieve consistent staining, all TMAs were stained with same protocol and scored by same image computation tool to determine the total periostin staining intensities. The TMAs were further scored by pathologists to characterize the stromal staining and epithelial staining. Results The periostin staining was observed mainly in peritumoral stromal cells and in some cases in tumor epithelial cells though the stronger staining was found in peritumoral stromal cells. Both periostin stromal staining and epithelial staining can differentiate BPH from CaP including low grade CaP (Gleason score <= 6), with significant p-value of 2.2e-16 and 0.001, respectively. Periostin epithelial staining differentiated PIN from low grade CaP (Gleason score <= 6) (p=0.001), while periostin stromal staining differentiated low grade Cap (Gleason score <= 6) from high grade Cap (Gleason score <= 6) (p=1.7e-05). In addition, a positive correlation between total periostin staining and Gleason score was observed (r=0.87, p=0.002). Conclusions The results showed that periostin staining was positively correlated with increasing Gleason score and the aggressiveness of prostate disease.	[Tian, Yuan; Choi, Caitlin H.; Li, Qing Kay; Veltri, Robert; Zhang, Zhen; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Rahmatpanah, Farah B.; Chen, Xin; Mercola, Dan] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Kim, Sara Ruth; Chia, David] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Zhang, H (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	hzhang32@jhmi.edu	mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840	National Institutes of Health, National Cancer Institute; Early Detection Research Network (EDRN) [U01CA152813]; Early Detection Research Network NCI [CA86366]; NATIONAL CANCER INSTITUTE [U24CA086366, T32CA009054, U24CA160036, U01CA152813] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network (EDRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health, National Cancer Institute, the Early Detection Research Network (EDRN, U01CA152813) to HZ and Early Detection Research Network NCI CA86366 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Gunia S, 2013, J CLIN PATHOL, V66, P297, DOI 10.1136/jclinpath-2012-201262; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Krajewska M, 2008, CLIN CANCER RES, V14, P3011, DOI 10.1158/1078-0432.CCR-07-1955; Krajewska M, 2007, PROSTATE, V67, P907, DOI 10.1002/pros.20578; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kyutoku M, 2011, INT J MOL MED, V28, P181, DOI 10.3892/ijmm.2011.712; Li MX, 2012, CLIN EXP METASTAS, V29, P865, DOI 10.1007/s10585-012-9465-5; Maresh EL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-680; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Nuzzo PV, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-625; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Seligson DB, 2007, CLIN CANCER RES, V13, P6056, DOI 10.1158/1078-0432.CCR-07-0960; Tian Y, 2011, PROTEOMICS, V11, P4677, DOI 10.1002/pmic.201000811; Tian Y, 2011, ANAL CHEM, V83, P7013, DOI 10.1021/ac200815q; Tischler V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-273; Wang HJ, 2013, INT J ONCOL, V42, P1716, DOI 10.3892/ijo.2013.1847; Wu GQ, 2013, CANCER BIOTHER RADIO, V28, P298, DOI 10.1089/cbr.2012.1374; Xu DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046670; Zhu M, 2010, GYNECOL ONCOL, V119, P337, DOI 10.1016/j.ygyno.2010.07.008	21	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121502	10.1371/journal.pone.0121502	http://dx.doi.org/10.1371/journal.pone.0121502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781169	Green Published, gold			2022-12-26	WOS:000351284600208
J	Voss, R; Quaas, MF; Schmidt, JO; Kapaun, U				Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.; Kapaun, Ute			Ocean Acidification May Aggravate Social-Ecological Trade-Offs in Coastal Fisheries	PLOS ONE			English	Article							AGE-SPECIFIC MORTALITY; ATLANTIC; CARBON; COD	Ocean Acidification (OA) will influence marine ecosystems by changing species abundance and composition. Major effects are described for calcifying organisms, which are significantly impacted by decreasing pH values. Direct effects on commercially important fish are less well studied. The early life stages of fish populations often lack internal regulatory mechanisms to withstand the effects of abnormal pH. Negative effects can be expected on growth, survival, and recruitment success. Here we study Norwegian coastal cod, one of the few stocks where such a negative effect was experimentally quantified, and develop a framework for coupling experimental data on OA effects to ecological-economic fisheries models. In this paper, we scale the observed physiological responses to the population level by using the experimentally determined mortality rates as part of the stock-recruitment relationship. We then use an ecological-economic optimization model, to explore the potential effect of rising CO2 concentration on ecological (stock size), economic (profits), consumer-related (harvest) and social (employment) indicators, with scenarios ranging from present day conditions up to extreme acidification. Under the assumptions of our model, yields and profits could largely be maintained under moderate OA by adapting future fishing mortality (and related effort) to changes owing to altered pH. This adaptation comes at the costs of reduced stock size and employment, however. Explicitly visualizing these ecological, economic and social tradeoffs will help in defining realistic future objectives. Our results can be generalized to any stressor (or stressor combination), which is decreasing recruitment success. The main findings of an aggravation of trade-offs will remain valid. This seems to be of special relevance for coastal stocks with limited options for migration to avoid unfavorable future conditions and subsequently for coastal fisheries, which are often small scale local fisheries with limited operational ranges.	[Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.; Kapaun, Ute] Univ Kiel, Dept Econ, Kiel, Germany; [Quaas, Martin F.] Kiel Inst World Econ, Kiel, Germany	University of Kiel; Institut fur Weltwirtschaft an der Universitat Kiel (IFW)	Voss, R (corresponding author), Univ Kiel, Dept Econ, Wilhelm Seelig Pl 1, Kiel, Germany.	voss@economics.uni-kiel.de	Voss, Rudi/A-6113-2011; Quaas, Martin/C-4220-2012; Schmidt, Jörn Oliver/A-7714-2008; /AAL-3738-2021	Quaas, Martin/0000-0003-0812-8829; Schmidt, Jörn Oliver/0000-0002-4420-6532; Voss, Rudi/0000-0002-4299-8791	Cluster of Excellence "Future Ocean" of Kiel University; German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID) [FKZ 03F0608A]	Cluster of Excellence "Future Ocean" of Kiel University; German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID)(Federal Ministry of Education & Research (BMBF))	This study has been carried out with financial support from the Cluster of Excellence "Future Ocean" of Kiel University. The research leading to the paper has also received funding by the German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID, FKZ 03F0608A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON JM, 1981, ANNU REV ANTHROPOL, V10, P275, DOI 10.1146/annurev.an.10.100181.001423; BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bellerby RGJ, 2005, GEOPH MONOG SERIES, V158, P189; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Denman K, 2011, ICES J MAR SCI, V68, P1019, DOI 10.1093/icesjms/fsr074; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fowler Charles W., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P1; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; ICES, 2012, REP ARCT FISH WORK G; Le Quesne WJF, 2012, FISH FISH, V13, P333, DOI 10.1111/j.1467-2979.2011.00423.x; McWhinnie SF, 2006, FISHERIES CTR RES RE, V14, P77; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Rabinovich JE, 2010, ENTOMOL EXP APPL, V135, P252, DOI 10.1111/j.1570-7458.2010.00986.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Tahvonen O, 2013, ENVIRON RESOUR ECON, V54, P21, DOI 10.1007/s10640-012-9579-x; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Voss R, 2014, MAR ECOL PROG SER, V498, P1, DOI 10.3354/meps10639; Voss R, 2012, PROG OCEANOGR, V107, P61, DOI 10.1016/j.pocean.2012.05.003	28	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120376	10.1371/journal.pone.0120376	http://dx.doi.org/10.1371/journal.pone.0120376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780914	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600156
J	Wang, LH; Fu, SH; Cao, L; Lei, WW; Cao, YX; Song, JD; Tang, Q; Zhang, HL; Feng, Y; Yang, WH; Liang, GD				Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Zhang, Hailin; Feng, Yun; Yang, Weihong; Liang, Guodong			Isolation and Identification of a Natural Reassortant Mammalian Orthoreovirus from Least Horseshoe Bat in China	PLOS ONE			English	Article							REOVIRUS; VIRUS; TYPE-3; CHILD	Background Mammalian orthoreoviruses (MRVs) have a wide geographic distribution and can infect virtually all mammals. Infections in humans may be either symptomatic or asymptomatic. This study describes the isolation and identification of a natural reassortant MRV from least horseshoe bats (Rhinolophus pusillu) in China, referred to as RpMRV-YN2012. Methods and Results The RpMRV-YN2012 was obtained from urine samples of Rhinolophus pusillus by cell culture. Negative-staining electron microscopy revealed that RpMRV-YN2012 was a non-enveloped icosahedral virus with similar to 75 nm in diameter. Polyacrylamide gel electrophoresis (PAGE) migration patterns of the genome segments showed that RpMRV-YN2012 contained 10 segments in a 3: 3: 4 arrangement. The whole genome sequence of RpMRV2012 was determined. The consensus terminal sequences of all segments of 5'-GCUAh center dot center dot center dot yUCAUC-3' (h = A, U or C; y = C or U) were similar to the MRV species within the genus Orthoreovirus. Its evolution and evidence of genetic reassortment were analyzed by sequence comparison and phylogenetic analysis. The results showed that RpMRV-YN2012 is a novel serotype 2 MRV that may have originated from reassortment among bat, human, and/or pig MRV strains which associated with diarrhea, acute gastroenteritis and necrotizing encephalopathy in animals and humans. Conclusions RpMRV-YN2012 is a novel bat reassortant MRV, which may have resulted from a reassortment involving MRVs known to infect humans and animals. It is necessary to identify whether RpMRV-YN2012 is associated with diarrhea, acute gastroenteritis and necrotizing encephalopathy in clinical patients. In addition, we should carefully monitor its evolution and virulence in real time.	[Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hailin; Feng, Yun; Yang, Weihong] Yunnan Inst Endem Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Yunnan Institute for Endemic Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	gdliang@hotmail.com	wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022	Wang, Lin-Fa/0000-0003-2752-0535	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; National Key Technology R & D Program of the Ministry of Science and Technology [2014BAI13B04]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Key Technology R & D Program of the Ministry of Science and Technology(National Key Technology R&D Program); State Key Laboratory for Infectious Disease Prevention and Control	Funding provided by National Natural Science Foundation of China (81290342); Ministry of Science and Technology, China (2011CB504702); National Key Technology R & D Program of the Ministry of Science and Technology (2014BAI13B04) and State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2011, FAMILY REOVIRIDAE, P541; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025434; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Dai YM, 2012, J VIROL, V86, P12456, DOI 10.1128/JVI.02254-12; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kohl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043106; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leary TP, 2002, J VIROL METHODS, V104, P161, DOI 10.1016/S0166-0934(02)00058-7; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; Mackenzie JS, 2005, J NEUROVIROL, V11, P434, DOI 10.1080/13550280591002487; Omatsu T, 2007, COMP IMMUNOL MICROB, V30, P357, DOI 10.1016/j.cimid.2007.05.006; Ouattara LA, 2011, EMERG INFECT DIS, V17, P1436, DOI 10.3201/eid1708.101528; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; Steyer A, 2013, J CLIN MICROBIOL, V51, P3818, DOI 10.1128/JCM.01531-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zhang CF, 2011, VIRUS GENES, V43, P342, DOI 10.1007/s11262-011-0642-4	30	19	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118598	10.1371/journal.pone.0118598	http://dx.doi.org/10.1371/journal.pone.0118598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781475	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600030
J	Wang, P; Tong, JJ; Ma, XH; Song, FL; Fan, L; Guo, CM; Shi, W; Yu, SJ; Yao, KH; Yang, YH				Wang, Ping; Tong, Jing-jing; Ma, Xiu-hua; Song, Feng-li; Fan, Ling; Guo, Cui-mei; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong			Serotypes, Antibiotic Susceptibilities, and Multi-Locus Sequence Type Profiles of Streptococcus agalactiae Isolates Circulating in Beijing, China	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; TELITHROMYCIN SUSCEPTIBILITY; PREGNANT-WOMEN; UNITED-STATES; EPIDEMIOLOGY; RESISTANCE; DISEASE; INFECTIONS; DIVERSITY; ERYTHROMYCIN	Background To investigate the serotypes, antibiotic susceptibilities, and multi-locus sequence type (MLST) profiles of Streptococcus agalactiae (S. agalactiae) in Beijing to provide references for the prevention and treatment of S. agalactiae infections. Methods All isolates were identified using the CAMP test and the latex-agglutination assay and serotyped using a Strep-B-Latex kit, after which they were assessed for antibiotic susceptibility, macrolide-resistance genes, and MLST profiles. Results In total, 56 S. agalactiae isolates were identified in 863 pregnant women (6.5%). Serotypes Ia, Ib, II, III, and V were identified, among which types III (32.1%), Ia (17.9%), Ib (16.1%), and V (14.3%) were the predominant serotypes. All isolates were susceptible to penicillin and ceftriaxone. The nonsusceptiblity rates measured for erythromycin, clarithromycin, azithromycin, telithromycin, clindamycin, tetracycline, and levofloxacin were 85.7%, 92.9%, 98.2%, 30.4%, 73.2%, 91%, and 39.3%, respectively. We identified 14 sequence types (STs) for the 56 isolates, among which ST19 (30.4%) was predominant. The rate of fluoroquinolone resistance was higher in serotype III than in the other serotypes. Among the 44 erythromycin-resistant isolates, 32 (72.7%) carried ermB. Conclusion S. agalactiae isolates of the serotypes Ia, Ib, III, and V are common in Beijing. Among the S. agalactiae isolates, the macrolide and clindamycin resistance rates are extremely high. Most of the erythromycin-resistant isolates carry ermB.	[Wang, Ping; Tong, Jing-jing; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong] Capital Med Univ, Key Lab Major Dis Children, Beijing 100045, Peoples R China; [Wang, Ping; Tong, Jing-jing; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing 100045, Peoples R China; [Ma, Xiu-hua; Song, Feng-li] Capital Med Univ, Peoples Hosp Beijing Daxing Dist, Dept Obstet, Beijing 102600, Peoples R China; [Wang, Ping; Fan, Ling; Guo, Cui-mei] Capital Med Univ, Beijing Obstet & Genecol Hosp, Dept Obstet, Beijing 100026, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Yao, KH (corresponding author), Capital Med Univ, Key Lab Major Dis Children, Beijing 100045, Peoples R China.	jiuhu2655@sina.com; yyh628628@sina.com			Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission [2014-bjsekyjs-3]	Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission	This study was financially supported by the Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission (2014-bjsekyjs-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinto TCA, 2013, BRAZ J INFECT DIS, V17, P131, DOI 10.1016/j.bjid.2012.09.006; Adong Shen, 2001, CHIN J PERINAT MED, V4, P233; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; ANTHONY BF, 1979, J PEDIATR-US, V95, P431, DOI 10.1016/S0022-3476(79)80530-2; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; Betriu C, 2003, ANTIMICROB AGENTS CH, V47, P1112, DOI 10.1128/AAC.47.3.1112-1114.2003; Bingen E, 2004, ANTIMICROB AGENTS CH, V48, P677, DOI 10.1128/AAC.48.2.677-680.2004; Bliss SJ, 2002, CLIN INFECT DIS, V34, P184, DOI 10.1086/338258; Borchardt SM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-57; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Desjardins M, 2004, J CLIN MICROBIOL, V42, P5620, DOI 10.1128/JCM.42.12.5620-5623.2004; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; EASMON CSF, 1981, BRIT MED J, V283, P459, DOI 10.1136/bmj.283.6289.459; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Farrell DJ, 2004, ANTIMICROB AGENTS CH, V48, P1882, DOI 10.1128/AAC.48.5.1882-1884.2004; Gherardi G, 2007, J CLIN MICROBIOL, V45, P2909, DOI 10.1128/JCM.00999-07; Gonzalez JJ, 2005, ANTIMICROB AGENTS CH, V49, P2525, DOI 10.1128/AAC.49.6.2525-2527.2005; Heath PT, 2011, EXPERT REV VACCINES, V10, P685, DOI [10.1586/erv.11.61, 10.1586/ERV.11.61]; Hsueh PR, 2001, ANTIMICROB AGENTS CH, V45, P3205, DOI 10.1128/AAC.45.11.3205-3208.2001; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Jones N, 2006, J CLIN PATHOL, V59, P363, DOI 10.1136/jcp.2005.029058; Kawamura Y, 2003, ANTIMICROB AGENTS CH, V47, P3605, DOI 10.1128/AAC.47.11.3605-3609.2003; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Lee Wen-Tsung, 2014, J MICROBIOL IMMUNOL; Lu B, 2014, CLIN MICROBIOL INFEC, V20, pO370, DOI 10.1111/1469-0691.12416; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2012, J CLIN MICROBIOL, V50, P1219, DOI 10.1128/JCM.05488-11; Martins ER, 2011, J CLIN MICROBIOL, V49, P2911, DOI 10.1128/JCM.00271-11; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Palmeiro JK, 2011, VACCINE, V29, P3729, DOI 10.1016/j.vaccine.2011.02.102; Palmeiro JK, 2010, J CLIN MICROBIOL, V48, P4397, DOI 10.1128/JCM.00419-10; Persson E, 2004, CLIN MICROBIOL INFEC, V10, P791, DOI 10.1111/j.1469-0691.2004.00931.x; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; RUBENS CE, 1987, P NATL ACAD SCI USA, V84, P7208, DOI 10.1073/pnas.84.20.7208; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Shen A-dong, 2005, Zhonghua Er Ke Za Zhi, V43, P661; Shen AD, 1998, CHINESE MED J-PEKING, V111, P615; Takaya A, 2010, FEMS MICROBIOL LETT, V307, P87, DOI 10.1111/j.1574-6968.2010.01962.x; Ueno H, 2012, JPN J INFECT DIS, V65, P516, DOI 10.7883/yoken.65.516; van der Mee-Marquet N, 2009, J MED MICROBIOL, V58, P169, DOI 10.1099/jmm.0.005827-0; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wang H, 2013, ANTIMICROB AGENTS CH, V57, P1538, DOI 10.1128/AAC.02317-12; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zhang JH, 1995, CHUNG HUA LIU HSING, V16, P36; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	51	51	61	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120035	10.1371/journal.pone.0120035	http://dx.doi.org/10.1371/journal.pone.0120035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781346	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600119
J	Montealegre, S; Venugopalan, V; Fritzsche, S; Kulicke, C; Hein, Z; Springer, S				Montealegre, Sebastian; Venugopalan, Vaishnavi; Fritzsche, Susanne; Kulicke, Corinna; Hein, Zeynep; Springer, Sebastian			Dissociation of beta 2-microglobulin determines the surface quality control of major histocompatibility complex class I molecules	FASEB JOURNAL			English	Article						endocytosis; receptor recycling; Brefeldin A; peptide	HEAVY-CHAINS; MHC MOLECULES; CELL-SURFACE; MONOCLONAL-ANTIBODIES; CONSTITUTIVE ENDOCYTOSIS; BREFELDIN-A; PEPTIDE; ANTIGEN; HLA; ASSOCIATION	Major histocompatibility complex class I proteins, which present antigenic peptides to cytotoxic T lymphocytes at the surface of all nucleated cells, are endocytosed and destroyed rapidly once their peptide ligand has dissociated. The molecular mechanism of this cellular quality control process, which prevents rebinding of exogenous peptides andthus erroneous immuneresponses, is unknown. To identify the nature of the decisive step in endocytic sorting of class I molecules and its location, we have followed the removal of optimally and suboptimally peptide-loaded murine H-2K(b) class I proteins from the cell surface. We find that the binding of their light chain, beta(2)-microglobulin (beta(2)m), protects them from endocytic destruction. Thus, the extended survival of suboptimally loaded K-b molecules at 25 degrees C is attributed to decreased dissociation of beta(2)m. Because all forms of K-b are constantly internalized but little beta(2)m-receptive heavy chain is present at the cell surface, it is likely that beta(2)m dissociation and recognition of the heavy chain for lysosomal degradation take place inanendocytic compartment.	[Montealegre, Sebastian; Venugopalan, Vaishnavi; Fritzsche, Susanne; Kulicke, Corinna; Hein, Zeynep; Springer, Sebastian] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany	Jacobs University	Hein, Z (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, Campus Ring, D-28759 Bremen, Germany.	hein@jacobs-university.de; sebastian.springer@queens.oxon.org	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149; Venugopalan, Vaishnavi/0000-0001-6772-6787	Deutsche Forschungsgemeinschaft [SP583/2-3, 7-1]; German Academic Exchange Service; Thyssen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Thyssen Foundation	The authors thank Ursula Wellbrock for excellent technical assistance; Henri de la Salle for cells; and Linda Janssen, Venkat Raman Ramnarayan, and Malgorzata Garstka for discussions. The work was supported by the Deutsche Forschungsgemeinschaft (SP583/2-3 and 7-1 to S.S.), the German Academic Exchange Service (to S.M.), and the Thyssen Foundation (to Z.H.).	ANDERSON KS, 1993, J IMMUNOL, V151, P3407; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Boulanger DSM, 2010, J IMMUNOL, V184, P73, DOI 10.4049/jimmunol.0803489; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; Edidin M, 1997, IMMUNOGENETICS, V46, P41, DOI 10.1007/s002510050240; Fritzsche S, 2013, MOL IMMUNOL, V55, P126, DOI 10.1016/j.molimm.2012.11.001; Gakamsky DM, 1999, BIOCHEMISTRY-US, V38, P12165, DOI 10.1021/bi9905821; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; Hein Z, 2014, J CELL SCI, V127, P2885, DOI 10.1242/jcs.145334; HOCHMAN JH, 1991, J IMMUNOL, V146, P1862; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KUBOTA K, 1984, J IMMUNOL, V133, P3203; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; Machold RP, 1996, J EXP MED, V184, P2251, DOI 10.1084/jem.184.6.2251; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; Mahmutefendic H, 2002, AM J REPROD IMMUNOL, V48, P87, DOI 10.1034/j.1600-0897.2002.01134.x; Mahmutefendic H, 2013, MOL IMMUNOL, V55, P149, DOI 10.1016/j.molimm.2012.10.008; Mahmutefendic H, 2011, INT J BIOCHEM CELL B, V43, P504, DOI 10.1016/j.biocel.2010.12.002; MATKO J, 1994, J IMMUNOL, V152, P3353; Merzougui N, 2011, EMBO REP, V12, P1257, DOI 10.1038/embor.2011.203; MOTAL UMA, 1993, EUR J IMMUNOL, V23, P3224, DOI 10.1002/eji.1830231227; MOTAL UMA, 1993, SCAND J IMMUNOL, V38, P395, DOI 10.1111/j.1365-3083.1993.tb01743.x; MYERS NB, 1989, J IMMUNOL, V142, P2751; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; ORTIZNAVARRETE V, 1991, P NATL ACAD SCI USA, V88, P3594, DOI 10.1073/pnas.88.9.3594; OTTEN GR, 1992, J IMMUNOL, V148, P3723; PARKER KC, 1992, J IMMUNOL, V149, P1896; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROCK KL, 1991, CELL, V65, P611, DOI 10.1016/0092-8674(91)90093-E; Saini SK, 2013, MOL IMMUNOL, V54, P386, DOI 10.1016/j.molimm.2013.01.004; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Shields MJ, 1999, MOL IMMUNOL, V36, P561, DOI 10.1016/S0161-5890(99)00077-2; STAM NJ, 1986, J IMMUNOL, V137, P2299; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Zagorac GB, 2012, J CELL PHYSIOL, V227, P2953, DOI 10.1002/jcp.23042	58	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2780	2788		10.1096/fj.14-268094	http://dx.doi.org/10.1096/fj.14-268094			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782992				2022-12-26	WOS:000356859100010
J	Odell, AV; Tran, F; Foderaro, JE; Poupart, S; Pathak, R; Westwood, NJ; Ward, GE				Odell, Anahi V.; Tran, Fanny; Foderaro, Jenna E.; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.; Ward, Gary E.			Yeast Three-Hybrid Screen Identifies TgBRADIN/GRA24 as a Negative Regulator of Toxoplasma gondii Bradyzoite Differentiation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PROTOZOAN PARASITE; MOLECULAR CHARACTERIZATION; SELECTABLE MARKER; GENE-EXPRESSION; CYST FORMATION; SYSTEM; TRANSFORMATION; TACHYZOITE; INHIBITION	Differentiation of the protozoan parasite Toxoplasma gondii into its latent bradyzoite stage is a key event in the parasite's life cycle. Compound 2 is an imidazopyridine that was previously shown to inhibit the parasite lytic cycle, in part through inhibition of parasite cGMP-dependent protein kinase. We show here that Compound 2 can also enhance parasite differentiation, and we use yeast three-hybrid analysis to identify TgBRADIN/GRA24 as a parasite protein that interacts directly or indirectly with the compound. Disruption of the TgBRADIN/GRA24 gene leads to enhanced differentiation of the parasite, and the TgBRADIN/GRA24 knockout parasites show decreased susceptibility to the differentiation-enhancing effects of Compound 2. This study represents the first use of yeast three-hybrid analysis to study small-molecule mechanism of action in any pathogenic microorganism, and it identifies a previously unrecognized inhibitor of differentiation in T. gondii. A better understanding of the proteins and mechanisms regulating T. gondii differentiation will enable new approaches to preventing the establishment of chronic infection in this important human pathogen.	[Odell, Anahi V.; Foderaro, Jenna E.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Tran, Fanny; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	University of Vermont; University of St Andrews; University of St Andrews	Westwood, NJ (corresponding author), Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland.	njw3@st-andrews.ac.uk; Gary.Ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Westwood, Nicholas/0000-0003-0630-0138; Foderaro, Jenna/0000-0001-5974-3827	National Institutes of Health (NIH) [AI054961]; Royal Society University Research [516002. K5682/KK]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research(Royal Society of London); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant AI054961 to GEW, and Royal Society University Research grant 516002. K5682/KK to NJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker K, 2003, ANAL BIOCHEM, V315, P134, DOI 10.1016/S0003-2697(02)00698-X; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Biftu T, 2006, BIOORG MED CHEM LETT, V16, P2479, DOI 10.1016/j.bmcl.2006.01.092; Bohne W, 1997, MOL BIOCHEM PARASIT, V88, P115, DOI 10.1016/S0166-6851(97)00087-X; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Brown T, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0209as21; Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Francis CL, 2002, AUST J CHEM, V55, P635, DOI 10.1071/CH02125; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gross U, 1996, CURR TOP MICROBIOL, V219, P235; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hassan MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-696; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jerome ME, 1998, INFECT IMMUN, V66, P4838, DOI 10.1128/IAI.66.10.4838-4844.1998; Knoll LJ, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P521, DOI 10.1016/B978-0-12-396481-6.00015-5; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Lescault PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014463; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Pszenny V, 2012, INFECT IMMUN, V80, P1156, DOI 10.1128/IAI.06167-11; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Rooney PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019570; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Ross M.T., 1999, CURRENT PROTOCOLS HU; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Scribner A, 2007, EUR J MED CHEM, V42, P1334, DOI 10.1016/j.ejmech.2007.02.006; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TOMAVO S, 1995, INT J PARASITOL, V25, P1293, DOI 10.1016/0020-7519(95)00066-B; Tran F, 2013, MOLECULES, V18, P11639, DOI 10.3390/molecules180911639; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Walton JGA, 2009, ORG BIOMOL CHEM, V7, P3049, DOI 10.1039/b902319d; Watson MA, 1996, BIOTECHNIQUES, V21, P255; WEISS LM, 1995, J EUKARYOT MICROBIOL, V42, P150, DOI 10.1111/j.1550-7408.1995.tb01556.x; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	56	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120331	10.1371/journal.pone.0120331	http://dx.doi.org/10.1371/journal.pone.0120331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789621	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400151
J	Boyer, B; Ezelin, J; Poulain, P; Saladin, A; Zacharias, M; Robert, CH; Prevost, C				Boyer, Benjamin; Ezelin, Johann; Poulain, Pierre; Saladin, Adrien; Zacharias, Martin; Robert, Charles H.; Prevost, Chantal			An Integrative Approach to the Study of Filamentous Oligomeric Assemblies, with Application to RecA	PLOS ONE			English	Article							PROTEIN QUATERNARY STRUCTURE; HOMOLOGOUS RECOMBINATION; HELICAL FILAMENTS; CRYSTAL-STRUCTURE; MACROMOLECULAR ASSEMBLIES; NUCLEOPROTEIN FILAMENTS; C-N; DNA; DOCKING; RING	Oligomeric macromolecules in the cell self-organize into a wide variety of geometrical motifs such as helices, rings or linear filaments. The recombinase proteins involved in homologous recombination present many such assembly motifs. Here, we examine in particular the polymorphic characteristics of RecA, the most studied member of the recombinase family, using an integrative approach that relates local modes of monomer/monomer association to the global architecture of their screw-type organization. In our approach, local modes of association are sampled via docking or Monte Carlo simulations. This enables shedding new light on fiber morphologies that may be adopted by the RecA protein. Two distinct RecA helical morphologies, the so-called "extended" and "compressed" forms, are known to play a role in homologous recombination. We investigate the variability within each form in terms of helical parameters and steric accessibility. We also address possible helical discontinuities in RecA filaments due to multiple monomer-monomer association modes. By relating local interface organization to global filament morphology, the strategies developed here to study RecA self-assembly are particularly well suited to other DNA-binding proteins and to filamentous protein assemblies in general.	[Boyer, Benjamin; Ezelin, Johann; Robert, Charles H.; Prevost, Chantal] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Lab Biochim Theor,UPR 9080, 13 Rue Pierre & Marie Curie, F-75005 Paris, France; [Poulain, Pierre] Inserm UMR S 665, DSIMB Team, F-75015 Paris, France; [Poulain, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INTS, F-75015 Paris, France; [Poulain, Pierre] Ets Poulain, Pointe Noire, Rep Congo; [Boyer, Benjamin; Saladin, Adrien] Univ Paris 07, MTI, INSERM UMR M 973, F-75205 Paris 13, France; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich	Prevost, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Lab Biochim Theor,UPR 9080, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Chantal.Prevost@ibpc.fr	; Poulain, Pierre/A-8287-2009	Chantal, Prevost/0000-0003-3516-6687; Poulain, Pierre/0000-0003-4177-3619; Robert, Charles/0000-0003-0337-1504	Universite Paris 6; French CNRS (Centre National de la Recherche Scientifique); IFCPAR (Indo-French Center for the Promotion of Advanced Research); German DFG (Deutsche Forschungsgemeinschaft) [SFB749, C5]; French State (Grant "DYNAMO") [ANR-11-LABX-0011-01]	Universite Paris 6; French CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); IFCPAR (Indo-French Center for the Promotion of Advanced Research)(French National Research Agency (ANR)); German DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); French State (Grant "DYNAMO")	The authors acknowledge support from Universite Paris 6 (to B.B.), the French CNRS (Centre National de la Recherche Scientifique, to J.E.), IFCPAR (Indo-French Center for the Promotion of Advanced Research, to C.H.R.), the German DFG (Deutsche Forschungsgemeinschaft, within SFB749, project C5, to M.Z.), and the "Initiative d'Excellence" program from the French State (Grant "DYNAMO", ANR-11-LABX-0011-01, to C.P. and C.H.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikesavan AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002244; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Angelidis A, 2004, TECHNICAL REPORT; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Bastard K, 2006, PROTEINS, V62, P956, DOI 10.1002/prot.20770; Bastard K, 2007, RECENT RES ADV STRUC, P249; Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; Berchanski A, 2003, PROTEINS, V53, P817, DOI 10.1002/prot.10480; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bianco P R, 1998, Front Biosci, V3, pD570; Bosaeus N, 2012, P NATL ACAD SCI USA, V109, P15179, DOI 10.1073/pnas.1213172109; Bottema O., 1979, THEORETICAL KINEMATI; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; CameriniOtero RD, 1995, ANNU REV GENET, V29, P509, DOI 10.1146/annurev.genet.29.1.509; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Casciari D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-340; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chang YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004890; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Comeau SR, 2005, J STRUCT BIOL, V150, P233, DOI 10.1016/j.jsb.2005.03.006; Conover AJ, 2011, NUCLEIC ACIDS RES, V39, P8833, DOI 10.1093/nar/gkr561; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; de Vries S, 2013, PROTEINS, V81, P2167, DOI 10.1002/prot.24400; EGELMAN EH, 1993, MICRON, V24, P309, DOI 10.1016/0968-4328(93)90056-7; Egelman EH, 2001, J MOL BIOL, V309, P539, DOI 10.1006/jmbi.2001.4686; Eisenstein M, 1997, J MOL BIOL, V266, P135, DOI 10.1006/jmbi.1996.0773; ELLOUZE C, 1995, EUR J BIOCHEM, V233, P579, DOI 10.1111/j.1432-1033.1995.579_2.x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Esquivel-Rodriguez J, 2012, PROTEINS, V80, P1818, DOI 10.1002/prot.24079; FRANKLIN RE, 1953, NATURE, V172, P156, DOI 10.1038/172156a0; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grudinin S, 2010, J COMPUT CHEM, V31, P1799, DOI 10.1002/jcc.21434; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Inbar Y, 2005, J MOL BIOL, V349, P435, DOI 10.1016/j.jmb.2005.03.039; JANIN J, 1990, J BIOL CHEM, V265, P16027; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Karlin S, 1996, J BACTERIOL, V178, P1881, DOI 10.1128/jb.178.7.1881-1894.1996; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee CD, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-37; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; Logan KM, 1997, J MOL BIOL, V266, P306, DOI 10.1006/jmbi.1996.0751; May A, 2005, BBA-PROTEINS PROTEOM, V1754, P225, DOI 10.1016/j.bbapap.2005.07.045; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Pierce B, 2005, BIOINFORMATICS, V21, P1472, DOI 10.1093/bioinformatics/bti229; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Riemann RN, 2005, PROTEIN ENG DES SEL, V18, P465, DOI 10.1093/protein/gzi052; Saladin A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-27; Schneider S, 2012, METHODS MOL BIOL, V819, P221, DOI 10.1007/978-1-61779-465-0_15; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Shi WX, 2005, NANO LETT, V5, P2476, DOI 10.1021/nl051783v; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; WANG AHJ, 1981, SCIENCE, V211, P171, DOI 10.1126/science.7444458; Wang TF, 2008, BIOESSAYS, V30, P48, DOI 10.1002/bies.20694; Wolfson HJ, 2005, CURR PROTEIN PEPT SC, V6, P171, DOI 10.2174/1389203053545435; Wu HY, 2014, CHEMPHYSCHEM, V15, P80, DOI 10.1002/cphc.201300835; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; YU X, 1991, J STRUCT BIOL, V106, P243, DOI 10.1016/1047-8477(91)90074-7; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303	83	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116414	10.1371/journal.pone.0116414	http://dx.doi.org/10.1371/journal.pone.0116414			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785454	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500008
J	Koskiniemi, S; Garza-Sanchez, F; Edman, N; Chaudhuri, S; Poole, SJ; Manoil, C; Hayes, CS; Low, DA				Koskiniemi, Sanna; Garza-Sanchez, Fernando; Edman, Natasha; Chaudhuri, Swarnava; Poole, Stephen J.; Manoil, Colin; Hayes, Christopher S.; Low, David A.			Genetic Analysis of the CDI Pathway from Burkholderia pseudomallei 1026b	PLOS ONE			English	Article							VI SECRETION SYSTEM; OUTER-MEMBRANE BIOGENESIS; COLICIN E9; GROWTH; INHIBITION; PROTEIN; TOXIN; IMMUNITY; DOMAIN; IDENTIFICATION	Contact-dependent growth inhibition (CDI) is a mode of inter-bacterial competition mediated by the CdiB/CdiA family of two-partner secretion systems. CdiA binds to receptors on susceptible target bacteria, then delivers a toxin domain derived from its C-terminus. Studies with Escherichia coli suggest the existence of multiple CDI growth-inhibition pathways, whereby different systems exploit distinct target-cell proteins to deliver and activate toxins. Here, we explore the CDI pathway in Burkholderia using the CDIIIBp1026b system encoded on chromosome II of Burkholderia pseudomallei 1026b as a model. We took a genetic approach and selected Burkholderia thailandensis E264 mutants that are resistant to growth inhibition by CDIIIBp1026b. We identified mutations in three genes, BTH_I0359, BTH_II0599, and BTH_I0986, each of which confers resistance to CDIIIBp1026b. BTH_I0359 encodes a small peptide of unknown function, whereas BTH_II0599 encodes a predicted inner membrane transport protein of the major facilitator superfamily. The inner membrane localization of BTH_II0599 suggests that it may facilitate translocation of CdiA-CTIIBp1026b toxin from the periplasm into the cytoplasm of target cells. BTH_I0986 encodes a putative transglycosylase involved in lipopolysaccharide (LPS) synthesis. Delta BTH_I0986 mutants have altered LPS structure and do not interact with CDI+ inhibitor cells to the same extent as BTH_I0986(+) cells, suggesting that LPS could function as a receptor for CdiA(II)(Bp1026b). Although Delta BTH_I0359, Delta BTH_II0599, and Delta BTH_I0986 mutations confer resistance to CDIIIBp1026b, they provide no protection against the CDIE264 system deployed by B. thailandensis E264. Together, these findings demonstrate that CDI growth-inhibition pathways are distinct and can differ significantly even between closely related species.	[Koskiniemi, Sanna; Garza-Sanchez, Fernando; Edman, Natasha; Chaudhuri, Swarnava; Poole, Stephen J.; Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	david.low@lifesci.ucsb.edu		Edman, Natasha/0000-0002-7315-7127	National Institutes of Health [U54 AI065359, UO1 GM102318]; Santa Barbara Cottage Hospital; Carl Tryggers Stiftelse; Wenner-Gren Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Santa Barbara Cottage Hospital; Carl Tryggers Stiftelse; Wenner-Gren Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received support from the following sources: National Institutes of Health U54 AI065359 (DAL); National Institutes of Health UO1 GM102318 (CSH); Santa Barbara Cottage Hospital (SK), http://cottagehealthsystem.org/tabid/1026/Default.aspx; Carl Tryggers Stiftelse (SK); Wenner-Gren Foundation (SK), http://www.swgc.org/welcome.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Anderson MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004076; Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Beck CM, 2014, MOL MICROBIOL, V93, P276, DOI 10.1111/mmi.12658; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Cota I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036863; Diner EJ, 2012, GENE DEV, V26, P515, DOI 10.1101/gad.182345.111; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Ruhe ZC, 2014, MOL MICROBIOL, V94, P466, DOI 10.1111/mmi.12779; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Stone JK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-250; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Trakulsomboon Suwanna, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P756; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	55	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120265	10.1371/journal.pone.0120265	http://dx.doi.org/10.1371/journal.pone.0120265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786241	Green Published, gold			2022-12-26	WOS:000352138500161
J	Scheinemann, HA; Dittmar, K; Stockel, FS; Muller, H; Kruger, ME				Scheinemann, Hendrik A.; Dittmar, Katja; Stoeckel, Frank S.; Mueller, Hermann; Krueger, Monika E.			Hygienisation and Nutrient Conservation of Sewage Sludge or Cattle Manure by Lactic Acid Fermentation	PLOS ONE			English	Article							ESCHERICHIA-COLI; CLOSTRIDIUM; POPULATION; WASTE	Manure from animal farms and sewage sludge contain pathogens and opportunistic organisms in various concentrations depending on the health of the herds and human sources. Other than for the presence of pathogens, these waste substances are excellent nutrient sources and constitute a preferred organic fertilizer. However, because of the pathogens, the risks of infection of animals or humans increase with the indiscriminate use of manure, especially liquid manure or sludge, for agriculture. This potential problem can increase with the global connectedness of animal herds fed imported feed grown on fields fertilized with local manures. This paper describes a simple, easy-to-use, low-tech hygienization method which conserves nutrients and does not require large investments in infrastructure. The proposed method uses the microbiotic shift during mesophilic fermentation of cow manure or sewage sludge during which gram-negative bacteria, enterococci and yeasts were inactivated below the detection limit of 3 log(10) cfu/g while lactobacilli increased up to a thousand fold. Pathogens like Salmonella, Listeria monocytogenes, Staphylococcus aureus, E. coli EHEC O:157 and vegetative Clostridium perfringens were inactivated within 3 days of fermentation. In addition, ECBO-viruses and eggs of Ascaris suum were inactivated within 7 and 56 days, respectively. Compared to the mass lost through composting (15-57%), the loss of mass during fermentation (< 2.45%) is very low and provides strong economic and ecological benefits for this process. This method might be an acceptable hygienization method for developed as well as undeveloped countries, and could play a key role in public and animal health while safely closing the nutrient cycle by reducing the necessity of using energy-inefficient inorganic fertilizer for crop production.	[Scheinemann, Hendrik A.; Krueger, Monika E.] Univ Leipzig, Inst Bacteriol & Mycol, Fac Vet Med, D-04103 Leipzig, Germany; [Dittmar, Katja; Stoeckel, Frank S.] Univ Leipzig, Inst Parasitol, Fac Vet Med, D-04103 Leipzig, Germany; [Mueller, Hermann] Univ Leipzig, Inst Virol, Fac Vet Med, D-04103 Leipzig, Germany; [Scheinemann, Hendrik A.] Gesell Forderung Med Bio & Umwelttechnol eV, D-06120 Halle, Saale, Germany	Leipzig University; Leipzig University; Leipzig University	Scheinemann, HA (corresponding author), Univ Leipzig, Inst Bacteriol & Mycol, Fac Vet Med, Tierkliniken 29, D-04103 Leipzig, Germany.	scheinemann@gmbu.de		Scheinemann, Hendrik/0000-0002-4275-7672	Deutsche Bundesstifung Umwelt (DBU) [AZ 27937/1, AZ 27937/2]; Sachsisches Landesamt Umwelt; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	Deutsche Bundesstifung Umwelt (DBU); Sachsisches Landesamt Umwelt; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	This study was funded by Deutsche Bundesstifung Umwelt (DBU) (AZ 27937/1&2) and by Sachsisches Landesamt Umwelt. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade-Kappelmann K, 2008, THESIS FREIE U BERLI; Al-Ghazali MR, 1990, J APPL BACTERIOLOGY, V69; Alberto F, 2003, LETT APPL MICROBIOL, V36, P41, DOI 10.1046/j.1472-765X.2003.01260.x; [Anonymous], 2007, RICHTL PRUF CHEM DES; Appel B, 2012, EHEC OUTBREAK 2011 I; Back W, 2008, MIKROBIOLOGIE LEBENS; Bagge E, 2005, WATER RES, V39, P4879, DOI 10.1016/j.watres.2005.03.016; Batmanglij N, 2000, MILK DAIRY, P64; Bernal MP, 1998, AGR ECOSYSTEMS ENV, V69; Biermann U, 1990, BERLINER MUNCHENER T, V103; Boegel K, 1960, ZBL VET MED, V7, P534; Boisvenue RJ, 1990, J HELMINTHOLOGICAL S, V57; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Christensen K.K., 2002, SUPERVISION SANITARY; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Colwell RR, 1979, NATIVE AQUATIC BACTE, P56, DOI DOI 10.1520/STP36003S; Conn VM, 2004, APPL ENVIRON MICROB, V70, P1787, DOI 10.1128/AEM.70.3.1787-1794.2004; Csonka LN, 1989, MICROBIOLOGICAL REV, V53; Denevan WM, 2002, CULTIVATED LANDSCAPE; Eghball B, 1997, J ENVIRON QUAL, V26, P189, DOI 10.2134/jeq1997.00472425002600010027x; Factura H, 2010, WATER SCI TECHNOL, V61, P2673, DOI 10.2166/wst.2010.201; Germans W, 1954, Z PARASITENKD, V16, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Glaser B, 2001, TERRA PRETA PHENOMEN; GLATHE H., 1963, Z. PflErnuhr. Dung., V101, P109, DOI 10.1002/jpln.19631010205; GOEPFERT JM, 1969, J BACTERIOL, V97, P956, DOI 10.1128/JB.97.2.956-958.1969; Haacker K, 1983, ARCH TIERERNAEHRUNG, V33, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; Hammes W. P., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. II., P1535; HARTMANN FA, 1995, J VET DIAGN INVEST, V7, P159, DOI 10.1177/104063879500700128; Herrmann C, 2011, BIORESOURCE TECHNOL, V102, P5153, DOI 10.1016/j.biortech.2011.01.012; HRUBANT GR, 1975, APPL MICROBIOL, V30, P113, DOI 10.1128/AEM.30.1.113-119.1975; Jeffers GT, 2001, MICROBIOL-SGM, V147, P1095, DOI 10.1099/00221287-147-5-1095; Jiang X, 2002, APPL ENV MICROBIOLOG, V68; Johnson PW, 1998, INT J PARASITOL, V28, P627, DOI 10.1016/S0020-7519(97)00210-5; Jones P., 2003, REV LIT OCCURRENCE S; Knarreborg A, 2002, ANIM FEED SCI TECH, V99, P131, DOI 10.1016/S0377-8401(02)00069-X; Kulp K, 2003, HDB DOUGH FERMENTATI; Lehmann E, 1960, Z PFLANZENERNAHR DUN, V89, P42, DOI [10.1002/jpln.19600890105, DOI 10.1002/JPLN.19600890105]; Levine AS, 1940, J BACTERIOL, V39, P499, DOI 10.1128/JB.39.5.499-515.1940; Lind O, 1937, UNTERSUCHUNGEN BAKTE; Linde K, 1981, ZBL BAKT HYG 1; Linde K, 1990, VACCINE, V8; Linde K, 2012, METABOLIC DRIFT MD M; Lund B, 1996, A VANLEEUWENHOEK, V69; Martens W, 1998, P RAMIRAN 98 8 INT C, P529; Maya C, 2010, WATER SCI TECHNOLOGY, V62; Minamisawa K, 2004, APPL ENVIRON MICROB, V70, P3096, DOI 10.1128/AEM.70.5.3096-3102.2004; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Nazir J, 2011, PERSISTENCE H4N6 H5N; NG H, 1969, APPL MICROBIOL, V17, P78, DOI 10.1108/03321649810202991; O'Donell CJ, 1984, APPL ENV MICROBIOLOG, V48; Pourcher AM, 2005, J APPL MICROBIOL, V99, P528, DOI 10.1111/j.1365-2672.2005.02642.x; Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773; Scheffer F, 1963, NEUE AUSGRABUNGEN FO, V1; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Schmidt MWI, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001939; Seamster AP, 1958, AM MIDLAND NATURALIS, V43; Shehata AA, 2012, AVIAN DIS IN PRESS; Skjemstad JO, 1996, AUSTR J SOIL RES; Slepecky RA, 1992, PROKARYOTES, P1663; Smith NJ, 1980, ANN ASS AM GEOGRAPHE, V70; Sommer SG, 2001, EUROPEAN J AGRONOMY, V14; Songer GJ, 2010, VET MICROBIOLOGY; Steiner C., 2009, P423, DOI 10.1007/978-1-4020-9031-8_24; Tavechio AT, 2002, J FOOD PROTECTION, V65; Tiquia SM, 2002, NUTR CYCLING AGROECO, V62; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Van Hofwegen G., 2009, P393; VDLUFA Methodenbuch Band III Die chemische Untersuchung von Futtermitteln, VDLUFA METH; Wilkinson J.M., 2003, SILAGE SCI TECHNOLOG, V42, P1, DOI DOI 10.2134/AGRONMONOGR42.C1	69	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118230	10.1371/journal.pone.0118230	http://dx.doi.org/10.1371/journal.pone.0118230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786255	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500023
J	Allen, HK; An, R; Handelsman, J; Moe, LA				Allen, Heather K.; An, Ran; Handelsman, Jo; Moe, Luke A.			A Response Regulator from a Soil Metagenome Enhances Resistance to the beta-Lactam Antibiotic Carbenicillin in Escherichia coli	PLOS ONE			English	Article							FUNCTIONAL METAGENOMICS; GENES; PERMEABILITY; PROTEINS; STRESS; SYSTEM	Functional metagenomic analysis of soil metagenomes is a method for uncovering as-yet unidentified mechanisms for antibiotic resistance. Here we report an unconventional mode by which a response regulator derived from a soil metagenome confers resistance to the beta-lactam antibiotic carbenicillin in Escherichia coli. A recombinant clone (beta lr16) harboring a 5,169 bp DNA insert was selected from a metagenomic library previously constructed from a remote Alaskan soil. The beta lr16 clone conferred specific resistance to carbenicillin, with limited increases in resistance to other tested antibiotics, including other beta-lactams (penicillins and cephalosporins), rifampin, ciprofloxacin, erythromycin, chloramphenicol, nalidixic acid, fusidic acid, and gentamicin. Resistance was more pronounced at 24 degrees C than at 37 degrees C. Zone-of-inhibition assays suggested that the mechanism of carbenicillin resistance was not due to antibiotic inactivation. The DNA insert did not encode any genes known to confer antibiotic resistance, but did have two putative open reading frames (ORFs) that were annotated as a metallopeptidase and a two-component response regulator. Transposon mutagenesis and subcloning of the two ORFs followed by phenotypic assays showed that the response regulator gene was necessary and sufficient to confer the resistance phenotype. Quantitative reverse transcriptase PCR showed that the response regulator suppressed expression of the ompF porin gene, independently of the small RNA regulator micF, and enhanced expression of the acrD, mdtA, and mdtB efflux pump genes. This work demonstrates that antibiotic resistance can be achieved by the modulation of gene regulation by heterologous DNA. Functional analyses such as these can be important for making discoveries in antibiotic resistance gene biology and ecology.	[Allen, Heather K.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [An, Ran; Moe, Luke A.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Handelsman, Jo] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	United States Department of Agriculture (USDA); University of Kentucky; Yale University	Moe, LA (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA.	luke.moe@uky.edu		Moe, Luke/0000-0001-6864-4660; Allen, Heather K./0000-0002-4232-0462	United States Department of Agriculture National Institute of Food and Agriculture [2011-67020-30195]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [WIS01312]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded in part by grants from United States Department of Agriculture National Institute of Food and Agriculture (2011-67020-30195) and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (WIS01312) to LAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; CDC, 2013, ANTIBIOTIC RESISTANC; Choudhury HG, 2013, PROTEIN SCI, V22, P1287, DOI 10.1002/pro.2311; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mazzariol A, 2000, ANTIMICROB AGENTS CH, V44, P1387, DOI 10.1128/AAC.44.5.1387-1390.2000; McGarvey KM, 2012, APPL ENVIRON MICROB, V78, P1708, DOI 10.1128/AEM.06759-11; NCCLS, 2004, PERF STAND ANT SUSC, P96; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Sambrook J., 2001, MOL CLONING LAB MANU; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; Wichmann F, 2014, MBIO, V5, P9	35	8	10	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120094	10.1371/journal.pone.0120094	http://dx.doi.org/10.1371/journal.pone.0120094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782011	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600125
J	Chetty, S; Govender, P; Zupkosky, J; Pillay, M; Ghebremichael, M; Moosa, MYS; Ndung'u, T; Porichis, F; Kasprowicz, VO				Chetty, Shivan; Govender, Pamla; Zupkosky, Jennifer; Pillay, Mona; Ghebremichael, Musie; Moosa, Mahomed-Yunus S.; Ndung'u, Thumbi; Porichis, Filippos; Kasprowicz, Victoria O.			Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+and CD4+T Cell Functionality	PLOS ONE			English	Article							T-CELLS; INFECTION; RESPONSES; REPLICATION; CYTOKINES; INDUCTION; LOAD	The ability of antigen-specific T cells to simultaneously produce multiple cytokines is thought to correlate with the functional capacity and efficacy of T cells. These 'polyfunctional' T cells have been associated with control of HIV. We aimed to assess the impact of co-infection with Mycobacterium tuberculosis (MTB) on HIV-specific CD8+ and CD4+ T cell function. We assessed T cell functionality in 34 South African adults by investigating the IFN-gamma, IL-2, TNF-alpha, IL-21 and IL-17 cytokine secretion capacity, using polychromatic flow cytometry, following HIV Gag-specific stimulation of peripheral blood mononuclear cells. We show that MTB is associated with lower HIV-specific T cell function in co-infected as compared to HIV mono-infected individuals. This decline in function was greatest in co-infection with active Tuberculosis (TB) compared to co-infection with latent MTB (LTBI), suggesting that mycobacterial load may contribute to this loss of function. The described impact of MTB on HIV-specific T cell function may be a mechanism for increased HIV disease progression in co-infected subjects as functionally impaired T cells may be less able to control HIV.	[Chetty, Shivan; Govender, Pamla; Pillay, Mona; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Chetty, Shivan; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Zupkosky, Jennifer; Ghebremichael, Musie; Ndung'u, Thumbi; Porichis, Filippos; Kasprowicz, Victoria O.] MGH MIT & Harvard, Ragon Inst, Cambridge, MA USA; [Moosa, Mahomed-Yunus S.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Div Internal Med, Dept Infect Dis, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; Max Planck Society	Kasprowicz, VO (corresponding author), Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa.	vkasprowicz@mgh.harvard.edu		Ndung'u, Thumbi/0000-0003-2962-3992	Howard Hughes Medical Institute; Harvard University CFAR grant [P30 AI060354]; South African Medical Research Council (MRC); CU-SA Fogarty AITRP programme; National Heart Lung and Blood Institute of the National Institutes of Health [RO1 HL-092565, R37 AI067073, P01 AI-080192]; Massachusetts General Hospital Executive Committee on Research; Harvard Global Health Institute (HGHI); South African Research Chairs Initiative; Victor Daitz Foundation; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R37AI067073, P01AI080192, R01AI067073] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard University CFAR grant; South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CU-SA Fogarty AITRP programme; National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital Executive Committee on Research; Harvard Global Health Institute (HGHI); South African Research Chairs Initiative; Victor Daitz Foundation; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the following funders: the Howard Hughes Medical Institute (support for T. N., V. O. K.), the Harvard University CFAR grant (P30 AI060354), the South African Medical Research Council (MRC) and The CU-SA Fogarty AITRP programme (S. C.), the National Heart Lung and Blood Institute of the National Institutes of Health (RO1 HL-092565 and R37 AI067073 and P01 AI-080192). F. P. is supported by fellowship grants of the Massachusetts General Hospital Executive Committee on Research and the Harvard Global Health Institute (HGHI). T. N. is also supported by the South African Research Chairs Initiative and the Victor Daitz Foundation. Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Garrait V, 1997, J IMMUNOL, V159, P2824; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Mitchell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037920; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08	15	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118654	10.1371/journal.pone.0118654	http://dx.doi.org/10.1371/journal.pone.0118654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781898	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600032
J	Ghunaim, H; Behnke, JM; Aigha, I; Sharma, A; Doiphode, SH; Deshmukh, A; Abu-Madi, MM				Ghunaim, Haitham; Behnke, Jerzy M.; Aigha, Idil; Sharma, Aarti; Doiphode, Sanjay H.; Deshmukh, Anand; Abu-Madi, Marawan M.			Analysis of Resistance to Antimicrobials and Presence of Virulence/Stress Response Genes in Campylobacter Isolates from Patients with Severe Diarrhoea	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; CIPROFLOXACIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CHICKEN CARCASSES; JEJUNI REQUIRES; INT-407 CELLS; PREVALENCE; STRAINS; MECHANISMS; INVASION	Campylobacter infections are a major cause of diarrhoea world-wide and two of the antimicrobials used for their control (erythromycin and ciprofloxacin) have been losing efficacy in recent years. In a sample of 174 genotyped isolates from the stools of patients with severe diarrhoea in Qatar, collected between 2005 and 2012, 63.2% showed resistance to ciprofloxacin, 8.6% to erythromycin, 0.57% to chloramphenicol and all were sensitive to gentamycin. While 33.9% of isolates were sensitive to all four antimicrobials, 59.8% were resistant to at least one, 6.3% were resistant to two and none showed resistance to three antimicrobials. There was no host sex-or age-dependence among isolates resistant to ciprofloxacin and erythromycin and no significant variation was found with the region of origin of the patients. All isolates were screened for the presence of 3 virulence factors (ciaB, cadF and cdtB) and two stress-response factors (htrB and clpP), all of which were present in more than 50% of the isolates. Host sex-, age- and region of origin-dependent variations in prevalence were found for some of these factors. Data analysis for the combination of virulence factors and their effect on antimicrobial resistance indicated that the prevalence of resistance to both erythromycin and ciprofloxacin was higher in isolates harbouring ciaB but not clpP. Prevalence of resistance to ciprofloxacin was similar in clpP positive and negative isolates also possessing htrB, while for htrB-negative isolates prevalence was higher in the absence of clpP. These results are discussed and their implications are highlighted.	[Ghunaim, Haitham; Aigha, Idil; Sharma, Aarti; Abu-Madi, Marawan M.] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Doha, Qatar; [Behnke, Jerzy M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Doiphode, Sanjay H.; Deshmukh, Anand] Hamad Med Corp, Dept Lab Med & Pathol, Doha, Qatar	Qatar University; University of Nottingham; Hamad Medical Corporation	Abu-Madi, MM (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, POB 2713, Doha, Qatar.	abumadi@qu.edu.qa		Deshmukh, Anand/0000-0001-9784-7192	National Priority Research Program grant from the Qatar National Research Fund [NPRP4-1283-3-327]; Hamad Medical Corporation [13334/13]	National Priority Research Program grant from the Qatar National Research Fund(Qatar National Research Fund (QNRF)); Hamad Medical Corporation	This publication was made possible by a National Priority Research Program grant number NPRP4-1283-3-327 from the Qatar National Research Fund (http://www.qnrf.org/), a member of Qatar Foundation, and Hamad Medical Corporation (http://www.hmc.org.qa) grant #13334/13. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi MA, 2013, AM J TROP MED HYG, V88, P1185, DOI 10.4269/ajtmh.13-0006; Adib N, 2014, TROP BIOMED, V31, P17; Al-Mahmeed A, 2006, J MED MICROBIOL, V55, P839, DOI 10.1099/jmm.0.46500-0; [Anonymous], BIOMED RES INT; Bagger-Skjot L, 2007, SCAND J INFECT DIS, V39, P724, DOI 10.1080/00365540701242400; Barnard C, 2007, ASKING QUESTION BIOL; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chansiripornchai N, 2009, J VET MED SCI, V71, P839, DOI 10.1292/jvms.71.839; CLSI, 2010, METH ANT DIL DISK SU, DOI [10.1016/j.vetmic.2010.01.010, DOI 10.1016/J.VETMIC.2010.01.010]; CLSI, 2014, PERFORMANCE STANDARD; COVER TL, 1990, FEMS MICROBIOL LETT, V70, P301, DOI 10.1016/S0378-1097(05)80012-6; Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0; Deckert A, 2010, J FOOD PROTECT, V73, P1317, DOI 10.4315/0362-028X-73.7.1317; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Dryden MS, 1996, CLIN INFECT DIS, V22, P1019, DOI 10.1093/clinids/22.6.1019; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; England PH, 2014, UK STAND MICR INV IN; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Helms M, 2005, J INFECT DIS, V191, P1050, DOI 10.1086/428453; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hou FQ, 2012, SCAND J INFECT DIS, V44, P439, DOI 10.3109/00365548.2011.652163; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; JIMENEZ A, 1994, J ANTIMICROB CHEMOTH, V33, P188, DOI 10.1093/jac/33.1.188; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Li CC, 1998, SCAND J INFECT DIS, V30, P39, DOI 10.1080/003655498750002286; Liao CH, 2012, J INFECTION, V65, P392, DOI 10.1016/j.jinf.2012.06.014; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; McDermott PF, 2002, J INFECT DIS, V185, P837, DOI 10.1086/339195; McGowan-Spicer LL, 2008, J FOOD PROTECT, V71, P760, DOI 10.4315/0362-028X-71.4.760; Momtaz H, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-39; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Nachamkin I, 2002, EMERG INFECT DIS, V8, P1501, DOI 10.3201/eid0812.020115; Nelson JM, 2004, J INFECT DIS, V190, P1150, DOI 10.1086/423282; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Payot S, 2006, MICROBES INFECT, V8, P1967, DOI 10.1016/j.micinf.2005.12.032; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Perez-Boto D, 2014, AVIAN PATHOL, V43, P176, DOI 10.1080/03079457.2014.898245; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; Rohlf F.J., 1995, STAT TABLES; Rozynek E, 2005, J MED MICROBIOL, V54, P615, DOI 10.1099/jmm.0.45988-0; Rozynek E, 2008, J FOOD PROTECT, V71, P602; Saenz Y, 2000, ANTIMICROB AGENTS CH, V44, P267, DOI 10.1128/AAC.44.2.267-271.2000; Sonnevend A, 2006, J MED MICROBIOL, V55, P1533, DOI 10.1099/jmm.0.46744-0; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Strachan NJC, 2008, EPIDEMIOL INFECT, V136, P1492, DOI 10.1017/S0950268807009934; Szymanski CM, 2012, GUT MICROBES, V3, P135, DOI 10.4161/gmic.19488; Unicomb LE, 2006, CLIN INFECT DIS, V42, P1368, DOI 10.1086/503426; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wiemer D, 2011, INT J MED MICROBIOL, V301, P577, DOI 10.1016/j.ijmm.2011.06.001; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	55	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119268	10.1371/journal.pone.0119268	http://dx.doi.org/10.1371/journal.pone.0119268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781009	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600057
J	Gigante, B; Strawbridge, RJ; Velasquez, IM; Golabkesh, Z; Silveira, A; Goel, A; Baldassarre, D; Veglia, F; Tremoli, E; Clarke, R; Watkins, H; Hamsten, A; Humphries, SE; de Faire, U				Gigante, Bruna; Strawbridge, Rona J.; Velasquez, Ilais Moreno; Golabkesh, Zahra; Silveira, Angela; Goel, Anuj; Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena; Clarke, Robert; Watkins, Hugh; Hamsten, Anders; Humphries, Steve E.; de Faire, Ulf			Analysis of the Role of Interleukin 6 Receptor Haplotypes in the Regulation of Circulating Levels of Inflammatory Biomarkers and Risk of Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENE; EXPRESSION; VARIANT; LOCUS; WOMEN	Variants at the interleukin 6 receptor (IL6R) gene regulate inflammation and are associated with risk of coronary heart disease (CHD). The aim of the present study was to investigate the effects of IL6R haplotypes on circulating levels of inflammatory biomarkers and risk of CHD. We performed a discovery analysis in SHEEP, a myocardial infarction (MI) case control study (n = 2,774) and replicated our results in two large, independent European populations, PROCARDIS, a CHD case control study (n = 7,998), and IMPROVE (n = 3,711) a prospective cardiovascular cohort study. Two major haplotype blocks (rs12083537A/G and rs4075015A/T-block 1; and rs8192282G/A, rs4553185T/C, rs8192284A/C, rs4240872T/C and rs7514452T/C-block 2) were identified in the IL6R gene. IL6R haplotype associations with C-reactive protein (CRP), fibrinogen, IL6, soluble IL6R (sIL6R), IL6, IL8 and TNF-alpha in SHEEP, CRP and fibrinogen in PROCARDIS and CRP in IMPROVE as well as association with risk of MI and CHD, were analyzed by THESIAS. Haplotypes in block 1 were associated neither with circulating inflammatory biomarkers nor with the MI/CHD risk. Haplotypes in block 2 were associated with circulating levels of CRP, in all three study populations, with fibrinogen in SHEEP and PROCARDIS, with IL8 and sIL6Rin SHEEP and with a modest, non significant, increase (7%) in MI/CHD risk in the three populations studied. Our results indicate that IL6R haplotypes regulate the circulating levels of inflammatory biomarkers. Lack of association with the risk of CHD may be explained by the combined effect of SNPs with opposite effect on the CHD risk, the sample size as well as by structural changes affecting sIL6R stability in the circulation.	[Gigante, Bruna; Velasquez, Ilais Moreno; Golabkesh, Zahra; de Faire, Ulf] Inst Environm Med IMM, Unit Cardiovasc Epidemiol, Stockholm, Sweden; [Gigante, Bruna] Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Strawbridge, Rona J.; Silveira, Angela; Hamsten, Anders] Karolinska Inst, Atherosclerosis Res Unit, Dept Med Solna, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Goel, Anuj; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Baldassarre, Damiano; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Hamsten, Anders; de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6BT, England	Danderyds Hospital; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of Milan; IRCCS Centro Cardiologico Monzino; University of Oxford; Karolinska Institutet; Karolinska University Hospital; University of London; University College London	Gigante, B (corresponding author), Inst Environm Med IMM, Unit Cardiovasc Epidemiol, Stockholm, Sweden.	bruna.gigante@ki.se	Veglia, Fabrizio/K-1958-2016; Baldassarre, Damiano/J-3295-2016; Strawbridge, Rona/H-5422-2012; Gigante, Bruna/I-9252-2012; TREMOLI, ELENA/I-8126-2018	Veglia, Fabrizio/0000-0002-9378-8874; Baldassarre, Damiano/0000-0002-2766-8882; Strawbridge, Rona/0000-0001-8506-3585; Gigante, Bruna/0000-0003-4508-7990; Watkins, Hugh/0000-0002-5287-9016; Moreno Velasquez, Ilais/0000-0001-6058-8983; Humphries, Stephen E/0000-0002-8221-6547; Silveira, Angela/0000-0003-2063-4935; TREMOLI, ELENA/0000-0002-0929-6106; Goel, Anuj/0000-0003-2307-4021	European Community Sixth Framework Program [LSHM-CT-2007-037273]; AstraZeneca; British Heart Foundation; Oxford British Heart Foundation Centre of Research Excellence; Wellcome Trust [075491/Z/04]; Swedish Research Council [8691, 0593]; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular and Diabetes Program of Karolinska Institutet; Strategic Cardiovascular and Diabetes Program of Stockholm County Council; Foundation for Strategic Research [560283]; European Commission [QLG1-CT-2002-00896]; Stockholm County Council; Academy of Finland [110413]; British Heart Foundation [RG2008/08, RG2008/014]; Italian Ministry of Health (Ricerca Corrente); Stockholm County Council [20130053]; Swedish Heart-Lung Foundation [20130220]; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	European Community Sixth Framework Program(European Commission); AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation); Oxford British Heart Foundation Centre of Research Excellence; Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular and Diabetes Program of Karolinska Institutet; Strategic Cardiovascular and Diabetes Program of Stockholm County Council; Foundation for Strategic Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Stockholm County Council(Stockholm County Council); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); British Heart Foundation(British Heart Foundation)	The PROCARDIS was supported by the European Community Sixth Framework Program (LSHM-CT-2007-037273), AstraZeneca, the British Heart Foundation, the Oxford British Heart Foundation Centre of Research Excellence, the Wellcome Trust (075491/Z/04), the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular and Diabetes Programs of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and the Stockholm County Council (560283) The IMPROVE study was supported by the European Commission (Contract number: QLG1-CT-2002-00896), the Swedish Heart-Lung Foundation, the Swedish Research Council (projects 8691 and 0593), the Knut and Alice Wallenberg Foundation, the Foundation for Strategic Research, the Stockholm County Council (project 592229), the Strategic Cardiovascular and Diabetes Programmes of Karolinska Institutet and Stockholm County Council, the European Union Framework Programme 7 (FP7/2007-2013) for the Innovative Medicine Initiative under grant agreement no IMI/115006 (the SUMMIT consortium), the Academy of Finland (Grant #110413), the British Heart Foundation (RG2008/08, RG2008/014) and the Italian Ministry of Health (Ricerca Corrente). The present study was funded by a research grant from Stockholm County Council (grant n. 20130053 to BG) and a research grant from the the Swedish Heart-Lung Foundation (grant 20130220 to UdF). The funding organizations and/or sponsors have not had any role in the design or conduct of the study, the collection, management, analysis or interpretation of the data, writing and/or approving the manuscript.	Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bland JM, 1996, BRIT MED J, V312, P1079; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Gigante B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011300; Gigante B, 2009, THROMB HAEMOSTASIS, V101, P943, DOI 10.1160/TH08-09-0612; Horiuchi S, 1998, IMMUNOLOGY, V95, P360, DOI 10.1046/j.1365-2567.1998.00622.x; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Leander K, 2012, CLIN CHIM ACTA, V413, P727, DOI 10.1016/j.cca.2012.01.002; Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Qi L, 2009, DIABETES, V58, P275, DOI 10.2337/db08-0968; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; Revez JA, 2013, GENES IMMUN, V14, P441, DOI 10.1038/gene.2013.38; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Small KM, 2008, J CARDIOVASC PHARM, V51, P106, DOI 10.1097/FJC.0b013e31815a958f; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793	30	17	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119980	10.1371/journal.pone.0119980	http://dx.doi.org/10.1371/journal.pone.0119980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781951	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000351284600114
J	Kim, EH; Kim, S; Lee, JH; Kim, J; Han, Y; Kim, YM; Kim, GB; Jung, K; Cheong, HK; Ahn, K				Kim, Eun-Hye; Kim, Soyeon; Lee, Jung Hyun; Kim, Jihyun; Han, Youngshin; Kim, Young-Min; Kim, Gyo-Boong; Jung, Kweon; Cheong, Hae-Kwan; Ahn, Kangmo			Indoor Air Pollution Aggravates Symptoms of Atopic Dermatitis in Children	PLOS ONE			English	Article							SICK BUILDING SYNDROME; BARRIER FUNCTION; SKIN BARRIER; RISK-FACTORS; FORMALDEHYDE; ASSOCIATION; EXPOSURE; ECZEMA; POLLUTANTS; EMISSIONS	Most of researches on the impact of indoor air pollutants on atopic dermatitis (AD) have been based upon animal models, in vitro experiments and case-control studies. However, human data to elucidate the role of indoor air pollution on worsening symptoms of preexisting AD from a longitudinal study are scarce. The objective of this prospective study was to evaluate the effect of indoor air pollution on AD symptoms in children. We surveyed 30 children with AD in a day-care centre, which moved to a new building during the study. These children stayed there for 8 hours a day Monday through Friday, and their daily symptom scores were recorded. Indoor and outdoor air pollutant levels were continuously measured 24 hours a day for 12 months (Period 1 to 4). Data were analyzed using a generalized linear mixed model. Compared to the period before moving (Period 1), concentrations of indoor air pollutants mostly increased after moving (Period 2) and decreased by natural ventilation and bake-out (Periods 3 and 4). The rate of positive AD symptom increased from 32.8% (Period 1) up to 43.8%(Period 2) and 50.5% (Period 3), then decreased to 35.4% in Period 4 (P < 0.0001). When the delayed effects of indoor air pollutants on AD symptoms 2 days later were evaluated, AD symptoms significantly increased by 12.7% (95% CI: -0.01 to 27.1) as toluene levels increased by 1 ppb (P = 0.05). In conclusion, indoor air pollutants increase the risk of AD aggravation in children and toluene in the indoor environment might act as an aggravating factor.	[Kim, Eun-Hye; Kim, Soyeon; Cheong, Hae-Kwan] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon, South Korea; [Kim, Eun-Hye; Cheong, Hae-Kwan] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Lee, Jung Hyun; Kim, Jihyun; Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Kim, Jihyun; Han, Youngshin; Kim, Young-Min; Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea; [Kim, Gyo-Boong; Jung, Kweon] Seoul Res Inst Publ Hlth & Environm, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cheong, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon, South Korea.	hkcheong@skku.edu; kmaped@gmail.com	Ahn, Kangmo/F-4609-2014	Cheong, Hae-Kwan/0000-0003-2758-9399	Ministry of Environment (MOE), Republic of Korea	Ministry of Environment (MOE), Republic of Korea	This study was financially supported by the Ministry of Environment (MOE), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P651, DOI 10.1016/j.jaci.2008.11.036; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Eberlein-Konig B, 1998, J ALLERGY CLIN IMMUN, V101, P141, DOI 10.1016/S0091-6749(98)70212-X; Flamant-Hulin M, 2010, J TOXICOL ENV HEAL A, V73, P272, DOI 10.1080/15287390903249206; Futamura M, 2009, TOXICOLOGY, V255, P100, DOI 10.1016/j.tox.2008.10.012; Giusti F, 2001, PEDIATR DERMATOL, V18, P93, DOI 10.1046/j.1525-1470.2001.018002093.x; GUZELIAN PS, 1992, PEDIATRICS, V89, P353; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; Hodgson AT, 2002, INDOOR AIR, V12, P235, DOI 10.1034/j.1600-0668.2002.01129.x; Hulin M, 2012, EUR RESPIR J, V40, P1033, DOI 10.1183/09031936.00159011; Huss-Marp J, 2006, CLIN EXP ALLERGY, V36, P338, DOI 10.1111/j.1365-2222.2006.02448.x; Kang DH, 2010, BUILD ENVIRON, V45, P1816, DOI 10.1016/j.buildenv.2010.02.010; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Landrigan P J, 1998, Int J Occup Med Environ Health, V11, P189; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; MONTGOMERY MR, 1994, J ALLERGY CLIN IMMUN, V94, P371; Nakayama K, 2007, Int J Immunopathol Pharmacol, V20, P35; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Saito A, 2011, ENVIRON TOXICOL, V26, P224, DOI 10.1002/tox.20547; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Xu BH, 2002, IMMUNOL LETT, V84, P49, DOI 10.1016/S0165-2478(02)00126-8	29	51	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119501	10.1371/journal.pone.0119501	http://dx.doi.org/10.1371/journal.pone.0119501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781186	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600068
J	Ebneter, A; Agca, C; Dysli, C; Zinkernagel, MS				Ebneter, Andreas; Agca, Cavit; Dysli, Chantal; Zinkernagel, Martin S.			Investigation of Retinal Morphology Alterations Using Spectral Domain Optical Coherence Tomography in a Mouse Model of Retinal Branch and Central Retinal Vein Occlusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYSTOID MACULAR EDEMA; RISK-FACTORS; RAT MODEL; NEOVASCULARIZATION; INTERLEUKIN-6; PATHOGENESIS; MICE	Retinal vein occlusion is a leading cause of visual impairment. Experimental models of this condition based on laser photocoagulation of retinal veins have been described and extensively exploited in mammals and larger rodents such as the rat. However, few reports exist on the use of this paradigm in the mouse. The objective of this study was to investigate a model of branch and central retinal vein occlusion in the mouse and characterize in vivo longitudinal retinal morphology alterations using spectral domain optical coherence tomography. Retinal veins were experimentally occluded using laser photocoagulation after intravenous application of Rose Bengal, a photo-activator dye enhancing thrombus formation. Depending on the number of veins occluded, variable amounts of capillary dropout were seen on fluorescein angiography. Vascular endothelial growth factor levels were markedly elevated early and peaked at day one. Retinal thickness measurements with spectral domain optical coherence tomography showed significant swelling (p<0.001) compared to baseline, followed by gradual thinning plateauing two weeks after the experimental intervention (p<0.001). Histological findings at day seven correlated with spectral domain optical coherence tomography imaging. The inner layers were predominantly affected by degeneration with the outer nuclear layer and the photoreceptor outer segments largely preserved. The application of this retinal vein occlusion model in the mouse carries several advantages over its use in other larger species, such as access to a vast range of genetically modified animals. Retinal changes after experimental retinal vein occlusion in this mouse model can be non-invasively quantified by spectral domain optical coherence tomography, and may be used to monitor effects of potential therapeutic interventions.	[Zinkernagel, Martin S.] Univ Hosp Bern, Dept Ophthalmol, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Zinkernagel, MS (corresponding author), Univ Hosp Bern, Dept Ophthalmol, Inselspital, CH-3010 Bern, Switzerland.	martin.zinkernagel@insel.ch	Zinkernagel, Martin/C-3799-2017; Agca, Cavit/AAY-9574-2020; Ebneter, Andreas/C-5226-2017	Zinkernagel, Martin/0000-0002-5622-114X; Agca, Cavit/0000-0001-8472-7052; Ebneter, Andreas/0000-0001-6666-2558; Zinkernagel, Martin S./0000-0003-3447-2359	Inselspital Bern; OPOS foundation	Inselspital Bern; OPOS foundation	These studies were supported by grants from the Inselspital Bern and the OPOS foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri H, 2008, GRAEF ARCH CLIN EXP, V246, P1429, DOI 10.1007/s00417-008-0878-4; Bek T, 2009, ACTA OPHTHALMOL, V87, P362, DOI 10.1111/j.1755-3768.2008.01429.x; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; CAMPBELL FP, 1961, ARCH OPHTHALMOL-CHIC, V65, P2, DOI 10.1001/archopht.1961.01840020004002; Campochiaro PA, 2012, OPHTHALMOLOGICA, V227, P30, DOI 10.1159/000337157; Chidlow G, 2006, INVEST OPHTH VIS SCI, V54, P2319, DOI DOI 10.1167/IOVS.12-11204; Chuang LH, 2011, OPHTHALMIC RES, V45, P31, DOI 10.1159/000315617; Comyn O, 2013, CURR OPIN OPHTHALMOL, V24, P248, DOI 10.1097/ICU.0b013e32835fab27; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Fischer M Dominik, 2013, Methods Mol Biol, V935, P79, DOI 10.1007/978-1-62703-080-9_5; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Genevois O, 2004, INVEST OPHTH VIS SCI, V45, P594, DOI 10.1167/iovs.03-0764; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Jaulim A, 2013, RETINA-J RET VIT DIS, V33, P901, DOI 10.1097/IAE.0b013e3182870c15; Karia N, 2010, CLIN OPHTHALMOL, V4, P809; Lozano DC, 2013, INVEST OPHTH VIS SCI, V54, P6446, DOI 10.1167/iovs.13-12575; Maier R, 2011, OPHTHALMOLOGY, V118, P1125, DOI 10.1016/j.ophtha.2010.10.014; McAllister IL, 2013, INVEST OPHTH VIS SCI, V54, P4910, DOI 10.1167/iovs.13-11967; McAllister IL, 2012, CLIN EXP OPHTHALMOL, V40, P48, DOI 10.1111/j.1442-9071.2011.02713.x; McAllister IL, 2010, OPHTHALMOLOGY, V117, P954, DOI 10.1016/j.ophtha.2009.10.026; Mendrinos E, 2011, INVEST OPHTH VIS SCI, V52, P3215, DOI 10.1167/iovs.10-6888; Nakao S, 2013, INVEST OPHTH VIS SCI, V54, P5288, DOI 10.1167/iovs.13-11946; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Noma H, 2013, JAMA OPHTHALMOL, V131, P160, DOI 10.1001/2013.jamaophthalmol.228; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Park SP, 2010, RETINA-J RET VIT DIS, V30, P281, DOI 10.1097/IAE.0b013e3181b9f153; Rehak M, 2011, GRAEF ARCH CLIN EXP, V249, P1175, DOI 10.1007/s00417-011-1683-z; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Scholl S, 2010, OPHTHALMOLOGICA, V224, P8, DOI 10.1159/000315155; Shen LJ, 2009, CURR EYE RES, V34, P415, DOI 10.1080/02713680902862989; Tameesh MK, 2004, AM J OPHTHALMOL, V138, P829, DOI 10.1016/j.ajo.2004.06.083; Weinberg DV, 2013, RETINA-J RET VIT DIS, V33, P287, DOI 10.1097/IAE.0b013e318263d106; WILSON CA, 1991, INVEST OPHTH VIS SCI, V32, P2357; WOLF S, 1994, GRAEF ARCH CLIN EXP, V232, P33, DOI 10.1007/BF00176435; YANOFF M, 1984, SURV OPHTHALMOL, V28, P505, DOI 10.1016/0039-6257(84)90233-9; Zhang H, 2007, JPN J OPHTHALMOL, V51, P251, DOI 10.1007/s10384-007-0445-2; Zhang Y, 2008, CURR EYE RES, V33, P365, DOI 10.1080/02713680801939318	41	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119046	10.1371/journal.pone.0119046	http://dx.doi.org/10.1371/journal.pone.0119046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775456	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500065
J	Wang, XB; Lou, MN; Li, YJ; Ye, WJ; Zhang, ZY; Jia, XF; Shi, HY; Zhu, XC; Wang, LX				Wang, XiaoBing; Lou, MeiNa; Li, Yongji; Ye, WenJing; Zhang, ZhiYong; Jia, Xiufen; Shi, HongYing; Zhu, XiaoChun; Wang, LiangXing			Cardiovascular Involvement in Connective Tissue Disease: The Role of Interstitial Lung Disease	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-ARTERY-DISEASE; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; ENDOTHELIAL FUNCTION; COMPUTED-TOMOGRAPHY; CARDIAC INVOLVEMENT; PULMONARY-FIBROSIS; RISK; ATHEROSCLEROSIS	Objective The aim of this study was to assess cardiovascular involvement in patients with connective tissue disease (CTD), and determine whether interstitial lung disease (ILD) in these patients is associated with elevated cardiovascular risk. Methods This study evaluated a retrospective cohort of 436 CTD patients admitted to a large teaching hospital in Zhejiang province, China, along with an additional 436 participants of an annual community health screening conducted in the physical examination center who served as age-and gender-matched controls. Demographic, clinical, serologic and imaging characteristics, as well as medications used by each participant were recorded. Cardiovascular involvement was defined by uniform criteria. Correlations between clinical/serologic factors and cardiovascular involvement were determined by univariate and multivariate analyses. Results CTD patients had a significantly higher cardiovascular involvement rate than controls (64.7% vs 23.4%), with higher rates of diabetes, hypertension, and hyperlipidemia, elevated systolic and diastolic pressures, C-reactive protein, total cholesterol, and low-density lipoprotein cholesterol, and lower albumin and high-density lipoprotein cholesterol (all p < 0.05). Furthermore, CTP patients with cardiovascular involvement were significantly older, had higher systolic and diastolic pressures, C-reactive protein, glucose, and uric acid, higher rates of diabetes, hypertension, and use of moderate-to high-dose glucocorticoids, and longer disease duration compared to patients without involvement (all p < 0.05). Moreover, CTD in patients with cardiovascular involvement was more likely to be complicated by ILD (p < 0.01), which manifested as a higher alveolar inflammation score (p < 0.05). In the multivariate analysis, cardiovascular involvement in CTD patients was associated with age, systolic pressure, body mass index, uric acid, disease duration > 2 years, use of moderate-to high-dose glucocorticoids, and ILD with a high alveolar inflammation score. Conclusion Cardiovascular involvement is increased in CTD patients, and is associated with ILD with a higher alveolar inflammation score. Thus, early-stage echocardiography and CT scans should be used to detect potential cardiovascular complications in these patients.	[Wang, XiaoBing; Li, Yongji; Ye, WenJing; Zhang, ZhiYong; Zhu, XiaoChun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Rheumal, Wenzhou, Zhejiang, Peoples R China; [Lou, MeiNa] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China; [Jia, Xiufen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Shi, HongYing] Wenzhou Med Univ, Sch Environm Sci & Publ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Wang, LiangXing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Zhejiang, Peoples R China.	wzyxywlx@163.com		Ye, Wenjing/0000-0003-0754-0643				[Anonymous], 1980, ARTHRITIS RHEUMATISM, V23, P581; Antoniou KM, 2009, EUR RESPIR J, V33, P882, DOI 10.1183/09031936.00152607; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arosio E, 2007, J HYPERTENS, V25, P1273, DOI 10.1097/HJH.0b013e3280b0157e; Bartoloni E, 2013, CLIN REV ALLERG IMMU, V44, P14, DOI 10.1007/s12016-010-8251-x; Bassi N, 2007, AUTOIMMUN REV, V7, P52, DOI 10.1016/j.autrev.2007.06.003; Belizna CC, 2007, AUTOIMMUN REV, V7, P46, DOI 10.1016/j.autrev.2007.06.002; Boueiz A, 2010, CURR OPIN RHEUMATOL, V22, P696, DOI 10.1097/BOR.0b013e32833dfbd8; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DeMarco P, 2006, CURR RHEUMATOL REP, V8, P114; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; Fimognari Filippo Luca, 2008, Int J Chron Obstruct Pulmon Dis, V3, P89; Flaherty KR, 2003, THORAX, V58, P143, DOI 10.1136/thorax.58.2.143; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; HEJTMANCIK MR, 1964, AM HEART J, V68, P119, DOI 10.1016/0002-8703(64)90248-0; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Kizer JR, 2004, ARCH INTERN MED, V164, P551, DOI 10.1001/archinte.164.5.551; Kocheril SV, 2005, ARTHRIT RHEUM-ARTHR, V53, P549, DOI 10.1002/art.21322; Launay D, 2006, J RHEUMATOL, V33, P1789; Maki-Petaja KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076; Meune C, 2008, ARTHRITIS RHEUM-US, V58, P1803, DOI 10.1002/art.23463; Mosca M, 2012, BEST PRACT RES CL RH, V26, P73, DOI 10.1016/j.berh.2012.01.005; Nurmohamed MT, 2009, AUTOIMMUN REV, V8, P663, DOI 10.1016/j.autrev.2009.02.015; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarzi-Puttini P, 2010, AUTOIMMUN REV, V9, P849, DOI 10.1016/j.autrev.2010.08.002; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Sitia S, 2009, AUTOIMMUN REV, V8, P281, DOI 10.1016/j.autrev.2008.08.004; TAN EM, 1982, ARTHRITIS RHEUM, V25, P753, DOI 10.1002/art.1780250707; Turiel M, 2005, LUPUS, V14, P727, DOI 10.1191/0961203305lu2209oa; Turiel M, 2010, AUTOIMMUN REV, V9, P414, DOI 10.1016/j.autrev.2009.11.002; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121976	10.1371/journal.pone.0121976	http://dx.doi.org/10.1371/journal.pone.0121976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775471	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500218
J	Guo, JC; Li, J; Zhao, YP; Zhou, L; Cui, QC; Zhou, WX; Zhang, TP; You, L				Guo, Jun-Chao; Li, Jian; Zhao, Yu-Pei; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun; Zhang, Tai-Ping; You, Lei			Expression of c-fos Was Associated with Clinicopathologic Characteristics and Prognosis in Pancreatic Cancer	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; LYMPH-NODE METASTASIS; CELL LUNG CARCINOMAS; DUCTAL ADENOCARCINOMA; PROGRESSION; SURVIVAL; PANCREATICODUODENECTOMY; RESECTION; INVASION; PROTEIN	It has long been regarded that pancreatic cancer (PC) is a life-threatening malignant tumor. Thus, much attention has been paid for factors, especially relative molecules, predictive for prognosis of PC. However, c-fos expression in PC was less investigated. In addition, its association with clinicopathologic variables and prognosis remains unknown. In the present study, expression of c-fos was detected by tissue microarray-based immunohistochemical staining in cancer and adjacent tissues from 333 patients with PC. The staining results were correlated with clinicopathologic parameters and overall survival. Furthermore, prognostic significance of c-fos in subsets of PC was also evaluated. It was shown that low expression of c-fos was more often in cancer than in adjacent tissues of PC (P<0.001). Besides, high cancerous c-fos expression was significantly associated with tumor site and T stage, whereas peri-neural invasion was of a borderline significant relevance. Log-rank test revealed that high expression of c-fos in cancer tissues was a significant marker of poor overall survival, accompanied by some conventional clinicopathologic variables, such as sex, grade, peri-neural invasion, T and N stages. More importantly, cancerous c-fos expression was identified as an independent prognosticator in multivariate analysis. Finally, the prognostic implication of c-fos expression was proven in four subsets of patients with PC. These data suggested that c-fos expression was of relationships with progression and dismal prognosis of PC.	[Guo, Jun-Chao; Li, Jian; Zhao, Yu-Pei; Zhou, Li; Zhang, Tai-Ping; You, Lei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China; [Cui, Quan-Cai; Zhou, Wei-Xun] Chinese Acad Med Sci, Peking Union Med Coll, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhao, YP (corresponding author), Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	zhao8028@263.net	Zhou, Li/GSE-4531-2022		National High Technology Research and Development Program (863 Program), China [2014AA020609]	National High Technology Research and Development Program (863 Program), China(National High Technology Research and Development Program of China)	This work was supported by National High Technology Research and Development Program (863 Program, 2014AA020609, http://program. most. gov.cn/), China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi J, 1997, INVAS METAST, V17, P16; Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; Briso EM, 2013, GENE DEV, V27, P1959, DOI 10.1101/gad.223339.113; Chatterjee D, 2012, AM J SURG PATHOL, V36, P552, DOI 10.1097/PAS.0b013e318240c1c0; Chatterjee D, 2012, AM J SURG PATHOL, V36, P409, DOI 10.1097/PAS.0b013e31824104c5; Distler M, 2013, INT J SURG, V11, P1067, DOI 10.1016/j.ijsu.2013.10.005; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Guo JC, 2014, WORLD J SURG, V38, P2126, DOI 10.1007/s00268-014-2500-8; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jin SP, 2007, PATHOL ONCOL RES, V13, P284, DOI 10.1007/BF02940306; Kim JH, 2010, TUMOR BIOL, V31, P541, DOI 10.1007/s13277-010-0067-z; La Torre M, 2011, J SURG ONCOL, V104, P629, DOI 10.1002/jso.22013; Lee C. Soon, 1994, Zentralblatt fuer Pathologie, V140, P271; Li BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057818; Li SQ, 2013, BIOCHEM BIOPH RES CO, V441, P976, DOI 10.1016/j.bbrc.2013.11.006; Ling SB, 2014, ONCOL LETT, V7, P1747, DOI 10.3892/ol.2014.2003; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murakami Y, 2010, WORLD J SURG, V34, P1900, DOI 10.1007/s00268-010-0577-2; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; Poi MJ, 2013, BIOCHEM BIOPH RES CO, V436, P217, DOI 10.1016/j.bbrc.2013.05.078; Sakorafas G H, 1995, Eur J Surg Oncol, V21, P251, DOI 10.1016/S0748-7983(95)91294-0; Shi RZ, 2013, J CELL BIOCHEM, V114, P1890, DOI 10.1002/jcb.24533; Singh A, 1998, AM J CLIN ONCOL-CANC, V21, P466, DOI 10.1097/00000421-199810000-00009; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010; VOLM M, 1993, J CANCER RES CLIN, V119, P507, DOI 10.1007/BF01686458; Volm M, 1998, BRIT J CANCER, V77, P663, DOI 10.1038/bjc.1998.106; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; Witkowski ER, 2013, J SURG ONCOL, V107, P97, DOI 10.1002/jso.23267; Zhang YJ, 2012, J GASTROINTEST SURG, V16, P1875, DOI 10.1007/s11605-012-1985-4; Zhou L, 2010, ARCH MED RES, V41, P201, DOI 10.1016/j.arcmed.2010.04.009	35	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120332	10.1371/journal.pone.0120332	http://dx.doi.org/10.1371/journal.pone.0120332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789763	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400152
J	do Rego, JL; Vaudry, D; Vaudry, H				do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert			The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; SEROTONIN REUPTAKE INHIBITORS; 17,20 LYASE ACTIVITY; BIOLOGICAL-ACTIVITY; NERVOUS-SYSTEM; IMMUNOCYTOCHEMICAL LOCALIZATION; OCTADECANEUROPEPTIDE ODN; SERINE PHOSPHORYLATION; PROGESTERONE SYNTHESIS	Neurosteroids can modulate the activity of the GABAA receptors, and thus affect anxiety-like behaviors. The non-benzodiazepine anxiolytic compound etifoxine has been shown to increase neurosteroid concentrations in brain tissue but the mode of action of etifoxine on neurosteroid formation has not yet been elucidated. In the present study, we have thus investigated the effect and the mechanism of action of etifoxine on neurosteroid biosynthesis using the frog hypothalamus as an experimental model. Exposure of frog hypothalamic explants to graded concentrations of etifoxine produced a dose-dependent increase in the biosynthesis of 17-hydroxypregnenolone, dehydroepiandrosterone, progesterone and tetrahydroprogesterone, associated with a decrease in the production of dihydroprogesterone. Time-course experiments revealed that a 15-min incubation of hypothalamic explants with etifoxine was sufficient to induce a robust increase in neurosteroid synthesis, suggesting that etifoxine activates steroidogenic enzymes at a post-translational level. Etifoxine-evoked neurosteroid biosynthesis was not affected by the central-type benzodiazepine (CBR) receptor antagonist flumazenil, the translocator protein (TSPO) antagonist PK11195 or the GABAA receptor antagonist bicuculline. In addition, the stimulatory effects of etifoxine and the triakontatetraneuropeptide TTN, a TSPO agonist, were additive, indicating that these two compounds act through distinct mechanisms. Etifoxine also induced a rapid stimulation of neurosteroid biosynthesis from frog hypothalamus homogenates, a preparation in which membrane receptor signalling is disrupted. In conclusion, the present study demonstrates that etifoxine stimulates neurosteroid production through a membrane receptor-independent mechanism.	[do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert] Univ Rouen, IRIB, Mont St Aignan, France; [do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert] Univ Rouen, Int Associated Lab Samuel Champlain, Reg Platform Cell Imaging PRIMACEN, Mont St Aignan, France; [Vaudry, David; Vaudry, Hubert] Univ Rouen, INSERM, Neurotroph Factors & Neuronal Differentiat, U982, Mont St Aignan, France	Universite de Rouen Normandie; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Vaudry, H (corresponding author), Univ Rouen, IRIB, Mont St Aignan, France.	hubert.vaudry@univ-rouen.fr	VAUDRY, David/M-1454-2018	VAUDRY, David/0000-0003-3567-7452	Inserm [U413]; University of Rouen; Region Haute-Normandie; pharmaceutical company BIOCODEX;  [IFRPM23/IRIB]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rouen; Region Haute-Normandie(Region Normandie); pharmaceutical company BIOCODEX; 	This work was partially supported by grants from Inserm (U413), IFRPM23/IRIB, University of Rouen and Region Haute-Normandie. Partial funding support was also provided by the pharmaceutical company BIOCODEX, which had no role in study design, data collection, analysis and interpretation, and writing of this manuscript.	Akwa Y, 1999, BEHAV BRAIN RES, V106, P119, DOI 10.1016/S0166-4328(99)00101-1; AKWA Y, 1991, J STEROID BIOCHEM, V40, P71, DOI 10.1016/0960-0760(91)90169-6; Aouad M, 2009, PAIN, V147, P54, DOI 10.1016/j.pain.2009.08.001; ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Beaujean D, 2002, ENDOCRINOLOGY, V143, P1950, DOI 10.1210/en.143.5.1950; Beaujean D, 1999, J NEUROCHEM, V72, P848, DOI 10.1046/j.1471-4159.1999.720848.x; Beyer C, 1999, HORM BEHAV, V35, P1, DOI 10.1006/hbeh.1998.1457; BOISSIER JR, 1972, THERAPIE, V27, P325; Burel D, 2013, ENDOCRINOLOGY, V154, P2114, DOI 10.1210/en.2013-1095; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Do Rego JL, 2007, J MED CHEM, V50, P3070, DOI 10.1021/jm0610548; Do Rego JL, 2007, J NEUROCHEM, V100, P251, DOI 10.1111/j.1471-4159.2006.04209.x; Do Rego Jean Luc, 2012, Front Endocrinol (Lausanne), V3, P4, DOI 10.3389/fendo.2012.00004; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Do-Rego JL, 2006, J NEUROSCI, V26, P6749, DOI 10.1523/JNEUROSCI.4469-05.2006; Do-Rego JL, 2000, P NATL ACAD SCI USA, V97, P13925, DOI 10.1073/pnas.240269897; Do-Rego JL, 2001, J NEUROCHEM, V76, P128, DOI 10.1046/j.1471-4159.2001.00053.x; Do-Rego JL, 1998, NEUROSCIENCE, V83, P555, DOI 10.1016/S0306-4522(97)00362-X; Dubrovsky B, 2000, BRAIN RES BULL, V51, P443, DOI 10.1016/S0361-9230(99)00269-5; Dubrovsky B, 2006, PHARMACOL BIOCHEM BE, V84, P644, DOI 10.1016/j.pbb.2006.06.016; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Duparc C, 2003, J CLIN ENDOCR METAB, V88, P5521, DOI 10.1210/jc.2003-030783; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Griffin LD, 1999, P NATL ACAD SCI USA, V96, P13512, DOI 10.1073/pnas.96.23.13512; Guidotti A, 1998, BIOL PSYCHIAT, V44, P865, DOI 10.1016/S0006-3223(98)00070-5; Hamon A, 2003, NEUROPHARMACOLOGY, V45, P293, DOI 10.1016/S0028-3908(03)00187-4; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Karchewski LA, 2004, EUR J NEUROSCI, V20, P671, DOI 10.1111/j.1460-9568.2004.03530.x; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koenig HL, 2000, REV REPROD, V5, P189; Kokate TG, 1999, J PHARMACOL EXP THER, V288, P679; KRUSE HJ, 1985, ARZNEIMITTEL-FORSCH, V35, P133; Lacor P, 1996, NEUROSCI LETT, V220, P61, DOI 10.1016/S0304-3940(96)13187-6; Laurijssens BE, 1996, CLIN PHARMACOKINET, V30, P52, DOI 10.2165/00003088-199630010-00004; Lesouhaitier O, 1998, J MOL ENDOCRINOL, V20, P45, DOI 10.1677/jme.0.0200045; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; MELCHIOR CL, 1994, PHARMACOL BIOCHEM BE, V47, P437, DOI 10.1016/0091-3057(94)90140-6; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Mellon SH, 2001, INT REV NEUROBIOL, V46, P33; MENSAHNYAGAN AG, 1994, J NEUROSCI, V14, P7306; MensahNyagan AG, 1996, P NATL ACAD SCI USA, V93, P1423, DOI 10.1073/pnas.93.4.1423; MensahNyagan AG, 1996, J NEUROCHEM, V67, P413; Micallef J, 2001, FUND CLIN PHARMACOL, V15, P209, DOI 10.1046/j.1472-8206.2001.00025.x; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Miller WL, 2015, MOL CELL ENDOCRINOL, V408, P99, DOI 10.1016/j.mce.2014.09.010; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Nguyen N, 2006, HUM PSYCHOPHARM CLIN, V21, P139, DOI 10.1002/hup.757; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2001, THERAPIE, V56, P549; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2014, ENDOCRINOLOGY, V155, P15, DOI 10.1210/en.2013-2033; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Graziano P, 2006, PSYCHOPHARMACOLOGY, V186, P362, DOI 10.1007/s00213-005-0213-2; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Prasad A, 1997, PHYSIOL BEHAV, V62, P1053, DOI 10.1016/S0031-9384(97)00239-4; Reddy DS, 1997, BRAIN RES, V752, P61, DOI 10.1016/S0006-8993(96)01447-3; Robert G, 2011, BEHAV BRAIN RES, V220, P344, DOI 10.1016/j.bbr.2011.01.051; Rogoz Z, 2011, PHARMACOL REP, V63, P1547, DOI 10.1016/S1734-1140(11)70719-8; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schlichter R, 2000, NEUROPHARMACOLOGY, V39, P1523, DOI 10.1016/S0028-3908(99)00253-1; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schweizer E, 1998, ACTA PSYCHIAT SCAND, V98, P95, DOI 10.1111/j.1600-0447.1998.tb05973.x; Servant D, 1998, ENCEPHALE, V24, P569; Takase M, 1999, ENDOCRINOLOGY, V140, P1936, DOI 10.1210/en.140.4.1936; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Tsutsui K, 2000, NEUROSCI RES, V36, P261, DOI 10.1016/S0168-0102(99)00132-7; Ugale RR, 2007, BRAIN RES, V1184, P193, DOI 10.1016/j.brainres.2007.09.041; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; van Broekhoven F, 2003, PSYCHOPHARMACOLOGY, V165, P97, DOI 10.1007/s00213-002-1257-1; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; Verleye M, 2004, PHYSIOL BEHAV, V82, P891, DOI 10.1016/j.physbeh.2004.07.010; Verleye M, 2002, NEUROSCI RES, V44, P167, DOI 10.1016/S0168-0102(02)00121-9; Verleye M, 1999, NEUROREPORT, V10, P3207, DOI 10.1097/00001756-199910190-00015; Verleye M, 2001, NEUROSCI LETT, V301, P191, DOI 10.1016/S0304-3940(01)01647-0; Verleye M, 2006, NEUROSCI RES, V56, P53, DOI 10.1016/j.neures.2006.05.005; WOODS JH, 1992, PHARMACOL REV, V44, P151; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	87	26	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120473	10.1371/journal.pone.0120473	http://dx.doi.org/10.1371/journal.pone.0120473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785994	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500174
J	Dolan, EB; Haugh, MG; Voisin, MC; Tallon, D; McNamara, LM				Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; Tallon, David; McNamara, Laoise M.			Thermally Induced Osteocyte Damage Initiates a Remodelling Signaling Cascade	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MECHANICALLY STIMULATED OSTEOCYTES; GAP-JUNCTIONS; OSTEOGENIC DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; BONE-RESORPTION; IN-VIVO; APOPTOSIS; PROLIFERATION; ACTIVATION	Thermal elevations experienced by bone during orthopaedic procedures, such as cutting and drilling, exothermal reactions from bone cement, and thermal therapies such as tumor ablation, can result in thermal damage leading to death of native bone cells (osteocytes, osteoblasts, osteoclasts and mesenchymal stem cells). Osteocytes are believed to be the orchestrators of bone remodeling, which recruit nearby osteoclast and osteoblasts to control resorption and bone growth in response to mechanical stimuli and physical damage. However, whether heat-induced osteocyte damage can directly elicit bone remodelling has yet to be determined. This study establishes the link between osteocyte thermal damage and the remodeling cascade. We show that osteocytes directly exposed to thermal elevations (47 degrees C for 1 minute) become significantly apoptotic and alter the expression of osteogenic genes (Opg and Cox2). The Rankl/Opg ratio is consistently down-regulated, at days 1, 3 and 7 in MLO-Y4s heat-treated to 47 degrees C for 1 minute. Additionally, the pro-osteoblastogenic signaling marker Cox2 is significantly up-regulated in heat-treated MLO-Y4s by day 7. Furthermore, secreted factors from heat-treated MLO-Y4s administered to MSCs using a novel co-culture system are shown to activate pre-osteoblastic MSCs to increase production of the pro-osteoblastic differentiation marker, alkaline phosphatase (day 7, 14), and calcium deposition (day 21). Most interestingly, an initial pro-osteoclastogenic signaling response (increase Rankl and Rankl/Opg ratio at day 1) followed by later stage pro-osteoblastogenic signaling (down-regulation in Rankl and the Rankl/Opg ratio and an up-regulation in Opg and Cox2 by day 7) was observed in non-heat-treated MLO-Y4s in co-culture when these were exposed to the biochemicals produced by heat-treated MLO-Y4s. Taken together, these results elucidate the vital role of osteocytes in detecting and responding to thermal damage by means of thermally induced apoptosis followed by a cascade of remodelling responses.	[Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; McNamara, Laoise M.] Natl Univ Ireland, Coll Engn & Informat, Biomed Engn, Biomech Res Ctr BMEC, Galway, Ireland; [Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; McNamara, Laoise M.] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Tallon, David] Stryker Ireland, Cork, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	McNamara, LM (corresponding author), Natl Univ Ireland, Coll Engn & Informat, Biomed Engn, Biomech Res Ctr BMEC, Galway, Ireland.	Laoise.McNamara@nuigalway.ie		McNamara, Laoise/0000-0002-5050-9230; Dolan, Eimear/0000-0002-6742-8461	National University of Ireland, Galway Fellowship Scheme; National University of Ireland Travelling Scholarships in Engineering; European Research Council (ERC) [258992]	National University of Ireland, Galway Fellowship Scheme; National University of Ireland Travelling Scholarships in Engineering; European Research Council (ERC)(European Research Council (ERC))	The work was supported by National University of Ireland, Galway Fellowship Scheme (ED LMcN), The National University of Ireland Travelling Scholarships in Engineering (ED LMcN), and the European Research Council (ERC) (under grant no. 258992; BONEMECHBIO) (LMcN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN AT, 1984, CLIN ORTHOP RELAT R, P284; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Birmingham E., 2012, OSTEOGENIC DIFFERENT; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; Dolan EB, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026177; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; ERIKSSON A, 1982, INT J ORAL MAXILLOF, V11, P115, DOI 10.1016/S0300-9785(82)80020-3; ERIKSSON AR, 1984, ACTA ORTHOP SCAND, V55, P629, DOI 10.3109/17453678408992410; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Freeman F, 2013, J TISSUE ENG REGENER; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kennedy OD, 2014, BONE; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kirkham G.R., 2007, TOPICS TISSUE ENG, V3; Kobayashi D, 2013, PROSTATE, V73, P913, DOI 10.1002/pros.22637; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kogianni Giolanta, 2007, Curr Osteoporos Rep, V5, P81; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundskog J, 1972, Scand J Plast Reconstr Surg, V9, P1; Mann V., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P408; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mulcahy LE, 2011, BONE, V48, P182, DOI 10.1016/j.bone.2010.09.014; Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013; Noble Brendon, 2003, European Cells & Materials, V6, P46; Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Qiu S-J, 1997, T ORTHOPEDIC RES SOC, V22; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Santiago FR, 2009, CURR REV MUSCULOSKE, V2, P43, DOI 10.1007/s12178-008-9042-3; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Stanczyk M, 2004, J BIOMECH, V37, P1803, DOI [10.1016/j.biomech.2004.03.002, 10.1016/j.jbiomech.2004.03.002]; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; TOKSVIGLARSEN S, 1991, J BONE JOINT SURG BR, V73, P13, DOI 10.1302/0301-620X.73B1.1991747; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	52	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119652	10.1371/journal.pone.0119652	http://dx.doi.org/10.1371/journal.pone.0119652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785846	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500125
J	Kawada, M; Inoue, H; Ohba, S; Yoshida, J; Masuda, T; Yamasaki, M; Usami, I; Sakamoto, S; Abe, H; Watanabe, T; Yamori, T; Shibasaki, M; Nomoto, A				Kawada, Manabu; Inoue, Hiroyuki; Ohba, Shun-ichi; Yoshida, Junjiro; Masuda, Tohru; Yamasaki, Manabu; Usami, Ihomi; Sakamoto, Shuichi; Abe, Hikaru; Watanabe, Takumi; Yamori, Takao; Shibasaki, Masakatsu; Nomoto, Akio			Stromal Cells Positively and Negatively Modulate the Growth of Cancer Cells: Stimulation via the PGE2-TNF alpha-IL-6 Pathway and Inhibition via Secreted GAPDH-E-Cadherin Interaction	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; ANCHORAGE-INDEPENDENT GROWTH; MESENCHYMAL STEM-CELLS; REACTIVE STROMA; GASTRIC-CANCER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROSTAGLANDIN E-2; MICROPLATE ASSAY; TUMOR-CELLS; IN-VITRO	Fibroblast-like stromal cells modulate cancer cells through secreted factors and adhesion, but those factors are not fully understood. Here, we have identified critical stromal factors that modulate cancer growth positively and negatively. Using a cell co-culture system, we found that gastric stromal cells secreted IL-6 as a growth and survival factor for gastric cancer cells. Moreover, gastric cancer cells secreted PGE2 and TNF alpha that stimulated IL-6 secretion by the stromal cells. Furthermore, we found that stromal cells secreted glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Extracellular GAPDH, or its N-terminal domain, inhibited gastric cancer cell growth, a finding confirmed in other cell systems. GAPDH bound to E-cadherin and downregulated the mTOR-p70S6 kinase pathway. These results demonstrate that stromal cells could regulate cancer cell growth through the balance of these secreted factors. We propose that negative regulation of cancer growth using GAPDH could be a new anti-cancer strategy.	[Kawada, Manabu; Inoue, Hiroyuki; Ohba, Shun-ichi; Yoshida, Junjiro; Masuda, Tohru; Usami, Ihomi; Sakamoto, Shuichi; Nomoto, Akio] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan; [Yamasaki, Manabu; Abe, Hikaru; Watanabe, Takumi; Shibasaki, Masakatsu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan; [Yamori, Takao] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan	Japanese Foundation for Cancer Research	Kawada, M (corresponding author), Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan.	kawadam@bikaken.or.jp		Kawada, Manabu/0000-0001-9348-4240; Sakamoto, Shuichi/0000-0001-9396-9475	MEXT KAKENHI [23112522]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT KAKENHI Grant Number 23112522. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Kai H, 2005, ANTICANCER RES, V25, P709; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239; Kawada M, 1998, JPN J CANCER RES, V89, P110, DOI 10.1111/j.1349-7006.1998.tb00537.x; Kawada M, 2004, ANTICANCER RES, V24, P1561; Kawada M, 2002, J BIOL CHEM, V277, P27765, DOI 10.1074/jbc.M200318200; Kawada M, 1999, JPN J CANCER RES, V90, P546, DOI 10.1111/j.1349-7006.1999.tb00782.x; Kawada M, 2008, ANTICANCER RES, V28, P721; Kawada M, 2006, CANCER LETT, V242, P46, DOI 10.1016/j.canlet.2005.10.040; Kawada M, 2010, J ANTIBIOT, V63, P319, DOI 10.1038/ja.2010.42; Kawada M, 2010, INT J CANCER, V126, P810, DOI 10.1002/ijc.24915; Kawada M, 2009, J ANTIBIOT, V62, P243, DOI 10.1038/ja.2009.20; Kawada M, 2009, CANCER SCI, V100, P150, DOI 10.1111/j.1349-7006.2008.00996.x; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Nakamura T, 1997, CANCER RES, V57, P3305; Nakatsu N, 2007, MOL PHARMACOL, V72, P1171, DOI 10.1124/mol.107.038836; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; PICARD O, 1986, CANCER RES, V46, P3290; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sekikawa A, 2008, CARCINOGENESIS, V29, P76, DOI 10.1093/carcin/bgm250; Shiraishi K, 2005, J IMMUNOL, V175, P1014, DOI 10.4049/jimmunol.175.2.1014; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Wagener J, 2013, J INVEST DERMATOL, V133, P144, DOI 10.1038/jid.2012.254; Wang TP, 2010, BIOCONJUGATE CHEM, V21, P1642, DOI 10.1021/bc1001505; Wernert N, 1997, VIRCHOWS ARCH, V430, P433, DOI 10.1007/s004280050053; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yamori T, 1999, CANCER RES, V59, P4042; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang JG, 2010, WORLD J GASTROENTERO, V16, P571, DOI 10.3748/wjg.v16.i5.571	54	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119415	10.1371/journal.pone.0119415	http://dx.doi.org/10.1371/journal.pone.0119415			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785838	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500101
J	Li, RH; Hempel, LU; Jiang, TB				Li, Renhua; Hempel, Leonie U.; Jiang, Tingbo			A Non-Parametric Peak Calling Algorithm for DamID-Seq	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; GENOME	Protein-DNA interactions play a significant role in gene regulation and expression. In order to identify transcription factor binding sites (TFBS) of double sex (DSX)-an important transcription factor in sex determination, we applied the DNA adenine methylation identification (DamID) technology to the fat body tissue of Drosophila, followed by deep sequencing (DamID-Seq). One feature of DamID-Seq data is that induced adenine methylation signals are not assured to be symmetrically distributed at TFBS, which renders the existing peak calling algorithms for ChIP-Seq, including SPP and MACS, inappropriate for DamID-Seq data. This challenged us to develop a new algorithm for peak calling. A challenge in peaking calling based on sequence data is estimating the averaged behavior of background signals. We applied a bootstrap resampling method to short sequence reads in the control (Dam only). After data quality check and mapping reads to a reference genome, the peaking calling procedure compromises the following steps: 1) reads resampling; 2) reads scaling (normalization) and computing signal-to-noise fold changes; 3) filtering; 4) Calling peaks based on a statistically significant threshold. This is a non-parametric method for peak calling (NPPC). We also used irreproducible discovery rate (IDR) analysis, as well as ChIP-Seq data to compare the peaks called by the NPPC. We identified approximately 6,000 peaks for DSX, which point to 1,225 genes related to the fat body tissue difference between female and male Drosophila. Statistical evidence from IDR analysis indicated that these peaks are reproducible across biological replicates. In addition, these peaks are comparable to those identified by use of ChIP-Seq on S2 cells, in terms of peak number, location, and peaks width.	[Li, Renhua; Jiang, Tingbo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Li, Renhua; Hempel, Leonie U.] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA	Northeast Forestry University - China; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jiang, TB (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	tbjiang@yahoo.com						Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; EFRON B, 2005, 200520B234 STANF U D; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Luo SZD, 2011, DEVELOPMENT, V138, P2761, DOI 10.1242/dev.065227; Schneider I, 1972, J EMBRYOL EXP MORPH, V27, P363; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wand M., 1995, KERNEL SMOOTHING CHA; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	17	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117415	10.1371/journal.pone.0117415	http://dx.doi.org/10.1371/journal.pone.0117415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785608	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500017
J	McGaha, TW; Young, RM; Burkett-Cadena, ND; Iburg, JP; Beau, JM; Hassan, S; Katholi, CR; Cupp, EW; Baker, BJ; Unnasch, TR; Noblet, R				McGaha, Tommy W., Jr.; Young, Ryan M.; Burkett-Cadena, Nathan D.; Iburg, Joseph P.; Beau, Jeremy M.; Hassan, Sayed; Katholi, Charles R.; Cupp, Eddie W.; Baker, Bill J.; Unnasch, Thomas R.; Noblet, Raymond			Identification of Communal Oviposition Pheromones from the Black Fly Simulium vittatum	PLOS ONE			English	Article							AGGREGATED OVIPOSITION; DAMNOSUM COMPLEX; REPTANS DIPTERA; BEETLE	The suite of pheromones that promote communal oviposition by Simulium vittatum, a North American black fly species, was identified and characterized using gas chromatography-mass spectrometry, electrophysiological, and behavioral bioassays. Behavioral assays demonstrated that communal oviposition was induced by egg-derived compounds that were active at short range and whose effect was enhanced through direct contact. Three compounds (cis-9-tetradecen-1-ol, 1-pentadecene, and 1-tridecene) were identified in a non-polar solvent extract of freshly deposited S. vittatum eggs that were capable of inducing the oviposition response. Electroantennography demonstrated that two of these three compounds (1-pentadecene and 1-tridecene) actively stimulated antennal neurons. Identification of the oviposition pheromones of this family may be helpful in developing control measures for nuisance black flies and for medically-important species such as Simulium damnosum sensu lato.	[McGaha, Tommy W., Jr.; Iburg, Joseph P.; Noblet, Raymond] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Young, Ryan M.; Beau, Jeremy M.; Baker, Bill J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Young, Ryan M.; Beau, Jeremy M.; Baker, Bill J.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA; [Burkett-Cadena, Nathan D.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA; [Hassan, Sayed] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Katholi, Charles R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Cupp, Eddie W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	University System of Georgia; University of Georgia; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Birmingham; Auburn University System; Auburn University	Unnasch, TR (corresponding author), Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA.	tunnasch@health.usf.edu	Baker, Bill/N-4312-2019	Burkett-Cadena, Nathan/0000-0001-6168-1637; McGaha Jr., Tommy/0000-0003-0374-6214	Bill and Melinda Gates Foundation [1017870]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (grant # 1017870). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellec C, 1976, MED PARASITOL ENTOMO, V14, P209; COUPLAND JB, 1991, ECOL ENTOMOL, V16, P11, DOI 10.1111/j.1365-2311.1991.tb00187.x; COUPLAND JB, 1992, J MED ENTOMOL, V29, P293, DOI 10.1093/jmedent/29.2.293; DAVIES JB, 1962, NATURE, V196, P149, DOI 10.1038/196149a0; Dougherty M, 1997, J CHEM ECOL, V23, P2657, DOI 10.1023/A:1022598523803; DUMESNIL JG, 1982, ARCH MAL COEUR VAISS, V75, P1149; Geiselhardt S, 2008, NATURWISSENSCHAFTEN, V95, P247, DOI 10.1007/s00114-007-0312-5; GOLINI VI, 1975, CAN J ZOOL, V53, P521, DOI 10.1139/z75-067; Gray EW, 1999, MAINTENANCE OF HUMAN, ANIMAL, AND PLANT PATHOGEN VECTORS, P83; LAURENCE BR, 1985, J CHEM ECOL, V11, P643, DOI 10.1007/BF00988573; McCall PJ, 1997, PHYSIOL ENTOMOL, V22, P224, DOI 10.1111/j.1365-3032.1997.tb01162.x; MCCALL PJ, 1994, MED VET ENTOMOL, V8, P76, DOI 10.1111/j.1365-2915.1994.tb00390.x; MCCALL PJ, 1995, MED VET ENTOMOL, V9, P101, DOI 10.1111/j.1365-2915.1995.tb00165.x; MCCALL PJ, 1995, PARASITOL TODAY, V11, P352, DOI 10.1016/0169-4758(95)80192-8; MUIRHEADTHOMSON RC, 1956, NATURE, V178, P1297, DOI 10.1038/1781297a0; OSGOOD CE, 1971, J ECON ENTOMOL, V64, P1038, DOI 10.1093/jee/64.5.1038; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Prokopy RJ, 2001, ANNU REV ENTOMOL, V46, P631, DOI 10.1146/annurev.ento.46.1.631; Rai MM, 1997, J INSECT PHYSIOL, V43, P83, DOI 10.1016/S0022-1910(96)00051-0; Rodriguez-Perez MA, 2003, ANN TROP MED PARASIT, V97, P203, DOI 10.1179/000349803235001534; Saini RK, 1996, J CHEM ECOL, V22, P1211, DOI 10.1007/BF02266961; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; SUTCLIFFE JF, 1976, CAN J ZOOL, V54, P1779, DOI 10.1139/z76-207; Velcheva N, 2012, RASTENIEVUDNI NAUKI, V49, P15; Verheggen F, 2007, J CHEM ECOL, V33, P525, DOI 10.1007/s10886-006-9236-3; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	26	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118904	10.1371/journal.pone.0118904	http://dx.doi.org/10.1371/journal.pone.0118904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786206	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500055
J	Meguro, S; Hasumura, T; Hase, T				Meguro, Shinichi; Hasumura, Takahiro; Hase, Tadashi			Body Fat Accumulation in Zebrafish Is Induced by a Diet Rich in Fat and Reduced by Supplementation with Green Tea Extract	PLOS ONE			English	Article							SALMO-SALAR L.; INDUCED OBESITY; SUBCUTANEOUS FAT; LIPID-METABOLISM; RAINBOW-TROUT; BROWN TROUT; ADIPOSITY; GROWTH; SEX; DEPOSITION	Fat-rich diets not only induce obesity in humans but also make animals obese. Therefore, animals that accumulate body fat in response to a high-fat diet (especially rodents) are commonly used in obesity research. The effect of dietary fat on body fat accumulation is not fully understood in zebrafish, an excellent model of vertebrate lipid metabolism. Here, we explored the effects of dietary fat and green tea extract, which has anti-obesity properties, on body fat accumulation in zebrafish. Adult zebrafish were allocated to four diet groups and over 6 weeks were fed a high-fat diet containing basal diet plus two types of fat or a low-fat diet containing basal diet plus carbohydrate or protein. Another group of adult zebrafish was fed a high-fat diet with or without 5% green tea extract supplementation. Zebrafish fed the high-fat diets had nearly twice the body fat (visceral, subcutaneous, and total fat) volume and body fat volume ratio (body fat volume/body weight) of those fed low-fat diets. There were no differences in body fat accumulation between the two high-fat groups, nor were there any differences between the two low-fat groups. Adding green tea extract to the high-fat diet significantly suppressed body weight, body fat volume, and body fat volume ratio compared with the same diet lacking green tea extract. 3-Hydroxyacyl-coenzyme A dehydrogenase and citrate synthase activity in the liver and skeletal muscle were significantly higher in fish fed the diet supplemented with green tea extract than in those fed the unsupplemented diet. Our results suggest that a diet rich in fat, instead of protein or carbohydrate, induced body fat accumulation in zebrafish with mechanisms that might be similar to those in mammals. Consequently, zebrafish might serve as a good animal model for research into obesity induced by high-fat diets.	[Meguro, Shinichi; Hasumura, Takahiro; Hase, Tadashi] Kao Corp, Biol Sci Res, Tokyo, Tochigi, Japan	KAO Corporation	Meguro, S (corresponding author), Kao Corp, Biol Sci Res, Tokyo, Tochigi, Japan.			Meguro, Shinichi/0000-0002-3072-2632				Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; [Anonymous], 2010, GUIDE CARE USE LAB A; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Bertrais S, 1999, INT J OBESITY, V23, P1085, DOI 10.1038/sj.ijo.0801033; BOOZER CN, 1995, AM J PHYSIOL-ENDOC M, V268, pE546; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; BOURGEOIS F, 1983, BRIT J NUTR, V49, P17, DOI 10.1079/BJN19830006; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130; GRAUER WO, 1984, AM J CLIN NUTR, V39, P631, DOI 10.1093/ajcn/39.4.631; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; HILL JO, 1992, INT J OBESITY, V16, P321; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jobling M, 1998, AQUAC RES, V29, P601, DOI 10.1111/j.1365-2109.1998.tb01174.x; Jobling M, 2003, AQUAC RES, V34, P311, DOI 10.1046/j.1365-2109.2003.00820.x; Jobling M, 2002, AQUAC RES, V33, P533, DOI 10.1046/j.1365-2109.2002.00738.x; Jobling M, 2002, AQUAC RES, V33, P739, DOI 10.1046/j.1365-2109.2002.00712.x; Kause A, 2007, AQUACULTURE, V271, P162, DOI 10.1016/j.aquaculture.2007.06.005; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; Meguro S, 2001, J OLEO SCI, V50, P593, DOI DOI 10.5650/JOS.50.593; Mori T, 2007, J NUTR, V137, P2629, DOI 10.1093/jn/137.12.2629; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Niva T, 1999, ANN ZOOL FENN, V36, P103; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Refstie Stale, 2001, Aquaculture, V193, P91, DOI 10.1016/S0044-8486(00)00473-7; Regost C, 2001, AQUACULTURE, V193, P325, DOI 10.1016/S0044-8486(00)00498-1; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001; Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Takahashi M, 1999, J NUTR SCI VITAMINOL, V45, P583, DOI 10.3177/jnsv.45.583; Truett AA, 1998, OBES RES, V6, P137, DOI 10.1002/j.1550-8528.1998.tb00328.x; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; WARWICK ZS, 1992, NEUROSCI BIOBEHAV R, V16, P585, DOI 10.1016/S0149-7634(05)80198-8; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Westerfield M, 2007, ZEBRAFISH BOOK EDITI; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; World Health Organization, OB OV; Yang SY, 1999, ADV EXP MED BIOL, V466, P133	54	44	46	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120142	10.1371/journal.pone.0120142	http://dx.doi.org/10.1371/journal.pone.0120142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785691	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500156
J	Pereira, I; Weber, S; Holzer, S; Fischer, G; Vass, C; Resch, H				Pereira, Ivania; Weber, Stephanie; Holzer, Stephan; Fischer, Georg; Vass, Clemens; Resch, Hemma			Compensation for Retinal Vessel Density Reduces the Variation of Circumpapillary RNFL in Healthy Subjects	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; THICKNESS PROFILES; BLOOD-VESSELS; GDX VCC; GLAUCOMA; MECHANISMS; EYES; SIZE	This work intends to assess circumpapillary retinal vessel density (RVD) at a 3.46 mm diameter circle and correlate it with circumpapillary retinal nerve fiber layer (RNFL) thickness measured with Fourier-Domain Optical Coherence Tomography. Furthermore, it aims to evaluate the reduction of intersubject variability of RNFL when considering RVD as a source of information for RNFL distribution. For that, 106 healthy subjects underwent circumpapillary RNFL measurement. Using the scanning laser ophthalmoscope fundus image, thickness and position of retinal vessels were assessed and integrated in a 256-sector RVD profile. The relationship between local RVD value and local RNFL thickness was modeled by linear regression. RNFL was then compensated for RVD variation by regression formulas. A strong statistically significant intrasubject correlation was found for all subjects between RVD and RNFL profiles (mean R = 0.769). In the intersubject regression analysis, 247 of 256 RNFL sectors showed a statistically significant positive correlation with RVD (mean R = 0.423). RVD compensation of RNFL resulted in a relative reduction of up to 20% of the intersubject variance. In conclusion, RVD in a 3.46mm circle has a clinically relevant influence on the RNFL distribution. RVD may be used to develop more individualized normative values for RNFL measurement, which might improve early diagnosis of glaucoma.	[Pereira, Ivania; Fischer, Georg] Med Univ Vienna, Sect Med Informat Management & Imaging, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Pereira, Ivania; Weber, Stephanie; Holzer, Stephan; Vass, Clemens; Resch, Hemma] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Resch, H (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	hemma.resch@meduniwien.ac.at	Vass, Clemens/AAZ-2564-2020; Fischer, Georg/Y-3059-2019	Vass, Clemens/0000-0003-4756-9088; Fischer, Georg/0000-0002-4033-2005; Resch, Hemma/0000-0001-9931-1834	Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF [LS11-046]	Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF	The study was funded by: Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF - LS11-046. The persons responsible for the funding are GF and CV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowd C, 2002, J OPT SOC AM A, V19, P197, DOI 10.1364/JOSAA.19.000197; Bowd C, 2001, INVEST OPHTH VIS SCI, V42, P1993; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chi Q M, 1995, J Glaucoma, V4, P406; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Funaki S, 1998, BRIT J OPHTHALMOL, V82, P1242, DOI 10.1136/bjo.82.11.1242; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Hong SW, 2010, INVEST OPHTH VIS SCI, V51, P3515, DOI 10.1167/iovs.09-4888; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2010, J GLAUCOMA, V19, P158, DOI 10.1097/IJG.0b013e3181af31ec; Kanamori A, 2006, GRAEF ARCH CLIN EXP, V244, P58, DOI 10.1007/s00417-005-0029-0; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Pereira I, 2014, BRIT J OPHTHALMOL, V98, P538, DOI 10.1136/bjophthalmol-2013-303910; Poinoosawmy D, 1997, BRIT J OPHTHALMOL, V81, P350, DOI 10.1136/bjo.81.5.350; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resch H, 2011, BRIT J OPHTHALMOL, V95, P680, DOI 10.1136/bjo.2009.170068; Savini G, 2005, BRIT J OPHTHALMOL, V89, P489, DOI 10.1136/bjo.2004.052498; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Townsend KA, 2009, BRIT J OPHTHALMOL, V93, P139, DOI 10.1136/bjo.2008.145540; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120378	10.1371/journal.pone.0120378	http://dx.doi.org/10.1371/journal.pone.0120378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786232	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500168
J	Poleszczuk, J; Hahnfeldt, P; Enderling, H				Poleszczuk, Jan; Hahnfeldt, Philip; Enderling, Heiko			Therapeutic Implications from Sensitivity Analysis of Tumor Angiogenesis Models	PLOS ONE			English	Article								Anti-angiogenic cancer treatments induce tumor starvation and regression by targeting the tumor vasculature that delivers oxygen and nutrients. Mathematical models prove valuable tools to study the proof-of-concept, efficacy and underlying mechanisms of such treatment approaches. The effects of parameter value uncertainties for two models of tumor development under angiogenic signaling and anti-angiogenic treatment are studied. Data fitting is performed to compare predictions of both models and to obtain nominal parameter values for sensitivity analysis. Sensitivity analysis reveals that the success of different cancer treatments depends on tumor size and tumor intrinsic parameters. In particular, we show that tumors with ample vascular support can be successfully targeted with conventional cytotoxic treatments. On the other hand, tumors with curtailed vascular support are not limited by their growth rate and therefore interruption of neovascularization emerges as the most promising treatment target.	[Poleszczuk, Jan; Hahnfeldt, Philip; Enderling, Heiko] Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Poleszczuk, Jan] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, Warsaw, Poland	Tufts University; University of Warsaw	Poleszczuk, J (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA.	Jan.Poleszczuk@moffitt.org	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Poleszczuk, Jan/0000-0001-8758-7200	Foundation for Polish Science; National Cancer Institute [U54CA149233]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Foundation for Polish Science (JP) and the National Cancer Institute under Award Number U54CA149233 (to Lynn Hlatky). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1; BYRD RH, 1987, SIAM J NUMER ANAL, V24, P1152, DOI 10.1137/0724076; Cooke R., 2001, FOLKMANS WAR ANGIOGE; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; Ergun A, 2003, B MATH BIOL, V65, P407, DOI 10.1016/S0092-8240(03)00006-5; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fujita K, 2007, ONCOL REP, V18, P47; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Klamka J., 2013, CONTROL CYBERN, V42, P125, DOI DOI 10.1109/TSMCB.2011.2162234; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Ledzewicz U, 2008, J THEOR BIOL, V252, P295, DOI 10.1016/j.jtbi.2008.02.014; Loeb LA, 2001, CANCER RES, V61, P3230; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Poleszczuk J, 2011, MATH BIOSCI ENG, V8, P591, DOI 10.3934/mbe.2011.8.591; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993	18	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120007	10.1371/journal.pone.0120007	http://dx.doi.org/10.1371/journal.pone.0120007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785600	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500147
J	Samuel, MS; Abigail, EAM; Chidambaram, R				Samuel, Melvin S.; Abigail, Evy Alice M.; Chidambaram, Ramalingam			Isotherm Modelling, Kinetic Study and Optimization of Batch Parameters Using Response Surface Methodology for Effective Removal of Cr(VI) Using Fungal Biomass	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; AQUEOUS-SOLUTIONS; BIOSORPTION; ADSORPTION; IONS; SORPTION; GASES; REDUCTION; EQUATIONS; CADMIUM	Biosorption is a promising alternative method to replace the existing conventional technique for Cr(VI) removal from the industrial effluent. In the present experimental design, the removal of Cr(VI) from the aqueous solution was studied by Aspergillus niger MSR4 under different environmental conditions in the batch systems. The optimum conditions of biosorption were determined by investigating pH (2.0) and temperature (27 degrees C). The effects of parameters such as biomass dosage (g/L), initial Cr(VI) concentration (mg/L) and contact time (min) on Cr(VI) biosorption were analyzed using a three parameter Box-Behnken design (BBD). The experimental data well fitted to the Langmuir isotherm, in comparison to the other isotherm models tested. The results of the D-R isotherm model suggested that a chemical ion-exchange mechanism was involved in the biosorption process. The biosorption process followed the pseudo-second-order kinetic model, which indicates that the rate limiting step is chemisorption process. Fourier transform infrared (FT-IR) spectroscopic studies revealed the possible involvement of functional groups, such as hydroxyl, carboxyl, amino and carbonyl group in the biosorption process. The thermodynamic parameters for Cr(VI) biosorption were also calculated, and the negative Delta G degrees values indicated the spontaneous nature of biosorption process.	[Samuel, Melvin S.; Abigail, Evy Alice M.; Chidambaram, Ramalingam] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Chidambaram, R (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	cramalingam@vit.ac.in	Chidambaram, Ramalingam/U-7922-2019	Chidambaram, Ramalingam/0000-0001-9549-7686	VIT University	VIT University	The authors are thankful to VIT University for providing laboratory facility and financial assistance. The isolated fungus was identified by Yaazh Xenomics, Chennai, India.	AHARONI C, 1991, SOIL SCI SOC AM J, V55, P1307, DOI 10.2136/sssaj1991.03615995005500050019x; Ajjabi LC, 2009, J ENVIRON MANAGE, V90, P3485, DOI 10.1016/j.jenvman.2009.06.001; Arica MY, 2005, COLLOID SURFACE A, V253, P203, DOI 10.1016/j.colsurfa.2004.11.012; Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7; Costa M, 2003, TOXICOL APPL PHARM, V188, P1, DOI 10.1016/S0041-008X(03)00011-5; Covelo EF, 2004, J COLLOID INTERF SCI, V280, P1, DOI 10.1016/j.jcis.2004.07.024; Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087; DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006; Edrissi M, 2008, TURK J CHEM, V32, P505; Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067; Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gupta VK, 2001, WATER RES, V35, P1125, DOI 10.1016/S0043-1354(00)00389-4; HALSEY G, 1948, J CHEM PHYS, V16, P931, DOI 10.1063/1.1746689; Harkins WD, 1944, J CHEM PHYS, V12, P112, DOI 10.1063/1.1723913; Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Kang SY, 2007, BIOCHEM ENG J, V36, P54, DOI 10.1016/j.bej.2006.06.005; KATZ SA, 1993, J APPL TOXICOL, V13, P217, DOI 10.1002/jat.2550130314; KAUFMAN DB, 1970, AM J DIS CHILD, V119, P374, DOI 10.1001/archpedi.1970.02100050376021; Kocberber N, 2007, BIORESOURCE TECHNOL, V98, P2178, DOI 10.1016/j.biortech.2006.08.017; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Liu T, 2007, WORLD J MICROB BIOT, V23, P1685, DOI 10.1007/s11274-007-9416-5; LOW MJD, 1960, CHEM REV, V60, P267, DOI 10.1021/cr60205a003; Malkoc E, 2007, CHEM ENG PROCESS, V46, P1020, DOI 10.1016/j.cep.2007.05.007; Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Ozer A, 2009, CHEM ENG J, V146, P377, DOI 10.1016/j.cej.2008.06.041; Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020; Prakasham RS, 1999, ENVIRON POLLUT, V104, P421, DOI 10.1016/S0269-7491(98)00174-2; Ramrakhiani L, 2011, CHEM ENG J, V171, P1060, DOI 10.1016/j.cej.2011.05.002; Sanghi R, 2009, J HAZARD MATER, V169, P1074, DOI 10.1016/j.jhazmat.2009.04.056; Say R, 2004, ENG LIFE SCI, V4, P276, DOI 10.1002/elsc.200420032; Shen L, 2007, J CENT SOUTH UNIV T, V14, P157, DOI 10.1007/s11771-007-0032-1; Temkin M.I., 1940, ACTA PHYSIOCHIM, V2, P217, DOI DOI 10.1016/J.JHAZMAT.2008.12.093; Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011; U.S, 1988, TOX REV HEX CHROM; Vieira Regine H. S. F., 2000, International Microbiology, V3, P17; WANG YT, 1995, J IND MICROBIOL, V14, P159, DOI 10.1007/BF01569898; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021	42	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116884	10.1371/journal.pone.0116884	http://dx.doi.org/10.1371/journal.pone.0116884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786227	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500014
J	Choudhary, S; Canalis, E; Estus, T; Adams, D; Pilbeam, C				Choudhary, Shilpa; Canalis, Ernesto; Estus, Thomas; Adams, Douglas; Pilbeam, Carol			Cyclooxygenase-2 Suppresses the Anabolic Response to PTH Infusion in Mice	PLOS ONE			English	Article							PARATHYROID-HORMONE; BONE-FORMATION; SIGNALING PATHWAYS; PROSTAGLANDIN E-2; T-CELLS; DIFFERENTIATION; EXPRESSION; INTERMITTENT; STIMULATION; OSTEOCLASTOGENESIS	We previously reported that the ability of continuously elevated PTH to stimulate osteoblastic differentiation in bone marrow stromal cell cultures was abrogated by an osteoclastic factor secreted in response to cyclooxygenase-2 (Cox2)-produced prostaglandin E-2. We now examine the impact of Cox2 (Ptgs2) knockout (KO) on the anabolic response to continuously elevated PTH in vivo. PTH (40 mu g/kg/d) or vehicle was infused for 12 or 21 days in 3-mo-old male wild type (WT) and KO mice in the outbred CD-1 background. Changes in bone phenotype were assessed by bone mineral density (BMD), mu CT and histomorphometry. PTH infusion for both 12 and 21 days increased femoral BMD in Cox2 KO mice and decreased BMD in WT mice. Femoral and vertebral trabecular bone volume fractions were increased in KO mice, but not in WT mice, by PTH infusion. In the femoral diaphysis, PTH infusion increased cortical area in Cox2 KO, but not WT, femurs. PTH infusion markedly increased trabecular bone formation rate in the femur, serum markers of bone formation, and expression of bone formation-related genes, growth factors, and Wnt target genes in KO mice relative to WT mice, and decreased gene expression of Wnt antagonists only in KO mice. In contrast to the differential effects of PTH on anabolic factors in WT and KO mice, PTH infusion increased serum markers of resorption, expression of resorption-related genes, and the percent bone surface covered by osteoclasts similarly in both WT and KO mice. We conclude that Cox2 inhibits the anabolic, but not the catabolic, effects of continuous PTH. These data suggest that the bone loss with continuously infused PTH in mice is due largely to suppression of bone formation and that this suppression is mediated by Cox2.	[Choudhary, Shilpa; Canalis, Ernesto; Estus, Thomas; Adams, Douglas; Pilbeam, Carol] Univ Connecticut, Ctr Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA; [Choudhary, Shilpa; Pilbeam, Carol] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA	University of Connecticut; University of Connecticut	Pilbeam, C (corresponding author), Univ Connecticut, Ctr Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA.	pilbeam@nso.uchc.edu			National Institute of Health from the National Institute of Arthritis and Musculoskeletal Research [AR060286, AR63049]; National Institute of Digestive and Diabetes and Kidney Research [DK045227]; National Institute of Dental and Craniofacial Research [T90DE021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286, R01AR063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institute of Health from the National Institute of Arthritis and Musculoskeletal Research; National Institute of Digestive and Diabetes and Kidney Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institute of Health awards from the National Institute of Arthritis and Musculoskeletal Research, AR060286 (CP) and AR63049 (EC), from the National Institute of Digestive and Diabetes and Kidney Research, DK045227 (EC), and from the National Institute of Dental and Craniofacial Research, T90DE021 (TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi B, 2012, P NATL ACAD SCI USA, V109, pE725, DOI 10.1073/pnas.1120735109; BELLOWS CG, 1990, ENDOCRINOLOGY, V127, P3111, DOI 10.1210/endo-127-6-3111; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bergenstock MK, 2007, ANN NY ACAD SCI, V1116, P354, DOI 10.1196/annals.1402.047; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Choudhary S, 2008, BIOCHEM BIOPH RES CO, V372, P536, DOI 10.1016/j.bbrc.2008.05.050; Choudhary S, 2013, BONE, V56, P31, DOI 10.1016/j.bone.2013.04.017; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fei YR, 2012, J CELL PHYSIOL, V227, P3539, DOI 10.1002/jcp.24075; Greenfield Edward M, 2012, Curr Mol Pharmacol, V5, P127; Hackett JA, 2006, J RHEUMATOL, V33, P1320; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; Jilka RL, 2010, J BONE MINER RES, V25, P2427, DOI 10.1002/jbmr.145; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Lane Nancy E, 2010, Curr Osteoporos Rep, V8, P23, DOI 10.1007/s11914-010-0005-4; Lee SK, 2002, BONE, V31, P252, DOI 10.1016/S8756-3282(02)00804-9; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Locklin RM, 2003, J CELL BIOCHEM, V89, P180, DOI 10.1002/jcb.10490; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Pacifici R, 2013, ENDOCRINE, V44, P576, DOI 10.1007/s12020-013-9960-8; Pilbeam CC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1235, DOI 10.1016/B978-0-12-373884-4.00072-0; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Richards JB, 2006, OSTEOPOROSIS INT, V17, P1410, DOI 10.1007/s00198-006-0142-x; Robling AG, 2011, ENDOCRINOLOGY, V152, P2963, DOI 10.1210/en.2011-0049; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Suponitzky I, 1998, J ENDOCRINOL, V156, P51, DOI 10.1677/joe.0.1560051; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tahimic CG, 2013, FRONT ENDOCRINOL LAU, V6, P2; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Tian XY, 2008, BONE, V42, P914, DOI 10.1016/j.bone.2007.12.228; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Xu MS, 2010, BONE, V47, P341, DOI 10.1016/j.bone.2010.05.006; Xu MS, 2005, ENDOCRINOLOGY, V146, P1843, DOI 10.1210/en.2004-0734; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120164	10.1371/journal.pone.0120164	http://dx.doi.org/10.1371/journal.pone.0120164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781979	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600135
J	Henriksson, PJG; Heijungs, R; Dao, HM; Phan, LT; de Snoo, GR; Guinee, JB				Henriksson, Patrik J. G.; Heijungs, Reinout; Dao, Hai M.; Phan, Lam T.; de Snoo, Geert R.; Guinee, Jeroen B.			Product Carbon Footprints and Their Uncertainties in Comparative Decision Contexts	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; VARIABILITY; SENSITIVITY; METHODOLOGY; PARAMETER	In response to growing awareness of climate change, requests to establish product carbon footprints have been increasing. Product carbon footprints are life cycle assessments restricted to just one impact category, global warming. Product carbon footprint studies generate life cycle inventory results, listing the environmental emissions of greenhouse gases from a product's lifecycle, and characterize these by their global warming potentials, producing product carbon footprints that are commonly communicated as point values. In the present research we show that the uncertainties surrounding these point values necessitate more sophisticated ways of communicating product carbon footprints, using different sizes of catfish (Pangasius spp.) farms in Vietnam as a case study. As most product carbon footprint studies only have a comparative meaning, we used dependent sampling to produce relative results in order to increase the power for identifying environmentally superior products. We therefore argue that product carbon footprints, supported by quantitative uncertainty estimates, should be used to test hypotheses, rather than to provide point value estimates or plain confidence intervals of products' environmental performance.	[Henriksson, Patrik J. G.; de Snoo, Geert R.; Guinee, Jeroen B.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [Heijungs, Reinout] Vrije Univ Amsterdam, Fac Econ & Business Adm, Dept Econometr & Operat Res, Amsterdam, Netherlands; [Dao, Hai M.] Can Tho Univ, Coll Aquaculture & Fisheries, Dept Coastal Aquaculture, Can Tho, Vietnam; [Phan, Lam T.] Res Inst Aquaculture 2, Dept Inland Resources & Fisheries Capture, Ho Chi Minh City, Vietnam	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Can Tho University	Henriksson, PJG (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.	henriksson@cml.leidenuniv.nl	Guinée, Jeroen/K-7931-2013; Heijungs, Reinout/K-7855-2013	Guinée, Jeroen/0000-0003-2558-6493; Heijungs, Reinout/0000-0002-0724-5962; Henriksson, Patrik JG/0000-0002-3439-623X	European Union [222889]	European Union(European Commission)	This research has been done as part of the Sustaining Ethical Aquaculture Trade (SEAT; www.seatglobal.eu) project, which is financed by the European Union within the Seventh Framework (http://cordis.europa.eu/fp7/home_en.html) Programme-Sustainable Development Global Change and Ecosystem (project no. 222889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PJGH, DHM, PLT, JB all received their funding through the SEAT project. RH and GRS received their funding from Leiden University.	[Anonymous], 2006, 140402006 ISO; Basset-Mens C, 2009, INT J LIFE CYCLE ASS, V14, P630, DOI 10.1007/s11367-009-0108-2; Beattie G, 2012, NAT CLIM CHANGE, V2, P214, DOI 10.1038/nclimate1468; BSI, 2008, 2050 BSI PAS; Chen XB, 2014, J CLEAN PROD, V81, P150, DOI 10.1016/j.jclepro.2014.06.046; Ciroth A, 2016, INT J LIFE CYCLE ASS, V21, P1338, DOI 10.1007/s11367-013-0670-5; de Koning A, 2010, INT J LIFE CYCLE ASS, V15, P79, DOI 10.1007/s11367-009-0123-3; Finnveden G, 1998, INT J LCA, V3, P65, DOI DOI 10.1007/BF02978486; Frischknecht R, 2007, 1 EC DBEND; HANSSEN OJ, 1996, J CLEAN PROD, V4, P149; Hauck M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074005; Heijungs R, 2005, INT J LIFE CYCLE ASS, V10, P103, DOI 10.1065/lca2004.06.161; Heijungs R, 2001, INT J LIFE CYCLE ASS, V6, P141, DOI 10.1007/BF02978732; Heijungs R., 2002, COMPUTATIONAL STRUCT, DOI [DOI 10.1007/978-94-015-9900-9, 10.1007/978-94-015-9900-9]; Heijungs R, 2014, INT J LIFE CYCLE ASS, V19, P1445, DOI 10.1007/s11367-014-0751-0; Henriksson P.J.G., 2014, FINAL LCA CASE STUDY; Henriksson PJG, 2014, INT J LIFE CYCLE ASS, V19, P429, DOI 10.1007/s11367-013-0647-4; Hertwich EG., 2000, J IND ECOL, V4, P13, DOI [10.1162/108819800569267, DOI 10.1162/108819800569267]; Hoekstra AY, THE WATER FOOTPRINT; Hong JL, 2010, INT J LIFE CYCLE ASS, V15, P499, DOI 10.1007/s11367-010-0175-4; Huijbregts M.A., 1998, INT J LIFE CYCLE ASS, V3, P273, DOI [10.1007/BF0297983519983:5, DOI 10.1007/BF02979835, 10.1007/BF02979835]; Huijbregts MAJ, 2003, ENVIRON SCI TECHNOL, V37, P2600, DOI 10.1021/es020971+; Huijbregts MAJ, 2001, INT J LIFE CYCLE ASS, V6, P127, DOI 10.1007/BF02978728; Huijbregts MAJ, 1998, INT J LIFE CYCLE ASS, V3, P343, DOI DOI 10.1007/BF02979345; IPCC, 2013, INT PAN CLIM WORK GR; ISO, 2012, 14067 ISO; ISO, 2006, 14044 ISO; JRC, 2010, ILCD HDB GEN GUID LC; Kennedy DJ, 1996, INT J LIFE CYCLE ASS, V1, P199, DOI DOI 10.1007/BF02978693; Linkov I, 2011, ENVIRON SCI TECHNOL, V45, P5068, DOI 10.1021/es100959q; Liu G, 2012, J CLEAN PROD, V35, P108, DOI 10.1016/j.jclepro.2012.05.030; Lloyd SM, 2007, J IND ECOL, V11, P161, DOI 10.1162/jiec.2007.1136; Lo SC, 2005, SCI TOTAL ENVIRON, V340, P23, DOI 10.1016/j.scitotenv.2004.08.020; Malca J, 2010, J IND ECOL, V14, P322, DOI 10.1111/j.1530-9290.2010.00227.x; Mattila T, 2011, J IND ECOL, V15, P217, DOI 10.1111/j.1530-9290.2010.00326.x; Maurice B., 2000, J CLEAN PROD, V8, P95, DOI [10.1016/S0959-6526(99)00324-8, DOI 10.1016/S0959-6526(99)00324-8]; Mutel CL, 2013, ENVIRON SCI TECHNOL, V47, P5660, DOI 10.1021/es3050949; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Prado-Lopez V, 2014, INT J LIFE CYCLE ASS, V19, P405, DOI 10.1007/s11367-013-0641-x; Ravetz JR, 1999, FUTURES, V31, P647; Bojaca CR, 2010, INT J LIFE CYCLE ASS, V15, P238, DOI 10.1007/s11367-010-0150-0; Roos E, 2011, INT J LIFE CYCLE ASS, V16, P338, DOI 10.1007/s11367-011-0270-1; Roos E, 2010, INT J LIFE CYCLE ASS, V15, P478, DOI 10.1007/s11367-010-0171-8; Sonnemann GW, 2003, J CLEAN PROD, V11, P279, DOI 10.1016/S0959-6526(02)00028-8; Steinmann ZJN, 2014, INT J LIFE CYCLE ASS, V19, P1146, DOI 10.1007/s11367-014-0717-2; Swarr TE, 2011, INT J LIFE CYCLE ASS, V16, P389, DOI 10.1007/s11367-011-0287-5; Upham P, 2011, J CLEAN PROD, V19, P348, DOI 10.1016/j.jclepro.2010.05.014; van der Harst E, 2014, ENVIRON MODELL SOFTW, V51, P123, DOI 10.1016/j.envsoft.2013.09.014; van Zelm R, 2013, ENVIRON SCI TECHNOL, V47, P9274, DOI 10.1021/es305107s; Vandenbergh MP, 2011, NAT CLIM CHANGE, V1, P4, DOI 10.1038/nclimate1071; Weber CL, 2012, J IND ECOL, V16, P203, DOI 10.1111/j.1530-9290.2011.00407.x; Weidema B.P., 1996, J CLEAN PROD, V4, P167, DOI [10.1016/S0959-6526(96)00043-1, DOI 10.1016/S0959-6526(96)00043-1]; Yoshida H, 2014, WATER RES, V56, P292, DOI 10.1016/j.watres.2014.03.014	53	78	79	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121221	10.1371/journal.pone.0121221	http://dx.doi.org/10.1371/journal.pone.0121221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781175	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600198
J	Mascuch, SJ; Moree, WJ; Hsu, CC; Turner, GG; Cheng, TL; Blehert, DS; Kilpatrick, AM; Frick, WF; Meehan, MJ; Dorrestein, PC; Gerwick, L				Mascuch, Samantha J.; Moree, Wilna J.; Hsu, Cheng-Chih; Turner, Gregory G.; Cheng, Tina L.; Blehert, David S.; Kilpatrick, A. Marm; Frick, Winifred F.; Meehan, Michael J.; Dorrestein, Pieter C.; Gerwick, Lena			Direct Detection of Fungal Siderophores on Bats with White-Nose Syndrome via Fluorescence Microscopy-Guided Ambient Ionization Mass Spectrometry	PLOS ONE			English	Article							MOLECULAR NETWORKING; IRON ASSIMILATION; EMERGING DISEASE; DESTRUCTANS; GEOMYCES; ECOLOGY	White-nose syndrome (WNS) caused by the pathogenic fungus Pseudogymnoascus destructans is decimating the populations of several hibernating North American bat species. Little is known about the molecular interplay between pathogen and host in this disease. Fluorescence microscopy ambient ionization mass spectrometry was used to generate metabolic profiles from the wings of both healthy and diseased bats of the genus Myotis. Fungal siderophores, molecules that scavenge iron from the environment, were detected on the wings of bats with WNS, but not on healthy bats. This work is among the first examples in which microbial molecules are directly detected from an infected host and highlights the ability of atmospheric ionization methodologies to provide direct molecular insight into infection.	[Mascuch, Samantha J.; Dorrestein, Pieter C.; Gerwick, Lena] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Hsu, Cheng-Chih; Meehan, Michael J.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Moree, Wilna J.; Hsu, Cheng-Chih; Meehan, Michael J.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Turner, Gregory G.] Penn Game Commiss, Harrisburg, PA 17110 USA; [Cheng, Tina L.; Kilpatrick, A. Marm; Frick, Winifred F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey	Gerwick, L (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	lgerwick@ucsd.edu	Frick, Winifred/ABA-3519-2020; Dorrestein, Pieter/ABF-2930-2020	Frick, Winifred/0000-0002-9469-1839; Hsu, Cheng-Chih/0000-0002-2892-5326; Blehert, David/0000-0002-1065-9760	National Institutes of Health Grant [GM094802]; National Science Foundation [DEB-1115895]; P.E.O. fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550, R01GM094802] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); P.E.O. fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the laboratory of PCD for the development of real-time MS was supported by National Institutes of Health Grant GM094802 (http://www.nih.gov/). Research in the laboratory of AMK was supported by National Science Foundation grant DEB-1115895 (http://www.nsf.gov/). Work by SJM was partially supported by a P.E.O. fellowship (http://www.peointernational.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boonen J, 2012, TOXICOLOGY, V301, P21, DOI 10.1016/j.tox.2012.06.012; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Flajs D, 2009, ARH HIG RADA TOKSIKO, V60, P457, DOI 10.2478/10004-1254-60-2009-1992; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hsu CC, 2013, P NATL ACAD SCI USA, V110, P14855, DOI 10.1073/pnas.1310618110; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller M, 2009, BIOMETALS, V22, P61, DOI 10.1007/s10534-008-9185-0; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1; Turner GG, 2014, J WILDL DIS, V50; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Winkelmann G, 2007, BIOMETALS, V20, P379, DOI 10.1007/s10534-006-9076-1; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	41	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119668	10.1371/journal.pone.0119668	http://dx.doi.org/10.1371/journal.pone.0119668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781976	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600084
J	Roscher, C; Schumacher, J; Schmid, B; Schulze, ED				Roscher, Christiane; Schumacher, Jens; Schmid, Bernhard; Schulze, Ernst-Detlef			Contrasting Effects of Intraspecific Trait Variation on Trait-Based Niches and Performance of Legumes in Plant Mixtures	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SPECIES RICHNESS; GRASSLAND COMMUNITIES; BIODIVERSITY; MECHANISMS; DIVERSITY; GROWTH; VARIABILITY; PATTERNS; SHADE	Niche differentiation, assumed to be a key mechanism of species coexistence, requires that species differ in their functional traits. So far it remains unclear to which extent trait plasticity leads to niche shifts of species at higher plant diversity, thereby increasing or decreasing niche overlap between species. To analyse this question it is convenient to measure niches indirectly via the variation in resource-uptake traits rather than directly via the resources used. We provisionally call these indirectly measured niches trait-based niches. We studied shoot- and leaf-morphological characteristics in seven legume species in monoculture and multi-species mixture in experimental grassland. Legume species varied in the extent of trait variation in response to plant diversity. Trait plasticity led to significant shifts in species niches in multiple dimensions. Single-species niches in several traits associated with height growth and filling of canopy space were expanded, while other niche dimensions were compressed or did not change with plant diversity. Niche separation among legumes decreased in dimensions related to height growth and space filling, but increased in dimensions related to leaf size and morphology. The total extent of occupied niche space was larger in mixture than in the combined monocultures for dimensions related to leaf morphology and smaller for dimensions related to whole-plant architecture. Taller growth, greater space filling and greater plasticity in shoot height were positively, while larger values and greater plasticity in specific leaf area were negatively related with increased performance of species in mixture. Our study shows that trait variation in response to plant diversity shifts species niches along trait axes. Plastically increased niche differentiation is restricted to niche dimensions that are apparently not related to size-dependent differences between species, but functional equivalence (convergence in height growth) rather than complementarity (divergence in traits associated with light acquisition) explains increased performance of legumes in mixture.	[Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; University of Zurich; University of Zurich; Max Planck Society	Roscher, C (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Schulze, Ernst-Detlef/K-9627-2014; Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	German Science Foundation [FOR456/1451, RO2397/3]; University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation [147092]	German Science Foundation(German Research Foundation (DFG)); University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Science Foundation (FOR456/1451) with additional support by the University of Jena and the Max Planck Institute for Biogeochemistry, Jena. This specific research project was further supported by the German Science Foundation (RO2397/3 to CR). Additional support was provided by the Swiss National Science Foundation (grant no. 147092 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 2014, R LANG ENV STAT COMP; Anten NPR, 1999, J ECOL, V87, P583, DOI 10.1046/j.1365-2745.1999.00365.x; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Boucher FC, 2013, FUNCT ECOL, V27, P382, DOI 10.1111/1365-2435.12034; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; CORRE WJ, 1983, ACTA BOT NEERL, V32, P49, DOI 10.1111/j.1438-8677.1983.tb01677.x; Dassler A, 2008, PLANT BIOLOGY, V10, P573, DOI 10.1111/j.1438-8677.2008.00073.x; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Ellenberg H., 1988, VEGETATION ECOLOGY C; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2009, OIKOS, V118, P1924, DOI 10.1111/j.1600-0706.2009.17884.x; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones, 1992, PLANTS MICROCLIMATES; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maire V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077372; Maire V, 2012, NEW PHYTOL, V196, P497, DOI 10.1111/j.1469-8137.2012.04287.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Price JN, 2014, FUNCT ECOL, V28, P509, DOI 10.1111/1365-2435.12186; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; ROUGHGARDEN J, 1974, AM NAT, V108, P429, DOI 10.1086/282924; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; SCHLICHTING CD, 1989, OECOLOGIA, V78, P496, DOI 10.1007/BF00378740; SCHLICHTING CD, 1989, BIOSCIENCE, V39, P460, DOI 10.2307/1311138; SCHMID B, 1992, EVOL TREND PLANT, V6, P45; SCHMID B, 1984, OECOLOGIA, V63, P1, DOI 10.1007/BF00379777; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Thein S, 2008, BASIC APPL ECOL, V9, P475, DOI 10.1016/j.baae.2007.08.004; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Werger MJA, 2002, J VEG SCI, V13, P615, DOI 10.1111/j.1654-1103.2002.tb02089.x; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	60	28	28	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119786	10.1371/journal.pone.0119786	http://dx.doi.org/10.1371/journal.pone.0119786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781938	Green Accepted, Green Published, gold			2022-12-26	WOS:000351284600093
J	Schreiber, T; Sorgatz, A; List, F; Bluher, D; Thieme, S; Wilmanns, M; Bonas, U				Schreiber, Tom; Sorgatz, Anika; List, Felix; Blueher, Doreen; Thieme, Sabine; Wilmanns, Matthias; Bonas, Ulla			Refined Requirements for Protein Regions Important for Activity of the TALE AvrBs3	PLOS ONE			English	Article							III EFFECTORS; EFFICIENT CONSTRUCTION; CRYSTAL-STRUCTURE; DNA RECOGNITION; NUCLEAR IMPORT; XANTHOMONAS; TRANSCRIPTION; CLONING; GENE; VESICATORIA	AvrBs3, the archetype of the family of transcription activator-like (TAL) effectors from phytopathogenic Xanthomonas bacteria, is translocated by the type III secretion system into the plant cell. AvrBs3 localizes to the plant cell nucleus and activates the transcription of target genes. Crucial for this is the central AvrBs3 region of 17.5 34-amino acid repeats that functions as a DNA-binding domain mediating recognition in a "one-repeat-to-one base pair" manner. Although AvrBs3 forms homodimers in the plant cell cytosol prior to nuclear import, it binds DNA as a monomer. Here, we show that complex formation of AvrBs3 proteins negatively affects their DNA-binding affinity in vitro. The conserved cysteine residues at position 30 of each repeat facilitate AvrBs3 complexes via disulfide bonds in vitro but are also required for the gene-inducing activity of the AvrBs3 monomer, i.e., activation of plant gene promoters. Our data suggest that the latter is due to a contribution to protein plasticity and that cysteine substitutions to alanine or serine result in a different DNA-binding mode. In addition, our studies revealed that extended parts of both the N-terminal and C-terminal regions of AvrBs3 contribute to DNA binding and, hence, gene-inducing activity in planta.	[Schreiber, Tom; Sorgatz, Anika; List, Felix; Blueher, Doreen; Thieme, Sabine; Bonas, Ulla] Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06108 Halle, Saale, Germany; [List, Felix; Wilmanns, Matthias] DESY, European Mol Biol Lab, Hamburg Unit, Hamburg, Germany	Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Bonas, U (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06108 Halle, Saale, Germany.	ulla.bonas@genetik.uni-halle.de		Wilmanns, Matthias/0000-0002-4643-5435	Deutsche Forschungsgemeinschaft [SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 648) to U.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; de Lange O, 2014, NUCLEIC ACIDS RES, V199, P773; de Lange O, 2014, PLANT J, V78, P753, DOI 10.1111/tpj.12431; de Lange O, 2013, NEW PHYTOL, V199, P773, DOI 10.1111/nph.12324; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Deng D, 2014, PROTEIN CELL, V5, P297, DOI 10.1007/s13238-014-0035-2; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gabriel DW, 1997, TRENDS PLANT SCI, V2, P204, DOI 10.1016/S1360-1385(97)89544-1; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; Juillerat A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03831; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Scholze H, 2011, THESIS M LUTHER U HA; Schreiber T, 2014, NUCLEIC ACIDS RES, V42, P7160, DOI 10.1093/nar/gku341; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Tartof K. E., 1987, BRL FOCUS, V9, P2; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	48	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120214	10.1371/journal.pone.0120214	http://dx.doi.org/10.1371/journal.pone.0120214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781334	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600139
J	Zhao, J; Li, H; Fu, SB; Chen, B; Sun, WT; Zhang, JQ; Zhang, JF				Zhao, Jian; Li, Hui; Fu, Shuangbin; Chen, Bo; Sun, Wenting; Zhang, Junqi; Zhang, Jinfeng			An iTRAQ-Based Proteomics Approach to Clarify the Molecular Physiology of Somatic Embryo Development in Prince Rupprecht's Larch (Larix principis-rupprechtii Mayr)	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; OXIDATIVE STRESS; BINDING-PROTEIN; AUXIN TRANSPORT; PLANT-CELLS; EMBRYOGENESIS; ARABIDOPSIS; INDUCTION; KINASE; GENES	Prince Rupprecht's larch (Larix principis-rupprechtii Mayr) is a native high-value forest tree species in North China whose clonal propagation through somatic embryogenesis (SE) has the potential to rapidly capture the benefits of breeding or genetic engineering programs and to improve raw material uniformity and quality. To date, research has focused on clarifying the molecular mechanism of SE, but proteomic studies are still in the early stages. In this study, isobaric tags for relative and absolute quantitation (iTRAQ) analysis was performed on three developmental stages of SE in L. principis-rupprechtii in an attempt to identify a wide range of proteins that are regulated differentially during this process. Proteins were extracted and analyzed from the pro-embryogenic mass (PEM), globular embryo (GE), and cotyledon embryo (CE) stages of embryo development. We detected 503 proteins in total and identified 96 proteins expressed differentially during different developmental stages. The identified proteins were analyzed further to provide information about their expression patterns and functions during SE. Four clusters of proteins based on shared expression profiles were generated. Functional analysis showed that proteins involved in primary metabolism, phosphorylation, and oxidation reduction were upregulated during somatic embryo development. This work provides novel insights into the process of larch embryo development in vitro and a basis for further study of the biological process and opportunities for practical application of this knowledge.	[Zhao, Jian; Li, Hui; Fu, Shuangbin; Chen, Bo; Sun, Wenting; Zhang, Junqi; Zhang, Jinfeng] Beijing Forestry Univ, Tree & Ornamental Plant Breeding & Biotechnol Lab, State Forestry Adm,Coll Biol Sci & Biotechnol,Min, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China	Beijing Forestry University	Zhang, JF (corresponding author), Beijing Forestry Univ, Tree & Ornamental Plant Breeding & Biotechnol Lab, State Forestry Adm,Coll Biol Sci & Biotechnol,Min, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China.	zjf@bjfu.edu.cn			"948" Project of China [2014-4-59]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]; Special Fund for Forestry Scientific Research in the Public Interest [201404422]; Project of National Natural Science Foundation of China [J1103516, 31370658]	"948" Project of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Forestry Scientific Research in the Public Interest; Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "948" Project of China (2014-4-59), Program for Changjiang Scholars and Innovative Research Team in University (IRT13047), the Special Fund for Forestry Scientific Research in the Public Interest (No. 201404422) and the Project of National Natural Science Foundation of China (J1103516 and 31370658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Almeida AM, 2012, PHYSIOL PLANTARUM, V146, P236, DOI 10.1111/j.1399-3054.2012.01633.x; Bian FH, 2010, PLANT MOL BIOL REP, V28, P22, DOI 10.1007/s11105-009-0104-5; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Carrari F, 2006, J EXP BOT, V57, P1883, DOI 10.1093/jxb/erj020; Cassells AC, 2001, PLANT CELL TISS ORG, V64, P145, DOI 10.1023/A:1010692104861; Chivasa S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003905; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Correia S, 2012, J PROTEOME RES, V11, P1666, DOI 10.1021/pr200856w; Dalal K, 2011, TRENDS CELL BIOL, V21, P506, DOI 10.1016/j.tcb.2011.04.005; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; DevilleBonne D, 1996, BIOCHEMISTRY-US, V35, P14643, DOI 10.1021/bi960945m; Ek-Ramos MJ, 2003, PHYSIOL PLANTARUM, V119, P270, DOI 10.1034/j.1399-3054.2003.00171.x; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Gendra E, 2004, PLANT J, V38, P875, DOI 10.1111/j.1365-313X.2004.02095.x; Imin N, 2005, PLANT PHYSIOL, V137, P1250, DOI 10.1104/pp.104.055277; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kitamiya E, 2000, PLANT CELL REP, V19, P551, DOI 10.1007/s002990050772; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; KONG LS, 1994, PLANT SCI, V104, P71, DOI 10.1016/0168-9452(94)90192-9; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Larsson E, 2008, NEW PHYTOL, V177, P356, DOI 10.1111/j.1469-8137.2007.02289.x; Lippert D, 2005, PROTEOMICS, V5, P461, DOI 10.1002/pmic.200400986; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Malerba M, 2008, PHYSIOL PLANTARUM, V133, P449, DOI 10.1111/j.1399-3054.2008.01085.x; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Pan ZY, 2010, PLANT CELL TISS ORG, V103, P145, DOI 10.1007/s11240-010-9762-0; Pan ZY, 2009, PLANT CELL REP, V28, P281, DOI 10.1007/s00299-008-0633-7; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Pliyev BK, 1999, BIOCHEMISTRY-MOSCOW+, V64, P738; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 2011, SCIENCE, V331, P681, DOI 10.1126/science.1202093; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rigbolt KTG, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.007450; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Rode C, 2012, PLANTA, V235, P995, DOI 10.1007/s00425-011-1554-1; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Sghaier-Hammami B, 2009, J PROTEOMICS, V73, P161, DOI 10.1016/j.jprot.2009.07.003; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Sun LF, 2013, PLANT CELL TISS ORG, V113, P103, DOI 10.1007/s11240-012-0255-1; Sun TT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00512; Teyssier C, 2014, PHYSIOL PLANTARUM, V150, P271, DOI 10.1111/ppl.12081; Varhanikova M, 2014, J PROTEOMICS, V104, P57, DOI 10.1016/j.jprot.2014.02.003; Wiweger M, 2003, J EXP BOT, V54, P2691, DOI 10.1093/jxb/erg299; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Zhang JW, 2009, PLANT SCI, V177, P103, DOI 10.1016/j.plantsci.2009.04.003; Zhang SG, 2010, PLANT CELL TISS ORG, V100, P21, DOI 10.1007/s11240-009-9612-0; Zhao J, 2015, PLANT CELL TISS ORG, V120, P655, DOI 10.1007/s11240-014-0633-y; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	61	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119987	10.1371/journal.pone.0119987	http://dx.doi.org/10.1371/journal.pone.0119987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781987	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600115
J	Tarpy, DR; Delaney, DA; Seeley, TD				Tarpy, David R.; Delaney, Deborah A.; Seeley, Thomas D.			Mating Frequencies of Honey Bee Queens (Apis mellifera L.) in a Population of Feral Colonies in the Northeastern United States	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; GENETIC DIVERSITY; SCIENTIFIC NOTE; POLYANDRY; EVOLUTION; PROMISCUITY; HYMENOPTERA; CLIMATES; DISEASE; GROWTH	Across their introduced range in North America, populations of feral honey bee (Apis mellifera L.) colonies have supposedly declined in recent decades as a result of exotic parasites, most notably the ectoparasitic mite Varroa destructor. Nonetheless, recent studies have documented several wild populations of colonies that have persisted. The extreme polyandry of honey bee queens-and the increased intracolony genetic diversity it confers-has been attributed, in part, to improved disease resistance and may be a factor in the survival of these populations of feral colonies. We estimated the mating frequencies of queens in feral colonies in the Arnot Forest in New York State to determine if the level of polyandry of these queens is especially high and so might contribute to their survival success. We geno-typed the worker offspring from 10 feral colonies in the Arnot Forest of upstate New York, as well as those from 20 managed colonies closest to this forest. We found no significant differences in mean mating frequency between the feral and managed queens, suggesting that queens in the remote, low-density population of colonies in the Arnot Forest are neither mate-limited nor adapted to mate at an especially high frequency. These findings support the hypothesis that the hyperpolyandry of honey bees has been shaped on an evolutionary timescale rather than on an ecological one.	[Tarpy, David R.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Delaney, Deborah A.] Univ Delaware, Dept Entomol & Wildlife Biol, Newark, DE USA; [Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Delaware; Cornell University	Tarpy, DR (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	david_tarpy@ncsu.edu		Tarpy, David/0000-0001-8601-6094	North American Pollinator Protection Campaign; USDA grant [2008-02404]	North American Pollinator Protection Campaign; USDA grant(United States Department of Agriculture (USDA))	This research was funded by a grant from the North American Pollinator Protection Campaign (to TDS, DAD and DRT), and by USDA grant number 2008-02404 (to DAD and DRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundel J, 2012, ECOL MODEL, V247, P48, DOI 10.1016/j.ecolmodel.2012.08.001; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Crozier RH, 1997, ELECTROPHORESIS, V18, P1672, DOI 10.1002/elps.1150180934; Delaney DA, 2009, ANN ENTOMOL SOC AM, V102, P666, DOI 10.1603/008.102.0411; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Engel Michael S., 2009, Proceedings of the California Academy of Sciences, V60, P23; Franck P, 2000, INSECT SOC, V47, P364, DOI 10.1007/PL00001732; Hamilton W.D., 1987, P81; Hamilton WD, 1975, Q REV BIOL, V50, P175, DOI [DOI 10.1086/408439, 10.1086/408439]; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; KRAUS B, 1995, APIDOLOGIE, V26, P149, DOI 10.1051/apido:19950208; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; Magnus R, 2010, SOCIOBIOLOGY, V55, P285; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Moritz RFA, 2008, J INSECT CONSERV, V12, P455, DOI 10.1007/s10841-007-9078-5; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Neumann P, 1999, J APICULT RES, V38, P11, DOI 10.1080/00218839.1999.11100990; Nielsen DI, 2000, THESIS U CALIFORNIA; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; OLDROYD BP, 1994, BEHAV ECOL SOCIOBIOL, V34, P169, DOI 10.1007/BF00167741; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Park S, 2008, EXCEL MICROSATELLITE; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Schmid-Hempel P., 1998, Parasites in social insects.; Seeley TD, 2002, APIDOLOGIE, V33, P75, DOI 10.1051/apido:2001008; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tarpy DR, 2012, J ECON ENTOMOL, V105, P20, DOI 10.1603/EC11276; Tarpy DR, 2010, J APICULT RES, V49, P302, DOI 10.3896/IBRA.1.49.4.02; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Tarpy DR, 2001, ANN ZOOL FENN, V38, P255; Tilley CA, 1997, ANIM BEHAV, V54, P1483, DOI 10.1006/anbe.1997.0546; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; VISSCHER PK, 1989, AM BEE J, V129, P536; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	49	31	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118734	10.1371/journal.pone.0118734	http://dx.doi.org/10.1371/journal.pone.0118734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775410	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500037
J	Xavier, C; Builes, JJ; Gomes, V; Ospino, JM; Aquino, J; Parson, W; Amorim, A; Gusmao, L; Goios, A				Xavier, Catarina; Builes, Juan Jose; Gomes, Veronica; Ospino, Jose Miguel; Aquino, Juliana; Parson, Walther; Amorim, Antonio; Gusmao, Leonor; Goios, Ana			Admixture and Genetic Diversity Distribution Patterns of Non-Recombining Lineages of Native American Ancestry in Colombian Populations	PLOS ONE			English	Article							AUTOSOMAL MICROSATELLITE DATA; MULTILOCUS GENOTYPE DATA; HUMAN MITOCHONDRIAL-DNA; COLUMBIAN BONE REMAINS; SOUTH-AMERICA; AMERINDIAN POPULATIONS; NORTHWESTERN COLOMBIA; INTERNATIONAL SOCIETY; ANTIOQUIA COLOMBIA; MTDNA HAPLOGROUPS	Genetic diversity of present American populations results from very complex demographic events involving different types and degrees of admixture. Through the analysis of lineage markers such as mtDNA and Y chromosome it is possible to recover the original Native American haplotypes, which remained identical since the admixture events due to the absence of recombination. However, the decrease in the effective population sizes and the consequent genetic drift effects suffered by these populations during the European colonization resulted in the loss or under-representation of a substantial fraction of the Native American lineages. In this study, we aim to clarify how the diversity and distribution of uniparental lineages vary with the different demographic characteristics (size, degree of isolation) and the different levels of admixture of extant Native groups in Colombia. We present new data resulting from the analyses of mtDNA whole control region, Y chromosome SNP haplogroups and STR haplotypes, and autosomal ancestry informative insertion-deletion polymorphisms in Colombian individuals from different ethnic and linguistic groups. The results demonstrate that populations presenting a high proportion of non-Native American ancestry have preserved nevertheless a substantial diversity of Native American lineages, for both mtDNA and Y chromosome. We suggest that, by maintaining the effective population sizes high, admixture allowed for a decrease in the effects of genetic drift due to Native population size reduction and thus resulting in an effective preservation of the Native American non-recombining lineages.	[Xavier, Catarina; Gomes, Veronica; Amorim, Antonio; Gusmao, Leonor; Goios, Ana] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Xavier, Catarina; Gomes, Veronica; Amorim, Antonio; Gusmao, Leonor; Goios, Ana] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Xavier, Catarina; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria; [Builes, Juan Jose] Univ Antioquia, Inst Biol, Medellin, Colombia; [Builes, Juan Jose; Ospino, Jose Miguel] Lab Genes Ltda, Medellin, Colombia; [Aquino, Juliana; Gusmao, Leonor] State Univ Rio de Janeiro UERJ, LDD, Rio De Janeiro, Brazil; [Parson, Walther] Penn State Univ, Eberly Coll Sci, University Pk, PA 16802 USA; [Amorim, Antonio] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Medical University of Innsbruck; Universidad de Antioquia; Universidade do Estado do Rio de Janeiro; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade do Porto	Goios, A (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aalmeida@ipatimup.pt	Parson, Walther/AAD-6845-2020; Gusmão, Leonor/L-8931-2019; Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Goios, Ana/J-6012-2013	Gusmão, Leonor/0000-0003-0432-6481; Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Goios, Ana/0000-0002-3297-8420; Xavier, Catarina/0000-0003-3522-1631; Builes Gomez, Juan Jose/0000-0001-8403-6809; Gomes, Veronica/0000-0003-2815-6376; Parson, Walther/0000-0002-5692-2392	FCT; FCT, the Portuguese Foundation for Science and Technology; European Social Fund (Human Potential Thematic Operational Programme) [SFRH/BD/90873/2012, SFRH/BPD/76207/2011, SFRH/BPD/43646/2008]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund (Human Potential Thematic Operational Programme)(European Social Fund (ESF))	Ipatimup is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT, the Portuguese Foundation for Science and Technology. CX, VG and AG are also supported by FCT fellowships co-financed by the European Social Fund (Human Potential Thematic Operational Programme; grants SFRH/BD/90873/2012, SFRH/BPD/76207/2011 and SFRH/BPD/43646/2008, respectively). The funders had no role in study	Aceituno FJ, 2013, QUATERN INT, V301, P23, DOI 10.1016/j.quaint.2012.05.017; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Adelaar W., 2004, LANGUAGES ANDES; Alonso A, 2003, INT CONGR SER, V1239, P585, DOI 10.1016/S0531-5131(02)00401-6; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arango R, 2004, PUEBLOS INDIGENAS CO; Arango Raul, 1998, PUEBLOS INDIGENAS CO; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Builes JJ, 2007, FORENSIC SCI INT, V167, P62, DOI 10.1016/j.forsciint.2005.12.015; Builes JJ, 2006, FORENSIC SCI INT, V164, P79, DOI 10.1016/j.forsciint.2005.10.005; Campbell Lyle, 2000, AM INDIAN LANGUAGES, P396; Carracedo A, 2000, FORENSIC SCI INT, V110, P79, DOI 10.1016/S0379-0738(00)00161-4; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Casas-Vargas A, 2011, AM J PHYS ANTHROPOL, V146, P637, DOI 10.1002/ajpa.21626; Noguera MC, 2014, ANN HUM BIOL, V41, P453, DOI 10.3109/03014460.2013.852244; Constenla Umana A., 1991, FILOLOGIA LINGUISTIC, V17, P137, DOI [10.15517/rfl.v17i1-2.20972, DOI 10.15517/RFL.V17I1-2.20972]; Curnow T.J., 1998, INT J AM LINGUIST, V64, P338, DOI [10.1086/466365, DOI 10.1086/466365]; Curtin Philip D., 1972, ATLANTIC SLAVE TRADE; DANE, 2007, COL NAC MULT DIV ETN; Palacio OD, 2006, FORENSIC SCI INT, V160, P217, DOI 10.1016/j.forsciint.2005.05.034; Drummond A., 2011, GENEIOUS V5 5; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gaviria A, 2004, FORENSIC SCI INT, V143, P69, DOI 10.1016/j.forsciint.2004.01.007; Gaviria AA, 2005, FORENSIC SCI INT, V151, P85, DOI 10.1016/j.forsciint.2004.07.006; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Gomez-Perez L, 2010, ANN HUM BIOL, V37, P488, DOI 10.3109/03014460903433810; Greenberg J. H, 1987, LANGUAGE AM; Gusmao L, 2006, INT J LEGAL MED, V120, P191, DOI 10.1007/s00414-005-0026-1; Ibarra A, 2014, INT J LEGAL MED, V128, P19, DOI 10.1007/s00414-013-0858-z; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Keyeux G, 2002, HUM BIOL, V74, P211, DOI 10.1353/hub.2002.0022; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kolman CJ, 1997, GENETICS, V147, P1289; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; Parson W, 2004, INT CONGR SER, V1261, P106, DOI 10.1016/S0531-5131(03)01629-7; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P13, DOI 10.1016/j.fsigen.2006.11.003; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Pritchard JK, 2000, GENETICS, V155, P945; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Rock AW, 2013, FORENSIC SCI INT-GEN, V7, P601, DOI 10.1016/j.fsigen.2013.07.005; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; S?nchez-Albornoz N., 2014, POBLACION AM LATINA; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Silva A, 2008, BIOMEDICA, V28, P569, DOI 10.7705/biomedica.v28i4.62; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Usme-Romero S, 2013, GENET MOL BIOL, V36, P149, DOI 10.1590/S1415-47572013005000011; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Yunis JJ, 2005, J FORENSIC SCI, V50, P682; Yunis JJ, 2001, HUM IMMUNOL, V62, P970, DOI 10.1016/S0198-8859(01)00295-6	62	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120155	10.1371/journal.pone.0120155	http://dx.doi.org/10.1371/journal.pone.0120155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD6EY	25775361	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500153
J	Ariestanti, DM; Ando, H; Hirose, S; Nakamura, N				Ariestanti, Donna Maretta; Ando, Hikaru; Hirose, Shigehisa; Nakamura, Nobuhiro			Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SURFACTANT PROTEIN-D; SMOKE-INDUCED EMPHYSEMA; LUNG INFLAMMATION; REDOX REGULATION; MATRIX METALLOPROTEINASES; NADPH OXIDASE; II CELLS; OXIDATIVE STRESS; GENE-EXPRESSION	Ig-Hepta/GPR116 is a member of the G protein-coupled receptor family predominantly expressed in the alveolar type II epithelial cells of the lung. Previous studies have shown that Ig-Hepta is essential for lung surfactant homeostasis, and loss of its function results in high accumulation of surfactant lipids and proteins in the alveolar space. Ig-Hepta knock-out (Ig-Hepta(-/-) mice also exhibit emphysema-like symptoms, including accumulation of foamy alveolar macrophages (AMs), but its pathogenic mechanism is unknown. Here, we show that the bronchoalveolar lavage fluid obtained from Ig-Hepta(-/-) mice contains high levels of inflammatory mediators, lipid hydroperoxides, and matrix metalloproteinases (MMPs), which are produced by AMs. Accumulation of reactive oxygen species was observed in the AMs of Ig-Hepta(-/-) mice in an age-dependent manner. In addition, nuclear factor-kappa B (NF-kappa B) is activated and translocated into the nuclei of the AMs of Ig-Hepta(-/-) mice. Release of MMP-2 and MMP-9 from the AMs was strongly inhibited by treatment with inhibitors of oxidants and NF-kappa B. We also found that the level of monocyte chemotactic protein-1 is increased in the embryonic lungs of Ig-Hepta(-/-) mice at 18.5 days postcoitum, when AMs are not accumulated and activated. These results suggest that Ig-Hepta plays an important role in regulating macrophage immune responses, and its deficiency leads to local inflammation in the lung, where AMs produce excessive amounts of reactive oxygen species and up-regulate MMPs through the NF-kappa B signaling pathway.	[Ariestanti, Donna Maretta; Ando, Hikaru; Hirose, Shigehisa; Nakamura, Nobuhiro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nakamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B13 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	nnakamur@bio.titech.ac.jp	Nakamura, Nobuhiro/C-4265-2015	Nakamura, Nobuhiro/0000-0002-0249-2665	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [21026010, 24117707, 22770123]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for scientific research 21026010, 24117707, and 22770123 from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan and the Japan Society for the Promotion of Science.	Abe J, 1999, J BIOL CHEM, V274, P19957, DOI 10.1074/jbc.274.28.19957; Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Andersson S, 1999, LUNG, V177, P179, DOI 10.1007/PL00007639; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Bridges JP, 2013, AM J RESP CELL MOL, V49, P348, DOI 10.1165/rcmb.2012-0439OC; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Deacu M, 2012, ROM J MORPHOL EMBRYO, V53, P173; DOELMAN CJA, 1990, FREE RADICAL BIO MED, V9, P381, DOI 10.1016/0891-5849(90)90015-B; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Fukuzawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069451; GILLIARD N, 1994, J CLIN INVEST, V93, P2608, DOI 10.1172/JCI117273; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Haugen TS, 1999, EUR RESPIR J, V14, P1100, DOI 10.1183/09031936.99.14511009; Hirama N, 2007, RESPIROLOGY, V12, P191, DOI 10.1111/j.1440-1843.2006.01009.x; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Kim MJ, 2013, TOXICOL APPL PHARM, V273, P77, DOI 10.1016/j.taap.2013.08.005; KINNULA VL, 1991, AM J PHYSIOL, V261, pL84, DOI 10.1152/ajplung.1991.261.2.L84; Kruse R, 2014, PURINERG SIGNAL, V10, P499, DOI 10.1007/s11302-014-9414-7; Lavigne MC, 2005, BIOCHEM BIOPH RES CO, V330, P194, DOI 10.1016/j.bbrc.2005.02.144; Lee SJ, 2007, FEBS LETT, V581, P4189, DOI 10.1016/j.febslet.2007.07.058; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; MACKAY AR, 1990, J BIOL CHEM, V265, P21929; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mechri M, 2010, PEDIATR PULM, V45, P1021, DOI 10.1002/ppul.21289; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Muller B, 1998, EUR J CLIN INVEST, V28, P762; Munaut C, 1999, J BIOL CHEM, V274, P5588, DOI 10.1074/jbc.274.9.5588; Ohnishi K, 1998, LAB INVEST, V78, P1077; Perez-Rial S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072975; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Schuchardt M, 2011, J MOL MED, V89, P799, DOI 10.1007/s00109-011-0750-6; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Stokes L, 2007, J IMMUNOL, V179, P6016, DOI 10.4049/jimmunol.179.9.6016; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Zoelen MAD, 2011, MOL IMMUNOL, V48, P1468, DOI 10.1016/j.molimm.2011.04.001; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	63	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11032	11040		10.1074/jbc.M115.648311	http://dx.doi.org/10.1074/jbc.M115.648311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778400	Green Published, hybrid			2022-12-26	WOS:000353404500039
J	van Rennings, L; von Munchhausen, C; Ottilie, H; Hartmann, M; Merle, R; Honscha, W; Kasbohrer, A; Kreienbrock, L				van Rennings, Lisa; von Muenchhausen, Christiane; Ottilie, Henry; Hartmann, Maria; Merle, Roswitha; Honscha, Walther; Kaesbohrer, Annemarie; Kreienbrock, Lothar			Cross-Sectional Study on Antibiotic Usage in Pigs in Germany	PLOS ONE			English	Article							ANTIMICROBIAL DRUG-USE; SWINE FARMS; VETERINARY-MEDICINE; CONSUMPTION; ONTARIO	To be able to analyze the relationship between the level of resistance and the use of antimicrobials, it is necessary to collect detailed data on antimicrobial usage. For this reason, data on antimicrobial use on 495 pig farms from entire Germany were collected and analyzed. In Germany, each application and dispensing of medicines to food-producing animals is documented in detail obligatorily by the veterinarian. This information was collected retrospectively for the year 2011. The analyses undertook separate examinations on the age groups sow, piglet, weaner and fattening pig; both the route of administration and indication per active ingredient, and active ingredient class, were evaluated. In total, 20,374 kg of antimicrobial substances were used in the study population. Tetracyclines were used in highest amounts, followed by beta-lactams, trimethoprim-sulfonamides and macrolides. Concerning the frequency of using an active substance per animal, polypeptides were most commonly administered. In all age groups, respiratory infections were the main indication for using antimicrobials, followed by intestinal diseases in piglets, weaners and fattening pigs and diseases of reproductive organs in sows. Over a period of 100 days, the median number of treatment days with one antimicrobial substance for piglets was 15 days, for weaners about 6 days, for fattening pigs about 4 days and for sows about 1 day. A multifactorial ANOVA was conducted to investigate which factors are associated with the treatment frequency. The factors "veterinarian" and "age group" were related to the treatment frequency, just as the interaction between "veterinarian" and "farm size" as well as the interaction between "veterinarian" and "age group".	[van Rennings, Lisa; von Muenchhausen, Christiane; Hartmann, Maria; Merle, Roswitha; Kreienbrock, Lothar] Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany; [Ottilie, Henry; Honscha, Walther] Univ Leipzig, Fac Vet, Inst Pharmacol Pharm & Toxicol, D-04109 Leipzig, Germany; [Kaesbohrer, Annemarie] Fed Inst Risk Assessment, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; Leipzig University; Federal Institute for Risk Assessment	van Rennings, L (corresponding author), Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany.	lisa.van.rennings@tiho-hannover.de		Merle, Roswitha/0000-0002-8688-2926	Federal Institute for Risk Assessment, Berlin [FK 1329-441, FK 1329-482]	Federal Institute for Risk Assessment, Berlin	This study was supported by research grants from the Federal Institute for Risk Assessment, Diedersdorfer Weg 1, D-12277 Berlin (Grant No.: FK 1329-441 and FK 1329-482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874; AURES, 2013, RES OST AURES 2012 A; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; BTK ArgeVET, 2000, DTSCH TIERARZTEBLATT, V48; Bundesamt Statistisches, 2012, LAND UND FORSTW FISC; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Casal J, 2007, VET RES, V38, P481, DOI 10.1051/vetres:2007010; Chauvin C, 2002, PREV VET MED, V55, P109, DOI 10.1016/S0167-5877(02)00091-0; Chavin C, 2001, VET RES, V32, P533, DOI 10.1051/vetres:2001145; DANMAP,, 2021, US ANT AG OCC ANT RE; DART, 2011, DART DTSCH ANT RES; Dunlop RH, 1998, CAN VET J, V39, P87; Dunlop RH, 1998, PREV VET MED, V34, P247, DOI 10.1016/S0167-5877(97)00093-7; EMA, 2013, EMA2864162012REV1; European commission, 2003, OFFICIAL J, VL268, P29; European Medicines Agency (EMA), 2013, SAL VET ANT AG 25 EU; Hajek P, 2009, J VET PHARMACOL THER, V32, P60; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jordan D, 2009, AUST VET J, V87, P222, DOI 10.1111/j.1751-0813.2009.00430.x; KTBL, 2012, BETR LANDW 2012 13 K; LAVES, 2011, BER ANT LANDW NUTZT; MARAN, 2013, MARAN 2012 MON ANT R; Merle R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-7; Merle R, 2013, BERL MUNCH TIERARZTL, V126, P326, DOI 10.2376/0005-9366-126-326; Merle R, 2012, PREV VET MED, V104, P34, DOI 10.1016/j.prevetmed.2011.10.013; Merle R, 2012, BERL MUNCH TIERARZTL, V125, P52, DOI 10.2376/0005-9366-125-52; Mollenhauer Y., 2010, THESIS TIERARZTLICHE; Moreno MA, 2012, VET REC, V171, DOI 10.1136/vr.100818; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Rajic A, 2006, CAN VET J, V47, P446; Robanus M, 2011, THESIS U LEIPZIG; Sanchez-Vazquez MJ, 2012, PREV VET MED, V104, P65, DOI 10.1016/j.prevetmed.2011.11.003; SVARM, 2013, SVARM 2012 SWED VET; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Ungemach FR, 2006, INT J MED MICROBIOL, V296, P33, DOI 10.1016/j.ijmm.2006.01.059; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Rennings L, 2014, BERL MUNCH TIERARZTL, V127, P10; van Rennings L, 2013, BERL MUNCH TIERARZTL, V126, P297, DOI 10.2376/0005-9366-126-297; Vieira AR, 2011, EPIDEMIOL INFECT, V139, P1601, DOI 10.1017/S0950268810002724; Wallmann J, 2013, DT TIERARZTEBL, V9, P1230; Wassenaar TM, 2005, CRIT REV MICROBIOL, V31, P155, DOI 10.1080/10408410591005110; WHO, 2009, ATC DDD IND 2013; WHO, 2011, WHO CRIT IMP ANT HUM	46	87	89	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119114	10.1371/journal.pone.0119114	http://dx.doi.org/10.1371/journal.pone.0119114			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785688	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500075
J	Vasalou, C; Helmlinger, G; Gomes, B				Vasalou, Christina; Helmlinger, Gabriel; Gomes, Bruce			A Mechanistic Tumor Penetration Model to Guide Antibody Drug Conjugate Design	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; VASCULAR-PERMEABILITY; MOLECULAR-SIZE; SOLID TUMORS; BINDING; MACROMOLECULES; GROWTH; AFFINITY; PLASMA; CELLS	Antibody drug conjugates (ADCs) represent novel anti-cancer modalities engineered to specifically target and kill tumor cells expressing corresponding antigens. Due to their large size and their complex kinetics, these therapeutic agents often face heterogeneous distributions in tumors, leading to large untargeted regions that escape therapy. We present a modeling framework which includes the systemic distribution, vascular permeability, interstitial transport, as well as binding and payload release kinetics of ADC-therapeutic agents in mouse xenografts. We focused, in particular, on receptor dynamics such as endocytic trafficking mechanisms within cancer cells, to simulate their impact on tumor mass shrinkage upon ADC administration. Our model identified undesirable tumor properties that can impair ADC tissue homogeneity, further compromising ADC success, and explored ADC design optimization scenarios to counteract upon such unfavorable intrinsic tumor tissue attributes. We further demonstrated the profound impact of cytotoxic payload release mechanisms and the role of bystander killing effects on tumor shrinkage. This model platform affords a customizable simulation environment which can aid with experimental data interpretation and the design of ADC therapeutic treatments.	[Vasalou, Christina; Helmlinger, Gabriel; Gomes, Bruce] Novartis, Adv Quantitat Sci, Cambridge, MA 02139 USA	Novartis	Gomes, B (corresponding author), Novartis, Adv Quantitat Sci, Cambridge, MA 02139 USA.	bruce.gomes@novartis.com			Novartis Institute for Biomedical Research	Novartis Institute for Biomedical Research	The authors would like to state that Novartis Institute for Biomedical Research provided support in the form of salaries for authors CV, BG, GH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams GP, 2001, CANCER RES, V61, P4750; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; BAXTER LT, 1991, MICROVASC RES, V41, P252, DOI 10.1016/0026-2862(91)90026-8; Berk DA, 1997, P NATL ACAD SCI USA, V94, P1785, DOI 10.1073/pnas.94.5.1785; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Dellian M, 2000, BRIT J CANCER, V82, P1513; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Erickson HK, 2010, BIOCONJUGATE CHEM, V21, P84, DOI 10.1021/bc900315y; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; FUJIMORI K, 1989, CANCER RES, V49, P5656; Gerber HP, 2013, NAT PROD REP, V30, P625, DOI 10.1039/c3np20113a; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hendriks BS, 2003, CANCER RES, V63, P1130; Hendriks BS, 2003, BIOPHYS J, V85, P2732, DOI 10.1016/S0006-3495(03)74696-7; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; ISOBE T, 1979, BLOOD, V53, P1028; JAIN RK, 1988, CANCER RES, V48, P7022; JUWEID M, 1992, CANCER RES, V52, P5144; Kovtun YV, 2006, CANCER RES, V66, P3214, DOI 10.1158/0008-5472.CAN-05-3973; Krop I, 2009, CANCER RES, V69, p795S; Lauffenburger DA, 1993, RECEPTORS MODELS BIN, P30; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Netti PA, 2000, CANCER RES, V60, P2497; Okeley NM, 2010, CLIN CANCER RES, V16, P888, DOI 10.1158/1078-0432.CCR-09-2069; Panetta JC, 1997, MATH BIOSCI, V146, P89, DOI 10.1016/S0025-5564(97)00077-1; Panetta JC, 2008, CLIN CANCER RES, V14, P318, DOI 10.1158/1078-0432.CCR-07-1243; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; PORSCHEN R, 1994, CANCER RES, V54, P587; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Shah DK, 2013, MABS-AUSTIN, V5, P297, DOI 10.4161/mabs.23684; Shah DK, 2012, J PHARMACOKINET PHAR, V39, P67, DOI 10.1007/s10928-011-9232-2; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thurber GM, 2007, J NUCL MED, V48, P995, DOI 10.2967/jnumed.106.037069; Thurber GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024696; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wadleigh M, 2003, BLOOD, V102, P1578, DOI 10.1182/blood-2003-01-0255; WATERS CM, 1990, BIOCHEMISTRY-US, V29, P3563, DOI 10.1021/bi00466a020; Wiig H, 2005, J PHYSIOL-LONDON, V567, P557, DOI 10.1113/jphysiol.2005.089615; Younes A, 2011, ASCO MEETING ABSTRAC, V15; YUAN F, 1995, CANCER RES, V55, P3752	48	50	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118977	10.1371/journal.pone.0118977	http://dx.doi.org/10.1371/journal.pone.0118977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786126	gold, Green Submitted, Green Published			2022-12-26	WOS:000352138500062
J	Vayalil, PK; Oh, JY; Zhou, F; Diers, AR; Smith, MR; Golzarian, H; Oliver, PG; Smith, RAJ; Murphy, MP; Velu, SE; Landar, A				Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Golzarian, Hafez; Oliver, Patsy G.; Smith, Robin A. J.; Murphy, Michael P.; Velu, Sadanandan E.; Landar, Aimee			A Novel Class of Mitochondria-Targeted Soft Electrophiles Modifies Mitochondrial Proteins and Inhibits Mitochondrial Metabolism in Breast Cancer Cells through Redox Mechanisms	PLOS ONE			English	Article							SENSITIVE K+ CHANNEL; OXIDATIVE STRESS; CELLULAR BIOENERGETICS; THIOL MODIFICATION; IN-VIVO; GLUTATHIONYLATION; DEHYDROGENASE; MUTATIONS; GLIOMAS; ATP	Despite advances in screening and treatment over the past several years, breast cancer remains a leading cause of cancer-related death among women in the United States. A major goal in breast cancer treatment is to develop safe and clinically useful therapeutic agents that will prevent the recurrence of breast cancers after front-line therapeutics have failed. Ideally, these agents would have relatively low toxicity against normal cells, and will specifically inhibit the growth and proliferation of cancer cells. Our group and others have previously demonstrated that breast cancer cells exhibit increased mitochondrial oxygen consumption compared with non-tumorigenic breast epithelial cells. This suggests that it may be possible to deliver redox active compounds to the mitochondria to selectively inhibit cancer cell metabolism. To demonstrate proof-of-principle, a series of mitochondria-targeted soft electrophiles (MTSEs) has been designed which selectively accumulate within the mitochondria of highly energetic breast cancer cells and modify mitochondrial proteins. A prototype MTSE, IBTP, significantly inhibits mitochondrial oxidative phosphorylation, resulting in decreased breast cancer cell proliferation, cell attachment, and migration in vitro. These results suggest MTSEs may represent a novel class of anti-cancer agents that prevent cancer cell growth by modification of specific mitochondrial proteins.	[Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Landar, Aimee] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Oliver, Patsy G.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Golzarian, Hafez; Velu, Sadanandan E.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Otago	Landar, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	landar@uab.edu	Murphy, Michael P/C-2120-2009	Murphy, Michael P/0000-0003-1115-9618; Velu, Sadanandan/0000-0002-0342-2378; Smith, Matthew Ryan/0000-0002-8889-3477	UAB Department of Pathology; National Institutes of Health (NIH) [T32 HL007918]; UAB Comprehensive Cancer Center [P30 CA013148]; UAB College of Arts and Sciences (CAS) [201307];  [HL096638]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL096638] Funding Source: NIH RePORTER; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	UAB Department of Pathology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Comprehensive Cancer Center; UAB College of Arts and Sciences (CAS); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by HL096638 (to AL), Start-up Funds from the UAB Department of Pathology (to AL), National Institutes of Health (NIH) Training Grant T32 HL007918 (ARD), a Pilot Award from the UAB Comprehensive Cancer Center P30 CA013148 (to AL), and UAB College of Arts and Sciences (CAS) Interdisciplinary Team Award No. 201307 (to AL and SEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Costa ADT, 2006, J BIOL CHEM, V281, P20801, DOI 10.1074/jbc.M600959200; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diers AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068348; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2011, CURR PHARM DESIGN, V17, P2421; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; Li ZX, 2009, CANCER BIOTHER RADIO, V24, P579, DOI 10.1089/cbr.2008.0606; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; LoPachin RM, 2007, TOXICOL SCI, V98, P561, DOI 10.1093/toxsci/kfm127; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Marley K, 2005, J PROTEOME RES, V4, P1403, DOI 10.1021/pr050078k; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Millard M, 2013, J MED CHEM, V56, P9170, DOI 10.1021/jm4012438; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Ricart KC, 2009, BIOCHEM J, V419, P427, DOI 10.1042/BJ20081350; Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Sanchez-Gomez FJ, 2004, MOL PHARMACOL, V66, P1349, DOI 10.1124/mol.104.002824; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Venkatraman A, 2004, AM J PHYSIOL-GASTR L, V286, pG521, DOI 10.1152/ajpgi.00399.2003; Wall SB, 2014, BBA-GEN SUBJECTS, V1840, P913, DOI 10.1016/j.bbagen.2013.09.003; Wall SB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00369; WARBURG O, 1956, SCIENCE, V124, P269; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	54	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120460	10.1371/journal.pone.0120460	http://dx.doi.org/10.1371/journal.pone.0120460			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785718	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500172
J	Becker, NI; Encarnacao, JA				Becker, Nina I.; Encarnacao, Jorge A.			Silvicolous on a Small Scale: Possibilities and Limitations of Habitat Suitability Models for Small, Elusive Mammals in Conservation Management and Landscape Planning	PLOS ONE			English	Article							DORMICE MUSCARDINUS-AVELLANARIUS; SPECIES DISTRIBUTION MODELS; NESTING-BEHAVIOR; PRESENCE-ABSENCE; COMMON DORMICE; SAMPLE-SIZE; WIND FARMS; ACCURACY; DORMOUSE; CHALLENGES	Species distribution and endangerment can be assessed by habitat-suitability modelling. This study addresses methodical aspects of habitat suitability modelling and includes an application example in actual species conservation and landscape planning. Models using species presence-absence data are preferable to presence-only models. In contrast to species presence data, absences are rarely recorded. Therefore, many studies generate pseudo- absence data for modelling. However, in this study model quality was higher with null samples collected in the field. Next to species data the choice of landscape data is crucial for suitability modelling. Landscape data with high resolution and ecological relevance for the study species improve model reliability and quality for small elusive mammals like Muscardinus avellanarius. For large scale assessment of species distribution, models with lowdetailed data are sufficient. For regional site-specific conservation issues like a conflict-free site for new wind turbines, high-detailed regional models are needed. Even though the overlap with optimally suitable habitat for M. avellanarius was low, the installation of wind plants can pose a threat due to habitat loss and fragmentation. To conclude, modellers should clearly state the purpose of their models and choose the according level of detail for species and environmental data.	[Becker, Nina I.; Encarnacao, Jorge A.] Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany	Justus Liebig University Giessen	Becker, NI (corresponding author), Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.	Nina.I.Becker@allzool.bio.uni-giessen.de; J.Encarnacao@bio.uni-giessen.de	Encarnação, Jorge A./I-8644-2018	Encarnação, Jorge A./0000-0001-8766-0607				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amori G, 2008, MUSCARDINUS AVELLANA; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bauschmann G, 1989, LEBENSRAM WALDRAND W; Becker NI, 2012, EUR J WILDLIFE RES, V58, P945, DOI 10.1007/s10344-012-0637-z; Belaire JA, 2014, CONSERV BIOL, V28, P541, DOI 10.1111/cobi.12199; Bell S, 2008, BIODIVERS CONSERV, V17, P3443, DOI 10.1007/s10531-008-9357-9; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Bright P.W., 2006, DORMOUSE CONSERVATIO; BRIGHT PW, 1992, J ZOOL, V226, P589, DOI 10.1111/j.1469-7998.1992.tb07502.x; Bright PW, 1996, MAMMAL REV, V26, P157, DOI 10.1111/j.1365-2907.1996.tb00151.x; BRIGHT PW, 1991, J ZOOL, V224, P177, DOI 10.1111/j.1469-7998.1991.tb04797.x; BRIGHT PW, 1990, BIOL CONSERV, V54, P307, DOI 10.1016/0006-3207(90)90143-D; Bright PW, 1998, ANIM BEHAV, V56, P1485, DOI 10.1006/anbe.1998.0921; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Buchner S, 2010, NUL, V8; Buchner S, 2012, FENA HESSEN FORST, P34; Buchner S, 2008, ACTA THERIOL, V53, P259, DOI 10.1007/BF03193122; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Dormann CF, 2011, MODELLING COMPLEX ECOLOGICAL DYNAMICS: AN INTRODUCTION INTO ECOLOGICAL MODELLING FOR STUDENTS, TEACHERS & SCIENTISTS, P179, DOI 10.1007/978-3-642-05029-9_13; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; FENA HF, 2004, ART EUR BIB CAST FIB; Gottschalk TK, 2007, J ORNITHOL, V148, P427, DOI 10.1007/s10336-007-0155-z; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Inman RD, 2013, ENDANGER SPECIES RES, V20, P1, DOI 10.3354/esr00487; Jiang DF, 2013, STAT METHODS MED RES, V22, P505, DOI 10.1177/0962280211428385; Juskaitis R, 2008, BIODIVERS CONSERV, V17, P3559, DOI 10.1007/s10531-008-9470-9; Katzner T, 2013, ANIM CONSERV, V16, P367, DOI 10.1111/acv.12067; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawrence A., 2010, TAKING STOCK NATURE, P251; Liechti F, 2013, BIOL CONSERV, V162, P24, DOI 10.1016/j.biocon.2013.03.018; Lindenmayer DB, 1999, BIOL CONSERV, V89, P83, DOI 10.1016/S0006-3207(98)00116-5; Loe L, 2011, EUR J WILDLIFE RES, P1; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; Maclean N, 2010, SILENT SUMMER STATE, P768; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meddins C, 2013, CLOCAENOG FOREST WIN, P49; Meinig H, 2009, ROTE LISTE GAFAHRDET, V1, P115; Morris P, 2004, DORMICE; Mortelliti A, 2013, MAMM BIOL, V78, P309, DOI 10.1016/j.mambio.2012.09.006; Naim DM, 2014, GENET MOL RES, V13, P167, DOI 10.4238/2014.January.10.8; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Reiners T. E., 2012, Peckiana, P87; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3; Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Russo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110894; Santos H, 2013, BIOL CONSERV, V157, P178, DOI 10.1016/j.biocon.2012.06.017; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tabassum-Abbasi, 2014, RENEW SUST ENERG REV, V31, P270, DOI 10.1016/j.rser.2013.11.019; Temple H., 2007, STATUS DISTRIBUTION; Temple HJ, 2009, FOLIA ZOOL, V58, P248; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zabala J, 2005, EUR J WILDLIFE RES, V51, P157, DOI 10.1007/s10344-005-0094-z	70	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120562	10.1371/journal.pone.0120562	http://dx.doi.org/10.1371/journal.pone.0120562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781894	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600172
J	Chen, Q; Zhang, F; Wang, YB; Liu, ZY; Sun, AY; Zen, K; Zhang, CY; Zhang, QP				Chen, Qun; Zhang, Fan; Wang, Yanbo; Liu, Zhengya; Sun, Anyang; Zen, Ke; Zhang, Chen-yu; Zhang, Qipeng			The Transcription Factor C-Myc Suppresses MiR-23b and MiR-27b Transcription during Fetal Distress and Increases the Sensitivity of Neurons to Hypoxia-Induced Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ACTIVATING FACTOR-I; BIRTH ASPHYXIA; MESSENGER-RNA; EXPRESSION; MICRORNAS; MITOCHONDRIAL; PROTEIN; MECHANISMS; MICROGLIA	Previous studies reported that the expression of miR-23b-27b cluster was downregulated in embryonic brain cortices during hypoxia-induced neuronal apoptosis. However, the mechanism underlying this downregulation is not completely understood. Here, we report that the transcription factor c-Myc plays an important role in regulating the expression of miR-23b-27b cluster during hypoxia. First, the c-Myc protein level was significantly elevated in embryonic brain cortices in a mouse model of fetal distress. Second, forced overexpression or knockdown of c-Myc could suppress or increase the expression of miR-23b-27b cluster polynucleotides. Third, we identified 2 conserved c-Myc binding sites (E-boxes) in the enhancer and promoter regions of miR-23b-27b cluster in the mouse genome. Finally, we showed that elevated c-Myc expression led to an increase in the Apaf-1 level by suppressing miR-23b-27b cluster expression and that this enhanced neuronal sensitivity to apoptosis. In summary, our study demonstrates that c-Myc may suppress the expression of the miR-23b-27b cluster, resulting in additional neuronal apoptosis during hypoxia.	[Chen, Qun; Zhang, Fan; Wang, Yanbo; Liu, Zhengya; Zen, Ke; Zhang, Chen-yu; Zhang, Qipeng] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Anyang] Yancheng Inst Hlth Sci, Lab Neurodegenerat Dis & Repair, Yancheng, Peoples R China	Nanjing University	Sun, AY (corresponding author), Yancheng Inst Hlth Sci, Lab Neurodegenerat Dis & Repair, Yancheng, Peoples R China.	anyangsun@hotmail.com; kzen@nju.edu.cn; cyzhang@nju.edu.cn; qpzhang@nju.edu.cn	Liu, Zhengya/AAA-2559-2020		National Natural Science Foundation of China [31100777, 30988003, 90608010]; Natural Science Foundation of Jiangsu Province [BK2011013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (31100777, 30988003 and 90608010) and the Natural Science Foundation of Jiangsu Province (BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIELTISON C, 1986, DEV MED CHILD NEUROL, V28, P671; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Ashraf QM, 2007, NEUROSCI LETT, V415, P253, DOI 10.1016/j.neulet.2007.01.023; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banasiak KJ, 2000, PROG NEUROBIOL, V62, P215, DOI 10.1016/S0301-0082(00)00011-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fleiss B, 2012, BRAIN RES, V1433, P9, DOI 10.1016/j.brainres.2011.11.035; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GIBSON AW, 1995, EXP CELL RES, V218, P351, DOI 10.1006/excr.1995.1166; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greenway SC, 2000, J EXP ZOOL, V287, P477, DOI 10.1002/1097-010X(20001201)287:7<477::AID-JEZ3>3.0.CO;2-4; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hung AC, 2000, J CELL BIOCHEM, V77, P323, DOI 10.1002/(SICI)1097-4644(20000501)77:2<323::AID-JCB14>3.0.CO;2-W; Hutton LC, 2009, DEV NEUROSCI-BASEL, V31, P523, DOI 10.1159/000251907; Ireland Z, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.790; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Trollmann R, 2008, AM J PHYSIOL-REG I, V295, pR1973, DOI 10.1152/ajpregu.00053.2008; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; Xue G., 2014, ONCOGENE; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yoshida H, 2002, CELL DEATH DIFFER, V9, P1273, DOI 10.1038/sj.cdd.4401128; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404	38	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120217	10.1371/journal.pone.0120217	http://dx.doi.org/10.1371/journal.pone.0120217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781629	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600141
J	Jones, CA; Ross, L; Surani, N; Dharamshi, N; Karmali, K				Jones, Charlotte A.; Ross, Leanne; Surani, Nadia; Dharamshi, Narissa; Karmali, Karima			Framingham Ten-Year General Cardiovascular Disease Risk: Agreement between BMI-Based and Cholesterol-Based Estimates in a South Asian Convenience Sample	PLOS ONE			English	Article							CARE; PREVENTION; MANAGEMENT; DIAGNOSIS; BARRIERS; SCORE	The goal of this analysis was to determine the agreement between body mass index-based and cholesterol-based ten-year Framingham general cardiovascular disease risk scores among a convenience sample of 773 South Asian Canadian adults attending community-based screening clinics. Scores were calculated using age, systolic blood pressure, antihypertensive use, current smoking, diabetes, and total cholesterol and high density lipoprotein (for cholesterol-based risk) or height and weight (for body mass index-based risk). Mean risk score differences (body mass index-based risk minus cholesterol-based risk) were estimated using paired t-tests. Bland-Altman plots were used to assess agreement between scores. Finally, agreement across risk categories (low [< 10%], moderate [10% to < 20%], high [> = 20%]) was examined using the kappa statistic. Average agreement between the two risk scores was quite good overall (mean differences of 0.6% for men and 0.5% for women), but increased to about 3% among participants 60-74 years of age. However, Bland-Altman plots revealed that the differences between the two scores and the variability of the differences increased with increasing average 10-year risk. In terms of clinical importance, the limits of agreement were reasonable for women < 60 years (95% confidence interval: -3.2% to 3.1%), but of concern for women 60-74 years (95% confidence interval: -6.0% to 12.3%), men < 60 years (95% confidence interval: -7.1% to 7.3%) and men 6-074 years (95% confidence interval: -13.8% to 18.8%). Agreement across categories was moderate for most sex and age groups examined (kappa values: 0.51 for women < 60 years, 0.50 for women 60-74 years, 0.65 for men < 60 years), except for men 60-74 years, where agreement was only fair (kappa = 0.26). In light of these disagreements, evaluation of a participant's change in cardiovascular disease risk over time will necessitate use of the same risk score (i.e., either body mass index-based or cholesterol-based) at all screening sessions.	[Jones, Charlotte A.; Ross, Leanne] Univ Calgary, Dept Med, Libin Cardiovasc Inst, Calgary, AB, Canada; [Jones, Charlotte A.; Ross, Leanne] Univ British Columbia Okanagan, Fac Med, Southern Med Program, Kelowna, BC, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia; University of British Columbia Okanagan	Jones, CA (corresponding author), Univ Calgary, Dept Med, Libin Cardiovasc Inst, Calgary, AB, Canada.	charlotte.jones@ubc.ca			Public Health Agency of Canada's Canadian Diabetes Strategy Community-Based Funding Program [6262-15-2010/8041049]	Public Health Agency of Canada's Canadian Diabetes Strategy Community-Based Funding Program	CJ received funding for this work from the Public Health Agency of Canada's (http://www.phacaspc. gc.ca/index-eng.php) Canadian Diabetes Strategy Community-Based Funding Program (Project Number: 6262-15-2010/8041049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi M, 2005, EUR J CARDIOV PREV R, V12, P46, DOI 10.1097/00149831-200502000-00007; Allison C, 2006, Issues Emerg Health Technol, P1; Altman D.G., 1991, PRACTICAL STATISTIC; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; Bryan Shirley, 2010, Health Rep, V21, P71; Canada Statistics, 2009, LEAD CAUS DEATH CAN; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; CYR L, 1992, COMPUT BIOL MED, V22, P239, DOI 10.1016/0010-4825(92)90063-S; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davachi S, 2005, CAN J DIABETES, V29, P87; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Green BB, 2012, AM J PREV MED, V42, P342, DOI 10.1016/j.amepre.2011.12.009; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jain A, 2011, ANN CLIN BIOCHEM, V48, P159, DOI 10.1258/acb.2010.010195; Jones C, 2008, CAN J CARDIOL, V24, P561, DOI 10.1016/S0828-282X(08)70634-2; Jones CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-160; Jones CA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-24; Lai DWL, 2010, CAN J AGING, V29, P249, DOI 10.1017/S0714980810000188; Myers MG, 2009, BLOOD PRESS MONIT, V14, P108, DOI 10.1097/MBP.0b013e32832c5167; Nijjar APK, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-38; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Parikh P, 2009, AM J HEALTH PROMOT, V23, P279, DOI 10.4278/ajhp.071221140; Patel JV, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-192; Patel M, 2012, J IMMIGR MINOR HEALT, V14, P774, DOI 10.1007/s10903-011-9550-x; Quinn RR, 2010, CAN J CARDIOL, V26, P241, DOI 10.1016/S0828-282X(10)70378-0; Ramaraj R, 2008, POSTGRAD MED J, V84, P518, DOI 10.1136/pgmj.2007.066381; Rao N, 2012, INT J CLIN PRACT, V66, P262, DOI 10.1111/j.1742-1241.2011.02773.x; Robinson Vollman A, 2008, CANADIAN COMMUNITY P, DOI [10.3109/01612840.2012.714054, DOI 10.3109/01612840.2012.714054]; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119183	10.1371/journal.pone.0119183	http://dx.doi.org/10.1371/journal.pone.0119183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781949	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600054
J	Ohuchi, SJ; Sagawa, F; Ohno, H; Inoue, T				Ohuchi, Shoji J.; Sagawa, Fumihiko; Ohno, Hirohisa; Inoue, Tan			A Purification Method for a Molecular Complex in Which a Scaffold Molecule Is Fully Loaded with Heterogeneous Molecules	PLOS ONE			English	Article							PROTEIN; AFFINITY; PEPTIDE	An affinity resin-based pull-down method is convenient for the purification of biochemical materials. However, its use is difficult for the isolation of a molecular complex fully loaded with multiple components from a reaction mixture containing the starting materials and intermediate products. To overcome this problem, we have developed a new purification procedure that depends on sequential elimination of the residues. In practice, two affinity resins were used for purifying a triangular-shaped RNP (RNA-protein complex) consisting of three ribosomal proteins (L7Ae) bound to an RNA scaffold. First, a resin with immobilized L7Ae protein captured the incomplete RNP complexes and the free RNA scaffold. Next, another resin with an immobilized chemically modified RNA of a derivative of Box C/ D motif, the binding partner of L7Ae, was used to capture free protein. The complete triangular RNP was successfully purified from the mixture by these two steps. Obviously, the purified triangular RNP displaying three protein-binding peptides exhibited an improved performance when compared with the unrefined product. Conceptually, this purification procedure should be applicable for the purification of a variety of complexes consisting of multiple components other than RNP.	[Ohuchi, Shoji J.; Sagawa, Fumihiko; Ohno, Hirohisa; Inoue, Tan] Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Kyoto, Japan	Kyoto University	Inoue, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Kyoto, Japan.	tan@kuchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science [23221011, 23119005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Japan Society for the Promotion of Science (23221011 and 23119005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Frey S, 2014, J CHROMATOGR A, V1337, P106, DOI 10.1016/j.chroma.2014.02.030; Fujita Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06422; Grabow WW, 2014, ACCOUNTS CHEM RES, V47, P1871, DOI 10.1021/ar500076k; Hara T, 2013, CHEM COMMUN, V49, P3833, DOI 10.1039/c3cc38688k; Koyfman AY, 2009, J AM CHEM SOC, V131, P14237, DOI 10.1021/ja9015638; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Patra A, 2012, ANGEW CHEM INT EDIT, V51, P11863, DOI 10.1002/anie.201204946; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Tintore M, 2014, CHEMBIOCHEM, V15, P1374, DOI 10.1002/cbic.201402014; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975	15	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120576	10.1371/journal.pone.0120576	http://dx.doi.org/10.1371/journal.pone.0120576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781936	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600173
J	Song, G; Dickins, BJA; Demeter, J; Engel, S; Dunn, B; Cherry, JM				Song, Giltae; Dickins, Benjamin J. A.; Demeter, Janos; Engel, Stacia; Dunn, Barbara; Cherry, J. Michael			AGAPE (Automated Genome Analysis PipelinE) for Pan-Genome Analysis of Saccharomyces cerevisiae	PLOS ONE			English	Article							GENETIC-VARIATION; SAKE YEASTS; STRAINS; DELETION; MUTANTS; S288C; IDENTIFICATION; BIOSYNTHESIS; FERMENTATION; ALIGNMENT	The characterization and public release of genome sequences from thousands of organisms is expanding the scope for genetic variation studies. However, understanding the phenotypic consequences of genetic variation remains a challenge in eukaryotes due to the complexity of the genotype-phenotype map. One approach to this is the intensive study of model systems for which diverse sources of information can be accumulated and integrated. Saccharomyces cerevisiae is an extensively studied model organism, with well-known protein functions and thoroughly curated phenotype data. To develop and expand the available resources linking genomic variation with function in yeast, we aim to model the pan-genome of S. cerevisiae. To initiate the yeast pan-genome, we newly sequenced or resequenced the genomes of 25 strains that are commonly used in the yeast research community using advanced sequencing technology at high quality. We also developed a pipeline for automated pan-genome analysis, which integrates the steps of assembly, annotation, and variation calling. To assign strain-specific functional annotations, we identified genes that were not present in the reference genome. We classified these according to their presence or absence across strains and characterized each group of genes with known functional and phenotypic features. The functional roles of novel genes not found in the reference genome and associated with strains or groups of strains appear to be consistent with anticipated adaptations in specific lineages. As more S. cerevisiae strain genomes are released, our analysis can be used to collate genome data and relate it to lineage-specific patterns of genome evolution. Our new tool set will enhance our understanding of genomic and functional evolution in S. cerevisiae, and will be available to the yeast genetics and molecular biology community.	[Song, Giltae; Demeter, Janos; Engel, Stacia; Dunn, Barbara; Cherry, J. Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Dickins, Benjamin J. A.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Stanford University; Nottingham Trent University	Song, G (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	gsong@stanford.edu	Song, Giltae/ABG-7799-2020	Song, Giltae/0000-0001-8796-4678; Engel, Stacia/0000-0001-5472-917X; Cherry, J. Michael/0000-0001-9163-5180; Snyder, Michael/0000-0003-0784-7987; Dunn, Barbara/0000-0002-7041-0035; Choe, Kisurb/0000-0002-6396-8452; Dickins, Benjamin/0000-0002-0866-6232	National Human Genome Research Institute at the United States National Institutes of Health [U41, HG001315]	National Human Genome Research Institute at the United States National Institutes of Health	This work is funded by a U41 grant from the National Human Genome Research Institute at the United States National Institutes of Health (HG001315). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Asano T, 2001, J BIOSCI BIOENG, V92, P429, DOI 10.1263/jbb.92.429; Atkinson R. W., 1881, P ROY SOC, V32, P299; Bedoya-Reina OC, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-17; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; BORTS RH, 1984, COLD SPRING HARB SYM, V49, P67, DOI 10.1101/SQB.1984.049.01.010; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Brachmann CB, 1998, YEAST, V14, P115; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; DUBIN RA, 1986, MOL CELL BIOL, V6, P2757, DOI 10.1128/MCB.6.8.2757; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Gibson AW, 1997, GENETICS, V146, P1287; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Harris R, 2007, THESIS PENNSYLBANIA; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Kumar C, 2003, YEAST, V20, P857, DOI 10.1002/yea.1012; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YD, 2014, GENOME BIOL EVOL, V6, P2516, DOI 10.1093/gbe/evu201; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Meyrial V, 2001, EUR J BIOCHEM, V268, P334, DOI 10.1046/j.1432-1327.2001.01882.x; MORTIMER RK, 1986, GENETICS, V113, P35; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Nitta A, 2000, SEIBUTSU-KOGAKU KAIS, V78, P77; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SHERMAN F, 1963, GENETICS, V48, P375; SIKORSKI RS, 1989, GENETICS, V122, P19; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Song G, 2012, GENOME BIOL EVOL, V4, P586, DOI 10.1093/gbe/evs032; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu H, 2005, APPL ENVIRON MICROB, V71, P6845, DOI 10.1128/AEM.71.11.6845-6855.2005; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	60	36	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120671	10.1371/journal.pone.0120671	http://dx.doi.org/10.1371/journal.pone.0120671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781462	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600180
J	Heo, SC; Shin, WC; Lee, MJ; Kim, BR; Jang, IH; Choi, EJ; Lee, JS; Kim, JH				Heo, Soon Chul; Shin, Won Chul; Lee, Mi Jeong; Kim, Ba Reun; Jang, Il Ho; Choi, Eun-Jung; Lee, Jung Sub; Kim, Jae Ho			Periostin Accelerates Bone Healing Mediated by Human Mesenchymal Stem Cell-Embedded Hydroxyapatite/Tricalcium Phosphate Scaffold	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; STROMAL CELLS; EXTRACELLULAR-MATRIX; IN-VITRO; GROWTH; DEFECTS; ANGIOGENESIS; PROGENITORS; EXPRESSION; MODEL	Background Periostin, an extracellular matrix protein, is expressed in bone, more specifically, the periosteum and periodontal ligaments, and plays a key role in formation and metabolism of bone tissues. Human adipose tissue-derived mesenchymal stem cells (hASCs) have been reported to differentiate into osteoblasts and stimulate bone repair. However, the role of periostin in hASC-mediated bone healing has not been clarified. In the current study, we examined the effect of periostin on bone healing capacity of hASCs in a critical size calvarial defect model. Methods and Results Recombinant periostin protein stimulated migration, adhesion, and proliferation of hASCs in vitro. Implantation of either hASCs or periostin resulted in slight, but not significant, stimulation of bone healing, whereas co-implantation of hASCs together with periostin further potentiated bone healing. In addition, the number of Ki67-positive proliferating cells was significantly increased in calvarial defects by co-implantation of both hASCs and periostin. Consistently, proliferation of administered hASCs was stimulated by co-implantation with periostin in vivo. In addition, co-delivery of hASCs with periostin resulted in markedly increased numbers of CD31-positive endothelial cells and alpha-SMA-positive arterioles in calvarial defects. Conclusions These results suggest that recombinant periostin potentiates hASC-mediated bone healing by stimulating proliferation of transplanted hASCs and angiogenesis in calvarial defects.	[Heo, Soon Chul; Lee, Mi Jeong; Kim, Ba Reun; Jang, Il Ho; Choi, Eun-Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, Gyeongsangnam D, South Korea; [Shin, Won Chul; Lee, Jung Sub] Pusan Natl Univ, Sch Med, Dept Orthopaed Surg, Yangsan 626870, Gyeongsangnam D, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, JS (corresponding author), Pusan Natl Univ, Sch Med, Dept Orthopaed Surg, Yangsan 626870, Gyeongsangnam D, South Korea.	jungsublee@pusan.ac.kr; jhkimst@pusan.ac.kr		Jang, Il Ho/0000-0002-0820-3035; Kim, Jae Ho/0000-0003-4323-4790	programs of the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2012R1A1A4A01011953, 2010-0020274]	programs of the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the programs of the National Research Foundation of Korea (www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A4A01011953; 2010-0020274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Cho YH, 2012, BIOMATERIALS, V33, P1376, DOI 10.1016/j.biomaterials.2011.10.078; DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gillan L, 2002, CANCER RES, V62, P5358; Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064; Heo SC, 2011, BBA-MOL CELL RES, V1813, P2061, DOI 10.1016/j.bbamcr.2011.08.004; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Keramaris NC, 2012, CURR STEM CELL RES T, V7, P293; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kuznetsov SA, 2011, STEM CELLS DEV, V20, P269, DOI 10.1089/scd.2009.0501; Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Supronowicz P, 2011, TISSUE ENG PT A, V17, P789, DOI [10.1089/ten.tea.2010.0357, 10.1089/ten.TEA.2010.0357]; Szoke K, 2012, STEM CELL TRANSL MED, V1, P658, DOI 10.5966/sctm.2012-0069; Tai IT, 2005, CARCINOGENESIS, V26, P908, DOI 10.1093/carcin/bgi034; Vahabi Surena, 2012, Chang Gung Med J, V35, P28; Yoshiba N, 2007, CELL TISSUE RES, V330, P133, DOI 10.1007/s00441-007-0439-x; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633; Zomorodian E, 2012, STEM CELLS INT, V2012, P1, DOI DOI 10.1155/2012/980353	45	28	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116698	10.1371/journal.pone.0116698	http://dx.doi.org/10.1371/journal.pone.0116698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775460	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500011
J	Meli, R; Weisova, P; Propst, F				Meli, Rajeshwari; Weisova, Petronela; Propst, Friedrich			Repulsive Axon Guidance by Draxin Is Mediated by Protein Kinase B (Akt), Glycogen Synthase Kinase-3 beta (GSK-3 beta) and Microtubule-Associated Protein 1B	PLOS ONE			English	Article							GROWTH-CONE COLLAPSE; NETRIN RECEPTOR DCC; NEURONAL MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; MAP1B; PHOSPHORYLATION; MECHANISM; OUTGROWTH; INHIBITION; INSULIN	Draxin is an important axon guidance cue necessary for the formation of forebrain commissures including the corpus callosum, but the molecular details of draxin signaling are unknown. To unravel how draxin signals are propagated we used murine cortical neurons and genetic and pharmacological approaches. We found that draxin-induced growth cone collapse critically depends on draxin receptors (deleted in colorectal cancer, DCC), inhibition of protein kinase B/Akt, activation of GSK-3 beta (glycogen synthase kinase-3 beta) and the presence of microtubule-associated protein MAP1B. This study, for the first time elucidates molecular events in draxin repulsion, links draxin and DCC to MAP1B and identifies a novel MAP1B-depenent GSK-3 beta pathway essential for chemo-repulsive axon guidance cue signaling.	[Meli, Rajeshwari; Weisova, Petronela; Propst, Friedrich] Univ Vienna, Vienna Bioctr VBC, Dept Biochem & Cell Biol, MFPL, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Propst, F (corresponding author), Univ Vienna, Vienna Bioctr VBC, Dept Biochem & Cell Biol, MFPL, Waehringer Guertel 18, A-1030 Vienna, Austria.	friedrich.propst@univie.ac.at	Weisova, Petronela/AAM-5989-2020		Doktoratskolleg 'Molecular Mechanisms of Cell Signaling' [P20839-B09, W1220-B09]	Doktoratskolleg 'Molecular Mechanisms of Cell Signaling'	This research was supported by grants P20839-B09 and W1220-B09 (Doktoratskolleg 'Molecular Mechanisms of Cell Signaling') from the Austrian Science Fund (FWF) to F.P.P.W. is funded by the Max F. Perutz Laboratories' Vienna International Postdoctoral Program for Molecular Life Sciences (Austrian Ministry of Science and Research and City of Vienna, Cultural Department-Science and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anilkumar U, 2013, J NEUROCHEM, V124, P721, DOI 10.1111/jnc.12108; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edstrorn A, 2003, J NEUROSCI RES, V74, P726, DOI 10.1002/jnr.10686; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Henle SJ, 2013, J BIOL CHEM, V288, P20837, DOI 10.1074/jbc.C113.487066; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Kapfhammer JP, 2007, NAT PROTOC, V2, P2005, DOI 10.1038/nprot.2007.295; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kim SR, 2011, ANN NEUROL, V70, P110, DOI 10.1002/ana.22383; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lucas FR, 1998, J CELL SCI, V111, P1351; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Naser IB, 2009, DEV BIOL, V332, P351, DOI 10.1016/j.ydbio.2009.06.004; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Oinuma I, 2010, J BIOL CHEM, V285, P28200, DOI 10.1074/jbc.M110.147546; Riyadh MA, 2014, BIOCHEM BIOPH RES CO, V449, P169, DOI 10.1016/j.bbrc.2014.05.013; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Tortosa E, 2013, EMBO J, V32, P1293, DOI 10.1038/emboj.2013.76; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Tymanskyj SR, 2012, MOL CELL NEUROSCI, V49, P110, DOI 10.1016/j.mcn.2011.10.003; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Waite K, 2010, CURR TOP MICROBIOL, V346, P245, DOI 10.1007/82_2010_82; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	55	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119524	10.1371/journal.pone.0119524	http://dx.doi.org/10.1371/journal.pone.0119524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775433	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500100
J	Muneer, S; Ko, CH; Soundararajan, P; Manivnnan, A; Park, YG; Jeong, BR				Muneer, Sowbiya; Ko, Chung Ho; Soundararajan, Prabhakaran; Manivnnan, Abinaya; Park, Yoo Gyeong; Jeong, Byoung Ryong			Proteomic Study Related to Vascular Connections in Watermelon Scions Grafted onto Bottle-Gourd Rootstock under Different Light Intensities	PLOS ONE			English	Article							CONTRASTING RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; EMITTING-DIODES; ROOT PROTEOME; HYBRID ASPEN; GROWTH; PROTEINS; UNION; TRANSCRIPTION	Although grafting is broadly used in the production of crops, no information is available about the proteins involved in vascular connections between rootstock and scion. Similarly, proteome changes under the light intensities widely used for grafted seedlings are of practical use. The objective of this study was to determine the proteome of vascular connections using watermelon (Citrullus vulgaris Schrad.) 'Sambok Honey' and 'Speed' as the scion and bottle gourd (Lagenaria siceraria Stanld.) 'RS Dongjanggun' as the rootstock grown under different light intensities (25, 50, 75 and 100 mu mol m(-2) s(-1)). Our proteomic analysis revealed 24 and 27 differentially expressed proteins in 'Sambok Honey' and 'Speed', respectively, under different light intensities. The identified proteins were largely involved in ion binding, amino acid metabolism, transcriptional regulation and defense response. The enhancement of ion-binding, transcriptional regulation, amino acid metabolism, and defense response proteins suggests a strengthening of the connection between the rootstock and scion under high light intensity. Indeed, the accumulation of key enzymes in the biological processes described above appears to play an important role in the vascular connections of grafted seedlings. Moreover, it appears that 100 mu mol m(-2) s(-1) results in better protein expression responses in grafted seedlings.	[Muneer, Sowbiya; Ko, Chung Ho; Soundararajan, Prabhakaran; Manivnnan, Abinaya; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Div Appl Life Sci, Plus BK21, Jinju 660701, South Korea; [Park, Yoo Gyeong; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Plus BK21, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Muneer, Sowbiya/S-5382-2019; Jeong, Byoung Ryong/D-7667-2014	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries [312034-04]; BK21 programme, Ministry of Education, Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries; BK21 programme, Ministry of Education, Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries (Project No. 312034-04). SM, CHK, PS, AM and YGP were supported by a scholarship from BK21 programme, Ministry of Education, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmageed AHA, 2009, EUR J HORTIC SCI, V74, P16; Alluvada J, 2014, ACTA PHYSIOL PLANT, V36, P2385, DOI 10.1007/s11738-014-1611-z; Aloni B, 2008, J HORTIC SCI BIOTECH, V83, P777, DOI 10.1080/14620316.2008.11512460; Baba K, 2011, P NATL ACAD SCI USA, V108, P3418, DOI 10.1073/pnas.1011506108; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Berta M, 2010, PLANT BIOLOGY, V12, P341, DOI 10.1111/j.1438-8677.2009.00320.x; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Colla G, 2010, SCI HORTIC-AMSTERDAM, V127, P147, DOI 10.1016/j.scienta.2010.08.004; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291; Geigenberger P, 2003, J EXP BOT, V54, P457, DOI 10.1093/jxb/erg074; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Henriksson E, 2005, PLANT CELL ENVIRON, V28, P202, DOI 10.1111/j.1365-3040.2004.01263.x; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Jensen PJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-9; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Kang HG, 2000, PLANT J, V21, P329, DOI 10.1046/j.1365-313x.2000.00678.x; Karpinska B, 2004, PLANT MOL BIOL, V56, P255, DOI 10.1007/s11103-004-3354-5; Kehr J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-11; Kim K., 2013, PLANT PATHOLOGY MICR, V4, P49; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Liu YS, 2006, ADV GENET, V56, P101, DOI 10.1016/S0065-2660(06)56003-1; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Mudge K., 2009, Horticultural Reviews, V35, P437; Muneer S, 2014, INT J MOL SCI, V15, P6343, DOI 10.3390/ijms15046343; Muneer S, 2014, INT J MOL SCI, V15, P4657, DOI 10.3390/ijms15034657; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Oka Y, 2004, J NEMATOL, V36, P137; Olmstead MA, 2006, HORTSCIENCE, V41, P674, DOI 10.21273/HORTSCI.41.3.674; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Pina A, 2005, SCI HORT, V127, P93; Qureshi MI, 2010, ADV BOT RES, V56, P1, DOI 10.1016/S0065-2296(10)56001-4; Raju Saravanan, 2013, Indian Journal of Plant Physiology, V18, P285, DOI 10.1007/s40502-013-0038-7; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Smith DL, 2000, PLANT PHYSIOL, V123, P1173, DOI 10.1104/pp.123.3.1173; Sorce C, 2013, PLANT CELL REP, V32, P885, DOI 10.1007/s00299-013-1431-4; SOUMELIDOU K, 1994, ANN BOT-LONDON, V74, P605, DOI 10.1006/anbo.1994.1161; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Vitale A, 2014, PLANT PHYSIOL BIOCH, V83, P207, DOI 10.1016/j.plaphy.2014.08.006; Vu NT, 2014, PROTECTED HORT PLANT, V23, P43, DOI DOI 10.12791/KSBEC.2014.23.1.043; Walz C, 2004, PHYTOCHEMISTRY, V65, P1795, DOI 10.1016/j.phytochem.2004.04.006; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Yang YJ, 2012, PLANT PHYSIOL BIOCH, V58, P54, DOI 10.1016/j.plaphy.2012.05.026; Yano A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-46; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380; Yuan K, 2011, AFR J BIOTECHNOL, V10, P14816, DOI 10.5897/AJB11.1844; Zhao FG, 2007, PLANT PHYSIOL, V145, P1061, DOI 10.1104/pp.107.105882; Zheng BS, 2010, TREE PHYSIOL, V30, P297, DOI 10.1093/treephys/tpp102	55	14	17	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120899	10.1371/journal.pone.0120899	http://dx.doi.org/10.1371/journal.pone.0120899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789769	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400182
J	Braun, M; Hettinger, N; Koentges, C; Pfeil, K; Cimolai, MC; Hoffmann, MM; Osterholt, M; Doenst, T; Bode, C; Bugger, H				Braun, Martin; Hettinger, Niko; Koentges, Christoph; Pfeil, Katharina; Cimolai, Maria C.; Hoffmann, Michael M.; Osterholt, Moritz; Doenst, Torsten; Bode, Christoph; Bugger, Heiko			Myocardial Mitochondrial and Contractile Function Are Preserved in Mice Lacking Adiponectin	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ISCHEMIA-REPERFUSION; PROTEIN; OXIDATION; MUSCLE; DYSFUNCTION; DECREASE; ADIPOSE; CLONING; FAMILY	Adiponectin deficiency leads to increased myocardial infarct size following ischemia reperfusion and to exaggerated cardiac hypertrophy following pressure overload, entities that are causally linked to mitochondrial dysfunction. In skeletal muscle, lack of adiponectin results in impaired mitochondrial function. Thus, it was our objective to investigate whether adiponectin deficiency impairs mitochondrial energetics in the heart. At 8 weeks of age, heart weight-to-body weight ratios were not different between adiponectin knockout (ADQ(-/-)) mice and wildtypes (WT). In isolated working hearts, cardiac output, aortic developed pressure and cardiac power were preserved in ADQ(-/-) mice. Rates of fatty acid oxidation, glucose oxidation and glycolysis were unchanged between groups. While myocardial oxygen consumption was slightly reduced (-24%) in ADQ(-/-) mice in isolated working hearts, rates of maximal ADP-stimulated mitochondrial oxygen consumption and ATP synthesis in saponin-permeabilized cardiac fibers were preserved in ADQ(-/-) mice with glutamate, pyruvate or palmitoyl-carnitine as a substrate. In addition, enzymatic activity of respiratory complexes I and II was unchanged between groups. Phosphorylation of AMP-activated protein kinase and SIRT1 activity were not decreased, expression and acetylation of PGC-1a were unchanged, and mitochondrial content of OXPHOS subunits was not decreased in ADQ(-/-) mice. Finally, increasing energy demands due to prolonged subcutaneous infusion of isoproterenol did not differentially affect cardiac contractility or mitochondrial function in ADQ(-/-) mice compared to WT. Thus, mitochondrial and contractile function are preserved in hearts of mice lacking adiponectin, suggesting that adiponectin may be expendable in the regulation of mitochondrial energetics and contractile function in the heart under non-pathological conditions.	[Braun, Martin; Hettinger, Niko; Koentges, Christoph; Pfeil, Katharina; Cimolai, Maria C.; Hoffmann, Michael M.; Bode, Christoph; Bugger, Heiko] Univ Freiburg, Ctr Heart, Div Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Osterholt, Moritz; Doenst, Torsten] Jena Univ Hosp, Dept Cardiothorac Surg, Jena, Germany; [Hoffmann, Michael M.] Freiburg Univ Hosp, Inst Clin Chem & Lab Med, Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; University of Freiburg	Bugger, H (corresponding author), Univ Freiburg, Ctr Heart, Div Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	heiko.bugger@universitaets-herzzentrum.de	Hoffmann, Michael M/D-4074-2015; Bugger, Heiko/ABA-4180-2021	Hoffmann, Michael M/0000-0001-8459-6080; Bugger, Heiko/0000-0002-3524-0405				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; TZAGOLOFF A, 1965, J BIOL CHEM, V240, P2628; Weibel ER, 1979, INT REV CYTOL, V26, P235; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	30	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119416	10.1371/journal.pone.0119416	http://dx.doi.org/10.1371/journal.pone.0119416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785965	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500102
J	Gordon-Dseagu, VLZ; Mindell, JS; Steptoe, A; Moody, A; Wardle, J; Demakakos, P; Shelton, NJ				Gordon-Dseagu, Vanessa L. Z.; Mindell, Jennifer S.; Steptoe, Andrew; Moody, Alison; Wardle, Jane; Demakakos, Panayotes; Shelton, Nicola J.			Impaired Glucose Metabolism among Those with and without Diagnosed Diabetes and Mortality: A Cohort Study Using Health Survey for England Data	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; CANCER-RISK; HBA(1C); ASSOCIATION; HBA1C; INDIVIDUALS; PREVALENCE; MELLITUS	Background The extent that controlled diabetes impacts upon mortality, compared with uncontrolled diabetes, and how pre-diabetes alters mortality risk remain issues requiring clarification. Methods We carried out a cohort study of 22,106 Health Survey for England participants with a HbA1(C) measurement linked with UK mortality records. We estimated hazard ratios (HRs) of all-cause, cancer and cardiovascular disease (CVD) mortality and 95% confidence intervals (CI) using Cox regression. Results Average follow-up time was seven years and there were 1,509 deaths within the sample. Compared with the non-diabetic and normoglycaemic group (HbA1C <5.7% [<39mmol/mol] and did not indicate diabetes), undiagnosed diabetes (HbA1(C) >= 6.5% [>= 48mmol/mol] and did not indicate diabetes) inferred an increased risk of mortality for all-causes (HR 1.40, 1.09-1.80) and CVD (1.99, 1.35-2.94), as did uncontrolled diabetes (diagnosed diabetes and HbA1(C)>= 6.5% [>= 48mmol/mol]) and diabetes with moderately raised HbA1(C) (diagnosed diabetes and HbA1(C) 5.7-< 6.5% [39-<48mmol/mol]). Those with controlled diabetes (diagnosed diabetes and HbA<5.7% [<39mmol/mol]) had an increased HR in relation to mortality from CVD only. Pre-diabetes (those who did not indicate diagnosed diabetes and HbA1(C) 5.7-< 6.5% [39-<48mmol/mol]) was not associated with increased mortality, and raised HbA1(C) did not appear to have a statistically significant impact upon cancer mortality. Adjustment for BMI and socioeconomic status had a limited impact upon our results. We also found women had a higher all-cause and CVD mortality risk compared with men. Conclusions We found higher rates of all-cause and CVD mortality among those with raised HbA1(C), but not for those with pre-diabetes, compared with those without diabetes. This excess differed by sex and diabetes status. The large number of deaths from cancer and CVD globally suggests that controlling blood glucose levels and policies to prevent hyperglycaemia should be considered public health priorities.	[Gordon-Dseagu, Vanessa L. Z.; Mindell, Jennifer S.; Steptoe, Andrew; Moody, Alison; Wardle, Jane; Demakakos, Panayotes; Shelton, Nicola J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Gordon-Dseagu, VLZ (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	vanessa.gordon-dseagu@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019; Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Demakakos, Panayotes/0000-0002-7663-2122; Gordon-Dseagu, Vanessa/0000-0003-1867-2238; Moody, Alison/0000-0002-8199-4830	Department of Health; Health and Social Care Information Centre; Cancer Research UK [14133] Funding Source: researchfish	Department of Health; Health and Social Care Information Centre; Cancer Research UK(Cancer Research UK)	The HSE was funded in 2003 by the Department of Health and since 2004 by the Health and Social Care Information Centre. The funders played no part in this study nor the decision to publish the findings and there are no relevant conflicts of interest to disclose.	Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Bao CP, 2013, J DIABETES COMPLICAT, V27, P357, DOI 10.1016/j.jdiacomp.2013.01.004; Craig R, 2009, HEALTH SURVEY FOR EN; Craig R, 2009, HEALTH SURVEY FOR EN; Dabrowski M, 2013, ANN AGR ENV MED, V20, P116; De Beer JC, 2014, BR J CANCER; Elley CR, 2008, DIABETIC MED, V25, P1295, DOI 10.1111/j.1464-5491.2008.02581.x; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Farmer A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7293; Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gapstur SM, 2001, CANCER CAUSE CONTROL, V12, P763, DOI 10.1023/A:1011279907108; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Huang YP, 2014, ROUTLEDGE STUD GROWT, V124, P1; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jonasson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038784; Joshu CE, 2012, INT J CANCER, V131, P1667, DOI 10.1002/ijc.27394; Kaaks Rudolf, 2004, Novartis Found Symp, V262, P247; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Mindell J, 2012, INT J EPIDEMIOL; Monami M, 2013, NUTR METAB CARDIOVAS, V23, P300, DOI 10.1016/j.numecd.2012.01.003; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; ONS, 2011, POPULATION ESTIMATES; Ostgren CJ, 2013, DIABETIC MED, V30, pE170, DOI 10.1111/dme.12145; Roche MM, 2013, DIABETES CARE, V36, P2582, DOI 10.2337/dc12-1272; Sakurai M, 2013, DIABETES CARE, V36, P3759, DOI 10.2337/dc12-2412; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Skriver MV, 2012, DIABETOLOGIA, V55, P2361, DOI 10.1007/s00125-012-2614-1; Sluik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038877; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Xu L, 2012, DIABETIC MED, V29, P393, DOI 10.1111/j.1464-5491.2011.03456.x; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119882	10.1371/journal.pone.0119882	http://dx.doi.org/10.1371/journal.pone.0119882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785731	Green Published, gold			2022-12-26	WOS:000352138500140
J	Yang, ZM; Chen, Y; Hu, BY; Tan, ZQ; Huang, BT				Yang, Zhimin; Chen, Yu; Hu, Baoyun; Tan, Zhiqun; Huang, Bingru			Identification and Validation of Reference Genes for Quantification of Target Gene Expression with Quantitative Real-time PCR for Tall Fescue under Four Abiotic Stresses	PLOS ONE			English	Article							TRANSCRIPT NORMALIZATION; HOUSEKEEPING GENES; FREEZING TOLERANCE; INTERNAL CONTROL; RT-PCR; ARABIDOPSIS; SELECTION; FAMILY; MODEL; GRASS	Tall fescue (Festuca arundinacea Schreb.) is widely utilized as a major forage and turfgrass species in the temperate regions of the world and is a valuable plant material for studying molecular mechanisms of grass stress tolerance due to its superior drought and heat tolerance among cool-season species. Selection of suitable reference genes for quantification of target gene expression is important for the discovery of molecular mechanisms underlying improved growth traits and stress tolerance. The stability of nine potential reference genes (ACT, TUB, EF1a, GAPDH, SAND, CACS, F-box, PEPKR1 and TIP41) was evaluated using four programs, GeNorm, NormFinder, BestKeeper, and RefFinder. The combinations of SAND and TUB or TIP41 and TUB were most stably expressed in salt-treated roots or leaves. The combinations of GAPDH with TIP41 or TUB were stable in roots and leaves under drought stress. TIP41 and PEPKR1 exhibited stable expression in cold-treated roots, and the combination of F-box, TIP41 and TUB was also stable in cold-treated leaves. CACS and TUB were the two most stable reference genes in heat-stressed roots. TIP41 combined with TUB and ACT was stably expressed in heat-stressed leaves. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) assays of the target gene FaWRKY1 using the identified most stable reference genes confirmed the reliability of selected reference genes. The selection of suitable reference genes in tall fescue will allow for more accurate identification of stress-tolerance genes and molecular mechanisms conferring stress tolerance in this stress-tolerant species.	[Yang, Zhimin; Chen, Yu; Hu, Baoyun; Tan, Zhiqun] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu	tan, zhiqun/GZM-9890-2022		China Postdoctoral Science Foundation [2014M551612]; Jiangsu Postdoctoral Science Foundation [1302018B]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the China Postdoctoral Science Foundation (2014M551612) and Jiangsu Postdoctoral Science Foundation (1302018B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Chen Y, 2014, PHYSL PLANT; Chen Y, 2014, MOL BIOL REP, V41, P815, DOI 10.1007/s11033-013-2921-8; Chen Y, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-121; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Li W, 2014, GENE, V547, P55, DOI 10.1016/j.gene.2014.06.015; Lin LY, 2013, MOL GENET GENOMICS, V288, P727, DOI 10.1007/s00438-013-0785-1; Lumba S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-8; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mian MAR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-27; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wang ZY, 2006, IN VITRO CELL DEV-PL, V42, P1, DOI 10.1079/IVP2005726; Wei Q, 2011, PLANT CELL REP, V30, P1201, DOI 10.1007/s00299-011-1028-8; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Xia SJ, 2013, MOL BIOL REP, V40, P237, DOI 10.1007/s11033-012-2054-5; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	35	50	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119569	10.1371/journal.pone.0119569	http://dx.doi.org/10.1371/journal.pone.0119569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786207	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500112
J	Fernandes, GHC; de Carvalho, PDC; Serra, AJ; Crespilho, AM; Peron, JPS; Rossato, C; Leal, ECP; Albertini, R				Fernandes, Guilherme Henrique C.; Camillo de Carvalho, Paulo de Tarso; Serra, Andrey Jorge; Crespilho, Andre Maciel; Schatzman Peron, Jean Pierre; Rossato, Cristiano; Pinto Leal-Junior, Ernesto Cesar; Albertini, Regiane			The Effect of Low-Level Laser Irradiation on Sperm Motility, and Integrity of the Plasma Membrane and Acrosome in Cryopreserved Bovine Sperm	PLOS ONE			English	Article							CALCIUM-TRANSPORT; SPERMATOZOA; THERAPY; MITOCHONDRIA; FERTILITY; QUALITY; CELLS; LIGHT	Background and Objective Freezing changes sperm integrity remarkably. Cryopreservation involves cooling, freezing, and thawing and all these contribute to structural damage in sperm, resulting in reduced fertility potential. Low-level laser irradiation (LLLI) could increase energy supply to the cell and cause reactive oxygen species reduction (ROS), contributing to the restoration of oxygen consumption and adenosine triphosphate synthesis (ATP) in the mitochondria. Our goal was to analyze the effects of low-level laser irradiation on sperm motility and integrity of the plasma membrane and acrosome in cryopreserved bovine sperm. Study Design/Materials and Methods We analyzed 09 samples of bull semen (Bos taurus indicus), divided into three groups: a control group without laser irradiation, a 4J group subjected to a laser irradiation dose of 4 joules, and a 6J group subjected to dose of 6 joules. Samples were divided for the analysis of cell viability and acrosomal membrane integrity using flow cytometry; another portion was used for motion analysis. Irradiation was performed in petri dishes of 30 mm containing 3 ml of semen by an aluminum gallium indium phosphide laser diode with a wavelength of 660 nm, 30mW power, and energy of 4 and 6 joules for 80 and 120 seconds respectively. Subsequently, the irradiated and control semen samples were subjected to cryopreservation and analyzed by flow cytometry (7AAD and FITC-PSA) using the ISAS - Integrated Semen Analysis System. Results Flow cytometry showed an increase in the percentage of live sperm cells and acrosome integrity in relation to control cells when subjected to irradiation of low-power laser in two different doses of 4 and 6 joules (p < 0.05). In the analysis of straightness, percentage of cell movement, and motility, a dose of 4 joules was more effective (p < 0.05). Conclusion We conclude that LLLI may exert beneficial effects in the preservation of live sperm. A dose of 4 joules prior to cryopreservation was more effective than a dose of 6 joules in preserving sperm motility.	[Fernandes, Guilherme Henrique C.; Camillo de Carvalho, Paulo de Tarso; Serra, Andrey Jorge; Pinto Leal-Junior, Ernesto Cesar; Albertini, Regiane] Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil; [Camillo de Carvalho, Paulo de Tarso; Albertini, Regiane] Univ Nove Julho UNINOVE, Postgrad Program Biophoton, Sao Paulo, SP, Brazil; [Crespilho, Andre Maciel] Univ Santo Amaro UNISA, Postgrad Program Vet Med, Sao Paulo, SP, Brazil; [Schatzman Peron, Jean Pierre; Rossato, Cristiano] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Santo Amaro (UNISA); Universidade de Sao Paulo	de Carvalho, PDC (corresponding author), Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil.	paulo.tarso@uninove.br	Leal-Junior, Ernesto Cesar/H-8920-2016; Fernandes, Guilherme/HHT-1055-2022; Peron, Jean Pierre S/F-9248-2012; Albertini, Regiane/AAL-7940-2020; de Tarso C de Carvalho, Paulo/G-5333-2011; Crespilho, André Maciel/L-5447-2013; Serra, Andrey Jorge/E-7460-2015	Leal-Junior, Ernesto Cesar/0000-0001-6393-7616; Albertini, Regiane/0000-0002-4143-0387; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Crespilho, André Maciel/0000-0003-4594-3961; Serra, Andrey Jorge/0000-0002-5407-8183; Rossato, Cristiano/0000-0003-1124-0520	CAPES; UNINOVE	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UNINOVE	The authors would like to thank Tairana Central de Congelamento de Semen Ltda., represented by Dr. Vet. Tatiana Isaa Uherara Berton, for the donation of semen samples and technical support and suggestions. The authors would also like to thank the CAPES scholarship of Guilherme H. C. Fernandes, and UNINOVE, for all support.	Albuquerque-Pontes GM, 2015, LASER MED SCI, V30, P59, DOI 10.1007/s10103-014-1616-2; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Breitbart H, 1996, J PHOTOCH PHOTOBIO B, V34, P117, DOI 10.1016/1011-1344(95)07281-0; Buyukleblebici S, 2014, ANIM REPROD SCI, V150, P77, DOI 10.1016/j.anireprosci.2014.09.006; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; Corral-Baques MI, 2009, LASER MED SCI, V24, P703, DOI 10.1007/s10103-008-0606-7; Da Silva AA, 2013, J COSMET LASER THER, V15, P210, DOI 10.3109/14764172.2012.761345; Dahlen C, 2014, ADV EXP MED BIOL, V752, P97, DOI 10.1007/978-1-4614-8887-3_5; Denadai AS, 2009, LASER MED SCI, V24, P689, DOI 10.1007/s10103-008-0595-6; Forero-Gonzalez RA, 2012, ANDROLOGIA, V44, P154, DOI 10.1111/j.1439-0272.2010.01154.x; Gadella BM, 2014, THERIOGENOLOGY, V81, P74, DOI 10.1016/j.theriogenology.2013.09.005; Gillan L, 2005, THERIOGENOLOGY, V63, P445, DOI 10.1016/j.theriogenology.2004.09.024; Graham JK, 2001, ANIM REPROD SCI, V68, P239, DOI 10.1016/S0378-4320(01)00160-9; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Iaffaldano N, 2005, ANIM REPROD SCI, V85, P317, DOI 10.1016/j.anireprosci.2004.04.043; Iaffaldano N, 2010, ANIM REPROD SCI, V119, P123, DOI 10.1016/j.anireprosci.2009.10.005; Karu TI, 2012, PHOTOMED LASER SURG, V30, P239, DOI 10.1089/pho.2012.9888; Kathiravan P, 2008, ANIM REPROD SCI, V104, P9, DOI 10.1016/j.anireprosci.2007.01.002; Lubart R, 1997, LASER SURG MED, V21, P493, DOI 10.1002/(SICI)1096-9101(1997)21:5<493::AID-LSM12>3.0.CO;2-A; LUBART R, 1992, J PHOTOCH PHOTOBIO B, V15, P337, DOI 10.1016/1011-1344(92)85139-L; Lubart R, 1996, LASER IN DER MED, P449, DOI DOI 10.1007/978-3-642-80264-5_107; Manchini MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101270; Motta JPR, 2014, CRYOBIOLOGY, V68, P343, DOI 10.1016/j.cryobiol.2014.04.007; RodriguezMartinez H, 1997, REPROD FERT DEVELOP, V9, P297, DOI 10.1071/R96081; Romon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059189; Shahverdi A, 2014, CELL J, V16, P279; Simoes R, 2013, REPRODUCTION, V146, P433, DOI 10.1530/REP-13-0123; Thibier M, 2005, REPROD NUTR DEV, V45, P235, DOI 10.1051/rnd:2005016; Torres-Junior JR, 2014, ANIM REPROD SCI; Verstegen J, 2002, THERIOGENOLOGY, V57, P149, DOI 10.1016/S0093-691X(01)00664-1; Yazdi RS, 2014, LASER MED SCI, V29, P97, DOI 10.1007/s10103-013-1276-7; Zeng CG, 2014, CRYOBIOLOGY, V69, P119, DOI 10.1016/j.cryobiol.2014.06.003	34	30	32	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121487	10.1371/journal.pone.0121487	http://dx.doi.org/10.1371/journal.pone.0121487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781016	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600207
J	Kittaka, H; Yagi, Y; Zushi, R; Hazui, H; Akimoto, H				Kittaka, Hirotada; Yagi, Yoshiki; Zushi, Ryosuke; Hazui, Hiroshi; Akimoto, Hiroshi			The Investigation of Posttraumatic Pseudoaneurysms in Patients Treated with Nonoperative Management for Blunt Abdominal Solid Organ Injuries	PLOS ONE			English	Article							SPLENIC INJURY; FOLLOW-UP; ARTERY PSEUDOANEURYSM; ANGIOGRAPHIC EMBOLIZATION; EASTERN ASSOCIATION; TRAUMATIC INJURIES; HEPATIC-INJURY; LIVER-INJURY; CHILDREN; COMPLICATIONS	Background Posttraumatic pseudoaneurysms (PAs) have been recognized as the cause of delayed hemorrhage complicated with nonoperative management (NOM), although the need for intervention in patients with small-sized PAs and the relationship between the occurrence of PAs and bed-rest has been also unclear. Objectives The purpose of this study was to investigate the clinical history of small-sized PAs (less than 10 mm in diameter) which occurred in abdominal solid organs, and to analyze the relationship between the occurrence of PAs and early mobilization from bed. Methods Sixty-two patients who were successfully managed with NOM were investigated. Mobilization within three days post-injury was defined as "early mobilization" and bed-rest lasting over three days was defined as "late mobilization." A comparison of the clinical factors, including the duration of bed-rest between patients with and without PAs detected by followup CT was performed. Furthermore, a multiple logistic regression model analysis on the occurrence of PAs was performed. Results PAs were detected in 7 of the 62 patients. The One patient with PAs measuring larger than 10 mm received trans-arterial embolization, and the remaining six patients with PAs smaller than 10 mm were managed conservatively. Consequently, no delayed hemorrhage occurred, and the PAs spontaneously disappeared in all of the six patients managed without intervention. The multiple regression model analysis revealed that early mobilization was not a significant factor predicting new-onset PAs. Conclusions Small PAs can be expected to disappear spontaneously. Moreover, early mobilization is not a significant risk factor for the occurrence of PAs.	[Kittaka, Hirotada; Yagi, Yoshiki; Zushi, Ryosuke; Hazui, Hiroshi; Akimoto, Hiroshi] Osaka Misihima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan		Kittaka, H (corresponding author), Osaka Misihima Emergency Crit Care Ctr, Dept Emergency, 11-1 Minami Akutagawa Cho, Takatsuki, Osaka, Japan.	kittaka142@osaka-mishima.jp						Archer LP, 1996, ARCH SURG-CHICAGO, V131, P309; Bhullar IS, 2012, J TRAUMA ACUTE CARE, V72, P1127, DOI 10.1097/TA.0b013e3182569849; Cho YP, 2003, J TRAUMA, V54, P1006, DOI 10.1097/01.TA.0000061493.80633.EC; Cocanour CS, 2000, J TRAUMA, V48, P606, DOI 10.1097/00005373-200004000-00005; Cox JC, 2005, J TRAUMA, V59, P1175, DOI 10.1097/01.ta.0000189003.01375.71; Crawford RS, 2007, SURGERY, V142, P337, DOI 10.1016/j.surg.2007.05.003; CROCE MA, 1994, AM J SURG, V168, P235, DOI 10.1016/S0002-9610(05)80193-X; Davis KA, 1998, J TRAUMA, V44, P1008, DOI 10.1097/00005373-199806000-00013; Dobremez E, 2006, EUR J PEDIATR SURG, V16, P166, DOI 10.1055/s-2006-924197; Francisco LE, 2010, WORLD J HEPATOL, V2, P87, DOI 10.4254/wjh.v2.i2.87; Farrell TM, 1996, J TRAUMA, V41, P1067, DOI 10.1097/00005373-199612000-00025; Frumiento C, 2000, J PEDIATR SURG, V35, P788, DOI 10.1053/jpsu.2000.6082; Galvan DA, 2006, CURR OPIN CRIT CARE, V12, P590, DOI 10.1097/MCC.0b013e328010d4ad; Goffette PP, 2002, EUR RADIOL, V12, P994, DOI 10.1007/s00330-002-1396-0; Gow KW, 1996, J PEDIATR SURG, V31, P812, DOI 10.1016/S0022-3468(96)90140-2; Haan JM, 2007, AM SURGEON, V73, P13; Hardcastle TC, 2010, J PEDIATR SURG, V45, pE1, DOI 10.1016/j.jpedsurg.2010.02.119; HUSMANN DA, 1990, J UROLOGY, V143, P682, DOI 10.1016/S0022-5347(17)40057-7; Kennedy JA, 1999, INJURY, V30, P535, DOI 10.1016/S0020-1383(99)00144-8; Kozar RA, 2005, J TRAUMA, V59, P1066, DOI 10.1097/01.ta.0000188937.75879.ab; London JA, 2008, ARCH SURG-CHICAGO, V143, P972, DOI 10.1001/archsurg.143.10.972; Madhusudhan KS, 2009, J POSTGRAD MED, V55, P124, DOI 10.4103/0022-3859.52844; Martin K, 2011, J PEDIATR SURG, V46, P933, DOI 10.1016/j.jpedsurg.2011.02.031; Mayglothling JA, 2011, J EMERG MED, V41, P21, DOI 10.1016/j.jemermed.2008.10.012; McCray VW, 2008, J TRAUMA, V65, P1354, DOI 10.1097/TA.0b013e31818e8fde; Minarik L, 2002, PEDIATR SURG INT, V18, P429, DOI 10.1007/s00383-002-0820-5; Moreno RD, 2007, J TRAUMA, V62, P1048, DOI 10.1097/01.ta.0000235295.02414.d7; Muroya T, 2013, J TRAUMA ACUTE CARE, V75, P417, DOI 10.1097/TA.0b013e31829fda77; Safavi A, 2011, J PEDIATR SURG, V46, P938, DOI 10.1016/j.jpedsurg.2011.02.035; Sartorelli KH, 2000, J TRAUMA, V49, P56, DOI 10.1097/00005373-200007000-00008; Sasaki H, 2009, EMERG MED J, V26, P223, DOI 10.1136/emj.2008.064766; Savage SA, 2008, J TRAUMA, V64, P1085, DOI 10.1097/TA.0b013e31816920f1; SCHURR MJ, 1995, J TRAUMA, V39, P507; Sidhu MK, 1999, PEDIATR RADIOL, V29, P46, DOI 10.1007/s002470050532; Skattum J, 2013, J TRAUMA ACUTE CARE, V74, P100, DOI 10.1097/TA.0b013e31827890b2; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; SUGG SL, 1995, J TRAUMA, V39, P593; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Von Rueden K T, 1995, AACN Clin Issues, V6, P212, DOI 10.1097/00044067-199505000-00005; Wahl WL, 2005, SURGERY, V138, P742, DOI 10.1016/j.surg.2005.07.021; Watson GA, 2006, J TRAUMA, V61, P1113, DOI 10.1097/01.ta.0000241363.97619.d6; Weinberg JA, 2007, J TRAUMA, V62, P1143, DOI 10.1097/TA.0b013e318047b7c2; Yardeni D, 2004, J TRAUMA, V57, P404, DOI 10.1097/01.TA.0000044633.53328.F0	45	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121078	10.1371/journal.pone.0121078	http://dx.doi.org/10.1371/journal.pone.0121078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781957	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600194
J	Sakurai-Yageta, M; Maruyama, T; Suzuki, T; Ichikawa, K; Murakami, Y				Sakurai-Yageta, Mika; Maruyama, Tomoko; Suzuki, Takashi; Ichikawa, Kazuhisa; Murakami, Yoshinori			Dynamic Regulation of a Cell Adhesion Protein Complex Including CADM1 by Combinatorial Analysis of FRAP with Exponential Curve-Fitting	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; LUNG-CANCER; E-CADHERIN; FLUORESCENCE RECOVERY; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; TSLC1; MEMBRANE; ASSOCIATION; DIFFUSION	Protein components of cell adhesion machinery show continuous renewal even in the static state of epithelial cells and participate in the formation and maintenance of normal epithelial architecture and tumor suppression. CADM1 is a tumor suppressor belonging to the immunoglobulin superfamily of cell adhesion molecule and forms a cell adhesion complex with an actin-binding protein, 4.1B, and a scaffold protein, MPP3, in the cytoplasm. Here, we investigate dynamic regulation of the CADM1-4.1B-MPP3 complex in mature cell adhesion by fluorescence recovery after photobleaching (FRAP) analysis. Traditional FRAP analysis were performed for relatively short period of around 10min. Here, thanks to recent advances in the sensitive laser detector systems, we examine FRAP of CADM1 complex for longer period of 60 min and analyze the recovery with exponential curve-fitting to distinguish the fractions with different diffusion constants. This approach reveals that the fluorescence recovery of CADM1 is fitted to a single exponential function with a time constant (tau) of approximately 16 min, whereas 4.1B and MPP3 are fitted to a double exponential function with two tau s of approximately 40-60 sec and 16 min. The longer t is similar to that of CADM1, suggesting that 4.1B and MPP3 have two distinct fractions, one forming a complex with CADM1 and the other present as a free pool. Fluorescence loss in photobleaching analysis supports the presence of a free pool of these proteins near the plasma membrane. Furthermore, double exponential fitting makes it possible to estimate the ratio of 4.1B and MPP3 present as a free pool and as a complex with CADM1 as approximately 3: 2 and 3: 1, respectively. Our analyses reveal a central role of CADM1 in stabilizing the complex with 4.1B and MPP3 and provide insight in the dynamics of adhesion complex formation.	[Sakurai-Yageta, Mika; Maruyama, Tomoko; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, Tokyo 1088639, Japan; [Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo 1088639, Japan; [Suzuki, Takashi; Ichikawa, Kazuhisa; Murakami, Yoshinori] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Div Math Sci, Toyonaka, Osaka 5608531, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Osaka University	Murakami, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ymurakam@ims.u-tokyo.ac.jp	Sakurai-Yageta, Mika/U-1842-2019	Sakurai-Yageta, Mika/0000-0001-5606-3324	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25290051, 24790310]; Ministry of Health, Labor, and Welfare, Japan [22090601, 23120701]; Grants-in-Aid for Scientific Research [24790310, 22117008] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A CREST project from Japan Science and Technology Agency [M. S. -Y., T. S., K. I., Y. M.]; a Grant-in-Aid for Scientific Research (B) [25290051 for Y. M.] and a Grant-in-Aid for Young Scientists (B) [24790310 for M. S. -Y.] from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare, Japan [22090601 and 23120701 for Y. M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; Kang M, 2008, BIOPHYS J, V95, pL13, DOI 10.1529/biophysj.108.135913; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082894; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Takahashi Y, 2012, BREAST CANCER-TOKYO, V19, P242, DOI 10.1007/s12282-011-0272-7; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tran YK, 1999, CANCER RES, V59, P35; Yageta M, 2002, CANCER RES, V62, P5129; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116637	10.1371/journal.pone.0116637	http://dx.doi.org/10.1371/journal.pone.0116637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780926	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600006
J	Ud-Din, AI; Liu, YC; Roujeinikova, A				Ud-Din, Abu I.; Liu, Yu C.; Roujeinikova, Anna			Crystal Structure of Helicobacter pylori Pseudaminic Acid Biosynthesis N-Acetyltransferase PseH: Implications for Substrate Specificity and Catalysis	PLOS ONE			English	Article							PROVIDES RESISTANCE; GNAT SUPERFAMILY; MECHANISM; ACETYLGLUCOSAMINE; PHENIX	Helicobacter pylori infection is the common cause of gastroduodenal diseases linked to a higher risk of the development of gastric cancer. Persistent infection requires functional flagella that are heavily glycosylated with 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (pseudaminic acid). Pseudaminic acid biosynthesis protein H (PseH) catalyzes the third step in its biosynthetic pathway, producing UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose. It belongs to the GCN5-related N-acetyltransferase (GNAT) superfamily. The crystal structure of the PseH complex with cofactor acetyl-CoA has been determined at 2.3 angstrom resolution. This is the first crystal structure of the GNAT superfamily member with specificity to UDP-4-amino-4,6-dideoxy-beta-L-AltNAc. PseH is a homodimer in the crystal, each subunit of which has a central twisted beta-sheet flanked by five alpha-helices and is structurally homologous to those of other GNAT superfamily enzymes. Interestingly, PseH is more similar to the GNAT enzymes that utilize amino acid sulfamoyl adenosine or protein as a substrate than a different GNAT-superfamily bacterial nucleotide-sugar N-acetyltransferase of the known structure, WecD. Analysis of the complex of PseH with acetyl-CoA revealed the location of the cofactor-binding site between the splayed strands beta 4 and beta 5. The structure of PseH, together with the conservation of the active-site general acid among GNAT superfamily transferases, are consistent with a common catalytic mechanism for this enzyme that involves direct acetyl transfer from AcCoA without an acetylated enzyme intermediate. Based on structural homology with microcin C7 acetyltransferase MccE and WecD, the Michaelis complex can be modeled. The model suggests that the nucleotide-and 4-amino-4,6-dideoxy-beta-L-AltNAc-binding pockets form extensive interactions with the substrate and are thus the most significant determinants of substrate specificity. A hydrophobic pocket accommodating the 6'-methyl group of the altrose dictates preference to the methyl over the hydroxyl group and thus to contributes to substrate specificity of PseH.	[Ud-Din, Abu I.; Liu, Yu C.; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Roujeinikova, A (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	anna.roujeinikova@monash.edu		Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council [DP1094619]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Fellowship to AR (DP1094619). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2011, J BIOL CHEM, V286, P21295, DOI 10.1074/jbc.M111.226282; [Anonymous], 2011, J DIGEST DIS, V12, P319, DOI 10.1111/j.1751-2980.2011.00529.x; [Anonymous], PYMOL MOL GRAPH SYST; Baldwin DN, 2007, INFECT IMMUN, V75, P1005, DOI 10.1128/IAI.01176-06; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61, P177; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kazakov T, 2014, J BACTERIOL, V196, P3377, DOI 10.1128/JB.01584-14; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu YC, 2014, ACTA CRYSTALLOGR F, V70, P1276, DOI 10.1107/S2053230X14015398; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Mio T, 1999, J BIOL CHEM, V274, P424, DOI 10.1074/jbc.274.1.424; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshiyama H, 2000, MICROBES INFECT, V2, P55, DOI 10.1016/S1286-4579(00)00285-9	37	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115634	10.1371/journal.pone.0115634	http://dx.doi.org/10.1371/journal.pone.0115634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781966	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600004
J	Yang, L; Shi, TY; Liu, F; Ren, CX; Wang, ZL; Li, YY; Tu, XY; Yang, G; Cheng, X				Yang, Li; Shi, Tingyan; Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong; Cheng, Xi			REV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells	PLOS ONE			English	Article							DNA-POLYMERASE-ZETA; MAINTAINING GENOME STABILITY; CATALYTIC SUBUNIT; TRANSLESION SYNTHESIS; POL-ZETA; OVARIAN TUMORIGENESIS; CISPLATIN RESISTANCE; EMBRYONIC LETHALITY; CARCINOMA CELLS; MISMATCH REPAIR	REV3L, the catalytic subunit of DNA Polymerase zeta (Pol zeta), plays a significant role in the DNA damage tolerance mechanism of translesion synthesis (TLS). The role of REV3L in chemosensitivity of cervical cancer needs exploration. In the present study, we evaluated the expression of the Pol zeta protein in paraffin-embedded tissues using immunohistochemistry and found that the expression of Pol zeta in cervical cancer tissues was higher than that in normal tissues. We then established some cervical cancer cell lines with REV3L suppression or overexpression. Depletion of REV3L suppresses cell proliferation and colony formation of cervical cancer cells through G1 arrest, and REV3L promotes cell proliferation and colony formation of cervical cancer cells by promoting G(1) phase to S phase transition. The suppression of REV3L expression enhanced the sensitivity of cervical cancer cells to cisplatin, and the overexpression of REV3L conferred resistance to cisplatin as evidenced by the alteration of apoptosis rates, and significantly expression level changes of anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2), myeloid cell leukemia sequence 1 (Mcl-1) and B-cell lymphoma-extra large (Bcl-xl) and proapoptotic Bcl-2-associated x protein (Bax). Our data suggest that REV3L plays an important role in regulating cervical cancer cellular response to cisplatin, and thus targeting REV3L may be a promising way to alter chemosensitivity in cervical cancer patients.	[Yang, Li; Liu, Fei; Cheng, Xi] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200433, Peoples R China; [Yang, Li] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China; [Shi, Tingyan; Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Shi, Tingyan] Fudan Univ, Zhongshan Hosp, Dept Obstet & Gynecol, Shanghai 200433, Peoples R China; [Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong; Cheng, Xi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ren, Chunxia] Peoples Hosp Wuxi, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China; [Tu, Xiaoyu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Zhejiang Cancer Hospital; Fudan University; Fudan University; Fudan University; Fudan University	Yang, G (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China.	yanggong@fudan.edu.cn; cheng_xi1@hotmail.com	Wang, Zhiquan/HHS-6768-2022	Shi, Tingyan/0000-0002-5356-0365	National Natural Science Foundation of China [81202050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (grant no. 81202050; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bhat A, 2013, NUCLEIC ACIDS RES, V41, P2328, DOI 10.1093/nar/gks1442; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Cheng X, 2011, GYNECOL ONCOL, V121, P323, DOI 10.1016/j.ygyno.2010.12.360; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Ferlay J, 2012, GLOBOCAN 2012 V1 0 C, V11, DOI [10.1097/QAI.0000000000000279, DOI 10.1097/QAI.0000000000000279]; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Kawamura K, 2001, INT J ONCOL, V18, P97; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Knobel PA, 2011, NEOPLASIA, V13, P961, DOI 10.1593/neo.11828; Lange SS, 2013, P NATL ACAD SCI USA, V110, pE687, DOI 10.1073/pnas.1217425110; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li ZQ, 2002, MUTAT RES-FUND MOL M, V510, P71, DOI 10.1016/S0027-5107(02)00253-1; Lin XJ, 2006, MOL CANCER THER, V5, P1239, DOI 10.1158/1535-7163.MCT-05-0491; Lin XJ, 2006, CLIN CANCER RES, V12, P563, DOI 10.1158/1078-0432.CCR-05-1380; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Okuda T, 2005, MOL PHARMACOL, V67, P1852, DOI 10.1124/mol.104.010579; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Sharma S, 2012, MOL PHARMACOL, V81, P778, DOI 10.1124/mol.111.076828; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Shi TY, 2013, MED ONCOL, V30, DOI [10.1007/s12032-013-0500-4, 10.1007/s12032-013-0697-2]; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050461; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Varadi V, 2011, BREAST CANCER RES TR, V129, P235, DOI 10.1007/s10549-011-1460-z; Wang HB, 2009, NEURO-ONCOLOGY, V11, P790, DOI 10.1215/15228517-2009-015; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32	50	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120334	10.1371/journal.pone.0120334	http://dx.doi.org/10.1371/journal.pone.0120334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781640	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600151
J	Yang, SF; Wei, K; Jia, FJ; Zhao, X; Cui, GL; Guo, FX; Zhu, RL				Yang, Shifa; Wei, Kai; Jia, Fengjuan; Zhao, Xue; Cui, Guolin; Guo, Fanxia; Zhu, Ruiliang			Characterization and Biological Activity of Taishan Pinus massoniana Pollen Polysaccharide In Vitro	PLOS ONE			English	Article							IMMUNOMODULATORY ACTIVITY; ANTICANCER ACTIVITY; PROLIFERATION; ENHANCE; VACCINE; VIRUS	Taishan Pinus massoniana pollen polysaccharide (TPPPS) improves cellular and humoral immune responses of animals and is a novel potential immunomodulator. However, the components of TPPPS have not been recognized. To investigate the composition of TPPPS, crude polysaccharide was obtained from Taishan P. massoniana pollen through water extraction and ethanol precipitation. Three homogeneous polysaccharide fractions (TPPPS1, TPPPS2, and TPPPS3) were purified fromTPPPS by DEAE-cellulose column chromatography. The average molecular weights of the three polysaccharides were 56, 25, and 128 kDa, respectively. Results of high-performance liquid chromatography (HPLC) showed that TPPPS comprised mannose, ribose, xylose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose. The biological activity assays showed that TPPPS2 and TPPPS3 significantly promoted spleen lymphocyte proliferation, and that TPPPS3 showed better effect than TPPPS2. TPPPS3 enhanced the secretion of cytokine IL-2 and TNF, whereas TPPPS2 mainly elevated IL-2 secretion. By contrast, TPPPS1 exhibited other effects, and it induced the highest amount of NO production, thereby indicating that TPPPS1 had the best antioxidant activity. TPPPS3 at 50 mu g/mL significantly inhibited the proliferation of subgroup B Avian Leukosis virus (ALV-B) through virus adsorption interference in vitro. Results indicated that TPPPS comprised three main components, among which, TPPPS1 mainly showed antioxidant effects, whereas TPPPS2 and TPPPS3 played key roles in immunomodulation, especially TPPPS3. Further studies on the use of a reasonable proportion of TPPPS1-3 may facilitate the development of an effective immunomodulator.	[Yang, Shifa; Wei, Kai; Jia, Fengjuan; Zhao, Xue; Cui, Guolin; Guo, Fanxia; Zhu, Ruiliang] Shandong Agr Univ, Coll Anim Sci & Technol, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Zhu, RL (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China.	zhurl1963@163.com			Technology Development Plan of Shandong Province [2012GNC11020]; Specific Technology Development Projects of Taian [20103001]	Technology Development Plan of Shandong Province; Specific Technology Development Projects of Taian	This study was funded by Technology Development Plan of Shandong Province (2012GNC11020) and Specific Technology Development Projects of Taian (20103001).	Bao H, 2010, BIOSCI BIOTECH BIOCH, V74, P1408, DOI 10.1271/bbb.100076; Chen HL, 2003, POULTRY SCI, V82, P760, DOI 10.1093/ps/82.5.760; Chen JR, 2010, FITOTERAPIA, V81, P1117, DOI 10.1016/j.fitote.2010.07.009; Chen SG, 2010, CARBOHYD POLYM, V81, P560, DOI 10.1016/j.carbpol.2010.03.009; Cui GL, 2013, INT J BIOL MACROMOL, V56, P94, DOI 10.1016/j.ijbiomac.2013.02.006; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; DING AH, 1988, J IMMUNOL, V141, P2407; Ge Y, 2009, CARBOHYD POLYM, V77, P188, DOI 10.1016/j.carbpol.2008.12.020; Guo FX, 2014, RES VET SCI, V96, P260, DOI 10.1016/j.rvsc.2013.11.010; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; He XiaoYan, 2007, Journal of Northeast Forestry University, V35, P78; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Huang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077355; IALENTI A, 1992, EUR J PHARMACOL, V211, P177, DOI 10.1016/0014-2999(92)90526-A; IRIBE H, 1984, CELL IMMUNOL, V88, P9, DOI 10.1016/0008-8749(84)90047-9; Jaulneau V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525291; Komatsu T, 2013, IMMUNOPHARM IMMUNOT, V35, P1, DOI 10.3109/08923973.2012.710636; Lee CJ, 2002, BIOLOGICALS, V30, P97, DOI 10.1006/biol.2001.0320; Lee KY, 2006, J ETHNOPHARMACOL, V103, P372, DOI 10.1016/j.jep.2005.08.037; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Li RJ, 2007, BIOL PHARM BULL, V30, P470, DOI 10.1248/bpb.30.470; Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626; Liu M, 2013, FOOD HYDROCOLLOID, V33, P186, DOI 10.1016/j.foodhyd.2013.03.003; Luo AX, 2010, CARBOHYD POLYM, V79, P1014, DOI 10.1016/j.carbpol.2009.10.033; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; Ooi VEC, 2000, CURR MED CHEM, V7, P715; SAHA SK, 1994, CARBOHYD RES, V254, P157; Schaer DA, 2010, CURR OPIN INVEST DR, V11, P1378; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; STEINMULLER C, 1993, INT J IMMUNOPHARMACO, V15, P605, DOI 10.1016/0192-0561(93)90078-D; Wei K, 2011, VACCINE, V29, P2530, DOI 10.1016/j.vaccine.2011.01.068; Wong KH, 2011, FOOD HYDROCOLLOID, V25, P150, DOI 10.1016/j.foodhyd.2010.04.008; Wu J, 2012, INT J BIOL MACROMOL, V51, P663, DOI 10.1016/j.ijbiomac.2012.06.040; Yang TH, 2006, INT J BIOL MACROMOL, V39, P179, DOI 10.1016/j.ijbiomac.2006.02.013; Zhao X, 2013, INT IMMUNOPHARMACOL, V17, P793, DOI 10.1016/j.intimp.2013.09.008; Zhu XL, 2007, J ETHNOPHARMACOL, V111, P219, DOI 10.1016/j.jep.2006.11.013	38	17	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115638	10.1371/journal.pone.0115638	http://dx.doi.org/10.1371/journal.pone.0115638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782009	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600005
J	Catala, S; Perez-Sierra, A; Abad-Campos, P				Catala, Santiago; Perez-Sierra, Ana; Abad-Campos, Paloma			The Use of Genus-Specific Amplicon Pyrosequencing to Assess Phytophthora Species Diversity Using eDNA from Soil and Water in Northern Spain	PLOS ONE			English	Article							FUNGAL COMMUNITIES; SEQUENCE ALIGNMENT; MULTIPLE; QUANTIFICATION; IDENTIFICATION; INTRODUCTIONS; ECOSYSTEMS; CITRICOLA; PATHOGEN; DATABASE	Phytophthora is one of the most important and aggressive plant pathogenic genera in agriculture and forestry. Early detection and identification of its pathways of infection and spread are of high importance to minimize the threat they pose to natural ecosystems. eDNA was extracted from soil and water from forests and plantations in the north of Spain. Phytophthora-specific primers were adapted for use in high-throughput Sequencing (HTS). Primers were tested in a control reaction containing eight Phytophthora species and applied to water and soil eDNA samples from northern Spain. Different score coverage threshold values were tested for optimal Phytophthora species separation in a custom-curated database and in the control reaction. Clustering at 99% was the optimal criteria to separate most of the Phytophthora species. Multiple Molecular Operational Taxonomic Units (MOTUs) corresponding to 36 distinct Phytophthora species were amplified in the environmental samples. Pyrosequencing of amplicons from soil samples revealed low Phytophthora diversity (13 species) in comparison with the 35 species detected in water samples. Thirteen of the MOTUs detected in rivers and streams showed no close match to sequences in international sequence databases, revealing that eDNA pyrosequencing is a useful strategy to assess Phytophthora species diversity in natural ecosystems.	[Catala, Santiago; Perez-Sierra, Ana; Abad-Campos, Paloma] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46022 Valencia, Spain; [Perez-Sierra, Ana] Forest Res, Alice Holt Lodge, Farnham, Surrey, England	Universitat Politecnica de Valencia	Catala, S (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Camino Vera S-N, E-46022 Valencia, Spain.	sangarca@upv.es	Perez-Sierra, Ana/AAE-9414-2021	Perez-Sierra, Ana/0000-0001-5403-1433; Abad-Campos, Paloma/0000-0002-5979-4349	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management")	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management")	This project has been supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S, FASTQC QUALITY CONTR; Bergmark L, 2012, FEMS MICROBIOL LETT, V333, P77, DOI 10.1111/j.1574-6968.2012.02601.x; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 2003, MYCOL RES, V107, P477, DOI 10.1017/S0953756203007548; Catala S, 2012, PHYT FOR NAT EC 6 IN, P34; Chen W, 2013, PHYTOPATHOLOGY, V103, P43, DOI 10.1094/PHYTO-04-12-0092-R; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Coince A, 2013, FUNGAL ECOL, V6, P223, DOI 10.1016/j.funeco.2013.01.002; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Creer S, 2012, MOL ECOL, V21, P1033, DOI 10.1111/j.1365-294X.2012.05437.x; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guha Roy S, 2014, REV PLANT P IN PRESS, V6; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Huai WX, 2013, FOREST PATHOL, V43, P87, DOI 10.1111/efp.12015; Huberli D, 2013, AUSTRALAS PLANT PATH, V42, P251, DOI 10.1007/s13313-012-0195-6; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jobard M, 2012, ENVIRON MICROBIOL, V14, P2480, DOI 10.1111/j.1462-2920.2012.02771.x; Jones DR, 2007, PLANT PATHOL, V56, P891, DOI 10.1111/j.1365-3059.2007.01619.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 2009, PERSOONIA, V22, P95, DOI 10.3767/003158509X442612; Li LL, 2013, CURR MICROBIOL, V67, P423, DOI 10.1007/s00284-013-0382-x; Livermore JA, 2013, ENVIRON MICROBIOL, V15, P2333, DOI 10.1111/1462-2920.12106; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Nakayama Jiro, 2013, Biosci Microbiota Food Health, V32, P69, DOI 10.12938/bmfh.32.69; Nechwatal J, 2013, PLANT PATHOL, V62, P355, DOI 10.1111/j.1365-3059.2012.02638.x; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Oh E, 2013, IMA FUNGUS, V4, P123, DOI 10.5598/imafungus.2013.04.01.12; Park J, 2008, PLANT DIS, V92, P966, DOI 10.1094/PDIS-92-6-0966; Pavon CF, 2008, PLANT DIS, V92, P143, DOI 10.1094/PDIS-92-1-0143; Reeser P, 2011, NZ J FORESTRY SCI, V41, P65; Reeser PW, 2011, MYCOLOGIA, V103, P22, DOI 10.3852/10-013; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Roche, 2010, GUID AMPL EXP DES; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Than DJ, 2013, FOREST PATHOL, V43, P324, DOI 10.1111/efp.12034; Tooley PW, 2006, PHYTOPATHOLOGY, V96, P336, DOI 10.1094/PHYTO-96-0336; Vannini A, 2013, FEMS MICROBIOL ECOL, V85, P433, DOI 10.1111/1574-6941.12132; Vettraino AM, 2012, LETT APPL MICROBIOL, V55, P390, DOI 10.1111/j.1472-765x.2012.03310.x; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	52	50	52	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119311	10.1371/journal.pone.0119311	http://dx.doi.org/10.1371/journal.pone.0119311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775250	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500081
J	Hohn, R; Kottler, U; Peto, T; Blettner, M; Munzel, T; Blankenberg, S; Lackner, KJ; Beutel, M; Wild, PS; Pfeiffer, N				Hoehn, Rene; Kottler, Ulrike; Peto, Tunde; Blettner, Maria; Muenzel, Thomas; Blankenberg, Stefan; Lackner, Karl J.; Beutel, Manfred; Wild, Philipp S.; Pfeiffer, Norbert			The Ophthalmic Branch of the Gutenberg Health Study: Study Design, Cohort Profile and Self-Reported Diseases	PLOS ONE			English	Article							MACULAR DEGENERATION; DIABETIC-RETINOPATHY; EYE DISEASES; RISK-FACTORS; PREVALENCE; POPULATION; CHILDREN; CLASSIFICATION; ASSOCIATION; NYSTAGMUS	Purpose This paper describes the study design, methodology, cohort profile and self-reported diseases in the ophthalmological branch of the Gutenberg Health Study (GHS). Methods The GHS is an ongoing, prospective, interdisciplinary, single-center, population-based cohort study in Germany. The main goals of the ophthalmological section are to assess the prevalence and incidence of ocular diseases and to explore risk factors, genetic determinants and associations with systemic diseases and conditions. The eye examination at baseline included a medical history, self-reported eye diseases, visual acuity, refractive errors, intraocular pressure, visual field, pachymetry, keratometry, fundus photography and tear sampling. The 5-year follow-up visit additionally encompassed optical coherence tomography, anterior segment imaging and optical biometry. The general examination included anthropometry; blood pressure measurement; carotid artery ultrasound; electrocardiogram; echocardiography; spirometry; cognitive tests; questionnaires; assessment of mental conditions; and DNA, RNA, blood and urine sampling. Results Of 15,010 participants (aged 35-74 years at the time of inclusion), ocular data are available for 14,700 subjects (97.9%). The mean visual acuity (standard deviation), mean spherical equivalent, median decimal visual acuity, and mean intraocular pressure were 0.08 (0.17) logMar, -0.42 (2.43) diopters, 0.9 and 14.24 (2.79) mm Hg, respectively. The frequencies of self-reported strabismus, glaucoma, surgery for retinal detachment and retinal vascular occlusions were 2.7%, 2.3%, 0.2% and 0.4%, respectively. Conclusions The GHS is the most extensive dataset of ophthalmic diseases and conditions and their risk factors in Germany and one of the largest cohorts worldwide. This dataset will provide new insight in the epidemiology of ophthalmic diseases and related medical specialties.	[Hoehn, Rene; Kottler, Ulrike; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Hoehn, Rene] Klin Pallas, Olten, Switzerland; [Peto, Tunde] NHS Fdn Trust, Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Blettner, Maria] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Muenzel, Thomas; Wild, Philipp S.] Univ Med Ctr Mainz, Prevent Cardiol & Prevent Med Dept Med 2, Mainz, Germany; [Blankenberg, Stefan] Univ Med Ctr Hamburg Eppendorf, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Beutel, Manfred] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Wild, Philipp S.] German Ctr Cardiovasc Res DZHK, Mainz, Germany	Johannes Gutenberg University of Mainz; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research	Hohn, R (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	rhoehn@gmx.de	Peto, Tunde/G-8812-2018; Wild, Philipp S./M-2106-2019; Pfeiffer, Norbert/AAO-7586-2020; Munzel, Thomas/A-2912-2014	Peto, Tunde/0000-0001-6265-0381; Munzel, Thomas/0000-0001-5503-4150; Hohn, Rene/0000-0003-2870-1469; Wild, Philipp/0000-0003-4413-9752	government of Rheinland-Pfalz [AZ 961-386261/733]; research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Novartis Pharma; Federal Ministry of Education and Research (BMBF) [01EO1003]; NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	government of Rheinland-Pfalz; research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Novartis Pharma; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland-Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS Medical Systems and Novartis Pharma, including an unrestricted grant for the Gutenberg Health Study. PSW is funded by the Federal Ministry of Education and Research (BMBF 01EO1003). TP was supported by the NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology. Funders were involved in the development of the study design as scientific consultants. However, they played no role in data collection, analysis, decision to publish, or preparation of the manuscript. Klinik Pallas provided support in the form of a salary for author RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	[Anonymous], 1991, Ophthalmology, V98, P786; Barry JC, 2003, BRIT J OPHTHALMOL, V87, P909, DOI 10.1136/bjo.87.7.909; Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P635, DOI 10.1111/j.1755-3768.2012.02511.x; Ehrt O, 2012, EUR J PAEDIATR NEURO, V16, P567, DOI 10.1016/j.ejpn.2012.02.010; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Gao Z, 2012, OPHTHAL EPIDEMIOL, V19, P16, DOI 10.3109/09286586.2011.632703; GRAHAM PA, 1974, BRIT J OPHTHALMOL, V58, P224, DOI 10.1136/bjo.58.3.224; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; Hoehn R, 2013, OPHTHALMOLOGY, V120, P961, DOI 10.1016/j.ophtha.2012.10.031; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; Korb CA, 2014, GRAEF ARCH CLIN EXP, V252, P1403, DOI 10.1007/s00417-014-2591-9; Kvarnstrom G, 2001, ACTA OPHTHALMOL SCAN, V79, P240, DOI 10.1034/j.1600-0420.2001.790306.x; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacLennan PA, 2013, CURR EYE RES, V38, P1, DOI 10.3109/02713683.2012.733054; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirshahi A, 2013, OPHTHALMOLOGE, V110, P210, DOI 10.1007/s00347-012-2666-0; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Sarvananthan N, 2009, INVEST OPHTH VIS SCI, V50, P5201, DOI 10.1167/iovs.09-3486; Sawaguchi S, 2012, OPHTHALMOLOGY, V119, P1134, DOI 10.1016/j.ophtha.2011.12.038; Takeda Y, 2011, J CARD FAIL, V17, P556, DOI 10.1016/j.cardfail.2011.03.007; Tham YC, 2013, CLIN EXP OPHTHALMOL, V41, P842, DOI 10.1111/ceo.12112; Volzke H, 2012, BUNDESGESUNDHEITSBLA, V55, P790, DOI 10.1007/s00103-012-1483-6; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zobor D, 2012, OPHTHALMOLOGE, V109, P501, DOI 10.1007/s00347-012-2555-6	32	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120476	10.1371/journal.pone.0120476	http://dx.doi.org/10.1371/journal.pone.0120476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775251	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500180
J	Kirsten, TB; Galvao, MC; Reis-Silva, TM; Queiroz-Hazarbassanov, N; Bernardi, MM				Kirsten, Thiago B.; Galvao, Marcella C.; Reis-Silva, Thiago M.; Queiroz-Hazarbassanov, Nicolle; Bernardi, Maria M.			Zinc Prevents Sickness Behavior Induced by Lipopolysaccharides after a Stress Challenge in Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; INDUCED TERATOGENICITY; PRENATAL EXPOSURE; RESTRAINT STRESS; SPATIAL MEMORY; MICE; BRAIN; SUPPLEMENTATION; HIPPOCAMPUS	Sickness behavior is considered part of the specific beneficial adaptive behavioral and neuroimmune changes that occur in individuals in response to infectious/inflammatory processes. However, in dangerous and stressful situations, sickness behavior should be momentarily abrogated to prioritize survival behaviors, such as fight or flight. Taking this assumption into account, we experimentally induced sickness behavior in rats using lipopolysaccharides (LPS), an endotoxin that mimics infection by gram-negative bacteria, and then exposed these rats to a restraint stress challenge. Zinc has been shown to play a regulatory role in the immune and nervous systems. Therefore, the objective of this study was to examine the effects of zinc treatment on the sickness response of stress-challenged rats. We evaluated 22-kHz ultrasonic vocalizations, open-field behavior, tumor necrosis factor a (TNF-alpha), corticosterone, and brain-derived neurotrophic factor (BDNF) plasma levels. LPS administration induced sickness behavior in rats compared to controls, i.e., decreases in the distance traveled, average velocity, rearing frequency, self-grooming, and number of vocalizations, as well as an increase in the plasma levels of TNF-alpha, compared with controls after a stressor challenge. LPS also decreased BDNF expression but did not influence anxiety parameters. Zinc treatment was able to prevent sickness behavior in LPS-exposed rats after the stress challenge, restoring exploratory/motor behaviors, communication, and TNF-alpha levels similar to those of the control group. Thus, zinc treatment appears to be beneficial for sick animals when they are facing risky/stressful situations.	[Kirsten, Thiago B.; Galvao, Marcella C.; Reis-Silva, Thiago M.; Queiroz-Hazarbassanov, Nicolle] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Kirsten, Thiago B.; Bernardi, Maria M.] Univ Estadual Paulista, Environm & Expt Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	thik@hotmail.com	Kirsten, Thiago Berti/AAS-2166-2021; Queiroz-Hazarbassanov, Nicolle/P-4333-2014; Bernardi, M. M./H-8418-2012; Reis-Silva, Thiago M./E-6318-2013; Bernardi, Maria/T-6813-2019; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; Reis-Silva, Thiago Moirinho/AAE-6346-2019	Kirsten, Thiago Berti/0000-0002-4032-4355; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Bernardi, M. M./0000-0002-6860-9416; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Reis-Silva, Thiago Moirinho/0000-0002-4134-4307	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sao Paulo Research Foundation (FAPESP) [2012/07007-8, 2009/51886-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio); Paulista University (UNIP) [7-02-908/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio); Paulista University (UNIP)	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Sao Paulo Research Foundation (FAPESP grant no. 2012/07007-8 and thematic grant no. 2009/51886-3), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio), and Paulista University (UNIP grant no. 7-02-908/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; Aubert A, 1999, NEUROSCI BIOBEHAV R, V23, P1029, DOI 10.1016/S0149-7634(99)00034-2; Aubert A, 1997, BRAIN BEHAV IMMUN, V11, P107, DOI 10.1006/brbi.1997.0485; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BLUTHE RM, 1994, CR ACAD SCI III-VIE, V317, P499; BLUTHE RM, 1992, BRAIN RES, V573, P318, DOI 10.1016/0006-8993(92)90779-9; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carey LC, 2003, BIRTH DEFECTS RES A, V67, P240, DOI 10.1002/bdra.10035; Chua JSC, 2012, BRAIN BEHAV IMMUN, V26, P326, DOI 10.1016/j.bbi.2011.10.002; Chua JSC, 2006, PEDIATR RES, V59, P355, DOI 10.1203/01.pdr.0000199906.37619.9c; Connor TJ, 2002, NEUROIMMUNOMODULAT, V10, P367, DOI 10.1159/000071478; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; Echeverry MB, 2004, NEUROSCIENCE, V125, P981, DOI 10.1016/j.neuroscience.2003.12.046; Engeland CG, 2003, PSYCHONEUROENDOCRINO, V28, P970, DOI 10.1016/S0306-4530(02)00118-X; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Haase H, 2008, EXP GERONTOL, V43, P394, DOI 10.1016/j.exger.2007.12.002; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hritcu L, 2014, PROG NEURO-PSYCHOPH, V51, P126, DOI 10.1016/j.pnpbp.2014.01.016; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870, DOI 10.1152/ajpregu.1997.273.6.R1870; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Maywald M, 2014, J TRACE ELE IN PRESS; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Nowak G, 2004, EUR J PHARMACOL, V492, P57, DOI 10.1016/j.ejphar.2004.03.038; Patti CL, 2005, PHARMACOL BIOCHEM BE, V81, P923, DOI 10.1016/j.pbb.2005.07.004; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Railey AM, 2011, J ALZHEIMERS DIS, V24, P375, DOI 10.3233/JAD-2011-101452; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Schnydrig S, 2007, NEUROSCI LETT, V429, P69, DOI 10.1016/j.neulet.2007.09.067; Summers BL, 2006, PEDIATR RES, V59, P66, DOI 10.1203/01.pdr.0000190573.23893.13; Takahashi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014115; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Yirmiya R, 1999, BRAIN RES, V829, P28, DOI 10.1016/S0006-8993(99)01274-3	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120263	10.1371/journal.pone.0120263	http://dx.doi.org/10.1371/journal.pone.0120263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775356	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500162
J	Samad, MA; Kim, UK; Kang, JJ; Ke, QG; Kang, PM				Samad, Mohammed A.; Kim, Ui Kyoung; Kang, Joshua J.; Ke, Qingen; Kang, Peter M.			Endothelin A Receptor Antagonist, Atrasentan, Attenuates Renal and Cardiac Dysfunction in Dahl Salt-Hypertensive Rats in a Blood Pressure Independent Manner	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING-ENZYME-INHIBITOR; CARDIOVASCULAR EVENTS; HEART-FAILURE; SELECTIVE ENDOTHELIN; EMERGING ROLE; RISK-FACTOR; BLOCKADE; ALBUMINURIA; HYPERTROPHY	Proteinuria is a hallmark of chronic kidney disease (CKD) and cardiovascular disease (CVD), and a good predictor of clinical outcome. Selective endothelin A (ETA) receptor antagonist used with renin-angiotensin system (RAS) inhibitors prevents development of proteinuria in CKD. However, whether the improvement in proteinuria would have beneficial effects on CVD, independent of RAS inhibition, is not well understood. In this study, we investigated whether atrasentan, an ETA receptor antagonist, has renal and cardiovascular effects independent of RAS inhibition. Male Dahl salt sensitive (DSS) rats, at six weeks of age, received water with or without different doses of atrasentan and/or enalapril under high salt (HS) diet or normal diet (ND) for 6 weeks. At the end of 12th week, atrasentan at a moderate dose significantly attenuated proteinuria and serum creatinine without reducing mean arterial pressure (MAP), thereby preventing cardiac hypertrophy and improving cardiac function. ACE inhibitor enalapril at a dose that did not significantly lowered BP, attenuated cardiac hypertrophy while moderately improving cardiac function without reducing proteinuria and serum creatinine level. Nonetheless, combined therapy of atrasentan and enalapril that does not altering BP exerted additional cardioprotective effect. Based on these findings, we conclude that BP independent monotherapy of ETA receptor antagonist attenuates the progression of CKD and significantly mitigates CVD independent of RAS inhibition.	[Samad, Mohammed A.; Kim, Ui Kyoung; Kang, Joshua J.; Ke, Qingen; Kang, Peter M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA; [Samad, Mohammed A.; Kang, Peter M.] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Jeonbuk National University	Kang, PM (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA.	pkang@bidmc.harvard.edu		SAMAD, MOHAMMED/0000-0001-7329-7325	AbbVie; Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea	AbbVie(AbbVie); Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea	This study was supported in part by research support from AbbVie (PMK) and Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea (MAS, PMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan A, 2005, BRIT J PHARMACOL, V146, P846, DOI 10.1038/sj.bjp.0706384; Ammarguellat FZ, 2002, HYPERTENSION, V39, P679, DOI 10.1161/hy0202.103481; Andress DL, 2012, LIFE SCI, V91, P739, DOI 10.1016/j.lfs.2012.01.011; Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012; Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133; Barton M, 2008, NAT CLIN PRACT NEPHR, V4, P490, DOI 10.1038/ncpneph0891; Barton M, 2010, BBA-MOL BASIS DIS, V1802, P1203, DOI 10.1016/j.bbadis.2010.03.012; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Bruzzi I, 1997, J NEPHROL, V10, P179; Callera GE, 2004, HYPERTENSION, V43, P872, DOI 10.1161/01.HYP.0000117296.30296.14; Chade AR, 2006, J AM SOC NEPHROL, V17, P3394, DOI 10.1681/ASN.2006060635; Chade AR, 2014, KIDNEY INT, V85, P833, DOI 10.1038/ki.2013.477; Chandrashekar K, 2014, J AM SOC NEPHROL, V25, P869, DOI 10.1681/ASN.2014020174; Channick RN, 2004, J AM COLL CARDIOL, V43, p62S, DOI 10.1016/j.jacc.2004.02.042; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; CODY RJ, 1992, CIRCULATION, V85, P504, DOI 10.1161/01.CIR.85.2.504; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Demuth K, 1998, NEPHROL DIAL TRANSPL, V13, P375, DOI 10.1093/oxfordjournals.ndt.a027833; Dhaun N, 2009, HYPERTENSION, V54, P113, DOI 10.1161/HYPERTENSIONAHA.109.132670; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ergul A, 2000, HYPERTENSION, V36, P62, DOI 10.1161/01.HYP.36.1.62; Gagliardini E, 2009, AM J PHYSIOL-RENAL, V297, pF1448, DOI 10.1152/ajprenal.00340.2009; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin KA, 2003, HYPERTENSION, V41, P201, DOI 10.1161/01.HYP.0000049881.25304.73; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hong HM, 2011, PROTEOMICS, V11, P283, DOI 10.1002/pmic.201000018; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Ideishi M, 1994, Blood Press Suppl, V5, P99; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Kakarla SK, 2010, BASIC RES CARDIOL, V105, P535, DOI 10.1007/s00395-010-0094-3; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kang PM, 2004, AM J PHYSIOL-HEART C, V287, pH72, DOI 10.1152/ajpheart.00556.2003; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kelsen S, 2011, AM J PHYSIOL-RENAL, V301, pF218, DOI 10.1152/ajprenal.00089.2011; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Kohan DE, 2011, J AM SOC NEPHROL, V22, P763, DOI 10.1681/ASN.2010080869; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Opgenorth TJ, 1996, J PHARMACOL EXP THER, V276, P473; Parfrey PS, 1996, NEPHROL DIAL TRANSPL, V11, P1277; Parvanova A, 2013, LANCET DIABETES ENDO, V1, P19, DOI 10.1016/S2213-8587(13)70029-9; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Piotrkowski B, 2009, FREE RADICAL RES, V43, P390, DOI 10.1080/10715760902801517; Plante E, 2004, CAN J PHYSIOL PHARM, V82, P191, DOI 10.1139/Y04-005; Raichlin E, 2008, HYPERTENSION, V52, P522, DOI 10.1161/HYPERTENSIONAHA.108.113068; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Saleh MA, 2011, DIABETOLOGIA, V54, P979, DOI 10.1007/s00125-010-2021-4; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Sharma J N, 1983, J Hypertens, V1, P251, DOI 10.1097/00004872-198310000-00009; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Tanaka Ryou, 2012, Vet Med Int, V2012, P105316, DOI 10.1155/2012/105316; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; Varagic J, 2002, J MOL CELL CARDIOL, V34, P1435, DOI 10.1006/jmcc.2002.2075; Vuurmans TJL, 2003, HYPERTENSION, V41, P1253, DOI 10.1161/01.HYP.0000072982.70666.E8; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wenzel RR, 2009, J AM SOC NEPHROL, V20, P655, DOI 10.1681/ASN.2008050482; Wessale JL, 2002, CLIN SCI, V103, p112S, DOI 10.1042/CS103S112S; Williams JM, 2012, HYPERTENSION, V60, P1157, DOI 10.1161/HYPERTENSIONAHA.112.199240; Xia QG, 2006, ACTA PHARMACOL SIN, V27, P1417, DOI 10.1111/j.1745-7254.2006.00447.x; Yamamoto S, 2005, CIRCULATION, V111, P302, DOI 10.1161/01.CIR.0000153351.86708.F7; Yan LD, 2010, J CARDIOVASC PHARM, V56, P246, DOI 10.1097/FJC.0b013e3181e89f36; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002	75	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121664	10.1371/journal.pone.0121664	http://dx.doi.org/10.1371/journal.pone.0121664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775254	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500216
J	Tsujioka, H; Kunieda, T; Katou, Y; Shirahige, K; Kubo, T				Tsujioka, Hiroshi; Kunieda, Takekazu; Katou, Yuki; Shirahige, Katsuhiko; Kubo, Takeo			Unique Gene Expression Profile of the Proliferating Xenopus Tadpole Tail Blastema Cells Deciphered by RNA-Sequencing Analysis	PLOS ONE			English	Article							LYSYL OXIDASE; REGENERATION; PLANARIAN; IDENTIFICATION; TRANSCRIPTION; CYTOKINE; BREVICAN; PROTEIN; LIMBS	Organ regenerative ability depends on the animal species and the developmental stage. The molecular bases for variable organ regenerative ability, however, remain unknown. Previous studies have identified genes preferentially expressed in the blastema tissues in various animals, but transcriptome analysis of the isolated proliferating blastema cells has not yet been reported. In the present study, we used RNA-sequencing analysis to analyze the gene expression profile of isolated proliferating blastema cells of regenerating Xenopus laevis tadpole tails. We used flow cytometry to isolate proliferating cells, and non-proliferating blastema cells, from regenerating tadpole tails as well as proliferating tail bud cells from tail bud embryos, the latter two of which were used as control cells, based on their DNA content. Among the 28 candidate genes identified by RNA-sequencing analysis, quantitative reverse transcription-polymerase chain reaction identified 10 genes whose expression was enriched in regenerating tadpole tails compared with non-regenerating tadpole tails or tails from the tail bud embryos. Among them, whole mount in situ hybridization revealed that chromosome segregation 1-like and interleukin 11 were expressed in the broad area of the tail blastema, while brevican, lysyl oxidase, and keratin 18 were mainly expressed in the notochord bud in regenerating tails. We further combined whole mount in situ hybridization with immunohistochemistry for the incorporated 5-bromo-2-deoxyuridine to confirm that keratin 18 and interleukin 11 were expressed in the proliferating tail blastema cells. Based on the proposed functions of their homologs in other animal species, these genes might have roles in the extracellular matrix formation in the notochord bud ( brevican and lysyl oxidase), cell proliferation (chromosome segregation 1-like and keratin 18), and in the maintenance of the differentiation ability of proliferating blastema cells (interleukin 11) in regenerating tadpole tails.	[Tsujioka, Hiroshi; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	stkubo@bs.s.u-tokyo.ac.jp	KUBO, TAKEO/G-4951-2014; Tsujioka, Hiroshi/M-1343-2014; Kunieda, Takekazu/G-4946-2014	Tsujioka, Hiroshi/0000-0001-7484-4191; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas 'Homeostatic Inflammation' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bamba S, 2003, AM J PHYSIOL-GASTR L, V285, pG529, DOI 10.1152/ajpgi.00050.2003; Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Corcoran JP, 1997, DEV DYNAM, V210, P355; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Frischknecht R, 2012, INT J BIOCHEM CELL B, V44, P1051, DOI 10.1016/j.biocel.2012.03.022; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Geach TJ, 2005, DIFFERENTIATION, V73, P414, DOI 10.1111/j.1432-0436.2005.00041.x; Grow M, 2006, DEV DYNAM, V235, P2667, DOI 10.1002/dvdy.20897; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Isoe Y, 2012, BIOCHEM BIOPH RES CO, V423, P627, DOI 10.1016/j.bbrc.2012.05.125; James-Zorn C, 2013, NUCLEIC ACIDS RES, V41, pD865, DOI 10.1093/nar/gks1025; Kernacki KA, 1998, INFECT IMMUN, V66, P376, DOI 10.1128/IAI.66.1.376-379.1998; King MW, 2003, DEV DYNAM, V226, P398, DOI 10.1002/dvdy.10250; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Love NR, 2014, BIOESSAYS, V36, P27, DOI 10.1002/bies.201300110; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Love NR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-70; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Mukaigasa K, 2009, P NATL ACAD SCI USA, V106, P18309, DOI 10.1073/pnas.0708837106; Naora Y, 2013, BIOCHEM BIOPH RES CO, V431, P152, DOI 10.1016/j.bbrc.2013.01.005; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Nieuwkoop DP, 1967, NORMAL TABLE OF XENO; Nishioka T, 2012, CELL STRUCT FUNCT, V37, P75, DOI 10.1247/csf.11015; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Okada N, 1991, CURR OPIN GENET DEV, V1, P498, DOI 10.1016/S0959-437X(05)80198-4; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Peterson H, 2013, FRONT PHYSIOL, V4, P1, DOI [10.3389/fphys.2013.00001, DOI 10.3389/FPHYS.2013.00001]; Sander V, 2001, MECH DEVELOP, V102, P251, DOI 10.1016/S0925-4773(01)00302-1; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Stefan H, 2012, XENOPUS PROTOCOLS PO; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tazaki A, 2005, DEV DYNAM, V233, P1394, DOI 10.1002/dvdy.20472; TERAMURA M, 1992, BLOOD, V79, P327; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; WAKEFIELD L, 1983, DEV BIOL, V95, P468, DOI 10.1016/0012-1606(83)90048-9; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Wellmann A, 1997, AM J PATHOL, V150, P25; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434	54	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0111655	10.1371/journal.pone.0111655	http://dx.doi.org/10.1371/journal.pone.0111655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775398	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500001
J	Liu, Y; Lear, T; Iannone, O; Shiva, S; Corey, C; Rajbhandari, S; Jerome, J; Chen, BB; Mallampalli, RK				Liu, Yuan; Lear, Travis; Iannone, Olivia; Shiva, Sruti; Corey, Catherine; Rajbhandari, Shristi; Jerome, Jacob; Chen, Bill B.; Mallampalli, Rama K.			The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; E3 Ubiquitin Ligase; Lung Injury; Mitochondria; Protein Degradation; Oxygen	SCF UBIQUITIN LIGASE; RECOGNIZES SUGAR CHAINS; X-LINKED INHIBITOR; IAP PROTEINS; CANCER; APOPTOSIS; COMPLEX; FAMILY; PHOSPHORYLATION; LOCALIZATION	Background: The SCF ubiquitin E3 ligase component Fbxl7 possesses proapoptotic activity. Results: Fbxl7 targets the antiapoptotic protein survivin for polyubiquitylation and proteasomal degradation. Conclusion: Survivin protects mitochondria from damage induced by Fbxl7. Significance: Understanding how F-box proteins regulate survivin might impact therapies to preserve cellular bioenergetics. Fbxl7, a component of the Skp1<bold>Cul</bold>1<bold>F</bold>-box protein type ubiquitin E3 ligase, regulates mitotic cell cycle progression. Here we demonstrate that overexpression of Fbxl7 in lung epithelia decreases the protein abundance of survivin, a member of the inhibitor of apoptosis family. Fbxl7 mediates polyubiquitylation and proteasomal degradation of survivin by interacting with Glu-126 within its carboxyl-terminal helix. Furthermore, both Lys-90 and Lys-91 within survivin serve as ubiquitin acceptor sites. Ectopically expressed Fbxl7 impairs mitochondrial function, whereas depletion of Fbxl7 protects mitochondria from actions of carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of oxidative phosphorylation. Compared with wild-type survivin, cellular expression of a survivin mutant protein deficient in its ability to interact with Fbxl7 (E126A) and a ubiquitylation-resistant double point mutant (KK90RR/KK91RR) rescued mitochondria to a larger extent from damage induced by overexpression of Fbxl7. Therefore, these data suggest that the Skp1<bold>Cul</bold>1<bold>F</bold>-box protein complex subunit Fbxl7 modulates mitochondrial function by controlling the cellular abundance of survivin. The results raise opportunities for F-box protein targeting to preserve mitochondrial function.	[Liu, Yuan; Lear, Travis; Iannone, Olivia; Rajbhandari, Shristi; Jerome, Jacob; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Shiva, Sruti; Corey, Catherine] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Chen, BB (corresponding author), Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Med, Biomed Sci Tower 1,W1254, Pittsburgh, PA 15213 USA.	chenb@upmc.edu; mallampallirk@upmc.edu	Regan, Clinton/E-6250-2012	Lear, Travis/0000-0001-9156-0844	National Institutes of Health [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01 HL114453, HL116472]; Department of Veterans Affairs; Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097376, R01HL096376, P01HL114453, UH2HL123502, R01HL098174, R01HL081784, R01HL116472] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, and P01 HL114453 (to R. K. M.) and HL116472 (to B. B. C.). This work was also supported by a merit review award from the Department of Veterans Affairs and the Flight Attendants Medical Research Institute.	Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Cai Q, 2011, J MED CHEM, V54, P2714, DOI 10.1021/jm101505d; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Coon TA, 2012, CELL CYCLE, V11, P721, DOI 10.4161/cc.11.4.19171; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li ZJ, 2014, MOL CELL, V54, P805, DOI 10.1016/j.molcel.2014.03.046; Liu Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.585; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Rico-Bautista E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-153; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zou CB, 2013, J BIOL CHEM, V288, P6306, DOI 10.1074/jbc.M112.426882	41	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11843	11852		10.1074/jbc.M114.629931	http://dx.doi.org/10.1074/jbc.M114.629931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778398	hybrid, Green Published			2022-12-26	WOS:000354388600004
J	Kobayashi, H; Yoshida, T; Miyakawa, T; Tashiro, M; Okamoto, K; Yamanaka, H; Tanokura, M; Tsuge, H				Kobayashi, Hidetomo; Yoshida, Toru; Miyakawa, Takuya; Tashiro, Mitsuru; Okamoto, Keinosuke; Yamanaka, Hiroyasu; Tanokura, Masaru; Tsuge, Hideaki			Structural Basis for Action of the External Chaperone for a Propeptide-deficient Serine Protease from Aeromonas sobria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS AEROMONAS; 3' END; SUBTILISIN; ACTIVATION; SUBTILASES; SEQUENCE; ASP	Subtilisin-like proteases are broadly expressed in organisms ranging from bacteria to mammals. During maturation of these enzymes, N-terminal propeptides function as intramolecular chaperones, assisting the folding of their catalytic domains. However, we have identified an exceptional case, the serine protease from Aeromonas sobria (ASP), that lacks a propeptide. Instead, ORF2, a protein encoded just downstream of asp, appears essential for proper ASP folding. The mechanism by which ORF2 functions remains an open question, because it shares no sequence homology with any known intramolecular propeptide or other protein. Here we report the crystal structure of the ORF2-ASP complex and the solution structure of free ORF2. ORF2 consists of three regions: an N-terminal extension, a central body, and a C-terminal tail. Together, the structure of the central body and the C-terminal tail is similar to that of the intramolecular propeptide. The N-terminal extension, which is not seen in other subtilisin-like enzymes, is intrinsically disordered but forms some degree of secondary structure upon binding ASP. Wealso show that C-terminal (Delta C1 and Delta C5) or N-terminal (Delta N43 and Delta N64) deletion eliminates the ability of ORF2 to function as a chaperone. Characterization of the maturation of ASP with ORF2 showed that folding occurs in the periplasmic space and is followed by translocation into extracellular space and dissociation from ORF2, generating active ASP. Finally, a PSI-BLAST search revealed that operons encoding subtilases and their external chaperones are widely distributed among Gram-negative bacteria, suggesting that ASP and its homologs form a novel family of subtilases having an external chaperone.	[Kobayashi, Hidetomo; Yamanaka, Hiroyasu] Hiroshima Int Univ, Lab Mol Microbiol Sci, Fac Pharmaceut Sci, Kure, Hiroshima 7370112, Japan; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 6038555, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Tashiro, Mitsuru] Meisei Univ, Coll Sci & Technol, Dept Chem, Hino, Tokyo 1910042, Japan; [Okamoto, Keinosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacogenet, Okayama 7008530, Japan	Kyoto Sangyo University; University of Tokyo; Meisei University; Okayama University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021; Tsuge, Hideaki/ABF-6424-2021	Tanokura, Masaru/0000-0001-5072-2480; Tsuge, Hideaki/0000-0003-0166-9163; Kobayashi, Hidetomo/0000-0002-5918-4268	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Strategic Research Foundation Grant-aided Project for Private Universities; MEXT/JSPS KAKENHI [25121733]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation Grant-aided Project for Private Universities; MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Strategic Research Foundation Grant-aided Project for Private Universities, and Grant-in-Aid for Scientific Research on Innovative Areas, MEXT/JSPS KAKENHI Grant 25121733.	Buevich AV, 2001, J BIOMOL NMR, V20, P233, DOI 10.1023/A:1011243116136; Chuang YC, 1997, MICROBIOL-SGM, V143, P803, DOI 10.1099/00221287-143-3-803; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Gamble M, 2011, P NATL ACAD SCI USA, V108, P3536, DOI 10.1073/pnas.1014229108; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Inouye M, 2001, NAT STRUCT BIOL, V8, P321, DOI 10.1038/86194; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Kobayashi H, 2006, FEMS MICROBIOL LETT, V256, P165, DOI 10.1111/j.1574-6968.2006.00134.x; Kobayashi H, 2009, MICROBIOL IMMUNOL, V53, P647, DOI 10.1111/j.1348-0421.2009.00175.x; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Nomura T, 2002, J BACTERIOL, V184, P7058, DOI 10.1128/JB.184.24.7058-7061.2002; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka S, 2009, J MOL BIOL, V394, P306, DOI 10.1016/j.jmb.2009.09.028; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11130	11143		10.1074/jbc.M114.622852	http://dx.doi.org/10.1074/jbc.M114.622852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25784551	Green Published, hybrid			2022-12-26	WOS:000353404500047
J	Ragone, PG; Brandan, CP; Rumi, MM; Tomasini, N; Lauthier, JJ; Cimino, RO; Uncos, A; Ramos, F; D'Amato, AMA; Basombrio, MA; Diosque, P				Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Cimino, Ruben O.; Uncos, Alejandro; Ramos, Federico; Alberti D'Amato, Anahi M.; Basombrio, Miguel A.; Diosque, Patricio			Experimental Evidence of Biological Interactions among Different Isolates of Trypanosoma cruzi from the Chaco Region	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHAGAS-DISEASE; MOLECULAR EPIDEMIOLOGY; CLONAL EVOLUTION; ENDEMIC AREA; INFECTIONS; PARASITE; POPULATIONS; IMPACT; HOST	Many infectious diseases arise from co-infections or re-infections with more than one genotype of the same pathogen. These mixed infections could alter host fitness, the severity of symptoms, success in pathogen transmission and the epidemiology of the disease. Trypanosoma cruzi, the etiological agent of Chagas disease, exhibits a high biological variability often correlated with its genetic diversity. Here, we developed an experimental approach in order to evaluate biological interaction between three T. cruzi isolates belonging to different Discrete Typing Units (DTUs TcIII, TcV and TcVI). These isolates were obtained from a restricted geographical area in the Chaco Region. Different mixed infections involving combinations of two isolates (TcIII + TcV, TcIII + TcVI and TcV + TcVI) were studied in a mouse model. The parameters evaluated were number of parasites circulating in peripheral blood, histopathology and genetic characterization of each DTU in different tissues by DNA hybridization probes. We found a predominance of TcVI isolate in blood and tissues respect to TcIII and TcV; and a decrease of the inflammatory response in heart when the damage of mice infected with TcVI and TcIII + TcVI mixture were compared. In addition, simultaneous presence of two isolates in the same tissue was not detected. Our results show that biological interactions between isolates with different biological behaviors lead to changes in their biological properties. The occurrence of interactions among different genotypes of T. cruzi observed in our mouse model suggests that these phenomena could also occur in natural cycles in the Chaco Region.	[Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Alberti D'Amato, Anahi M.; Diosque, Patricio] Univ Nacl Salta, CONICET, Inst Patol Expt, Unidad Epidemiol Mol, Salta Capital, Argentina; [Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Uncos, Alejandro; Ramos, Federico; Alberti D'Amato, Anahi M.; Basombrio, Miguel A.; Diosque, Patricio] Univ Nacl Salta, CONICET, Inst Patol Expt, Salta Capital, Argentina; [Cimino, Ruben O.] Univ Nacl Salta, Fac Ciencias Nat, Catedra Quim Biol, Salta Capital, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ragone, PG (corresponding author), Univ Nacl Salta, CONICET, Inst Patol Expt, Unidad Epidemiol Mol, Salta Capital, Argentina.	p_ragone@yahoo.com.ar	Cimino, Rubén Oscar/AAH-1847-2020; Lauthier, Juan Jose/AAX-8493-2021	Cimino, Rubén Oscar/0000-0002-4253-9077; Perez Brandan, Cecilia/0000-0002-9282-0959; Lauthier, Juan Jose/0000-0002-7604-4128	Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2012-2174]	Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica	This manuscript was supported by funding agency Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar), through a grant given to Dr. Patricio Diosque (PICT-2012-2174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade SG, 2006, REV SOC BRAS MED TRO, V39, P1, DOI 10.1590/S0037-86822006000100001; Balmer O, 2006, ACTA TROP, V97, P94, DOI 10.1016/j.actatropica.2005.09.002; Bastrenta B, 2003, MEM I OSWALDO CRUZ, V98, P255, DOI 10.1590/S0074-02762003000200015; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Bosseno MF, 2000, MEM I OSWALDO CRUZ, V95, P601, DOI 10.1590/S0074-02762000000500002; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Cardinal MV, 2008, INT J PARASITOL, V38, P1533, DOI 10.1016/j.ijpara.2008.04.010; Coronado X, 2006, AM J TROP MED HYG, V74, P1008, DOI 10.4269/ajtmh.2006.74.1008; Corrales RM, 2009, INFECT GENET EVOL, V9, P278, DOI 10.1016/j.meegid.2008.12.008; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; D'Avila DA, 2009, J CLIN MICROBIOL, V47, P1718, DOI 10.1128/JCM.01658-08; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Diez C, 2010, AM J TROP MED HYG, V82, P67, DOI 10.4269/ajtmh.2010.09-0391; Dinko B, 2013, INT J PARASITOL-DRUG, V3, P45, DOI 10.1016/j.ijpddr.2013.01.001; Diosque P, 2003, INT J PARASITOL, V33, P997, DOI 10.1016/S0020-7519(03)00139-5; dos Reis D, 2012, EXP PARASITOL, V130, P321, DOI 10.1016/j.exppara.2012.02.016; dos Santos DM, 2009, EXP PARASITOL, V121, P8, DOI 10.1016/j.exppara.2008.09.012; Ezeokonkwo RC, 2010, VET PARASITOL, V173, P48, DOI 10.1016/j.vetpar.2010.06.020; Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489; Franco DJ, 2003, EXP PARASITOL, V104, P54, DOI 10.1016/S0014-4894(03)00119-X; Garcia A, 2014, PARASITOL INT, V63, P138, DOI 10.1016/j.parint.2013.10.010; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Grossblatt A, 1996, GUIDE USE CARE LAB A; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lisboa CV, 2007, EXP PARASITOL, V116, P150, DOI 10.1016/j.exppara.2006.12.005; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Martins HR, 2007, ANTIMICROB AGENTS CH, V51, P3282, DOI 10.1128/AAC.01590-06; Martins HR, 2006, EXP PARASITOL, V112, P237, DOI 10.1016/j.exppara.2005.11.006; Mendes DG, 2007, TROP MED INT HEALTH, V12, P629, DOI 10.1111/j.1365-3156.2007.01831.x; Rumi MMM, 2013, ACTA TROP, V128, P130, DOI 10.1016/j.actatropica.2013.07.003; Monje-Rumi MM, 2015, INFECT GENET EVOL, V29, P53, DOI 10.1016/j.meegid.2014.11.001; Omeje JN, 2012, VET PARASITOL, V190, P368, DOI 10.1016/j.vetpar.2012.07.008; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pena DA, 2011, J INFECT DIS, V204, P478, DOI 10.1093/infdis/jir292; Ragone PG, 2012, ACTA TROP, V123, P196, DOI 10.1016/j.actatropica.2012.05.003; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; Rozas M, 2007, AM J TROP MED HYG, V77, P647, DOI 10.4269/ajtmh.2007.77.647; Sales-Campos H, 2014, PARASITOL RES, V113, P375, DOI 10.1007/s00436-013-3665-z; Lo Presti MS, 2014, ACTA TROP, V133, P98, DOI 10.1016/j.actatropica.2014.02.010; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Toledo MJD, 2003, ANTIMICROB AGENTS CH, V47, P223, DOI 10.1128/AAC.47.1.223-230.2003; Toledo MJD, 2002, EXP PARASITOL, V100, P161, DOI 10.1016/S0014-4894(02)00003-6; VEAS F, 1991, CELL MOL BIOL, V37, P73; Veland N, 2013, AM J TROP MED HYG, V88, P774, DOI 10.4269/ajtmh.12-0594; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119866	10.1371/journal.pone.0119866	http://dx.doi.org/10.1371/journal.pone.0119866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789617	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400111
J	Agrawal, S; Fledderjohann, J; Vellakkal, S; Stuckler, D				Agrawal, Sutapa; Fledderjohann, Jasmine; Vellakkal, Sukumar; Stuckler, David			Adequately Diversified Dietary Intake and Iron and Folic Acid Supplementation during Pregnancy Is Associated with Reduced Occurrence of Symptoms Suggestive of Pre-Eclampsia or Eclampsia in Indian Women	PLOS ONE			English	Article							PERICONCEPTIONAL MULTIVITAMIN USE; RISK-FACTORS; GESTATIONAL HYPERTENSION; OXIDATIVE STRESS; CARBOHYDRATE INTOLERANCE; ALCOHOL-CONSUMPTION; MATERNAL HEALTH; FOOD; NUTRITION; SMOKING	Background/Objective Pre-eclampsia or Eclampsia (PE or E) accounts for 25% of cases of maternal mortality worldwide. There is some evidence of a link to dietary factors, but few studies have explored this association in developing countries, where the majority of the burden falls. We examined the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E in Indian women. Methods Cross-sectional data from India's third National Family Health Survey (NFHS-3, 2005-06) was used for this study. Self-reported symptoms suggestive of PE or E during pregnancy were obtained from 39,657 women aged 15-49 years who had had a live birth in the five years preceding the survey. Multivariable logistic regression analysis was used to estimate the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E after adjusting for maternal, health and lifestyle factors, and socio-demographic characteristics of the mother. Results In their most recent pregnancy, 1.2% (n=456) of the study sample experienced symptoms suggestive of PE or E. Mothers who consumed an adequately diversified diet were 34% less likely (OR: 0.66; 95% CI: 0.51-0.87) to report PE or E symptoms than mothers with inadequately diversified dietary intake. The likelihood of reporting PE or E symptoms was also 36% lower (OR: 0.64; 95% CI: 0.47-0.88) among those mothers who consumed iron and folic acid supplementation for at least 90 days during their last pregnancy. As a sensitivity analysis, we stratified our models sequentially by education, wealth, antenatal care visits, birth interval, and parity. Our results remained largely unchanged: both adequately diversified dietary intake and iron and folic acid supplementation during pregnancy were associated with a reduced occurrence of PE or E symptoms. Conclusion Having a adequately diversified dietary intake and iron and folic acid supplementation in pregnancy was associated with a reduced occurrence of symptoms suggestive of PE or E in Indian women.	[Agrawal, Sutapa; Vellakkal, Sukumar; Stuckler, David] Publ Hlth Fdn India, South Asia Network Chron Dis, Gurgaon 122022, Haryana, India; [Fledderjohann, Jasmine; Vellakkal, Sukumar; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	Public Health Foundation of India; University of Oxford	Agrawal, S (corresponding author), Publ Hlth Fdn India, South Asia Network Chron Dis, Gurgaon 122022, Haryana, India.	sutapa.agrawal@phfi.org	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0003-2635-1944; Fledderjohann, Jasmine/0000-0003-4952-7658; Stuckler, David/0000-0002-1288-8401; Vellakkal, Sukumar/0000-0002-0594-1454	Economic and Social Research Council; NWO-WOTRO; Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme [ES/K13130/1]; Economic and Social Research Council [ES/K013130/1] Funding Source: researchfish; ESRC [ES/K013130/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Support for this project was provided by a grant from the Economic and Social Research Council, NWO-WOTRO, Population Reference Bureau, and Population, Reproductive Health, and Economic Development, and the RCN foundation joint research scheme (Grant number: ES/K13130/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2005, CLIN OBSTET GYNECOL, V48, P12, DOI 10.1097/01.grf.0000153882.58132.ba; Agrawal S, 2014, INDOOR AIR; Agrawal S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-89; Ali Abdelaziem A, 2011, BMC Res Notes, V4, P311, DOI 10.1186/1756-0500-4-311; [Anonymous], 2001, CONFIDENTIAL ENQUIRI; [Anonymous], 2012, GUID DAIL IR FOL AC; Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; ARORA R, 1994, AUST NZ J OBSTET GYN, V34, P537, DOI 10.1111/j.1479-828X.1994.tb01104.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bdolah Y, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.783; Beck Laurie F, 2002, MMWR Surveill Summ, V51, P1; Begum Mosammat Rashida, 2004, MedGenMed, V6, P52; Bhutta ZA, 2010, SEMIN PERINATOL, V34, P434, DOI 10.1053/j.semperi.2010.09.002; Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2; Bilodeau Jean-Francois, 2003, J Obstet Gynaecol Can, V25, P742; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; BREWER T, 1969, OBSTET GYNECOL, V33, P448; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Burchi F, 2011, INT J ENV RES PUB HE, V8, P358, DOI 10.3390/ijerph8020358; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Chesley L, 1978, HYPERTENSIVE DISORDE; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Feig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001425; GOI, 2007, 11 5 YEAR PLAN 2007; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Herrera JA, 1998, OBSTET GYNECOL, V91, P585, DOI 10.1016/S0029-7844(97)00711-4; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Hidalgo B, 2013, AM J PUBLIC HEALTH, V103, P39, DOI 10.2105/AJPH.2012.300897; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4; Indian Consensus Group, 1996, J NUTR ENV MED, V6, P309, DOI DOI 10.3109/13590849609007257; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jain S, 2010, BIOL TRACE ELEM RES, V133, P162, DOI 10.1007/s12011-009-8423-9; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kaaja R, 2005, EUR HEART J, V26, P44, DOI 10.1093/eurheartj/ehi015; Kahn SR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-91; Kiondo P, 2012, TROP MED INT HEALTH, V17, P480, DOI 10.1111/j.1365-3156.2011.02926.x; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Lichtenstein AH, 2005, JAMA-J AM MED ASSOC, V294, P351, DOI 10.1001/jama.294.3.351; Lindheimer MD, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P1, DOI 10.1016/B978-0-12-374213-1.00001-X; Longo-Mbenza B, 2008, Niger J Med, V17, P265; MARDONESSANTANDER F, 1988, AM J CLIN NUTR, V47, P413, DOI 10.1093/ajcn/47.3.413; McCarthy FP, 2013, OBSTET GYNECOL, V122, P830, DOI 10.1097/AOG.0b013e3182a6b226; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Misra A, 2009, J Assoc Physicians India, V57, P163; Morris CD, 2001, AM J OBSTET GYNECOL, V184, P643, DOI 10.1067/mob.2001.111101; National Center for Health Statistics, 1997, REP FIN NAT STAT 199; North CJ, 2009, EUR J CLIN NUTR, V63, P921, DOI 10.1038/ejcn.2009.8; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Pal A, 2011, Bangladesh Med Res Counc Bull, V37, P66; Parretti E, 2006, HYPERTENSION, V47, P449, DOI 10.1161/01.HYP.0000205122.47333.7f; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Phares Tanya M, 2004, MMWR Surveill Summ, V53, P1; Pipkin FB, 2008, HYPERTENSION, V51, P1042, DOI 10.1161/HYPERTENSIONAHA.107.106559; Prasannan-Nair C, 2006, J Obstet Gynaecol, V26, P817; Qiu CF, 2008, AM J HYPERTENS, V21, P903, DOI 10.1038/ajh.2008.209; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Ray JG, 2002, ARCH INTERN MED, V162, P1776, DOI 10.1001/archinte.162.15.1776; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Roberts JM, 2000, BMJ-BRIT MED J, V321, P33, DOI 10.1136/bmj.321.7252.33; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Roberts JM, 2003, J NUTR, V133, p1684S, DOI 10.1093/jn/133.5.1684S; Roberts JM, 2007, REPORT WIC NUTR RISK; Rosenberg TJ, 2003, OBSTET GYNECOL, V102, P1022, DOI [10.1016/j.obstetgynecol.2003.07.005, 10.1016/S0029-7844(03)00878-0]; Rudra CB, 2011, ENVIRON HEALTH PERSP, V119, P886, DOI 10.1289/ehp.1002947; Rudra CB, 2006, J REPROD MED, V51, P94; Ruel MT, 2003, IS DIETARY DIVERSITY; Sacks FM, 1999, CLIN CARDIOL, V22, P6, DOI 10.1002/clc.4960221503; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Salihu HM, 2011, ALCOHOL, V45, P73, DOI 10.1016/j.alcohol.2010.05.010; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Scholl TO, 2005, AM J CLIN NUTR, V81, P1390; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; Sharma JB, 2006, INT J GYNECOL OBSTET, V94, P23, DOI 10.1016/j.ijgo.2006.03.025; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai B M, 2000, J Matern Fetal Med, V9, P62; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sierra-Laguado J, 2007, AM J HYPERTENS, V20, P437, DOI 10.1016/j.amjhyper.2006.10.009; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Singh S, 2010, INTERNET J GYNECOLOG, V15; Swain S, 1993, Indian Pediatr, V30, P771; TAYLOR DJ, 1982, BRIT J OBSTET GYNAEC, V89, P1011, DOI 10.1111/j.1471-0528.1982.tb04656.x; Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Torheim LE, 2003, EUR J CLIN NUTR, V57, P1283, DOI 10.1038/sj.ejcn.1601686; Torjusen H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006143; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Tsai AC, 2013, AM J PUBLIC HEALTH, V103, pE1, DOI 10.2105/AJPH.2013.301234; US Congress Office of Technology Assessment, 1988, US C PUBL; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Vittinghoff E, 2012, SERIES STAT BIOL HLT; Wen SW, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/294312; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; WHO, 2008, CONCL CONS M HELD 1; World Health Organization, 2009, GLOB HLTH RISKS; World Health Organization, 2007, INT MAN PREGN CHILDB; Xu HR, 2009, NUTR REV, V67, P639, DOI 10.1111/j.1753-4887.2009.00249.x	116	29	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119120	10.1371/journal.pone.0119120	http://dx.doi.org/10.1371/journal.pone.0119120			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785774	Green Accepted, gold, Green Published			2022-12-26	WOS:000352138500076
J	Lv, XF; Liu, K; Qiu, YW; Cai, PQ; Li, J; Jiang, GH; Deng, YJ; Zhang, XL; Wu, PH; Xie, CM; Wen, G				Lv, Xiao-Fei; Liu, Kai; Qiu, Ying-Wei; Cai, Pei-Qiang; Li, Jing; Jiang, Gui-Hua; Deng, Yan-Jia; Zhang, Xue-Lin; Wu, Pei-Hong; Xie, Chuan-Miao; Wen, Ge			Anomalous Gray Matter Structural Networks in Patients with Hepatitis B Virus-Related Cirrhosis without Overt Hepatic Encephalopathy	PLOS ONE			English	Article							HBV-RELATED CIRRHOSIS; CORTICAL NETWORKS; BRAIN ACTIVITY; ORGANIZATION; VOXEL; ABNORMALITIES	Background and Purpose Increasing evidence suggests that cirrhosis may affect the connectivity among different brain regions in patients before overt hepatic encephalopathy (OHE) occurs. However, there has been no study investigating the structural reorganization of these altered connections at the network level. The primary focus of this study was to investigate the abnormal topological organization of the structural network in patients with hepatitis B virus-related cirrhosis (HBV-RC) without OHE using structural MRI. Methods Using graph theoretical analysis, we compared the global and regional topological properties of gray matter structural networks between 28 patients with HBV-RC without OHE and 30 age-, sex-and education-matched healthy controls. The structural correlation networks were constructed for the two groups based on measures of gray matter volume. Results The brain network of the HBV-RC group exhibited a significant decrease in the clustering coefficient and reduced small-worldness at the global level across a range of network densities. Regionally, brain areas with altered nodal degree/betweenness centrality were observed predominantly in association cortices (frontal and temporal regions) (p < 0.05, uncorrected), including a significantly decreased nodal degree in the inferior temporal gyrus (p < 0.001, uncorrected). Furthermore, the HBV-RC group exhibited a loss of association hubs and the emergence of an increased number of non-association hubs compared with the healthy controls. Conclusion The results of this large-scale gray matter structural network study suggest reduced topological organization efficiency in patients with HBV-RC without OHE. Our findings provide new insight concerning the mechanisms of neurobiological reorganization in the HBV-RC brain from a network perspective.	[Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] Sun Yat Sen Univ, Ctr Canc, Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, Kai; Deng, Yan-Jia; Zhang, Xue-Lin; Wen, Ge] Southern Medial Univ, Nanfang Hosp, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Qiu, Ying-Wei] Gannan Med Univ, Affiliated Hosp 1, Dept Med Imaging, Ganzhou, Peoples R China; [Qiu, Ying-Wei; Jiang, Gui-Hua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Southern Medical University - China; Gannan Medical University	Xie, CM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China.	xiecm_image@163.com; wenge67@aliyun.com			Natural Science Foundation of China [81401399]; Medical Scientific Research Foundation of Guangdong Province [B2014162]; Science and Technology Planning Project of Guangdong Province, China [2010B031600226]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province; Science and Technology Planning Project of Guangdong Province, China	This work was supported by the grants from the Natural Science Foundation of China (Grant No. 81401399 for XFL), Medical Scientific Research Foundation of Guangdong Province (Grant No. B2014162 for XFL) and Science and Technology Planning Project of Guangdong Province (Grant No. 2010B031600226 for CMX), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Burra P, 2004, EUR J GASTROEN HEPAT, V16, P885, DOI 10.1097/00042737-200409000-00012; Chen HJ, 2012, EUR J RADIOL, V81, P2463, DOI 10.1016/j.ejrad.2011.10.008; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guan R, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/918017; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Iwasa M, 2012, METAB BRAIN DIS, V27, P551, DOI 10.1007/s11011-012-9314-x; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee HW, 2000, NEUROLOGY, V54, P849, DOI 10.1212/WNL.54.4.849; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Lv XF, 2013, METAB BRAIN DIS, V28, P485, DOI 10.1007/s11011-013-9420-4; Lv XF, 2013, LIVER INT, V33, P375, DOI 10.1111/liv.12096; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Montoliu C, 2012, NEUROIMAGE, V61, P1165, DOI 10.1016/j.neuroimage.2012.03.041; Moriwaki H, 2010, J GASTROEN HEPATOL, V25, P858, DOI 10.1111/j.1440-1746.2010.06242.x; Qi RF, 2013, EUR RADIOL, V23, P3370, DOI 10.1007/s00330-013-2963-2; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Singh MK, 2013, BIOL PSYCHIAT, V74, P777, DOI 10.1016/j.biopsych.2013.03.005; Tao R, 2013, EUR J RADIOL, V82, pE715, DOI 10.1016/j.ejrad.2013.07.029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenborn K, 2008, J HEPATOL, V49, P308, DOI 10.1016/j.jhep.2008.06.023; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang YC, 2012, SCHIZOPHR RES, V141, P109, DOI 10.1016/j.schres.2012.08.021; Zheng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/727452	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119339	10.1371/journal.pone.0119339	http://dx.doi.org/10.1371/journal.pone.0119339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786256	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500097
J	Poluzzi, E; Raschi, E; Godman, B; Koci, A; Moretti, U; Kalaba, M; Wettermark, B; Sturkenboom, M; De Ponti, F				Poluzzi, Elisabetta; Raschi, Emanuel; Godman, Brian; Koci, Ariola; Moretti, Ugo; Kalaba, Marija; Wettermark, Bjorn; Sturkenboom, Miriam; De Ponti, Fabrizio			Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe	PLOS ONE			English	Article							TORSADES-DE-POINTES; QT PROLONGATION; CETIRIZINE; LORATADINE; RISK; KETOCONAZOLE; FEXOFENADINE; BILASTINE; INTERVAL; CURRENTS	Background There is appreciable utilisation of antihistamines (H1) in European countries, either prescribed by physician and purchased by patients for self-medication. Terfenadine and astemizole underwent regulatory restrictions in '90 because of their cardiac toxicity, but only scarce clinical data are available on other antihistamines. Aim To investigate the pro-arrhythmic potential of antihistamines by combining safety reports of the FDA Adverse Event Reporting System (FAERS) with drug utilization data from 13 European Countries. Methods We identified signals of antihistamine arrhythmogenic potential by analyzing FAERS database for all cases of Torsades de Pointes (TdP), QT abnormalities (QTabn), ventricular arrhythmia (VA) and sudden cardiac death/cardiac arrest (SCD/CA). Number of cases >= 3 and disproportionality were used to define alert signals: TdP and QTabn identified stronger signals, whereas SCD/CA identified weaker signals. Drug utilization data from 2005 to 2010 were collected from administrative databases through health authorities and insurance. Results Antihistamines were reported in 109 cases of TdP/QT prolongation, 278 VA and 610 SCD/CA. Five agents resulted in stronger signals (cetirizine, desloratadine, diphenhydramine, fexofenadine, loratadine) and 6 in weaker signals (alimemazine, carbinoxamine, cyclizine, cyproeptadine, dexchlorpheniramine and doxylamine). Exposure to antihistamines with stronger signal was markedly different across European countries and was at least 40% in each Country. Cetirizine was > 29 Defined Daily Doses per 1000 inhabitants per day (DID) in Norway, desloratadine > 11 DID in France and loratadine > 9 DID in Sweden and Croatia. Drugs with weaker signals accounted for no more than 10% (in Sweden) and in most European countries their use was negligible. Conclusions Some second-generation antihistamines are associated with signal of torsadogenicity and largely used in most European countries. Although confirmation by analytical studies is required, regulators and clinicians should consider risk-minimisation activities. Also antihistamines without signal but with peculiar use in a few Countries (e.g., levocetirizine) or with increasing consumption (e.g., rupatadine) deserve careful surveillance.	[Poluzzi, Elisabetta; Raschi, Emanuel; Koci, Ariola; De Ponti, Fabrizio] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy; [Godman, Brian; Wettermark, Bjorn] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden; [Godman, Brian] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Moretti, Ugo] Univ Verona, Clin Pharmacol Unit, I-37100 Verona, Italy; [Kalaba, Marija] Republ Fund Hlth Insurance, Belgrade, Serbia; [Wettermark, Bjorn] Karolinska Univ Hosp, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Wettermark, Bjorn] Cty Council, Stockholm, Sweden; [Sturkenboom, Miriam] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	University of Bologna; Karolinska Institutet; University of Strathclyde; University of Verona; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	De Ponti, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy.	fabrizio.deponti@unibo.it	Raschi, Emanuel/H-8821-2019; De Ponti, Fabrizio/H-8701-2019; Godman, Brian/R-8897-2019	Raschi, Emanuel/0000-0003-0487-7996; De Ponti, Fabrizio/0000-0002-0367-9595; Godman, Brian/0000-0001-6539-6972; POLUZZI, ELISABETTA/0000-0002-7209-0426; Sturkenboom, Miriam/0000-0003-1360-2388	European Community [241679]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241679 - the ARITMO project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli D, 2005, ISRAEL MED ASSOC J, V7, P163; Atar S, 2003, PACE, V26, P785, DOI 10.1046/j.1460-9592.2003.00137.x; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Caillet C, 2012, BRIT J CLIN PHARMACO, V74, P886, DOI 10.1111/j.1365-2125.2012.04262.x; Craig-McFeely PM, 2000, BRIT J GEN PRACT, V50, P148; de Abajo FJ, 1999, BRIT J CLIN PHARMACO, V47, P307; Dhar S, 2000, BRIT J DERMATOL, V142, P1260, DOI 10.1046/j.1365-2133.2000.03576.x; Donado E, 2010, BRIT J CLIN PHARMACO, V69, P401, DOI 10.1111/j.1365-2125.2009.03599.x; Garuoliene K, 2011, EXPERT REV PHARM OUT, V11, P343, DOI [10.1586/ERP.11.24, 10.1586/erp.11.24]; Graff C, 2012, CLIN DRUG INVEST, V32, P339, DOI 10.2165/11599270-000000000-00000; Grant JA, 2000, ALLERGY ASTHMA PROC, V21, P135, DOI 10.2500/108854100778149034; Hoffman KB, 2014, DRUG SAFETY, V37, P971, DOI 10.1007/s40264-014-0225-0; Hoffman KB, 2014, DRUG SAFETY, V37, P283, DOI 10.1007/s40264-014-0150-2; Hulhoven R, 2007, EUR J CLIN PHARMACOL, V63, P1011, DOI 10.1007/s00228-007-0366-5; Katchman AN, 2006, J PHARMACOL EXP THER, V316, P1098, DOI 10.1124/jpet.105.093393; Kosoglou T, 2000, BRIT J CLIN PHARMACO, V50, P581, DOI 10.1046/j.1365-2125.2000.00290.x; Lacerda AE, 1997, MOL PHARMACOL, V52, P314, DOI 10.1124/mol.52.2.314; Layton D, 2009, DRUG SAFETY, V32, P169, DOI 10.2165/00002018-200932020-00009; Pinto YM, 1999, LANCET, V353, P980, DOI 10.1016/S0140-6736(99)01009-0; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Poluzzi E, 2013, DRUG SAFETY, V36, P467, DOI 10.1007/s40264-013-0032-z; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Raschi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081208; Ravera S, 2009, EUR J CLIN PHARMACOL, V65, P1139, DOI 10.1007/s00228-009-0695-7; Renard S, 2005, ARCH MAL COEUR VAISS, V98, P157; Scherer CR, 2002, BRIT J PHARMACOL, V137, P892, DOI 10.1038/sj.bjp.0704873; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Taglialatela M, 1998, MOL PHARMACOL, V54, P113, DOI 10.1124/mol.54.1.113; Tsuruoka S, 2006, CLIN PHARMACOL THER, V79, P389, DOI 10.1016/j.clpt.2005.12.302; Tyl B, 2012, J CLIN PHARMACOL, V52, P893, DOI 10.1177/0091270011407191; WHO, 2003, INTR DRUG UT RES	31	37	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119551	10.1371/journal.pone.0119551	http://dx.doi.org/10.1371/journal.pone.0119551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785934	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500110
J	Thacker, PC; Karunagaran, D				Thacker, Pooja Chandrakant; Karunagaran, Devarajan			Curcumin and Emodin Down-Regulate TGF-beta Signaling Pathway in Human Cervical Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-PAPILLOMAVIRUS; BREAST-CANCER; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MECHANISMS; ACTIVATION; MIGRATION; APOPTOSIS	Cervical cancer is the major cause of cancer related deaths in women, especially in developing countries and Human Papilloma Virus infection in conjunction with multiple deregulated signaling pathways leads to cervical carcinogenesis. TGF-beta signaling in later stages of cancer is known to induce epithelial to mesenchymal transition promoting tumor growth. Phytochemicals, curcumin and emodin, are effective as chemopreventive and chemotherapeutic compounds against several cancers including cervical cancer. The main objective of this work was to study the effect of curcumin and emodin on TGF-beta signaling pathway and its functional relevance to growth, migration and invasion in two cervical cancer cell lines, SiHa and HeLa. Since TGF-beta and Wnt/beta-catenin signaling pathways are known to cross talk having common downstream targets, we analyzed the effect of TGF-beta on beta-catenin (an important player in Wnt/beta-catenin signaling) and also studied whether curcumin and emodin modulate them. We observed that curcumin and emodin effectively down regulate TGF-beta signaling pathway by decreasing the expression of TGF-beta Receptor II, P-Smad3 and Smad4, and also counterbalance the tumorigenic effects of TGF-beta by inhibiting the TGF-beta-induced migration and invasion. Expression of downstream effectors of TGF-beta signaling pathway, cyclinD1, p21 and Pin1, was inhibited along with the down regulation of key mesenchymal markers (Snail and Slug) upon curcumin and emodin treatment. Curcumin and emodin were also found to synergistically inhibit cell population and migration in SiHa and HeLa cells. Moreover, we found that TGF-beta activates Wnt/beta-catenin signaling pathway in HeLa cells, and curcumin and emodin down regulate the pathway by inhibiting beta-catenin. Taken together our data provide a mechanistic basis for the use of curcumin and emodin in the treatment of cervical cancer.	[Thacker, Pooja Chandrakant; Karunagaran, Devarajan] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Karunagaran, D (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	karuna@iitm.ac.in						Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bakhshayesh M, 2012, CL LYMPH MYELOM LEUK, V12, P138, DOI 10.1016/j.clml.2011.12.001; BRAUN L, 1990, CANCER RES, V50, P7324; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chen Ting-fang, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P59, DOI 10.3736/jcim20090109; Chen WC, 2013, J AGR FOOD CHEM, V61, P11817, DOI 10.1021/jf404092f; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dai M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3441; Datta R, 2013, J CANCER RES CLIN, V139, P563, DOI 10.1007/s00432-012-1352-6; Debata PR, 2013, GYNECOL ONCOL, V129, P145, DOI 10.1016/j.ygyno.2012.12.005; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Fan DM, 2012, MOL BIOL REP, V39, P3925, DOI 10.1007/s11033-011-1171-x; Farrand L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890141; Florenes VA, 1996, ONCOGENE, V13, P2447; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo JL, 2013, MOL CELL BIOCHEM, V382, P103, DOI 10.1007/s11010-013-1723-6; Hazelbag S, 2002, HUM PATHOL, V33, P1193, DOI 10.1053/hupa.2002.130109; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hossain Dewan Md Sakib, 2012, Front Biosci (Schol Ed), V4, P335; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kitano A, 2007, INVEST OPHTH VIS SCI, V48, P5013, DOI 10.1167/iovs.07-0393; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Lee SH, 2001, INT J CANCER, V94, P500, DOI 10.1002/ijc.1494; Li Mu, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1752; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Li Yu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1224; Liu A, 2011, ONCOL REP, V26, P81, DOI 10.3892/or.2011.1257; Lopez-Munoz H, 2013, ARCH GYNECOL OBSTET, V287, P755, DOI 10.1007/s00404-012-2621-y; Lou K X, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P433; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maliekal TT, 2004, J BIOL CHEM, V279, P36287, DOI 10.1074/jbc.M404568200; Maliekal TT, 2003, ONCOGENE, V22, P4889, DOI 10.1038/sj.onc.1206806; Massague J, 2000, GENE DEV, V14, P627; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mo N, 2012, ASIAN PAC J CANCER P, V13, P5709, DOI 10.7314/APJCP.2012.13.11.5709; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Nyati S, 2011, CLIN CANCER RES, V17, P7424, DOI 10.1158/1078-0432.CCR-11-1248; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Perez-Plasencia Carlos, 2008, Int Arch Med, V1, P10, DOI 10.1186/1755-7682-1-10; Pooja T, 2014, EUR J PHARMACOL, V742, P55, DOI 10.1016/j.ejphar.2014.08.028; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; Rao Cui, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P591; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Roy M, 2014, ASIAN PAC J CANCER P, V15, P1403, DOI 10.7314/APJCP.2014.15.3.1403; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Singh M, 2011, MOL CELL BIOCHEM, V347, P1, DOI 10.1007/s11010-010-0606-3; Srinivas G, 2003, EUR J PHARMACOL, V473, P117, DOI 10.1016/S0014-2999(03)01976-9; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Tang T, 2007, EUR J PHARMACOL, V567, P177, DOI 10.1016/j.ejphar.2007.02.033; Teng ZH, 2007, BIOSCI BIOTECH BIOCH, V71, P1636, DOI 10.1271/bbb.70025; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang YX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-71; Wei WT, 2013, ONCOL REP, V30, P2555, DOI 10.3892/or.2013.2741; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; WOODWORTH CD, 1990, J VIROL, V64, P4767, DOI 10.1128/JVI.64.10.4767-4775.1990; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yi JY, 2002, EUR J CELL BIOL, V81, P457, DOI 10.1078/0171-9335-00265; Yoysungnoen-Chintana P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/817972; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZerfassThome K, 1996, ONCOGENE, V13, P2323	74	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120045	10.1371/journal.pone.0120045	http://dx.doi.org/10.1371/journal.pone.0120045			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786122	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500151
J	Tomioka, H; Yamagata, B; Kawasaki, S; Pu, SH; Iwanami, A; Hirano, J; Nakagome, K; Mimura, M				Tomioka, Hiroi; Yamagata, Bun; Kawasaki, Shingo; Pu, Shenghong; Iwanami, Akira; Hirano, Jinichi; Nakagome, Kazuyuki; Mimura, Masaru			A Longitudinal Functional Neuroimaging Study in Medication-Naive Depression after Antidepressant Treatment	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; GRAY-MATTER REDUCTION; VERBAL FLUENCY TASK; MAJOR DEPRESSION; FOLLOW-UP; PREFRONTAL ACTIVATION; EMOTION REGULATION; BIPOLAR DISORDER; DSM-IV; BRAIN	Recent studies have indicated the potential clinical use of near infrared spectroscopy (NIRS) as a tool in assisting the diagnosis of major depressive disorder (MDD); however, it is still unclear whether NIRS signal changes during cognitive task are state-or trait-dependent, and whether NIRS could be a neural predictor of treatment response. Therefore, we conducted a longitudinal study to explore frontal haemodynamic changes following antidepressant treatment in medication-naive MDD using 52-channel NIRS. This study included 25 medication-naive individuals with MDD and 62 healthy controls (HC). We performed NIRS scans before and after antidepressant treatment and measured changes of [oxy-Hb] activation during a verbal fluency task (VFT) following treatment. Individuals with MDD showed significantly decreased [oxy-Hb] values during a VFT compared with HC in the bilateral frontal and temporal cortices at baseline. There were no [oxy-Hb] changes between pre- and post-antidepressant treatment time points in the MDD cohort despite significant improvement in depressive symptoms. There was a significant association between mean [oxy-Hb] values during a VFT at baseline and improvement in depressive symptoms following treatment in the bilateral inferior frontal and middle temporal gyri in MDD. These findings suggest that hypofrontality response to a VFT may represent a potential trait marker for depression rather than a state marker. Moreover, the correlation analysis indicates that the NIRS signals before the initiation of treatment may be a biological marker to predict patient's clinical response to antidepressant treatment. The present study provides further evidence to support a potential application of NIRS for the diagnosis and treatment of depression.	[Tomioka, Hiroi; Yamagata, Bun; Iwanami, Akira] Showa Univ, Sch Med, Dept Psychiat, Tokyo 1578577, Japan; [Yamagata, Bun; Hirano, Jinichi; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Chiba 2770804, Japan; [Pu, Shenghong; Nakagome, Kazuyuki] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neuropsychiat, Tottori 6838504, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan	Showa University; Keio University; Hitachi Limited; Tottori University; National Center for Neurology & Psychiatry - Japan	Yamagata, B (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 1578577, Japan.	yamagata@a6.keio.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	Intramural Research Grant [23-10]; Hitachi Medical Corporation	Intramural Research Grant; Hitachi Medical Corporation	This study was supported by the Intramural Research Grant (23-10) for Neurological and Psychiatric Disorders of NCNP (National Center of Neurology and Psychiatry). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi Medical Corporation provided support in the form of a salary for author SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1985, Am J Psychiatry, V142, P469; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Elliott R, 2012, ARCH GEN PSYCHIAT, V69, P37, DOI 10.1001/archgenpsychiatry.2011.139; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Fu CHY, 2003, GUIDE NEUROIMAGING P, P131; GELLER B, 1994, J AM ACAD CHILD PSY, V33, P461, DOI 10.1097/00004583-199405000-00003; Geller B, 2001, AM J PSYCHIAT, V158, P125, DOI 10.1176/appi.ajp.158.1.125; Heller AS, 2013, JAMA PSYCHIAT, V70, P1181, DOI 10.1001/jamapsychiatry.2013.2430; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kanske P, 2012, NEUROIMAGE, V61, P686, DOI 10.1016/j.neuroimage.2012.03.089; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lee HY, 2011, J AFFECT DISORDERS, V133, P128, DOI 10.1016/j.jad.2011.04.006; Matsuo K, 2002, PSYCHOL MED, V32, P1029, DOI 10.1017/S0033291702005974; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okada G, 2009, PSYCHIAT CLIN NEUROS, V63, P423, DOI 10.1111/j.1440-1819.2009.01952.x; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Ritchey M, 2011, J PSYCHIATR RES, V45, P577, DOI 10.1016/j.jpsychires.2010.09.007; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; SHEA MT, 1992, ARCH GEN PSYCHIAT, V49, P782, DOI 10.1001/archpsyc.1992.01820100026006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smoski MJ, 2013, J AFFECT DISORDERS, V151, P171, DOI 10.1016/j.jad.2013.05.073; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086290; Wagner G, 2008, J PSYCHIATR NEUROSCI, V33, P199; Walsh ND, 2007, BIOL PSYCHIAT, V62, P1236, DOI 10.1016/j.biopsych.2006.12.022; Zhang HJ, 2015, PSYCHIAT CLIN NEUROS, V69, P22, DOI 10.1111/pcn.12209; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhong MT, 2011, BIOL PSYCHOL, V88, P233, DOI 10.1016/j.biopsycho.2011.08.007	45	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120828	10.1371/journal.pone.0120828	http://dx.doi.org/10.1371/journal.pone.0120828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786240	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500193
J	Xie, LN; Guo, HY; Gabler, CA; Li, QF; Ma, CC				Xie, Li-Na; Guo, Hong-Yu; Gabler, Christopher A.; Li, Qing-Fang; Ma, Cheng-Cang			Changes in Spatial Patterns of Caragana stenophylla along a Climatic Drought Gradient on the Inner Mongolian Plateau	PLOS ONE			English	Article							SOIL SEED BANK; DESERT; DYNAMICS; ESTABLISHMENT; FACILITATION; VEGETATION; PLANT	Few studies have investigated the influence of water availability on plant population spatial patterns. We studied changes in the spatial patterns of Caragana stenophylla along a climatic drought gradient within the Inner Mongolian Plateau, China. We examined spatial patterns, seed density, "nurse effects" of shrubs on seedlings, transpiration rates and water use efficiency (WUE) of C. stenophylla across semi-arid, arid, and intensively arid zones. Our results showed that patches of C. stenophylla populations shifted from a random to a clumped spatial pattern towards drier environments. Seed density and seedling survival rate of C. stenophylla decreased from the semi-arid zone to the intensively arid zone. Across the three zones, there were more C. stenophylla seeds and seedlings underneath shrub canopies than outside shrub canopies; and in the intensively arid zone, there were almost no seeds or seedlings outside shrub canopies. Transpiration rates of outer-canopy leaves and WUE of both outer-canopy and inner-canopy leaves increased from the semi-arid zone to the intensively arid zone. In the intensively arid zone, transpiration rates and WUE of inner-canopy leaves were significantly lower and higher, respectively, than those of outer-canopy leaves. We conclude that, as drought stress increased, seed density decreased, seed proportions inside shrubs increased, and "nurse effects" of shrubs on seedlings became more important. These factors, combined with water-saving characteristics associated with clumped spatial patterns, are likely driving the changes in C. stenophylla spatial patterns.	[Xie, Li-Na; Guo, Hong-Yu; Li, Qing-Fang; Ma, Cheng-Cang] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Coll Life Sci, Tianjin, Peoples R China; [Gabler, Christopher A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Tianjin Normal University; University of Houston System; University of Houston	Ma, CC (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Coll Life Sci, Tianjin, Peoples R China.	machengcang@163.com		Gabler, Christopher/0000-0001-9311-7248	National Natural Science Foundation of China [31170381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31170381) (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1997, ECOLOGY, V78, P93, DOI 10.1890/0012-9658(1997)078[0093:SDCTDO]2.0.CO;2; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; Bleher B, 2001, OECOLOGIA, V129, P385, DOI 10.1007/s004420100747; Burns SL, 2013, FOREST SYST, V22, P170, DOI 10.5424/fs/2013222-02834; [崔艳 CUI Yan], 2010, [生态学报, Acta Ecologica Sinica], V30, P1981; Dong XW, 2009, PLANT SOIL ENVIRON, V55, P288, DOI 10.17221/13/2009-PSE; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Guo QF, 1998, J ARID ENVIRON, V38, P465, DOI 10.1006/jare.1997.0353; [贺山峰 He Shanfeng], 2013, [水土保持研究, Research of Soil and Water Conservation], V20, P145; JIMENEZ HE, 1992, J VEG SCI, V3, P579, DOI 10.2307/3235824; [张钦弟 Zhang Qindi], 2012, [生态学报, Acta Ecologica Sinica], V32, P5713; Li Qiu-shuang, 2009, Yingyong Shengtai Xuebao, V20, P2105; [李秋艳 LI Qiuyan], 2008, [干旱区研究, Arid Zone Research], V25, P502; Liu Z, 2015, ARID ZONE R IN PRESS; Ma CC, 2008, J ARID ENVIRON, V72, P247, DOI 10.1016/j.jaridenv.2007.05.009; Ma CC, 2003, ACTA BOT SIN, V45, P1218; Ma CC, 2014, ARID LAND RES MANAG, V28, P87, DOI 10.1080/15324982.2013.808717; Ma CC, 2013, FLORA, V208, P97, DOI 10.1016/j.flora.2013.02.002; [马成仓 Ma Chengcang], 2004, [生态学报, Acta Ecologica Sinica], V24, P1594; [马成仓 MA ChengCang], 2006, [生态学报, Acta Ecologica Sinica], V26, P2308; [马成仓 Ma Chengcang], 2004, [生态学报, Acta Ecologica Sinica], V24, P1442; Malkinson D, 2007, ECOGRAPHY, V30, P339, DOI 10.1111/j.2007.0906-7590.04983.x; Matesanz S, 2009, J ARID ENVIRON, V73, P784, DOI 10.1016/j.jaridenv.2009.03.009; Osem Y, 2007, ISR J PLANT SCI, V55, P35, DOI 10.1560/IJPS.55.1.35; Schade JD, 2005, BIOGEOCHEMISTRY, V73, P541, DOI 10.1007/s10533-004-1718-1; Shaukat SS, 2004, J ARID ENVIRON, V57, P311, DOI 10.1016/S0140-1963(03)00112-5; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; Smit C, 2006, FOREST ECOL MANAG, V237, P471, DOI 10.1016/j.foreco.2006.09.069; Sun B, 1994, B BOT RES, V14, P201; Titus JH, 2002, J ARID ENVIRON, V52, P269, DOI 10.1006/jare.2002.1010; Vanderklein DW, 2004, NORTHEAST NAT, V11, P343, DOI 10.1656/1092-6194(2004)011[0343:PAALDI]2.0.CO;2; Wei Xin-Zeng, 2008, Zhiwu Shengtai Xuebao, V32, P825, DOI 10.3773/j.issn.1005-264x.2008.04.011; [熊小刚 Xiong Xiaogang], 2003, [生态学报, Acta Ecologica Sinica], V23, P2436; Yang MH, 1987, APPL STUDY REMOTE SE, P46; Yin ZY, 2005, PLANT ECOL, V178, P189, DOI 10.1007/s11258-004-3285-x; Zhang J.T., 1998, ACTA PHYTOECCOL SIN, V22, P344; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010	37	14	14	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121234	10.1371/journal.pone.0121234	http://dx.doi.org/10.1371/journal.pone.0121234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785848	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500205
J	Asamitsu, K; Hirokawa, T; Hibi, Y; Okamoto, T				Asamitsu, Kaori; Hirokawa, Takatsugu; Hibi, Yurina; Okamoto, Takashi			Molecular Dynamics Simulation and Experimental Verification of the Interaction between Cyclin T1 and HIV-1 Tat Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN P-TEFB; TRANSCRIPTIONAL ACTIVATION; IN-VITRO; KINASE; TRANSACTIVATION; ELONGATION; COMPLEX; RNA; REPLICATION	The viral encoded Tat protein is essential for the transcriptional activation of HIV proviral DNA. Interaction of Tat with a cellular transcription elongation factor P-TEFb containing CycT1 is critically required for its action. In this study, we performed MD simulation using the 3D data for wild-type and 4CycT1mutants3D data. We found that the dynamic structural change of CycT1 H2' helix is indispensable for its activity for the Tat action. Moreover, we detected flexible structural changes of the Tat-recognition cavity in the WT CycT1 comprising of ten AAs that are in contact with Tat. These structural fluctuations in WT were lost in the CycT1 mutants. We also found the critical importance of the hydrogen bond network involving H1, H1' and H2 helices of CycT1. Since similar AA substitutions of the Tat-CycT1 chimera retained the Tat-supporting activity, these interactions are considered primarily involved in interaction with Tat. These findings described in this paper should provide vital information for the development of effective anti-Tat compound.	[Asamitsu, Kaori; Hibi, Yurina; Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan	Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST)	Okamoto, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011	Research on HIV/AIDS; Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI [21390142]; IMAI MEMORIAL TRUST FOR AIDS RESEARCH; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Research on HIV/AIDS; Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI; IMAI MEMORIAL TRUST FOR AIDS RESEARCH; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by grants form Grants-in-Aid from Research on HIV/AIDS, the Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI Grant Number 21390142, The IMAI MEMORIAL TRUST FOR AIDS RESEARCH, Grant-in-Aid for Research in Nagoya City University, and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Asamitsu K, 2011, J MOL BIOL, V410, P887, DOI 10.1016/j.jmb.2011.04.061; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fujinaga K, 2002, J VIROL, V76, P12934, DOI 10.1128/JVI.76.24.12934-12939.2002; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hamasaki T, 2013, ANTIMICROB AGENTS CH, V57, P1323, DOI 10.1128/AAC.01711-12; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ivanov D, 1999, J MOL BIOL, V288, P41, DOI 10.1006/jmbi.1999.2663; Jadlowsky JK, 2008, J GEN VIROL, V89, P2783, DOI 10.1099/vir.0.2008/002857-0; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kuzmina A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-51; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Miteva MA, 2004, BIOPHYS J, V86, P488, DOI 10.1016/S0006-3495(04)74127-2; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Okamoto H, 2000, VIROLOGY, V272, P402, DOI 10.1006/viro.2000.0396; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Petukhov M, 1999, PROTEIN SCI, V8, P2144, DOI 10.1110/ps.8.10.2144; Petukhov M, 2002, PROTEIN SCI, V11, P766, DOI 10.1110/ps.2610102; Sarol LC, 2002, BIOCHEM BIOPH RES CO, V291, P890, DOI 10.1006/bbrc.2002.6532; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Takada N, 2002, J VIROL, V76, P8019, DOI 10.1128/JVI.76.16.8019-8030.2002; Taube R, 1999, VIROLOGY, V264, P245, DOI 10.1006/viro.1999.9944; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Verstraete N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-50; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	44	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119451	10.1371/journal.pone.0119451	http://dx.doi.org/10.1371/journal.pone.0119451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781978	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600064
J	Dunlop, A; Welsh, L; McQuaid, D; Dean, J; Gulliford, S; Hansen, V; Bhide, S; Nutting, C; Harrington, K; Newbold, K				Dunlop, Alex; Welsh, Liam; McQuaid, Dualta; Dean, Jamie; Gulliford, Sarah; Hansen, Vibeke; Bhide, Shreerang; Nutting, Chris; Harrington, Kevin; Newbold, Kate			Brain-Sparing Methods for IMRT of Head and Neck Cancer	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; COGNITIVE DECLINE; RADIATION-THERAPY; RADIOTHERAPY; CISPLATIN; TUMORS	Purpose Radical radiotherapy for head and neck cancer (HNC) may deliver significant doses to brain structures. There is evidence that this may cause a decline in neurocognitive function (NCF). Radiation dose to the medial temporal lobes, and particularly to the hippocampi, seems to be critical in determining NCF outcomes. We evaluated the feasibility of two alternative intensity-modulated radiotherapy (IMRT) techniques to generate hippocampus-and brain-sparing HNC treatment plans to preserve NCF. Methods and Materials A planning study was undertaken for ten patients with HNC whose planning target volume (PTV) included the nasopharynx. Patients had been previously treated using standard (chemo)-IMRT techniques. Bilateral hippocampi were delineated according to the RTOG atlas, on T1w MRI co-registered to the RT planning CT. Hippocampus-sparing plans (HSRT), and whole-brain/hippocampus-sparing fixed-field non-coplanar IMRT (BSRT) plans, were generated. DVHs and dose difference maps were used to compare plans. NTCP calculations for NCF impairment, based on hippocampal dosimetry, were performed for all plans. Results Significant reductions in hippocampal doses relative to standard plans were achieved in eight of ten cases for both HSRT and BSRT. EQD2 D40% to bilateral hippocampi was significantly reduced from a mean of 23.5 Gy (range 14.5-35.0) in the standard plans to a mean of 8.6 Gy (4.2-24.7) for HSRT (p = 0.001) and a mean of 9.0 Gy (4.3-17.3) for BSRT (p < 0.001). Both HSRT and BSRT resulted in a significant reduction in doses to the whole brain, brain stem, and cerebellum. Conclusion We demonstrate that IMRT plans for HNC involving the nasopharynx can be successfully optimised to significantly reduce dose to the bilateral hippocampi and whole brain. The magnitude of the achievable dose reductions results in significant reductions in the probability of radiation-induced NCF decline. These results could readily be translated into a future clinical trial.	[Dunlop, Alex; McQuaid, Dualta; Gulliford, Sarah; Hansen, Vibeke] Inst Canc Res, Joint Dept Phys, London SW3 6JB, England; [Dunlop, Alex; McQuaid, Dualta; Gulliford, Sarah; Hansen, Vibeke] Royal Marsden NHS Fdn Trust, London, England; [Welsh, Liam; Bhide, Shreerang; Nutting, Chris; Harrington, Kevin; Newbold, Kate] Royal Marsden Hosp, London SW3 6JJ, England; [Welsh, Liam; Dean, Jamie; Bhide, Shreerang; Harrington, Kevin] Inst Canc Res, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dunlop, A (corresponding author), Inst Canc Res, Joint Dept Phys, London SW3 6JB, England.	Alex.Dunlop@rmh.nhs.uk	Dean, Jamie/H-4618-2019; Newbold, Kate/AAA-9176-2022	Dean, Jamie/0000-0002-5434-8032; Harrington, Kevin/0000-0002-6014-348X; Gulliford, Sarah/0000-0002-1768-2904	NHS Executive; Cancer Research UK [C46/A10588, C7224/A13407]; National Institute for Health Research Royal Marsden; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK [13407] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1240077] Funding Source: researchfish	NHS Executive; Cancer Research UK(Cancer Research UK); National Institute for Health Research Royal Marsden; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was undertaken in The Royal Marsden NHS Foundation Trust which received a proportion of its funding from the NHS Executive; the views expressed in this publication are those of the authors and not necessarily those of the NHS Executive. This work was supported by Cancer Research UK Programme Grants C46/A10588 and C7224/A13407. The authors also acknowledge the support of the National Institute for Health Research Royal Marsden and Institute of Cancer Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 2002, ACTA ONCOL, V41, P346, DOI 10.1080/028418602760169389; Bhide SA, 2008, BRIT J CANCER, V99, P57, DOI 10.1038/sj.bjc.6604444; Bhide SA, 2012, BRIT J RADIOL, V85, P487, DOI 10.1259/bjr/85942136; Cao Y, 2009, CLIN CANCER RES, V15, P1747, DOI 10.1158/1078-0432.CCR-08-1420; Chapman CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057768; Cheung MC, 2000, ARCH NEUROL-CHICAGO, V57, P1347, DOI 10.1001/archneur.57.9.1347; Corvo R, 2007, RADIOTHER ONCOL, V85, P156, DOI 10.1016/j.radonc.2007.04.002; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; Gan HK, 2011, INT J RADIAT ONCOL, V81, P126, DOI 10.1016/j.ijrobp.2010.05.004; Gondi V, 2013, INT J RADIAT ONCOL, V87, P1186, DOI DOI 10.1016/J.IJR0BP.2013.10.005; Gondi V, 2013, INT J RADIAT ONCOL, V85, P348, DOI 10.1016/j.ijrobp.2012.11.031; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Gulliford SL, 2012, RADIOTHER ONCOL, V104, P205, DOI 10.1016/j.radonc.2012.07.005; Holliday EB, 2014, INT J RADIAT ONCOL, V89, P292, DOI 10.1016/j.ijrobp.2014.02.029; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; International Commission on Radiation Units and Measurements, 2010, J ICRU, V10, P1; LEE PWH, 1989, J NEUROL NEUROSUR PS, V52, P488, DOI 10.1136/jnnp.52.4.488; Li YQ, 2003, CANCER RES, V63, P5950; Miah AB, 2012, INT J RADIAT ONCOL, V82, P539, DOI 10.1016/j.ijrobp.2010.09.055; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Namikawa K, 2000, BIOL TRACE ELEM RES, V74, P223, DOI 10.1385/BTER:74:3:223; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Peiffer AM, 2013, NEUROLOGY, V80, P747, DOI 10.1212/WNL.0b013e318283bb0a; Powell C., 2013, RADIOTHER ONCOL; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z; Welsh L, 2014, CLIN ONCOLOGY	29	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120141	10.1371/journal.pone.0120141	http://dx.doi.org/10.1371/journal.pone.0120141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781636	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600131
J	Heurich, M; Brand, TTG; Kaandorp, MY; Sustr, P; Muller, J; Reineking, B				Heurich, Marco; Brand, Tom T. G.; Kaandorp, Manon Y.; Sustr, Pavel; Mueller, Joerg; Reineking, Bjoern			Country, Cover or Protection: What Shapes the Distribution of Red Deer and Roe Deer in the Bohemian Forest Ecosystem?	PLOS ONE			English	Article							CAPREOLUS-CAPREOLUS DEER; LYNX LYNX-LYNX; CERVUS-ELAPHUS; ALTITUDINAL GRADIENT; HABITAT SELECTION; HOME-RANGE; WILDLIFE MANAGEMENT; POPULATION-DENSITY; PARTIAL MIGRATION; NATIONAL-PARK	The Bohemian Forest Ecosystem encompasses various wildlife management systems. Two large, contiguous national parks (one in Germany and one in the Czech Republic) form the centre of the area, are surrounded by private hunting grounds, and hunting regulations in each country differ. Here we aimed at unravelling the influence of management-related and environmental factors on the distribution of red deer (Cervus elaphus) and roe deer (Capreolus capreolus) in this ecosystem. We used the standing crop method based on counts of pellet groups, with point counts every 100 m along 218 randomly distributed transects. Our analysis, which accounted for overdispersion as well as zero inflation and spatial autocorrelation, corroborated the view that both human management and the physical and biological environment drive ungulate distribution in mountainous areas in Central Europe. In contrast to our expectations, protection by national parks was the least important variable for red deer and the third important out of four variables for roe deer; protection negatively influenced roe deer distribution in both parks and positively influenced red deer distribution in Germany. Country was the most influential variable for both red and roe deer, with higher counts of pellet groups in the Czech Republic than in Germany. Elevation, which indicates increasing environmental harshness, was the second most important variable for both species. Forest cover was the least important variable for roe deer and the third important variable for red deer; the relationship for roe deer was positive and linear, and optimal forest cover for red deer was about 70% within a 500 m radius. Our results have direct implications for the future conservation management of deer in protected areas in Central Europe and show in particular that large non-intervention zones may not cause agglomerations of deer that could lead to conflicts along the border of protected, mountainous areas.	[Heurich, Marco; Mueller, Joerg] Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Fac Environm & Nat Resources, Chair Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Brand, Tom T. G.; Kaandorp, Manon Y.] Univ Appl Sci, Van Hall Larenstein, Leeuwarden, Netherlands; [Sustr, Pavel] Acad Sci Czech Republ, Global Change Res Ctr, Dept Biodivers Res, Brno, Czech Republic; [Sustr, Pavel] Sumava Natl Pk, Vimperk, Czech Republic; [Mueller, Joerg] Tech Univ Munich, Dept Ecol & Ecosyst Management, Chair Terr Ecol, Freising Weihenstephan, Germany; [Reineking, Bjoern] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Biogeog Modelling, Bayreuth, Germany; [Reineking, Bjoern] UR EMGR Ecosyst Montagnards, St Martin Dheres, France	University of Freiburg; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Technical University of Munich; University of Bayreuth	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany.	marco.heurich@npv-bw.bayern.de	Heurich, Marco/O-4653-2014; Šustr, Pavel/G-9876-2014	Heurich, Marco/0000-0003-0051-2930; Reineking, Bjorn/0000-0001-5277-9181; Muller, Jorg/0000-0002-1409-1586	project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt); EU programme INTERREG IV (EFRE Ziel 3); Bavarian Forest National Park Administration; GA CR [14-36098G]; MSMT [CZ.1.05/1.1.00/02.0073]	project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt); EU programme INTERREG IV (EFRE Ziel 3); Bavarian Forest National Park Administration; GA CR(Grant Agency of the Czech Republic); MSMT(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt). This study was part of a project on the predator-prey relationship of the Eurasian lynx, roe deer and red deer carried out by the Bavarian Forest National Park Administration, Department of Research. Financial support was provided by the EU programme INTERREG IV (EFRE Ziel 3), and the Bavarian Forest National Park Administration. Pavel Sustr's contribution was funded by the grants No. 14-36098G of the GA CR and No. CZ.1.05/1.1.00/02.0073 of the MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M., 2010, EUROPEAN UNGULATES T; AULAK W, 1990, ACTA THERIOL, V35, P111, DOI 10.4098/AT.arch.90-12; Barancekova M, 2010, EUR J WILDLIFE RES, V56, P327, DOI 10.1007/s10344-009-0321-0; Bartos L., 2010, EUROPEAN UNGULATES T; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; BOBEK B, 1984, J APPL ECOL, V21, P881, DOI 10.2307/2405053; Borkowski J, 2008, FOREST ECOL MANAG, V255, P468, DOI 10.1016/j.foreco.2007.09.013; BOYCE MS, 1991, GREATER YELLOWSTONE ECOSYSTEM, P183; Bradford JB, 2008, J ENVIRON MANAGE, V86, P520, DOI 10.1016/j.jenvman.2006.12.005; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Conover MR, 2001, WILDLIFE SOC B, V29, P521; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Forsyth DM, 2007, J WILDLIFE MANAGE, V71, P964, DOI 10.2193/2005-695; GARNER DL, 1995, ENVIRON MANAGE, V19, P233, DOI 10.1007/BF02471993; Gerner J, 2011, J NAT CONSERV, V19, P319, DOI 10.1016/j.jnc.2011.06.002; Gill R. M. A., 1990, GEMS INFORM SERIES, V8; Gill RMA, 1996, FOREST ECOLOGY; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Hagen R, 2014, SCI TOTAL ENVIRON, V468, P140, DOI 10.1016/j.scitotenv.2013.08.022; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Hemami MR, 2005, FOREST ECOL MANAG, V215, P224, DOI 10.1016/j.foreco.2005.05.013; Heurich M, 2012, EUR J WILDLIFE RES, V58, P567, DOI 10.1007/s10344-011-0606-y; Hothorn T, 2010, FOREST ECOL MANAG, V260, P1416, DOI 10.1016/j.foreco.2010.07.019; Huff DE, 1999, ECOL APPL, V9, P17; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; IUCN, 1994, GUID PROT AR MAN CAT; JANZEN DH, 1983, OIKOS, V41, P402, DOI 10.2307/3544100; JEDRZEJEWSKA B, 1994, J APPL ECOL, V31, P664, DOI 10.2307/2404157; Jiang GS, 2008, WILDLIFE BIOL, V14, P92, DOI 10.2981/0909-6396(2008)14[92:HUASBR]2.0.CO;2; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; Kramer K, 2006, FOREST ECOL MANAG, V226, P238, DOI 10.1016/j.foreco.2006.01.037; Krojerova-Prokesova J, 2010, WILDLIFE BIOL, V16, P173, DOI 10.2981/09-004; Latham J, 1996, J ZOOL, V240, P285, DOI 10.1111/j.1469-7998.1996.tb05285.x; Latham J, 2009, J ZOOL, V240, P285; Lovari S, 1997, BEHAV PROCESS, V40, P239, DOI 10.1016/S0376-6357(97)00019-3; Ludwig M, 2012, ERDKUNDE, V66, P143, DOI 10.3112/erdkunde.2012.02.04; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; MITCHELL B, 1985, J ZOOL, V207, P1; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nahlik A., 2005, Wildlife Biology in Practice, V1, P47; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Porter WF, 1999, ECOL APPL, V9, P3, DOI 10.2307/2641162; Prokesova J, 2006, FOLIA ZOOL, V55, P1; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Richardson L, 2009, ECOL ECON, V68, P1535, DOI 10.1016/j.ecolecon.2008.10.016; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Smart JCR, 2004, MAMMAL REV, V34, P99, DOI 10.1046/j.0305-1838.2003.00026.x; STAINES BW, 1984, P ROY SOC EDINB B, V82, P303, DOI 10.1017/S026972700000381X; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Treves A, 2005, CONSERV BIOL SER, V9, P86; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; WELCH D, 1990, J ZOOL, V221, P453, DOI 10.1111/j.1469-7998.1990.tb04013.x; Williams SC, 2013, WILDLIFE SOC B, V37, P137, DOI 10.1002/wsb.236; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176; WILSON E O, 1992; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wotschikowsky U, 1981, ROT UND REHWILD NATI	72	32	32	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120960	10.1371/journal.pone.0120960	http://dx.doi.org/10.1371/journal.pone.0120960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781942	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600193
J	Makanae, K; Kintaka, R; Ishikawa, K; Moriya, H				Makanae, Koji; Kintaka, Reiko; Ishikawa, Koji; Moriya, Hisao			Small Toxic Protein Encoded on Chromosome VII of Saccharomyces cerevisiae	PLOS ONE			English	Article							PLASMA-MEMBRANE FUSION; GENE DISRUPTION; IDENTIFICATION; EXPRESSION; CASSETTES; AZOLE	In a previous study, we found an unknown element that caused growth inhibition after its copy number increased in the 30 region of DIE2 in Saccharomyces cerevisiae. In this study, we further identified this element and observed that overexpression of a small protein (sORF2) of 57 amino acids encoded in this region caused growth inhibition. The transcriptional response and multicopy suppression of the growth inhibition caused by sORF2 overexpression suggest that sORF2 overexpression inhibits the ergosterol biosynthetic pathway. sORF2 was not required in the normal growth of S. cerevisiae, and not conserved in related yeast species including S. paradoxus. Thus, sORF2 (designated as OTO1) is an orphan ORF that determines the specificity of this species.	[Makanae, Koji; Moriya, Hisao] Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan; [Kintaka, Reiko; Ishikawa, Koji] Okayama Univ, Grad Sch Sci & Technol, Kita Ku, Okayama 7008530, Japan	Okayama University; Okayama University	Moriya, H (corresponding author), Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan.	hisaom@cc.okayama-u.ac.jp	Moriya, Hisao/B-2424-2011	Moriya, Hisao/0000-0001-7638-3640; Makanae, Koji/0000-0002-8560-4561; Ishikawa, Koji/0000-0001-8241-9523	MEXT KAKENHI [221S0002]; Asahi Glass Foundation; Okayama University	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Asahi Glass Foundation; Okayama University	This research was supported partly by MEXT KAKENHI (B, Challenging Exploratory Research, and 221S0002), the Asahi Glass Foundation, and grants-in-aid for strategic research promotion from Okayama University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Amberg DC., 2005, METHODS YEAST GENETI; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Brachmann CB, 1998, YEAST, V14, P115; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; KELLY SL, 1993, BIOCHEM SOC T, V21, P1034, DOI 10.1042/bst0211034; Kessler MM, 2003, GENOME RES, V13, P264, DOI 10.1101/gr.232903; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Li QR, 2008, GENOME RES, V18, P1294, DOI 10.1101/gr.076661.108; Makanae K, 2013, GENOME RES, V23, P300, DOI 10.1101/gr.146662.112; Moriya H, 2012, MOL BIOSYST, V8, P2513, DOI 10.1039/c2mb25100k; Moriya H, 2006, PLOS GENET, V2, P2176, DOI 10.1371/journal.pgen.0020218; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Sasabe M, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-2; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130	24	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120678	10.1371/journal.pone.0120678	http://dx.doi.org/10.1371/journal.pone.0120678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781884	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600182
J	Rotherham, M; El Haj, AJ				Rotherham, Michael; El Haj, Alicia J.			Remote Activation of the Wnt/beta-Catenin Signalling Pathway Using Functionalised Magnetic Particles	PLOS ONE			English	Article							SUPPRESSES OSTEOGENIC DIFFERENTIATION; BETA-CATENIN; PROMOTES PROLIFERATION; UP-REGULATION; WNT SIGNALS; MECHANISM; CELLS; NANOPARTICLES; INSIGHTS; COMPLEX	Wnt signalling pathways play crucial roles in developmental biology, stem cell fate and tissue patterning and have become an attractive therapeutic target in the fields of tissue engineering and regenerative medicine. Wnt signalling has also been shown to play a role in human Mesenchymal Stem Cell (hMSC) fate, which have shown potential as a cell therapy in bone and cartilage tissue engineering. Previous work has shown that biocompatible magnetic nanoparticles (MNP) can be used to stimulate specific mechanosensitive membrane receptors and ion channels in vitro and in vivo. Using this strategy, we determined the effects of mechano-stimulation of the Wnt Frizzled receptor on Wnt pathway activation in hMSC. Frizzled receptors were tagged using anti-Frizzled functionalised MNP (Fz-MNP). A commercially available oscillating magnetic bioreactor (MICA Biosystems) was used to mechanically stimulate Frizzled receptors remotely. Our results demonstrate that Fz-MNP can activate Wnt/beta-catenin signalling at key checkpoints in the signalling pathway. Immunocytochemistry indicated nuclear localisation of the Wnt intracellular messenger beta-catenin after treatment with Fz-MNP. A Wnt signalling TCF/LEF responsive luciferase reporter transfected into hMSC was used to assess terminal signal activation at the nucleus. We observed an increase in reporter activity after treatment with Fz-MNP and this effect was enhanced after mechano-stimulation using the magnetic array. Western blot analysis was used to probe the mechanism of signalling activation and indicated that Fz-MNP signal through an LRP independent mechanism. Finally, the gene expression profiles of stress response genes were found to be similar when cells were treated with recombinant Wnt-3A or Fz-MNP. This study provides proof of principle that Wnt signalling and Frizzled receptors are mechanosensitive and can be remotely activated in vitro. Using magnetic nanoparticle technology it may be possible to modulate Wnt signalling pathways and thus control stem cell fate for therapeutic purposes.	[Rotherham, Michael; El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	Keele University	Rotherham, M (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	m.rotherham@keele.ac.uk	Rotherham, Michael/K-7275-2019	Rotherham, Michael/0000-0002-9297-7681; El Haj, Alicia/0000-0003-3544-5678	Biotechnology and Biological Sciences Research Council [BB/G010560/1]; BBSRC [BB/G010560/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (Grant number BB/G010560/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cong F, 2003, MOL CELL BIOL, V23, P8462, DOI 10.1128/MCB.23.23.8462-8470.2003; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Ehrlich D, 2010, PEDIATR DEVEL PATHOL, V13, P1, DOI 10.2350/08-03-0443.1; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; FENG L, 1995, J CLIN INVEST, V95, P1669, DOI 10.1172/JCI117842; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gujral TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010024; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henstock JR, 2014, REMOTELY ACTIVATED M; Holmen SL, 2005, BIOCHEM BIOPH RES CO, V328, P533, DOI 10.1016/j.bbrc.2005.01.009; Hu B, 2014, NANOMED-NANOTECHNOL, V10, P45, DOI 10.1016/j.nano.2013.06.014; Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Kanczler JM, 2010, TISSUE ENG PT A, V16, P3241, DOI [10.1089/ten.tea.2009.0638, 10.1089/ten.TEA.2009.0638]; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McBain SC, 2008, INT J NANOMED, V3, P169; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Perobner I, 2012, INT J BIOCHEM CELL B, V44, P1970, DOI 10.1016/j.biocel.2012.07.025; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Quarto N, 2010, TISSUE ENG PT A, V16, P3185, DOI 10.1089/ten.tea.2010.0133; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Steinauer KK, 2000, INT J RADIAT ONCOL, V48, P325, DOI 10.1016/S0360-3016(00)00671-4; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yiu HHP, 2011, NANOMEDICINE-UK, V6, P1429, DOI [10.2217/NNM.11.132, 10.2217/nnm.11.132]; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	51	47	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121761	10.1371/journal.pone.0121761	http://dx.doi.org/10.1371/journal.pone.0121761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781466	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000351284600210
J	Sanada-Morimura, S; Otuka, A; Matsumura, M; Etoh, T; Zhu, YQ; Zhou, YJ; Zhang, GF				Sanada-Morimura, Sachiyo; Otuka, Akira; Matsumura, Masaya; Etoh, Tomoki; Zhu, Yeqin; Zhou, Yijun; Zhang, Gufeng			Take-Off Time of the First Generation of the Overwintering Small Brown Planthopper, Laodelphax striatellus in the Temperate Zone in East Asia	PLOS ONE			English	Article							NILAPARVATA-LUGENS STAL; SOGATELLA-FURCIFERA HORVATH; LONG-DISTANCE MIGRATION; LEVEL JET-STREAM; RICE PLANTHOPPERS; DELPHACIDAE; POPULATION; CHINA; IMMIGRATION; PREDICTION	Overseas migration of the small brown planthopper, Laodelphax striatellus (Fallen), occurs during the winter wheat harvest season in East Asia. Knowing the take-off time of emigrating L. striatellus is crucial for predicting such migrations with a simulation technique because winds, carriers of migratory insects, change continuously. Several methods were used in China and Japan from late May to early June 2012 and again in 2013 to identify the precise timing of take-off. These methods included: a tow net trap mounted to a pole at 10 m above the ground, a helicopter-towed net trap, and a canopy trap (which also had video monitoring) set over wheat plants. Laodelphax striatellus emigrated from wheat fields mainly in the early evening, before dusk. The insects also emigrated during the daytime but rarely emigrated at dawn, showing a pattern that is unlike the bimodal emigration at dusk and dawn of two other rice planthoppers, the brown planthopper, Nilaparvata lugens (Stal), and the white-backed planthopper, Sogatella furcifera (Horvath). There was no significant difference in the temporal pattern of take-off behavior between females and males of Japanese L. striatellus populations.	[Sanada-Morimura, Sachiyo; Otuka, Akira; Matsumura, Masaya] Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan; [Etoh, Tomoki] Saga Prefectural Agr Res Ctr, Saga, Japan; [Zhu, Yeqin] Plant Protect Stn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Yijun; Zhang, Gufeng] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Otuka, A (corresponding author), Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan.	atouka@affrc.go.jp			science and technology research promotion program for agriculture, forestry, fisheries and food industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [24018]; research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" from the Ministry of Agriculture, Forestry and Fisheries of Japan	science and technology research promotion program for agriculture, forestry, fisheries and food industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was funded by the science and technology research promotion program for agriculture, forestry, fisheries and food industry, No. 24018 (2012-2013), and a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" (2012-2013). Both funds were from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT CH, 1951, ECOLOGY, V32, P155, DOI 10.2307/1930414; Beerwinkle KR, 1990, TRANSACTIONS OF THE, V32, P1847, DOI 10.13031/2013.31233; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Cheng ZhaoBang, 2013, Chinese Journal of Applied Entomology, V50, P706; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; He Yuan, 2012, Chinese Journal of Rice Science, V26, P109, DOI 10.3969/j.issn.1001-7216.2012.01.0.17; IRWIN ME, 1988, PHILOS T R SOC B, V321, P421, DOI 10.1098/rstb.1988.0101; Johnson CG, 1955, ANN APPL BIOL, V43, P51, DOI 10.1111/j.1744-7348.1955.tb02452.x; KISIMOTO R, 1976, ECOL ENTOMOL, V1, P95, DOI 10.1111/j.1365-2311.1976.tb01210.x; KISIMOTO R, 1968, Applied Entomology and Zoology, V3, P37; LAI ZL, 1982, ACTA ENTOMOL SINICA, V25, P397; Liu XD, 2013, INSECT SCI, V20, P385, DOI 10.1111/j.1744-7917.2012.01533.x; Ohkubo N, 1971, Japanese Journal of Applied Entomology and Zoology, V15, P8; Osborne J, 2002, DISPERSAL ECOLOGY, P24; Otuka A, 2005, AGR FOREST ENTOMOL, V7, P1, DOI 10.1111/j.1461-9555.2005.00236.x; Otuka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00309; Otuka A, 2012, APPL ENTOMOL ZOOL, V47, P379, DOI 10.1007/s13355-012-0130-x; Otuka A, 2010, APPL ENTOMOL ZOOL, V45, P259, DOI 10.1303/aez.2010.259; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; Sanada-Morimura S., 2014, MONTHLY JOURNAL OF A, V51, P44; Seino Hiroshi, 1987, Journal of Agricultural Meteorology, V43, P203; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Tochigi Prefectural Sustainable Agriculture Extension Center, 2014, DISEASE AND INSECT P; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; WATANABE T, 1991, APPL ENTOMOL ZOOL, V26, P457, DOI 10.1303/aez.26.457; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang Ai-Min, 2008, Acta Entomologica Sinica, V51, P640; Zhang Gu-Feng, 2012, Chinese Journal of Applied Entomology, V49, P1716; Zhang Hai-Yan, 2011, Chinese Journal of Applied Entomology, V48, P1298; Zhou Y., 2010, RICE STRIPE VIRUS DI; Zhou YJ, 2009, APEC WORKSHOP ON THE, V2, P27	32	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120271	10.1371/journal.pone.0120271	http://dx.doi.org/10.1371/journal.pone.0120271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780936	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600146
J	Kluger, B; Bueschl, C; Lemmens, M; Michlmayr, H; Malachova, A; Koutnik, A; Maloku, I; Berthiller, F; Adam, G; Krska, R; Schuhmacher, R				Kluger, Bernhard; Bueschl, Christoph; Lemmens, Marc; Michlmayr, Herbert; Malachova, Alexandra; Koutnik, Andrea; Maloku, Imer; Berthiller, Franz; Adam, Gerhard; Krska, Rudolf; Schuhmacher, Rainer			Biotransformation of the Mycotoxin Deoxynivalenol in Fusarium Resistant and Susceptible Near Isogenic Wheat Lines	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; MASKED MYCOTOXINS; STRUCTURE ELUCIDATION; SPRING WHEAT; PLANT; DETOXIFICATION; QTLS; ARABIDOPSIS; GLUTATHIONE; METABOLISM	In this study, a total of nine different biotransformation products of the Fusarium mycotoxin deoxynivalenol (DON) formed in wheat during detoxification of the toxin are characterized by liquid chromatography-high resolution mass spectrometry (LC-HRMS). The detected metabolites suggest that DON is conjugated to endogenous metabolites via two major metabolism routes, namely 1) glucosylation (DON-3-glucoside, DON-di-hexoside, 15-acetyl-DON-3-glucoside, DON-malonylglucoside) and 2) glutathione conjugation (DON-S-glutathione, "DON-2H"-S-glutathione, DON-S-cysteinyl-glycine and DON-S-cysteine). Furthermore, conjugation of DON to a putative sugar alcohol (hexitol) was found. A molar mass balance for the cultivar 'Remus' treated with 1 mg DON revealed that under the test conditions approximately 15% of the added DON were transformed into DON-3-glucoside and another 19% were transformed to the remaining eight biotransformation products or irreversibly bound to the plant matrix. Additionally, metabolite abundance was monitored as a function of time for each DON derivative and was established for six DON treated wheat lines (1 mg/ear) differing in resistance quantitative trait loci (QTL) Fhb1 and/or Qfhs.ifa-5A. All cultivars carrying QTL Fhb1 showed similar metabolism kinetics: Formation of DON-Glc was faster, while DON-GSH production was less efficient compared to cultivars which lacked the resistance QTL Fhb1. Moreover, all wheat lines harboring Fhb1 showed significantly elevated D3G/DON abundance ratios.	[Kluger, Bernhard; Bueschl, Christoph; Malachova, Alexandra; Berthiller, Franz; Krska, Rudolf; Schuhmacher, Rainer] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna BOKU, Tulln, Austria; [Lemmens, Marc; Koutnik, Andrea; Maloku, Imer] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Inst Biotechnol Plant Prod, Vienna BOKU, Tulln, Austria; [Michlmayr, Herbert; Adam, Gerhard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna BOKU, Tulln, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Schuhmacher, R (corresponding author), Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna BOKU, Tulln, Austria.	rainer.schuhmacher@boku.ac.at	Schuhmacher, Rainer/U-5174-2019	Schuhmacher, Rainer/0000-0002-7520-4943; Krska, Rudolf/0000-0001-6843-9755; Berthiller, Franz/0000-0001-5883-2879; Michlmayr, Herbert/0000-0001-7998-1494; bueschl, christoph/0000-0003-1729-9785; Adam, Gerhard/0000-0002-3008-3797	Austrian Science Fund (projects SFB Fusarium) [3706-B11, F3702-B11]; Federal Country Lower Austria; European Regional Development Fund (ERDF) of the European Union [GZ WST3-T-95/001-2006]	Austrian Science Fund (projects SFB Fusarium)(Austrian Science Fund (FWF)); Federal Country Lower Austria; European Regional Development Fund (ERDF) of the European Union	The Austrian Science Fund (projects SFB Fusarium #3706-B11 and #F3702-B11), the Federal Country Lower Austria and the European Regional Development Fund (ERDF) of the European Union (Grant Number GZ WST3-T-95/001-2006) are greatly acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; [Anonymous], 2014, R LANG ENV STAT COMP; Armstrong RN, 1999, COMP NAT PROD CHEM, P51; BAILLIE TA, 1981, PHARMACOL REV, V33, P81; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Berthiller F, 2011, TOXICOL LETT, V206, P264, DOI 10.1016/j.toxlet.2011.08.006; Berthiller F, 2009, ANAL BIOANAL CHEM, V395, P1243, DOI 10.1007/s00216-009-2874-x; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Bueschl C, 2013, METABOLOMICS, P1; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dall'asta C, 2005, Mycotoxin Res, V21, P123, DOI 10.1007/BF02954435; Dall'Erta A, 2013, CHEM RES TOXICOL, V26, P305, DOI 10.1021/tx300438c; Day B, 2007, ANN NY ACAD SCI, V1113, P123, DOI 10.1196/annals.1391.029; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Engelhardt Gabriele, 1999, Advances in Food Sciences, V21, P71; Fruhmann P, 2014, ORG BIOMOL CHEM, V12, P5144, DOI 10.1039/c4ob00458b; Fruhmann P, 2014, TOXINS, V6, P325, DOI 10.3390/toxins6010325; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Kluger B, 2013, ANAL BIOANAL CHEM, V405, P5031, DOI 10.1007/s00216-012-6483-8; Laurent F, 2007, ENVIRON TOXICOL CHEM, V26, P2299, DOI 10.1897/07-036R.1; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Nagl V, 2014, TOXICOL LETT, V229, P190, DOI 10.1016/j.toxlet.2014.06.032; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rychlik M, 2014, MYCOTOXIN RES, P1; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Schweiger W, 2013, MOL PLANT MICROBE IN, V26, P781, DOI 10.1094/MPMI-08-12-0205-R; SEWALD N, 1992, TETRAHEDRON-ASYMMETR, V3, P953, DOI 10.1016/S0957-4166(00)82193-X; Shima J, 1997, APPL ENVIRON MICROB, V63, P3825, DOI 10.1128/AEM.63.10.3825-3830.1997; Skidmore MW, 1998, PURE APPL CHEM, V70, P1423, DOI 10.1351/pac199870071423; Stobiecki M, 2010, J NAT PROD, V73, P1254, DOI 10.1021/np100139d; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Walter Stephanie, 2011, Mycotoxin Res, V27, P221, DOI 10.1007/s12550-011-0099-2; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Warth B, 2014, METABOLOMICS, P1, DOI [10.5339/gcsp.2014.4, DOI 10.5339/GCSP.2014.4]; Wolf AE, 1996, FEBS LETT, V384, P31, DOI 10.1016/0014-5793(96)00272-4; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Zachariasova M, 2012, J AGR FOOD CHEM, V60, P9280, DOI 10.1021/jf302069z	52	67	73	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119656	10.1371/journal.pone.0119656	http://dx.doi.org/10.1371/journal.pone.0119656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775425	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500109
J	Ogawa, T; Kawashima, N; Obata, H; Kanosue, K; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Obata, Hiroki; Kanosue, Kazuyuki; Nakazawa, Kimitaka			Distinct Motor Strategies Underlying Split-Belt Adaptation in Human Walking and Running	PLOS ONE			English	Article							LOCOMOTOR ADAPTATION; INTERLIMB COORDINATION; ELECTRICAL-STIMULATION; TREADMILL ADAPTATION; MUSCLE CONTRIBUTIONS; NETWORKS; SUPPORT; TRANSITIONS; MOVEMENT; FEEDBACK	The aim of the present study was to elucidate the adaptive and de-adaptive nature of human running on a split-belt treadmill. The degree of adaptation and de-adaptation was compared with those in walking by calculating the antero-posterior component of the ground reaction force (GRF). Adaptation to walking and running on a split-belt resulted in a prominent asymmetry in the movement pattern upon return to the normal belt condition, while the two components of the GRF showed different behaviors depending on the gaits. The anterior braking component showed prominent adaptive and de-adaptive behaviors in both gaits. The posterior propulsive component, on the other hand, exhibited such behavior only in running, while that in walking showed only short-term aftereffect (lasting less than 10 seconds) accompanied by largely reactive responses. These results demonstrate a possible difference in motor strategies (that is, the use of reactive feedback and adaptive feedforward control) by the central nervous system (CNS) for split-belt locomotor adaptation between walking and running. The present results provide basic knowledge on neural control of human walking and running as well as possible strategies for gait training in athletic and rehabilitation scenes.	[Ogawa, Tetsuya; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Ogawa, Tetsuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Ogawa, Tetsuya; Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	Waseda University; Japan Society for the Promotion of Science; University of Tokyo	Ogawa, T (corresponding author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama, Japan.	t.ogawa@aoni.waseda.jp						Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Blanchette A, 2009, J NEUROPHYSIOL, V102, P568, DOI 10.1152/jn.91096.2008; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Earhart GM, 2001, J NEUROPHYSIOL, V86, P1666, DOI 10.1152/jn.2001.86.4.1666; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Mawase F, 2013, J NEUROPHYSIOL, V109, P2216, DOI 10.1152/jn.00938.2012; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; Ogawa T, 2014, J NEUROPHYSIOL, V111, P722, DOI 10.1152/jn.00497.2012; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; SHIK ML, 1966, BIOPHYS-USSR, V11, P756; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292	35	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121951	10.1371/journal.pone.0121951	http://dx.doi.org/10.1371/journal.pone.0121951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775426	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500217
J	Signorelli, S; Dans, PD; Coitino, EL; Borsani, O; Monza, J				Signorelli, Santiago; Dans, Pablo D.; Laura Coitino, E.; Borsani, Omar; Monza, Jorge			Connecting Proline and gamma-Aminobutyric Acid in Stressed Plants through Non-Enzymatic Reactions	PLOS ONE			English	Article							POLARIZABLE CONTINUUM MODEL; SIMPLE COMPUTATIONAL MODEL; FREE-RADICAL INTERVENTION; CATALYZED OXIDATION; MOLECULAR-MECHANISMS; SOLVATION ENERGY; OXYGEN RADICALS; WATER-DEFICIT; GABA; ACCUMULATION	The accumulation of proline (Pro) in plants exposed to biotic/abiotic stress is a well-documented and conserved response in most vegetal species. Stress conditions induce the overproduction of reactive oxygen species which can lead to cellular damage. In vitro assays have shown that enzyme inactivation by hydroxyl radicals ((OH)-O-center dot) can be avoided in presence of Pro, suggesting that this amino acid could act as an (OH)-O-center dot scavenger. We applied Density Functional Theory coupled with a polarizable continuum model to elucidate how Pro reacts with (OH)-O-center dot. In this work we suggest that Pro reacts favourably with (OH)-O-center dot by H-abstraction on the amine group. This reaction produces the spontaneous decarboxylation of Pro leading to the formation of pyrrolidin-1-yl. In turn, pyrrolidin-1-yl can easily be converted to Delta(1)-pyrroline, the substrate of the enzyme Delta(1)-pyrroline dehydrogenase, which produces gamma-aminobutyric acid (GABA). GABA and Pro are frequently accumulated in stressed plants and several protective roles have been assigned to these molecules. Thereby we present an alternative non-enzymatic way to synthetize GABA under oxidative stress. Finally this work sheds light on a new beneficial role of Pro accumulation in the maintenance of photosynthetic activity.	[Signorelli, Santiago; Borsani, Omar; Monza, Jorge] Univ Republica, Fac Agron, Dept Biol Vegetal, Lab Bioquim, Montevideo, Uruguay; [Dans, Pablo D.] Inst Res Biomed IRB Barcelona, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Laura Coitino, E.] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Quim Teor & Computac, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universidad de la Republica, Uruguay	Signorelli, S (corresponding author), Univ Republica, Fac Agron, Dept Biol Vegetal, Lab Bioquim, Montevideo, Uruguay.	ssignorelli@fagro.edu.uy	Signorelli, Santiago/AGL-8124-2022; Signorelli, Santiago/AAV-7069-2020; Coitiño Izaguirre, Elena Laura/A-8101-2016; Dans, Pablo D./K-6330-2019	Signorelli, Santiago/0000-0002-1854-3164; Coitiño Izaguirre, Elena Laura/0000-0002-6214-2413; Dans, Pablo D./0000-0002-5927-372X; Borsani, Omar/0000-0002-9111-5801	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII); Programa de desarrollo de las ciencias basicas (PEDECIBA); Comision Academica de Posgrado (CAP); Sistema Nacional de Investigadores (SNI)	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII); Programa de desarrollo de las ciencias basicas (PEDECIBA); Comision Academica de Posgrado (CAP); Sistema Nacional de Investigadores (SNI)	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII), Programa de desarrollo de las ciencias basicas (PEDECIBA), http://www.pedeciba. edu.uy/indice.php, SS. Comision Academica de Posgrado (CAP), http://www.posgrados.udelar.edu.uy/, SS. Sistema Nacional de Investigadores (SNI): http://www.sni.org.uy/, SS PDD ELC OB JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Alia, 2001, AMINO ACIDS, V21, P195; AMICI A, 1989, J BIOL CHEM, V264, P3341; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; BARNETT NM, 1966, PLANT PHYSIOL, V41, P1222, DOI 10.1104/pp.41.7.1222; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bonifacic M, 1998, J AM CHEM SOC, V120, P9930, DOI 10.1021/ja9815428; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bussis D, 1998, J EXP BOT, V49, P1361, DOI 10.1093/jexbot/49.325.1361; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; CHIANG HH, 1995, PLANT CELL ENVIRON, V18, P1280, DOI 10.1111/j.1365-3040.1995.tb00187.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; Diaz P, 2014, PLANT ADAPTATION TO ENVIRONMENTAL CHANGE: SIGNIFICANCE OF AMINO ACIDS AND THEIR DERIVATIVES, P53, DOI 10.1079/9781780642734.0053; DOVER S, 1972, J BACTERIOL, V110, P165, DOI 10.1128/JB.110.1.165-170.1972; DOVER S, 1972, J BACTERIOL, V109, P835, DOI 10.1128/JB.109.2.835-843.1972; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Feng Z, 2004, ACTA PHYSIOL PLANT, V26, P345; FLORES HE, 1985, PLANT GROWTH REGUL, V3, P277, DOI 10.1007/BF00117586; FLORIS F, 1989, J COMPUT CHEM, V10, P616, DOI 10.1002/jcc.540100504; FLORIS FM, 1991, J COMPUT CHEM, V12, P784, DOI 10.1002/jcc.540120703; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Frisch M. J., 2009, GAUSSIAN 16 REVISION; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hiremath MI, 2006, RUSS J PHYS CHEM+, V80, P1029, DOI 10.1134/S0036024406070053; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hratchian HP, 2005, J PHYS CHEM A, V109, P8579, DOI 10.1021/jp052616m; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kapitan J, 2006, J AM CHEM SOC, V128, P2438, DOI 10.1021/ja057337r; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mayer I, 2007, J COMPUT CHEM, V28, P204, DOI 10.1002/jcc.20494; Miertus S, 1997, INT J BIOL MACROMOL, V20, P85, DOI 10.1016/S0141-8130(96)01143-9; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Polle A, 1997, OXIDATIVE STRESS MOL; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; Renew S, 2005, PLANT J, V44, P342, DOI 10.1111/j.1365-313X.2005.02528.x; Scheiner S, 2010, J AM CHEM SOC, V132, P16450, DOI 10.1021/ja105204v; Seregar VC, 2006, TRANSIT METAL CHEM, V31, P541, DOI 10.1007/s11243-006-0029-x; Sharma S, 2011, PLANT PHYS, V157; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Signorelli S, 2014, J PHYS CHEM B, V118, P37, DOI 10.1021/jp407773u; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V64, P80, DOI 10.1016/j.plaphy.2012.12.017; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tomasi J, 2011, WIRES COMPUT MOL SCI, V1, P855, DOI 10.1002/wcms.54; Vega D, 2014, J COMPUT METHODS SCI, V14, P131, DOI 10.3233/JCM-140491; Wheeler SE, 2010, J CHEM THEORY COMPUT, V6, P395, DOI 10.1021/ct900639j; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	62	91	91	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0115349	10.1371/journal.pone.0115349	http://dx.doi.org/10.1371/journal.pone.0115349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775459	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500002
J	Haile, Y; Nakhaei-Nejad, M; Boakye, PA; Baker, G; Smith, PA; Murray, AG; Giuliani, F; Jahroudi, N				Haile, Yohannes; Nakhaei-Nejad, Maryam; Boakye, Paul A.; Baker, Glen; Smith, Peter A.; Murray, Allan G.; Giuliani, Fabrizio; Jahroudi, Nadia			Reprogramming of HUVECs into Induced Pluripotent Stem Cells (HiPSCs), Generation and Characterization of HiPSC-Derived Neurons and Astrocytes	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; CLINICAL-TRIAL; AMINO-ACIDS; ACTIVIN-A; IPS CELLS; EXPRESSION; DIFFERENTIATION; INDUCTION	Neurodegenerative diseases are characterized by chronic and progressive structural or functional loss of neurons. Limitations related to the animal models of these human diseases have impeded the development of effective drugs. This emphasizes the need to establish disease models using human-derived cells. The discovery of induced pluripotent stem cell (iPSC) technology has provided novel opportunities in disease modeling, drug development, screening, and the potential for "patient-matched" cellular therapies in neurodegenerative diseases. In this study, with the objective of establishing reliable tools to study neurodegenerative diseases, we reprogrammed human umbilical vein endothelial cells (HUVECs) into iPSCs (HiPSCs). Using a novel and direct approach, HiPSCs were differentiated into cells of central nervous system (CNS) lineage, including neuronal, astrocyte and glial cells, with high efficiency. HiPSCs expressed embryonic genes such as nanog, sox2 and Oct-3/4, and formed embryoid bodies that expressed markers of the 3 germ layers. Expression of endothelial-specific genes was not detected in HiPSCs at RNA or protein levels. HiPSC-derived neurons possess similar morphology but significantly longer neurites compared to primary human fetal neurons. These stem cell-derived neurons are susceptible to inflammatory cell-mediated neuronal injury. HiPSC-derived neurons express various amino acids that are important for normal function in the CNS. They have functional receptors for a variety of neurotransmitters such as glutamate and acetylcholine. HiPSC-derived astrocytes respond to ATP and acetylcholine by elevating cytosolic Ca2+ concentrations. In summary, this study presents a novel technique to generate differentiated and functional HiPSC-derived neurons and astrocytes. These cells are appropriate tools for studying the development of the nervous system, the pathophysiology of various neurodegenerative diseases and the development of potential drugs for their treatments.	[Haile, Yohannes; Nakhaei-Nejad, Maryam; Murray, Allan G.; Giuliani, Fabrizio; Jahroudi, Nadia] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Boakye, Paul A.; Smith, Peter A.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Boakye, Paul A.; Baker, Glen; Smith, Peter A.; Giuliani, Fabrizio] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Baker, Glen] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Giuliani, F (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	giuliani@ualberta.ca; nadia.jahroudi@ualberta.ca		BOAKYE, PAUL/0000-0002-6351-5437	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jumah M, 2012, MULT SCLER J, V18, P1395, DOI 10.1177/1352458512440832; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254.abs; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Dell'Era P, 2001, ONCOGENE, V20, P2655, DOI 10.1038/sj.onc.1204368; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fu W, 2012, J BIOL CHEM, V287, P18820, DOI 10.1074/jbc.M111.331181; Gao ZY, 1998, BIOCHEM BIOPH RES CO, V247, P407, DOI 10.1006/bbrc.1998.8826; Garate Z, 2013, HUM GENE THER, V24, P571, DOI 10.1089/hum.2012.251; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; Haile Y, 2011, J IMMUNOL, V187, P4861, DOI 10.4049/jimmunol.1100943; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; Ho PJ, 2010, ARTERIOSCL THROM VAS, V30, P1905, DOI 10.1161/ATVBAHA.110.206540; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; ICHIKAWA M, 1993, SYNAPSE, V13, P50, DOI 10.1002/syn.890130107; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; Kastenberg Zachary J, 2008, Transplant Rev (Orlando), V22, P215, DOI 10.1016/j.trre.2008.04.002; Kerkovich DM, 1999, INT J DEV NEUROSCI, V17, P347, DOI 10.1016/S0736-5748(99)00036-2; KERNELL D, 1981, BRAIN RES, V204, P311, DOI 10.1016/0006-8993(81)90591-6; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Lin Rui, 2012, Pract Neurol, V12, P279, DOI 10.1136/practneurol-2012-000276; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Murashov AK, 2005, BIOCHEM BIOPH RES CO, V332, P653, DOI 10.1016/j.bbrc.2005.04.167; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Panopoulos AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019743; Paulsen JS, 2013, PROG NEUROBIOL, V110, P2, DOI 10.1016/j.pneurobio.2013.08.003; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Rodriguez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043797; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; ROSENSTEIN JM, 1995, CELL TRANSPLANT, V4, P83, DOI 10.1016/0963-6897(94)00041-H; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sanchez-Danes A, 2013, CNS NEUROL DISORD-DR, V6, P6; Shah AJ, 2002, J CHROMATOGR B, V781, P151, DOI 10.1016/S1570-0232(02)00621-9; Shefner JM, 2004, NEUROLOGY, V63, P1656, DOI 10.1212/01.WNL.0000142992.81995.F0; Shutova MV, 2009, ACTA NATURAE, V1, P91, DOI 10.32607/20758251-2009-1-2-91-92; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Suzuki K, 2010, BIOCHEM BIOPH RES CO, V394, P639, DOI 10.1016/j.bbrc.2010.03.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; van Pelt J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00160; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Vargas-Lowy D, 2012, J CHILD NEUROL, V27, P1394, DOI 10.1177/0883073812456084; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wilcock DM, 2014, NEURODEGENER DIS, V13, P183, DOI 10.1159/000354228; Pinto MCX, 2014, J CHEM NEUROANAT, V55, P24, DOI 10.1016/j.jchemneu.2013.11.002; Yagita Y, 1999, NEUROSCIENCE, V92, P1417, DOI 10.1016/S0306-4522(99)00079-2; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan SH, 2013, AGEING RES REV, V12, P739, DOI 10.1016/j.arr.2013.04.002; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015; Zotova E, 2013, BRAIN, V136, P2677, DOI 10.1093/brain/awt210	75	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119617	10.1371/journal.pone.0119617	http://dx.doi.org/10.1371/journal.pone.0119617			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789622	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400091
J	Liu, M; Zhao, YX; Zhang, XM				Liu, Min; Zhao, Yunxue; Zhang, Xiumei			Knockdown of Glutamate Cysteine Ligase Catalytic Subunit by siRNA Causes the Gold Nanoparticles-Induced Cytotoxicity in Lung Cancer Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTATHIONE; APOPTOSIS; RADIOSENSITIZATION; NECROSIS; ASSOCIATION; SURVIVAL; THERAPY; PATHWAY; LEVEL	Gold nanoparticles (GNPs) have shown promising medical applications in cancer treatment involved in the regulation of intracellular redox balance. Previously, we have reported that GNPs can trigger apoptosis and necrosis in human lung cancer cells (A549) when L-buthionine-sulfoximine (BSO) was used to decrease the expression of intracellular glutathione (GSH). Herein, we investigated the cytotoxicity of GNPs toward lung cancer cells under the glutamate cysteine ligase catalytic subunit (GCLC) was silenced by siRNA. Our results showed that GNPs cause apoptosis and necrosis in cells transfected with GCLC siRNA by elevating intracellular reactive oxygen species (ROS). These findings demonstrated that the regulation of glutathione synthesis by GCLC siRNA in A549 cells can initiate the gold nanoparticles-induced cytotoxicity.	[Liu, Min; Zhao, Yunxue; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China.	zhangxm@sdu.edu.cn			National Natural Science Foundation of China [81102468]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81102468 to Y. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai S, 2007, J BIOL CHEM, V282, P23996, DOI 10.1074/jbc.M702819200; Aydogan B, 2010, MOL IMAGING BIOL, V12, P463, DOI 10.1007/s11307-010-0299-8; Bahadur KCR, 2006, J BIOMAT SCI-POLYM E, V17, P579, DOI 10.1163/156856206776986279; Beurel E, 2009, BIOCHEM PHARMACOL, V77, P54, DOI 10.1016/j.bcp.2008.09.026; Burger N, 2014, NANOMED-NANOTECHNOL, V10, P1365, DOI 10.1016/j.nano.2014.03.011; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; Calixto G, 2014, INT J NANOMED, V9, P3719, DOI 10.2147/IJN.S61670; Cardinal J, 2008, SURGERY, V144, P125, DOI 10.1016/j.surg.2008.03.036; Chatterjee A, 2013, NUTRIENTS, V5, P525, DOI 10.3390/nu5020525; Das S, 2011, CHEM-BIOL INTERACT, V193, P129, DOI 10.1016/j.cbi.2011.06.002; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fooladi AAI, 2008, BIOTECHNOL LETT, V30, P2053, DOI 10.1007/s10529-008-9805-3; Freitas M, 2012, FEBS OPEN BIO, V2, P119, DOI 10.1016/j.fob.2012.05.001; Geng F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285101; Glazer ES, 2011, THER DELIV, V2, P1325, DOI 10.4155/TDE.11.102; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Jeremic B, 2013, CLIN TRANSL ONCOL, V15, P593, DOI 10.1007/s12094-013-1003-7; Joh DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062425; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Khan M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719858; Kim Y, 2010, FEBS LETT, V584, P3550, DOI 10.1016/j.febslet.2010.07.006; Li MN, 2014, BIOMED REP, V2, P831, DOI 10.3892/br.2014.359; Li N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04164; Lim SC, 2010, INT J CANCER, V126, P1582, DOI 10.1002/ijc.24853; Liu M, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1745-8; Liu T, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/34/345103; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Mateo D, 2014, TOXICOL MECH METHOD, V24, P161, DOI 10.3109/15376516.2013.869783; Nagy D, 2014, ARCH DERMATOL RES, V306, P885, DOI 10.1007/s00403-014-1511-5; Ngwa W, 2013, NANOMED-NANOTECHNOL, V9, P25, DOI 10.1016/j.nano.2012.09.001; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; Piao JG, 2014, ACS NANO, V8, P10414, DOI 10.1021/nn503779d; Slyusarenko K, 2014, NANOSCALE, V6, P13527, DOI 10.1039/c4nr04155k; Solecki GM, 2013, CHEM RES TOXICOL, V26, P252, DOI 10.1021/tx300435p; Sun HJ, 2013, ASIAN PAC J CANCER P, V14, P6379, DOI 10.7314/APJCP.2013.14.11.6379; Valverde M, 2006, MUTAT RES-FUND MOL M, V594, P172, DOI 10.1016/j.mrfmmm.2005.08.004; Wang J, 2013, MOL BIOSYST, V9, P1489, DOI 10.1039/c3mb25461e; Xia DL, 2014, APPL BIOCHEM BIOTECH, V174, P2458, DOI 10.1007/s12010-014-1193-7; Yuan XH, 2012, J CELL PHYSIOL, V227, P194, DOI 10.1002/jcp.22717; Zeng J, 2013, ANGEW CHEM INT EDIT, V52, P4169, DOI 10.1002/anie.201210359; Zhao YX, 2011, J PHYS CHEM C, V115, P12797, DOI 10.1021/jp2025413	44	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118870	10.1371/journal.pone.0118870	http://dx.doi.org/10.1371/journal.pone.0118870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789740	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400052
J	Reuchlin-Hugenholtz, E; Shackell, NL; Hutchings, JA				Reuchlin-Hugenholtz, Emilie; Shackell, Nancy L.; Hutchings, Jeffrey A.			The Potential for Spatial Distribution Indices to Signal Thresholds in Marine Fish Biomass	PLOS ONE			English	Article							COD GADUS-MORHUA; ATLANTIC COD; HABITAT SELECTION; TRAWL SURVEYS; ABUNDANCE; DENSITY; SEA; CATCHABILITY; INDICATORS; OCCUPANCY	The frequently observed positive relationship between fish population abundance and spatial distribution suggests that changes in distribution can be indicative of trends in abundance. If contractions in spatial distribution precede declines in spawning stock biomass (SSB), spatial distribution reference points could complement the SSB reference points that are commonly used in marine conservation biology and fisheries management. When relevant spatial distribution information is integrated into fisheries management and recovery plans, risks and uncertainties associated with a plan based solely on the SSB criterion would be reduced. To assess the added value of spatial distribution data, we examine the relationship between SSB and four metrics of spatial distribution intended to reflect changes in population range, concentration, and density for 10 demersal populations (9 species) inhabiting the Scotian Shelf, Northwest Atlantic. Our primary purpose is to assess their potential to serve as indices of SSB, using fisheries independent survey data. We find that metrics of density offer the best correlate of spawner biomass. A decline in the frequency of encountering high density areas is associated with, and in a few cases preceded by, rapid declines in SSB in 6 of 10 populations. Density-based indices have considerable potential to serve both as an indicator of SSB and as spatially based reference points in fisheries management.	[Reuchlin-Hugenholtz, Emilie; Hutchings, Jeffrey A.] Dalhousie Univ, Dept Biol, POB 15000, Halifax, NS B3H 4R2, Canada; [Shackell, Nancy L.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Hutchings, Jeffrey A.] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, NO-0316 Oslo, Norway	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; University of Oslo	Reuchlin-Hugenholtz, E (corresponding author), Dalhousie Univ, Dept Biol, POB 15000, Halifax, NS B3H 4R2, Canada.	ereuchlin@gmail.com	Shackell, Nancy L/AAF-8209-2019; Hutchings, Jeffrey/ABA-1098-2020	Shackell, Nancy L/0000-0001-5128-948X; Hutchings, Jeffrey/0000-0003-1572-5429	Prins Bernhard Cultuurfonds; Dalhousie University Biology Department	Prins Bernhard Cultuurfonds; Dalhousie University Biology Department	This work was supported by Prins Bernhard Cultuurfonds (http://www.cultuurfonds.nl/), and Dalhousie University Biology Department (http://www.dal.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Caddy JF, 1995, FOOD AGR ORG UN FISH, V349, P1; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P243, DOI 10.1051/alr/2009025; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P135, DOI 10.1051/alr/2009016; CRECCO V, 1990, CAN J FISH AQUAT SCI, V47, P385, DOI 10.1139/f90-040; DFO, 2009, 2009025 DFO, V2009, P025; Doubleday W. G., 1981, MANUAL GROUNDFISH SU; FAO, 2012, REV STAT WORLD MAR F, P209; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frisk MG, 2011, ECOL APPL, V21, P227, DOI 10.1890/09-1698.1; Garrison LP, 2000, ICES J MAR SCI, V57, P723, DOI 10.1006/jmsc.2000.0713; Gaston KJ, 1999, OIKOS, V84, P353, DOI 10.2307/3546417; Gaston KJ, 2003, STRUCTURE DYNAMICS G; HANSKI I, 1992, AM NAT, V139, P657, DOI 10.1086/285349; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1760, DOI 10.1139/cjfas-58-9-1760; HILBORN R, 1992; Horsman T, 2009, CANADIAN TECHNICAL R; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Jakobsen T., 2009, FISH REPROD BIOL IMP; Jennings S., 2009, MARINE FISHERIES ECO; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Levins R., 1970, SOME MATH PROBLEMS B, P77; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; McKinney Michael L., 1997, Population and Community Biology Series, V17, P110; Mesnil B, 2009, AQUAT LIVING RESOUR, V22, P207, DOI 10.1051/alr/2009003; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1274, DOI 10.1139/f95-124; Myers RA, 1989, ICES CM, P15; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; Quinn TJ, 1999, GEOPHYS J INT; R Development Core Team, 2014, R LANG ENV STAT COMP; Rangeley RW, 1998, ECOLOGY, V79, P943; Ricard D, 2013, MAP PRODUCED BEDFORD; Ricard D, 2012, THESIS; Rowe S, 2004, ICES J MAR SCI, V61, P1144, DOI 10.1016/j.icesjms.2004.07.007; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shackell NL, 2005, ECOL APPL, V15, P1440, DOI 10.1890/04-0642; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Shumway R.H., 2006, TIME SERIES ANAL ITS; Simmonds EJ, 2010, STECF STUD GROUP EV, P227; SWAIN DP, 1995, MAR ECOL PROG SER, V116, P11, DOI 10.3354/meps116011; SWAIN DP, 1994, CAN J FISH AQUAT SCI, V51, P1046, DOI 10.1139/f94-104; Trenkel VM, 2013, AQUAT LIVING RESOUR, V26, P319, DOI 10.1051/alr/2013060; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Zwanenburg KC, 2002, INDICES FISH DISTRIB	61	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120500	10.1371/journal.pone.0120500	http://dx.doi.org/10.1371/journal.pone.0120500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789624	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400161
J	Dively, GP; Embrey, MS; Kamel, A; Hawthorne, DJ; Pettis, JS				Dively, Galen P.; Embrey, Michael S.; Kamel, Alaa; Hawthorne, David J.; Pettis, Jeffery S.			Assessment of Chronic Sublethal Effects of Imidacloprid on Honey Bee Colony Health	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; NEONICOTINOID INSECTICIDES; PESTICIDE-RESIDUES; COLLAPSE DISORDER; NATIONAL-SURVEY; UNITED-STATES; POLLEN; LOSSES; EXPOSURE; TOXICITY	Here we present results of a three-year study to determine the fate of imidacloprid residues in hive matrices and to assess chronic sublethal effects on whole honey bee colonies fed supplemental pollen diet containing imidacloprid at 5, 20 and 100 mu g/kg over multiple brood cycles. Various endpoints of colony performance and foraging behavior were measured during and after exposure, including winter survival. Imidacloprid residues became diluted or non-detectable within colonies due to the processing of beebread and honey and the rapid metabolism of the chemical. Imidacloprid exposure doses up to 100 mu g/kg had no significant effects on foraging activity or other colony performance indicators during and shortly after exposure. Diseases and pest species did not affect colony health but infestations of Varroa mites were significantly higher in exposed colonies. Honey stores indicated that exposed colonies may have avoided the contaminated food. Imidacloprid dose effects was delayed later in the summer, when colonies exposed to 20 and 100 mu g/kg experienced higher rates of queen failure and broodless periods, which led to weaker colonies going into the winter. Pooled over two years, winter survival of colonies averaged 85.7, 72.4, 61.2 and 59.2% in the control, 5, 20 and 100 mu g/kg treatment groups, respectively. Analysis of colony survival data showed a significant dose effect, and all contrast tests comparing survival between control and treatment groups were significant, except for colonies exposed to 5 mu g/kg. Given the weight of evidence, chronic exposure to imidacloprid at the higher range of field doses (20 to 100 mu g/kg) in pollen of certain treated crops could cause negative impacts on honey bee colony health and reduced overwintering success, but the most likely encountered high range of field doses relevant for seed-treated crops (5 mu g/kg) had negligible effects on colony health and are unlikely a sole cause of colony declines.	[Dively, Galen P.; Embrey, Michael S.; Hawthorne, David J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Kamel, Alaa] US EPA, Analyt Chem Branch, Biol & Econ Anal Div, Off Pesticide Programs, Ft George G Meade, MD USA; [Pettis, Jeffery S.] USDA ARS Bee Res Lab, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Environmental Protection Agency	Dively, GP (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	galen@umd.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF) [DBI-1052875]; ARS [ARS-0425645] Funding Source: Federal RePORTER; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF)(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded primarily by a Cooperative Agreement with the USDA-ARS Bee Research Laboratory. Partial funding by the Maryland Agricultural Experiment Station. Funding for Open Access provided by the UMD Libraries Open Access Publishing Fund. D.J.H. received support from the National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF) award DBI-1052875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ENV SCI POLLUT RES; [Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Charvet R., 2004, Annales Pharmaceutiques Francaises, V62, P29, DOI 10.1016/S0003-4509(04)94278-2; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DeGrandi-Hoffman G, 2008, J APICULT RES, V47, P265, DOI 10.3896/IBRA.1.47.4.06; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Faucon JP, 2002, BEE WORLD, V83, P14, DOI 10.1080/0005772X.2002.11099532; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; FRAZIER J., 2011, AM BEE J, V151, P779; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kamel A, 2010, J AGR FOOD CHEM, V58, P5926, DOI 10.1021/jf904120n; Krieger R. I, 2001, HDB PESTICIDE TOXICO, V2, P1123; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kunkel GR., 2014, THESIS; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Lu CS, 2012, B INSECTOL, V65, P99; Matsuda K, 2005, ACS SYM SER, P172; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Research Council, 2007, STAT POLL N AM; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Sanchez-Bayo F, 2014, SCIENCE, V346, P806, DOI 10.1126/science.1259159; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481	76	146	150	6	227	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118748	10.1371/journal.pone.0118748	http://dx.doi.org/10.1371/journal.pone.0118748			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786127	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500046
J	Hu, YD; Teng, WP; Liu, LM; Chen, K; Liu, L; Hua, R; Chen, J; Zhou, Y; Chen, L				Hu, Yuedong; Teng, Weiping; Liu, Limin; Chen, Kang; Liu, Lei; Hua, Rui; Chen, Jun; Zhou, Yun; Chen, Lei			Prevalence and Risk Factors of Diabetes and Diabetic Retinopathy in Liaoning Province, China: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; MICROVASCULAR OUTCOMES; ASSOCIATION; MELLITUS; SMOKING; HEALTH; MEN; ATHEROSCLEROSIS; COMPLICATIONS; TRIAL	Aim To evaluate the prevalence and risk factors of diabetes and diabetic retinopathy (DR) in northeast area of China with a population-based study. Methods A population of 3173 (aged from 20 to 80 years old) was stratified by geographical location and age in Liaoning province, China. Prediabetes and diabetes were diagnosed according to the guideline of American Diabetes Association. Retinal photographs were obtained by using digital non-mydriatic camera for the presence and grading of DR according to the modified ETDRS Airlie house classification. Blood samples and comprehensive questionnaires were obtained for evaluation of laboratory results and risk factors. Results The prevalence of prediabetes and diabetes was 20.7% and 10.4%, respectively. Among diabetes patients, DR prevalence was 11.9%. Age, obesity, total cholesterol, triglycerides, hypertension, living in rural areas and diabetes family history are all risk factors for prediabetes and diabetes. Waist-to-hip circumference rate served as a better obesity index to estimate diabetes risk compared with body mass index and waist circumference. Among all risk factors that we investigated, only the length of diabetes history was associated with the incidence of DR. However, DR prevalence in the newly discovered patients in rural areas was significantly higher than that in urban areas. Conclusion According to this study, 1 in 10 people has diabetes, 2 in 10 people have prediabetes, and 1 in 10 diabetics has DR in Liaoning province. In rural areas, diabetes was poorly recognized with limited medical resources, which probably resulted in more diabetes patient at a high risk of DR.	[Hu, Yuedong; Liu, Limin; Chen, Kang; Liu, Lei; Hua, Rui; Chen, Jun; Zhou, Yun; Chen, Lei] China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang 110001, Liaoning Provin, Peoples R China; [Hu, Yuedong; Liu, Limin; Liu, Lei; Chen, Lei] Diabet Eye Ctr Liaoning Prov, Shenyang, Liaoning Provin, Peoples R China; [Teng, Weiping] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang 110001, Liaoning Provin, Peoples R China; [Teng, Weiping; Chen, Lei] Key Lab Endocrine Dis Liaoning Prov, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Chen, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang 110001, Liaoning Provin, Peoples R China.	leichen1952@163.com	liu, li/HGC-0900-2022		Science and technique projects of Liaoning province [2009225005]; 11th five-year national technology support program [2007BAI18B07]	Science and technique projects of Liaoning province; 11th five-year national technology support program	This study was supported by grants of Science and technique projects of Liaoning province (2009225005) and the 11th five-year national technology support program (2007BAI18B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LM, 2003, AM J OPHTHALMOL, V136, P122, DOI 10.1016/S0002-9394(03)00219-8; Al Sayed A, 2006, ENDOCR J, V53, P653, DOI 10.1507/endocrj.K06-018; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], GLOB BURD DIS 2004 U; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Beulens JWJ, 2009, DIABETOLOGIA, V52, P2027, DOI 10.1007/s00125-009-1457-x; Cai XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091174; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Deladoey J, 2013, J CLIN ENDOCR METAB, V98, pE882, DOI 10.1210/jc.2013-1212; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Hansen AB, 2004, ACTA OPHTHALMOL SCAN, V82, P656, DOI 10.1111/j.1600-0420.2004.00347.x; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jee SH, 2010, DIABETES CARE, V33, P2567, DOI 10.2337/dc10-0261; Kastelan S, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-124; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Namperumalsamy P, 2009, BRIT J OPHTHALMOL, V93, P429, DOI 10.1136/bjo.2008.147934; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Society CD, 2011, CHIN GUID TYP 2 DIAB; Uchimoto S, 1999, DIABETIC MED, V16, P951, DOI 10.1046/j.1464-5491.1999.00173.x; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; World Health Organization, 2001, OB PREV MAN GLOB EP, V894, pi; Xie XW, 2009, EUR J OPHTHALMOL, V19, P91, DOI 10.1177/112067210901900114; Yang JK, 2010, DIABETES CARE, V33, P1018, DOI 10.2337/dc09-1784; Yang JY, 2013, DIABETES RES CLIN PR, V102, P218, DOI 10.1016/j.diabres.2013.10.016; Yang L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/264579; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Hong-Xia, 2009, Zhonghua Yi Xue Za Zhi, V89, P1749; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	37	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121477	10.1371/journal.pone.0121477	http://dx.doi.org/10.1371/journal.pone.0121477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785633	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500211
J	Koukoui, F; Desmoulin, F; Galinier, M; Barutaut, M; Caubere, C; Evaristi, MF; Murat, G; De Boer, R; Berry, M; Smih, F; Rouet, P				Koukoui, Francois; Desmoulin, Franck; Galinier, Michel; Barutaut, Manon; Caubere, Celine; Evaristi, Maria Francesca; Murat, Gurbuz; De Boer, Rudolf; Berry, Matthieu; Smih, Fatima; Rouet, Philippe			The Prognostic Value of Plasma Galectin-3 in Chronic Heart Failure Patients Is Maintained when Treated with Mineralocorticoid Receptor Antagonists	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX TURNOVER; SERUM GALECTIN-3; TASK-FORCE; FIBROSIS; ALDOSTERONE; SPIRONOLACTONE; THERAPY; MARKER; MACROPHAGES; EPLERENONE	Objective Galectin-3 (Gal-3) is considered as a myocardial fibrosis biomarker with prognostic value in heart failure (HF). Since aldosterone is a neurohormone with established fibrotic properties, we aimed to investigate if mineralocorticoid receptor antagonists (MRAs) would modulate the prognostic value of Gal-3. Methods The IBLOMAVED cohort comprised 427 eligible chronic HF patients (CHF) with echocardiography and heart failure biomarkers assessments (BNP). After propensity score matching CHF patients for cardiovascular risk factors, to form balanced groups, Gal-3 levels were measured at baseline in plasma from patients treated with MRAs (MRA-Plus, n=101) or not (MRA-Neg, n=101). The primary end point was all-cause mortality with a follow-up of 3 years. Results Gal-3 in plasma from these patients were similar with median values of 14.0 ng/mL [IQR, 9.9-19.3] and 14.4 ng/mL [IQR, 12.3-19.8] (P=0.132) in MRA-Neg and MRA-Plus, respectively. Patients with Gal-3 <= 17.8 ng/mL had an HR of 1 (reference group) and 1.5 [0.4-5.7] in MRA-Neg and MRA-Plus, respectively (p=0.509). Patients with Gal-3 <= 17.8 ng/mL had an HR of 7.4 [2.2-24.6] and 9.0 [2.9-27.8] in MRA-Plus and MRA-Neg, respectively (p=0.539) and a median survival time of 2.4 years [95% CI, 1.8-2.4]. Multivariate Cox proportional hazard analysis confirmed that MRA and the interaction term between MRA treatment and Gal-3 >17.8 ng/mL were not factors associated with survival. Conclusions MRA treatment did not impair the prognostic value of Gal-3 assessed with a 17.8 ng/mL cut off. Gal-3 levels maintained its strong prognostic value in CHF also in patients treated with MRAs. The significance of the observed lack of an interaction between Gal-3 and treatment effect of MRAs remains to be elucidated.	[Koukoui, Francois; Desmoulin, Franck; Galinier, Michel; Barutaut, Manon; Caubere, Celine; Evaristi, Maria Francesca; Murat, Gurbuz; Berry, Matthieu; Smih, Fatima; Rouet, Philippe] Univ UPS, UMR 1048, INSERM I2MC, Equipe,Obes & Insuffisance Cardiaque Approche Mol, F-31432 Toulouse, France; [Galinier, Michel; Murat, Gurbuz; Berry, Matthieu] CHU Rangueil, Serv Cardiol A, F-31432 Toulouse, France; [De Boer, Rudolf] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; University of Groningen	Rouet, P (corresponding author), Univ UPS, UMR 1048, INSERM I2MC, Equipe,Obes & Insuffisance Cardiaque Approche Mol, F-31432 Toulouse, France.	Philippe.rouet@inserm.fr	de Boer, Rudolf/ABE-9879-2020; desmoulin, franck/AAU-4544-2020; DESMOULIN, Franck/O-1895-2018	desmoulin, franck/0000-0003-0560-6266; DESMOULIN, Franck/0000-0003-0560-6266; Rouet, Philippe/0000-0001-6204-2079; Evaristi, Maria Francesca/0000-0002-5188-4446; GALINIER, Michel/0000-0003-1735-3390	BioMerieux	BioMerieux	This work was supported by BioMerieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Brilla CG, 2000, HERZ, V25, P299, DOI 10.1007/s000590050024; Calvier L, 2013, ARTERIOSCL THROM VAS, V33, P67, DOI 10.1161/ATVBAHA.112.300569; Collier TJ, 2013, EUR HEART J, V34, P2823, DOI 10.1093/eurheartj/eht247; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; De Berardinis B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/983098; de Boer RA, 2012, J INTERN MED, V272, P55, DOI 10.1111/j.1365-2796.2011.02476.x; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fiuzat M, 2014, J CARD FAIL, V20, P38, DOI 10.1016/j.cardfail.2013.11.011; Gopal DM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000760; Gullestad L, 2012, EUR HEART J, V33, P2290, DOI 10.1093/eurheartj/ehs077; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Carrasco-Sanchez FJ, 2013, INT J CARDIOL, V169, P177, DOI 10.1016/j.ijcard.2013.08.081; Kasama S, 2013, INT J CARDIOL, V167, P244, DOI 10.1016/j.ijcard.2011.12.080; Lin YH, 2009, CLIN CHIM ACTA, V409, P96, DOI 10.1016/j.cca.2009.09.001; Lok DJA, 2010, CLIN RES CARDIOL, V99, P323, DOI 10.1007/s00392-010-0125-y; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; McCullough PA, 2011, REV CARDIOVASC MED, V12, P200, DOI 10.3909/ricm0624; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Peacock William Frank, 2014, Crit Pathw Cardiol, V13, P73, DOI 10.1097/HPC.0000000000000012; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; Seferovic JP, 2014, CLIN CHEM LAB MED, V52, P1499, DOI 10.1515/cclm-2014-0265; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Smih F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020414; van der Velde AR, 2013, CIRC-HEART FAIL, V6, P219, DOI 10.1161/CIRCHEARTFAILURE.112.000129; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; White PC, 2003, J CLIN ENDOCR METAB, V88, P2376, DOI 10.1210/jc.2003-030373; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	38	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119160	10.1371/journal.pone.0119160	http://dx.doi.org/10.1371/journal.pone.0119160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786035	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500078
J	Velkoska, E; Patel, SK; Griggs, K; Pickering, RJ; Tikellis, C; Burrell, LM				Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Pickering, Raelene J.; Tikellis, Chris; Burrell, Louise M.			Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; URINARY ACE2; EXPRESSION; INJURY; DISEASE; RENIN; LOCALIZATION; PROGRESSION; ACTIVATORS; INCREASES	Angiotensin converting enzyme (ACE) 2 is an important modulator of the renin angiotensin system (RAS) through its role to degrade angiotensin (Ang) II. Depletion of kidney ACE2 occurs following kidney injury due to renal mass reduction and may contribute to progressive kidney disease. This study assessed the effect of diminazine aceturate (DIZE), which has been described as an ACE2 activator, on kidney ACE2 mRNA and activity in rats with kidney injury due to subtotal nephrectomy (STNx). Sprague Dawley rats were divided into Control groups or underwent STNx; rats then received vehicle or the DIZE (s.c. 15 mg/kg/day) for 2 weeks. STNx led to hypertension (P<0.01), kidney hypertrophy (P<0.001) and impaired kidney function (P<0.001) compared to Control rats. STNx was associated with increased kidney cortical ACE activity, and reduced ACE2 mRNA in the cortex (P<0.01), with reduced cortical and medullary ACE2 activity (P<0.05), and increased urinary ACE2 excretion (P<0.05) compared to Control rats. Urinary ACE2 activity correlated positively with urinary protein excretion (P<0.001), and negatively with creatinine clearance (P=0.04). In STNx rats, DIZE had no effect on blood pressure or kidney function, but was associated with reduced cortical ACE activity (P<0.01), increased cortical ACE2 mRNA (P<0.05) and increased cortical and medullary ACE2 activity (P<0.05). The precise in vivo mechanism of action of DIZE is not clear, and its effects to increase ACE2 activity may be secondary to an increase in ACE2 mRNA abundance. In ex vivo studies, DIZE did not increase ACE2 activity in either Control or STNx kidney cortical membranes. It is not yet known if chronic administration of DIZE has long-term benefits to slow the progression of kidney disease.	[Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Burrell, Louise M.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Pickering, Raelene J.; Tikellis, Chris] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Baker Heart and Diabetes Institute	Velkoska, E (corresponding author), Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia.	velkoska@unimelb.edu.au	Pickering, Raelene/AAM-8647-2021	Pickering, Raelene/0000-0002-2128-1281; Patel, Sheila/0000-0002-0626-1899	National Health and Medical Research Council of Australia [APP1048285]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding granted to EV from National Health and Medical Research Council of Australia (APP1048285). https://www.nhmrc.gov.au/.	Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2012, EXP PHYSIOL, V97, P477, DOI 10.1113/expphysiol.2011.063156; Cao ZM, 2001, SEMIN NEPHROL, V21, P554, DOI 10.1053/snep.2001.26794; Cao ZM, 2001, KIDNEY INT, V60, P715, DOI 10.1046/j.1523-1755.2001.060002715.x; CHERNEY DZ, 2014, CAN J PHYSIOL PHARM, P1, DOI DOI 10.1139/CJPP-2013-0063; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Haber PK, 2014, HYPERTENSION, V63, P774, DOI 10.1161/HYPERTENSIONAHA.113.02856; Ibrahim HS, 2014, REPROD TOXICOL, V49, P155, DOI 10.1016/j.reprotox.2014.08.006; Kulemina LV, 2011, J BIOMOL SCREEN, V16, P878, DOI 10.1177/1087057111413919; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Mizuiri S, 2008, AM J KIDNEY DIS, V51, P613, DOI 10.1053/j.ajkd.2007.11.022; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Park SE, 2013, EUR J ENDOCRINOL, V168, P203, DOI 10.1530/EJE-12-0782; PEREGRINE AS, 1993, ACTA TROP, V54, P185, DOI 10.1016/0001-706X(93)90092-P; Prada JAH, 2008, HYPERTENSION, V51, P1312, DOI 10.1161/HYPERTENSIONAHA.107.108944; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF749, DOI 10.1152/ajprenal.00383.2009; Qi YF, 2013, HYPERTENSION, V62, P746, DOI 10.1161/HYPERTENSIONAHA.113.01337; Raffai G, 2014, J CARDIOVASC PHARM, V63, P453, DOI 10.1097/FJC.0000000000000069; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; Shenoy V, 2013, AM J RESP CRIT CARE, V187, P648, DOI 10.1164/rccm.201205-0880OC; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Soler MJ, 2009, AM J PHYSIOL-RENAL, V296, pF398, DOI 10.1152/ajprenal.90488.2008; Taal MW, 2008, BRENNER RECTORS KIDN, V8, P783; Thatcher SE, 2014, ARTERIOSCL THROM VAS, V34, P2617, DOI 10.1161/ATVBAHA.114.304613; Thomas MC, 2005, J AM SOC NEPHROL, V16, P2976, DOI 10.1681/ASN.2005010013; Tikellis C, 2006, KIDNEY INT, V70, P34, DOI 10.1038/sj.ki.5000428; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Varagic J, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0420-5; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Wang G, 2011, KIDNEY BLOOD PRESS R, V34, P141, DOI 10.1159/000324521; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2013, AM J PHYSIOL-RENAL, V305, pF600, DOI 10.1152/ajprenal.00600.2012; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	43	31	31	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118758	10.1371/journal.pone.0118758	http://dx.doi.org/10.1371/journal.pone.0118758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786223	Green Published, gold			2022-12-26	WOS:000352138500047
J	Fan, ZD; Wang, FF; Huang, H; Huang, N; Ma, HH; Guo, YH; Zhang, YY; Qian, XQ; Yu, HG				Fan, Zhi-Dan; Wang, Fei-Fei; Huang, Hui; Huang, Na; Ma, Hui-Hui; Guo, Yi-Hong; Zhang, Ya-Yuan; Qian, Xiao-Qing; Yu, Hai-Guo			STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C Polymorphisms Influence the Risk of Developing Juvenile Idiopathic Arthritis in Han Chinese Patients	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PROMOTER POLYMORPHISM; SUSCEPTIBILITY LOCI; GENE; ASSOCIATION; CLASSIFICATION; POPULATION; HAPLOTYPE; SUPPORT; VARIANT	Juvenile idiopathic arthritis (JIA) is a common autoimmune disease characterized by environmental influences along with several predisposing genes in the pathogenesis. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) and signal transducer and activator of transcription factor 4 (STAT4) have been recognized as susceptibility genes for numerous autoimmune diseases. Associations of STAT4 rs7574865 G/T and PTPN22 (rs2488457 G/C and rs2476601 C/T) polymorphisms with JIA have repeatedly been replicated in several Caucasian populations. The aim of this study was to investigate the influence of three polymorphisms mentioned above on the risk of developing JIA in Han Chinese patients. Genotyping was performed on a total of 137 Chinese patients with JIA (JIA group) and 150 sex and age frequency-matched healthy volunteers (Control group). The single-nucleotide polymorphisms (SNP) were determined by using direct sequencing of PCR-amplified products. There were significant differences of PTPN22 rs2488457 G/C and STAT4 rs7574865 G/T polymorphisms between both groups. However, no significant difference was observed in distribution frequencies of PTPN22 rs2476601 polymorphism. The association with the PTPN22 rs2488457 G/C polymorphism remained significant in the stratifications by age at onset, ANA status, splenomegaly, lymphadenectasis and involvement joints. As with the STAT4 rs7574865 G/T polymorphisms, the enthesitis-related arthritis and presence of hepatomegaly had strong effect on the association. Our data strengthen STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms as susceptibility factors for JIA.	[Fan, Zhi-Dan; Wang, Fei-Fei; Huang, Hui; Huang, Na; Ma, Hui-Hui; Guo, Yi-Hong; Zhang, Ya-Yuan; Qian, Xiao-Qing; Yu, Hai-Guo] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Rheumatol & Immunol, Nanjing 210008, Jiangsu, Peoples R China		Yu, HG (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Rheumatol & Immunol, 72 Guangzhou Rd, Nanjing 210008, Jiangsu, Peoples R China.	yuhaiguo73@126.com	ma, huihui/HDM-4386-2022	ma, huihui/0000-0002-3463-1842	Chinese National Natural Science Fund [81202345, 81102256]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science Fund (No. 81202345, 81102256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Chinoy H, 2008, ARTHRITIS RHEUM-US, V58, P3247, DOI 10.1002/art.23900; Clark A, 2013, INFECT GENET EVOL, V18, P257, DOI 10.1016/j.meegid.2013.05.025; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Dimopoulou DG, 2013, HUM IMMUNOL, V74, P1194, DOI 10.1016/j.humimm.2013.06.018; El-Zawahry BM, 2013, GENE, V523, P147, DOI 10.1016/j.gene.2013.03.070; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hinks A, 2010, ANN RHEUM DIS, V69, P1049, DOI 10.1136/ard.2009.110650; Huang H, 2013, CLIN RHEUMATOL, V32, P1021, DOI 10.1007/s10067-013-2232-4; Kang M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1953; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z; Liu F, 2012, CELL BIOCHEM BIOPHYS, V62, P273, DOI 10.1007/s12013-011-9291-4; Martini A, 2012, ANN RHEUM DIS, V71, P1437, DOI 10.1136/annrheumdis-2012-201388; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Pazar B, 2008, CLIN EXP RHEUMATOL, V26, P1146; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Seldin MF, 2005, GENES IMMUN, V6, P720, DOI 10.1038/sj.gene.6364255; Sugiura T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1930; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Viola S, 2005, ARTHRITIS RHEUM-US, V52, P2092, DOI 10.1002/art.21119; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Woo P, 2006, NAT CLIN PRACT RHEUM, V2, P28, DOI 10.1038/ncprheum0084	29	19	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117389	10.1371/journal.pone.0117389	http://dx.doi.org/10.1371/journal.pone.0117389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781893	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600012
J	Lee, DK; Jeong, JH; Oh, S; Jo, YH				Lee, Dong Kun; Jeong, Jae Hoon; Oh, Seunghoon; Jo, Young-Hwan			Apelin-13 Enhances Arcuate POMC Neuron Activity via Inhibiting M-Current	PLOS ONE			English	Article							REGULATES GLUCOSE-HOMEOSTASIS; PROOPIOMELANOCORTIN NEURONS; PHOSPHOLIPASE-C; PERTUSSIS TOXIN; BETA-GAMMA; INSULIN SENSITIVITY; POTASSIUM CHANNELS; TRPC CHANNELS; AGRP NEURONS; RECEPTOR APJ	The hypothalamus is a key element of the neural circuits that control energy homeostasis. Specific neuronal populations within the hypothalamus are sensitive to a variety of homeostatic indicators such as circulating nutrient levels and hormones that signal circulating glucose and body fat content. Central injection of apelin secreted by adipose tissues regulates feeding and glucose homeostasis. However, the precise neuronal populations and cellular mechanisms involved in these physiological processes remain unclear. Here we examine the electrophysiological impact of apelin-13 on proopiomelanocortin (POMC) neuron activity. Approximately half of POMC neurons examined respond to apelin-13. Apelin-13 causes a dose-dependent depolarization. This effect is abolished by the apelin (APJ) receptor antagonist. POMC neurons from animals pre-treated with pertussis toxin still respond to apelin, whereas the G beta gamma. signaling inhibitor gallein blocks apelin-mediated depolarization. In addition, the effect of apelin is inhibited by the phospholipase C and protein kinase inhibitors. Furthermore, single-cell qPCR analysis shows that POMC neurons express the APJ receptor, PLC-beta isoforms, and KCNQ subunits (2, 3 and 5) which contribute to M-type current. Apelin-13 inhibits M-current that is blocked by the KCNQ channel inhibitor. Therefore, our present data indicate that apelin activates APJ receptors, and the resultant dissociation of the G alpha q heterotrimer triggers a G beta gamma-dependent activation of PLC-beta signaling that inhibits M-current.	[Lee, Dong Kun; Jeong, Jae Hoon; Jo, Young-Hwan] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; [Jo, Young-Hwan] Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Oh, Seunghoon] Dankook Univ, Coll Med, Dept Physiol, Cheonan 330714, South Korea	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Dankook University	Jo, YH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Endocrinol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	young-hwan.jo@einstein.yu.edu		Jo, Young-Hwan/0000-0001-6939-8000; Lee, Dong Kun/0000-0001-9969-0117	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1DK092246]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092246] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; RO1DK092246) to Y.- H. J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brailoiu GC, 2002, NEUROSCI LETT, V327, P193, DOI 10.1016/S0304-3940(02)00411-1; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Clarke KJ, 2009, J NEUROENDOCRINOL, V21, P83, DOI 10.1111/j.1365-2826.2008.01815.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Drougard A, 2014, ANTIOXID REDOX SIGN, V20, P557, DOI 10.1089/ars.2013.5182; Duparc T, 2011, ANTIOXID REDOX SIGN, V15, P1477, DOI 10.1089/ars.2010.3454; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; FUNADA M, 1993, BRAIN RES, V619, P163, DOI 10.1016/0006-8993(93)91608-U; Jo YH, 2012, J NEUROPHYSIOL, V107, P42, DOI 10.1152/jn.00353.2011; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Knauf C, 2013, HORM METAB RES, V45, P928, DOI 10.1055/s-0033-1351321; Korolkiewicz R, 1996, PHARMACOL RES, V33, P211, DOI 10.1006/phrs.1996.0029; Leao RN, 2009, J NEUROSCI, V29, P13353, DOI 10.1523/JNEUROSCI.1463-09.2009; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pope GR, 2012, PEPTIDES, V33, P139, DOI 10.1016/j.peptides.2011.12.005; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2011, AM J PHYSIOL-ENDOC M, V301, pE955, DOI 10.1152/ajpendo.00090.2011; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roepke TA, 2012, AM J PHYSIOL-ENDOC M, V302, pE1399, DOI 10.1152/ajpendo.00565.2011; Roepke TA, 2011, J NEUROSCI, V31, P11825, DOI 10.1523/JNEUROSCI.1395-11.2011; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; van den Top M, 2006, PROG BRAIN RES, V153, P141, DOI 10.1016/S0079-6123(06)53008-0; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Wu ZQ, 2006, MOL PHARMACOL, V69, P866, DOI 10.1124/mol.106.016501; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119457	10.1371/journal.pone.0119457	http://dx.doi.org/10.1371/journal.pone.0119457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782002	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600065
J	Lynn, GE; Oliver, JD; Nelson, CM; Felsheim, RF; Kurtti, TJ; Munderloh, UG				Lynn, Geoffrey E.; Oliver, Jonathan D.; Nelson, Curtis M.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Tissue Distribution of the Ehrlichia muris-Like Agent in a Tick Vector	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; IN-SITU HYBRIDIZATION; LYME-DISEASE; ANAPLASMA-MARGINALE; DERMACENTOR-ANDERSONI; IXODES-SCAPULARIS; SALIVARY-GLANDS; CAUSATIVE AGENT; CLIMATE-CHANGE; RICKETTSIA	Human pathogens transmitted by ticks undergo complex life cycles alternating between the arthropod vector and a mammalian host. While the latter has been investigated to a greater extent, examination of the biological interactions between microbes and the ticks that carry them presents an equally important opportunity for disruption of the disease cycle. In this study, we used in situ hybridization to demonstrate infection by the Ehrlichia muris-like organism, a newly recognized human pathogen, of Ixodes scapularis ticks, a primary vector for several important human disease agents. This allowed us to assess whole sectioned ticks for the patterns of tissue invasion, and demonstrate generalized dissemination of ehrlichiae in a variety of cell types and organs within ticks infected naturally via blood feeding. Electron microscopy was used to confirm these results. Here we describe a strong ehrlichial affinity for epithelial cells, neuronal cells of the synganglion, salivary glands, and male accessory glands.	[Lynn, Geoffrey E.; Oliver, Jonathan D.; Nelson, Curtis M.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Lynn, GE (corresponding author), Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA.	lynnx044@umn.edu		Lynn, Geoffrey/0000-0002-7095-0912	National Institutes of Health (USA) [R01AI042792]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117173, R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded under grant number R01AI042792, which was generously provided by the National Institutes of Health (USA) and awarded to UGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2010, INFECT IMMUN, V78, P2446, DOI 10.1128/IAI.00108-10; [Anonymous], 2011, GUIDE CARE USE LAB A; Balashov YS, 1983, ATLAS IXODID TICK UL; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Chavez ASO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036012; Cortinas MR, 2006, J MED ENTOMOL, V43, P810, DOI 10.1603/0022-2585(2006)43[810:CSOWDI]2.0.CO;2; Dawson JE, 2001, AM J TROP MED HYG, V65, P603, DOI 10.4269/ajtmh.2001.65.603; DUMLER JS, 1995, J CLIN MICROBIOL, V33, P1704, DOI 10.1128/JCM.33.7.1704-1711.1995; Felek S, 2004, INFECT IMMUN, V72, P659, DOI 10.1128/IAI.72.2.659-666.2004; Ge NL, 1996, J MED ENTOMOL, V33, P911, DOI 10.1093/jmedent/33.6.911; GOFF W, 1988, P NATL ACAD SCI USA, V85, P919, DOI 10.1073/pnas.85.3.919; Goodman JL, 1996, NEW ENGL J MED, V334, P209, DOI 10.1056/NEJM199601253340401; Hammac GK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-193; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; ITO S, 1975, ANN NY ACAD SCI, V266, P35, DOI 10.1111/j.1749-6632.1975.tb35087.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kocan K.M., 1986, P472; KOCAN KM, 1983, AM J VET RES, V44, P798; KOCAN KM, 1992, AM J VET RES, V53, P499; KOCAN KM, 1987, ONDERSTEPOORT J VET, V54, P87; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Kurtti TJ, 2015, INT J SYST EVOL MICR, V65, P965, DOI 10.1099/ijs.0.000047; Kurtti TJ, 1996, INFECT IMMUN, V64, P4148, DOI 10.1128/IAI.64.10.4148-4153.1996; KURTTI TJ, 1994, CAN J ZOOL, V72, P977, DOI 10.1139/z94-134; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Liu L, 2011, EMBO REP, V12, P1196, DOI 10.1038/embor.2011.177; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Long SW, 2003, J MED ENTOMOL, V40, P1000, DOI 10.1603/0022-2585-40.6.1000; Lynn GE, 2012, 25 ANN AM SOC RICK M; Massung RF, 2007, J CLIN MICROBIOL, V45, P2138, DOI 10.1128/JCM.00478-07; Munderloh UG, 2009, ANN NY ACAD SCI, V1166, P112, DOI 10.1111/j.1749-6632.2009.04520.x; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Niebylski ML, 1997, INT J SYST BACTERIOL, V47, P446, DOI 10.1099/00207713-47-2-446; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Oliver JD, 2014, APPL ENVIRON MICROB, V80, P1170, DOI 10.1128/AEM.03352-13; Popov VL, 2007, VECTOR-BORNE ZOONOT, V7, P699, DOI 10.1089/vbz.2007.0148; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reichard MV, 2009, VECTOR-BORNE ZOONOT, V9, P565, DOI 10.1089/vbz.2008.0106; Saito TB, 2015, J INFECT DIS, V211, P452, DOI 10.1093/infdis/jiu372; Sauer J. R., 1986, MORPHOLOGY PHYSL BEH; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SMITH RD, 1976, AM J VET RES, V37, P119; Sonenshine DE, 1991, BIOL TICKS, V1; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Thepparit C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-149; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; Walker DH, 2004, T AM CLIN CLIMAT ASS, V115, P382	54	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122007	10.1371/journal.pone.0122007	http://dx.doi.org/10.1371/journal.pone.0122007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781930	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600213
J	Tarasov, S; Genier, F				Tarasov, Sergei; Genier, Francois			Innovative Bayesian and Parsimony Phylogeny of Dung Beetles (Coleoptera, Scarabaeidae, Scarabaeinae) Enhanced by Ontology-Based Partitioning of Morphological Characters	PLOS ONE			English	Article							EVOLUTION; DIVERSITY; INFERENCE; LIGHT	Scarabaeine dung beetles are the dominant dung feeding group of insects and are widely used as model organisms in conservation, ecology and developmental biology. Due to the conflicts among 13 recently published phylogenies dealing with the higher-level relationships of dung beetles, the phylogeny of this lineage remains largely unresolved. In this study, we conduct rigorous phylogenetic analyses of dung beetles, based on an unprecedented taxon sample (110 taxa) and detailed investigation of morphology (205 characters). We provide the description of morphology and thoroughly illustrate the used characters. Along with parsimony, traditionally used in the analysis of morphological data, we also apply the Bayesian method with a novel approach that uses anatomy ontology for matrix partitioning. This approach allows for heterogeneity in evolutionary rates among characters from different anatomical regions. Anatomy ontology generates a number of parameter-partition schemes which we compare using Bayes factor. We also test the effect of inclusion of autapomorphies in the morphological analysis, which hitherto has not been examined. Generally, schemes with more parameters were favored in the Bayesian comparison suggesting that characters located on different body regions evolve at different rates and that partitioning of the data matrix using anatomy ontology is reasonable; however, trees from the parsimony and all the Bayesian analyses were quite consistent. The hypothesized phylogeny reveals many novel clades and provides additional support for some clades recovered in previous analyses. Our results provide a solid basis for a new classification of dung beetles, in which the taxonomic limits of the tribes Dichotomiini, Deltochilini and Coprini are restricted and many new tribes must be described. Based on the consistency of the phylogeny with biogeography, we speculate that dung beetles may have originated in the Mesozoic contrary to the traditional view pointing to a Cenozoic origin.	[Tarasov, Sergei] Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Dept Res & Collect, NO-0318 Oslo, Norway; [Genier, Francois] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Coleoptera Sect, Ottawa, ON K1A 0C6, Canada	University of Oslo; Agriculture & Agri Food Canada	Tarasov, S (corresponding author), Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Dept Res & Collect, POB 1172 Blindern, NO-0318 Oslo, Norway.	sergxf@yandex.ru			SYNTHESYS grant	SYNTHESYS grant	Visits of Sergei Tarasov to the MNHN in Paris received support from the SYNTHESYS grant (http://www.synthesys.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1470; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021600; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Clements JF, 2007, CLEMENTS CHECKLIST B; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Donitz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070695; Edmonds WD, 1972, KANS U SCI B, V49, P731; Emlen DJ, 2005, EVOLUTION, V59, P1060; Goloboff P, 2008, CLADISTICS, V24, P91; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; Lawrence JF, 2011, ANN ZOOL, V61, P1, DOI 10.3161/000345411X576725; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Losos JB, 2012, SCIENCE, V338, P1428, DOI 10.1126/science.1232455; Maddison WP, 2019, MESQUITE MODULAR SYS; Mlambo S, 2013, ORG DIVERS EVOL, P1; Moczek Armin, 2011, P126; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Montreuil O, 1998, ANN SOC ENTOMOL FR, V34, P135; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols Elizabeth S., 2011, P267; Nikolajev G. V., 2007, MESOZOIC STAGE EVOLU; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ocampo FC, 2006, INVERTEBR SYST, V20, P557, DOI 10.1071/IS05031; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Philips T. Keith, 2011, P21; Philips TK, 2004, INVERTEBR SYST, V18, P53, DOI 10.1071/IS03030; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Pretorius Resia, 2000, Elytron (Barcelona), V14, P125; Rambaut A, 2013, TRACER V1 6; Rannala B, 2012, MOL BIOL EVOL, V29, P325, DOI 10.1093/molbev/msr210; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Remane A., 1961, Zoologischer Anzeiger, V166, P447; Remane A, 1952, TEORETISCHE MORPHOLO, VI; Scholtz C., 2009, EVOLUTIONARY BIOL CO; SHAFER G, 1982, J AM STAT ASSOC, V77, P325, DOI 10.2307/2287244; Smith ABT, 2006, COLEOPTS BULL, V60, P35, DOI 10.1649/0010-065X(2006)60[35:AOOTCA]2.0.CO;2; Sole CL, 2010, MOL PHYLOGENET EVOL, V56, P631, DOI 10.1016/j.ympev.2010.04.023; Solodovnikov A, 2013, CLADISTICS, V29, P360, DOI 10.1111/j.1096-0031.2012.00433.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tarasov SI, 2011, CLADISTICS, V27, P490, DOI 10.1111/j.1096-0031.2011.00351.x; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Vaz-de-Mello FZ, 2007, ANN SOC ENTOMOL FR, V43, P231, DOI 10.1080/00379271.2007.10697516; Vaz-De-Mello FZ, 2008, ZOOTAXA, P1; Vaz-de-Mello FZ, 2007, REVISION TAXANOMICA; Villalba S, 2002, J MOL EVOL, V55, P116, DOI 10.1007/s00239-002-2314-4; Wagele JW, 2005, FDN PHYLOGENETIC SYS, V1st; Wirta H, 2008, MOL PHYLOGENET EVOL, V47, P1076, DOI 10.1016/j.ympev.2008.03.010; Wirta H, 2010, MOL PHYLOGENET EVOL, V57, P710, DOI 10.1016/j.ympev.2010.08.013; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991; Zunino M., 1984, Bulletin de la Societe Entomologique de France, V88, P531	63	104	114	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116671	10.1371/journal.pone.0116671	http://dx.doi.org/10.1371/journal.pone.0116671			86	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781019	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600007
J	Wex, E; Bouyssou, T				Wex, Eva; Bouyssou, Thierry			Olodaterol Attenuates Citric Acid-Induced Cough in Naive and Ovalbumin-Sensitized and Challenged Guinea Pigs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PHARMACOLOGICAL CHARACTERIZATION; RECEPTOR SENSITIVITY; ALLERGIC COUGH; INDACATEROL; CAPSAICIN; AGONIST; NEURONS; COPD; BRONCHODILATORS	Excessive coughing is a common feature of airway diseases. Different G-protein coupled receptors, including beta 2-adrenergic receptors (beta 2-AR), have been implicated in the molecular mechanisms underlying the cough reflex. However, the potential antitussive property of beta 2-AR agonists in patients with respiratory disease is a matter of ongoing debate. The aim of our study was to test the efficacy of the long-acting beta 2-AR agonist olodaterol with regard to its antitussive property in a pre-clinical model of citric acid-induced cough in guinea pigs and to compare the results to different clinically relevant beta 2-AR agonists. In our study beta 2-AR agonists were intratracheally administered, as dry powder, into the lungs of naive or ovalbumin-sensitized guinea pigs 15 minutes prior to induction of cough by exposure to citric acid. Cough events were counted over 15 minutes during the citric acid exposure. Olodaterol dose-dependently inhibited the number of cough events in naive and even more potently and with a greater maximal efficacy in ovalbumin-sensitized guinea pigs (p < 0.01). Formoterol and salmeterol showed a trend towards reducing cough. On the contrary, indacaterol demonstrated pro-tussive properties as it significantly increased the number of coughs, both in naive and ovalbumin-sensitized animals (p < 0.001). In conclusion, olodaterol, at doses eliciting bronchodilation, showed antitussive properties in a model of citric acid-induced cough in naive and ovalbumin-sensitized guinea pigs. This is in agreement with pre-clinical and clinical studies showing antitussive efficacy of beta 2-AR agonists. Indacaterol increased the number of coughs in this model, which concurs with clinical data where a transient cough has been observed after indacaterol inhalation. While the antitussive properties of beta 2-AR agonists can be explained by their ability to lead to the cAMP-induced hyperpolarization of the neuron membrane thereby inhibiting sensory nerve activation and the cough reflex, the mechanism underlying the pro-tussive property of indacaterol is not known.	[Wex, Eva; Bouyssou, Thierry] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Bouyssou, T (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	thierry.bouyssou@boehringer-ingelheim.com		Wex, Eva/0000-0002-4643-1899	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder provided support in the form of salaries for authors EW and TB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; [Anonymous], 2010, AUSTR PUBL ASS REP I; [Anonymous], 2009, ASS REP HIR BREEZH; Battram C, 2006, J PHARMACOL EXP THER, V317, P762, DOI 10.1124/jpet.105.098251; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Beier J, 2007, PULM PHARMACOL THER, V20, P740, DOI 10.1016/j.pupt.2006.09.001; BOLSER DC, 1995, EUR J PHARMACOL, V277, P159, DOI 10.1016/0014-2999(95)00076-W; Bouyssou T, 2010, J PHARMACOL EXP THER, V334, P53, DOI 10.1124/jpet.110.167007; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Campbell M, 2005, RESP MED, V99, P1511, DOI 10.1016/j.rmed.2005.08.016; Canning BJ, 2011, AM J PHYSIOL-REG I, V300, pR369, DOI 10.1152/ajpregu.00044.2010; Cazzola M, 2013, J THORAC DIS, V5, P559, DOI 10.3978/j.issn.2072-1439.2013.07.35; Chang AB, 1998, ARCH DIS CHILD, V79, P6, DOI 10.1136/adc.79.1.6; Chong CF, 2005, EMERG MED J, V22, P429, DOI 10.1136/emj.2004.015719; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dicpinigaitis Peter V, 2012, Cough, V8, P10, DOI 10.1186/1745-9974-8-10; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; ELLULMICALLEF R, 1983, BRIT MED J, V287, P940, DOI 10.1136/bmj.287.6397.940; Feldman G, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-11; Freund-Michel VC, 2010, EUR RESPIR J, V35, P647, DOI 10.1183/09031936.00034009; FUJIMURA M, 1993, THORAX, V48, P615, DOI 10.1136/thx.48.6.615; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Gibb A, 2013, DRUGS, V73, P1841, DOI 10.1007/s40265-013-0137-9; Gu QH, 2007, J APPL PHYSIOL, V102, P1545, DOI 10.1152/japplphysiol.01010.2006; Lewis CA, 2007, PULM PHARMACOL THER, V20, P325, DOI 10.1016/j.pupt.2006.12.001; Lieu TM, 2012, AM J PHYSIOL-LUNG C, V302, pL941, DOI 10.1152/ajplung.00366.2011; LOWRY R, 1987, BRIT J CLIN PHARMACO, V24, P503, DOI 10.1111/j.1365-2125.1987.tb03204.x; Maher SA, 2011, CURR OPIN PHARMACOL, V11, P248, DOI 10.1016/j.coph.2011.06.005; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Mulrennan S, 2004, PULM PHARMACOL THER, V17, P127, DOI 10.1016/j.pupt.2004.01.002; Niimi A, 2011, PULM PHARMACOL THER, V24, P328, DOI 10.1016/j.pupt.2011.01.011; Ohkura N, 2010, EUR RESPIR J, V36, P459, DOI 10.1183/09031936.00057410; POUNSFORD JC, 1985, THORAX, V40, P662, DOI 10.1136/thx.40.9.662; Prudon B, 2005, CHEST, V127, P550, DOI 10.1378/chest.127.2.550; Ray SM, 2012, PHARMACOTHERAPY, V32, P456, DOI 10.1002/j.1875-9114.2012.01025.x; SMITH CA, 1991, EUR RESPIR J, V4, P1076; Tamaoki J, 2010, ALLERGY ASTHMA PROC, V31, pE78, DOI 10.2500/aap.2010.31.3366; Terada K, 2009, RESPIROLOGY, V14, P1151, DOI 10.1111/j.1440-1843.2009.01620.x; Walland A, 1997, EUR J PHARMACOL, V330, P213, DOI 10.1016/S0014-2999(97)01011-X; Watanabe N, 2005, PULM PHARMACOL THER, V18, P187, DOI 10.1016/j.pupt.2004.12.002	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119953	10.1371/journal.pone.0119953	http://dx.doi.org/10.1371/journal.pone.0119953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781609	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600111
J	Zheng, MG; Chen, XA				Zheng, Mingguo; Chen, Xiaoan			Statistical Determination of Rainfall-Runoff Erosivity Indices for Single Storms in the Chinese Loess Plateau	PLOS ONE			English	Article							FLOW-SEDIMENT RELATIONSHIP; HILLY AREAS; HYPERCONCENTRATED FLOW; INTERRILL EROSION; SOIL-EROSION; RIVER	Correlation analysis is popular in erosion-or earth-related studies, however, few studies compare correlations on a basis of statistical testing, which should be conducted to determine the statistical significance of the observed sample difference. This study aims to statistically determine the erosivity index of single storms, which requires comparison of a large number of dependent correlations between rainfall-runoff factors and soil loss, in the Chinese Loess Plateau. Data observed at four gauging stations and five runoff experimental plots were presented. Based on the Meng's tests, which is widely used for comparing correlations between a dependent variable and a set of independent variables, two methods were proposed. The first method removes factors that are poorly correlated with soil loss from consideration in a stepwise way, while the second method performs pairwise comparisons that are adjusted using the Bonferroni correction. Among 12 rainfall factors, I-30 (the maximum 30-minute rainfall intensity) has been suggested for use as the rainfall erosivity index, although I-30 is equally correlated with soil loss as factors of I-20, EI10 (the product of the rainfall kinetic energy, E, and I-10), EI20 and EI30 are. Runoff depth (total runoff volume normalized to drainage area) is more correlated with soil loss than all other examined rain-fall-runoff factors, including I-30, peak discharge and many combined factors. Moreover, sediment concentrations of major sediment-producing events are independent of all examined rainfall-runoff factors. As a result, introducing additional factors adds little to the prediction accuracy of the single factor of runoff depth. Hence, runoff depth should be the best erosivity index at scales from plots to watersheds. Our findings can facilitate predictions of soil erosion in the Loess Plateau. Our methods provide a valuable tool while determining the predictor among a number of variables in terms of correlations.	[Zheng, Mingguo] Chinese Acad Sci, Key Lab Water Cycle & Related Land Surface Proc, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Chen, Xiaoan] Jiangxi Inst Soil & Water Conservat, Nanchang 330029, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zheng, MG (corresponding author), Chinese Acad Sci, Key Lab Water Cycle & Related Land Surface Proc, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	zhengmg.04b@igsnrr.ac.cn			National Natural Science Foundation of China [41271306]; Non-profit Industry Financial Program of MWR [201201083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Non-profit Industry Financial Program of MWR	The research is funded by the National Natural Science Foundation of China (41271306; http://www.nsfc.gov.cn/) and the Non-profit Industry Financial Program of MWR (201201083; http://www.mwr.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hammad AH, 2006, SOIL TILL RES, V87, P39, DOI 10.1016/j.still.2005.02.037; Angulo-Martinez M, 2009, J HYDROL, V379, P111, DOI 10.1016/j.jhydrol.2009.09.051; [Anonymous], J SOIL WATER CONSERV; [蔡强国 Cai Qiangguo], 2004, [地理研究, Geographical Research], V23, P433; Chaplot VAM, 2003, SOIL SCI SOC AM J, V67, P844, DOI 10.2136/sssaj2003.0844; Chen XA, 2010, J SEDIMENT RES, P5; Diodato N, 2007, J HYDROL, V345, P224, DOI 10.1016/j.jhydrol.2007.08.008; DRAGOUN FJ, 1962, J GEOPHYS RES, V67, P1495, DOI 10.1029/JZ067i004p01495; FOSTER GR, 1982, T ASAE, V25, P124, DOI 10.13031/2013.33490; Goyal JK, 2009, MATH STAT; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hudson N., 1971, SOIL CONSERVATION; HUSSEIN MH, 1994, HYDROLOG SCI J, V39, P535, DOI 10.1080/02626669409492773; Jia Z, 1990, MEMOIR NISWC ACAD SI, V12, P9; Jia ZJ, 1987, SOIL WATER CONSERV C, P18; Jiang ZS, 1983, SOIL WATER CONSERVAT, P32; Kiassari EM, 2012, TURK J AGRIC FOR, V36, P365, DOI 10.3906/tar-1103-9; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Kinnell PIA, 1998, SOIL SCI SOC AM J, V62, P1667, DOI 10.2136/sssaj1998.03615995006200060026x; KINNELL PIA, 1995, J SOIL WATER CONSERV, V50, P507; LAL R, 1976, GEODERMA, V16, P389, DOI 10.1016/0016-7061(76)90003-3; Lee JH, 2011, J HYDROL, V409, P30, DOI 10.1016/j.jhydrol.2011.07.031; Liu QJ, 2013, GEOMORPHOLOGY, V186, P181, DOI 10.1016/j.geomorph.2013.01.012; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Mou JZ, 1980, P 1 INT S RIV SED, P73; Pierson TC, 2005, S-P BKS GEOPHYS SCI, P159; Renard KG, 1997, AGR HDB, V384, P703; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; SALAKO F K, 1991, Soil Technology, V4, P93, DOI 10.1016/0933-3630(91)90042-L; Sharifah Mastura SA, 2003, GEOGRAFIA, V4, P44; Shi ZH, 2013, SOIL SCI SOC AM J, V77, P257, DOI 10.2136/sssaj2012.0273; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Shi ZH, 2004, CATENA, V55, P33, DOI 10.1016/S0341-8162(03)00088-2; Silver NC, 2006, APPL PSYCH MEAS, V30, P152, DOI 10.1177/0146621605277132; SINZOT A, 1989, EARTH SURF PROCESSES, V14, P509; Sukhanovski YP, 2002, J PLANT NUTR SOIL SC, V165, P51, DOI 10.1002/1522-2624(200202)165:1<51::AID-JPLN51>3.0.CO;2-3; Uson A, 2001, CATENA, V43, P293, DOI 10.1016/S0341-8162(00)00150-8; Wang WZ., 1996, B SOIL WATER CONSERV, V16, P1; Wang WZ, 1987, SOIL WATER CONSERV C, P34; Wang WZ, 1996, B SOIL WATER CONSERV, V16, P12; Wang WZ, 1983, B SOIL WATER CONSERV, P62; Williams J.R., 1975, PRESENT PROSPECTIVE, P244; Williams JW, 2008, 200817 BRC; Wischmeier W.H., 1978, USDA AGR HDB, P537; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; WISCHMEIER WALTER H., 1959, SOIL SCI SOC AMER PROC, V23, P246; Wischmeier WH., 1958, AGR ENG, V39, P458; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu JX, 1999, CATENA, V36, P1, DOI 10.1016/S0341-8162(99)00009-0; Yu GQ, 2014, HYDROL PROCESS, V28, P5322, DOI 10.1002/hyp.10020; Yue BJ, 2014, NAT HAZARDS, V74, P585, DOI 10.1007/s11069-014-1199-z; Zheng MG, 2008, GEOMORPHOLOGY, V93, P288, DOI 10.1016/j.geomorph.2007.03.001; Zheng MG, 2013, CATENA, V109, P164, DOI 10.1016/j.catena.2013.03.017; Zheng MG, 2012, CATENA, V98, P29, DOI 10.1016/j.catena.2012.05.013; Zheng MG, 2011, EARTH SURF PROC LAND, V36, P1499, DOI 10.1002/esp.2176	55	16	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117989	10.1371/journal.pone.0117989	http://dx.doi.org/10.1371/journal.pone.0117989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781173	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600018
J	Hou, CL; Liu, H; Zhang, J; Zhang, SH; Yang, FJ; Zeng, XF; Thacker, PA; Zhang, GL; Qiao, SY				Hou, Chengli; Liu, Hong; Zhang, Jiang; Zhang, Shihai; Yang, Fengjuan; Zeng, Xiangfang; Thacker, Philip A.; Zhang, Guolong; Qiao, Shiyan			Intestinal Microbiota Succession and Immunomodulatory Consequences after Introduction of Lactobacillus reuteri I5007 in Neonatal Piglets	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; GUT MICROBIOTA; GASTROINTESTINAL-TRACT; IMMUNE-SYSTEM; HYGIENE HYPOTHESIS; FERMENTUM I5007; MUCOSAL DEFENSE; HOST; BACTERIA; COMPLEX	Seventy-two, suckling piglets, obtained from 9 litters standardized to 8 piglets, were assigned to 1 of 3 treatments (n = 24) to compare short-term, early administration with intermittent, longer-term administration of Lactobacillus reuteri I5007. The treatments were a control (given a placebo of 0.1% peptone water from day 1 to 5) or treatments in which 1.7 x 10 (10) CFU Lactobacillus reuteri was administrated either daily for 4 days starting on day 1 or every 4th day from day 1 to 17. Five piglets per treatment were killed at 3 time points (day 7, 14 and 21). Denaturing Gradient Electrophoresis of ileal digesta revealed an increase in the presence of Lactobacillus reuteri I5007 and Clostridium lentocellum (on day 14 and 21) in the every 4th-day treatment and Actinobacillus porcinus (on day 7 and 14) in both Lactobacillus reuteri treatments, while reducing the abundance of E. coli on day 21 in the every 4th-day treatment. Real-time qPCR of ileal digesta showed an increase in Bifidobacterium spp. on day 14 for both Lactobacillus reuteri I5007 treatments. An increase in the concentration of lactic acid and a lower pH was observed in the first 4-day treatment on day 7 and the every 4th day treatment on day 14. The relative abundance of mRNA for TGF-beta was increased while that for IFN-gamma was decreased in the mesenteric lymph nodes of piglets treated with Lactobacillus reuteri every 4th day. In conclusion, early intervention with Lactobacillus reuteri increases the presence of beneficial bacteria and decreases the presence of undesirable microbes in the lower gastrointestinal tract. The changes appear to be mediated by altering the intestinal pH through lactic acid production resulting in favorable bacterial species colonization. A prolonged duration of treatment (i.e. every 4th day) would appear to be superior to treatment only during the first 4 days.	[Hou, Chengli; Liu, Hong; Zhang, Jiang; Zhang, Shihai; Yang, Fengjuan; Zeng, Xiangfang; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Thacker, Philip A.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada; [Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	China Agricultural University; University of Saskatchewan; Oklahoma State University System; Oklahoma State University - Stillwater	Qiao, SY (corresponding author), China Agr Univ, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qiaoshy@mafic.ac.cn	Zhang, Guolong/HCI-5587-2022; Hou, Chengli/AGY-1396-2022; chengli, Hou/AGZ-4530-2022; Zhang, Guolong/AAU-8197-2020	chengli, Hou/0000-0002-5617-8655; Zhang, Guolong/0000-0003-4781-5816	National Natural Science Foundation of China [31420103908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant Number 31420103908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Bezkorovainy A, 2001, AM J CLIN NUTR, V73, p399S, DOI 10.1093/ajcn/73.2.399s; Bjorksten B, 2006, CLIN EXP ALLERGY, V36, P1215, DOI 10.1111/j.1365-2222.2006.02579.x; Bjorksten B, 2009, NESTLE NUTR WORKS SE, V64, P11, DOI 10.1159/000235780; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Brandt K, 2012, CLINICS, V67, P113, DOI 10.6061/clinics/2012(02)05; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Claud EC, 2011, ANAEROBE, V17, P180, DOI 10.1016/j.anaerobe.2011.02.004; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duncker SC, 2006, VET IMMUNOL IMMUNOP, V111, P239, DOI 10.1016/j.vetimm.2006.01.017; Forchielli ML, 2005, BRIT J NUTR, V93, pS41, DOI 10.1079/BJN20041356; Franklin MA, 2002, J ANIM SCI, V80, P2904; Gaskins HR, 2008, CLIN INFECT DIS, V46, pS80, DOI 10.1086/523336; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hou CL, 2014, J BIOTECHNOL, V179, P63, DOI 10.1016/j.jbiotec.2014.03.019; Isolauri E., 2004, CURR PAEDIAT, V14, P104, DOI DOI 10.1016/J.CUPE.2003.11.002; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kok RG, 1996, APPL ENVIRON MICROB, V62, P3668, DOI 10.1128/AEM.62.10.3668-3672.1996; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Li XJ, 2008, J APPL MICROBIOL, V104, P1082, DOI 10.1111/j.1365-2672.2007.03636.x; Liu H, 2014, J AGR FOOD CHEM, V62, P860, DOI 10.1021/jf403288r; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Marzotto M, 2006, RES MICROBIOL, V157, P857, DOI 10.1016/j.resmic.2006.06.007; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nubel U, 1996, J BACTERIOL, V178, P5636; Paulin SM, 2007, INFECT IMMUN, V75, P3950, DOI 10.1128/IAI.00366-07; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; SWORDS WE, 1993, BIOL NEONATE, V63, P191, DOI 10.1159/000243931; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang XQ, 2012, J NUTR, V142, P7, DOI 10.3945/jn.111.147074; Ye LL, 2008, DEV COMP IMMUNOL, V32, P966, DOI 10.1016/j.dci.2008.01.008; Yi JQ, 2013, ASIAN AUSTRAL J ANIM, V26, P1181, DOI 10.5713/ajas.2013.13129; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	51	27	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119505	10.1371/journal.pone.0119505	http://dx.doi.org/10.1371/journal.pone.0119505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775260	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500099
J	Meunier, CNJ; Callebert, J; Cancela, JM; Fossier, P				Meunier, Claire Nicole Jeanne; Callebert, Jacques; Cancela, Jose-Manuel; Fossier, Philippe			Effect of Dopaminergic D1 Receptors on Plasticity Is Dependent of Serotoninergic 5-HT1A Receptors in L5-Pyramidal Neurons of the Prefrontal Cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXCITATION-INHIBITION BALANCE; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CELLULAR-LOCALIZATION; GABAERGIC INHIBITION; AREA CA1; MODULATION; DEPRESSION; MECHANISMS	Major depression and schizophrenia are associated with dysfunctions of serotoninergic and dopaminergic systems mainly in the prefrontal cortex (PFC). Both serotonin and dopamine are known to modulate synaptic plasticity. 5-HT1A receptors (5-HT(1A)Rs) and dopaminergic type D1 receptors are highly represented on dendritic spines of layer 5 pyramidal neurons (L5PyNs) in PFC. How these receptors interact to tune plasticity is poorly understood. Here we show that D1-like receptors (D1Rs) activation requires functional 5HT(1A)Rs to facilitate LTP induction at the expense of LTD. Using 129/Sv and 5-HT1AR-KO mice, we recorded post-synaptic currents evoked by electrical stimulation in layer 2/3 after activation or inhibition of D1Rs. High frequency stimulation resulted in the induction of LTP, LTD or no plasticity. The D1 agonist markedly enhanced the NMDA current in 129/Sv mice and the percentage of L5PyNs displaying LTP was enhanced whereas LTD was reduced. In 5HT(1A)R-KO mice, the D1 agonist failed to increase the NMDA current and orientated the plasticity towards L5PyNs displaying LTD, thus revealing a prominent role of 5-HT(1A)Rs in dopamine-induced modulation of plasticity. Our data suggest that in pathological situation where 5-HT(1A)Rs expression varies, dopaminergic treatment used for its ability to increase LTP could turn to be less and less effective.	[Meunier, Claire Nicole Jeanne; Cancela, Jose-Manuel; Fossier, Philippe] Univ Paris 11, Neurosci Paris Saclay Inst NeuroPSI, CNRS, UMR 8197, F-91405 Orsay, France; [Callebert, Jacques] Univ Paris 05, Lab Neuropharmacol Addict, INSERM, CNRS,U705,UMR 7157, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fossier, P (corresponding author), Univ Paris 11, Neurosci Paris Saclay Inst NeuroPSI, CNRS, UMR 8197, Batiment 446, F-91405 Orsay, France.	philippe.fossier@u-psud.fr	callebert, jacques/L-4569-2017	Cancela, Jose-Manuel/0000-0002-6234-1500	CNRS; SANOFI-AVENTIS R.D. Exploratory Unit	CNRS(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS R.D. Exploratory Unit	This research has been supported by grants from CNRS. C.N.J Meunier is the recipient of a fellowship from CNRS and SANOFI-AVENTIS R.D. Exploratory Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2011, PHARMACOL BIOCHEM BE, V99, P211, DOI 10.1016/j.pbb.2011.01.020; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Azmitia EC, 1996, NEUROPSYCHOPHARMACOL, V14, P35, DOI 10.1016/S0893-133X(96)80057-1; Bai J, 2014, CEREB CORTEX, V24, P945, DOI 10.1093/cercor/bhs376; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bhagwagar Z, 2004, MOL PSYCHIATR, V9, P386, DOI 10.1038/sj.mp.4001401; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; Diaz-Mataix L, 2005, J NEUROSCI, V25, P10831, DOI 10.1523/JNEUROSCI.2999-05.2005; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Gamo NJ, 2011, BEHAV NEUROSCI, V125, P282, DOI 10.1037/a0023165; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Granon S, 2012, BEHAV BRAIN RES, V229, P419, DOI 10.1016/j.bbr.2011.11.011; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Huang F-S, 2004, PNAS, V101, P3236; Huang FS, 2010, NEUROSCI RES, V67, P108, DOI 10.1016/j.neures.2010.02.005; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; Koch G, 2011, CLIN NEUROPHYSIOL, V122, P703, DOI 10.1016/j.clinph.2010.10.033; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Kruse MS, 2009, EUR NEUROPSYCHOPHARM, V19, P296, DOI 10.1016/j.euroneuro.2008.12.006; Ladepeche L, 2014, SEMIN CELL DEV BIOL, V27, P3, DOI 10.1016/j.semcdb.2013.10.005; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Meunier CNJ, 2013, NEUROPHARMACOLOGY, V71, P37, DOI 10.1016/j.neuropharm.2013.03.003; Moreau AW, 2013, NEUROSCIENCE, V238, P148, DOI 10.1016/j.neuroscience.2013.02.013; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Oda S, 2010, BRAIN RES, V1329, P89, DOI 10.1016/j.brainres.2010.03.011; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; SAKAI N, 1993, BRAIN RES, V613, P326, DOI 10.1016/0006-8993(93)90921-9; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sheynikhovich D, 2011, J PHYSIOL-PARIS, V105, P45, DOI 10.1016/j.jphysparis.2011.08.001; Shively CA, 2006, ARCH GEN PSYCHIAT, V63, P396, DOI 10.1001/archpsyc.63.4.396; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P252, DOI 10.1016/S1364-6613(99)01345-5; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Van den Oever MC, 2010, NEUROSCI BIOBEHAV R, V35, P276, DOI 10.1016/j.neubiorev.2009.11.016; Varela JA, 2009, J NEUROSCI, V29, P3109, DOI 10.1523/JNEUROSCI.4746-08.2009; Vargas R, 2011, SYNAPSE, V65, P441, DOI 10.1002/syn.20862; Wirkner K, 2004, NEUROSCI LETT, V372, P89, DOI 10.1016/j.neulet.2004.09.015; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; Wolf ME, 2010, NEUROTOX RES, V18, P393, DOI 10.1007/s12640-010-9176-0; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	74	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120286	10.1371/journal.pone.0120286	http://dx.doi.org/10.1371/journal.pone.0120286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775449	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500163
J	Shivanna, S; Harrold, I; Shashar, M; Meyer, R; Kiang, C; Francis, J; Zhao, Q; Feng, H; Edelman, ER; Rahimi, N; Chitalia, VC				Shivanna, Sowmya; Harrold, Itrat; Shashar, Moshe; Meyer, Rosanna; Kiang, Chrystelle; Francis, Jean; Zhao, Qing; Feng, Hui; Edelman, Elazer R.; Rahimi, Nader; Chitalia, Vipul C.			The c-Cbl Ubiquitin Ligase Regulates Nuclear beta-Catenin and Angiogenesis by Its Tyrosine Phosphorylation Mediated through the Wnt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INHIBITS ANGIOGENESIS; TUMOR-GROWTH; ACTIVATION; PLC-GAMMA-1; STABILITY; TARGETS; ROLES	Wnt signaling plays important roles in both the tumor-induced angiogenesis and tumorigenesis through the transcriptionally active nuclear beta-catenin. Recently, c-Cbl was identified as a unique E3 ubiquitin ligase targeting the active nuclear beta-catenin. However, little is known about the molecular mechanisms by which c-Cbl regulates ubiquitination and degradation of active beta-catenin. Here, we demonstrate that Wnt activation promotes the phosphorylation of c-Cbl at tyrosine 731(Tyr-731), which increases c-Cbl dimerization and binding to beta-catenin. Tyr-731 phosphorylation and dimerization mediate c-Cbl nuclear translocation and lead to the degradation of nuclearly active beta-catenin in the Wnt-on phase. c-Cbl activation also inhibits expression of the pro-angiogenic Wnt targets, IL-8 and VEGF. Phospho-Tyr-731-inactive mutant c-Cbl (Y731F) enhances and phosphomimetic mutant c-Cbl (Y731E) suppresses angiogenesis in zebrafish. Taken together, we have identified a novel mechanism for the regulation of active nuclear beta-catenin by c-Cbl and its critical role in angiogenesis. This mechanism can be further explored to modulate both the pathological angiogenesis and the tumorigenesis.	[Shivanna, Sowmya; Shashar, Moshe; Francis, Jean; Chitalia, Vipul C.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA; [Harrold, Itrat; Feng, Hui] Boston Univ, Sch Med, Dept Pharmacol, Sect Hematol & Med Oncol, Boston, MA 02118 USA; [Harrold, Itrat; Feng, Hui] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Meyer, Rosanna; Zhao, Qing; Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Kiang, Chrystelle; Edelman, Elazer R.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA	Boston University; Boston University; Boston University; Boston University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chitalia, VC (corresponding author), Boston Univ, Med Ctr, Evans Biomed Res Ctr, Renal Sect,Dept Med, X-530, Boston, MA 02118 USA.	vichital@bu.edu	Feng, Hui/L-4343-2019; Francis, Jean M/O-9968-2017; Feng, Hui/D-4423-2019	Feng, Hui/0000-0003-1318-821X; shashar, moshe/0000-0002-9744-856X; Rahimi, Nader/0000-0002-6745-1725	National Institutes of Health from NCI [RO1 CA175382]; NHLBI [R01 GM49039, CA191970, R01EY017955, T32 HL007501]; American Cancer Society [IRG-72-001-36]; Sharon Anderson American Society of Nephrology Fellowship Award;  [R00CA134743]; NATIONAL CANCER INSTITUTE [R00CA134743, R21CA191970, R01CA175382] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); Sharon Anderson American Society of Nephrology Fellowship Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA175382 from NCI (to V. C. C.), Grant R01 GM49039 (to E. R. E.), Grants CA191970 and R01EY017955 (to N. R.), Grant T32 HL007501 from NHLBI (to I. H.), and Grant R00CA134743 (to H. F.). This work was also supported by American Cancer Society Grant IRG-72-001-36 (to H. F.) and the Sharon Anderson American Society of Nephrology Fellowship Award (to M. S.).	Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Chitalia V, 2013, J BIOL CHEM, V288, P23505, DOI 10.1074/jbc.M113.473801; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Harisis GN, 2013, J PEDIATR SURG, V48, P1573, DOI 10.1016/j.jpedsurg.2012.08.038; Hartsough EJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004289; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Luscan A, 2014, CLIN CANCER RES, V20, P358, DOI 10.1158/1078-0432.CCR-13-0780; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meyer RD, 2011, ONCOGENE, V30, P2198, DOI 10.1038/onc.2010.597; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parmalee NL, 2008, CURR DRUG TARGETS, V9, P558, DOI 10.2174/138945008784911822; Planutis K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05630; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	30	29	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12537	12546		10.1074/jbc.M114.616623	http://dx.doi.org/10.1074/jbc.M114.616623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25784557	Green Published, hybrid			2022-12-26	WOS:000354569000010
J	Steblyanko, M; Anikeeva, N; Campbell, KS; Keen, JH; Sykulev, Y				Steblyanko, Maria; Anikeeva, Nadia; Campbell, Kerry S.; Keen, James H.; Sykulev, Yuri			Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; immunology; lymphocyte; natural killer cells (NK cells); signaling; ADCC; Cytotoxic lymphocytes; Integrin receptors; signaling microclusters; killing kinetics	T-CELL-RECEPTOR; IMMUNOLOGICAL SYNAPSE; CYTOLYTIC ACTIVITY; TYROSINE KINASE; RING JUNCTION; ADHESION; ACTIVATION; LYMPHOCYTES; MOLECULES; BINDING	Background: The mechanism by which integrin signaling regulates lymphocyte cytolytic activity is poorly understood. Results: The extent of integrin ligation influences the size and dynamics of signaling microclusters. Conclusion: Integrins regulate the magnitude and duration of proximal signaling that affect lymphocyte degranulation kinetics and the rate of target cell lysis. Significance: Integrin engagement ensures more rapid cytolytic granule release and faster target cell destruction. Integrin engagement on lymphocytes initiates outside-in signaling that is required for cytoskeleton remodeling and the formation of the synaptic interface. However, the mechanism by which the outside-in signal contributes to receptor-mediated intracellular signaling that regulates the kinetics of granule delivery and efficiency of cytolytic activity is not well understood. We have found that variations in ICAM-1 expression on tumor cells influence killing kinetics of these cells by CD16.NK-92 cytolytic effectors suggesting that changes in integrin ligation on the effector cells regulate the kinetics of cytolytic activity by the effector cells. To understand how variations of the integrin receptor ligation may alter cytolytic activity of CD16.NK-92 cells, we analyzed molecular events at the contact area of these cells exposed to planar lipid bilayers that display integrin ligands at different densities and activating CD16-specific antibodies. Changes in the extent of integrin ligation on CD16.NK-92 cells at the cell/bilayer interface revealed that the integrin signal influences the size and the dynamics of activating receptor microclusters in a Pyk2-dependent manner. Integrin-mediated changes of the intracellular signaling significantly affected the kinetics of degranulation of CD16.NK-92 cells providing evidence that integrins regulate the rate of target cell destruction in antibody-dependent cell cytotoxicity (ADCC).	[Steblyanko, Maria; Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Keen, James H.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Campbell, Kerry S.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Jefferson University; Jefferson University; Fox Chase Cancer Center	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, 233S 10th St,BLSB 706, Philadelphia, PA 19107 USA.	Yuri.Sykulev@Jefferson.edu	Regan, Clinton/E-6250-2012; Campbell, Kerry S./T-1381-2019		National Institutes of Health [AI52812, CA131973, CA083859, GM49217]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA083859, R21CA131973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052812, R56AI052812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants to Y.S. (AI52812; CA131973), to K.S.C. (CA083859), and to J.H.K. (GM49217). CD16.NK-92 cells are protected by patents or pending patents by K.S.C. and licensed through Conkwest, Inc.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2014, EUR J IMMUNOL, V44, P2331, DOI 10.1002/eji.201344179; Anikeeva N, 2011, IMMUNOL RES, V51, P183, DOI 10.1007/s12026-011-8252-8; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho DH, 2000, CELL IMMUNOL, V199, P1, DOI 10.1006/cimm.1999.1592; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Dagnino L, 2011, J CELL COMMUN SIGNAL, V5, P81, DOI 10.1007/s12079-011-0124-4; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; Gustafson KS, 1996, J BIOL CHEM, V271, P20035, DOI 10.1074/jbc.271.33.20035; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; Jenkins MR, 2014, ELIFE, V3, DOI 10.7554/eLife.01310; Kahn ML, 2006, NAT IMMUNOL, V7, P1286, DOI 10.1038/ni1206-1286; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; March ME, 2011, J IMMUNOL, V186, P2998, DOI 10.4049/jimmunol.1002438; Miah SMS, 2010, METHODS MOL BIOL, V612, P199, DOI 10.1007/978-1-60761-362-6_13; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Poenie M., 2012, ROLE MTOC T CELL EFF; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; Treanor B, 2009, BIOCHEM SOC T, V37, P1014, DOI 10.1042/BST0371014; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210; Zhang MG, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005629	51	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11833	11842		10.1074/jbc.M114.614719	http://dx.doi.org/10.1074/jbc.M114.614719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778396	hybrid, Green Published			2022-12-26	WOS:000354388600003
J	Escobar, C; Pateira, S; Lobo, E; Lobo, L; Teodosio, R; Dias, F; Fernandes, N; Arez, AP; Varandas, L; Nogueira, F				Escobar, Carlos; Pateira, Sara; Lobo, Elsa; Lobo, Lis; Teodosio, Rosa; Dias, Fernanda; Fernandes, Natercia; Arez, Ana Paula; Varandas, Luis; Nogueira, Fatima			Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs	PLOS ONE			English	Article							RESISTANCE; MALARIA	We report the presence of SNPs in Plasmodium falciparum K13-propeller gene in two African countries, Angola and Mozambique, where malaria is a serious public health problem. Samples were collected before and after ACT introduction as first-line treatment. In each country 50 samples collected before and 50 after ACT introduction were analysed. A total of three different mutations (R471R and R575R in Angola and V494I in Mozambique) were identified in five samples, all collected after the introduction of ACT. The R471R mutation detected in Angola has already been reported in Africa (DR-Congo and Gabon). However, the mutations R575R (Angola) and V494I (Mozambique), have never been reported. V494I is adjacent to the known K13 resistance-associated mutation Y493H, although functional analysis did not predict a deleterious effect on protein function.	[Escobar, Carlos] Hosp Prof Doutor Fernando Fonseca EPE, Dept Pediat, Amadora, Portugal; [Escobar, Carlos; Teodosio, Rosa; Varandas, Luis] Univ Nova Lisboa, Inst Higiene & Med Trop, UEICT, P-1200 Lisbon, Portugal; [Pateira, Sara; Lobo, Elsa; Arez, Ana Paula; Nogueira, Fatima] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal; [Lobo, Elsa; Lobo, Lis] Univ Eduardo Mondlane, Fac Med, Dept Ciencias Fisiol, Maputo, Mozambique; [Lobo, Lis; Arez, Ana Paula; Varandas, Luis; Nogueira, Fatima] Univ Nova Lisboa, Inst Higiene & Med Trop, CMDT, P-1200 Lisbon, Portugal; [Dias, Fernanda] Univ Agostinho Neto, Fac Med, Dept Med Interna, Luanda, Angola; [Fernandes, Natercia] Univ Eduardo Mondlane, Fac Med, Dept Pediat, Maputo, Mozambique	Hospital Professor Doutor Fernando Fonseca, EPE; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Eduardo Mondlane University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University Agostinho Neto; Eduardo Mondlane University	Nogueira, F (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal.	fnogueira@ihmt.unl.pt	nogueira, fatima/I-2148-2012; Arez, Ana Paula/I-1729-2012; Ibáñez, Carlos Escobar/B-3761-2017; Varandas, Luis/K-4592-2013	nogueira, fatima/0000-0003-0313-0778; Arez, Ana Paula/0000-0002-0497-6532; Ibáñez, Carlos Escobar/0000-0003-4442-4537; Tavares Coelho Lobo, Lis/0000-0001-7251-5538; Teodosio, Rosa/0000-0001-7330-6930; Varandas, Luis/0000-0002-8419-6033	Universidade Eduardo Mondlane, Maputo, Mocambique; Universidade Agostinho Neto, Luanda, Angola; Centro de Malaria e outras Doencas Tropicais [PEst-OE/SAU/LA0018/2011, LA0018 2011/2012]	Universidade Eduardo Mondlane, Maputo, Mocambique; Universidade Agostinho Neto, Luanda, Angola; Centro de Malaria e outras Doencas Tropicais	Field work was supported by Universidade Eduardo Mondlane (http://www.uem.mz/index.php/faculdades-e-escolas/faculdades/faculdade-demedicina), Maputo, Mocambique and by Universidade Agostinho Neto (http://www.agostinhoneto.co.ao), Luanda, Angola. Molecular analysis was supported by Centro de Malaria e outras Doencas Tropicais [PEst-OE/SAU/LA0018/2011 - Proj. Estrategico LA0018 2011/2012 (more information available at: http://cmdt.ihmt.unl.pt/index.php/pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; [Anonymous], J INFECT DIS; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; DHS program, 2011, ANG INQ IND MAL; Fernandes N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-35; Figueiredo P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-236; Kamau E., 2014, J INFECT DIS; Lobo E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-300; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Ministerio de Saude da Republica de Mocambique, 2011, PLAN ESTR MAL 2012 2; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Taylor SM, 2014, J INFECT DIS; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2014, STAT REP ART RES SEP	15	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119215	10.1371/journal.pone.0119215	http://dx.doi.org/10.1371/journal.pone.0119215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789669	Green Published, gold			2022-12-26	WOS:000351425400072
J	Tran, TT; Gordon, SC; Fung, S; Dinh, P; Yee, L; Martins, EB; Buti, M; Marcellin, P				Tran, Tram T.; Gordon, Stuart C.; Fung, Scott; Dinh, Phillip; Yee, Leland; Martins, Eduardo Bruno; Buti, Maria; Marcellin, Patrick			Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials	PLOS ONE			English	Article							PREVENT PERINATAL TRANSMISSION; TO-CHILD TRANSMISSION; VERTICAL TRANSMISSION; VIRUS INFECTION; PREGNANT-WOMEN; FAILURE; LAMIVUDINE; MOTHERS; IMMUNOPROPHYLAXIS; INTERRUPTION	Background Perinatal or mother-to-child transmission of hepatitis B virus (HBV) results in a high frequency of chronic infection. Risk of mother-to-child transmission is associated with maternal viral factors including hepatitis B e antigen (HBeAg) positivity and viral load. Aim To investigate associations between age, HBeAg status, HBV DNA levels and genotype in female patients screened for inclusion into two contemporary, randomized HBV trials. Methods Retrospective analyses focused on differences between women of childbearing age (<= 44 years) and older women. Female patients (N = 355; 18-69 years) were included in the analysis: 41.7% of patients were Asian. In total, 44.4% were HBeAg-positive. Results Significantly more women aged <= 44 years were HBeAg-positive compared to women >= 45 years (57.2% versus 27.5%, respectively, p<0.0001), this proportion declined with increasing age. Younger women were significantly more likely to have high HBV viral load (HBV DNA>10(8) copies mL: <= 44 years 46.0% vs >= 45 years 25.5%, respectively; p<0.0001), and this declined with increasing age. HBeAg positivity was slightly higher in Asian women, associated with a higher proportion of HBV genotypes B and C in this population. There was no obvious relationship between genotype and viral load. Conclusions Women of childbearing age with CHB are more likely to have high HBV viral load and HBeAg positivity than older women; this likelihood decreases with age. Maternal serological and virological status should therefore be established early in pregnancy, taking into account age and genotype, and a risk-reducing strategy implemented in any patient who is HBeAg positive and has a high viral load.	[Tran, Tram T.] Cedars Sinai Med Ctr, Liver Dis & Transplant Ctr, Los Angeles, CA 90048 USA; [Gordon, Stuart C.] Henry Ford Hosp, Div Hepatol, Detroit, MI 48202 USA; [Fung, Scott] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dinh, Phillip; Yee, Leland; Martins, Eduardo Bruno] Gilead Sci, Foster City, CA USA; [Buti, Maria] Univ Valle Hebron & Ciberehd, Dept Hepatol, Inst Carlos 3, Gen Hosp, Barcelona, Spain; [Marcellin, Patrick] Univ Paris, Dept Hepatol, F-75252 Paris, France	Cedars Sinai Medical Center; Henry Ford Health System; Henry Ford Hospital; University of Toronto; Gilead Sciences; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; UDICE-French Research Universities; Universite Paris Cite	Tran, TT (corresponding author), Cedars Sinai Med Ctr, Liver Dis & Transplant Ctr, Los Angeles, CA 90048 USA.	Tram.Tran@cshs.org		Martins, Eduardo/0000-0003-1947-7784; Buti Ferret, Maria/0000-0002-0732-3078; Yee, Leland Jonathan/0000-0002-0369-5878	Gilead Sciences, Foster City, USA; Gilead Sciences	Gilead Sciences, Foster City, USA; Gilead Sciences(Gilead Sciences)	This study was funded by Gilead Sciences (www.Gilead.com), Foster City, USA. (Study 102; NCT00117676, Study 103; NCT00116805) The writing of this paper was funded by Gilead Sciences, Foster City, USA. Initial data analyses were undertaken by and funded by Gilead Sciences. The funders participated in the study design and data collection and analysis, and funded editorial assistance with the preparation of the manuscript.	BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; DELCANHO R, 1994, J HEPATOL, V20, P483, DOI 10.1016/S0168-8278(05)80494-5; Ding Y, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-17, 10.1186/1743-422X-10-78]; Gilead Sciences, TENOFOVIR PRESCRIBIN; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Han L, 2011, WORLD J GASTROENTERO, V17, P4321, DOI 10.3748/wjg.v17.i38.4321; Inui A, 2007, J MED VIROL, V79, P670, DOI 10.1002/jmv.20884; Li XM, 2004, WORLD J GASTROENTERO, V10, P3215; Liu SL, 2009, ARCH VIROL, V154, P437, DOI 10.1007/s00705-009-0315-y; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; Oshitani H, 1996, T ROY SOC TROP MED H, V90, P235, DOI 10.1016/S0035-9203(96)90227-8; Ott JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-131; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P520, DOI 10.1016/j.cgh.2012.01.019; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; Soderstrom A, 2003, SCAND J INFECT DIS, V35, P814, DOI 10.1080/00365540310016547; Song YM, 2007, EUR J PEDIATR, V166, P813, DOI 10.1007/s00431-006-0327-5; Sun KX, 2012, VACCINE, V30, P5335, DOI 10.1016/j.vaccine.2012.06.036; van Zonneveld M, 2003, J VIRAL HEPATITIS, V10, P294, DOI 10.1046/j.1365-2893.2003.00440.x; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121632	10.1371/journal.pone.0121632	http://dx.doi.org/10.1371/journal.pone.0121632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789483	Green Submitted, Green Published, gold			2022-12-26	WOS:000351425400200
J	Kines, RC; Zarnitsyn, V; Johnson, TR; Pang, YYS; Corbett, KS; Nicewonger, JD; Gangopadhyay, A; Chen, M; Liu, J; Prausnitz, MR; Schiller, JT; Graham, BS				Kines, Rhonda C.; Zarnitsyn, Vladimir; Johnson, Teresa R.; Pang, Yuk-Ying S.; Corbett, Kizzmekia S.; Nicewonger, John D.; Gangopadhyay, Anu; Chen, Man; Liu, Jie; Prausnitz, Mark R.; Schiller, John T.; Graham, Barney S.			Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; WEST-NILE-VIRUS; FUSION GLYCOPROTEIN; MONOCLONAL-ANTIBODY; CELL RESPONSES; MOUSE MODEL; DNA; DELIVERY; INFECTION; PROTECTION	Human papilloma virus-like particles (HPV VLP) serve as the basis of the current licensed vaccines for HPV. We have previously shown that encapsidation of DNA expressing the model antigen M/M2 from respiratory syncytial virus (RSV) in HPV pseudovirions (PsV) is immunogenic when delivered intravaginally. Because the HPV capsids confer tropism for basal epithelium, they represent attractive carriers for vaccination targeted to the skin using microneedles. In this study we asked: 1) whether HPV16 VLP administered by microneedles could induce protective immune responses to HPV16 and 2) whether HPV16 PsV-encapsidated plasmids delivered by microneedles could elicit immune responses to both HPV and the antigen delivered by the transgene. Mice immunized with HPV16 VLP coated microneedles generated robust neutralizing antibody responses and were protected from HPV16 challenge. Microneedle arrays coated with HPV16-M/M2 or HPV16-F protein (genes of RSV) were then tested and dose-dependent HPV and F-specific antibody responses were detected post-immunization, and M/M2-specific T-cell responses were detected post RSV challenge, respectively. HPV16 PsV-F immunized mice were fully protected from challenge with HPV16 PsV and had reduced RSV viral load in lung and nose upon intranasal RSV challenge. In summary, HPV16 PsV-encapsidated DNA delivered by microneedles induced neutralizing antibody responses against HPV and primed for antibody and T-cell responses to RSV antigens encoded by the encapsidated plasmids. Although the immunogenicity of the DNA component was just above the dose response threshold, the HPV-specific immunity was robust. Taken together, these data suggest microneedle delivery of lyophilized HPV PsV could provide a practical, thermostable combined vaccine approach that could be developed for clinical evaluation.	[Kines, Rhonda C.; Pang, Yuk-Ying S.; Schiller, John T.] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Zarnitsyn, Vladimir; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Johnson, Teresa R.; Corbett, Kizzmekia S.; Nicewonger, John D.; Gangopadhyay, Anu; Chen, Man; Liu, Jie; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Graham, Barney S./AAC-5898-2019; Schiller, John/ABK-8287-2022	Graham, Barney S./0000-0001-8112-0853; Prausnitz, Mark/0000-0002-9076-8448	National Institute of Allergy and Infectious Diseases; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005061, ZIAAI005029] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Buck C. B., 2007, CURR PROTOC CELL BIO, V26, P261; Corbett HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013460; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; Favard C, 2007, CURR GENE THER, V7, P67, DOI 10.2174/156652307779940207; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gill HS, 2010, GENE THER, V17, P811, DOI 10.1038/gt.2010.22; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Gonzalez-Gonzalez E, 2011, SCI REP-UK, V1, DOI 10.1038/srep00158; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Graham BS, 2010, MUCOSAL IMMUNOL, V3, P475, DOI 10.1038/mi.2010.31; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Graham BS, 2011, IMMUNE RESPONSE TO INFECTION, P559; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; Hopkins TG, 2013, VACCINE, V31, P1673, DOI 10.1016/j.vaccine.2013.01.028; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Liu J, 2009, J VIROL, V83, P4934, DOI 10.1128/JVI.02140-08; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Meissner HC, 1999, PEDIATR INFECT DIS J, V18, P223, DOI 10.1097/00006454-199903000-00004; Mitsunaga M, 2011, CANCER PREV RES, V4, P767, DOI 10.1158/1940-6207.CAPR-10-0334; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pearton M, 2012, J CONTROL RELEASE, V160, P561, DOI 10.1016/j.jconrel.2012.04.005; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Sheets RL, 2006, TOXICOL SCI, V91, P610, DOI 10.1093/toxsci/kfj169; Song JM, 2012, MOL THER, V20, P1472, DOI 10.1038/mt.2012.69; Song JM, 2010, CLIN VACCINE IMMUNOL, V17, P1381, DOI 10.1128/CVI.00100-10; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252	46	36	39	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120797	10.1371/journal.pone.0120797	http://dx.doi.org/10.1371/journal.pone.0120797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785935	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500190
J	Kwon, CW; Park, KM; Kang, BC; Kweon, DH; Kim, MD; Shin, SW; Je, YH; Chang, PS				Kwon, Chang Woo; Park, Kyung-Min; Kang, Byoung-Cheorl; Kweon, Dae-Hyuk; Kim, Myoung-Dong; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick			Cysteine Protease Profiles of the Medicinal Plant Calotropis procera R. Br. Revealed by De Novo Transcriptome Analysis	PLOS ONE			English	Article							CATHEPSIN-L; LATEX; EXPRESSION; PURIFICATION; PROPEPTIDE; ACTIVATION	Calotropis procera R. Br., a traditional medicinal plant in India, is a promising source of commercial proteases, because the cysteine proteases from the plant exhibit high thermostability, broad pH optima, and plasma-clotting activity. Though several proteases such as Procerain, Procerain B, CpCp-1, CpCp-2, and CpCp-3 have been isolated and characterized, the information of their transcripts is limited to cDNAs encoding their mature peptides. Due to this limitation, in this study, to determine the cDNA sequences encoding full open reading frame of these cysteine proteases, transcripts were sequenced with an Illumina Hiseq2000 sequencer. A total of 171,253,393 clean reads were assembled into 106,093 contigs with an average length of 1,614 bp and an N50 of 2,703 bp, and 70,797 contigs with an average length of 1,565 bp and N50 of 2,082 bp using Trinity and Velvet-Oases software, respectively. Among these contigs, we found 20 unigenes related to papain-like cysteine proteases by BLASTX analysis against a non-redundant NCBI protein database. Our expression analysis revealed that the cysteine protease contains an N-terminal pro-peptide domain (inhibitor region), which is necessary for correct folding and proteolytic activity. It was evident that expression yields using an inducible T7 expression system in Escherichia coli were considerably higher with the pro-peptide domain than without the domain, which could contribute to molecular cloning of the Calotropis procera protease as an active form with correct folding.	[Kwon, Chang Woo; Park, Kyung-Min; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea; [Kang, Byoung-Cheorl; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kweon, Dae-Hyuk] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Kweon, Dae-Hyuk] Sungkyunkwan Univ, Ctr Human Interface Nanotechnol, Suwon, South Korea; [Kim, Myoung-Dong] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Kangwon National University; Seoul National University (SNU)	Chang, PS (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	pschang@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019	Park, Kyung-Min/0000-0002-4706-8681; Chang, Pahn-Shick/0000-0001-9645-7010	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013R1A1A2074378]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A2074378), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2007, MOL BIOCHEM PARASIT, V156, P191, DOI 10.1016/j.molbiopara.2007.07.021; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Choedon T, 2006, WORLD J GASTROENTERO, V12, P2517, DOI 10.3748/wjg.v12.i16.2517; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dewan Soneera, 2000, Indian Journal of Pharmacology, V32, P252; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hellberg A, 2002, PROTEIN EXPRES PURIF, V24, P131, DOI 10.1006/prep.2001.1548; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hwang HS, 2002, PROTEIN EXPRES PURIF, V25, P541, DOI 10.1016/S1046-5928(02)00033-5; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kumar VL, 2007, MEDIAT INFLAMM, V2007, DOI 10.1055/2007/47523; KUMAR VL, 1994, J ETHNOPHARMACOL, V44, P123, DOI 10.1016/0378-8741(94)90078-7; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nandana V, 2014, PROTEIN EXPRES PURIF, V103, P16, DOI 10.1016/j.pep.2014.08.003; Ramos MV, 2013, INT J BIOL MACROMOL, V58, P211, DOI 10.1016/j.ijbiomac.2013.04.001; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shivkar YM, 2003, PHARM BIOL, V41, P263, DOI 10.1076/phbi.41.4.263.15666; Singh AN, 2010, PROCESS BIOCHEM, V45, P399, DOI 10.1016/j.procbio.2009.10.014; Singh AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059806; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	28	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119328	10.1371/journal.pone.0119328	http://dx.doi.org/10.1371/journal.pone.0119328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786229	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500096
J	Li, S; Sun, X; Bai, YM; Qin, HM; Wu, XM; Zhang, X; Jolkkonen, J; Boltze, J; Wang, SP				Li, Shen; Sun, Xin; Bai, Yu-meng; Qin, Hua-min; Wu, Xiao-mei; Zhang, Xiao; Jolkkonen, Jukka; Boltze, Johannes; Wang, Su-ping			Infarction of the Corpus Callosum: A Retrospective Clinical Investigation	PLOS ONE			English	Article							ALIEN HAND SYNDROME; CEREBROVASCULAR-DISEASE; LESIONS; ARTERY; CHINA	Objectives The aim of this study was to investigate patients with ischemic infarctions in the territory of the corpus callosum to advance our understanding of this rare stroke subtype by providing comprehensive descriptive and epidemiological data. Methods From January 1, 2010 to June 30, 2014, all cases of acute ischemic stroke diagnosed by clinical manifestation and diffusion weighted imaging in Dalian Municipal Central Hospital were investigated. The patients presenting with corpus callosum infarctions were selected and further allocated into genu and/or body and splenium infarction groups. Proportion, lesion patterns, clinical features, risk factors and etiology of corpus callosum infarction were analyzed. Results Out of 1,629 cases, 59 patients (3.6%) with corpus callosum infarctions were identified by diffusion weighted imaging, including 7 patients who had ischemic lesions restricted to the corpus callosum territory. Thirty six patients had lesions in the splenium (61.0%). Corpus callosum infarction patients suffered from a broad spectrum of symptoms including weakness and/or numbness of the limbs, clumsy speech, and vertigo, which could not be explained by lesions in corpus callosum. A classical callosal disconnection syndrome was found in 2 out of all patients with corpus callosum infarctions. Statistical differences in the risk factor and infarct pattern between the genu and/or body group and splenium group were revealed. Conclusion Corpus callosum infarction and the callosal disconnection syndrome were generally rare. The most susceptible location of ischemic corpus callosum lesion was the splenium. Splenium infarctions were often associated with bilateral cerebral hemisphere involvement (46.2%). The genu and/or body infarctions were associated with atherosclerosis. The most common cause of corpus callosum infarction probably was embolism.	[Li, Shen; Sun, Xin; Bai, Yu-meng; Wang, Su-ping] Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Neurol, Dalian 116033, Peoples R China; [Qin, Hua-min] Dalian Med Univ, Hosp 2, Dept Pathol, Dalian 116027, Peoples R China; [Wu, Xiao-mei] China Med Univ, Hosp 1, Dept Clin Epidemiol, Shenyang 110001, Peoples R China; [Wu, Xiao-mei] China Med Univ, Hosp 1, Ctr Evidence Based Med, Shenyang 110001, Peoples R China; [Zhang, Xiao] Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Radiol, Dalian 116033, Peoples R China; [Jolkkonen, Jukka] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio 70210, Finland; [Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Dept Cell Therapy, D-04103 Leipzig, Germany; [Boltze, Johannes] Translat Ctr Regenerat Med, D-04103 Leipzig, Germany	Dalian Medical University; Dalian Medical University; China Medical University; China Medical University; Dalian Medical University; University of Eastern Finland; Fraunhofer Gesellschaft	Wang, SP (corresponding author), Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Neurol, Dalian 116033, Peoples R China.	wangsuping@medmail.com		Boltze, Johannes/0000-0003-3956-4164				Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Bourekas EC, 2002, AM J ROENTGENOL, V179, P251, DOI 10.2214/ajr.179.1.1790251; Chrysikopoulos H, 1997, EUR J RADIOL, V25, P2, DOI 10.1016/S0720-048X(96)01155-2; Devinsky O, 2003, EPILEPSY BEHAV, V4, P607, DOI 10.1016/j.yebeh.2003.08.029; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Gass A, 2004, LANCET NEUROL, V3, P39, DOI 10.1016/S1474-4422(03)00621-5; GIROUD M, 1995, J NEUROL NEUROSUR PS, V59, P238, DOI 10.1136/jnnp.59.3.238; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Kahilogullari G, 2008, CLIN ANAT, V21, P383, DOI 10.1002/ca.20647; Kasow DL, 2000, AM J NEURORADIOL, V21, P1876; LI SC, 1985, NEUROLOGY, V35, P1708, DOI 10.1212/WNL.35.12.1708; Liu LS, 2007, BIOCHEM CELL BIOL, V85, P157, DOI 10.1139/O07-004; Murthy SB, 2013, J CLIN NEUROSCI, V20, P175, DOI 10.1016/j.jocn.2012.05.013; Sharma B, 2014, AM J EMERG MED, V32, DOI [10.1016/j.ajem.2014.04.015, DOI 10.1016/J.AJEM.2014.04.015]; Suwanwela NC, 2002, J NEUROL NEUROSUR PS, V72, P533; Uchino A, 2006, EUR RADIOL, V16, P905, DOI 10.1007/s00330-005-0037-9; Yuan JL, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-142	17	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120409	10.1371/journal.pone.0120409	http://dx.doi.org/10.1371/journal.pone.0120409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785450	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500170
J	Sharma, H; Nagaraj, R				Sharma, Himanshu; Nagaraj, Ramakrishnan			Human beta-Defensin 4 with Non-Native Disulfide Bridges Exhibit Antimicrobial Activity	PLOS ONE			English	Article							MU-CONOTOXIN-PIIIA; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITIES; HUMAN BETA-DEFENSIN-2; BACTERICIDAL-ACTIVITY; ALPHA-DEFENSINS; MAMMALIAN DEFENSINS; BIOLOGICAL-ACTIVITY; INDUCIBLE PEPTIDE; SODIUM-CHANNELS	Human defensins play multiple roles in innate immunity including direct antimicrobial killing and immunomodulatory activity. They have three disulfide bridges which contribute to the stability of three anti-parallel beta-strands. The exact role of disulfide bridges and canonical beta-structure in the antimicrobial action is not yet fully understood. In this study, we have explored the antimicrobial activity of human beta-defensin 4 (HBD4) analogs that differ in the number and connectivity of disulfide bridges. The cysteine framework was similar to the disulfide bridges present in mu-conotoxins, an unrelated class of peptide toxins. All the analogs possessed enhanced antimicrobial potency as compared to native HBD4. Among the analogs, the single disulfide bridged peptide showedmaximum potency. However, there were no marked differences in the secondary structure of the analogs. Subtle variations were observed in the localization and membrane interaction of the analogs with bacteria and Candida albicans, suggesting a role for disulfide bridges in modulating their antimicrobial action. All analogs accumulated in the cytosol where they can bind to anionic molecules such as nucleic acids which would affect several cellular processes leading to cell death. Our study strongly suggests that native disulfide bridges or the canonical beta-strands in defensins have not evolved for maximal activity but they play important roles in determining their antimicrobial potency.	[Sharma, Himanshu; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.	nraj@ccmb.res.in			Council of Scientific and Industrial Research (CSIR) Network [NWP 05]; Department of Science and Technology (DST); JC Bose fellowship from the Department of Science and Technology (DST), India	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); JC Bose fellowship from the Department of Science and Technology (DST), India	This work was supported by funding from the Council of Scientific and Industrial Research (CSIR) Network project NWP 05 and Department of Science and Technology (DST). RN is the recipient of the JC Bose fellowship from the Department of Science and Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton E., 1990, SOLID PHASE PEPTIDE; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Circo R, 2002, BIOCHEM BIOPH RES CO, V293, P586, DOI 10.1016/S0006-291X(02)00267-X; Daly NL, 2009, IUBMB LIFE, V61, P144, DOI 10.1002/iub.158; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jacob RB, 2010, CELL MOL LIFE SCI, V67, P17, DOI 10.1007/s00018-009-0125-0; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Lourenzoni MR, 2007, J PHYS CHEM B, V111, P11318, DOI 10.1021/jp067127g; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Maria-Neto S, 2012, ANTIMICROB AGENTS CH, V56, P1714, DOI 10.1128/AAC.05558-11; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; SABERWAL G, 1994, BBA-REV BIOMEMBRANES, V1197, P109, DOI 10.1016/0304-4157(94)90002-7; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schmidt NW, 2012, J BIOL CHEM, V287, P21866, DOI 10.1074/jbc.M112.358721; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Schulz A, 2005, BIOPOLYMERS, V80, P34, DOI 10.1002/bip.20193; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sharma H, 2012, PEPTIDES, V38, P255, DOI 10.1016/j.peptides.2012.08.024; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; TANG YQ, 1993, J BIOL CHEM, V268, P6649; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thennarasu S, 1999, BIOCHEM BIOPH RES CO, V254, P281, DOI 10.1006/bbrc.1998.9933; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Xu Z, 2006, APPL MICROBIOL BIOT, V72, P471, DOI 10.1007/s00253-005-0287-0; Yao SG, 2008, BIOCHEMISTRY-US, V47, P10940, DOI 10.1021/bi801010u; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	75	28	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119525	10.1371/journal.pone.0119525	http://dx.doi.org/10.1371/journal.pone.0119525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785690	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500108
J	DiVall, SA; Herrera, D; Sklar, B; Wu, S; Wondisford, F; Radovick, S; Wolfe, A				DiVall, Sara A.; Herrera, Danny; Sklar, Bonnie; Wu, Sheng; Wondisford, Fredric; Radovick, Sally; Wolfe, Andrew			Insulin Receptor Signaling in the GnRH Neuron Plays a Role in the Abnormal GnRH Pulsatility of Obese Female Mice	PLOS ONE			English	Article							POLYCYSTIC OVARIAN SYNDROME; BODY-MASS INDEX; LUTEINIZING-HORMONE; NEUROPEPTIDE SECRETION; HYPOTHALAMIC NEURONS; INVERSE RELATIONSHIP; METABOLIC SYNDROME; DEPENDENT PATHWAY; MALE RATS; EXPRESSION	Infertility associated with obesity is characterized by abnormal hormone release from reproductive tissues in the hypothalamus, pituitary, and ovary. These tissues maintain insulin sensitivity upon peripheral insulin resistance. Insulin receptor signaling may play a role in the dysregulation of gonadotropin-releasing hormone (GnRH) secretion in obesity, but the interdependence of hormone secretion in the reproductive axis and the multi-hormone and tissue dysfunction in obesity hinders investigations of putative contributing factors to the disrupted GnRH secretion. To determine the role of GnRH insulin receptor signaling in the dysregulation of GnRH secretion in obesity, we created murine models of diet-induced obesity (DIO) with and without intact insulin signaling in the GnRH neuron. Obese control female mice were infertile with higher luteinizing hormone levels and higher GnRH pulse amplitude and total pulsatile secretion compared to lean control mice. In contrast, DIO mice with a GnRH specific knockout of insulin receptor had improved fertility, luteinizing hormone levels approaching lean mice, and GnRH pulse amplitude and total secretion similar to lean mice. Pituitary responsiveness was similar between genotypes. These results suggest that in the obese state, insulin receptor signaling in GnRH neurons increases GnRH pulsatile secretion and consequent LH secretion, contributing to reproductive dysfunction.	[DiVall, Sara A.; Herrera, Danny; Sklar, Bonnie; Wu, Sheng; Wondisford, Fredric; Radovick, Sally; Wolfe, Andrew] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University	DiVall, SA (corresponding author), Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.	sara.divall@seattlechildrens.org			National Institutes of Health [K08 HD056139, UO1-HD-066432]; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD056139, U54HD028934, P50HD028934, R00HD068130, U01HD066432] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health Grants K08 HD056139 to SD and UO1-HD-066432 to AW and SR. Technical support was provided by the Integrated Physiology Core of the Baltimore Diabetes Research Training Center (P60-DK-079637). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1999, NEUROENDOCRINOLOGY, V70, P353, DOI 10.1159/000054496; BOURGUIGNON JP, 1984, ENDOCRINOLOGY, V114, P1941, DOI 10.1210/endo-114-5-1941; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burcelin R, 2003, ENDOCRINOLOGY, V144, P4484, DOI 10.1210/en.2003-0457; Castellano JM, 2006, DIABETES, V55, P2602, DOI 10.2337/db05-1584; Castellano JM, 2011, ENDOCRINOLOGY, V152, P3396, DOI 10.1210/en.2010-1415; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DiVall SA, 2007, MOL CELL ENDOCRINOL, V270, P64, DOI 10.1016/j.mce.2007.02.007; DiVall SA, 2010, J CLIN INVEST, V120, P2900, DOI 10.1172/JCI41069; Heger S, 2003, ENDOCRINOLOGY, V144, P2566, DOI 10.1210/en.2002-221107; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Jain A, 2007, J CLIN ENDOCR METAB, V92, P2468, DOI 10.1210/jc.2006-2274; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Kovacs P, 2002, NEUROENDOCRINOLOGY, V76, P357, DOI 10.1159/000067585; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Nelson JF, LONGITUDINAL STUDY E; Novaira HJ, 2011, J NEUROSCI, V31, P3336, DOI 10.1523/JNEUROSCI.5419-10.2011; Pagan YL, 2006, J CLIN ENDOCR METAB, V91, P1309, DOI 10.1210/jc.2005-2099; Qiu XL, 2013, ENDOCRINOLOGY, V154, P1337, DOI 10.1210/en.2012-2056; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; RISMA KA, 1995, P NATL ACAD SCI USA, V92, P1322, DOI 10.1073/pnas.92.5.1322; Simpson HL, 1998, GROWTH HORM IGF RES, V8, P83, DOI 10.1016/S1096-6374(98)80098-1; Srouji SS, 2007, J CLIN ENDOCR METAB, V92, P1347, DOI 10.1210/jc.2006-2716; Suter KJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE130, DOI 10.1152/ajpendo.90300.2008; Tanaka T, 2000, BIOL REPROD, V62, P1256, DOI 10.1095/biolreprod62.5.1256; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; Wolfe A, 2008, J NEUROENDOCRINOL, V20, P909, DOI 10.1111/j.1365-2826.2008.01746.x; Woller MJ, 2010, AM J PHYSIOL-REG I, V298, pR70, DOI 10.1152/ajpregu.00193.2009; Wu S, 2011, DIABETES; Wu S., 2013, DIABETES; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yang JL, 2010, ENDOCRINOLOGY, V151, P774, DOI 10.1210/en.2009-0751	38	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119995	10.1371/journal.pone.0119995	http://dx.doi.org/10.1371/journal.pone.0119995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780937	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600116
J	Harris, ML; Byles, JE; Sibbritt, D; Loxton, D				Harris, Melissa L.; Byles, Julie E.; Sibbritt, David; Loxton, Deborah			"Just Get on with It": Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PSYCHOLOGICAL ADJUSTMENT; MIDDLE-AGE; DEPRESSION; IMPACT; ILLNESS; LIFE; PERSPECTIVE; PREDICTORS; DISTRESS	Objective To qualify the psychosocial burden of osteoarthritis for older women and identify factors perceived to assist with psychological adjustment to the disease. Methods Women who indicated being diagnosed/treated for osteoarthritis in the previous three years in the fifth survey of the Australian Longitudinal Study on Women's Health provided the sampling frame. Participants were randomly sampled until saturation was reached using a systematic process. Thematic content analysis was applied to the 19 semi-structured telephone interviews using a realist framework. Results The findings indicate that the emotional burden of osteoarthritis is considerable, and the process of psychological adjustment complex. Older women with osteoarthritis have psychological difficulties associated with increasing pain and functional impairment. Psychological adjustment over time was attributed primarily to cognitive and attitudinal factors (e.g. stoicism, making downward comparisons and possessing specific notions about the cause of arthritis). This was a dynamic 'day to day' process involving a constant struggle between grieving physical losses and increasing dependence amidst symptom management. Conclusion The findings of this study add to the current understanding of the complex processes involved in psychological adjustment over time. Targeted interventions focused on assisting women with arthritis redefine self-concepts outside the confines of caring responsibilities, coupled with public health education programs around understanding the destructive nature of arthritis are required. Understanding the destructive and (potentially) preventable nature of arthritis may facilitate early detection and increased uptake of appropriate treatment options for osteoarthritis that have the ability to modify disease trajectories.	[Harris, Melissa L.; Byles, Julie E.; Sibbritt, David; Loxton, Deborah] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Sibbritt, David] Univ Technol Sydney, Fac Hlth, Broadway, NSW, Australia	University of Newcastle; University of Technology Sydney	Harris, ML (corresponding author), Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	Melissa.Harris@newcastle.edu.au	Byles, Julie E/C-5062-2008; Sibbritt, David W/F-8070-2017	Byles, Julie E/0000-0002-3984-6877; Sibbritt, David W/0000-0003-3561-9447	Australian Government Department of Health [G0189875]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The Australian Longitudinal Study on Women's Health was funded by the Australian Government Department of Health (G0189875), http://www.health.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2005, RHEUMATOLOGY, V44, P105, DOI 10.1093/rheumatology/keh412; Ailinger R L, 1993, West J Nurs Res, V15, P340, DOI 10.1177/019394599301500306; Andrianakos AA, 2005, RHEUMATOLOGY, V44, P932, DOI 10.1093/rheumatology/keh650; Avci Dilek, 2004, Menopause, V11, P615, DOI 10.1097/01.GME.0000119985.45613.7E; Axford J, 2010, CLIN RHEUMATOL, V29, P1277, DOI 10.1007/s10067-010-1547-7; Badley Elizabeth M, 2004, BMC Womens Health, V4 Suppl 1, pS18, DOI 10.1186/1472-6874-4-S1-S18; Baird C L, 2000, Clin Excell Nurse Pract, V4, P231; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P985; Bolen J., 2005, Morbidity and Mortality Weekly Report, V54, P119; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BROWN GK, 1989, J CONSULT CLIN PSYCH, V57, P652, DOI 10.1037/0022-006X.57.5.652; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Buckwalter JA, 2000, CLIN ORTHOP RELAT R, P159; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Covic T, 2000, RHEUMATOLOGY, V39, P1027, DOI 10.1093/rheumatology/39.9.1027; Covinsky KE, 2008, J AM GERIATR SOC, V56, P23, DOI 10.1111/j.1532-5415.2007.01511.x; de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Evers AWM, 2002, J RHEUMATOL, V29, P2327; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Gorevic PD, 2004, GERIATRICS-US, V59, P28; Gronning K, 2011, CLIN RHEUMATOL, V30, P1425, DOI 10.1007/s10067-011-1836-9; Harris ML, 2012, J PSYCHOSOM RES, V73, P251, DOI 10.1016/j.jpsychores.2012.06.009; HAWLEY DJ, 1993, J RHEUMATOL, V20, P2025; Iaquinta ML, 2004, J NURS CARE QUAL, V19, P280, DOI 10.1097/00001786-200407000-00016; KATZ PP, 1995, ARTHRITIS RHEUM, V38, P49, DOI 10.1002/art.1780380108; Kee CC, 1998, APPL NURS RES, V11, P19, DOI 10.1016/S0897-1897(98)80041-4; Kitto SC, 2008, MED J AUSTRALIA, V188, P243, DOI 10.5694/j.1326-5377.2008.tb01595.x; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Ling SM, 1998, J AM GERIATR SOC, V46, P216, DOI 10.1111/j.1532-5415.1998.tb02543.x; Lutze U, 2007, SCAND J CARING SCI, V21, P64, DOI 10.1111/j.1471-6712.2007.00443.x; Marks R., 2013, AM J MED STUD SCI ED, V1, P11, DOI [10.12691/ajms-1-3-1], DOI 10.12691/AJMS-1-3-1]; Martel-Pelletier J, 1999, OSTEOARTHR CARTILAGE, V7, P371, DOI 10.1053/joca.1998.0214; Melanson PM, 2003, J ADV NURS, V42, P125, DOI 10.1046/j.1365-2648.2003.02595.x; Melanson PM, 1995, ACT ADAPT AGING, V19, P33; Mengshoel AM, 2008, ARTHRIT RHEUM-ARTHR, V59, P1439, DOI 10.1002/art.24103; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Persson LO, 2005, SCAND J RHEUMATOL, V34, P191, DOI 10.1080/03009740510017698; Plach SK, 2004, J FAMILY NURS, V10, P33; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Rosemann Thomas, 2007, J Orthop Surg Res, V2, P12, DOI 10.1186/1749-799X-2-12; Sharma L, 2006, CURR OPIN RHEUMATOL, V18, P147, DOI 10.1097/01.bor.0000209426.84775.f8; Sharpe L, 2001, J PSYCHOSOM RES, V51, P713, DOI 10.1016/S0022-3999(01)00266-5; Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x; Stamm T, 2008, QUAL HEALTH RES, V18, P658, DOI 10.1177/1049732308316348; Strauss A, 1990, BASICS QUALITATIVE R, DOI [10.1111/j.1365-2702.2009.02908.x, DOI 10.1111/J.1365-2702.2009.02908.X]; Sturgeon JA, 2010, CURR PAIN HEADACHE R, V14, P105, DOI 10.1007/s11916-010-0095-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Turner AP, 2007, ARTHRIT RHEUM-ARTHR, V57, P267, DOI 10.1002/art.22537; Uhlig T, 2000, RHEUMATOLOGY, V39, P732, DOI 10.1093/rheumatology/39.7.732; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; *WHO SCI GROUP, 2003, WHO TECHN REP SER, V919; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yelin E, 1989, GERIATR MED TODAY, V8, P103	60	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120507	10.1371/journal.pone.0120507	http://dx.doi.org/10.1371/journal.pone.0120507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781471	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600170
J	Hung, N; Shen, CC; Hu, YW; Hu, LY; Yeh, CM; Teng, CJ; Kuan, AS; Chen, SC; Chen, TJ; Liu, CJ				Hung, Ning; Shen, Cheng-Che; Hu, Yu-Wen; Hu, Li-Yu; Yeh, Chiu-Mei; Teng, Chung-Jen; Kuan, Ai-Seon; Chen, San-Chi; Chen, Tzeng-Ji; Liu, Chia-Jen			Risk of Cancer in Patients with Iron Deficiency Anemia: A Nationwide Population-Based Study	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC ADENOCARCINOMA; SERUM FERRITIN; PREVALENCE; CARCINOGENICITY; ESOPHAGUS; OUTCOMES; STORES; CARDIA; WOMEN	Objective This study evaluated the risk of cancer among patients with iron deficiency anemia (IDA) by using a nationwide population-based data set. Method Patients newly diagnosed with IDA and without antecedent cancer between 2000 and 2010 were recruited from the Taiwan National Health Insurance Research Database. The standardized incidence ratios (SIRs) of cancer types among patients with IDA were calculated. Results Patients with IDA exhibited an increased overall cancer risk (SIR: 2.15). Subgroup analysis showed that patients of both sexes and in all age groups had an increased SIR. After we excluded patients diagnosed with cancer within the first and first 5 years of IDA diagnosis, the SIRs remained significantly elevated at 1.43 and 1.30, respectively. In addition, the risks of pancreatic (SIR: 2.31), kidney (SIR: 2.23), liver (SIR: 1.94), and bladder cancers (SIR: 1.74) remained significantly increased after exclusion of patients diagnosed with cancer within 5 years after IDA diagnosis. Conclusion The overall cancer risk was significantly elevated among patients with IDA. After we excluded patients diagnosed with IDA and cancer within 1 and 5 years, the SIRs remained significantly elevated compared with those of the general population. The increased risk of cancer was not confined to gastrointestinal cancer when the SIRs of pancreatic, kidney, liver, and bladder cancers significantly increased after exclusion of patients diagnosed with IDA and cancer within the first 5 years. This finding may be caused by immune activities altered by IDA. Further study is necessary to determine the association between IDA and cancer risk.	[Hung, Ning; Hu, Yu-Wen; Teng, Chung-Jen; Kuan, Ai-Seon; Liu, Chia-Jen] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Shen, Cheng-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Hu, Yu-Wen] Natl Chung Cheng Univ, Dept Informat Magagement, Chiayi, Taiwan; [Hu, Yu-Wen; Teng, Chung-Jen; Chen, Tzeng-Ji; Liu, Chia-Jen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Li-Yu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, New Taipei City, Taiwan; [Chen, San-Chi; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Cheng University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan.	pures1000@yahoo.com.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Shen, Cheng-Che/0000-0003-1587-5590				AKIBA S, 1991, CANCER-AM CANCER SOC, V67, P1707, DOI 10.1002/1097-0142(19910315)67:6<1707::AID-CNCR2820670638>3.0.CO;2-C; Aslan M, 2006, MUTAT RES-FUND MOL M, V601, P144, DOI 10.1016/j.mrfmmm.2006.06.013; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Attia MA, 2009, INDIAN J HEMATOL BLO, V25, P70, DOI 10.1007/s12288-009-0017-3; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Beguin Y, 2014, CRIT REV ONCOL HEMAT, V89, P1, DOI 10.1016/j.critrevonc.2013.10.008; Bird CL, 1996, AM J EPIDEMIOL, V144, P34, DOI 10.1093/oxfordjournals.aje.a008852; Boffetta P, 2003, BRIT MED BULL, V68, P71, DOI 10.1093/bmp/ldg023; Cross AJ, 2006, INT J CANCER, V118, P3147, DOI 10.1002/ijc.21780; Das Indranil, 2014, J Nat Sci Biol Med, V5, P158, DOI 10.4103/0976-9668.127317; deBenoist B, 2008, WORLDWIDE PREVALENCE; Ekiz C, 2005, HEMATOL J, V5, P579, DOI 10.1038/sj.thj.6200574; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harhaji L, 2004, CLIN EXP IMMUNOL, V137, P109, DOI 10.1111/j.1365-2249.2004.02515.x; Harrison LE, 1997, CANCER-AM CANCER SOC, V80, P1021; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P692, DOI 10.1093/oxfordjournals.aje.a117698; Ioannou GN, 2002, AM J MED, V113, P276, DOI 10.1016/S0002-9343(02)01214-7; JAGADEESAN V, 1994, NUTR CANCER, V22, P285, DOI 10.1080/01635589409514354; Kabat GC, 2007, CANCER CAUSE CONTROL, V18, P1047, DOI 10.1007/s10552-007-9058-9; Kato I, 1999, INT J CANCER, V80, P693, DOI 10.1002/(SICI)1097-0215(19990301)80:5&lt;693::AID-IJC11&gt;3.0.CO;2-G; KNEKT P, 1994, INT J CANCER, V56, P379, DOI 10.1002/ijc.2910560315; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Nakama H, 2000, INT J COLORECTAL DIS, V15, P271; Nelson RL, 2001, NUTR REV, V59, P140, DOI 10.1111/j.1753-4887.2001.tb07002.x; NOMURA A, 1992, CANCER EPIDEM BIOMAR, V1, P547; Payne CM, 2005, CANCER EPIDEM BIOMAR, V14, P2066, DOI 10.1158/1055-9965.EPI-05-0180; PRIME SS, 1983, BRIT J CANCER, V47, P413, DOI 10.1038/bjc.1983.62; Shirai T, 1997, CANCER RES, V57, P195; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tang Yong-Mei, 2006, Wei Sheng Yan Jiu, V35, P79; Tatemichi M, 2005, CANCER LETT, V217, P197, DOI 10.1016/j.canlet.2004.09.002; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Umbreit J, 2005, AM J HEMATOL, V78, P225, DOI 10.1002/ajh.20249; Vitale J J, 1977, Adv Exp Med Biol, V91, P229; Wang YP, 2012, CAN MED ASSOC J, V184, pE804, DOI 10.1503/cmaj.120518; Zhang ZF, 1997, NUTR CANCER, V27, P298, DOI 10.1080/01635589709514541; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	43	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119647	10.1371/journal.pone.0119647	http://dx.doi.org/10.1371/journal.pone.0119647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781632	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600081
J	Lamikanra, AA; Merryweather-Clarke, AT; Tipping, AJ; Roberts, DJ				Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.			Distinct Mechanisms of Inadequate Erythropoiesis Induced by Tumor Necrosis Factor Alpha or Malarial Pigment	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISM; ANEMIA; EXPRESSION; CELLS; INTERLEUKIN-10; PROLIFERATION; TRANSCRIPTION; APOPTOSIS; SURVIVAL	The role of infection in erythropoietic dysfunction is poorly understood. In children with P. falciparum malaria, the by-product of hemoglobin digestion in infected red cells (hemozoin) is associated with the severity of anemia which is independent of circulating levels of the inflammatory cytokine tumor necrosis alpha (TNF-alpha). To gain insight into the common and specific effects of TNF-alpha and hemozoin on erythropoiesis, we studied the gene expression profile of purified primary erythroid cultures exposed to either TNF-alpha (10ng/ml) or to hemozoin (12.5 mu g/ml heme units) for 24 hours. Perturbed gene function was assessed using co-annotation of associated gene ontologies and expression of selected genes representative of the profile observed was confirmed by real time PCR (rtPCR). The changes in gene expression induced by each agent were largely distinct; many of the genes significantly modulated by TNF-alpha were not affected by hemozoin. The genes modulated by TNF-alpha were significantly enriched for those encoding proteins involved in the control of type 1 interferon signalling and the immune response to viral infection. In contrast, genes induced by hemozoin were significantly enriched for functional roles in regulation of transcription and apoptosis. Further analyses by rtPCR revealed that hemozoin increases expression of transcription factors that form part of the integrated stress response which is accompanied by reduced expression of genes involved in DNA repair. This study confirms that hemozoin induces cellular stress on erythroblasts that is additional to and distinct from responses to inflammatory cytokines and identifies new genes that may be involved in the pathogenesis of severe malarial anemia. More generally the respective transcription profiles highlight the varied mechanisms through which erythropoiesis may be disrupted during infectious disease.	[Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford OX3 9BQ, England; [Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Oxford OX3 9BQ, England	University of Oxford; NHS Blood & Transplant (NHSBT); University of Oxford	Lamikanra, AA (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Oxford OX3 9BQ, England.	abigail.lamikanra@ndcls.ox.ac.uk	Lamikanra, Abigail/AAD-9603-2019		National Institute for Health Research (NIHR) [RP-PG-0310-1004]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article summarizes independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0310-1004). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; Aguilar R, 2014, BLOOD, V123, P959, DOI 10.1182/blood-2013-08-520767; [Anonymous], 2011, HUMAN ERYTHROBLAST M; Awandare GA, 2011, AM J HEMATOL, V86, P155, DOI 10.1002/ajh.21933; Bailis JM, 2004, CURR OPIN GENET DEV, V14, P17, DOI 10.1016/j.gde.2003.11.002; Betin VMS, 2013, AUTOPHAGY, V9, P881, DOI 10.4161/auto.24172; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; Bohmer RM, 2004, STEM CELLS, V22, P216, DOI 10.1634/stemcells.22-2-216; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bulinski JC, 2001, J CELL SCI, V114, P3885; Casals-Pascual C, 2006, BLOOD; Casals-Pascual C, 2012, HAEMATOL-HEMATOL J, V97, P1695, DOI 10.3324/haematol.2012.065854; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; FIBACH E, 1989, BLOOD, V73, P100; Giribaldi G, 2010, INFECT IMMUN, V78, P4912, DOI 10.1128/IAI.00455-10; GOLDIE P, 1990, AM J TROP MED HYG, V43, P584, DOI 10.4269/ajtmh.1990.43.584; GOODMAN JW, 1985, P NATL ACAD SCI USA, V82, P3291, DOI 10.1073/pnas.82.10.3291; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Grigorakaki C, 2011, BIOCHEM PHARMACOL, V82, P156, DOI 10.1016/j.bcp.2011.03.030; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Inger L, 2004, METHODS MALARIA RES; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jesnowski R, 2002, PANCREATOLOGY, V2, P421, DOI 10.1159/000065091; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; RUSTEN LS, 1995, BLOOD, V85, P989, DOI 10.1182/blood.V85.4.989.bloodjournal854989; Schrimpe AC, 2009, CHEM RES TOXICOL, V22, P433, DOI 10.1021/tx8002752; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Sexton AC, 2004, J INFECT DIS, V189, P1245, DOI 10.1086/382596; Skorokhod OA, 2010, BLOOD, V116, P4328, DOI 10.1182/blood-2010-03-272781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tamez PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019307; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhou YD, 2012, HUM MOL GENET, V21, P196, DOI 10.1093/hmg/ddr454	63	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119836	10.1371/journal.pone.0119836	http://dx.doi.org/10.1371/journal.pone.0119836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781011	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600097
J	Rose, NH; Halitschke, R; Morse, DH				Rose, Noah H.; Halitschke, Rayko; Morse, Douglass H.			Tri-Trophic Effects of Seasonally Variable Induced Plant Defenses Vary across the Development of a Shelter Building Moth Larva and Its Parasitoid	PLOS ONE			English	Article							HOST; STRATEGIES; HERBIVORES; ECOLOGY; WASPS; MANIPULATION; MECHANISMS; COMPLEXITY; HYPOTHESIS; BEHAVIOR	Plant chemical defenses can negatively affect insect herbivore fitness, but they can also decrease herbivore palatability to predators or decrease parasitoid fitness, potentially changing selective pressures on both plant investment in production of chemical defenses and host feeding behavior. Larvae of the fern moth Herpetogramma theseusalis live in and feed upon leaf shelters of their own construction, and their most abundant parasitoid Alabagrus texanus oviposits in early instar larvae, where parasitoid larvae lay dormant for most of host development before rapidly developing and emerging just prior to host pupation. As such, both might be expected to live in a relatively constant chemical environment. Instead, we find that a correlated set of phenolic compounds shows strong seasonal variation both within shelters and in undamaged fern tissue, and the relative level of these compounds in these two different fern tissue types switches across the summer. Using experimental feeding treatments, in which we exposed fern moth larvae to different chemical trajectories across their development, we show that exposure to this set of phenolic compounds reduces the survival of larvae in early development. However, exposure to this set of compounds just before the beginning of explosive parasitoid growth increased parasitoid survival. Exposure during the period of rapid parasitoid growth and feeding decreased parasitoid survival. These results highlight the spatial and temporal complexity of leaf shelter chemistry, and demonstrate the developmental contingency of associated effects on both host and parasitoid, implying the existence of complex selective pressures on plant investment in chemical defenses, host feeding behavior, and parasitoid life history.	[Rose, Noah H.; Morse, Douglass H.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Halitschke, Rayko] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Brown University; Cornell University	Morse, DH (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Box G-W, Providence, RI 02912 USA.	d_morse@brown.edu	Halitschke, Rayko/AAY-2365-2020	Halitschke, Rayko/0000-0002-1109-8782; Rose, Noah/0000-0001-7129-4753	Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University	Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University	NHR was supported by an Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, CURR OPIN PLANT BIOL, V3, P329, DOI 10.1016/S1369-5266(00)00089-3; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Baldwin IT, 1999, PLANTA, V208, P137, DOI 10.1007/s004250050543; Ballhorn DJ, 2011, J ECOL, V99, P313, DOI 10.1111/j.1365-2745.2010.01747.x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Bukovinszky T, 2009, OECOLOGIA, V160, P299, DOI 10.1007/s00442-009-1308-y; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fukui Akiko, 2002, Entomological Science, V5, P263; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2000, OIKOS, V88, P621, DOI 10.1034/j.1600-0706.2000.880319.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; HARVEY JA, 1995, ENTOMOL EXP APPL, V75, P213, DOI 10.1007/BF02382255; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Kaplan I, 2007, OECOLOGIA, V152, P665, DOI 10.1007/s00442-007-0692-4; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Lind JT, 2007, ENTOMOLOGIA EXPT APP, V124, P45; Malcolm SB, 1996, ENTOMOL EXP APPL, V80, P193, DOI 10.1007/BF00194755; Matsuki S, 2004, ANN BOT-LONDON, V93, P141, DOI 10.1093/aob/mch022; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Morse DH, 2011, AM MIDL NAT, V166, P252, DOI 10.1674/0003-0031-166.2.252; Morse DH, 2009, ECOL ENTOMOL, V34, P246, DOI 10.1111/j.1365-2311.2008.01073.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; SAGERS CL, 1992, FUNCT ECOL, V6, P741, DOI 10.2307/2389971; SEQUEIRA R, 1994, ENTOMOL EXP APPL, V71, P15, DOI 10.1007/BF02380565	28	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120769	10.1371/journal.pone.0120769	http://dx.doi.org/10.1371/journal.pone.0120769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781029	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600187
J	Wang, L; Jiang, YL; Zhang, JR; Zhou, CZ; Chen, YX				Wang, Lei; Jiang, Yong-Liang; Zhang, Jing-Ren; Zhou, Cong-Zhao; Chen, Yuxing			Structural and Enzymatic Characterization of the Choline Kinase LicA from Streptococcus pneumoniae	PLOS ONE			English	Article							NUTRITIONAL-REQUIREMENTS; LIPOTEICHOIC ACID; PHOSPHOCHOLINE; SEQUENCE; GENE; PROTEINS	LicA plays a key role in the cell-wall phosphorylcholine biosynthesis of Streptococcus pneumonia. Here we determined the crystal structures of apo-form LicA at 1.94 angstrom and two complex forms LicA-choline and LicA-AMP-MES, at 2.01 and 1.45 angstrom resolution, respectively. The overall structure adopts a canonical protein kinase-like fold, with the active site located in the crevice of the N-and C-terminal domains. The three structures present distinct poses of the active site, which undergoes an open-closed-open conformational change upon substrate binding and product release. The structure analyses combined with mutageneses and enzymatic assays enabled us to figure out the key residues for the choline kinase activity of LicA. In addition, structural comparison revealed the loop between helices alpha 7 and alpha 8 might modulate the substrate specificity and catalytic activity. These findings shed light on the structure and mechanism of the prokaryotic choline kinase LicA, and might direct the rational design of novel anti-pneumococcal drugs.	[Wang, Lei; Jiang, Yong-Liang; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Lei; Jiang, Yong-Liang; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhang, Jing-Ren] Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing 100084, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Jiang, YL (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	jyl@mail.ustc.edu.cn; cyxing@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; Wang, Lei/AAA-1917-2020	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Wang, Lei/0000-0002-3024-8627; Jiang, YongLiang/0000-0001-5441-4936	National Natural Science Foundation of China [31470739, 31270781, 31400628, U1332114]; Research Fund for the Doctoral Program of Higher Education [20123402110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 31470739, 31270781, 31400628 and U1332114: http://www.nsfc.gov.cn/) and the Research Fund for the Doctoral Program of Higher Education (Grant No. 20123402110004: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badger E, 1944, J BACTERIOL, V47, P509, DOI 10.1128/JB.47.6.509-518.1944; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fischer W, 2000, RES MICROBIOL, V151, P421, DOI 10.1016/S0923-2508(00)00174-1; Gibellini F, 2008, BIOCHEM J, V415, P135, DOI 10.1042/BJ20080435; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Hudson CS, 2013, BBA-PROTEINS PROTEOM, V1834, P1107, DOI 10.1016/j.bbapap.2013.02.008; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao HN, 2006, BBA-MOL CELL BIOL L, V1761, P111, DOI 10.1016/j.bbalip.2006.01.005; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Qiu W, 2010, CRYSTAL STRUCTURE CH; Rane L, 1940, J BACTERIOL, V40, P695, DOI 10.1128/JB.40.5.695-704.1940; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Serino L, 2002, MOL MICROBIOL, V43, P437, DOI 10.1046/j.1365-2958.2002.02755.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wernimont AK, 2009, CRYSTAL STRUCTURE CH; Wernimont AK, 2008, CRYSTAL STRUCTURE PL; Young NM, 2013, MOL IMMUNOL, V56, P563, DOI 10.1016/j.molimm.2013.05.237; Yuan C, 2004, J BIOL CHEM, V279, P17801, DOI 10.1074/jbc.M401382200; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	46	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120467	10.1371/journal.pone.0120467	http://dx.doi.org/10.1371/journal.pone.0120467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781969	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600164
J	Zheng, X; Li, AS; Zheng, HY; Zhao, DM; Guan, DG; Zou, HW				Zheng, Xu; Li, Allison S.; Zheng, Huanyu; Zhao, Dongmei; Guan, Dagang; Zou, Huawei			Different Associations of CD45 Isoforms with STAT3, PKC and ERK Regulate IL-6-Induced Proliferation in Myeloma	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE CD45; CELL ANTIGEN RECEPTOR; NF-KAPPA-B; MULTIPLE-MYELOMA; LIPID RAFTS; IN-VITRO; LYMPHOCYTE-ACTIVATION; SIGNAL-TRANSDUCTION; MEMBRANE RAFTS; T-LYMPHOCYTES	In response to interleukin 6 (IL-6) stimulation, both CD45RO and CD45RB, but not CD45RA, translocate to lipid rafts. However, the significance of this distinct translocation and the downstream signals in CD45 isoforms-participated IL-6 signal are not well understood. Using sucrose fractionation, we found that phosphorylated signal transducer and activator of transcription (STAT) 3 and STAT1 were mainly localized in lipid rafts in response to IL-6 stimulation, despite both STAT3 and STAT1 localizing in raft and non-raft fractions in the presence or absence of IL-6. On the other hand, extracellular signal-regulated kinase (ERK), and phosphorylated ERK were localized in non-raft fractions regardless of the existence of IL-6. The rafts inhibitor significantly impeded the phosphorylation of STAT3 and STAT1 and nuclear translocation, but had little effect on (and only postponing) the phosphorylation of ERK. This data suggests that lipid raft-dependent STAT3 and STAT1 pathways are dominant pathways of IL-6 signal in myeloma cells. Interestingly, the phosphorylation level of STAT3 but not STAT1 in CD45(+) cells was significantly higher compared to that of CD45-cells, while the phosphorylation level of ERK in CD45(+) myeloma cells was relatively low. Furthermore, exogenously expressed CD45RO/RB significantly enhanced STAT3, protein kinase C (PKC) and downstream NF-kappa B activation; however, CD45RA/RB inhibited IL-6-induced ERK phosphorylation. CD45 also enhanced the nuclear localization of STAT3 but not that of STAT1. In response to IL-6 stimulation, CD45RO moved into raft compartments and formed a complex with STAT3 and PKC in raft fraction, while CD45RA remained outside of lipid rafts and formed a complex with ERK in non-raft fraction. This data suggests a different role of CD45 isoforms in IL-6-induced signaling, indicating that while CD45RA/RB seems inhibit the rafts-unrelated ERK pathway, CD45RO/RB may actually work to enhance the rafts-related STAT3 and PKC/NF-kappa B pathways.	[Zheng, Xu; Zhao, Dongmei; Guan, Dagang; Zou, Huawei] China Med Univ, ShengJing Hosp, Dept Oncol, Shenyang 110001, Liaoning, Peoples R China; [Li, Allison S.] Harvard Univ, Cambridge, MA 02138 USA; [Zheng, Huanyu] He Univ, Shenyang, Liaoning, Peoples R China	China Medical University; Harvard University	Zheng, X (corresponding author), China Med Univ, ShengJing Hosp, Dept Oncol, Shenyang 110001, Liaoning, Peoples R China.	zhengx@sj-hospital.org		Zheng, Xu/0000-0002-4185-9765	National Natural Science Foundation of China (NSFC) [81101487]; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) [20102104120014]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry [2011508]; Scientific Research Fund of Liaoning Provincial Education Department [L2010640]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Scientific Research Fund of Liaoning Provincial Education Department	This work was supported by National Natural Science Foundation of China (NSFC) (Grants 81101487; X. Z.), Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) (Grants 20102104120014; X. Z.), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (Grants 2011508; X. Z.). A Project Supported by Scientific Research Fund of Liaoning Provincial Education Department (Grants L2010640; X. Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroun S, 2008, BRIT J HAEMATOL, V142, P754, DOI 10.1111/j.1365-2141.2008.07252.x; Blank N, 2001, J IMMUNOL, V166, P6034, DOI 10.4049/jimmunol.166.10.6034; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; CONLON K, 1995, EUR J IMMUNOL, V25, P644, DOI 10.1002/eji.1830250303; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; FERRER JM, 1992, CELL IMMUNOL, V141, P10, DOI 10.1016/0008-8749(92)90123-7; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Fujii R, 1999, BRIT J HAEMATOL, V105, P131, DOI 10.1046/j.1365-2141.1999.01281.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; HATA H, 1994, LEUKEMIA, V8, P1768; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hryniewicz-Jankowska A, 2014, BBA-REV CANCER, V1845, P155, DOI 10.1016/j.bbcan.2014.01.006; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ishikawa H, 2002, BLOOD, V99, P2172, DOI 10.1182/blood.V99.6.2172; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KLEIN B, 1989, BLOOD, V73, P517; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Li FJ, 2005, BLOOD, V105, P3295, DOI 10.1182/blood-2004-10-4083; Liu S, 2006, ONCOGENE, V25, P419, DOI 10.1038/sj.onc.1208982; Mahmoud MS, 1998, BLOOD, V92, P3887, DOI 10.1182/blood.V92.10.3887.422a48_3887_3897; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Mollinedo F, 2010, ONCOGENE, V29, P3748, DOI 10.1038/onc.2010.131; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; Ogata A, 1997, J IMMUNOL, V159, P2212; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; ROBINSON AT, 1993, EUR J IMMUNOL, V23, P61, DOI 10.1002/eji.1830230111; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Rowley M, 2002, ONCOGENE, V21, P8769, DOI 10.1038/sj.onc.1205387; Sadahira K, 2014, INT J ONCOL, V45, P2278, DOI 10.3892/ijo.2014.2652; Schneider U, 1997, BRIT J HAEMATOL, V97, P56, DOI 10.1046/j.1365-2141.1997.d01-2115.x; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; TORIMOTO Y, 1992, CELL IMMUNOL, V145, P111, DOI 10.1016/0008-8749(92)90317-I; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119780	10.1371/journal.pone.0119780	http://dx.doi.org/10.1371/journal.pone.0119780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781885	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600092
J	Arevalo-Herrera, M; Vallejo, AF; Rubiano, K; Solarte, Y; Marin, C; Castellanos, A; Cespedes, N; Herrera, S				Arevalo-Herrera, Myriam; Vallejo, Andres F.; Rubiano, Kelly; Solarte, Yezid; Marin, Catherin; Castellanos, Angelica; Cespedes, Nora; Herrera, Socrates			Recombinant Pvs48/45 Antigen Expressed in E-coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; MONOCLONAL-ANTIBODIES; VIVAX; VACCINE; PROTEIN; IMMUNITY; PVS25; GALLINACEUM; CANDIDATE; GENOMICS	Transmission of malaria parasites from humans to Anopheles mosquitoes can be inhibited by specific antibodies elicited during malaria infection, which target surface Plasmodium gametocyte/gamete proteins. Some of these proteins may have potential for vaccine development. Pvs48/45 is a P. vivax gametocyte surface antigen orthologous to Pfs48/45, which may play a role during parasite fertilization and thus has potential for transmission blocking (TB) activity. Here we describe the expression of a recombinant Pvs48/45 protein expressed in Escherichia coli as a similar to 60kDa construct which we tested for antigenicity using human sera and for its immunogenicity and transmission blocking activity of specific anti-mouse and anti-monkey Pvs48/45 antibodies. The protein reacted with sera of individuals from malaria-endemic areas and in addition induced specific IgG antibody responses in BALB/c mice and Aotus l. griseimembra monkeys. Sera from both immunized animal species recognized native P. vivax protein in Western blot (WB) and immunofluorescence assays. Moreover, sera from immunized mice and monkeys produced significant inhibition of parasite transmission to Anopheles Albimanus mosquitoes as shown by membrane feeding assays. Results indicate the presence of reactive epitopes in the Pvs48/45 recombinant product that induce antibodies with TB activity. Further testing of this protein is ongoing to determine its vaccine potential.	[Arevalo-Herrera, Myriam; Rubiano, Kelly; Cespedes, Nora; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr, Cali, Colombia; [Vallejo, Andres F.; Rubiano, Kelly; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Arevalo-Herrera, Myriam; Solarte, Yezid] Univ Valle, Sch Hlth, Cali, Colombia; [Marin, Catherin; Castellanos, Angelica; Herrera, Socrates] Primates Ctr Fdn, Cali, Colombia	Universidad del Valle	Arevalo-Herrera, M (corresponding author), Malaria Vaccine & Drug Dev Ctr, Cali, Colombia.	marevalo@inmuno.org	Solarte, Yezid A/C-1196-2013; Solarte, Yezid/ABG-5392-2020	Solarte, Yezid A/0000-0003-4173-0256; Solarte, Yezid/0000-0003-4173-0256; Castellanos Sanchez, Angelica Maria/0000-0002-6602-9696; Vallejo, Andres Felipe/0000-0002-4688-0598; Rubiano, Kely/0000-0002-4149-4030; Arevalo, Myriam/0000-0002-3434-9425	Colciencias [360-2011, 685-2013, 719-2013]; National Institutes of Health (NIH) [5U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Colciencias (Contracts 360-2011, 685-2013 and 719-2013) and by the National Institutes of Health (NIH) (Grant number 5U19AI089702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala P, 2003, FEBS LETT, V533, P115, DOI 10.1016/S0014-5793(02)03775-4; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P38; AVMA, 2013, AVMA GUID EUTH AN, P102; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Collins WE, 2006, AM J TROP MED HYG, V74, P215, DOI 10.4269/ajtmh.2006.74.215; Collins WE, 1994, AOTUS THE OWL MONKEY; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; GAMAGEMENDIS AC, 1992, PARASITE IMMUNOL, V14, P385, DOI 10.1111/j.1365-3024.1992.tb00013.x; Gaspar P, 2012, BIOINFORMATICS, V28, P2683, DOI 10.1093/bioinformatics/bts465; GROTENDORST CA, 1984, INFECT IMMUN, V45, P775, DOI 10.1128/IAI.45.3.775-777.1984; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; KASLOW DC, 1994, BIO-TECHNOL, V12, P494, DOI 10.1038/nbt0594-494; KAUSHAL DC, 1983, J IMMUNOL, V131, P2557; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; MENDIS KN, 1987, INFECT IMMUN, V55, P369, DOI 10.1128/IAI.55.2.369-372.1987; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Pain A, 2009, NAT REV MICROBIOL, V7, P180, DOI 10.1038/nrmicro2096; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Resources IoLA, 1985, GUIDE CARE USE LAB A; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Shevchenko A, 2001, ANAL BIOCHEM, V296, P279, DOI 10.1006/abio.2001.5321; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Tachibana M, 2012, VACCINE, V30, P1807, DOI 10.1016/j.vaccine.2012.01.003; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3	45	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119335	10.1371/journal.pone.0119335	http://dx.doi.org/10.1371/journal.pone.0119335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775466	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500083
J	Fu, J; Hu, XH; Velroyen, A; Bech, M; Jiang, M; Pfeiffer, F				Fu, Jian; Hu, Xinhua; Velroyen, Astrid; Bech, Martin; Jiang, Ming; Pfeiffer, Franz			3D Algebraic Iterative Reconstruction for Cone-Beam X-Ray Differential Phase-Contrast Computed Tomography	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; ALGORITHMS; TOPOGRAPHY	Due to the potential of compact imaging systems with magnified spatial resolution and contrast, cone-beam x-ray differential phase-contrast computed tomography (DPC-CT) has attracted significant interest. The current proposed FDK reconstruction algorithm with the Hilbert imaginary filter will induce severe cone-beam artifacts when the cone-beam angle becomes large. In this paper, we propose an algebraic iterative reconstruction (AIR) method for cone-beam DPC-CT and report its experiment results. This approach considers the reconstruction process as the optimization of a discrete representation of the object function to satisfy a system of equations that describes the cone-beam DPC-CT imaging modality. Unlike the conventional iterative algorithms for absorption-based CT, it involves the derivative operation to the forward projections of the reconstructed intermediate image to take into account the differential nature of the DPC projections. This method is based on the algebraic reconstruction technique, reconstructs the image ray by ray, and is expected to provide better derivative estimates in iterations. This work comprises a numerical study of the algorithm and its experimental verification using a dataset measured with a three-grating interferometer and a mini-focus x-ray tube source. It is shown that the proposed method can reduce the cone-beam artifacts and performs better than FDK under large cone-beam angles. This algorithm is of interest for future cone-beam DPC-CT applications.	[Fu, Jian; Hu, Xinhua] Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging & Biomed Imaging, Beijing 100191, Peoples R China; [Velroyen, Astrid; Bech, Martin; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, D-85748 Garching, Germany; [Velroyen, Astrid; Bech, Martin; Pfeiffer, Franz] Tech Univ Munich, Inst Med Tech, D-85748 Garching, Germany; [Bech, Martin] Lund Univ, S-22185 Lund, Sweden; [Jiang, Ming] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China	Beihang University; Technical University of Munich; Technical University of Munich; Lund University; Peking University	Fu, J (corresponding author), Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging & Biomed Imaging, Beijing 100191, Peoples R China.	fujian706@buaa.edu.cn	Bech, Martin/K-4331-2012; Jiang, Ming/A-9840-2008	Bech, Martin/0000-0001-9109-7175; Jiang, Ming/0000-0002-1661-0538	National Basic Research Program of China (973 Program) [2011CB809105]; National Science Foundation of China [11179009, 61121002, 10990013]; Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China; Beijing NOVA program [2009A09]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China(Program for New Century Excellent Talents in University (NCET)); Beijing NOVA program(Beijing Municipal Science & Technology Commission)	This work was partially supported by the National Basic Research Program of China (973 Program) (2011CB809105) and the National Science Foundation of China (11179009, 61121002, 10990013), Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China and Beijing NOVA program (2009A09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fessler J., 2000, HDB MED IMAGING, V2, P1, DOI DOI 10.1117/3.831079; Fu J, 2013, Z MED PHYS, V23, P186, DOI 10.1016/j.zemedi.2012.11.002; Fu J, 2012, OPT EXPRESS, V20, P21512, DOI 10.1364/OE.20.021512; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; Hahn D, 2013, BONE ARTIFACT REDUCT, P416; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; HERMAN GT, 1993, IEEE T MED IMAGING, V12, P600, DOI 10.1109/42.241889; Huang ZF, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013815; INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012; Jerjen I, 2010, AIP CONF PROC, V1236, P227, DOI 10.1063/1.3426118; Jiang M, 2003, IEEE T MED IMAGING, V22, P569, DOI 10.1109/TMI.2003.812253; Jiang M, 2001, J X-RAY SCI TECHNOL, V10, P77; Jonas P, 2004, INVERSE PROBL, V20, P75, DOI 10.1088/0266-5611/20/1/005; Kaczmarz S., 1937, B INT ACAD POL SCI L, V35, P355; Kohler T, 2011, MED PHYS, V38, P4542, DOI 10.1118/1.3608906; Kudo H, 1998, PHYS MED BIOL, V43, P2885, DOI 10.1088/0031-9155/43/10/016; Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Natterer F, 2001, THE MATHEMATICS OF C; Natterer F, 2001, MATHEMATICAL METHODS; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Shimura T, 2013, OPT LETT, V38, P157, DOI 10.1364/OL.38.000157; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2009, MED PHYS, V36, P4920, DOI 10.1118/1.3232211; SMITH BD, 1983, COMPUT BIOL MED, V13, P81, DOI 10.1016/S0010-4825(83)80001-8; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; TUY HK, 1983, SIAM J APPL MATH, V43, P546, DOI 10.1137/0143035; Wang J, 2009, MED PHYS, V36, P252, DOI 10.1118/1.3036112; Wang ZT, 2011, J X-RAY SCI TECHNOL, V19, P403, DOI 10.3233/XST-2011-0303; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu T, 2003, MED PHYS, V30, P365, DOI 10.1118/1.1543934; Xu F, 2005, IEEE T NUCL SCI, V52, P654, DOI 10.1109/TNS.2005.851398; Xu QF, 2012, OPT EXPRESS, V20, P10724, DOI 10.1364/OE.20.010724; Zhang K, 2011, ANAL BIOANAL CHEM, V401, P837, DOI 10.1007/s00216-011-5080-6; Zhang L, 2008, IEEE NUCL SCI S M06, P4193; Zhu PP, 2010, P NATL ACAD SCI USA, V107, P13576, DOI 10.1073/pnas.1003198107	52	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117502	10.1371/journal.pone.0117502	http://dx.doi.org/10.1371/journal.pone.0117502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775480	gold, Green Published			2022-12-26	WOS:000351183500020
J	Serebryany, E; King, JA				Serebryany, Eugene; King, Jonathan A.			Wild-type Human gamma D-crystallin Promotes Aggregation of Its Oxidation-mimicking, Misfolding-prone W42Q Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEK KEY DOMAINS; PROTEIN AGGREGATION; IN-VITRO; SUPEROXIDE-DISMUTASE; S-CRYSTALLIN; HUMAN LENS; CATARACT FORMATION; STABILITY; MECHANISM; POLYMERIZATION	Non-native protein conformers generated by mutation or chemical damage template aggregation of wild-type, undamaged polypeptides in diseases ranging from amyotrophic lateral sclerosis to cancer. We tested for such interactions in the natively monomeric human eye lens protein gamma D-crystallin, whose aggregation leads to cataract disease. The oxidation-mimicking W42Q mutant of gamma D-crystallin formed non-native polymers starting from a native-like state under physiological conditions. Aggregation occurred in the temperature range 35-45 degrees C, in which the mutant protein began to lose the native conformation of its N-terminal domain. Surprisingly, wild-type gamma D-crystallin promoted W42Q polymerization in a catalytic manner, even at mutant concentrations too low for homogeneous nucleation to occur. The presence of wild-type protein also downshifted the temperature range of W42Q aggregation. W42Q aggregation required formation of a non-native intramolecular disulfide bond but not intermolecular cross-linking. Transient WT/W42Q binding may catalyze this oxidative mis-folding event in the mutant. That a more stable variant in a mixture can specifically promote aggregation of a less stable one rationalizes how extensive aggregation of rare damaged polypeptides can occur during the course of aging.	[Serebryany, Eugene; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave 68-318, Cambridge, MA 02139 USA.	jaking@mit.edu	Serebryany, Eugene/E-4595-2017		National Institutes of Health from the National Eye Institute [EY015834]; Massachusetts Institute of Technology Biology/Merck academic support fellowships; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER	National Institutes of Health from the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Massachusetts Institute of Technology Biology/Merck academic support fellowships; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY015834 from the National Eye Institute (to J. A. K.). This work was also supported by Massachusetts Institute of Technology Biology/Merck academic support fellowships to (E. S.).	Adachi K, 2006, J MOL BIOL, V362, P528, DOI 10.1016/j.jmb.2006.07.047; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Audet JN, 2010, NEUROBIOL DIS, V40, P245, DOI 10.1016/j.nbd.2010.05.031; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Chen J, 2009, BIOCHEMISTRY-US, V48, P3708, DOI 10.1021/bi802177g; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Ji FL, 2013, PROTEINS, V81, P1493, DOI 10.1002/prot.24321; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; Ji FL, 2012, BIOCHEMISTRY-US, V51, P2588, DOI 10.1021/bi300199d; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Keenan J, 2008, MOL VIS, V14, P1245; Kirby E. P., 1970, J PHYS CHEM-US, V74, P4480, DOI DOI 10.1021/J100720A004; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; Lindahl K, 2009, BIOCHEM BIOPH RES CO, V384, P501, DOI 10.1016/j.bbrc.2009.05.006; Lynch M, 2012, MOL BIOL EVOL, V29, P1353, DOI 10.1093/molbev/msr300; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Pande A, 2009, BIOCHEMISTRY-US, V48, P4937, DOI 10.1021/bi9004182; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; SIEZEN RJ, 1985, P NATL ACAD SCI USA, V82, P1701, DOI 10.1073/pnas.82.6.1701; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang Y, 2010, P NATL ACAD SCI USA, V107, P13282, DOI 10.1073/pnas.1008353107; Wei M, 2015, INVEST OPHTH VIS SCI, V56, P598, DOI 10.1167/iovs.14-15452; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xia Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01560; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171	61	22	22	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11491	11503		10.1074/jbc.M114.621581	http://dx.doi.org/10.1074/jbc.M114.621581			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787081	hybrid, Green Published			2022-12-26	WOS:000353719400025
J	Fredriksson, K; Van Itallie, CM; Aponte, A; Gucek, M; Tietgens, AJ; Anderson, JM				Fredriksson, Karin; Van Itallie, Christina M.; Aponte, Angel; Gucek, Marjan; Tietgens, Amber J.; Anderson, James M.			Proteomic Analysis of Proteins Surrounding Occludin and Claudin-4 Reveals Their Proximity to Signaling and Trafficking Networks	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; CANINE KIDNEY-CELLS; ADHESION MOLECULE; EPITHELIAL-CELLS; INTERCELLULAR-JUNCTIONS; REGULATED EXPRESSION; ACTIN CYTOSKELETON; MEMBRANE-PROTEIN; IMMUNOGLOBULIN SUPERFAMILY; PARACELLULAR PERMEABILITY	Tight junctions are complex membrane structures that regulate paracellular movement of material across epithelia and play a role in cell polarity, signaling and cytoskeletal organization. In order to expand knowledge of the tight junction proteome, we used biotin ligase (BioID) fused to occludin and claudin-4 to biotinylate their proximal proteins in cultured MDCK II epithelial cells. We then purified the biotinylated proteins on streptavidin resin and identified them by mass spectrometry. Proteins were ranked by relative abundance of recovery by mass spectrometry, placed in functional categories, and compared not only among the N- and C-termini of occludin and the N-terminus of claudin-4, but also with our published inventory of proteins proximal to the adherens junction protein E-cadherin and the tight junction protein ZO-1. When proteomic results were analyzed, the relative distribution among functional categories was similar between occludin and claudin-4 proximal proteins. Apart from already known tight junction-proteins, occludin and claudin-4 proximal proteins were enriched in signaling and trafficking proteins, especially endocytic trafficking proteins. However there were significant differences in the specific proteins comprising the functional categories near each of the tagging proteins, revealing spatial compartmentalization within the junction complex. Taken together, these results expand the inventory of known and unknown proteins at the tight junction to inform future studies of the organization and physiology of this complex structure.	[Fredriksson, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Aponte, Angel; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fredriksson, K (corresponding author), NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA.	fredrikssonk@nhlbi.nih.gov		Anderson, James/0000-0003-2765-7996	Intramural Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006176, ZICHL005903, ZICHL006019] Funding Source: NIH RePORTER	Intramural Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Intramural Program of the National Institutes of Health to JMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsky K, 2003, J CELL SCI, V116, P1279, DOI 10.1242/jcs.00302; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; BACALLAO R, 1994, J CELL SCI, V107, P3301; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Beardsley DI, 2003, EXP CELL RES, V290, P402, DOI 10.1016/S0014-4827(03)00353-7; Bosse F, 2003, J NEUROCHEM, V86, P508, DOI 10.1046/j.1471-4159.2003.01870.x; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUTZ S, 1994, FEBS LETT, V355, P195, DOI 10.1016/0014-5793(94)01205-9; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cipriano R, 2012, J CLIN INVEST, V122, P3197, DOI 10.1172/JCI60517; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Deora AA, 2004, MOL BIOL CELL, V15, P4148, DOI 10.1091/mbc.E04-01-0058; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Engelhardt B, 2011, J CEREBR BLOOD F MET, V31, P1969, DOI 10.1038/jcbfm.2011.98; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Haines BP, 2006, DEV BIOL, V297, P14, DOI 10.1016/j.ydbio.2006.04.004; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lacaz-Vieira F, 1999, J MEMBRANE BIOL, V168, P289, DOI 10.1007/s002329900518; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Massari S, 2009, TRAFFIC, V10, P246, DOI 10.1111/j.1600-0854.2008.00854.x; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mauris J, 2014, J CELL SCI, V127, P3141, DOI 10.1242/jcs.148510; McCarthy KM, 1996, J CELL SCI, V109, P2287; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Papageorgiou DN, 2013, PROTEIN EXPRES PURIF, V89, P80, DOI 10.1016/j.pep.2013.02.015; Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487; Pisitkun T, 2012, PROTEOM CLIN APPL, V6, P268, DOI 10.1002/prca.201100108; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Ruffer C, 2004, EUR J CELL BIOL, V83, P135, DOI 10.1078/0171-9335-00366; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Scott BJ, 2009, INT J CANCER, V125, P1193, DOI 10.1002/ijc.24465; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tai G, 2004, MOL BIOL; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z; Walter JK, 2009, CELL MOL LIFE SCI, V66, P3655, DOI 10.1007/s00018-009-0150-z; Walter JK, 2009, ANN NY ACAD SCI, V1165, P19, DOI 10.1111/j.1749-6632.2009.04058.x; Wesolowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049886; WILLOTT E, 1992, AM J PHYSIOL, V262, pC1119, DOI 10.1152/ajpcell.1992.262.5.C1119; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Yasuda T, 2014, J CELL SCI, V127, P557, DOI 10.1242/jcs.134056; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	123	58	58	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117074	10.1371/journal.pone.0117074	http://dx.doi.org/10.1371/journal.pone.0117074			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789658	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400022
J	Ye, C; Li, SY; Yang, YY; Shu, X; Zhang, JQ; Zhang, QF				Ye, Chen; Li, Siyue; Yang, Yuyi; Shu, Xiao; Zhang, Jiaquan; Zhang, Quanfa			Advancing Analysis of Spatio-Temporal Variations of Soil Nutrients in the Water Level Fluctuation Zone of China's Three Gorges Reservoir Using Self-Organizing Map	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; RIPARIAN BUFFER ZONES; NITROGEN DYNAMICS; RIVER FLOODPLAIN; LAND-USE; SEDIMENT; DAMS; DENITRIFICATION; VEGETATION; QUALITY	The similar to 350 km(2) water level fluctuation zone (WLFZ) in the Three Gorges Reservoir (TGR) of China, situated at the intersection of terrestrial and aquatic ecosystems, experiences a great hydrological change with prolonged winter inundation. Soil samples were collected in 12 sites pre- (September 2008) and post submergence (June 2009) in the WLFZ and analyzed for soil nutrients. Self-organizing map (SOM) and statistical analysis including multi-way ANOVA, paired-T test, and stepwise least squares multiple regression were employed to determine the spatio-temporal variations of soil nutrients in relation to submergence, and their correlations with soil physical characteristics. Results showed significant spatial variability in nutrients along similar to 600 km long shoreline of the TGR before and after submergence. There were higher contents of organic matter, total nitrogen (TN), and nitrate (NO3-) in the lower reach and total phosphorus (TP) in the upper reach that were primarily due to the spatial variations in soil particle size composition and anthropogenic activities. Submergence enhanced soil available potassium (K), while significantly decreased soil N, possibly due to the alterations of soil particle size composition and increase in soil pH. In addition, SOM analysis determined important roles of soil pH value, bulk density, soil particle size (i.e., silt and sand) and nutrients (TP, TK, and AK) on the spatial and temporal variations in soil quality. Our results suggest that urban sewage and agricultural runoffs are primary pollutants that affect soil nutrients in the WLFZ of TGR.	[Ye, Chen; Li, Siyue; Yang, Yuyi; Shu, Xiao; Zhang, Jiaquan; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China; [Zhang, Jiaquan] Hubei Polytech Univ, Coll Environm Sci & Engn, Huangshi 435003, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Hubei Polytechnic University	Zhang, QF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China.	qzhang@wbgcas.cn	Yang, Yuyi/N-5428-2015; Zhang, Quanfa/H-1922-2011; Yang, Yuyi/H-6600-2015; Li, Siyue/DCN-3040-2022; Zhang, Jiaquan/D-4905-2013; Li, Siyue/E-8297-2012	Yang, Yuyi/0000-0001-9807-6844; Yang, Yuyi/0000-0001-9807-6844; Li, Siyue/0000-0002-3097-6819; Zhang, Jiaquan/0000-0002-1559-1240; Li, Siyue/0000-0002-3097-6819; Ye, Chen/0000-0001-7204-246X	National Natural Science Foundation of China [31130010, 31300441, 31100347]; Executive Office of the State Council Three Gorges Construction Committee [SX2011-037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Executive Office of the State Council Three Gorges Construction Committee	This work was supported by National Natural Science Foundation of China (No. 31130010, 31300441 and 31100347) and the Executive Office of the State Council Three Gorges Construction Committee (SX2011-037). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Alvarez-Guerra M, 2008, ENVIRON INT, V34, P782, DOI 10.1016/j.envint.2008.01.006; Antheunisse AM, 2007, PLANT SOIL, V292, P45, DOI 10.1007/s11104-007-9200-1; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Beumer V, 2008, SCI TOTAL ENVIRON, V402, P70, DOI 10.1016/j.scitotenv.2008.03.044; Bieroza M, 2011, ENVIRONMETRICS, V22, P256, DOI 10.1002/env.1045; Brady N.C, 2000, NATURE PROPERTIES SO; Brunet RC, 1997, LANDSCAPE ECOL, V12, P171, DOI 10.1023/A:1007937201321; Burt TP, 2002, J HYDROL, V262, P1, DOI 10.1016/S0022-1694(01)00567-4; Casey RE, 2001, J ENVIRON QUAL, V30, P1732, DOI 10.2134/jeq2001.3051732x; Cho KH, 2009, SCI TOTAL ENVIRON, V407, P2536, DOI 10.1016/j.scitotenv.2009.01.017; DEJONGE VN, 1995, LIMNOL OCEANOGR, V40, P766; Forshay KJ, 2011, HYDROBIOLOGIA, V668, P21, DOI 10.1007/s10750-011-0619-2; Forshay KJ, 2005, BIOGEOCHEMISTRY, V75, P43, DOI 10.1007/s10533-004-6016-4; Gergel SE, 2005, GLOBAL CHANGE BIOL, V11, P1352, DOI 10.1111/j.1365-2486.2005.00966.x; Hefting MM, 2005, ECOL ENG, V24, P465, DOI 10.1016/j.ecoleng.2005.01.003; Hoffmann CC, 2006, J HYDROL, V331, P315, DOI 10.1016/j.jhydrol.2006.05.019; Keeney D.R, 1982, AGRON MONOGR, P643; Kennedy R.H., 1990, RESERVOIR LIMNOLOGY; Ki SJ, 2011, WATER RES, V45, P4183, DOI 10.1016/j.watres.2011.05.021; Knoepp JD, 2007, PEDOBIOLOGIA, V51, P89, DOI 10.1016/j.pedobi.2007.02.002; Kohonen T., 2001, SELF ORG MAPS; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; Liu WZ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044007; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Liu YG, 2011, SELF ORGANIZING MAPS - APPLICATIONS AND NOVEL ALGORITHM DESIGN, P253; Lu Zhi-Jun, 2010, Wuhan Zhiwuxue Yanjiu, V28, P303, DOI 10.3724/SP.J.1142.2010.30303; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; McCartney M, 2009, WATER POLICY, V11, P121, DOI 10.2166/wp.2009.108; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V3, P653, DOI DOI 10.5194/HESSD-3-653-2006; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Pinay G, 2002, ENVIRON MANAGE, V30, P481, DOI 10.1007/s00267-002-2736-1; Pinay G, 2000, BIOGEOCHEMISTRY, V50, P163, DOI 10.1023/A:1006317004639; Rinklebe J, 2006, SOIL BIOL BIOCHEM, V38, P2144, DOI 10.1016/j.soilbio.2006.01.018; Rivett MO, 2008, WATER RES, V42, P4215, DOI 10.1016/j.watres.2008.07.020; Schade JD, 2001, ECOLOGY, V82, P3363, DOI 10.1890/0012-9658(2001)082[3363:TIOARS]2.0.CO;2; Schramm HL, 2009, WETLANDS, V29, P476, DOI 10.1672/08-62.1; State Environmental Protection Administration of China (SEPA), 2009, EC ENV MON COMM 3 GO; Subida MD, 2013, SCI TOTAL ENVIRON, V450, P289, DOI 10.1016/j.scitotenv.2013.02.009; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; [王洪杰 Wang Hongjie], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P44; Wang Xiao-rong, 2010, Shengtaixue Zazhi, V29, P281; Weissteiner CJ, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013044; West JB, 2006, GLOBAL CHANGE BIOL, V12, P1400, DOI 10.1111/j.1365-2486.2006.01177.x; Ye C, 2014, ENVIRON SCI POLLUT R, V21, P2018, DOI 10.1007/s11356-013-2128-5; Ye C, 2013, ENVIRON SCI POLLUT R, V20, P1794, DOI 10.1007/s11356-012-1148-x; Ye C, 2012, ECOL ENG, V38, P37, DOI 10.1016/j.ecoleng.2011.10.005; Ye C, 2011, J HAZARD MATER, V191, P366, DOI 10.1016/j.jhazmat.2011.04.090; [詹艳慧 ZHAN Yanhui], 2006, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V29, P10; Zhang QF, 2011, ENVIRON SCI POLICY, V14, P1132, DOI 10.1016/j.envsci.2011.07.008; Zhou JJ, 2013, WATER RESOUR RES, V49, P3659, DOI 10.1002/wrcr.20283	52	15	18	9	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121210	10.1371/journal.pone.0121210	http://dx.doi.org/10.1371/journal.pone.0121210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789612	gold, Green Submitted, Green Published			2022-12-26	WOS:000351425400191
J	Al-Husseini, A; Wijesinghe, DS; Farkas, L; Kraskauskas, D; Drake, JI; Van Tassel, B; Abbate, A; Chalfant, CE; Voelkel, NF				Al-Husseini, Aysar; Wijesinghe, Dayanjan S.; Farkas, Laszlo; Kraskauskas, Donatas; Drake, Jennifer I.; Van Tassel, Ben; Abbate, Antonio; Chalfant, Charles E.; Voelkel, Norbert F.			Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; RAT LUNG; CELLS; CYCLOOXYGENASE-2; VASOCONSTRICTION; INHIBITION; PROSTAGLANDIN; INFLAMMATION; THROMBOXANE; EXPRESSION	Inflammation and altered immunity are recognized components of severe pulmonary arterial hypertension in human patients and in animal models of PAH. While eicosanoid metabolites of cyclooxygenase and lipoxygenase pathways have been identified in the lungs from pulmonary hypertensive animals their role in the pathogenesis of severe angioobliterative PAH has not been examined. Here we investigated whether a cyclooxygenase-2 (COX-2) inhibitor or diethylcarbamazine (DEC), that is known for its 5-lipoxygenase inhibiting and antioxidant actions, modify the development of PAH in the Sugen 5416/hypoxia (SuHx) rat model. The COX-2 inhibitor SC-58125 had little effect on the right ventricular pressure and did not prevent the development of pulmonary angioobliteration. In contrast, DEC blunted the muscularization of pulmonary arterioles and reduced the number of fully obliterated lung vessels. DEC treatment of SuHx rats, after the lung vascular disease had been established, reduced the degree of PAH, the number of obliterated arterioles and the degree of perivascular inflammation. We conclude that the non-specific anti-inflammatory drug DEC affects developing PAH and is partially effective once angioobliterative PAH has been established.	[Al-Husseini, Aysar; Farkas, Laszlo; Kraskauskas, Donatas; Drake, Jennifer I.; Voelkel, Norbert F.] Victoria Johnson Ctr Lung Res, Pulm & Crit Care Med Div, Richmond, VA 23298 USA; [Al-Husseini, Aysar] Montefiore Mt Vernon Hosp, Dept Internal Med, Westchester, NY USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA USA; [Van Tassel, Ben; Abbate, Antonio] Virginia Commonwealth Univ, Div Cardiol, Richmond, VA USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Reanimat Engn Sci Ctr VCURES, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Voelkel, NF (corresponding author), Victoria Johnson Ctr Lung Res, Pulm & Crit Care Med Div, Richmond, VA 23298 USA.	nfvoelkel@gmail.com	Abbate, Antonio/G-8805-2016	Abbate, Antonio/0000-0002-1930-785X; Drake, Jennifer/0000-0002-2808-4475	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; Veteran's Administration (VA Merit Award) [BX001792]; Veteran's Administration (Research Career Scientist Award); National Institutes of Health [HL072925, CA154314, S10OD10641-1A1]; US-Israel Binational Science Foundation [2011380, NH1C06-RR17393]; NIH/NCI Cancer Center [P30 CA016059]; National Research Service [GM008695]; Department of Veterans Affairs; VCU Developing Lipidomics Core via the VCU Massey Cancer Center; State of Virginia HEETF funds; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA154314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353, R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008695] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; Veteran's Administration (VA Merit Award)(US Department of Veterans Affairs); Veteran's Administration (Research Career Scientist Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); VCU Developing Lipidomics Core via the VCU Massey Cancer Center; State of Virginia HEETF funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the funds from the Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; research grants from the Veteran's Administration (VA Merit Award BX001792 to C.E.C. and a Research Career Scientist Award to C.E.C.); from the National Institutes of Health via HL072925 (C.E.C.), CA154314 (C.E.C.); from the US-Israel Binational Science Foundation via BSF#2011380 (C.E.C.), NH1C06-RR17393 (to Virginia Commonwealth University for renovation), NIH/NCI Cancer Center Support Grant P30 CA016059 (to Massey Cancer Center), a National Research Service Award-T32 Post-Doctoral Fellowship in Wound Healing GM008695 (D.S.W.), a Career Development Award (CDA1) from the Department of Veterans Affairs (D.S.W.). This work was also supported by the VCU Developing Lipidomics Core via the VCU Massey Cancer Center as well as an instrument grant from the National Institutes of Health (S10OD10641-1A1 (C.E.C.)) and State of Virginia HEETF funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Barst R, 2010, INT J CLIN PRACT, V64, P23, DOI 10.1111/j.1742-1241.2010.02525.x; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Chida M, 1996, AM J PHYSIOL-LUNG C, V270, pL872, DOI 10.1152/ajplung.1996.270.5.L872; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Delannoy E, 2010, CARDIOVASC RES, V85, P582, DOI 10.1093/cvr/cvp292; Dhakal HP, 2012, HISTOL HISTOPATHOL, V27, P1315, DOI 10.14670/HH-27.1315; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; HAUGE A, 1969, J APPL PHYSIOL, V26, P693, DOI 10.1152/jappl.1969.26.6.693; Janssen LJ, 2008, AM J RESP CELL MOL B, V39, P3383, DOI [10.1165/rcmb.2008-0117TR, DOI 10.1165/RCMB.2008-0117TR]; Karavitis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046342; Kawut SM, 2011, CIRCULATION, V123, P2985, DOI 10.1161/CIRCULATIONAHA.110.015693; KAY JM, 1967, AM J PATHOL, V51, P1031; Maciag A, 2004, CARCINOGENESIS, V25, P2231, DOI 10.1093/carcin/bgh245; MCDONNELL TJ, 1990, AM J PHYSIOL, V259, pH751, DOI 10.1152/ajpheart.1990.259.3.H751; MORGANROTH ML, 1985, AM REV RESPIR DIS, V131, P488, DOI 10.1164/arrd.1985.131.4.488; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Obermajer N, 2012, ONCOIMMUNOLOGY, V1, P762, DOI 10.4161/onci.19681; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; ONO S, 1992, J APPL PHYSIOL, V73, P1084, DOI 10.1152/jappl.1992.73.3.1084; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; REEVES JT, 1987, AM REV RESPIR DIS, V136, P196, DOI 10.1164/ajrccm/136.1.196; Robbins IM, 2006, EUR RESPIR J, V27, P578, DOI 10.1183/09031936.06.00095705; Ryan EP, 2008, CANCER IMMUNOL IMMUN, V57, P347, DOI 10.1007/s00262-007-0374-4; Sagliani KD, 2013, PULM CIRC, V3, P82, DOI 10.4103/2045-8932.109918; Seta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023439; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; STENMARK KR, 1983, NEW ENGL J MED, V309, P77, DOI 10.1056/NEJM198307143090204; STENMARK KR, 1985, AM J PHYSIOL, V248, pH859, DOI 10.1152/ajpheart.1985.248.6.H859; Tabata T, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P160; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tian W, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006674; Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; van Heumen BWH, 2012, EXP CELL RES, V318, P819, DOI 10.1016/j.yexcr.2012.02.004; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; VOELKEL NF, 1981, CIRC RES, V48, P207, DOI 10.1161/01.RES.48.2.207; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; WALKER BR, 1982, J APPL PHYSIOL, V52, P705, DOI 10.1152/jappl.1982.52.3.705; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Zuo X, 2012, PROSTAG OTH LIPID M, V139, P104	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120157	10.1371/journal.pone.0120157	http://dx.doi.org/10.1371/journal.pone.0120157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785937	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500158
J	Bauer, S; Olson, J; Cockrill, A; van Hattem, M; Miller, L; Tauzer, M; Leppig, G				Bauer, Scott; Olson, Jennifer; Cockrill, Adam; van Hattem, Michael; Miller, Linda; Tauzer, Margaret; Leppig, Gordon			Impacts of Surface Water Diversions for Marijuana Cultivation on Aquatic Habitat in Four Northwestern California Watersheds	PLOS ONE			English	Article							REGIONAL CLIMATE-CHANGE; INSTREAM DIVERSIONS; STREAM AMPHIBIANS; PACIFIC-NORTHWEST; DISSOLVED-OXYGEN; FLOW REGIMES; TEMPERATURE; GROWTH; CONSEQUENCES; BIODIVERSITY	Marijuana (Cannabis sativa L.) cultivation has proliferated in northwestern California since at least the mid-1990s. The environmental impacts associated with marijuana cultivation appear substantial, yet have been difficult to quantify, in part because cultivation is clandestine and often occurs on private property. To evaluate the impacts of water diversions at a watershed scale, we interpreted high-resolution aerial imagery to estimate the number of marijuana plants being cultivated in four watersheds in northwestern California, USA. Lowaltitude aircraft flights and search warrants executed with law enforcement at cultivation sites in the region helped to validate assumptions used in aerial imagery interpretation. We estimated the water demand of marijuana irrigation and the potential effects water diversions could have on stream flow in the study watersheds. Our results indicate that water demand for marijuana cultivation has the potential to divert substantial portions of streamflow in the study watersheds, with an estimated flow reduction of up to 23% of the annual sevenday low flow in the least impacted of the study watersheds. Estimates from the other study watersheds indicate that water demand for marijuana cultivation exceeds streamflow during the low-flow period. In the most impacted study watersheds, diminished streamflow is likely to have lethal or sub-lethal effects on state-and federally-listed salmon and steelhead trout and to cause further decline of sensitive amphibian species.	[Bauer, Scott; Olson, Jennifer; Cockrill, Adam; van Hattem, Michael; Miller, Linda; Leppig, Gordon] Calif Dept Fish & Wildlife, Eureka, CA 95501 USA; [Tauzer, Margaret] Natl Marine Fisheries Serv, Arcata, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Bauer, S (corresponding author), Calif Dept Fish & Wildlife, Eureka, CA 95501 USA.	scott.bauer@wildlife.ca.gov						Abell R., 2000, FRESHWATER ECOREGION; [Anonymous], 2013, EXECUTIVE OFFICE OF; [Anonymous], 1915, J AGR RES; [Anonymous], 2015, SPEC AN LIST; Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Arnold JM, 2013, THESIS HUMBOLDT STAT; Averyt K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015001; Bailey L. H., 1935, STANDARD CYCLOPEDIA; Bondi CA, 2013, HERPETOL CONSERV BIO, V8, P88; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Bury RB, 2008, APPL HERPETOL, V5, P63, DOI 10.1163/157075408783489211; California Department of Fish and Game, 2004, REC STRAT CAL COH SA; California Interagency Watershed Mapping Committee, 2004, CAL INT WAT MAP 1999; Cashman SM, 1995, 1454B US GEOL SURV; Cervantes J., 2006, MARIJUANA HORTICULTU; Clipp HL, 2014, FORESTS, V5, P2679, DOI 10.3390/f5112679; Corva D, 2014, INT J DRUG POLICY, V25, P71, DOI 10.1016/j.drugpo.2013.02.003; Deitch MJ, 2009, AQUAT CONSERV, V19, P274, DOI 10.1002/aqc.1012; Deitch MJ, 2009, RIVER RES APPL, V25, P118, DOI 10.1002/rra.1100; DeOreo W.B., 2011, CALIFORNIA SINGLE FA; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gabriel M.W., 2013, WILDL PROF, P46; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gleick PH, 2003, ANNU REV ENV RESOUR, V28, P275, DOI 10.1146/annurev.energy.28.040202.122849; Harvey BC, 2006, T AM FISH SOC, V135, P998, DOI 10.1577/T05-233.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; HGA [Humboldt Growers Association], 2010, HUMBOLDT COUNTY OUTD; Howell TA, 2001, AGRON J, V93, P281, DOI 10.2134/agronj2001.932281x; Humboldt County Planning and Building Department, 2002, FOR RES; JENSEN M. E., 1968, Water Deficits and Plant Growth., V2, P1; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Kelsey Kathryn A., 1998, P235; Kim J, 2002, J CLIMATE, V15, P1926, DOI [10.1175/1520-0442(2002)015<1926:IOIACO>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;1926:IOIACO&gt;2.0.CO;2]; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Kupferberg SJ, 2012, CONSERV BIOL, V26, P513, DOI 10.1111/j.1523-1739.2012.01837.x; Lang M., 2004, IMPROVING STREAM CRO; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Leeper Joseph, 1990, CALIFORNIA GEOGRAPHE, V30, P93; Leung LR, 2004, CLIMATIC CHANGE, V62, P75, DOI 10.1023/B:CLIM.0000013692.50640.55; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Madej MA, 2011, P 4 INT C RES WAT US; Mallery M, 2011, BERKELEY UNDERGRAD J, V23; Marine KR, 2004, N AM J FISH MANAGE, V24, P198, DOI 10.1577/M02-142; Mayer TD, 2011, J AM WATER RESOUR AS, V47, P724, DOI 10.1111/j.1752-1688.2011.00537.x; Milestone JF, 2012, RETHINKING PROTECTED; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; Mills E, 2012, ENERG POLICY, V46, P58, DOI 10.1016/j.enpol.2012.03.023; Mohseni O, 2003, CLIMATIC CHANGE, V59, P389, DOI 10.1023/A:1024847723344; Moore MK, 1998, OIKOS, V81, P329, DOI 10.2307/3547053; Moyle P.B., 2002, INLAND FISHES CALIFO; North Coast Water Quality Control Board, 2011, WAT QUAL CONTR PLAN; ONeal K., 2002, EFFECTS GLOBAL WARMI; Pilliod DS, 2008, HABITAT MANAGEMENT G; Poff N.L., 2002, AQUATIC ECOSYSTEMS G; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; PRWEB, 2012, LEAD CAL MAR ATT SAY; Rantz SE., 1964, 1758 US GEOL SURV US; Rantz SE, 1968, HA298 US GEOL SURV; RAY C, 1958, ECOLOGY, V39, P75, DOI 10.2307/1929968; Ricketts T. H., 1999, TERRESTRIAL ECOREGIO; Sawyer J.O., 2009, MANUAL CALIFORNIA VE; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Shaw MR, 2011, CLIMATIC CHANGE, V109, P465, DOI 10.1007/s10584-011-0313-4; SILVER STUART J., 1963, TRANS AMER FISH SOC, V92, P327, DOI 10.1577/1548-8659(1963)92[327:DORODS]2.0.CO;2; Snyder MA, 2004, J AM WATER RESOUR AS, V40, P591, DOI 10.1111/j.1752-1688.2004.tb04445.x; Snyder MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014431; Snyder MA, 2005, EARTH INTERACT, V9; Starrs P.F, 2010, FIELD GUIDE CALIFORN; State Water Resources Control Board, 2013, MAR CULT N COAST THR; Stevens PW, 2006, ESTUARIES COASTS, V29, P997, DOI 10.1007/BF02798661; Suttle KB, 2004, ECOL APPL, V14, P969, DOI 10.1890/03-5190; Thompson C, 2014, CONSERV LETT, V7, P91, DOI 10.1111/conl.12038; Tockner Klement, 2008, P45, DOI 10.1017/CBO9780511751790.006; United States Department of Justice, 2007, DOM CANN CULT ASS 20; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2008, FRESHWATER BIOL, V53, P1470, DOI 10.1111/j.1365-2427.2008.01963.x; Welsh HH, 1998, ECOL APPL, V8, P1118; Welsh HH, 1996, J HERPETOL, V30, P385, DOI 10.2307/1565176; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Western Regional Climate Center, 2014, COOP CLIM DAT SUMM; Williams L.E., 2001, PRACT WINERY VINEYAR, P42; Yates D, 2008, CLIMATIC CHANGE, V91, P335, DOI 10.1007/s10584-008-9427-8	85	51	54	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120016	10.1371/journal.pone.0120016	http://dx.doi.org/10.1371/journal.pone.0120016			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785849	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500149
J	Bode, NWF; Holl, S; Mehner, W; Seyfried, A				Bode, Nikolai W. F.; Holl, Stefan; Mehner, Wolfgang; Seyfried, Armin			Disentangling the Impact of Social Groups on Response Times and Movement Dynamics in Evacuations	PLOS ONE			English	Article							BEHAVIOR; ORGANIZATION	Crowd evacuations are paradigmatic examples for collective behaviour, as interactions between individuals lead to the overall movement dynamics. Approaches assuming that all individuals interact in the same way have significantly improved our understanding of pedestrian crowd evacuations. However, this scenario is unlikely, as many pedestrians move in social groups that are based on friendship or kinship. We test how the presence of social groups affects the egress time of individuals and crowds in a representative crowd evacuation experiment. Our results suggest that the presence of social groups increases egress times and that this is largely due to differences at two stages of evacuations. First, individuals in social groups take longer to show a movement response at the start of evacuations, and, second, they take longer to move into the vicinity of the exits once they have started to move towards them. Surprisingly, there are no discernible time differences between the movement of independent individuals and individuals in groups directly in front of the exits. We explain these results and discuss their implications. Our findings elucidate behavioural differences between independent individuals and social groups in evacuations. Such insights are crucial for the control of crowd evacuations and for planning mass events.	[Bode, Nikolai W. F.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Holl, Stefan; Mehner, Wolfgang; Seyfried, Armin] Julich Supercomp Ctr, Julich, Germany; [Holl, Stefan; Seyfried, Armin] Univ Wuppertal, Wuppertal, Germany	University of Essex; University of Wuppertal	Seyfried, A (corresponding author), Julich Supercomp Ctr, Julich, Germany.	a.seyfried@fz-juelich.de	Seyfried, Armin/T-4868-2017	Seyfried, Armin/0000-0001-8888-0978; Bode, Nikolai/0000-0003-0958-5191	AXA; German Federal Ministry of Education and Research	AXA; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	NWFB is supported by an AXA research fellowship. The project "Basigo - Bausteine fur die Sicherheit von Grossveranstaltungen" is funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode NWF, 2013, ANIM BEHAV, V86, P347, DOI 10.1016/j.anbehav.2013.05.025; Bode NWF, 2012, AM NAT, V179, P621, DOI 10.1086/665005; Braun A, 2003, COMP ANIM CONF PROC, P143, DOI 10.1109/CASA.2003.1199317; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Clement RJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077943; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Drury J, 2009, BRIT J SOC PSYCHOL, V48, P487, DOI 10.1348/014466608X357893; French JRP, 1944, U IOWA STUD CHILD WE, V20, P229; Ge WN, 2012, IEEE T PATTERN ANAL, V34, P1003, DOI 10.1109/TPAMI.2011.176; Hoogendoorn SP, 2005, TRANSPORT SCI, V39, P147, DOI 10.1287/trsc.1040.0102; Johnson C. W., 2005, Cognition, Technology & Work, V7, P214, DOI 10.1007/s10111-005-0009-5; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; LATANE B, 1968, J PERS SOC PSYCHOL, V10, P215, DOI 10.1037/h0026570; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Ozel F, 2001, SAFETY SCI, V38, P95, DOI 10.1016/S0925-7535(00)00061-8; Pinheiro J, 2020, R PACKAGE VERSION 31; Proulx G., 2002, SFPE HDB FIRE PROTEC, P343; Qiu FS, 2010, SIMUL MODEL PRACT TH, V18, P190, DOI 10.1016/j.simpat.2009.10.005; R Core Team, 2013, LANG ENV STAT COMP; RUTKOWSKI GK, 1983, J PERS SOC PSYCHOL, V44, P545, DOI 10.1037/0022-3514.44.3.545; Schadschneider A., 2011, ENCY COMPLEXITY SYST, P517, DOI [DOI 10.1007/978-0-387-30440-3_187, 10.1007/978-1-4419-7695-6_29, 10.1007/978-0-387-30440-3_187]; Seyfried A, 2009, TRANSPORT SCI, V43, P395, DOI 10.1287/trsc.1090.0263; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Sime JD, 1983, J ENVIRON PSYCHOL, V3, P21, DOI [10.1016/S0272-4944(83)80019-X, DOI 10.1016/S0272-4944(83)80019-X]; Sochman J., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P830, DOI 10.1109/ICCVW.2011.6130338; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; vom Lehn D, 2013, LINGUAE LITT, V20, P65; Yang LZ, 2005, BUILD ENVIRON, V40, P411, DOI 10.1016/j.buildenv.2004.08.005	30	53	53	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121227	10.1371/journal.pone.0121227	http://dx.doi.org/10.1371/journal.pone.0121227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785603	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500203
J	Bottazzi, B; Santini, L; Savino, S; Giuliani, MM; Diez, AID; Mancuso, G; Beninati, C; Sironi, M; Valentino, S; Deban, L; Garlanda, C; Teti, G; Pizza, M; Rappuoli, R; Mantovani, A				Bottazzi, Barbara; Santini, Laura; Savino, Silvana; Giuliani, Marzia M.; Duenas Diez, Ana I.; Mancuso, Giuseppe; Beninati, Concetta; Sironi, Marina; Valentino, Sonia; Deban, Livija; Garlanda, Cecilia; Teti, Giuseppe; Pizza, Mariagrazia; Rappuoli, Rino; Mantovani, Alberto			Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEROGROUP-B; INNATE IMMUNITY; FACTOR-H; MENINGOCOCCAL DISEASE; LIGAND RECOGNITION; MOLECULE PTX3; COMPLEMENT; VACCINE; BINDING	Long pentraxin 3 (PTX3) is a non-redundant component of the humoral arm of innate immunity. The present study was designed to investigate the interaction of PTX3 with Neisseria meningitidis. PTX3 bound acapsular meningococcus, Neisseria-derived outer membrane vesicles (OMV) and 3 selected meningococcal antigens (GNA0667, GNA1030 and GNA2091). PTX3-recognized microbial moieties are conserved structures which fulfil essential microbial functions. Ptx3-deficient mice had a lower antibody response in vaccination protocols with OMV and co-administration of PTX3 increased the antibody response, particularly in Ptx3-deficient mice. Administration of PTX3 reduced the bacterial load in infant rats challenged with Neisseria meningitidis. These results suggest that PTX3 recognizes a set of conserved structures from Neisseria meningitidis and acts as an amplifier/endogenous adjuvant of responses to this bacterium.	[Bottazzi, Barbara; Sironi, Marina; Valentino, Sonia; Deban, Livija; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy; [Santini, Laura; Savino, Silvana; Giuliani, Marzia M.; Pizza, Mariagrazia; Rappuoli, Rino] Novartis Vaccines & Diagnost Res Ctr, Siena, Italy; [Duenas Diez, Ana I.] Hosp Clin Univ, Unidad Invest, Valladolid, Spain; [Mancuso, Giuseppe; Beninati, Concetta; Teti, Giuseppe] Univ Messina, Metchnikoff Lab, Messina, Italy; [Mantovani, Alberto] Humanitas Univ, Milan, Italy	Novartis; Universidad de la Laguna; University of Messina; Humanitas University	Bottazzi, B (corresponding author), Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy.	barbara.bottazzi@humanitasresearch.it	Valentino, Sonia/AAB-4066-2020; sironi, marina/AAB-5757-2020; bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022; Garlanda, Cecilia/K-4601-2016	Valentino, Sonia/0000-0001-8652-3168; sironi, marina/0000-0002-3342-1149; bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703; BENINATI, Concetta/0000-0001-8305-1337; Mancuso, Giuseppe/0000-0001-5454-3228	European Research Council (ERC project HIIS); European Commission [FP7-HEALTH-2011-ADITEC-280873]	European Research Council (ERC project HIIS); European Commission(European CommissionEuropean Commission Joint Research Centre)	BB and AM were founded by the European Research Council (ERC project HIIS) and by the European Commission (FP7-HEALTH-2011-ADITEC-280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beninati C, 2006, J EXP MED, V203, P111, DOI 10.1084/jem.20051540; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Braunschweig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023991; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Coureuil M, 2012, VIRULENCE, V3, P164, DOI 10.4161/viru.18639; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; DUCLOS TW, 1991, J IMMUNOL, V146, P1220; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Inforzato A, 2013, SEMIN IMMUNOL; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Ingalls RR, 2001, INFECT IMMUN, V69, P2230, DOI 10.1128/IAI.69.4.2230-2236.2001; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jaillon S, 2014, IMMUNITY, V40, P621, DOI 10.1016/j.immuni.2014.02.015; Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Lewis LA, 2014, VIRULENCE, V5, P98, DOI 10.4161/viru.26515; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mathew S, 2006, PEDIATR INFECT DIS J, V25, P255, DOI 10.1097/01.inf.0000209215.65445.04; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moya-Quiles MR, 2013, GENE, V521, P204, DOI 10.1016/j.gene.2013.03.027; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pluddemann A, 2009, J INNATE IMMUN, V1, P153, DOI 10.1159/000155227; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Schejbel L, 2013, IMMUNOBIOLOGY; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Sprong T, 2001, J LEUKOCYTE BIOL, V70, P283; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Szalai AJ, 2002, MICROBES INFECT, V4, P201, DOI 10.1016/S1286-4579(01)01528-3; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Uronen H, 2000, CLIN EXP IMMUNOL, V122, P312, DOI 10.1046/j.1365-2249.2000.01409.x; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Welsch JA, 2003, J INFECT DIS, V188, P1730, DOI 10.1086/379375; Wong HEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026130	79	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120807	10.1371/journal.pone.0120807	http://dx.doi.org/10.1371/journal.pone.0120807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786110	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500191
J	Ding, D; Su, DF; Li, XR; Li, ZX; Wang, YJ; Qiu, J; Lin, PQ; Zhang, Y; Guo, P; Xia, M; Li, D; Yang, Y; Hu, G; Ling, WH				Ding, Ding; Su, Dongfang; Li, Xinrui; Li, Zhongxia; Wang, Yujie; Qiu, Jian; Lin, Puqing; Zhang, Yuan; Guo, Pi; Xia, Min; Li, Dan; Yang, Yan; Hu, Gang; Ling, Wenhua			Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease	PLOS ONE			English	Article							PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; PLASMA-LEVELS; TISSUE FACTOR; EXPRESSION; MCP-1; ATHEROSCLEROSIS; RECOMMENDATIONS; INFLAMMATION	Background Monocyte chemoattractant protein-1 (MCP-1) is an important chemokine at multiple phases of atherosclerosis in animals, but human studies are few and inconsistent. The aim of this study is to investigate the association of serum MCP-1with all-cause and cardiovascular disease (CVD) mortality among coronary artery disease (CAD) patients and determine whether this biomarker can add secondary prognostic value to standard risk predictors. Methods MCP-1 was measured at baseline in 1411 CAD patients who were 40-85 years of age. Cox proportional hazards regression models were used to estimate the association of MCP-1 levels with death risk. Results During a median follow-up of 3.3 years, 117 deaths were recorded, 88 of which were due to CVD. The multivariable-adjusted hazard ratios across tertiles of MCP-1 were 1.51 (95% confidence intervals [CI] 0.89-2.58), 1.00, and 2.11 (95% CI 1.31-3.40) for all-cause mortality, and 1.50 (95% CI 0.80-2.81), 1.00, and 2.21 (95% CI 1.27-3.87) for CVD mortality. The addition of serum MCP-1 to the fully adjusted model increased the C-index by 0.009 (p<0.0001) for all-cause mortality and 0.008 (p<0.0001) for CVD mortality and significantly improved the predictive ability by 12.1%(P = 0.006) on all-cause mortality and 12.6% (P = 0.003) on CVD mortality using the net reclassification improvement method. Conclusions Both lower and higher MCP-1 levels are associated with an increased risk of all-cause and CVD mortality among CAD patients. More research is needed to confirm its clinical relevance.	[Ding, Ding; Su, Dongfang; Li, Xinrui; Li, Zhongxia; Xia, Min; Li, Dan; Yang, Yan; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Ding; Wang, Yujie; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA; [Qiu, Jian; Lin, Puqing; Zhang, Yuan] Guangzhou Mil Command Peoples Liberat Army, Dept Cardiol, Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Guo, Pi] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sun Yat Sen University	Li, D (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China.	dolphin_danli@yahoo.com.cn; gang.hu@pbrc.edu	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022; Hu, Gang/V-7947-2019; Stefanadis, Christodoulos/ABH-2232-2020; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Stefanadis, Christodoulos/0000-0001-5974-6454; Hu, Gang/0000-0002-6172-8017; Li, Dan/0000-0001-6458-6096	Key Project of National Natural Science Fund, China [81130052]	Key Project of National Natural Science Fund, China	This work was supported by the Key Project of National Natural Science Fund [grant number 81130052], China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsall HH, 1997, CIRCULATION, V95, P684, DOI 10.1161/01.CIR.95.3.684; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Cipollone F, 2001, ARTERIOSCL THROM VAS, V21, P327, DOI 10.1161/01.ATV.21.3.327; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Economou E, 2001, INT J CARDIOL, V80, P55, DOI 10.1016/S0167-5273(01)00454-5; Feng AN, 1999, CIRCULATION, V100, P2254, DOI 10.1161/01.CIR.100.22.2254; Ghanim H, 2001, J CLIN ENDOCR METAB, V86, P1306, DOI 10.1210/jc.86.3.1306; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hokimoto S, 2000, JPN CIRC J, V64, P831, DOI 10.1253/jcj.64.831; Kavsak PA, 2007, CLIN CHEM, V53, P2112, DOI 10.1373/clinchem.2007.090613; Kervinen H, 2004, AM J CARDIOL, V94, P993, DOI 10.1016/j.amjcard.2004.06.052; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li ZS, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1365-8; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Martinez-Gonzalez J, 2001, ATHEROSCLEROSIS, V159, P27, DOI 10.1016/S0021-9150(01)00469-5; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nishiyama K, 1998, JPN CIRC J, V62, P710, DOI 10.1253/jcj.62.710; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Stork S, 2002, CARDIOVASC RES, V53, P642, DOI 10.1016/S0008-6363(01)00461-8; World Health Organization, GLOB HLTH OBS DAT RE; Zhang B, 2010, PUBLIC HEALTH NUTR, V13, P1546, DOI 10.1017/S1368980009992849	31	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120633	10.1371/journal.pone.0120633	http://dx.doi.org/10.1371/journal.pone.0120633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786118	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500183
J	Khan, JA; Mustafa, M; Hayat, T; Sheikholeslami, M; Alsaedi, A				Khan, Junaid Ahmad; Mustafa, M.; Hayat, T.; Sheikholeslami, M.; Alsaedi, A.			Three-Dimensional Flow of Nanofluid Induced by an Exponentially Stretching Sheet: An Application to Solar Energy	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER ENHANCEMENT; STAGNATION-POINT FLOW; ALUMINA/WATER NANOFLUID; VISCOELASTIC FLUID; WATER NANOFLUID; MASS-TRANSFER; MHD FLOW; CONVECTION; EQUATIONS	This work deals with the three-dimensional flow of nanofluid over a bi-directional exponentially stretching sheet. The effects of Brownian motion and thermophoretic diffusion of nanoparticles are considered in the mathematical model. The temperature and nanoparticle volume fraction at the sheet are also distributed exponentially. Local similarity solutions are obtained by an implicit finite difference scheme known as Keller-box method. The results are compared with the existing studies in some limiting cases and found in good agreement. The results reveal the existence of interesting Sparrow-Gregg-type hills for temperature distribution corresponding to some range of parametric values.	[Khan, Junaid Ahmad] NUST, RCMS, Islamabad 44000, Pakistan; [Mustafa, M.] NUST, SNS, Islamabad 44000, Pakistan; [Hayat, T.] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah 21589, Saudi Arabia; [Sheikholeslami, M.] Babol Univ Technol, Dept Mech Engn, Babol Sar, Iran	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University; Babol Noshirvani University of Technology	Mustafa, M (corresponding author), NUST, SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Alsaedi, Ahmed/A-2094-2013; Mustafa Hashmi, Meraj/P-1769-2014; Hayat, Tasawar/E-9449-2015; Ahmad, Junaid/AAE-8872-2019; Sheikholeslami, Mohsen/G-9034-2015; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Ganji, Davood Domiri/Z-3664-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Sheikholeslami, Mohsen/0000-0002-8839-0458; Ganji, Davood Domiri/0000-0002-2344-526X				Abbas Z, 2014, HEAT TRANSF-ASIAN RE, V43, P233, DOI 10.1002/htj.21074; Abramowitz M., 1965, HDB MATH FUNCTIONS; ALI ME, 1995, INT J HEAT FLUID FL, V16, P280, DOI 10.1016/0142-727X(95)00001-7; Ashorynejad HR, 2013, HEAT MASS TRANSFER, V49, P427, DOI 10.1007/s00231-012-1087-6; BANKS WHH, 1983, J MEC THEOR APPL, V2, P375; Beg OA, 2013, APPL NANOSCI; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Cebeci T, 1988, PHYS COMPUTATIONAL A; CHEN CK, 1988, J MATH ANAL APPL, V135, P568, DOI 10.1016/0022-247X(88)90172-2; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Ebaid A, 2013, COMPUT MATH METHODS; GRUBKA LJ, 1985, J HEAT TRANS-T ASME, V107, P248, DOI 10.1115/1.3247387; Hayat T, 2008, NONLINEAR ANAL-REAL, V9, P1811, DOI 10.1016/j.nonrwa.2007.05.010; Hayat T, 2011, NUMER METH PART D E, V27, P915, DOI 10.1002/num.20561; Ibrahim W, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4026118; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Javed T, 2013, CHEM ENG COMMUN, V200, P327, DOI 10.1080/00986445.2012.703151; Karimipour A, 2014, PHYSICA A, V402, P150, DOI 10.1016/j.physa.2014.01.057; Khan JA, 2014, J MOL LIQ, V194, P41, DOI 10.1016/j.molliq.2013.12.045; Khan SK, 2005, INT J HEAT MASS TRAN, V48, P1534, DOI 10.1016/j.ijheatmasstransfer.2004.10.032; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kumar H, 2013, CHEM ENG COMMUN, V200, P895, DOI 10.1080/00986445.2012.727509; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Ladjevardi SM, 2013, SOL ENERGY, V94, P327, DOI 10.1016/j.solener.2013.05.012; LAWRENCE PS, 1992, ACTA MECH, V93, P53, DOI 10.1007/BF01182572; Liao SJ, 2003, J FLUID MECH, V488, P189, DOI 10.1017/S0022112003004865; Liu IC, 2008, INT J HEAT MASS TRAN, V51, P4018, DOI 10.1016/j.ijheatmasstransfer.2007.10.041; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Magyari E, 2000, EUR J MECH B-FLUID, V19, P109, DOI 10.1016/S0997-7546(00)00104-7; Maiga SE, 2006, INT J NUMER METHOD H, V16, P275, DOI 10.1108/09615530610649717; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Malvandi A, 2014, ADV POWDER TECHNOL, V25, P1369, DOI 10.1016/j.apt.2014.03.017; Malvandi A, 2014, INT J THERM SCI, V84, P196, DOI 10.1016/j.ijthermalsci.2014.05.013; Malvandi A, 2014, POWDER TECHNOL, V263, P37, DOI 10.1016/j.powtec.2014.04.084; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Mushtaq A, 2014, J TAIWAN INST CHEM E, V45, P1176, DOI 10.1016/j.jtice.2013.11.008; Mustafa M, 2013, J MECH, V29, P423, DOI 10.1017/jmech.2013.9; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Mustafa M, 2013, PLOS ONE, V8; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nadeem S, 2011, NUMER ALGORITHMS, V57, P187, DOI 10.1007/s11075-010-9423-8; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Otanicar TP, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3429737; Pop I, 1998, MECH RES COMMUN, V25, P263, DOI 10.1016/S0093-6413(98)00037-8; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rasekh A, 2012, FRONT HEAT MASS TRAN, V3, DOI 10.5098/hmt.v3.4.3003; Sadeqi S, 2011, COMMUN NONLINEAR SCI, V16, P711, DOI 10.1016/j.cnsns.2010.05.009; Safaei MR, 2014, NUMER HEAT TR A-APPL, V66, P1321, DOI 10.1080/10407782.2014.916101; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Shijun Liao, 2006, Communications in Nonlinear Science and Numerical Simulation, V11, P326, DOI 10.1016/j.cnsns.2004.09.004; Trieb F, 1998, RENEW ENERG, V14, P17, DOI 10.1016/S0960-1481(98)00041-X; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4025730; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Xu H, 2007, EUR J MECH B-FLUID, V26, P15, DOI 10.1016/j.euromechflu.2005.12.003; Xu H, 2009, COMPUT MATH APPL, V57, P1425, DOI 10.1016/j.camwa.2009.01.029	62	70	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116603	10.1371/journal.pone.0116603	http://dx.doi.org/10.1371/journal.pone.0116603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785857	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500011
J	Maura, F; Mosca, L; Fabris, S; Cutrona, G; Matis, S; Lionetti, M; Agnelli, L; Barbieri, M; D'Anca, M; Manzoni, M; Colombo, M; Massucco, C; Reverberi, D; Gentile, M; Recchia, AG; Bossio, S; Ilariucci, F; Musolino, C; Di Raimondo, F; Cortelezzi, A; Morabito, F; Ferrarini, M; Neri, A				Maura, Francesco; Mosca, Laura; Fabris, Sonia; Cutrona, Giovanna; Matis, Serena; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Colombo, Monica; Massucco, Carlotta; Reverberi, Daniele; Gentile, Massimo; Recchia, Anna Grazia; Bossio, Sabrina; Ilariucci, Fiorella; Musolino, Caterina; Di Raimondo, Francesco; Cortelezzi, Agostino; Morabito, Fortunato; Ferrarini, Manlio; Neri, Antonino			Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia	PLOS ONE			English	Article							FACTOR-I RECEPTOR; BORTEZOMIB; SURVIVAL; ZAP-70; IMPACT; GENES; IGF1R; STAGE; RISK; CD38	IGF1R is emerging as an important gene in the pathogenesis of many solid and haematological cancers and its over-expression has been reported as frequently associated with aggressive disease and chemotherapy resistance. In this study we performed an investigation of the role of IGF1R expression in a large and representative prospective series of 217 chronic lymphocytic leukaemia (CLL) patients enrolled in the multicentre O-CLL1 protocol (clinicaltrial.gov #NCT00917540). High IGF1R gene expression was significantly associated with IGHV unmutated (IGHV-UM) status (p<0.0001), high CD38 expression (p<0.0001), trisomy 12 (p<0.0001), and del(11)(q23) (p=0.014). Interestingly, higher IGF1R expression (p=0.002) characterized patients with NOTCH1 mutation (c.7541_7542delCT), identified in 15.5% of cases of our series by next generation sequencing and ARMS-PCR. Furthermore, IGF1R expression has been proven as an independent prognostic factor associated with time to first treatment in our CLL prospective cohort. These data suggest that IGF1R may play an important role in CLL biology, in particular in aggressive CLL clones characterized by IGHV-UM, trisomy 12 and NOTCH1 mutation.	[Maura, Francesco; Mosca, Laura; Fabris, Sonia; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Cortelezzi, Agostino; Neri, Antonino] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Maura, Francesco; Mosca, Laura; Fabris, Sonia; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Cortelezzi, Agostino; Neri, Antonino] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Hematol CTMO 1, Milan, Italy; [Cutrona, Giovanna] IRCCS S Martino IST, SS Mol Diagnost, Genoa, Italy; [Matis, Serena; Colombo, Monica; Massucco, Carlotta; Ferrarini, Manlio] Sci Direct IRCCS S Martino IST, Genoa, Italy; [Reverberi, Daniele; Morabito, Fortunato] Dept Pathol IRCCS S Martino IST, Genoa, Italy; [Gentile, Massimo; Recchia, Anna Grazia; Bossio, Sabrina] Azienda Osped Cosenza, UOC Ematol, Cosenza, Italy; [Ilariucci, Fiorella] AO Arcispedale Santa Maria Nuova IRCCS, Div Hematol, Reggio Emilia, Italy; [Musolino, Caterina] Univ Messina, Div Haematol, Messina, Italy; [Di Raimondo, Francesco] Univ Catania, Dept Biomed Sci, Div Hematol, Catania, Italy; [Di Raimondo, Francesco] Ferrarotto Hosp, Catania, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Azienda Ospedaliera di Cosenza; IRCCS Arcispedale S. Maria Nuova; University of Messina; University of Catania	Neri, A (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.	antonino.neri@unimi.it	Neri, Antonino/I-9690-2014; D'Anca, Marianna/K-5759-2016; Di Raimondo, Francesco/K-7965-2016; Colombo, Monica/AAI-2484-2019; cortelezzi, agostino/L-2633-2016; Morabito, Francesco Carlo/AAB-9698-2019; Cutrona, Giovanna/I-7868-2018; Bossio, Sabrina/GVS-5999-2022; Gentile, Massimo/R-3270-2016; Matis, Serena/AAB-2832-2020; ilariucci, fiorella/AAA-8256-2019; Recchia, Anna Grazia/ABA-5228-2020	Neri, Antonino/0000-0001-9047-5912; D'Anca, Marianna/0000-0001-8625-6506; Di Raimondo, Francesco/0000-0002-7749-0293; Colombo, Monica/0000-0001-5512-8106; Morabito, Francesco Carlo/0000-0003-0734-9136; Cutrona, Giovanna/0000-0002-3335-1101; Gentile, Massimo/0000-0002-5256-0726; Matis, Serena/0000-0003-3023-0213; ilariucci, fiorella/0000-0002-4279-3358; Agnelli, Luca/0000-0003-0582-6170; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Barbieri, Marzia/0000-0002-9027-1888; Ferrarini, Manlio/0000-0002-6154-2570; Fabris, Sonia/0000-0003-1341-0503; MANZONI, MARTINA/0000-0003-0861-9951	Associazione Italiana Ricerca sul Cancro (AIRC) [AN-IG10136, MF464 IG10492, FM-RG6432]; AIRC-Special Program Molecular Clinical Oncology (5 per Mille) [9980]; Ricerca Finalizzata from the Italian Ministry of Health; Fondo Investimento per la Ricerca di Base [RBIP06LCA9]; progetto Compagnia San Paolo; AIRC; Fondazione Italiana Ricerca sul Cancro (FIRC)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC-Special Program Molecular Clinical Oncology (5 per Mille)(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata from the Italian Ministry of Health(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Fondo Investimento per la Ricerca di Base; progetto Compagnia San Paolo; AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC, AN-IG10136, MF464 IG10492, and FM-RG6432), AIRC-Special Program Molecular Clinical Oncology (5 per Mille, grant 9980, 2010-15; Antonino Neri, Manlio Ferrarini, and Fortunato Morabito), Ricerca Finalizzata from the Italian Ministry of Health 2006 (Giovanna Cutrona, Fortunato Morabito, and Manlio Ferrarini) and 2007 (Giovanna Cutrona), Fondo Investimento per la Ricerca di Base (grant RBIP06LCA9; Manlio Ferrarini), progetto Compagnia San Paolo (G.C.). Sabrina Bossio was supported by fellowships from the AIRC. Marta Lionetti was supported by a fellowship from the Fondazione Italiana Ricerca sul Cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen J, 2005, CLIN CANCER RES, V11, P206; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cutrona G, 2006, EUR J IMMUNOL, V36, P558, DOI 10.1002/eji.200526355; Cutrona G, 2008, HAEMATOLOGICA, V93, P413, DOI 10.3324/haematol.11646; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Furman RR, 2014, N ENGL J MED; Gopal AK, 2014, N ENGL J MED; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087474; Lionetti M, 2014, BRIT J HAEMATOL, V165, P629, DOI 10.1111/bjh.12800; Maura F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024313; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Morabito F, 2009, BRIT J HAEMATOL, V146, P44, DOI 10.1111/j.1365-2141.2009.07703.x; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; PAPA V, 1993, CANCER RES, V53, P3736; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Schillaci R, 2005, BRIT J HAEMATOL, V130, P58, DOI 10.1111/j.1365-2141.2005.05579.x; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Vishwamitra D, 2011, HAEMATOL-HEMATOL J, V96, P871, DOI 10.3324/haematol.2010.031567; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yaktapour N, 2013, BLOOD, V122, P1621, DOI 10.1182/blood-2013-02-484386	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118801	10.1371/journal.pone.0118801	http://dx.doi.org/10.1371/journal.pone.0118801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786252	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500048
J	Pozzi, LM; Borboroglu, PG; Boersma, PD; Pascual, MA				Pozzi, Luciana M.; Borboroglu, Pablo Garcia; Boersma, P. Dee; Pascual, Miguel A.			Population Regulation in Magellanic Penguins: What Determines Changes in Colony Size?	PLOS ONE			English	Article							ENVIRONMENTAL VARIABILITY; SPHENISCUS-MAGELLANICUS; REPRODUCTIVE SUCCESS; DENSITY-DEPENDENCE; HABITAT SELECTION; WINTER MIGRATION; FORAGING EFFORT; SEABIRD; DYNAMICS; DISPERSAL	Seabirds are often studied at individual colonies, but the confounding effects of emigration and mortality processes in open populations may lead to inappropriate conclusions on the mechanisms underlying population changes. Magellanic penguin (Spheniscus magellanicus) colonies of variable population sizes are distributed along the Argentine coastline. In recent decades, several population and distributional changes have occurred, with some colonies declining and others newly established or increasing. We integrated data of eight colonies scattered along similar to 600 km in Northern Patagonia (from 41 degrees 26'S, 65 degrees 01'W to 45 degrees 11 'S, 66 degrees 30'W, Rio Negro and Chubut provinces) and conducted analysis in terms of their growth rates, production of young and of the dependence of those vital rates on colony age, size, and location. We contrasted population trends estimated from abundance data with those derived from population modeling to understand if observed growth rates were attainable under closed population scenarios. Population trends were inversely related to colony size, suggesting a density dependent growth pattern. All colonies located in the north-which were established during the last decades-increased at high rates, with the smallest, recently established colonies growing at the fastest rate. In central-southern Chubut, where colonies are the oldest, the largest breeding aggregations declined, but smaller colonies remained relatively stable. Results provided strong evidence that dispersal played a major role in driving local trends. Breeding success was higher in northern colonies, likely mediated by favorable oceanographic conditions. However, mean foraging distance and body condition of chicks at fledging were influenced by colony size. Recruitment of penguins in the northern area may have been triggered by a combination of density dependence, likely exacerbated by less favorable oceanographic conditions in the southern sector. Our results reaffirm the idea that individual colony trends do not provide confident indicators of population health, highlighting the need to redefine the scale for the study of population changes.	[Pozzi, Luciana M.; Borboroglu, Pablo Garcia; Pascual, Miguel A.] Ctr Nacl Patagon CONICET, RA-9120 Puerto Madryn, Chubut, Argentina; [Borboroglu, Pablo Garcia; Boersma, P. Dee] Global Penguin Soc, Seattle, WA USA; [Borboroglu, Pablo Garcia; Boersma, P. Dee] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pascual, Miguel A.] Univ Nacl Patagonia San Juan Bosco, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle; Universidad Nacional de la Patagonia San Juan Bosco	Pozzi, LM (corresponding author), Ctr Nacl Patagon CONICET, Blvd Brown 2915, RA-9120 Puerto Madryn, Chubut, Argentina.	pozzi@cenpat.edu.ar		Chiaradia, Andre/0000-0002-6178-4211	Rufford Small Grants; Whitley Fund for Nature; Pew Fellows Program in Marine Conservation	Rufford Small Grants; Whitley Fund for Nature; Pew Fellows Program in Marine Conservation	The research was funded by Rufford Small Grants, Whitley Fund for Nature and Pew Fellows Program in Marine Conservation, Luc Hoffman and Tom and Kathy Leiden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Alemany D, 2009, J BIOGEOGR, V36, P2111, DOI 10.1111/j.1365-2699.2009.02148.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bates D., 2014, LINEAR MIXED EFFECTS; Bertellotti M, 2005, 11 REUN ARG ORN, V66; Bicknell AWJ, 2014, DIVERS DISTRIB, V20, DOI 10.1111/ddi.12137; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bivand R., 2013, BINDINGS GEOSPATIAL; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085602; Boersma PD, 2010, J FIELD ORNITHOL, V81, P195, DOI 10.1111/j.1557-9263.2010.00277.x; Boersma PD, 2009, MAR ECOL PROG SER, V375, P263, DOI 10.3354/meps07753; Boersma PD, 2009, ECOL MONOGR, V79, P59, DOI 10.1890/06-0419.1; Boersma PD, 1990, PENGUIN BIOL; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P1; Borboroglu PG, 2002, AUK, V119, P233, DOI 10.1642/0004-8038(2002)119[0233:HUABDO]2.0.CO;2; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Bouzat JL, 2009, AUK, V126, P326, DOI 10.1525/auk.2009.07122; Carribero Alejandro, 1995, Hornero, V14, P33; Caswell, 2000, MATRIX POPULATION MO; Caughley G., 1977, ANAL VERTEBRATE POPU; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E., 1991, P1641; Davies RD, 2013, MAR ECOL PROG SER, V485, P287, DOI 10.3354/meps10348; DEEBOERSMA P, 1978, SCIENCE, V200, P1481, DOI 10.1126/science.200.4349.1481; Delord K, 2004, POLAR BIOL, V27, P793, DOI 10.1007/s00300-004-0651-z; Dumrauf C, 1991, HIST DE CHUBUT; Efron B., 1993, INTRO BOOSTRAP; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Frederiksen M, 2000, IBIS, V142, P48, DOI 10.1111/j.1474-919X.2000.tb07683.x; Frere E., 1996, Ornitologia Neotropical, V7, P35; Frere E, 1996, INFORME TECNICO NUME, V8; Furness R.W., 1987, SEABIRD ECOLOGY; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Gandini P., 1996, Bird Conservation International, V6, P307; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; HANSKI I, 1997, METAPOPULATION BIOL; Hilborn Ray, 1997, V28; Hunt G.L. Jr, 1990, Polar Research, V8, P43, DOI 10.1111/j.1751-8369.1990.tb00374.x; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; Inchausti P, 2003, J AVIAN BIOL, V34, P170, DOI 10.1034/j.1600-048X.2003.03031.x; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; James D, 2013, CHRON CHRONOLOGICAL, P4; Kildaw S. Dean, 2005, Marine Ornithology, V33, P49; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lewis S, 2001, NATURE, P412; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Martinez-Abrain A, 2001, WATERBIRDS, V24, P97, DOI 10.2307/1522248; McCarthy MA, 1996, J APPL ECOL, V33, P45, DOI 10.2307/2405014; Pozzi LM, 2013, ARDEOLA, V60, P279, DOI 10.13157/arla.60.2.2013.279; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; Numata M, 2000, NEW ZEAL J ZOOL, V27, P277, DOI 10.1080/03014223.2000.9518236; Orians G.H., 1979, P155; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Oro D, 2001, J ANIM ECOL, V70, P527, DOI 10.1046/j.1365-2656.2001.00511.x; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2000, IBIS, V142, P614, DOI 10.1111/j.1474-919X.2000.tb04461.x; QGIS DevelopmentTeam, 2012, QGIS GEOGR INF SYST; R Core Team, 2012, R LANG ENV STAT COMP; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Sabatini Marina E., 2004, Revista de Investigacion y Desarrollo Pesquero, V16, P5; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Sala JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051487; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schiavini Adrián, 2005, Hornero, V20, P5; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; SCOLARO JA, 1978, PUBLICACIONES OCASIO, V8, P1; STUBBEN C, 2007, J STAT SOFTWARE, V22; THOMPSON KR, 1991, J ZOOL, V225, P427, DOI 10.1111/j.1469-7998.1991.tb03826.x; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Villanueva C, 2012, J ORNITHOL, V153, P219, DOI 10.1007/s10336-011-0730-1; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; Whittington PA, 2002, THESIS U CAPE TOWN; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilson Rory P., 2007, Marine Ornithology, V35, P109; Wilson RP, 2005, ECOL MONOGR, V75, P379, DOI 10.1890/04-1238; Yorio P., 2001, Marine Ornithology, V29, P75; Yorio P, 1998, PLAN MANEJO INTEGRAD; [No title captured]	93	30	30	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119002	10.1371/journal.pone.0119002	http://dx.doi.org/10.1371/journal.pone.0119002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786254	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500064
J	Ren, ZY; Do, LD; Bechkoff, G; Mebarek, S; Keloglu, N; Ahamada, S; Meena, S; Magne, D; Pikula, S; Wu, YQ; Buchet, R				Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Pikula, Slawomir; Wu, Yuqing; Buchet, Rene			Direct Determination of Phosphatase Activity from Physiological Substrates in Cells	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RAPID IDENTIFICATION; CANCER CELLS; SPECTROSCOPY; TISSUE; QUANTIFICATION; DISCRIMINATION; MECHANISM; VESICLES	A direct and continuous approach to determine simultaneously protein and phosphate concentrations in cells and kinetics of phosphate release from physiological substrates by cells without any labeling has been developed. Among the enzymes having a phosphatase activity, tissue non-specific alkaline phosphatase (TNAP) performs indispensable, multiple functions in humans. It is expressed in numerous tissues with high levels detected in bones, liver and neurons. It is absolutely required for bone mineralization and also necessary for neurotransmitter synthesis. We provided the proof of concept that infrared spectroscopy is a reliable assay to determine a phosphatase activity in the osteoblasts. For the first time, an overall specific phosphatase activity in cells was determined in a single step by measuring simultaneously protein and substrate concentrations. We found specific activities in osteoblast like cells amounting to 116 +/- 13 nmol min(-1) mg(-1) for PPi, to 56 +/- 11 nmol min(-1) mg(-1) for AMP, to 79 +/- 23 nmol min(-1) mg(-1) for beta-glycerophosphate and to 73 +/- 15 nmol min(-1) mg(-1) for 1-alpha-D glucose phosphate. The assay was also effective to monitor phosphatase activity in primary osteoblasts and in matrix vesicles. The use of levamisole - a TNAP inhibitorserved to demonstrate that a part of the phosphatase activity originated from this enzyme. An IC50 value of 1.16 +/- 0.03 mM was obtained for the inhibition of phosphatase activity of levamisole in osteoblast like cells. The infrared assay could be extended to determine any type of phosphatase activity in other cells. It may serve as a metabolomic tool to monitor an overall phosphatase activity including acid phosphatases or other related enzymes.	[Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Univ Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Univ Lyon 1, F-69622 Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] INSA Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] CPE Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Inst Chim & Biochim Mol & Supramol, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] CNRS, UMR 5246, Villeurbanne, France; [Ren, Zhongyuan; Wu, Yuqing] Jilin Univ Changchun, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China; [Le Duy Do; Pikula, Slawomir] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Le Duy Do; Pikula, Slawomir] Polish Acad Sci, PL-02093 Warsaw, Poland	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Jilin University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences	Buchet, R (corresponding author), Univ Lyon, Villeurbanne, France.	rbuchet@univ-lyon1.fr	Rene, Buchet/I-9781-2019; Mebarek, Saida/AAI-8237-2020	Rene, Buchet/0000-0002-7966-3856; DO, Le Duy/0000-0001-7664-533X; Pikula, Slawomir/0000-0003-4640-3094; Magne, David/0000-0002-6511-9390; Ren, Zhongyuan/0000-0002-0300-7801	China Scholarship Council; International PhD program in Neurobiology [06]; French Agency for the promotion of higher education and international mobility (Campus France) [27727TA]; CNRS International project of scientific cooperation (PICS) [5096]; Polish Ministry of Science and Higher Education [N401 140639]; European Union [264173]	China Scholarship Council(China Scholarship Council); International PhD program in Neurobiology; French Agency for the promotion of higher education and international mobility (Campus France); CNRS International project of scientific cooperation (PICS); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	Mr. Zhongyuan Ren received a PhD scholarship from the China Scholarship Council http://en.csc.edu.cn. Mr. Le Duy Do is a recipient of the fellowship from the International PhD program in Neurobiology (project No 06 - collaborative PhD project between the Nencki Institute of Experimental Biology and Universite Lyon 1) http://neurophd.nencki.gov.pl. This research was supported by the following: the French Agency for the promotion of higher education and international mobility (Campus France) (Grant: Polonium No 27727TA), http://www.campusfrance.org/fr/; CNRS International project of scientific cooperation (PICS) (Grant No 5096) http://www.cnrs.fr/derci/spip.php?article51; Polish Ministry of Science and Higher Education (Grant No N401 140639) http://www.nauka.gov.pl/en/ and European Union Capacities Programme (Research potential) (Grant No EU FP7 Project Bio-imaging in research Innovation and education, GA No. 264173) http://bioimagine.nencki.gov.pl/en/?p = glowna&lng = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Benard A, 2014, ANALYST, V139, P1044, DOI 10.1039/c3an01454a; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Bosch A, 2008, J CLIN MICROBIOL, V46, P2535, DOI 10.1128/JCM.02267-07; Bosch A, 2010, J BIOPHOTONICS, V3, P522, DOI 10.1002/jbio.201000027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3; COX RP, 1967, BIOCHEM J, V105, P155, DOI 10.1042/bj1050155; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Derenne A, 2014, BBA-MOL CELL BIOL L, V1841, P1200, DOI 10.1016/j.bbalip.2013.10.010; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; Diem M, 2009, APPL SPECTROSC, V63, p307A, DOI 10.1366/000370209789806894; Do L, 2012, ANAL BIOCHEM, V430, P32, DOI 10.1016/j.ab.2012.07.017; Flower KR, 2011, ANALYST, V136, P498, DOI 10.1039/c0an00564a; Gasper R, 2011, BBA-BIOMEMBRANES, V1808, P597, DOI 10.1016/j.bbamem.2010.11.033; Gasper R, 2010, BBA-MOL BASIS DIS, V1802, P1087, DOI 10.1016/j.bbadis.2010.07.012; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Harvey TJ, 2007, ANALYST, V132, P292, DOI 10.1039/b618618a; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Holton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096878; Holton SE, 2011, ANALYST, V136, P2953, DOI 10.1039/c1an15112f; Krishna CM, 2006, BIOPOLYMERS, V82, P462, DOI 10.1002/bip.20485; Kumar S, 2013, ANALYST, V138, P4058, DOI 10.1039/c3an00241a; Lendl B, 1998, FRESEN J ANAL CHEM, V360, P717, DOI 10.1007/s002160050788; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Matthaus C, 2008, METHOD CELL BIOL, V89, P275, DOI 10.1016/S0091-679X(08)00610-9; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Pereira TM, 2013, ANALYST, V138, P7094, DOI 10.1039/c3an00296a; Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006; Sergienko EA, 2010, NAT PROTOC, V5, P1431, DOI 10.1038/nprot.2010.86; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; TSUBOI M, 1957, J AM CHEM SOC, V79, P1351, DOI 10.1021/ja01563a026; Vileno B, 2010, BIOPHYS CHEM, V152, P164, DOI 10.1016/j.bpc.2010.09.004; Wang JH, 1998, BIOCHEMISTRY-US, V37, P11106, DOI 10.1021/bi980471m; WU LNY, 1993, J BIOL CHEM, V268, P25084; YAMAMOTO I, 1995, BBA-BIOMEMBRANES, V1233, P21, DOI 10.1016/0005-2736(94)00220-J; Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t; Zwielly A, 2009, ANALYST, V134, P294, DOI 10.1039/b805223a	39	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120087	10.1371/journal.pone.0120087	http://dx.doi.org/10.1371/journal.pone.0120087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785438	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500154
J	Schendzielorz, T; Schirmer, K; Stolte, P; Stengl, M				Schendzielorz, Thomas; Schirmer, Katja; Stolte, Paul; Stengl, Monika			Octopamine Regulates Antennal Sensory Neurons via Daytime-Dependent Changes in cAMP and IP3 Levels in the Hawkmoth Manduca sexta	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; UNPAIRED MEDIAN NEURONS; CENTRAL-NERVOUS-SYSTEM; PHEROMONE-RESPONSE; CIRCADIAN-RHYTHMS; MODULATORY ACTION; IMMUNOREACTIVE NEURONS; SUBESOPHAGEAL GANGLION; PHOTOPERIOD CUES; BIOGENIC-AMINES	The biogenic amine octopamine (OA) mediates reward signals in olfactory learning and memory as well as circadian rhythms of sleep and activity. In the crepuscular hawkmoth Manduca sexta, OA changed pheromone detection thresholds daytime-dependently, suggesting that OA confers circadian control of olfactory transduction. Thus, with enzyme-linked immunosorbent assays we searched hawkmoth antennae for daytime-dependent changes in the concentration of OA and its respective second messengers. Antennal stimulation with OA raised cAMP-and IP3 levels. Furthermore, antennae expressed daytime-dependent changes in the concentration of OA, with maxima at Zeitgebertime (ZT) 20 when moths were active and also maximal concentrations of cAMP occurred. Maximal IP3 levels at ZT 18 and 23 correlated with maximal flight activity of male moths, while minimal IP3 levels at dusk correlated with peaks of feeding activity. Half maximal effective concentration (EC50) for activation of the OA-receptor decreased during the moth's activity phase suggesting daytime-dependent changes in OA receptor sensitivity. With an antiserum against tyramine, the precursor of OA, two centrifugal neurons were detected projecting out into the sensory cell layer of the antenna, possibly mediating more rapid stimulus-dependent OA actions. Indeed, in fast kinetic assays OA receptor stimulation increased cAMP concentrations within 50 msec. Thus, we hypothesize that fast, stimulus-dependent centrifugal control of OA-release in the antenna occurs. Additional slow systemic OA actions might be based upon circadian release of OA into the hemolymph mediating circadian rhythms of antennal second messenger levels. The resulting rhythms of odor sensitivity are suggested to underlie circadian rhythms in odor-mediated behavior.	[Schendzielorz, Thomas; Schirmer, Katja; Stolte, Paul; Stengl, Monika] Univ Kassel, Biol, Anim Physiol, D-34132 Kassel, Germany	Universitat Kassel	Stengl, M (corresponding author), Univ Kassel, Biol, Anim Physiol, D-34132 Kassel, Germany.	stengl@uni-kassel.d			Deutsche Forschungsgemeinschaft [STE531/21-1 TS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft STE531/21-1 TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; DUDAI Y, 1987, J COMP PHYSIOL A, V161, P739, DOI 10.1007/BF00605015; ECKERT M, 1992, J COMP NEUROL, V322, P1, DOI 10.1002/cne.903220102; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; Farooqui T, 2003, J NEUROSCI, V23, P5370; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Field LH, 2008, J INSECT PHYSIOL, V54, P240, DOI 10.1016/j.jinsphys.2007.09.006; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Guerenstein PG, 2004, NATURWISSENSCHAFTEN, V91, P329, DOI 10.1007/s00114-004-0532-x; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HERTEL W, 1992, ACTA BIOL HUNG, V43, P113; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; ITAGAKI H, 1988, ANN ENTOMOL SOC AM, V81, P798, DOI 10.1093/aesa/81.5.798; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEHMAN H K, 1990, Society for Neuroscience Abstracts, V16, P1334; LINGREN PD, 1977, ANN ENTOMOL SOC AM, V70, P161, DOI 10.1093/aesa/70.2.161; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P265, DOI 10.1002/arch.940200404; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P285, DOI 10.1002/arch.940200405; Linn CE, 1996, J INSECT PHYSIOL, V42, P881, DOI 10.1016/0022-1910(96)00034-0; Madden AH, 1945, DC TECHNICAL BULLETI, P896; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nolte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062648; Ohtani A, 2006, INSECT MOL BIOL, V15, P763, DOI 10.1111/j.1365-2583.2006.00676.x; Page TL, 2003, J INSECT PHYSIOL, V49, P697, DOI 10.1016/S0022-1910(03)00071-4; Pfluger HJ, 2004, ACTA BIOL HUNG, V55, P3, DOI 10.1556/ABiol.55.2004.1-4.2; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Rosen WQ, 2003, J BIOL RHYTHM, V18, P402, DOI 10.1177/0748730403256869; Rosen WQ, 2002, ARCH INSECT BIOCHEM, V50, P21, DOI 10.1002/arch.10026; Rymer J, 2007, J BIOL RHYTHM, V22, P43, DOI 10.1177/0748730406295462; Saifullah ASM, 2009, J BIOL RHYTHM, V24, P144, DOI 10.1177/0748730408331166; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SASAKI M, 1984, PHYSIOL ENTOMOL, V9, P315, DOI 10.1111/j.1365-3032.1984.tb00713.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2012, J BIOL RHYTHM, V27, P388, DOI 10.1177/0748730412456265; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; SPORHASEEICHMANN U, 1992, CELL TISSUE RES, V268, P287, DOI 10.1007/BF00318798; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tomioka K, 2012, J COMP PHYSIOL B, V182, P729, DOI 10.1007/s00360-012-0651-1; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217	78	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121230	10.1371/journal.pone.0121230	http://dx.doi.org/10.1371/journal.pone.0121230			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785721	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500204
J	Chen, P; Liu, Z; Wang, XJ; Peng, JH; Sun, QQ; Li, JZ; Wang, MX; Niu, LW; Zhang, ZY; Cai, G; Teng, MK; Li, X				Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Li, Jianzhong; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu			Crystal and EM Structures of Human Phosphoribosyl Pyrophosphate Synthase I (PRS1) Provide Novel Insights into the Disease-Associated Mutations	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; DIPHOSPHATE SYNTHASE; SYNTHETASE; PRPS1; VISUALIZATION; SUPERACTIVITY; DYNAMICS; PROTEIN; CLONING; ENZYME	Human PRS1, which is indispensable for the biosynthesis of nucleotides, deoxynucleotides and their derivatives, is associated directly with multiple human diseases because of single base mutation. However, a molecular understanding of the effect of these mutations is hampered by the lack of understanding of its catalytic mechanism. Here, we reconstruct the 3D EM structure of the PRS1 apo state. Together with the native stain EM structures of AMPNPP, AMPNPP and R5P, ADP and the apo states with distinct conformations, we suggest the hexamer is the enzymatically active form. Based on crystal structures, sequence analysis, mutagenesis, enzyme kinetics assays, and MD simulations, we reveal the conserved substrates binding motifs and make further analysis of all pathogenic mutants.	[Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China; [Li, Jianzhong] PLA, Nanjing Command, Fuzhou Gen Hosp, Dept Otolaryngol Head & Neck Surg, Fuzhou 350025, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Cai, G (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	gcai@ustc.edu.cn; mkteng@ustc.edu.cn; sachem@ustc.edu.cn	Cai, Gang/AAA-4439-2020; Peng, Junhui/ABH-7078-2020; Wang, Xuejuan/G-5093-2018; Cai, Gang/B-1103-2012	Cai, Gang/0000-0001-8622-3907; Peng, Junhui/0000-0003-2855-2299; Wang, Xuejuan/0000-0001-6493-9971; Cai, Gang/0000-0001-8622-3907; Li, Xu/0000-0001-5221-0817	Chinese Ministry of Science and Technology [2012CB917200]; Chinese National Natural Science Foundation [31130018, 31370732, 31270014, 31270760, U1432107]; Scientific Research Grant of Hefei Science Center of CAS [2015SRG-HSC042]; Science and Technological Fund of Anhui Province for Outstanding Youth [1308085JGD08]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Grant of Hefei Science Center of CAS; Science and Technological Fund of Anhui Province for Outstanding Youth	Financial support for this project was provided by the Chinese Ministry of Science and Technology (Grant Nos. 2012CB917200), Chinese National Natural Science Foundation (Grant Nos. 31130018, 31370732, 31270014, 31270760 and U1432107), the Scientific Research Grant of Hefei Science Center of CAS (Grant No. 2015SRG-HSC042) and the Science and Technological Fund of Anhui Province for Outstanding Youth (Grant No. 1308085JGD08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chen P, 2013, IUBMB LIFE; Cherney MM, 2011, J MOL BIOL, V413, P844, DOI 10.1016/j.jmb.2011.09.007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; de Brouwer APM, 2010, AM J HUM GENET, V86, P506, DOI 10.1016/j.ajhg.2010.02.024; Eriksen TA, 2000, NAT STRUCT BIOL, P24; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fisher D, 2002, EWEEK, V19, P1; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hove-Jensen B, 2005, FEBS J, V272, P3631, DOI 10.1111/j.1742-4658.2005.04785.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; Kamal MA, 2004, INT J BIOCHEM CELL B, V36, P545, DOI 10.1016/j.biocel.2003.08.014; Katashima R, 1998, BBA-GENE STRUCT EXPR, V1396, P245, DOI 10.1016/S0167-4781(97)00217-0; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; KITA K, 1994, J BIOL CHEM, V269, P8334; Krath BN, 2001, J BIOL CHEM, V276, P17851, DOI 10.1074/jbc.M010172200; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Liu HL, 2009, BIOCHEM BIOPH RES CO, V379, P1120, DOI 10.1016/j.bbrc.2009.01.034; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Moran R, 2012, AM J MED GENET A, V158A, P455, DOI 10.1002/ajmg.a.34428; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Voss NR, 2010, J STRUCT BIOL, V169, P389, DOI 10.1016/j.jsb.2009.12.005	37	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120304	10.1371/journal.pone.0120304	http://dx.doi.org/10.1371/journal.pone.0120304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781187	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600148
J	Kishabongo, AS; Katchunga, P; Van Aken, EH; Speeckaert, R; Lagniau, S; Coopman, R; Speeckaert, MM; Delanghe, JR				Kishabongo, Antoine Sadiki; Katchunga, Philippe; Van Aken, Elisabeth H.; Speeckaert, Reinhart; Lagniau, Sabrina; Coopman, Renaat; Speeckaert, Marijn M.; Delanghe, Joris R.			Glycation of Nail Proteins: From Basic Biochemical Findings to a Representative Marker for Diabetic Glycation-Associated Target Organ Damage	PLOS ONE			English	Article							DISSOCIATION MASS-SPECTROMETRY; NONENZYMATIC GLYCATION; AFFINITY-CHROMATOGRAPHY; MAILLARD REACTION; STRATUM-CORNEUM; HAIR FOLLICLE; HUMAN PLASMA; EYE LENS; PEPTIDES; COMPLICATIONS	Background Although assessment of glycated nail proteins may be a useful marker for monitoring of diabetes, their nature and formation are still poorly understood. Besides a detailed anatomical analysis of keratin glycation, the usefulness of glycated nail protein assessment for monitoring diabetic complications was investigated. Methods 216 patients (94 males, 122 females; mean age +/- standard deviation: 75.0 +/- 8.7 years) were enrolled. Glycation of nail and eye lens proteins was assessed using a photometric nitroblue tetrazolium-based assay. Following chromatographic separation of extracted nail proteins, binding and nonbinding fractions were analyzed using one-dimensional gel electrophoresis. Using a hand piece containing a latch-type-bur, a meticulous cutting of the nail plate into superficial and deep layers was performed, followed by a differential analysis of fructosamine. Results Using SDS PAGE, four and two bands were identified among the nonglycated and glycated nail fraction respectively. Significantly lower fructosamine concentrations were found in the superficial nail layer (mean: 2.16 +/- 1.37 mu mol/g nails) in comparison with the deep layer (mean: 4.36 +/- 2.55 mu mol/g nails) (P<0.05). A significant higher amount of glycated eye lens proteins was found in diabetes mellitus patients (mean: 3.80 +/- 1.57 mu mol/g eye lens) in comparison with nondiabetics (mean: 3.35 +/- 1.34 mu mol/g eye lens) (P<0.05). A marked correlation was found between glycated nail and glycated eye lens proteins [y (glycated nail proteins) = 0.39 + 0.99 x (eye lens glycated proteins); r(2) = 0.58, P<0.001]. The concentration of glycated eye lens proteins and the HbA1c level were found to be predictors of the concentration of glycated nail proteins. Conclusions Glycation of nail proteins takes place in the deep layer of finger nails, which is in close contact with blood vessels and interstitial fluid. Glycation of nail proteins can be regarded as a representative marker for diabetic glycation-associated target organ damage.	[Kishabongo, Antoine Sadiki] Catholic Univ Bukavu, Dept Lab Med, Bukavu, DEM REP CONGO; [Katchunga, Philippe] Catholic Univ Bukavu, Dept Internal Med, Bukavu, DEM REP CONGO; [Van Aken, Elisabeth H.] Sint Elisabeth Ziekenhuis, Dept Ophthalmol, Zottegem, Belgium; [Speeckaert, Reinhart] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; [Lagniau, Sabrina; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, Ghent, Belgium; [Coopman, Renaat] Ghent Univ Hosp, Dept Dent, Ghent, Belgium; [Speeckaert, Marijn M.] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Delanghe, JR (corresponding author), Ghent Univ Hosp, Dept Clin Chem, Ghent, Belgium.	joris.delanghe@ugent.be			Ghent University	Ghent University(Ghent University)	Antoine Sadiki Kishabongo received a PhD scholarship from Ghent University.	Abraham EC, 2008, MOL CELL BIOCHEM, V310, P235, DOI 10.1007/s11010-007-9685-1; Adler FH, 2003, ADLERS PHYSL EYE CLI; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; ARAKI N, 1992, J BIOL CHEM, V267, P10211; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; BAKAN E, 1985, CLIN CHIM ACTA, V147, P1, DOI 10.1016/0009-8981(85)90003-8; BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Burns T, 2010, ROOKS TXB DERMATOLOG, V4; Cashman MW, 2010, CLIN DERMATOL, V28, P420, DOI 10.1016/j.clindermatol.2010.03.037; Costello MJ, 2013, EXP EYE RES, V116, P411, DOI 10.1016/j.exer.2013.10.015; de Berker D, 2000, BRIT J DERMATOL, V142, P89, DOI 10.1046/j.1365-2133.2000.03246.x; de Berker D. A. R., 2007, International Journal of Cosmetic Science, V29, P241, DOI 10.1111/j.1467-2494.2007.00372.x; de Berker D, 2013, CLIN DERMATOL, V31, P509, DOI 10.1016/j.clindermatol.2013.06.006; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; GARLICK RL, 1984, J CLIN INVEST, V74, P1742, DOI 10.1172/JCI111592; Goldsmith L.A., 1991, PHYSL BIOCH MOL BIOL, V2nd; Hage DS, 1999, CLIN CHEM, V45, P593; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Inoue T, 2001, BIOSCI BIOTECH BIOCH, V65, P895, DOI 10.1271/bbb.65.895; Jansirani, 2004, Indian J Clin Biochem, V19, P110, DOI 10.1007/BF02872403; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kim KJ, 2012, DIABETES METAB J, V36, P98, DOI 10.4093/dmj.2012.36.2.98; Kishabongo AS, 2014, TROP MED INT HEALTH, V19, P58, DOI 10.1111/tmi.12218; KITAHARA T, 1991, Journal of Dermatological Science, V2, P402, DOI 10.1016/0923-1811(91)90003-G; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Machan CM, 2012, OPTOMETRY VISION SCI, V89, P1165, DOI 10.1097/OPX.0b013e3182644cd1; MAROVA I, 1995, ACTA DIABETOL, V32, P38, DOI 10.1007/BF00581043; Mennella C, 2006, J PEPT SCI, V12, P291, DOI 10.1002/psc.722; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nagaraj RH, 2012, AMINO ACIDS, V42, P1205, DOI 10.1007/s00726-010-0778-x; Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569; Nawale RB, 2006, INDIAN J BIOCHEM BIO, V43, P337; OIMOMI M, 1986, HORM METAB RES, V18, P827, DOI 10.1055/s-2007-1012449; ORSONNEAU JL, 1989, CLIN CHEM, V35, P2233; Pepaj M, 2015, J LIQ CHROMATOGR R T, V38, P20, DOI 10.1080/10826076.2013.864980; Priego-Capote F, 2010, MOL CELL PROTEOMICS, V9, P579, DOI 10.1074/mcp.M900439-MCP200; Raguz M, 2014, EXP EYE RES, V120, P138, DOI 10.1016/j.exer.2014.01.018; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Speeckaert M, 2014, NEPHROL DIAL TRANSPL, V29, P2167, DOI 10.1093/ndt/gfu006; Tessier FJ, 2010, PATHOL BIOL, V58, P214, DOI 10.1016/j.patbio.2009.09.014; Wiley LA, 2010, MOL VIS, V16, P1253; Zhang Q, 2008, RAPID COMMUN MASS SP, V22, P3027, DOI 10.1002/rcm.3703; Zhang QB, 2008, J PROTEOME RES, V7, P2025, DOI 10.1021/pr700763r; Zhang QB, 2007, J PROTEOME RES, V6, P2323, DOI 10.1021/pr070112q; Zhang QB, 2007, RAPID COMMUN MASS SP, V21, P661, DOI 10.1002/rcm.2884; Zhang Q, 2008, ANAL CHEM, V80, P9822, DOI 10.1021/ac801704j	50	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120112	10.1371/journal.pone.0120112	http://dx.doi.org/10.1371/journal.pone.0120112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781337	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600129
J	Peregrin, LS; Butcher, PA; Broadhurst, MK; Millar, RB				Peregrin, Laura S.; Butcher, Paul A.; Broadhurst, Matt K.; Millar, Russell B.			Angling-Induced Barotrauma in Snapper Chrysophrys auratus: Are There Consequences for Reproduction?	PLOS ONE			English	Article							PAGRUS-AURATUS; FISH REPRODUCTION; RELEASE SURVIVAL; HANDLING STRESS; CAPTURE DEPTH; SEX STEROIDS; MORTALITY; CAUGHT; CATCH; QUALITY	In response to concerns regarding the potential for sub-lethal impacts of barotrauma on reproductively active Chrysophrys auratus during catch and release, 90 males and 90 females representing five reproductive stages (immature or resting-28%, developing-8%, developed-7%, ripe or spawning-23% and spent-34%) were angled from 8-70 m and macroscopically assessed (on-board and then in a laboratory). Irrespective of sex, all fish exhibited various clinical signs of barotrauma, including a prolapsed cloaca (60% of fish); gastric herniation (46%); ruptured swim bladder (73%); organ displacement (48%); and kidney (3%), liver (73%) and coloemic-cavity haemorrhaging (33%); with the frequency of nearly all positively associated with capture depth. Reproductive stage was also an important barotrauma predictor (reflecting related morphological changes) with a general trend towards spent fish least likely to incur the various clinical signs-especially for a prolapsed cloaca (also common among immature or resting fish and significantly affected by food in the digestive tract) and a ruptured swim bladder (common among ripe or spawning fish). The only macroscopically visible gonad damage was haemorrhaging, which was least common among immature or resting and spent fish and, irrespective of reproductive stage, temporally reduced in frequency, and more quickly among males than females. While further research is required to accurately describe the effects of angling at each stage of the reproductive cycle and the physiological consequences of barotrauma on the gonads of C. auratus, given the observed influences of reproductive stage and depth on barotrauma found in this study, any adverse effects might be partially managed by regulating either temporal or spatial fishing effort.	[Peregrin, Laura S.; Butcher, Paul A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Butcher, Paul A.; Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, NSW, Australia; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	Southern Cross University; NSW Department of Primary Industries; University of Auckland	Butcher, PA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	Paul.Butcher@dpi.nsw.gov.au	Broadhurst, Matt K/I-6783-2015; Butcher, Paul/T-4367-2019	Broadhurst, Matt K/0000-0003-0184-7249; Butcher, Paul/0000-0001-7338-6037; Peregrin, Laura/0000-0002-2555-7257	NSW Recreational Fishing Trusts; NSW Department of Primary Industries	NSW Recreational Fishing Trusts; NSW Department of Primary Industries	This research was funded by the NSW Recreational Fishing Trusts and the NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bettinger JM, 2005, N AM J FISH MANAGE, V25, P1273, DOI 10.1577/M04-156.1; Broadhurst MK, 2012, J FISH BIOL, V80, P638, DOI 10.1111/j.1095-8649.2011.03202.x; Broadhurst MK, 2005, J EXP MAR BIOL ECOL, V321, P171, DOI 10.1016/j.jembe.2005.02.001; Butcher PA, 2012, FISH RES, V127, P49, DOI 10.1016/j.fishres.2012.04.013; Campbell MD, 2010, ICES J MAR SCI, V67, P513, DOI 10.1093/icesjms/fsp255; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Carragher J.F., 1991, P253; CARRAGHER JF, 1993, AQUACULTURE, V109, P375, DOI 10.1016/0044-8486(93)90176-Y; Clearwater SJ, 1997, J FISH BIOL, V50, P429, DOI 10.1006/jfbi.1996.0311; Cleary JJ, 2002, AQUAC RES, V33, P829, DOI 10.1046/j.1365-2109.2002.00718.x; Cleary JJ, 2000, J WORLD AQUACULT SOC, V31, P558, DOI 10.1111/j.1749-7345.2000.tb00905.x; Ferrell D, 1995, ASSESSMENT FISHERY S; Grixti D, 2010, FISHERIES MANAG ECOL, V17, P1, DOI 10.1111/j.1365-2400.2009.00704.x; Hall KC, 2014, J FISH DIS, V37, P251, DOI 10.1111/jfd.12103; Hall KC, 2009, J FISH BIOL, V75, P2737, DOI 10.1111/j.1095-8649.2009.02474.x; Hannah RW, 2007, T AM FISH SOC, V136, P24, DOI 10.1577/T06-022.1; Henry GW, 2003, NATL RECREATIONAL IN; Jarvis ET, 2008, CAN J FISH AQUAT SCI, V65, P1286, DOI 10.1139/F08-071; Lenanton R, 2009, MAXIMISING SURVIVAL; Lucy JA, 2002, AM FISHERIES SOC S, V30, P114; McGrath SP, 2011, ICES J MAR SCI, V68, P2114, DOI 10.1093/icesjms/fsr151; McLennan MF, 2014, FISHERIES MANAG ECOL, V21, P330, DOI 10.1111/fme.12083; Nguyen V, 2009, FISH RES, V96, P313, DOI 10.1016/j.fishres.2008.12.003; Pankhurst NW, 1997, FISH STRESS HLTH AQU, P74; Phelan M., 2008, 91 NO TERR DEP PRIM; R Core Team, 2012, R LANG ENV STAT COMP; Roach JP, 2011, J FISH BIOL, V79, P1130, DOI 10.1111/j.1095-8649.2011.03096.x; Rummer JL, 2005, T AM FISH SOC, V134, P1457, DOI 10.1577/T04-235.1; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; St John J, 2005, FISH RES, V76, P106, DOI 10.1016/j.fishres.2005.05.014; Stewart J, 2010, FISHERIES REPORT SER, V27; Stewart J, 2008, FISH RES, V90, P289, DOI 10.1016/j.fishres.2007.11.003; Wakefield CB, 2011, J FISH BIOL, V77, P1359	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119158	10.1371/journal.pone.0119158	http://dx.doi.org/10.1371/journal.pone.0119158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781929	gold, Green Published			2022-12-26	WOS:000351284600053
J	Ueda, K; Yoshimura, K; Yamashita, O; Harada, T; Morikage, N; Hamano, K				Ueda, Koshiro; Yoshimura, Koichi; Yamashita, Osamu; Harada, Takasuke; Morikage, Noriyasu; Hamano, Kimikazu			Possible Dual Role of Decorin in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; N-TERMINAL KINASE; INHIBITION; EXPRESSION; BIGLYCAN; MATRIX-METALLOPROTEINASE-9; ACTIVATION; REGRESSION; PATHWAY; DISEASE	Abdominal aortic aneurysm (AAA) is characterized by chronic inflammation, which leads to pathological remodeling of the extracellular matrix. Decorin, a small leucine-rich repeat proteoglycan, has been suggested to regulate inflammation and stabilize the extracellular matrix. Therefore, the present study investigated the role of decorin in the pathogenesis of AAA. Decorin was localized in the aortic adventitia under normal conditions in both mice and humans. AAA was induced in mice using CaCl2 treatment. Initially, decorin protein levels decreased, but as AAA progressed decorin levels increased in all layers. Local administration of exogenous decorin prevented the development of CaCl2-induced AAA. However, decorin was highly expressed in the degenerative lesions of human AAA walls, and this expression positively correlated with matrix metalloproteinase (MMP)-9 expression. In cell culture experiments, the addition of decorin inhibited secretion of MMP-9 in vascular smooth muscle cells, but had the opposite effect in macrophages. The results suggest that decorin plays a dual role in AAA. Adventitial decorin in normal aorta may protect against the development of AAA, but macrophages expressing decorin in AAA walls may facilitate the progression of AAA by up-regulating MMP-9 secretion.	[Ueda, Koshiro; Yoshimura, Koichi; Yamashita, Osamu; Harada, Takasuke; Morikage, Noriyasu; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 7558505, Japan; [Yoshimura, Koichi] Yamaguchi Prefectural Univ, Grad Sch Hlth & Welf, Yamaguchi 7538502, Japan	Yamaguchi University	Yoshimura, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 7558505, Japan.	yoshimko@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 24390302, 26670618]; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24390302] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 24390302 and 26670618 to KY), the Takeda Science Foundation (to KY), and the Uehara Memorial Foundation (to KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zen AA, 2006, ATHEROSCLEROSIS, V187, P31, DOI 10.1016/j.atherosclerosis.2005.08.023; Ang LS, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.88; Dil N, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-11; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Humphrey JD, 2013, J VASC RES, V50, P1, DOI 10.1159/000342436; Kadirvel R, 2010, NEUROSURGERY, V66, P578, DOI 10.1227/01.NEU.0000365769.78334.8C; Kimura T, 2011, PATHOL INT, V61, P559, DOI 10.1111/j.1440-1827.2011.02699.x; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Marzoll A, 2011, J CELL MOL MED, V15, P232, DOI 10.1111/j.1582-4934.2009.00986.x; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Mohamed SA, 2009, BIOMARK INSIGHTS, V4, P81; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nagasawa A, 2013, J SURG RES, V183, P472, DOI 10.1016/j.jss.2012.12.012; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nomura S, 2005, EUR SURG RES, V37, P370, DOI 10.1159/000090339; NORDSTROM T, 1994, FEBS LETT, V350, P82, DOI 10.1016/0014-5793(94)00738-1; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Singla Sandeep, 2011, Ther Adv Cardiovasc Dis, V5, P305, DOI 10.1177/1753944711429715; Tedesco MM, 2010, VASCULAR SURG, P117; Theocharis AD, 2002, ATHEROSCLEROSIS, V165, P221, DOI 10.1016/S0021-9150(02)00231-9; Wang YT, 2013, CARDIOVASC PATHOL, V22, P126, DOI 10.1016/j.carpath.2012.07.005; Wu IC, 2010, INT J CANCER, V127, P2138, DOI 10.1002/ijc.25239; Wu Z, 2014, MATRIX BIOL, V35, P266, DOI 10.1016/j.matbio.2013.12.006; Xu YZ, 2012, NEUROCHEM RES, V37, P1843, DOI 10.1007/s11064-012-0787-0; Yamashita O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079753; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P403, DOI 10.1196/annals.1383.049; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031; Yoshimura K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/648167; Zhang K, 2014, EUR J CARDIO-THORAC	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120689	10.1371/journal.pone.0120689	http://dx.doi.org/10.1371/journal.pone.0120689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781946	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600184
J	Yadav, MK; Chae, SW; Im, GJ; Chung, JW; Song, JJ				Yadav, Mukesh Kumar; Chae, Sung-Won; Im, Gi Jung; Chung, Jae-Woo; Song, Jae-Jun			Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms	PLOS ONE			English	Article							ESSENTIAL OILS; GENE-EXPRESSION; IN-VIVO; EPIDERMIDIS; CARVACROL; SARA; MECHANISMS; DISCOVERY; MODEL	Background Inhibition and eradication of Staphylococcus aureus biofilms with conventional antibiotic is difficult, and the treatment is further complicated by the rise of antibiotic resistance among staphylococci. Consequently, there is a need for novel antimicrobials that can treat biofilm-related infections and decrease antibiotics burden. Natural compounds such as eugenol with anti-microbial properties are attractive agents that could reduce the use of conventional antibiotics. In this study we evaluated the effect of eugenol on MRSA and MSSA biofilms in vitro and bacterial colonization in vivo. Methods and Results Effect of eugenol on in vitro biofilm and in vivo colonization were studied using microtiter plate assay and otitis media-rat model respectively. The architecture of in vitro biofilms and in vivo colonization of bacteria was viewed with SEM. Real-time RT-PCR was used to study gene expression. Check board method was used to study the synergistic effects of eugenol and carvacrol on established biofilms. Eugenol significantly inhibited biofilms growth of MRSA and MSSA in vitro in a concentration-dependent manner. Eugenol at MIC or 2xMIC effectively eradicated the pre-established biofilms of MRSA and MSSA clinical strains. In vivo, sub-MIC of eugenol significantly decreased 88% S. aureus colonization in rat middle ear. Eugenol was observed to damage the cell-membrane and cause a leakage of the cell contents. At sub-inhibitory concentration, it decreases the expression of biofilm- and enterotoxin-related genes. Eugenol showed a synergistic effect with carvacrol on the eradication of pre-established biofilms. Conclusion/Major Finding This study demonstrated that eugenol exhibits notable activity against MRSA and MSSA clinical strains biofilms. Eugenol inhibited biofilm formation, disrupted the cell-to-cell connections, detached the existing biofilms, and killed the bacteria in biofilms of both MRSA and MSSA with equal effectiveness. Therefore, eugenol may be used to control or eradicate S. aureus biofilm-related infections.	[Yadav, Mukesh Kumar] Korea Univ, Coll Med, Inst Med Device Clin Trials, Seoul 136705, South Korea; [Yadav, Mukesh Kumar; Chae, Sung-Won; Im, Gi Jung; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Chung, Jae-Woo] Dongguk Univ, Ilsan Hosp, Lab Med, Goyang, Gyeonggi, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Dongguk University; NHIS Ilsan Hospital	Song, JJ (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea.	jjsong23@gmail.com	Yadav, Mukesh Kumar/M-9154-2015; IM, GI JUNG/AAI-9755-2020	Yadav, Mukesh Kumar/0000-0002-4703-8554; IM, GI JUNG/0000-0002-9457-4253	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of education [2013R1A1A2A10004451]; Korea government (MSIP) [2012M2A2A6035679]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of education; Korea government (MSIP)	The research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of education (2013R1A1A2A10004451). And NRF grant funded by the Korea government (MSIP) No2012M2A2A6035679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chopra I, 2002, J APPL MICROBIOL, V92, p4S, DOI 10.1046/j.1365-2672.92.5s1.13.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clinical Laboratory Standards Institute, 2015, M100S15 CLSINCCLS M100S15 CLSINCCLS; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Guskey MT, 2010, PHARMACOTHERAPY, V30, P80, DOI 10.1592/phco.30.1.80; Hammer KA, 2012, INT J ANTIMICROB AG, V40, P239, DOI 10.1016/j.ijantimicag.2012.05.015; HASHIMOTO S, 1988, J DENT RES, V67, P1092, DOI 10.1177/00220345880670080601; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Hemaiswarya S, 2009, PHYTOMEDICINE, V16, P997, DOI 10.1016/j.phymed.2009.04.006; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Kristinsson KG, 2005, J INFECT DIS, V191, P1876, DOI 10.1086/430003; Kwiecinski J, 2009, INT J ANTIMICROB AG, V33, P343, DOI 10.1016/j.ijantimicag.2008.08.028; La Storia A, 2011, RES MICROBIOL, V162, P164, DOI 10.1016/j.resmic.2010.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047255; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mohammed MJ, 2009, PHYTOMEDICINE, V16, P632, DOI 10.1016/j.phymed.2008.12.026; Moon SE, 2011, ARCH ORAL BIOL, V56, P907, DOI 10.1016/j.archoralbio.2011.02.005; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2012, APMIS, V120, P967, DOI 10.1111/j.1600-0463.2012.02928.x; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Qiu JZ, 2010, APPL ENVIRON MICROB, V76, P5846, DOI 10.1128/AEM.00704-10; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Snowden JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084089; Thomas JG, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P21; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Yadav MK, 2013, APMIS, V121, P1198, DOI 10.1111/apm.12067; Yadav MK, 2012, CLIN EXP OTORHINOLAR, V5, P139, DOI 10.3342/ceo.2012.5.3.139	51	119	123	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119564	10.1371/journal.pone.0119564	http://dx.doi.org/10.1371/journal.pone.0119564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781975	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600074
J	Shimizu-Motohashi, Y; Asakura, Y; Motohashi, N; Belur, NR; Baumrucker, MG; Asakura, A				Shimizu-Motohashi, Yuko; Asakura, Yoko; Motohashi, Norio; Belur, Nandkishore R.; Baumrucker, Michael G.; Asakura, Atsushi			Pregnancy-Induced Amelioration of Muscular Dystrophy Phenotype in mdx Mice via Muscle Membrane Stabilization Effect of Glucocorticoid	PLOS ONE			English	Article							ANNEXIN A1; EVANS BLUE; PREDNISONE; MOUSE; PATHOLOGY; ESTROGEN; CALCIUM; CELLS; CORTICOSTERONE; INACTIVATION	Duchenne muscular dystrophy (DMD), the most common and severe type of dystrophinopathy, is an X-linked recessive genetic disease caused by the absence of dystrophin, which leads to fragility and vulnerability of the sarcolemma to mechanical stretching with increased membrane permeability. Currently, glucocorticoids such as prednisolone are the only medication available for DMD. However, molecular pathways responsible for this effect are still unclear. In addition, it remains unclear whether sex-related factors, including pregnancy and the postpartum period, affect the phenotype of dystrophinopathy. Here, we report the amelioration of muscle membrane permeability in the diaphragm muscle of pregnant and postpartum, but not in nulliparous, mdx mice, an animal model for DMD, during the physiological surge of corticosterone, the most abundant glucocorticoid in rodents. Cultures of single muscle fibers and myotubes isolated from mdx mouse diaphragm demonstrate resistance to hypo-osmotic shock when treated with corticosterone but not with estradiol or progesterone. This corticosterone-mediated resistance was diminished by an antagonist of corticosterone, indicating that the glucocorticoid-glucocorticoid receptor axis plays a role in this membrane stabilization effect on muscle. Moreover, subcutaneous injection of corticosterone into mdx mice showed decreased membrane permeability. This is the first report to demonstrate that pregnancy-related resistance to muscle fiber damage in mdx mice due to the membrane stabilization effect of corticosterone. We also propose that this membrane stabilization effect is exerted through annexin A1 up-regulation as the molecular mechanisms of glucocorticoid effects on DMD muscle. Furthermore, single muscle fiber culture studies provide a sensitive chemical screening platform for muscular dystrophies.	[Shimizu-Motohashi, Yuko; Asakura, Yoko; Motohashi, Norio; Belur, Nandkishore R.; Baumrucker, Michael G.; Asakura, Atsushi] Univ Minnesota, Sch Med, Dept Neurol, Stem Cell Inst,Paul & Sheila Wellstone Muscular D, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Asakura, A (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Stem Cell Inst,Paul & Sheila Wellstone Muscular D, Minneapolis, MN 55455 USA.	asakura@umn.edu	Motohashi, Norio/AGE-8809-2022; Asakura, Atsushi/H-2745-2019	Motohashi, Norio/0000-0002-8172-4339; Asakura, Atsushi/0000-0001-8078-1027; BELUR, NANDKISHORE/0000-0003-2229-8007	NIH [R01AR62142, R03AR61545]; Muscular Dystrophy Association [MDA 241600]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061545, R01AR062142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH (R01AR62142), NIH (R03AR61545), and Muscular Dystrophy Association (MDA 241600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; ATKINSON HC, 1995, ENDOCRINOLOGY, V136, P512, DOI 10.1210/en.136.2.512; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Besedovsky L, 2014, FASEB J, V28, P67, DOI 10.1096/fj.13-237958; Bizzarro V, 2012, J CELL PHYSIOL, V227, P3007, DOI 10.1002/jcp.24032; Brioschi S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-73; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Ennen JP, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-9; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Figueiredo HF, 2007, AM J PHYSIOL-ENDOC M, V292, pE1173, DOI 10.1152/ajpendo.00102.2006; Fisher I, 2005, FASEB J, V19, P834, DOI 10.1096/fj.04-2511fje; Gaud A, 2004, NEUROMUSCULAR DISORD, V14, P365, DOI 10.1016/j.nmd.2004.02.011; Givertz MM, 2013, CIRCULATION, V127, pE622, DOI 10.1161/CIRCULATIONAHA.113.001851; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; GUERRIERO V, 1980, ENDOCRINOLOGY, V106, P1198, DOI 10.1210/endo-106-4-1198; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houtchens M, 2013, CLIN OBSTET GYNECOL, V56, P342, DOI 10.1097/GRF.0b013e31828f272b; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Jacobs SCJM, 1996, J NEUROL, V243, P410, DOI 10.1007/BF00869001; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; Leijendekker WJ, 1996, BRIT J PHARMACOL, V118, P611, DOI 10.1111/j.1476-5381.1996.tb15445.x; Leung DG, 2013, ANN NEUROL, V74, P404, DOI 10.1002/ana.23989; Matsuda C., 2012, PLOS CURR, V4, DOI DOI 10.1371/5035ADD8CAFF4; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; MENKE A, 1995, J CELL SCI, V108, P727; METZINGER L, 1995, BRIT J PHARMACOL, V116, P2811, DOI 10.1111/j.1476-5381.1995.tb15930.x; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Motohashi N, 2014, JOVE-J VIS EXP, DOI 10.3791/50846; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; Passaquin AC, 1998, BRIT J PHARMACOL, V124, P1751, DOI 10.1038/sj.bjp.0702036; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seppanen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062662; Shimizu-Motohashi Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00050; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; SKLAR RM, 1991, J NEUROL SCI, V101, P73, DOI 10.1016/0022-510X(91)90019-4; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Verma M, 2010, J HISTOCHEM CYTOCHEM; Verma M, 2010, HUM MOL GENET, V19, P4145, DOI 10.1093/hmg/ddq334; Viggiano E, 2013, CLIN GENET, V84, P265, DOI 10.1111/cge.12048; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; VOOGT JL, 1969, AM J PHYSIOL, V216, P655, DOI 10.1152/ajplegacy.1969.216.3.655; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wooddell CI, 2010, MUSCLE NERVE, V41, P487, DOI 10.1002/mus.21527; Wuebbles RD, 2013, DIS MODEL MECH, V6, P1175, DOI 10.1242/dmm.012211	65	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120325	10.1371/journal.pone.0120325	http://dx.doi.org/10.1371/journal.pone.0120325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775477	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500164
J	Yeh, CH; Kuo, PL; Wang, YY; Wu, YY; Chen, MF; Lin, DY; Lai, TH; Chiang, HS; Lin, YH				Yeh, Chung-Hsin; Kuo, Pao-Lin; Wang, Ya-Yun; Wu, Ying-Yu; Chen, Mei-Feng; Lin, Ding-Yen; Lai, Tsung-Hsuan; Chiang, Han-Sun; Lin, Ying-Hung			SEPT12/SPAG4/LAMINB1 Complexes Are Required for Maintaining the Integrity of the Nuclear Envelope in Postmeiotic Male Germ Cells	PLOS ONE			English	Article							SUN-DOMAIN PROTEINS; SEPTIN GENE FAMILY; HUMAN ASTHENOZOOSPERMIA; MAMMALIAN SEPTINS; MALE-INFERTILITY; CYTOSKELETON; EXPRESSION; MICE; ORGANIZATION; IDENTIFICATION	Male infertility affects approximately 50% of all infertile couples. The male-related causes of intracytoplasmic sperm injection failure include the absence of sperm, immotile or immature sperm, and sperm with structural defects such as those caused by premature chromosomal condensation and DNA damage. Our previous studies based on a knockout mice model indicated that SEPT12 proteins are critical for the terminal morphological formation of sperm. SEPT12 mutations in men result in teratozospermia and oligozospermia. In addition, the spermatozoa exhibit morphological defects of the head and tail, premature chromosomal condensation, and nuclear damage. However, the molecular functions of SEPT12 during spermatogenesis remain unclear. To determine the molecular functions of SEPT12, we applied a yeast 2-hybrid system to identify SEPT12 interactors. Seven proteins that interact with SEPT12 were identified: SEPT family proteins (SEPT4 and SEPT6), nuclear or nuclear membrane proteins (protamine 2, sperm-associated antigen 4, and NDC1 transmembrane nucleoproine), and sperm-related structural proteins (pericentriolar material 1 and obscurinlike 1). Sperm-associated antigen 4 (SPAG4; also known as SUN4) belongs to the SUN family of proteins and acts as a linker protein between nucleoskeleton and cytoskeleton proteins and localizes in the nuclear membrane. We determined that SEPT12 interacts with SPAG4 in a male germ cell line through coimmunoprecipitation. During human spermiogenesis, SEPT12 is colocalized with SPAG4 near the nuclear periphery in round spermatids and in the centrosome region in elongating spermatids. Furthermore, we observed that SEPT12/SPAG4/LAMINB1 formed complexes and were coexpressed in the nuclear periphery of round spermatids. In addition, mutated SEPT12, which was screened from an infertile man, affected the integration of these nuclear envelope complexes through coimmunoprecipitation. This was the first study that suggested that SEPT proteins link to the SUN/LAMIN complexes during the formation of nuclear envelopes and are involved in the development of postmeiotic germ cells.	[Yeh, Chung-Hsin] Shin Kong Wu Ho Su Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Yeh, Chung-Hsin; Lai, Tsung-Hsuan; Chiang, Han-Sun] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Kuo, Pao-Lin; Wang, Ya-Yun] Natl Cheng Kung Univ, Coll Med, Dept Obstet & Gynecol, Tainan 70101, Taiwan; [Wu, Ying-Yu; Chiang, Han-Sun; Lin, Ying-Hung] Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, New Taipei City, Taiwan; [Chen, Mei-Feng] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Ding-Yen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Lai, Tsung-Hsuan] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Tsung-Hsuan] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli City, Taoyuan County, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Cheng Kung University; Fu Jen Catholic University; Chang Gung University; National Cheng Kung University; Cathay General Hospital; National Central University	Lin, YH (corresponding author), Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, New Taipei City, Taiwan.	084952@mail.fju.edu.tw	Chen, Mei Feng/I-2763-2016; Lin, Ying-Hung/AAC-6327-2019	Chen, Mei Feng/0000-0002-7170-0843; Lin, Ying-Hung/0000-0002-1574-1579	Ministry of Science and Technology of the Republic of China [NSC 101-2320-B-030-012-MY2, NSC 102-2320-B-030- 006-MY3, MOST 103-2314-B-030-002-]; Shin-Kong Wu Ho-Su Memorial Hospital [101-SKH-FJU-06]; Cathay General Hospital [102-CGH-FJU-03]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Shin-Kong Wu Ho-Su Memorial Hospital; Cathay General Hospital	This study was supported by grants from the Ministry of Science and Technology of the Republic of China (YHL: NSC 101-2320-B-030-012-MY2, NSC 102-2320-B-030- 006-MY3 and MOST 103-2314-B-030-002-), Shin-Kong Wu Ho-Su Memorial Hospital (YHL: 101-SKH-FJU-06), and Cathay General Hospital (YHL: 102-CGH-FJU-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao HCA, 2010, J ASSIST REPROD GEN, V27, P299, DOI 10.1007/s10815-010-9409-4; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Frohnert C, 2011, MOL HUM REPROD, V17, P207, DOI 10.1093/molehr/gaq099; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hsu CC, 2012, J BIOL CHEM, V287, P22533, DOI 10.1074/jbc.M111.335331; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Javed M, 2010, REPROD BIOMED ONLINE, V20, P56, DOI 10.1016/j.rbmo.2009.10.010; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 2007, CELL, V130, P777, DOI 10.1016/j.cell.2007.08.022; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kracklauer MP, 2010, J CELL SCI, V123, P2763, DOI 10.1242/jcs.066589; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuo PL, 2013, INT J MOL SCI, V14, P22102, DOI 10.3390/ijms141122102; Kuo YC, 2012, HUM MUTAT, V33, P710, DOI 10.1002/humu.22028; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Lin YH, 2011, INT J ANDROL, V34, pE358, DOI 10.1111/j.1365-2605.2010.01126.x; Lin YH, 2006, FERTIL STERIL, V86, P1650, DOI 10.1016/j.fertnstert.2006.04.039; Lin Ying-Hung, 2011, Spermatogenesis, V1, P298; Lin YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034011; Lin YH, 2011, FERTIL STERIL, V95, P363, DOI 10.1016/j.fertnstert.2010.07.1064; Lin YH, 2009, AM J PATHOL, V174, P1857, DOI 10.2353/ajpath.2009.080955; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Silber SJ, 2000, CLIN OBSTET GYNECOL, V43, P854, DOI 10.1097/00003081-200012000-00017; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Sugino Y, 2008, J UROLOGY, V180, P2706, DOI 10.1016/j.juro.2008.08.005; Tasi YC, 2013, J ASSIST REPROD GEN, V30, P505, DOI 10.1007/s10815-013-9954-8; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; World Health Organization, 1992, WHO LAB MAN EX HUM S; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	47	31	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120722	10.1371/journal.pone.0120722	http://dx.doi.org/10.1371/journal.pone.0120722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775403	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500190
J	Meng, XB; Yang, SJ; Zhang, YP; Wang, XJ; Goodfellow, RX; Jia, YC; Thiel, KW; Reyes, HD; Yang, BL; Leslie, KK				Meng, Xiangbing; Yang, Shujie; Zhang, Yuping; Wang, Xinjun; Goodfellow, Renee X.; Jia, Yichen; Thiel, Kristina W.; Reyes, Henry D.; Yang, Baoli; Leslie, Kimberly K.			Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; DNA Damage; Meiosis; MicroRNA (miRNA); Reproduction; Spermatogenesis; MTDH; Male Infertility; Pachytene; piRNA; AEG-1; Mili; Rad18	ASTROCYTE ELEVATED GENE-1; BINDING PROTEIN; MOUSE MEIOSIS; AEG-1; CANCER; CELLS; MILI; HEPATOCARCINOGENESIS; CHEMORESISTANCE; METASTASIS	Background: MTDH is associated with poor prognosis in cancer, yet its biologic function is unclear. Results:Mtdh-null male mice are infertile, with a lack of mature sperm in testes and altered expression of small non-coding RNAs. Conclusion:Mtdh deficiency results in male infertility due to impaired spermatogenesis. Significance: The oncogene MTDH plays an indispensable role in male fertility. Increased expression of metadherin (MTDH, also known as AEG-1 and 3D3/LYRIC) has been associated with drug resistance, metastasis, and angiogenesis in a variety of cancers. However, the specific mechanisms through which MTDH is involved in these processes remain unclear. To uncover these mechanisms, we generated Mtdh knock-out mice via a targeted disruption of exon 3. Homozygous Mtdh knock-out mice are viable, but males are infertile. The homozygous male mice present with massive loss of spermatozoa as a consequence of meiotic failure. Accumulation of -H2AX in spermatocytes of homozygous Mtdh knock-out mice confirms an increase in unrepaired DNA breaks. We also examined expression of the DNA repair protein Rad18, which is regulated by MTDH at the post-transcriptional level. In testes from Mtdh exon 3-deficient mice, Rad18 foci were increased in the lumina of the seminiferous tubules. The Piwi-interacting RNA (piRNA)-interacting protein Mili was expressed at high levels in testes from Mtdh knock-out mice. Accordingly, genome-wide small RNA deep sequencing demonstrated altered expression of piRNAs in the testes of Mtdh knock-out mice as compared with wild type mice. In addition, we observed significantly reduced expression of microRNAs (miRNAs) including miR-16 and miR-19b, which are known to be significantly reduced in the semen of infertile men. In sum, our observations indicate a crucial role for MTDH in male fertility and the DNA repair mechanisms required for normal spermatogenesis.	[Meng, Xiangbing; Yang, Shujie; Zhang, Yuping; Wang, Xinjun; Goodfellow, Renee X.; Jia, Yichen; Thiel, Kristina W.; Reyes, Henry D.; Yang, Baoli; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Yang, Shujie; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Meng, XB (corresponding author), Univ Iowa, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	xiangbing-meng@uiowa.edu	Regan, Clinton/E-6250-2012	Thiel, Kristina/0000-0001-8295-864X; meng, xiangbing/0000-0002-9612-6438; Yang, Shujie/0000-0003-1753-3068; Wang, Xinjun/0000-0002-5062-4765; Leslie, Kimberly/0000-0002-2704-8990	National Institutes of Health [R01CA184101, R01CA99908]; Department of Obstetrics and Gynecology Research Development Fund; NATIONAL CANCER INSTITUTE [R01CA099908, R01CA184101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology Research Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA184101 (to X. M. and K. K. L.) and R01CA99908 (to K. K. L.) and by the Department of Obstetrics and Gynecology Research Development Fund (to K. K. L.).	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Blanco-Rodriguez J, 2012, REPRODUCTION, V144, P699, DOI 10.1530/REP-12-0326; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Emdad L, 2013, ADV CANCER RES, V120, P75, DOI 10.1016/B978-0-12-401676-7.00003-6; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Gudmundsdottir K, 2004, TRENDS CELL BIOL, V14, P401, DOI 10.1016/j.tcb.2004.07.002; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jeon HY, 2010, GENE EXPR PATTERNS, V10, P361, DOI 10.1016/j.gep.2010.08.004; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee SG, 2013, ADV CANCER RES, V120, P1, DOI 10.1016/B978-0-12-401676-7.00001-2; Liu T, 2012, MOL MED REP, V6, P535, DOI 10.3892/mmr.2012.967; Meng XB, 2013, ADV CANCER RES, V120, P135, DOI 10.1016/B978-0-12-401676-7.00005-X; Meng XB, 2012, J BIOL CHEM, V287, P4485, DOI 10.1074/jbc.C111.291518; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Ran Maoliang, 2014, Yichuan, V36, P646, DOI 10.3724/SP.J.1005.2014.0646; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2013, ADV CANCER RES, V120, pXI, DOI 10.1016/B978-0-12-401676-7.09987-3; Sarkar D, 2013, ADV CANCER RES, V120, P193, DOI 10.1016/B978-0-12-401676-7.00007-3; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Sciurano R, 2007, HUM REPROD, V22, P142, DOI 10.1093/humrep/del330; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Syrjanen JL, 2014, ELIFE, V3, DOI 10.7554/eLife.02963; Takubo K, 2006, BIOCHEM BIOPH RES CO, V351, P993, DOI 10.1016/j.bbrc.2006.10.145; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Zhao J, 2014, DNA CELL BIOL, V33, P715, DOI 10.1089/dna.2014.2376	39	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11853	11864		10.1074/jbc.M114.627653	http://dx.doi.org/10.1074/jbc.M114.627653			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25787082	Green Published, hybrid			2022-12-26	WOS:000354388600005
J	Fernandez, M; Hamilton, H				Fernandez, Miguel; Hamilton, Healy			Ecological Niche Transferability Using Invasive Species as a Case Study	PLOS ONE			English	Article							POPULATION GENETIC-ANALYSIS; BIOCLIMATE ENVELOPE MODELS; CLIMATE-CHANGE; DISTRIBUTIONAL AREAS; AMERICAN BULLFROG; RAPID EVOLUTION; ARGENTINE ANTS; RANGE SHIFTS; DATA SETS; CONSERVATISM	Species distribution modeling is widely applied to predict invasive species distributions and species range shifts under climate change. Accurate predictions depend upon meeting the assumption that ecological niches are conserved, i.e., spatially or temporally transferable. Here we present a multi-taxon comparative analysis of niche conservatism using biological invasion events well documented in natural history museum collections. Our goal is to assess spatial transferability of the climatic niche of a range of noxious terrestrial invasive species using two complementary approaches. First we compare species' native versus invasive ranges in environmental space using two distinct methods, Principal Components Analysis and Mahalanobis distance. Second we compare species' native versus invaded ranges in geographic space as estimated using the species distribution modeling technique Maxent and the comparative index Hellinger's I. We find that species exhibit a range of responses, from almost complete transferability, in which the invaded niches completely overlap with the native niches, to a complete dissociation between native and invaded ranges. Intermediate responses included expansion of dimension attributable to either temperature or precipitation derived variables, as well as niche expansion in multiple dimensions. We conclude that the ecological niche in the native range is generally a poor predictor of invaded range and, by analogy, the ecological niche may be a poor predictor of range shifts under climate change. We suggest that assessing dimensions of niche transferability prior to standard species distribution modeling may improve the understanding of species' dynamics in the invaded range.	[Fernandez, Miguel] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fernandez, Miguel] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Hamilton, Healy] NatureServe, Arlington, VA USA	University of California System; University of California Berkeley; Nature Conservancy	Fernandez, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	miguel.fernandez@berkeley.edu		Fernandez, Miguel/0000-0002-8301-1340	Russell E. Train Education for Nature Fellowship	Russell E. Train Education for Nature Fellowship	This work was supported by the Russell E. Train Education for Nature Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2006, SOUTHWEST NAT, V51, P471, DOI 10.1894/0038-4909(2006)51[471:VMPAVT]2.0.CO;2; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Dormann CF, 2009, ECOGRAPHY, V32, P379, DOI 10.1111/j.1600-0587.2009.05907.x; Dunlop EA, 2006, WEED RES, V46, P404, DOI 10.1111/j.1365-3180.2006.00524.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fernandez M., 2009, BIODIVERSITY INFORM, V6, DOI 10.17161/bi.v6i1.3314; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kanda LL, 2009, ECOLOGY, V90, P1574, DOI 10.1890/08-1263.1; Lavergne S, 2010, ANN BOT-LONDON, V105, P109, DOI 10.1093/aob/mcp271; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; McGarigal K., 2000, MULTIVARIATE STAT WI; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Neubert MG, 2004, RISK ANAL, V24, P817, DOI 10.1111/j.0272-4332.2004.00481.x; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Ozesmi U, 1997, ECOL MODEL, V101, P139, DOI 10.1016/S0304-3800(97)01983-2; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Ridley CE, 2010, EVOL APPL, V3, P64, DOI 10.1111/j.1752-4571.2009.00099.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Strauss B, 2007, ECOL MODEL, V204, P104, DOI 10.1016/j.ecolmodel.2006.12.027; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	82	39	40	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119891	10.1371/journal.pone.0119891	http://dx.doi.org/10.1371/journal.pone.0119891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785858	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500141
J	Kolarova, J; Ammerpohl, O; Gutwein, J; Welzel, M; Baus, I; Riepe, FG; Eggermann, T; Caliebe, A; Holterhus, PM; Siebert, R; Bens, S				Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Welzel, Maik; Baus, Inka; Riepe, Felix G.; Eggermann, Thomas; Caliebe, Almuth; Holterhus, Paul-Martin; Siebert, Reiner; Bens, Susanne			In vivo Investigations of the Effect of Short- and Long-Term Recombinant Growth Hormone Treatment on DNA-Methylation in Humans	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; DEFICIENCY; CHILDHOOD; CANCER; MORTALITY; CHILDREN; GH; EPIGENETICS; RECEPTOR	Treatment with recombinant human growth hormone (rhGH) has been consistently reported to induce transcriptional changes in various human tissues including peripheral blood. For other hormones it has been shown that the induction of such transcriptional effects is conferred or at least accompanied by DNA-methylation changes. To analyse effects of short term rhGH treatment on the DNA-methylome we investigated a total of 24 patients at baseline and after 4-day rhGH stimulation. We performed array-based DNA-methylation profiling of paired peripheral blood mononuclear cell samples followed by targeted validation using bisulfite pyrosequencing. Unsupervised analysis of DNA-methylation in this short-term treated cohort revealed clustering according to individuals rather than treatment. Supervised analysis identified 239 CpGs as significantly differentially methylated between baseline and rhGH-stimulated samples (p<0.0001, unadjusted paired t-test), which nevertheless did not retain significance after adjustment for multiple testing. An individualized evaluation strategy led to the identification of 2350 CpG and 3 CpH sites showing methylation differences of at least 10% in more than 2 of the 24 analyzed sample pairs. To investigate the long term effects of rhGH treatment on the DNA-methylome, we analyzed peripheral blood cells from an independent cohort of 36 rhGH treated children born small for gestational age (SGA) as compared to 18 untreated controls. Median treatment interval was 33 months. In line with the groupwise comparison in the short-term treated cohort no differentially methylated targets reached the level of significance in the long-term treated cohort. We identified marked intra-individual responses of DNA-methylation to short-term rhGH treatment. These responses seem to be predominately associated with immunologic functions and show considerable inter-individual heterogeneity. The latter is likely the cause for the lack of a rhGH induced homogeneous DNA-methylation signature after short- and long-term treatment, which nevertheless is well in line with generally assumed safety of rhGH treatment.	[Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Caliebe, Almuth; Siebert, Reiner; Bens, Susanne] Univ Kiel, Inst Human Genet, Kiel, Germany; [Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Welzel, Maik; Baus, Inka; Riepe, Felix G.; Caliebe, Almuth; Holterhus, Paul-Martin; Siebert, Reiner; Bens, Susanne] Univ Hosp Schleswig Holstein, Kiel, Germany; [Welzel, Maik; Baus, Inka; Riepe, Felix G.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Kiel, Germany; [Eggermann, Thomas] Univ Hosp Aachen, Inst Human Genet, Aachen, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; RWTH Aachen University; RWTH Aachen University Hospital	Bens, S (corresponding author), Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany.	sbens@medgen.uni-kiel.de	Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010; Caliebe, Almuth/G-1248-2018; Eggermann, Thomas/F-3807-2014	Caliebe, Almuth/0000-0003-2157-425X; 	German national BMBF (Ministry of Education and Science) [FKZ: 01GM0886, 01GM1114]; Medical Faculty of the Christian-Albrechts-University Kiel	German national BMBF (Ministry of Education and Science)(Federal Ministry of Education & Research (BMBF)); Medical Faculty of the Christian-Albrechts-University Kiel	The research leading to these results received funding from the German national BMBF (Ministry of Education and Science)-funded consortium 'Diseases caused by imprinting defects: clinical spectrum and pathogenetic mechanisms' (FKZ: 01GM0886 and 01GM1114) and the Medical Faculty of the Christian-Albrechts-University Kiel. The study used for the short-term rhGH treatment cohort left-over samples from a different study supported by Novo Nordisk. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Ammerpohl O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073288; [Anonymous], 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14420; BADOLATO R, 1994, J CLIN ENDOCR METAB, V79, P984, DOI 10.1210/jc.79.4.984; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Bens S, 2011, SEX DEV, V5, P70, DOI 10.1159/000323807; Bens S, 2013, EUR J HUM GENET, V21, P838, DOI 10.1038/ejhg.2012.262; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P5176, DOI 10.1210/jc.86.11.5176; Bunting KL, 2013, CURR OPIN IMMUNOL, V25, P339, DOI 10.1016/j.coi.2013.05.003; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Ergun-Longmire B, 2006, J CLIN ENDOCR METAB, V91, P3494, DOI 10.1210/jc.2006-0656; Fernandez-Perez L, 2010, CLIN ENDOCRINOL, V72, P800, DOI 10.1111/j.1365-2265.2009.03732.x; Frick KM, 2011, EPIGENETICS-US, V6, P675, DOI 10.4161/epi.6.6.16177; GLASBRENNER K, 1986, JAMA-J AM MED ASSOC, V255, P443; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; HERMANUSSEN M, 1988, ANN HUM BIOL, V15, P1, DOI 10.1080/03014468800009411; KELLEY KW, 1990, ANN NY ACAD SCI, V594, P95; KIESS W, 1988, CLIN IMMUNOL IMMUNOP, V48, P85, DOI 10.1016/0090-1229(88)90159-6; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; PETERSEN BH, 1990, J CLIN ENDOCR METAB, V70, P1756, DOI 10.1210/jcem-70-6-1756; RAPAPORT R, 1995, J CLIN ENDOCR METAB, V80, P2612, DOI 10.1210/jc.80.9.2612; RAPAPORT R, 1987, LIFE SCI, V41, P2319, DOI 10.1016/0024-3205(87)90545-5; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Sookoian S, 2013, CURR DIABETES REP, V13, P229, DOI 10.1007/s11892-012-0361-9; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Trovato L, 2012, PITUITARY, V15, P482, DOI 10.1007/s11102-011-0354-8; WATANABE S, 1988, LANCET, V1, P1159; Welzel M, 2011, GROWTH HORM IGF RES, V21, P336, DOI 10.1016/j.ghir.2011.09.001; Whatmore AJ, 2009, CLIN ENDOCRINOL, V70, P429, DOI 10.1111/j.1365-2265.2008.03477.x; Wilton P, 2010, J PEDIATR-US, V157, P265, DOI 10.1016/j.jpeds.2010.02.028	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120463	10.1371/journal.pone.0120463	http://dx.doi.org/10.1371/journal.pone.0120463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785847	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500173
J	Schwalbe, B; Schreiber, M				Schwalbe, Birco; Schreiber, Michael			Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; CORECEPTOR USAGE PREDICTION; ENVELOPE GLYCOPROTEIN; PROTEIN TRANSDUCTION; DOMAIN; CCR5; SEQUENCE; REGION; ANTIBODY	HIV-1 infection is characterized by an ongoing replication leading to T-lymphocyte decline which is paralleled by the switch from CCR5 to CXCR4 coreceptor usage. To predict coreceptor usage, several computer algorithms using gp120 V3 loop sequence data have been developed. In these algorithms an occupation of the V3 positions 11 and 25, by one of the amino acids lysine (K) or arginine (R), is an indicator for CXCR4 usage. Amino acids R and K dominate at these two positions, but can also be identified at positions 9 and 10. Generally, CXCR4-viruses possess V3 sequences, with an overall positive charge higher than the V3 sequences of R5-viruses. The net charge is calculated by subtracting the number of negatively charged amino acids (D, aspartic acid and E, glutamic acid) from the number of positively charged ones (K and R). In contrast to D and E, which are very similar in their polar and acidic properties, the characteristics of the R guanidinium group differ significantly from the K ammonium group. However, in coreceptor predictive computer algorithms R and K are both equally rated. The study was conducted to analyze differences in infectivity and coreceptor usage because of R-to-K mutations at the V3 positions 9, 10 and 11. V3 loop mutants with all possible RRR-to-KKK triplets were constructed and analyzed for coreceptor usage, infectivity and neutralization by SDF-1a and RANTES. Virus mutants R9R10R11 showed the highest infectivity rates, and were inhibited more efficiently in contrast to the K9K10K11 viruses. They also showed higher efficiency in a virus-gp120 paired infection assay. Especially V3 loop position 9 was relevant for a switch to higher infectivity when occupied by R. Thus, K-to-R exchanges play a role for enhanced viral entry efficiency and should therefore be considered when the viral phenotype is predicted based on V3 sequence data.	[Schwalbe, Birco; Schreiber, Michael] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Schreiber, M (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	Michael.Schreiber@bnitm.de		Schreiber, Michael/0000-0002-0690-6431				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arroyo MA, 2002, AIDS RES HUM RETROV, V18, P447, DOI 10.1089/088922202753614218; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; CANN AJ, 1992, J VIROL, V66, P305, DOI 10.1128/JVI.66.1.305-309.1992; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Foley B, 1995, HUM RETROVIRUSES AID, P77; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Gallay P, 2004, MICROBES INFECT, V6, P617, DOI 10.1016/j.micinf.2004.02.004; Gilbert PB, 2003, VACCINE, V21, P2933, DOI 10.1016/S0264-410X(03)00158-0; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kalinina OV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-130; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200; Mefford ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/aid.2008.0009; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pfeifer N, 2012, BIOINFORMATICS, V28, pI589, DOI 10.1093/bioinformatics/bts373; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; Polzer S, 2001, GLYCOBIOLOGY, V11, P11, DOI 10.1093/glycob/11.1.11; Polzer Svenja, 2010, BMC Res Notes, V3, P155, DOI 10.1186/1756-0500-3-155; Polzer S, 2009, FEBS LETT, V583, P1201, DOI 10.1016/j.febslet.2009.03.010; PYLE SW, 1988, J VIROL, V62, P2258, DOI 10.1128/JVI.62.7.2258-2264.1988; REED L. J., 1938, AMER JOUR HYG, V27, P493; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; SCHNEIDER J, 1986, J GEN VIROL, V67, P2533, DOI 10.1099/0022-1317-67-11-2533; Schreiber M, 1996, J GEN VIROL, V77, P2403, DOI 10.1099/0022-1317-77-10-2403; Schreiber M, 1997, CLIN EXP IMMUNOL, V107, P15, DOI 10.1046/j.1365-2249.1996.d01-909.x; SCHREIBER M, 1994, J VIROL, V68, P3908, DOI 10.1128/JVI.68.6.3908-3916.1994; Schwalbe B, 2014, J VIROL METHODS, V205, P91, DOI 10.1016/j.jviromet.2014.05.009; Siddiqui KS, 2006, PROTEINS, V64, P486, DOI 10.1002/prot.20989; Sierra S, 2007, EUR J MED RES, V12, P453; Sing T, 2007, ANTIVIR THER, V12, P1097; THOMPSON PD, 1991, BIOCHEMISTRY-US, V30, P8124, DOI 10.1021/bi00247a005; Tsuchiya K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02389; Van Baelen K, 2007, J VIROL METHODS, V146, P61, DOI 10.1016/j.jviromet.2007.06.003; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119879	10.1371/journal.pone.0119879	http://dx.doi.org/10.1371/journal.pone.0119879			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785610	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500139
J	Dong, G; Wei, DD; Wang, JS; Guo, PP; Li, MH; Yang, MH; Kong, LY				Dong, Ge; Wei, Dandan; Wang, Junsong; Guo, Pingping; Li, Minghui; Yang, Minghua; Kong, Lingyi			Study of the Cardiotoxicity of Venenum Bufonis in Rats using an 1H NMR-Based Metabolomics Approach	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; TOAD VENOM; MASS-SPECTROMETRY; TOXICITY; BUFADIENOLIDES; METABONOMICS; SERUM; CHROMATOGRAPHY; THIOACETAMIDE; SPECTROSCOPY	Venenum Bufonis, a well-known traditional Chinese medicine, has been widely used in Asia and has gained popularity in Western countries over the last decade. Venenum Bufonis has obvious side effects that have been observed in clinical settings, but few studies have reported on its cardiotoxicity. In this work, the cardiotoxicity of Venenum Bufonis was investigated using a H-11 NMR-based metabolomics approach. The H-1 NMR profiles of the serum, myocardial extracts and liver extracts of specific-pathogen-free rats showed that Venenum Bufonis produced significant metabolic perturbations dose-dependently with a distinct time effect, peaking at 2 hr after dosing and attenuating gradually. Clinical chemistry, electrocardiographic recordings, and histopathological evaluation provided additional evidence of Venenum Bufonis-induced cardiac damage that complemented and supported the metabolomics findings. The combined results demonstrated that oxidative stress, mitochondrial dysfunction, and energy metabolism perturbations were associated with the cardiac damage that results from Venenum Bufonis.	[Dong, Ge; Wei, Dandan; Guo, Pingping; Yang, Minghua; Kong, Lingyi] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wang, Junsong; Li, Minghui] Nanjing Univ Sci & Technol, Ctr Mol Metab, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Science & Technology	Wang, JS (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China.	wang.junsong@gmail.com; cpu_lykong@126.com	WANG, JS/C-8780-2013	WANG, JS/0000-0002-8935-4969	National Science Foundation of China [81430092, 81173526]; Program for New Century Excellent Talents in University (Ministry of Education, China) [NCET-11-0738]; Fundamental Research Funds for the Central Universities (Ministry of Education, China) [30920130112014]; Program for Changjiang Scholars and Innovative Research Team in University (Ministry of Education) [PCSIRT-IRT1193]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (Ministry of Education, China)(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities (Ministry of Education, China); Program for Changjiang Scholars and Innovative Research Team in University (Ministry of Education)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by National Science Foundation of China (81430092; 81173526; National Science Foundation of China; http://www.nsfc.gov.cn/), the Program for New Century Excellent Talents in University (NCET-11-0738; Ministry of Education, China; http://www.moe.gov.cn/), the Fundamental Research Funds for the Central Universities (No. 30920130112014; Ministry of Education, China; http://www.moe.gov.cn/) granted to Prof. Wang, and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1193; Ministry of Education, China; http://www.moe.gov.cn/) granted to Prof. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2009, NMR BIOMED, V22, P585, DOI 10.1002/nbm.1370; Arica V, 2013, HUM EXP TOXICOL, V32, P655, DOI 10.1177/0960327112467043; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cai YM, 2013, J ETHNOPHARMACOL, V147, P349, DOI 10.1016/j.jep.2013.03.017; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; China TPCotPsRo, 2010, PHARMACOPOEIA OF THE, VI, P360; Constantinou MA, 2007, TOXICOL APPL PHARM, V218, P11, DOI 10.1016/j.taap.2006.10.007; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; Gowda R M, 2003, Heart, V89, pe14, DOI 10.1136/heart.89.4.e14; Hu YM, 2011, J PHARMACEUT BIOMED, V56, P210, DOI 10.1016/j.jpba.2011.05.014; Jiang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066786; Jiang P, 2011, MOL BIOSYST, V7, P824, DOI 10.1039/c0mb00110d; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; KWAN T, 1992, CHEST, V102, P949, DOI 10.1378/chest.102.3.949; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li JA, 2011, J PROTEOME RES, V10, P1073, DOI 10.1021/pr100862t; Li L, 2008, J ETHNOPHARMACOL, V116, P561, DOI 10.1016/j.jep.2008.01.014; Luo XP, 2006, ANAL BIOANAL CHEM, V384, P1254, DOI 10.1007/s00216-005-0251-y; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Schaffer SW, 2014, AMINO ACIDS, V46, P21, DOI 10.1007/s00726-012-1378-8; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SHIMADA K, 1977, CHEM PHARM BULL, V25, P714; Steyn PS, 1998, NAT PROD REP, V15, P397; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tian N, 2013, METABOLOMICS, V9, P1228, DOI 10.1007/s11306-013-0535-8; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065675; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Waters NJ, 2005, CHEM RES TOXICOL, V18, P639, DOI 10.1021/tx049869b; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Ye M, 2006, J CHROMATOGR B, V838, P86, DOI 10.1016/j.jchromb.2006.04.042; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhang ZH, 2013, J ETHNOPHARMACOL, V149, P303, DOI 10.1016/j.jep.2013.06.039; Zhao YF, 2006, J PHARMACEUT BIOMED, V41, P124, DOI 10.1016/j.jpba.2005.10.046	41	88	95	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119515	10.1371/journal.pone.0119515	http://dx.doi.org/10.1371/journal.pone.0119515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781638	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600071
J	Fagan, KJ; Rogers, GB; Melino, M; Arthur, DM; Costello, ME; Morrison, M; Powell, EE; Irvine, KM				Fagan, Kevin J.; Rogers, Geraint B.; Melino, Michelle; Arthur, Dionne M.; Costello, Mary-Ellen; Morrison, Mark; Powell, Elizabeth E.; Irvine, Katharine M.			Ascites Bacterial Burden and Immune Cell Profile Are Associated with Poor Clinical Outcomes in the Absence of Overt Infection	PLOS ONE			English	Article							IFN-GAMMA; LIVER; DNA; EXPRESSION; DIVERSITY; CIRRHOSIS; SERUM	Bacterial infections, most commonly spontaneous bacterial peritonitis in patients with ascites, occur in one third of admitted patients with cirrhosis, and account for a 4-fold increase in mortality. Bacteria are isolated from less than 40% of ascites infections by culture, necessitating empirical antibiotic treatment, but culture-independent studies suggest bacteria are commonly present, even in the absence of overt infection. Widespread detection of low levels of bacteria in ascites, in the absence of peritonitis, suggests immune impairment may contribute to higher susceptibility to infection in cirrhotic patients. However, little is known about the role of ascites leukocyte composition and function in this context. We determined ascites bacterial composition by quantitative PCR and 16S rRNA gene sequencing in 25 patients with culture-negative, non- neutrocytic ascites, and compared microbiological data with ascites and peripheral blood leukocyte composition and phenotype. Bacterial DNA was detected in ascitic fluid from 23 of 25 patients, with significant positive correlations between bacterial DNA levels and poor 6-month clinical outcomes (death, readmission). Ascites leukocyte composition was variable, but dominated by macrophages or T lymphocytes, with lower numbers of B lymphocytes and natural killer cells. Consistent with the hypothesis that impaired innate immunity contributes to susceptibility to infection, high bacterial DNA burden was associated with reduced major histocompatibility complex class II expression on ascites (but not peripheral blood) monocytes/macrophages. These data indicate an association between the presence of ascites bacterial DNA and early death and readmission in patients with decompensated cirrhosis. They further suggest that impairment of innate immunity contributes to increased bacterial translocation, risk of peritonitis, or both.	[Fagan, Kevin J.; Melino, Michelle; Arthur, Dionne M.; Powell, Elizabeth E.; Irvine, Katharine M.] Univ Queensland, Translat Res Inst, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Fagan, Kevin J.; Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia; [Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Infect & Immun Theme, Adelaide, SA 5001, Australia; [Costello, Mary-Ellen; Morrison, Mark] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Queensland	Irvine, KM (corresponding author), Univ Queensland, Translat Res Inst, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia.	Katharine.irvine@uq.edu.au	Rogers, Geraint/AAD-1011-2020; Morrison, Mark/C-9707-2013; Irvine, Katharine M/A-5559-2011; Powell, Elizabeth/B-4455-2011; Rogers, Geraint/N-1957-2013	Morrison, Mark/0000-0001-9257-9133; Irvine, Katharine M/0000-0002-6716-1605; Powell, Elizabeth/0000-0001-5008-8061; Rogers, Geraint/0000-0003-4054-1947; Melino, Michelle/0000-0001-6962-9016	PA Hospital Foundation; Australian Liver Foundation; Australian National Health and Medical Research Council	PA Hospital Foundation; Australian Liver Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the PA Hospital Foundation (www.pafoundation.org.au) and the Australian Liver Foundation (www.liver.org.au) Pauline Hall Fellowship (to KMI) and the Australian National Health and Medical Research Council (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades CG, 2006, HEPATOLOGY, V44, P34, DOI 10.1002/hep.21240; Arroyo V, 2014, J HEPATOL, V61, P396, DOI 10.1016/j.jhep.2014.04.012; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Balkhy HH, 1999, J IMMUNOL, V162, P3633; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bellot P, 2010, HEPATOLOGY, V52, P2044, DOI 10.1002/hep.23918; Berry PA, 2011, INTENS CARE MED, V37, P453, DOI 10.1007/s00134-010-2099-7; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cholongitas E, 2005, LIVER INT, V25, P57, DOI 10.1111/j.1478-3231.2004.0985.x; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagan KJ, 2014, INTERN MED J; GARCIAGONZALEZ M, 1993, GASTROENTEROLOGY, V105, P527, DOI 10.1016/0016-5085(93)90730-Z; Leber B, 2012, SEMIN RESP CRIT CARE, V33, P80, DOI 10.1055/s-0032-1301737; LEBRUN L, 1992, J HEPATOL, V16, P98, DOI 10.1016/S0168-8278(05)80100-X; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Lu MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003339; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Philippart F, 2012, CRIT CARE MED, V40, P2987, DOI 10.1097/CCM.0b013e31825b8d57; Pievani A, 2011, BLOOD, V118, P3301, DOI 10.1182/blood-2011-02-336321; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quigley EM, 2013, EXPERT REV GASTROENT, V7, P723, DOI 10.1586/17474124.2013.848167; Rogers GB, 2010, EUR J CLIN MICROBIOL, V29, P533, DOI 10.1007/s10096-010-0891-5; Rogers GB, 2014, LANCET RESPIRATORY M; Rogers GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074884; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	37	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120642	10.1371/journal.pone.0120642	http://dx.doi.org/10.1371/journal.pone.0120642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781164	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600178
J	Kalyani, D; Tiwari, MK; Li, JL; Kim, SC; Kalia, VC; Kang, YC; Lee, JK				Kalyani, Dayanand; Tiwari, Manish Kumar; Li, Jinglin; Kim, Sun Chang; Kalia, Vipin C.; Kang, Yun Chan; Lee, Jung-Kul			A Highly Efficient Recombinant Laccase from the Yeast Yarrowia lipolytica and Its Application in the Hydrolysis of Biomass	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; MULTICOPPER OXIDASE; PHENOLIC-COMPOUNDS; MOLECULAR-CLONING; RICE STRAW; PURIFICATION; TECHNOLOGIES; PRETREATMENT; SUBSTRATE	A modified thermal asymmetric interlaced polymerase chain reaction was performed to obtain the first yeast laccase gene (YlLac) from the isolated yeast Yarrowia lipolytica. The 1557-bp full-length cDNA of YlLac encoded a mature laccase protein containing 519 amino acids preceded by a signal peptide of 19 amino acids, and the YlLac gene was expressed in the yeast Pichia pastoris. YlLac is a monomeric glycoprotein with a molecular mass of similar to 55 kDa as determined by polyacrylamide-gel electrophoresis. It showed a higher catalytic efficiency towards 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (k(cat)/K-m = 17.5 s(-1) mu M-1) and 2,6-dimethoxyphenol (k(cat)/K-m = 16.1 s(-1) mu M-1) than other reported laccases. The standard redox potential of the T1 site of the enzyme was found to be 772 mV. The highest catalytic efficiency of the yeast recombinant laccase, YlLac, makes it a good candidate for industrial applications: it removes phenolic compounds in acid-pretreated woody biomass (Populus balsamifera) and enhanced saccharification.	[Kalyani, Dayanand; Tiwari, Manish Kumar; Li, Jinglin; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul, South Korea; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kalia, Vipin C.] CSIR, Inst Genom & Integrat Biol, Microbial Biotechnol & Genom, Delhi, India; [Kang, Yun Chan] Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea	Konkuk University; Korea Advanced Institute of Science & Technology (KAIST); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Korea University	Kang, YC (corresponding author), Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea.	yckang@korea.ac.kr; jkrhee@konkuk.ac.kr	Tiwari, Manish K./D-9034-2011; Kalyani, Dayanand/AAF-3120-2020; Lee, Jungkukl/D-9104-2011; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011; Kang, Yun Chan/H-2457-2015	Tiwari, Manish K./0000-0002-4667-1112; Kalyani, Dayanand/0000-0001-5829-9357; Kang, Yun Chan/0000-0001-5769-5761	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [201320200000420]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0031955]; KU Brain Pool fellowship of Konkuk University	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea; KU Brain Pool fellowship of Konkuk University	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (201320200000420). This research was also supported by a grant from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. This work was supported by 2013 KU Brain Pool fellowship of Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baldrian P, 2004, FEMS MICROBIOL ECOL, V50, P245, DOI 10.1016/j.femsec.2004.07.005; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Dedeyan B, 2000, APPL ENVIRON MICROB, V66, P925, DOI 10.1128/AEM.66.3.925-929.2000; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Frasconi M, 2010, BBA-PROTEINS PROTEOM, V1804, P899, DOI 10.1016/j.bbapap.2009.12.018; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gu CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093912; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Huang WT, 2011, PROCESS BIOCHEM, V46, P1469, DOI 10.1016/j.procbio.2011.03.020; Jeya M, 2010, APPL MICROBIOL BIOT, V86, P1473, DOI 10.1007/s00253-009-2395-8; Jin SY, 2006, PROCESS BIOCHEM, V41, P1261, DOI 10.1016/j.procbio.2005.12.022; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kalyani D, 2012, PROCESS BIOCHEM, V47, P671, DOI 10.1016/j.procbio.2012.01.013; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kudanga T, 2014, APPL MICROBIOL BIOT, V98, P6525, DOI 10.1007/s00253-014-5810-8; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KM, 2012, BIORESOURCE TECHNOL, V123, P636, DOI 10.1016/j.biortech.2012.07.066; Litthauer D, 2007, ENZYME MICROB TECH, V40, P563, DOI 10.1016/j.enzmictec.2006.05.011; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Matera I, 2008, INORG CHIM ACTA, V361, P4129, DOI 10.1016/j.ica.2008.03.091; Parawira W, 2011, CRIT REV BIOTECHNOL, V31, P20, DOI 10.3109/07388551003757816; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Sanchez-Amat A, 2001, BBA-PROTEIN STRUCT M, V1547, P104, DOI 10.1016/S0167-4838(01)00174-1; Singer T, 2003, METH MOL B, V236, P241; SINGLETON VL, 1978, J SCI FOOD AGR, V29, P403, DOI 10.1002/jsfa.2740290416; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2012, J BIOL CHEM, V287, P19429, DOI 10.1074/jbc.M111.335752; Wong KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066426; Xiao YZ, 2004, MYCOLOGIA, V96, P26, DOI 10.2307/3761984; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Yaver DS, 1996, APPL ENVIRON MICROB, V62, P834, DOI 10.1128/AEM.62.3.834-841.1996; Zhu JY, 2010, APPL MICROBIOL BIOT, V87, P847, DOI 10.1007/s00253-010-2654-8	36	36	39	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120156	10.1371/journal.pone.0120156	http://dx.doi.org/10.1371/journal.pone.0120156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781945	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600133
J	Linn, DE; Bronson, RT; Li, Z				Linn, Douglas E.; Bronson, Roderick T.; Li, Zhe			Genetic Interaction between Tmprss2-ERG Gene Fusion and Nkx3.1-Loss Does Not Enhance Prostate Tumorigenesis in Mouse Models	PLOS ONE			English	Article							PATHOLOGY COMMITTEE; CANCER PROGRESSION; CONSENSUS REPORT; ENGINEERED MICE; ERG EXPRESSION; PTEN LOSS; CARCINOGENESIS; COOPERATIVITY; ACTIVATION; PATHWAYS	Gene fusions involving ETS family transcription factors (mainly TMPRSS2-ERG and TMPRSS2-ETV1 fusions) have been found in similar to 50% of human prostate cancer cases. Although expression of TMPRSS2-ERG or TMPRSS2-ETV1 fusion alone is insufficient to initiate prostate tumorigenesis, they appear to sensitize prostate epithelial cells for cooperation with additional oncogenic mutations to drive frank prostate adenocarcinoma. To search for such ETS-cooperating oncogenic events, we focused on a well-studied prostate tumor suppressor NKX3.1, as loss of NKX3.1 is another common genetic alteration in human prostate cancer. Previous studies have shown that deletions at 8p21 (harboring NKX3.1) and 21q22 (resulting in TMPRSS2-ERG fusion) were both present in a subtype of prostate cancer cases, and that ERG can lead to epigenetic silencing of NKX3.1 in prostate cancer cells, whereas NKX3.1 can in turn negatively regulate TMPRSS2-ERG fusion expression via suppression of the TMPRSS2 promoter activity. We recently generated knockin mouse models for TMPRSS2-ERG and TMPRSS2-ETV1 fusions, utilizing the endogenous Tmprss2 promoter. We crossed these knockin models to an Nkx3.1 knockout mouse model. In Tmprss2-ERG; Nkx3.1(+/-)(or (-/-)) male mice, although we observed a slight but significant upregulation of Tmprss2-ERG fusion expression upon Nkx3.1 loss, we did not detect any significant cooperation between these two genetic events to enhance prostate tumorigenesis in vivo. Furthermore, retrospective analysis of a previously published human prostate cancer dataset revealed that within ERG-overexpressing prostate cancer cases, NKX3.1 loss or deletion did not predict biochemical relapse after radical prostatectomy. Collectively, these data suggest that although TMPRSS2-ERG fusion and loss of NKX3.1 are among the most common mutational events found in prostate cancer, and although each of them can sensitize prostate epithelial cells for cooperating with other oncogenic events, these two events themselves do not appear to cooperate at a significant level in vivo to enhance prostate tumorigenesis.	[Linn, Douglas E.; Li, Zhe] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Linn, Douglas E.; Li, Zhe] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Rodent Histopathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Li, Z (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	zli4@rics.bwh.harvard.edu			Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE [P50CA090381]; Idea Development Award from Department of Defense [PC100704]; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER	Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE; Idea Development Award from Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (P50CA090381) and an Idea Development Award from Department of Defense (PC100704) to Z.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Casey OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041668; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thangapazham R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-16; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Yang Chih-Cheng, 2014, F1000Res, V3, P115, DOI 10.12688/f1000research.3818.2; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120628	10.1371/journal.pone.0120628	http://dx.doi.org/10.1371/journal.pone.0120628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780911	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600176
J	Pelc, RS; McClure, JC; Kaur, SJ; Sears, KT; Rahman, MS; Ceraul, SM				Pelc, Rebecca S.; McClure, Jennifer C.; Kaur, Simran J.; Sears, Khandra T.; Rahman, M. Sayeedur; Ceraul, Shane M.			Disrupting Protein Expression with Peptide Nucleic Acids Reduces Infection by Obligate Intracellular Rickettsia	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; GREEN FLUORESCENT PROTEIN; MARINER-BASED TRANSPOSON; OUTER-MEMBRANE PROTEIN; DERMACENTOR-VARIABILIS; ANTISENSE INHIBITION; GENE-EXPRESSION; ARP2/3 COMPLEX; TRANSFORMATION; CONORII	Peptide Nucleic Acids (PNAs) are single-stranded synthetic nucleic acids with a pseudopeptide backbone in lieu of the phosphodiester linked sugar and phosphate found in traditional oligos. PNA designed complementary to the bacterial Shine-Dalgarno or start codon regions of mRNA disrupts translation resulting in the transient reduction in protein expression. This study examines the use of PNA technology to interrupt protein expression in obligate intracellular Rickettsia sp. Their historically intractable genetic system limits characterization of protein function. We designed PNA targeting mRNA for rOmpB from Rickettsia typhi and rickA from Rickettsia montanensis, ubiquitous factors important for infection. Using an in vitro translation system and competitive binding assays, we determined that our PNAs bind target regions. Electroporation of R. typhi and R. montanensis with PNA specific to rOmpB and rickA, respectively, reduced the bacteria's ability to infect host cells. These studies open the possibility of using PNA to suppress protein synthesis in obligate intracellular bacteria.	[Pelc, Rebecca S.; McClure, Jennifer C.; Kaur, Simran J.; Sears, Khandra T.; Rahman, M. Sayeedur; Ceraul, Shane M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Ceraul, SM (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	scera001@umaryland.edu	Sears, Khandra T/AAI-2485-2020	Sears, Khandra T/0000-0001-9400-8262; Pelc, Rebecca/0000-0001-5080-4945	National Institutes of Health/National Institute of Allergy and Infectious Diseases [1K22AI08040-01A1, R01AI043006, R01AI017828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017828, R37AI017828, R01AI043006] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work for this manuscript was supported by funds from the National Institutes of Health/National Institute of Allergy and Infectious Diseases 1K22AI08040-01A1 to Shane M. Ceraul and R01AI043006 and R01AI017828 to Abdu F. Azad. The content is solely the responsibility of the authors and does not represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. http://www.niaid.nih.gov. National Institutes of Health/National Institute of Allergy and Infectious Diseases R01AI043006 and R01AI017828 to Abdu F. Azad provided partial support to personnel who authored this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2007, J INVERTEBR PATHOL, V94, P163, DOI 10.1016/j.jip.2006.10.003; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Clark TR, 2011, J BACTERIOL, V193, P4993, DOI 10.1128/JB.05279-11; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 1999, Curr Issues Mol Biol, V1, P111; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Ma S, 2014, INTEGR BIOL-UK, V6, P973, DOI 10.1039/c4ib00172a; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Oliver JD, 2014, APPL ENVIRON MICROB, V80, P1170, DOI 10.1128/AEM.03352-13; Pelc RS, 2014, INSECT MOL BIOL, V23, P457, DOI 10.1111/imb.12094; Petchampai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093768; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rajasekaran P, 2013, INT J ANTIMICROB AG, V41, P358, DOI 10.1016/j.ijantimicag.2012.11.017; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119283	10.1371/journal.pone.0119283	http://dx.doi.org/10.1371/journal.pone.0119283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781160	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600058
J	Penarrubia, L; Sanz, N; Pla, C; Vidal, O; Vinas, J				Penarrubia, Luis; Sanz, Nuria; Pla, Carles; Vidal, Oriol; Vinas, Jordi			Using Massive Parallel Sequencing for the Development, Validation, and Application of Population Genetics Markers in the Invasive Bivalve Zebra Mussel (Dreissena polymorpha)	PLOS ONE			English	Article							MICROSATELLITE LOCI; NORTH-AMERICA; FRESH-WATER; GENOME SIZE; EUROPE; DIFFERENTIATION; PALLAS; SOFTWARE; DYNAMICS; PATTERNS	The zebra mussel (Dreissena polymorpha, Pallas, 1771) is one of the most invasive species of freshwater bivalves, due to a combination of biological and anthropogenic factors. Once this species has been introduced to a new area, individuals form dense aggregations that are very difficult to remove, leading to many adverse socioeconomic and ecological consequences. In this study, we identified, tested, and validated a new set of polymorphic microsatellite loci (also known as SSRs, Single Sequence Repeats) using a Massive Parallel Sequencing (MPS) platform. After several pruning steps, 93 SSRs could potentially be amplified. Out of these SSRs, 14 were polymorphic, producing a polymorphic yield of 15.05%. These 14 polymorphic microsatellites were fully validated in a first approximation of the genetic population structure of D. polymorpha in the Iberian Peninsula. Based on this polymorphic yield, we propose a criterion for establishing the number of SSRs that require validation in similar species, depending on the final use of the markers. These results could be used to optimize MPS approaches in the development of microsatellites as genetic markers, which would reduce the cost of this process.	[Penarrubia, Luis; Sanz, Nuria; Pla, Carles; Vidal, Oriol; Vinas, Jordi] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain	Universitat de Girona	Vinas, J (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Campus Montilivi, Girona, Spain.	jordi.vinas@udg.edu	Pla, Carles/L-5765-2014; Sanz, Nuria/L-3074-2014; Vidal, Oriol/C-8973-2009; Vinas, Jordi/A-5397-2010	Pla, Carles/0000-0002-3749-4740; Sanz, Nuria/0000-0001-5274-1917; Vidal, Oriol/0000-0002-8197-1567; Penarrubia, Luis/0000-0001-6024-1832; Vinas, Jordi/0000-0003-0193-1141	Spanish MICINN (Ministerio de Ciencia e Innovacion) [CGL200909407]	Spanish MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was carried out within the objectives of the research project CGL200909407 of the Spanish MICINN (Ministerio de Ciencia e Innovacion), http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown JE, 2010, BIOL INVASIONS, V12, P3687, DOI 10.1007/s10530-010-9763-2; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diez-del-Molino D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082501; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Duran C, 2012, LIMNETICA, V31, P213; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feldheim KA, 2011, MOL ECOL RESOUR, V11, P725, DOI 10.1111/j.1755-0998.2011.03012.x; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hoshino AA, 2012, GENETIC DIVERSITY IN MICROORGANISMS, P149; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Karatayev AY, 2015, HYDROBIOLOGIA, V746, P97, DOI 10.1007/s10750-014-1901-x; KINZELBACH R, 1992, LIMNOL AKTUELL, V4, P5; Lewis KM, 2000, CAN J FISH AQUAT SCI, V57, P637, DOI 10.1139/cjfas-57-3-637; Lopes-Lima M, 2014, HYDROBIOLOGIA, V735, P1, DOI 10.1007/s10750-014-1902-9; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; MARSDEN JE, 1995, CAN J FISH AQUAT SCI, V52, P836, DOI 10.1139/f95-083; May GE, 2006, MOL ECOL, V15, P1021, DOI 10.1111/j.1365-294X.2006.02814.x; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Naish KA, 2001, MOL ECOL NOTES, V1, P286, DOI 10.1046/j.1471-8278 .2001.00111.x; Navarro A, 2013, ECOTOXICOLOGY, V22, P915, DOI 10.1007/s10646-013-1084-7; Penarrubia L, 2014, CONSERV GENET RESOUR; Pritchard JK, 2000, GENETICS, V155, P945; Rajagopal S, 2009, BIOL INVASIONS, V11, P2147, DOI 10.1007/s10530-009-9495-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Altaba C., 2001, QUERCUS, V188, P50; Saavedra C, 2006, AQUACULTURE, V256, P1, DOI 10.1016/j.aquaculture.2006.02.023; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Therriault TW, 2005, HEREDITY, V95, P16, DOI 10.1038/sj.hdy.6800691; Thomas G, 2011, J SHELLFISH RES, V30, P123, DOI 10.2983/035.030.0118; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidal O, 2012, ECOL FRESHW FISH, V21, P100, DOI 10.1111/j.1600-0633.2011.00527.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhan Aibin, 2009, Journal of Ocean University of China, V8, P161, DOI 10.1007/s11802-009-0161-2	52	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120732	10.1371/journal.pone.0120732	http://dx.doi.org/10.1371/journal.pone.0120732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780924	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600186
J	Wu, CL; Fu, TF; Chou, YY; Yeh, SR				Wu, Chia-Lin; Fu, Tsai-Feng; Chou, Yen-Yun; Yeh, Sheng-Rong			A Single Pair of Neurons Modulates Egg-Laying Decisions in Drosophila	PLOS ONE			English	Article							ANESTHESIA-RESISTANT MEMORY; MUSHROOM BODY; BODIES; SLEEP; CIRCUITS; PATHWAY; ETHANOL; BRAIN	Animals have to judge environmental cues and choose the most suitable option for them from many different options. Female fruit flies selecting an optimum site to deposit their eggs is a biologically important reproductive behavior. When given the direct choice between ovipositing their eggs in a sucrose-containing medium or a caffeine-containing medium, female flies prefer the latter. However, the neural circuits and molecules that regulate this decision-making processes during egg-laying site selection remain poorly understood. In the present study, we found that amnesiac (amn) mutant flies show significant defects in egg-laying decisions, and such defects can be reversed by expressing the wild-type amn transgene in two dorsal paired medial (DPM) neurons in the brain. Silencing neuronal activity with an inward rectifier potassium channel (Kir2.1) in DPM neurons also impairs egg-laying decisions. Finally, the activity in mushroom body alpha beta neurons is required for the egg-laying behavior, suggesting a possible "DPM-alpha beta neurons" brain circuit modulating egg-laying decisions. Our results highlight the brain circuits and molecular mechanisms of egg-laying decisions in Drosophila.	[Wu, Chia-Lin; Chou, Yen-Yun] Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Mem Hosp, Dept Med Res, Taoyuan, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Yeh, Sheng-Rong] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; National Chi Nan University; Chang Gung University	Wu, CL (corresponding author), Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan.	clwu@mail.cgu.edu.tw		Wu, Chia-Lin/0000-0002-7906-2364; Fu, Tsai-Feng/0000-0002-0343-3018	Ministry of Science and Technology [101-2221-E-182-080-MY3, 102-2321-B-182-010, 101-2221-E-007-071-MY3, 101-2311-M-260-002, 103-2633-B-260 -001]; Chang Gung Memorial Hospital [CMRPD1B0323]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1037905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by grants from the Ministry of Science and Technology 101-2221-E-182-080-MY3, 102-2321-B-182-010, 101-2221-E-007-071-MY3 (to C.-L.W), 101-2311-M-260-002, 103-2633-B-260 -001 (to T.-F.F), a grant from the Chang Gung Memorial Hospital CMRPD1B0323 (to C.-L.W), and a grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1037905 (to T.-F.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Bang S, 2011, J KOREAN MED ASSOC, V54, P10, DOI 10.5124/jkma.2011.54.1.10; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wu CL, 2013, CURR BIOL, V23, P2346, DOI 10.1016/j.cub.2013.09.056; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Wu CL, 2008, J NEUROGENET, V22, P257, DOI 10.1080/01677060802307755; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	30	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121335	10.1371/journal.pone.0121335	http://dx.doi.org/10.1371/journal.pone.0121335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781933	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600203
J	Pauwels, K; Simoens, S; Casteels, M; Huys, I				Pauwels, Kim; Simoens, Steven; Casteels, Minne; Huys, Isabelle			Insights into European Drug Shortages: A Survey of Hospital Pharmacists	PLOS ONE			English	Article							NATIONAL-SURVEY; UNITED-STATES; PHARMACEUTICALS; STRATEGIES; IMPACT; CARE	Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the moment of patient demand, every stakeholder in the health care system is affected. The aim of this study was to investigate the characteristics, clinical impact, financial impact and management of drug shortages in European hospital pharmacies and identify opportunities for prevention and mitigation of drug shortages in Europe. An online survey was designed based on a review of the literature and interviews and was sent to subscribers of Hospital Pharmacy Europe between June and September 2013. Forty-five percent of respondents (n = 161) indicated that life sustaining or life preserving drugs such as oncology drugs were affected by drug shortages. More than 30% of respondents indicated that drug shortages in Europe were always or often associated with increased costs for hospitals, increased personnel costs and more expensive alternative drugs (n = 161). On the question when information about a drug shortage was obtained, 42% of respondents answered that information from the pharmaceutical company was obtained at the time of no delivery, 50% indicated that information from the wholesaler was obtained at the time of no delivery, while 40% of respondents indicated that information was never or rarely received from the government (n = 161). Fifty seven percent of respondents strongly agreed that an obligation to the producer to notify further shortages could help to solve the problem (n = 161). These results showed that pharmaceutical companies and wholesalers are already involved in the management of drug shortages, while a role is still reserved for the government. Mandatory notification in advance and centralized information can help to reduce workload for hospital pharmacists, will allow early anticipation of drug shortages and will facilitate mitigation of the clinical impact on patients.	[Pauwels, Kim; Simoens, Steven; Casteels, Minne; Huys, Isabelle] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium	KU Leuven	Pauwels, K (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium.	Kim.Pauwels@pharm.kuleuven.be	Huys, Isabelle/M-8673-2016	Simoens, Steven/0000-0002-9512-2005	Agency for Innovation by Science and Technology; Research Foundation Flanders; TEVA	Agency for Innovation by Science and Technology; Research Foundation Flanders(FWO); TEVA(Teva Pharmaceutical Industries)	KP is funded by the Agency for Innovation by Science and Technology (http://www.iwt.be/english/welcome). The study is included in a project supported by Research Foundation Flanders (http://www.fwo.be/en/). The study is included in a project supported by TEVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspach JG, 2012, CRIT CARE NURSE, V32, P11, DOI 10.4037/ccn2012818; American Hospital Association, 2011, AHA SURV DRUG SHORT; [Anonymous], 2013, COMP MACR GEOGR CONT; Bart TN, 2008, VALUE HEALTH, V11, P996, DOI 10.1111/j.1524-4733.2008.00339.x; Birgli ag, 2013, EV MED SHORT EUR MOR; Capstick TGD, 2011, INT J TUBERC LUNG D, V15, P754, DOI 10.5588/ijtld.10.0568; Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Cherici C, 2013, NAVIGATING DRUG SHOR; Dal MF, 2013, PREV MED, V57, P146; Dylst P, 2011, HEALTH POLICY, V101, P146, DOI 10.1016/j.healthpol.2011.03.004; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Association of Pharmaceutical Full-line Wholesalers, 2012, MED SHORT EUR THEIR; European Generic medicines Association (EGA), 2013, EGA POS PAP TEND UNS; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Generics and Biosimilarrs Initiative, 2012, UK DRUG SHORT AR FAR; Generics and Biosimilarrs Initiative, 2012, APPG REP DRUG SHORT; Generics and Biosimilarrs Initiative, 2011, BIOS CANC DRUG SHORT; Generics and Biosimilarrs Initiative, 2012, DRUG SHORT WOES CONT; Gray A, 2012, B WORLD HEALTH ORGAN, V154-154A; Hall R, 2013, CAN J ANESTH, V60, P539, DOI 10.1007/s12630-013-9920-z; IHS Healthcare and Pharma Blog, 2013, DRUG SHORT RES PRIC; IHS Healthcare and Pharma Blog, 2012, PAR EXP LEAD DRUG SH; IHS Healthcare and Pharma Blog, 2012, COST CONT POL IMP DR; IMS institute, 2011, DRUG SHORT CLOS LOOK; Institute for Safe Medication Practices, 2010, DRUG SHORT NAT SURV; ISPE, 2013, REP ISPE DRUG SHORT; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Mayer DK, 2012, CLIN J ONCOL NURS, V16, P107, DOI 10.1188/12.CJON.107-108; McBride A, 2013, AM J HEALTH-SYST PH, V70, P609, DOI 10.2146/ajhp120563; Morrissey John, 2012, Hosp Health Netw, V86, P46; Pharmaceutical Service Negotiating Committee (PSNC), 2013, BRAND MED SHORT; Rider Anne Elise, 2013, J Pharm Pract, V26, P183, DOI 10.1177/0897190013482332; Tirelli U, 2012, EUR REV MED PHARMACO, V16, P138; Ventola C Lee, 2011, P T, V36, P740; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220	35	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119322	10.1371/journal.pone.0119322	http://dx.doi.org/10.1371/journal.pone.0119322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775406	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000351183500082
J	Bogdanova, VS; Zaytseva, OO; Mglinets, AV; Shatskaya, NV; Kosterin, OE; Vasiliev, GV				Bogdanova, Vera S.; Zaytseva, Olga O.; Mglinets, Anatoliy V.; Shatskaya, Natalia V.; Kosterin, Oleg E.; Vasiliev, Gennadiy V.			Nuclear-Cytoplasmic Conflict in Pea (Pisum sativum L.) Is Associated with Nuclear and Plastidic Candidate Genes Encoding Acetyl-CoA Carboxylase Subunits	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; REPRODUCTIVE ISOLATION; SUBSECTION OENOTHERA; MALE-STERILITY; INCOMPATIBILITY; MITOCHONDRIAL; GENOME; COMPATIBILITY; PROTEIN; INHERITANCE	In crosses of wild and cultivated peas (Pisum sativum L.), nuclear-cytoplasmic incompatibility frequently occurs manifested as decreased pollen fertility, male gametophyte lethality, sporophyte lethality. High-throughput sequencing of plastid genomes of one cultivated and four wild pea accessions differing in cross-compatibility was performed. Candidate genes for involvement in the nuclear-plastid conflict were searched in the reconstructed plastid genomes. In the annotated Medicago truncatula genome, nuclear candidate genes were searched in the portion syntenic to the pea chromosome region known to harbor a locus involved in the conflict. In the plastid genomes, a substantial variability of the accD locus represented by nucleotide substitutions and indels was found to correspond to the pattern of cross-compatibility among the accessions analyzed. Amino acid substitutions in the polypeptides encoded by the alleles of a nuclear locus, designated as Bccp3, with a complementary function to accD, fitted the compatibility pattern. The accD locus in the plastid genome encoding beta subunit of the carboxyltransferase of acetyl-coA carboxylase and the nuclear locus Bccp3 encoding biotin carboxyl carrier protein of the same multi-subunit enzyme were nominated as candidate genes for main contribution to nuclear-cytoplasmic incompatibility in peas. Existence of another nuclear locus involved in the accD-mediated conflict is hypothesized.	[Bogdanova, Vera S.; Zaytseva, Olga O.; Mglinets, Anatoliy V.; Shatskaya, Natalia V.; Kosterin, Oleg E.; Vasiliev, Gennadiy V.] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Zaytseva, Olga O.; Kosterin, Oleg E.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Kosterin, OE (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia.	kosterin@bionet.nsc.ru	Vasiliev, Gennady V/U-7686-2018; Kosterin, Oleg/AAC-6480-2019	Kosterin, Oleg/0000-0001-5955-4057; Zaytseva, Olga/0000-0003-3960-5157	Presidium of Russian Academy of Sciences [30.27]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the grant 30.27 of the Presidium of Russian Academy of Sciences within the program 'Live Nature'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENZEEV N, 1973, ISRAEL J BOT, V22, P73; Bogdanova V S, 2006, Dokl Biol Sci, V406, P44, DOI 10.1134/S0012496606010121; Bogdanova VS, 2014, THEOR APPL GENET, V127, P1163, DOI 10.1007/s00122-014-2288-9; Bogdanova VS, 2007, THEOR APPL GENET, V114, P333, DOI 10.1007/s00122-006-0436-6; Bogdanova VS, 2012, THEOR APPL GENET, V124, P1503, DOI 10.1007/s00122-012-1804-z; Bogdanova VS, 2009, THEOR APPL GENET, V118, P801, DOI 10.1007/s00122-008-0940-y; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Gurdon C, 2014, DNA RES, V21, P417, DOI 10.1093/dnares/dsu007; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kosterin OE, 2014, GENET RES CROP EVOL; Kozaki AK, 2001, J BIOL CHEM, V276, P39919, DOI 10.1074/jbc.M103525200; Kubo T, 2013, BREEDING SCI, V63, P359, DOI 10.1270/jsbbs.63.359; KUSHNIR S, 1991, MOL GEN GENET, V225, P225, DOI 10.1007/BF00269852; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Levin DA, 2003, SYST BOT, V28, P5; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Maxted N, 2001, CURR PLANT SCI BIOT, V39, P181; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; NAGANO Y, 1991, CURR GENET, V20, P431, DOI 10.1007/BF00317074; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; PALMER JD, 1985, GENETICS, V109, P195; Pershina LA, 2014, RUSS J GENET+, V50, P1017, DOI 10.1134/S102279541410010X; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; SASAKI Y, 1993, J BIOL CHEM, V268, P25118; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; Schweer J, 2010, ENDOCYTOBIOSIS CELL, V20, P1; Simons KJ, 2003, GENETICS, V165, P2129; STUBBE W, 1959, Z VEREBUNGSL, V90, P288, DOI 10.1007/BF00888761; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thelen JJ, 2001, PLANT PHYSIOL, V125, P2016, DOI 10.1104/pp.125.4.2016; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Yadrikhinskiy AK, 2011, DOKL AKAD NAUK, V441, P392; Zhao ZG, 2011, PLANTA, V233, P485, DOI 10.1007/s00425-010-1313-8; Zubko MK, 2001, PLANT J, V25, P627, DOI 10.1046/j.1365-313x.2001.00997.x	56	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119835	10.1371/journal.pone.0119835	http://dx.doi.org/10.1371/journal.pone.0119835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789472	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400110
J	Lee, HJ; Cho, H; Kim, MG; Heo, YK; Cho, Y; Gwon, YD; Park, KH; Jin, H; Kim, J; Oh, YK; Kim, YB				Lee, Hee-Jung; Cho, Hansam; Kim, Mi-Gyeong; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Park, Ki Hoon; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung; Kim, Young Bong			Sublingual Immunization of Trivalent Human Papillomavirus DNA Vaccine in Baculovirus Nanovector for Protection against Vaginal Challenge	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; IMMUNE-RESPONSES; SENSITIVE MEASURE; MUCOSAL VACCINES; PROTEIN; ORGANS; MODEL; HPV	Here, we report the immunogenicity of a sublingually delivered, trivalent human papillomavirus (HPV) DNA vaccine encapsidated in a human endogenous retrovirus (HERV) envelopecoated, nonreplicable, baculovirus nanovector. The HERV envelope-coated, nonreplicable, baculovirus-based DNA vaccine, encoding HPV16L1, -18L1 and -58L1 (AcHERV-triHPV), was constructed and sublingually administered to mice without adjuvant. Following sublingual (SL) administration, AcHERV-triHPV was absorbed and distributed throughout the body. At 15 minutes and 1 day post-dose, the distribution of AcHERV-triHPV to the lung was higher than that to other tissues. At 30 days post-dose, the levels of AcHERV-triHPV had diminished throughout the body. Six weeks after the first of three doses, 1x10(8) copies of SL AcHERV-triHPV induced HPV type-specific serum IgG and neutralizing antibodies to a degree comparable to that of IM immunization with 1x10(9) copies. AcHERV-triHPV induced HPV type-specific vaginal IgA titers in a dose-dependent manner. SL immunization with 1x10(10) copies of AcHERV-triHPV induced Th1 and Th2 cellular responses comparable to IM immunization with 1x10(9) copies. Molecular imaging revealed that SL AcHERV-triHPV in mice provided complete protection against vaginal challenge with HPV16, HPV18, and HPV58 pseudoviruses. These results support the potential of SL immunization using multivalent DNA vaccine in baculovirus nanovector for induction of mucosal, systemic, and cellular immune responses.	[Lee, Hee-Jung; Cho, Hansam; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Park, Ki Hoon; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Kim, Mi-Gyeong; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, Mi-Gyeong; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Konkuk University; Seoul National University (SNU); Seoul National University (SNU)	Oh, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ohyk@snu.ac.kr; kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Gwon, Yong-Dae/0000-0002-0703-4188; Oh, Yu-Kyoung/0000-0002-0969-3339	Korean Health Technology RD Project [A092010]	Korean Health Technology RD Project	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has been financially supported by grants from the Korean Health Technology R&D Project (No. A092010).	Azegami T, 2014, INT IMMUNOL, V26, P517, DOI 10.1093/intimm/dxu063; Bello A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06644; Borde A, 2012, EUR J PHARM SCI, V47, P695, DOI 10.1016/j.ejps.2012.08.014; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095961; Cho HJ, 2012, PHARM RES-DORDR, V29, P585, DOI 10.1007/s11095-011-0598-z; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Hervouet C, 2014, MUCOSAL IMMUNOL, V7, P280, DOI 10.1038/mi.2013.45; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Jun S, 2012, INT IMMUNOL, V24, P117, DOI 10.1093/intimm/dxr106; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kraan H, 2014, J CONTROL RELEASE, V190, P580, DOI 10.1016/j.jconrel.2014.05.060; Kumar SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063856; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050296; Lee HJ, 2010, VACCINE, V28, P1613, DOI 10.1016/j.vaccine.2009.11.044; Liu XS, 1998, VIROLOGY, V252, P39, DOI 10.1006/viro.1998.9442; Liu XS, 2002, IMMUNOL CELL BIOL, V80, P21, DOI 10.1046/j.1440-1711.2002.01051.x; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Luo WY, 2013, J VIROL, V87, P4965, DOI 10.1128/JVI.03510-12; Martinez X, 1997, P NATL ACAD SCI USA, V94, P8726, DOI 10.1073/pnas.94.16.8726; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rossi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107377; Shim Byoung-Shik, 2013, Immune Netw, V13, P81, DOI 10.4110/in.2013.13.3.81; Shim BS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-215; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090001; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Xu YF, 2006, ARCH VIROL, V151, P2133, DOI 10.1007/s00705-006-0798-8	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119408	10.1371/journal.pone.0119408	http://dx.doi.org/10.1371/journal.pone.0119408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789464	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400080
J	Li, ZJ; Hou, Y; Qin, DA; Jin, ZM; Hu, ML				Li, Zhao-Jun; Hou, Yong; Qin, Da-An; Jin, Zhi-Min; Hu, Mao-Lin			Two Half-Sandwiched Ruthenium (II) Compounds Containing 5-Fluorouracil Derivatives: Synthesis and Study of DNA Intercalation	PLOS ONE			English	Article							COORDINATION CHEMISTRY; BINDING-PROPERTIES; COMPLEXES; SPECTROSCOPY; BERBERINE; DESIGN; MOTIFS; RNA	Two novel coordination compounds of half-sandwiched ruthenium(II) containing 2-(5-fluorouracil)-yl-N-(pyridyl)-acetamide were synthesized, and their intercalation binding modes with calf thymus DNA were revealed by hyperchromism of ultraviolet-visible spectroscopy; the binding constants were determined according to a Langmuir adsorption equation that was deduced on the base of careful cyclic voltammetry measurements. The two compounds exhibited DNA intercalation binding activities with the binding constants of 1.13x10(6) M-1 and 5.35 x10(5) M-1, respectively.	[Li, Zhao-Jun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China; [Hou, Yong] Sichuan Acad Agr Sci, Inst Biotechnol & Nucle Technol, Chengdu, Peoples R China; [Qin, Da-An; Hu, Mao-Lin] Wenzhou Univ, Coll Chem & Mat Engn, Wenzhou, Peoples R China; [Jin, Zhi-Min] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Sichuan Academy of Agricultural Sciences (SAAS); Wenzhou University; Zhejiang University of Technology	Jin, ZM (corresponding author), Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	zimichem@sina.com; maolin@wzu.edu.cn	Li, zhaojun/E-5735-2012		Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences [20143]; special projects foundation of Beijing Municipal Science & Technology Commission [Z141105000614012]; Natural Science Foundation of China [21071111, 21371137]	Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences; special projects foundation of Beijing Municipal Science & Technology Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences (Project No. 20143; website: http://www.iarrp.cn) and the special projects foundation of Beijing Municipal Science & Technology Commission (Z141105000614012). This research was also supported by the Natural Science Foundation of China (Nos. 21071111 and 21371137); website: http://www.nsfc.gov.cn (Nos. 21071111 and 21371137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2008, J AM CHEM SOC, V130, P9650, DOI 10.1021/ja802905g; Arjmand F, 2005, EUR J MED CHEM, V40, P1103, DOI 10.1016/j.ejmech.2005.05.005; Arjmand F, 2006, BIOINORG CHEM APPL, V2006, DOI 10.1155/BCA/2006/32896; Baldini M, 2003, INORG CHEM, V42, P2049, DOI 10.1021/ic026131d; Bathaie SZ, 1999, NUCLEIC ACIDS RES, V27, P1001, DOI 10.1093/nar/27.4.1001; Campbell NH, 2011, ORG BIOMOL CHEM, V9, P1328, DOI 10.1039/c0ob00886a; CARTER MT, 1989, J AM CHEM SOC, V111, P8901, DOI 10.1021/ja00206a020; Conejo-Garcia A, 2005, BIOORG MED CHEM LETT, V15, P4004, DOI 10.1016/j.bmcl.2005.06.026; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dougan SJ, 2007, CHIMIA, V61, P704, DOI 10.2533/chimia.2007.704; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Erkkila KE, 1999, CHEM REV, V99, P2777, DOI 10.1021/cr9804341; Froehlich E, 2011, BIOMACROMOLECULES, V12, P2780, DOI 10.1021/bm200547e; Hobro AJ, 2007, NUCLEIC ACIDS RES, V35, P1169, DOI 10.1093/nar/gkm012; Jin BK, 2004, ELECTROCHIM ACTA, V50, P1049, DOI 10.1016/j.electacta.2004.08.017; Kalanur SS, 2011, COLLOID SURFACE B, V82, P438, DOI 10.1016/j.colsurfb.2010.09.017; Kashanian S, 2007, SPECTROCHIM ACTA A, V67, P472, DOI 10.1016/j.saa.2006.08.017; Kashanian S, 2008, DNA CELL BIOL, V27, P325, DOI 10.1089/dna.2007.0718; Li LL, 2012, DALTON T, V41, P12766, DOI 10.1039/c2dt30665d; Li QS, 1996, J INORG BIOCHEM, V64, P181, DOI 10.1016/0162-0134(96)00039-6; Li XC, 2012, J MOL STRUCT, V1027, P104, DOI 10.1016/j.molstruc.2012.05.070; Li XL, 2012, BIOMACROMOLECULES, V13, P873, DOI 10.1021/bm2017959; Liang MM, 2011, MOL PHARMACEUT, V8, P126, DOI 10.1021/mp100229z; Liu KG, 2012, INORG CHIM ACTA, V388, P78, DOI 10.1016/j.ica.2012.02.046; Liu SQ, 2004, COLLOID SURFACE B, V36, P155, DOI 10.1016/j.colsurfb.2004.03.020; Lyles MB, 2002, BIOPHYS CHEM, V96, P53, DOI 10.1016/S0301-4622(02)00036-4; Pang DW, 1998, ANAL CHEM, V70, P3162, DOI 10.1021/ac980211a; Ping Y, 2008, J MOL STRUCT, V882, P75, DOI 10.1016/j.molstruc.2007.09.017; Rahban M, 2010, J PHYS CHEM C, V114, P5798, DOI 10.1021/jp910656g; Ronconi L, 2007, COORDIN CHEM REV, V251, P1633, DOI 10.1016/j.ccr.2006.11.017; Ruiz J, 2011, INORG CHEM, V50, P9164, DOI 10.1021/ic201388n; Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w; Sinha R, 2011, CHEM BIODIVERS, V8, P1512, DOI 10.1002/cbdv.201000182; Tan JH, 2007, EUR J MED CHEM, V42, P1169, DOI 10.1016/j.ejmech.2007.02.002; Tong CL, 2010, J AGR FOOD CHEM, V58, P5257, DOI 10.1021/jf1000748; Wang BD, 2007, J INORG BIOCHEM, V101, P1492, DOI 10.1016/j.jinorgbio.2007.04.007; Wang BD, 2006, BIOORGAN MED CHEM, V14, P6012, DOI 10.1016/j.bmc.2006.05.015; Xu ZQ, 2013, COLLOID SURFACE B, V110, P321, DOI 10.1016/j.colsurfb.2013.04.040	38	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120211	10.1371/journal.pone.0120211	http://dx.doi.org/10.1371/journal.pone.0120211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789618	gold, Green Published, Green Submitted			2022-12-26	WOS:000351425400141
J	Tribouillois, H; Fort, F; Cruz, P; Charles, R; Flores, O; Garnier, E; Justes, E				Tribouillois, Helene; Fort, Florian; Cruz, Pablo; Charles, Raphael; Flores, Olivier; Garnier, Eric; Justes, Eric			A Functional Characterisation of a Wide Range of Cover Crop Species: Growth and Nitrogen Acquisition Rates, Leaf Traits and Ecological Strategies	PLOS ONE			English	Article							PLANT TRAITS; CATCH CROPS; WILD; GRASSLANDS; ROOT; DECOMPOSABILITY; PHOTOSYNTHESIS; TOLERANCE; ECONOMICS; DEPEND	Cover crops can produce ecosystem services during the fallow period, as reducing nitrate leaching and producing green manure. Crop growth rate (CGR) and crop nitrogen acquisition rate (CNR) can be used as two indicators of the ability of cover crops to produce these services in agrosystems. We used leaf functional traits to characterise the growth strategies of 36 cover crops as an approach to assess their ability to grow and acquire N rapidly. We measured specific leaf area (SLA), leaf dry matter content (LDMC), leaf nitrogen content (LNC) and leaf area (LA) and we evaluated their relevance to characterise CGR and CNR. Cover crop species were positioned along the Leaf Economics Spectrum (LES), the SLA-LDMC plane, and the CSR triangle of plant strategies. LA was positively correlated with CGR and CNR, while LDMC was negatively correlated with CNR. All cover crops could be classified as resource-acquisitive species from their relative position on the LES and the SLA-LDMC plane. Most cover crops were located along the Competition/Ruderality axis in the CSR triangle. In particular, Brassicaceae species were classified as very competitive, which was consistent with their high CGR and CNR. Leaf functional traits, especially LA and LDMC, allowed to differentiate some cover crops strategies related to their ability to grow and acquire N. LDMC was lower and LNC was higher in cover crop than in wild species, pointing to an efficient acquisitive syndrome in the former, corresponding to the high resource availability found in agrosystems. Combining several leaf traits explained approximately half of the CGR and CNR variances, which might be considered insufficient to precisely characterise and rank cover crop species for agronomic purposes. We hypothesised that may be the consequence of domestication process, which has reduced the range of plant strategies and modified the leaf trait syndrome in cultivated species.	[Tribouillois, Helene; Fort, Florian; Cruz, Pablo; Justes, Eric] INRA, UMR AGIR, 24 Chem Borde Rouge Auzeville,CS 52627, F-31326 Castanet Tolosan, France; [Charles, Raphael] Agroscope, Inst Plant Prod Sci, CH-1260 Nyon 1, Switzerland; [Flores, Olivier] Univ Reunion, CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, F-97410 St Pierre, France; [Garnier, Eric] Univ Paul Valery Montpellier, Univ Montpellier, CNRS, EPHE,Ctr Ecol Fonct & Evolut,UMR 5175, F-34293 Montpellier 5, France	INRAE; Swiss Federal Research Station Agroscope; CIRAD; University of La Reunion; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Justes, E (corresponding author), INRA, UMR AGIR, 24 Chem Borde Rouge Auzeville,CS 52627, F-31326 Castanet Tolosan, France.	eric.justes@toulouse.inra.fr	Garnier, Eric/D-1650-2012; Justes, Eric/GLT-6299-2022; Fort, Florian/H-4827-2019; Charles, Raphaël/AAA-8722-2022	Garnier, Eric/0000-0002-9392-5154; Justes, Eric/0000-0001-7390-7058; Fort, Florian/0000-0001-7983-6254; Flores, Olivier/0000-0002-1416-0449; Charles, Raphael/0000-0001-6563-7764	Arvalis-Institut du Vegetal; Midi-Pyrenees Region; UMR AGIR lab; INRA (Institut national de la recherche agronomique); ANR (Agence nationale de la recherche) (MicMac-design, Programme STRA) [ANR-09-STRA-06]	Arvalis-Institut du Vegetal; Midi-Pyrenees Region(Region Occitanie); UMR AGIR lab; INRA (Institut national de la recherche agronomique); ANR (Agence nationale de la recherche) (MicMac-design, Programme STRA)(French National Research Agency (ANR))	This study was supported by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the UMR AGIR lab, INRA (Institut national de la recherche agronomique) and the ANR (Agence nationale de la recherche) (project ANR-09-STRA-06; MicMac-design, Programme STRA 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Al Haj Khaled R, 2005, J VEG SCI, V16, P391, DOI 10.1111/j.1654-1103.2005.tb02378.x; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; Damour G, 2014, EUR J AGRON, V52, P218, DOI 10.1016/j.eja.2013.09.004; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Gambino P, 2011, IND CROP PROD, V34, P1269, DOI 10.1016/j.indcrop.2010.07.014; Garcia-Palacios P, 2013, NEW PHYTOL, V198, P504, DOI 10.1111/nph.12127; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; JENSEN ES, 1991, ACTA AGR SCAND, V41, P333, DOI 10.1080/00015129109439917; Justes E, 2009, PLANT SOIL, V325, P171, DOI 10.1007/s11104-009-9966-4; Justes E., 2012, INT FERT SOC M CAMBR, P4; Justes E, 2012, REDUIRE FUITES NITRA, P404; KARIMI MM, 1991, AUST J AGR RES, V42, P13, DOI 10.1071/AR9910013; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kazakou E, 2014, J VEG SCI, V25, P235, DOI 10.1111/jvs.12066; Kazakou E, 2009, ANN BOT-LONDON, V104, P1151, DOI 10.1093/aob/mcp202; Kristensen HL, 2004, SOIL SCI SOC AM J, V68, P529, DOI 10.2136/sssaj2004.0529; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; LUDLOW MM, 1990, ADV AGRON, V43, P107; Pierce S, 2013, FUNCT ECOL, V27, P1002, DOI 10.1111/1365-2435.12095; POORTER H, 1992, PLANT CELL ENVIRON, V15, P221, DOI 10.1111/j.1365-3040.1992.tb01476.x; Poorter H., 2007, FUNCTIONAL PLANT ECO, P67, DOI DOI 10.1201/9781420007626; Pujol B, 2008, BIOTROPICA, V40, P305, DOI 10.1111/j.1744-7429.2007.00373.x; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WILSON JW, 1981, ANN BOT-LONDON, V48, P507, DOI 10.1093/oxfordjournals.aob.a086154; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	45	67	72	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122156	10.1371/journal.pone.0122156	http://dx.doi.org/10.1371/journal.pone.0122156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789485	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400210
J	Yao, FC; Hoteit, I				Yao, Fengchao; Hoteit, Ibrahim			Thermocline Regulated Seasonal Evolution of Surface Chlorophyll in the Gulf of Aden	PLOS ONE			English	Article							RED-SEA; ARABIAN SEA; MONSOON	The Gulf of Aden, although subject to seasonally reversing monsoonal winds, has been previously reported as an oligotrophic basin during summer, with elevated chlorophyll concentrations only occurring during winter due to convective mixing. However, the Sea-Viewing Wide Field-of-View Sensor (SeaWiFS) ocean color data reveal that the Gulf of Aden also exhibits a prominent summer chlorophyll bloom and sustains elevated chlorophyll concentrations throughout the fall, and is a biophysical province distinct from the adjacent Arabian Sea. Climatological hydrographic data suggest that the thermocline, hence the nutricline, in the entire gulf is markedly shoaled by the southwest monsoon during summer and fall. Under this condition, cyclonic eddies in the gulf can effectively pump deep nutrients to the surface layer and lead to the chlorophyll bloom in late summer, and, after the transition to the northeast monsoon in fall, coastal upwelling driven by the northeasterly winds produces a pronounced increase in surface chlorophyll concentrations along the Somali coast.	[Yao, Fengchao; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Makkah, Saudi Arabia	King Abdullah University of Science & Technology	Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Makkah, Saudi Arabia.	ibrahim.hoteit@kaust.edu.sa		Yao, Fengchao/0000-0002-8218-0150; Hoteit, Ibrahim/0000-0002-3751-4393	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Research reported in this publication was supported by the King Abdullah University of Science and Technology (http://www.kaust.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiki H, 2006, CONT SHELF RES, V26, P1448, DOI 10.1016/j.csr.2006.02.017; Al Saafani MA, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004020; Almogi-Labina A, 2000, MAR MICROPALEONTOL, V40, P295, DOI 10.1016/S0377-8398(00)00043-8; Beal LM, 2013, J PHYS OCEANOGR, V43, P2008, DOI 10.1175/JPO-D-13-033.1; Bower AS, 2012, PROG OCEANOGR, V96, P14, DOI 10.1016/j.pocean.2011.09.003; Brewin RJW, 2013, REMOTE SENS ENVIRON, V136, P218, DOI 10.1016/j.rse.2013.04.018; BROCK JC, 1991, J GEOPHYS RES-OCEANS, V96, P20623, DOI 10.1029/91JC01711; Fratantoni DM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003338; Garcia HE, 2010, NOAA ATLAS NESDIS, V4; Levy M, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004090; Locarnini RA, 2010, NOAA ATLAS NESDIS 68, V1; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; POISSON A, 1984, DEEP-SEA RES, V31, P707, DOI 10.1016/0198-0149(84)90036-0; Resplandy L, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007006; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Sofianos SS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003886; Tegen I, 1997, J GEOPHYS RES-ATMOS, V102, P23895, DOI 10.1029/97JD01864; Triantafyllou G, 2014, J GEOPHYS RES-OCEANS, V119, P1791, DOI 10.1002/2013JC009641; Van Couwelaar M, 1997, DEEP-SEA RES PT II, V44, P1213, DOI 10.1016/S0967-0645(97)00009-X; Wiggert JD, 2005, PROG OCEANOGR, V65, P176, DOI 10.1016/j.pocean.2005.03.008; Wilson C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014063; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2238, DOI 10.1002/2013JC009004	22	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119951	10.1371/journal.pone.0119951	http://dx.doi.org/10.1371/journal.pone.0119951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789465	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400120
J	Bao, CD; Zhang, DF; Sun, B; Lan, L; Cui, WX; Xu, GH; Sui, CL; Wang, YBN; Zhao, YS; Wang, J; Li, HY				Bao, Chundan; Zhang, Dianfeng; Sun, Bo; Lan, Li; Cui, Wenxiu; Xu, Guohua; Sui, Conglan; Wang, Yibaina; Zhao, Yashuang; Wang, Jian; Li, Hongyuan			Optimal Cut-Off Points of Fasting Plasma Glucose for Two-Step Strategy in Estimating Prevalence and Screening Undiagnosed Diabetes and Pre-Diabetes in Harbin, China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; POPULATION; RISK	To identify optimal cut-off points of fasting plasma glucose (FPG) for two-step strategy in screening abnormal glucose metabolism and estimating prevalence in general Chinese population. A population-based cross-sectional study was conducted on 7913 people aged 20 to 74 years in Harbin. Diabetes and pre-diabetes were determined by fasting and 2 hour post-load glucose from the oral glucose tolerance test in all participants. Screening potential of FPG, cost per case identified by two-step strategy, and optimal FPG cut-off points were described. The prevalence of diabetes was 12.7%, of which 65.2% was undiagnosed. Twelve percent or 9.0% of participants were diagnosed with pre-diabetes using 2003 ADA criteria or 1999 WHO criteria, respectively. The optimal FPG cut-off points for two-step strategy were 5.6 mmol/l for previously undiagnosed diabetes (area under the receiver-operating characteristic curve of FPG 0.93; sensitivity 82.0%; cost per case identified by two-step strategy (sic)261), 5.3 mmol/l for both diabetes and pre-diabetes or pre-diabetes alone using 2003 ADA criteria (0.89 or 0.85; 72.4% or 62.9%; (sic)110 or (sic)258), 5.0 mmol/l for pre-diabetes using 1999 WHO criteria (0.78; 66.8%; (sic)399), and 4.9 mmol/l for IGT alone (0.74; 62.2%; (sic)502). Using the two-step strategy, the underestimates of prevalence reduced to nearly 38% for prediabetes or 18.7% for undiagnosed diabetes, respectively. Approximately a quarter of the general population in Harbin was in hyperglycemic condition. Using optimal FPG cut-off points for two-step strategy in Chinese population may be more effective and less costly for reducing the missed diagnosis of hyperglycemic condition.	[Bao, Chundan; Zhang, Dianfeng; Wang, Yibaina; Zhao, Yashuang; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Dianfeng; Sun, Bo; Lan, Li; Cui, Wenxiu; Xu, Guohua; Sui, Conglan; Wang, Jian] Harbin Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control & Prevent, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net; Wjwjwj111@sina.com; lihy09@yahoo.com	Zhao, Yashuang/I-6145-2019		Harbin Science and Technology Bureau [2007AA3CS084-2]; Heilongjiang Province Health and Family Planning Commission [2014-425]	Harbin Science and Technology Bureau; Heilongjiang Province Health and Family Planning Commission	The study was supported by the scientific and technological project of Harbin Science and Technology Bureau (2007AA3CS084-2) and the scientific research project of Heilongjiang Province Health and Family Planning Commission (2014-425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Borch-Johnsen K, 2004, DIABETOLOGIA, V47, P1396, DOI 10.1007/s00125-004-1468-6; Borch-Johnsen K, 1999, LANCET, V354, P617; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Ito C, 2000, DIABETES RES CLIN PR, V49, P181, DOI 10.1016/S0168-8227(00)00156-X; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; Melidonis Andrew M, 2006, Rural Remote Health, V6, P534; Moadab MH, 2010, PEDIATR DIABETES, V11, P101, DOI 10.1111/j.1399-5448.2009.00534.x; Nakagami T, 2002, DIABETIC MED, V19, P549; Nathan DM, 2007, DIABETIC MED, V24, P137; Onat A, 2013, ACTA DIABETOL, V50, P519, DOI 10.1007/s00592-011-0313-x; Onat A, 2011, DIABETES RES CLIN PR, V91, P220, DOI 10.1016/j.diabres.2010.11.035; Qiao Q, 2003, DIABETES CARE, V26, P688; SAS Institute Inc, 2010, SAS STAT 9 22 US GUI; Tai ES, 2004, DIABETES CARE, V27, P1728, DOI 10.2337/diacare.27.7.1728; Wang H, 2009, DIABETES METAB, V35, P378, DOI 10.1016/j.diabet.2009.03.006; Wei W, 2010, PUBLIC HEALTH, V124, P593, DOI 10.1016/j.puhe.2010.05.014; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087690; Zhang P, 2005, DIABETES CARE, V28, P1321, DOI 10.2337/diacare.28.6.1321; Zhang SY, 2009, DIABETES RES CLIN PR, V86, P124, DOI 10.1016/j.diabres.2009.07.013; Zhang YL, 2013, PRIM CARE DIABETES, V7, P275, DOI 10.1016/j.pcd.2013.08.003; Zhao Jing-bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P110; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593; Zhou XH, 2010, DIABETES CARE, V33, P545, DOI 10.2337/dc09-1410	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119510	10.1371/journal.pone.0119510	http://dx.doi.org/10.1371/journal.pone.0119510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785585	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500107
J	Chikaev, AN; Bakulina, AY; Burdick, RC; Karpenko, LI; Pathak, VK; Ilyichev, AA				Chikaev, Anton N.; Bakulina, Anastasiya Yu.; Burdick, Ryan C.; Karpenko, Larisa I.; Pathak, Vinay K.; Ilyichev, Alexander A.			Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; MIMOTOPE; DESIGN; VACCINATION; PROTEIN	The ability to induce anti-HIV-1 antibodies that can neutralize a broad spectrum of viral isolates from different subtypes seems to be a key requirement for development of an effective HIV-1 vaccine. The epitopes recognized by the most potent broadly neutralizing antibodies that have been characterized are largely discontinuous. Mimetics of such conformational epitopes could be potentially used as components of a synthetic immunogen that can elicit neutralizing antibodies. Here we used phage display technology to identify peptide motifs that mimic the epitope recognized by monoclonal antibody VRC01, which is able to neutralize up to 91% of circulating primary isolates. Three rounds of biopanning were performed against 2 different phage peptide libraries for this purpose. The binding specificity of selected phage clones to monoclonal antibody VRC01 was estimated using dot blot analysis. The putative peptide mimics exposed on the surface of selected phages were analyzed for conformational and linear homology to the surface of HIV-1 gp120 fragment using computational analysis. Corresponding peptides were synthesized and checked for their ability to interfere with neutralization activity of VRC01 in a competitive inhibition assay. One of the most common peptides selected from 12-mer phage library was found to partially mimic a CD4-binding loop fragment, whereas none of the circular C7C-mer peptides was able to mimic any HIV-1 domains. However, peptides identified from both the 12-mer and C7C-mer peptide libraries showed rescue of HIV-1 infectivity in the competitive inhibition assay. The identification of epitope mimics may lead to novel immunogens capable of inducing broadly reactive neutralizing antibodies.	[Chikaev, Anton N.; Bakulina, Anastasiya Yu.; Karpenko, Larisa I.; Ilyichev, Alexander A.] State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia; [Burdick, Ryan C.; Pathak, Vinay K.] NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA	State Research Center of Virology & Biotechnology VECTOR; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chikaev, AN (corresponding author), State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia.	chikaev@vector.nsc.ru	Karpenko, Larisa Ivanovna/A-9682-2014; Ilyichev, Alexander/AAT-9390-2020; Chikaev, Anton/A-8117-2014; Ilyicheva, Tatyana N./B-1327-2012	Ilyichev, Alexander/0000-0001-5356-0843; Chikaev, Anton/0000-0001-5423-3457; Ilyicheva, Tatyana N./0000-0002-2354-7688; Pathak, Vinay/0000-0003-2441-8412; Karpenko, Larisa/0000-0003-4365-8809	National Institute of Allergy and Infectious Diseases (NIAID); Russian Foundation for Basic Research (RFBR) [RUB1-31084-NO-12]; Russian Science Foundation [14-14-00660]; NATIONAL CANCER INSTITUTE [ZIABC010595] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the joint grant from the National Institute of Allergy and Infectious Diseases (NIAID) and the Russian Foundation for Basic Research (RFBR) RUB1-31084-NO-12. http://www.rfbr.ru/rffi/eng/contests international announcement/o 60903. Homology modeling and molecular docking experiments were also supported by Russian Science Foundation grant 14-14-00660. http://www.rscf.ru/sites/default/files/docfiles/Spisok pobediteley.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchwald UK, 2005, INFECT IMMUN, V73, P325, DOI 10.1128/IAI.73.1.325-333.2005; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Delhalle S, 2012, INT J MOL SCI, V13, P4727, DOI 10.3390/ijms13044727; Eroshkin AM, 2014, NUCLEIC ACIDS RES, V42, pD1133, DOI 10.1093/nar/gkt1083; EROSHKIN AM, 1995, PROTEIN ENG, V8, P167, DOI 10.1093/protein/8.2.167; Gazarian KG, 2013, MOL IMMUNOL, V54, P148, DOI 10.1016/j.molimm.2012.11.016; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; James TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049728; Karpenko LI, 2012, MOL IMMUNOL, V50, P193, DOI 10.1016/j.molimm.2012.01.003; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Larralde OG, 2007, J VIROL METHODS, V140, P49, DOI 10.1016/j.jviromet.2006.10.015; Li M, 2006, CELL IMMUNOL, V239, P136, DOI 10.1016/j.cellimm.2006.05.005; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Schiavone M, 2012, INT J MOL SCI, V13, P5674, DOI 10.3390/ijms13055674; Shmelkov E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089987; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sykes KF, 2013, TRENDS BIOTECHNOL, V31, P45, DOI 10.1016/j.tibtech.2012.10.012; Tumanova OY, 2002, MOL BIOL+, V36, P517, DOI 10.1023/A:1019804511163; Wierzbicki A, 2008, J IMMUNOL, V181, P6644, DOI 10.4049/jimmunol.181.9.6644; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	33	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120847	10.1371/journal.pone.0120847	http://dx.doi.org/10.1371/journal.pone.0120847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785734	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500196
J	Costanzo, AE; Taylor, KR; Dutt, S; Han, PP; Fujioka, K; Jameson, JM				Costanzo, Anne E.; Taylor, Kristen R.; Dutt, Shelley; Han, Peggy P.; Fujioka, Ken; Jameson, Julie M.			Obesity Impairs gamma delta T Cell Homeostasis and Antiviral Function in Humans	PLOS ONE			English	Article							PRENYL PYROPHOSPHATE ANTIGENS; IFN-GAMMA; LYMPH-NODES; INFLUENZA; LYMPHOCYTES; ACTIVATION; RESPONSES; MEMORY; DIFFERENTIATION; PROLIFERATION	Obese patients are susceptible to increased morbidity and mortality associated with infectious diseases such as influenza A virus gamma delta T cells and memory alpha beta T cells play key roles in reducing viral load by rapidly producing IFN-gamma and lysing infected cells. In this article we analyze the impact of obesity on T lymphocyte antiviral immunity. Obese donors exhibit a reduction in gamma delta T cells in the peripheral blood. The severity of obesity negatively correlates with the number of gamma delta T cells. The remaining gamma delta T cells have a skewed maturation similar to that observed in aged populations. This skewed gamma delta T cell population exhibits a blunted antiviral IFN-gamma response. Full gamma delta T cell function can be restored by potent stimulation with 1-Hydroxy- 2-methyl-buten-4yl 4-diphosphate (HDMAPP), suggesting that gamma delta T cells retain the ability to produce IFN-gamma. Additionally, gamma delta T cells from obese donors have reduced levels of IL-2R alpha. IL-2 is able to restore gamma delta T cell antiviral cytokine production, which suggests that gamma delta T cells lack key T cell specific growth factor signals. These studies make the novel finding that the gamma delta T cell antiviral immune response to influenza is compromised by obesity. This has important implications for the development of therapeutic strategies to improve vaccination and antiviral responses in obese patients.	[Costanzo, Anne E.; Dutt, Shelley; Jameson, Julie M.] Calif State Univ San Marcos, Dept Biol, San Marcos, CA 92096 USA; [Costanzo, Anne E.; Taylor, Kristen R.; Jameson, Julie M.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Han, Peggy P.] PHDataGroup, San Diego, CA 92119 USA; [Fujioka, Ken] Scripps Clin, Res Ctr, La Jolla, CA 92037 USA	California State University System; California State University San Marcos; Scripps Research Institute; Scripps Research Institute	Jameson, JM (corresponding author), Calif State Univ San Marcos, Dept Biol, 333 South Twin Oaks Dr, San Marcos, CA 92096 USA.	jjameson@csusm.edu		Jameson, Julie/0000-0003-0727-4066	NIH/NCRR Grant [UL1 RR025774]; Department of Immunology and Microbial Sciences Institutional Training grant [5T32 AI007244-24]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	NIH/NCRR Grant; Department of Immunology and Microbial Sciences Institutional Training grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	JJ was supported by NIH/NCRR Grant Number UL1 RR025774 and KT was funded by Department of Immunology and Microbial Sciences Institutional Training grant 5T32 AI007244-24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2001, J IMMUNOL, V166, P3655, DOI 10.4049/jimmunol.166.6.3655; Argentati K, 2002, J LEUKOCYTE BIOL, V72, P65; Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; Boullier S, 1997, J IMMUNOL, V159, P3629; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Caccamo N, 2005, EUR J IMMUNOL, V35, P1764, DOI 10.1002/eji.200525983; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; HACKER G, 1992, J IMMUNOL, V149, P3984; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Jameson JM, 2010, CELL IMMUNOL, V264, P71, DOI 10.1016/j.cellimm.2010.04.013; Kabelitz D, 2011, CELL MOL LIFE SCI, V68, P2331, DOI 10.1007/s00018-011-0696-4; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; KASAHARA T, 1983, J IMMUNOL, V130, P1784; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; LANG F, 1995, J IMMUNOL, V154, P5986; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Re F, 2005, EXP GERONTOL, V40, P59, DOI 10.1016/j.exger.2004.09.008; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Smith AG, 2009, IMMUNOLOGY, V126, P268, DOI 10.1111/j.1365-2567.2008.02895.x; Su HC, 1998, J IMMUNOL, V160, P5007; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Wei CH, 2005, J IMMUNOL, V175, P6615, DOI 10.4049/jimmunol.175.10.6615	35	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120918	10.1371/journal.pone.0120918	http://dx.doi.org/10.1371/journal.pone.0120918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785862	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500197
J	Flesch, AD; Hutto, RL; van Leeuwen, WJD; Hartfield, K; Jacobs, S				Flesch, Aaron D.; Hutto, Richard L.; van Leeuwen, Willem J. D.; Hartfield, Kyle; Jacobs, Sky			Spatial, Temporal, and Density-Dependent Components of Habitat Quality for a Desert Owl	PLOS ONE			English	Article							LIFETIME REPRODUCTIVE SUCCESS; NEST-SITE SELECTION; POPULATION-DENSITY; TERRITORY-QUALITY; BREEDING PERFORMANCE; FITNESS COMPONENTS; RIPARIAN ISLAND; CLUTCH SIZE; CLIMATE; DEMOGRAPHY	Spatial variation in resources is a fundamental driver of habitat quality but the realized value of resources at any point in space may depend on the effects of conspecifics and stochastic factors, such as weather, which vary through time. We evaluated the relative and combined effects of habitat resources, weather, and conspecifics on habitat quality for ferruginous pygmy-owls (Glaucidium brasilianum) in the Sonoran Desert of northwest Mexico by monitoring reproductive output and conspecific abundance over 10 years in and around 107 territory patches. Variation in reproductive output was much greater across space than time, and although habitat resources explained a much greater proportion of that variation (0.70) than weather (0.17) or conspecifics (0.13), evidence for interactions among each of these components of the environment was strong. Relative to habitat that was persistently low in quality, high-quality habitat buffered the negative effects of conspecifics and amplified the benefits of favorable weather, but did not buffer the disadvantages of harsh weather. Moreover, the positive effects of favorable weather at low conspecific densities were offset by intraspecific competition at high densities. Although realized habitat quality declined with increasing conspecific density suggesting interference mechanisms associated with an Ideal Free Distribution, broad spatial heterogeneity in habitat quality persisted. Factors linked to food resources had positive effects on reproductive output but only where nest cavities were sufficiently abundant to mitigate the negative effects of heterospecific enemies. Annual precipitation and brooding-season temperature had strong multiplicative effects on reproductive output, which declined at increasing rates as drought and temperature increased, reflecting conditions predicted to become more frequent with climate change. Because the collective environment influences habitat quality in complex ways, integrated approaches that consider habitat resources, stochastic factors, and conspecifics are necessary to accurately assess habitat quality.	[Flesch, Aaron D.; van Leeuwen, Willem J. D.; Hartfield, Kyle] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Flesch, Aaron D.; Hutto, Richard L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Jacobs, Sky] Watershed Management Grp, Tucson, AZ USA	University of Arizona; University of Montana System; University of Montana	Flesch, AD (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	flesch@email.arizona.edu	van Leeuwen, Willem/ABB-6711-2020	van Leeuwen, Willem/0000-0002-3188-7172	U.S. National Park Service; Desert Southwest Cooperative Ecosystem Studies Unit; Tucson Audubon Society,; Arizona Department of Transportation; TE Inc.; Defenders of Wildlife; Center for Biological Diversity; Sonoran Joint Venture; U.S. Fish and Wildlife Service; Arizona Zoological Society; Global Owl Project; Sierra Club; University of Montana Graduate College; Shared Earth Foundation	U.S. National Park Service; Desert Southwest Cooperative Ecosystem Studies Unit; Tucson Audubon Society,; Arizona Department of Transportation; TE Inc.; Defenders of Wildlife; Center for Biological Diversity; Sonoran Joint Venture; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Arizona Zoological Society; Global Owl Project; Sierra Club; University of Montana Graduate College; Shared Earth Foundation	Agencies and organizations that funded this work include the U.S. National Park Service, Desert Southwest Cooperative Ecosystem Studies Unit, Tucson Audubon Society, Arizona Department of Transportation, T&E Inc., Defenders of Wildlife, Center for Biological Diversity, Sonoran Joint Venture, U.S. Fish and Wildlife Service, Arizona Zoological Society, Global Owl Project, Sierra Club, University of Montana Graduate College and Shared Earth Foundation. Additionally, the authors acknowledge	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Altwegg R, 2007, AM NAT, V169, P47, DOI 10.1086/510215; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Bernstein C., 1991, Oxford Ornithology Series, P317; BLANCHER PJ, 1985, J ANIM ECOL, V54, P1017, DOI 10.2307/4394; Block William M., 1993, Current Ornithology, V11, P35; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Both C, 1998, J ANIM ECOL, V67, P659, DOI 10.1046/j.1365-2656.1998.00227.x; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; BOWMAN GB, 1980, J WILDLIFE MANAGE, V44, P806, DOI 10.2307/3808308; Breininger DR, 2004, ECOL APPL, V14, P1079, DOI 10.1890/03-5002; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Chalfoun AD, 2009, J ANIM ECOL, V78, P497, DOI 10.1111/j.1365-2656.2008.01506.x; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; DHONDT AA, 1992, J ANIM ECOL, V61, P643, DOI 10.2307/5619; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ezard THG, 2008, AM NAT, V172, P424, DOI 10.1086/589897; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Flesch AD, 2007, J WILDLIFE MANAGE, V71, P981, DOI 10.2193/2006-081; Flesch AD, 2014, BIOL CONSERV, V175, P110, DOI 10.1016/j.biocon.2014.04.021; Flesch AD, 2010, ECOL APPL, V20, P1021, DOI 10.1890/09-0076.1; Flesch AD, 2003, THESIS; Fowler C.W., 1987, Current Mammalogy, V1, P401; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRETWELL S D, 1972, P217; Fretwell S.D., 1969, THEOR DEV ACTA BIOTH, V19, P16, DOI [DOI 10.1007/BF01601953, 10.1007/BF01601953]; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GONZALEZ-ROMERO A, 1989, Amphibia-Reptilia, V10, P1, DOI 10.1163/156853889X00250; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Gullett P, 2014, OIKOS, V123, P389, DOI 10.1111/j.1600-0706.2013.00620.x; Hardy PC, 1999, SOUTHWEST NAT, V44, P311; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutto R.L., 1985, P455; Huxley J. S., 1934, British Birds, V27, P270; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Johnson RR, 2003, SOUTHWEST NAT, V48, P389, DOI 10.1894/0038-4909(2003)048<0389:CFPIA>2.0.CO;2; Jones K.B., 1985, U S Forest Service General Technical Report RM, P342; KLUYVER H. N., 1953, ARCH NEERLAND ZOOL, V10, P265; KNOPF FL, 1988, WILSON BULL, V100, P272; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lack D., 1954, P343; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lloyd J, 1998, WILSON BULL, V110, P403; LOMNICKI A, 1980, OIKOS, V35, P185, DOI 10.2307/3544426; Lopez-Sepulcre A, 2010, P ROY SOC B-BIOL SCI, V277, P3477, DOI 10.1098/rspb.2010.0819; MacArthur R.H., 1972, pvii; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; McClure CJW, 2012, CONDOR, V114, P482, DOI 10.1525/cond.2012.110139; McDonald TL, 2010, J WILDLIFE MANAGE, V74, P514, DOI 10.2193/2009-270; McGarigal K., 2012, TECH REP; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MORRIS DW, 1989, EVOL ECOL, V3, P80, DOI 10.1007/BF02147934; Morris DW, 1985, B I MATH ITS APPLICA, V21, P193; Morrison ML, 2007, WILDLIFE HABITAT REL; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Nevoux M, 2011, P ROY SOC B-BIOL SCI, V278, P2173, DOI 10.1098/rspb.2010.2352; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; NEWTON I, 1977, J ANIM ECOL, V46, P425, DOI 10.2307/3821; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; OWENSMITH N, 1990, J ANIM ECOL, V59, P893, DOI 10.2307/5021; Ozgul A, 2007, OECOLOGIA, V154, P95, DOI 10.1007/s00442-007-0817-9; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Pettorelli N, 2005, J ANIM ECOL, V74, P972, DOI 10.1111/j.1365-2656.2005.00988.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2003, ECOLOGY, V84, P3307, DOI 10.1890/02-0602; Pettorelli N, 2001, OECOLOGIA, V128, P400, DOI 10.1007/s004420100682; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preston KL, 2006, ECOLOGY, V87, P160, DOI 10.1890/05-0344; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; Ray C, 1996, J ANIM ECOL, V65, P556, DOI 10.2307/5736; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Saether B.-E., 1990, Current Ornithology, V7, P251; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Searle SR., 1992, VARIANCE COMPONENTS; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; SHERRY TW, 1989, BEHAV ECOL SOCIOBIOL, V25, P327, DOI 10.1007/BF00302990; Sillett TS, 2004, ECOLOGY, V85, P2467, DOI 10.1890/03-0272; Sinclair A.R.E., 1989, P197; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; STAMPS JA, 1990, AM NAT, V135, P614, DOI 10.1086/285065; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; SVARDSON G, 1949, OIKOS, V1, P157, DOI 10.2307/3564710; SZARO RC, 1985, CONDOR, V87, P511, DOI 10.2307/1367948; SZARO RC, 1986, J WILDLIFE MANAGE, V50, P752, DOI 10.2307/3800996; Tafani M, 2013, ECOLOGY, V94, P580, DOI 10.1890/12-0833.1; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; USFWS [U.S. Fish and Wildlife Service], 2011, FED REGISTER, V76, P61856; Van valen L, 1976, EVOL THEORY, V1, P179; VanHorne B, 1997, ECOL MONOGR, V67, P295, DOI 10.1890/0012-9615(1997)067[0295:EODAPW]2.0.CO;2; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WAUTERS LA, 1995, ECOLOGY, V76, P2460, DOI 10.2307/2265820; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Wiens JA, 1989, ECOLOGY BIRD COMMUNT; Williams DW, 2000, OECOLOGIA, V124, P544, DOI 10.1007/s004420000412; Zanette L, 2003, P ROY SOC B-BIOL SCI, V270, P799, DOI 10.1098/rspb.2002.2311	123	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119986	10.1371/journal.pone.0119986	http://dx.doi.org/10.1371/journal.pone.0119986			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786257	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500145
J	Frost, R; Quinones, I; Veldhuizen, M; Alava, JI; Small, D; Carreiras, M				Frost, Ram; Quinones, Ileana; Veldhuizen, Maria; Alava, Jose-Inaki; Small, Dana; Carreiras, Manuel			What Can the Brain Teach Us about Winemaking? An fMRI Study of Alcohol Level Preferences	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; ACTIVATION; ACQUISITION; INFORMATION; INTENSITY; ATTENTION; CORTEX; TASTE	Over the last few decades, wine makers have been producing wines with a higher alcohol content, assuming that they are more appreciated by consumers. To test this hypothesis, we used functional magnetic imaging to compare reactions of human subjects to different types of wine, focusing on brain regions critical for flavor processing and food reward. Participants were presented with carefully matched pairs of high- and low- alcohol content red wines, without informing them of any of the wine attributes. Contrary to expectation, significantly greater activation was found for low- alcohol than for high- alcohol content wines in brain regions that are sensitive to taste intensity, including the insula as well as the cerebellum. Wines were closely matched for all physical attributes except for alcohol content, thus we interpret the preferential response to the low- alcohol content wines as arising from top-down modulation due to the low alcohol content wines inducing greater attentional exploration of aromas and flavours. The findings raise intriguing possibilities for objectively testing hypotheses regarding methods of producing a highly complex product such as wine.	[Frost, Ram] Hebrew Univ Jerusalem, Jerusalem, Israel; [Frost, Ram; Quinones, Ileana; Carreiras, Manuel] Basque Ctr Cognit Brain & Language, BCBL, Donostia San Sebastian, Spain; [Frost, Ram] Haskins Labs Inc, New Haven, CT USA; [Veldhuizen, Maria; Small, Dana] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Alava, Jose-Inaki] Basque Culinary Ctr, Donostia San Sebastian, Spain; [Small, Dana] Yale Univ, Sch Med, New Haven, CT USA; [Small, Dana] Univ Cologne, D-50931 Cologne, Germany; [Carreiras, Manuel] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Carreiras, Manuel] Univ Basque Country EHU UPV, Dept Basque Language & Commun, Bilbao, Spain	Hebrew University of Jerusalem; Yale University; Haskins Laboratories; Yale University; The John B Pierce Laboratory, Inc; Mondragon Unibertsitatea; Yale University; University of Cologne; Basque Foundation for Science; University of Basque Country	Frost, R (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	ram.frost@mail.huji.ac.il	Quiñones, Ileana/I-1574-2015; Veldhuizen, Maria G/P-6209-2018; Carreiras, Manuel/D-5267-2009; Veldhuizen, Maria Geraldine/P-8149-2019	Quiñones, Ileana/0000-0002-0288-364X; Carreiras, Manuel/0000-0001-6726-7613; Veldhuizen, Maria Geraldine/0000-0001-8375-7719; Small, Dana/0000-0001-7363-1100; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Frost, Ram/0000-0002-5625-0813				Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; BOWER JM, 1981, BRAIN BEHAV EVOLUT, V18, P1, DOI 10.1159/000121772; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gil J. M., 1997, British Food Journal, V99, P3, DOI 10.1108/00070709810202167; Gottfried J. A., 2006, ORBITOFRONTAL CORTEX, P125; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Ogawa H, 2005, CHEM SENSES, V30, P583, DOI 10.1093/chemse/bji052; Parsons LM, 1997, LEARN MEMORY, V4, P49, DOI 10.1101/lm.4.1.49; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; PRITCHARD TC, 1989, J NEUROPHYSIOL, V61, P1; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; Sobel N, 1998, J NEUROSCI, V18, P8990; Veldhuizen MG, 2007, CHEM SENSES, V32, P569, DOI 10.1093/chemse/bjm025; Veldhuizen MG, 2012, CHEMOSENS PERCEPT, V5, P117, DOI 10.1007/s12078-012-9122-z; Veldhuizen MG, 2011, J NEUROSCI, V31, P14735, DOI 10.1523/JNEUROSCI.1502-11.2011	21	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119220	10.1371/journal.pone.0119220	http://dx.doi.org/10.1371/journal.pone.0119220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785844	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500084
J	Gupta, A; Nitoiu, D; Brennan-Crispi, D; Addya, S; Riobo, NA; Kelsell, DP; Mahoney, MG				Gupta, Abhilasha; Nitoiu, Daniela; Brennan-Crispi, Donna; Addya, Sankar; Riobo, Natalia A.; Kelsell, David P.; Mahoney, My. G.			Cell Cycle- and Cancer-Associated Gene Networks Activated by Dsg2: Evidence of Cystatin A Deregulation and a Potential Role in Cell-Cell Adhesion	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; STEFIN-A; PROTEASE INHIBITOR; DESMOGLEIN 2; CATHEPSIN-B; EXPRESSION; MUTATIONS; PEMPHIGUS; APOPTOSIS; CSTA	Cell-cell adhesion is paramount in providing and maintaining multicellular structure and signal transmission between cells. In the skin, disruption to desmosomal regulated intercellular connectivity may lead to disorders of keratinization and hyperproliferative disease including cancer. Recently we showed transgenic mice overexpressing desmoglein 2 (Dsg2) in the epidermis develop hyperplasia. Following microarray and gene network analysis, we demonstrate that Dsg2 caused a profound change in the transcriptome of keratinocytes in vivo and altered a number of genes important in epithelial dysplasia including: calcium-binding proteins (S100A8 and S100A9), members of the cyclin protein family, and the cysteine protease inhibitor cystatin A (CSTA). CSTA is deregulated in several skin cancers, including squamous cell carcinomas (SCC) and loss of function mutations lead to recessive skin fragility disorders. The microarray results were confirmed by qPCR, immunoblotting, and immunohistochemistry. CSTA was detected at high level throughout the newborn mouse epidermis but dramatically decreased with development and was detected predominantly in the differentiated layers. In human keratinocytes, knockdown of Dsg2 by siRNA or shRNA reduced CSTA expression. Furthermore, siRNA knockdown of CSTA resulted in cytoplasmic localization of Dsg2, perturbed cytokeratin 14 staining and reduced levels of desmoplakin in response to mechanical stretching. Both knockdown of either Dsg2 or CSTA induced loss of cell adhesion in a dispase-based assay and the effect was synergistic. Our findings here offer a novel pathway of CSTA regulation involving Dsg2 and a potential crosstalk between Dsg2 and CSTA that modulates cell adhesion. These results further support the recent human genetic findings that loss of function mutations in the CSTA gene result in skin fragility due to impaired cell-cell adhesion: autosomal-recessive exfoliative ichthyosis or acral peeling skin syndrome.	[Gupta, Abhilasha; Brennan-Crispi, Donna; Mahoney, My. G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Nitoiu, Daniela; Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Brennan-Crispi, Donna; Riobo, Natalia A.; Mahoney, My. G.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Addya, Sankar] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; University of London; Queen Mary University London; Jefferson University; Jefferson University	Mahoney, MG (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	my.mahoney@jefferson.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020; Kelsell, David P/F-8767-2011	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Kelsell, David/0000-0002-9910-7144	National Institutes of Health [R01AR056067, RO1 GM088256]; British Heart Foundation [RG/13/19/30568] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (Mahoney, R01AR056067; Riobo, RO1 GM088256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Barber AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098786; BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bilodeau M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007500; Bitu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070925; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Brennan D, 2004, DIFFERENTIATION, V72, P434, DOI 10.1111/j.1432-0436.2004.07208009.x; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Brown WM, 1997, PROTEIN SCI, V6, P5; Butler MW, 2011, CANCER RES, V71, P2572, DOI 10.1158/0008-5472.CAN-10-2046; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hartlieb E, 2014, J BIOL CHEM, V289, P17043, DOI 10.1074/jbc.M113.489336; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; HAWLEYNELSON P, 1988, MOL CARCINOGEN, V1, P202, DOI 10.1002/mc.2940010309; Ishida M, 2013, J EUR ACAD DERMATOL, V27, pe128, DOI 10.1111/j.1468-3083.2011.04436.x; Iwatsuki K, 1999, BRIT J DERMATOL, V140, P35; Kavaklieva S, 2013, CASE REP DERMATOL, V5, P210, DOI 10.1159/000354572; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Krunic AL, 2013, PEDIATR DERMATOL, V30, pE87, DOI 10.1111/pde.12092; Kuopio T, 1998, CANCER RES, V58, P432; Kuracha MR, 2013, DEV BIOL, V383, P227, DOI 10.1016/j.ydbio.2013.09.014; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lazic D, 2011, J DERMATOL SCI, V62, P84, DOI 10.1016/j.jdermsci.2011.02.006; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; Pavlova A, 2003, BIOCHEMISTRY-US, V42, P11326, DOI 10.1021/bi030119v; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Petrof G, 2012, BRIT J DERMATOL, V166, P36, DOI 10.1111/j.1365-2133.2011.10640.x; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Rinne A, 2010, PATHOL RES PRACT, V206, P259, DOI 10.1016/j.prp.2009.12.005; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Scott DK, 2007, BRIT J DERMATOL, V156, P1156, DOI 10.1111/j.1365-2133.2007.07875.x; Sorenson BS, 2012, MUCOSAL IMMUNOL, V5, P66, DOI 10.1038/mi.2011.48; STEVEN AC, 1994, J CELL SCI, V107, P693; STRAUSS M, 1988, BIOL CHEM H-S, V369, P1019, DOI 10.1515/bchm3.1988.369.2.1019; Strojan P, 2007, INT J RADIAT ONCOL, V68, P1335, DOI 10.1016/j.ijrobp.2007.02.004; Takahashi H, 1997, J INVEST DERMATOL, V108, P843, DOI 10.1111/1523-1747.ep12292575; Takahashi H, 2001, J BIOL CHEM, V276, P36632, DOI 10.1074/jbc.M102021200; Takahashi H, 2007, J DERMATOL SCI, V46, P179, DOI 10.1016/j.jdermsci.2007.02.003; Takai T, 2009, J IMMUNOL, V183, P7958, DOI 10.4049/jimmunol.0713276; Teh MT, 2011, J ORAL PATHOL MED, V40, P67, DOI 10.1111/j.1600-0714.2010.00951.x; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; TSUI FWL, 1993, GENOMICS, V15, P507, DOI 10.1006/geno.1993.1101; Vasilopoulos Y, 2007, ALLERGY, V62, P514, DOI 10.1111/j.1398-9995.2007.01350.x; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; ZETTERGREN JG, 1984, P NATL ACAD SCI-BIOL, V81, P238, DOI 10.1073/pnas.81.1.238	67	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120091	10.1371/journal.pone.0120091	http://dx.doi.org/10.1371/journal.pone.0120091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785582	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500155
J	Johst, S; Maderwald, S; Fischer, A; Quick, HH; Ladd, ME; Orzada, S				Johst, Soeren; Maderwald, Stefan; Fischer, Anja; Quick, Harald H.; Ladd, Mark E.; Orzada, Stephan			Investigation of the Saturation Pulse Artifact in Non-Enhanced MR Angiography of the Lower Extremity Arteries at 7 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TIME-INTERLEAVED ACQUISITION; STEADY-STATE; DISEASE; MODES; SAR; TOF	When performing non-enhanced time-of-flight MR angiography of the lower extremity arteries at 7 T with cardiac triggering, the acquisition time is a crucial consideration. Therefore, in previous studies, saturation RF pulses were applied only every second TR. In the axial source images a slight artifact with an appearance similar to aliasing could be observed. The purpose of this study was to investigate the origin of this artifact. The reason for the artifact is supposed to be related to the two effective TRs during acquisition caused by the sparsely applied saturation RF pulse. Several sequence variants were simulated and implemented within the sequence source code to examine this hypothesis. An adaptation of the excitation flip angles for each TR as well as a correction factor for the k-space data was calculated. Additionally, a different ordering of the k-space data during acquisition was implemented as well as the combination of the latter with the k-space correction factor. The observations from the simulations were verified using both a static and a flow phantom and, finally, in a healthy volunteer using the same measurement setup as in previous volunteer and patient studies. Of all implemented techniques, only the reordering of the k-space was capable of suppressing the artifact almost completely at the cost of creating a ringing artifact. The phantom measurements showed the same results as the simulations and could thus confirm the hypothesis regarding the origin of the artifact. This was additionally verified in the healthy volunteer. The origin of the artifact could be confirmed to be the periodic signal variation caused by two effective TRs during acquisition.	[Johst, Soeren; Maderwald, Stefan; Fischer, Anja; Quick, Harald H.; Ladd, Mark E.; Orzada, Stephan] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Fischer, Anja] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Quick, Harald H.] Univ Duisburg Essen, Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Johst, S (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	soeren.johst@uni-duisburg-essen.de	Maderwald, Stefan/B-4241-2011; Orzada, Stephan/H-6745-2019	Orzada, Stephan/0000-0001-9784-4354; Ladd, Mark/0000-0002-4128-9440	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [291903]	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 291903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was supported by the library of the University Duisburg-Essen.	Ackerman M J, 1995, Medinfo, V8 Pt 2, P1195; [Anonymous], 2011, P INT SOC MAGN RESON; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bitz AK, 2009, P INT SOC MAG RESON, V17, P4767; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Cukur T, 2009, MAGN RESON MED, V61, P1533, DOI 10.1002/mrm.21921; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Fischer A, 2014, INVEST RADIOL, V49, P331, DOI 10.1097/RLI.0000000000000044; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; Gutzeit A, 2011, EUR RADIOL, V21, P1979, DOI 10.1007/s00330-011-2132-4; Herborn CU, 2004, AM J ROENTGENOL, V182, P1427, DOI 10.2214/ajr.182.6.1821427; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Johst S, 2014, P 22 ANN M ISMRM MIL, P2191; Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274; Lanzman RS, 2010, ROFO-FORTSCHR RONTG, V182, P861, DOI 10.1055/s-0029-1245328; Leupold J, 2006, MAGN RESON MED, V55, P557, DOI 10.1002/mrm.20790; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Nakamura K, 2011, MAGN RESON MED, V65, P595, DOI 10.1002/mrm.22614; Nassenstein K, 2012, EUR RADIOL, V22, P2679, DOI 10.1007/s00330-012-2547-6; Nassenstein K, 2012, EUR RADIOL, V22, P559, DOI 10.1007/s00330-011-2279-z; Nayak KS, 2007, MAGN RESON MED, V58, P931, DOI 10.1002/mrm.21296; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S., 2010, 18 P INT SOC MRM, V18, P50; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Quick HH, 2004, ROFO-FORTSCHR RONTG, V176, P163, DOI 10.1055/s-2004-817623; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Thomsen HS, 2006, EUR RADIOL, V16, P2619, DOI 10.1007/s00330-006-0495-8; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Voigt T, 2010, MAGN RESON MED, V64, P725, DOI 10.1002/mrm.22333; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yazdanbakhsh P, 2009, VARIABLE POWER COMBI, P397; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119845	10.1371/journal.pone.0119845	http://dx.doi.org/10.1371/journal.pone.0119845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785837	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500133
J	Teixeira, AL; Ramos, PS; Vianna, LC; Ricardo, DR				Teixeira, Andre L.; Ramos, Plinio S.; Vianna, Lauro C.; Ricardo, Djalma R.			Effects of Ovarian Hormones and Oral Contraceptive Pills on Cardiac Vagal Withdrawal at the Onset of Dynamic Exercise	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MENSTRUAL-CYCLE; RATE RESPONSES; YOUNG-WOMEN; ESTROGEN; REACTIVATION; GENDER; RISK; SEX	The purpose of this study was to investigate the effects of the ovarian hormones and the use of oral contraceptive pills (OCP) on cardiac vagal withdrawal at the onset of dynamic exercise. Thirty physically active women aged 19-32 years were divided into two groups: OCP users (n = 17) and non-OCP users (n = 13). Participants were studied randomly at three different phases of the menstrual cycle: early follicular (day 3.6 +/- 1.2; range 1-5), ovulatory (day 14.3 +/- 0.8; range 13-16) and midluteal (day 21.3 +/- 0.8; range 20-24), according to endogenous (in non-OCP users) or exogenous (in OCP users) estradiol and progesterone variations. The cardiac vagal withdrawal was represented by the cardiac vagal index (CVI), which was obtained by the 4-s exercise test. Additionally, resting heart rate, systolic (SBP) and diastolic blood pressure (DBP) were obtained. The CVI was not significantly different between the three phases of the menstrual cycle in either the non-OCP users (early follicular: 1.58 +/- 0.1; ovulatory: 1.56 +/- 0.1; midluteal: 1.58 +/- 0.1, P > 0.05) or OCP users (early follicular: 1.47 +/- 0.1; ovulatory: 1.49 +/- 0.1; midluteal: 1.47 +/- 0.1, P > 0.05) (mean +/- SEM). Resting cardiovascular responses were not affected by hormonal phase or OCP use, except that the SBP was higher in the OCP users than non-OCP users in all phases of the cycle (P < 0.05). In summary, our results demonstrate that cardiac vagal withdrawal at the onset of dynamic exercise was not impacted by the menstrual cycle or OCP use in physically active women.	[Teixeira, Andre L.; Ramos, Plinio S.; Ricardo, Djalma R.] Matern Hosp Therezinha de Jesus, Fac Med & Hlth Sci SUPREMA, Juiz De Fora, MG, Brazil; [Teixeira, Andre L.; Ramos, Plinio S.; Ricardo, Djalma R.] State Univ Rio de Janeiro UERJ, Postgrad Program Exercise & Sports Sci, Rio De Janeiro, Brazil; [Vianna, Lauro C.] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Brasilia	Ricardo, DR (corresponding author), Matern Hosp Therezinha de Jesus, Fac Med & Hlth Sci SUPREMA, Juiz De Fora, MG, Brazil.	djalmaricardo@suprema.edu.br	Vianna, Lauro/A-8188-2008; Ramos, Plinio/J-1291-2018; Teixeira, André L./H-8588-2013; Ramos, Plinio/F-7453-2012	Vianna, Lauro/0000-0002-5747-0295; Ramos, Plinio/0000-0003-4035-3890; Teixeira, André L./0000-0003-4268-7560; Ramos, Plinio/0000-0003-4035-3890	CNPq - Brazil [481481/2011-7]	CNPq - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was partially supported by CNPq - Brazil scholarships. Website: http://www.cnpq.br/. The grant numbers are: CNPq-Brazil (481481/2011-7). DRR received grants from the CNPq - Brazil scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Marcos Bezerra de, 2004, Arq Bras Cardiol, V83, P160; Araujo C G, 1992, Clin Auton Res, V2, P35, DOI 10.1007/BF01824209; Araujo CG, 1993, J CARDIOPULM REHABIL, V13, P348; ARAUJO CGS, 1989, BRAZ J MED BIOL RES, V22, P909; Araújo Claudio Gil Soares de, 2003, Rev Bras Med Esporte, V9, P293, DOI 10.1590/S1517-86922003000500005; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; Beller JP, 2013, AM J OBSTET GYNECOL, V208, P39, DOI 10.1016/j.ajog.2012.01.037; Cohen J.E., 1988, STAT POWER ANAL BEHA; FAGRAEUS L, 1976, J APPL PHYSIOL, V40, P679, DOI 10.1152/jappl.1976.40.5.679; Freyschuss U, 1970, Acta Physiol Scand Suppl, V342, P1; Hage FG, 2013, CURR OPIN CARDIOL, V28, P411, DOI 10.1097/HCO.0b013e32836205e7; HOLLANDER AP, 1975, J APPL PHYSIOL, V38, P272, DOI 10.1152/jappl.1975.38.2.272; Knopfli BH, 1999, CLIN J SPORT MED, V9, P170; Leicht AS, 2003, EXP PHYSIOL, V88, P441, DOI 10.1113/eph8802535; Magder SA, 2012, CRIT CARE MED, V40, P239, DOI 10.1097/CCM.0b013e318232e50c; Mairer K, 2013, INT J SPORTS MED, V34, P700, DOI 10.1055/s-0032-1327577; Matsuo H, 2003, EUR J APPL PHYSIOL, V90, P100, DOI 10.1007/s00421-003-0873-8; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; McKinley PS, 2009, PSYCHOPHYSIOLOGY, V46, P904, DOI 10.1111/j.1469-8986.2009.00811.x; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Middlekauff HR, 2012, AM J PHYSIOL-HEART C, V302, pH2560, DOI 10.1152/ajpheart.00579.2011; Miles J., 2001, APPL REGRESSION CORR; Millar PJ, 2009, EUR J APPL PHYSIOL, V107, P509, DOI 10.1007/s00421-009-1142-2; NOBREGA ACL, 1993, MED SCI SPORT EXER, V25, P37; Oliveira RB, 2006, EUR J APPL PHYSIOL, V97, P607, DOI 10.1007/s00421-006-0222-9; Ricardo DR, 2010, EUR J APPL PHYSIOL, V110, P933, DOI 10.1007/s00421-010-1555-y; Ricardo DR, 2005, CHEST, V127, P318, DOI 10.1378/chest.127.1.318; SATO N, 1995, PSYCHOSOM MED, V57, P331, DOI 10.1097/00006842-199507000-00004; Tanaka M, 2003, AM J PHYSIOL-REG I, V285, pR1091, DOI 10.1152/ajpregu.00162.2003; Teixeira AL, 2015, INT J SPORTS MED, V36, P204, DOI 10.1055/s-0034-1389971; Teixeira ALS., 2012, J EXERCISE PHYSIOLOG, V15, P47, DOI 10.7860/JCDR/2015/13795.6592; Vianna LC, 2008, EUR J APPL PHYSIOL, V102, P283, DOI 10.1007/s00421-007-0584-7; Weissman A, 2009, EUR J APPL PHYSIOL, V105, P381, DOI 10.1007/s00421-008-0914-4; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119626	10.1371/journal.pone.0119626	http://dx.doi.org/10.1371/journal.pone.0119626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785599	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500123
J	Li, ZY; Wang, JB; Zhang, XQ; Xu, L				Li, Zhiying; Wang, Jiabin; Zhang, Xuequan; Xu, Li			Comparative Transcriptome Analysis of Anthurium "Albama" and Its Anthocyanin-Loss Mutant	PLOS ONE			English	Article							BIOSYNTHETIC GENES; EXPRESSION; ANNOTATION; MAIZE; KEGG; TOOL	Anthurium is one of the most important tropical ornamental plants in the world. The traded value of anthurium is second only to that of tropical orchids among the tropical flowers. The spathe is the main ornamental organ and its color variation mainly arises from anthocyanin contents. Understanding the molecular regulation of spathe color will accelerate new variety creation of anthurium. To announce gene expression differences between Anthurium andraeanum 'Albama' and its one unique anthocyanin-loss mutant, we collected spathes of the wild-type and the mutant from two stages in spathe development (the flower separates protrude from the sheath and the spathe is fully expanded) and extracted total RNAs for transcriptome profiling. Using short read sequencing technology (Illumina), 51,955,564, 53,822,224, 54,221,990 and 52,276,418 sequencing raw reads, respectively, for wild-type and mutant in the two stages were assembled de novo into 111,268 unique sequences (unigenes) with a mean length of 652 bp. 47,563 unigenes had significant hits to the sequences in the Nr database, and 32,768 unigenes showed significant similarity to known proteins in the Swiss-Prot database. 28,350 and 19,293 unigenes had significant similarity to existing sequences in the KEGG and COG databases, respectively. Further, analysis of differentially expressed genes in the comparison between wild-type and mutant and between the two different developmental stages was carried out, indicating that the expression of an extensive set of genes changed as the result of mutation. Taken together, these data demonstrated that the Illumina sequencing allowed de novo transcriptome assembly and could obtain differentially expressed genes between A. andraeanum wild-type and the anthocyanin-loss mutant. The expression differences of AN2 and UFGT might cause the anthocyaninloss mutation.	[Li, Zhiying; Wang, Jiabin; Zhang, Xuequan; Xu, Li] Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China; [Li, Zhiying; Zhang, Xuequan; Xu, Li] Hainan Univ, Haikou 571700, Hainan Province, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Xu, L (corresponding author), Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China.	xllzy@263.net			Hainan Province Natural Science Foundation [313069]; Species Conservation Project [14RZZY-4]	Hainan Province Natural Science Foundation; Species Conservation Project	This work was funded by the Hainan Province Natural Science Foundation (313069) and the Species Conservation Project (14RZZY-4). LX and ZL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Castellarin SD, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-46; Chen WH, 2011, PLANT CELL REP, V30, P1007, DOI 10.1007/s00299-011-1006-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COCCIOLONE SM, 1993, GENETICS, V135, P575; Collette VE, 2004, PHYSIOL PLANTARUM, V122, P297, DOI 10.1111/j.1399-3054.2004.00402.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Elibox W, 2008, HORTSCIENCE, V43, P787, DOI 10.21273/HORTSCI.43.3.787; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matus JT, 2010, PLANT MOL BIOL, V72, P607, DOI 10.1007/s11103-010-9597-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng'oma E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-754; Pairoba CF, 2003, PLANT MOL BIOL, V53, P75, DOI 10.1023/B:PLAN.0000009267.76482.ce; Petersen M, 2010, ANNU PLANT REV, V40, P182, DOI 10.1002/9781444320503.ch4; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Procissi A, 2002, PLANT MOL BIOL, V49, P239, DOI 10.1023/A:1014959230492; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma M, 2011, GENETICS, V188, P69, DOI 10.1534/genetics.110.126136; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; WILLIAMS CA, 1981, PHYTOCHEMISTRY, V20, P217, DOI 10.1016/0031-9422(81)85096-0; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Wu BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105959; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689	36	16	20	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119027	10.1371/journal.pone.0119027	http://dx.doi.org/10.1371/journal.pone.0119027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781998	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600045
J	Syka, M; Keller, J; Klempir, J; Rulseh, AM; Roth, J; Jech, R; Vorisek, I; Vymazal, J				Syka, Michael; Keller, Jiri; Klempir, Jiri; Rulseh, Aaron M.; Roth, Jan; Jech, Robert; Vorisek, Ivan; Vymazal, Josef			Correlation between Relaxometry and Diffusion Tensor Imaging in the Globus Pallidus of Huntington's Disease Patients	PLOS ONE			English	Article							BASAL GANGLIA; GRAY-MATTER; MR RELAXOMETRY; BRAIN-TISSUE; IRON; AGE; RELAXATION; TIME; PARKINSON; PATHOLOGY	Huntington's disease (HD) is an inherited neurodegenerative disorder with progressive impairment of motor, behavioral and cognitive functions. The clinical features of HD are closely related to the degeneration of the basal ganglia, predominantly the striatum. The main striatal output structure, the globus pallidus, strongly accumulates metalloprotein-bound iron, which was recently shown to influence the diffusion tensor scalar values. To test the hypothesis that this effect dominates in the iron-rich basal ganglia of HD patients, we examined the globus pallidus using DTI and T2 relaxometry sequences. Quantitative magnetic resonance (MR), clinical and genetic data (number of CAG repeats) were obtained from 14 HD patients. MR parameters such as the T2 relaxation rate (RR), fractional anisotropy (FA) and mean diffusivity (MD) were analysed. A positive correlation was found between RR and FA (R2=0.84), between CAG and RR (R2=0.59) and between CAG and FA (R2=0.44). A negative correlation was observed between RR and MD (R2=0.66). A trend towards correlation between CAG and MD was noted. No correlation between MR and clinical parameters was found. Our results indicate that especially magnetic resonance FA measurements in the globus pallidus of HD patients may be strongly affected by metalloprotein-bound iron accumulation.	[Syka, Michael; Keller, Jiri; Rulseh, Aaron M.; Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic; [Syka, Michael] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Keller, Jiri] Charles Univ Prague, Dept Neurol, Fac Med 3, Prague, Czech Republic; [Klempir, Jiri; Roth, Jan; Jech, Robert] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Klempir, Jiri; Roth, Jan; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic; [Klempir, Jiri; Rulseh, Aaron M.; Roth, Jan; Jech, Robert] Charles Univ Prague, Gen Univ Hosp Prague, Prague, Czech Republic; [Klempir, Jiri] Charles Univ Prague, Inst Anat, Fac Med 1, Prague, Czech Republic; [Rulseh, Aaron M.] Charles Univ Prague, Dept Radiol, Fac Med 1, Prague, Czech Republic; [Syka, Michael; Vorisek, Ivan] Acad Sci Czech Republ, Inst Expt Med, Vvi, Prague, Czech Republic	Na Homolce Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Syka, M (corresponding author), Na Homolce Hosp, Dept Radiol, Prague, Czech Republic.	msyka@email.cz	Klempir, Jiri/P-3897-2017; Keller, Jiří/AAE-4791-2019; Jech, Robert/HHY-7342-2022; Roth, Jan/O-1817-2017; Klempir, Jiri/AAI-7300-2021; Rulseh, Aaron/D-3924-2015	Klempir, Jiri/0000-0002-0735-7155; Keller, Jiří/0000-0002-6799-7840; Jech, Robert/0000-0002-9732-8947; Roth, Jan/0000-0002-5247-7746; Rulseh, Aaron/0000-0002-8332-4419	Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH) [00023884]; project FNUSA-ICRC from the European Regional Development Fund [CZ.1.05/1.1.00/02.0123]; Research Projects of Charles University in Prague [PRVOUK P34, PRVOUK P26]; IGA of Ministry of Health, Czech Republic [NT12094/2011]; Grant Agency of the Czech Republic [P303/11/2378]	Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH); project FNUSA-ICRC from the European Regional Development Fund; Research Projects of Charles University in Prague; IGA of Ministry of Health, Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH, 00023884), the project FNUSA-ICRC (no. CZ.1.05/1.1.00/02.0123) from the European Regional Development Fund, the Research Projects of Charles University in Prague (PRVOUK P34 and PRVOUK P26), and the grants from IGA of Ministry of Health, Czech Republic (NT12094/2011) and from Grant Agency of the Czech Republic (P303/11/2378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 1995, ANN NEUROL, V38, P835, DOI 10.1002/ana.410380602; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHEN JC, 1993, AM J NEURORADIOL, V14, P275; Dezortova M, 2012, CONTRAST MEDIA MOL I, V7, P509, DOI 10.1002/cmmi.1482; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Gusella JF, 1998, CURR OPIN NEUROBIOL, V8, P425, DOI 10.1016/S0959-4388(98)80071-8; Hajek M, 2005, EUR RADIOL, V15, P1060, DOI 10.1007/s00330-004-2553-4; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; Herynek V, 2012, J MAGN RESON IMAGING, V35, P1332, DOI 10.1002/jmri.23599; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mascalchi M, 2004, RADIOLOGY, V232, P867, DOI 10.1148/radiol.2322030820; McGahan MC, 2005, AM J PHYSIOL-CELL PH, V288, pC1117, DOI 10.1152/ajpcell.00444.2004; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Peran P, 2009, HUM BRAIN MAPP, V30, P2667, DOI 10.1002/hbm.20698; Pfefferbaum A, 2010, NEUROBIOL AGING, V31, P482, DOI 10.1016/j.neurobiolaging.2008.04.013; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2012, ARCH NEUROL-CHICAGO, V69, P887, DOI 10.1001/archneurol.2011.2945; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Rulseh AM, 2013, J MAGN RESON IMAGING, V38, P1103, DOI 10.1002/jmri.24065; Sanchez-Castaneda C, 2013, HUM BRAIN MAPP, V34, P1625, DOI 10.1002/hbm.22019; SCHENKER C, 1993, NEURORADIOLOGY, V35, P119, DOI 10.1007/BF00593967; Seppi K, 2006, MOVEMENT DISORD, V21, P1043, DOI 10.1002/mds.20868; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Vorisek I, 2009, ACTA PHYSIOL, V195, P101, DOI 10.1111/j.1748-1716.2008.01924.x; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; VYMAZAL J, 1995, JMRI-J MAGN RESON IM, V5, P554; Vymazal J, 2007, J NEUROL SCI, V263, P20, DOI 10.1016/j.jns.2007.05.018; Walimuni IS, 2011, NEUROIMAGE, V57, P1402, DOI 10.1016/j.neuroimage.2011.05.063; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	47	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118907	10.1371/journal.pone.0118907	http://dx.doi.org/10.1371/journal.pone.0118907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781024	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600037
J	Tsai, YC; Grimm, S; Chao, JL; Wang, SC; Hofmeyer, K; Shen, J; Eichinger, F; Michalopoulou, T; Yao, CK; Chang, CH; Lin, SH; Sun, YH; Pflugfelder, GO				Tsai, Yu-Chen; Grimm, Stefan; Chao, Ju-Lan; Wang, Shih-Chin; Hofmeyer, Kerstin; Shen, Jie; Eichinger, Fred; Michalopoulou, Theoni; Yao, Chi-Kuang; Chang, Chih-Hsuan; Lin, Shih-Han; Sun, Y. Henry; Pflugfelder, Gert O.			Optomotor-Blind Negatively Regulates Drosophila Eye Development by Blocking Jak/STAT Signaling	PLOS ONE			English	Article							MORPHOGENETIC FURROW PROGRESSION; GENE-EXPRESSION; CELL FATE; RETINAL DIFFERENTIATION; COMPARTMENT BOUNDARY; ACTS DOWNSTREAM; REPORTER GENE; IMAGINAL DISK; COMPOUND EYE; GLIAL-CELLS	Organ formation requires a delicate balance of positive and negative regulators. In Drosophila eye development, wingless (wg) is expressed at the lateral margins of the eye disc and serves to block retinal development. The T-box gene optomotor-blind (omb) is expressed in a similar pattern and is regulated by Wg. Omb mediates part of Wg activity in blocking eye development. Omb exerts its function primarily by blocking cell proliferation. These effects occur predominantly in the ventral margin. Our results suggest that the primary effect of Omb is the blocking of Jak/STAT signaling by repressing transcription of upd which encodes the Jak receptor ligand Unpaired.	[Tsai, Yu-Chen; Chao, Ju-Lan; Yao, Chi-Kuang; Sun, Y. Henry] Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan; [Tsai, Yu-Chen; Chao, Ju-Lan; Yao, Chi-Kuang; Sun, Y. Henry] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Tsai, Yu-Chen; Wang, Shih-Chin; Chang, Chih-Hsuan; Lin, Shih-Han] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Tsai, Yu-Chen; Wang, Shih-Chin; Chang, Chih-Hsuan; Lin, Shih-Han] Tunghai Univ, Life Sci Ctr, Taichung 40704, Taiwan; [Grimm, Stefan; Hofmeyer, Kerstin; Pflugfelder, Gert O.] Univ Wurzburg, Lehrstuhl Genet & Neurobiol, Biozentrum, Theodor Boveri Inst, D-97070 Wurzburg, Germany; [Shen, Jie; Eichinger, Fred; Michalopoulou, Theoni; Pflugfelder, Gert O.] Johannes Gutenberg Univ Mainz, Inst Genet, D-55122 Mainz, Germany; [Shen, Jie] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Tunghai University; Tunghai University; University of Wurzburg; Johannes Gutenberg University of Mainz; China Agricultural University	Sun, YH (corresponding author), Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan.	mbyhsun@gate.sinica.edu.tw; pflugfel@uni-mainz.de	shen, jie/H-9087-2016; Pflugfelder, Gert/ABG-9562-2021; Yao, Chi-Kuang/Y-9325-2019; Sun, Y. Henry/ABC-4614-2021; shen, jie/W-9807-2019; Sun, Y. Henry/AAZ-7966-2021	Yao, Chi-Kuang/0000-0003-0977-4347; Sun, Y. Henry/0000-0001-8279-5270; shen, jie/0000-0002-6021-7151; 	National Science Council of the Republic of China [NSC 88-2312-B-001-016, NSC 90-2312-B-001-006, NSC 91-2312-B-001-006, NSC 99-2311-B-029-002-MY3, NSC-102-2633-B-029-002]; Deutsche Forschungsgemeinschaft [Pf 163/11-1]; ROC-Germany exchange program [PPP 87-I-2911-01]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ROC-Germany exchange program	This study was supported by grants to Y.H. S. (NSC 88-2312-B-001-016, NSC 90-2312-B-001-006, NSC 91-2312-B-001-006) to Y.C.T. (NSC 99-2311-B-029-002-MY3, NSC-102-2633-B-029-002) from the National Science Council (http://www.most.gov.tw/mp.aspx?mp=7) of the Republic of China, to G.O.P. (Pf 163/11-1) from Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) and a ROC-Germany exchange program (PPP 87-I-2911-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BASLER K, 1988, CELL, V54, P299; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bonini NM, 1999, BIOESSAYS, V21, P991, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;991::AID-BIES3&gt;3.0.CO;2-3; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Burke R, 1996, DEV BIOL, V179, P360, DOI 10.1006/dbio.1996.0267; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Cadigan KM, 2002, DEVELOPMENT, V129, P3393; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Chanut F, 1997, DEV GENET, V20, P197; Chanut F, 1997, DEVELOPMENT, V124, P559; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Ekas LA, 2010, DEV BIOL, V344, P621, DOI 10.1016/j.ydbio.2010.05.497; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 1997, DEVELOPMENT, V124, P261; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gorfinkiel N, 1999, MECH DEVELOP, V86, P113, DOI 10.1016/S0925-4773(99)00122-7; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Gruenauer-Kloevekorn Claudia, 2005, Ophthalmic Genet, V26, P1, DOI 10.1080/13816810590918073; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Ito K, 1997, DEVELOPMENT, V124, P761; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kopp A, 1997, DEVELOPMENT, V124, P3715; Kumar JP, 2011, DEV NEUROBIOL, V71, P1133, DOI 10.1002/dneu.20921; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Lee JD, 2001, DEVELOPMENT, V128, P1519; Lopes CS, 2010, DEV BIOL, V339, P78, DOI 10.1016/j.ydbio.2009.12.020; Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390; MA CY, 1995, DEVELOPMENT, V121, P2279; Mayer LR, 2013, FLY, V7, P118, DOI 10.4161/fly.23657; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Oros SM, 2010, DEV BIOL, V346, P258, DOI 10.1016/j.ydbio.2010.07.030; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pflugfelder GO, 2009, J NEUROGENET, V23, P15, DOI 10.1080/01677060802471619; PFLUGFELDER GO, 1995, COMP BIOCHEM PHYS A, V110, P185, DOI 10.1016/0300-9629(94)00159-Q; Pignoni F, 1997, DEVELOPMENT, V124, P271; POECK B, 1993, DEVELOPMENT, V117, P1017; POECK B, 1993, MOL GEN GENET, V238, P325, DOI 10.1007/BF00291990; Porsch M, 2005, MECH DEVELOP, V122, P81, DOI 10.1016/j.mod.2004.08.007; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005; Roignant JY, 2010, DEVELOPMENT, V137, P273, DOI 10.1242/dev.041244; Sen A, 2014, J NEUROGENET, V28, P250, DOI 10.3109/01677063.2014.917645; Sen A, 2010, MOL GENET GENOMICS, V283, P147, DOI 10.1007/s00438-009-0505-z; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Shen J, 2008, MECH DEVELOP, V125, P233, DOI 10.1016/j.mod.2007.11.006; Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Singh A, 2003, DEVELOPMENT, V130, P6351, DOI 10.1242/dev.00864; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; Sowden JC, 2001, INVEST OPHTH VIS SCI, V42, P3095; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Strutt DI, 1995, DEVELOPMENT, V121, P4247; SUN YH, 1995, GENETICS, V141, P1075; Tang CY, 2002, GENESIS, V34, P39, DOI 10.1002/gene.10135; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Treisman JE, 2013, WIRES DEV BIOL, V2, P545, DOI 10.1002/wdev.100; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Tsai YC, 2007, DEV BIOL, V306, P760, DOI 10.1016/j.ydbio.2007.04.011; Wernet MF, 2014, DEVELOPMENT, V141, P918, DOI 10.1242/dev.103127; Wiersdorff V, 1996, DEVELOPMENT, V122, P2153; WOLFF T, 1991, DEVELOPMENT, V113, P841; Wolff TaR DN, 1993, THE DEVELOPMENT OF D, P1277; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342; Zhang XB, 2013, DEVELOPMENT, V140, P2917, DOI 10.1242/dev.094300	91	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120236	10.1371/journal.pone.0120236	http://dx.doi.org/10.1371/journal.pone.0120236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781970	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600144
J	Zhang, Z; Zheng, XL; Zeng, DDJ; Leischow, SJ				Zhang, Zhu; Zheng, Xiaolong; Zeng, Daniel Dajun; Leischow, Scott J.			Information Seeking Regarding Tobacco and Lung Cancer: Effects of Seasonality	PLOS ONE			English	Article							ELECTRONIC CIGARETTES; SMOKING; PATTERNS; SALES	This paper conducted one of the first comprehensive international Internet analyses of seasonal patterns in information seeking concerning tobacco and lung cancer. Search query data for the terms "tobacco" and "lung cancer" from January 2004 to January 2014 was collected from Google Trends. The relevant countries included the USA, Canada, the UK, Australia, and China. Two statistical approaches including periodogram and cross-correlation were applied to analyze seasonal patterns in the collected search trends and their associations. For these countries except China, four out of six cross-correlations of seasonal components of the search trends regarding tobacco were above 0.600. For these English-speaking countries, similar patterns existed in the data concerning lung cancer, and all cross-correlations between seasonal components of the search trends regarding tobacco and that regarding lung cancer were also above 0.700. Seasonal patterns widely exist in information seeking concerning tobacco and lung cancer on an international scale. The findings provide a piece of novel Internet-based evidence for the seasonality and health effects of tobacco use.	[Zhang, Zhu; Zheng, Xiaolong; Zeng, Daniel Dajun] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Zeng, Daniel Dajun] Univ Arizona, Dept Management Informat Syst, Tucson, AZ 85721 USA; [Leischow, Scott J.] Mayo Clin, Scottsdale, AZ USA	Chinese Academy of Sciences; Institute of Automation, CAS; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix	Zeng, DDJ (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	dajun.zeng@ia.ac.cn			National Natural Science Foundation of China [71103180, 71472175, 71025001, 91224008]; National Institutes of Health (NIH) of USA [1R01DA037378-01]; Ministry of Health of China [2012ZX10004801, 2013ZX10004218];  [2013A127]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037378] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH) of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health of China; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is partially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 71103180 (PI: XZ), 71472175 (PI: XZ), 71025001 (PI: DDZ), 91224008 (PI: DDZ), and 61175040 (PI: WM); National Institutes of Health (NIH) of USA (http://www.nih.gov/) under Grant No. 1R01DA037378-01 (PI: DDZ); the Ministry of Health of China (http://www.nhfpc.gov.cn/) under Grant No. 2012ZX10004801 (PI: DDZ) and 2013ZX10004218 (PI: DDZ); and by the Grant No. 2013A127 (PI: DDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATHWORKS MATLAB 7 1; Ayers JW, 2012, J MED INTERNET RES, V14, P288, DOI 10.2196/jmir.2148; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; Carr LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048158; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Chandra S, 2003, TOB CONTROL, V12, P105, DOI 10.1136/tc.12.1.105; Chandra S, 2011, NICOTINE TOB RES, V13, P395, DOI 10.1093/ntr/ntq258; Chang W, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P1120; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Cobb NK, 2010, AM J PREV MED, V38, pS429, DOI 10.1016/j.amepre.2009.12.001; Colwell B, 2006, NICOTINE TOB RES, V8, P239, DOI 10.1080/14622200600576503; Cui KN, 2014, LECT NOTES COMPUT SC, V8549, P44, DOI 10.1007/978-3-319-08416-9_5; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Li XC, 2008, LECT NOTES COMPUT SC, V5075, P401; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Luo CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1028; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Momperousse D, 2007, TOB CONTROL, V16, P69, DOI 10.1136/tc.2006.018135; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Sheffer MA, 2010, AM J PREV MED, V38, pS343, DOI 10.1016/j.amepre.2009.11.014; Wellman RJ, 2003, TOB CONTROL, V12, P339, DOI 10.1136/tc.12.3.339; World Health Organization, 2012, WHO GLOB REP MORT AT; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Yuan Luo, 2010, 2010 IEEE International Conference on Service Operations and Logistics and Informatics (SOLI 2010), P76, DOI 10.1109/SOLI.2010.5551614; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhang Z, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P371, DOI 10.1109/ISI.2013.6578861; Zheng Min., 2011, LECT NOTES COMPUTER, P85, DOI [10.1007/978-3-642-22039-5_9, DOI 10.1007/978-3-642-22039-5_9]	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117938	10.1371/journal.pone.0117938	http://dx.doi.org/10.1371/journal.pone.0117938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781020	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600017
J	Zheng, H; Gao, JX; Teng, YG; Feng, CY; Tian, MR				Zheng, Hao; Gao, Jixi; Teng, Yanguo; Feng, Chaoyang; Tian, Meirong			Temporal Variations in Soil Moisture for Three Typical Vegetation Types in Inner Mongolia, Northern China	PLOS ONE			English	Article							LOESS-PLATEAU; VARIABILITY; INFILTRATION; HYDROLOGY; CATCHMENT	Drought and shortages of soil water are becoming extremely severe due to global climate change. A better understanding of the relationship between vegetation type and soil-moisture conditions is crucial for conserving soil water in forests and for maintaining a favorable hydrological balance in semiarid areas, such as the Saihanwula National Nature Reserve in Inner Mongolia, China. We investigated the temporal dynamics of soil moisture in this reserve to a depth of 40 cm under three types of vegetation during a period of rainwater recharge. Rainwater from most rainfalls recharged the soil water poorly below 40 cm, and the rainfall threshold for increasing the moisture content of surface soil for the three vegetations was in the order: artificial Larix spp. (AL) > Quercus mongolica (QM) > unused grassland (UG). QM had the highest mean soil moisture content (21.13%) during the monitoring period, followed by UG (16.52%) and AL (14.55%); and the lowest coefficient of variation (CV 9.6-12.5%), followed by UG (CV 10.9-18.7%) and AL (CV 13.9-21.0%). QM soil had a higher nutrient content and higher soil porosities, which were likely responsible for the higher ability of this cover to retain soil water. The relatively smaller QM trees were able to maintain soil moisture better in the study area.	[Zheng, Hao; Gao, Jixi; Teng, Yanguo] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Zheng, Hao; Gao, Jixi; Tian, Meirong] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Feng, Chaoyang] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Gao, JX (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	gaojx168@163.com			National Special Scientific Research of Environmental Protection Public Welfare Project [201209027]; National Science and Technology Support Project [2012BAC01B00]	National Special Scientific Research of Environmental Protection Public Welfare Project; National Science and Technology Support Project	This work was supported by the National Special Scientific Research of Environmental Protection Public Welfare Project (No. 201209027) and the National Science and Technology Support Project (No. 2012BAC01B00). The funders played a role in the data collection and analysis and in the decision to publish. The funders played no role in the study design nor in the preparation of the manuscript.	Baroni G, 2013, J HYDROL, V489, P148, DOI 10.1016/j.jhydrol.2013.03.007; Baskan O, 2013, ENVIRON MONIT ASSESS, V185, P10441, DOI 10.1007/s10661-013-3343-8; BELL KR, 1980, WATER RESOUR RES, V16, P796, DOI 10.1029/WR016i004p00796; Bharati L, 2002, AGROFOREST SYST, V56, P249, DOI 10.1023/A:1021344807285; Brooks SM, 1997, J ENVIRON MANAGE, V49, P297, DOI 10.1006/jema.1996.0091; Calder I.R., 2007, NEW UNDERSTANDING FO; CHARPENTIER MA, 1992, J GEOPHYS RES-ATMOS, V97, P18987, DOI 10.1029/92JD00882; Chen HS, 2010, ENVIRON EARTH SCI, V61, P1105, DOI 10.1007/s12665-009-0428-3; Daly E, 2005, ENVIRON ENG SCI, V22, P9, DOI 10.1089/ees.2005.22.9; Duan L, 2011, HYDROL EARTH SYST SC, V8, P1895; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; [高磊 Gao Lei], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P964; Garcia-Estringana P, 2013, ECOHYDROLOGY, V6, P741, DOI 10.1002/eco.1295; Hagyo A, 2006, BIOLOGIA, V61, pS261, DOI 10.2478/s11756-006-0169-7; Hai APH, 2012, GEODERMA, V177, P8, DOI 10.1016/j.geoderma.2012.01.031; HAWLEY ME, 1983, J HYDROL, V62, P179, DOI 10.1016/0022-1694(83)90102-6; Lakshmi V, 2003, HYDROL PROCESS, V17, P3041, DOI 10.1002/hyp.1275; [李慧星 LI Huixing], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P172; Lull HW, 1955, 140 USDA SO EXPSTA; Peng HH, 2013, THESIS LANZHOU U GAN; Qiu Y, 2001, J HYDROL, V240, P243, DOI 10.1016/S0022-1694(00)00362-0; REYNOLDS S G, 1970, Journal of Hydrology (Amsterdam), V11, P288, DOI 10.1016/0022-1694(70)90068-5; Santamarta-Cerezal JC, 2012, NOT BOT HORTI AGROBO, V40, P9; Sharda VN, 2006, INT WORKSH IMP REF D; SKLASH MG, 1979, J HYDROL, V43, P45, DOI 10.1016/0022-1694(79)90164-1; Tyagi J. V., 2011, Journal of Forestry Research (Harbin), V22, P543, DOI 10.1007/s11676-011-0197-1; Vereecken H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031813; [王根绪 Wang Genxu], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P653; Wang XY, 2014, POL J ENVIRON STUD, V23, P511; Zhao HL, 2006, CATENA, V65, P71, DOI 10.1016/j.catena.2005.10.001; Zhu FR, 2013, HUBEI AGR SCI, V1, P39	31	25	26	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118964	10.1371/journal.pone.0118964	http://dx.doi.org/10.1371/journal.pone.0118964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781333	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600039
J	Heine, M; van den Akker, LE; Verschuren, O; Visser-Meily, A; Kwakkel, G				Heine, Martin; van den Akker, Lizanne Eva; Verschuren, Olaf; Visser-Meily, Anne; Kwakkel, Gert		TREFAMS-ACE Study Grp	Reliability and Responsiveness of Cardiopulmonary Exercise Testing in Fatigued Persons with Multiple Sclerosis and Low to Mild Disability	PLOS ONE			English	Article							UPTAKE EFFICIENCY SLOPE; QUALITY-OF-LIFE; OXYGEN-UPTAKE; FITNESS; VALIDITY; REPRODUCIBILITY; PARAMETERS; AGREEMENT; THERAPY; IMPACT	Background Peak oxygen uptake (VO(2)peak) via cardiopulmonary exercise testing is considered the gold standard for testing aerobic capacity in healthy participants and people with various medical conditions. The reliability and responsiveness of cardiopulmonary exercise testing outcomes in persons with MS (PwMS) have not been extensively studied. Objective (1) to investigate the reliability of cardiopulmonary exercise parameters in PwMS; (2) to determine the responsiveness, in terms of the smallest detectable change (SDC), for each parameter. Design Two repeated measurements of cardiopulmonary exercise outcomes were obtained, with a median time interval of 16 days. Methods Thirty-two PwMS suffering from subjective fatigue performed cardiopulmonary exercise tests on a cycle ergometer, to voluntary exhaustion. We calculated the reliability, in terms of the intra-class correlation coefficient (ICC [2, k]; absolute agreement), and the measurement error, in terms of standard error of measurement (SEM) and SDC at individual (SDCindividual) and group level (SDCgroup). Results The ICC for VO(2)peak was 0.951, with an SEM of 0.131 L.min(-1) and an SDCindividual of 0.364 L.min(-1). When corrected for bodyweight, the ICC of VO(2)peak was 0.933, with an SEM of 1.7 mL.kg(-1).min(-1) and in an SDCindividual of 4.6 mL.kg(-1).min(-1). Limitations Generalization of our study results is restricted to fatigued PwMS with a low to mild level of disability. Conclusions At individual level, cardiopulmonary exercise testing can be used reliably to assess physical fitness in terms of VO(2)peak, but less so to determine significant changes. At group level, VO(2)peak can be reliably used to determine physical fitness status and establish change over time.	[Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, NL-3583 TM Utrecht, Netherlands; [Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, NL-3583 TM Utrecht, Netherlands; [Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Rehabil Ctr Hoogstr, NL-3583 TM Utrecht, Netherlands; [van den Akker, Lizanne Eva] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [van den Akker, Lizanne Eva] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [Kwakkel, Gert] Ctr Rehabil & Rheumatol READE, Dept Neurorehabil, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Heine, M (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands.	m.heine@dehoogstraat.nl	de Groot, Vincent/J-8977-2013; Heine, Martin/C-8674-2012; Knoop, Hans/D-3264-2009	de Groot, Vincent/0000-0002-6073-6250; Heine, Martin/0000-0003-4131-2863; Knoop, Hans/0000-0001-7763-3517; Blikman, Lyan/0000-0002-3334-2504; Kwakkel, Gert/0000-0002-4041-4043	Fonds NutsOhra [ZonMw 89000005]	Fonds NutsOhra	The TREFAMS-ACE study is funded by the Fonds NutsOhra (ZonMw 89000005). The funders had no role in study desgin, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman M, 2010, J CARDIOPULM REHABIL, V30, P357, DOI 10.1097/HCR.0b013e3181ebf316; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Barron A, 2014, EUR J PREV CARDIOL, V21, P445, DOI 10.1177/2047487313518474; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Beckerman H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-250; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borg G, 1970, Lakartidningen, V67, P4548; Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0966-6362(03)00097-3; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Golzari Z, 2010, INT IMMUNOPHARMACOL, V10, P1415, DOI 10.1016/j.intimp.2010.08.008; Heine M, 2014, PHYS THER, V94, P1168, DOI 10.2522/ptj.20130418; Heine M, 2014, J REHABIL MED, V46, P656, DOI 10.2340/16501977-1825; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langeskov-Christensen M, 2015, SPORTS MED IN PRESS; Langeskov-Christensen M, 2014, J NEUROL SCI, V342, P79, DOI 10.1016/j.jns.2014.04.028; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1800, DOI 10.1016/j.apmr.2013.04.020; Marrie Ruth Ann, 2013, Continuum (Minneap Minn), V19, P1046, DOI 10.1212/01.CON.0000433284.07844.6b; Medbo JI, 2002, SCAND J CLIN LAB INV, V62, P585, DOI 10.1080/003655102764654321; Meyer T, 2001, INT J SPORTS MED, V22, P593, DOI 10.1055/s-2001-18523; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Mostert S, 2002, MULT SCLER J, V8, P161, DOI 10.1191/1352458502ms779oa; Motl RW, 2012, NAT REV NEUROL, V8, P487, DOI 10.1038/nrneurol.2012.136; Motl RW, 2012, ARCH PHYS MED REHAB, V93, P490, DOI 10.1016/j.apmr.2011.08.025; Petajan JH, 1996, ANN NEUROL, V39, P432, DOI 10.1002/ana.410390405; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Rampello A, 2007, PHYS THER, V87, P545, DOI 10.2522/ptj.20060085; Rasova K, 2006, MULT SCLER J, V12, P227, DOI 10.1191/135248506ms1248oa; Rietberg MB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003980.pub2; Schulz KH, 2004, J NEUROL SCI, V225, P11, DOI 10.1016/j.jns.2004.06.009; Stickland MK, 2012, PULM MED, V2012, DOI 10.1155/2012/824091; Streiner DL, 2000, HLTH MEASUREMENT SCA; Thompson WR, 2000, ACSMS GUID EX TEST P, P105; Van Laethem C, 2009, EUR J CARDIOV PREV R, V16, P493, DOI 10.1097/HJR.0b013e32832c88a8; Vercoulen JHMM, 1996, ARCH NEUROL-CHICAGO, V53, P642, DOI 10.1001/archneur.1996.00550070080014; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122260	10.1371/journal.pone.0122260	http://dx.doi.org/10.1371/journal.pone.0122260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789625	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400211
J	Hozumi, H; Enomoto, N; Kono, M; Fujisawa, T; Inui, N; Nakamura, Y; Sumikawa, H; Johkoh, T; Nakashima, R; Imura, Y; Mimori, T; Suda, T				Hozumi, Hironao; Enomoto, Noriyuki; Kono, Masato; Fujisawa, Tomoyuki; Inui, Naoki; Nakamura, Yutaro; Sumikawa, Hiromitsu; Johkoh, Takeshi; Nakashima, Ran; Imura, Yoshitaka; Mimori, Tsuneyo; Suda, Takafumi			Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study	PLOS ONE			English	Article							MYOSITIS-SPECIFIC AUTOANTIBODIES; AMYOPATHIC DERMATOMYOSITIS; CLINICAL-FEATURES; GENE 5; POLYMYOSITIS; MANIFESTATIONS; CLASSIFICATION; AUTOANTIGEN; SOCIETY; HRCT	Background In polymyositis/dermatomyositis (PM/DM), anti-aminoacyl-tRNA synthetase (ARS) antibodies are closely associated with interstitial lung disease (ILD), a frequent pulmonary complication. However, the clinical significance of anti-ARS antibodies is not well established. Objective We aimed to evaluate the clinical significance of anti-ARS antibodies in PM/DM-ILD patients. Methods Forty-eight consecutive PM/DM-ILD patients were studied retrospectively. Anti-ARS antibodies were screened by ELISA and confirmed by RNA immunoprecipitation test. Medical records, high-resolution computed tomography images, and surgical lung biopsy specimens were compared between ARS-positive (ARS group) and ARS-negative patients (non-ARS group). Results Anti-ARS antibodies were detected in 23 of 48 patients (48%). Radiologically, nonspecific interstitial pneumonia (NSIP) pattern was observed more frequently in the ARS group than in the non-ARS group (73.9% vs. 40%, P = 0.02). Pathologically, NSIP was the most frequent in both groups. Ten-year survival rate was also significantly higher in the ARS group than in the non-ARS group (91.6% vs. 58.7%, P = 0.02). Univariate Cox hazards analysis revealed that the presence of anti-ARS antibodies was associated with better prognosis (HR = 0.34, 95% CI 0.08-0.80; P = 0.01). Conclusions The presence of anti-ARS antibodies is a possible prognostic marker in patients with PM/DM-ILD.	[Hozumi, Hironao; Enomoto, Noriyuki; Kono, Masato; Fujisawa, Tomoyuki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4312102, Japan; [Sumikawa, Hiromitsu] Osaka Univ, Grad Sch Med, Diagnost & Intervent Radiol, Suita, Osaka, Japan; [Johkoh, Takeshi] Kinki Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Radiol, Itami, Hyogo, Japan; [Nakashima, Ran; Imura, Yoshitaka; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Kyoto University	Enomoto, N (corresponding author), Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan.	norieno@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264				Aggarwal R, 2014, ANN RHEUM DIS, V73, P227, DOI 10.1136/annrheumdis-2012-201800; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cottin V, 2003, EUR RESPIR J, V22, P245, DOI 10.1183/09031936.03.00026703; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182, DOI 10.1164/ajrccm.164.7.2103110; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Fujisawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098824; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Hamaguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060442; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hervier B, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0349-8; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Kalluri M, 2009, CHEST, V135, P1550, DOI 10.1378/chest.08-2233; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Marie I, 2013, ARTHRIT CARE RES, V65, P800, DOI 10.1002/acr.21895; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085062; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richards TJ, 2009, ARTHRITIS RHEUM-US, V60, P2183, DOI 10.1002/art.24631; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Schneider F, 2014, J CLIN PATHOL, V67, P678, DOI 10.1136/jclinpath-2014-202367; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Suda T, 2006, EUR RESPIR J, V28, P1005, DOI 10.1183/09031936.06.00038806; Suda T, 2010, RESP MED, V104, P1527, DOI 10.1016/j.rmed.2010.04.022; Takato H, 2013, RESP MED, V107, P128, DOI 10.1016/j.rmed.2012.09.005; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Tanizawa K, 2011, RESP MED, V105, P1380, DOI 10.1016/j.rmed.2011.05.006; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727, DOI 10.1164/ajrccm/141.3.727; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022; Yoshifuji H, 2006, AUTOIMMUNITY, V39, P233, DOI 10.1080/08916930600622884; Yousem SA, 2014, HUM PATHOL, V45, P1199, DOI 10.1016/j.humpath.2014.01.018	39	59	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120313	10.1371/journal.pone.0120313	http://dx.doi.org/10.1371/journal.pone.0120313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789468	Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400150
J	Balmant, W; Sugai-Guerios, MH; Coradin, JH; Krieger, N; Furigo, A; Mitchell, DA				Balmant, Wellington; Sugai-Guerios, Maura Harumi; Coradin, Juliana Hey; Krieger, Nadia; Furigo Junior, Agenor; Mitchell, David Alexander			A Model for Growth of a Single Fungal Hypha Based on Well-Mixed Tanks in Series: Simulation of Nutrient and Vesicle Transport in Aerial Reproductive Hyphae	PLOS ONE			English	Article							SPREADING COLONIAL MUTANTS; NEUROSPORA-CRASSA; CHITIN SYNTHASES; TIP GROWTH; WILD-TYPE; SPITZENKORPER; MORPHOGENESIS; PHYCOMYCES; NETWORKS; MICROORGANISMS	Current models that describe the extension of fungal hyphae and development of a mycelium either do not describe the role of vesicles in hyphal extension or do not correctly describe the experimentally observed profile for distribution of vesicles along the hypha. The present work uses the n-tanks-in-series approach to develop a model for hyphal extension that describes the intracellular transport of nutrient to a sub-apical zone where vesicles are formed and then transported to the tip, where tip extension occurs. The model was calibrated using experimental data from the literature for the extension of reproductive aerial hyphae of three different fungi, and was able to describe different profiles involving acceleration and deceleration of the extension rate. A sensitivity analysis showed that the supply of nutrient to the sub-apical vesicle-producing zone is a key factor influencing the rate of extension of the hypha. Although this model was used to describe the extension of a single reproductive aerial hypha, the use of the n-tanks-in-series approach to representing the hypha means that the model has the flexibility to be extended to describe the growth of other types of hyphae and the branching of hyphae to form a complete mycelium.	[Balmant, Wellington; Mitchell, David Alexander] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, Parana, Brazil; [Sugai-Guerios, Maura Harumi; Furigo Junior, Agenor] Univ Fed Santa Catarina, Dept Engn Quim & Engn Alimentos, BR-88040900 Florianopolis, SC, Brazil; [Coradin, Juliana Hey] Univ Fed Parana, Dept Engn Quim, BR-81531980 Curitiba, Parana, Brazil; [Krieger, Nadia] Univ Fed Parana, Dept Quim, BR-81531980 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal do Parana	Mitchell, DA (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, Cx P 19046 Ctr Politecn, BR-81531980 Curitiba, Parana, Brazil.	davidmitchell@ufpr.br	Sugai-Guerios, Maura Harumi/AAF-7090-2020; Krieger, Nadia/A-5749-2011; Mitchell, David A/A-8935-2008; balmant, wellington/AAG-5537-2020	Sugai-Guerios, Maura Harumi/0000-0002-3576-2879; Krieger, Nadia/0000-0003-0492-7308; Mitchell, David A/0000-0001-9355-5520; 	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science; Fundacao Araucaria, a funding agency of the state of Parana	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science; Fundacao Araucaria, a funding agency of the state of Parana	Research scholarships were granted to Wellington Balmant and Juliana Hey Coradin by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education, and to Nadia Krieger, Agenor Furigo Junior and David Alexander Mitchell by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science. This research was supported by a grant from Fundacao Araucaria, a funding agency of the state of Parana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Boswell GP, 2002, J THEOR BIOL, V217, P459, DOI 10.1006/jtbi.2002.3048; Boswell GP, 2008, MYCOL RES, V112, P1015, DOI 10.1016/j.mycres.2008.02.006; Boswell GP, 2007, B MATH BIOL, V69, P605, DOI 10.1007/s11538-005-9056-6; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; Bull A T, 1977, Adv Microb Physiol, V15, P1, DOI 10.1016/S0065-2911(08)60314-8; BUTLER EE, 1970, RHIZOCTONIA SOLANI B, P32; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; COLLINGE AJ, 1974, ARCH MICROBIOL, V99, P353, DOI 10.1007/BF00696249; Coradin JH, 2011, BIOCHEM ENG J, V54, P164, DOI 10.1016/j.bej.2011.02.012; COWAN MC, 1972, T BRIT MYCOL SOC, V58, P113, DOI 10.1016/S0007-1536(72)80077-9; Davidson Fordyce A., 2007, Fungal Biology Reviews, V21, P30, DOI 10.1016/j.fbr.2007.02.005; Dyson P, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P1; GOODAY GW, 1971, J GEN MICROBIOL, V67, P125, DOI 10.1099/00221287-67-2-125; GRUEN HE, 1959, PLANT PHYSIOL, V34, P158, DOI 10.1104/pp.34.2.158; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; HAYDUK W, 1974, AICHE J, V20, P611, DOI 10.1002/aic.690200329; JOHNSON DL, 1972, PLANT PHYSIOL, V49, P898, DOI 10.1104/pp.49.6.898; LopezIsunza F, 1997, CHEM ENG SCI, V52, P2629, DOI 10.1016/S0009-2509(97)00078-X; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Nopharatana M, 2003, BIOTECHNOL BIOENG, V84, P71, DOI 10.1002/bit.10752; Nopharatana M, 1998, BIOTECHNOL TECH, V12, P313, DOI 10.1023/A:1008810500243; Nopharatana M, 1999, THESIS U QUEENSLAND; Oostra J, 2001, BIOTECHNOL BIOENG, V75, P13, DOI 10.1002/bit.1159; PETZOLD L, 1989, NUMERICAL SOLUTION I; PROSSER JI, 1991, CRIT REV BIOTECHNOL, V10, P253, DOI 10.3109/07388559109038211; PROSSER JI, 1979, J GEN MICROBIOL, V111, P153, DOI 10.1099/00221287-111-1-153; Regalado CM, 1997, PHILOS T R SOC B, V352, P1963, DOI 10.1098/rstb.1997.0182; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Riquelme Meritxell, 2008, Fungal Biology Reviews, V22, P56, DOI 10.1016/j.fbr.2008.05.003; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Steinberg G, 2011, CURR OPIN MICROBIOL, V14, P660, DOI 10.1016/j.mib.2011.09.013; Steyaert JM, 2010, MICROBIOL-SGM, V156, P2887, DOI 10.1099/mic.0.041715-0; Tindemans SH, 2006, J THEOR BIOL, V238, P937, DOI 10.1016/j.jtbi.2005.07.004; TRINCI APJ, 1971, J GEN MICROBIOL, V67, P325, DOI 10.1099/00221287-67-3-325; TRINCI APJ, 1967, T BRIT MYCOL SOC, V50, P525, DOI 10.1016/S0007-1536(67)80084-6; TRINCI APJ, 1973, ARCH MIKROBIOL, V91, P127, DOI 10.1007/BF00424756; Trinci APJ, 1965, THESIS DURHAM U; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; YANG H, 1992, BIOTECHNOL BIOENG, V39, P49, DOI 10.1002/bit.260390109	43	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120307	10.1371/journal.pone.0120307	http://dx.doi.org/10.1371/journal.pone.0120307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785863	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500165
J	Bradfute, SB; Anthony, SM; Stuthman, KS; Ayithan, N; Tailor, P; Shaia, CI; Bray, M; Ozato, K; Bavari, S				Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Ayithan, Natarajan; Tailor, Prafullakumar; Shaia, Carl I.; Bray, Mike; Ozato, Keiko; Bavari, Sina			Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection	PLOS ONE			English	Article							PROTECTS NONHUMAN-PRIMATES; MARBURG HEMORRHAGIC-FEVER; T-CELL RESPONSES; DENDRITIC CELLS; MOUSE MODEL; GUINEA-PIGS; PATHOGENESIS; ANTIBODY; PROPHYLAXIS; PARTICLES	Ebolaviruses can cause severe hemorrhagic fever that is characterized by rapid viral replication, coagulopathy, inflammation, and high lethality rates. Although there is no clinically proven vaccine or treatment for Ebola virus infection, a virus-like particle (VLP) vaccine is effective in mice, guinea pigs, and non-human primates when given pre-infection. In this work, we report that VLPs protect Ebola virus-infected mice when given 24 hours post-infection. Analysis of cytokine expression in serum revealed a decrease in pro-inflammatory cytokine and chemokine levels in mice given VLPs post-exposure compared to infected, untreated mice. Using knockout mice, we show that VLP-mediated post-exposure protection requires perforin, B cells, macrophages, conventional dendritic cells (cDCs), and either CD4+ or CD8+ T cells. Protection was Ebola virus-specific, as marburgvirus VLPs did not protect Ebola virus-infected mice. Increased antibody production in VLP-treated mice correlated with protection, and macrophages were required for this increased production. However, NK cells, IFN-gamma, and TNF-alpha were not required for post-exposure-mediated protection. These data suggest that a non-replicating Ebola virus vaccine can provide post-exposure protection and that the mechanisms of immune protection in this setting require both increased antibody production and generation of cytotoxic T cells.	[Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Shaia, Carl I.; Bavari, Sina] US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Ayithan, Natarajan; Ozato, Keiko] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Tailor, Prafullakumar] Natl Inst Immunol, New Delhi 110067, India; [Bray, Mike] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bavari, S (corresponding author), US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	sina.bavari.civ@mail.mil	Shaia, Carl/X-3555-2019; Bavari, Sina/L-3642-2019; Ayithan, Natarajan/ABH-3392-2020	Shaia, Carl/0000-0001-8907-8821; Bavari, Sina/0000-0001-8424-5635; Anthony, Scott/0000-0002-1590-7401	Defense Threat Reduction Agency [1.1C003_08_RD_B]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815, ZIAHD001310] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Defense Threat Reduction Agency to SB (1.1C003_08_RD_B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Arora S, 2006, INFECT IMMUN, V74, P4339, DOI 10.1128/IAI.01989-05; Ayithan N, 2015, PLOS ONE IN PRESS; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Bradfute SB, 2011, HUM VACCIN, V7; Bradfute SB, 2008, J IMMUNOL, V180, P4058, DOI 10.4049/jimmunol.180.6.4058; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Christiansen AJ, 2011, P NATL ACAD SCI USA, V108, P4141, DOI 10.1073/pnas.1011037108; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dunne PJ, 2009, J IMMUNOL, V183, P400, DOI 10.4049/jimmunol.0900169; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08; Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; GEISBERT TW, 1992, J COMP PATHOL, V106, P137, DOI 10.1016/0021-9975(92)90043-T; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Huffnagle GB, 1996, J IMMUNOL, V157, P4529; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Muniz LR, 2011, J IMMUNOL, V187, P828, DOI 10.4049/jimmunol.1004233; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Onyango CO, 2007, J INFECT DIS, V196, pS193, DOI 10.1086/520609; Panchal RG, 2009, CELL HOST MICROBE, V6, P162, DOI 10.1016/j.chom.2009.07.003; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Wyers M, 1999, J INFECT DIS, V179, pS54, DOI 10.1086/514300; Yang CL, 2008, EXPERT REV VACCINES, V7, P333, DOI 10.1586/14760584.7.3.333; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zhong WM, 2001, J IMMUNOL, V167, P1379, DOI 10.4049/jimmunol.167.3.1379	69	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118434	10.1371/journal.pone.0118434	http://dx.doi.org/10.1371/journal.pone.0118434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785602	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500034
J	Colloca, F; Garofalo, G; Bitetto, I; Facchini, MT; Grati, F; Martiradonna, A; Mastrantonio, G; Nikolioudakis, N; Ordinas, F; Scarcella, G; Tserpes, G; Tugores, MP; Valavanis, V; Carlucci, R; Fiorentino, F; Follesa, MC; Iglesias, M; Knittweis, L; Lefkaditou, E; Lembo, G; Manfredi, C; Massuti, E; Pace, ML; Papadopoulou, N; Sartor, P; Smith, CJ; Spedicato, MT				Colloca, Francesco; Garofalo, Germana; Bitetto, Isabella; Facchini, Maria Teresa; Grati, Fabio; Martiradonna, Angela; Mastrantonio, Gianluca; Nikolioudakis, Nikolaos; Ordinas, Francesc; Scarcella, Giuseppe; Tserpes, George; Pilar Tugores, M.; Valavanis, Vasilis; Carlucci, Roberto; Fiorentino, Fabio; Follesa, Maria C.; Iglesias, Magdalena; Knittweis, Leyla; Lefkaditou, Eugenia; Lembo, Giuseppe; Manfredi, Chiara; Massuti, Enric; Pace, Marie Louise; Papadopoulou, Nadia; Sartor, Paolo; Smith, Christopher J.; Spedicato, Maria Teresa			The Seascape of Demersal Fish Nursery Areas in the North Mediterranean Sea, a First Step Towards the Implementation of Spatial Planning for Trawl Fisheries	PLOS ONE			English	Article							HAKE MERLUCCIUS-MERLUCCIUS; EFFECTIVE JUVENILE HABITATS; WATER ROSE SHRIMP; PARAPENAEUS-LONGIROSTRIS; MARINE NURSERIES; ENVIRONMENTAL-FACTORS; STRAIT; ASSEMBLAGES; VARIABILITY; MANAGEMENT	The identification of nursery grounds and other essential fish habitats of exploited stocks is a key requirement for the development of spatial conservation planning aimed at reducing the adverse impact of fishing on the exploited populations and ecosystems. The reduction in juvenile mortality is particularly relevant in the Mediterranean and is considered as one of the main prerequisites for the future sustainability of trawl fisheries. The distribution of nursery areas of 11 important commercial species of demersal fish and shellfish was analysed in the European Union Mediterranean waters using time series of bottom trawl survey data with the aim of identifying the most persistent recruitment areas. A high interspecific spatial overlap between nursery areas was mainly found along the shelf break of many different sectors of the Northern Mediterranean indicating a high potential for the implementation of conservation measures. Overlap of the nursery grounds with existing spatial fisheries management measures and trawl fisheries restricted areas was also investigated. Spatial analyses revealed considerable variation depending on species and associated habitat/depth preferences with increased protection seen in coastal nurseries and minimal protection seen for deeper nurseries (e.g. Parapenaeus longirostris 6%). This is partly attributed to existing environmental policy instruments (e.g. Habitats Directive and Mediterranean Regulation EC 1967/2006) aiming at minimising impacts on coastal priority habitats such as seagrass, coralligenous and maerl beds. The new knowledge on the distribution and persistence of demersal nurseries provided in this study can support the application of spatial conservation measures, such as the designation of no-take Marine Protected Areas in EU Mediterranean waters and their inclusion in a conservation network. The establishment of no-take zones will be consistent with the objectives of the Common Fisheries Policy applying the ecosystem approach to fisheries management and with the requirements of the Marine Strategy Framework Directive to maintain or achieve seafloor integrity and good environmental status.	[Colloca, Francesco; Garofalo, Germana; Fiorentino, Fabio] CNR, IAMC, Mazara Del Vallo, Italy; [Bitetto, Isabella; Facchini, Maria Teresa; Martiradonna, Angela; Lembo, Giuseppe; Spedicato, Maria Teresa] COISPA Tecnol & Ric, Bari, Italy; [Grati, Fabio; Scarcella, Giuseppe] CNR, Ist Sci Marine ISMAR, Ancona, Italy; [Mastrantonio, Gianluca] Univ Rome Tre, Dept Econ, I-00146 Rome, Italy; [Nikolioudakis, Nikolaos; Tserpes, George; Valavanis, Vasilis; Lefkaditou, Eugenia; Papadopoulou, Nadia; Smith, Christopher J.] Hellen Ctr Marine Res, Iraklion, Greece; [Ordinas, Francesc; Pilar Tugores, M.; Iglesias, Magdalena; Massuti, Enric] Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Carlucci, Roberto] Univ Bari, Dept Biol, Bari, Italy; [Follesa, Maria C.] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Knittweis, Leyla] Univ Malta, Dept Biol, Msida, Malta; [Manfredi, Chiara] Univ Bologna, Lab Biol Marina Fano, Bologna, Italy; [Pace, Marie Louise] Minist Sustainable Dev Environm & Climate Change, Dept Fisheries & Aquaculture, Santa Venera, Malta; [Sartor, Paolo] Ctr Interuniv Biol Marina & Ecol Applicata G Bacc, Livorno, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Roma Tre University; Hellenic Centre for Marine Research; Spanish Institute of Oceanography; Universita degli Studi di Bari Aldo Moro; University of Cagliari; University of Malta; University of Bologna	Colloca, F (corresponding author), CNR, IAMC, Mazara Del Vallo, Italy.	francesco.colloca@iamc.cnr.it	Tugores, M.P./AAE-5569-2020; mastrantonio, gianluca/ABE-5936-2021; Nikolioudakis, Nikolaos/A-9986-2013; Massutí, Enric/AAG-5117-2021; Fiorentino, Fabio/AAX-2883-2020; Isajlovic, Igor/AAP-9861-2020; Valavanis, Vasilis D/G-8869-2011; Scarcella, Giuseppe/AAW-3850-2020; Tserpes, George/L-6201-2013; Carlucci, Roberto/C-5728-2009; Ordinas, Francesc/AAG-7079-2021; Carlucci, Roberto/ABC-7196-2020; Grati, Fabio/AAT-4760-2020	Tugores, M.P./0000-0003-2923-3038; mastrantonio, gianluca/0000-0002-2963-6729; Nikolioudakis, Nikolaos/0000-0002-5029-5164; Fiorentino, Fabio/0000-0002-6302-649X; Valavanis, Vasilis D/0000-0001-6288-6044; Tserpes, George/0000-0001-9052-4091; Carlucci, Roberto/0000-0002-9287-6936; Colloca, Francesco/0000-0002-0574-2893; martiradonna, angela/0000-0001-9147-1200; Spedicato, Maria Teresa/0000-0001-9939-9426; Iglesias, M. (Magdalena)/0000-0002-9983-558X; Lembo, Giuseppe/0000-0002-9899-6189; GRATI, FABIO/0000-0002-1793-303X; SARTOR, PAOLO/0000-0001-7239-8255; Papadopoulou, Nadia/0000-0003-4767-9949; Smith, Christopher/0000-0002-3031-5316; Scarcella, Giuseppe/0000-0001-6540-1997; Ordines, F. (Francesc)/0000-0002-2456-2214; Knittweis-Mifsud, Leyla/0000-0001-9023-2750; Massuti, Enric/0000-0002-9524-5873; Lefkaditou, Evgenia/0000-0002-7868-5375	Commission of the European Union (DG MARE) [MAREA/2009/05]	Commission of the European Union (DG MARE)	This study was supported and financed by the Commission of the European Union (DG MARE) through the Project MEDISEH: Mediterranean Sensitive Habitats within the MAREA Framework contract (Call for tenders MAREA/2009/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2008, J MARINE SYST, V71, P279, DOI 10.1016/j.jmarsys.2007.05.010; Abello P, 2002, SCI MAR, V66, P125, DOI 10.3989/scimar.2002.66s2125; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Ardizzone GD, 1997, ATLAS ITALIAN DEMERS; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Artioli Y, 2005, ECOL MODEL, V184, P55, DOI 10.1016/j.ecolmodel.2004.11.008; Bakun A., 1996, OCEAN PROCESSES MARI; Bartolino V, 2008, ICES J MAR SCI, V65, P963, DOI 10.1093/icesjms/fsn079; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Beverton R.J.H., 1957, FISHERY INVESTIGAT 2, V2; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; Bradai M. N., 2012, ELASMOBRANCHS MEDITE; Caddy JF, 1993, SCI MAR, V57, P121; Carlucci R, 2009, ESTUAR COAST SHELF S, V83, P529, DOI 10.1016/j.ecss.2009.04.034; Carpentieri P, 2005, ESTUAR COAST SHELF S, V63, P577, DOI 10.1016/j.ecss.2005.01.005; CASANOVA B, 1970, Revue des Travaux de l'Institut des Peches Maritimes, V34, P205; Cau A, 2002, SCI MAR, V66, P103, DOI 10.3989/scimar.2002.66s2103; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Colloca F, 2004, MAR BIOL, V145, P1129, DOI 10.1007/s00227-004-1405-8; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Colloca F, 2009, MAR ECOL PROG SER, V381, P287, DOI 10.3354/meps07942; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; de Juan S, 2012, OCEAN COAST MANAGE, V65, P51, DOI 10.1016/j.ocecoaman.2012.04.024; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Early R, 2008, J APPL ECOL, V45, P228, DOI 10.1111/j.1365-2664.2007.01424.x; Estrada M, 1996, SCI MAR, V60, P55; Fiorentino F, 2003, HYDROBIOLOGIA, V503, P223, DOI 10.1023/B:HYDR.0000008485.85468.ef; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Grati F, 2013, J SEA RES, V84, P122, DOI 10.1016/j.seares.2013.05.001; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hinckley S, 2001, ICES J MAR SCI, V58, P1042, DOI 10.1006/jmsc.2001.1096; Hueter Robert E., 1998, Shark News, V12, P1; Lavaleye MSS, 2002, PROG OCEANOGR, V52, P459, DOI 10.1016/S0079-6611(02)00019-8; Lembo G., 2000, Biologia Marina Mediterranea, V7, P98; Lembo G, 2000, CRUSTACEANA, V73, P39, DOI 10.1163/156854000504101; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Manson FJ, 2005, FISH RES, V74, P69, DOI 10.1016/j.fishres.2005.04.001; Massuti E, 2003, ICES J MAR SCI, V60, P753, DOI 10.1016/S1054-3139(03)00089-4; Maynou F, 2003, FISH RES, V60, P65, DOI 10.1016/S0165-7836(02)00062-0; McCullagh P, 1989, GEN LINEAR MODELS; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059038; MMO, 2013, MMO PROJECT NO 1044; Morfin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037907; Murenu M, 2010, GIS SPATIAL ANAL FIS, P51; Nagelkerken I, 2013, FISH FISH; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Ordines F, 2011, CONT SHELF RES, V31, P1835, DOI 10.1016/j.csr.2011.08.007; Pinazo C, 1996, J MARINE SYST, V7, P161, DOI 10.1016/0924-7963(95)00028-3; Planque B, 2011, FISH OCEANOGR, V20, P1, DOI 10.1111/j.1365-2419.2010.00546.x; Ragonese S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074865; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Roberts CM, 2003, ECOL APPL, V13, pS199; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Rochet MJ, 2013, E21 ICES CM, VE, P21; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; SABATES A, 1989, MAR BIOL, V103, P153, DOI 10.1007/BF00543342; Salat J, 1996, SCI MAR, V60, P21; Sartor P, 2002, SCI MAR, V66, P83, DOI 10.3989/scimar.2002.66s283; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Schumaker LL, 1976, APPROXIMATION THEORY, VII, P203; Sheaves M, 2006, MAR ECOL PROG SER, V318, P303, DOI 10.3354/meps318303; STECF (Scientific Technical Economic Committee for Fisheries), 2011, STECF1114; STECF (Scientific Technical Economic Committee for Fisheries), 2013, EUR SCI TECHN RES SE; Tsagarakis K., 2013, ICES J MAR SCI; Tserpes G, 2008, HYDROBIOLOGIA, V612, P125, DOI 10.1007/s10750-008-9486-x; Tsikliras AC, 2010, REV FISH BIOL FISHER, V20, P499, DOI 10.1007/s11160-010-9158-6; Tudela S., 2004, FAO STUDIES REV, V74; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Vasconcelos RP, 2011, ECOL INDIC, V11, P1123, DOI 10.1016/j.ecolind.2010.12.012; Vilibic I, 2002, DEEP-SEA RES PT I, V49, P1321, DOI 10.1016/S0967-0637(02)00028-6; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	81	77	77	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119590	10.1371/journal.pone.0119590	http://dx.doi.org/10.1371/journal.pone.0119590			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785737	Green Published, gold			2022-12-26	WOS:000352138500116
J	Holland, EP; James, A; Ruscoe, WA; Pech, RP; Byrom, AE				Holland, E. Penelope; James, Alex; Ruscoe, Wendy A.; Pech, Roger P.; Byrom, Andrea E.			Climate-Based Models for Pulsed Resources Improve Predictability of Consumer Population Dynamics: Outbreaks of House Mice in Forest Ecosystems	PLOS ONE			English	Article							MAST; PREDATION; RODENT; SEED; MOUSE; RESPONSES; DISEASE; FLUCTUATIONS; TEMPERATURE; AUSTRALIA	Accurate predictions of the timing and magnitude of consumer responses to episodic seeding events (masts) are important for understanding ecosystem dynamics and for managing outbreaks of invasive species generated by masts. While models relating consumer populations to resource fluctuations have been developed successfully for a range of natural and modified ecosystems, a critical gap that needs addressing is better prediction of resource pulses. A recent model used change in summer temperature from one year to the next (Delta T) for predicting masts for forest and grassland plants in New Zealand. We extend this climate-based method in the framework of a model for consumer-resource dynamics to predict invasive house mouse (Mus musculus) outbreaks in forest ecosystems. Compared with previous mast models based on absolute temperature, the Delta T method for predicting masts resulted in an improved model for mouse population dynamics. There was also a threshold effect of Delta T on the likelihood of an outbreak occurring. The improved climate-based method for predicting resource pulses and consumer responses provides a straightforward rule of thumb for determining, with one year's advance warning, whether management intervention might be required in invaded ecosystems. The approach could be applied to consumer-resource systems worldwide where climatic variables are used to model the size and duration of resource pulses, and may have particular relevance for ecosystems where global change scenarios predict increased variability in climatic events.	[Holland, E. Penelope; Ruscoe, Wendy A.; Pech, Roger P.; Byrom, Andrea E.] Landcare Res, Canterbury, New Zealand; [Holland, E. Penelope] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [James, Alex] Univ Canterbury, Biomath Res Ctr, Christchurch 1, New Zealand; [Ruscoe, Wendy A.] Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia	Landcare Research - New Zealand; University of York - UK; University of Canterbury; University of Canberra	Holland, EP (corresponding author), Landcare Res, Canterbury, New Zealand.	pen.holland@york.ac.uk	Ruscoe, Wendy A./A-5273-2018	Ruscoe, Wendy A./0000-0002-7763-0356; James, Alex/0000-0002-1543-7139	Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment [C09X0909]	Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	The authors were funded by the Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment (contract C09X0909 and core funding to Crown Research Institutes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Ackerley D, 2012, WEATHER CLIM, V32, P3; Allen RB, 2012, OIKOS, V121, P367, DOI 10.1111/j.1600-0706.2011.19306.x; Bayliss P., 1987, P119; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Choquenot D, 2006, CONSERV BIOL, V20, P480, DOI 10.1111/j.1523-1739.2006.00343.x; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; Choquenot D, 2000, J ANIM ECOL, V69, P1058, DOI 10.1046/j.1365-2656.2000.00462.x; Cleaveland S, 2007, SERENGETI, P209; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Davis SA, 2002, PHILOS T ROY SOC B, V357, P1249, DOI 10.1098/rstb.2002.1125; Drobyshev I, 2010, FOREST ECOL MANAG, V259, P2160, DOI 10.1016/j.foreco.2010.01.037; EILER JH, 1989, J WILDLIFE MANAGE, V53, P353, DOI 10.2307/3801137; FITZGERALD BM, 1979, NEW ZEAL J ZOOL, V6, P107; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Haynes KJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2373; Holland EP, 2015, THEOR ECOL-NETH, V8, P121, DOI 10.1007/s12080-014-0238-4; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2008, POPUL ECOL, V50, P343, DOI 10.1007/s10144-008-0109-1; Kelly D, 2013, ECOL LETT, V16, P90, DOI [1, 10.1111/ele.12020]; KING CM, 1983, J ANIM ECOL, V52, P141, DOI 10.2307/4593; Koenig WD, 2014, POPUL ECOL, V56, P63, DOI 10.1007/s10144-013-0408-z; Korpela K, 2013, GLOBAL CHANGE BIOL, V19, P697, DOI 10.1111/gcb.12099; Krebs CJ, 2012, BOTANY, V90, P113, DOI [10.1139/B11-088, 10.1139/b11-088]; Krebs CJ, 2004, WILDLIFE RES, V31, P465, DOI 10.1071/WR03131; LaMontagne JM, 2009, J VEG SCI, V20, P745, DOI 10.1111/j.1654-1103.2009.01068.x; Leirs H, 1996, J APPL ECOL, V33, P937, DOI 10.2307/2404675; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; McKone MJ, 1998, GLOB CHANGE BIOL, V4, P591, DOI 10.1046/j.1365-2486.1998.00172.x; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; ODonnell CFJ, 1996, NEW ZEAL J ZOOL, V23, P287, DOI 10.1080/03014223.1996.9518087; Ostfeld RS, 2008, J ANIM ECOL, V77, P201, DOI 10.1111/j.1365-2656.2008.01364.x; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 1997, AM SCI, V85, P338; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; Pearse IS, 2014, OIKOS, V123, P179, DOI 10.1111/j.1600-0706.2013.00608.x; Pech R, 1997, REPROD FERT DEVELOP, V9, P41, DOI 10.1071/R96059; Pech R.P., 2002, ACIAR Monograph Series, V96, P311; Pech R. P., 1999, Ecologically-based management of rodent pests., P81; Pech RP, 1998, J APPL ECOL, V35, P434, DOI 10.1046/j.1365-2664.1998.00318.x; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Poncet BN, 2009, OECOLOGIA, V159, P527, DOI 10.1007/s00442-008-1233-5; Ruscoe W.A., 2010, RODENT OUTBREAKS ECO, P239; Ruscoe WA, 2005, J ANIM ECOL, V74, P1005, DOI 10.1111/j.1365-2656.2005.00998.x; Ruscoe WA, 2013, CONSERV BIOL, V27, P74, DOI 10.1111/j.1523-1739.2012.01932.x; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Shi DZ, 2002, J APPL ECOL, V39, P337, DOI 10.1046/j.1365-2664.2002.00716.x; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; Skalski GT, 2001, ECOLOGY, V82, P3083; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Tompkins DM, 2013, ECOL APPL, V23, P1075, DOI 10.1890/12-0915.1; Turnbull MH, 2012, FUNCT PLANT BIOL, V39, P38, DOI 10.1071/FP11116; Wardle J., 1984, NZ BEECHES ECOLOGY U; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; Wilson PR, 1998, BIOL CONSERV, V83, P175, DOI 10.1016/S0006-3207(97)00055-4; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Zhang ZB, 2003, OIKOS, V100, P299, DOI 10.1034/j.1600-0706.2003.11810.x	64	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119139	10.1371/journal.pone.0119139	http://dx.doi.org/10.1371/journal.pone.0119139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785866	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500077
J	Li, QJ; Serb, A; Prodromakis, T; Xu, H				Li, Qingjiang; Serb, Alexander; Prodromakis, Themistoklis; Xu, Hui			A Memristor SPICE Model Accounting for Synaptic Activity Dependence	PLOS ONE			English	Article							PLASTICITY; SYSTEMS	In this work, we propose a new memristor SPICE model that accounts for the typical synaptic characteristics that have been previously demonstrated with practical memristive devices. We show that this model could account for both volatile and non-volatile memristance changes under distinct stimuli. We then demonstrate that our model is capable of supporting typical STDP with simple non-overlapping digital pulse pairs. Finally, we investigate the capability of our model to simulate the activity dependence dynamics of synaptic modification and present simulated results that are in excellent agreement with biological results.	[Li, Qingjiang; Xu, Hui] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China; [Serb, Alexander; Prodromakis, Themistoklis] Univ Southampton, Southampton Nanofabricat Ctr, Dept Elect & Comp Sci, Nano Grp, Southampton, Hants, England	National University of Defense Technology - China; University of Southampton	Xu, H (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	xuhui@nudt.edu.cn	Serb, Alexantrou/AAI-4054-2020; Prodromakis, Themistoklis/N-9315-2015	Serb, Alexantrou/0000-0002-8034-2398; Prodromakis, Themistoklis/0000-0002-6267-6909	National Natural Science Foundation of China [61171017]; Engineering and Physical Sciences Research Council [EP/K017829/1]; EPSRC [EP/K017829/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	1. National Natural Science Foundation of China, 61171017, http://www.nsfc.gov.cn/. L.Q. and X.H. 2. Engineering and Physical Sciences Research Council EP/K017829/1, http://www.epsrc.ac.uk/. A.S. and T.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli A, 2013, IEEE CIRC SYST MAG, V13, P89, DOI 10.1109/MCAS.2013.2256272; Berdan R, 2014, IEEE ELECTR DEVICE L, V35, P135, DOI 10.1109/LED.2013.2291158; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Biolek Z, 2009, RADIOENGINEERING, V18, P210; Chang T, 2012, CELL NAN NETW THEIR, P29; Chang T, 2011, ACS NANO, V5, P7669, DOI 10.1021/nn202983n; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Fursina AA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245131; Giacomo I, 2013, NANOTECHNOLOGY, V24, DOI [10.1088/0957-4484/24/38/384010, DOI 10.1088/0957-4484/24/38/384010]; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kumar S, 2013, ADV MATER, V25, P6128, DOI 10.1002/adma.201302046; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01619; Pershin YV, ARXIV201212042600; Pfister JP, 2005, ADV NEURAL INFORM PR, P1081; Serb A, 2014, CIRC SYST ISCAS 2014, P2085; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Wang ZQ, 2012, ADV FUNCT MATER, V22, P2759, DOI 10.1002/adfm.201103148; Williamson A, 2013, NANOSCALE, V5, P7297, DOI 10.1039/c3nr01834b; Zamarreno-Ramos C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00026	20	22	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120506	10.1371/journal.pone.0120506	http://dx.doi.org/10.1371/journal.pone.0120506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785597	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000352138500179
J	Portovedo, M; Ignacio-Souza, LM; Bombassaro, B; Coope, A; Reginato, A; Razolli, DS; Torsoni, MA; Torsoni, AS; Leal, RF; Velloso, LA; Milanski, M				Portovedo, Mariana; Ignacio-Souza, Leticia M.; Bombassaro, Bruna; Coope, Andressa; Reginato, Andressa; Razolli, Daniela S.; Torsoni, Marcio A.; Torsoni, Adriana S.; Leal, Raquel F.; Velloso, Licio A.; Milanski, Marciane			Saturated Fatty Acids Modulate Autophagy's Proteins in the Hypothalamus	PLOS ONE			English	Article							N-TERMINAL KINASE; BETA/NF-KAPPA-B; INSULIN-RESISTANCE; ENERGY-METABOLISM; CELL-DEATH; ER STRESS; OBESITY; BRAIN; MECHANISM; NEURONS	Autophagy is an important process that regulates cellular homeostasis by degrading dysfunctional proteins, organelles and lipids. In this study, the hypothesis that obesity could lead to impairment in hypothalamic autophagy in mice was evaluated by examining the hypothalamic distribution and content of autophagic proteins in animal with obesity induced by 8 or 16 weeks high fat diet to induce obesity and in response to intracerebroventricular injections of palmitic acid. The results showed that chronic exposure to a high fat diet leads to an increased expression of inflammatory markers and downregulation of autophagic proteins. In obese mice, autophagic induction leads to the downregulation of proteins, such as JNK and Bax, which are involved in the stress pathways. In neuron cell-line, palmitate has a direct effect on autophagy even without inflammatory activity. Understanding the cellular and molecular bases of overnutrition is essential for identifying new diagnostic and therapeutic targets for obesity.	[Portovedo, Mariana; Reginato, Andressa; Torsoni, Marcio A.; Torsoni, Adriana S.; Milanski, Marciane] Univ Estadual Campinas, UNICAMP, Fac Sci Appl, Limeira, Brazil; [Portovedo, Mariana; Bombassaro, Bruna; Coope, Andressa; Reginato, Andressa; Razolli, Daniela S.; Torsoni, Marcio A.; Torsoni, Adriana S.; Leal, Raquel F.; Velloso, Licio A.; Milanski, Marciane] Univ Estadual Campinas, UNICAMP, Obes & Comorbid Res Ctr, Campinas, SP, Brazil; [Ignacio-Souza, Leticia M.] Univ Fed Mato Grosso, Fac Nutr, Cuiaba, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Mato Grosso	Milanski, M (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Sci Appl, Limeira, Brazil.	marciane.milanski@fca.unicamp.br	Leal, Raquel/W-7997-2019; Torsoni, Marcio A/E-9982-2012; Milanski, Marciane/F-5410-2012; Razolli, Daniela S/B-1630-2014; Velloso, Licio/AAJ-3778-2020; Torsoni, Marcio/AAH-3450-2020; Torsoni, Adriana/HGC-4584-2022; Ignacio-Souza, Leticia/D-7510-2013	Leal, Raquel/0000-0003-4285-4402; Milanski, Marciane/0000-0002-6322-5368; Razolli, Daniela S/0000-0002-2217-0946; Torsoni, Adriana/0000-0003-2287-7180; Ignacio-Souza, Leticia/0000-0002-2040-1851; Torsoni, Marcio/0000-0002-9663-5291; Coope, Andressa/0000-0002-7356-9690; Portovedo, Mariana/0000-0001-6417-8252	Sao Paulo Research Foundation (FAPESP) [2011/14565-4, RA 2011/51205-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project has been funded by grants 2011/14565-4 (MP) and RA 2011/51205-6 (MM), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Coupe B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; National Research Council, GUIDE CARE USE LAB A; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Quan W, 2012, ENDOCRINOLOGY, V153, P1817, DOI 10.1210/en.2011-1882; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; van de Sande-Lee S, 2011, DIABETES, V60, P1699, DOI 10.2337/db10-1614; Velloso LA, 2011, INT J OBESITY, V35, P1455, DOI 10.1038/ijo.2011.56; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang X, 2013, AUTOPHAGY, V12, P9; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	57	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119850	10.1371/journal.pone.0119850	http://dx.doi.org/10.1371/journal.pone.0119850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786112	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500135
J	Solodenko, N; Zupancich, A; Cesaro, SN; Marder, O; Lemorini, C; Barkai, R				Solodenko, Natalya; Zupancich, Andrea; Cesaro, Stella Nunziante; Marder, Ofer; Lemorini, Cristina; Barkai, Ran			Fat Residue and Use-Wear Found on Acheulian Biface and Scraper Associated with Butchered Elephant Remains at the Site of Revadim, Israel	PLOS ONE			English	Article							STONE TOOL FUNCTION; OLDUVAI GORGE; EARLY HUMANS; FT-IR; BONE; SPECTROSCOPY; AGE; IDENTIFICATION; NEANDERTHAL; WOODWORKING	The archaeological record indicates that elephants must have played a significant role in early human diet and culture during Palaeolithic times in the Old World. However, the nature of interactions between early humans and elephants is still under discussion. Elephant remains are found in Palaeolithic sites, both open-air and cave sites, in Europe, Asia, the Levant, and Africa. In some cases elephant and mammoth remains indicate evidence for butchering and marrow extraction performed by humans. Revadim Quarry (Israel) is a Late Acheulian site where elephant remains were found in association with characteristic Lower Palaeolithic flint tools. In this paper we present results regarding the use of Palaeolithic tools in processing animal carcasses and rare identification of fat residue preserved on Lower Palaeolithic tools. Our results shed new light on the use of Palaeolithic stone tools and provide, for the first time, direct evidence (residue) of animal exploitation through the use of an Acheulian biface and a scraper. The association of an elephant rib bearing cut marks with these tools may reinforce the view suggesting the use of Palaeolithic stone tools in the consumption of large game.	[Solodenko, Natalya; Zupancich, Andrea; Barkai, Ran] Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel; [Cesaro, Stella Nunziante] Univ Roma La Sapienza, Dept Chem, ISMN CNR, SMATCH, I-00185 Rome, Italy; [Marder, Ofer] Ben Gurion Univ Negev, Dept Bible Archaeol & Ancient Near Eastern Studie, IL-84105 Beer Sheva, Israel; [Lemorini, Cristina] Univ Roma La Sapienza, Dept Class, I-00185 Rome, Italy	Tel Aviv University; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Sapienza University Rome; Ben Gurion University; Sapienza University Rome	Barkai, R (corresponding author), Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel.	barkaran@post.tau.ac.il	Barkai, Ran/L-6495-2019; lemorini, cristina/ABD-5327-2020	lemorini, cristina/0000-0002-6998-1615; BARKAI, RAN/0000-0002-8125-8788; Zupancich, Andrea/0000-0002-9503-1234				Acerbo AS, 2012, ANAL CHEM, V84, P3607, DOI 10.1021/ac203375d; Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Agam A, 2014, QUAT INT IN PRESS; Anderson PC, 2013, INTERDISCIPLINARY FO, P89; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; Anzidel AP, 2012, QUATERN INT, V255, P171, DOI 10.1016/j.quaint.2011.06.005; Ashton N., 1992, P PREHIST SOC, V58, P21; Bar-Yosef O, 2011, QUATERNARY SCI REV, V30, P1318, DOI 10.1016/j.quascirev.2010.02.016; Barkai R., 2013, DYNAMICS LEARNING NE, V1, P115, DOI DOI 10.1007/978-4-431-54511-8_7; Barkai R, 2009, CURR ANTHROPOL, V50, P356; BARYOSEF O, 1994, J WORLD PREHIST, V8, P211, DOI 10.1007/BF02221050; Ben-Dor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028689; Bisson MS, 2001, CAMB ARCHAEOL J, V11, P165, DOI 10.1017/S0959774301000099; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; Brumm A, 2011, J HUM EVOL, V60, P185, DOI 10.1016/j.jhevol.2010.09.005; Burdukiewicz J. M., 2003, LOWER PALAEOLITHIC S; Cesaro SN, 2012, SPECTROCHIM ACTA A, V86, P299, DOI 10.1016/j.saa.2011.10.040; Chazan M, 2000, MITEKUFAT HAEVEN J I, V30, P7; Chazan M, 2006, J ANTHROPOL ARCHAEOL, V25, P436, DOI 10.1016/j.jaa.2006.03.005; Claud E, 2012, GALLIA PREHISTOIRE, V54, P332; Demay L, 2012, QUATERN INT, V276, P212, DOI 10.1016/j.quaint.2011.11.019; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P32, DOI 10.1016/j.quaint.2013.09.042; Forbes SL, 2005, FORENSIC SCI INT, V154, P24, DOI 10.1016/j.forsciint.2004.09.107; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; Genestar C, 2005, ANAL BIOANAL CHEM, V382, P269, DOI 10.1007/s00216-005-3085-8; Germonpre M, 2014, QUATERN INT, V337, P28, DOI 10.1016/j.quaint.2012.10.035; Germonpre M, 2008, J ANTHROPOL ARCHAEOL, V27, P475, DOI 10.1016/j.jaa.2008.07.003; Goren-Inbar N, 2008, J HUM EVOL, V55, P702, DOI 10.1016/j.jhevol.2008.07.005; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Goren-Inbar N., 1985, PALEORIENT, V11, P7; Goren-Inbar N, 1998, ARCHAEOLOGY SOC HOLY; Gowlett JAJ, 2001, PALEOANTHROPOLOGY SO, P174; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hardy BL, 1998, J ARCHAEOL SCI, V25, P177, DOI 10.1006/jasc.1997.0234; Hardy BL, 2001, P NATL ACAD SCI USA, V98, P10972, DOI 10.1073/pnas.191384498; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; HARRIS JWK, 1978, THESIS U CALIFORNIA; Herrygers C., 2002, MCNAIR SCHOLARS J, V6, P65; Howell FC, 1962, ACT 4 C PAN PREH ET, P43; HUNT GR, 1972, APPL OPTICS, V11, P142, DOI 10.1364/AO.11.000142; Izzo FC, 2013, J ARCHAEOL SCI, V40, P595, DOI 10.1016/j.jas.2012.06.017; Keeley L.H., 1980, EXPT DETERMINATION S; KEELEY LH, 1977, J ARCHAEOL SCI, V4, P29, DOI 10.1016/0305-4403(77)90111-X; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Kohn M, 1999, ANTIQUITY, V73, P518, DOI 10.1017/S0003598X00065078; Koirala B, 2009, J ARCHAEOL SCI, V36, P1229, DOI 10.1016/j.jas.2009.01.012; Lemorini C, 1999, ANNUARIO STORICO VAL, P47; Lombard M, 2004, S AFR J SCI, V100, P159; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; LOY TH, 1983, SCIENCE, V220, P1269, DOI 10.1126/science.220.4603.1269; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Machin A, 2009, J SOC ARCHAEOL, V9, P35, DOI 10.1177/1469605308099370; Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6; Marder O, 1999, J ISRAEL PREHISTORIC, V28, P21; Marder O, 2011, J HUM EVOL, V60, P508, DOI 10.1016/j.jhevol.2010.01.007; Matheson CD, 2014, J ARCHAEOL SCI, V52, P116, DOI 10.1016/j.jas.2014.08.016; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Nowell A, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P67; Odell GH, 1980, J FIELD ARCHAEOL, V7, P87120; Odell GH, 2004, LITHIC ANAL, P135; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Pope M., 2006, LITHICS J LITHIC STU, V27, P47; Preysler J.B., 2003, EXPT INTERPRETATION, P171; Prinsloo LC, 2014, J ARCHAEOL SCI, V41, P732, DOI 10.1016/j.jas.2013.10.011; Rabinovich R, 2012, QUATERN INT, V276, P183, DOI 10.1016/j.quaint.2012.05.009; Rosenfeld A, 1971, BRIT MUSEUM Q, V35, P176; Rots V., 2009, QUARTAR, V56, P37; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; Semenov SA, 1957, ARCHAEOLOGICAL MAT R, V54; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shillito LM, 2009, SPECTROCHIM ACTA A, V72, P120, DOI 10.1016/j.saa.2008.08.016; Shimelmitz R, 2014, QUAT INT IN PRESS; Solodenko N., 2010, THESIS TEL AVIV U; Stuart BH, 2000, VIB SPECTROSC, V24, P233, DOI 10.1016/S0924-2031(00)00097-7; TCHERNOV E, 1994, QUATERNARY RES, V42, P328, DOI 10.1006/qres.1994.1083; Tringham R., 1974, J FIELD ARCHAEOL, V1, P171, DOI 10.1179/jfa.1974.1.1-2.171; Vaculikova L., 2005, ACTA GEODYN GEOMATER, V2, P167; van Gijn AL, 1990, ANALECTA PREHISTORIC, P22; Wenban-Smith FF, 2006, J QUATERNARY SCI, V21, P471, DOI 10.1002/jqs.1033; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007; Zaidner Y, 2003, ANTHROPOLOGIE, V107, P203, DOI 10.1016/S0003-5521(03)00010-4; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851	86	76	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118572	10.1371/journal.pone.0118572	http://dx.doi.org/10.1371/journal.pone.0118572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE9BN	25786123	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500038
J	Specht, IO; Bonde, JP; Toft, G; Lindh, CH; Jonsson, BAG; Jorgensen, KT				Specht, Ina Olmer; Bonde, Jens Peter; Toft, Gunnar; Lindh, Christian H.; Jonsson, Bo A. G.; Jorgensen, Kristian T.			Serum Phthalate Levels and Time to Pregnancy in Couples from Greenland, Poland and Ukraine	PLOS ONE			English	Article							EXPERT PANEL REPORT; DI(2-ETHYLHEXYL) PHTHALATE; BISPHENOL-A; SEMEN QUALITY; ORGANOCHLORINE PESTICIDES; POLYCHLORINATED-BIPHENYLS; DEVELOPMENTAL TOXICITY; REPRODUCTIVE HORMONES; TO-PREGNANCY; NTP CENTER	Phthalates are ubiquitous industrial chemicals that have been associated with altered reproductive function in rodents. Several human studies have reported an inverse association between male testosterone and phthalate levels. Our aim was to investigate time to pregnancy (TTP) according to serum levels of diethylhexyl phthalate (DEHP) and diisononyl phthalate (DiNP) metabolites in both partners. In 2002-2004 we enrolled 938 pregnant women and 401 male spouses from Greenland, Poland and Ukraine. Six oxidized metabolites of DEHP and DiNP were summarized for each of the two parent compounds to provide proxies of the internal exposure. We used Cox discrete-time models to estimate fecundability ratios (FR) and 95% confidence intervals (95% CIs) for men and women according to their proxy-DEHP or -DiNP serum levels adjusted for a fixed set of covariates. The FR was slightly elevated among women with high levels of DEHP (FR=1.14, 95% CI 1.00; 1.30) suggesting a shorter TTP in these women. The FR was unrelated to DiNP in women, whereas the results for men were inconsistent pointing in opposite directions. First-time pregnant women from Greenland with high serum DiNP levels had a longer TTP. This study spanning large contrast in environmental exposure does not indicate adverse effects of phthalates on couple fecundity. The shorter TTP in women with high levels of DEHP metabolites is unexplained and needs further investigation.	[Specht, Ina Olmer; Bonde, Jens Peter; Jorgensen, Kristian T.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen NV, Denmark; [Toft, Gunnar] Aarhus Univ Hosp, Dept Occupat Med, Aarhus C, Denmark; [Lindh, Christian H.; Jonsson, Bo A. G.] Lund Univ, Div Occupat & Environm Med, Lund, Sweden	University of Copenhagen; Bispebjerg Hospital; Aarhus University; Lund University	Specht, IO (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen NV, Denmark.	ina.olmer.specht@regionh.dk		Toft, Gunnar/0000-0002-7542-6853; Lindh, Christian/0000-0001-7435-9890; Specht, Ina Olmer/0000-0002-3114-4715	European Commission [FP7-ENV-2008-1, 226217]; Danish Research Council [10-082745]; ReproHigh a Oresund-Kattegat-Skagerrak-Program - European Regional Development Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); ReproHigh a Oresund-Kattegat-Skagerrak-Program - European Regional Development Fund	The study was part of the CLEAR Project: Climate, Environmental Contaminants and Reproductive Health (www.inuendo.dk/clear) supported by The European Commission 7th Framework Programme FP7-ENV-2008-1 Environment (including Climate Change) Grant no.: 226217; the Danish Research Council (10-082745), and ReproHigh a Oresund-Kattegat-Skagerrak-Program funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert O, 2014, HUM REPROD UPDATE, V20, P231, DOI 10.1093/humupd/dmt050; Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001; Bonde JP, 2008, ENVIRON HEALTH PERSP, V116, P269, DOI 10.1289/ehp.10700; Bonde JP, 2006, EPIDEMIOLOGY, V17, P347, DOI 10.1097/01.ede.0000210239.80406.46; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Calafat AM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3494; Chevrier C, 2013, EPIDEMIOLOGY, V24, P251, DOI 10.1097/EDE.0b013e31827f53ec; Cohn BA, 2003, LANCET, V361, P2205, DOI 10.1016/S0140-6736(03)13776-2; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Eskenazi B, 2010, EPIDEMIOLOGY, V21, P224, DOI 10.1097/EDE.0b013e3181cb8b95; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Gennings C, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-66; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hougaard KS, 2009, REPROD TOXICOL, V27, P186, DOI 10.1016/j.reprotox.2009.01.003; Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093; Inada H, 2012, J TOXICOL SCI, V37, P483; Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005; Joensen UN, 2012, ENVIRON HEALTH PERSP, V120, P1397, DOI 10.1289/ehp.1205113; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5; Klinefelter GR, 2012, REPRODUCTION, V144, P747, DOI 10.1530/REP-12-0266; Kristensen SL, 2013, HUM REPROD, V28, P3337, DOI 10.1093/humrep/det382; Li XW, 2012, TOXICOL LETT, V215, P84, DOI 10.1016/j.toxlet.2012.10.001; Louis GMB, 2014, FERTIL STERIL, V101, P1359, DOI 10.1016/j.fertnstert.2014.01.022; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403; Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x; Modigh CM, 2002, SCAND J WORK ENV HEA, V28, P418, DOI 10.5271/sjweh.694; Mutsaerts MAQ, 2012, HUM REPROD, V27, P583, DOI 10.1093/humrep/der429; OLSEN J, 1991, AM J EPIDEMIOL, V133, P734, DOI 10.1093/oxfordjournals.aje.a115948; Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016; Park Moon-seo, 2010, J Prev Med Public Health, V43, P301, DOI 10.3961/jpmph.2010.43.4.301; ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198; Snijder CA, 2012, HUM REPROD UPDATE, V18, P284, DOI 10.1093/humupd/dms005; Specht IO, 2014, ENVIRON INT, V66, P146, DOI 10.1016/j.envint.2014.02.002; Toft Gunnar, 2005, Environ Health, V4, P26, DOI 10.1186/1476-069X-4-26; Toshima H, 2012, INT J HYG ENVIR HEAL, V215, P502, DOI 10.1016/j.ijheh.2011.09.005; Vagi SJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-86; Vested A, 2013, ENVIRON HEALTH PERSP, V121, P453, DOI 10.1289/ehp.1205118; WEINBERG CR, 1994, STAT MED, V13, P671, DOI 10.1002/sim.4780130528; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037	46	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120070	10.1371/journal.pone.0120070	http://dx.doi.org/10.1371/journal.pone.0120070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786246	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500153
J	Tezuka, T; Ogawa, H; Azuma, M; Goto, H; Uehara, H; Aono, Y; Hanibuchi, M; Yamaguchi, Y; Fujikawa, T; Itai, A; Nishioka, Y				Tezuka, Toshifumi; Ogawa, Hirohisa; Azuma, Masahiko; Goto, Hisatsugu; Uehara, Hisanori; Aono, Yoshinori; Hanibuchi, Masaki; Yamaguchi, Yoichi; Fujikawa, Tomoyuki; Itai, Akiko; Nishioka, Yasuhiko			IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KINASE-BETA INHIBITOR; MURINE MODEL; PAI-1; INFLAMMATION; MICE; CELLS; LUNG; UPA; HYPERRESPONSIVENESS	Plasminogen activator inhibitor (PAI)-1 is the principal inhibitor of plasminogen activators, and is responsible for the degradation of fibrin and extracellular matrix. IMD-4690 is a newly synthesized inhibitor for PAI-1, whereas the effect on allergic airway inflammation and remodeling is still unclear. We examined the in vivo effects by using a chronic allergen exposure model of bronchial asthma in mice. The model was generated by an immune challenge for 8 weeks with house dust mite antigen, Dermatophagoides pteronyssinus (Dp). IMD-4690 was intraperitoneally administered during the challenge. Lung histopathology, hyper-responsiveness and the concentrations of mediators in lung homogenates were analyzed. The amount of active PAI-1 in the lungs was increased in mice treated with Dp. Administration with IMD-4690 reduced an active/total PAI-1 ratio. IMD-4690 also reduced the number of bronchial eosinophils in accordance with the decreased expressions of Th2 cytokines in the lung homogenates. Airway remodeling was inhibited by reducing subepithelial collagen deposition, smooth muscle hypertrophy, and angiogenesis. The effects of IMD-4690 were partly mediated by the regulation of TGF-beta, HGF and matrix metalloproteinase. These results suggest that PAI-1 plays crucial roles in airway inflammation and remodeling, and IMD-4690, a specific PAI-1 inhibitor, may have therapeutic potential for patients with refractory asthma due to airway remodeling.	[Tezuka, Toshifumi; Azuma, Masahiko; Goto, Hisatsugu; Aono, Yoshinori; Hanibuchi, Masaki; Nishioka, Yasuhiko] Univ Tokushima, Inst Hlth Biosci, Grad Sch, Dept Resp Med & Rheumatol, Tokushima 770, Japan; [Ogawa, Hirohisa; Uehara, Hisanori] Univ Tokushima, Dept Mol & Environm Pathol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Yamaguchi, Yoichi; Fujikawa, Tomoyuki; Itai, Akiko] Inst Med Mol Design Inc, Tokyo, Japan	Tokushima University; Tokushima University	Nishioka, Y (corresponding author), Univ Tokushima, Inst Hlth Biosci, Grad Sch, Dept Resp Med & Rheumatol, Tokushima 770, Japan.	yasuhiko@tokushima-u.ac.jp			Institute of Medicinal Molecular Design, Inc.; Grants-in-Aid for Scientific Research [24591167] Funding Source: KAKEN	Institute of Medicinal Molecular Design, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Institute of Medicinal Molecular Design, Inc. provided support in the form of salaries for authors YY, TF, and AI, but did not have any additional role in the study design, data collection and analysis (except for Fig. 1B), decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section with a slight modification.	Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bosse Y, 2006, AM J RESP CELL MOL, V34, P746, DOI 10.1165/rcmb.2005-0309OC; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chen G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-2; Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Cho SH, 2004, EXP BIOL MED, V229, P138, DOI 10.1177/153537020422900202; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; DENG G, 1995, THROMB HAEMOSTASIS, V74, P66; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Gutierrez LS, 2000, CANCER RES, V60, P5839; Holgate ST, 2001, INT ARCH ALLERGY IMM, V124, P253, DOI 10.1159/000053726; Inayama M, 2006, AM J RESP CRIT CARE, V173, P1016, DOI 10.1164/rccm.200506-947OC; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Kowal K, 2010, FOLIA HISTOCHEM CYTO, V48, P518, DOI 10.2478/v10042-010-0075-2; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Lee YC, 2002, J IMMUNOL, V168, P3595, DOI 10.4049/jimmunol.168.7.3595; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; Ma Z, 2009, CLIN EXP ALLERGY, V39, P1136, DOI 10.1111/j.1365-2222.2009.03272.x; MARS WM, 1993, AM J PATHOL, V143, P949; Mautino G, 1997, AM J RESP CELL MOL, V17, P583, DOI 10.1165/ajrcmb.17.5.2562; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Nishioka Y, 1997, INT J CANCER, V71, P170; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Pappot H, 2006, LUNG CANCER, V51, P193, DOI 10.1016/j.lungcan.2005.10.002; Ribatti D, 2009, CLIN EXP ALLERGY, V39, P1815, DOI 10.1111/j.1365-2222.2009.03385.x; Sejima T, 2005, J IMMUNOL, V174, P8135, DOI 10.4049/jimmunol.174.12.8135; Sillalber C, 1999, J IMMUNOL, V162, P1032; Sugita A, 2009, INT ARCH ALLERGY IMM, V148, P186, DOI 10.1159/000161579; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Wakugawa M, 2001, J DERMATOL SCI, V25, P116, DOI 10.1016/S0923-1811(00)00118-3; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; [No title captured]	38	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121615	10.1371/journal.pone.0121615	http://dx.doi.org/10.1371/journal.pone.0121615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785861	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500213
J	Vermeulen, E; Brager, S				Vermeulen, Els; Braeger, Stefan			Demographics of the Disappearing Bottlenose Dolphin in Argentina: A Common Species on Its Way Out?	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; CAPTURE-RECAPTURE; TEMPORARY EMIGRATION; SMALL CETACEANS; SITE FIDELITY; HEAVY-METALS; GROUP-SIZE; REPRODUCTIVE SUCCESS; POPULATION-STRUCTURE; RELATIVE ABUNDANCE	Populations of the once common bottlenose dolphin (Tursiops truncatus) in Argentina have precipitously declined throughout the country in the past decades. Unfortunately, local declines of common species are easily overlooked when establishing priorities for conservation. In this study, demographics of what may well be the last remaining resident population in the country were assessed using mark-recapture analysis (Pollock's Robust Design) of a photo-identification dataset collected during 2006-2011 in Bahia San Antonio (Patagonia, Argentina). Total abundance, corrected for unmarked individuals, ranged from 40 (95% CI: 16.1-98.8) to 83 (95% CI = 45.8-151.8) individuals and showed a decrease over the years. Adult survival rates varied between 0.97 (+/- 0.037 SE) and 0.99 (+/- 0.010 SE). Average calving interval equalled 3.5 +/- 1.03 years, with 3.5 births/year in the entire population and a minimum annual birth rate of 4.2%. However, data suggest that calves may have been born and lost before being documented, underestimating birth rate, calf mortality, and possibly the number of reproductive females. Either way, the recruitment rate of calves appears to be insufficient to support the size of the population. This population is relatively small and declining. Considering the disappearance of populations north and south of the study area, an incessant decline will have severe consequences for the continuous existence of this species in Argentina, indicating an urgent need for serious conservation efforts. This study provides insight into how the failure to recognize local population declines can threaten the national (and eventually the international) status of a common species like the bottlenose dolphin.	[Vermeulen, Els] Univ Liege, Lab Oceanol, MARE Res Ctr, Liege, Belgium; [Braeger, Stefan] Int Seabed Author, Kingston, Jamaica	University of Liege	Vermeulen, E (corresponding author), Univ Liege, Lab Oceanol, MARE Res Ctr, Liege, Belgium.	elsvermeulen5@gmail.com	Vermeulen, Els/AAW-2716-2020	Vermeulen, Els/0000-0002-3667-1290	Cetacean Society International; Trigon N.V.; Marybio Foundation	Cetacean Society International; Trigon N.V.; Marybio Foundation	The funding received for this research was very limited because there was no PhD scholarship available for the corresponding author. Most funds came from investments of personal money. Received funds came from the following organisations: 1. Cetacean Society International (www.csiwhalesalive.com): US$3,000 was given for the completion of fieldwork in 2007 and 2008. No specific grant number is available. 2. Trigon N.V. (www.trigon.be): This software company contributed to the project by donating portable computers and hard drives. 3. Marybio Foundation (www.marybio.org): The Marybio foundation was the NGO the corresponding author created and directed over the course of the study period. With this NGO, the corresponding author was able to receive the above-mentioned funds, gather membership fees, and receive students who contributed to the project with work and funds (for their dissertation research) from their respective universities. The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, P 20 BIENN C BIOL MA; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Ansmann IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065239; Baines ME, 2002, P 16 ANN C EUR CET S; Barragan-Barrera DC, 2013, SC65ASM15 IWC; Bastida R., 2003, MAMIFEROS MARINOS PA; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berghan J, 2008, NEW ZEAL J MAR FRESH, V42, P465, DOI 10.1080/00288330809509974; Birkun A, 2002, CETACEANS MEDITERRAN; Birkun A.A. Jr, 2004, P64; Bonuccelli R, 2004, IBPM SERIE PUBLICACI, V3, P63; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 1987, AM FISHERIES SOC MON; Campbell Gregory S., 2002, Aquatic Mammals, V28, P170; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Cauhepe M.E., 1999, MANAGEMENT ARGENTINE; Claps EL., 2005, MINES COMMUNITIE OCT; Cockcroft V.G., 1990, P295; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; Coscarella MA, 2012, J MAR BIOL ASSOC UK, V92, P1843, DOI 10.1017/S0025315411001901; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Currey RJC, 2008, NEW ZEAL J MAR FRESH, V42, P439, DOI 10.1080/00288330809509972; Currey Rohan J. C., 2007, Pacific Conservation Biology, V13, P274; Daura-Jorge FG, 2013, MAR MAMMAL SCI, V29, P293, DOI 10.1111/j.1748-7692.2012.00571.x; Doyle J, 2007, P 21 ANN C EUR CET S; Englund A., 2007, POPULATION STATUS RE; Evans PGH, 2003, UK CETACEAN STATUS R; Felix F., 1994, ECOLOGY, V25, P235; Fernandez R, 2011, HYDROBIOLOGIA, V670, P111, DOI 10.1007/s10750-011-0669-5; Frodello JP, 2002, MAR POLLUT BULL, V44, P551, DOI 10.1016/S0025-326X(02)00067-X; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Fruet PF, 2011, ZOOLOGIA-CURITIBA, V28, P23, DOI 10.1590/S1984-46702011000100004; Fruet PF, 2012, J MAR BIOL ASSOC UK, V92, P1865, DOI 10.1017/S0025315410001888; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Gaspar R., 2003, THESIS ST ANDREWS U; Genov Tilen, 2008, Annales Series Historia Naturalis, V18, P227; Gil MN, 1999, B ENVIRON CONTAM TOX, V63, P52, DOI 10.1007/s001289900947; Gil Mónica N, 2006, Rev. biol. mar. oceanogr., V41, P167; Gilpin M, 1996, CONSERV BIOL, V10, P1491, DOI 10.1046/j.1523-1739.1996.10061491.x; Gonzalez J., 1989, ESTUDIOS OCEANOL, V8, P67; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Grellier K, 1995, MANAGEMENT RECOMMEND; Grellier Kate, 2003, Aquatic Mammals, V29, P378, DOI 10.1578/01675420360736550; Haase PA, 2001, NEW ZEAL J MAR FRESH, V35, P675, DOI 10.1080/00288330.2001.9517034; Hammond PS, IUCN 2012 IUCN RES L; HARRIS R B, 1987, Conservation Biology, V1, P72, DOI 10.1111/j.1523-1739.1987.tb00011.x; Ingram S, 1999, EUROPEAN RES CETACEA, V13, P328; IRVINE AB, 1981, FISH B-NOAA, V79, P671; *IUCN, IUCN RED LIST CAT CR; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kerr KA, 2005, CARIBB J SCI, V41, P172; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; La Manna G, 2013, AQUAT CONSERV, V23, P745, DOI 10.1002/aqc.2355; Lahaye V, 2001, EUROPEAN RES CETACEA, V14, P335; Laporta P, 2008, THESIS U FEDERAL RIO; Lauriano G., 2004, Journal of Cetacean Research and Management, V6, P165; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lemos LS, 2013, ECOTOX ENVIRON SAFE, V97, P166, DOI 10.1016/j.ecoenv.2013.07.025; Lodi Liliane, 2012, Biotemas, V25, P157; Lopez A, 2004, J MAR BIOL ASSOC UK, V84, P283; Lopez A., 2003, THESIS U SANTIAGO CO; Lopez-Hernandez I, 1997, THESIS U NACL AUTONO, DOI [10.1016/j.watres.2013.08.031, DOI 10.1016/J.WATRES.2013.08.031]; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Mann J, 2005, ANIM BEHAV, V69, P899, DOI 10.1016/j.anbehav.2004.04.024; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; MARCOVECCHIO JE, 1990, MAR POLLUT BULL, V21, P299, DOI 10.1016/0025-326X(90)90595-Y; MARCOVECCHIO JE, 1994, SCI TOTAL ENVIRON, V154, P141, DOI 10.1016/0048-9697(94)90084-1; Merriman MG, 2007, THESIS MASSEY U NZ; Miller PS., 2005, VORTEX STOCHASTIC SI; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Oviedo L, 2005, REV BIOL TROP, V53, P595; Pace D.S., 1999, European Research on Cetaceans, V12, P165; Parsons KM, 2002, BIOL CONSERV, V108, P175, DOI 10.1016/S0006-3207(02)00103-9; Peddemors V. M., 1999, Journal of Cetacean Research and Management, V1, P157; Pereira A, 2013, AFR J MAR SCI, V35, P501, DOI 10.2989/1814232X.2013.850444; Pikesley SK, 2012, J MAR BIOL ASSOC UK, V92, P1809, DOI 10.1017/S0025315411000464; Pleslic G, 2015, AQUAT CONSERV, V25, P125, DOI 10.1002/aqc.2416; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pulcini M, 2013, J MAR BIOL ASSOC UK, P1; Rako N, 2013, MAR POLLUT BULL, V68, P77, DOI 10.1016/j.marpolbul.2012.12.019; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; Reid J.B., 2003, ATLAS CETACEAN DISTR; Rogan E, 2000, MARINE RESOURCE SERI, V9, P48; Rojas-Bracho L, 1999, MAR MAMMAL SCI, V15, P974, DOI 10.1111/j.1748-7692.1999.tb00873.x; Rojas-Bracho L, 2013, ENDANGER SPECIES RES, V21, P77, DOI 10.3354/esr00501; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sanders-Reed CA, 1999, 156 SCOTT NAT HER; SANINO G.P., 2000, REVISTA GESTION AMBI, V6, P41; Sanino GP, 2008, SC60SM18 IWC; Scheinin A, 2005, P 16 BIENN C BIOL MA; Scott M.D., 1990, P235; Shane SH, 1990, BOTTLENOSE DOLPHIN, P653; Silva CA, 2008, THESIS U LISBOA PORT, DOI [10.1503/cmaj.081050, DOI 10.1503/CMAJ.081050]; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Simoes-Lopes PC, 2008, PARCEIROS SOBREVIVEN, V52; Smith H., 2012, THESIS MURDOCH U AUS; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Steckenreuter A, 2012, J ENVIRON MANAGE, V97, P14, DOI 10.1016/j.jenvman.2011.11.002; Stensland E, 2006, MAR MAMMAL SCI, V22, P667, DOI 10.1111/j.1748-7692.2006.00051.x; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Sutherland W., 2000, CONSERVATION HDB RES; Tezanos-Pinto G, 2013, POPULATION VIABILITY; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Valdes-Arellanes MP, 2011, REV MEX BIODIVERS, P82; Van Waerebeek K, 2008, 9 FDN INT BANC ARG; VanWaerebeek K, 1997, BIOL CONSERV, V81, P43, DOI 10.1016/S0006-3207(96)00152-8; Vazquez NN, 2007, B ENVIRON CONTAM TOX, V79, P121, DOI 10.1007/s00128-007-9084-z; Vermeulen Els, 2009, Aquatic Mammals, V35, P378, DOI 10.1578/AM.35.3.2009.378; Vidal ML, 2004, IBMP SERIE PUBLICACI, V3, P67; Vos J. G, 2003, TOXICOLOGY MARINE MA; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 1999, HDB MARINE MAMMALS S, P1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WILSON B, 1995, THESIS U ABERDEEN SC; Wood CJ, 1998, J ZOOL, V246, P155, DOI 10.1017/S0952836998010048; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1; Zappes CA, 2013, OCEAN COAST MANAGE, V85, P46, DOI 10.1016/j.ocecoaman.2013.09.004	140	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119182	10.1371/journal.pone.0119182	http://dx.doi.org/10.1371/journal.pone.0119182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786234	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500080
J	Wong, CW; Liao, JM; Cheung, GC; Khor, CC; Vithana, EN; Wang, JJ; Mitchell, P; Aung, T; Wong, TY; Cheng, CY				Wong, Chee Wai; Liao, Jiemin; Cheung, Gemmy C.; Khor, Chiea Chuen; Vithana, Eranga N.; Wang, Jie Jin; Mitchell, Paul; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu			Lens Status Influences the Association between CFH Polymorphisms and Age-Related Macular Degeneration: Findings from Two Population-Based Studies in Singapore	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; BLUE MOUNTAINS EYE; BEAVER DAM EYE; INTRAOCULAR LENSES; CATARACT-SURGERY; RISK-FACTORS; POOLED FINDINGS; MALAY EYE; MACULOPATHY; SUSCEPTIBILITY	Aims To determine the differential effects of genetic polymorphism in CFH and ARMS2 on risk of age-related macular degeneration (AMD) between phakic vs. pseudophakic/aphakic eyes. Methods 9,529 eyes of 4,918 participants from the Singapore Malay Eye Study and Singapore Indian Eye Study were analyzed. Participants had detailed eye examinations, including slit-lamp examinations and dilated fundus photography. AMD grading was performed according to the Wisconsin age-related maculopathy grading system. Lens status was defined. Single nucleotide polymorphisms (SNPs) rs10801555 (Y402H) within CFH and rs3750847 in ARMS2 were assessed. The main outcome measure was early AMD or any AMD. Results No significant associations between the CFH Y402H genotypes and early AMD were found in phakic individuals. In contrast, among pseudophakic/aphakic individuals, the CFH Y402H risk genotypes were significantly associated with higher odds of early AMD, with an OR of 1.57 (95% CI: 1.07-2.29) for GA genotype and 2.40 (95% CI: 1.25-4.61) for AA genotype, compared to those with GG genotype. There was significant interaction between pseudophakic/aphakic status and CFH Y402H variant on risk of early AMD (p = 0.037), adjusting for age, gender, and the first 5 genetic principal components. No significant interaction was found between lens status and ARMS2 rs3750847. Conclusions CFH genetic polymorphism and pseudophakic/aphakic status may have a potential synergistic effect on early AMD, suggesting roles for the complement system and related pathways in the pathogenesis of AMD in eyes after cataract surgery.	[Wong, Chee Wai; Liao, Jiemin; Cheung, Gemmy C.; Vithana, Eranga N.; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Liao, Jiemin; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Liao, Jiemin; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Cheung, Gemmy C.; Vithana, Eranga N.; Wong, Tien Y.; Cheng, Ching-Yu] Duke NUS Grad Med Sch, Singapore, Singapore; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Wang, Jie Jin; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Sydney; Westmead Institute for Medical Research	Cheng, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	chingyu.cheng@duke-nus.edu.sg	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; wang, jie/GRS-0942-2022; Cheng, Ching-Yu/Y-2229-2019	Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Khor, Chiea Chuen/0000-0002-1128-4729; Cheung, Chui Ming Gemmy/0000-0003-3358-3516	American Health Assistance Foundation [M2011068]; National Medical Research Council, Singapore [NMRC 0976/2003, STaR/0003/2008, CSA/033/2012, CG/SERI/2010]; Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550]; NMRC [CSA/033/2012]	American Health Assistance Foundation; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore)	Supported by funding from the American Health Assistance Foundation (M2011068), and grants from the National Medical Research Council, Singapore (NMRC 0976/2003, STaR/0003/2008, CSA/033/2012, CG/SERI/2010), and the Biomedical Research Council, Singapore (BMRC 09/1/35/19/616 and 08/1/35/19/550). Ching-Yu Cheng is supported by an award from NMRC (CSA/033/2012). The Singapore Tissue Network and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Barbour W, 2005, OPHTHAL RES, V37, P255, DOI 10.1159/000087100; BOULTON M, 1993, J PHOTOCH PHOTOBIO B, V19, P201, DOI 10.1016/1011-1344(93)87085-2; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Buch H, 2005, OPHTHALMOLOGY, V112, P787, DOI 10.1016/j.ophtha.2004.11.040; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Clark SJ, 2010, BIOCHEM SOC T, V38, P1342, DOI 10.1042/BST0381342; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Edwards KH, 2010, CLIN EXP OPTOM, V93, P390, DOI 10.1111/j.1444-0938.2010.00538.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fritsche LG, 2013, NAT GENET; GAILLARD ER, 1995, PHOTOCHEM PHOTOBIOL, V61, P448, DOI 10.1111/j.1751-1097.1995.tb02343.x; Gemmy Cheung CM, 2012, AM J OPHTHALMOL; Gold G, 2003, AM J MED GENET B, V119B, P44, DOI 10.1002/ajmg.b.10010; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ho L, 2008, INVEST OPHTH VIS SCI, V49, P4795, DOI 10.1167/iovs.08-2066; Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1735, DOI 10.1016/j.ophtha.2008.02.012; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2002, ARCH OPHTHALMOL-CHIC, V120, P1551, DOI 10.1001/archopht.120.11.1551; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P6576, DOI 10.1167/iovs.12-10219; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pokidysheva EN, 2001, ARTIF ORGANS, V25, P453, DOI 10.1046/j.1525-1594.2001.025006453.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sobrin L, 2011, AM J OPHTHALMOL, V151, P345, DOI 10.1016/j.ajo.2010.08.015; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; Wang JJ, 2003, OPHTHALMOLOGY, V110, P1960, DOI 10.1016/S0161-6420(03)00816-9; WENZEL M, 1988, GRAEF ARCH CLIN EXP, V226, P449, DOI 10.1007/BF02170007; Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132; Xu L, 2011, GRAEF ARCH CLIN EXP, V249, P981, DOI 10.1007/s00417-010-1571-y; Xu YT, 2012, INT J OPHTHALMOL-CHI, V5, P125, DOI 10.3980/j.issn.2222-3959.2012.02.02	49	3	3	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119570	10.1371/journal.pone.0119570	http://dx.doi.org/10.1371/journal.pone.0119570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786237	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500113
J	Choi, YJ; Kim, SY; So, KS; Baek, IJ; Kim, WS; Choi, SH; Lee, JC; Bivona, TG; Rho, JK; Choi, CM				Choi, Yun Jung; Kim, Seon Ye; So, Kwang Sup; Baek, In-Jeoung; Kim, Woo Sung; Choi, Se Hoon; Lee, Jae Cheol; Bivona, Trever G.; Rho, Jin Kyung; Choi, Chang-Min			AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROTEIN 90 INHIBITOR; HSP90 INHIBITOR; ACQUIRED-RESISTANCE; TUMOR-GROWTH; CYCLE ARREST; MULTIPLE-MYELOMA; MUTATIONS; METASTASIS; GEFITINIB	The activation of bypass signals, such as MET and AXL, has been identified as a possible mechanism of EGFR-TKI resistance. Because various oncoproteins depend on HSP90 for maturation and stability, we investigated the effects of AUY922, a newly developed nongeldanamycin class HSP90 inhibitor, in lung cancer cells with MET-and AXL-mediated resistance. We established resistant cell lines with HCC827 cells harboring an exon 19-deletion mutation in of the EGFR gene via long-term exposure to increasing concentrations of gefitinib and erlotinib (HCC827/GR and HCC827/ER, respectively). HCC827/GR resistance was mediated by MET activation, whereas AXL activation caused resistance in HCC827/ER cells. AUY922 treatment effectively suppressed proliferation and induced cell death in both resistant cell lines. Accordingly, the downregulation of EGFR, MET, and AXL led to decreased Akt activation. The inhibitory effects of AUY922 on each receptor were confirmed in gene-transfected LK2 cells. AUY922 also effectively controlled tumor growth in xenograft mouse models containing HCC827/GR and HCC827/ER cells. In addition, AUY922 reduced invasion and migration by both types of resistant cells. Our study findings thus show that AUY922 is a promising therapeutic option for MET-and AXL-mediated resistance to EGFR-TKI in lung cancer.	[Choi, Yun Jung; Kim, Seon Ye; So, Kwang Sup; Kim, Woo Sung; Rho, Jin Kyung; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea; [Choi, Yun Jung; Baek, In-Jeoung; Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Choi, Se Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Thorac & Cardiovasc Surg, Seoul, South Korea; [Lee, Jae Cheol; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Div Hematol Oncol, San Francisco, CA 94143 USA	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rho, JK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea.	jkrho@amc.seoul.kr; ccm@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021	Baek, In-Jeoung/0000-0002-0641-7208	National Research Foundation of Korea (NRF) [2013R1A1A2005112]; Asan Institute for Life Sciences [2014-597]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Asan Institute for Life Sciences	J.K. Rho had been awarded a grant of the National Research Foundation of Korea (NRF, 2013R1A1A2005112) and S.H. Choi had been awarded a grant of the Asan Institute for Life Sciences (2014-597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao RD, 2009, CLIN CANCER RES, V15, P4046, DOI 10.1158/1078-0432.CCR-09-0152; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; CARMICHAEL J, 1987, CANCER RES, V47, P943; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Georgakis GV, 2006, CLIN CANCER RES, V12, P584, DOI 10.1158/1078-0432.CCR-05-1194; Graham B, 2012, CANCER SCI, V103, P522, DOI 10.1111/j.1349-7006.2011.02191.x; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Kim HR, 2013, MOL ONCOL, V7, P1093, DOI 10.1016/j.molonc.2013.08.001; Kobayashi N, 2012, LUNG CANCER, V75, P161, DOI 10.1016/j.lungcan.2011.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koizumi H, 2012, J THORAC ONCOL, V7, P1078, DOI 10.1097/JTO.0b013e3182519a2c; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lamottke B, 2012, EUR J HAEMATOL, V88, P406, DOI 10.1111/j.1600-0609.2012.01764.x; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Rice JW, 2009, ONCOL RES, V18, P229, DOI 10.3727/096504009X12596189659240; Robinson KW, 2013, ONCOLOGIST, V18, P115, DOI 10.1634/theoncologist.2012-0262; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ueno T, 2012, LUNG CANCER, V76, P26, DOI 10.1016/j.lungcan.2011.09.011; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Wu WJ, 2013, CLIN CANCER RES, V19, P5699, DOI 10.1158/1078-0432.CCR-13-1758; Xu L, 2012, CANCER RES, V72, P3302, DOI 10.1158/0008-5472.CAN-11-3720; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	39	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119832	10.1371/journal.pone.0119832	http://dx.doi.org/10.1371/journal.pone.0119832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780909	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600096
J	Gounder, K; Padayachi, N; Mann, JK; Radebe, M; Mokgoro, M; van der Stok, M; Mkhize, L; Mncube, Z; Jaggernath, M; Reddy, T; Walker, BD; Ndung'u, T				Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Reddy, Tarylee; Walker, Bruce D.; Ndung'u, Thumbi			High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; VIRAL LOAD; LYMPHOCYTE ESCAPE; REPLICATION CAPACITY; MALE CIRCUMCISION; P24 GAG; SUBTYPE; MUTATIONS; EVOLUTION	In chronic HIV infection, CD8+ T cell responses to Gag are associated with lower viral loads, but longitudinal studies of HLA-restricted CD8+ T cell-driven selection pressure in Gag from the time of acute infection are limited. In this study we examined Gag sequence evolution over the first year of infection in 22 patients identified prior to seroconversion. A total of 310 and 337 full-length Gag sequences from the earliest available samples (median = 14 days after infection [Fiebig stage I/II]) and at one-year post infection respectively were generated. Six of 22 (27%) individuals were infected with multiple variants. There was a trend towards early intra-patient viral sequence diversity correlating with viral load set point (p = 0.07, r = 0.39). At 14 days post infection, 59.7% of Gag CTL epitopes contained non-consensus polymorphisms and over half of these (35.3%) comprised of previously described CTL escape variants. Consensus and variant CTL epitope proportions were equally distributed irrespective of the selecting host HLA allele and most epitopes remained unchanged over 12 months post infection. These data suggest that intrapatient diversity during acute infection is an indicator of disease outcome. In this setting, there is a high rate of transmitted CTL escape variants and limited immune selection in Gag during the first year of infection. These data have relevance for vaccine strategies designed to elicit effective CD8+ T cell immune responses.	[Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Walker, Bruce D.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Reddy, Tarylee] MRC, Biostat Unit, Durban, South Africa; [Walker, Bruce D.; Ndung'u, Thumbi] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Walker, Bruce D.; Ndung'u, Thumbi] Harvard Univ, Boston, MA 02115 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; Max Planck Society	Ndung'u, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, 719 Umbilo Rd, Durban, South Africa.	ndungu@ukzn.ac.za		Ndung'u, Thumbi/0000-0003-2962-3992; Reddy, Tarylee/0000-0002-9521-2692; Radebe, Mopo/0000-0002-2672-5232; Gounder, Kamini/0000-0002-1674-6021	National Institutes of Health (NIH) [RO1 AI067073-02]; South African NRF/DST (Ndung'u); Gates Foundation, IAVI; Victor Daitz Chair in HIV/TB Research; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH Fogarty International Clinical Research Fellows (FICRF); Medical Research Council; K-RITH Collaborative grant award; National Research Foundation; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology; Harvard University; UNESCO/ L'Oreal Corporate Foundation fellowship; Technology Innovation Agency of the Department of Science and Technology of South Africa; Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067073, UM1AI100663] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African NRF/DST (Ndung'u); Gates Foundation, IAVI; Victor Daitz Chair in HIV/TB Research; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH Fogarty International Clinical Research Fellows (FICRF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); K-RITH Collaborative grant award; National Research Foundation; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology; Harvard University; UNESCO/ L'Oreal Corporate Foundation fellowship(L'Oreal Group); Technology Innovation Agency of the Department of Science and Technology of South Africa; Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) grants RO1 AI067073-02 (Walker), South African NRF/DST (Ndung'u), Gates Foundation, IAVI. Partial funding was also received from the Victor Daitz Chair in HIV/TB Research and an International Early Career Scientist Award from the Howard Hughes Medical Institute to TN. KG was funded by the NIH Fogarty International Clinical Research Fellows (FICRF), Medical Research Council and K-RITH Collaborative grant award. JKM was supported by the National Research Foundation and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University. MR was funded by a UNESCO/ L'Oreal Corporate Foundation fellowship and the Technology Innovation Agency of the Department of Science and Technology of South Africa. Open Access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Abrahams MR, 2013, AIDS, V27, P507, DOI 10.1097/QAD.0b013e32835cab64; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009; Baeten JM, 2012, SEX TRANSM DIS, V39, P21, DOI 10.1097/OLQ.0b013e31823b50c6; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hansasuta P, 2001, BRIT MED BULL, V58, P109, DOI 10.1093/bmb/58.1.109; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber B, 2000, COMPUTATIONAL ANAL H; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Monaco D, 2014, HIV R4P; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky V, 2011, AIDS, V25, P1515, DOI 10.1097/QAD.0b013e3283471eb2; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; Rodrigo A.G., 2001, COMPUTATIONAL EVOLUT; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; SAFRIT JT, 1994, J EXP MED, V179, P463, DOI 10.1084/jem.179.2.463; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schaefer M, 2009, AIDS VACCINE; Schellens IMM, 2011, AIDS, V25, P1691, DOI 10.1097/QAD.0b013e32834981b3; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shaw GM, 2012, COLD SPRING HARB PER, V2; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker B., 2012, COLD SPRING HARB PER, P2; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Watkins DI, 2008, MEM I OSWALDO CRUZ, V103, P119, DOI 10.1590/S0074-02762008000200001; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yusim K, 2009, THEORETICAL BIOL BIO, P3	89	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119886	10.1371/journal.pone.0119886	http://dx.doi.org/10.1371/journal.pone.0119886			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781986	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600105
J	Hawro, T; Bogucki, A; Krupinska-Kun, M; Maurer, M; Wozniacka, A				Hawro, Tomasz; Bogucki, Andrzej; Krupinska-Kun, Maria; Maurer, Marcus; Wozniacka, Anna			Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-beta 2GPI Antibodies in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							13TH INTERNATIONAL-CONGRESS; NEUROPSYCHIATRIC MANIFESTATIONS; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; CLASSIFICATION CRITERIA; ANTINUCLEAR ANTIBODIES; PREVALENCE; ASSOCIATION; DIAGNOSIS; MIGRAINE	Background Neuropsychiatric systemic lupus erythematosus (NPSLE) is a common and potentially fatal manifestation of SLE. Antiphospholipid antibodies (aPL) such as lupus anticoagulant (LA), anticardiolipin (aCL) and antibodies to beta 2glycoprotein I (anti-beta 2GPI), the most important aPL antigen, are thought to play a role in some forms of NPSLE. As of yet, their specific roles in NPSLE manifestations remain to be elucidated. Methodology/Principal Findings 57 SLE patients (53 women) were assessed for LA, aCL and anti-beta(2)GPI twice, to determine persistent positivity. All patients were examined by neurology and psychiatry specialists. 69 healthy subjects were assessed as controls. NPSLE was diagnosed in 74% of patients. Headaches were the most prevalent manifestation of NPSLE (39%), followed by cerebrovascular disease (CVD) (23%), depressive disorders (19.0%), and seizures (14%). NPSLE and non-NPSLE patients showed comparable SLE activity and corticosteroid use. In 65% of patients neuropsychiatric manifestations preceded SLE diagnosis. aPL profiles of NPSLE patients and non-NPSLE patients were similar. Headaches and ischemic stroke were independently associated with anti-beta(2)GPI-IgM (OR=5.6; p<0.05), and seizures were linked to anti-beta(2)GPI-IgG (OR=11.3; p= 0.01). Conclusions In SLE patients, neuropsychiatric manifestations occur frequently and early, often before the disease is diagnosed. Autoantibodies to beta 2GPI are linked to non-specific headaches, ischemic stroke and seizures, and show a better predictive value than aCL and LA. These findings may help to improve the diagnosis of NPSLE and should prompt further studies to characterize the role of anti-beta 2GPI in the pathogenesis of this condition.	[Hawro, Tomasz; Maurer, Marcus] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Bogucki, Andrzej] Med Univ Lodz, Dept Extrapyramidal Dis, Lodz, Poland; [Krupinska-Kun, Maria] Med Univ Lodz, Dept Affect & Psychot Disorders, Lodz, Poland; [Wozniacka, Anna] Med Univ Lodz, Dept Dermatol & Venereol, Lodz, Poland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University Lodz; Medical University Lodz; Medical University Lodz	Maurer, M (corresponding author), Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Maurer, Marcus/ABG-2174-2020; Wozniacka, Anna Jolanta/S-9674-2016	Maurer, Marcus/0000-0002-4121-481X; Hawro, Tomasz/0000-0001-9990-1332	Medical University of Lodz [503/1-152-01/503-01]	Medical University of Lodz	This work was funded by the grant from the Medical University of Lodz nr. 503/1-152-01/503-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; Amit M, 1999, CLIN EXP RHEUMATOL, V17, P467; ASHERSON RA, 1989, AM J MED, V86, P391, DOI 10.1016/0002-9343(89)90335-5; Avcin T, 2002, LUPUS, V11, P4, DOI 10.1191/0961203302lu146rr; Avcin T, 2008, ARTHRIT RHEUM-ARTHR, V59, P206, DOI 10.1002/art.23334; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Cavestro C, 2011, J THROMB HAEMOST, V9, P1350, DOI 10.1111/j.1538-7836.2011.04348.x; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Chapman J, 1999, LUPUS, V8, P127, DOI 10.1191/096120399678847524; Chiewthanakul P, 2012, ASIAN PAC J ALLERGY, V30, P55; Cuadrado MJ, 2001, QJM-MON J ASSOC PHYS, V94, P114, DOI 10.1093/qjmed/94.2.114; de Carvalho JF, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/981519; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Fernandez-Nebro A, 1999, LUPUS, V8, P151, DOI 10.1191/096120399678847443; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Hanly JG, 2008, ARTHRITIS RHEUM-US, V58, P843, DOI 10.1002/art.23218; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2011, ANN RHEUM DIS, V70, P1726, DOI 10.1136/ard.2010.148502; Hanly JG, 2013, ARTHRITIS RHEUM-US, V65, P2887, DOI 10.1002/art.38106; Hanly JG, 2012, ANN RHEUM DIS, V71, P1502, DOI 10.1136/annrheumdis-2011-201089; HARRIS EN, 1984, CLIN EXP RHEUMATOL, V2, P47; Hawro Tomasz, 2009, Pol Merkur Lekarski, V26, P43; HERRANZ MT, 1994, ARTHRITIS RHEUM, V37, P568, DOI 10.1002/art.1780370418; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kozora E, 2012, LUPUS, V21, P402, DOI 10.1177/0961203311429116; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; LIANG MH, 1988, ARTHRITIS RHEUM, V31, P817, DOI 10.1002/art.1780310701; MARKUS HS, 1992, J NEUROL, V239, P39, DOI 10.1007/BF00839210; Martincz-Berriotxoa A, 2007, LUPUS, V16, P810, DOI 10.1177/0961203307083316; Mevorach D, 1996, LUPUS, V5, P173, DOI 10.1177/096120339600500301; Mikdashi J, 2005, NEUROLOGY, V64, P2102, DOI 10.1212/01.WNL.0000165959.98370.D5; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mok CC, 2001, J RHEUMATOL, V28, P766; MONTALBAN J, 1992, NEUROLOGY, V42, P681, DOI 10.1212/WNL.42.3.681; Peltola JT, 2000, AM J MED, V109, P712, DOI 10.1016/S0002-9343(00)00617-3; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pierangeli SS, 2012, CLIN CHIM ACTA, V413, P358, DOI 10.1016/j.cca.2011.09.048; Piette JC, 1998, CIRCULATION, V97, P2195, DOI 10.1161/01.CIR.97.22.2195; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; Robert M, 2006, NEUROL INDIA, V54, P75, DOI 10.4103/0028-3886.24713; Sabbadini MG, 1999, LUPUS, V8, P11, DOI 10.1191/096120399678847344; Sanna G, 2003, J RHEUMATOL, V30, P985; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Sastre-Garriga J, 2003, LUPUS, V12, P877, DOI 10.1191/0961203303lu496oa; Sciascia S, 2014, J NEUROL, V261, P1706, DOI 10.1007/s00415-014-7406-8; Sfikakis PP, 1998, BRIT J RHEUMATOL, V37, P300; SIBLEY JT, 1992, J RHEUMATOL, V19, P47; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Singh S, 2009, RHEUMATOL INT, V29, P1455, DOI 10.1007/s00296-009-0887-6; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tietjen GE, 1998, NEUROLOGY, V50, P1433, DOI 10.1212/WNL.50.5.1433; Tincani A, 2004, THROMB RES, V114, P553, DOI 10.1016/j.thromres.2004.06.035; Tincani A, 2009, LUPUS, V18, P913, DOI 10.1177/0961203309106919; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; Verrot D, 1997, AM J MED, V103, P33, DOI 10.1016/S0002-9343(97)90046-2; von Scheven E, 2002, ARTHRIT RHEUM-ARTHR, V47, P414, DOI 10.1002/art.10510; Ward MM, 1996, ARCH INTERN MED, V156, P1337, DOI 10.1001/archinte.156.12.1337; Willis R, 2013, ANN NY ACAD SCI, V1285, P44, DOI 10.1111/nyas.12080	66	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119911	10.1371/journal.pone.0119911	http://dx.doi.org/10.1371/journal.pone.0119911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781014	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600107
J	Kuo, YM; Henry, RA; Huang, LQ; Chen, X; Stargell, LA; Andrews, AJ				Kuo, Yin-Ming; Henry, Ryan A.; Huang, Liangqun; Chen, Xu; Stargell, Laurie A.; Andrews, Andrew J.			Utilizing Targeted Mass Spectrometry to Demonstrate Asf1-Dependent Increases in Residue Specificity for Rtt109-Vps75 Mediated Histone Acetylation	PLOS ONE			English	Article							ACETYLTRANSFERASE-CHAPERONE COMPLEX; NUCLEOSOME CORE PARTICLE; RECOMBINANT HISTONES; H3; DNA; LYSINE-56; ASF1; H4; VPS75; TRANSCRIPTION	In Saccharomyces cerevisiae, Rtt109, a lysine acetyltransferase (KAT), associates with a histone chaperone, either Vps75 or Asf1. It has been proposed that these chaperones alter the selectivity of Rtt109 or which residues it preferentially acetylates. In the present study, we utilized a label-free quantitative mass spectrometry-based method to determine the steady-state kinetic parameters of acetylation catalyzed by Rtt109-Vps75 on H3 monomer, H3/H4 tetramer, and H3/H4-Asf1 complex. These results show that among these histone conformations, only H3K9 and H3K23 are significantly acetylated under steady-state conditions and that Asf1 promotes H3/H4 acetylation by Rtt109-Vps75. Asf1 equally increases the Rtt109-Vps75 specificity for both of these residues with a maximum stoichiometry of 1: 1 (Asf1 to H3/H4), but does not alter the selectivity between these two residues. These data suggest that the H3/H4-Asf1 complex is a substrate for Rtt109-Vps75 without altering selectivity between residues. The deletion of either Rtt109 or Asf1 in vivo results in the same reduction of H3K9 acetylation, suggesting that Asf1 is required for efficient H3K9 acetylation both in vitro and in vivo. Furthermore, we found that the acetylation preference of Rtt109-Vps75 could be directed to H3K56 when those histones already possess modifications, such as those found on histones purified from chicken erythrocytes. Taken together, Vps75 and Asf1 both enhance Rtt109 acetylation for H3/H4, although via different mechanisms, but have little impact on the residue selectivity. Importantly, these results provide evidence that histone chaperones can work together via interactions with either the enzyme or the substrate to more efficiently acetylate histones.	[Kuo, Yin-Ming; Henry, Ryan A.; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, Philadelphia, PA 19111 USA; [Huang, Liangqun; Chen, Xu; Stargell, Laurie A.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Fox Chase Cancer Center; Colorado State University	Andrews, AJ (corresponding author), Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu	Stargell, Laurie/GWC-7423-2022		W. W. Smith Charitable Trust; Pennsylvania Department of Health; National Institute of General Medical Sciences of the National Institutes of Health [R01 GM102503, GM088409]; NATIONAL CANCER INSTITUTE [T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102503, P01GM088409] Funding Source: NIH RePORTER	W. W. Smith Charitable Trust; Pennsylvania Department of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the W. W. Smith Charitable Trust, the Pennsylvania Department of Health, and the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01 GM102503 to AJA and GM088409 to LAS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshiru N, 2013, J PROTEOMICS, V81, P80, DOI 10.1016/j.jprot.2012.09.026; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Downs JA, 2008, DNA REPAIR, V7, P2020, DOI 10.1016/j.dnarep.2008.08.016; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Gilibili RR, 2011, BIOMED CHROMATOGR, V25, P1352, DOI 10.1002/bmc.1608; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Keck KM, 2011, TRAFFIC, V12, P826, DOI 10.1111/j.1600-0854.2011.01202.x; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kuo YM, 2014, METHODS, V70, P127, DOI 10.1016/j.ymeth.2014.08.003; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Pupaibool J, 2013, INFECT IMMUN, V81, P2268, DOI 10.1128/IAI.01173-12; Radovani E, 2013, EUKARYOT CELL, V12, P654, DOI 10.1128/EC.00291-12; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006	45	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118516	10.1371/journal.pone.0118516	http://dx.doi.org/10.1371/journal.pone.0118516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781956	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600024
J	Muhlenberg, T; Grunewald, S; Treckmann, J; Podleska, L; Schuler, M; Fletcher, JA; Bauer, S				Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian			Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor	PLOS ONE			English	Article							PHASE-II TRIAL; IMATINIB MESYLATE; CELL-DEATH; 2-DEOXY-D-GLUCOSE; CANCER; PET; ACTIVATION; MUTATIONS; AUTOPHAGY; BREAST	Positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG) is frequently used for visualizing gastrointestinal stromal tumors (GIST), which are highly glucose-avid tumors. Dramatic metabolic responses following imatinib treatment indicate a high, KIT-dependent glucose turnover which has been particularly helpful for predicting tumor response to imatinib. The glucose analogue 2-deoxyglucose (2DG) inhibits glucose metabolism in cancer cells that depend on aerobic glycolysis for ATP production. We show that 2DG inhibits proliferation in both imatinib-sensitive and imatinib-resistant GIST cell lines at levels that can be achieved clinically. KIT-negative GIST48B have 3-14-fold higher IC50 levels than KIT-positive GIST cells indicating that oncogenic KIT may sensitize cells to 2DG. GIST sensitivity to 2DG is increased in low-glucose media (110mg/dl). 2DG leads to dose- and glucose dependent inhibition of KIT glycosylation with resultant reduction of membrane-bound KIT, inhibition of KIT-phosphorylation and inactivation of KIT-dependent signaling intermediates. In contrast to imatinib, 2DG caused ER-stress and elicited the unfolded protein response (UPR). Mannose but not pyruvate rescued GIST cells from 2DG-induced growth arrest, suggesting that loss of KIT integrity is the predominant effect of 2DG in GIST. Additive anti-tumoral effects were seen with imatinib and BH3-mimetics. Our data provide the first evidence that modulation of the glucose-metabolism by 2DG may have a disease-specific effect and may be therapeutically useful in GIST.	[Muehlenberg, Thomas; Grunewald, Susanne; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, Essen, Germany; [Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, Sarcoma Ctr, Essen, Germany; [Treckmann, Juergen; Podleska, Lars] Univ Duisburg Essen, Univ Hosp Essen, Dept Visceral & Transplant Surg, Essen, Germany; [Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schuler, Martin] German Canc Consortium DKTK, Heidelberg, Germany; [Fletcher, Jonathan A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Muhlenberg, T (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, Essen, Germany.	thomas.muehlenberg@uni-due.de	Bauer, Sebastian/D-8120-2012; Mühlenberg, Thomas/J-8423-2019; Bauer, Sebastian/HHR-9319-2022	Bauer, Sebastian/0000-0001-5949-8120; Mühlenberg, Thomas/0000-0002-2078-8857; 	Deutsche Krebshilfe [109757]; National Institutes of Health [NIH 1P50CA127003, NIH 1P50CA168512-01]; Life Raft Group Research Initiative; NATIONAL CANCER INSTITUTE [P50CA127003, U54CA168512] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Raft Group Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supportet by a Max Eder Fellowship (SB) of the Deutsche Krebshilfe (No. 109757), the National Institutes of Health (JF; NIH 1P50CA127003, NIH 1P50CA168512-01) and received funds from the Life Raft Group Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2005, INT J CANCER, V117, P316, DOI 10.1002/ijc.21164; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Leung HJ, 2012, ANTIMICROB AGENTS CH, V56, P5794, DOI 10.1128/AAC.01126-12; Liu Y, 2008, CANCER RES, V68, P9015, DOI 10.1158/0008-5472.CAN-08-1935; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Muhlenberg T, 2010, EJC SUPPL, V8, P69, DOI 10.1016/S1359-6349(10)71916-9; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Nakatani H, 2006, INT J MOL MED, V17, P893; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rubin BP, 2001, CANCER RES, V61, P8118; Simon S, 2013, CANCER RES, V73, P3661, DOI 10.1158/0008-5472.CAN-12-3839; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smeland Eivind, 2012, Sarcoma, V2012, P541650, DOI 10.1155/2012/541650; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Steinert DM, 2006, CANCER-AM CANCER SOC, V106, P1617, DOI 10.1002/cncr.21781; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Van den Abbeele AID, 2012, J NUCL MED, V53, P567, DOI 10.2967/jnumed.111.094425; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454	37	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120531	10.1371/journal.pone.0120531	http://dx.doi.org/10.1371/journal.pone.0120531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781619	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600171
J	Pajares, S; Souza, V; Eguiarte, LE				Pajares, Silvia; Souza, Valeria; Eguiarte, Luis E.			Multivariate and Phylogenetic Analyses Assessing the Response of Bacterial Mat Communities from an Ancient Oligotrophic Aquatic Ecosystem to Different Scenarios of Long-Term Environmental Disturbance	PLOS ONE			English	Article							CUATRO CIENEGAS BASIN; 16S RIBOSOMAL-RNA; 2 MICROBIAL MATS; COMPARATIVE METAGENOMICS; FUNCTIONAL-SIGNIFICANCE; ECOLOGICAL RESPONSES; DIVERSITY; BIODIVERSITY; TEMPERATURE; MODEL	Understanding the response of bacterial communities to environmental change is extremely important in predicting the effect of biogeochemical modifications in ecosystem functioning. The Cuatro Cienegas Basin is an ancient oasis in the Mexican Chihuahuan desert that hosts a wide diversity of microbial mats and stromatolites that have survived in extremely oligotrophic pools with nearly constant conditions. However, thus far, the response of these unique microbial communities to long- term environmental disturbances remains unexplored. We therefore studied the compositional stability of these bacterial mat communities by using a replicated (3x) mesocosm experiment: a) Control; b) Fluct: fluctuating temperature; c) 40C: increase to 40 degrees C; d) UVplus: artificial increase in UV radiation; and f) UVmin: UV radiation protection. In order to observe the changes in biodiversity, we obtained 16S rRNA gene clone libraries from microbial mats at the end of the experiment (eight months) and analyzed them using multivariate and phylogenetic tools. Sequences were assigned to 13 major lineages, among which Cyanobacteria (38.8%) and Alphaproteobacteria (25.5%) were the most abundant. The less extreme treatments (Control and UVmin) had a more similar composition and distribution of the phylogenetic groups with the natural pools than the most extreme treatments (Fluct, 40C, and UVplus), which showed drastic changes in the community composition and structure, indicating a different community response to each environmental disturbance. An increase in bacterial diversity was found in the UVmin treatment, suggesting that protected environments promote the establishment of complex bacterial communities, while stressful environments reduce diversity and increase the dominance of a few Cyanobacterial OTUs (mainly Leptolyngbya sp) through environmental filtering. Mesocosm experiments using complex bacterial communities, along with multivariate and phylogenetic analyses of molecular data, can assist in addressing questions about bacterial responses to long-term environmental stress.	[Pajares, Silvia; Souza, Valeria; Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, CU, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Souza, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, CU, Mexico City 04510, DF, Mexico.	souza@unam.mx		souza, valeria/0000-0002-2992-4229	office of APFF of Cuatro Cienegas; CBTA22	office of APFF of Cuatro Cienegas; CBTA22	We would like to thank the teachers CH Hernandez and PL Arizpe and the high school students from the CBTA22 of Cuatro Cienegas for technical assistance with the mesocosm experiment and L. Espinosa for logistic support. We specially thank PRONATURA Noreste for the access to the Pozas Azules ranch, the office of APFF of Cuatro Cienegas for their support, and above all the CBTA22 for providing housing and support for the experiment.	Abed RMM, 2006, AQUAT MICROB ECOL, V44, P21, DOI 10.3354/ame044021; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, AR5 IPCC; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Cardinale B.J., 2009, ECOLOGY, V90, P854, DOI DOI 10.1890/08-1584.1; Castenholz R.W., 2012, ECOLOGY CYANOBACTERI, P481, DOI [10.1007/978-94-007-3855-3_19, DOI 10.1007/978-94-007-3855-3_19]; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Des Marais DJ, 2003, BIOL BULL-US, V204, P160, DOI 10.2307/1543552; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; FUERST JA, 2004, WORLD FED CULT COLLE, V38, P1; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Guisan A, 2014, NAT CLIM CHANGE, V4, P175, DOI 10.1038/nclimate2157; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hall EK, 2008, ISME J, V2, P471, DOI 10.1038/ismej.2008.9; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Havemann SA, 2008, APPL ENVIRON MICROB, V74, P7410, DOI 10.1128/AEM.01710-08; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McCaig AE, 1999, APPL ENVIRON MICROB, V65, P1721; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nitti A, 2012, ASTROBIOLOGY, V12, P685, DOI 10.1089/ast.2011.0812; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paerl H.W., 2010, MICROBIAL MATS MODER, P423; Pajares S, 2013, ANTON LEEUW INT J G, V104, P1159, DOI 10.1007/s10482-013-0038-7; Pajares S, 2012, MICROB ECOL, V64, P346, DOI 10.1007/s00248-012-0045-7; Peimbert M, 2012, ASTROBIOLOGY, V12, P648, DOI 10.1089/ast.2011.0694; Pizzetti I, 2011, APPL ENVIRON MICROB, V77, P5009, DOI 10.1128/AEM.02931-10; Pringault O, 2001, AQUAT MICROB ECOL, V26, P127, DOI 10.3354/ame026127; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rebollar EA, 2012, ENVIRON MICROBIOL, V14, P2323, DOI 10.1111/j.1462-2920.2012.02784.x; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Ross KA, 2012, MICROB ECOL, V64, P162, DOI 10.1007/s00248-012-0012-3; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wolaver BD, 2013, GEOSPHERE, V9, P113, DOI 10.1130/GES00849.1; Yannarell AC, 2007, ENVIRON MICROBIOL, V9, P576, DOI 10.1111/j.1462-2920.2006.01173.x	72	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119741	10.1371/journal.pone.0119741	http://dx.doi.org/10.1371/journal.pone.0119741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781013	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600087
J	Schicktanz, N; Fastenrath, M; Milnik, A; Spalek, K; Auschra, B; Nyffeler, T; Papassotiropoulos, A; de Quervain, DJF; Schwegler, K				Schicktanz, Nathalie; Fastenrath, Matthias; Milnik, Annette; Spalek, Klara; Auschra, Bianca; Nyffeler, Thomas; Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.; Schwegler, Kyrill			Continuous Theta Burst Stimulation over the Left Dorsolateral Prefrontal Cortex Decreases Medium Load Working Memory Performance in Healthy Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; EXCITABILITY; COMPONENT; FMRI; TMS	The dorsolateral prefrontal cortex (DLPFC) plays a key role in working memory. Evidence indicates that transcranial magnetic stimulation (TMS) over the DLPFC can interfere with working memory performance. Here we investigated for how long continuous theta-burst stimulation (cTBS) over the DLPFC decreases working memory performance and whether the effect of cTBS on performance depends on working memory load. Forty healthy young subjects received either cTBS over the left DLPFC or sham stimulation before performing a 2-, and 3-back working memory letter task. An additional 0-back condition served as a nonmemory- related control, measuring general attention. cTBS over the left DLPFC significantly impaired 2-back working memory performance for about 15 min, whereas 3-back and 0-back performances were not significantly affected. Our results indicate that the effect of left DLPFC cTBS on working memory performance lasts for roughly 15 min and depends on working memory load.	[Schicktanz, Nathalie; Fastenrath, Matthias; Spalek, Klara; de Quervain, Dominique J. -F.; Schwegler, Kyrill] Univ Basel, Dept Psychol, Div Cognit Neurosci, Basel, Switzerland; [Milnik, Annette; Auschra, Bianca; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland; [Schicktanz, Nathalie; Milnik, Annette; Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.; Schwegler, Kyrill] Univ Basel, Psychiat Univ Clin, Basel, Switzerland; [Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Clin Res, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Nyffeler, Thomas] Univ Bern, Bern, Switzerland; [Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabil, Luzern, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital	Schicktanz, N (corresponding author), Univ Basel, Dept Psychol, Div Cognit Neurosci, Basel, Switzerland.	nathalie.schicktanz@unibas.ch		Spalek, Klara/0000-0002-4244-6495; Papassotiropoulos, Andreas/0000-0002-2210-9651; Milnik, Annette/0000-0002-3933-3289; Nyffeler, Thomas/0000-0003-2504-8935; de Quervain, Dominique/0000-0001-7131-2464	Uniscientia Stiftung	Uniscientia Stiftung	Uniscientia Stiftung generously supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Balanza-Martinez V, 2008, NEUROSCI BIOBEHAV R, V32, P1426, DOI 10.1016/j.neubiorev.2008.05.019; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Goldsworthy MR, 2015, CEREB CORTEX, V25, P1724, DOI 10.1093/cercor/bht353; Goldsworthy MR, 2013, BRAIN STIMUL, V6, P340, DOI 10.1016/j.brs.2012.06.005; Heck A, 2014, NEURON, V81, P1203, DOI 10.1016/j.neuron.2014.01.010; Honey GD, 2002, NEUROIMAGE, V17, P573, DOI 10.1006/nimg.2002.1193; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kaminski JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024836; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laux L, 1981, STATE TRADIT ANGSTIN; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Ma LS, 2012, HUM BRAIN MAPP, V33, P1850, DOI 10.1002/hbm.21329; Manelis A, 2015, CEREB CORTEX, V25, P726, DOI 10.1093/cercor/bht262; Morgan HM, 2013, BRAIN STIMUL, V6, P122, DOI 10.1016/j.brs.2012.03.001; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Nyffeler T, 2006, EUR J NEUROSCI, V24, P2961, DOI 10.1111/j.1460-9568.2006.05154.x; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Schicktanz N, 2014, ANN CLIN TRANSL NEUR, V1, P69, DOI 10.1002/acn3.22; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704	35	27	26	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120640	10.1371/journal.pone.0120640	http://dx.doi.org/10.1371/journal.pone.0120640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781012	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600177
J	Tominaga, M; Kawai-Noma, S; Kawagishi, I; Sowa, Y; Saito, K; Umeno, D				Tominaga, Masahiro; Kawai-Noma, Shigeko; Kawagishi, Ikuro; Sowa, Yoshiyuki; Saito, Kyoichi; Umeno, Daisuke			Liquid-Based Iterative Recombineering Method Tolerant to Counter-Selection Escapes	PLOS ONE			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; SELECTABLE MARKER; GENOME; MUTATIONS; DEPENDENCE; EVOLUTION; MUTANTS; REPLICATION; POLYMERASE	Selection-based recombineering is a flexible and proven technology to precisely modify bacterial genomes at single base resolution. It consists of two steps of homologous recombination followed by selection/counter-selection. However, the shortage of efficient counter-selectable markers limits the throughput of this method. Additionally, the emergence of 'selection escapees' can affect recombinant pools generated through this method, and they must be manually removed at each step of selection-based recombineering. Here, we report a series of efforts to improve the throughput and robustness of selection-based recombineering and to achieve seamless and automatable genome engineering. Using the nucleoside kinase activity of herpes simplex virus thymidine kinase (hsvTK) on the non-natural nucleoside dP, a highly efficient, rapid, and liquid-based counter-selection system was established. By duplicating hsvtk gene, combined with careful control of the population size for the subsequent round, we effectively eliminated selection escapes, enabling seamless and multiple insertions/replacement of gene-size fragments in the chromosome. Four rounds of recombineering could thus be completed in 10 days, requiring only liquid handling and without any need for colony isolation or genotype confirmation. The simplicity and robustness of our method make it broadly accessible for multi-locus chromosomal modifications.	[Tominaga, Masahiro; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Kawagishi, Ikuro; Sowa, Yoshiyuki] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan; [Sowa, Yoshiyuki] Hosei Univ, Res Ctr Micronano Technol, Tokyo 1848584, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Chiba University; Hosei University; Hosei University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cyo, Chiba 2638522, Japan.	umeno@faculty.chiba-u.jp	Tominaga, Masahiro/GYJ-1256-2022	Tominaga, Masahiro/0000-0001-9691-0428; Sowa, Yoshiyuki/0000-0002-1691-2018	Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan); Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS) [23108507]; Grants-in-Aid for Scientific Research [25840054] Funding Source: KAKEN	Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan); Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan), the Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST), and Grant-in-Aid for Scientific Research on Innovative Areas (23108507) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansho Y, 2012, CHEM BIOL, V19, P478, DOI 10.1016/j.chembiol.2012.01.019; Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; BRESCH C, 1980, J THEOR BIOL, V85, P399, DOI 10.1016/0022-5193(80)90314-8; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; DRAKE JW, 1993, J MOL BIOL, V229, P8, DOI 10.1006/jmbi.1993.1002; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DUBE DK, 1993, GENE, V137, P41, DOI 10.1016/0378-1119(93)90249-3; FUJITANI Y, 1995, GENETICS, V140, P797; Gregg CJ, 2014, NUCLEIC ACIDS RES, V42, P4779, DOI 10.1093/nar/gkt1374; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hanczyc MM, 1998, RNA, V4, P268; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; LIN PKT, 1989, NUCLEIC ACIDS RES, V17, P10373, DOI 10.1093/nar/17.24.10373; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOVETT ST, 1988, GENETICS, V120, P37; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Negishi K, 2002, GENETICS, V161, P1363; Pal C, 2014, NAT REV GENET, V15, P504, DOI 10.1038/nrg3746; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; SHEN P, 1986, GENETICS, V112, P441; Stavropoulos TA, 2001, GENOMICS, V72, P99, DOI 10.1006/geno.2000.6481; SUMMERS WC, 1993, J BACTERIOL, V175, P6049, DOI 10.1128/JB.175.18.6049-6051.1993; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Tashiro Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1070; VERROUST PJ, 1979, KIDNEY INT, V16, P9, DOI 10.1038/ki.1979.97; Vickers MF, 1999, BIOCHEM J, V339, P21, DOI 10.1042/0264-6021:3390021; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119818	10.1371/journal.pone.0119818	http://dx.doi.org/10.1371/journal.pone.0119818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775434	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500127
J	Seo, YA; Wessling-Resnick, M				Seo, Young Ah; Wessling-Resnick, Marianne			Ferroportin deficiency impairs manganese metabolism in flatiron mice	FASEB JOURNAL			English	Article						iron metabolism; hepcidin; manganese transport	IRON EXPORTER; INTRACELLULAR TRAFFICKING; SH-SY5Y CELLS; HEPCIDIN; TRANSPORTER; DISEASE; PARKINSONISM; MUTATIONS; SLC30A10; EFFLUX	We examined the physiologic role of ferroportin (Fpn) in manganese (Mn) export using flatiron (ffe/+) mice, a genetic model of Fpn deficiency. Blood (0.0123 vs. 0.0107 mg/kg; P = 0.0003), hepatic (1.06 vs. 0.96 mg/kg; P = 0.0125), and bile Mn levels (79 vs. 38 mg/kg; P = 0.0204) were reduced in ffe/+ mice compared to +/+ controls. Erythrocyte Mn-superoxide dismutase was also reduced at 6 (0.154 vs. 0.096, P = 0.0101), 9 (0.131 vs. 0.089, P = 0.0162), and 16 weeks of age (0.170 vs. 0.090 units/mg protein/min; P < 0.0001). Mn-54 uptake after intragastric gavage was markedly reduced in ffe/+ mice (0.0187 vs. 0.0066% dose; P = 0.0243), while clearance of injected isotope was similar in ffe/+ and +/+ mice. These values were compared to intestinal absorption of Fe-59, which was significantly reduced in ffe/+ mice (8.751 vs. 3.978% dose; P = 0.0458). The influence of the ffe mutation was examined in dopaminergic SH-SY5Y cells and human embryonic HEK293T cells. While expression of wild-type Fpn reversed Mn-induced cytotoxicity, ffe mutant H32R failed to confer protection. These combined results demonstrate that Fpn plays a central role in Mn transport and that flatiron mice provide an excellent genetic model to explore the role of this exporter in Mn homeostasis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis & Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu	Seo, Young Ah/AAT-5022-2020	Seo, Young Ah/0000-0003-3884-0665	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [R01ES0146380, K99ES024340]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES024340, R01ES014638, R00ES024340] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the U.S. National Institutes of Health, National Institute of Environmental Health Sciences to M.W.R. (R01ES0146380) and Y.A.S. (K99ES024340).	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Bartnikas TB, 2012, BIOMETALS, V25, P677, DOI 10.1007/s10534-012-9520-3; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Boserup MW, 2011, BIOMETALS, V24, P357, DOI 10.1007/s10534-010-9405-2; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; DeWitt MR, 2013, BIOCHEM BIOPH RES CO, V432, P1, DOI 10.1016/j.bbrc.2013.01.058; DONALDSON J, 1987, NEUROTOXICOLOGY, V8, P451; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; FINLEY JW, 1994, AM J CLIN NUTR, V60, P949, DOI 10.1093/ajcn/60.6.949; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Frumkin H, 1997, AM J IND MED, V31, P107; Golub MS, 2012, NEUROTOXICOL TERATOL, V34, P220, DOI 10.1016/j.ntt.2011.11.002; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; HONG JS, 1984, ENVIRON RES, V34, P242, DOI 10.1016/0013-9351(84)90092-6; KIM J, 2013, NATL GEOGR, V224, P8; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Lahousse SA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-41; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; Liu SC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-21; Lucchini R, 1997, ENVIRON RES, V73, P175, DOI 10.1006/enrs.1997.3702; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MENA I, 1969, NEUROLOGY, V19, P1000, DOI 10.1212/WNL.19.10.1000; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Morello A, 2007, BRAIN RES BULL, V74, P406, DOI 10.1016/j.brainresbull.2007.07.011; Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697; Park Bo-Yeon, 2008, Nutr Res Pract, V2, P317, DOI 10.4162/nrp.2008.2.4.317; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Prahalad AK, 1999, TOXICOL APPL PHARM, V158, P81, DOI 10.1006/taap.1999.8701; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Seo YA, 2013, NEUROTOXICOLOGY, V38, P67, DOI 10.1016/j.neuro.2013.06.002; Soundararajan R, 2008, J BIOL CHEM, V283, P2231, DOI 10.1074/jbc.M703583200; Sriram K, 2010, ARCH TOXICOL, V84, P521, DOI 10.1007/s00204-010-0525-9; Thomas C, 2004, GUT, V53, P44, DOI 10.1136/gut.53.1.44; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Tran TT, 2002, NEUROTOXICOLOGY, V23, P635, DOI 10.1016/S0161-813X(02)00091-8; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Tussing-Humphreys L., 2012, J ACAD NUTR DIET, V112, P762; Tussing-Humphreys L, 2012, J ACAD NUTR DIET, V112, P391, DOI 10.1016/j.jada.2011.08.038; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109; ZAYED J, 1994, AM IND HYG ASSOC J, V55, P53, DOI 10.1202/0002-8894(1994)055<0053:OAEEOG>2.0.CO;2; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	63	33	34	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2726	2733		10.1096/fj.14-262592	http://dx.doi.org/10.1096/fj.14-262592			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782988	Green Published			2022-12-26	WOS:000356859100005
J	Kara, N; Hossain, M; Prasanth, SG; Stillman, B				Kara, Nihan; Hossain, Manzar; Prasanth, Supriya G.; Stillman, Bruce			Orc1 Binding to Mitotic Chromosomes Precedes Spatial Patterning during G(1) Phase and Assembly of the Origin Recognition Complex in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA-binding Protein; DNA Replication; Mitosis; Protein-DNA Interaction; FOXA1; Origin Recognition Complex	EUKARYOTIC DNA-REPLICATION; MEIER-GORLIN SYNDROME; EARLY G1 PHASE; S-PHASE; FISSION YEAST; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION	Background: Orc1 is the largest subunit of the origin recognition complex that promotes genome duplication. Results: We studied the dynamics of Orc1 during the cell division cycle. Conclusion: Orc1 binds to mitotic chromosomes, and during G(1) phase in the daughter cells it then forms spatial-temporal patterns in the nucleus. Significance: The large subunit of ORC orchestrates the earliest stages of chromosome inheritance. Replication of eukaryotic chromosomes occurs once every cell division cycle in normal cells and is a tightly controlled process that ensures complete genome duplication. The origin recognition complex (ORC) plays a key role during the initiation of DNA replication. In human cells, the level of Orc1, the largest subunit of ORC, is regulated during the cell division cycle, and thus ORC is a dynamic complex. Upon S phase entry, Orc1 is ubiquitinated and targeted for destruction, with subsequent dissociation of ORC from chromosomes. Time lapse and live cell images of human cells expressing fluorescently tagged Orc1 show that Orc1 re-localizes to condensing chromatin during early mitosis and then displays different nuclear localization patterns at different times during G(1) phase, remaining associated with late replicating regions of the genome in late G(1) phase. The initial binding of Orc1 to mitotic chromosomes requires C-terminal amino acid sequences that are similar to mitotic chromosome-binding sequences in the transcriptional pioneer protein FOXA1. Depletion of Orc1 causes concomitant loss of the mini-chromosome maintenance (Mcm2-7) helicase proteins on chromatin. The data suggest that Orc1 acts as a nucleating center for ORC assembly and then pre-replication complex assembly by binding to mitotic chromosomes, followed by gradual removal from chromatin during the G(1) phase.	[Kara, Nihan; Hossain, Manzar; Prasanth, Supriya G.; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kara, Nihan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11779 USA; [Prasanth, Supriya G.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Illinois System; University of Illinois Urbana-Champaign	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu	Hossain, Manzar/AAT-7482-2021	Hossain, Manzar/0000-0003-3399-581X	National Institutes of Health Program Project from the NCI [CA13106];  [CA45508]; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099669] Funding Source: NIH RePORTER	National Institutes of Health Program Project from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant CA13106 from the NCI and Support Grant CA45508 (to Cold Spring Harbor Laboratory Cancer Center).	Abdurashidova G, 2003, EMBO J, V22, P4294, DOI 10.1093/emboj/cdg404; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Baldinger T, 2009, MOL CELL BIOL, V29, P140, DOI 10.1128/MCB.00981-08; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Harlow E., 1988, ANTIBODIES LAB MANUA; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; HUMBERT C, 1992, CYTOMETRY, V13, P603, DOI 10.1002/cyto.990130608; Jackson D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a010389; Kaykov A, 2015, GENOME RES, V25, P391, DOI 10.1101/gr.180372.114; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Li F, 2001, J CELL BIOL, V154, P283, DOI 10.1083/jcb.200104043; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lu JJ, 2010, J CELL BIOL, V189, P967, DOI 10.1083/jcb.201002002; Lygerou Z, 1999, J CELL SCI, V112, P3703; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Moindrot B, 2012, NUCLEIC ACIDS RES, V40, P9470, DOI 10.1093/nar/gks736; Muller P, 2010, GENE DEV, V24, P1418, DOI 10.1101/gad.1906410; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Neuwald AF, 1999, GENOME RES, V9, P27; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Rhind N., 2013, COLD SPRING HARB PER, V3; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sadoni N, 2004, J CELL SCI, V117, P5353, DOI 10.1242/jcs.01412; SANDERS MM, 1978, J CELL BIOL, V79, P97, DOI 10.1083/jcb.79.1.97; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takebayashi S, 2012, NUCLEUS-PHILA, V3, P500, DOI 10.4161/nucl.22318; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wu JR, 1997, MOL CELL BIOL, V17, P4312, DOI 10.1128/MCB.17.8.4312; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wu R, 2006, J CELL BIOL, V174, P185, DOI 10.1083/jcb.200601113; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	101	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12355	12369		10.1074/jbc.M114.625012	http://dx.doi.org/10.1074/jbc.M114.625012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25784553	hybrid, Green Published			2022-12-26	WOS:000354388600044
J	Cennamo, N; Di Giovanni, S; Varriale, A; Staiano, M; Di Pietrantonio, F; Notargiacomo, A; Zeni, L; D'Auria, S				Cennamo, Nunzio; Di Giovanni, Stefano; Varriale, Antonio; Staiano, Maria; Di Pietrantonio, Fabio; Notargiacomo, Andrea; Zeni, Luigi; D'Auria, Sabato			Easy to Use Plastic Optical Fiber-Based Biosensor for Detection of Butanal	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; SOLID-PHASE MICROEXTRACTION; SURFACE-PLASMON RESONANCE; STABILITY; MECHANISM; DERIVATIZATION; ALDEHYDES; DYNAMICS; SPR	The final goal of this work is to achieve a selective detection of butanal by the realization of a simple, small-size and low cost experimental approach. To this end, a porcine odorant-binding protein was used in connection with surface plasmon resonance transduction in a plastic optical fiber tool for the selective detection of butanal by a competitive assay. This allows to reduce the cost and the size of the sensing device and it offers the possibility to design a "Lab-on-a-chip" platform. The obtained results showed that this systema pproach is able to selectively detect the presence of butanal in the concentration range from 20 mu M to 1000 mu M.	[Cennamo, Nunzio; Zeni, Luigi] SUN, Dept Ind & Informat Engn, Aversa, Italy; [Di Giovanni, Stefano; Varriale, Antonio; Staiano, Maria; D'Auria, Sabato] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Di Pietrantonio, Fabio] OM Corbino Inst Acoust & Sensors, Rome, Italy; [Notargiacomo, Andrea] CNR, Inst Photon & Nanotechnol, Rome, Italy; [D'Auria, Sabato] CNR, Inst Food Sci, Avellino, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Acustica e Sensoristica "Orso Mario Corbino" (IDASC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Zeni, L (corresponding author), SUN, Dept Ind & Informat Engn, Aversa, Italy.	luigi.zeni@unina2.it; sabato.dauria@cnr.it	Varriale, Antonio/AAL-1439-2020; Di Pietrantonio, Fabio/AAB-3685-2019; STAIANO, MARIA/B-9584-2015; Zeni, Luigi/AAC-5044-2022; Cennamo, Nunzio/AAC-5026-2022; Notargiacomo, Andrea/C-3178-2013	Di Pietrantonio, Fabio/0000-0002-6629-6401; STAIANO, MARIA/0000-0003-0223-1825; Zeni, Luigi/0000-0001-8356-7480; Cennamo, Nunzio/0000-0001-7769-0984; Notargiacomo, Andrea/0000-0002-7177-9096				Abbas A, 2011, BIOSENS BIOELECTRON, V26, P1815, DOI 10.1016/j.bios.2010.09.030; Beranek J, 2008, J CHROMATOGR A, V1209, P44, DOI 10.1016/j.chroma.2008.09.013; Bonnot K, 2014, ANAL CHEM, V86, P5125, DOI 10.1021/ac500903s; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; Cennamo N, 2013, SENSOR ACTUAT B-CHEM, V188, P221, DOI 10.1016/j.snb.2013.07.005; Cennamo N, 2013, SENSOR ACTUAT B-CHEM, V176, P1008, DOI 10.1016/j.snb.2012.10.055; Cennamo N, 2013, SENSORS-BASEL, V13, P721, DOI 10.3390/s130100721; Cennamo N, 2011, SENSORS-BASEL, V11, P11752, DOI 10.3390/s111211752; Dal Monte M, 1993, CHEM SENSES, V18, P713; Deng CH, 2004, RAPID COMMUN MASS SP, V18, P1715, DOI 10.1002/rcm.1544; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Lobel D, 2002, CHEM SENSES, V27, P39, DOI 10.1093/chemse/27.1.39; McGregor D, 2006, CRIT REV TOXICOL, V36, P821, DOI 10.1080/10408440600977669; Schmarr HG, 2008, ANAL CHIM ACTA, V617, P119, DOI 10.1016/j.aca.2008.02.002; Scott PK, 2007, ANAL BIOANAL CHEM, V387, P1831; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Staiano M, 2008, BIOPOLYMERS, V89, P284, DOI 10.1002/bip.20908; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; Verma R, 2013, SENSOR ACTUAT B-CHEM, V177, P279, DOI 10.1016/j.snb.2012.10.135	20	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116770	10.1371/journal.pone.0116770	http://dx.doi.org/10.1371/journal.pone.0116770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789470	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400020
J	Hososhima, S; Sakai, S; Ishizuka, T; Yawo, H				Hososhima, Shoko; Sakai, Seiichiro; Ishizuka, Toru; Yawo, Hiromu			Kinetic Evaluation of Photosensitivity in Bi-Stable Variants of Chimeric Channelrhodopsins	PLOS ONE			English	Article							LIGHT; CHANNEL; PHOTOCYCLE; CHLAMYDOMONAS; RHODOPSINS; MODEL	Channelrhodopsin-1 and 2 (ChR1 and ChR2) form cation channels that are gated by light through an unknown mechanism. We tested the DC-gate hypothesis that C167 and D195 are involved in the stabilization of the cation-permeable state of ChRWR/C1C2 which consists of TM1-5 of ChR1 and TM6-7 of ChR2 and ChRFR which consists of TM1-2 of ChR1 and TM3-7 of ChR2. The cation permeable state of each ChRWR and ChRFR was markedly prolonged in the order of several tens of seconds when either C167 or D195 position was mutated to alanine (A). Therefore, the DC-gate function was conserved among these chimeric ChRs. We next investigated the kinetic properties of the ON/OFF response of these bi-stable ChR mutants as they are important in designing the photostimulation protocols for the optogenetic manipulation of neuronal activities. The turning-on rate constant of each photocurrent followed a linear relationship to 0-0.12 mWmm(-2) of blue LED light or to 0-0.33 mWmm(-2) of cyan LED light. Each photocurrent of bi-stable ChR was shut off to the non-conducting state by yellow or orange LED light in a manner dependent on the irradiance. As the magnitude of the photocurrent was mostly determined by the turning-on rate constant and the irradiation time, the minimal irradiance that effectively evoked an action potential (threshold irradiance) was decreased with time only if the neuron, which expresses bi-stable ChRs, has a certain large membrane time constant (eg. tau(m) > 20 ms). On the other hand, in another group of neurons, the threshold irradiance was not dependent on the irradiation time. Based on these quantitative data, we would propose that these bi-stable ChRs would be most suitable for enhancing the intrinsic activity of excitatory pyramidal neurons at a minimal magnitude of irradiance.	[Hososhima, Shoko; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Hososhima, Shoko; Sakai, Seiichiro; Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Sakai, Seiichiro] RIKEN, Brain Sci Inst, Lab Local Neuronal Circuits, Wako, Saitama, Japan; [Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); RIKEN; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288	Japan Society for the Promotion of Science (JSPS) [13J06372]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23115501, 25115701]; MEXT, Japan [25250001, 25670103, 25290002]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Research Foundation for Opto-Science and Technology	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Research Foundation for Opto-Science and Technology	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 13J06372) of Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (Nos. 23115501 & 25115701) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in Aid for Scientific Research (No. 25250001), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for challenging Exploratory Research (No. 25670103), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in Aid for Scientific Research (No. 25290002), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) (http://www.nibio.go.jp/english/index.html), and Research Foundation for Opto-Science and Technology (http://www.refost-hq.jp/kenkyu.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Okada Y, 2012, J PHYSIOL-LONDON, V590, P4933, DOI 10.1113/jphysiol.2012.231464; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yamazaki Y, 2014, GLIA, V62, P1299, DOI 10.1002/glia.22681; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	35	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119558	10.1371/journal.pone.0119558	http://dx.doi.org/10.1371/journal.pone.0119558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789474	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400090
J	Rutsche, B; Hauser, TU; Jancke, L; Grabner, RH				Ruetsche, Bruno; Hauser, Tobias U.; Jaencke, Lutz; Grabner, Roland H.			When Problem Size Matters: Differential Effects of Brain Stimulation on Arithmetic Problem Solving and Neural Oscillations	PLOS ONE			English	Article							TRANSCRANIAL DC STIMULATION; HUMAN MOTOR CORTEX; ELECTRICAL-STIMULATION; THETA OSCILLATIONS; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; MENTAL ADDITION; UPPER ALPHA; EEG; RETRIEVAL	The problem size effect is a well-established finding in arithmetic problem solving and is characterized by worse performance in problems with larger compared to smaller operand size. Solving small and large arithmetic problems has also been shown to involve different cognitive processes and distinct electroencephalography (EEG) oscillations over the left posterior parietal cortex (LPPC). In this study, we aimed to provide further evidence for these dissociations by using transcranial direct current stimulation (tDCS). Participants underwent anodal (30min, 1.5 mA, LPPC) and sham tDCS. After the stimulation, we recorded their neural activity using EEG while the participants solved small and large arithmetic problems. We found that the tDCS effects on performance and oscillatory activity critically depended on the problem size. While anodal tDCS improved response latencies in large arithmetic problems, it decreased solution rates in small arithmetic problems. Likewise, the lower-alpha desynchronization in large problems increased, whereas the theta synchronization in small problems decreased. These findings reveal that the LPPC is differentially involved in solving small and large arithmetic problems and demonstrate that the effects of brain stimulation strikingly differ depending on the involved neuro-cognitive processes.	[Ruetsche, Bruno] Swiss Fed Inst Technol, Inst Behav Sci, Res Learning & Instruct, Zurich, Switzerland; [Ruetsche, Bruno; Hauser, Tobias U.] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Ruetsche, Bruno; Hauser, Tobias U.] Swiss Fed Inst Technol, Zurich, Switzerland; [Hauser, Tobias U.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Hauser, Tobias U.] Univ Zurich, Univ Clin Child & Adolescent Psychiat, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Div Neuropsychol, Inst Psychol, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Univ Res Prior Program, Dynam Healthy Aging, Zurich, Switzerland; [Jaencke, Lutz] King Abdulaziz Univ, Dept Special Educ, Jeddah 21413, Saudi Arabia; [Grabner, Roland H.] Graz Univ, Sect Educ Neurosci, Dept Psychol, Graz, Austria; [Grabner, Roland H.] Univ Gottingen, Inst Psychol, Dept Educ Psychol, D-37073 Gottingen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; University College London; University of Zurich; University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; King Abdulaziz University; University of Graz; University of Gottingen	Rutsche, B (corresponding author), Swiss Fed Inst Technol, Inst Behav Sci, Res Learning & Instruct, Zurich, Switzerland.	bruno.ruetsche@ifv.gess.ethz.ch	Grabner, Roland/AAE-7272-2020	Grabner, Roland/0000-0003-0385-8910; Rutsche, Bruno/0000-0002-5432-2721; Hauser, Tobias U./0000-0002-7997-8137	Swiss National Science Foundation [100014_140515 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by a grant awarded to TUH and RHG by the Swiss National Science Foundation (100014_140515 / 1; http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Ashcraft M. H., 1987, FORMAL METHODS DEV P, P302, DOI DOI 10.1007/978-1-4612-4694-7_9; Ashcraft MH, 2009, PSYCHOL LEARN MOTIV, V51, P121, DOI 10.1016/S0079-7421(09)51004-3; ASHCRAFT MH, 1981, MEM COGNITION, V9, P185, DOI 10.3758/BF03202334; Balconi M, 2012, NEUROSCI LETT, V517, P25, DOI 10.1016/j.neulet.2012.04.010; Bastiaansen M, 2006, PROG BRAIN RES, V159, P179, DOI 10.1016/S0079-6123(06)59012-0; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Campbell, 1995, MATH COGNITION, V1, P121, DOI DOI 10.3758/BF03197037; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; CAMPBELL JID, 1987, J EXP PSYCHOL LEARN, V13, P109, DOI 10.1037/0278-7393.13.1.109; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Smedt B, 2009, EXP BRAIN RES, V195, P635, DOI 10.1007/s00221-009-1839-9; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elmer S, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-29; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2007, BRAIN RES BULL, V72, P57, DOI 10.1016/j.brainresbull.2007.01.001; Grabner RH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00428; Grabner RH, 2011, BIOL PSYCHOL, V87, P128, DOI 10.1016/j.biopsycho.2011.02.019; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Hauser TU, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00244; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jacobson L, 2012, BRAIN RES, V1439, P66, DOI 10.1016/j.brainres.2011.12.036; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kadosh RC, 2013, TRENDS NEUROSCI EDUC, V2, P85, DOI 10.1016/j.tine.2013.04.001; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Kirk EP, 2001, J EXP PSYCHOL LEARN, V27, P157, DOI 10.1037/0278-7393.27.1.157; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Klimesch W., 1993, Brain Topography, V5, P241, DOI 10.1007/BF01128991; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W., 1992, J PSYCHOPHYSIOL, V6, P185; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Krause B, 2013, DEV COGN NEUROSCI; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; Miniussi C, 2012, CLIN EEG NEUROSCI, V43, P184, DOI 10.1177/1550059412444976; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; PARKMAN JM, 1971, J EXP PSYCHOL, V89, P335, DOI 10.1037/h0031198; Parsons S., 2005, DOES NUMERACY MATTER; PFURTSCHELLER G, 1970, Z GES EXP MED, V152, P284, DOI 10.1007/BF02044912; Pfurtscheller G, 2005, ELECTROENCEPHALOGRAP, P1004; Pisoni A, 2012, NEUROSCIENCE, V223, P56, DOI 10.1016/j.neuroscience.2012.07.046; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Royer JM, 1999, CONTEMP EDUC PSYCHOL, V24, P181, DOI 10.1006/ceps.1999.1004; Sarkar A, 2014, J NEUROSCI, V34, P16605, DOI 10.1523/JNEUROSCI.3129-14.2014; Schlaug G, 2011, NEUROPSYCHOL REV, V21, P288, DOI 10.1007/s11065-011-9181-y; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Stone DB, 2009, NEUROREPORT, V20, P1115, DOI 10.1097/WNR.0b013e32832e9aa2; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Verguts T, 2005, MEM COGNITION, V33, P1, DOI 10.3758/BF03195293; Vines BW, 2006, NEUROREPORT, V17, P1047, DOI 10.1097/01.wnr.0000223396.05070.a2; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697; Zbrodoff W., 2005, HDB MATH COGNITION, P331; Zhou XL, 2007, NEUROIMAGE, V35, P871, DOI 10.1016/j.neuroimage.2006.12.017; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	93	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120665	10.1371/journal.pone.0120665	http://dx.doi.org/10.1371/journal.pone.0120665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789486	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000351425400170
J	Dias, JG; de Oliveira, IT				Dias, Jose G.; de Oliveira, Isabel Tiago			Multilevel Effects of Wealth on Women's Contraceptive Use in Mozambique	PLOS ONE			English	Article							FERTILITY; MODELS; EQUITY; COVERAGE; POOR	Objective This paper analyzes the impact of wealth on the use of contraception in Mozambique unmixing the contextual effects due to community wealth from the individual effects associated with the women's situation within the community of residence. Methods Data from the 2011 Mozambican Demographic and Health Survey on women who are married or living together are analyzed for the entire country and also for the rural and urban areas separately. We used single level and multilevel probit regression models. Findings A single level probit regression reveals that region, religion, age, previous fertility, education, and wealth impact contraceptive behavior. The multilevel analysis shows that average community wealth and the women's relative socioeconomic position within the community have significant positive effects on the use of modern contraceptives. The multilevel framework proved to be necessary in rural settings but not relevant in urban areas. Moreover, the contextual effects due to community wealth are greater in rural than in urban areas and this feature is associated with the higher socioeconomic heterogeneity within the richest communities. Conclusion This analysis highlights the need for the studies on contraceptive behavior to specifically address the individual and contextual effects arising from the poverty-wealth dimension in rural and urban areas separately. The inclusion in a particular community of residence is not relevant in urban areas, but it is an important feature in rural areas. Although the women's individual position within the community of residence has a similar effect on contraceptive adoption in rural and urban settings, the impact of community wealth is greater in rural areas and smaller in urban areas.	[Dias, Jose G.] Inst Univ Lisboa ISCTE IUL, BRU, Lisbon, Portugal; [de Oliveira, Isabel Tiago] Inst Univ Lisboa ISCTE IUL, CIES Ctr Estudos & Invest Sociol, Lisbon, Portugal	Instituto Universitario de Lisboa; Instituto Universitario de Lisboa	Dias, JG (corresponding author), Inst Univ Lisboa ISCTE IUL, BRU, Lisbon, Portugal.	jose.dias@iscte.pt	Dias, José G./N-6217-2015; Oliveira, Isabel/AAE-4688-2022	Oliveira, Isabel/0000-0002-9350-4130; Dias, Jose G./0000-0003-4732-7230	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/CS-DEM/108033/2008]; Fundação para a Ciência e a Tecnologia [PTDC/CS-DEM/108033/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by the Fundacao para a Ciencia e Tecnologia (Portugal), Grant PTDC/CS-DEM/108033/2008. (URL: http://www.fct.pt/index.phtml.pt) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2001, POP STUD-J DEMOG, V55, P135, DOI 10.1080/00324720127691; Agadjanian V, 2011, DEMOGRAPHY, V48, P1029, DOI 10.1007/s13524-011-0039-y; Arnaldo C., 2004, Journal of Population Research, V21, P177; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fotso JC, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-71; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gwatkin D., 2005, SOCIOECONOMIC DIFFER, V2nd ed.; Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639802400504; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Jacobstein R, 2009, STUD FAMILY PLANN, V40, P147, DOI 10.1111/j.1728-4465.2009.00197.x; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Montgomery MR, 1996, POPUL DEV REV, V22, P151, DOI 10.2307/2808010; Ortayli N, 2010, STUD FAMILY PLANN, V41, P101, DOI 10.1111/j.1728-4465.2010.00230.x; Rogers E.M., 1995, DIFFUSION INNOVATION; Rutstein S. O., 2008, 60 DHS MACR INC; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Yazbeck A. S., 2005, Reaching the poor with health, nutrition, and population services: what works, what doesn't and why, P3	28	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121758	10.1371/journal.pone.0121758	http://dx.doi.org/10.1371/journal.pone.0121758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786228	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500216
J	Gomez-Carballa, A; Pardo-Seco, J; Amigo, J; Martinon-Torres, F; Salas, A				Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Martinon-Torres, Federico; Salas, Antonio			Mitogenomes from The 1000 Genome Project Reveal New Near Eastern Features in Present-Day Tuscans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MTDNA VARIATION; MIDDLE-EAST; ETRUSCAN; ORIGIN; EUROPE; PERSPECTIVE; EXPANSION; GENETICS; SEQUENCE	Background Genetic analyses have recently been carried out on present-day Tuscans (Central Italy) in order to investigate their presumable recent Near East ancestry in connection with the long-standing debate on the origins of the Etruscan civilization. We retrieved mitogenomes and genome-wide SNP data from 110 Tuscans analyzed within the context of The 1000 Genome Project. For phylogeographic and evolutionary analysis we made use of a large worldwide database of entire mitogenomes (>26,000) and partial control region sequences (>180,000). Results Different analyses reveal the presence of typical Near East haplotypes in Tuscans representing isolated members of various mtDNA phylogenetic branches. As a whole, the Near East component in Tuscan mitogenomes can be estimated at about 8%; a proportion that is comparable to previous estimates but significantly lower than admixture estimates obtained from autosomal SNP data (21%). Phylogeographic and evolutionary inter-population comparisons indicate that the main signal of Near Eastern Tuscan mitogenomes comes from Iran. Conclusions Mitogenomes of recent Near East origin in present-day Tuscans do not show local or regional variation. This points to a demographic scenario that is compatible with a recent arrival of Near Easterners to this region in Italy with no founder events or bottlenecks.	[Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Galicia 15872, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Galicia 15872, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Martinon-Torres, Federico; Salas, Antonio] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Martinon-Torres, Federico; Salas, Antonio] Univ Santiago Compostela, Galicia, Spain; [Martinon-Torres, Federico] Univ Santiago, Hosp Clin, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Galicia 15872, Spain.	antonio.salas@usc.es	Pardo-Seco, Jacobo J/G-3752-2016; Martinon-Torres, Federico/E-4982-2016; Amigo Lechuga, Jorge/A-4892-2010; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014	Pardo-Seco, Jacobo J/0000-0002-8059-8908; Martinon-Torres, Federico/0000-0002-9023-581X; Amigo Lechuga, Jorge/0000-0002-1362-2605; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272	Spanish Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT; Xunta de Galicia [EM 2012/045]; Conselleria de Sanidade/Xunta de Galicia [RHI07/2, 10PXIB918184PR]; Instituto Carlos III (Intensificacion de la Actividad Investigadora); Fondo de Investigacion Sanitaria (FIS) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.) [PI070069, PI1000540]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Conselleria de Sanidade/Xunta de Galicia(Xunta de Galicia); Instituto Carlos III (Intensificacion de la Actividad Investigadora)(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (FIS) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.)	This project received funding from the Spanish Ministerio de Ciencia e Innovacion (SAF2011-26983) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (A.S.) and Conselleria de Sanidade/Xunta de Galicia (RHI07/2-Intensificacion Actividad Investigadora and 10PXIB918184PR), Instituto Carlos III (Intensificacion de la Actividad Investigadora) and Fondo de Investigacion Sanitaria (FIS; PI070069 and PI1000540) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Badro DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054616; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brisighelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050794; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Ghirotto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055519; Gonzalez AM, 2008, ANN HUM BIOL, V35, P212, DOI 10.1080/03014460801946538; Guimaraes S, 2009, MOL BIOL EVOL, V26, P2157, DOI 10.1093/molbev/msp126; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Mairal Q, 2013, FORENSIC SCI INT-GEN, V7, P618, DOI 10.1016/j.fsigen.2013.08.009; Pardo-Seco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105920; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2012, FORENSIC SCI INT-GEN, V6, pE182, DOI 10.1016/j.fsigen.2012.06.015; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tassi F, 2013, AM J PHYS ANTHROPOL, V152, P11, DOI 10.1002/ajpa.22319; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	33	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119242	10.1371/journal.pone.0119242	http://dx.doi.org/10.1371/journal.pone.0119242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786119	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500086
J	Ma, XF; Jiang, GH; Li, SM; Wang, JH; Zhan, WF; Zeng, SQ; Tian, JZ; Xu, YK				Ma, Xiaofen; Jiang, Guihua; Li, Shumei; Wang, Jinhui; Zhan, Wenfeng; Zeng, Shaoqing; Tian, Junzhang; Xu, Yikai			Aberrant Functional Connectome in Neurologically Asymptomatic Patients with End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CEREBRAL-BLOOD-FLOW; GRAPH-THEORETICAL ANALYSIS; COMPLEX BRAIN NETWORKS; RESTING-STATE FMRI; DEFAULT-MODE; COGNITIVE FUNCTION; SMALL-WORLD; MODULAR ORGANIZATION; CONNECTIVITY MRI	Purpose This study aimed to investigate the topological organization of intrinsic functional brain networks in patients with end-stage renal disease (ESRD). Materials and Methods Resting-state functional MRI data were collected from 22 patients with ESRD (16 men, 18-61 years) and 29age- and gender-matched healthy controls (HCs, 19 men, 32-61 years). Whole-brain functional networks were obtained by calculating the interregional correlation of low-frequency fluctuations in spontaneous brain activity among 1,024 parcels that cover the entire cerebrum. Weighted graph-based models were then employed to topologically characterize these networks at different global, modular and nodal levels. Results Compared to HCs, the patients exhibited significant disruption in parallel information processing over the whole networks (P < 0.05). The disruption was present in all the functional modules (default mode, executive control, sensorimotor and visual networks) although decreased functional connectivity was observed only within the default mode network. Regional analysis showed that the disease disproportionately weakened nodal efficiency of the default mode components and tended to preferentially affect central or hub-like regions. Intriguingly, the network abnormalities correlated with biochemical hemoglobin and serum calcium levels in the patients. Finally, the functional changes were substantively unchanged after correcting for gray matter atrophy in the patients. Conclusion Our findings provide evidence for the disconnection nature of ESRD's brain and therefore have important implications for understanding the neuropathologic substrate of the disease from disrupted network organization perspective.	[Ma, Xiaofen; Xu, Yikai] Southern Medial Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Jiang, Guihua; Li, Shumei; Zhan, Wenfeng; Zeng, Shaoqing; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wang, Jinhui] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Jinhui] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Southern Medical University - China; Hangzhou Normal University	Tian, JZ (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jz.tian@163.com; mayuqin2004@163.com	Wang, jinhui/AAF-8668-2019	Tian, Junzhang/0000-0002-6212-1882	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2012B031800170, 2012A030400019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This research was supported by grants from National Natural Science Foundation of China (No. 81471639) and The Science and Technology Planning Project of Guangdong Province, China (No. 2011B031800044, 2012B031800170, 2012A030400019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Altmann P, 2007, KIDNEY INT, V71, P252, DOI 10.1038/sj.ki.5001932; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bornivelli C, 2012, J REN CARE, V38, P93, DOI 10.1111/j.1755-6686.2012.00259.x; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chou MC, 2013, AM J NEURORADIOL, V34, P1945, DOI 10.3174/ajnr.A3511; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; DEDEYN PP, 1992, ACTA NEUROL BELG, V92, P191; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Foti NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016431; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GOTTLIEB D, 1987, J CEREBR BLOOD F MET, V7, P659, DOI 10.1038/jcbfm.1987.119; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HATA R, 1994, STROKE, V25, P408, DOI 10.1161/01.STR.25.2.408; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; HOLZER H, 1981, P EUR DIAL TRANS, V18, P126; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hosseini SMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067354; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Jassal SV, 2008, INT UROL NEPHROL, V40, P849, DOI 10.1007/s11255-008-9375-2; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Kalender B, 2006, NEPHRON CLIN PRACT, V102, pC115, DOI 10.1159/000089669; Kim HS, 2011, NEUROREHABILITATION, V29, P111, DOI 10.3233/NRE-2011-0684; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murray AM, 2007, AM J KIDNEY DIS, V50, P270, DOI 10.1053/j.ajkd.2007.05.010; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Ni L, 2014, RADIOLOGY, V271, P543, DOI 10.1148/radiol.13130816; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pliskin NH, 1996, KIDNEY INT, V49, P1435, DOI 10.1038/ki.1996.202; POSTIGLIONE A, 1991, STROKE, V22, P1508, DOI 10.1161/01.STR.22.12.1508; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raphael KL, 2012, AM J NEPHROL, V35, P49, DOI 10.1159/000334872; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2013, TRENDS COGN SCI, V17, P641, DOI 10.1016/j.tics.2013.10.007; Schultz-Larsen K, 2007, J CLIN EPIDEMIOL, V60, P260, DOI 10.1016/j.jclinepi.2006.06.008; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Skinner H, 2005, BRIT J ANAESTH, V94, P203, DOI 10.1093/bja/aei016; Song SH, 2008, PSYCHIAT CLIN NEUROS, V62, P554, DOI 10.1111/j.1440-1819.2008.01849.x; Song SH, 2009, PSYCHIAT RES-NEUROIM, V173, P243, DOI 10.1016/j.pscychresns.2008.08.007; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang ZJ, 2015, NEUROSCIENTIST, V21, P290, DOI 10.1177/1073858414537560; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7	104	23	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121085	10.1371/journal.pone.0121085	http://dx.doi.org/10.1371/journal.pone.0121085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786231	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500200
J	MacIvor, JS; Packer, L				MacIvor, J. Scott; Packer, Laurence			'Bee Hotels' as Tools for Native Pollinator Conservation: A Premature Verdict?	PLOS ONE			English	Article							MEGACHILE-ROTUNDATA; LEAFCUTTING BEE; NESTING BEES; HYMENOPTERA; SCALE; PARASITISM; DIVERSITY; RICHNESS; DECLINES; BRITAIN	Society is increasingly concerned with declining wild bee populations. Although most bees nest in the ground, considerable effort has centered on installing 'bee hotels'-also known as nest boxes or trap nests-which artificially aggregate nest sites of above ground nesting bees. Campaigns to 'save the bees' often promote these devices despite the absence of data indicating they have a positive effect. From a survey of almost 600 bee hotels set up over a period of three years in Toronto, Canada, introduced bees nested at 32.9% of sites and represented 24.6% of more than 27,000 total bees and wasps recorded (47.1% of all bees recorded). Native bees were parasitized more than introduced bees and females of introduced bee species provisioned nests with significantly more female larva each year. Native wasps were significantly more abundant than both native and introduced bees and occupied almost 3/4 of all bee hotels each year; further, introduced wasps were the only group to significantly increase in relative abundance year over year. More research is needed to elucidate the potential pitfalls and benefits of using bee hotels in the conservation and population dynamics of wild native bees.	[MacIvor, J. Scott; Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	MacIvor, JS (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	jsmacivor@gmail.com		packer, laurence/0000-0002-1711-8203	Natural Science and Engineering Council of Canada [CGS D 408565]; Natural Science and Engineering Council of Canada	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	JSM received funding from a Natural Science and Engineering Council of Canada (CGS D 408565) (http://www.nserc-crsng.gc.ca/index_eng. asp). LP received funding from a Natural Science and Engineering Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng. asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthell JF, 1998, ENVIRON ENTOMOL, V27, P240, DOI 10.1093/ee/27.2.240; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BOHART GE, 1972, ANNU REV ENTOMOL, V17, P287, DOI 10.1146/annurev.en.17.010172.001443; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cane JH, 2003, FOR NONNATIVE CROPS; EVES J D, 1970, Melanderia, V4, P1; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Giles V, 2006, J HYMENOPT RES, V15, P208; Grissell E, 2010, BEES WASPS AND ANTS; Hanley M. E., 2003, Weed Biology and Management, V3, P204, DOI 10.1046/j.1444-6162.2003.00108.x; Jones D, 2010, BIRD BEE AND BUG HOU; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Krombein K. V., 1967, TRAP NESTING WASPS A; Lee-Mader E., 2010, MANAGING ALTERNATIVE; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; MacIvor JS, 2014, URBAN ECOSYST, V17, P139, DOI 10.1007/s11252-013-0321-4; Macivor JS, 2014, ENVIRON ENTOMOL, V43, P1027, DOI 10.1603/EN13241; Martins CF, 2012, NEOTROP ENTOMOL, V41, P105, DOI 10.1007/s13744-012-0020-5; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Matteson KC, 2011, INSECT CONSERV DIVER, V4, P89, DOI 10.1111/j.1752-4598.2010.00103.x; Moore LJ., 2013, BUZZ URBAN BEEKEEPIN; Morales Carolina L., 2002, Biological Invasions, V4, P87, DOI 10.1023/A:1020513012689; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; PACKER L, 1986, INSECT SOC, V33, P190, DOI 10.1007/BF02224597; Packer L, CITY OF TORONTO BIOD; Pawelek JC, 2009, CITIES ENV, V2, P1; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROSENHEIM JA, 1990, ANN ENTOMOL SOC AM, V83, P277, DOI 10.1093/aesa/83.3.277; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; STEPHEN WP, 1965, J ECON ENTOMOL, V58, P965, DOI 10.1093/jee/58.5.965; Stephen WP, 1961, PAN-PAC ENTOMOL, V37, P89; Taki H, 2004, CAN ENTOMOL, V136, P889; TORCHIO PF, 1980, EVOLUTION, V34, P993, DOI [10.2307/2408004, 10.1111/j.1558-5646.1980.tb04037.x]; Torne-Noguera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097255; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Vickruck JL, 2012, ANIM BEHAV, V83, P1083, DOI 10.1016/j.anbehav.2012.01.039; Walker K, 2012, J BUS ETHICS, V109, P227, DOI 10.1007/s10551-011-1122-4; Wcislo WT, 1996, J INSECT BEHAV, V9, P643, DOI 10.1007/BF02213885; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Williams NM, 2011, BASIC APPL ECOL, V12, P332, DOI 10.1016/j.baae.2010.11.008; Woodward DR, 1996, AUST J ENTOMOL, V35, P187, DOI 10.1111/j.1440-6055.1996.tb01385.x; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x	50	69	77	4	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0122126	10.1371/journal.pone.0122126	http://dx.doi.org/10.1371/journal.pone.0122126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785609	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500219
J	Morse, AF; Benitez, VL; Belpaeme, T; Cangelosi, A; Smith, LB				Morse, Anthony F.; Benitez, Viridian L.; Belpaeme, Tony; Cangelosi, Angelo; Smith, Linda B.			Posture Affects How Robots and Infants Map Words to Objects	PLOS ONE			English	Article							ATTENTION; MOTOR; PERSPECTIVE; SIMULATION; MOVEMENTS; PARIETAL; CHILDREN; BEHAVIOR; TASK	For infants, the first problem in learning a word is to map the word to its referent; a second problem is to remember that mapping when the word and/or referent are again encountered. Recent infant studies suggest that spatial location plays a key role in how infants solve both problems. Here we provide a new theoretical model and new empirical evidence on how the body - and its momentary posture - may be central to these processes. The present study uses a name-object mapping task in which names are either encountered in the absence of their target (experiments 1-3, 6 & 7), or when their target is present but in a location previously associated with a foil (experiments 4, 5, 8 & 9). A humanoid robot model (experiments 1-5) is used to instantiate and test the hypothesis that body-centric spatial location, and thus the bodies' momentary posture, is used to centrally bind the multimodal features of heard names and visual objects. The robot model is shown to replicate existing infant data and then to generate novel predictions, which are tested in new infant studies (experiments 6-9). Despite spatial location being task-irrelevant in this second set of experiments, infants use body-centric spatial contingency over temporal contingency to map the name to object. Both infants and the robot remember the name-object mapping even in new spatial locations. However, the robot model shows how this memory can emerge -not from separating bodily information from the word-object mapping as proposed in previous models of the role of space in word-object mapping - but through the body's momentary disposition in space.	[Morse, Anthony F.; Belpaeme, Tony; Cangelosi, Angelo] Univ Plymouth, Ctr Robot & Neural Syst, Cognit Inst, Plymouth PL4 8AA, Devon, England; [Benitez, Viridian L.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Smith, Linda B.] Indiana Univ, Psychol & Brain Sci, Bloomington, IN 47405 USA	University of Plymouth; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington	Morse, AF (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Cognit Inst, Plymouth PL4 8AA, Devon, England.	anthony.morse@plymouth.ac.uk	Cangelosi, Angelo/D-6784-2011; Belpaeme, Tony/AAR-8743-2020	Cangelosi, Angelo/0000-0002-4709-2243; Belpaeme, Tony/0000-0001-5207-7745	EU [214668]; Poeticon++ [288382]; NIH [R21HD068475]; NSF GRFP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068475] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G008353/1] Funding Source: researchfish; EPSRC [EP/G008353/1] Funding Source: UKRI	EU(European Commission); Poeticon++; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported by the EU FP7 projects ITALK (no. 214668) and Poeticon++ (no. 288382), NIH grant R21HD068475 and NSF GRFP.	[Anonymous], 2007, BODY SHAPES WAY WE T; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; BALDWIN DA, 1993, DEV PSYCHOL, V29, P832, DOI 10.1037/0012-1649.29.5.832; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Benitez VL, 2012, COGNITION, V125, P339, DOI 10.1016/j.cognition.2012.08.006; BERTENTHAL BI, 1994, CURR DIR PSYCHOL SCI, V3, P140, DOI 10.1111/1467-8721.ep10770621; Brooks R. A., 1990, Robotics and Autonomous Systems, V6, P3, DOI 10.1016/S0921-8890(05)80025-9; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; Byrge L, 2014, DEVELOPMENTAL PROCES; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Einhauser W, 2007, NETWORK-COMP NEURAL, V18, P267, DOI 10.1080/09548980701671094; Flanders M, 1999, EXP BRAIN RES, V126, P19, DOI 10.1007/s002210050713; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A., 2010, LOT 2 LANGUAGE THOUG; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hartman E, 2010, J INTELL DISABIL RES, V54, P468, DOI 10.1111/j.1365-2788.2010.01284.x; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Iverson JM, 2010, J CHILD LANG, V37, P229, DOI 10.1017/S0305000909990432; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jovancevic-Misic J, 2009, J NEUROSCI, V29, P6234, DOI 10.1523/JNEUROSCI.5570-08.2009; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Lobo MA, 2008, CHILD DEV, V79, P1869, DOI 10.1111/j.1467-8624.2008.01231.x; Luck S, 2002, ATTENTION; MARKMAN EM, 1990, COGNITIVE SCI, V14, P57, DOI 10.1207/s15516709cog1401_4; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Metta G., 2008, P 8 WORKSH PERF METR, P50, DOI [10.1145/1774674.1774683, DOI 10.1145/1774674.1774683]; Morse AF, 2010, IEEE T AUTON MENT DE, V2, P325, DOI 10.1109/TAMD.2010.2087020; Mostofsky SH, 2006, BIOL PSYCHIAT, V59, P48, DOI 10.1016/j.biopsych.2005.06.011; Munakata Y, 2004, DEV REV, V24, P133, DOI 10.1016/j.dr.2003.09.008; No? A., 2004, ACTION PERCEPTION; O'Regan J.K., 2011, WHY RED DOESNT SOUND; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Osina MA, 2013, DEV PSYCHOL, V49, P138, DOI 10.1037/a0027903; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Samuelson LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028095; SEARLE JR, 1982, BEHAV BRAIN SCI, V5, P345, DOI 10.1017/S0140525X00012425; Shapiro L., 2010, EMBODIED COGNITION; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; Steels L, 2003, TRENDS COGN SCI, V7, P308, DOI 10.1016/S1364-6613(03)00129-3; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Thaler L, 2009, NEUROPSYCHOLOGIA, V47, P1227, DOI 10.1016/j.neuropsychologia.2008.12.039; Thura D, 2008, BEHAV BRAIN RES, V186, P148, DOI 10.1016/j.bbr.2007.07.035; Tillman CM, 2008, CHILD NEUROPSYCHOL, V14, P42, DOI 10.1080/09297040701249020; VANBEEK Y, 1994, J CHILD PSYCHOL PSYC, V35, P1093, DOI 10.1111/j.1469-7610.1994.tb01811.x; Webb B, 2000, ANIM BEHAV, V60, P545, DOI 10.1006/anbe.2000.1514; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wilson RA., 2009, CAMBRIDGE HDB SITUAT, P55; Woods RJ, 2013, DEV PSYCHOL, V49, P1413, DOI 10.1037/a0030344; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x; Ziemke T, 2003, WHATS THING CALLED E, P1310; Ziemke T, 2009, COGN COMPUT, V1, P104, DOI 10.1007/s12559-009-9012-0	61	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116012	10.1371/journal.pone.0116012	http://dx.doi.org/10.1371/journal.pone.0116012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785834	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352138500002
J	Moyo, S; Cox, HS; Hughes, J; Daniels, J; Synman, L; De Azevedo, V; Shroufi, A; Cox, V; van Cutsem, G				Moyo, Sizulu; Cox, Helen S.; Hughes, Jennifer; Daniels, Johnny; Synman, Leigh; De Azevedo, Virginia; Shroufi, Amir; Cox, Vivian; van Cutsem, Gilles			Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa	PLOS ONE			English	Article							BEHAVIOR; DEFAULT	Background A community based drug resistant tuberculosis (DR-TB) program has been incrementally implemented in Khayelitsha, a high HIV and TB burden community in South Africa. We investigated loss from treatment (LFT), and post treatment outcomes of DR-TB patients in this setting. Methodology LFT, defined as interruption of treatment for >= 2 consecutive months was assessed among patients initiating DR-TB treatment for the first time between January 2009 and July 2011. Patients were traced through routine data sources to identify those who subsequently restarted treatment and those who died. Additional information on patient status and survival after LTF was obtained from community DR-TB counselors and from the national death registry. Post treatment outcomes were observed until July 2013. Results Among 452 patients initiating treatment for the first time within the given period, 30% (136) were LFT, with 67% retention at 18 months. Treatment was restarted in 27 (20%) patients, with additional resistance recorded in 2/25 (8%), excluding two with presumed DR-TB. Overall, 34 (25%) patients died, including 11 who restarted treatment. Males and those in the age category 15-25 years had a greater hazard of LFT; HR 1.93 (95% CI 1.35-2.75), and 2.43 (95% CI 1.52-3.88) respectively. Older age (>35 years) was associated with a greater hazard of death; HR 3.74 (1.13-12.37) post treatment. Overall two-year survival was 62%. It was lower ( 45%) in older patients, and was 92% among those who received >12 months treatment. Conclusion LFT was high, occurred throughout the treatment period and was particularly high among males and those aged 15-25 years. Overall long term survival was poor. High rates of LFT should however not preclude scale up of community based care given its impact in increasing access to treatment. Further research is needed to support retention of DR-TB patients on treatment, even within community based treatment programs.	[Moyo, Sizulu; Hughes, Jennifer; Daniels, Johnny; Synman, Leigh; Shroufi, Amir; Cox, Vivian; van Cutsem, Gilles] MSF Doctors Without Borders, Cape Town, South Africa; [Cox, Helen S.] Univ Cape Town, Dept Med Microbiol, ZA-7925 Cape Town, South Africa; [De Azevedo, Virginia] City Cape Town Dept Hlth, Cape Town, South Africa; [van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Moyo, Sizulu] Human Sci Res Council, HIV AIDS STIs & TB Programme, Cape Town, South Africa	University of Cape Town; University of Cape Town; Human Sciences Research Council-South Africa	Moyo, S (corresponding author), MSF Doctors Without Borders, Cape Town, South Africa.	sizulumoyo@gmail.com	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Hughes, Jennifer/0000-0002-5349-9509; Cox, Helen/0000-0002-6538-7192	Medecins sans Frontieres	Medecins sans Frontieres	This work was funded by Medecins sans Frontieres. Staff from Medecins sans Frontieres were involved in study design, data collection and analysis, manuscript preparation and decision to publish the manuscript.	Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Chiang CY, 2003, INT J TUBERC LUNG D, V6, P714; City of Cape Town, 2013, CITY OF CAPE TOWN 20; City of Cape Town, 2006, SOCIOECONOMIC PROFIL; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; De Azevedo V, 2013, INTERSECTORAL ACTION; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Geldenhuys H, 2011, AFR J PSYCHIATRY, V14, P383, DOI [10.4314/ajpsy.v14i5.6, http://dx.doi.org/10.4314/ajpsy.v14i5.6]; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Lalor MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078364; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Letsela L, 2009, I AM TOTSI FROM SOPH; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154; Medecins sans Frontieres, 2011, SCALING UP DIAGNOSIS; Medecins sans Frontieres, 2013, DR TB DRUGS UNDER TH; National Department of Health, 2011, MANAGEMENT OF DRUG R; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Sanchez-Padilla E, 2014, INT J TUBERC LUNG D, V18, P160, DOI 10.5588/ijtld.13.0369; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sripad A, 2014, INT J TUBERC LUNG D, V18, P44, DOI 10.5588/ijtld.13.0253; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, DEFINITIONS AND REPO; World Health Organization, 2012, UPDATE IMPLEMENTATIO; World Health Organization, 2013, MULTI DRUG RESISTANT; World Health Organization, 2008, GUIDELINES FOR THE P; World Health Organization, 2013, COUNTDOWN TO 2015 GL	41	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118919	10.1371/journal.pone.0118919	http://dx.doi.org/10.1371/journal.pone.0118919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785451	Green Published, gold			2022-12-26	WOS:000352138500057
J	Atalla, H; Lysnyansky, I; Raviv, Y; Rottem, S				Atalla, Hazem; Lysnyansky, Inna; Raviv, Yossef; Rottem, Shlomo			Mycoplasma gallisepticum Inactivated by Targeting the Hydrophobic Domain of the Membrane Preserves Surface Lipoproteins and Induces a Strong Immune Response	PLOS ONE			English	Article							STRUCTURAL INTEGRITY; PROTEINS; HYOPNEUMONIAE; VACCINATION; INVASION; DISEASE; CULTURE; CELLS	An innovative approach for inactivation of Mycoplasma gallisepticum using the hydrophobic photoinduced alkylating probe 1, 5-iodonaphthylazide (INA) is described. Treatment of washed M. gallisepticum mid-exponential culture (0.2 mg cell protein / mL) with INA followed by irradiation with far-ultraviolet light (310-380 nm) completely abolished viability. Transmission electron microscopy showed that the majority of the inactivated M. gallisepticum were comparable in size to intact cells, but that part of the INA-treated M. gallisepticum preparation also contained low density cells and membrane vesicles. Confocal microscopy revealed that untreated M. gallisepticum cells were internalized by chicken red blood cells (c-RBCs), whereas the INA-inactivated cells remained attached to the outer surface of the c-RBCs. INA treatment of M. gallisepticum resulted in a complete inactivation of F0F1 - ATPase and of the L-arginine uptake system, but the cytoplasmatic soluble NADH2 dehydrogenase was only partially affected. Western blot analysis of the lipoprotein fraction showed that the INA-treated M. gallisepticum retained their lipoproteins. Following subcutaneous injection of M. gallisepticum INA-bacterin, 100% and 68.8% of chickens were positive by the rapid serum agglutination test and enzyme-linked immunosorbent assay respectively, 2 weeks post-injection. These data suggest that the photoinducible alkylating agent INA inactivates M. gallisepticum but preserves its surface lipoproteins and thus has the potential to be used as a general approach for the inactivation of mycoplasmas for vaccine development.	[Atalla, Hazem; Rottem, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Lysnyansky, Inna] Kimron Vet Inst, Div Avian & Aquat Dis, Bet Dagan, Israel; [Raviv, Yossef] SAIC Frederick Inc, Natl Canc Inst, Frederick, MD USA	Hebrew University of Jerusalem; Kimron Veterinary Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Lysnyansky, I (corresponding author), Kimron Vet Inst, Div Avian & Aquat Dis, Bet Dagan, Israel.	innal@moag.gov.il			SAIC-Frederick	SAIC-Frederick	The authors received no specific funding for this work. SAIC-Frederick provided support in the form of salaries for Dr. Y. Raviv, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MOL BIOL PATHOGENICI; Bearson SMD, 2003, AVIAN DIS, V47, P745, DOI 10.1637/6099; Belanger JM, 2010, PHOTOCHEM PHOTOBIOL, V86, P1099, DOI 10.1111/j.1751-1097.2010.00780.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; El Gazzar M, 2011, AVIAN DIS, V55, P569, DOI 10.1637/9689-021711-Reg.1; FERGUSON M, 1993, J GEN VIROL, V74, P685, DOI 10.1099/0022-1317-74-4-685; Furuya Y, 2010, J GEN VIROL, V91, P1450, DOI 10.1099/vir.0.018168-0; GAISSER HD, 1987, BIOCHEM PHARMACOL, V36, P3237, DOI 10.1016/0006-2952(87)90639-3; Garcia M, 2005, AVIAN DIS, V49, P125, DOI 10.1637/7261-0812204R1; GEARY SJ, 1990, J RECEPTOR RES, V9, P465, DOI 10.3109/10799898909066071; Glew MD, 2000, INFECT IMMUN, V68, P6027, DOI 10.1128/IAI.68.10.6027-6033.2000; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; HAYFLICK L, 1960, ANN NY ACAD SCI, V79, P433, DOI 10.1111/j.1749-6632.1960.tb42709.x; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Kleven SH, 2004, AVIAN DIS, V48, P562, DOI 10.1637/7148; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232; Mateusen B, 2002, VET REC, V151, P135, DOI 10.1136/vr.151.5.135; Nicholas RA, 2008, J COMP PATHOL, V24, P24; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Raviv Y, 2005, J VIROL, V79, P12394, DOI 10.1128/JVI.79.19.12394-12400.2005; RAVIV Y, 1987, P NATL ACAD SCI USA, V84, P6103, DOI 10.1073/pnas.84.17.6103; Raviv Y, 2008, J VIROL, V82, P4612, DOI 10.1128/JVI.02233-07; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rechnitzer H, 2006, CURR MICROBIOL, V53, P293, DOI 10.1007/s00284-006-0007-8; ROTTEM S, 1966, J BACTERIOL, V92, P714, DOI 10.1128/JB.92.3.714-722.1966; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; SALMAN M, 1995, BBA-BIOMEMBRANES, V1235, P369, DOI 10.1016/0005-2736(95)80026-C; Shirvan M H, 1993, Subcell Biochem, V20, P261; Simionatto S, 2013, VET MICROBIOL, V165, P234, DOI 10.1016/j.vetmic.2013.04.019; Steinlage SJT, 2003, AVIAN DIS, V47, P499, DOI 10.1637/0005-2086(2003)047[0499:IACOAL]2.0.CO;2; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Tola S, 1999, VACCINE, V17, P2764, DOI 10.1016/S0264-410X(99)00070-5; Viard M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-21; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Waites K. B., 2014, MOLLICUTES MOL BIOL, P289; Warfield KL, 2007, J INFECT DIS, V196, pS276, DOI 10.1086/520605; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120462	10.1371/journal.pone.0120462	http://dx.doi.org/10.1371/journal.pone.0120462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781939	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600163
J	He, ZY; Wu, SG; Zhou, J; Li, FY; Lin, Q; Lin, HX; Sun, JY				He, Zhen-Yu; Wu, San-Gang; Zhou, Juan; Li, Fang-Yan; Lin, Qin; Lin, Huan-Xin; Sun, Jia-Yuan			Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes	PLOS ONE			English	Article							SYSTEMIC THERAPY; LYMPH-NODES; MASTECTOMY; IRRADIATION; BENEFIT; TUMOR	Objectives The indications for post-mastectomy radiotherapy (PMRT) with T1-2 breast cancer and 1-3 positive axillary lymph nodes is still controversial. The purpose of this study was to investigate the role of PMRT in T1-2 breast cancer with 1-3 positive axillary lymph node. Methods We retrospectively reviewed the file records of 79 patients receiving PMRT and not receiving PMRT (618 patients). Results The median follow-up was 65 months. Multivariate analysis showed that PMRT was an independent prognostic factor of locoregional recurrence-free survival (LRFS) (P = 0.010). Subgroup analysis of patients who did not undergo PMRT showed that pT stage, number of positive axillary lymph nodes, and molecular subtype were independent prognostic factors of LRFS. PMRT improved LRFS in the entire group (P = 0.005), but did not affect distant metastasis- free survival (DMFS) (P = 0.494), disease-free survival (DFS) (P = 0.215), and overall survival (OS) (P = 0.645). For patients without PMRT, the 5-year LRFS of low-risk patients (0-1 risk factor for locoregional recurrence) of 94.5% was significantly higher than that of high-risk patients (2-3 risk factors for locoregional recurrence) (80.9%, P < 0.001). PMRT improved LRFS (P = 0.001) and DFS (P = 0.027) in high-risk patients, but did not improve LRFS, DMFS, DFS, and OS in low-risk patients. Conclusions PMRT is beneficial in patients with high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.	[He, Zhen-Yu; Li, Fang-Yan; Lin, Huan-Xin; Sun, Jia-Yuan] Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Radiat Oncol, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Wu, San-Gang; Lin, Qin] Xiamen Univ, Xiamen Canc Ctr, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China; [Zhou, Juan] Xiamen Univ, Xiamen Canc Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Xiamen, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Xiamen University; Xiamen University	Sun, JY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Radiat Oncol, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	sunjy@sysucc.org.cn	Wu, San-Gang/AAA-8959-2022		Sci-Tech Office of Guangdong Province [2008B060600019, 2013B021800157]; Youth Foundation of the First Affiliated Hospital of Xiamen University [XYY2012005]; education scientific research project of young teachers in Fujian Province [JB13131]; National Natural Science Foundation of China [81402527]; Youth Foundation of Fujian Provincial Health and Family Planning Commission [2014-2-63]	Sci-Tech Office of Guangdong Province; Youth Foundation of the First Affiliated Hospital of Xiamen University; education scientific research project of young teachers in Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Fujian Provincial Health and Family Planning Commission	This study was supported by the Sci-Tech Office of Guangdong Province (No. 2008B060600019 and No. 2013B021800157), the Youth Foundation of the First Affiliated Hospital of Xiamen University (No. XYY2012005), the education scientific research project of young teachers in Fujian Province (No. JB13131), the National Natural Science Foundation of China (No. 81402527), and the Youth Foundation of Fujian Provincial Health and Family Planning Commission (No. 2014-2-63).	Aebi S, 2011, ANN ONCOL, V22, pvi12, DOI 10.1093/annonc/mdr371; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Cosar R, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-28; Duraker N, 2012, JPN J CLIN ONCOL, V42, P601, DOI 10.1093/jjco/hys052; Fodor J, 2003, STRAHLENTHER ONKOL, V179, P197, DOI 10.1007/s00066-003-1010-7; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Hamamoto Y, 2014, BREAST CANCER-TOKYO, V21, P177, DOI 10.1007/s12282-012-0369-7; Japan Comprehensive Cancer Network Breast, 2007, PRACT GUID SURG THER; Klinik Onkoloji Dernegi, 2013, GEOGR PROF COMP CONS; Kuo SH, 2008, INT J RADIAT ONCOL, V72, P1456, DOI 10.1016/j.ijrobp.2008.03.042; Matsunuma R, 2012, INT J RADIAT ONCOL, V83, P845, DOI 10.1016/j.ijrobp.2011.08.029; McBride A, 2014, INT J RADIAT ONCOL, V89, P392, DOI 10.1016/j.ijrobp.2014.02.013; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Munshi A, 2012, ACTA ONCOL, V51, P547, DOI 10.3109/0284186X.2011.633929; Nagao T, 2013, INT J CLIN ONCOL, V18, P54, DOI 10.1007/s10147-011-0343-y; National Comprehensive Cancer Network (NCCN), 2012, CLIN PRACT GUID ONC; Offersen BV, 2011, BREAST CARE, V6, P347, DOI 10.1159/000333250; Overgaard M, 2007, RADIOTHER ONCOL, V82, P247, DOI 10.1016/j.radonc.2007.02.001; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Panoff JE, 2011, BREAST CANCER RES TR, V128, P899, DOI 10.1007/s10549-011-1495-1; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Schiavon G, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3636; Taylor ME, 2009, INT J RADIAT ONCOL, V73, P997, DOI 10.1016/j.ijrobp.2008.10.080; van der Hage JA, 2003, EUR J CANCER, V39, P2192, DOI 10.1016/S0959-8049(03)00572-0; Wu SG, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-119; Wu San-Gang, 2010, Chin J Cancer, V29, P668; Yang PS, 2010, INT J RADIAT ONCOL, V77, P516, DOI 10.1016/j.ijrobp.2009.05.016	27	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119105	10.1371/journal.pone.0119105	http://dx.doi.org/10.1371/journal.pone.0119105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781605	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600051
J	Liu, X; Zhu, L; Liao, S; Xu, ZW; Zhou, YC				Liu, Xiao; Zhu, Ling; Liao, Shan; Xu, Zhiwen; Zhou, Yuancheng			The Porcine MicroRNA Transcriptome Response to Transmissible Gastroenteritis Virus Infection	PLOS ONE			English	Article							EXPRESSION; TARGETS; DIFFERENTIATION; PATHOGENESIS; RECOGNITION; DROSOPHILA; GENES; TGEV; RNAS	Transmissible gastroenteritis virus (TGEV; Coronaviridae family) causes huge economic losses to the swine industry. MicroRNAs (miRNAs) play a regulatory role in viral infection and may be involved in the mammalian immune response. Here, we report a comprehensive analysis of host miRNA expression in TGEV-infected swine testis (ST) cells. Deep sequencing generated 3,704,353 and 2,763,665 reads from uninfected ST cells and infected ST cells, respectively. The reads were aligned to known Sus scrofa pre-miRNAs in miR-Base 19, identifying 284 annotated miRNAs. Certain miRNAs were differentially regulated during TGEV infection. 59 unique miRNAs displayed significant differentially expression between the normal and TGEV-infected ST cell samples: 15 miRNAs were significantly up-regulated and 44 were significantly down-regulated. Stem-loop RT-PCR was carried out to determine the expression levels of specific miRNAs in the two samples, and the results were consistent with those of sequencing. Gene ontology enrichment analysis of host target genes demonstrated that the differentially expressed miRNAs are involved in regulatory networks, including cellular process, metabolic process, immune system process. This is the first report of the identification of ST cell miRNAs and the comprehensive analysis of the miRNA regulatory mechanism during TGEV infection, which revealed the miRNA molecular regulatory mechanisms for the viral infection, expression of viral genes and the expression of immune-related genes. The results presented here will aid research on the prevention and treatment of viral diseases.	[Liu, Xiao; Zhu, Ling; Liao, Shan; Xu, Zhiwen; Zhou, Yuancheng] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China; [Liu, Xiao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Liver, Boston, MA USA; [Liu, Xiao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Div,Dept Med, Boston, MA USA	Sichuan Agricultural University; Sichuan Agricultural University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com		Zhou, Yuancheng/0000-0001-5295-826X	Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-11-1059]; program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team [2013TD0015]; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	This study was supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (Project No: NCET-11-1059), program for Changjiang Scholars and Innovative Research Team in University (Project No: IRT13083), Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team (Project No: 2013TD0015), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; CALLEBAUT P, 1989, VET MICROBIOL, V20, P9, DOI 10.1016/0378-1135(89)90003-5; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Dolken L, 2009, VIRUS GENES, V38, P355, DOI 10.1007/s11262-009-0347-0; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hipfner DR, 2002, GENETICS, V161, P1527; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kim L, 2000, ARCH VIROL, V145, P1133, DOI 10.1007/s007050070114; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin Z, 2011, CANCER LETT, V305, P186, DOI 10.1016/j.canlet.2010.08.018; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tajima M, 1970, Arch Gesamte Virusforsch, V29, P105, DOI 10.1007/BF01253886; TUBOLY T, 1994, ARCH VIROL, V137, P55, DOI 10.1007/BF01311173; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988	48	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120377	10.1371/journal.pone.0120377	http://dx.doi.org/10.1371/journal.pone.0120377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781021	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600157
J	Murata, Y; Itoh, Y; Iwashita, T; Namba, K				Murata, Yoshiko; Itoh, Yoshiyuki; Iwashita, Takashi; Namba, Kosuke			Transgenic Petunia with the Iron(III)-Phytosiderophore Transporter Gene Acquires Tolerance to Iron Deficiency in Alkaline Environments	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; MUGINEIC ACID; GRAMINEOUS PLANTS; MASS-SPECTROMETRY; PHYTOSIDEROPHORE TRANSPORTER; 2'-DEOXYMUGINEIC ACID; YELLOW STRIPE1; NICOTIANAMINE; METAL; ACQUISITION	Iron is an essential nutrient for all plants. However, terrestrial plants often suffer from iron deficiency in alkaline soil due to its extremely low solubility. Alkaline soil accounts for about 30% of all cultivated ground in the world. Plants have evolved two distinct strategies, I and II, for iron uptake from the soil. Dicots and non-graminaceous monocots use Strategy I, which is primarily based on the reduction of iron(III) to iron(II) and the uptake of iron(II) by the iron-regulated transporter, IRT1. In contrast, graminaceous plants use Strategy II to efficiently acquire insoluble iron(III). Strategy II comprises the synthesis and secretion of iron-chelating phytosiderophores, such as mugineic acids and the Yellow Stripe 1 transporter proteins of the iron(III)-phytosiderophore complex. Barley, which exhibits the highest tolerance to iron deficiency in alkaline soil among graminaceous plants, utilizes mugineic acids and the specific iron(III)-mugineic acids transporter, HvYS1. In this study, we established the transgenic plant Petunia hybrida, which originally had only Strategy I, by introducing the HvYS1 transporter gene derived from barley. When the transgenic plants were grown hydroponically in media containing the iron(III)-20-deoxymugineic acid complex, free 2'-deoxymugineic acid and its iron(III) complex were detected in the root extract of the transgenic plant by electrospray ionization-Fourier transform-ion cyclotron resonance mass spectrometry. The growth of the transgenic petunia was significantly better than that of the control host in alkaline conditions. Consequently, the transgenic plant acquired a significantly enhanced tolerance to alkaline hydroponic media in the presence of the iron(III)-20-deoxymugineic acid complex. Furthermore, the flower color of the transgenic plant deepened. The results showed that iron-phytosiderophore complexes and their transporters can potentially be utilized to overcome the worldwide iron uptake problems to diverse plant species that are found in areas with alkaline conditions.	[Murata, Yoshiko; Itoh, Yoshiyuki; Iwashita, Takashi; Namba, Kosuke] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan	Suntory Holdings Ltd	Murata, Y (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan.	murata@sunbor.or.jp		Namba, Kosuke/0000-0003-1548-5656	MEXT Japan [18510200]; Suntory Holdings; Grants-in-Aid for Scientific Research [26102734] Funding Source: KAKEN	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suntory Holdings; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research Grant, MEXT Japan (No. 18510200 to YM) and the financial support of Suntory Holdings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Araki R, 2011, PLANT CELL PHYSIOL, V52, P1931, DOI 10.1093/pcp/pcr126; Bakkaus E, 2006, J CHROMATOGR A, V1129, P208, DOI 10.1016/j.chroma.2006.07.004; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; BRITSCH L, 1990, ARCH BIOCHEM BIOPHYS, V282, P152, DOI 10.1016/0003-9861(90)90099-K; BRUGLIERA F, 1994, PLANT J, V5, P81, DOI 10.1046/j.1365-313X.1994.5010081.x; CARLQUIST S, 1982, STAIN TECHNOL, V57, P311, DOI 10.3109/10520298209066729; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; COMAI L, 1990, PLANT MOL BIOL, V15, P373, DOI 10.1007/BF00019155; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DECAROLIS E, 1994, PHYTOCHEMISTRY, V36, P1093, DOI 10.1016/S0031-9422(00)89621-1; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Gomez-Galera S, 2012, PLANT PHYSIOL BIOCH, V53, P46, DOI 10.1016/j.plaphy.2012.01.009; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Kakei Y, 2012, PLANT MOL BIOL, V79, P583, DOI 10.1007/s11103-012-9930-1; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; KAWAI S, 1988, J PLANT NUTR, V11, P633, DOI 10.1080/01904168809363829; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; Ma JF, 1996, PHYSIOL PLANTARUM, V97, P609, DOI 10.1111/j.1399-3054.1996.tb00522.x; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Masuda H, 2013, RICE, V6, DOI 10.1186/1939-8433-6-40; Meda AR, 2007, PLANT PHYSIOL, V143, P1761, DOI 10.1104/pp.106.094474; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Namba K, 2007, ANGEW CHEM INT EDIT, V46, P7060, DOI 10.1002/anie.200702403; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; SKINNER BJ, 1979, P NATL ACAD SCI USA, V76, P4212, DOI 10.1073/pnas.76.9.4212; SUGIURA Y, 1981, J AM CHEM SOC, V103, P6979, DOI 10.1021/ja00413a043; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; TAKEMOTO T, 1978, P JPN ACAD B-PHYS, V54, P469, DOI 10.2183/pjab.54.469; TANAKA Y, 1995, PLANT CELL PHYSIOL, V36, P1023, DOI 10.1093/oxfordjournals.pcp.a078844; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Weber G, 2006, RAPID COMMUN MASS SP, V20, P973, DOI 10.1002/rcm.2402; Xiong HC, 2013, PLANT CELL ENVIRON, V36, P1888, DOI 10.1111/pce.12097; Xuan Y, 2006, J CHROMATOGR A, V1136, P73, DOI 10.1016/j.chroma.2006.09.060; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Zheng LQ, 2011, PLANT CELL PHYSIOL, V52, P765, DOI 10.1093/pcp/pcr009	57	9	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120227	10.1371/journal.pone.0120227	http://dx.doi.org/10.1371/journal.pone.0120227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781941	gold, Green Published, Green Submitted			2022-12-26	WOS:000351284600143
J	Qian, Y; Li, XF; Zhang, DD; Cai, DS; Tian, HY; Liu, WB				Qian, Yu; Li, Xiang-Fei; Zhang, Ding-Dong; Cai, Dong-Sen; Tian, Hong-Yan; Liu, Wen-Bin			Effects of Dietary Pantothenic Acid on Growth, Intestinal Function, Anti-Oxidative Status and Fatty Acids Synthesis of Juvenile Blunt Snout Bream Megalobrama amblycephala	PLOS ONE			English	Article							DIGESTIVE ENZYME-ACTIVITIES; ACYL CARRIER PROTEIN; COENZYME-A; BODY-COMPOSITION; GENE-EXPRESSION; PRACTICAL DIETS; RAINBOW-TROUT; REQUIREMENT; PURIFICATION; BIOSYNTHESIS	Four groups of juvenile Megalobrama amblycephala were fed three times daily with six semi-purified diets containing 3.39 (PA unsupplied diet), 10.54, 19.28, 31.04, 48.38 and 59.72 mg kg(-1) calcium D-pantothenate. The results showed that survival rate, final weight, specific growth rate, protein efficiency ratio and nitrogen retention efficiency all increased significantly (P < 0.01) as dietary PA levels increased from 3.39 to 19.28 mg kg(-1), whereas the opposite was true for feed conversion ratio. Whole-body crude protein increased as dietary PA levels increased, while the opposite pattern was found for the crude lipid content. Intestinal alpha-amylase, lipase, protease, Na+-K+-ATPase, alkaline phosphatase and gamma-glutamyl transferase activities were all elevated in fish fed PA-supplemented diets. Hepatic catalase activities improved with increases in dietary PA, while the opposite was true for malondialdehyde contents. The liver PA concentration and coenzyme A content rose significantly (P < 0.01), up to 31.04 mg kg(-1), with increasing dietary PA levels and then plateaued. The percentage of hepatic saturated fatty acids increased significantly (P < 0.01) as dietary PA levels increased, while the percentages of monounsaturated fatty acids and polyunsaturated fatty acid (PUFA) decreased as dietary PA increased. Fish fed diets containing 19.28 and 31.04 mg kg(-1) PA exhibited higher (P < 0.01) docosahexaenoic acid and PUFA percentages in muscle than those fed with other diets. The expression of the gene encoding pantothenate kinase was significantly up-regulated (P < 0.01) in fish fed PA-supplemented diets. Hepatic Acetyl-CoA carboxylase a, fatty acid synthetase, stearoyl regulatory element-binding protein 1 and X receptor a genes all increased significantly (P < 0.01) as dietary PA levels increased from 3.39 to 31.04 mg kg(-1). Based on broken-line regression analyses of weight gain, liver CoA concentrations and PA contents against dietary PA levels, the optimal dietary PA requirements of juvenile blunt snout bream were estimated to be 24.08 mg kg(-1).	[Qian, Yu; Li, Xiang-Fei; Zhang, Ding-Dong; Cai, Dong-Sen; Tian, Hong-Yan; Liu, Wen-Bin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, WB (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wbliu@njau.edu.cn	Tian, Hongyan/HII-4786-2022; Li, Xiang-Fei/I-2742-2019	Li, Xiang-Fei/0000-0003-0841-0584	Special Fund for Agro-scientific Research in the Public Interest of Ministry [201003020]; funds of the National Technology System for Conventional Freshwater Fish Industries of China [CARS-46-20]	Special Fund for Agro-scientific Research in the Public Interest of Ministry; funds of the National Technology System for Conventional Freshwater Fish Industries of China	Funding provided by Special Fund for Agro-scientific Research in the Public Interest of Ministry (201003020); the funds of the National Technology System for Conventional Freshwater Fish Industries of China (CARS-46-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AOAC, 1995, OFF METH AN OFF AN C; BESSEY OA, 1946, J BIOL CHEM, V164, P321; BIRGE CH, 1972, J BIOL CHEM, V247, P4930; Cheng HL, 2011, GENE, V487, P46, DOI 10.1016/j.gene.2011.07.027; Cho C.Y., 1990, FASEB J, V4, P3747; CLARKE SD, 1993, J ANIM SCI, V71, P1957, DOI 10.2527/1993.7171957x; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Hakim Y, 2006, AQUACULTURE, V257, P420, DOI 10.1016/j.aquaculture.2006.02.034; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HSU RY, 1965, J BIOL CHEM, V240, P3736; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; Jiang GZ, 2013, AQUACULT NUTR, V19, P499, DOI 10.1111/anu.12001; KARGES RG, 1984, J FISH BIOL, V25, P57, DOI 10.1111/j.1095-8649.1984.tb04850.x; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Lazo JP, 1998, AQUACULTURE, V169, P225, DOI 10.1016/S0044-8486(98)00384-6; Li XF, 2010, AQUACULTURE, V303, P65, DOI 10.1016/j.aquaculture.2010.03.014; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Lin YH, 2012, AQUACULTURE, V324, P92, DOI 10.1016/j.aquaculture.2011.10.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Lygren B, 1999, J AQUAT ANIM HEALTH, V11, P211, DOI 10.1577/1548-8667(1999)011&lt;0211:EODPAA&gt;2.0.CO;2; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Moro GV, 2010, AQUAC RES, V41, P394, DOI 10.1111/j.1365-2109.2009.02352.x; MURAI T, 1979, J NUTR, V109, P1140, DOI 10.1093/jn/109.7.1140; NELSON RA, 1968, AM J CLIN NUTR, V21, P495, DOI 10.1093/ajcn/21.5.495; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Ogino C., 1967, B JPN SOC SCI FISH, V33, P351; Parvez S, 2005, ENVIRON TOXICOL PHAR, V20, P112, DOI 10.1016/j.etap.2004.11.002; REIBEL DK, 1982, J NUTR, V112, P1144, DOI 10.1093/jn/112.6.1144; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; ROEM AJ, 1991, PROG FISH CULT, V53, P216, DOI 10.1577/1548-8640(1991)053&lt;0216:DPAROT&gt;2.3.CO;2; ROSALKI SB, 1970, LANCET, V2, P1139; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; SERONDE J, 1963, YALE J BIOL MED, V36, P141; Sheikhzadeh N, 2012, FISH PHYSIOL BIOCHEM, V38, P413, DOI 10.1007/s10695-011-9519-7; Shiau SY, 1999, J NUTR, V129, P718, DOI 10.1093/jn/129.3.718; Shimeno S., 1991, HDB NUTR REQUIREMENT, P181, DOI 10.1201/9780203712146-20; SLYSHENKOV VS, 1995, FREE RADICAL BIO MED, V19, P767, DOI 10.1016/0891-5849(95)00084-B; SOLIMAN AK, 1992, AQUACULTURE, V104, P121, DOI 10.1016/0044-8486(92)90142-8; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; SWANK RL, 1948, J NEUROPATH EXP NEUR, V7, P274, DOI 10.1097/00005072-194807000-00003; VALLARI DS, 1988, J BACTERIOL, V170, P3961, DOI 10.1128/jb.170.9.3961-3966.1988; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; WAKIL SJ, 1961, J LIPID RES, V2, P1; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; WILSON RP, 1983, J NUTR, V113, P2124, DOI 10.1093/jn/113.10.2124; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Woollard DC, 2000, FOOD CHEM, V69, P201, DOI 10.1016/S0308-8146(99)00255-1; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; ZAR JH, 1984, BIOSTAT ANAL, P236; Zhao S, 2012, AQUACULT NUTR, V18, P400, DOI 10.1111/j.1365-2095.2011.00905.x	59	54	58	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119518	10.1371/journal.pone.0119518	http://dx.doi.org/10.1371/journal.pone.0119518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781913	Green Submitted, gold, Green Published			2022-12-26	WOS:000351284600072
J	Hadjiaghai, O; Ladich, F				Hadjiaghai, Oliwia; Ladich, Friedrich			Sex-Specific Differences in Agonistic Behaviour, Sound Production and Auditory Sensitivity in the Callichthyid Armoured Catfish Megalechis thoracata	PLOS ONE			English	Article							GOBIO L COTTIDAE; CICHLID FISH; SONIC MUSCLE; LATERAL-LINE; HEARING; VOCALIZATION; DIMORPHISM; DIVERSITY; TELEOSTEI; EVOLUTION	Background Data on sex-specific differences in sound production, acoustic behaviour and hearing abilities in fishes are rare. Representatives of numerous catfish families are known to produce sounds in agonistic contexts (intraspecific aggression and interspecific disturbance situations) using their pectoral fins. The present study investigates differences in agonistic behaviour, sound production and hearing abilities in males and females of a callichthyid catfish. Methodology/Principal Findings Eight males and nine females of the armoured catfish Megalechis thoracata were investigated. Agonistic behaviour displayed during male-male and female-female dyadic contests and sounds emitted were recorded, sound characteristics analysed and hearing thresholds measured using the auditory evoked potential (AEP) recording technique. Male pectoral spines were on average 1.7-fold longer than those of same-sized females. Visual and acoustic threat displays differed between sexes. Males produced low-frequency harmonic barks at longer distances and thumps at close distances, whereas females emitted broadband pulsed crackles when close to each other. Female aggressive sounds were significantly shorter than those of males (167 ms versus 219 to 240 ms) and of higher dominant frequency (562 Hz versus 132 to 403 Hz). Sound duration and sound level were positively correlated with body and pectoral spine length, but dominant frequency was inversely correlated only to spine length. Both sexes showed a similar U-shaped hearing curve with lowest thresholds between 0.2 and 1 kHz and a drop in sensitivity above 1 kHz. The main energies of sounds were located at the most sensitive frequencies. Conclusions/Significance Current data demonstrate that both male and female M. thoracata produce aggressive sounds, but the behavioural contexts and sound characteristics differ between sexes. Sexes do not differ in hearing, but it remains to be clarified if this is a general pattern among fish. This is the first study to describe sex-specific differences in agonistic behaviour in fishes.	[Hadjiaghai, Oliwia; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim Maria Clara P., 2006, P71; Bradbury Jack W., 1998, pi; BRANTLEY RK, 1993, BRAIN BEHAV EVOLUT, V42, P336, DOI 10.1159/000114170; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P239, DOI 10.1163/156853961X00150; Burgess WE, 1998, ATLAS FRESHWATER MAR; COHEN MJ, 1967, J EXP ZOOL, V165, P355, DOI 10.1002/jez.1401650305; Connaughton MA, 2002, J EXP BIOL, V205, P2183; COURTENAY WR, 1971, COPEIA, P259, DOI 10.2307/1442826; Fay R. R., 1988, HEARING VERTEBRATES; Fine ML, 2003, CATFISHES, VOLS 1-2, P249; Fine ML, 1997, COPEIA, P777, DOI 10.2307/1447295; FINE ML, 1990, CAN J ZOOL, V68, P1374, DOI 10.1139/z90-205; Fine ML, 1981, HEARING SOUND COMMUN, P257; GEE JH, 1978, J EXP BIOL, V74, P1; GRAY GA, 1961, ECOLOGY, V42, P274, DOI 10.2307/1932079; Heyd A, 2000, REV SUISSE ZOOL, V107, P165, DOI 10.5962/bhl.part.80125; Higgs DM, 2013, J EXP BIOL, V216, P1484, DOI 10.1242/jeb.078816; HILL GL, 1987, COPEIA, P708; Kaatz IM, 1999, BIOL BULL, V197, P241, DOI 10.2307/1542626; Kaatz IM, 2010, CURR ZOOL, V56, P73, DOI 10.1093/czoolo/56.1.73; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kever L, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-34; KRATOCHVIL H, 1985, ZOOL JAHRB ALLG ZOOL, V89, P203; LADICH F, 1990, ETHOLOGY, V84, P193; LADICH F, 1989, ZOOL JAHRB ALLG ZOOL, V93, P501; Ladich F, 1999, BRAIN BEHAV EVOLUT, V53, P288, DOI 10.1159/000006600; Ladich F, 1998, J COMP PHYSIOL A, V182, P737, DOI 10.1007/s003590050218; LADICH F, 1989, J FISH BIOL, V35, P531, DOI 10.1111/j.1095-8649.1989.tb03004.x; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F., 2006, COMMUNICATION FISHES, V1, P3; Ladich F., SOUND COMMUNICATION; Ladich F, 2007, ANIM BEHAV, V73, P379, DOI 10.1016/j.anbehav.2006.04.014; Ladich F, 2014, SPRINGER HANDB AUDIT, V49, P289, DOI 10.1007/2506_2013_26; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Ladich F, 2009, COMP BIOCHEM PHYS A, V154, P341, DOI 10.1016/j.cbpa.2009.07.004; Lagardere JP, 2007, J EXP ZOOL PART A, V303A, P1066; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Maruska KP, 2007, J EXP BIOL, V210, P3990, DOI 10.1242/jeb.004390; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; Mayr M, 1987, THESIS U VIENNA; Myrberg A.A. Jr., 1972, Animal Behav Monogr, V5, P199, DOI 10.1016/0003-3472(72)90002-4; MYRBERG AA, 1965, SCIENCE, V149, P555, DOI 10.1126/science.149.3683.555; MYRBERG AA, 1980, J COMP PHYSIOL, V140, P135, DOI 10.1007/BF00606305; Myrberg Arthur A. Jr, 2006, P149; Oliveira TPR, 2014, J ZOOL, V294, P114, DOI 10.1111/jzo.12160; Parmentier E, 2005, MAR BIOL, V146, P455, DOI 10.1007/s00227-004-1467-7; Pruzsinszky I, 1998, ENVIRON BIOL FISH, V53, P183, DOI 10.1023/A:1007413108550; Rowe S, 2004, CAN J ZOOL, V82, P1391, DOI 10.1139/Z04-119; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; Schulz-Mirbach T, 2010, HEARING RES, V267, P137, DOI 10.1016/j.heares.2010.04.001; SCHWARZ AL, 1980, ENVIRON BIOL FISH, V5, P335, DOI 10.1007/BF00005187; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; STABENTHEINER A, 1988, J COMP PHYSIOL A, V162, P67, DOI 10.1007/BF01342704; TAKEMURA A, 1978, B JPN SOC SCI FISH, V44, P121; TEMPLEMAN W, 1958, J FISH RES BOARD CAN, V15, P355, DOI 10.1139/f58-019; Ueng JP, 2007, ZOOL STUD, V46, P103; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Zeyl JN, 2013, J EXP BIOL, V216, P1075, DOI 10.1242/jeb.076935	62	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121219	10.1371/journal.pone.0121219	http://dx.doi.org/10.1371/journal.pone.0121219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775458	gold, Green Published			2022-12-26	WOS:000351183500209
J	Yan, SM; Wu, G				Yan, Shaomin; Wu, Guang			Large-Scale Evolutionary Analyses on SecB Subunits of Bacterial Sec System	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; CHAPERONE SECB; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; BACILLUS-SUBTILIS; SIGNAL PEPTIDE; SUBSTRATE-SPECIFICITY; MOLECULAR CHAPERONE; SECRETORY PATHWAY	Protein secretion systems are extremely important in bacteria because they are involved in many fundamental cellular processes. Of the various secretion systems, the Sec system is composed of seven different subunits in bacteria, and subunit SecB brings secreted preproteins to subunit SecA, which with SecYEG and SecDF forms a complex for the translocation of secreted preproteins through the inner membrane. Because of the wide existence of Sec system across bacteria, eukaryota, and archaea, each subunit of the Sec system has a complicated evolutionary relationship. Until very recently, 5,162 SecB sequences have been documented in UniProtKB, however no phylogenetic study has been conducted on a large sampling of SecBs from bacterial Sec secretion system, and no statistical study has been conducted on such size of SecBs in order to exhaustively investigate their variances of pairwise p-distance along taxonomic lineage from kingdom to phylum, to class, to order, to family, to genus and to organism. To fill in these knowledge gaps, 3,813 bacterial SecB sequences with full taxonomic lineage from kingdom to organism covering 4 phyla, 11 classes, 41 orders, 82 families, 269 genera, and 3,744 organisms were studied. Phylogenetic analysis revealed how the SecBs evolved without compromising their function with examples of 3-D structure comparison of two SecBs from Proteobacteria, and possible factors that affected the SecB evolution were considered. The average pairwise p-distances showed that the variance varied greatly in each taxonomic group. Finally, the variance was further partitioned into inter-and intra-clan variances, which could correspond to vertical and horizontal gene transfers, with relevance for Achromobacter, Brevundimonas, Ochrobactrum, and Pseudoxanthomonas.	[Yan, Shaomin; Wu, Guang] Guangxi Acad Sci, State Key Lab Nonfood Biomass Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Industrializat Engn Inst,Guangxi, Nanning 530007, Guangxi, Peoples R China		Wu, G (corresponding author), Guangxi Acad Sci, State Key Lab Nonfood Biomass Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Industrializat Engn Inst,Guangxi, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	hongguanglishibahao@yahoo.com		Wu, Guang/0000-0003-0775-5759; Yan, Shaomin/0000-0001-7642-3972	National Natural Science Foundation of China [31460296]; Guangxi Science Foundation [12237022, 1347004-1, 2013GXNSFDA019007]; Building of Guangxi Talent Highland	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Foundation; Building of Guangxi Talent Highland	This study was partly supported by National Natural Science Foundation of China (31460296), Guangxi Science Foundation (12237022, 1347004-1 and 2013GXNSFDA019007) and Building of Guangxi Talent Highland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biello D., 2010, SCI AM; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Crane JM, 2005, J MOL BIOL, V353, P295, DOI 10.1016/j.jmb.2005.08.022; Darwin C., 1872, P458; Debarbieux L, 2001, EMBO J, V20, P4657, DOI 10.1093/emboj/20.17.4657; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Dekker C, 2001, BIOPHYS J, V81, P455, DOI 10.1016/S0006-3495(01)75713-X; Dempsey BR, 2004, BIOCHEMISTRY-US, V43, P9361, DOI 10.1021/bi0493057; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Diao LY, 2012, APPL ENVIRON MICROB, V78, P651, DOI 10.1128/AEM.07209-11; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eichler J, 2001, TRENDS MICROBIOL, V9, P130, DOI 10.1016/S0966-842X(01)01954-0; Eichler J, 2000, EUR J BIOCHEM, V267, P3402, DOI 10.1046/j.1432-1327.2000.01396.x; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Ha SC, 2004, BIOCHEM BIOPH RES CO, V315, P1039, DOI 10.1016/j.bbrc.2004.02.002; HANADA M, 1994, J BIOL CHEM, V269, P23625; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P1327, DOI 10.1111/j.1462-2920.2009.01949.x; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; Jumas-Bilak E, 2009, INT J SYST EVOL MICR, V59, P1028, DOI 10.1099/ijs.0.006718-0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim SW, 2007, J MICROBIOL BIOTECHN, V17, P1316; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Kulothungan SR, 2009, LANGMUIR, V25, P6637, DOI 10.1021/la900198h; KUMAMOTO CA, 1993, J BACTERIOL, V175, P2184, DOI 10.1128/JB.175.8.2184-2188.1993; Kuruma Y, 2005, BIOTECHNOL PROGR, V21, P1243, DOI 10.1021/bp049553u; Kuzuoglu-Ozturk D, 2012, NUCLEIC ACIDS RES, V40, P5651, DOI 10.1093/nar/gks218; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CN, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-17; Linde D, 2003, FEMS MICROBIOL LETT, V226, P93, DOI 10.1016/S0378-1097(03)00578-0; Mao CF, 2009, J BACTERIOL, V191, P978, DOI 10.1128/JB.01321-08; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Michener JK, 2014, J BACTERIOL, V196, P2101, DOI 10.1128/JB.00034-14; Miller A, 2002, BIOCHEMISTRY-US, V41, P5325, DOI 10.1021/bi025639p; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Muller JP, 2000, MICROBIOL-SGM, V146, P77, DOI 10.1099/00221287-146-1-77; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; Mykytczuk NCS, 2011, ANTON LEEUW INT J G, V100, P259, DOI 10.1007/s10482-011-9584-z; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pradel N, 2003, BIOCHEM BIOPH RES CO, V306, P786, DOI 10.1016/S0006-291X(03)01043-X; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 2004, PROTEIN SCI, V13, P1124, DOI 10.1110/ps.03410104; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reusch RN, 2012, FEBS J, V279, P894, DOI 10.1111/j.1742-4658.2012.08484.x; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sala A, 2013, CELL STRESS CHAPERON, V18, P129, DOI 10.1007/s12192-012-0396-5; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sapriel G, 2003, J BACTERIOL, V185, P80, DOI 10.1128/JB.185.1.80-88.2003; Sapriel G, 2002, J BIOL CHEM, V277, P6726, DOI 10.1074/jbc.M108632200; Sarkar A, 2014, ENVIRON SCI POLLUT R, V21, P8645, DOI 10.1007/s11356-014-2759-1; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; Shapova YA, 2007, ACTA CRYSTALLOGR D, V63, P478, DOI 10.1107/S0907444907005045; Sjostrand J, 2014, SYST BIOL, V63, P409, DOI 10.1093/sysbio/syu007; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SPSS Inc, 1992, SIGMASTAT WIND VERS; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Topping TB, 2001, J BIOL CHEM, V276, P7437, DOI 10.1074/jbc.M009584200; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; van Wely KHM, 2000, MICROBIOL-SGM, V146, P2573, DOI 10.1099/00221287-146-10-2573; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200; Wu G, 1999, ACTA NEUROL BELG, V99, P182; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Yan S, 2013, TRANSBOUND EMERG DIS, V60, P110, DOI 10.1111/j.1865-1682.2012.01323.x; Yan S, 2010, TRANSBOUND EMERG DIS, V57, P254, DOI 10.1111/j.1865-1682.2010.01143.x; Yan SM, 2009, INTERDISCIP SCI, V1, P303, DOI 10.1007/s12539-009-0068-1; Yan SM, 2014, APPL MICROBIOL BIOT, V98, P5329, DOI 10.1007/s00253-014-5742-3; Yan SM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-177; Yan SM, 2013, VIRULENCE, V4, P716, DOI 10.4161/viru.26612; Yan SM, 2011, PROTEIN PEPTIDE LETT, V18, P434, DOI 10.2174/092986611794927956; Yan SM, 2010, VIRAL IMMUNOL, V23, P105, DOI 10.1089/vim.2009.0080; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x	103	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120417	10.1371/journal.pone.0120417	http://dx.doi.org/10.1371/journal.pone.0120417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775430	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500172
J	Butler, PL; Staruschenko, A; Snyder, PM				Butler, Phillip L.; Staruschenko, Alexander; Snyder, Peter M.			Acetylation Stimulates the Epithelial Sodium Channel by Reducing Its Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; LIDDLES-SYNDROME; HISTONE DEACETYLASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; CELL-SURFACE; PY MOTIF; A6 CELLS; ENAC; EXPRESSION	The epithelial Na+ channel (ENaC) functions as a pathway for Na+ absorption in the kidney and lung, where it is crucial for Na+ homeostasis and blood pressure regulation. ENaC is regulated in part through signaling pathways that control the ubiquitination state of ENaC lysines. A defect in ubiquitination causes Liddle syndrome, an inherited form of hypertension. Here we determined that alpha-, beta-, and gamma ENaC are also substrates for lysine acetylation. Trichostatin A (TSA), a histone deacetylase inhibitor, enhanced ENaC acetylation and increased ENaC abundance in the total cell lysate and at the cell surface. Moreover, TSA increased ENaC current in Fischer rat thyroid and kidney collecting duct epithelia. We found that HDAC7 is expressed in the kidney collecting duct, supporting a potential role for this histone deacetylase in ENaC regulation. HDAC7 overexpression reduced ENaC abundance and ENaC current, whereas ENaC abundance and current were increased by silencing of HDAC7. ENaC and HDAC7 form a complex, as detected by coimmunoprecipitation. We observed a reciprocal relationship between acetylation and ubiquitination; TSA reduced ENaC ubiquitination, whereas HDAC7 increased ubiquitination. By reducing ENaC ubiquitination, TSA decreased the rate of ENaC degradation. Thus, acetylation increases epithelial Na+ absorption by antagonizing ENaC ubiquitination. This stabilizes ENaC, and hence, increases its abundance at the cell surface.	[Butler, Phillip L.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Butler, Phillip L.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Snyder, Peter M.] Iowa City Vet Affairs Healthcare Syst, Iowa City, IA 52246 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Medical College of Wisconsin	Snyder, PM (corresponding author), Univ Iowa, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Regan, Clinton/E-6250-2012	Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [HL058812, HL072256, HL108880]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [BX001862]; American Heart Association Postdoctoral Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880, R01HL072256, R01HL058812, R29HL058812] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant(US Department of Veterans Affairs); American Heart Association Postdoctoral Research Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants HL058812 and HL072256 (to P. M. S.) and HL108880 (A. S.), Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant BX001862 (to P. M. S.), and an American Heart Association Postdoctoral Research Fellowship (to P. B.).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gao CZ, 2010, BBA-MOL CELL RES, V1803, P1186, DOI 10.1016/j.bbamcr.2010.06.008; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Jain L, 1999, AM J PHYSIOL-LUNG C, V276, pL1046, DOI 10.1152/ajplung.1999.276.6.L1046; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kao HY, 2000, GENE DEV, V14, P55; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Oberfeld B, 2011, AM J PHYSIOL-RENAL, V301, pF189, DOI 10.1152/ajprenal.00487.2010; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272; Zhou RF, 2010, J BIOL CHEM, V285, P30523, DOI 10.1074/jbc.M110.150755; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	45	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12497	12503		10.1074/jbc.M114.635540	http://dx.doi.org/10.1074/jbc.M114.635540			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25787079	hybrid, Green Published			2022-12-26	WOS:000354569000006
J	Walton, RG; Zhu, BB; Unal, R; Spencer, M; Sunkara, M; Morris, AJ; Charnigo, R; Katz, WS; Daugherty, A; Howatt, DA; Kern, PA; Finlin, BS				Walton, R. Grace; Zhu, Beibei; Unal, Resat; Spencer, Michael; Sunkara, Manjula; Morris, Andrew J.; Charnigo, Richard; Katz, Wendy S.; Daugherty, Alan; Howatt, Deborah A.; Kern, Philip A.; Finlin, Brian S.			Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERITABLE HYPERLIPIDEMIC RABBITS; PPAR-GAMMA ACTIVATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BODY-WEIGHT; MICE; MACROPHAGES; OVEREXPRESSION; EXPRESSION; MUSCLE	Lipid accumulation in liver and skeletal muscle contributes to co-morbidities associated with diabetes and obesity. We made a transgenic mouse in which the adiponectin (Adipoq) promoter drives expression of lipoprotein lipase (LPL) in adipocytes to potentially increase adipose tissue lipid storage. These mice (Adipoq-LPL) have improved glucose and insulin tolerance as well as increased energy expenditure when challenged with a high fat diet (HFD). To identify the mechanism(s) involved, we determined whether the Adipoq-LPL mice diverted dietary lipid to adipose tissue to reduce peripheral lipotoxicity, but we found no evidence for this. Instead, characterization of the adipose tissue of the male mice after HFD challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-gamma (PPAR gamma) and a number of PPAR gamma-regulated genes were higher in the epididymal fat pads of Adipoq-LPL mice than control mice. This included adiponectin, whose mRNA levels were increased, leading to increased adiponectin serum levels in the Adipoq-LPL mice. In many respects, the adipose phenotype of these animals resembles thiazolidinedione treatment except for one important difference, the Adipoq-LPL mice did not gain more fat mass on HFD than control mice and did not have increased expression of genes in adipose such as glycerol kinase, which are induced by high affinity PPAR agonists. Rather, there was selective induction of PPAR gamma-regulated genes such as adiponectin in the adipose of the Adipoq-LPL mice, suggesting that increasing adipose tissue LPL improves glucose metabolism in diet-induced obesity by improving the adipose tissue phenotype. Adipoq-LPL mice also have increased energy expenditure.	[Walton, R. Grace; Zhu, Beibei; Spencer, Michael; Kern, Philip A.; Finlin, Brian S.] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Dept Med, Div Endocrinol, Lexington, KY 40536 USA; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Charnigo, Richard] Univ Kentucky, Dept Biostat, Coll Publ Hlth, Lexington, KY 40536 USA; [Katz, Wendy S.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Daugherty, Alan; Howatt, Deborah A.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Unal, Resat] Mugla Sitki Kocman Univ, Dept Mol Biol & Genet, Fac Life Sci, TR-48000 Mugla, Turkey	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Mugla Sitki Kocman University	Finlin, BS (corresponding author), Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Dept Med, Div Endocrinol, Lexington, KY 40536 USA.	bfinlin@uky.edu	sunkara, Manjula/H-7944-2016; Daugherty, Alan/C-8282-2009	sunkara, Manjula/0000-0001-6151-1929; Daugherty, Alan/0000-0003-2093-3775; Katz, Wendy/0000-0003-3038-6314	National Institutes of Health Institutional Development Award [P20 GM103527-06]; NIGMS [DK039176, DK071349]; Clinical and Translational Science Award [UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK039176, R37DK039176, R01DK039176, R01DK071349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health Institutional Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Institutional Development Award P20 GM103527-06 (to B. S. F.) and Grants DK039176 (to P. A. K.) and DK071349 (to P. A. K.) from NIGMS. This work was also supported in part by Clinical and Translational Science Award Grant UL1TR000117.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Deevska G, 2014, J LIPID RES, V55, P2041, DOI 10.1194/jlr.M048223; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Finlin BS, 2013, J NUTR BIOCHEM, V24, P1571, DOI 10.1016/j.jnutbio.2013.01.007; Finlin BS, 2012, J NUTR BIOCHEM, V23, P885, DOI 10.1016/j.jnutbio.2011.04.013; GREENWOOD MRC, 1985, INT J OBESITY, V9, P67; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hosseini M, 2012, ARTERIOSCL THROM VAS, V32, P1204, DOI 10.1161/ATVBAHA.112.245696; Ichikawa T, 2004, LAB INVEST, V84, P715, DOI 10.1038/labinvest.3700102; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Koike T, 2004, J BIOL CHEM, V279, P7521, DOI 10.1074/jbc.M311514200; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Ranganathan G, 1999, J BIOL CHEM, V274, P9122, DOI 10.1074/jbc.274.13.9122; RANGANATHAN G, 1995, J BIOL CHEM, V270, P7149, DOI 10.1074/jbc.270.13.7149; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; Reue K, 2000, J LIPID RES, V41, P1067; Salous AK, 2013, J LIPID RES, V54, P2775, DOI 10.1194/jlr.M039685; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	41	34	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11547	11556		10.1074/jbc.M114.628487	http://dx.doi.org/10.1074/jbc.M114.628487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25784555	Green Published, hybrid			2022-12-26	WOS:000353719400030
J	Girard, BJ; Anderson, TMR; Welch, SL; Nicely, J; Seewaldt, VL; Ostrander, JH				Girard, Brian J.; Anderson, Tarah M. Regan; Welch, Siya Lem; Nicely, Julie; Seewaldt, Victoria L.; Ostrander, Julie H.			Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTORS; BREAST-CANCER CELLS; ERR-GAMMA; TAMOXIFEN RESISTANCE; IN-VITRO; EXPRESSION; APOPTOSIS; AUTOPHAGY; 4-HYDROXYTAMOXIFEN; MECHANISMS	Tamoxifen (Tam) is the only FDA-approved chemoprevention agent for pre-menopausal women at high risk for developing breast cancer. While Tam reduces a woman's risk of developing estrogen receptor positive (ER+) breast cancer, the molecular mechanisms associated with risk reduction are poorly understood. Prior studies have shown that cytoplasmic proline, glutamic acid and leucine rich protein 1 (PELP1) promotes Tam resistance in breast cancer cell lines. Herein, we tested for PELP1 localization in breast epithelial cells from women at high risk for developing breast cancer and found that PELP1 was localized to the cytoplasm in 36% of samples. In vitro, immortalized HMECs expressing a nuclear localization signal (NLS) mutant of PELP1 (PELP1-cyto) were resistant to Tam-induced death. Furthermore, PELP1-cyto signaling through estrogen-related receptor gamma (ERR.) promoted cell survival in the presence of Tam. Overexpression of ERR gamma in immortalized HMECs protected cells from Tam-induced death, while knockdown of ERR gamma sensitized PELP1-cyto expressing HMECs to Tam. Moreover, Tam-induced HMEC cell death was independent of apoptosis and involved accumulation of the autophagy marker LC3-II. Expression of PELP1-cyto and ERR gamma reduced Tam-induced LC3-II accumulation, and knockdown of ERR gamma increased LC3-II levels in response to Tam. Additionally, PELP1-cyto expression led to the upregulation of MMP-3 and MAOB, known PELP1 and ERR gamma target genes, respectively. Our data indicate that cytoplasmic PELP1 induces signaling pathways that converge on ERR gamma to promote cell survival in the presence of Tam. These data suggest that PELP1 localization and/or ERR gamma activation could be developed as tissue biomarkers for Tam responsiveness.	[Girard, Brian J.; Anderson, Tarah M. Regan; Ostrander, Julie H.] Univ Minnesota, Mason Canc Ctr, Dept Med, Minneapolis, MN 55455 USA; [Welch, Siya Lem; Nicely, Julie; Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Minnesota System; University of Minnesota Twin Cities; Duke University	Ostrander, JH (corresponding author), Univ Minnesota, Mason Canc Ctr, Dept Med, Minneapolis, MN 55455 USA.	hans1354@umn.edu	Nicely, Julie M/E-3668-2016	Nicely, Julie M/0000-0003-4828-0032	National Institutes of Health [K07CA131501]; American Cancer Society [124166-IRG-58-001-52-IRG5]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; NATIONAL CANCER INSTITUTE [K07CA131501, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JHO was supported by National Institutes of Health K07CA131501, an Institutional Research Grant #124166-IRG-58-001-52-IRG5 from the American Cancer Society, and National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1TR000114 (K to R01 pilot funding to JHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 1998, J MAMMARY GLAND BIOL, V3, P23, DOI 10.1023/A:1018718117113; Ariazi EA, 2002, CANCER RES, V62, P6510; Baker JC, 2008, CANCER EPIDEM BIOMAR, V17, P1884, DOI 10.1158/1055-9965.EPI-07-2696; Benson JR, 1996, BRIT J CANCER, V74, P352, DOI 10.1038/bjc.1996.365; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; CHARLIER C, 1995, BIOCHEM PHARMACOL, V49, P351, DOI 10.1016/0006-2952(94)00492-5; Cho KS, 2012, INVEST OPHTH VIS SCI, V53, P5344, DOI 10.1167/iovs.12-9827; Deblois G, 2011, BBA-MOL BASIS DIS, V1812, P1032, DOI 10.1016/j.bbadis.2010.12.009; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dietze EC, 2004, ONCOGENE, V23, P3851, DOI 10.1038/sj.onc.1207480; Dietze EC, 2001, J BIOL CHEM, V276, P5384, DOI 10.1074/jbc.M007915200; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Friedman ZY, 1998, CANCER INVEST, V16, P391, DOI 10.3109/07357909809115779; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; GRENMAN SE, 1990, INT J CANCER, V45, P920, DOI 10.1002/ijc.2910450524; GRENMAN SE, 1990, GYNECOL ONCOL, V37, P188, DOI 10.1016/0090-8258(90)90332-F; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Heckler MM, 2014, FEBS J, V281, P2431, DOI 10.1111/febs.12797; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Kohli L, 2013, CANCER RES, V73, P4395, DOI 10.1158/0008-5472.CAN-12-3765; Koritzinsky M, 2013, SEMIN RADIAT ONCOL, V23, P252, DOI 10.1016/j.semradonc.2013.05.006; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Lee JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002901; Liu XH, 2010, J BIOCHEM, V148, P247, DOI 10.1093/jb/mvq056; LOPES MCF, 1990, CANCER RES, V50, P2753; Lu XY, 2012, CURR PHARM DESIGN, V18, P3421, DOI 10.2174/138161212801227113; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; OBRIAN CA, 1985, CANCER RES, V45, P2462; Ohshiro K, 2008, AUTOPHAGY, V4, P104, DOI 10.4161/auto.5223; Ohshiro K, 2007, CANCER RES, V67, P8164, DOI 10.1158/0008-5472.CAN-07-0038; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Riggins RB, 2010, ENDOCR-RELAT CANCER, V17, pR213, DOI 10.1677/ERC-10-0058; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8; Seewaldt VL, 2001, CANCER RES, V61, P616; Tan CK, 2000, J GASTROEN HEPATOL, V15, P725, DOI 10.1046/j.1440-1746.2000.02235.x; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Vadlamudi RK, 2010, J STEROID BIOCHEM, V118, P211, DOI 10.1016/j.jsbmb.2009.09.009; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Vallabhaneni S, 2010, BREAST CANC RES TREA	52	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121206	10.1371/journal.pone.0121206	http://dx.doi.org/10.1371/journal.pone.0121206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789479	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400190
J	Zhang, HX; Zhuang, SY; Qian, HY; Wang, F; Ji, HB				Zhang, Houxi; Zhuang, Shunyao; Qian, Haiyan; Wang, Feng; Ji, Haibao			Spatial Variability of the Topsoil Organic Carbon in the Moso Bamboo Forests of Southern China in Association with Soil Properties	PLOS ONE			English	Article							NORTHEAST CHINA; CLIMATE-CHANGE; BLACK SOIL; LAND-USE; PH; MANAGEMENT; GRASSLAND; SEQUESTRATION; PLANTATIONS; TEMPERATURE	Understanding the spatial variability of soil organic carbon (SOC) must be enhanced to improve sampling design and to develop soil management strategies in terrestrial ecosystems. Moso bamboo (Phyllostachys pubescens Mazel ex Houz.) forests have a high SOC storage potential; however, they also vary significantly spatially. This study investigated the spatial variability of SOC (0-20 cm) in association with other soil properties and with spatial variables in the Moso bamboo forests of Jian'ou City, which is a typical bamboo hometown in China. 209 soil samples were collected from Moso bamboo stands and then analyzed for SOC, bulk density (BD), pH, cation exchange capacity (CEC), and gravel content (GC) based on spatial distribution. The spatial variability of SOC was then examined using geostatistics. A Kriging map was produced through ordinary interpolation and required sample numbers were calculated by classical and Kriging methods. An aggregated boosted tree (ABT) analysis was also conducted. A semivariogram analysis indicated that ln(SOC) was best fitted with an exponential model and that it exhibited moderate spatial dependence, with a nugget/sill ratio of 0.462. SOC was significantly and linearly correlated with BD (r = -0.373**), pH (r = -0.429**), GC (r = -0.163*), CEC (r = 0.263**), and elevation (r = 0.192**). Moreover, the Kriging method requires fewer samples than the classical method given an expected standard error level as per a variance analysis. ABT analysis indicated that the physicochemical variables of soil affected SOC variation more significantly than spatial variables did, thus suggesting that the SOC in Moso bamboo forests can be strongly influenced by management practices. Thus, this study provides valuable information in relation to sampling strategy and insight into the potential of adjustments in agronomic measure, such as in fertilization for Moso bamboo production.	[Zhang, Houxi; Zhuang, Shunyao; Qian, Haiyan; Wang, Feng; Ji, Haibao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Zhang, Houxi; Qian, Haiyan; Wang, Feng; Ji, Haibao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhuang, SY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	syzhuang@issas.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05070303]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank for the financial support from Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05070303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2001, SOIL BIOL BIOCHEM, V33, P1181, DOI 10.1016/S0038-0717(01)00022-0; Cambardella CA, 1994, SOIL SCI SOC AM J, V58, P1505; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chuai XW, 2012, PEDOSPHERE, V22, P404, DOI 10.1016/S1002-0160(12)60026-5; Cline MG, 1944, SOIL SCI, V58, P275, DOI 10.1097/00010694-194410000-00003; Curran PJ, 1998, PROG PHYS GEOG, V22, P61, DOI 10.1177/030913339802200103; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Evrendilek F, 2004, J ARID ENVIRON, V59, P743, DOI 10.1016/j.jaridenv.2004.03.002; Fu J., 2001, BAMBOO, V22, P5; Fu J., 2000, AM BAMBOO SOC MAG, V21, P12; Garten CT, 2011, GEODERMA, V167-68, P30, DOI 10.1016/j.geoderma.2011.08.007; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Hati KA, 2007, AGR ECOSYST ENVIRON, V119, P127, DOI 10.1016/j.agee.2006.06.017; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu G., 1996, SOIL PHYS CHEM ANAL; Lu R.K., 1999, ANAL METHOD SOIL AGR; Ludovisi A, 2005, ECOL MODEL, V181, P247, DOI 10.1016/j.ecolmodel.2004.06.033; Martin D, 2010, AGR ECOSYST ENVIRON, V138, P64, DOI 10.1016/j.agee.2010.04.001; Materechera SA, 1995, BIOL FERT SOILS, V19; MCBRATNEY AB, 1983, SOIL SCI, V135, P177, DOI 10.1097/00010694-198303000-00007; McGrath D, 2004, ENVIRON POLLUT, V127, P239, DOI 10.1016/j.envpol.2003.07.002; Olaleye AO, 2011, COMMUN SOIL SCI PLAN, V42, P2624, DOI 10.1080/00103624.2011.614038; Oueslati I, 2013, PEDOSPHERE, V23, P48, DOI 10.1016/S1002-0160(12)60079-4; PENG G, 2013, PLOS ONE, V0008; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Powers JS, 2002, GEODERMA, V109, P165, DOI 10.1016/S0016-7061(02)00147-7; Salako FK, 1999, GEODERMA, V91, P103, DOI 10.1016/S0016-7061(99)00006-3; Sebastia MT, 2004, BASIC APPL ECOL, V5, P331, DOI 10.1016/j.baae.2003.10.001; Shrestha BM, 2004, NUTR CYCL AGROECOSYS, V68, P155, DOI 10.1023/B:FRES.0000019044.52811.11; Song XZ, 2011, ENVIRON REV, V19, P418, DOI [10.1139/a11-015, 10.1139/A11-015]; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tonon G, 2010, EUR J SOIL SCI, V61, P970, DOI 10.1111/j.1365-2389.2010.01310.x; Tsui CC, 2013, GEODERMA, V209, P119, DOI 10.1016/j.geoderma.2013.06.013; Wang B, 2013, J TROP FOR SCI, V25, P137; Wang HQ, 2002, LANDSCAPE ECOL, V17, P671, DOI 10.1023/A:1022962116313; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Wang ZM, 2010, PEDOSPHERE, V20, P80, DOI 10.1016/S1002-0160(09)60285-X; Webster R., 2000, GEOSTATISTICS ENV SC; Wei YC, 2009, AGR SCI CHINA, V8, P1103, DOI 10.1016/S1671-2927(08)60318-1; WEIGAND S, 1995, BIOL FERT SOILS, V19, P129, DOI 10.1007/BF00336148; Yen TM, 2011, FOREST ECOL MANAG, V261, P995, DOI 10.1016/j.foreco.2010.12.015; Zhang CS, 2004, GEODERMA, V119, P261, DOI 10.1016/j.geoderma.2003.08.004; Zhang XY, 2007, PEDOSPHERE, V17, P19, DOI 10.1016/S1002-0160(07)60003-4; Zhi JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097757; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2; [庄舜尧 Zhuang Shunyao], 2012, [生态环境学报, Ecology and Environmental Sciences], V21, P1200; Zhuang WM, 2008, SOIL ATLAS SUBCOUNTY	50	29	31	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119175	10.1371/journal.pone.0119175	http://dx.doi.org/10.1371/journal.pone.0119175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789615	Green Published, Green Submitted, gold			2022-12-26	WOS:000351425400071
J	Assady, S; Alter, J; Axelman, E; Zohar, Y; Sabo, E; Litvak, M; Kaplan, M; Ilan, N; Vlodavsky, I; Abassi, Z				Assady, Suheir; Alter, Joel; Axelman, Elena; Zohar, Yaniv; Sabo, Edmond; Litvak, Michael; Kaplan, Marielle; Ilan, Neta; Vlodavsky, Israel; Abassi, Zaid			Nephroprotective Effect of Heparanase in Experimental Nephrotic Syndrome	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MAMMALIAN HEPARANASE; ADRIAMYCIN NEPHROPATHY; DIABETIC-NEPHROPATHY; FILTRATION BARRIER; COLLABORATIVE METAANALYSIS; ENDOTHELIAL GLYCOCALYX; INCREASED EXPRESSION; REDUCES PROTEINURIA	Background Heparanase, an endoglycosidase that cleaves heparan sulfate (HS), is involved in various biologic processes. Recently, an association between heparanase and glomerular injury was suggested. The present study examines the involvement of heparanase in the pathogenesis of Adriamycin-induced nephrotic syndrome (ADR-NS) in a mouse model. Methods BALB/c wild-type (wt) mice and heparanase overexpressing transgenic mice (hpa-TG) were tail-vein injected with either Adriamycin (ADR, 10 mg/kg) or vehicle. Albuminuria was investigated at days 0, 7, and 14 thereafter. Mice were sacrificed at day 15, and kidneys were harvested for various analyses: structure and ultrastructure alterations, podocyte proteins expression, and heparanase enzymatic activity. Results ADR-injected wt mice developed severe albuminuria, while ADR-hpa-TG mice showed only a mild elevation in urinary albumin excretion. In parallel, light microscopy of stained cross sections of kidneys from ADR-injected wt mice, but not hpa-TG mice, showed mild to severe glomerular and tubular damage. Western blot and immunofluorescence analyses revealed significant reduction in nephrin and podocin protein expression in ADR-wt mice, but not in ADR-hpa-TG mice. These results were substantiated by electron-microscopy findings showing massive foot process effacement in injected ADR-wt mice, in contrast to largely preserved integrity of podocyte architecture in ADR-hpa-TG mice. Conclusions Our results suggest that heparanase may play a nephroprotective role in ADR-NS, most likely independently of HS degradation. Moreover, hpa-TG mice comprise an invaluable in vivo platform to investigate the interplay between heparanase and glomerular injury.	[Assady, Suheir; Alter, Joel; Axelman, Elena; Litvak, Michael] Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel; [Zohar, Yaniv; Sabo, Edmond] Rambam Hlth Care Campus, Dept Pathol, Haifa, Israel; [Kaplan, Marielle] Rambam Hlth Care Campus, Div Clin Labs, Haifa, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel; [Abassi, Zaid] Rambam Hlth Care Campus, Res Unit, Haifa, Israel; [Abassi, Zaid] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Assady, S (corresponding author), Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel.	s_assady@rambam.health.gov.il		Abassi, Zaid/0000-0002-7272-197X	Ministry of Health (MOH, Israel) [3-00000-9895]; Israel Science Foundation (ISF) [593/10]	Ministry of Health (MOH, Israel); Israel Science Foundation (ISF)(Israel Science Foundation)	This work is in part supported by the Ministry of Health (MOH, Israel) grant 3-00000-9895 (awarded to SA and ZA) and by the Israel Science Foundation (ISF) grant 593/10 (awarded to IV). MOH and ISF had no role in study design, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Boyango I, 2014, CANCER RES, V74, P4504, DOI 10.1158/0008-5472.CAN-13-2962; Chen S, 2008, KIDNEY INT, V74, P289, DOI 10.1038/ki.2008.159; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kramer A, 2006, J AM SOC NEPHROL, V17, P2513, DOI 10.1681/ASN.2006020184; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Levidiotis V, 2005, NEPHROLOGY, V10, P167, DOI 10.1111/j.1440-1797.2005.00388.x; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P2882, DOI 10.1097/01.ASN.0000142426.55612.6D; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levidiotis V, 2001, KIDNEY INT, V60, P1287, DOI 10.1046/j.1523-1755.2001.00934.x; Lewis EJ, 2011, AM J KIDNEY DIS, V58, P729, DOI 10.1053/j.ajkd.2011.06.020; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Nadir Y, 2012, THROMB RES, V129, pS76, DOI 10.1016/S0049-3848(12)70021-X; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rops ALWMM, 2012, NEPHROL DIAL TRANSPL, V27, P2853, DOI 10.1093/ndt/gfr732; Rostgaard J, 2002, CELLS TISSUES ORGANS, V170, P132, DOI 10.1159/000046186; Salmon AHJ, 2009, CURR OPIN NEPHROL HY, V18, P197, DOI 10.1097/MNH.0b013e328329f837; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shafat I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044076; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; van den Hoven MJ, 2009, NEPHROL DIAL TRANSPL, V24, P2637, DOI 10.1093/ndt/gfp182; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	50	8	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119610	10.1371/journal.pone.0119610	http://dx.doi.org/10.1371/journal.pone.0119610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786136	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500119
J	Cohen, C; Moyes, J; Tempia, S; Groome, M; Walaza, S; Pretorius, M; Dawood, H; Chhagan, M; Haffejee, S; Variava, E; Kahn, K; von Gottberg, A; Wolter, N; Cohen, AL; Malope-Kgokong, B; Venter, M; Madhi, SA				Cohen, Cheryl; Moyes, Jocelyn; Tempia, Stefano; Groome, Michelle; Walaza, Sibongile; Pretorius, Marthi; Dawood, Halima; Chhagan, Meera; Haffejee, Summaya; Variava, Ebrahim; Kahn, Kathleen; von Gottberg, Anne; Wolter, Nicole; Cohen, Adam L.; Malope-Kgokong, Babatyi; Venter, Marietjie; Madhi, Shabir A.			Mortality amongst Patients with Influenza-Associated Severe Acute Respiratory Illness, South Africa, 2009-2013	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; SYNCYTIAL VIRUS; UNITED-STATES; HIV; PREVALENCE; INFECTION; ADULTS; HOSPITALIZATIONS	Introduction Data on the burden and risk groups for influenza-associated mortality from Africa are limited. We aimed to estimate the incidence and risk-factors for in-hospital influenza-associated severe acute respiratory illness (SARI) deaths. Methods Hospitalised patients with SARI were enrolled prospectively in four provinces of South Africa from 2009-2013. Using polymerase chain reaction, respiratory samples were tested for ten respiratory viruses and blood for pneumococcal DNA. The incidence of influenza-associated SARI deaths was estimated at one urban hospital with a defined catchment population. Results We enrolled 1376 patients with influenza-associated SARI and 3% (41 of 1358 with available outcome data) died. In patients with available HIV-status, the case-fatality proportion (CFP) was higher in HIV-infected (5%, 22/419) than HIV-uninfected individuals (2%, 13/620; p = 0.006). CFPs varied by age group, and generally increased with increasing age amongst individuals >5 years (p<0.001). On multivariable analysis, factors associated with death were age-group 45-64 years (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.01-16.3) and >= 65 years (OR 6.5, 95% CI 1.2-34.3) compared to 1-4 year age-group who had the lowest CFP, HIV-infection (OR 2.9, 95% CI 1.1-7.8), underlying medical conditions other than HIV (OR 2.9, 95% CI 1.2-7.3) and pneumococcal co-infection (OR 4.1, 95% CI 1.5-11.2). The estimated incidence of influenza-associated SARI deaths per 100,000 population was highest in children <1 year (20.1, 95% CI 12.1-31.3) and adults aged 45-64 years (10.4, 95% CI 8.4-12.9). Adjusting for age, the rate of death was 20-fold (95% CI 15.0-27.8) higher in HIV-infected individuals than HIV-uninfected individuals. Conclusion Influenza causes substantial mortality in urban South Africa, particularly in infants aged <1 year and HIV-infected individuals. More widespread access to antiretroviral treatment and influenza vaccination may reduce this burden.	[Cohen, Cheryl; Moyes, Jocelyn; Walaza, Sibongile; von Gottberg, Anne; Wolter, Nicole; Malope-Kgokong, Babatyi; Madhi, Shabir A.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent South Africa, Influenza Programme, Pretoria, South Africa; [Groome, Michelle; von Gottberg, Anne; Wolter, Nicole; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Groome, Michelle; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Pretorius, Marthi; Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonosis Res Unit, ZA-0002 Pretoria, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp, Dept Med, Uraniaville, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Dept Med, Fac Hlth Sci, ZA-2001 Johannesburg, South Africa; [Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Kahn, Kathleen] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Chhagan, Meera] Univ KwaZulu Natal, Dept Paediat, Durban, South Africa; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp, Dept Med, Pietermaritzburg, South Africa; [Dawood, Halima] Univ KwaZulu Natal, Dept Med, Durban, South Africa; [Haffejee, Summaya] Univ KwaZulu Natal, Sch Pathol, Durban, South Africa; [Venter, Marietjie] US Ctr Dis Control & Prevent South Africa, Global Dis Detect, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; University of Pretoria; University of Witwatersrand; University of Witwatersrand; Umea University; INDEPTH Network; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Cohen, C (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.	cherylc@nicd.ac.za	Groome, Michelle Jennifer/AAI-9967-2021; Variava, Ebrahim/AAO-5717-2020; Venter, Marietjie/P-9604-2016; Dawood, Halima/AAF-6045-2020; Dawood, Halima/AAO-6963-2020; Moyes, Jocelyn/AAF-7882-2019	Groome, Michelle Jennifer/0000-0001-5893-3725; Variava, Ebrahim/0000-0003-2888-789X; Venter, Marietjie/0000-0003-2696-824X; Dawood, Halima/0000-0001-8180-6791; von Gottberg, Anne/0000-0002-0243-7455; Malope-Kgokong, Babatyi/0000-0001-7446-7664; Cohen, Cheryl/0000-0003-0376-2302; Pretorius, Marthi/0000-0003-2163-6158; Kahn, Kathleen/0000-0003-3339-3931	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U51/IP000155-04]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U51IP000155] Funding Source: NIH RePORTER	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the NICD/NHLS and was supported in part by funds from the United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa (Cooperative Agreement Number: U51/IP000155-04). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. The funders had no role in study design, implementation, manuscript writing or the decision to submit for publication. The corresponding author had full access to all the data in the study and takes final responsibility for the decision to submit for publication.	Actuarial Society of South Africa, AIDS DEM MOD 2008; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P221; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2009, CDC PROTOCOL REALTIM; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Azzari C, 2008, J MED MICROBIOL, V57, P1205, DOI 10.1099/jmm.0.2008/000935-0; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Day C., 2011, S AFRICAN HLTH REV 2, P119; Fajardo-Dolci G, 2010, THORAX, V65, P505, DOI 10.1136/thx.2009.126953; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P272, DOI 10.2471/BLT.11.095653; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; McMorrow M, 2015, JINFECTDIS IN PRESS; Peters PJ, 2011, CLIN INFECT DIS, V52, pS183, DOI 10.1093/cid/ciq036; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Singh E., 2008, COMMUNICABLE DIS SUR, V6, P16; Statistics South Africa, 2008, MID POP EST 2003 200; Statistics South Africa. Statistical release P030903, 2009, STAT REL P030903 MOR; Tempia S, 2015, EMERGINFECT IN PRESS; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wolter N, 2014, J INFECT DIS, V209, P56, DOI 10.1093/infdis/jit427; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2011, WHO GLOB TECHN CONS; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	39	56	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118884	10.1371/journal.pone.0118884	http://dx.doi.org/10.1371/journal.pone.0118884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786103	Green Submitted, Green Published, gold			2022-12-26	WOS:000352138500054
J	Collignon, P; Athukorala, PC; Senanayake, S; Khan, F				Collignon, Peter; Athukorala, Prema-chandra; Senanayake, Sanjaya; Khan, Fahad			Antimicrobial Resistance: The Major Contribution of Poor Governance and Corruption to This Growing Problem	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EPIDEMIOLOGY; ASSOCIATION; BACTERIA; EUROPE	Objectives To determine how important governmental, social, and economic factors are in driving antibiotic resistance compared to the factors usually considered the main driving factors-antibiotic usage and levels of economic development. Design A retrospective multivariate analysis of the variation of antibiotic resistance in Europe in terms of human antibiotic usage, private health care expenditure, tertiary education, the level of economic advancement (per capita GDP), and quality of governance (corruption). The model was estimated using a panel data set involving 7 common human bloodstream isolates and covering 28 European countries for the period 1998-2010. Results Only 28% of the total variation in antibiotic resistance among countries is attributable to variation in antibiotic usage. If time effects are included the explanatory power increases to 33%. However when the control of corruption indicator is included as an additional variable, 63% of the total variation in antibiotic resistance is now explained by the regression. The complete multivariate regression only accomplishes an additional 7% in terms of goodness of fit, indicating that corruption is the main socioeconomic factor that explains antibiotic resistance. The income level of a country appeared to have no effect on resistance rates in the multivariate analysis. The estimated impact of corruption was statistically significant (p< 0.01). The coefficient indicates that an improvement of one unit in the corruption indicator is associated with a reduction in antibiotic resistance by approximately 0.7 units. The estimated coefficient of private health expenditure showed that one unit reduction is associated with a 0.2 unit decrease in antibiotic resistance. Conclusions These findings support the hypothesis that poor governance and corruption contributes to levels of antibiotic resistance and correlate better than antibiotic usage volumes with resistance rates. We conclude that addressing corruption and improving governance will lead to a reduction in antibiotic resistance.	[Collignon, Peter] Australian Natl Univ, Canberra Hosp, ACT Pathol, Garran, NSW, Australia; [Collignon, Peter] Australian Natl Univ, Canberra Clin Sch, Garran, ACT, Australia; [Athukorala, Prema-chandra; Khan, Fahad] Australian Natl Univ, Arndt Corden Dept Econ, Acton, ACT, Australia; [Athukorala, Prema-chandra] Univ Manchester, Sch Environm & Dev, Manchester, England; [Senanayake, Sanjaya] Australian Natl Univ, Garran, ACT, Australia; [Senanayake, Sanjaya] Canberra Hosp, Garran, ACT, Australia	Australian National University; Canberra Hospital; Australian National University; Australian National University; University of Manchester; Australian National University; Australian National University; Canberra Hospital	Collignon, P (corresponding author), Australian Natl Univ, Canberra Hosp, ACT Pathol, Garran, NSW, Australia.	peter.collignon@act.gov.au	Collignon, Peter/U-4846-2019	Collignon, Peter/0000-0001-8648-9203	Arndt-Corden Department of Economics, Australian National University	Arndt-Corden Department of Economics, Australian National University	These authors have no external funding to report. Some additional support for some of FK's time came from the Arndt-Corden Department of Economics, Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Ades A, 1997, ECON J, V107, P1023, DOI 10.1111/1468-0297.00204; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Bond S. R., 2001, CTR EC POLICY RES DI, V159, P99; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Canadian Integrated Program for Antimicrobial Resistance Surveillance, 2008, CIPARS 2008 REP; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2010, DANMAP 2010 REP; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Elbasha EH, 2003, HEALTH ECON, V12, P125, DOI 10.1002/hec.702; European Centre for Disease Prevention and Control, 2009, EUR SURV ANT CONS ES, P35; European Centre for Disease Prevention and Control, 2014, EARS NET RES DAT EUR; European Commission, 2014, EU ANT REP 2014; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hall RE, 1999, Q J ECON, V114, P83, DOI 10.1162/003355399555954; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Joint Expert Advisory committee on antibiotic resistance, 2009, JETACAR 2009 REP ANT; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Rodrik D., 2004, J EC GROWTH, V9; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Roodman D, 2009, OXFORD B ECON STAT, V71, P135, DOI 10.1111/j.1468-0084.2008.00542.x; Sen K, 2013, WORLD DEV, V47, P71, DOI 10.1016/j.worlddev.2013.02.015; The PRS Group Inc., 2008, INT COUNTR RISK GUID; Turnidge J, 2005, LANCET, V365, P548; Vieira AR, 2011, FOODBORNE PATHOG DIS, V8, P1295, DOI 10.1089/fpd.2011.0950; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Waterfielf B, 2014, SYDNEY MORNING HERAL; WHO, 2003, JOINT FAO OIE WHO EX; World Bank, 2012, WORLDW GOV IND 2012; World Bank, 2012, WORLD DEV IND 2012; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09	34	69	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116746	10.1371/journal.pone.0116746	http://dx.doi.org/10.1371/journal.pone.0116746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786027	Green Published, gold, Green Submitted			2022-12-26	WOS:000352138500012
J	Debowski, K; Warthemann, R; Lentes, J; Salinas-Riester, G; Dressel, R; Langenstroth, D; Gromoll, J; Sasaki, E; Behr, R				Debowski, Katharina; Warthemann, Rita; Lentes, Jana; Salinas-Riester, Gabriela; Dressel, Ralf; Langenstroth, Daniel; Gromoll, Joerg; Sasaki, Erika; Behr, Ruediger			Non-Viral Generation of Marmoset Monkey iPS Cells by a Six-Factor-in-One-Vector Approach	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE SOMATIC-CELLS; COMMON MARMOSET; HUMAN FIBROBLASTS; NEUROSCIENCE RESEARCH; SENDAI-VIRUS; INDUCTION; MODEL; PIGGYBAC; VECTOR	Groundbreaking studies showed that differentiated somatic cells of mouse and human origin could be reverted to a stable pluripotent state by the ectopic expression of only four proteins. The resulting pluripotent cells, called induced pluripotent stem(iPS) cells, could be an alternative to embryonic stem cells, which are under continuous ethical debate. Hence, iPS cell-derived functional cells such as neurons may become the key for an effective treatment of currently incurable degenerative diseases. However, besides the requirement of efficacy testing of the therapy also its long-term safety needs to be carefully evaluated in settings mirroring the clinical situation in an optimal way. In this context, we chose the long-lived common marmoset monkey (Callithrix jacchus) as a non-human primate species to generate iPS cells. The marmoset monkey is frequently used in biomedical research and is gaining more and more preclinical relevance due to the increasing number of disease models. Here, we describe, to our knowledge, the first-time generation of marmoset monkey iPS cells from postnatal skin fibroblasts by non-viral means. We used the transposon-based, fully reversible piggyback system. We cloned the marmoset monkey reprogramming factors and established robust and reproducible reprogramming protocols with a six-factor-in-one-construct approach. We generated six individual iPS cell lines and characterized them in comparison with marmoset monkey embryonic stem cells. The generated iPS cells are morphologically indistinguishable from marmoset ES cells. The iPS cells are fully reprogrammed as demonstrated by differentiation assays, pluripotency marker expression and transcriptome analysis. They are stable for numerous passages (more than 80) and exhibit euploidy. In summary, we have established efficient non-viral reprogramming protocols for the derivation of stable marmoset monkey iPS cells, which can be used to develop and test cell replacement therapies in preclinical settings.	[Debowski, Katharina; Warthemann, Rita; Lentes, Jana; Behr, Ruediger] German Primate Ctr Leibniz Inst Primate Res, Stem Cell Biol Unit, Gottingen, Germany; [Salinas-Riester, Gabriela] Univ Med Ctr Gottingen UMG, Microarray & Deep Sequencing Core Facil, Gottingen, Germany; [Dressel, Ralf] Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Langenstroth, Daniel; Gromoll, Joerg] Univ Munster, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Sasaki, Erika] Keio Univ, Keio Adv Res Ctr, Shinjuku Ku, Tokyo, Japan; [Behr, Ruediger] Partner Site Gottingen, DZHK German Ctr Cardiovasc Res, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Munster; Keio University; German Centre for Cardiovascular Research	Debowski, K (corresponding author), German Primate Ctr Leibniz Inst Primate Res, Stem Cell Biol Unit, Gottingen, Germany.	kdebowski@dpz.eu; rbehr@dpz.eu	Gromoll, Joerg/AAB-2146-2019; Dressel, Ralf/R-7065-2016	Gromoll, Joerg/0000-0002-7788-8138; Dressel, Ralf/0000-0002-1651-1214	Bundesministerium fur Bildung und Forschung [FKZ: 01GN0817]; Deutsche Forschungsgemeinschaft [DFG-FOR1041]; Collaborative Research Centre from the Deutsche Forschungsgemeinschaft [SFB1002, TP C05]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Centre from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was mainly supported by a grant from the Bundesministerium fur Bildung und Forschung (www.bmbf.de; grant title: Induced pluripotent stem cells in large animal models; FKZ: 01GN0817) to RB and by institutional resources of the German Primate Center. Epigenetic analysis was supported by a grant from the Deutsche Forschungsgemeinschaft (www.dfg.de) entitled "Pluripotent cells from marmoset testis" to JG, Stefan Schlatt, and RB (DFG-FOR1041; Research Unit Germ Cell Potential). The teratoma formation assays performed by Ralf Dressel were supported by a Collaborative Research Centre from the Deutsche Forschungsgemeinschaft (SFB1002, TP C05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Behr R, 2005, STEM CELLS, V23, P805, DOI 10.1634/stemcells.2004-0234; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen WW, 2012, STEM CELLS, V30, P2612, DOI 10.1002/stem.1240; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Fontes Andrew, 2013, Methods Mol Biol, V997, P57, DOI 10.1007/978-1-62703-348-0_6; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Holditch SJ, 2014, STEM CELL TRANSL MED, V3, P653, DOI 10.5966/sctm.2013-0184; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lin ZYC, 2012, REPRODUCTION, V143, P597, DOI 10.1530/REP-11-0215; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; MIYAZAKI J, 1989, GENE, V79, P269; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Muller T, 2009, HUM REPROD, V24, P1359, DOI 10.1093/humrep/dep012; Nakatsuji Norio, 2002, ScientificWorldJournal, V2, P1762; Nishishita Naoki, 2011, J Stem Cells, V6, P101; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Shiozawa S, 2011, STEM CELLS DEV, V20, P1588, DOI 10.1089/scd.2010.0351; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Vogt EJ, 2012, DEVELOPMENT, V139, P4514, DOI 10.1242/dev.083279; Wang Peizhe, 2013, Methods Mol Biol, V969, P221, DOI 10.1007/978-1-62703-260-5_14; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Warren Luigi, 2013, Curr Protoc Stem Cell Biol, V27, DOI 10.1002/9780470151808.sc04a06s27; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiedemann A, 2012, CELL REPROGRAM, V14, P485, DOI 10.1089/cell.2012.0036; Wislocki GB, 1939, AM J ANAT, V64, P445, DOI 10.1002/aja.1000640305; Wistuba J, 2013, REPRODUCTION, V145, P439, DOI 10.1530/REP-12-0373; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Yang GH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-86; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zeng XM, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt173; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	54	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118424	10.1371/journal.pone.0118424	http://dx.doi.org/10.1371/journal.pone.0118424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785453	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500033
J	Fite, BZ; Wong, A; Liu, Y; Mahakian, LM; Tam, SM; Aina, O; Hubbard, NE; Borowsky, A; Cardiff, RD; Dumont, E; Ferrara, KW				Fite, Brett Z.; Wong, Andrew; Liu, Yu; Mahakian, Lisa M.; Tam, Sarah M.; Aina, Olulanu; Hubbard, Neil E.; Borowsky, Alexander; Cardiff, Robert D.; Dumont, Erik; Ferrara, Katherine W.			Magnetic Resonance Imaging Assessment of Effective Ablated Volume following High Intensity Focused Ultrasound	PLOS ONE			English	Article							LOCALIZED PROSTATE-CANCER; COMBINED RADIOFREQUENCY ABLATION; MR THERMOMETRY; THERMAL ABLATION; BREAST-CANCER; HISTOPATHOLOGIC CORRELATION; TRANSRECTAL HIFU; UTERINE FIBROIDS; TISSUE-DAMAGE; TUMOR-MODEL	Under magnetic resonance (MR) guidance, high intensity focused ultrasound (HIFU) is capable of precise and accurate delivery of thermal dose to tissues. Given the excellent soft tissue imaging capabilities of MRI, but the lack of data on the correlation of MRI findings to histology following HIFU, we sought to examine tumor response to HIFU ablation to determine whether there was a correlation between histological findings and common MR imaging protocols in the assessment of the extent of thermal damage. Female FVB mice (n = 34), bearing bilateral neu deletion tumors, were unilaterally insonated under MR guidance, with the contralateral tumor as a control. Between one and five spots (focal size 0.5 x 0.5 x 2.5 mm(3)) were insonated per tumor with each spot receiving approximately 74.2 J of acoustic energy over a period of 7 seconds. Animals were then imaged on a 7T MR scanner with several protocols. T1 weighted images (with and without gadolinium contrast) were collected in addition to a series of T2 weighted and diffusion weighted images (for later reconstruction into T2 and apparent diffusion coefficient maps), immediately following ablation and at 6, 24, and 48 hours post treatment. Animals were sacrificed at each time point and both insonated/treated and contralateral tumors removed and stained for NADH-diaphorase, caspase 3, or with hematoxylin and eosin (H&E). We found the area of non-enhancement on contrast enhanced T1 weighted imaging immediately post ablation correlated with the region of tissue receiving a thermal dose CEM43 >= 240 min. Moreover, while both tumor T2 and apparent diffusion coefficient values changed from pre-ablation values, contrast enhanced T1 weighted images appeared to be more senstive to changes in tissue viability following HIFU ablation.	[Fite, Brett Z.; Wong, Andrew; Liu, Yu; Mahakian, Lisa M.; Tam, Sarah M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Aina, Olulanu; Hubbard, Neil E.; Borowsky, Alexander; Cardiff, Robert D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Borowsky, Alexander; Cardiff, Robert D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Dumont, Erik] Image Guided Therapy, Pessac, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	kwferrara@ucdavis.edu	Borowsky, Alexander D/S-5404-2017	Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [R01CA103828, R01CA134659]; National Cancer Institute [U01 CA141582]; NATIONAL CANCER INSTITUTE [R01CA112356, R01CA134659, R01CA103828, P30CA093373, U01CA141582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants R01CA103828, R01CA134659 (http://www.nih.gov), and the National Cancer Institute grant U01 CA141582 (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Ahmed M, 2005, J VASC INTERV RADIOL, V16, P1365, DOI 10.1097/01.RVI.0000175324.63304.25; Blana A, 2008, EUR UROL, V53, P1194, DOI 10.1016/j.eururo.2007.10.062; Brace CL, 2009, IEEE ENG MED BIO, P4299, DOI 10.1109/IEMBS.2009.5333500; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Crouzet S, 2014, EUR UROL, V65, P907, DOI 10.1016/j.eururo.2013.04.039; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; Germer CT, 1998, SURG ENDOSC-ULTRAS, V12, P1317, DOI 10.1007/s004649900849; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Grissom WA, 2010, MED PHYS, V37, P5014, DOI 10.1118/1.3475943; Grissom WA, 2009, MAGN RESON MED, V62, P1242, DOI 10.1002/mrm.22118; HARMON BV, 1991, INT J RADIAT BIOL, V59, P489, DOI 10.1080/09553009114550441; Harris GR, 2011, ULTRASOUND MED BIOL, V37, P580, DOI 10.1016/j.ultrasmedbio.2011.01.005; Hazle JD, 2002, J MAGN RESON IMAGING, V15, P409, DOI 10.1002/jmri.10076; Hectors SJCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099936; Hesley GK, 2013, CARDIOVASC INTER RAD, V36, P5, DOI 10.1007/s00270-012-0367-3; Holbrook AB, 2010, MAGN RESON MED, V63, P365, DOI 10.1002/mrm.22206; HYNYNEN K, 1993, EUR UROL, V23, P12; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; Lee JD, 2001, KOREAN J RADIOL, V2, P151, DOI 10.3348/kjr.2001.2.3.151; Leyendecker JR, 2002, AM J ROENTGENOL, V178, P1147, DOI 10.2214/ajr.178.5.1781147; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Mumtaz H, 1996, RADIOLOGY, V200, P651, DOI 10.1148/radiology.200.3.8756910; Park MJ, 2013, EUR RADIOL, V23, P943, DOI 10.1007/s00330-012-2665-1; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Quesson B, 2011, NMR BIOMED, V24, P145, DOI 10.1002/nbm.1563; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rieke V, 2007, IEEE T MED IMAGING, V26, P813, DOI 10.1109/TMI.2007.892647; Roubidoux MA, 2014, TECH VASC INTERV RAD, V17, P49, DOI 10.1053/j.tvir.2013.12.008; Rouviere O, 2001, EUR UROL, V40, P265, DOI 10.1159/000049786; Rueff LE, 2013, SEMIN INTERVENT RAD, V30, P347, DOI 10.1055/s-0033-1359728; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Subramanian S, 2014, ULTRASOUND MED BIOL, V40, P102, DOI 10.1016/j.ultrasmedbio.2013.09.007; Uchida T, 2006, INT J UROL, V13, P228, DOI 10.1111/j.1442-2042.2006.01272.x; Vallancien G, 1996, UROLOGY, V47, P204, DOI 10.1016/S0090-4295(99)80417-8; Varghese T, 2004, J ULTRAS MED, V23, P535, DOI 10.7863/jum.2004.23.4.535; Viglianti BL, 2009, CLIN CANCER RES, V15, P4993, DOI 10.1158/1078-0432.CCR-08-2222; Wijlemans JW, 2013, INVEST RADIOL, V48, P381, DOI 10.1097/RLI.0b013e3182820257; Wu F, 2004, ULTRASON SONOCHEM, V11, P149, DOI 10.1016/j.ultsonch.2004.01.011; Wu F, 2006, AM J SURG, V192, P179, DOI 10.1016/j.amjsurg.2006.03.014; Zhang L, 2009, EUR RADIOL, V19, P437, DOI 10.1007/s00330-008-1137-0	42	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120037	10.1371/journal.pone.0120037	http://dx.doi.org/10.1371/journal.pone.0120037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785992	Green Published, Green Submitted, gold			2022-12-26	WOS:000352138500150
J	Jia, JJ; Li, JH; Jiang, L; Zhang, J; Chen, SS; Wang, L; Zhou, YF; Xie, HY; Zhou, L; Zheng, SS				Jia, Junjun; Li, Jianhui; Jiang, Li; Zhang, Jing; Chen, Shasha; Wang, Li; Zhou, Yanfei; Xie, Haiyang; Zhou, Lin; Zheng, Shusen			Protective Effect of Remote Limb Ischemic Perconditioning on the Liver Grafts of Rats with a Novel Model	PLOS ONE			English	Article							REPERFUSION INJURY; HEPATIC ISCHEMIA/REPERFUSION; PRECONDITIONING PROTECTS; TRANSPLANTATION; MECHANISMS; HEART	Background Remote ischemic conditioning (RIC) is a known manual conditioning to decrease ischemic reperfusion injury (IRI) but not increase ischemic time. Here we tried to establish a rat RIC model of liver transplantation (LT), optimize the applicable protocols and investigate the protective mechanism. Methods The RIC model was developed by a standard tourniquet. Sprague-Dawley rats were assigned randomly to the sham operated control (N), standard rat liver transplantation (OLT) and RIC groups. According to the different protocols, RIC group was divided into 3 subgroups (10minx3, n = 6; 5minx3, n = 6; 1minx3, n = 6) respectively. Serum transaminases (ALT, AST), creatine kinase (CK), histopathologic changes, malondialdehyde (MDA), myeloperoxidase (MPO) and expressions of p-Akt were evaluated. Results Compared with the OLT group, the grafts subjected to RIC 5min*3 algorithm showed significant reduction of morphological damage and improved the graft function. Also, production of reactive oxygen species (MDA) and neutrophil accumulation (MPO) were markedly depressed and p-Akt was upregulated. Conclusion In conclusion, we successfully established a novel model of RIC in rat LT, the optimal RIC 5min*3 algorithm seemed to be more efficient to alleviate IRI of the liver graft in both functional and morphological categories, which due to its antioxidative, anti-inflammation activities and activating PI3K Akt pathway.	[Jia, Junjun; Li, Jianhui; Jiang, Li; Zhang, Jing; Wang, Li; Zhou, Yanfei; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Dept Hepatobiliary & Pancreat Surg,Minist Publ Hl, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Shasha] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesia, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Dept Hepatobiliary & Pancreat Surg,Minist Publ Hl, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			N National ST Major Project [2012ZX10002-017]; National Natural Science Foundation of China [81000137]; Qianjiang Talent Program of Zhejiang Province, China [2012R10045]; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China [J20112008]	N National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Program of Zhejiang Province, China; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China	This work was supported, in part, by N National S&T Major Project (NO: 2012ZX10002-017); National Natural Science Foundation of China (Nr 81000137); the Qianjiang Talent Program of Zhejiang Province, China (Nr2012R10045); and the Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China (J20112008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselm E, 2005, FASEB J, V19, pA1230; Czigany Z, 2014, J SURG RES, V185, P605; Czigany Z, 2013, J SURG RES, V185, P605, DOI 10.1016/j.jss.2013.07.018; Czigany Zoltan, 2012, Orvosi Hetilap, V153, P1579, DOI 10.1556/OH.2012.29469; Costa FLD, 2014, J SURG RES, V192, P98, DOI 10.1016/j.jss.2014.05.046; Eberlin KR, 2008, J SURG RES, V148, P24, DOI 10.1016/j.jss.2008.01.040; Hausenloy DJ, 2012, CARDIOVASC DRUG THER, V26, P87, DOI 10.1007/s10557-011-6364-y; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hicks M, 2006, METH MOL B, V333, P331; Jin LM, 2010, PATHOBIOLOGY, V77, P136, DOI 10.1159/000292647; KAMADA N, 1983, SURGERY, V93, P64; Kanoria S, 2006, BRIT J SURG, V93, P762, DOI 10.1002/bjs.5331; Lai IR, 2006, TRANSPLANTATION, V81, P1311, DOI 10.1097/01.tp.0000203555.14546.63; Nardo B, 2001, TRANSPLANTATION, V71, P1816, DOI 10.1097/00007890-200106270-00018; Park KM, 2005, BIOCHEM BIOPH RES CO, V328, P312, DOI 10.1016/j.bbrc.2004.12.177; Pavione MA, 2012, J THORAC CARDIOV SUR, V144, P178, DOI 10.1016/j.jtcvs.2011.12.029; Peralta C, 2001, HEPATOLOGY, V33, P100, DOI 10.1053/jhep.2001.20529; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Shen KZ, 2008, AM J PHYSIOL-GASTR L, V294, pG1070, DOI 10.1152/ajpgi.00554.2007; Skyschally A, 2009, BASIC RES CARDIOL, V104, P469, DOI 10.1007/s00395-009-0040-4; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takaoka A, 1999, J AM COLL CARDIOL, V33, P556, DOI 10.1016/S0735-1097(98)00559-2; Taki-Eldin A, 2012, J SURG RES, V178, P646, DOI 10.1016/j.jss.2012.05.069; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Van Gelder F, 2008, ACTA CHIR BELG, V108, P35, DOI 10.1080/00015458.2008.11680172; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002874; Wang M, 2013, J SURG RES, V179, pE245, DOI 10.1016/j.jss.2012.02.007; Yan S, 2010, HEPATOB PANCREAT DIS, V9, P346; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121972	10.1371/journal.pone.0121972	http://dx.doi.org/10.1371/journal.pone.0121972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785455	Green Submitted, gold, Green Published			2022-12-26	WOS:000352138500218
J	Abuduwaili, J; Zhang, ZY; Jiang, FQ				Abuduwaili, Jilili; Zhang, Zhao Yong; Jiang, Feng Qing			Assessment of the Distribution, Sources and Potential Ecological Risk of Heavy Metals in the Dry Surface Sediment of Aibi Lake in Northwest China	PLOS ONE			English	Article							STREET DUSTS; TRACE-METALS; CONTAMINATION; POLLUTION; SPECIATION; CATCHMENT; ACCUMULATION; SOILS	The distribution, sources and potential ecological risk of heavy metals in the sediment of lakes in eastern China and other areas of the world that have undergone rapid economic development have been widely researched by scholars. However, this is not true for heavy metals in the sediment of rump lakes in the arid regions of China and world-wide. Because of this, we chose Aibi Lake to serve as a typical rump lake in an oasis in an arid area in northwest China for our study. Sediment samples were collected from the lake and then the quantities of the heavy metals Pb, Ni, Cd, Cu, Zn, Hg and Cr were measured. Then using a variety of statistical methods, we analyzed the distribution, sources, pollution status and the potential ecological risk of these metals. The results show that: (1) The amounts of the seven heavy metals all fell within the Second Soil National Standard, but the average and maximum values were all higher than the background values of Xinjiang in northwest China. (2) Multivariate statistical analysis determined that the Cd, Pb, Hg and Zn in the sediment were mainly derived from man-sources, and Cu, Ni, and Cr were mainly from the natural geological background. (3) Enrichment factor analysis and the geo-accumulation index evaluation method show that Cd, Hg and Pb in the surface sediment of the Aibi Lake were at low and partial pollution levels, while Zn, Cr, Ni and Cu were at no and low pollution levels. (4) Calculation of the potential ecological hazards index found that, among the seven tested heavy metals, Cd, Hg and Pb were the main potential ecological risk factors, and the contribution of each was 42.6%, 28.6%, and 24.0%, respectively. Cd is the main potential ecological risk factor, followed by Hg and Pb. This work revealed that recent economic development of the Aibi Lake Basin has negatively influenced the accumulation of heavy metals in the sediments of the lake, and, therefore, we should pay increasing attention to this problem and take effective measures to protect the ecology of the Aibi Lake Basin. This work can provide a scientific basis for an early warning of heavy metal pollution and for protection of the environment. Furthermore, it can serve as a reference when creating policies for the economic development in Aibi Lake Basin and environmental protection of rump lakes in arid regions of northwest China and other areas of the world.	[Abuduwaili, Jilili; Zhang, Zhao Yong; Jiang, Feng Qing] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Zhang, Zhao Yong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, ZY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	baiyangdian313@163.com		ji, li li/0000-0001-8483-1554	National Natural Science Foundation of China [41471098]; National Natural Science Foundation of China Xinjiang Joint Fund in China [U1138301]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-308, KZCX2-YW-GJ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China Xinjiang Joint Fund in China; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China (No. 41471098), the National Natural Science Foundation of China Xinjiang Joint Fund in China (Nos. U1138301), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-308, KZCX2-YW-GJ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao Liang, 2014, Huanjing Kexue, V35, P179; Bing HJ, 2011, J ENVIRON SCI-CHINA, V23, P1671, DOI 10.1016/S1001-0742(10)60593-1; Bing Haijian, 2010, Hupo Kexue, V22, P675; Chen Chun-xiao, 2011, China Environmental Science, V31, P1842; Chen J, 2007, HENAN SCI, V25, P303; Chen YZ, 2007, PEDOSPHERE, V17, P284, DOI 10.1016/S1002-0160(07)60035-6; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; HORN MK, 1966, GEOCHIM COSMOCHIM AC, V30, P279, DOI 10.1016/0016-7037(66)90003-2; [黄顺生 Huang shunsheng], 2008, [地学前缘, Earth Science Frontiers], V15, P161; Jilili A., 2009, Arid Land Geography, V32, P211; Kankilic GB, 2013, ENVIRON MONIT ASSESS, V185, P6739, DOI 10.1007/s10661-013-3061-2; Kukrer S, 2014, ENVIRON MONIT ASSESS, V186, P3847, DOI 10.1007/s10661-014-3662-4; Lan W H, 2002, ARID ENV MONITORING, V16, P167; Li Bi-cai, 2012, Huanjing Kexue, V33, P2376; Li M, 2014, ECOTOXICOLOGY, V23, P681, DOI 10.1007/s10646-014-1180-3; Li MY, 2009, WATER RESOURCES PROT, V5, P44; [李珊珊 Li Shanshan], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2277; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Liu De-hong, 2012, Huanjing Kexue, V33, P253; [刘东伟 Liu Dongwei], 2014, [冰川冻土, Journal of Glaciology and Geocryology], V36, P352; Liu DW, 2011, WATER AIR SOIL POLL, V218, P175, DOI 10.1007/s11270-010-0633-4; Liu Qiang, 2013, China Environmental Science, V33, P2220; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; Liu ZK, 2005, JIANG SU ENV SCI TEC, V4, P016; [吕建树 Lu Jianshu], 2012, [地理学报, Acta Geographica Sinica], V67, P971; [吉力力·阿不都外力 JILILI Abuduwaili], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P928; Mamat Z, 2014, SCI TOTAL ENVIRON, V493, P1098, DOI 10.1016/j.scitotenv.2014.03.087; MI Y, 2008, J LAKE SCI, V21, P891; Mi Yan, 2009, Hupo Kexue, V21, P891; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Munksgaard NC, 2001, MAR CHEM, V75, P165, DOI 10.1016/S0304-4203(01)00033-0; [钱亦兵 Qian Yibing], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P17; [乔敏敏 Qiao Minmin], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P3324; [乔胜英 Qiao Shengying], 2005, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V14, P353; Ren WX, 2014, LAND USE POLICY, V38, P138, DOI 10.1016/j.landusepol.2013.11.005; SEPA (State Environmental Protection Administration), 2006, GB204232006 STAT ENV; Sutherland RA, 2000, ENVIRON GEOL, V39, P611, DOI 10.1007/s002540050473; Tam NFY, 2000, ENVIRON POLLUT, V110, P195, DOI 10.1016/S0269-7491(99)00310-3; The State Environmental Protection Administration (SEPA), 1990, CHIN SOIL EL BACKGR; Wang L, 2011, J ENV MANAGEMENT COL, V21, P8; Xia JQ, 1995, NATL STANDARD SOIL E; [夏希凡 XIA Xifan], 2006, [新疆地质, Xinjiang Geology], V24, P392; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112; [杨世琦 Yang Shiqi], 2010, [生态学报, Acta Ecologica Sinica], V30, P6201; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Zeng HA, 2007, QUATERNARY SCI, V27, P128; [张永三 ZHANG Yong-san], 2009, [地球与环境, Earth and Environment], V37, P50; Zhang Zhao-yong, 2012, China Environmental Science, V32, P1799; Zhang ZY, 2013, ANAL LETT, V46, P2122, DOI 10.1080/00032719.2013.784919; Zhao YF, 2007, PEDOSPHERE, V17, P44, DOI 10.1016/S1002-0160(07)60006-X; Zheng SongLin, 2011, Environmental Science & Technology (China), V34, P85; Zhong Xiao-lan, 2010, Huanjing Kexue, V31, P1608; Zhou ChangHai, 2005, Arid Land Geography, V28, P98; Zhu BQ, 2013, J HYDROL, V486, P151, DOI 10.1016/j.jhydrol.2013.01.016; Zhu G.W., 2005, J LAKE SCI, V17, P143, DOI [DOI 10.18307/2005.0209.[, 10.18307/2005.0209, DOI 10.18307/2005.0209]	55	39	44	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120001	10.1371/journal.pone.0120001	http://dx.doi.org/10.1371/journal.pone.0120001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781032	Green Published, Green Submitted, gold			2022-12-26	WOS:000351284600117
J	Acuff, NV; Li, X; Kirkland, R; Nagy, T; Watford, WT				Acuff, Nicole V.; Li, Xin; Kirkland, Rebecca; Nagy, Tamas; Watford, Wendy T.			Tumor Progression Locus 2 Differentially Regulates IFN gamma and IL-17 Production by Effector CD4(+) T Cells in a T Cell Transfer Model of Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TGF-BETA; TH17 CELLS; AUTOIMMUNE-DISEASE; PROTEIN-KINASE; T(H)17 CELLS; ACTIVATE ERK; TPL2 KINASE; ROR-GAMMA; KAPPA-B	Autoimmune diseases are approaching epidemic levels, estimated to affect 5-8% of the population. A number of autoimmune diseases are believed to be driven by autoreactive T cells, specifically by T helper 1 (Th1) cells and T helper 17 (Th17) cells. One molecule gaining interest as a therapeutic target is the serine-threonine kinase, Tpl2, which promotes expression of proinflammatory mediators. We previously demonstrated that Tpl2 regulates Th1 differentiation, secretion of the inflammatory cytokine IFN gamma, and host defense against the intracellular parasite Toxoplasma gondii. The goal of this study was to determine whether Tpl2 also regulates Th1 or Th17 differentiation in vivo in a model of colitis associated with mixed Th1/Th17 pathology. In vitro, Tpl2(-/-) naive CD4 T cells were significantly impaired in IL-17A secretion under traditional Th17 inducing conditions. Reduced IL-17A secretion correlated with increased expression of FoxP3, a transcription factor known to antagonize ROR gamma t function. In a murine T cell transfer model of colitis, transfer of Tpl2(-/-) T cells resulted in reduced proportions of CD4 T cells expressing IFN gamma, but not IL-17A, compared to that induced by wild type T cells. Further studies revealed that IL-17A differentiation induced by IL-6 and IL-23, cytokines implicated in driving Th17 differentiation in vivo, was unaffected by Tpl2 deficiency. Collectively, these results implicate Tpl2 in TGF-beta-induced FoxP3 expression. Additionally, they underscore the contribution of Tpl2 to Th1 immunopathology specifically, which suggests that Tpl2 inhibitors may selectively target Th1-based inflammation.	[Acuff, Nicole V.; Li, Xin; Kirkland, Rebecca; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu	Li, Xin V./ABA-4321-2021; Li, Xin/AAH-2983-2019	Li, Xin V./0000-0002-9444-8214; Watford, Wendy/0000-0003-4261-5399	National Institute of Allergy and Infectious Diseases, NIH [R01AI099058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099058, R56AI099058] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01AI099058 (WTW), http://www.niaid.nih.gov/Pages/default.aspx, National Institute of Allergy and Infectious Diseases, NIH.	Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; BELL EB, 1987, J IMMUNOL, V139, P1379; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lawrenz M, 2012, MUCOSAL IMMUNOL, V5, P129, DOI 10.1038/mi.2011.57; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mus AMC, 2010, ARTHRITIS RHEUM-US, V62, P1043, DOI 10.1002/art.27336; Nguyen TLM, 2011, J IMMUNOL, V187, P1745, DOI 10.4049/jimmunol.1004112; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Ostanin DV BJ, 2009, AM J PHYSIOL-GASTR L, V296, P135; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Soria-Castro I, 2010, J BIOL CHEM, V285, P33805, DOI 10.1074/jbc.M110.169409; Sriskantharajah S, 2014, J IMMUNOL; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xiao Y, 2014, J EXP MED; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	55	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119885	10.1371/journal.pone.0119885	http://dx.doi.org/10.1371/journal.pone.0119885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781948	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600104
J	Alanazi, I; Hoffmann, P; Adelson, DL				Alanazi, Ibrahim; Hoffmann, Peter; Adelson, David L.			MicroRNAs Are Part of the Regulatory Network that Controls EGF Induced Apoptosis, Including Elements of the JAK/STAT Pathway, in A431 Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; ERBB RECEPTORS; INHIBITION; THERAPY; PROTEIN; OVEREXPRESSION; PROLIFERATION; SUPPRESSION; EXPRESSION	MiRNAs are known to regulate gene expression and in the context of cancer have been shown to regulate metastasis, cell proliferation and cell death. In this report we describe potential miRNA regulatory roles with respect to induction of cell death by pharmacologic dose of Epidermal Growth Factor (EGF). Our previous work suggested that multiple pathways are involved in the induction of apoptosis, including interferon induced genes, cytokines, cytoskeleton and cell adhesion and TP53 regulated genes. Using miRNA time course expression profiling of EGF treated A431 cells and coupling this to our previous gene expression and proteomic data, we have been able to implicate a number of additional miRNAs in the regulation of apoptosis. Specifically we have linked miR-134, miR-145, miR-146b-5p, miR-432 and miR-494 to the regulation of both apoptotic and anti-apoptotic genes expressed as a function of EGF treatment. Whilst additional miRNAs were differentially expressed, these had the largest number of apoptotic and anti-apoptotic targets. We found 5 miRNAs previously implicated in the regulation of apoptosis and our results indicate that an additional 20 miRNAs are likely to be involved based on their correlated expression with targets. Certain targets were linked to multiple miRNAs, including PEG10, BTG1, ID1, IL32 and NCF2. Some miRNAs that target the interferon pathway were found to be down regulated, consistent with a novel layer of regulation of interferon pathway components downstream of JAK/STAT. We have significantly expanded the repertoire of miRNAs that may regulate apoptosis in cancer cells as a result of this work.	[Alanazi, Ibrahim; Hoffmann, Peter; Adelson, David L.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adelson, David L.] Univ Adelaide, Zhendong Australia China Ctr Mol Chinese Med, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011; Hoffmann, Peter/U-5996-2017	Adelson, David L/0000-0003-2404-5636; Hoffmann, Peter/0000-0001-8493-2208; Alanazi, Ibrahim O./0000-0002-8479-7875	University of Adelaide	University of Adelaide	This work was supported by The University of Adelaide. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DK, 1994, CANCER RES, V54, P5280; BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cerchia L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73104; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GILL GN, 1982, J CELL BIOCHEM, V19, P249, DOI 10.1002/jcb.240190306; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Hu HY, 2013, J BIOL CHEM, V288, P10973, DOI 10.1074/jbc.M112.434340; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janmaat ML, 2003, DRUG TODAY, V39, P61; Kari C, 2003, CANCER RES, V63, P1; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin CC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-18; Liu HJ, 2007, INT J DERMATOL, V46, P1171, DOI 10.1111/j.1365-4632.2007.03335.x; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Mlcochova J., 2013, J CANC RES CLIN ONCO; Nahta R, 2006, MOL CANCER THER, V5, P1593, DOI 10.1158/1535-7163.MCT-06-0133; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Papadopoulou N, 2008, EXP CELL RES, V314, P3162, DOI 10.1016/j.yexcr.2008.07.012; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; Qiu CX, 2010, BMC SYSTEMS BIOLOGY, P4; Rodeck U, 1997, J CELL SCI, V110, P113; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Schmidt M, 2002, DRUG RESIST UPDATE, V5, P11, DOI 10.1016/S1368-7646(02)00004-3; Schneeweiss A, 2004, ANTI-CANCER DRUG, V15, P235, DOI 10.1097/00001813-200403000-00007; Solomon B, 2003, INT J RADIAT ONCOL, V55, P713, DOI 10.1016/S0360-3016(02)04357-2; Sun XH, 2008, BMC IMMUNOLOGY, V9; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Weinstein EJ, 1998, ONCOGENE, V17, P2107, DOI 10.1038/sj.onc.1202428; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28	43	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120337	10.1371/journal.pone.0120337	http://dx.doi.org/10.1371/journal.pone.0120337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781916	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600152
J	Hidano, A; Yamamoto, T; Hayama, Y; Muroga, N; Kobayashi, S; Nishida, T; Tsutsui, T				Hidano, Arata; Yamamoto, Takehisa; Hayama, Yoko; Muroga, Norihiko; Kobayashi, Sota; Nishida, Takeshi; Tsutsui, Toshiyuki			Unraveling Antimicrobial Resistance Genes and Phenotype Patterns among Enterococcus faecalis Isolated from Retail Chicken Products in Japan	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; VANCOMYCIN RESISTANCE; BAYESIAN NETWORKS; FOOD ANIMALS; ERM(B) GENE; FAECIUM; DETERMINANTS; HUMANS	Multidrug-resistant enterococci are considered crucial drivers for the dissemination of antimicrobial resistance determinants within and beyond a genus. These organisms may pass numerous resistance determinants to other harmful pathogens, whose multiple resistances would cause adverse consequences. Therefore, an understanding of the coexistence epidemiology of resistance genes is critical, but such information remains limited. In this study, our first objective was to determine the prevalence of principal resistance phenotypes and genes among Enterococcus faecalis isolated from retail chicken domestic products collected throughout Japan. Subsequent analysis of these data by using an additive Bayesian network (ABN) model revealed the co-appearance patterns of resistance genes and identified the associations between resistance genes and phenotypes. The common phenotypes observed among E. faecalis isolated from the domestic products were the resistances to oxytetracycline (58.4%), dihydrostreptomycin (50.4%), and erythromycin (37.2%), and the gene tet(L) was detected in 46.0% of the isolates. The ABN model identified statistically significant associations between tet(L) and erm(B), tet(L) and ant(6)-Ia, ant(6)-Ia and aph(3')IIIa, and aph(3')-IIIa and erm(B), which indicated that a multiple-resistance profile of tetracycline, erythromycin, streptomycin, and kanamycin is systematic rather than random. Conversely, the presence of tet(O) was only negatively associated with that of erm(B) and tet (M), which suggested that in the presence of tet(O), the aforementioned multiple resistance is unlikely to be observed. Such heterogeneity in linkages among genes that confer the same phenotypic resistance highlights the importance of incorporating genetic information when investigating the risk factors for the spread of resistance. The epidemiological factors that underlie the persistence of systematic multiple-resistance patterns warrant further investigations with appropriate adjustments for ecological and bacteriological factors.	[Hidano, Arata; Yamamoto, Takehisa; Hayama, Yoko; Muroga, Norihiko; Kobayashi, Sota; Tsutsui, Toshiyuki] Natl Inst Anim Hlth, Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan; [Hidano, Arata] Massey Univ, Inst Vet Anim & Biomed Sci, EpiCtr, Palmerston North, New Zealand; [Nishida, Takeshi] Minist Agr Forestry & Fisheries, Food Safety & Consumer Affairs Bur, Anim Prod Safety Div, Chiyoda Ku, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Massey University; Ministry of Agriculture Forestry & Fisheries - Japan	Tsutsui, T (corresponding author), Natl Inst Anim Hlth, Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan.	tsutsui@affrc.go.jp	Hidano, Arata/S-1719-2019	Hidano, Arata/0000-0003-1707-5319	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection - Ministry of Agriculture, Forestry and Fisheries, Japan	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection - Ministry of Agriculture, Forestry and Fisheries, Japan	This study was supported by Regulatory Research Projects for Food Safety, Animal Health and Plant Protection funded by the Ministry of Agriculture, Forestry and Fisheries, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Aslam M, 2012, INT J FOOD MICROBIOL, V156, P222, DOI 10.1016/j.ijfoodmicro.2012.03.026; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; BENTORCHA F, 1991, ANTIMICROB AGENTS CH, V35, P808, DOI 10.1128/AAC.35.5.808; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Cauwerts K, 2007, AVIAN PATHOL, V36, P395, DOI 10.1080/03079450701589167; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Dahl KH, 2007, J ANTIMICROB CHEMOTH, V59, P478, DOI 10.1093/jac/dkl530; De Leener E, 2004, MICROB DRUG RESIST, V10, P341, DOI 10.1089/mdr.2004.10.341; Denwood MJ, 2011, P ROY SOC B-BIOL SCI, V278, P1434, DOI 10.1098/rspb.2010.1719; Di Cesare A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062838; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Hiroi M, 2012, J FOOD PROTECT, V75, P1774, DOI 10.4315/0362-028X.JFP-11-479; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Hosoi Y, 2014, REV SCI TEC IN PRESS, V33; Huys G, 2004, APPL ENVIRON MICROB, V70, P1555, DOI 10.1128/AEM.70.3.1555-1562.2004; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lewis FI, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-4; Lewis FI, 2012, AM J EPIDEMIOL, V176, P1051, DOI 10.1093/aje/kws183; Ludwig A, 2013, PREV VET MED, V110, P64, DOI 10.1016/j.prevetmed.2013.02.005; National Veterinary Assay Laboratory, REP JAP VET ANT RES; Nomura T, 2012, ANTIMICROB AGENTS CH, V56, P6389, DOI 10.1128/AAC.00747-12; PEPPER K, 1987, ANTIMICROB AGENTS CH, V31, P1394, DOI 10.1128/AAC.31.9.1394; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Schwaiger K, 2009, VET MICROBIOL, V139, P386, DOI 10.1016/j.vetmic.2009.06.005; Singer RS, 2014, CURR OPIN MICROBIOL, V19, P1, DOI 10.1016/j.mib.2014.05.014; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Summers AO, 2002, CLIN INFECT DIS, V34, pS85, DOI 10.1086/340245; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; Watanabe S, 2009, MICROB DRUG RESIST, V15, P185, DOI 10.1089/mdr.2009.0917; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Wooldridge M, 2012, REV SCI TECH OIE, V31, P231	43	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121189	10.1371/journal.pone.0121189	http://dx.doi.org/10.1371/journal.pone.0121189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781022	gold, Green Submitted, Green Published			2022-12-26	WOS:000351284600197
J	Mehta, J; Asthana, S; Mandal, CC; Saxena, S				Mehta, Jatin; Asthana, Shailendra; Mandal, Chandi Charan; Saxena, Sunita			A Molecular Analysis Provides Novel Insights into Androgen Receptor Signalling in Breast Cancer	PLOS ONE			English	Article							TYROSINE KINASE; TUMOR-SUPPRESSOR; BINDING DOMAIN; EXPRESSION; PROTEIN; GROWTH; RESISTANCE; APOPTOSIS; GENE; TRANSCRIPTION	Background Androgen Receptor (AR) is an essential transcription factor for the development of secondary sex characteristics, spermatogenesis and carcinogenesis. Recently AR has been implicated in the development and progression of breast and prostate cancers. Although some of the functions of the AR are known but the mechanistic details of these divergent processes are still not clear. Therefore understanding the regulatory mechanisms of the functioning of the AR in ER-/AR+ breast cancer will provide many novel targets for the purpose of therapeutic intervention. Methods/Results Using bioinformatics tools, we have identified 75 AR targets having prominent roles in cell cycle, apoptosis and metabolism. Herein, we validated 10 genes as AR targets by studying the regulation of these genes in MDA-MB-453 cell line on stimulation by androgens like 5 alpha-dihydrotestosterone (DHT), using RT-qPCR and ChIP assay. It was observed that all the identified genes involved in cell cycle except MAD1L1 were found to be up regulated whereas expression of apoptosis related genes was decreased in response to DHT treatment. We performed an exhaustive, rigid-body docking between individual ARE and DNA binding domain (DBD) of the AR protein and it was found that novel residues K567, K588, K591 and R592 are involved in the process of DNA binding. To verify these specific DNA-protein interactions electrostatic energy term calculations for each residue was determined using the linearized Poisson-Boltzmann equation. Our experimental data showed that treatment of breast cancer cells with DHT promotes cell proliferation and decreases apoptosis. It was observed that bicalutamide treatment was able to reverse the effect of DHT. Conclusion Taken together, our results provide new insights into the mechanism by which AR promotes breast cancer progression. Moreover our work proposes to use bicalutamide along with taxanes as novel therapy for the treatment of TNBCs, which are positive for downstream AR signalling.	[Mehta, Jatin; Asthana, Shailendra; Saxena, Sunita] Safdarjang Hosp, ICMR, Natl Inst Pathol, New Delhi, India; [Mandal, Chandi Charan] Cent Univ Rajasthan, Dept Biochem, Ajmer, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Vardhman Mahavir Medical College & Safdarjung Hospital; Central University of Rajasthan (CURAJ)	Saxena, S (corresponding author), Safdarjang Hosp, ICMR, Natl Inst Pathol, New Delhi, India.	sunita_saxena@yahoo.com		Mandal, Chandi/0000-0002-2292-6635	Indian Council of Medical Research (ICMR), New Delhi, India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This work is financially supported by Indian Council of Medical Research (ICMR), New Delhi, India. JM is recipient of ICMR post doctoral fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brinkmann AO, 2000, NAT MED, V6, P628, DOI 10.1038/76194; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Choi YH, 2012, ONCOL REP, V28, P2163, DOI 10.3892/or.2012.2060; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; Fargo KN, 2008, J NEUROTRAUM, V25, P561, DOI 10.1089/neu.2007.0466; Gan L, 2009, CANCER RES, V69, P8386, DOI 10.1158/0008-5472.CAN-09-1504; Ghosh-Choudhury N, 2013, J BIOL CHEM, V288, P24503, DOI 10.1074/jbc.M113.455733; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hatami R, 2013, SCIENCE TRANSLATIONA, V5; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Kahn B, 2014, INT J BIOL SCI, V10, P588, DOI 10.7150/ijbs.8671; Kimmick GG, 2009, BREAST CANCER RES TR, V113, P479, DOI 10.1007/s10549-008-9943-2; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lessard L, 2012, CANCER RES, V72, P1529, DOI 10.1158/0008-5472.CAN-11-2602; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lose F, 2012, THE KALLIKREIN 14 GE; Ma S, 2014, LAB INVEST, V94, P430, DOI 10.1038/labinvest.2014.13; Magklara A, 2002, INT J CANCER, V100, P507, DOI 10.1002/ijc.10520; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2012, CARCINOGENESIS, V33, P1897, DOI 10.1093/carcin/bgs198; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Mishra AK, 2012, INDIAN J MED RES, V135, P843; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Nelson M, 2014, INTERNATIONAL JOURNA; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Oluwagbemiga LA, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-83; Osaki M, 2007, VIRCHOWS ARCH, V451, P771, DOI 10.1007/s00428-007-0470-z; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peddi PF, 2011, INTERNATIONAL JOURNA, V2012; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Rialland M, 2002, J CELL SCI, V115, P1435; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007398; Singh LC, 2012, MED ONCOL, V29, P539, DOI 10.1007/s12032-011-9952-6; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tchirkov A, 2010, CLIN CHEM LAB MED, V48, P1167, DOI 10.1515/CCLM.2010.219; Ten Eyck LF, 1995, SURVEYING MOL INTERA, P22; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tomomura M, 2001, ONCOGENE, V20, P1022, DOI 10.1038/sj.onc.1204210; Tsukasaki K, 2001, ONCOGENE, V20, P3301, DOI 10.1038/sj.onc.1204421; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E	72	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120622	10.1371/journal.pone.0120622	http://dx.doi.org/10.1371/journal.pone.0120622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781993	Green Submitted, Green Published, gold			2022-12-26	WOS:000351284600175
J	Tripathi, D; Raikhy, G; Goodin, MM; Dietzgen, RG; Pappu, HR				Tripathi, Diwaker; Raikhy, Gaurav; Goodin, Michael M.; Dietzgen, Ralf G.; Pappu, Hanu R.			In Vivo Localization of Iris yellow spot Tospovirus (Bunyaviridae)-Encoded Proteins and Identification of Interacting Regions of Nucleocapsid and Movement Proteins	PLOS ONE			English	Article							WILT-VIRUS; FLUORESCENCE MICROSCOPY; TRANSIENT EXPRESSION; SELF-ASSOCIATION; PLANT-PROTEINS; NSM PROTEIN; GENE; DOMAINS; SUPPRESSOR; CELLS	Background Localization and interaction studies of viral proteins provide important information about their replication in their host plants. Tospoviruses (Family Bunyaviridae) are economically important viruses affecting numerous field and horticultural crops. Iris yellow spot virus (IYSV), one of the tospoviruses, has recently emerged as an important viral pathogen of Allium spp. in many parts of the world. We studied the in vivo localization and interaction patterns of the IYSV proteins in uninfected and infected Nicotiana benthamiana and identified the interacting partners. Principal Findings Bimolecular fluorescence complementation (BiFC) analysis demonstrated homotypic and heterotypic interactions between IYSV nucleocapsid (N) and movement (NSm) proteins. These interactions were further confirmed by pull-down assays. Additionally, interacting regions of IYSV N and NSm were identified by the yeast-2-hybrid system and beta-galactosidase assay. The N protein self-association was found to be mediated through the N- and C-terminal regions making head to tail interaction. Self-interaction of IYSV NSm was shown to occur through multiple interacting regions. In yeast-2-hybrid assay, the N- and C-terminal regions of IYSV N protein interacted with an N-terminal region of IYSV NSm protein. Conclusion/Significance Our studies provide new insights into localization and interactions of IYSV N and NSm proteins. Molecular basis of these interactions was studied and is discussed in the context of tospovirus assembly, replication, and infection processes.	[Tripathi, Diwaker; Raikhy, Gaurav; Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Goodin, Michael M.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Dietzgen, Ralf G.] Univ Queensland, QAAFI, St Lucia, Qld, Australia	Washington State University; University of Kentucky; University of Queensland	Pappu, HR (corresponding author), Washington State Univ, Dept Plant Pathol, POB 646430, Pullman, WA 99164 USA.	hrp@wsu.edu	Tripathi, Diwaker/AAC-9897-2020; Dietzgen, Ralf Georg/A-5565-2010; Raikhy, Gaurav/AAB-3614-2020	Tripathi, Diwaker/0000-0003-3857-2760; Dietzgen, Ralf Georg/0000-0002-7772-2250; Raikhy, Gaurav/0000-0003-4361-3213	Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center [0684]; Hatch Project [WNPO 0545]; Washington State University, Pullman, WA, USA	Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center; Hatch Project(United States Department of Agriculture (USDA)); Washington State University, Pullman, WA, USA	The work was supported by PPNS No. 0684, Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center, Hatch Project # WNPO 0545, Washington State University, Pullman, WA 99164-6430, USA. The authors also acknowledge the support from the Franceschi Microscopy and Imaging Center (FMIC) at the Washington State University, Pullman.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bandyopadhyay A, 2010, VIROLOGY, V402, P61, DOI 10.1016/j.virol.2010.03.013; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; CHIEMSOMBAT P, 2006, CHARACTERIZATION DIA, V3, P1; Cortes I, 1998, PHYTOPATHOLOGY, V88, P1276, DOI 10.1094/PHYTO.1998.88.12.1276; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Dietzgen RG, 2012, J GEN VIROL, V93, P2490, DOI 10.1099/vir.0.042515-0; Elliot R.M., 1996, BUNYAVIRIDAE; Feng ZK, 2013, NEW PHYTOL, V200, P1212, DOI 10.1111/nph.12447; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Goodin M, 2005, MOL PLANT MICROBE IN, V18, P703, DOI 10.1094/MPMI-18-0703; Goodin MM, 2007, PLANT PHYSIOL, V145, P1100, DOI 10.1104/pp.107.106641; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HALL JM, 1993, PLANT DIS, V77, P952, DOI 10.1094/PD-77-0952B; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Li YZ, 2002, MOL PLANT MICROBE IN, V15, P1050, DOI 10.1094/MPMI.2002.15.10.1050; Mandal B, 2012, PLANT DIS, V96, P468, DOI 10.1094/PDIS-06-11-0520; Margaria P, 2014, J VIROL, V88, P5788, DOI 10.1128/JVI.00079-14; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Paape M, 2006, MOL PLANT MICROBE IN, V19, P874, DOI 10.1094/MPMI-19-0874; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Raikhy G, 2011, VIRUS RES, V159, P69, DOI 10.1016/j.virusres.2011.04.026; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Ribeiro D, 2008, J GEN VIROL, V89, P1811, DOI 10.1099/vir.0.2008/001164-0; Ribeiro D, 2013, PLANT CELL, V25, P3602, DOI 10.1105/tpc.113.114298; Schwartz HF, 2013, ONION HLTH MANAGEMEN, DOI [10.1002/14651858.CD003826.pub3, DOI 10.1002/14651858.CD003826.PUB3]; Sherwood JL, 2003, PLANT HLTH INSTRUCTO; Silva MS, 2001, ARCH VIROL, V146, P1267, DOI 10.1007/s007050170090; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Snippe M, 2005, ADV VIRUS RES, V65, P63, DOI 10.1016/S0065-3527(05)65003-8; Snippe M, 2005, J VIROL METHODS, V125, P15, DOI 10.1016/j.jviromet.2004.11.028; Snippe M, 2007, VIROLOGY, V357, P115, DOI 10.1016/j.virol.2006.06.037; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Turina M, 2012, ADV VIRUS RES, V84, P403, DOI 10.1016/B978-0-12-394314-9.00012-9; Uhrig JF, 1999, P NATL ACAD SCI USA, V96, P55, DOI 10.1073/pnas.96.1.55; Zilian E, 2011, J VIROL METHODS, V174, P158, DOI 10.1016/j.jviromet.2011.03.032	43	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118973	10.1371/journal.pone.0118973	http://dx.doi.org/10.1371/journal.pone.0118973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781476	Green Published, gold, Green Submitted			2022-12-26	WOS:000351284600040
J	Liu, F; Qi, L; Liu, B; Liu, J; Zhang, H; Che, DH; Cao, JY; Shen, J; Geng, JX; Bi, Y; Ye, LG; Pan, B; Yu, Y				Liu, Fang; Qi, Li; Liu, Bao; Liu, Jie; Zhang, Hua; Che, Dehai; Cao, JingYan; Shen, Jing; Geng, JianXiong; Bi, Yi; Ye, LieGuang; Pan, Bo; Yu, Yan			Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; DIFFERENT EXPRESSION PATTERNS; CANCER-ASSOCIATED FIBROBLASTS; TO-MESENCHYMAL TRANSITION; SERINE-PROTEASE; CELL; SEPRASE; STROMA; ALPHA; MICROENVIRONMENT	Objective Fibroblast activation protein (FAP) plays a vital role in tumor invasion and metastasis. Previous studies have reported its prognostic value in different tumors. However, the results of these reports remain controversial. In this study, a meta-analysis was performed to clarify this issue. Methods A search of the PubMed, Embase and CNKI databases was conducted to analyze relevant articles. The outcomes included the relations between FAP expression and histological differentiation, tumor invasion, lymph node metastasis, distant metastasis and overall survival (OS). Sensitivity analysis by FAP expression in different cells and tumor types were further subjected to sensitivity analyses as subgroups. Pooled odds ratios (ORs) and hazard ratios (HRs) were evaluated using the random-effects model. Results The global analysis included 15 studies concerning various solid tumors. For global analysis, FAP overexpression in tumor tissue displayed significant associations with poor OS and tumor progression (OS: HR = 2.18, P = 0.004; tumor invasion: OR = 4.48, P = 0.007; and lymph node metastasis: OR = 3.80, P = 0.004). The subgroup analyses yielded two notable results. First, the relation between FAP overexpression and poor OS and tumor lymph node metastasis was closer in the patients with FAP expression in tumor cells. Second, the pooled analyses of colorectal cancers or pancreatic cancers all indicated that FAP overexpression was associated with a detrimental OS (HR: 1.72, P = 0.009; HR: 3.18, P = 0.005, respectively). The magnitude of this effect was not statistically significant compared with that in patients with non-colorectal cancers or non-pancreatic cancers. These analyses did not display a statistically significant correlation between FAP expression and histological differentiation and distant metastasis in all of the groups. Conclusions FAP expression is associated with worse prognosis in solid tumors, and this association is particularly pronounced if FAP overexpression is found in the tumor cells rather than the stroma.	[Liu, Fang; Liu, Bao; Zhang, Hua; Che, Dehai; Cao, JingYan; Shen, Jing; Geng, JianXiong; Bi, Yi; Ye, LieGuang; Pan, Bo; Yu, Yan] Harbin Med Univ, Dept Internal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China; [Qi, Li] Harbin Med Univ, Dept Radiat Oncol, Affiliated Hosp 2, Harbin, Peoples R China; [Liu, Jie] Gen Hosp Hegang Min Grp, Digest Dept Internal Med, Hegang, Heilonhjiang Pr, Peoples R China; [Bi, Yi] Heilongjiang Prov Elect Power Hosp, Emergency Dept, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Yu, Y (corresponding author), Harbin Med Univ, Dept Internal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China.	yuyan@hrbmu.edu.cn	Xu, Ping/I-1910-2013	Xu, Ping/0000-0002-1516-4986				Ariga N, 2001, INT J CANCER, V95, P67, DOI 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dohi O, 2009, HISTOPATHOLOGY, V55, P432, DOI 10.1111/j.1365-2559.2009.03399.x; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Goscinski MA, 2008, ULTRASTRUCT PATHOL, V32, P89, DOI 10.1080/01913120802034934; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Iwasa S, 2003, CANCER LETT, V199, P91, DOI 10.1016/S0304-3835(03)00315-X; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Koperek O, 2007, INT J ONCOL, V31, P59; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Liao YD, 2013, J CANCER RES CLIN, V139, P1523, DOI 10.1007/s00432-013-1471-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; [刘蕊 Liu Rui], 2013, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V20, P225; Mori Y, 2004, ONCOLOGY-BASEL, V67, P411, DOI 10.1159/000082926; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Okada K, 2003, ONCOLOGY-BASEL, V65, P363, DOI 10.1159/000074650; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Paulette MF, 2013, CANC MICROENVIRONMEN; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Qin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079864; Rubin H, 2001, CANCER RES, V61, P799; Saigusa S, 2011, INT J ONCOL, V38, P655, DOI 10.3892/ijo.2011.906; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Song J, 2011, J HARBIN MED U, V45, P153; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang HY, 2009, CHIN J GASTROENTEROL, V18, P1102; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zhang JP, 2013, FASEB J, V27, P581, DOI 10.1096/fj.12-210377; Zhang L, 2008, CHIN J STOMATOLOGY, V28, P449	48	72	74	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116683	10.1371/journal.pone.0116683	http://dx.doi.org/10.1371/journal.pone.0116683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775399	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500010
J	Rathe, J; Andersen, M; Jarbol, DE; Christensen, RD; Hallas, J; Sondergaard, J				Rathe, Jette; Andersen, Morten; Jarbol, Dorte Ejg; Christensen, Rene dePont; Hallas, Jesper; Sondergaard, Jens			Generic Switching and Non-Persistence among Medicine Users: A Combined Population-Based Questionnaire and Register Study	PLOS ONE			English	Article							MEDICATION ADHERENCE; ANTIEPILEPTIC DRUGS; SUBSTITUTION; BELIEFS; PATIENT	Background Generic substitution means that one medicinal product is replaced by another product containing the same active substance. It is strictly regulated with respect to its bioequivalence, and all products must have undergone appropriate studies. Although generic substitution is widely implemented, it still remains to be answered how generic switch influences persistence to long-term treatment, and if it is modified by patients' concerns about medicine and views on generic medicine. This study focuses on users of antidepressants and antiepileptics, and their experience of generic switching. Methods The study was an observational cohort study. By use of a prescription database, we identified patients who had redeemed prescriptions on generically substitutable drugs, and a questionnaire was mailed to them. We analyzed predictors of discontinuation in relation to generic switch and patients' attitudes towards generic medicines and concerns about their medicine. Results Patients who experience their first-time switch of a specific drug were at higher risk of non-persistence, Hazard Ratio 2.98, 95% CI (1.81; 4.89) versus those who have never switched, and 35.7% became non-persistent during the first year of follow-up. Generic switching did not influence persistence considerably in those having previous experience with generic switching of the specific drug. Stratified analyses on users of antidepressants and antiepileptics underpin the results, showing higher risk of non-persistence for first-time switchers for both drug categories. Conclusion In conclusion, patients who are first-time switchers of a specific drug were at higher risk of non-persistence compared to never switchers and those having experienced previous generic switching.	[Rathe, Jette; Jarbol, Dorte Ejg; Christensen, Rene dePont; Sondergaard, Jens] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Andersen, Morten] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Hallas, Jesper] Univ Southern Denmark, Inst Publ Hlth, Res Unit Clin Pharmacol, Odense, Denmark	University of Southern Denmark; Karolinska Institutet; University of Southern Denmark	Rathe, J (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark.	jrathe@health.sdu.dk	Andersen, Morten/H-3555-2011; Søndergaard, Jens js/F-3031-2013; Jarbøl, Dorte E/P-8791-2015	Andersen, Morten/0000-0001-7029-2860; Søndergaard, Jens js/0000-0002-1629-1864; Jarbøl, Dorte E/0000-0002-3241-4190	Danish Ministry of Health [2007/S145-180398]; Region of Southern Denmark Research PhD Foundation [11/28042]; Region of Southern Denmark Research Foundation [12/21277]	Danish Ministry of Health; Region of Southern Denmark Research PhD Foundation; Region of Southern Denmark Research Foundation	The study was partly funded through a contract with the Danish Ministry of Health, tender number 2007/S145-180398, the Region of Southern Denmark Research PhD Foundation (j.nr: 11/28042) and the Region of Southern Denmark Research Foundation (j.nr: 12/21277). The funder (The Danish Ministry of Health) initiated this study, but the authors designed the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhewiti Abdullah, 2014, Int J Family Med, V2014, P479596, DOI 10.1155/2014/479596; Andersen M, 2009, GENERIC SUBSTITUTION; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Barron TI, 2010, VALUE HEALTH, V13, P796, DOI 10.1111/j.1524-4733.2010.00741.x; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Berg MJ, 2008, EPILEPSY BEHAV, V13, P693, DOI 10.1016/j.yebeh.2008.06.001; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gaist D, 1997, DAN MED BULL, V44, P445; Hamann J, 2013, EUR NEUROPSYCHOPHARM, V23, P686, DOI 10.1016/j.euroneuro.2012.08.007; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2000, HDB DRUG RES METHODO; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Howland RH, 2010, J PSYCHOSOC NURS MEN, V48, P13, DOI 10.3928/02793695-20101105-01; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Johnston A, 2011, BRIT J CLIN PHARMACO, V72, P727, DOI 10.1111/j.1365-2125.2011.03987.x; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Larsen J, 2002, BRIT J CLIN PHARMACO, V53, P375, DOI 10.1046/j.1365-2125.2002.01563.x; Mardby AC, 2007, PATIENT EDUC COUNS, V69, P158, DOI 10.1016/j.pec.2007.08.011; Moller Pedersen K, 2003, Eur J Health Econ, V4, P60; Nakhutina L, 2011, EPILEPSY BEHAV, V22, P584, DOI 10.1016/j.yebeh.2011.08.007; Olesen C, 2013, PHARMACOEPIDEM DR S, V22, P1093, DOI 10.1002/pds.3497; Ostergaard K, 2012, EUR J CLIN PHARMACOL, V68, P1631, DOI 10.1007/s00228-012-1293-7; Pechlivanoglou P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-89; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Rathe J, 2014, PHARMACOEPIDEM DR S, V23, P965, DOI 10.1002/pds.3671; Rathe J, 2013, EUR J CLIN PHARMACOL, V69, P1827, DOI 10.1007/s00228-013-1539-z; Sander JW, 2010, EXPERT REV NEUROTHER, V10, P1887, DOI [10.1586/ern.10.163, 10.1586/ERN.10.163]; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Strom O, 2012, OSTEOPOROSIS INT, V23, P2201, DOI 10.1007/s00198-011-1850-4; The Association of Danish Pharmacies, DRUGS IN DENM; Ude M, 2011, J HYPERTENS, V29, P1837, DOI 10.1097/HJH.0b013e32834942be; Van Wijk BLG, 2006, J CLIN EPIDEMIOL, V59, P11, DOI 10.1016/j.jclinepi.2005.05.005; Van Wijk BLG, 2006, ANN PHARMACOTHER, V40, P15, DOI 10.1345/aph.1G163; Verbeeck RK, 2012, J PHARM PHARM SCI, V15, P376, DOI 10.18433/J3VC8J; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x	38	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119688	10.1371/journal.pone.0119688	http://dx.doi.org/10.1371/journal.pone.0119688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775472	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500110
J	Voldgorn, YI; Adilgereeva, EP; Nekrasov, ED; Lavrov, AV				Voldgorn, Yana I.; Adilgereeva, Elmira P.; Nekrasov, Evgeny D.; Lavrov, Alexander V.			Cultivation and Differentiation Change Nuclear Localization of Chromosome Centromeres in Human Mesenchymal Stem Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; RNA INTERFERENCE; ORGANIZATION; TERRITORIES; PLURIPOTENCY; MOVEMENTS; CULTURE; GENES	Chromosome arrangement in the interphase nucleus is not accidental. Strong evidences support that nuclear localization is an important mechanism of epigenetic regulation of gene expression. The purpose of this research was to identify differences in the localization of centromeres of chromosomes 6, 12, 18 and X in human mesenchymal stem cells depending on differentiation and cultivating time. We analyzed centromere positions in more than 4000 nuclei in 19 mesenchymal stem cell cultures before and after prolonged cultivation and after differentiation into osteogenic and adipogenic directions. We found a centromere reposition of HSAX at late passages and after differentiation in osteogenic direction as well as of HSA12 and HSA18 after adipogenic differentiation. The observed changes of the nuclear structure are new nuclear characteristics of the studied cells which may reflect regulatory changes of gene expression during the studied processes.	[Voldgorn, Yana I.; Adilgereeva, Elmira P.; Lavrov, Alexander V.] Russian Acad Med Sci, Fed State Budgetary Inst, Med Genet Res Ctr, Moscow 115478, Russia; [Voldgorn, Yana I.; Lavrov, Alexander V.] Minist Hlth Russian Federat, Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Moscow 117997, Russia; [Nekrasov, Evgeny D.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Ministry of Health of the Russian Federation; Pirogov Russian National Research Medical University; Moscow Institute of Physics & Technology	Lavrov, AV (corresponding author), Russian Acad Med Sci, Fed State Budgetary Inst, Med Genet Res Ctr, Moskvorechie 1, Moscow 115478, Russia.	avlavrov@yandex.ru			Ministry of Education and Science of Russia [02-740-11-0779]; OPTEK [27/2013]	Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); OPTEK	This work was funded by Contract No. 02-740-11-0779 of Ministry of Education and Science of Russia (http://fasi.gov.ru/) - AVL and Grant N<SUP>o</SUP> 27/2013 from OPTEK (http://www.optecgroup.com/) - YIV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bi Y, 2014, INT J BIOCHEM CELL B, V46, P148, DOI 10.1016/j.biocel.2013.11.009; Birbrair A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016816; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Csink AK, 1998, J CELL BIOL, V143, P13, DOI 10.1083/jcb.143.1.13; Delorme Bruno, 2007, V140, P67; Finch KA, 2008, J CELL SCI, V121, P655, DOI 10.1242/jcs.025205; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Gadji M, 2011, ADV CANCER RES, V112, P77, DOI 10.1016/B978-0-12-387688-1.00004-1; Galiova G, 2004, BLOOD CELL MOL DIS, V33, P4, DOI 10.1016/j.bcmd.2004.03.006; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; Li CX, 2010, MOL BIOL REP, V37, P2347, DOI 10.1007/s11033-009-9740-y; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mehta IS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r135; Mora L, 2006, CHROMOSOMA, V115, P367, DOI 10.1007/s00412-006-0064-6; Mudrak OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052944; Pan QW, 2014, EXP BIOL MED, V239, P105, DOI 10.1177/1535370213506802; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rubtsov NB, 2007, PRIRODA, V8, P3; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Vorsanova SG, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-1; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Yu Q, 2013, BIOCHEM BIOPH RES CO, V439, P297, DOI 10.1016/j.bbrc.2013.08.030; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zeitz MJ, 2009, J CELL PHYSIOL, V221, P120, DOI 10.1002/jcp.21842	32	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118350	10.1371/journal.pone.0118350	http://dx.doi.org/10.1371/journal.pone.0118350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775427	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500028
J	Wang, Z; Yang, Y; Yuan, LJ; Liu, J; Duan, YY; Cao, TS				Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng			Noninvasive Method for Measuring Local Pulse Wave Velocity by Dual Pulse Wave Doppler: In Vitro and In Vivo Studies	PLOS ONE			English	Article							ARTERIAL STIFFNESS; AORTIC STIFFNESS; 17.6 TESLA; ALL-CAUSE; MORTALITY; MICE; POPULATION; ULTRASOUND; INDEX; AGE	Objectives To evaluate the validity and reproducibility of a noninvasive dual pulse wave Doppler (DPWD) method, which involves simultaneous recording of flow velocity of two independent sample volumes with a measurable distance, for measuring the local arterial pulse wave velocity (PWV) through in vitro and in vivo studies. Methods The DPWD mode of Hitachi HI Vision Preirus ultrasound system with a 5-13MHz transducer was used. An in vitro model was designed to compare the PWV of a homogeneous rubber tubing with the local PWV of its middle part measured by DPWD method. In the in vivo study, local PWV of 45 hypertensive patients (25 male, 49.8 +/- 3.1 years) and 45 matched healthy subjects (25 male, 49.3 +/- 3.0 years) were investigated at the left common carotid artery (LCCA) by DPWD method. Results In the in vitro study, the local PWV measured by DPWP method and the PWV of the homogeneous rubber tubing did not show statistical difference (5.16 +/- 0.28 m/s vs 5.03 +/- 0.15 m/s, p = 0.075). The coefficient of variation (CV) of the intra-and inter-measurements for local PWV were 3.46% and 4.96%, for the PWV of the homogeneous rubber tubing were 0.99% and 1.98%. In the in vivo study, a significantly higher local PWV of LCCA was found in the hypertensive patients as compared to that in healthy subjects (6.29 +/- 1.04m/s vs. 5.31 +/- 0.72m/s, P = 0.019). The CV of the intra-and inter-measurements in hypertensive patients were 2.22% and 3.94%, in healthy subjects were 2.07% and 4.14%. Conclusions This study demonstrated the feasibility of the noninvasive DPWD method to determine the local PWV, which was accurate and reproducible not only in vitro but also in vivo studies. This noninvasive echocardiographic method may be illuminating to clinical use.	[Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China	Air Force Military Medical University	Yuan, LJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	yuanlj@fmmu.edu.cn; caots4335@126.com	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China (NSFC) [81171348]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Grant 81171348 from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutouyrie P, 2009, ARTERY RES, V3, P3, DOI 10.1016/j.artres.2008.11.002; Calabia J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-13; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hermeling E, 2007, ULTRASOUND MED BIOL, V33, P774, DOI 10.1016/j.ultrasmedbio.2006.11.018; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2007, J NEPHROL, V20, pS45; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liu J, 2011, ARTHRIT CARE RES, V63, P579, DOI 10.1002/acr.20306; Nichols WW, 1990, MCDONALDS BLOOD FLOW; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053917; Wang Z, 2012, ULTRASOUND MED BIOL, V38, P1778, DOI 10.1016/j.ultrasmedbio.2012.05.016; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yu HY, 2006, MAGN RESON MED, V56, P876, DOI 10.1002/mrm.21034	24	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120482	10.1371/journal.pone.0120482	http://dx.doi.org/10.1371/journal.pone.0120482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786124	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500175
J	Yang, YR; Han, XZ; Liang, Y; Ghosh, A; Chen, J; Tang, M				Yang, Yurong; Han, Xiaozhen; Liang, Yan; Ghosh, Amit; Chen, Jie; Tang, Ming			The Combined Effects of Arbuscular Mycorrhizal Fungi (AMF) and Lead (Pb) Stress on Pb Accumulation, Plant Growth Parameters, Photosynthesis, and Antioxidant Enzymes in Robinia pseudoacacia L.	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; WATER STATUS; GLUTATHIONE; TOXICITY; DAMAGE; MAIZE; SOIL	Arbuscular mycorrhizal fungi (AMF) are considered as a potential biotechnological tool for improving phytostabilization efficiency and plant tolerance to heavy metal-contaminated soils. However, the mechanisms through which AMF help to alleviate metal toxicity in plants are still poorly understood. A greenhouse experiment was conducted to evaluate the effects of two AMF species (Funneliformis mosseae and Rhizophagus intraradices) on the growth, Pb accumulation, photosynthesis and antioxidant enzyme activities of a leguminous tree (Robinia pseudoacacia L.) at Pb addition levels of 0, 500, 1000 and 2000 mg kg(-1) soil. AMF symbiosis decreased Pb concentrations in the leaves and promoted the accumulation of biomass as well as photosynthetic pigment contents. Mycorrhizal plants had higher gas exchange capacity, non-photochemistry efficiency, and photochemistry efficiency compared with non-mycorrhizal plants. The enzymatic activities of superoxide dismutase (SOD), ascorbate peroxidases (APX) and glutathione peroxidase (GPX) were enhanced, and hydrogen peroxide (H2O2) and malondialdehyde (MDA) contents were reduced in mycorrhizal plants. These findings suggested that AMF symbiosis could protect plants by alleviating cellular oxidative damage in response to Pb stress. Furthermore, mycorrhizal dependency on plants increased with increasing Pb stress levels, indicating that AMF inoculation likely played a more important role in plant Pb tolerance in heavily contaminated soils. Overall, both F. mosseae and R. intraradices were able to maintain efficient symbiosis with R. pseudoacacia in Pb polluted soils. AMF symbiosis can improve photosynthesis and reactive oxygen species (ROS) scavenging capabilities and decrease Pb concentrations in leaves to alleviate Pb toxicity in R. pseudoacacia. Our results suggest that the application of the two AMF species associated with R. pseudoacacia could be a promising strategy for enhancing the phytostabilization efficiency of Pb contaminated soils.	[Yang, Yurong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Yang, Yurong; Chen, Jie; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Han, Xiaozhen] Natl Univ Ireland, Sch Nat Sci, Plant Syst Biol Lab, Bot & Plant Sci, Galway, Ireland; [Liang, Yan] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Liang, Yan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ghosh, Amit] Indian Inst Technol Kharagpur, Sch Energy Sci & Engn, PK Sinha Ctr Bioenergy, Kharagpur 721302, W Bengal, India	Northwest A&F University - China; Northwest A&F University - China; Ollscoil na Gaillimhe-University of Galway; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China [31270639, 31170607, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; PhD Programs Foundation of Education Ministry of China [20100204110033, 20110204130001]; China Scholarship Council [201306300018]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); PhD Programs Foundation of Education Ministry of China; China Scholarship Council(China Scholarship Council); DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Yurong Yang, Jie Chen and Ming Tang were financially supported by the National Natural Science Foundation of China (31270639, 31170607, 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035) and the PhD Programs Foundation of Education Ministry of China (20100204110033, 20110204130001). Xiaozhen Han was supported by the China Scholarship Council (201306300018). Yan Liang was funded by the DOE Joint BioEnergy Institute (http://www.jbei.org) which is supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chen X, 2005, CHEMOSPHERE, V60, P665, DOI 10.1016/j.chemosphere.2005.01.029; Deng CN, 2014, BIOL TRACE ELEM RES, V160, P268, DOI 10.1007/s12011-014-0039-z; Diaz G, 1996, PLANT SOIL, V180, P241, DOI 10.1007/BF00015307; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Eichler A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400196; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; Foyer CH, 2002, ADV PHOTO RESPIRAT, V12, P1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gao J, 2000, EXPT TECHNIQUES PLAN; Garg N, 2015, PLANT GROWTH REGUL, V75, P521, DOI 10.1007/s10725-014-0016-8; Garrido I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046137; Giannakoula A, 2010, ENVIRON EXP BOT, V67, P487, DOI 10.1016/j.envexpbot.2009.07.010; Gohre V, 2006, PLANTA, V223, P1115, DOI 10.1007/s00425-006-0225-0; Hadi F., 2015, J BIOL LIFE SCI, V6, P91, DOI 10.5296/jbls.v6i2.7152; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Islam E, 2008, J HAZARD MATER, V154, P914, DOI 10.1016/j.jhazmat.2007.10.121; Iturbe-Ormaetxe I, 2001, MOL PLANT MICROBE IN, V14, P1189, DOI 10.1094/MPMI.2001.14.10.1189; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Kosobrukhov A, 2004, PLANT GROWTH REGUL, V42, P145, DOI 10.1023/B:GROW.0000017490.59607.6b; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124304; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Mateos-Naranjo E, 2008, MAR ENVIRON RES, V66, P459, DOI 10.1016/j.marenvres.2008.07.007; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mishra S, 2006, CHEMOSPHERE, V65, P1027, DOI 10.1016/j.chemosphere.2006.03.033; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ouziad F, 2006, ENVIRON EXP BOT, V57, P177, DOI 10.1016/j.envexpbot.2005.05.011; Padmavathiamma PK, 2007, WATER AIR SOIL POLL, V184, P105, DOI 10.1007/s11270-007-9401-5; Pande M, 2004, APPL SOIL ECOL, V26, P233, DOI 10.1016/j.apsoil.2003.12.009; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; PLENCHETTE C, 1983, PLANT SOIL, V70, P211, DOI 10.1007/BF02374781; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Ralph PJ, 1998, ENVIRON POLLUT, V103, P91, DOI 10.1016/S0269-7491(98)00121-3; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Ruley AT, 2006, ENVIRON POLLUT, V144, P11, DOI 10.1016/j.envpol.2006.01.016; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Shi GR, 2010, B ENVIRON CONTAM TOX, V85, P256, DOI 10.1007/s00128-010-0067-0; Singh S, 2006, CHEMOSPHERE, V62, P233, DOI 10.1016/j.chemosphere.2005.05.017; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Sousa RHV, 2015, PLANT CELL ENVIRON, V38, P499, DOI 10.1111/pce.12409; Sudova R, 2007, PLANT SOIL, V296, P77, DOI 10.1007/s11104-007-9291-8; Sun SQ, 2010, ENVIRON MONIT ASSESS, V163, P303, DOI 10.1007/s10661-009-0835-7; Toussaint JP, 2007, MYCORRHIZA, V17, P349, DOI 10.1007/s00572-007-0133-6; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Varadi G, 2003, PHYSIOL PLANTARUM, V118, P47, DOI 10.1034/j.1399-3054.2003.00089.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Vogel-Mikus K, 2006, ENVIRON POLLUT, V139, P362, DOI 10.1016/j.envpol.2005.05.005; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Wioleta W, 2015, BIOMETALS, V28, P151, DOI 10.1007/s10534-014-9811-y; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Xu ZY, 2014, ENVIRON SCI POLLUT R, V21, P12671, DOI 10.1007/s11356-014-3209-9; Yang YR, 2015, ENVIRON SCI POLLUT R, V22, P13179, DOI 10.1007/s11356-015-4521-8; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Yemets O, 2015, ECOL INDIC, V55, P59, DOI 10.1016/j.ecolind.2015.03.015; Zhang HH, 2010, EUR J SOIL BIOL, V46, P306, DOI 10.1016/j.ejsobi.2010.05.006; Zhu XQ, 2014, PHOTOSYNTHETICA, V52, P247, DOI 10.1007/s11099-014-0031-z	80	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145726	10.1371/journal.pone.0145726	http://dx.doi.org/10.1371/journal.pone.0145726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	25786124	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600123
